PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Trempolec, N; Dave-Coll, N; Nebreda, AR				Trempolec, Natalia; Dave-Coll, Natalia; Nebreda, Angel R.			SnapShot: p38 MAPK Signaling	CELL			English	Editorial Material							ACTIVATED PROTEIN-KINASE; PATHWAY		[Trempolec, Natalia; Dave-Coll, Natalia; Nebreda, Angel R.] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Nebreda, Angel R.] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Trempolec, N (corresponding author), Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.		Nebreda, Angel Rodriguez/R-9594-2019		ICREA Funding Source: Custom	ICREA(ICREA)		Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Oeztuerk-Winder F, 2012, BIOCHEM J, V445, P1, DOI 10.1042/BJ20120401; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694	10	86	90	6	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 31	2013	152	3					656	+	656.e1	10.1016/j.cell.2013.01.029	http://dx.doi.org/10.1016/j.cell.2013.01.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23415236	Bronze			2022-12-24	WOS:000314362800032
J	Rosenau, AM				Rosenau, Alex M.			Guidelines for Opioid Prescription: The Devil Is in the Details	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Lehigh Valley Hlth Network, Allentown, PA 18103 USA	Lehigh Valley Health Network	Rosenau, AM (corresponding author), Lehigh Valley Hlth Network, JDMCC 214,I-78 & Cedar Crest Blvd, Allentown, PA 18103 USA.	alex.rosenau@gmail.com						American College of Emergency Physicians, 2013, POL COMP EL PRESCR M; American College of Emergency Physicians, 2013, POL COMP OPT TREATM; American College of Emergency Physicians, 2013, POL COMP EM PHYS RIG; Benard A, 2013, AM MED ASS STAT LEG; Cantrill SV, 2012, ANN EMERG MED, V60, P499, DOI 10.1016/j.annemergmed.2012.06.013; Chu J, 2013, NEW YORK CITY EMERGE; Governale L., 2010, JOINT M AN LIF SUPP; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Warner Margaret, 2011, NCHS Data Brief, P1	9	6	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					843	+		10.7326/0003-4819-158-11-201306040-00632	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00632			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164AA	23567867				2022-12-24	WOS:000320379800009
J	Losman, JA; Looper, RE; Koivunen, P; Lee, S; Schneider, RK; McMahon, C; Cowley, GS; Root, DE; Ebert, BL; Kaelin, WG				Losman, Julie-Aurore; Looper, Ryan E.; Koivunen, Peppi; Lee, Sungwoo; Schneider, Rebekka K.; McMahon, Christine; Cowley, Glenn S.; Root, David E.; Ebert, Benjamin L.; Kaelin, William G., Jr.			(R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible	SCIENCE			English	Article							ACUTE MYELOID-LEUKEMIA; ISOCITRATE DEHYDROGENASE 1; ONCOMETABOLITE 2-HYDROXYGLUTARATE; MUTATIONS; HYPOXIA; TET2; DIFFERENTIATION; MORTALITY; ALTITUDE; CANCER	Mutations in IDH1 and IDH2, the genes coding for isocitrate dehydrogenases 1 and 2, are common in several human cancers, including leukemias, and result in overproduction of the (R)-enantiomer of 2-hydroxyglutarate [(R)-2HG]. Elucidation of the role of IDH mutations and (R)-2HG in leukemogenesis has been hampered by a lack of appropriate cell-based models. Here, we show that a canonical IDH1 mutant, IDH1 R132H, promotes cytokine independence and blocks differentiation in hematopoietic cells. These effects can be recapitulated by (R)-2HG, but not (S)-2HG, despite the fact that (S)-2HG more potently inhibits enzymes, such as the 5'-methylcytosine hydroxylase TET2, that have previously been linked to the pathogenesis of IDH mutant tumors. We provide evidence that this paradox relates to the ability of (S)-2HG, but not (R)-2HG, to inhibit the EglN prolyl hydroxylases. Additionally, we show that transformation by (R)-2HG is reversible.	[Losman, Julie-Aurore; Lee, Sungwoo; McMahon, Christine; Kaelin, William G., Jr.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Losman, Julie-Aurore; Schneider, Rebekka K.; Ebert, Benjamin L.] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02215 USA; [Looper, Ryan E.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Koivunen, Peppi] Univ Oulu, Oulu Ctr Cell Matrix Res, Dept Med Biochem & Mol Biol, Bioctr Oulu, FIN-90014 Oulu, Finland; [Cowley, Glenn S.; Root, David E.; Ebert, Benjamin L.] Broad Inst MIT & Harvard, Cambridge, MA 02143 USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Utah System of Higher Education; University of Utah; University of Oulu; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	william_kaelin@dfci.harvard.edu		Looper, Ryan/0000-0003-1626-1363	NIH; HHMI; NATIONAL CANCER INSTITUTE [R01CA068490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Yen, M. Su, and Agios Pharmaceuticals for the IDH1 inhibitor and for sharing unpublished data; R. Bejar and A. Mullally for their valuable input; A. Lane and D. Sykes for assistance with the SCF ER-Hoxb8 cells; M. Paktinat and R. Mathieu for assistance with flow cytometry; and members of the Kaelin and Ebert lab for technical help and valuable discussion. This work was supported by the NIH (W. G. K. and J.-A.L.) and HHMI (W. G. K.). W. G. K. is a HHMI Investigator and a paid Scientific Advisor for Agios, a biotechnology company developing IDH inhibitors. W. G. K. is also a paid consultant for and owns equity in Fibrogen, Inc., a biotechnology company developing EglN inhibitors.	Abdel-Wahab O, 2011, HEMATOL ONCOL CLIN N, V25, P1119, DOI 10.1016/j.hoc.2011.09.013; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Chow DC, 2001, BIOPHYS J, V81, P675, DOI 10.1016/S0006-3495(01)75732-3; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; ECKHOFF ND, 1974, HEALTH PHYS, V27, P377, DOI 10.1097/00004032-197410000-00006; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Forristal CE, 2013, BLOOD, V121, P759, DOI 10.1182/blood-2012-02-408419; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Jensen PO, 2000, CELL PROLIFERAT, V33, P381, DOI 10.1046/j.1365-2184.2000.00183.x; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Liu W, 2006, BLOOD, V107, P698, DOI 10.1182/blood-2005-03-1278; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Popovici-Muller J, 2012, ACS MED CHEM LETT, V3, P850, DOI 10.1021/ml300225h; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Salomon-Nguyen F, 2000, P NATL ACAD SCI USA, V97, P6757, DOI 10.1073/pnas.120162297; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Song LP, 2008, ONCOGENE, V27, P519, DOI 10.1038/sj.onc.1210670; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; WEINBERG CR, 1987, RADIAT RES, V112, P381, DOI 10.2307/3577265; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014	28	515	552	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1621	1625		10.1126/science.1231677	http://dx.doi.org/10.1126/science.1231677			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23393090	Green Accepted			2022-12-24	WOS:000316731600053
J	Collins, M; Latimer, N				Collins, Marissa; Latimer, Nicholas			NICE's end of life decision making scheme: impact on population health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Collins, Marissa] Glasgow Caledonian Univ, Yunus Ctr Social Business & Hlth, Glasgow G4 0BA, Lanark, Scotland; [Latimer, Nicholas] Univ Sheffield, ScHARR, Sheffield, S Yorkshire, England	Glasgow Caledonian University; University of Sheffield	Collins, M (corresponding author), Glasgow Caledonian Univ, Yunus Ctr Social Business & Hlth, Glasgow G4 0BA, Lanark, Scotland.	marissa.collins@gcu.ac.uk		Collins, Marissa/0000-0002-0896-6673; Latimer, Nicholas/0000-0001-5304-5585				[Anonymous], 2010, NICE TECHN APPR GUID; [Anonymous], 2010, NICE TECHN APPR GUID; [Anonymous], 2009, NICE TECHN APPR GUID; [Anonymous], 2009, NICE TECHN APPR GUID; [Anonymous], 2011, NICE TECHN APPR GUID; [Anonymous], 2010, NICE TECHN APPR GUID; [Anonymous], 2011, NICE TECHN APPR GUID; [Anonymous], 2009, NICE TECHN APPR GUID; [Anonymous], 2009, NIC TECHN APPR GUID; Claxton K, 2013, 81 CHE; Department of Health, 2011, GUID SUPP OP CANC DR; Kerr M, 2012, CHRONIC KIDNEY DIS E; Linley WG, 2012, HLTH EC; National Institute for Health and Clinical Excellence (NICE), 2008, GUID METH TECHN APPR; NICE, 2004, GUID METH TECHN APPR; NICE, 2009, APPR LIF EXT END LIF; Raftery JP, 2009, BMJ-BRIT MED J, V338, P271; Shah K, 2012, VALUING HLTH END LIF, P56	18	36	37	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2013	346								f1363	10.1136/bmj.f1363	http://dx.doi.org/10.1136/bmj.f1363			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113MJ	23518274				2022-12-24	WOS:000316671800004
J	Chan, PS; Nallamothu, BK; Krumholz, HM; Spertus, JA; Li, Y; Hammill, BG; Curtis, LH				Chan, Paul S.; Nallamothu, Brahmajee K.; Krumholz, Harlan M.; Spertus, John A.; Li, Yan; Hammill, Bradley G.; Curtis, Lesley H.		Amer Heart Assoc Get Guidelines	Long-Term Outcomes in Elderly Survivors of In-Hospital Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUSTRALIAN-RESUSCITATION-COUNCIL; AMERICAN-HEART-ASSOCIATION; HEALTH-CARE-PROFESSIONALS; CAUSE READMISSION RATES; CARDIOPULMONARY-RESUSCITATION; STROKE-FOUNDATION; SOUTHERN-AFRICA; PERFORMANCE; STATEMENT; REGISTRY	BACKGROUND Little is known about the long-term outcomes in elderly survivors of in-hospital cardiac arrest. We determined rates of long-term survival and readmission among survivors of in-hospital cardiac arrest and examined whether these outcomes differed according to demographic characteristics and neurologic status at discharge. METHODS We linked data from a national registry of inpatient cardiac arrests with Medicare files and identified 6972 adults, 65 years of age or older, who were discharged from the hospital after surviving an in-hospital cardiac arrest between 2000 and 2008. Predictors of 1-year survival and of readmission to the hospital were examined. RESULTS One year after hospital discharge, 58.5% of the patients were alive, and 34.4% had not been readmitted to the hospital. The risk-adjusted rate of 1-year survival was lower among older patients than among younger patients (63.7%, 58.6%, and 49.7% among patients 65 to 74, 75 to 84, and >= 85 years of age, respectively; P<0.001), among men than among women (58.6% vs. 60.9%, P = 0.03), and among black patients than among white patients (52.5% vs. 60.4%, P = 0.001). The risk-adjusted rate of 1-year survival was 72.8% among patients with mild or no neurologic disability at discharge, as compared with 61.1% among patients with moderate neurologic disability, 42.2% among those with severe neurologic disability, and 10.2% among those in a coma or vegetative state (P<0.001 for all comparisons). Moreover, 1-year readmission rates were higher among patients who were black, those who were women, and those who had substantial neurologic disability (P<0.05 for all comparisons). These differences in survival and readmission rates persisted at 2 years. At 3 years, the rate of survival among survivors of in-hospital cardiac arrest was similar to that of patients who had been hospitalized with heart failure and were discharged alive (43.5% and 44.9%, respectively; risk ratio, 0.98; 95% confidence interval, 0.95 to 1.02; P = 0.35). CONCLUSIONS Among elderly survivors of in-hospital cardiac arrest, nearly 60% were alive at 1 year, and the rate of 3-year survival was similar to that among patients with heart failure. Survival and readmission rates differed according to the demographic characteristics of the patients and neurologic status at discharge. (Funded by the American Heart Association and the National Heart, Lung, and Blood Institute.)	[Chan, Paul S.; Spertus, John A.; Li, Yan] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Nallamothu, Brahmajee K.] Univ Michigan, VA Ann Arbor Healthcare Syst, Vet Affairs VA Hlth Serv Res & Dev Ctr, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Hammill, Bradley G.; Curtis, Lesley H.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Curtis, Lesley H.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; Yale University; Yale University; Yale University; Duke University; Duke University	Chan, PS (corresponding author), St Lukes Hosp, Mid Amer Heart Inst, 5th Fl,4401 Wornall Rd, Kansas City, MO 64111 USA.	pchan@cc-pc.com	Spertus, John/ABD-3075-2021; , Harlan/AAI-2875-2020		American Heart Association; National Heart, Lung, and Blood Institute [K23HL102224, 1U01HL105270-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224, U01HL105270] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the American Heart Association and by a Career Development Grant Award (K23HL102224, to Dr. Chan) from the National Heart, Lung, and Blood Institute. Dr. Krumholz was supported, in part, by a grant (1U01HL105270-02) from the National Heart, Lung, and Blood Institute to the Center for Cardiovascular Outcomes Research at Yale University.	Becker LB, 2011, CIRCULATION, V124, P2158, DOI 10.1161/CIR.0b013e3182340239; Bloom HL, 2007, AM HEART J, V153, P831, DOI 10.1016/j.ahj.2007.02.011; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Herlitz J, 2000, RESUSCITATION, V45, P167, DOI 10.1016/S0300-9572(00)00187-8; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; JENNETT B, 1975, LANCET, V1, P480; Kalbag A, 2006, RESUSCITATION, V68, P79, DOI 10.1016/j.resuscitation.2005.06.003; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Kutsogiannis DJ, 2011, CAN MED ASSOC J, V183, P1589, DOI 10.1503/cmaj.100034; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; R Core Team, 2022, R LANG ENV STAT COMP; Raghunathan T. E., 2002, IVEWARE IMPUTATION V; Topjian AA, 2010, CRIT CARE MED, V38, P1254, DOI 10.1097/CCM.0b013e3181d8ca43; Zoch TW, 2000, ARCH INTERN MED, V160, P1969, DOI 10.1001/archinte.160.13.1969; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	21	112	113	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					1019	1026		10.1056/NEJMoa1200657	http://dx.doi.org/10.1056/NEJMoa1200657			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104HF	23484828	Green Accepted			2022-12-24	WOS:000315982100008
J	Downar, J; Kritek, PA				Downar, James; Kritek, Patricia A.			Family Presence during Cardiac Resuscitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Downar, James] Univ Hlth Network, Toronto, ON, Canada; [Kritek, Patricia A.] Univ Washington, Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98195 USA	University of Toronto; University Health Network Toronto; University of Washington; University of Washington Seattle	Downar, J (corresponding author), Univ Hlth Network, Toronto, ON, Canada.							Aidman EV, 2006, PSYCHOL REP, V99, P569, DOI 10.2466/PR0.99.2.569-580; Compton S, 2011, J PALLIAT MED, V14, P715, DOI 10.1089/jpm.2010.0463; Curley MAQ, 2012, AM J RESP CRIT CARE, V186, P1133, DOI 10.1164/rccm.201205-0915OC; Dudley NC, 2009, ANN EMERG MED, V53, P777, DOI 10.1016/j.annemergmed.2008.10.002; Itzhaki M, 2012, J ADV NURS, V68, P1967, DOI 10.1111/j.1365-2648.2011.05883.x; Jabre P, 2013, NEW ENGL J MED, V368, P1008, DOI 10.1056/NEJMoa1203366; Kotler M, 2001, J NERV MENT DIS, V189, P162, DOI 10.1097/00005053-200103000-00004; O'Connell KJ, 2007, PEDIATRICS, V120, pE565, DOI 10.1542/peds.2006-2914	8	8	8	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					1060	1062		10.1056/NEJMclde1301020	http://dx.doi.org/10.1056/NEJMclde1301020			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104HF	23484836				2022-12-24	WOS:000315982100016
J	Okamoto, K; Bartocci, C; Ouzounov, I; Diedrich, JK; Yates, JR; Denchi, EL				Okamoto, Keiji; Bartocci, Cristina; Ouzounov, Iliana; Diedrich, Jolene K.; Yates, John R., III; Denchi, Eros Lazzerini			A two-step mechanism for TRF2-mediated chromosome-end protection	NATURE			English	Article							DNA-DAMAGE; MAMMALIAN TELOMERES; TRF2; COMPLEX; UBIQUITINATION; PROTEINS; REPAIR; SITES; BRCA1; NHEJ	Mammalian telomeres repress DNA-damage activation at natural chromosome ends by recruiting specific inhibitors of the DNA-damage machinery that form a protective complex termed shelterin. Within this complex, TRF2 (also known as TERF2) has a crucial role in end protection through the suppression of ATM activation and the formation of end-to-end chromosome fusions(1,2). Here we address the molecular properties of TRF2 that are both necessary and sufficient to protect chromosome ends in mouse embryonic fibroblasts. Our data support a two-step mechanism for TRF2-mediated end protection. First, the dimerization domain of TRF2 is required to inhibit ATM activation, the key initial step involved in the activation of a DNA-damage response (DDR). Next, TRF2 independently suppresses the propagation of DNA-damage signalling downstream of ATM activation. This novel modulation of the DDR at telomeres occurs at the level of the E3 ubiquitin ligase RNF168 (ref. 3). Inhibition of RNF168 at telomeres involves the deubiquitinating enzyme BRCC3 and the ubiquitin ligase UBR5, and is sufficient to suppress chromosome end-to-end fusions. This two-step mechanism for TRF2-mediated end protection helps to explain the apparent paradox of frequent localization of DDR proteins at functional telomeres without concurrent induction of detrimental DNA-repair activities.	[Okamoto, Keiji; Bartocci, Cristina; Ouzounov, Iliana; Denchi, Eros Lazzerini] Scripps Res Inst, Dept Mol & Expt Med, Lab Chromosome Biol & Genom Stabil, La Jolla, CA 92037 USA; [Diedrich, Jolene K.; Yates, John R., III] Scripps Res Inst, Dept Chem Physiol & Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Denchi, EL (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Lab Chromosome Biol & Genom Stabil, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	edenchi@scripps.edu	lazzerini denchi, eros/F-7913-2010; Denchi, Eros Lazzerini/AAD-8208-2020	lazzerini denchi, eros/0000-0001-5378-4644; Diedrich, Jolene/0000-0001-6489-4558	Pew Scholars Award; Novartis Advanced Discovery Institute; National Institutes of Health [AG038677]; National Center for Research Resources [5P41RR011823-17]; National Institute of General Medical Sciences [8 P41 GM103533-17]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038677] Funding Source: NIH RePORTER	Pew Scholars Award; Novartis Advanced Discovery Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. de Lange, M. D. Weitzman, D. Durucher, X. Yu and X. Wu for providing reagents. We are grateful to A. Sfeir, T. Stracker, K. Miller and C. Attwooll for critical reading of the manuscript This work was supported by a Pew Scholars Award (E.L.D.), the Novartis Advanced Discovery Institute (E.L.D.), National Institutes of Health AG038677 (E.L.D.), National Center for Research Resources (5P41RR011823-17) (J.R.Y.) and National Institute of General Medical Sciences (8 P41 GM103533-17) (J.R.Y.).	Al-Wahiby S, 2005, CYTOGENET GENOME RES, V109, P491, DOI 10.1159/000084208; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Carneiro T, 2010, NATURE, V467, P228, DOI 10.1038/nature09353; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; McPherson JP, 2006, HUM MOL GENET, V15, P831, DOI 10.1093/hmg/ddl002; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Sarthy J, 2009, EMBO J, V28, P3390, DOI 10.1038/emboj.2009.275; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang Y, 2000, GENE DEV, V14, P927; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	29	148	155	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					502	505		10.1038/nature11873	http://dx.doi.org/10.1038/nature11873			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23389450	Green Accepted			2022-12-24	WOS:000315661500044
J	Sloane, KL				Sloane, Kelly Lauren			If Only Grown-ups Would Pay Attention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRAJECTORIES		Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Sloane, KL (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	ksloane1@jhmi.edu						Chen JH, 2007, J GERONTOL A-BIOL, V62, P531, DOI 10.1093/gerona/62.5.531; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Hardy SE, 2005, ARCH INTERN MED, V165, P106, DOI 10.1001/archinte.165.1.106; Heschel A.J., 1963, INSECURITY FREEDOM; SILVERSTEIN S, 1981, LIGHT ATTIC	5	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					779	780		10.1001/jama.2013.364	http://dx.doi.org/10.1001/jama.2013.364			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23443440				2022-12-24	WOS:000315332200022
J	Njor, SH; Olsen, AH; Blichert-Toft, M; Schwartz, W; Vejborg, I; Lynge, E				Njor, Sisse Helle; Olsen, Anne Helene; Blichert-Toft, Mogens; Schwartz, Walter; Vejborg, Ilse; Lynge, Elsebeth			Overdiagnosis in screening mammography in Denmark: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; NATURAL-HISTORY; FOLLOW-UP; TRIAL; OVERTREATMENT; PROGRAMS; SURVIVAL; TRENDS; END	Objective To use data from two longstanding, population based screening programmes to study overdiagnosis in screening mammography. Design Population based cohort study. Setting Copenhagen municipality (from 1991) and Funen County (from 1993), Denmark. Participants 57 763 women targeted by organised screening, aged 56-69 when the screening programmes started, and followed up to 2009. Main outcome measures Overdiagnosis of breast cancer in women targeted by screening, assessed by relative risks compared with historical control groups from screening regions, national control groups from non-screening regions, and historical national control groups. Results In total, 3279 invasive breast carcinomas and ductal carcinomas in situ occurred. The start of screening led to prevalence peaks in breast cancer incidence: relative risk 2.06 (95% confidence interval 1.64 to 2.59) for Copenhagen and 1.84 (1.46 to 2.32) for Funen. During subsequent screening rounds, relative risks were slightly above unity: 1.04 (0.85 to 1.27) for Copenhagen and 1.14 (0.98 to 1.32) for Funen. A compensatory dip was seen after the end of invitation to screening: relative risk 0.80 (0.65 to 0.98) for Copenhagen and 0.67 (0.55 to 0.81) for Funen during the first four years. The relative risk of breast cancer accumulated over the entire follow-up period was 1.06 (0.90 to 1.25) for Copenhagen and 1.01 (0.93 to 1.10) for Funen. Relative risks for participants corrected for selection bias were estimated to be 1.08 for Copenhagen and 1.02 for Funen; for participants followed for at least eight years after the end of screening, they were 1.05 and 1.01. A pooled estimate gave 1.040 (0.99 to 1.09) for all targeted women and 1.023 (0.97 to 1.08) for targeted women followed for at least eight years after the end of screening. Conclusions On the basis of combined data from the two screening programmes, this study indicated that overdiagnosis most likely amounted to 2.3% (95% confidence interval -3% to 8%) in targeted women. Among participants, it was most likely 1-5%. At least eight years after the end of screening were needed to compensate for the excess incidence during screening.	[Njor, Sisse Helle; Lynge, Elsebeth] Univ Copenhagen, Dept Publ Hlth, DK-1014 Copenhagen K, Denmark; [Olsen, Anne Helene] Univ Tromso, Inst Community Med, Tromso, Norway; [Blichert-Toft, Mogens] Danish Breast Canc Cooperat Grp, DK-2100 Copenhagen O, Denmark; [Schwartz, Walter] Odense Univ Hosp, Mammog Screening Clin, DK-5000 Odense, Denmark; [Vejborg, Ilse] Univ Copenhagen Hosp, Diagnost Ctr, DK-2100 Copenhagen O, Denmark	University of Copenhagen; UiT The Arctic University of Tromso; Danish Breast Cancer Cooperative Group (DBCG); University of Southern Denmark; Odense University Hospital; University of Copenhagen	Njor, SH (corresponding author), Univ Copenhagen, Dept Publ Hlth, Ostre Farimagsgade 5, DK-1014 Copenhagen K, Denmark.	sissenj@sund.ku.dk	Njor, Sisse Helle/S-4486-2017	Njor, Sisse Helle/0000-0003-0429-4176; Lynge, Elsebeth/0000-0003-4785-5236	Esper and Olga Boel Foundation	Esper and Olga Boel Foundation	This study was financially supported by the Esper and Olga Boel Foundation. The funding source had no role in the writing of the manuscript or the decision to submit it for publication.	Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; BOER R, 1994, LANCET, V343, P979, DOI 10.1016/S0140-6736(94)90105-8; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; Donella P, 2009, EUR J CANCER, V45, P3166, DOI 10.1016/j.ejca.2009.06.014; Duffy SW, 2008, BRIT J CANCER, V99, P1176, DOI 10.1038/sj.bjc.6604638; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Jensen A, 2005, INT J CANCER, V113, P464, DOI 10.1002/ijc.20604; Johnstone PAS, 2000, J SURG ONCOL, V73, P273, DOI 10.1002/(SICI)1096-9098(200004)73:4<273::AID-JSO15>3.0.CO;2-H; Jorgensen Karsten J, 2009, BMC Womens Health, V9, P36, DOI 10.1186/1472-6874-9-36; Lynge E, 1998, APMIS Suppl, V83, P1; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Moller B, 2005, EUR J CANCER PREV, V14, P117, DOI 10.1097/00008469-200504000-00007; Moss S, 2005, BREAST CANCER RES, V7, P230, DOI 10.1186/bcr1314; National Cancer Institute Breast Cancer Surveillance Consortium, CANC 22640989 SCREEN; Njor Sisse Helle, 2003, APMIS Suppl, P1; Olsen AH, 2006, BREAST J, V12, P338, DOI 10.1111/j.1075-122X.2006.00272.x; Paci E, 2005, BREAST CANCER RES, V7, P266, DOI 10.1186/bcr1339; Puliti D, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3090; Svendsen AL, 2006, CANCER-AM CANCER SOC, V106, P1883, DOI 10.1002/cncr.21823; Tryggvadottir L, 2010, ACTA ONCOL, V49, P624, DOI 10.3109/02841860903575323; Weedon-Fekjaer H, 2009, ARCH INTERN MED, V169, P996, DOI 10.1001/archinternmed.2009.90; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311; Zahl PH, 2011, LANCET ONCOL, V12, P1118, DOI 10.1016/S1470-2045(11)70250-9	25	68	70	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2013	346								f1064	10.1136/bmj.f1064	http://dx.doi.org/10.1136/bmj.f1064			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BJ	23444414	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000315669400002
J	Tsubouchi, T; Soza-Ried, J; Brown, K; Piccolo, FM; Cantone, I; Landeira, D; Bagci, H; Hochegger, H; Merkenschlager, M; Fisher, AG				Tsubouchi, Tomomi; Soza-Ried, Jorge; Brown, Karen; Piccolo, Francesco M.; Cantone, Irene; Landeira, David; Bagci, Hakan; Hochegger, Helfrid; Merkenschlager, Matthias; Fisher, Amanda G.			DNA Synthesis Is Required for Reprogramming Mediated by Stem Cell Fusion	CELL			English	Article							SOMATIC-CELLS; HYBRID-CELLS; G1 PHASE; IN-VITRO; PLURIPOTENT CELLS; CYCLE REGULATION; GENE-EXPRESSION; SELF-RENEWAL; ES CELLS; REPLICATION	Embryonic stem cells (ESCs) can instruct the conversion of differentiated cells toward pluripotency following cell-to-cell fusion by a mechanism that is rapid but poorly understood. Here, we used centrifugal elutriation to enrich for mouse ESCs at sequential stages of the cell cycle and showed that ESCs in S/G2 phases have an enhanced capacity to dominantly reprogram lymphocytes and fibroblasts in heterokaryon and hybrid assays. Reprogramming success was associated with an ability to induce precocious nucleotide incorporation within the somatic partner nuclei in heterokaryons. BrdU pulse-labeling experiments revealed that virtually all successfully reprogrammed somatic nuclei, identified on the basis of Oct4 re-expression, had undergone DNA synthesis within 24 hr of fusion with ESCs. This was essential for successful reprogramming because drugs that inhibited DNA polymerase activity effectively blocked pluripotent conversion. These data indicate that nucleotide incorporation is an early and critical event in the epigenetic reprogramming of somatic cells in experimental ESC-heterokaryons.	[Tsubouchi, Tomomi; Soza-Ried, Jorge; Brown, Karen; Piccolo, Francesco M.; Cantone, Irene; Landeira, David; Bagci, Hakan; Merkenschlager, Matthias; Fisher, Amanda G.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England; [Tsubouchi, Tomomi; Hochegger, Helfrid] Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	Imperial College London; University of Sussex	Fisher, AG (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, Du Cane Rd, London W12 0NN, England.	amanda.fisher@csc.mrc.ac.uk	Landeira, David/F-5001-2018; Cantone, Irene/AAB-1071-2020; Landeira, David/ADY-5662-2022	Landeira, David/0000-0002-3267-454X; Cantone, Irene/0000-0002-8156-7126; Tsubouchi, Tomomi/0000-0001-9960-3888; Merkenschlager, Matthias/0000-0003-2889-3288; Hochegger, Helfrid/0000-0001-8366-6198	Medical Research Council UK; Human Frontier Science Program; European Research Council; MRC [MR/K015834/1, MC_U120081295, MC_U120027516] Funding Source: UKRI; Medical Research Council [MC_U120027516, MC_U120081295] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C.F. Pereira, H. Tsubouchi, and E. Petretto for help and discussions; S. Amoils for GG1 and ME2.5 probes for DNA FISH; and T. Carr and members of the CSC FACS facility for advice and technical support. This work was funded by the Medical Research Council UK (F.M.P., K.B., M.M., A.G.F.), the Human Frontier Science Program (T.T. and I.C.), and the European Research Council (A.G.F. and J.S.-R).	Ambrosi DJ, 2007, STEM CELLS, V25, P1104, DOI 10.1634/stemcells.2006-0532; Azuara V, 2003, NAT CELL BIOL, V5, P668, DOI 10.1038/ncb1006; Ballabeni A, 2011, P NATL ACAD SCI USA, V108, P19252, DOI 10.1073/pnas.1116794108; Banfalvi G, 2008, NAT PROTOC, V3, P663, DOI 10.1038/nprot.2008.34; Bar-On O, 2010, CELL CYCLE, V9, P1986, DOI 10.4161/cc.9.10.11727; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; Brown KE, 2001, NAT CELL BIOL, V3, P602, DOI 10.1038/35078577; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Calder A, 2013, STEM CELLS DEV, V22, P279, DOI 10.1089/scd.2012.0168; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Campbell K H, 1996, Rev Reprod, V1, P40, DOI 10.1530/ror.0.0010040; Campbell KHS, 2003, REPRODUCTION, P477; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Do JT, 2007, STEM CELLS, V25, P1013, DOI 10.1634/stemcells.2006-0691; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Foshay KM, 2012, MOL CELL, V46, P159, DOI 10.1016/j.molcel.2012.02.013; Fujii-Yamamoto H, 2005, J BIOL CHEM, V280, P12976, DOI 10.1074/jbc.M412224200; Ganier O, 2011, P NATL ACAD SCI USA, V108, P17331, DOI 10.1073/pnas.1100733108; Ghule PN, 2011, J CELL PHYSIOL, V226, P1149, DOI 10.1002/jcp.22440; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; GURDON JB, 1960, J EMBRYOL EXP MORPH, V8, P505; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; Koledova Z, 2010, STEM CELLS DEV, V19, P1663, DOI 10.1089/scd.2010.0136; Koledova Z, 2010, STEM CELLS DEV, V19, P181, DOI 10.1089/scd.2009.0065; Matveeva NM, 1998, MOL REPROD DEV, V50, P128, DOI 10.1002/(SICI)1098-2795(199806)50:2&lt;128::AID-MRD2&gt;3.0.CO;2-M; McNairn AJ, 2003, BIOESSAYS, V25, P647, DOI 10.1002/bies.10305; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; MILLER RA, 1976, CELL, V9, P45, DOI 10.1016/0092-8674(76)90051-9; Neganova I, 2008, J ANAT, V213, P30, DOI 10.1111/j.1469-7580.2008.00931.x; Niehrs C, 2012, TRENDS CELL BIOL, V22, P220, DOI 10.1016/j.tcb.2012.01.002; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Papp B, 2011, CELL RES, V21, P486, DOI 10.1038/cr.2011.28; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; Pereira CF, 2009, CURR PROTOC STEM CEL, V1; Piccolo F.M., 2013, MOL CELL; Piccolo FM, 2011, PHILOS T R SOC B, V366, P2260, DOI 10.1098/rstb.2011.0004; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Savatier Pierre, 2002, Journal de la Societe de Biologie, V196, P117; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Sullivan S, 2006, CLONING STEM CELLS, V8, P174, DOI 10.1089/clo.2006.8.174; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tat PA, 2011, CELL REPROGRAM, V13, P331, DOI 10.1089/cell.2011.0002; Terranova R, 2006, J CELL SCI, V119, P2065, DOI 10.1242/jcs.02945; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yang VS, 2011, CURR BIOL, V21, P692, DOI 10.1016/j.cub.2011.03.026; Yeom YI, 1996, DEVELOPMENT, V122, P881	72	59	60	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					873	883		10.1016/j.cell.2013.01.012	http://dx.doi.org/10.1016/j.cell.2013.01.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415233	Green Published, hybrid			2022-12-24	WOS:000314945600020
J	Feng, ZD; Hensley, L; McKnight, KL; Hu, FY; Madden, V; Ping, LF; Jeong, SH; Walker, C; Lanford, RE; Lemon, SM				Feng, Zongdi; Hensley, Lucinda; McKnight, Kevin L.; Hu, Fengyu; Madden, Victoria; Ping, LiFang; Jeong, Sook-Hyang; Walker, Christopher; Lanford, Robert E.; Lemon, Stanley M.			A pathogenic picornavirus acquires an envelope by hijacking cellular membranes	NATURE			English	Article							HEPATITIS-A VIRUS; CULTURE-ADAPTED VARIANT; LYSOSOMAL DEGRADATION; ALIX; MECHANISMS; INFECTION; REGIONS; ANTIGEN	Animal viruses are broadly categorized structurally by the presence or absence of an envelope composed of a lipid-bilayer membrane(1), attributes that profoundly affect stability, transmission and immune recognition. Among those lacking an envelope, the Picornaviridae are a large and diverse family of positive-strand RNA viruses that includes hepatitis A virus (HAV), an ancient human pathogen that remains a common cause of enterically transmitted hepatitis(2-4). HAV infects in a stealth-like manner and replicates efficiently in the liver(5). Virus-specific antibodies appear only after 3-4 weeks of infection, and typically herald its resolution(3,4). Although unexplained mechanistically, both anti-HAV antibody and inactivated whole-virus vaccines prevent disease when administered as late as 2 weeks after exposure(6), when virus replication is well established in the liver(5). Here we show that HAV released from cells is cloaked in host-derived membranes, thereby protecting the virion from antibody-mediated neutralization. These enveloped viruses ('eHAV') resemble exosomes(7), small vesicles that are increasingly recognized to be important in intercellular communications. They are fully infectious, sensitive to extraction with chloroform, and circulate in the blood of infected humans. Their biogenesis is dependent on host proteins associated with endosomal-sorting complexes required for transport (ESCRT)(8), namely VPS4B and ALIX. Whereas the hijacking of membranes by HAV facilitates escape from neutralizing antibodies and probably promotes virus spread within the liver, anti-capsid antibodies restrict replication after infection with eHAV, suggesting a possible explanation for prophylaxis after exposure. Membrane hijacking by HAV blurs the classic distinction between 'enveloped' and 'non-enveloped' viruses and has broad implications for mechanisms of viral egress from infected cells as well as host immune responses.	[Feng, Zongdi; Hensley, Lucinda; McKnight, Kevin L.; Hu, Fengyu; Ping, LiFang; Lemon, Stanley M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Madden, Victoria] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Jeong, Sook-Hyang] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam 463707, Gyeonggi Do, South Korea; [Walker, Christopher] Nationwide Childrens Hosp, Res Inst, Ctr Vaccines & Immun, Columbus, OH 43205 USA; [Walker, Christopher] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43205 USA; [Lanford, Robert E.] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX 78227 USA; [Lemon, Stanley M.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Lemon, Stanley M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Seoul National University (SNU); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Texas Biomedical Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Lemon, SM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	smlemon@med.unc.edu	Feng, Zongdi/Y-7645-2019; Ariel, Pablo/AGJ-4118-2022	Feng, Zongdi/0000-0001-7913-1027	National Institutes of Health [R01-AI103083]; University Cancer Research Fund; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047367, R01AI103083] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Duncan for helpful discussions; staff of the Michael Hooker Microscopy Facility for assistance with confocal microscopy; G. Kaplan for the gift of 190-4 antibody and GL37 cells; M. Fried for anti-HAV-negative human sera; A. Blikslager for porcine bile; and C. Rice for Huh-7.5 cells. This work was supported in part by a grant from the National Institutes of Health (R01-AI103083) and the University Cancer Research Fund.	ASHER LVS, 1995, J MED VIROL, V47, P260, DOI 10.1002/jmv.1890470312; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Balasubramanian S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003200; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Cohen L, 2002, J VIROL, V76, P7495, DOI 10.1128/JVI.76.15.7495-7505.2002; Counihan NA, 2006, J VIROL METHODS, V133, P62, DOI 10.1016/j.jviromet.2005.10.023; Feigelstock D, 1998, J VIROL, V72, P6621, DOI 10.1128/JVI.72.8.6621-6628.1998; Feigelstock D, 1998, J VIROL, V72, P6218, DOI 10.1128/JVI.72.7.6218-6222.1998; Feng Z. D., 2010, The picornaviruses, P383, DOI 10.1128/ISBN978-1-55581-603-2.24; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Graff J, 1999, J VIROL, V73, P6015, DOI 10.1128/JVI.73.7.6015-6023.1999; Harrison SC, 2007, FIELDS VIROLOGY, P59; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; JANSEN RW, 1988, VIROLOGY, V163, P299, DOI 10.1016/0042-6822(88)90270-X; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Lanford RE, 2011, P NATL ACAD SCI USA, V108, P11223, DOI 10.1073/pnas.1101939108; LEMON SM, 1982, J MED VIROL, V10, P25, DOI 10.1002/jmv.1890100105; LEMON SM, 1985, NEW ENGL J MED, V313, P1059, DOI 10.1056/NEJM198510243131706; LEMON SM, 1991, J VIROL, V65, P2056, DOI 10.1128/JVI.65.4.2056-2065.1991; LEMON SM, 1980, INFECT IMMUN, V28, P927; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; Martin A, 2002, HEPATITIS VIRUSES, P23; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; PING LH, 1992, J VIROL, V66, P2208, DOI 10.1128/JVI.66.4.2208-2216.1992; Ren XF, 2011, TRAFFIC, V12, P1282, DOI 10.1111/j.1600-0854.2011.01208.x; SCHULMAN AN, 1976, J INFECT DIS, V134, P80, DOI 10.1093/infdis/134.1.80; Sette P, 2011, STRUCTURE, V19, P1485, DOI 10.1016/j.str.2011.07.016; SHIMIZU YK, 1982, INFECT IMMUN, V36, P320, DOI 10.1128/IAI.36.1.320-324.1982; TAYLOR KL, 1993, J INFECT DIS, V168, P592, DOI 10.1093/infdis/168.3.592; Taylor MP, 2009, J VIROL, V83, P6599, DOI 10.1128/JVI.01819-08; Victor JC, 2007, NEW ENGL J MED, V357, P1685, DOI 10.1056/NEJMoa070546; ZHANG HC, 1995, VIROLOGY, V212, P686, DOI 10.1006/viro.1995.1526	33	449	470	6	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					367	+		10.1038/nature12029	http://dx.doi.org/10.1038/nature12029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23542590	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000317599200039
J	Chang, WC; Dey, M; Liu, PH; Mansoorabadi, SO; Moon, SJ; Zhao, ZBK; Drennan, CL; Liu, HW				Chang, Wei-chen; Dey, Mishtu; Liu, Pinghua; Mansoorabadi, Steven O.; Moon, Sung-Ju; Zhao, Zongbao K.; Drennan, Catherine L.; Liu, Hung-wen			Mechanistic studies of an unprecedented enzyme-catalysed 1,2-phosphono-migration reaction	NATURE			English	Article							(S)-2-HYDROXYPROPYLPHOSPHONIC ACID EPOXIDASE; ANTIBIOTIC FOSFOMYCIN BIOSYNTHESIS; MONONUCLEAR IRON ENZYME; ESCHERICHIA-COLI; IDENTIFICATION; ACTIVATION; RESISTANT; INSIGHT; OXYGEN; SITE	(S)-2-hydroxypropylphosphonate ((S)-2-HPP) epoxidase (HppE) is a mononuclear non-haem-iron-dependent enzyme(1-3) responsible for the final step in the biosynthesis of the clinically useful antibiotic fosfomycin(4). Enzymes of this class typically catalyse oxygenation reactions that proceed via the formation of substrate radical intermediates. By contrast, HppE catalyses an unusual dehydrogenation reaction while converting the secondary alcohol of (S)-2-HPP to the epoxide ring of fosfomycin(1,5). Here we show that HppE also catalyses a biologically unprecedented 1,2-phosphono migration with the alternative substrate (R)-1-HPP. This transformation probably involves an intermediary carbocation, based on observations with additional substrate analogues, such as (1R)-1-hydroxyl-2-aminopropylphosphonate, and model reactions for both radical- and carbocation-mediated migration. The ability of HppE to catalyse distinct reactions depending on the regio- and stereochemical properties of the substrate is given a structural basis using X-ray crystallography. These results provide compelling evidence for the formation of a substrate-derived cation intermediate in the catalytic cycle of a mononuclear non-haem-iron-dependent enzyme. The underlying chemistry of this unusual phosphono migration may represent a new paradigm for the in vivo construction of phosphonate-containing natural products that can be exploited for the preparation of new phosphonate derivatives.	[Chang, Wei-chen; Liu, Pinghua; Mansoorabadi, Steven O.; Moon, Sung-Ju; Zhao, Zongbao K.; Liu, Hung-wen] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA; [Chang, Wei-chen; Liu, Pinghua; Mansoorabadi, Steven O.; Moon, Sung-Ju; Zhao, Zongbao K.; Liu, Hung-wen] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Dey, Mishtu; Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Dey, Mishtu; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Dey, Mishtu; Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 02139 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Liu, HW (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA.	h.w.liu@mail.utexas.edu	Mansoorabadi, Steven/I-3688-2017; Zhao, Zongbao K/F-5518-2011	Mansoorabadi, Steven/0000-0002-6369-3815; Zhao, Zongbao K/0000-0003-0654-1193; CHANG, WEI-CHEN/0000-0002-2341-9846	National Institutes of Health [GM040541]; Welch Foundation [F-1511]; Advanced Light Source, a Department of Energy (DOE) national user facility [DE-AC02-05CH11231]; DOE; National Institutes of Health/National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Advanced Light Source, a Department of Energy (DOE) national user facility; DOE(United States Department of Energy (DOE)); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Johnson and S. Sorey for assistance with the NMR experiment setup. This work is supported in part by grants from The National Institutes of Health (GM040541 to H.-w.L.) and the Welch Foundation (F-1511). C. L. D. is a Howard Hughes Medical Institute Investigator. Crystallographic data collection were conducted at the Advanced Light Source, a Department of Energy (DOE) national user facility (Contract DE-AC02-05CH11231), at beamline 8.2.2 operated by the Berkeley Center for Structural Biology, which is supported in part by DOE and National Institutes of Health/National Institute of General Medical Sciences.	BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; Cassone M, 2004, MICROB DRUG RESIST, V10, P43, DOI 10.1089/107662904323047790; CHURI RH, 1966, J AM CHEM SOC, V88, P1824, DOI 10.1021/ja00960a049; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Girotra N. N., 1969, TETRAHEDRON LETT, V10, P4647; Hammerschmidt F., 1990, LIEBIGS ANN CHEM, P1055; HIDAKA T, 1995, MOL GEN GENET, V249, P274, DOI 10.1007/BF00290527; Higgins LJ, 2005, NATURE, V437, P838, DOI 10.1038/nature03924; Huang H., 2012, J AM CHEM SOC, V134, P13946; Kappock TJ, 1996, CHEM REV, V96, P2659, DOI 10.1021/cr9402034; Ko KS, 2007, DIAGN MICR INFEC DIS, V58, P111, DOI [10.1016/j.diaginicrobio.2006.11.015, 10.1016/j.diagmicrobio.2006.11.015]; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Lesburg CA, 1998, CURR OPIN STRUC BIOL, V8, P695, DOI 10.1016/S0959-440X(98)80088-2; Liu PH, 2001, J AM CHEM SOC, V123, P4619, DOI 10.1021/ja004153y; Liu PH, 2003, BIOCHEMISTRY-US, V42, P11577, DOI 10.1021/bi030140w; Liu SJ, 2002, BIOCHEMISTRY-US, V41, P10270, DOI 10.1021/bi026024v; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; Mirica LM, 2008, J AM CHEM SOC, V130, P8122, DOI 10.1021/ja800265s; Nakazawa Hiroaki, 2003, Journal of Infection and Chemotherapy, V9, P304, DOI 10.1007/s10156-003-0266-2; SEIDEL HM, 1988, NATURE, V335, P457, DOI 10.1038/335457a0; Stengel D, 2005, J CHEMOTHERAPY, V17, P527, DOI 10.1179/joc.2005.17.5.527; van der Donk WA, 2010, CURR OPIN STRUC BIOL, V20, P673, DOI 10.1016/j.sbi.2010.08.005; Woodyer RD, 2007, CHEM COMMUN, P359, DOI 10.1039/b614678c; YAMASHITA M, 1987, SYNTHESIS-STUTTGART, P62; Yan F, 2005, ARCH BIOCHEM BIOPHYS, V442, P82, DOI 10.1016/j.abb.2005.07.024; Yan F, 2007, BIOCHEMISTRY-US, V46, P12628, DOI 10.1021/bi701370e; Yan F, 2006, BIOCHEMISTRY-US, V45, P11473, DOI 10.1021/bi060839c; Yun D, 2011, J AM CHEM SOC, V133, P11262, DOI 10.1021/ja2025728; Zhao ZB, 2002, ANGEW CHEM INT EDIT, V41, P4529, DOI 10.1002/1521-3773(20021202)41:23<4529::AID-ANIE4529>3.0.CO;2-2	29	46	48	1	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2013	496	7443					114	118		10.1038/nature11998	http://dx.doi.org/10.1038/nature11998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23552950	Green Accepted, Green Submitted			2022-12-24	WOS:000316993400036
J	Atianand, MK; Rathinam, VA; Fitzgerald, KA				Atianand, Maninjay K.; Rathinam, Vijay A.; Fitzgerald, Katherine A.			SnapShot: Inflammasomes	CELL			English	Editorial Material							AIM2 INFLAMMASOME; RECOGNITION; ACTIVATION; BACTERIA; IMMUNITY		[Atianand, Maninjay K.; Rathinam, Vijay A.; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Atianand, MK (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.		Rathinam, Vijay/ABE-7544-2020; Fitzgerald, Katherine/ABE-6317-2020; Atianand, Maninjay/AAF-7823-2019	Rathinam, Vijay/0000-0002-8009-3977; Atianand, Maninjay/0000-0003-4135-2515; Fitzgerald, Kate/0000-0003-3175-609X				Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006	10	19	21	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 28	2013	153	1					272	+		10.1016/j.cell.2013.03.009	http://dx.doi.org/10.1016/j.cell.2013.03.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540703	Bronze			2022-12-24	WOS:000316853700023
J	Zhang, LH; Malik, S; Pang, JJ; Wang, H; Park, KM; Yule, DI; Blaxall, BC; Smrcka, AV				Zhang, Lianghui; Malik, Sundeep; Pang, Jinjiang; Wang, Huan; Park, Keigan M.; Yule, David I.; Blaxall, Burns C.; Smrcka, Alan V.			Phospholipase C epsilon Hydrolyzes Perinuclear Phosphatidylinositol 4-Phosphate to Regulate Cardiac Hypertrophy	CELL			English	Article							PROTEIN-KINASE-C; PLASMA-MEMBRANE; NUCLEAR-ENVELOPE; PHOSPHATASE SAC1; GOLGI-APPARATUS; CA2+ RELEASE; RECEPTOR; MYOCYTES; MAKAP; ACTIVATION	Phospholipase C epsilon (PLC epsilon) is a multifunctional enzyme implicated in cardiovascular, pancreatic, and inflammatory functions. Here we show that conditional deletion of PLC epsilon in mouse cardiac myocytes protects from stress-induced pathological hypertrophy. PLC epsilon small interfering RNA (siRNA) in ventricular myocytes decreases endothelin-1 (ET-1)-dependent elevation of nuclear calcium and activation of nuclear protein kinase D (PKD). PLC epsilon scaffolded to muscle-specific A kinase-anchoring protein (mAKAP), along with PKC epsilon and PKD, localizes these components at or near the nuclear envelope, and this complex is required for nuclear PKD activation. Phosphatidylinositol 4-phosphate (PI4P) is identified as a perinuclear substrate in the Golgi apparatus for mAKAP-scaffolded PLC epsilon. We conclude that perinuclear PLC epsilon, scaffolded to mAKAP in cardiac myocytes, responds to hypertrophic stimuli to generate diacylglycerol (DAG) from PI4P in the Golgi apparatus, in close proximity to the nuclear envelope, to regulate activation of nuclear PKD and hypertrophic signaling pathways.	[Zhang, Lianghui; Malik, Sundeep; Park, Keigan M.; Yule, David I.; Blaxall, Burns C.; Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; [Wang, Huan; Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Pang, Jinjiang; Blaxall, Burns C.; Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Aab Inst Cardiovasc Res, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Smrcka, AV (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pharmacol & Physiol, 601 Elmwood Ave, Rochester, NY 14642 USA.	alan_smrcka@urmc.rochester.edu	Blaxall, Burns/ABD-8289-2021		National Institutes of Health [5R01GM053536, R01DE041756, R01 HL089885, R01 HL091475]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091475, R01HL089885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Tamas Balla for fluorescent phosphoinositide reporter fusion and PI5 ptase constructs and for valuable critical reading of this manuscript. We would also like to thank Peter Mayinger for providing the Sac1-K2A construct and Alexandra Newton for the nDKAR and DAG reporter constructs. This work was supported by National Institutes of Health grants 5R01GM053536 (A.V.S.), R01DE041756 (D.I.Y.), and R01 HL089885 and R01 HL091475 (B.C.B.).	Arantes LAM, 2012, J MOL CELL CARDIOL, V53, P475, DOI 10.1016/j.yjmcc.2012.06.017; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Balla T, 2009, PHYSIOLOGY, V24, P231, DOI 10.1152/physiol.00014.2009; Blagoveshchenskaya A, 2008, J CELL BIOL, V180, P803, DOI 10.1083/jcb.200708109; Bossuyt J, 2011, J BIOL CHEM, V286, P33390, DOI 10.1074/jbc.M111.246447; Campelo F, 2012, ANNU REV BIOCHEM, V81, P407, DOI 10.1146/annurev-biochem-051710-094912; COCCO L, 1989, BIOCHEM BIOPH RES CO, V159, P720, DOI 10.1016/0006-291X(89)90054-5; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; DIVECHA N, 1993, CELL, V74, P405, DOI 10.1016/0092-8674(93)80041-C; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dorn GW, 1999, TRENDS CARDIOVAS MED, V9, P26, DOI 10.1016/S1050-1738(99)00004-3; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Filtz TM, 2009, FASEB J, V23, P3564, DOI 10.1096/fj.09-133983; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Grubb DR, 2011, FASEB J, V25, P1040, DOI 10.1096/fj.10-171470; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Keune WJ, 2011, ADV ENZYME REGUL, V51, P91, DOI 10.1016/j.advenzreg.2010.09.009; KNOWLTON KU, 1993, J BIOL CHEM, V268, P15374; KRONEBUSCH PJ, 1987, J CELL SCI, V88, P25; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; Kunkel MT, 2010, J BIOL CHEM, V285, P22746, DOI 10.1074/jbc.C110.123133; McKinsey TA, 2007, CARDIOVASC RES, V73, P667, DOI 10.1016/j.cardiores.2006.11.036; Nakayama H, 2010, CIRC RES, V107, P659, DOI 10.1161/CIRCRESAHA.110.220038; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Ram R, 2011, AM J PHYSIOL-HEART C, V301, pH1765, DOI 10.1152/ajpheart.00559.2011; Ramazzotti G, 2011, J CELL PHYSIOL, V226, P14, DOI 10.1002/jcp.22334; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rohde HM, 2003, J BIOL CHEM, V278, P52689, DOI 10.1074/jbc.M307983200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Seifert JP, 2004, J BIOL CHEM, V279, P47992, DOI 10.1074/jbc.M407111200; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Steinberg SF, 2012, MOL PHARMACOL, V81, P284, DOI 10.1124/mol.111.075986; TASSIN AM, 1985, J CELL BIOL, V101, P630, DOI 10.1083/jcb.101.2.630; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zhang LH, 2011, J BIOL CHEM, V286, P23012, DOI 10.1074/jbc.M111.231993	48	104	113	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 28	2013	153	1					216	227		10.1016/j.cell.2013.02.047	http://dx.doi.org/10.1016/j.cell.2013.02.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540699	Bronze, Green Accepted			2022-12-24	WOS:000316853700018
J	Payne, DC; Vinje, J; Szilagyi, PG; Edwards, KM; Staat, MA; Weinberg, GA; Hall, CB; Chappell, J; Bernstein, DI; Curns, AT; Wikswo, M; Shirley, SH; Hall, AJ; Lopman, B; Parashar, UD				Payne, Daniel C.; Vinje, Jan; Szilagyi, Peter G.; Edwards, Kathryn M.; Staat, Mary Allen; Weinberg, Geoffrey A.; Hall, Caroline B.; Chappell, James; Bernstein, David I.; Curns, Aaron T.; Wikswo, Mary; Shirley, S. Hannah; Hall, Aron J.; Lopman, Benjamin; Parashar, Umesh D.			Norovirus and Medically Attended Gastroenteritis in U.S. Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; ROTAVIRUS-VACCINATION; IMPACT; SURVEILLANCE; SEASONALITY; OUTBREAKS; DECLINE; DISEASE; RATES	Background Cases of rotavirus-associated acute gastroenteritis have declined since the introduction of rotavirus vaccines, but the burden of norovirus-associated acute gastroenteritis in children remains to be assessed. Methods We conducted active surveillance for laboratory-confirmed cases of norovirus among children younger than 5 years of age with acute gastroenteritis in hospitals, emergency departments, and outpatient clinical settings. The children resided in one of three U.S. counties during the years 2009 and 2010. Fecal specimens were tested for norovirus and rotavirus. We calculated population-based rates of norovirus-associated acute gastroenteritis and reviewed billing records to determine medical costs; these data were extrapolated to the U.S. population of children younger than 5 years of age. Results Norovirus was detected in 21% of young children (278 of 1295) seeking medical attention for acute gastroenteritis in 2009 and 2010, with norovirus detected in 22% (165 of 742) in 2009 and 20% (113 of 553) in 2010 (P = 0.43). The virus was also detected in 4% of healthy controls (19 of 493) in 2009. Rotavirus was identified in 12% of children with acute gastroenteritis (152 of 1295) in 2009 and 2010. The respective rates of hospitalization, emergency department visits, and outpatient visits for the norovirus were 8.6, 146.7, and 367.7 per 10,000 children younger than 5 years of age in 2009 and 5.8, 134.3, and 260.1 per 10,000 in 2010, with an estimated cost per episode of $3,918, $435, and $151, respectively, in 2009. Nationally, we estimate that the average numbers of annual hospitalizations, emergency department visits, and outpatient visits due to norovirus infection in 2009 and 2010 among U.S. children in this age group exceeded 14,000, 281,000, and 627,000, respectively, with more than $273 million in treatment costs each year. Conclusions Since the introduction of rotavirus vaccines, norovirus has become the leading cause of medically attended acute gastroenteritis in U.S. children and is associated with nearly 1 million health care visits annually. (Funded by the Centers for Disease Control and Prevention.)	[Payne, Daniel C.; Curns, Aaron T.; Wikswo, Mary; Hall, Aron J.; Lopman, Benjamin; Parashar, Umesh D.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Epidemiol Branch, Atlanta, GA 30333 USA; [Vinje, Jan; Shirley, S. Hannah] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Gastroenteritis & Resp Viruses Lab Branch, Atlanta, GA 30333 USA; [Szilagyi, Peter G.; Weinberg, Geoffrey A.; Hall, Caroline B.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Hall, Caroline B.] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; [Edwards, Kathryn M.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Chappell, James] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Chappell, James] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Staat, Mary Allen; Bernstein, David I.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Shirley, S. Hannah] Atlanta Res & Educ Fdn, Decatur, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Rochester; University of Rochester; Vanderbilt University; Vanderbilt University; Vanderbilt University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Payne, DC (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS A34, Atlanta, GA 30333 USA.	dvp6@cdc.gov	Weinberg, Geoffrey A./W-7510-2019; Vinje, Jan/ABE-6336-2020	Weinberg, Geoffrey A./0000-0002-3900-379X; Vinje, Jan/0000-0002-1530-3675	GlaxoSmithKline; Merck; Luminex Molecular Diagnostics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Luminex Molecular Diagnostics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Dr. Staat reports receiving consulting and lecture fees from GlaxoSmithKline and Merck and grant support through her institution from GlaxoSmithKline; Dr. Chappell, receiving consulting fees and grant support from Luminex Molecular Diagnostics; and Dr. Bernstein, receiving royalties, both individually and through his institution, for the Rotarix vaccine from GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.	Atchison C, 2010, VACCINE, V28, P3118, DOI 10.1016/j.vaccine.2010.02.060; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Chan MCW, 2006, EMERG INFECT DIS, V12, P1278, DOI 10.3201/eid1708.060081; Cortese MM, 2010, PEDIATR INFECT DIS J, V29, P489, DOI 10.1097/INF.0b013e3181d95b53; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; El-Kamary SS, 2011, J INFECT DIS, V203, P1036, DOI 10.1093/infdis/jiq151; Frey ST JJ, 2011, 49 ANN M INF DIS SOC; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Kilgore A, VACCINE IN PRESS; Lee N, 2007, EMERG INFECT DIS, V13, P1399, DOI 10.3201/eid1309.061535; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Mast T Christopher, 2010, Pediatr Infect Dis J, V29, pe19, DOI 10.1097/INF.0b013e3181ca7e2e; Panozzo C. A., 2009, Morbidity and Mortality Weekly Report, V58, P1146; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Payne DC, 2011, CLIN INFECT DIS, V53, P245, DOI 10.1093/cid/cir307; Payne DC, 2009, PEDIATR INFECT DIS J, V28, P948, DOI 10.1097/INF.0b013e3181a6ad6e; Payne DC, 2008, PEDIATRICS, V122, P1235, DOI 10.1542/peds.2007-3378; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS56, DOI 10.1097/INF.0b013e3181fefdc0; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS30, DOI 10.1097/INF.0b013e3181ffe3eb; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; VANBEEK J, 2013, EURO SURVEILL, V18; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Vesikari T, 2011, 6 INT VACC ENT DIS C; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09	29	409	433	2	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					1121	1130		10.1056/NEJMsa1206589	http://dx.doi.org/10.1056/NEJMsa1206589			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108TH	23514289	Green Accepted			2022-12-24	WOS:000316318600005
J	Dimick, JB; Nicholas, LH; Ryan, AM; Thumma, JR; Birkmeyer, JD				Dimick, Justin B.; Nicholas, Lauren H.; Ryan, Andrew M.; Thumma, Jyothi R.; Birkmeyer, John D.			Bariatric Surgery Complications Before vs After Implementation of a National Policy Restricting Coverage to Centers of Excellence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSPECTIVE RANDOMIZED-TRIAL; ADMINISTRATIVE DATA; MEDICARE BENEFICIARIES; SURGICAL-PROCEDURES; HOSPITAL VOLUME; GASTRIC BYPASS; OUTCOMES; MORTALITY; SAFETY; RATES	Importance Starting in 2006, the Centers for Medicare & Medicaid Services (CMS) has restricted coverage of bariatric surgery to hospitals designated as centers of excellence (COE) by 2 major professional organizations. Objective To evaluate whether the implementation of the COE component of the national coverage decision was associated with improved bariatric surgery outcomes in Medicare patients. Design, Setting, and Patients Retrospective, longitudinal study using 20042009 hospital discharge data from 12 states (n=321 464 patients) of changes in outcomes in Medicare patients undergoing bariatric surgery (n=6723 before and n=15 854 after implementation of the policy). A difference-in-differences analytic approach was used to evaluate whether the national coverage decision was associated with improved outcomes in Medicare patients above and beyond existing time trends in non-Medicare patients (n=95 558 before and n=155 117 after implementation of the policy). Main Outcome Measures Risk-adjusted rates of any complication, serious complications, and reoperation. Results Bariatric surgery outcomes improved during the study period in both Medicare and non-Medicare patients; however, this change was already under way prior to the CMS coverage decision. After accounting for patient factors, changes in procedure type, and preexisting time trends toward improved outcomes, there were no statistically significant improvements in outcomes after (vs before) implementation of the CMS national coverage decision for any complication (8.0% after vs 7.0% before; relative risk [RR], 1.14 [95% CI, 0.95-1.33]), serious complications (3.3% vs 3.6%, respectively; RR, 0.92 [95% CI, 0.62-1.22]), and reoperation (1.0% vs 1.1%; RR, 0.90 [95% CI, 0.64-1.17]). In a direct assessment comparing outcomes at hospitals designated as COEs (n=179) vs hospitals without the COE designation (n=519), no significant differences were found for any complication (5.5% vs 6.0%, respectively; RR, 0.98 [95% CI, 0.90-1.06]), serious complications (2.2% vs 2.5%; RR, 0.92 [95% CI, 0.84-1.00]), and reoperation (0.83% vs 0.96%; RR, 1.00 [95% CI, 0.86-1.17]). Conclusions and Relevance Among Medicare patients undergoing bariatric surgery, there was no significant difference in the rates of complications and reoperation before vs after the CMS policy of restricting coverage to COEs. Combined with prior studies showing no association of COE designation and outcomes, these results suggest that Medicare should reconsider this policy. JAMA. 2013;309(8):792-799 www.jama.com	[Dimick, Justin B.; Nicholas, Lauren H.; Thumma, Jyothi R.; Birkmeyer, John D.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Ryan, Andrew M.] Weill Cornell Med Coll, Div Outcomes & Effectiveness, New York, NY USA	University of Michigan System; University of Michigan; Cornell University	Dimick, JB (corresponding author), Ctr Healthcare Outcomes & Policy, 2800 Plymouth Rd,Bldg 520,Off 3144, Ann Arbor, MI 48109 USA.	jdimick@umich.edu			Commonwealth Fund; Russell Sage Foundation; Agency for Healthcare Research and Quality; RWJ Foundation; Phelps Memorial Hospital; National Institute on Aging [R01AG039434, K01AG041763]; Agency for Healthcare Research and Quality [K08HS017765]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS017765] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG041763, R01AG039434] Funding Source: NIH RePORTER	Commonwealth Fund; Russell Sage Foundation; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); RWJ Foundation; Phelps Memorial Hospital; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Dimick and Birkmeyer reported serving as consultants and having an equity interest in ArborMetrix Inc, which provided software and analytics for measuring hospital quality and efficiency but had no role in the study. Dr Nicholas reported receiving travel reimbursement from Stanford University, Indiana University, the National Institute on Aging, and the University of Pennsylvania; and receiving institutional grants from the Commonwealth Fund and the Russell Sage Foundation. Dr Ryan reported receiving institutional grants from the Agency for Healthcare Research and Quality, the RWJ Foundation, and the Commonwealth Fund; receiving payment for lectures from Phelps Memorial Hospital; receiving payment for manuscript preparation from the New England Journal of Medicine; and receiving payment for the development of educational presentations from Health Affairs. Ms Thumma did not report any disclosures.; This study was supported by National Institute on Aging grant R01AG039434 awarded to Drs Dimick, Nicholas, and Birkmeyer. Dr Dimick is also supported by career development award K08HS017765 from the Agency for Healthcare Research and Quality. Dr Nicholas is also supported by career development award K01AG041763 from the National Institute on Aging.	Angrisani L, 2007, SURG OBES RELAT DIS, V3, P127, DOI 10.1016/j.soard.2006.12.005; Birkmeyer NJO, 2010, JAMA-J AM MED ASSOC, V304, P435, DOI 10.1001/jama.2010.1034; Colla CH, 2012, JAMA-J AM MED ASSOC, V308, P1015, DOI 10.1001/2012.jama.10812; Dimick JB, 2009, J AM COLL SURGEONS, V209, P702, DOI 10.1016/j.jamcollsurg.2009.09.009; Donald SG, 2007, REV ECON STAT, V89, P221, DOI 10.1162/rest.89.2.221; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Flum DR, 2011, ANN SURG, V254, P860, DOI 10.1097/SLA.0b013e31822f2101; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; HCUP, OV STAT INP DAT; Hollenbeak CS, 2008, SURGERY, V144, P736, DOI 10.1016/j.surg.2008.05.013; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; Lanthaler M, 2010, OBES SURG, V20, P1078, DOI 10.1007/s11695-010-0190-3; Livingston EH, 2010, ARCH SURG-CHICAGO, V145, P993, DOI 10.1001/archsurg.2010.218; Livingston EH, 2009, ARCH SURG-CHICAGO, V144, P319, DOI 10.1001/archsurg.2009.23; Livingston EH, 2004, AM J SURG, V188, P105, DOI 10.1016/j.amjsurg.2004.03.001; Mittermair RP, 2009, OBES SURG, V19, P1636, DOI 10.1007/s11695-009-9967-7; Nguyen NT, 2010, ARCH SURG-CHICAGO, V145, P72, DOI 10.1001/archsurg.2009.228; Nguyen NT, 2009, ANN SURG, V250, P631, DOI 10.1097/SLA.0b013e3181b92480; Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24; Pratt Gary M, 2006, Surg Obes Relat Dis, V2, P497, DOI 10.1016/j.soard.2006.07.004; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Schirmer Bruce, 2007, Bull Am Coll Surg, V92, P21; Snow JM, 2011, SURG CLIN N AM, V91, P1249, DOI 10.1016/j.suc.2011.08.008; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Weingart SN, 2000, MED CARE, V38, P796, DOI 10.1097/00005650-200008000-00004; Weller WE, 2006, J AM COLL SURGEONS, V202, P753, DOI 10.1016/j.jamcollsurg.2006.02.002; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	31	148	148	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					792	799		10.1001/jama.2013.755	http://dx.doi.org/10.1001/jama.2013.755			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23443442	Green Accepted			2022-12-24	WOS:000315332200024
J	Chaudhuri, M				Chaudhuri, Mohuya			What can India do about dengue fever?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mohuya.chaudhuri@gmail.com						[Anonymous], DENG CAS DEATHS COUN; Bush KF, 2011, ENVIRON HEALTH PERSP, V119, P765, DOI 10.1289/ehp.1003000; Duggal R., PRIVATE HLTH SECTOR; Nature, 2021, NATURE; Sankari T, 2012, INDIAN J MED RES, V136, P649; Singh PK, 2012, J VECTOR DIS, V49, P55	6	3	3	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2013	346								f643	10.1136/bmj.f643	http://dx.doi.org/10.1136/bmj.f643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088AL	23381202				2022-12-24	WOS:000314806100009
J	Mariner, WK; Annas, GJ				Mariner, Wendy K.; Annas, George J.			Limiting "Sugary Drinks" to Reduce Obesity - Who Decides?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mariner, Wendy K.; Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Mariner, WK (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Mariner, Wendy/0000-0001-5176-5917; Annas, George/0000-0001-5836-7831				Callahan D, 2013, HASTINGS CENT REP, V43, P34, DOI 10.1002/hast.114; Grynbaum MM, 2013, NEW YORK TIMES  0311, pA1; Mariner Wendy, 2007, J HLTH CARE LAW POLI, V10, P121	3	15	15	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1763	1765		10.1056/NEJMp1303706	http://dx.doi.org/10.1056/NEJMp1303706			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138WA	23550600	Green Published			2022-12-24	WOS:000318540000002
J	Matthews, HD; Solomon, S				Matthews, H. Damon; Solomon, Susan			Irreversible Does Not Mean Unavoidable	SCIENCE			English	Editorial Material							CUMULATIVE CARBON; CLIMATE-CHANGE; EMISSIONS		[Matthews, H. Damon] Concordia Univ, Dept Geog Planning & Environm, Montreal, PQ H3G 1M8, Canada; [Solomon, Susan] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Concordia University - Canada; Massachusetts Institute of Technology (MIT)	Matthews, HD (corresponding author), Concordia Univ, Dept Geog Planning & Environm, Montreal, PQ H3G 1M8, Canada.	damon.matthews@concordia.ca; solos@mit.edu	/AAD-2430-2020	/0000-0003-3625-390X				Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; [Anonymous], 2012, WASHINGTON POST; Bolin B, 2001, P NATL ACAD SCI USA, V98, P4850, DOI 10.1073/pnas.081078998; Davis SJ, 2010, SCIENCE, V329, P1330, DOI 10.1126/science.1188566; Hansen J, 2005, SCIENCE, V308, P1431, DOI 10.1126/science.1110252; Matthews HD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032388; Matthews HD, 2012, PHILOS T R SOC A, V370, P4365, DOI 10.1098/rsta.2012.0064; Matthews HD, 2010, NAT GEOSCI, V3, P142, DOI 10.1038/ngeo813; Matthews HD, 2009, NATURE, V459, P829, DOI 10.1038/nature08047; Parry M L, 2007, CLIMATE CHANGE 2007, P19; Solomon S., 2011, CLIMATE STABILIZATIO; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Stocker TF, 2013, SCIENCE, V339, P280, DOI 10.1126/science.1232468; Victor D, 2011, GLOBAL WARMING GRIDL	14	40	40	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					438	439		10.1126/science.1236372	http://dx.doi.org/10.1126/science.1236372			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131SQ	23539182	Green Accepted, Green Submitted			2022-12-24	WOS:000318016700028
J	Pierce, NW; Lee, JE; Liu, X; Sweredoski, MJ; Graham, RLJ; Larimore, EA; Rome, M; Zheng, N; Clurman, BE; Hess, S; Shan, SO; Deshaies, RJ				Pierce, Nathan W.; Lee, J. Eugene; Liu, Xing; Sweredoski, Michael J.; Graham, Robert L. J.; Larimore, Elizabeth A.; Rome, Michael; Zheng, Ning; Clurman, Bruce E.; Hess, Sonja; Shan, Shu-ou; Deshaies, Raymond J.			Cand1 Promotes Assembly of New SCF Complexes through Dynamic Exchange of F Box Proteins	CELL			English	Article							UBIQUITIN LIGASE COMPLEX; COP9 SIGNALOSOME; SUBSTRATE; NEDD8; NEDDYLATION; ACTIVATION; CUL1; CRYPTOCHROME; RECOGNITION; DEGRADATION	The modular SCF (Skp1, cullin, and F box) ubiquitin ligases feature a large family of F box protein substrate receptors that enable recognition of diverse targets. However, how the repertoire of SCF complexes is sustained remains unclear. Real-time measurements of formation and disassembly indicate that SCFFbxw7 is extraordinarily stable, but, in the Nedd8-deconjugated state, the cullin-binding protein Cand1 augments its dissociation by one-million-fold. Binding and ubiquitylation assays show that Cand1 is a protein exchange factor that accelerates the rate at which Cul1-Rbx1 equilibrates with multiple F box protein-Skp1 modules. Depletion of Cand1 from cells impedes recruitment of new F box proteins to pre-existing Cul1 and profoundly alters the cellular landscape of SCF complexes. We suggest that catalyzed protein exchange may be a general feature of dynamic macromolecular machines and propose a hypothesis for how substrates, Nedd8, and Cand1 collaborate to regulate the cellular repertoire of SCF complexes.	[Pierce, Nathan W.; Lee, J. Eugene; Liu, Xing; Rome, Michael; Deshaies, Raymond J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Sweredoski, Michael J.; Graham, Robert L. J.; Hess, Sonja] CALTECH, Proteome Explorat Lab, Beckman Inst, Pasadena, CA 91125 USA; [Rome, Michael; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Larimore, Elizabeth A.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; [Clurman, Bruce E.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Larimore, Elizabeth A.; Clurman, Bruce E.] Fred Hutchinson Canc Res Ctr, Human Biol, Seattle, WA 98109 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Deshaies, RJ (corresponding author), CALTECH, Div Biol, MC 156-29,1200 East Calif Blvd, Pasadena, CA 91125 USA.	deshaies@caltech.edu	Graham, Robert l/A-7857-2010; Clurman, Bruce/AAV-3854-2021; Hess, Sonja/K-4842-2013; Deshaies, Raymond/B-8354-2014	Hess, Sonja/0000-0002-5904-9816; Deshaies, Raymond/0000-0002-3671-9354; Liu, Xing/0000-0001-9677-4470	Gordon Ross Fellowship; NIH Training Grant; Ruth L. Kirschstein NRSA Fellowship from the NIH [CA138126]; NIH [GM065997, 10565784]; Gordon and Betty Moore Foundation; Beckman Institute; NATIONAL CANCER INSTITUTE [F32CA138126, T32CA080416, R01CA084069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065997] Funding Source: NIH RePORTER	Gordon Ross Fellowship; NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NRSA Fellowship from the NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Vielmetter of the Caltech Protein Expression Facility for providing Fbxw7-Skp1, beta-TrCP-Skp1, and ubiquitin E1. We thank B. Schulman, L. Busino, M. Pagano, F. Bassermann, O. Schneewind, A. Saha, and W. den Besten for gifts of reagents. We thank G. Smith for assistance with mass spectrometry analyses. We thank all the members of the Deshaies and Shan lab for support and helpful discussions. We thank D. Wolf and T. Kurz for communicating unpublished results. N.W.P. was supported by the Gordon Ross Fellowship, and an NIH Training Grant. J.E.L. was supported by the Ruth L. Kirschstein NRSA Fellowship (CA138126) from the NIH. R.J.D. is an Investigator of the HHMI. This work was supported in part by NIH GM065997 to R.J.D. The Proteome Exploration lab is supported in part by grants from the Gordon and Betty Moore Foundation and the Beckman Institute and an instrumentation grant from NIH (10565784).	Bandau S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-36; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Bergqvist S, 2009, P NATL ACAD SCI USA, V106, P19328, DOI 10.1073/pnas.0908797106; Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Bosu DR, 2010, DEV BIOL, V346, P113, DOI 10.1016/j.ydbio.2010.07.020; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Chua YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016071; Chuang HW, 2004, PLANT CELL, V16, P1883, DOI 10.1105/tpc.021923; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Feng SH, 2004, PLANT CELL, V16, P1870, DOI 10.1105/tpc.021949; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Goody RS, 2002, EUR BIOPHYS J BIOPHY, V31, P268, DOI 10.1007/s00249-002-0225-3; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Helmstaedt K, 2011, MOL BIOL CELL, V22, P153, DOI 10.1091/mbc.E10-08-0732; Hewel JA, 2010, MOL CELL PROTEOMICS, V9, P2460, DOI 10.1074/mcp.M900456-MCP200; Kim SH, 2010, DEV BIOL, V346, P247, DOI 10.1016/j.ydbio.2010.07.031; Kulasingam V, 2008, J PROTEOME RES, V7, P640, DOI 10.1021/pr7005999; Lee JE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006460; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lo SC, 2006, MOL CELL BIOL, V26, P1235, DOI 10.1128/MCB.26.4.1235-1244.2006; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Proft T, 2010, BIOTECHNOL LETT, V32, P1, DOI 10.1007/s10529-009-0116-0; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sandhu C, 2008, J PROTEOME RES, V7, P1529, DOI 10.1021/pr700836q; Schmidt MW, 2009, MOL CELL, V35, P586, DOI 10.1016/j.molcel.2009.07.024; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Siergiejuk E, 2009, EMBO J, V28, P3845, DOI 10.1038/emboj.2009.354; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Yen JL, 2012, MOL CELL, V48, P288, DOI 10.1016/j.molcel.2012.08.015; Zhang WD, 2008, ECON LETT, V99, P1, DOI 10.1016/j.econlet.2007.09.029; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	41	170	173	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					206	215		10.1016/j.cell.2013.02.024	http://dx.doi.org/10.1016/j.cell.2013.02.024			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23453757	Green Accepted, Bronze			2022-12-24	WOS:000316853700017
J	Horwitz, RI; Cullen, MR; Abell, J; Christian, JB				Horwitz, Ralph I.; Cullen, Mark R.; Abell, Jill; Christian, Jennifer B.			(De)Personalized Medicine	SCIENCE			English	Editorial Material							GENOMICS		[Horwitz, Ralph I.] GlaxoSmithKline, Clin Evaluat Sci, King Of Prussia, PA 19406 USA; [Cullen, Mark R.] Stanford Univ, Sch Med, Div Gen Med Disciplines, Stanford, CA 94305 USA; [Abell, Jill] GlaxoSmithKline, Clin Effectiveness & Safety, King Of Prussia, PA 19406 USA; [Christian, Jennifer B.] GlaxoSmithKline, Clin Effectiveness & Safety, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline; Stanford University; GlaxoSmithKline; GlaxoSmithKline	Horwitz, RI (corresponding author), GlaxoSmithKline, Clin Evaluat Sci, King Of Prussia, PA 19406 USA.	mrcullen@stanford.edu		cullen, mark/0000-0001-7996-1864				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Burke W, 2007, JAMA-J AM MED ASSOC, V298, P1682, DOI 10.1001/jama.298.14.1682; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Goodman SN, 1999, ANN INTERN MED, V130, P604, DOI 10.7326/0003-4819-130-7-199904060-00022; Guttmacher AE, 2007, NAT REV GENET, V8, P151, DOI 10.1038/nrg2007; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; 1982, JAMA, V247, P1707	7	35	36	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1155	1156		10.1126/science.1234106	http://dx.doi.org/10.1126/science.1234106			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471391				2022-12-24	WOS:000315709900030
J	Huang, DY; Nel, A; Cai, CY; Li, QB; Engel, MS				Huang, Diying; Nel, Andre; Cai, Chenyang; Li, Qibin; Engel, Michael S.			Amphibious flies and paedomorphism in the Jurassic period	NATURE			English	Article							NYMPHOMYIIDAE DIPTERA; LARVA; FLY	The species of the Strashilidae (strashilids) have been the most perplexing of fossil insects from the Jurassic period of Russia and China(1,2). They have been widely considered to be ectoparasites of pterosaurs or feathered dinosaurs, based on the putative presence of piercing and sucking mouthparts and hind tibio-basitarsal pincers purportedly used to fix onto the host's hairs or feathers(1-6). Both the supposed host and parasite occur in the Daohugou beds from the Middle Jurassic epoch of China (approximately 165 million years ago)(7,8). Here we analyse the morphology of strashilids from the Daohugou beds, and reach markedly different conclusions; namely that strashilids are highly specialized flies (Diptera) bearing large membranous wings, with substantial sexual dimorphism of the hind legs and abdominal extensions. The idea that they belong to an extinct order(2) is unsupported, and the lineage can be placed within the true flies. In terms of major morphological and inferred behavioural features, strashilids resemble the recent (extant) and relict members of the aquatic fly family Nymphomyiidae. Their ontogeny are distinguished by the persistence in adult males of larval abdominal respiratory gills, representing a unique case of paedomorphism among endopterygote insects. Adult strashilids were probably aquatic or amphibious, shedding their wings after emergence and mating in the water.	[Huang, Diying; Cai, Chenyang; Li, Qibin] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Jiangsu, Peoples R China; [Nel, Andre] Museum Natl Hist Nat, CNRS UMR 7205, CP 50, F-75005 Paris, France; [Engel, Michael S.] Univ Kansas, Nat Hist Museum, Div Entomol, Lawrence, KS 66045 USA; [Engel, Michael S.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	Chinese Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); University of Kansas; University of Kansas	Huang, DY (corresponding author), Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Jiangsu, Peoples R China.	dyhuang@nigpas.ac.cn	Engel, Michael S/C-5461-2012	Engel, Michael S/0000-0003-3067-077X	National Basic Research Program of China [2012CB821903]; National Natural Science Foundation of China [91114201, J1210006]; Outstanding Youth Foundation of Jiangsu Province [BK2012049]; Chinese Academy of Sciences [KZCX2-YW-QN104]; US National Science Foundation [DEB-0542909]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth Foundation of Jiangsu Province; Chinese Academy of Sciences(Chinese Academy of Sciences); US National Science Foundation(National Science Foundation (NSF))	We are grateful to C. C. Labandeira for suggestions; A. P. Rasnitsyn for early discussions; and J. Sun for reconstructions. Financial support was provided by the National Basic Research Program of China (2012CB821903), the National Natural Science Foundation of China (91114201 and J1210006), the Outstanding Youth Foundation of Jiangsu Province (BK2012049), the Chinese Academy of Sciences (KZCX2-YW-QN104), and the US National Science Foundation (DEB-0542909).	Barclay A, 2005, J KANSAS ENTOMOL SOC, V78, P181, DOI 10.2317/0409.23.1; Cao Cheng-Quan, 2011, Chinese Journal of Applied Entomology, V48, P392; Courtney G. W., 1994, SMITH CONT ZOOL; Crampton G. C., 1922, Transactions of the American Entomological Society, V48, P207; CUTTEN FEA, 1970, CAN J ZOOLOG, V48, P1, DOI 10.1139/z70-001; Daugeron C, 2011, BIOL LETTERS, V7, P11, DOI 10.1098/rsbl.2010.0726; FURTH DG, 1990, SYST ENTOMOL, V15, P443, DOI 10.1111/j.1365-3113.1990.tb00076.x; Gao TP, 2012, CURR BIOL, V22, P732, DOI 10.1016/j.cub.2012.03.012; Grimaldi David, 2005, pi; Huang DY, 2012, NATURE, V483, P201, DOI 10.1038/nature10839; Huang Diying, 2010, Dixue Qianyuan, V17, P149; IDE FP, 1965, CAN ENTOMOL, V97, P496, DOI 10.4039/Ent97496-5; Kevan D.K.M., 1981, Canada Department of Agriculture Research Branch Monograph, P203; KEVAN DKM, 1975, CAN J ZOOL, V53, P853, DOI 10.1139/z75-099; Labandeira Conrad C., 2002, Paleontological Society Papers, V8, P211; Marden JH, 2003, BIOL J LINN SOC, V79, P341, DOI 10.1046/j.1095-8312.2003.00192.x; Poinar GO, 2012, CURR BIOL, V22, pR278, DOI 10.1016/j.cub.2012.03.014; Rasnitsyn A. P., 1992, Psyche (Cambridge), V99, P323, DOI 10.1155/1992/20491; Richmond EA, 1920, B AM MUS NAT HIST, V42, P1; Speidel W., 1998, MEMOIRES SOC ENTOMOL, V38, P25; Stys P., 1980, Acta Universitatis Carolinae Biologica, V1978, P409; Vransky Peter, 2010, AMBA Projekty, V8, P1; Wagner R, 2000, SYST ENTOMOL, V25, P115, DOI 10.1046/j.1365-3113.2000.025001115.x; Wang XL, 2002, CHINESE SCI BULL, V47, P226, DOI 10.1360/02tb9054; WILLMANN R, 1981, Z ZOOL SYST EVOL, V19, P96; WOOD DM, 1991, PROCEEDINGS OF THE SECOND INTERNATIONAL CONGRESS OF DIPTEROLOGY, P255; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447	27	30	33	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2013	495	7439					94	97		10.1038/nature11898	http://dx.doi.org/10.1038/nature11898			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23426262				2022-12-24	WOS:000316039800046
J	Juurlink, DN; Dhalla, IA; Nelson, LS				Juurlink, David N.; Dhalla, Irfan A.; Nelson, Lewis S.			Improving Opioid Prescribing The New York City Recommendations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC NONCANCER PAIN		[Juurlink, David N.; Dhalla, Irfan A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Juurlink, David N.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Juurlink, David N.; Dhalla, Irfan A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Juurlink, David N.] St Michaels Hosp, Sunnybrook Res Inst, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Nelson, Lewis S.] NYU, Sch Med, Dept Emergency Med, New York, NY USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; New York University	Juurlink, DN (corresponding author), Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave,G-106, Toronto, ON M4N 3M5, Canada.	david.juurlink@ices.on.ca		Nelson, Lewis/0000-0001-9551-3922				[Anonymous], 2012, PRESCR DRUG AB OV PU; Cantrill SV, 2012, ANN EMERG MED, V60, P499, DOI 10.1016/j.annemergmed.2012.06.013; Chou R, 2009, J PAIN, V10, P147, DOI 10.1016/j.jpain.2008.10.007; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Juurlink DN, 2012, J MED TOXICOL, V8, P393, DOI 10.1007/s13181-012-0269-4; Nelson LS, 2012, JAMA-J AM MED ASSOC, V308, P457, DOI 10.1001/jama.2012.8165; Paone D., 2011, OPIOID ANALGESICS NE; Trescott CE, 2011, HEALTH AFFAIR, V30, P1420, DOI 10.1377/hlthaff.2011.0759; Zgierska A, 2012, JAMA-J AM MED ASSOC, V307, P1377, DOI 10.1001/jama.2012.419	9	30	30	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					879	880		10.1001/jama.2013.1139	http://dx.doi.org/10.1001/jama.2013.1139			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23462783				2022-12-24	WOS:000315632700020
J	Kulendran, M; Leff, DR; Kerr, K; Tekkis, PP; Athanasiou, T; Darzi, A				Kulendran, Myutan; Leff, Daniel R.; Kerr, Karen; Tekkis, Paris P.; Athanasiou, Thanos; Darzi, Ara			Global cancer burden and sustainable health development	LANCET			English	Editorial Material									[Kulendran, Myutan; Leff, Daniel R.; Kerr, Karen; Tekkis, Paris P.; Athanasiou, Thanos; Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, Div Surg, Acad Surg Unit, Dept Canc & Surg, London W2 1NY, England; [Tekkis, Paris P.; Darzi, Ara] Royal Marsden Hosp, Dept Colorectal Surg, London SW3 6JJ, England	Imperial College London; Royal Marsden NHS Foundation Trust	Kulendran, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Surg, Acad Surg Unit, Dept Canc & Surg, London W2 1NY, England.	m.kulendran09@imperial.ac.uk		Leff, Daniel/0000-0002-5310-1046	National Institute for Health Research [NF-SI-0510-10186] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Consortium of Social Science Association (COSSA), 2004, COSSA WASHINGTON UPD, V23, P4; Frenk J, 2009, B WORLD HEALTH ORGAN, V87, P542, DOI 10.2471/BLT.08.053199; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, 2011, CLOS CANC DIV BLUEP; Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1; Hwang J, 2008, HEALTH AFFAIR, V27, P1329, DOI 10.1377/hlthaff.27.5.1329; International Agency for Research on Cancer and Cancer research UK, 2012, WORLD CANC FACTSH; Sarhan M, 2010, 3 REG C CANC BLOOD D; Silver HJ, SOCIAL BEHAV SCI RES; UNGA, 2012, FUTURE WE WANT; World Health Organization and International Agency for Research on Cancer, 2012, PREV CERV CANC SCREE	11	7	7	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2013	381	9865					427	429		10.1016/S0140-6736(13)60138-5	http://dx.doi.org/10.1016/S0140-6736(13)60138-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088CH	23388076				2022-12-24	WOS:000314810900007
J	[Anonymous]				[Anonymous]			Stop Cancer Now!	LANCET			English	Editorial Material																			0	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2013	381	9865					426	+		10.1016/S0140-6736(13)60060-4	http://dx.doi.org/10.1016/S0140-6736(13)60060-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088CH	23388079				2022-12-24	WOS:000314810900006
J	Bartels-Rausch, T				Bartels-Rausch, Thorsten			Ten things we need to know about ice and snow	NATURE			English	Editorial Material									Paul Scherrer Inst, Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Bartels-Rausch, T (corresponding author), Paul Scherrer Inst, Villigen, Switzerland.	thorsten.bartels-rausch@psi.ch	Bartels-Rausch, Thorsten/A-7651-2008	Bartels-Rausch, Thorsten/0000-0002-7548-2572				Bartels-Rausch T., 2012, ATMOS CHEM PHYS DISC, V12, P30, DOI [10.5194/acpd-12-30409-2012, DOI 10.5194/ACPD-12-30409-2012]; Bartels-Rausch T, 2012, REV MOD PHYS, V84, P885, DOI 10.1103/RevModPhys.84.885	2	118	122	6	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					27	29		10.1038/494027a	http://dx.doi.org/10.1038/494027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23389527	Bronze			2022-12-24	WOS:000314741200015
J	DeFina, LF; Willis, BL; Radford, NB; Gao, A; Leonard, D; Haskell, WL; Weiner, MF; Berry, JD				DeFina, Laura F.; Willis, Benjamin L.; Radford, Nina B.; Gao, Ang; Leonard, David; Haskell, William L.; Weiner, Myron F.; Berry, Jarett D.			The Association Between Midlife Cardiorespiratory Fitness Levels and Later-Life Dementia	ANNALS OF INTERNAL MEDICINE			English	Review							PHYSICAL-ACTIVITY; ALZHEIMERS-DISEASE; MEDICARE CLAIMS; RISK-FACTORS; COGNITIVE FUNCTION; DIABETES-MELLITUS; EXERCISE; MORTALITY; MEN; AGE	Background: Primary prevention of Alzheimer disease and other types of dementia (all-cause dementia) is an important public health goal. Evidence to date is insufficient to recommend any lifestyle change to prevent or delay the onset of dementia. Objective: To assess the association between objectively measured midlife cardiorespiratory fitness ("fitness") levels and development of all-cause dementia in advanced age. Design: Prospective, observational cohort study. Setting: Preventive medicine clinic. Patients: 19 458 community-dwelling, nonelderly adults who had a baseline fitness examination. Measurements: Fitness levels, assessed using the modified Balke treadmill protocol between 1971 and 2009, and incident all-cause dementia using Medicare Parts A and B claims data from 1999 to 2009. Results: 1659 cases of incident all-cause dementia occurred during 125 700 person-years of Medicare follow-up (median follow-up, 25 years [interquartile range, 19 to 30 years]). After multivariable adjustment, participants in the highest quintile of fitness level had lower hazard of all-cause dementia than those in the lowest quintile (hazard ratio, 0.64 [95% CI, 0.54 to 0.77]). Higher fitness levels were associated with lower hazard of all-cause dementia with previous stroke (hazard ratio, 0.74 [CI, 0.53 to 1.04]) or without previous stroke (hazard ratio, 0.74 [CI, 0.61 to 0.90]). Limitations: Dementia diagnoses were based on Medicare claims, and participants generally were non-Hispanic white, healthy, and well-educated and had access to preventive health care. This study evaluated fitness levels, so a specific exercise prescription cannot be generated from results and the findings may not be causal. Conclusion: Higher midlife fitness levels seem to be associated with lower hazards of developing all-cause dementia later in life. The magnitude and direction of the association were similar with or without previous stroke, suggesting that higher fitness levels earlier in life may lower risk for dementia later in life, independent of cerebrovascular disease. Primary Funding Source: The Cooper Institute; University of Texas Southwestern Medical Center; National Heart, Lung, and Blood Institute; and American Heart Association. Ann Intern Med. 2013;158:162-168.	[DeFina, Laura F.] Cooper Inst, Dallas, TX 75230 USA; Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA	Cooper Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University	DeFina, LF (corresponding author), Cooper Inst, 12330 Preston Rd, Dallas, TX 75230 USA.	ldefina@cooperinst.org		Weiner, Myron/0000-0001-5682-4410; Radford, Nina/0000-0003-0847-9514	Dedman Family Scholar in Clinical Care endowment at the University of Texas Southwestern Medical Center; National Heart, Lung, and Blood Institute; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092229] Funding Source: NIH RePORTER	Dedman Family Scholar in Clinical Care endowment at the University of Texas Southwestern Medical Center; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Cooper Institute. Dr. Berry receives funding from the Dedman Family Scholar in Clinical Care endowment at the University of Texas Southwestern Medical Center; the National Heart, Lung, and Blood Institute; and the American Heart Association.	Abbott RD, 2004, JAMA-J AM MED ASSOC, V292, P1447, DOI 10.1001/jama.292.12.1447; Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Akomolafe A, 2006, ARCH NEUROL-CHICAGO, V63, P1551, DOI 10.1001/archneur.63.11.1551; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; American College of Sports Medicine, 2009, ACSMS GUID EX TEST P, VV; Andel R, 2008, J GERONTOL A-BIOL, V63, P62, DOI 10.1093/gerona/63.1.62; Barnes DE, 2003, J AM GERIATR SOC, V51, P459, DOI 10.1046/j.1532-5415.2003.51153.x; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Bullitt E, 2009, AM J NEURORADIOL, V30, P1857, DOI 10.3174/ajnr.A1695; Burns JM, 2008, NEUROLOGY, V71, P210, DOI 10.1212/01.wnl.0000317094.86209.cb; Carlson MC, 2008, ALZHEIMERS DEMENT, V4, P324, DOI 10.1016/j.jalz.2008.07.002; Chapman Daniel P, 2006, Prev Chronic Dis, V3, pA34; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Daviglus ML, 2010, NIH CONSENS STATE SC, P27; DUNCAN JJ, 1991, JAMA-J AM MED ASSOC, V266, P3295, DOI 10.1001/jama.266.23.3295; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; Honea RA, 2009, ALZ DIS ASSOC DIS, V23, P188, DOI 10.1097/WAD.0b013e31819cb8a2; Hooker SP, 2008, STROKE, V39, P2950, DOI 10.1161/STROKEAHA.107.495275; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Liu R, 2012, MED SCI SPORT EXER, V44, P253, DOI 10.1249/MSS.0b013e31822cf717; Martin CK, 2009, ARCH INTERN MED, V169, P269, DOI 10.1001/archinternmed.2008.545; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; POLLOCK ML, 1976, AM HEART J, V92, P39, DOI 10.1016/S0002-8703(76)80401-2; POLLOCK ML, 1982, AM HEART J, V103, P363, DOI 10.1016/0002-8703(82)90275-7; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Ravaglia G, 2008, NEUROLOGY, V70, P1786, DOI 10.1212/01.wnl.0000296276.50595.86; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Skinner JS, 2001, J APPL PHYSIOL, V90, P1770, DOI 10.1152/jappl.2001.90.5.1770; Sui X, 2008, DIABETES CARE, V31, P550, DOI 10.2337/dc07-1870; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Taylor DH, 2000, J AM GERIATR SOC, V48, P639, DOI 10.1111/j.1532-5415.2000.tb04721.x; Taylor DH, 2004, J GERONTOL A-BIOL, V59, P762; Taylor DH, 2002, J CLIN EPIDEMIOL, V55, P929, DOI 10.1016/S0895-4356(02)00452-3; Taylor DH, 2009, J ALZHEIMERS DIS, V17, P807, DOI 10.3233/JAD-2009-1099; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Wei M, 1999, ANN INTERN MED, V130, P89, DOI 10.7326/0003-4819-130-2-199901190-00002; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Willis BL, 2011, MED SCI SPORT EXER, V43, P2134, DOI 10.1249/MSS.0b013e31821c00a7; Yamada M, 2003, J AM GERIATR SOC, V51, P410, DOI 10.1046/j.1532-5415.2003.51117.x	45	103	109	1	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3					162	+		10.7326/0003-4819-158-3-201302050-00005	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087JP	23381040	Green Accepted			2022-12-24	WOS:000314757900003
J	Braveman, P				Braveman, Paula			Health in Europe-a view from across the Atlantic	LANCET			English	Editorial Material							UNITED-STATES; DISADVANTAGE; ENGLAND; US		Univ Calif San Francisco, Ctr Social Dispar Hlth, San Francisco, CA 94118 USA	University of California System; University of California San Francisco	Braveman, P (corresponding author), Univ Calif San Francisco, Ctr Social Dispar Hlth, San Francisco, CA 94118 USA.	braveman@fcm.ucsf.edu						Avendano M, 2009, AM J PUBLIC HEALTH, V99, P540, DOI 10.2105/AJPH.2008.139469; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Crimmins EM, 2010, INT DIFFERENCES MORT; CUTLER D, 2005, WHAT EXPLAINS DIFFER; Institute ofMedicine and National Research Council, 2013, US HLTH INT PERSP SH; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; Mackenbach JP, 2013, LANCET; Martinson ML, 2011, AM J EPIDEMIOL, V173, P858, DOI 10.1093/aje/kwq325; Organisation for Economic Co-operation and Development, 2011, HLTH GLANC 2011 OECD; Organisation for Economic Co-operation and Development, 2013, GDP GROWTH NAT ACC G; Pampel F., 2010, DIVERGENT PATTERNS S, P132; Rechel B, 2013, LANCET; Wilkinson R., 2010, SPIRIT LEVEL WHY GRE; [No title captured]	15	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 13	2013	381	9874					1257	1259		10.1016/S0140-6736(13)60587-5	http://dx.doi.org/10.1016/S0140-6736(13)60587-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122XD	23541060	Bronze			2022-12-24	WOS:000317351000009
J	Paul, S; Million-Weaver, S; Chattopadhyay, S; Sokurenko, E; Merrikh, H				Paul, Sandip; Million-Weaver, Samuel; Chattopadhyay, Sujay; Sokurenko, Evgeni; Merrikh, Houra			Accelerated gene evolution through replication-transcription conflicts	NATURE			English	Article							ESCHERICHIA-COLI; FLUCTUATION ANALYSIS; DNA-REPLICATION; LEADING-STRAND; LAGGING-STRAND; ESSENTIALITY; ORGANIZATION; MUTAGENESIS; EXPRESSION; MUTATIONS	Several mechanisms that increase the rate of mutagenesis across the entire genome have been identified; however, how the rate of evolution might be promoted in individual genes is unclear. Most genes in bacteria are encoded on the leading strand of replication(1-4). This presumably avoids the potentially detrimental head-on collisions that occur between the replication and transcription machineries when genes are encoded on the lagging strand(1-4). Here we identify the ubiquitous (core) genes in Bacillus subtilis and determine that 17% of them are on the lagging strand. We find a higher rate of point mutations in the core genes on the lagging strand compared with those on the leading strand, with this difference being primarily in the amino-acid-changing (nonsynonymous) mutations. We determine that, overall, the genes under strong negative selection against amino-acid-changing mutations tend to be on the leading strand, co-oriented with replication. In contrast, on the basis of the rate of convergent mutations, genes under positive selection for amino-acid-changing mutations are more commonly found on the lagging strand, indicating faster adaptive evolution in many genes in the head-on orientation. Increased gene length and gene expression amounts are positively correlated with the rate of accumulation of nonsynonymous mutations in the head-on genes, suggesting that the conflict between replication and transcription could be a driving force behind these mutations. Indeed, using reversion assays, we show that the difference in the rate of mutagenesis of genes in the two orientations is transcription dependent. Altogether, our findings indicate that head-on replication-transcription conflicts are more mutagenic than co-directional conflicts and that these encounters can significantly increase adaptive structural variation in the coded proteins. We propose that bacteria, and potentially other organisms, promote faster evolution of specific genes through orientation-dependent encounters between DNA replication and transcription.	[Paul, Sandip; Million-Weaver, Samuel; Chattopadhyay, Sujay; Sokurenko, Evgeni; Merrikh, Houra] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Sokurenko, E (corresponding author), Univ Washington, Dept Microbiol, Hlth Sci Bldg J Wing, Seattle, WA 98195 USA.	evs@u.washington.edu; merrikh@uw.edu	Chattopadhyay, Sujay/AAA-5772-2022; Paul, Sandip/C-1224-2010	Chattopadhyay, Sujay/0000-0003-1785-2683; Paul, Sandip/0000-0001-7406-3598; Million-Weaver, Samuel/0000-0001-9057-6326	Department of Microbiology at the University of Washington; University of Washington Biophysics Training Grant; National Institutes of Health (NIH) [RC4 AI092828, R01 GM084318]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC4AI092828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084318, T32GM008268] Funding Source: NIH RePORTER	Department of Microbiology at the University of Washington; University of Washington Biophysics Training Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the work of others that has contributed to our understanding of the topic, which we were unable to cite here. We thank B. Brewer, J. Mougous, F. Fang, M. Parsek and S. Miller for reading the manuscript. We thank C. Merrikh for comments on the manuscript and technical help with sequencing of revertants. We thank E. Robleto for the auxotrophic YB955 strain. H. M. was supported by start-up funds from the Department of Microbiology at the University of Washington. S.M.-W. was supported by the University of Washington Biophysics Training Grant. E. S., S. P, and S. C. were supported by National Institutes of Health (NIH) grants RC4 AI092828 and R01 GM084318.	Chattopadhyay S, 2009, P NATL ACAD SCI USA, V106, P12412, DOI 10.1073/pnas.0906217106; Chattopadhyay S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-187; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Christin PA, 2010, TRENDS GENET, V26, P400, DOI 10.1016/j.tig.2010.06.005; De Septenville AL, 2012, PLOS GENET, V8, P116, DOI 10.1371/journal.pgen.1002622; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fijalkowska IJ, 1998, P NATL ACAD SCI USA, V95, P10020, DOI 10.1073/pnas.95.17.10020; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Juurik T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048511; Kim N, 2007, DNA REPAIR, V6, P1285, DOI 10.1016/j.dnarep.2007.02.023; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin CH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S9-S19; Maliszewska-Tkaczyk M, 2000, P NATL ACAD SCI USA, V97, P12678, DOI 10.1073/pnas.220424697; Merrikh H, 2012, NAT REV MICROBIOL, V10, P449, DOI 10.1038/nrmicro2800; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Price MN, 2005, NUCLEIC ACIDS RES, V33, P3224, DOI 10.1093/nar/gki638; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rocha EPC, 2003, NUCLEIC ACIDS RES, V31, P6570, DOI 10.1093/nar/gkg859; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; Suzuki Y, 2003, PHYLOGENETIC HDB PRA, P283; Szczepanik D, 2001, J MOL EVOL, V52, P426, DOI 10.1007/s002390010172; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; VEAUTE X, 1993, SCIENCE, V261, P598, DOI 10.1126/science.8342022	30	93	93	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					512	+		10.1038/nature11989	http://dx.doi.org/10.1038/nature11989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23538833	Green Accepted			2022-12-24	WOS:000316682800046
J	Pijnappel, WWMP; Esch, D; Baltissen, MPA; Wu, GM; Mischerikow, N; Bergsma, AJ; van der Wal, E; Han, DW; vom Bruch, H; Moritz, S; Lijnzaad, P; Altelaar, AFM; Sameith, K; Zaehres, H; Heck, AJR; Holstege, FCP; Scholer, HR; Timmers, HTM				Pijnappel, W. W. M. Pim; Esch, Daniel; Baltissen, Marijke P. A.; Wu, Guangming; Mischerikow, Nikolai; Bergsma, Atze J.; van der Wal, Erik; Han, Dong Wook; vom Bruch, Hermann; Moritz, Soeren; Lijnzaad, Phillip; Altelaar, A. F. Maarten; Sameith, Katrin; Zaehres, Holm; Heck, Albert J. R.; Holstege, Frank C. P.; Schoeler, Hans R.; Timmers, H. T. Marc			A central role for TFIID in the pluripotent transcription circuitry	NATURE			English	Article							STEM-CELLS; NETWORK; MECHANISMS; SURVIVAL; GENES	Embryonic stem (ES) cells are pluripotent and characterized by open chromatin and high transcription levels, achieved through auto-regulatory and feed-forward transcription factor loops(1,2). ES-cell identity is maintained by a core of factors including Oct4 (also known as Pou5f1), Sox2, Klf4, c-Myc (OSKM) and Nanog(2-4), and forced expression of the OSKM factors can reprogram somatic cells into induced pluripotent stem cells (iPSCs) resembling ES cells(5,6). These gene-specific factors for RNA-polymerase-II-mediated transcription recruit transcriptional cofactors and chromatin regulators that control access to and activity of the basal transcription machinery on gene promoters(7,8). How the basal transcription machinery is involved in setting and maintaining the pluripotent state is unclear. Here we show that knockdown of the transcription factor IID (TFIID) complex affects the pluripotent circuitry in mouse ES cells and inhibits reprogramming of fibroblasts. TFIID subunits and the OSKM factors forma feed-forward loop to induce and maintain a stable transcription state. Notably, transient expression of TFIID subunits greatly enhanced reprogramming. These results show that TFIID is critical for transcription-factor-mediated reprogramming. We anticipate that, by creating plasticity in gene expression programs, transcription complexes such as TFIID assist reprogramming into different cellular states.	[Pijnappel, W. W. M. Pim; Baltissen, Marijke P. A.; Bergsma, Atze J.; Lijnzaad, Phillip; Sameith, Katrin; Holstege, Frank C. P.; Timmers, H. T. Marc] Univ Med Ctr Utrecht, Mol Canc Res, NL-3584 CG Utrecht, Netherlands; [Pijnappel, W. W. M. Pim; Baltissen, Marijke P. A.; Mischerikow, Nikolai; Altelaar, A. F. Maarten; Heck, Albert J. R.; Timmers, H. T. Marc] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands; [Pijnappel, W. W. M. Pim; van der Wal, Erik] Erasmus MC, Dept Pediat, NL-3015 GE Rotterdam, Netherlands; [Pijnappel, W. W. M. Pim; van der Wal, Erik] Erasmus MC, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; [Esch, Daniel; Wu, Guangming; van der Wal, Erik; Han, Dong Wook; vom Bruch, Hermann; Moritz, Soeren; Zaehres, Holm; Schoeler, Hans R.] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Mischerikow, Nikolai; Altelaar, A. F. Maarten; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Mischerikow, Nikolai; Altelaar, A. F. Maarten; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Max Planck Society; Utrecht University; Utrecht University	Timmers, HTM (corresponding author), Univ Med Ctr Utrecht, Mol Canc Res, NL-3584 CG Utrecht, Netherlands.	h.t.m.timmers@umcutrecht.nl	Heck, Albert/D-7098-2011; Holstege, Frank/AAM-9944-2021; , HS/AAB-4434-2019; Bergsma, Atze/AAV-6273-2020; Lijnzaad, Philip/ABE-4205-2021; Altelaar, Maarten/I-3845-2016	Heck, Albert/0000-0002-2405-4404; , HS/0000-0003-2643-5136; Bergsma, Atze/0000-0002-8733-5078; Lijnzaad, Philip/0000-0002-7535-583X; Altelaar, Maarten/0000-0001-5093-5945; Sameith, Katrin/0000-0003-4306-930X; Pijnappel, Pim/0000-0002-7042-2482	Netherlands Proteomics Centre, Netherlands Organization for Scientific Research [700.57.302]; Deutsche Forschungsgemeinschaft (DFG) [SPP 1356/2]; European Union [EUTRACC LSHG-CT-2006-037445]	Netherlands Proteomics Centre, Netherlands Organization for Scientific Research; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union(European Commission)	This work is funded by the Netherlands Proteomics Centre, Netherlands Organization for Scientific Research (TOP#700.57.302), Deutsche Forschungsgemeinschaft (DFG Priority Program SPP 1356/2) and the European Union (EUTRACC LSHG-CT-2006-037445). We thank M. Groot Koerkamp and D. van Leenen for microarray analysis, M. de Bruijn and O. Kranenburg for advice on lentiviral knockdown experiments, F. Stewart for help with BAC recombineering, I. Davidson and R. Tjian for TAF cDNA constructs, N. Outchkourov for the GFP-tagging vector, B. Roeder, T. Oelgeschlager and G. Kops for antibodies, M. Stehling for help with the FACS analyses, A. Schambach and C. Baum for the lentiviral OSKM vector, M. Sgodda and T. Cantz for human fibroblasts, M. Radstaak for assistance with human iPSC culture and P. de Graaf, N. Jelluma and M. Vermeulen for critical reading of the manuscript.	Bieniossek C., 2013, NATURE; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gegonne A, 2012, MOL CELL BIOL, V32, P1984, DOI 10.1128/MCB.06305-11; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Maston GA, 2012, ELIFE, V1, DOI 10.7554/eLife.00068; Munoz J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.84; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sterneckert J, 2012, STEM CELLS, V30, P15, DOI 10.1002/stem.765; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Voss AK, 2000, DEVELOPMENT, V127, P5449; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180	29	59	62	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					516	519		10.1038/nature11970	http://dx.doi.org/10.1038/nature11970			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23503660				2022-12-24	WOS:000316682800047
J	Loscalzo, J				Loscalzo, Joseph			BASIC IMPLICATIONS OF CLINICAL OBSERVATIONS Venous Thrombosis in the Nephrotic Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GLOMERULAR PERMEABILITY; PATHOPHYSIOLOGY; EXPRESSION		[Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Loscalzo, J (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.		Loscalzo, Joseph/ABD-8980-2021					BRENNER BM, 1978, AM J PHYSIOL, V234, pF455, DOI 10.1152/ajprenal.1978.234.6.F455; COSIO FG, 1985, J LAB CLIN MED, V106, P218; Derow HA, 1939, ARCH INTERN MED, V63, P626, DOI 10.1001/archinte.1939.00180210019002; Dickinson WH, 1885, RENAL URINARY AFFECT, P32; Hamano K, 2002, AM J KIDNEY DIS, V39, P695, DOI 10.1053/ajkd.2002.31986; HUANG F, 1967, NATURE, V216, P87, DOI 10.1038/216087a0; KAUFFMANN R H, 1978, American Journal of Medicine, V65, P607, DOI 10.1016/0002-9343(78)90848-3; KAUFFMANN RH, 1976, AM J MED, V60, P1048, DOI 10.1016/0002-9343(76)90579-9; KENDALL AG, 1971, ARCH INTERN MED, V127, P1021, DOI 10.1001/archinte.127.6.1021; Kerlin BA, 2012, CLIN J AM SOC NEPHRO, V7, P513, DOI 10.2215/CJN.10131011; Rabelink TJ, 1994, KIDNEY INT, V46, P287; Resh M, 2011, THROMB RES, V127, P395, DOI 10.1016/j.thromres.2010.12.020; ROBSON AM, 1974, J CLIN INVEST, V54, P1190, DOI 10.1172/JCI107862; SHATTIL SJ, 1975, J CLIN INVEST, V55, P636, DOI 10.1172/JCI107971; Singhal R, 2006, THROMB RES, V118, P397, DOI 10.1016/j.thromres.2005.03.030; Sraer J D, 1988, Adv Nephrol Necker Hosp, V17, P27; THOMSON C, 1974, Q J MED, V43, P399; VAZIRI ND, 1984, ARCH INTERN MED, V144, P1802, DOI 10.1001/archinte.144.9.1802; VENKATACHALAM MA, 1969, J EXP MED, V130, P381, DOI 10.1084/jem.130.2.381; YASHIRO M, 1994, NEPHROL DIAL TRANSPL, V9, P1842; YOSHIDA N, 1978, BLOOD, V52, P969; Yoshida Y, 2001, NEPHRON, V88, P24, DOI 10.1159/000045954	22	55	61	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					956	958		10.1056/NEJMcibr1209459	http://dx.doi.org/10.1056/NEJMcibr1209459			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BG	23465106				2022-12-24	WOS:000315669100014
J	Chan, TK				Chan, Tak Kwong			Doctors have a duty to breach patient confidentiality to protect others at risk of HIV infection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Chan, TK (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	theo@hku.hk						Erin Charles A, 1993, J Appl Philos, V10, P165, DOI 10.1111/j.1468-5930.1993.tb00073.x; General Medical Council, 2009, CONFIDENTIALITY GUID; HM Government, 1988, THE PUBLIC HEALTH IN; Hogben M, 2007, AM J PREV MED, V33, pS89, DOI 10.1016/j.amepre.2007.04.015; Mill JS, 2005, ON LIBERTY 1859; Mulheron R, 2010, MEDICAL NEGLIGENCE: NON-PATIENT AND THIRD PARTY CLAIMS, P1; Przybyla SM, 2012, AIDS CARE; Suzan-Monti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055225	8	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2013	346								f1471	10.1136/bmj.f1471	http://dx.doi.org/10.1136/bmj.f1471			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104MS	23468325	Green Submitted			2022-12-24	WOS:000315998300013
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: antenatal screening	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Dani C, 2009, J PERINAT MED, V37, P599, DOI 10.1515/JPM.2009.117; Department of Health, 2011, AB STAT ENGL WAL 201; Kucik JE, 2013, PEDIATRICS, V131, pE27, DOI 10.1542/peds.2012-1616; RCOG, 2010, TERM PREGN FET ABN E; Wilson JMG, 1968, PRINCIPLES PRACTICE	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2013	346								f1226	10.1136/bmj.f1226	http://dx.doi.org/10.1136/bmj.f1226			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BJ	23444415				2022-12-24	WOS:000315669400013
J	Warr, MR; Binnewies, M; Flach, J; Reynaud, D; Garg, T; Malhotra, R; Debnath, J; Passegue, E				Warr, Matthew R.; Binnewies, Mikhail; Flach, Johanna; Reynaud, Damien; Garg, Trit; Malhotra, Ritu; Debnath, Jayanta; Passegue, Emmanuelle			FOXO3A directs a protective autophagy program in haematopoietic stem cells	NATURE			English	Article							GENE ATG5; MITOCHONDRIA; MAINTENANCE; MECHANISMS; SURVIVAL; PATHWAYS; PLAYS; DEATH	Blood production is ensured by rare, self-renewing haematopoietic stem cells (HSCs). How HSCs accommodate the diverse cellular stresses associated with their life-long activity remains elusive. Here we identify autophagy as an essential mechanism protecting HSCs from metabolic stress. We show that mouse HSCs, in contrast to their short-lived myeloid progeny, robustly induce autophagy after ex vivo cytokine withdrawal and in vivo calorie restriction. We demonstrate that FOXO3A is critical to maintain a gene expression program that poises HSCs for rapid induction of autophagy upon starvation. Notably, we find that old HSCs retain an intact FOXO3A-driven pro-autophagy gene program, and that ongoing autophagy is needed to mitigate an energy crisis and allow their survival. Our results demonstrate that autophagy is essential for the life-long maintenance of the HSC compartment and for supporting an old, failing blood system.	[Warr, Matthew R.; Binnewies, Mikhail; Flach, Johanna; Reynaud, Damien; Garg, Trit; Passegue, Emmanuelle] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Malhotra, Ritu; Debnath, Jayanta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Passegue, E (corresponding author), Univ Calif San Francisco, Dept Med, Div Hematol Oncol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	PassegueE@stemcell.ucsf.edu		Reynaud, Damien/0000-0001-8765-8419; Passegue, Emmanuelle/0000-0002-3516-297X; Debnath, Jayanta/0000-0002-8745-4069	Culpepper Scholar Award; NIH [CA126792, HL092471]; CIRM New Faculty Award; NATIONAL CANCER INSTITUTE [R01CA126792, R01CA184014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092471, R01HL111266] Funding Source: NIH RePORTER	Culpepper Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM New Faculty Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Brunet for Foxo3a<SUP>-/-</SUP> mice, S. Oakes for Bak<SUP>-/-</SUP> Sax<SUP>fl/fl</SUP> mice, N. Mizushima for GFP-LC3 transgenic mice, J. Wong for electron microscopy analyses, M. Kissner for management of our Flow Cytometry Core Facility, and all members of the Passegue, particularly E. Pietras, and Debnath laboratories for critical insights and suggestions. M.R.W. is an LLS Special Fellow. This work was supported by a Culpepper Scholar Award (Partnership for Cures) and NIH grant CA126792 to J.D., and a CIRM New Faculty Award and NIH grant HL092471 to E.P.	Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730; Ferraro E, 2007, ARCH BIOCHEM BIOPHYS, V462, P210, DOI 10.1016/j.abb.2007.02.006; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Oguro H, 2007, CURR OPIN IMMUNOL, V19, P503, DOI 10.1016/j.coi.2007.05.001; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Warr MR, 2011, WIRES SYST BIOL MED, V3, P681, DOI 10.1002/wsbm.145; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005	33	411	429	2	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					323	327		10.1038/nature11895	http://dx.doi.org/10.1038/nature11895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23389440	Green Accepted, Green Submitted			2022-12-24	WOS:000315312900031
J	Jones, CM; Mack, KA; Paulozzi, LJ				Jones, Christopher M.; Mack, Karin A.; Paulozzi, Leonard J.			Pharmaceutical Overdose Deaths, United States, 2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Jones, Christopher M.; Mack, Karin A.; Paulozzi, Leonard J.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Jones, CM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30329 USA.	fjr0@cdc.gov	Mack, Karin A/A-3263-2012; MACK, KARIN/P-9227-2019	Mack, Karin A/0000-0001-9274-3001; 				Becker WC, 2008, DRUG ALCOHOL DEPEN, V94, P38, DOI 10.1016/j.drugalcdep.2007.09.018; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Centers for Disease Control and Prevention. National Vital Statistics System, 2010, NAT VIT STAT SYST 20; Edlund MJ, 2010, J PAIN SYMPTOM MANAG, V40, P279, DOI 10.1016/j.jpainsymman.2010.01.012; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Wysowski DK, 2007, DRUG SAFETY, V30, P533, DOI 10.2165/00002018-200730060-00007	6	506	513	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					657	659		10.1001/jama.2013.272	http://dx.doi.org/10.1001/jama.2013.272			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091EK	23423407	Bronze			2022-12-24	WOS:000315032000016
J	Kamerow, D				Kamerow, Douglas			Reassessing hospital readmission penalties	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							30-DAY READMISSIONS		RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; Rau J, 2012, KAISER HLTH NEW 1126; Williams MV, 2013, JAMA-J AM MED ASSOC, V309, P394, DOI 10.1001/jama.2012.233964	5	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2013	346								f1043	10.1136/bmj.f1043	http://dx.doi.org/10.1136/bmj.f1043			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZR	23412742				2022-12-24	WOS:000315088800006
J	Lindenauer, PK; Lagu, T; Rothberg, MB; Avrunin, J; Pekow, PS; Wang, YF; Hines, HMKHJ				Lindenauer, Peter K.; Lagu, Tara; Rothberg, Michael B.; Avrunin, Jill; Pekow, Penelope S.; Wang, Yongfei; Hines, Harlan M. Krumholz Harold J., Jr.			Income inequality and 30 day outcomes after acute myocardial infarction, heart failure, and pneumonia: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROFILING HOSPITAL PERFORMANCE; CAUSE READMISSION RATES; 30-DAY MORTALITY-RATES; HEALTH; RISK; CARE	Objectives To examine the association between income inequality and the risk of mortality and readmission within 30 days of hospitalization. Design Retrospective cohort study of Medicare beneficiaries in the United States. Hierarchical, logistic regression models were developed to estimate the association between income inequality (measured at the US state level) and a patient's risk of mortality and readmission, while sequentially controlling for patient, hospital, other state, and patient socioeconomic characteristics. We considered a 0.05 unit increase in the Gini coefficient as a measure of income inequality. Setting US acute care hospitals. Participants Patients aged 65 years and older, and hospitalized in 2006-08 with a principal diagnosis of acute myocardial infarction, heart failure, or pneumonia. Main outcome measures Risk of death within 30 days of admission or rehospitalization for any cause within 30 days of discharge. The potential number of excess deaths and readmissions associated with higher levels of inequality in US states in the three highest quarters of income inequality were compared with corresponding data in US states in the lowest quarter. Results Mortality analyses included 555 962 admissions (4348 hospitals) for acute myocardial infarction, 1 092 285 (4484) for heart failure, and 1 146 414 (4520); readmission analyses included 553 037 (4262), 1 345 909 (4494), and 1 345 909 (4524) admissions, respectively. In 2006-08, income inequality in US states (as measured by the average Gini coefficient over three years) varied from 0.41 in Utah to 0.50 in New York. Multilevel models showed no significant association between income inequality and mortality within 30 days of admission for patients with acute myocardial infarction, heart failure, or pneumonia. By contrast, income inequality was associated with rehospitalization (acute myocardial infarction, risk ratio 1.09 (95% confidence interval 1.03 to 1.15), heart failure 1.07 (1.01 to 1.12), pneumonia 1.09 (1.03 to 1.15)). Further adjustment for individual income and educational achievement did not significantly attenuate these findings. Over the three year period, we estimate an excess of 7153 (2297 to 11 733) readmissions for acute myocardial infarction, 17 991 (3410 to 31 772) for heart failure, and 14 127 (4617 to 23 115) for pneumonia, that are associated with inequality levels in US states in the three highest quarters of income inequality, compared with US states in the lowest quarter. Conclusions Among patients hospitalized with acute myocardial infarction, heart failure, and pneumonia, exposure to higher levels of income inequality was associated with increased risk of readmission but not mortality. In view of the observational design of the study, these findings could be biased, owing to residual confounding.	[Lindenauer, Peter K.; Lagu, Tara; Rothberg, Michael B.; Avrunin, Jill; Pekow, Penelope S.] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA; [Lindenauer, Peter K.; Lagu, Tara; Rothberg, Michael B.] Baystate Med Ctr, Div Gen Internal Med, Springfield, MA 01199 USA; [Lindenauer, Peter K.; Lagu, Tara; Rothberg, Michael B.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Pekow, Penelope S.] Univ Massachusetts, Div Biostat & Epidemiol, Dept Publ Hlth, Amherst, MA 01003 USA; [Wang, Yongfei; Hines, Harlan M. Krumholz Harold J., Jr.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Wang, Yongfei; Hines, Harlan M. Krumholz Harold J., Jr.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Wang, Yongfei; Hines, Harlan M. Krumholz Harold J., Jr.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, Dept Med, New Haven, CT USA; [Wang, Yongfei; Hines, Harlan M. Krumholz Harold J., Jr.] Yale Univ, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT USA	Baystate Medical Center; Baystate Medical Center; Tufts University; Massachusetts Department of Public Health; University of Massachusetts System; University of Massachusetts Amherst; Yale University; Yale University; Yale University; Yale University	Lindenauer, PK (corresponding author), Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA.	peter.lindenauer@bhs.org	Lagu, Tara/GPT-5173-2022	Lagu, Tara/0000-0001-6155-5796	(Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute [U01 HL105270-02]; National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	(Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	HMK is supported by grant U01 HL105270-02 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the National Heart, Lung, and Blood Institute for the submitted work; PKL, TCL, MBR, JSA, and PSP have no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; HMK is the recipient of a research grant from Medtronic, through Yale University and is chair of a cardiac scientific advisory board for UnitedHealth; PKL, TCL, MBR, JA, PSP, and YW have no other relationships or activities that could appear to have influenced the submitted work.	American Hospital Association, 2012, ANN SURV HOSP DAT; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Bernstein J., 2008, PULLING APART STATE; Bishaw A, 2008, AM COMMUNITY SURVEY; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Epstein AM, 2011, NEW ENGL J MED, V365, P2287, DOI 10.1056/NEJMsa1101942; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kaiser Family Foundation, 2012, KAIS STAT HLTH FACTS; Kaplan GA, 1996, BRIT MED J, V312, P999; Kawachi I, 1999, AM J PUBLIC HEALTH, V89, P1187, DOI 10.2105/AJPH.89.8.1187; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kawachi I., 2006, HLTH NATIONS WHY INE; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kennedy BP, 1996, BRIT MED J, V312, P1004, DOI 10.1136/bmj.312.7037.1004; Kondo N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4471; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Mellor JM, 2003, HEALTH SERV RES, V38, P137, DOI 10.1111/1475-6773.00109; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Pickett KE, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4320; Pope GC., 2000, DIAGNOSTIC COST GROU; Smith GD, 1996, BRIT MED J, V312, P987; Subramanian SV, 2006, INT J SOC WELF, V15, pS13, DOI 10.1111/j.1468-2397.2006.00440.x; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; U.S. Census Bureau, 2021, AM COMMUNITY SURVEY; *US CENS BUR, 2008, AM COMM SURV; US Census Bureau, ANN SOCIAL EC S; US Census Bureau, 2011, ANN SOCIAL EC S; Wilkinson R, 2005, IMPACT INEQUALITY MA; Wilkinson R., 1996, UNHEALTHY SOC AFFLIC; WILKINSON RG, 1992, BRIT MED J, V304, P165, DOI 10.1136/bmj.304.6820.165; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	36	89	92	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2013	346								f521	10.1136/bmj.f521	http://dx.doi.org/10.1136/bmj.f521			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZR	23412830	Green Published, hybrid			2022-12-24	WOS:000315088800010
J	Hawton, K; Bergen, H; Simkin, S; Dodd, S; Pocock, P; Bernal, W; Gunnell, D; Kapur, N				Hawton, Keith; Bergen, Helen; Simkin, Sue; Dodd, Sue; Pocock, Phil; Bernal, William; Gunnell, David; Kapur, Navneet			Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: interrupted time series analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-KINGDOM; SELF-HARM; CHANGING PATTERNS; UK; ACETAMINOPHEN; LEGISLATION; SUICIDE; FAILURE; IMPACT; AVAILABILITY	Objective To assess the long term effect of United Kingdom legislation introduced in September 1998 to restrict pack sizes of paracetamol on deaths from paracetamol poisoning and liver unit activity. Design Interrupted time series analyses to assess mean quarterly changes from October 1998 to the end of 2009 relative to projected deaths without the legislation based on pre-legislation trends. Setting Mortality (1993-2009) and liver unit activity (1995-2009) in England and Wales, using information from the Office for National Statistics and NHS Blood and Transplant, respectively. Participants Residents of England and Wales. Main outcome measures Suicide, deaths of undetermined intent, and accidental poisoning deaths involving single drug ingestion of paracetamol and paracetamol compounds in people aged 10 years and over, and liver unit registrations and transplantations for paracetamol induced hepatotoxicity. Results Compared with the pre-legislation level, following the legislation there was an estimated average reduction of 17 (95% confidence interval -25 to -9) deaths per quarter in England and Wales involving paracetamol alone (with or without alcohol) that received suicide or undetermined verdicts. This decrease represented a 43% reduction or an estimated 765 fewer deaths over the 11 1/4 years after the legislation. A similar effect was found when accidental poisoning deaths were included, and when a conservative method of analysis was used. This decrease was largely unaltered after controlling for a non-significant reduction in deaths involving other methods of poisoning and also suicides by all methods. There was a 61% reduction in registrations for liver transplantation for paracetamol induced hepatotoxicity (-11 (-20 to -1) registrations per quarter). But no reduction was seen in actual transplantations (-3 (-12 to 6)), nor in registrations after a conservative method of analysis was used. Conclusions UK legislation to reduce pack sizes of paracetamol was followed by significant reductions in deaths due to paracetamol overdose, with some indication of fewer registrations for transplantation at liver units during the 11 years after the legislation. The continuing toll of deaths suggests, however, that further preventive measures should be sought.	[Hawton, Keith; Bergen, Helen; Simkin, Sue] Univ Oxford, Ctr Suicide Res, Dept Psychiat, Warneford Hosp, Oxford OX3 7JX, England; [Dodd, Sue] Med & Healthcare Prod Regulatory Agcy, Post Authorisat Signal Unit, London, England; [Pocock, Phil] NHS Blood & Transplant, Stat & Clin Audit, Bristol, Avon, England; [Bernal, William] Kings Coll Hosp London, Liver Intens Therapy Unit, Inst Liver Studies, London, England; [Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Kapur, Navneet] Univ Manchester, Ctr Suicide Prevent, Manchester, Lancs, England	University of Oxford; The Medicines & Healthcare Products Regulatory Agency; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of Bristol; University of Manchester	Hawton, K (corresponding author), Univ Oxford, Ctr Suicide Res, Dept Psychiat, Warneford Hosp, Oxford OX3 7JX, England.	keith.hawton@psych.ox.ac.uk	Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Kapur, Nav/0000-0002-3100-3234	National Institute for Health Research (NIHR) [RP-PG-0606-1247]; Oxford Health NHS Foundation Trust; Department of Health under the NHS Research and Development Programme [DH/DSH2008]; Manchester Mental Health and Social Care Trust; National Institute for Health Research [NF-SI-0508-10053, RP-PG-0606-1247, NF-SI-0512-10068] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Oxford Health NHS Foundation Trust; Department of Health under the NHS Research and Development Programme; Manchester Mental Health and Social Care Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (RP-PG-0606-1247) as part of a programme of work related to suicide prevention. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health, or the Medicines and Healthcare Products Regulatory Agency. The funder had no role in the study design; collection, analysis, and interpretation of data; writing of the report; and decision to submit the paper for publication. KH and DG are NIHR senior investigators. KH is also supported by the Oxford Health NHS Foundation Trust, HB by the Department of Health under the NHS Research and Development Programme (DH/DSH2008), and NK by the Manchester Mental Health and Social Care Trust.	Bateman DN, 2006, BRIT J CLIN PHARMACO, V62, P573, DOI 10.1111/j.1365-2125.2006.02668.x; Bateman DN, 2009, CLIN TOXICOL, V47, P536, DOI 10.1080/15563650903093192; Bergen H, 2010, BRIT J PSYCHIAT, V197, P493, DOI 10.1192/bjp.bp.110.077651; Bernal W, 2003, SEMIN LIVER DIS, V23, P227; Bernal W, 2008, SEMIN LIVER DIS, V28, P188, DOI 10.1055/s-2008-1073118; Bialas MC, 1996, QJM-INT J MED, V89, P893; BRAY GP, 1993, BRIT MED J, V306, P157, DOI 10.1136/bmj.306.6871.157; Buckley NA, 2007, PLOS MED, V4, P612, DOI 10.1371/journal.pmed.0040152; Charlton J., 1993, POPULATION TRENDS, V71, P34; Gottlieb S, 2005, BRIT MED J, V330, P9, DOI 10.1136/bmj.330.7481.9-c; Gow PJ, 1999, J GASTROEN HEPATOL, V14, P817, DOI 10.1046/j.1440-1746.1999.01959.x; Greene SL, 2006, POSTGRAD MED J, V82, P520, DOI 10.1136/pgmj.2005.042036; Gunnell D, 1997, J EPIDEMIOL COMMUN H, V51, P175, DOI 10.1136/jech.51.2.175; Gunnell D, 2000, SUICIDE LIFE-THREAT, V30, P313; Gunnell D, 1997, CURRENT PROBLEMS PHA, V23, P9; Hawkins LC, 2007, DRUG SAFETY, V30, P465, DOI 10.2165/00002018-200730060-00002; HAWTON K, 1995, BRIT MED J, V310, P164, DOI 10.1136/bmj.310.6973.164; Hawton K, 2004, BMJ-BRIT MED J, V329, P1076, DOI 10.1136/bmj.38253.572581.7C; Hawton K, 2001, BMJ-BRIT MED J, V322, P1203, DOI 10.1136/bmj.322.7296.1203; Hawton K, 1997, BRIT J PSYCHIAT, V171, P556, DOI 10.1192/bjp.171.6.556; Hawton K, 1996, BRIT J PSYCHIAT, V168, P43, DOI 10.1192/bjp.168.1.43; Hawton K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001213; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; Moller LR, 2004, EUR J CLIN PHARMACOL, V59, P911, DOI 10.1007/s00228-003-0713-0; Morgan O, 2005, J PUBLIC HEALTH, V27, P19, DOI 10.1093/pubmed/fdh216; Morgan OW, 2007, PLOS MED, V4, P654, DOI 10.1371/journal.pmed.0040105; Neuberger J, 2008, GUT, V57, P252, DOI 10.1136/gut.2007.131730; Prince MI, 2000, LANCET, V355, P2047, DOI 10.1016/S0140-6736(00)02354-0; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Sheen CL, 2002, PHARMACOEPIDEM DR S, V11, P329, DOI 10.1002/pds.701; Simkin S, 2012, QJM-INT J MED, V105, P41, DOI 10.1093/qjmed/hcr135; *STAT CORP, 2007, STAT STAT SOFTW REL; U.S. Food and Drug Administration, 2011, FDA LIM AC PRESCR CO; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Zhang F, 2002, ESTIMATING CONFIDENC	36	127	128	0	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2013	346								f403	10.1136/bmj.f403	http://dx.doi.org/10.1136/bmj.f403			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088AV	23393081	hybrid, Green Published			2022-12-24	WOS:000314807100001
J	Kornfeld, JW; Baitzel, C; Konner, AC; Nicholls, HT; Vogt, MC; Herrmanns, K; Scheja, L; Haumaitre, C; Wolf, AM; Knippschild, U; Seibler, J; Cereghini, S; Heeren, J; Stoffel, M; Bruning, JC				Kornfeld, Jan-Wilhelm; Baitzel, Catherina; Koenner, A. Christine; Nicholls, Hayley T.; Vogt, Merly C.; Herrmanns, Karolin; Scheja, Ludger; Haumaitre, Cecile; Wolf, Anna M.; Knippschild, Uwe; Seibler, Jost; Cereghini, Silvia; Heeren, Joerg; Stoffel, Markus; Bruening, Jens C.			Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b	NATURE			English	Article							INSULIN; CDKN2A/B; CDKAL1; TCF2	Insulin resistance represents a hallmark during the development of type 2 diabetes mellitus and in the pathogenesis of obesity-associated disturbances of glucose and lipid metabolism(1-3). MicroRNA (miRNA)-dependent post-transcriptional gene silencing has been recognized recently to control gene expression in disease development and progression, including that of insulin-resistant type 2 diabetes. The deregulation of miRNAs miR-143 (ref. 4), miR-181 (ref. 5), and miR-103 and miR-107 (ref. 6) alters hepatic insulin sensitivity. Here we report that the expression of miR-802 is increased in the liver of two obese mouse models and obese human subjects. Inducible transgenic overexpression of miR-802 in mice causes impaired glucose tolerance and attenuates insulin sensitivity, whereas reduction of miR-802 expression improves glucose tolerance and insulin action. We identify Hnf1b (also known as Tcf2) as a target of miR-802-dependent silencing, and show that short hairpin RNA (shRNA)-mediated reduction of Hnf1b in liver causes glucose intolerance, impairs insulin signalling and promotes hepatic gluconeogenesis. In turn, hepatic overexpression of Hnf1b improves insulin sensitivity in Lepr(db/db) mice. Thus, this study defines a critical role for deregulated expression of miR-802 in the development of obesity-associated impairment of glucose metabolism through targeting of Hnf1b, and assigns Hnf1b an unexpected role in the control of hepatic insulin sensitivity.	[Kornfeld, Jan-Wilhelm; Baitzel, Catherina; Koenner, A. Christine; Nicholls, Hayley T.; Vogt, Merly C.; Bruening, Jens C.] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Kornfeld, Jan-Wilhelm; Baitzel, Catherina; Koenner, A. Christine; Nicholls, Hayley T.; Vogt, Merly C.; Bruening, Jens C.] Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Kornfeld, Jan-Wilhelm; Baitzel, Catherina; Koenner, A. Christine; Nicholls, Hayley T.; Vogt, Merly C.; Bruening, Jens C.] Univ Cologne, Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, Dept Mouse Genet & Metab,Inst Genet, D-50674 Cologne, Germany; [Kornfeld, Jan-Wilhelm; Baitzel, Catherina; Koenner, A. Christine; Nicholls, Hayley T.; Vogt, Merly C.; Bruening, Jens C.] Ctr Mol Med Cologne, D-50674 Cologne, Germany; [Herrmanns, Karolin; Stoffel, Markus] Swiss Fed Inst Technol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland; [Scheja, Ludger; Heeren, Joerg] Univ Hosp Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, D-20246 Hamburg, Germany; [Haumaitre, Cecile; Cereghini, Silvia] INSERM, U969, F-75005 Paris, France; [Haumaitre, Cecile; Cereghini, Silvia] Univ Paris 06, CNRS, UMR7622, F-75005 Paris, France; [Wolf, Anna M.; Knippschild, Uwe] Univ Hosp Ulm, Dept Gen & Visceral Surg, D-89081 Ulm, Germany; [Seibler, Jost] TaconicArtemis GmbH, D-51063 Cologne, Germany	Max Planck Society; University of Cologne; University of Cologne; University of Cologne; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Ulm University	Bruning, JC (corresponding author), Max Planck Inst Neurol Res, Gleueler Str 50A, D-50931 Cologne, Germany.	bruening@nf.mpg.de	Haumaitre, Cecile/E-5455-2017; Kornfeld, Jan-Wilhelm/AAF-1170-2019; Vogt, Merly/AAF-3789-2021	Haumaitre, Cecile/0000-0003-3526-7832; Kornfeld, Jan-Wilhelm/0000-0002-6802-4442; Stoffel, Markus/0000-0003-1304-5817	EMBO; CECAD; INSERM; CNRS; EU FP7 (Mane Curie Initial Training Network BOLD); ERC; DFG [SFB 841, Br1492-7]	EMBO(European Molecular Biology Organization (EMBO)); CECAD; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); EU FP7 (Mane Curie Initial Training Network BOLD); ERC(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG))	J.-W.K. was supported by stipends from EMBO and CECAD. S.C. received funds from INSERM, CNRS and EU FP7 (Mane Curie Initial Training Network BOLD). This work was in part supported by ERC grant 'Metabolomirs' (to M.S.), by a grant to J.H. by the DFG (SFB 841) and DFG funding to J.C.B. (Br1492-7). We thank D. Wagner-Stippich, J. Alber, P. Scholl and B. Hampel for technical assistance.	Barbacci E, 1999, DEVELOPMENT, V126, P4795; Bellanne-Chantelot C, 2004, ANN INTERN MED, V140, P510, DOI 10.7326/0003-4819-140-7-200404060-00009; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Han XY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-81; Haumaitre C, 2006, HUM MOL GENET, V15, P2363, DOI 10.1093/hmg/ddl161; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Lindner TH, 1999, HUM MOL GENET, V8, P2001, DOI 10.1093/hmg/8.11.2001; Ma ZD, 2007, P NATL ACAD SCI USA, V104, P20386, DOI 10.1073/pnas.0705957104; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Wen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009153; Zhou B, 2012, DIABETOLOGIA, V55, P2032, DOI 10.1007/s00125-012-2539-8	17	238	257	3	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					111	115		10.1038/nature11793	http://dx.doi.org/10.1038/nature11793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23389544				2022-12-24	WOS:000314741200044
J	Kesselheim, AS; Mello, MM; Avorn, J				Kesselheim, Aaron S.; Mello, Michelle M.; Avorn, Jerry			FDA Regulation of Off-label Drug Promotion Under Attack	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHARMACEUTICAL PROMOTION		[Kesselheim, Aaron S.; Avorn, Jerry] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Mello, Michelle/0000-0003-2877-4270	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER; AHRQ HHS [K08HS18465-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; Jazz Pharmaceuticals Inc, 2007, AGR PAY 20 MILL RES; Kesselheim AS, 2008, NEW ENGL J MED, V358, P1727, DOI 10.1056/NEJMsb0708920; Mello MM, 2011, NEW ENGL J MED, V365, P1248, DOI 10.1056/NEJMhle1107678; Orphan Medical, 2002, XYR DRUG LAB	5	9	10	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					445	446		10.1001/jama.2012.207972	http://dx.doi.org/10.1001/jama.2012.207972			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083LY	23385267				2022-12-24	WOS:000314466900022
J	Caliskan, M; Bochkov, YA; Kreiner-Moller, E; Bonnelykke, K; Stein, MM; Du, GX; Bisgaard, H; Jackson, DJ; Gern, JE; Lemanske, RF; Nicolae, DL; Ober, C				Caliskan, Minal; Bochkov, Yury A.; Kreiner-Moller, Eskil; Bonnelykke, Klaus; Stein, Michelle M.; Du, Gaixin; Bisgaard, Hans; Jackson, Daniel J.; Gern, James E.; Lemanske, Robert F., Jr.; Nicolae, Dan L.; Ober, Carole			Rhinovirus Wheezing Illness and Genetic Risk of Childhood-Onset Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASDERMIN-LIKE GSDML; 17Q21 VARIANTS; SMOKE EXPOSURE; EXPRESSION; ORMDL3; ASSOCIATION; INFECTIONS; DISEASE; FAMILY	BACKGROUND Both genetic variation at the 17q21 locus and virus-induced respiratory wheezing illnesses are associated with the development of asthma. Our aim was to determine the effects of these two factors on the risk of asthma in the Childhood Origins of Asthma (COAST) and the Copenhagen Prospective Study on Asthma in Childhood (COPSAC) birth cohorts. METHODS We tested genotypes at the 17q21 locus for associations with asthma and with human rhinovirus (HRV) and respiratory syncytial virus (RSV) wheezing illnesses and tested for interactions between 17q21 genotypes and HRV and RSV wheezing illnesses with respect to the risk of asthma. Finally, we examined genotype-specific expression of 17q21 genes in unstimulated and HRV-stimulated peripheral-blood mononuclear cells (PBMCs). RESULTS The 17q21 variants were associated with HRV wheezing illnesses in early life, but not with RSV wheezing illnesses. The associations of 17q21 variants with asthma were restricted to children who had had HRV wheezing illnesses, resulting in a significant interaction effect with respect to the risk of asthma. Moreover, the expression levels of ORMDL3 and of GSDMB were significantly increased in HRV-stimulated PBMCs, as compared with unstimulated PBMCs. The expression of these genes was associated with 17q21 variants in both conditions, although the increase with exposure to HRV was not genotype-specific. CONCLUSIONS Variants at the 17q21 locus were associated with asthma in children who had had HRV wheezing illnesses and with expression of two genes at this locus. The expression levels of both genes increased in response to HRV stimulation, although the relative increase was not associated with the 17q21 genotypes. (Funded by the National Institutes of Health.)	[Caliskan, Minal; Stein, Michelle M.; Du, Gaixin; Nicolae, Dan L.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Nicolae, Dan L.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nicolae, Dan L.] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Ober, Carole] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Bochkov, Yury A.; Jackson, Daniel J.; Gern, James E.; Lemanske, Robert F., Jr.] Univ Wisconsin, Dept Pediat, Madison, WI USA; [Lemanske, Robert F., Jr.] Univ Wisconsin, Dept Med, Madison, WI USA; [Kreiner-Moller, Eskil; Bonnelykke, Klaus; Bisgaard, Hans] Univ Copenhagen, Fac Hlth Sci, Gentofte, Denmark; [Kreiner-Moller, Eskil; Bonnelykke, Klaus; Bisgaard, Hans] Copenhagen Univ Hosp, Danish Pediat Asthma Ctr, Gentofte, Denmark	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Copenhagen; University of Copenhagen	Caliskan, M (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	caliskan@uchicago.edu; c-ober@genetics.uchicago.edu	Du, Gaixin/M-9901-2014; Bisgaard, Hans/N-4761-2016	Du, Gaixin/0000-0002-4616-7725; Bisgaard, Hans/0000-0003-4131-7592; Bonnelykke, Klaus/0000-0003-2003-1018; Nicolae, Dan/0000-0002-0918-4630; Stein, Michelle/0000-0002-7680-9012; Kreiner, Eskil/0000-0003-1204-2438; Bochkov, Yury/0000-0003-2618-4496; Ober, Carole/0000-0003-4626-9809; Caliskan, Minal/0000-0002-0942-7073	National Institutes of Health [HL070831, AI070503]; KL2 from the National Institutes of Health [UL1TR00042]; Lundbeck Foundation; Danish Council for Strategic Research; Danish Pediatric Asthma Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KL2 from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Pediatric Asthma Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health.; Supported by grants (HL070831 and AI070503) from the National Institutes of Health. Dr. Jackson was supported by KL2 grant UL1TR000427 from the National Institutes of Health. The Lundbeck Foundation, Danish Council for Strategic Research, and Danish Pediatric Asthma Center provided the core funding for the COPSAC research unit.	Akhabir L, 2011, RESPIROLOGY, V16, P396, DOI 10.1111/j.1440-1843.2011.01939.x; Bisgaard H, 2010, BMJ-BRIT MED J, V341; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V127, P1155, DOI 10.1016/j.jaci.2011.02.007; Bisgaard H, 2009, AM J RESP CRIT CARE, V179, P179, DOI 10.1164/rccm.200809-1436OC; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Carl-Mcgrath S, 2008, PATHOLOGY, V40, P13, DOI 10.1080/00313020701716250; DiFranza JR, 2004, PEDIATRICS, V113, P1007; Flory JH, 2009, J ALLERGY CLIN IMMUN, V124, P605, DOI 10.1016/j.jaci.2009.05.047; Halapi E, 2010, EUR J HUM GENET, V18, P902, DOI 10.1038/ejhg.2010.38; Hirota T, 2008, J ALLERGY CLIN IMMUN, V121, P769, DOI 10.1016/j.jaci.2007.09.038; Hyvarinen MK, 2005, PEDIATR PULM, V40, P316, DOI 10.1002/ppul.20273; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kotaniemi-Syrjanen A, 2003, J ALLERGY CLIN IMMUN, V111, P66, DOI 10.1067/mai.2003.33; Lemanske RF, 2002, PEDIAT ALLERG IMM-UK, V13, P38, DOI 10.1034/j.1399-3038.13.s.15.8.x; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Ober C, 2011, TRENDS GENET, V27, P107, DOI 10.1016/j.tig.2010.12.004; Saeki N, 2009, GENE CHROMOSOME CANC, V48, P261, DOI 10.1002/gcc.20636; Smit LAM, 2010, EUR RESPIR J, V36, P57, DOI 10.1183/09031936.00154509; Sykes A, 2008, J ALLERGY CLIN IMMUN, V122, P685, DOI 10.1016/j.jaci.2008.08.017; Trujillo-Alonso V, 2011, J VIROL, V85, P12594, DOI 10.1128/JVI.05620-11; van der Valk RJP, 2012, ALLERGY, V67, P767, DOI 10.1111/j.1398-9995.2012.02819.x; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Wu H, 2009, ALLERGY, V64, P629, DOI 10.1111/j.1398-9995.2008.01912.x	29	339	351	3	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1398	1407		10.1056/NEJMoa1211592	http://dx.doi.org/10.1056/NEJMoa1211592			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122QT	23534543	Green Accepted, Bronze			2022-12-24	WOS:000317333600007
J	Raaschou, P; Simard, JF; Holmqvist, M; Askling, J				Raaschou, Pauline; Simard, Julia F.; Holmqvist, Marie; Askling, Johan		ARTIS Study Grp	Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TNF-ALPHA; CANCER INCIDENCE; SKIN-CANCER; METAANALYSIS; RECIPIENTS; REGISTER	Objectives To investigate the potential association between tumour necrosis factor (TNF) inhibitor treatment and malignant melanomas in rheumatoid arthritis, melanoma risks in rheumatoid arthritis patients not treated with biological drugs, and risk of all site cancer with TNF inhibitors as used in rheumatoid arthritis. Design Population based cohort study. Setting Prospectively recorded data from national clinical, health, and demographic registers in Sweden 2001-10. Patients with rheumatoid arthritis treated (n=10 878) or not (n=42 198) with TNF inhibitors and matched general population comparators (n=162 743). Main outcome measures The primary outcome was first invasive melanoma in people without any history of invasive cancer of any type. Hazard ratios were estimated using Cox regression, comparing non-biological drug treated rheumatoid arthritis patients with the general population comparator and TNF inhibitor treated rheumatoid arthritis patients with those not treated with biological drugs. Secondary outcomes included in situ melanomas, second primary melanomas, and all site cancer. Results 113 first invasive melanomas occurred in rheumatoid arthritis patients not treated with biological drugs, and 393 occurred in the general population comparator cohort. Rheumatoid arthritis patients not treated with biological drugs were not at significantly increased risk of melanoma compared with the general population (hazard ratio 1.2, 95% confidence interval 0.9 to 1.5). 38 first invasive melanomas occurred in rheumatoid arthritis patients treated with TNF inhibitors; these patients had an increased risk of melanoma compared with rheumatoid arthritis patients not treated with biological drugs (hazard ratio 1.5, 1.0 to 2.2; 20 additional cases per 100 000 person years). The risk of a second primary melanoma was non-significantly increased (hazard ratio 3.2, 0.8 to 13.1; n=3 v 10) in rheumatoid arthritis patients treated with TNF inhibitors compared with those not treated with biological drugs. Conclusion Overall, patients with rheumatoid arthritis who have not been treated with biological drugs are not at increased risk of invasive melanoma compared with the general population. Rheumatoid arthritis patients selected for TNF inhibitor treatment are not at increased overall risk for cancer but have a 50% increased relative risk of invasive melanoma. Given the small increase in absolute risk, these finding may not markedly shift the overall risk-benefit balance of TNF inhibitors as used in clinical practice but might do so in patients at high risk of melanoma for other reasons.	[Raaschou, Pauline; Simard, Julia F.; Holmqvist, Marie; Askling, Johan] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden; [Raaschou, Pauline] Karolinska Inst, Dept Med Solna, Clin Pharmacol Unit, SE-17176 Stockholm, Sweden; [Askling, Johan] Karolinska Inst, Dept Med Solna, Rheumatol Unit, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Raaschou, P (corresponding author), Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden.	pauline.raaschou@karolinska.se		Simard, Julia/0000-0001-5735-9856; Holmqvist, Marie/0000-0001-8996-5260; Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863; Klareskog, Lars/0000-0001-9601-6186	Swedish Cancer Society; Swedish Research Council; Stockholm County Council; Swedish Foundation for Strategic Research; Merck; BMS; Pfizer; Abbott Laboratories; SOBI; UCB; Roche; Astra-Zeneca	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Merck(Merck & Company); BMS(Bristol-Myers Squibb); Pfizer(Pfizer); Abbott Laboratories(Abbott Laboratories); SOBI; UCB(UCB Pharma SA); Roche(Roche Holding); Astra-Zeneca(AstraZeneca)	This study was supported by public grants from the Swedish Cancer Society, the Swedish Research Council, Stockholm County Council, and the Swedish Foundation for Strategic Research. The ARTIS Study Group conducts scientific analyses using data from the Swedish biologics register ARTIS run by the Swedish Society for Rheumatology. For the maintenance of this register, the Swedish Society for Rheumatology has received funding, independent of the conduct of these scientific analyses, from Merck, BMS, Pfizer, Abbott Laboratories, SOBI, UCB, and Roche. These entities had no influence on the data collection, statistical analyses, manuscript preparation, or decision to submit. They were allowed to comment on the findings before submission, although all final decisions resided with the investigators.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: JA has received research grants from Pfizer and Astra-Zeneca as part of a public-private research consortium (COMBINE, www.combinesweden.se) and speakers' honorariums from Merck; no other relationships or activities that could appear to have influenced the submitted work.	Alaibac M, 2003, J AM ACAD DERMATOL, V49, P1020, DOI 10.1016/S0190-9622(03)02482-4; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Askling J, 2006, ANN RHEUM DIS, V65, P707, DOI 10.1136/ard.2005.045872; Askling J., 2009, ANNUAL EUROPEAN CONG; Askling J, 2011, PHARMACOEPIDEM DR S, V20, P119, DOI 10.1002/pds.2046; Askling J, 2009, ARTHRITIS RHEUM-US, V60, P3180, DOI 10.1002/art.24941; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Bongartz T, 2009, ANN RHEUM DIS, V68, P1177, DOI 10.1136/ard.2008.094904; Buchbinder R, 2008, ARTHRIT RHEUM-ARTHR, V59, P794, DOI 10.1002/art.23716; Chakravarty EF, 2008, EXPERT OPIN DRUG SAF, V7, P539, DOI 10.1517/14740338.7.5.539 ; Collett D, 2010, AM J TRANSPLANT, V10, P1889, DOI 10.1111/j.1600-6143.2010.03181.x; Deroose JP, 2011, CURR OPIN ONCOL, V23, P183, DOI 10.1097/CCO.0b013e3283424dbc; Dixon WG, 2010, ARTHRIT CARE RES, V62, P755, DOI 10.1002/acr.20129; Dreyer L, 2013, ANN RHEUM DIS, V72, P79, DOI 10.1136/annrheumdis-2012-201969; Fulchiero GJ, 2007, J AM ACAD DERMATOL, V56, pS65, DOI 10.1016/j.jaad.2006.12.024; GRIDLEY G, 1993, JNCI-J NATL CANCER I, V85, P307, DOI 10.1093/jnci/85.4.307; Gruenhagen Dirk J., 2009, V179, P257; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Haynes K, 2013, ARTHRITIS RHEUM-US, V65, P48, DOI 10.1002/art.37740; Hofmann MA, 2011, J CANCER RES CLIN, V137, P455, DOI 10.1007/s00432-010-0900-1; Jack A, 2006, SURG ONCOL, V15, P13, DOI 10.1016/j.suronc.2006.05.003; Kasiske BL, 2004, AM J TRANSPLANT, V4, P905, DOI 10.1111/j.1600-6143.2004.00450.x; Katoulis AC, 2010, DERMATOLOGY, V221, P9, DOI 10.1159/000300136; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; Leombruno JP, 2009, ANN RHEUM DIS, V68, P1136, DOI 10.1136/ard.2008.091025; Lizee G, 2006, CLIN CANCER RES, V12, p2359S, DOI 10.1158/1078-0432.CCR-05-2537; Lopez-Olivo MA, 2012, JAMA-J AM MED ASSOC, V308, P898, DOI 10.1001/2012.jama.10857; Manganoni Ausilia Maria, 2011, Dermatol Online J, V17, P12; Mellemkjaer L, 1996, EUR J CANCER, V32A, P1753, DOI 10.1016/0959-8049(96)00210-9; Moloney FJ, 2006, BRIT J DERMATOL, V154, P498, DOI 10.1111/j.1365-2133.2005.07021.x; Mukherji Bijay, 1995, Current Opinion in Oncology, V7, P175, DOI 10.1097/00001622-199503000-00014; Neovius M, 2011, ANN RHEUM DIS, V70, P516, DOI 10.1136/ard.2010.130914; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Oble Darryl A, 2009, Cancer Immun, V9, P3; Perkins S, 2012, CLIN RHEUMATOL, V31, P1001, DOI 10.1007/s10067-011-1908-x; Setoguchi S, 2006, ARTHRITIS RHEUM-US, V54, P2757, DOI 10.1002/art.22056; Socialstyrelsen, CANCER INCIDENCE IN; Thomas E, 2000, INT J CANCER, V88, P497, DOI 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.3.CO;2-A; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P2886, DOI 10.1002/art.22864; World Health Organization, 1955, INTERNATIONAL CLASSI; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465	45	122	126	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2013	346								f1939	10.1136/bmj.f1939	http://dx.doi.org/10.1136/bmj.f1939			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125YO	23568792	hybrid			2022-12-24	WOS:000317578300001
J	McMullan, CJ; Schernhammer, ES; Rimm, EB; Hu, FB; Forman, JP				McMullan, Ciaran J.; Schernhammer, Eva S.; Rimm, Eric B.; Hu, Frank B.; Forman, John P.			Melatonin Secretion and the Incidence of Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPORTED SLEEP DURATION; URINARY MELATONIN; PHYSICAL-ACTIVITY; PLASMA MELATONIN; CANCER-RISK; MELLITUS; INSULIN; VARIANTS; RECEPTOR; MTNR1B	Importance Loss-of-function mutations in the melatonin receptor are associated with insulin resistance and type 2 diabetes. Additionally, in a cross-sectional analysis of persons without diabetes, lower nocturnal melatonin secretion was associated with increased insulin resistance. Objective To study the association between melatonin secretion and the risk of developing type 2 diabetes. Design, Setting, and Participants Case-control study nested within the Nurses' Health Study cohort. Among participants without diabetes who provided urine and blood samples at baseline in 2000, we identified 370 women who developed type 2 diabetes from 2000-2012 and matched 370 controls using risk-set sampling. Main Outcome Measures Associations between melatonin secretion at baseline and incidence of type 2 diabetes were evaluated with multivariable conditional logistic regression controlling for demographic characteristics, lifestyle habits, measures of sleep quality, and biomarkers of inflammation and endothelial dysfunction. Results The median urinary ratios of 6-sulfatoxymelatonin to creatinine were 28.2 ng/mg (5%-95% range, 5.5-84.2 ng/mg) among cases and 36.3 ng/mg (5%-95% range, 6.9-110.8 ng/mg) among controls. Women with lower ratios of 6-sulfatoxymelatonin to creatinine had increased risk of diabetes (multivariable odds ratio, 1.48 [95% CI, 1.11-1.98] per unit decrease in the estimated log ratio of 6-sulfatoxymelatonin to creatinine). Compared with women in the highest ratio category of 6-sulfatoxymelatonin to creatinine, those in the lowest category had a multivariable odds ratio of 2.17 (95% CI, 1.18-3.98) of developing type 2 diabetes. Women in the highest category of melatonin secretion had an estimated diabetes incidence rate of 4.27 cases/1000 person-years compared with 9.27 cases/1000 person-years in the lowest category. Conclusions and Relevance Lower melatonin secretion was independently associated with a higher risk of developing type 2 diabetes. Further research is warranted to assess if melatonin secretion is a modifiable risk factor for diabetes within the general population. JAMA. 2013;309(13):1388-1396 www.jama.com	[McMullan, Ciaran J.; Forman, John P.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Div Renal, Boston, MA 02115 USA; [McMullan, Ciaran J.; Schernhammer, Eva S.; Rimm, Eric B.; Hu, Frank B.; Forman, John P.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Channing Div Network Med, Boston, MA 02115 USA; [Rimm, Eric B.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [McMullan, Ciaran J.; Schernhammer, Eva S.; Rimm, Eric B.; Hu, Frank B.; Forman, John P.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	McMullan, CJ (corresponding author), 41 Ave Louis Pasteur,Ste 121, Boston, MA USA.	cmcmullan1@partners.org	Schernhammer, Eva S/L-7898-2018	Schernhammer, Eva S/0000-0002-4337-9415	Merck; Walnut Commission; National Institutes of Health [DK58845, HL103607]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845] Funding Source: NIH RePORTER	Merck(Merck & Company); Walnut Commission; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Hu reported serving as a consultant to Novo Nordisk; and receiving grants from Merck and the Walnut Commission. No other author reported disclosures.; This work was supported by National Institutes of Health grants DK58845 and HL103607.	Al-Delaimy WK, 2002, AM J EPIDEMIOL, V155, P387, DOI 10.1093/aje/155.5.387; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Baskett JJ, 1998, J PINEAL RES, V24, P58, DOI 10.1111/j.1600-079X.1998.tb00366.x; Bertone ER, 2001, J NATL CANCER I, V93, P942, DOI 10.1093/jnci/93.12.942; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Broderick CR, 2012, JAMA-J AM MED ASSOC, V308, P1452, DOI 10.1001/jama.2012.12727; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Claustrat B, 2005, SLEEP MED REV, V9, P11, DOI 10.1016/j.smrv.2004.08.001; Cuesta S, 2012, AGE DORDR; De Koning L, 2011, DIABETES CARE, V34, P1150, DOI 10.2337/dc10-2352; Diethelm K, 2010, HORM RES PAEDIAT, V74, P390, DOI 10.1159/000303134; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fox CS, 2006, CIRCULATION, V113, P2914, DOI 10.1161/CIRCULATIONAHA.106.613828; Graham C, 1998, J PINEAL RES, V24, P230, DOI 10.1111/j.1600-079X.1998.tb00538.x; Griefahn B, 2001, ENDOCRINE, V15, P199, DOI 10.1385/ENDO:15:2:199; Hernandez C, 2007, EUR RESPIR J, V30, P496, DOI 10.1183/09031936.00051906; Hikichi T, 2011, CLIN OPHTHALMOL, V5, P655, DOI 10.2147/OPTH.S19559; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Kemp DM, 2002, MOL CELL ENDOCRINOL, V191, P157, DOI 10.1016/S0303-7207(02)00064-3; Kwak SH, 2012, DIABETES, V61, P531, DOI 10.2337/db11-1034; LANG U, 1981, J CLIN ENDOCR METAB, V53, P645, DOI 10.1210/jcem-53-3-645; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Mason JM, 2005, J HYPERTENS, V23, P1777, DOI 10.1097/01.hjh.0000177537.91527.09; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; Oh K, 2005, AM J EPIDEMIOL, V161, P161, DOI 10.1093/aje/kwi026; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; PEARCE N, 1993, INT J EPIDEMIOL, V22, P1189, DOI 10.1093/ije/22.6.1189; Peschke E, 2006, J PINEAL RES, V40, P135, DOI 10.1111/j.1600-079X.2005.00287.x; Peschke E, 2010, BEST PRACT RES CL EN, V24, P829, DOI 10.1016/j.beem.2010.09.001; Picinato MC, 2008, J PINEAL RES, V44, P88, DOI 10.1111/j.1600-079X.2007.00493.x; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Prunet-Marcassus B, 2003, ENDOCRINOLOGY, V144, P5347, DOI 10.1210/en.2003-0693; Puchalski SS, 2003, ENDOCRINE, V21, P163, DOI 10.1385/ENDO:21:2:163; Ramos E, 2011, DIABETOLOGIA, V54, P783, DOI 10.1007/s00125-010-2002-7; Ramraeheya RD, 2008, J PINEAL RES, V44, P273, DOI 10.1111/j.1600-079X.2007.00523.x; Robeva R, 2008, J PINEAL RES, V44, P52, DOI 10.1111/j.1600-079X.2007.00527.x; Robeva R, 2006, ANDROLOGIA, V38, P216, DOI 10.1111/j.1439-0272.2006.00743.x; RODRIGUES L, 1990, INT J EPIDEMIOL, V19, P205, DOI 10.1093/ije/19.1.205; Sartori C, 2009, ENDOCRINOLOGY, V150, P5311, DOI 10.1210/en.2009-0425; Schernhammer ES, 2004, CANCER EPIDEM BIOMAR, V13, P936; Schernhammer ES, 2004, BRIT J CANCER, V90, P941, DOI 10.1038/sj.bjc.6601626; Schernhammer ES, 2009, CANCER EPIDEM BIOMAR, V18, P74, DOI 10.1158/1055-9965.EPI-08-0637; Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057; SHIMAKAWA T, 1993, DIABETES CARE, V16, P1356, DOI 10.2337/diacare.16.10.1356; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703; WALDHAUSER F, 1985, ANN NY ACAD SCI, V453, P205, DOI 10.1111/j.1749-6632.1985.tb11811.x; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879	51	215	229	0	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1388	1396		10.1001/jama.2013.2710	http://dx.doi.org/10.1001/jama.2013.2710			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EC	23549584	Green Accepted			2022-12-24	WOS:000316934500028
J	Davidson, DJ; Andrews, J				Davidson, Debra J.; Andrews, Jeffrey			Not All About Consumption	SCIENCE			English	Editorial Material							ECONOMIC-GROWTH; OIL; POPULATION; EMISSIONS; IMPACT		[Davidson, Debra J.; Andrews, Jeffrey] Dept Resource Econ & Environm Sociol, Edmonton, AB T6G 2H1, Canada		Davidson, DJ (corresponding author), Dept Resource Econ & Environm Sociol, Edmonton, AB T6G 2H1, Canada.	debra.davidson@ualberta.ca						American Petroleum Institute, 2011, BAS PETR DAT BOOK PE, V31; [Anonymous], ST982012 EN RES CONS; Anticamara JA, 2011, FISH RES, V107, P131, DOI 10.1016/j.fishres.2010.10.016; Clausen R, 2008, CONSERV BIOL, V22, P458, DOI 10.1111/j.1523-1739.2007.00851.x; Dietz T, 1997, P NATL ACAD SCI USA, V94, P175, DOI 10.1073/pnas.94.1.175; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Fantazzini D, 2011, ENERG POLICY, V39, P7865, DOI 10.1016/j.enpol.2011.09.035; Jordaan SM, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024004; Murphy DJ, 2011, ANN NY ACAD SCI, V1219, P52, DOI 10.1111/j.1749-6632.2010.05940.x; Ricardo D., 1966, EC ESSAYS EDITED INT; Wang JX, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014035; Yeh S, 2010, ENVIRON SCI TECHNOL, V44, P8766, DOI 10.1021/es1013278; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5	13	25	25	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1286	1287		10.1126/science.1234205	http://dx.doi.org/10.1126/science.1234205			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	105GC	23493704				2022-12-24	WOS:000316053400027
J	Huang, LE				Huang, L. Eric			How HIF-1 alpha Handles Stress	SCIENCE			English	Editorial Material							CELL-CYCLE ARREST; C-MYC; DNA-REPLICATION; HYPOXIA; PROLIFERATION; HIF; HIF-2-ALPHA		Univ Utah, Dept Oncol Sci, Dept Neurosurg, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Huang, LE (corresponding author), Univ Utah, Dept Oncol Sci, Dept Neurosurg, Salt Lake City, UT 84132 USA.	eric.huang@hsc.utah.edu		Huang, Eric/0000-0002-6444-1708	NCI NIH HHS [R01 CA131355] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Freiberg RA, 2006, MOL CELL BIOL, V26, P1598, DOI 10.1128/MCB.26.5.1598-1609.2006; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Hubbi ME, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003417; Ilves I, 2012, P NATL ACAD SCI USA, V109, P13163, DOI 10.1073/pnas.1211525109; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; To KKW, 2006, EMBO J, V25, P4784, DOI 10.1038/sj.emboj.7601369	15	18	19	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1285	1286		10.1126/science.1236966	http://dx.doi.org/10.1126/science.1236966			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493703				2022-12-24	WOS:000316053400026
J	Bayer, R; Oppenheimer, GM				Bayer, Ronald; Oppenheimer, Gerald M.			Routine HIV Testing, Public Health, and the USPSTF - An End to the Debate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREVENTION		[Bayer, Ronald; Oppenheimer, Gerald M.] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA	Columbia University	Bayer, R (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA.							Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Chou R, 2012, ANN INTERN MED, V157, P706, DOI 10.7326/0003-4819-157-10-201211200-00007; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Neff S, 2011, JAMA-J AM MED ASSOC, V305, P1767, DOI 10.1001/jama.2011.564; US Preventive Serv Task Force, 2005, ANN INTERN MED, V143, P32, DOI 10.7326/0003-4819-143-1-200507050-00008	5	16	17	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					881	884		10.1056/NEJMp1214535	http://dx.doi.org/10.1056/NEJMp1214535			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BG	23425134				2022-12-24	WOS:000315669100001
J	Bland, RM; Ndirangu, J; Newell, ML				Bland, Ruth M.; Ndirangu, James; Newell, Marie-Louise			Maximising opportunities for increased antiretroviral treatment in children in an existing HIV programme in rural South Africa	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-HEALTH-CARE; CD4 CELL RESPONSE; THERAPY; INFECTION; OUTCOMES; PREVENTION; MORTALITY	Problem Infants and young children infected with HIV as a result of mother to child transmission are not being identified or started with antiretroviral treatment (ART) in line with HIV guidelines in resource limited settings. Design Retrospective analysis of data from a paediatric cohort before and after an intervention strategy. Setting Rural public HIV treatment programme in the province of KwaZulu-Natal, South Africa. Key measures for improvement Increase in the number of HIV infected infants and children who start HIV treatment each year; increase in the proportion of children starting ART with less immune suppression, shown by higher CD4 counts and less advanced World Health Organization clinical stages for HIV. Strategies for change Late 2008: training in paediatric HIV for all staff in contact with mothers and children; campaigns for increased HIV testing at immunisation and clinics; routine testing of children with tuberculosis and malnutrition for HIV, and HIV testing of all children admitted to hospital. The establishment of a family HIV clinic in late 2007. Effects of change The number of children (1 year to <= 15 years) starting ART each year increased from 43 in 2004 to 254 in 2011; the corresponding number of infants (<1 year) starting treatment increased from 2 to 59. A trend towards increasing CD4 counts at the start of treatment was found. Lessons learnt It is possible to improve the identification of HIV infected children and ensure a prompt start on ART where needed with relatively simple measures and limited implications for staffing and budgets.	[Bland, Ruth M.; Ndirangu, James] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, ZA-3935 Mtubatuba, Kwazulu Natal, South Africa; [Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Africa Ctr, ZA-3935 Mtubatuba, Kwazulu Natal, South Africa; [Bland, Ruth M.] Univ Glasgow, Sch Med, Glasgow G12 8XX, Lanark, Scotland; [Newell, Marie-Louise] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1E 6BT, England	University of Kwazulu Natal; University of Kwazulu Natal; University of Glasgow; University of London; University College London	Bland, RM (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, POB 198, ZA-3935 Mtubatuba, Kwazulu Natal, South Africa.	rbland@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Bland, Ruth/0000-0003-1675-9268; Ndirangu, James/0000-0002-2768-5631	Wellcome Trust [050524, 097410] Funding Source: Medline; PEPFAR Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); PEPFAR		Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Cooke GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007101; Coovadia H, 2008, LANCET, V372, P866, DOI 10.1016/S0140-6736(08)61373-2; Ginsburg AS, 2007, AIDS, V21, P2529, DOI 10.1097/QAD.0b013e3282f155f4; Horwood C, 2003, B WORLD HEALTH ORGAN, V81, P858; Horwood C, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-62; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Houlihan CF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-23; Janssen N, 2010, ARCH DIS CHILD, V95, P414, DOI 10.1136/adc.2009.169367; Johnson L., 2012, SO AFRICAN J HIV MED, V13; Joint United Nations Programme on HIV/AIDS, AIDS EP UPD 2009; Kiboneka A, 2008, AIDS, V22, P2493, DOI 10.1097/QAD.0b013e328318f148; National Department of Health, 2010, GUID MAN HIV CHILDR; Ndirangu J, 2009, TROP MED INT HEALTH, V14, P1383, DOI 10.1111/j.1365-3156.2009.02382.x; Newell ML, 2006, J INFECT DIS, V193, P954, DOI 10.1086/500842; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Prendergast A, 2008, AIDS, V22, P1333, DOI 10.1097/QAD.0b013e32830437df; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Rollins NC, 2007, JAIDS-J ACQ IMM DEF, V44, P321, DOI 10.1097/QAI.0b013e31802ea4b0; Tanser F, 2012, C RETR OPP INF SEATT; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; Wilkinson D, 1997, S AFR MED J, V87, P456; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, ANT THER HIV INF INF	26	5	5	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2013	346								f550	10.1136/bmj.f550	http://dx.doi.org/10.1136/bmj.f550			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BL	23447354				2022-12-24	WOS:000315669600011
J	Kopetz, H				Kopetz, Heinz			Build a biomass energy market	NATURE			English	Editorial Material									World Bioenergy Assoc, Stockholm, Sweden		Kopetz, H (corresponding author), World Bioenergy Assoc, Stockholm, Sweden.	hg.kopetz@netway.at						[Anonymous], 2010, GLOBAL FOREST RESOUR; [Anonymous], REN 2012 GLOB STAT R; International Energy Agency, 2011, WORLD EN OUTL 2011; International Energy Agency, 2012, KEY WORLD EN STAT 20; World Bioenergy Association, 2009, WBO POS PAP GLOB POT; WWF, 2011, FULLY DECARBONISING	6	90	93	2	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					29	31		10.1038/494029a	http://dx.doi.org/10.1038/494029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087DJ	23389528	Bronze			2022-12-24	WOS:000314741200016
J	Knaul, FM; Atun, R; Farmer, P; Frenk, J				Knaul, Felicia Marie; Atun, Rifat; Farmer, Paul; Frenk, Julio			Seizing the opportunity to close the cancer divide	LANCET			English	Editorial Material							COVERAGE		[Knaul, Felicia Marie] Harvard Global Equ Initiat, Boston, MA 02115 USA; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Sch Business, London, England; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Farmer, Paul] Harvard Univ, Sch Med, Boston, MA USA; [Frenk, Julio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Imperial College London; Imperial College London; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Knaul, FM (corresponding author), Harvard Global Equ Initiat, Boston, MA 02115 USA.	felicia_knaul@harvard.edu	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983; Knaul, Felicia/0000-0002-0512-4788				Atun R, 2013, LANCET; Bhadelia A, 2012, CLOSING CANC DIVIDE, P129; Binagwaho A, 2012, B WORLD HEALTH ORGAN, V90, P623, DOI 10.2471/BLT.11.097253; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Hazin R, 2010, LANCET ONCOL, V11, P204, DOI 10.1016/S1470-2045(09)70288-8; Institute for Health Metrics and Evaluation, GBD 2010 PATT BROAD; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pickhardt M., 2012, CLOSING CANC DIVIDE, P3; Shafey O, 2009, TOBACCO ATLAS, V3, P37	11	21	22	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2013	381	9885					2238	2239		10.1016/S0140-6736(13)60176-2	http://dx.doi.org/10.1016/S0140-6736(13)60176-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173SU	23388077				2022-12-24	WOS:000321100300011
J	Southworth, MR; Reichman, ME; Unger, EF				Southworth, Mary Ross; Reichman, Marsha E.; Unger, Ellis F.			Dabigatran and Postmarketing Reports of Bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Southworth, Mary Ross; Reichman, Marsha E.; Unger, Ellis F.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Southworth, MR (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.							Connolly SJ, 2010, NEW ENGL J MED, V363, P1877; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; FDA Drug Safety Communication, FDA DRUG SAF COMM SA; Weber J.C.P., 1984, ADV INFLAMMAT RES, V6, P1	4	277	287	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1272	1274		10.1056/NEJMp1302834	http://dx.doi.org/10.1056/NEJMp1302834			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117YT	23484796				2022-12-24	WOS:000316989900002
J	Chatterjee, S; Riaz, H				Chatterjee, Subhankar; Riaz, Haris			PUBLIC HEALTH Death by insecticide	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PESTICIDE; PREVENTION; MANAGEMENT		[Chatterjee, Subhankar] RG Kar Med Coll & Hosp, Kolkata, India; [Riaz, Haris] Dow Univ Hlth Sci, Karachi, Pakistan	RG Kar Medical College & Hospital; Dow University of Health Sciences	Riaz, H (corresponding author), Dow Univ Hlth Sci, Karachi, Pakistan.	harisriaz73@yahoo.com						[Anonymous], 2013, BUSINESS STANDARD; Balali-Mood M, 2012, IRAN J MED SCI, V37, P74; Bigbee JW, 2000, BRAIN RES, V861, P354, DOI 10.1016/S0006-8993(00)02046-1; Burgess JL, 1999, ANN EMERG MED, V34, P205, DOI 10.1016/S0196-0644(99)70230-1; Dash SK, 2008, MED SCI LAW, V48, P241, DOI 10.1258/rsmmsl.48.3.241; Dharmani Chandrabhan, 2005, Reviews on Environmental Health, V20, P215; Eddleston M, 2004, J TOXICOL-CLIN TOXIC, V42, P865, DOI 10.1081/CLT-200035223; Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1; Eddleston M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000104; Goel A, 2007, NATL MED J INDIA, V20, P182; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; MCCONNELL R, 1993, AM J PUBLIC HEALTH, V83, P1559, DOI 10.2105/AJPH.83.11.1559; Paudyal BP, 2008, J NEPAL MED ASSOC, V47, P251; Rao CS, 2005, TROP MED INT HEALTH, V10, P581, DOI 10.1111/j.1365-3156.2005.01412.x; Ravi G, 2007, 6 ANN C AS PAC ASS M; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Saunders M, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S5; Singh S, 2000, NEUROL INDIA, V48, P308; Stone DL, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-18; Sudakin DL, 2007, J TOXICOL ENV HEAL A, V70, P141, DOI 10.1080/15287390600755224; Times of India, 2013, TIMES INDIA 0916; van Heel W, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-32; ZWIENER RJ, 1988, PEDIATRICS, V81, P121	23	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2013	346								f2029	10.1136/bmj.f2029	http://dx.doi.org/10.1136/bmj.f2029			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117XI	23539101				2022-12-24	WOS:000316986200016
J	De Cock, KM; El-Sadr, WM				De Cock, Kevin M.; El-Sadr, Wafaa M.			When to Start ART in Africa - An Urgent Research Priority	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANTIRETROVIRAL THERAPY		[De Cock, Kevin M.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [El-Sadr, Wafaa M.] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA	Centers for Disease Control & Prevention - USA; Columbia University	De Cock, KM (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069466, UM1AI068619] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CL999999] Funding Source: Medline; NIAID NIH HHS [UM1 AI069466, UM1 AI068619] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUID US ANT AG HIV 1; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; WHO, 2010, ANT THER HIV INF AD	4	55	55	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					886	889		10.1056/NEJMp1300458	http://dx.doi.org/10.1056/NEJMp1300458			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BG	23425131	Green Accepted, Green Published			2022-12-24	WOS:000315669100003
J	Silverio, DL; Torker, S; Pilyugina, T; Vieira, EM; Snapper, ML; Haeffner, F; Hoveyda, AH				Silverio, Daniel L.; Torker, Sebastian; Pilyugina, Tatiana; Vieira, Erika M.; Snapper, Marc L.; Haeffner, Fredrik; Hoveyda, Amir H.			Simple organic molecules as catalysts for enantioselective synthesis of amines and alcohols	NATURE			English	Article							ASYMMETRIC ALLYLATION; HYDRAZONO ESTERS; ANALOGS; ALLYLBORATION; CROTYLATION; DERIVATIVES; EFFICIENT; IMINES	The discovery of catalysts that can be used to synthesize complex organic compounds by enantioselective transformations is central to advances in the life sciences(1); for this reason, many chemists aim to discover catalysts that allow for preparation of chiral molecules as predominantly one mirror-image isomer(2). The ideal catalyst should not contain precious elements' and should bring reactions to completion in a few hours through operationally simple procedures. Here we introduce a set of small organic molecules that can catalyse reactions of unsaturated organoboron reagents with imines and carbonyls; the products of the reactions are enantiomerically pure amines and alcohols, which might serve as intermediates in the preparation of biologically active molecules. A distinguishing feature of this catalyst class is the presence of a 'key' proton embedded within their structure. Catalysts are derived from the abundant amino add valine and are prepared in large quantities in four steps with inexpensive reagents. Reactions are scalable, do not demand stringent conditions, and can be performed with as little as 0.25 mole per cent catalyst in less than six hours at room temperature to generate products in more than 85 per cent yield and >= 97:3 enantiomeric ratio. The efficiency, selectivity and operational simplicity of the transformations and the range of boron-based reagents are expected to render this advance important for future progress in syntheses of amines and alcohols, which are useful in chemistry, biology and medicine.	[Silverio, Daniel L.; Torker, Sebastian; Pilyugina, Tatiana; Vieira, Erika M.; Snapper, Marc L.; Haeffner, Fredrik; Hoveyda, Amir H.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA	Boston College	Hoveyda, AH (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	Silverio, Daniel/C-4953-2016	Silverio, Daniel/0000-0003-3240-2816	US National Institutes of Health, Institute of General Medical Sciences [GM-57212]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057212] Funding Source: NIH RePORTER	US National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Institutes of Health, Institute of General Medical Sciences (grant GM-57212). S.T. was a Swiss National Science Foundation Postdoctoral Fellow; E.M.V. was an AstraZeneca Graduate Fellow. We thank B. Li for assistance in securing X-ray structures, S. J. Meek, S. J. Malcolmson and K. L Tan for discussions, Boston College for providing access to computational facilities and Frontier Scientific for gifts of various organoboron reagents.	Aydin J, 2007, J ORG CHEM, V72, P4689, DOI 10.1021/jo070288b; Barnett DS, 2009, ANGEW CHEM INT EDIT, V48, P8679, DOI 10.1002/anie.200904715; Borzilleri RM, 2000, J AM CHEM SOC, V122, P8890, DOI 10.1021/ja001899n; Chakrabarti A, 2010, ANGEW CHEM INT EDIT, V49, P1838, DOI 10.1002/anie.200906308; Coste A, 2008, CR CHIM, V11, P1544, DOI 10.1016/j.crci.2008.06.003; Cravotto G, 2006, TETRAHEDRON-ASYMMETR, V17, P3070, DOI 10.1016/j.tetasy.2006.11.021; Ferraris D, 2002, J AM CHEM SOC, V124, P67, DOI 10.1021/ja016838j; Fujita M, 2008, J AM CHEM SOC, V130, P2914, DOI 10.1021/ja710627x; Guzman-Martinez A, 2010, J AM CHEM SOC, V132, P10634, DOI 10.1021/ja104254d; Hamada T, 2003, ANGEW CHEM INT EDIT, V42, P3927, DOI 10.1002/anie.200351778; Hanhan NV, 2010, ANGEW CHEM INT EDIT, V49, P744, DOI 10.1002/anie.200904393; Itoh J, 2009, ANGEW CHEM INT EDIT, V48, P6313, DOI 10.1002/anie.200902328; Itoh T, 2009, ORG LETT, V11, P3854, DOI 10.1021/ol901432a; Kargbo R, 2007, J AM CHEM SOC, V129, P3846, DOI 10.1021/ja070742t; Kim SJ, 2010, J AM CHEM SOC, V132, P12168, DOI 10.1021/ja1035336; Lou S, 2007, J AM CHEM SOC, V129, P15398, DOI 10.1021/ja075204v; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Nakamura E, 2011, NAT MATER, V10, P158, DOI 10.1038/nmat2969; Naodovic M, 2009, EUR J ORG CHEM, V2009, P5129, DOI 10.1002/ejoc.200900669; Ojima I., 2010, CATALYTIC ASYMMETRIC; Peddibhotla S., 2009, CURR BIOACT COMPD, V5, P20, DOI [10.2174/157340709787580900, DOI 10.2174/157340709787580900]; Sirasani G, 2011, ORG LETT, V13, P4736, DOI 10.1021/ol202056w; Tan KL, 2007, ANGEW CHEM INT EDIT, V46, P1315, DOI 10.1002/anie.200603354; Vieira EM, 2012, ANGEW CHEM INT EDIT, V51, P6618, DOI 10.1002/anie.201202694; Vieira EM, 2011, J AM CHEM SOC, V133, P3332, DOI 10.1021/ja200311n; Wada R, 2006, J AM CHEM SOC, V128, P7687, DOI 10.1021/ja061510h; Weinreb SM, 2005, SYNTHESIS-STUTTGART, P1205, DOI 10.1055/s-2005-865315; Xie WQ, 2005, ORG LETT, V7, P2775, DOI 10.1021/ol050991r; Yamamoto D, 2006, BIOORG MED CHEM LETT, V16, P2807, DOI 10.1016/j.bmcl.2006.01.107; Yus M, 2011, CHEM REV, V111, P7774, DOI 10.1021/cr1004474	30	160	162	3	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2013	494	7436					216	221		10.1038/nature11844	http://dx.doi.org/10.1038/nature11844			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23407537	Green Accepted			2022-12-24	WOS:000315137700035
J	Teno, JM; Gozalo, PL; Bynum, JPW; Leland, NE; Miller, SC; Morden, NE; Scupp, T; Goodman, DC; Mor, V				Teno, Joan M.; Gozalo, Pedro L.; Bynum, Julie P. W.; Leland, Natalie E.; Miller, Susan C.; Morden, Nancy E.; Scupp, Thomas; Goodman, David C.; Mor, Vincent			Change in End-of-Life Care for Medicare Beneficiaries Site of Death, Place of Care, and Health Care Transitions in 2000, 2005, and 2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NURSING-HOME RESIDENTS; PALLIATIVE CARE; DECISION-MAKING; HOSPICE; OUTCOMES; CANCER; COST	Importance A recent Centers for Disease Control and Prevention report found that more persons die at home. This has been cited as evidence that persons dying in the United States are using more supportive care. Objective To describe changes in site of death, place of care, and health care transitions between 2000, 2005, and 2009. Design, Setting, and Patients Retrospective cohort study of a random 20% sample of fee-for-service Medicare beneficiaries, aged 66 years and older, who died in 2000 (n=270 202), 2005 (n=291 819), or 2009 (n=286 282). A multivariable regression model examined outcomes in 2000 and 2009 after adjustment for sociodemographic characteristics. Based on billing data, patients were classified as having a medical diagnosis of cancer, chronic obstructive pulmonary disease, or dementia in the last 180 days of life. Main Outcome Measures Site of death, place of care, rates of health care transitions, and potentially burdensome transitions (eg, health care transitions in the last 3 days of life). Results Comparing 2000, 2005, and 2009 shows a decrease in deaths in acute care hospitals and increases in intensive care unit (ICU) use in the last 30 days, hospice use at the time of death, and health care transitions at the end of the life (test of trend P < .001 for each). [GRAPHICS] In 2009, 28.4% (95% CI, 27.9%-28.5%) of hospice use at the time of death was for 3 days or less. Of these late hospice referrals, 40.3% (95% CI, 39.7%-40.8%) were preceded by hospitalization with an ICU stay. Conclusion and Relevance Among Medicare beneficiaries who died in 2009 and 2005 compared with 2000, a lower proportion died in an acute care hospital, although both ICU use and the rate of health care transitions increased in the last month of life. JAMA. 2013; 309(5): 470-477 www.jama.	[Teno, Joan M.; Gozalo, Pedro L.; Miller, Susan C.; Scupp, Thomas; Mor, Vincent] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Bynum, Julie P. W.; Morden, Nancy E.; Goodman, David C.] Dartmouth Med Sch, Lebanon, NH USA; [Leland, Natalie E.] Univ So Calif, Los Angeles, CA USA; [Mor, Vincent] Providence VA Med Ctr, Hlth Serv Res & Dev, Providence, RI USA	Brown University; Dartmouth College; University of Southern California; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Teno, JM (corresponding author), Brown Univ, Warren Alpert Med Sch, 121 S Main St, Providence, RI 02912 USA.	joan_teno@brown.edu	Miller, Susan/J-5450-2014; Goodman, David/AAG-7497-2020; Leland, Natalie/F-7223-2012	Miller, Susan/0000-0003-2008-6385; Leland, Natalie/0000-0002-0329-3772	National Institutes of Health; Center for Gerontology and Healthcare Research of Brown University; AmericanOccupational Therapy Association; Robert Wood Johnson Foundation; World Congress; Illinois Hospital Association; National Hospice Workgroup; National Association of Health Data Organizations; St Peters University Hospital; Massachusetts Hospital Association; Cooper Health System; Organizzato dal Laboratoria Management e Sanit a Scuola Superiore Sant'Anna di Pisa; Kentucky Academy of Family Physicians; Southern Illinois University Health Policy Institute; Ohio University College of Osteopathic Medicine; Institute for Clinical Quality and Value; Marwood Group; American Society of Clinical Oncologists; Delta Health Alliance; SUNY Upstate University; Intermountain Healthcare; Canadian Health Services Research Foundation; Massachusetts Health Data Consortium; Organisation for Economic Cooperation and Development; NATIONAL INSTITUTE ON AGING [P01AG027296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Gerontology and Healthcare Research of Brown University; AmericanOccupational Therapy Association; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); World Congress; Illinois Hospital Association; National Hospice Workgroup; National Association of Health Data Organizations; St Peters University Hospital; Massachusetts Hospital Association; Cooper Health System; Organizzato dal Laboratoria Management e Sanit a Scuola Superiore Sant'Anna di Pisa; Kentucky Academy of Family Physicians; Southern Illinois University Health Policy Institute; Ohio University College of Osteopathic Medicine; Institute for Clinical Quality and Value; Marwood Group; American Society of Clinical Oncologists; Delta Health Alliance; SUNY Upstate University; Intermountain Healthcare; Canadian Health Services Research Foundation; Massachusetts Health Data Consortium; Organisation for Economic Cooperation and Development; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Teno reported having received honoraria for speeches and lectures from nonprofit organizations. Dr Bynum reported having received a grant from the National Institutes of Health. Dr Leland reported having received grants from the National Institutes of Health; having received a fellowship from the Center for Gerontology and Healthcare Research of Brown University; and having received a stipend for collaboratively writing practice guidelines for productive aging from the AmericanOccupational Therapy Association. Dr Miller reported having received funding as a co-investigator to design and simulate modification to the Medicare hospice benefit payment system from the National Hospice and Palliative CareOrganization. Dr Morden reported having received a grant from the Robert Wood Johnson Foundation. Dr Goodman reported having received grants from the Robert Wood Johnson Foundation and National Institutes of Health; having served as a consultant for HealthDialog; and having received speakers' fees from the World Congress, Illinois Hospital Association, National Hospice Workgroup, National Association of Health Data Organizations, St Peters University Hospital, Massachusetts Hospital Association, Cooper Health System, Organizzato dal Laboratoria Management e Sanit a Scuola Superiore Sant'Anna di Pisa, Kentucky Academy of Family Physicians, Southern Illinois University Health Policy Institute, Ohio University College of Osteopathic Medicine, Institute for Clinical Quality and Value, Marwood Group, American Society of Clinical Oncologists, OR Manager, Delta Health Alliance, SUNY Upstate University, Intermountain Healthcare, Canadian Health Services Research Foundation, Massachusetts Health Data Consortium, and Organisation for Economic Cooperation and Development. Dr Mor reported having received grants or having grants pending from the National Institutes of Health, Agency for Healthcare Research and Quality, National Institute on Aging, Commonwealth Fund, American Health Care Association, and Kidney Care Partners; having received travel support from the National Institutes of Health and Agency for Healthcare Research and Quality; having received speakers' fees from the Alliance for Long Term Care Quality; having served on a board for PointRight and HCR Manor Care; having consulted for Abt Associates, Research Triangle Institute, and Welsh Carson Investment; and owning stock in PointRight. No other disclosures were reported.	[Anonymous], HOSP SERV; Bakitas Marie, 2009, Palliat Support Care, V7, P75, DOI 10.1017/S1478951509000108; Barnato AE, 2012, INTENS CARE MED, V38, P1886, DOI 10.1007/s00134-012-2661-6; Berke EM, 2009, J PALLIAT MED, V12, P128, DOI 10.1089/jpm.2008.0239; Brody AA, 2010, J PALLIAT MED, V13, P541, DOI 10.1089/jpm.2009.0300; Gallup GH, 1997, SPIRITUAL BELIEFS DY; Gozalo P, 2011, NEW ENGL J MED, V365, P1212, DOI 10.1056/NEJMsa1100347; GREER DS, 1986, J CHRON DIS, V39, P5, DOI 10.1016/0021-9681(86)90102-5; Higginson I J, 2000, J Palliat Med, V3, P287, DOI 10.1089/jpm.2000.3.287; Higginson IJ, 2002, J PAIN SYMPTOM MANAG, V23, P96, DOI 10.1016/S0885-3924(01)00406-7; Intrator O, 2011, HEALTH SERV RES, V46, P120, DOI 10.1111/j.1475-6773.2010.01194.x; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Meier DE, 2011, MILBANK Q, V89, P343, DOI 10.1111/j.1468-0009.2011.00632.x; Morrison RS, 2008, ARCH INTERN MED, V168, P1783, DOI 10.1001/archinte.168.16.1783; Morrison RS, 2005, J PALLIAT MED, V8, P1127, DOI 10.1089/jpm.2005.8.1127; National Center for Health Statistics, HLTH US 2010 SPEC FE; National Hospice and Palliative Care Organization, 2019, NHPCO FACTS FIG HOSP; Smith TJ, 2009, J PAIN SYMPTOM MANAG, V38, P32, DOI 10.1016/j.jpainsymman.2009.05.001; Taylor DH, 2007, SOC SCI MED, V65, P1466, DOI 10.1016/j.socscimed.2007.05.028; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM., FACTS DYING BROWN AT; Teno JM, 2012, J PAIN SYMPTOM MANAG, V43, P732, DOI 10.1016/j.jpainsymman.2011.05.012; Teno JM, 2011, J AM GERIATR SOC, V59, P881, DOI 10.1111/j.1532-5415.2011.03385.x; Unroe KT, 2011, ARCH INTERN MED, V171, P196, DOI 10.1001/archinternmed.2010.371; Waldrop DP, 2005, J PALLIAT CARE, V21, P88, DOI 10.1177/082585970502100204; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863	27	716	718	6	120	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					470	477		10.1001/jama.2012.207624	http://dx.doi.org/10.1001/jama.2012.207624			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083LY	23385273	Green Accepted, Bronze			2022-12-24	WOS:000314466900028
J	Ginsburg, GS				Ginsburg, Geoffrey S.			Realizing the Opportunities of Genomics in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Duke Univ, Inst Genome Sci & Policy, Ctr Personalized Med, Durham, NC 27708 USA	Duke University	Ginsburg, GS (corresponding author), Duke Univ, Inst Genome Sci & Policy, Ctr Personalized Med, 101 Sci Dr, Durham, NC 27708 USA.	geoffrey.ginsburg@duke.edu						Bianchi DW, 2012, NAT MED, V18, P1041, DOI 10.1038/nm.2829; Damman CJ, 2012, AM J GASTROENTEROL, V107, P1452, DOI 10.1038/ajg.2012.93; Food and Drug Administration, TABL PHARM BIOM DRUG; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; National Human Genome Research Institute, STRAT PLAN CHART COU	6	24	24	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1463	1464		10.1001/jama.2013.1465	http://dx.doi.org/10.1001/jama.2013.1465			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571581				2022-12-24	WOS:000317271700020
J	Joynt, KE; Orav, EJ; Jha, AK				Joynt, Karen E.; Orav, E. John; Jha, Ashish K.			Mortality Rates for Medicare Beneficiaries Admitted to Critical Access and Non-Critical Access Hospitals, 2002-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							30-DAY MORTALITY; MYOCARDIAL-INFARCTION; QUALITY; CARE; OUTCOMES; COSTS	Importance Critical access hospitals (CAHs) provide inpatient care to Americans living in rural communities. These hospitals are at high risk of falling behind with respect to quality improvement, owing to their limited resources and vulnerable patient populations. How they have fared on patient outcomes during the past decade is unknown. Objective To evaluate trends in mortality for patients receiving care at CAHs and compare these trends with those for patients receiving care at non-CAHs. Design, Setting, and Patients Retrospective observational study using data from Medicare fee-for-service patients admitted to US acute care hospitals with acute myocardial infarction (1 902 586 admissions), congestive heart failure (4 488 269 admissions), and pneumonia (3 891 074 admissions) between 2002 and 2010. Main Outcome Measures Trends in risk-adjusted 30-day mortality rates for CAHs and other acute care US hospitals. Results Accounting for differences in patient, hospital, and community characteristics, CAHs had mortality rates comparable with those of non-CAHs in 2002 (composite mortality across all 3 conditions, 12.8% vs 13.0%; difference, -0.3% [95% CI, -0.7% to 0.2%]; P=.25). Between 2002 and 2010, mortality rates increased 0.1% per year in CAHs but decreased 0.2% per year in non-CAHs, for an annual difference in change of 0.3% (95% CI, 0.2% to 0.3%; P<.001). Thus, by 2010, CAHs had higher mortality rates compared with non-CAHs (13.3% vs 11.4%; difference, 1.8% [95% CI, 1.4% to 2.2%]; P<.001). The patterns were similar when each individual condition was examined separately. Comparing CAHs with other small, rural hospitals, similar patterns were found. Conclusions and Relevance Among Medicare beneficiaries with acute myocardial infarction, congestive heart failure, or pneumonia, 30-day mortality rates for those admitted to CAHs, compared with those admitted to other acute care hospitals, increased from 2002 to 2010. New efforts may be needed to help CAHs improve. JAMA. 2013;309(13):1379-1387 www.jama.com	[Joynt, Karen E.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Orav, E. John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Joynt, Karen E.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Orav, E. John; Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Joynt, KE (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			National Heart, Lung, and Blood Institute, National Institutes of Health [1K23HL109177-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109177] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Joynt was supported by grant 1K23HL109177-01 from the National Heart, Lung, and Blood Institute, National Institutes of Health.	Ambardekar AV, 2010, AM J CARDIOL, V105, P139, DOI 10.1016/j.amjcard.2009.09.003; Bodenheimer T, 2005, ANN INTERN MED, V142, P932, DOI 10.7326/0003-4819-142-11-200506070-00012; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Desai MM, 2009, 2009 MEASURES MAINTE; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Institute of Medicine Committee on the Future of Rural Health Care Quality Board on Health Care Services., 2005, QUAL COLL FUT RUR HL; James PA, 2007, ANN FAM MED, V5, P105, DOI 10.1370/afm.625; Joynt KE, 2011, JAMA-J AM MED ASSOC, V306, P45, DOI 10.1001/jama.2011.902; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Li P, 2007, HEALTH SERV RES, V42, P2294; Li PX, 2007, HEALTH SERV RES, V42, P2089, DOI 10.1111/j.1475-6773.2007.00731.x; Li PX, 2009, J RURAL HEALTH, V25, P70, DOI 10.1111/j.1748-0361.2009.00201.x; Li PX, 2009, INQUIRY-J HEALTH CAR, V46, P46, DOI 10.5034/inquiryjrnl_46.01.46; Lichtman JH, 2012, STROKE, V43, P2741, DOI 10.1161/STROKEAHA.112.665646; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; Medicare Payment Advisory Commission, 2008, C PAYM BAS CRIT ACC; MedPAC, 2005, C ISS MOD MED PROGR; Rosko MD, 2010, J HEALTH POLIT POLIC, V35, P95, DOI 10.1215/03616878-2009-042; Ross JS, 2008, HEALTH AFFAIR, V27, P1707, DOI 10.1377/hlthaff.27.6.1707; Share DA, 2011, HEALTH AFFAIR, V30, P636, DOI 10.1377/hlthaff.2010.0526; Snyder C, 2005, JAMA-J AM MED ASSOC, V293, P2900, DOI 10.1001/jama.293.23.2900; Stensland J, 2004, 44 U MINN RUR HLTH R; United States Department of Agriculture (USDA) Economic Research Service, 2005, MEAS RUR RUR URB COM; Wang M, 2012, URBAN STUD, V49, P563, DOI 10.1177/0042098011404932; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Werner RM, 2010, HEALTH AFFAIR, V29, P1319, DOI 10.1377/hlthaff.2008.0770; Yeh RW, 2012, CIRC-CARDIOVASC QUAL, V5, P197, DOI 10.1161/CIRCOUTCOMES.111.962456	29	60	60	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1379	1387		10.1001/jama.2013.2366	http://dx.doi.org/10.1001/jama.2013.2366			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117EC	23549583	Bronze			2022-12-24	WOS:000316934500027
J	Juergens, N				Juergens, Norbert			The Biological Underpinnings of Namib Desert Fairy Circles	SCIENCE			English	Article							MYSTERIOUS CIRCLES	The sand termite Psammotermes allocerus generates local ecosystems, so-called fairy circles, through removal of short-lived vegetation that appears after rain, leaving circular barren patches. Because of rapid percolation and lack of evapotranspiration, water is retained within the circles. This process results in the formation of rings of perennial vegetation that facilitate termite survival and locally increase biodiversity. This termite-generated ecosystem persists through prolonged droughts lasting many decades.	Univ Hamburg, Bioctr Klein Flottbek, D-22609 Hamburg, Germany	University of Hamburg	Juergens, N (corresponding author), Univ Hamburg, Bioctr Klein Flottbek, Ohnhorststr 18, D-22609 Hamburg, Germany.	norbert.juergens@t-online.de	Juergens, Norbert/K-4792-2013	Juergens, Norbert/0000-0003-3211-0549	German Federal Ministry of Education and Research [01 LC 0024, 01 LC 0024A, 01 LC 0624A2]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Funding of long-term monitoring was provided by the German Federal Ministry of Education and Research 01 LC 0024, 01 LC 0024A, and 01 LC 0624A2 [Biodiversity Monitoring Transect Analysis in Africa (BIOTA)-Southern Africa]. Data presented in this paper	Albrecht CF, 2001, S AFR J SCI, V97, P23; Grube S., 1997, THESIS FREIE U BERLI; Jankowitz WJ, 2008, S AFR J BOT, V74, P332, DOI 10.1016/j.sajb.2007.10.010; Kaffarnik S., 2009, THESIS U HAMBURG HAM; NAIMAN RJ, 1994, ECOLOGY, V75, P905, DOI 10.2307/1939415; Naude Y, 2011, J ARID ENVIRON, V75, P446, DOI 10.1016/j.jaridenv.2010.12.018; Picker MD, 2012, ECOL ENTOMOL, V37, P33, DOI 10.1111/j.1365-2311.2011.01332.x; Tschinkel WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038056; van Rooyen MW, 2004, J ARID ENVIRON, V57, P467, DOI 10.1016/S0140-1963(03)00111-3	9	71	73	3	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1618	1621		10.1126/science.1222999	http://dx.doi.org/10.1126/science.1222999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539605				2022-12-24	WOS:000316731600052
J	Li, L; Hanahan, D				Li, Leanne; Hanahan, Douglas			Hijacking the Neuronal NMDAR Signaling Circuit to Promote Tumor Growth and Invasion	CELL			English	Article							MOUSE MODELS; PANCREATIC NEUROENDOCRINE; RECEPTOR TRAFFICKING; E-CADHERIN; CANCER; ANGIOGENESIS; CELLS; DISSEMINATION; ACTIVATION; EXPRESSION	Glutamate and its receptor N-methyl-D-aspartate receptor (NMDAR) have been associated with cancer, although their functions are not fully understood. Herein, we implicate glutamate-driven NMDAR signaling in a mouse model of pancreatic neuroendocrine tumorigenesis (PNET) and in selected human cancers. NMDAR was upregulated at the periphery of PNET tumors, particularly invasive fronts. Moreover, elevated coexpression of NMDAR and glutamate exporters correlated with poor prognosis in cancer patients. Treatment of a tumor-derived cell line with NMDAR antagonists impaired cancer cell proliferation and invasion. Flow conditions mimicking interstitial fluid pressure induced autologous glutamate secretion, activating NMDAR and its downstream MEK-MAPK and CaMK effectors, thereby promoting invasiveness. Congruently, pharmacological inhibition of NMDAR in mice with PNET reduced tumor growth and invasiveness. Therefore, beyond its traditional role in neurons, NMDAR may be activated in human tumors by fluid flow consequent to higher interstitial pressure, inducing an autocrine glutamate signaling circuit with resultant stimulation of malignancy.	[Li, Leanne; Hanahan, Douglas] Swiss Fed Inst Technol Lausanne EPFL, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Hanahan, D (corresponding author), Swiss Fed Inst Technol Lausanne EPFL, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland.	douglas.hanahan@epfl.ch		Li, Leanne/0000-0002-1598-1564	EPFL	EPFL	We wish to thank M. Luisa Iruela-Arispe, Igor Allaman, and Anita Wolfer for advice, discussions, and insightful comments on the manuscript; Jessica Sordet-Dessimoz and Alessandra Piersigilli for pathology, Jacques Rougemont and Marion Leleu for statistical consultations; Ehud Drori, Mei-Wen Peng, and Jean-Paul Abbuhl for help with animal experiments; Yunyun Han, Hsin-Ying Huang, Sukhvinder Sidhu, and all Hanahan lab members for biological samples and discussions; Melody Swartz, Adrian C. Shieh, and Jacqueline Shields for advice and instruction on the modified invasion assay; Janet Iwasa for the schematic figure; and the EPFL School of Life Sciences technology cores and animal care facility. This research was supported by a core grant from EPFL. Some results are based on data generated by the TCGA pilot project.	Bai LQ, 2003, AM J PHYSIOL-GASTR L, V284, pG808, DOI 10.1152/ajpgi.00333.2002; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Braithwaite SP, 2006, EUR J NEUROSCI, V23, P2847, DOI 10.1111/j.1460-9568.2006.04837.x; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; Chun MGH, 2010, P NATL ACAD SCI USA, V107, P17268, DOI 10.1073/pnas.1012705107; Chun MGH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001120; Dafni H, 2002, CANCER RES, V62, P6731; Du YCN, 2007, PLOS BIOL, V5, P2255, DOI 10.1371/journal.pbio.0050276; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Grippo PJ, 2010, CANCER PREV RES, V3, P1382, DOI 10.1158/1940-6207.CAPR-10-0258; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Herner A, 2011, INT J CANCER, V129, P2349, DOI 10.1002/ijc.25898; Herzig M, 2007, ONCOGENE, V26, P2290, DOI 10.1038/sj.onc.1210029; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Marsden KC, 2007, J NEUROSCI, V27, P14326, DOI 10.1523/JNEUROSCI.4433-07.2007; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nicoletti F, 2007, TRENDS PHARMACOL SCI, V28, P206, DOI 10.1016/j.tips.2007.03.008; North WG, 2010, CLIN PHARMACOL-ADV A, V2, P31, DOI 10.2147/CPAA.S6262; North WG, 2010, BREAST CANCER RES TR, V122, P307, DOI 10.1007/s10549-009-0556-1; Olson P, 2011, P NATL ACAD SCI USA, V108, pE1275, DOI 10.1073/pnas.1111079108; Perl AK, 1999, NAT MED, V5, P286, DOI 10.1038/6502; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; POITOUT V, 1995, DIABETES, V44, P306, DOI 10.2337/diabetes.44.3.306; Prickett TD, 2012, CLIN CANCER RES, V18, P4240, DOI 10.1158/1078-0432.CCR-11-1217; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharma MK, 2010, BIOCHEM BIOPH RES CO, V391, P91, DOI 10.1016/j.bbrc.2009.10.168; Shieh AC, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015012; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Stepulak A, 2009, HISTOCHEM CELL BIOL, V132, P435, DOI 10.1007/s00418-009-0613-1; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Wegener N, 2011, NEUROSCI LETT, V503, P68, DOI 10.1016/j.neulet.2011.08.012; Wu JH, 2005, PSYCHOPHARMACOLOGY, V177, P256, DOI 10.1007/s00213-004-1944-1	44	92	100	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					86	100		10.1016/j.cell.2013.02.051	http://dx.doi.org/10.1016/j.cell.2013.02.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540692	Bronze, Green Submitted			2022-12-24	WOS:000316853700008
J	Zoghbi, WA; Holmes, DR				Zoghbi, William A.; Holmes, David R., Jr.			Improving Cardiovascular Health A Balance Between Discovery and Delivery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASE		[Zoghbi, William A.; Holmes, David R., Jr.] Cardiol Fdn, Amer Coll, Washington, DC USA; [Holmes, David R., Jr.] Mayo Clin Fdn, Rochester, MN USA; [Zoghbi, William A.] Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA	Mayo Clinic; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Zoghbi, WA (corresponding author), Methodist DeBakey Heart & Vasc Ctr, Cardiovasc Imaging Inst, 6550 Fannin St,SM 677, Houston, TX 77030 USA.	wzoghbi@tmhs.org						Marrero SL, 2012, JAMA-J AM MED ASSOC, V307, P2037, DOI 10.1001/jama.2012.3546; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Valderrama Amy L., 2011, Morbidity and Mortality Weekly Report, V60, P1248; World Health Organization, GLOB ATL CARD DIS PR	4	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1117	1118		10.1001/jama.2013.2416	http://dx.doi.org/10.1001/jama.2013.2416			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FF	23475314				2022-12-24	WOS:000316276500022
J	Leach, RM; Brotherton, A; Stroud, M; Thompson, R				Leach, Richard M.; Brotherton, Ailsa; Stroud, Michael; Thompson, Richard			Nutrition and fluid balance must be taken seriously	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MALNUTRITION		[Leach, Richard M.] Guys & St Thomas NHS Fdn Trust, London, England; [Brotherton, Ailsa] Salford Royal NHS Fdn Trust, NHS Quest, Salford, Lancs, England; [Stroud, Michael] Southampton Univ Hosp NHS Trust, Southampton, Hants, England; [Thompson, Richard] Royal Coll Physicians, London NW1 4LE, England	Guy's & St Thomas' NHS Foundation Trust; Salford Royal NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; Royal College of Physicians	Leach, RM (corresponding author), Guys & St Thomas NHS Fdn Trust, London, England.	richard.leach@gstt.nhs.uk						Academy of Medical Royal Colleges, UNEIG UND CURR; Age UK, 2010, STILL HEARD SCAND PE; Arieff AI, 1999, CHEST, V115, P1371, DOI 10.1378/chest.115.5.1371; BISTRIAN BR, 1976, JAMA-J AM MED ASSOC, V235, P1567, DOI 10.1001/jama.235.15.1567; Brotherton A., 2010, MALNUTRITION MATTERS; Callum KG, 2002 REP NAT CONF EN; Care Quality Commission, 2011, NAT REP DIGN NUTR; Elia M, 2005, COST DIS RELATED MAL; Elia M, 2009, COMBATING MALNUTRITI; Gosling P, 2011, BRIT CONSENSUS GUIDE; Guest JF, 2011, CLIN NUTR, V30, P422, DOI 10.1016/j.clnu.2011.02.002; Marcos A, 2003, EUR J CLIN NUTR, V57, pS66, DOI 10.1038/sj.ejcn.1601819; MCWHIRTER JP, 1994, BRIT MED J, V308, P945, DOI 10.1136/bmj.308.6934.945; Milne AC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003288.pub3; National Institute for Health and Clinical Excellence, 2006, NUTR SUPP AD CLIN GU; National Patient Safety Agency, 1994, RED HARM CAUS MISPL; NCEPOD, 2010, ART NUTR ENQ REP MIX; NHS Institute for Innovation and Improvement, 2009, HIGH IMP ACT NURS MI; NICE, 2009, COST SAV GUID; Parliamentary and Health Service Ombudsman, 2011, CAR COMP REP HLTH SE; Patients' Association, 2011, MALNUTRITION COMMUNI; Powell AGMT, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2741; Rooker JC, 2007, CLIN MED, V7, P482, DOI 10.7861/clinmedicine.7-5-482; Royal College of Physicians, 2012, WARD ROUNDS MED; Russell CA, NUTR SCREENING SURVE; Schneider SM, 2004, BRIT J NUTR, V92, P105, DOI 10.1079/BJN20041152; Soong JBV, 2012, IMPROVING WARD ROUND; Sorensen J, 2008, CLIN NUTR, V27, P340, DOI 10.1016/j.clnu.2008.03.012; Stechmiller JK, 2010, NUTR CLIN PRACT, V25, P61, DOI 10.1177/0884533609358997; Stratton RJ, 2003, DIS RELATED MALNUTRI; Tang VCY., 2010, CLIN RISK, V16, P10, DOI [10.1258/cr.2009.090005, DOI 10.1258/CR.2009.090005]; Walsh SR, 2008, INT J CLIN PRACT, V62, P492, DOI 10.1111/j.1742-1241.2007.01386.x; Walsh SR, 2005, ANN ROY COLL SURG, V87, P126, DOI 10.1308/147870805X28127	33	20	21	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2013	346								f801	10.1136/bmj.f801	http://dx.doi.org/10.1136/bmj.f801			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088AY	23396386				2022-12-24	WOS:000314807400006
J	Sherkow, JS; Greely, HT				Sherkow, Jacob S.; Greely, Henry T.			What If Extinction Is Not Forever?	SCIENCE			English	Editorial Material									[Sherkow, Jacob S.] Stanford Law Sch, Ctr Law & Biosci, Stanford, CA 94305 USA; [Greely, Henry T.] Stanford Univ, Stanford, CA 94305 USA	Stanford University; Stanford University	Greely, HT (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	hgreely@stanford.edu		Sherkow, Jacob/0000-0002-9724-9261				[Anonymous], 1933, LAST TASMANIAN TIGER; Chavatte-Palmer P, 2012, PLACENTA, V33, pS99, DOI 10.1016/j.placenta.2011.09.012; Folch J, 2009, THERIOGENOLOGY, V71, P1026, DOI 10.1016/j.theriogenology.2008.11.005; IUCN, 1994, IUCN RED LIST CAT CR; RIDLEY M, 2013, WALL STREET J   0330, pC4; Rohrbaugh Mark L, 1997, AIPLA QJ, V25, P371; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/NMETH.1971, 10.1038/nmeth.1971]; Zimmer Carl, 2013, NATL GEOGR; Zimov SA, 2005, SCIENCE, V308, P796, DOI 10.1126/science.1113442	9	92	96	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					32	33		10.1126/science.1236965	http://dx.doi.org/10.1126/science.1236965			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	118XS	23559235	Green Submitted, Green Published			2022-12-24	WOS:000317061100031
J	Bishop, TF				Bishop, Tara F.			Pushing the Outpatient Quality Envelope	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bishop, Tara F.] Weill Cornell Med Coll, Dept Publ Hlth, Div Outcomes & Effectiveness, New York, NY 10021 USA; [Bishop, Tara F.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA	Cornell University; Cornell University	Bishop, TF (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, 402 E 67th St,Room LA 218, New York, NY 10021 USA.	tlfernan@med.cornell.edu			NATIONAL INSTITUTE ON AGING [K23AG043499] Funding Source: NIH RePORTER; NIA NIH HHS [K23 AG043499, K23AG043499] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Casalino LP, 1999, NEW ENGL J MED, V341, P1147, DOI 10.1056/NEJM199910073411511; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Insitute of Medicine, 2008, FUT NURS LEAD CHANG; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kupfer JM, 2012, JAMA-J AM MED ASSOC, V308, P139, DOI 10.1001/jama.2012.7381; The Joint Commission, 2012 NAT PAT SAF GOA; Volpp KG, 2012, JAMA-J AM MED ASSOC, V308, P1635, DOI 10.1001/jama.2012.13616; Workgroup ACQA, 2005, REC START SET CLIN P	8	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1353	1354		10.1001/jama.2013.1220	http://dx.doi.org/10.1001/jama.2013.1220			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EC	23519384	Green Accepted			2022-12-24	WOS:000316934500022
J	Lafaurie-Janvore, J; Maiuri, P; Wang, I; Pinot, M; Manneville, JB; Betz, T; Balland, M; Piel, M				Lafaurie-Janvore, Julie; Maiuri, Paolo; Wang, Irene; Pinot, Mathieu; Manneville, Jean-Baptiste; Betz, Timo; Balland, Martial; Piel, Matthieu			ESCRT-III Assembly and Cytokinetic Abscission Are Induced by Tension Release in the Intercellular Bridge	SCIENCE			English	Article							MIDBODY; CONSTRICTION; RECRUITMENT; DYNAMICS; SPASTIN; FORCES	The last step of cell division, cytokinesis, produces two daughter cells that remain connected by an intercellular bridge. This state often represents the longest stage of the division process. Severing the bridge (abscission) requires a well-described series of molecular events, but the trigger for abscission remains unknown. We found that pulling forces exerted by daughter cells on the intercellular bridge appear to regulate abscission. Counterintuitively, these forces prolonged connection, whereas a release of tension induced abscission. Tension release triggered the assembly of ESCRT-III (endosomal sorting complex required for transport-III), which was followed by membrane fission. This mechanism may allow daughter cells to remain connected until they have settled in their final locations, a process potentially important for tissue organization and morphogenesis.	[Lafaurie-Janvore, Julie; Maiuri, Paolo; Pinot, Mathieu; Manneville, Jean-Baptiste; Piel, Matthieu] Inst Curie, CNRS, UMR 144, F-75248 Paris 05, France; [Wang, Irene; Balland, Martial] Univ Grenoble 1, CNRS, LIPhy UMR 5588, F-38041 Grenoble, France; [Betz, Timo] Inst Curie, CNRS, UMR 168, F-75248 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Piel, M (corresponding author), Inst Curie, CNRS, UMR 144, 26 Rue Ulm, F-75248 Paris 05, France.	matthieu.piel@curie.fr	Manneville, Jean-Baptiste/L-5914-2019; Pinot, Mathieu/P-8192-2014; Betz, Timo/ABF-9946-2021	Maiuri, Paolo/0000-0001-5079-445X; Betz, Timo/0000-0002-1548-0655; Manneville, Jean-Baptiste/0000-0002-8670-3940; Balland, martial/0000-0002-6585-9735	French ministerial fellowship; Fondation pour la Recherche Medicale fellowship; Ligue Contre le Cancer grant; Fondation Nanosciences RTRA;  [ANR-11-JSV5-0002]	French ministerial fellowship; Fondation pour la Recherche Medicale fellowship(Fondation pour la Recherche Medicale); Ligue Contre le Cancer grant; Fondation Nanosciences RTRA; 	We thank D. Gerlich for the Hela Kyoto alpha-tubulin-EGFP histone2B-mCherry cell line and the alpha-tubulin plasmids; I. Poser and A. Hyman for the CHMP4B-GFP cell line; A. Roux, A. Echard, N. Minc, C. Janke, and members of the Piel lab for critical reading of the manuscript and C. Ainsworth for editing it; L. Sengmanivong, V. Fraisier, the Nikon Imaging Center, and the PICT-IBiSA of the Institut Curie for technical support in microscopy; C. Sykes; and E. Terriac and A. Jimenez for helpful discussions. Supported by a French ministerial fellowship (J.L.-J.), a Fondation pour la Recherche Medicale fellowship (J.L.-J. and P. M.), a Ligue Contre le Cancer grant (M. P.), ANR-11-JSV5-0002 (T. B.), and Fondation Nanosciences RTRA (M. B.). The data are contained in the manuscript and the supplementary materials.	Bastos RN, 2010, J CELL BIOL, V191, P751, DOI 10.1083/jcb.201008108; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Elia N, 2012, BIOPHYS J, V102, P2309, DOI 10.1016/j.bpj.2012.04.007; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Fyfe I, 2011, J BIOL CHEM, V286, P34262, DOI 10.1074/jbc.M111.266411; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Iwamori T, 2010, MOL CELL BIOL, V30, P2280, DOI 10.1128/MCB.01392-09; Kechad A, 2012, CURR BIOL, V22, P197, DOI 10.1016/j.cub.2011.11.062; Khodjakov A, 1997, CELL MOTIL CYTOSKEL, V38, P311, DOI 10.1002/(SICI)1097-0169(1997)38:4<311::AID-CM1>3.3.CO;2-M; Morin P, 2009, EUR J CELL BIOL, V88, P495, DOI 10.1016/j.ejcb.2009.04.005; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Schiel JA, 2012, NAT CELL BIOL, V14, P1068, DOI 10.1038/ncb2577; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tanimoto H, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248110; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512	23	106	107	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1625	1629		10.1126/science.1233866	http://dx.doi.org/10.1126/science.1233866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539606				2022-12-24	WOS:000316731600054
J	Chang, CY; Pasolli, HA; Giannopoulou, EG; Guasch, G; Gronostajski, RM; Elemento, O; Fuchs, E				Chang, Chiung-Ying; Pasolli, H. Amalia; Giannopoulou, Eugenia G.; Guasch, Geraldine; Gronostajski, Richard M.; Elemento, Olivier; Fuchs, Elaine			NFIB is a governor of epithelial-melanocyte stem cell behaviour in a shared niche	NATURE			English	Article							HAIR FOLLICLE; EPIDERMAL MELANOCYTES; DIFFERENTIATION; SKIN; REGENERATION; ENDOTHELIN; MAINTENANCE; ACTIVATION; EXPRESSION; ROLES	Adult stem cells reside in specialized niches where they receive environmental cues to maintain tissue homeostasis. In mammals, the stem cell niche within hair follicles is home to epithelial hair follicle stem cells and melanocyte stem cells, which sustain cyclical bouts of hair regeneration and pigmentation(1-4). To generate pigmented hairs, synchrony is achieved such that upon initiation of a new hair cycle, stem cells of each type activate lineage commitment(2,5). Dissecting the inter-stem-cell crosstalk governing this intricate coordination has been difficult, because mutations affecting one lineage often affect the other. Here we identify transcription factor NFIB as. an unanticipated coordinator of stem cell behaviour. Hair follicle stem-cell-specific conditional targeting of Nfib in mice uncouples stem cell synchrony. Remarkably, this happens not by perturbing hair cycle and follicle architecture, but rather by promoting melanocyte stem cell proliferation and differentiation. The early production of melanin is restricted to melanocyte stem cells at the niche base. Melanocyte stem cells more distant from the dermal papilla are unscathed, thereby preventing hair greying typical of melanocyte stem cell differentiation mutants. Furthermore, we pinpoint KIT-ligand as a dermal papilla signal promoting melanocyte stem cell differentiation. Additionally, through chromatin-immunoprecipitation with high-throughput-sequencing and transcriptional profiling, we identify endothelin 2 (Edn2) as an NFIB target aberrantly activated in NFIB-deficient hair follicle stem cells. Ectopically induced Edn2 recapitulates NFIB-deficient phenotypes in wildtype mice. Conversely, endothelin receptor antagonists and/or KIT blocking antibodies prevent precocious melanocyte stem cell differentiation in the NFIB-deficient niche. Our findings reveal how melanocyte and hair follicle stem cell behaviours maintain reliance upon cooperative factors within the niche, and how this can be uncoupled in injury, stress and disease states.	[Chang, Chiung-Ying; Pasolli, H. Amalia; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Giannopoulou, Eugenia G.; Elemento, Olivier] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Guasch, Geraldine] Univ Cincinnati, Sch Med, Div Dev Biol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Gronostajski, Richard M.] SUNY Buffalo, Dept Biochem, Dev Genom Grp, NYS Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14203 USA	Howard Hughes Medical Institute; Rockefeller University; Cornell University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016; Giannopoulou, Evgenia/K-9576-2019	Gronostajski, Richard/0000-0003-4264-208X; Guasch, Geraldine/0000-0001-7362-9318; Pasolli, Hilda Amalia/0000-0003-3899-3530	NIH [R01-AR050452, R01-AR31737, R01-HL080624]; National Science Foundation [DB1054964]; Div Of Biological Infrastructure [1054964] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737, R01AR050452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Y.-C. Hsu, T. Chen, B. Keyes, S. E. Williams, A. Rodriguez-Folgueras and other Fuchs laboratory members for intellectual input and suggestions; L. Polak and N. Stokes for breeding of mouse lines and conducting in utero lentiviral injections; V.J. Hearing for providing anti-DCT,TYRP1 and TYR antibodies. We also thank Rockefeller facilities: Comparative Bioscience Center (AAALAC accredited) for care and husbandry care of mice in accordance with National Institutes of Health (NIH) guidelines; Bioimaging Center for advice on image acquisition; Flow Cytometry facility for FACS sorting. E.F. is an investigator of the Howard Hughes Medical Institute. This work was supported by grants from the NIH to E.F. (R01-AR050452 and R01-AR31737) and R.M.G. (R01-HL080624), and a CAREER grant to O.E. from the National Science Foundation (DB1054964).	Adur J, 2007, PEPTIDES, V28, P1083, DOI 10.1016/j.peptides.2007.03.009; Aoki H, 2009, DEVELOPMENT, V136, P2511, DOI 10.1242/dev.037168; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Botchkareva NV, 2001, FASEB J, V15, P645, DOI 10.1096/fj.00-0368com; Cotsarelis G, 2006, J CLIN INVEST, V116, P19, DOI 10.1172/JCI27490; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Grunder A, 2002, MECH DEVELOP, V112, P69, DOI 10.1016/S0925-4773(01)00640-2; Hirobe T, 2011, PIGM CELL MELANOMA R, V24, P462, DOI 10.1111/j.1755-148X.2011.00845.x; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Klipper E, 2010, ENDOCRINOLOGY, V151, P1914, DOI 10.1210/en.2009-0767; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; McDade SS, 2012, NUCLEIC ACIDS RES, V40, P7190, DOI 10.1093/nar/gks389; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Pjanic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-181; Pla P, 2003, INT J DEV BIOL, V47, P315; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Reid K, 1996, DEVELOPMENT, V122, P3911; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Weiner L, 2007, CELL, V130, P932, DOI 10.1016/j.cell.2007.07.024	30	107	114	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					98	102		10.1038/nature11847	http://dx.doi.org/10.1038/nature11847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23389444	Green Accepted			2022-12-24	WOS:000316039800047
J	Chinthapalli, K				Chinthapalli, Krishna			The Liverpool care pathway: what do specialists think?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				[Anonymous], 2012, DAILY TELEGRAPH; Bingham J., 2012, DAILY TELEGRAPH; Chan R, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008006.pub2, 10.1002/14651858.CD008006.pub4]; DAVIES HTO, 1994, BRIT MED J, V309, P1579, DOI 10.1136/bmj.309.6968.1579a; Department of Health, 2013, LIV CAR PATHW IND RE; Department of Health, 2011, OP FRAM NHS ENGL 201; Ellershaw J, 2003, BRIT MED J, V326, P30, DOI 10.1136/bmj.326.7379.30; Heatherwood and Wexham Park Hospitals NHS Foundation Trust, 2012, LIV CAR PATHW CQUINS; McCartney M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7316; MILLS M, 1994, BRIT MED J, V309, P583, DOI 10.1136/bmj.309.6954.583; National End of Life Care Programme, 2012, LEARN PEOPL EXP LAST; National Institute for Health and Clinical Excellence, 2011, GUID COMM END LIF CA; Phillips M., 2012, DAILY MAIL; Royal Brompton and Harefield NHS Foundation Trust, QUAL ACC 2010 11; Torjesen I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f175; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899	16	11	11	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2013	346								f1184	10.1136/bmj.f1184	http://dx.doi.org/10.1136/bmj.f1184			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	149WE	23449644				2022-12-24	WOS:000319351300002
J	Schuetz, P; Briel, M; Mueller, B				Schuetz, Philipp; Briel, Matthias; Mueller, Beat			Clinical Outcomes Associated With Procalcitonin Algorithms to Guide Antibiotic Therapy in Respiratory Tract Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Schuetz, Philipp; Mueller, Beat] Kantonsspital Aarau, Med Univ Dept, CH-5001 Aarau, Switzerland; [Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland; [Briel, Matthias] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	Kantonsspital Aarau AG (KSA); University of Basel; McMaster University	Schuetz, P (corresponding author), Kantonsspital Aarau, Med Univ Dept, Tellstr, CH-5001 Aarau, Switzerland.	schuetzph@gmail.com	Briel, Matthias/AAT-9284-2021; Mueller, Beat/G-2662-2012; schuetz, philipp/C-8475-2013	schuetz, philipp/0000-0001-6400-4949; Briel, Matthias/0000-0002-2070-5230				Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; Heyland DK, 2011, CRIT CARE MED, V39, P1792, DOI 10.1097/CCM.0b013e31821201a5; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Muller F, 2010, CHEST, V138, P121, DOI 10.1378/chest.09-2920; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Schuetz P, 2011, ARCH INTERN MED, V171, P1322, DOI 10.1001/archinternmed.2011.318; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x	7	62	78	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					717	718		10.1001/jama.2013.697	http://dx.doi.org/10.1001/jama.2013.697			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091EK	23423417				2022-12-24	WOS:000315032000027
J	Kamberov, YG; Wang, SJ; Tan, JZ; Gerbault, P; Wark, A; Tan, LZ; Yang, YJ; Li, SL; Tang, K; Chen, H; Powell, A; Itan, Y; Fuller, D; Lohmueller, J; Mao, JH; Schachar, A; Paymer, M; Hostetter, E; Byrne, E; Burnett, M; McMahon, AP; Thomas, MG; Lieberman, DE; Jin, L; Tabin, CJ; Morgan, BA; Sabeti, PC				Kamberov, Yana G.; Wang, Sijia; Tan, Jingze; Gerbault, Pascale; Wark, Abigail; Tan, Longzhi; Yang, Yajun; Li, Shilin; Tang, Kun; Chen, Hua; Powell, Adam; Itan, Yuval; Fuller, Dorian; Lohmueller, Jason; Mao, Junhao; Schachar, Asa; Paymer, Madeline; Hostetter, Elizabeth; Byrne, Elizabeth; Burnett, Melissa; McMahon, Andrew P.; Thomas, Mark G.; Lieberman, Daniel E.; Jin, Li; Tabin, Clifford J.; Morgan, Bruce A.; Sabeti, Pardis C.			Modeling Recent Human Evolution in Mice by Expression of a Selected EDAR Variant	CELL			English	Article							ECTODYSPLASIN-A RECEPTOR; TO-HIP RATIO; NF-KAPPA-B; POSITIVE SELECTION; ECTODERMAL DYSPLASIA; STATISTICAL EVALUATION; ETHNIC-DIFFERENCES; HAIR THICKNESS; HUMAN GENOME; BODY-WEIGHT	An adaptive variant of the human Ectodysplasin receptor, EDARV370A, is one of the strongest candidates of recent positive selection from genome-wide scans. We have modeled EDAR370A in mice and characterized its phenotype and evolutionary origins in humans. Our computational analysis suggests the allele arose in central China approximately 30,000 years ago. Although EDAR370A has been associated with increased scalp hair thickness and changed tooth morphology in humans, its direct biological significance and potential adaptive role remain unclear. We generated a knockin mouse model and find that, as in humans, hair thickness is increased in EDAR370A mice. We identify new biological targets affected by the mutation, including mammary and eccrine glands. Building on these results, we find that EDAR370A is associated with an increased number of active eccrine glands in the Han Chinese. This interdisciplinary approach yields unique insight into the generation of adaptive variation among modern humans.	[Kamberov, Yana G.; Wark, Abigail; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kamberov, Yana G.; Burnett, Melissa; Morgan, Bruce A.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Kamberov, Yana G.; Morgan, Bruce A.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; [Burnett, Melissa] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Kamberov, Yana G.; Wang, Sijia; Tan, Longzhi; Lohmueller, Jason; Schachar, Asa; Paymer, Madeline; Hostetter, Elizabeth; Byrne, Elizabeth; Sabeti, Pardis C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Kamberov, Yana G.; Lieberman, Daniel E.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Kamberov, Yana G.; Wang, Sijia; Schachar, Asa; Paymer, Madeline; Sabeti, Pardis C.] Harvard Univ, Ctr Syst Biol, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Mao, Junhao; McMahon, Andrew P.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Tan, Jingze; Yang, Yajun; Li, Shilin; Jin, Li] Fudan Univ, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Gerbault, Pascale; Itan, Yuval; Thomas, Mark G.] UCL, Dept Genet Evolut & Environm, London WC1H 0PY, England; [Powell, Adam] UCL, UCL Genet Inst UGI, London WC1H 0PY, England; [Fuller, Dorian] UCL, Inst Archaeol, London WC1H 0PY, England; [Tang, Kun; Jin, Li] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai 200031, Peoples R China; [Chen, Hua] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Sabeti, Pardis C.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; Fudan University; University of London; University College London; University of London; University College London; University of London; University College London; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Jin, L (corresponding author), Fudan Univ, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China.	lijin.fudan@gmail.com; bruce.morgan@cbrc2.mgh.harvard.edu; pardis@broadinstitute.org	Sabeti, Pardis/GQH-8610-2022; Tang, Kun/GSD-3218-2022; Jin, Li/C-1468-2009; Fuller, Dorian Q/C-1908-2008; Jin, Li/M-5063-2019; Fuller, Dorian/AAF-7400-2019; McMahon, Andrew P/ABE-7520-2020; Thomas, Mark G/A-2219-2012	Jin, Li/0000-0002-4546-2415; Fuller, Dorian Q/0000-0002-4859-080X; Fuller, Dorian/0000-0002-4859-080X; Thomas, Mark G/0000-0002-2452-981X; Gerbault, Pascale/0000-0003-3824-0870; Tan, Longzhi/0000-0002-5618-1299; Lohmueller, Jason/0000-0001-6089-9992; Chen, Hua/0000-0002-9829-6561	Harvard University Science and Engineering Committee Seed Fund for Interdisciplinary Science; Packard Foundation Fellowship in Science and Engineering; NIH Innovator Award [1DP2OD006514-01]; BIRT Award from NIAMS [AR055256-04S1]; NIH grant [R37 HD032443]; American School of Prehistoric Research; NSFC [30890034]; MOST [2011BAI09B00]; MOH [201002007]; AXA Research Fund; LeCHE Marie Curie FP7; NIH [R37 054364]; NERC [NE/G005540/1] Funding Source: UKRI; Natural Environment Research Council [NE/G005540/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055256] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006514] Funding Source: NIH RePORTER	Harvard University Science and Engineering Committee Seed Fund for Interdisciplinary Science; Packard Foundation Fellowship in Science and Engineering; NIH Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BIRT Award from NIAMS; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American School of Prehistoric Research; NSFC(National Natural Science Foundation of China (NSFC)); MOST; MOH; AXA Research Fund(AXA Research Fund); LeCHE Marie Curie FP7; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded by a grant from the Harvard University Science and Engineering Committee Seed Fund for Interdisciplinary Science to CJT, PCS, BAM and DEL; a Packard Foundation Fellowship in Science and Engineering and an NIH Innovator Award 1DP2OD006514-01 to PCS; a BIRT Award AR055256-04S1 from NIAMS to BAM; an NIH grant R37 HD032443 to CJT; and funding from the American School of Prehistoric Research to DEL. Human association study work was additionally supported by NSFC 30890034; MOST 2011BAI09B00; MOH 201002007 to LJ. YI was funded by an AXA Research Fund postdoctoral fellowship and PG by the LeCHE Marie Curie FP7 framework. Work in APM's laboratory was supported by an NIH R37 054364 grant. We acknowledge the UCL Legion High Performance Computing Facility and support services and thank O. Bar Yosef, C. Zhao, E. Rohling, S. Schaffner, L. Gaffney, C. Edwards, J. Vitti, S. Tabrizi and A. Tariela for feedback on the manuscript and A. Carpenter, C. Wahlby, and M. Morgan for data analysis help. The authors declare no conflict of interest.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; ANDERSON P, 1983, CURR ANTHROPOL, V24, P25, DOI 10.1086/202933; Beaumont MA, 2002, GENETICS, V162, P2025; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Bryk J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002209; Cann HM, 2002, SCIENCE, V296, P261; CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chang SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007591; Chen H, 2012, THEOR POPUL BIOL, V81, P179, DOI 10.1016/j.tpb.2011.11.004; Chen ZJ, 2004, AM J EPIDEMIOL, V159, P140, DOI 10.1093/aje/kwh028; CLARKE A, 1987, ARCH DIS CHILD, V62, P989, DOI 10.1136/adc.62.10.989; Cluzeau C, 2012, BRIT J DERMATOL, V166, P678, DOI 10.1111/j.1365-2133.2011.10620.x; Cluzeau C, 2011, HUM MUTAT, V32, P70, DOI 10.1002/humu.21384; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cox RD, 2003, CURR OPIN GENET DEV, V13, P278, DOI 10.1016/S0959-437X(03)00051-0; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Cui CY, 2003, HUM MOL GENET, V12, P2931, DOI 10.1093/hmg/ddg325; Dixson BJ, 2011, ARCH SEX BEHAV, V40, P1271, DOI 10.1007/s10508-010-9680-6; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fujimoto A, 2008, HUM GENET, V124, P179, DOI 10.1007/s00439-008-0537-1; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Furnham A, 1998, SEX ROLES, V39, P311, DOI 10.1023/A:1018810723493; Furnham A, 2006, PERS INDIV DIFFER, V41, P443, DOI 10.1016/j.paid.2006.02.007; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; GRUNEBERG H, 1971, J EMBRYOL EXP MORPH, V25, P1; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; JUNIPER K, 1964, AM J DIG DIS, V9, P31, DOI 10.1007/BF02232677; Kimura R, 2009, AM J HUM GENET, V85, P528, DOI 10.1016/j.ajhg.2009.09.006; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kondo S, 2001, CURR BIOL, V11, P1202, DOI 10.1016/S0960-9822(01)00324-4; Kuno Y., 1956, HUMAN PERSPIRATION; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lefevre CM, 2010, ANNU REV GENOM HUM G, V11, P219, DOI 10.1146/annurev-genom-082509-141806; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Maskarinec G, 2001, INT J EPIDEMIOL, V30, P959, DOI 10.1093/ije/30.5.959; Mauldin EA, 2009, AM J MED GENET A, V149A, P2045, DOI 10.1002/ajmg.a.32916; Mikkola ML, 2011, ADV EXP MED BIOL, V691, P23, DOI 10.1007/978-1-4419-6612-4_3; Mou C, 2008, HUM MUTAT, V29, P1405, DOI 10.1002/humu.20795; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Neville MC, 1998, J MAMMARY GLAND BIOL, V3, P109, DOI 10.1023/A:1018786604818; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Oftedal OT, 2002, J MAMMARY GLAND BIOL, V7, P225, DOI 10.1023/A:1022896515287; OKADA N, 1983, ARCH DERMATOL RES, V275, P130, DOI 10.1007/BF00412889; Park JH, 2012, J HUM GENET, V57, P508, DOI 10.1038/jhg.2012.60; Peter BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003011; Pispa J, 2003, GENE EXPR PATTERNS, V3, P675, DOI 10.1016/S1567-133X(03)00092-9; Prodi DA, 2008, J INVEST DERMATOL, V128, P2268, DOI 10.1038/jid.2008.60; RANDALL WC, 1946, J CLIN INVEST, V25, P761, DOI 10.1172/JCI101760; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Sun YB, 2012, NAT GEOSCI, V5, P46, DOI [10.1038/ngeo1326, 10.1038/NGEO1326]; Sundberg, 1994, HDB MOUSE MUTATIONS; Voutilainen M, 2012, P NATL ACAD SCI USA, V109, P5744, DOI 10.1073/pnas.1110627109; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220	68	168	180	3	125	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					691	702		10.1016/j.cell.2013.01.016	http://dx.doi.org/10.1016/j.cell.2013.01.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415220	Bronze, Green Accepted			2022-12-24	WOS:000314945600006
J	Inouye, SK; O'Connell, JJ; Puelle, MR				Inouye, Sharon K.; O'Connell, James J.; Puelle, Margaret R.			Falling Off the Edge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MENTAL-ILLNESS; HOMELESS; ADULTS		[Inouye, Sharon K.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Cambridge, MA 02138 USA; [O'Connell, James J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Cambridge, MA 02138 USA; [Inouye, Sharon K.; O'Connell, James J.] Boston Healthcare Homeless Program, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital	Inouye, SK (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Cambridge, MA 02138 USA.	agingbraincenter@hsl.harvard.edu	Inouye, Sharon/R-7216-2019					Bremner AJ, 1996, BRIT J PSYCHIAT, V169, P434, DOI 10.1192/bjp.169.4.434; Brown RT, 2012, J GEN INTERN MED, V27, P16, DOI 10.1007/s11606-011-1848-9; Burra TA, 2009, CAN J PSYCHIAT, V54, P123, DOI 10.1177/070674370905400210; Culhane DP, 2010, AGE STRUCTURE CONT H; Geddes J R, 1996, Health Bull (Edinb), V54, P276; Hahn JA, 2006, J GEN INTERN MED, V21, P775, DOI 10.1111/j.1525-1497.2006.00493.x; Helfrich CA, 2011, AM J OCCUP THER, V65, P277, DOI 10.5014/ajot.2011.001321; Joyce DP, 2009, CAN FAM PHYSICIAN, V55, P1110; Witte P, 2012, STAT HOM AM 2012	9	2	2	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					451	452		10.1001/jama.2012.214089	http://dx.doi.org/10.1001/jama.2012.214089			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083LY	23385270	Green Published			2022-12-24	WOS:000314466900025
J	Chen, BT; Yau, HJ; Hatch, C; Kusumoto-Yoshida, I; Cho, SL; Hopf, FW; Bonci, A				Chen, Billy T.; Yau, Hau-Jie; Hatch, Christina; Kusumoto-Yoshida, Ikue; Cho, Saemi L.; Hopf, F. Woodward; Bonci, Antonello			Rescuing cocaine-induced prefrontal cortex hypoactivity prevents compulsive cocaine seeking	NATURE			English	Article							PYRAMIDAL CELLS; DRUG SEEKING; RAT; ADDICTION; INTERNEURONS; DYSFUNCTION; EXTINCTION; CHANNELS; BEHAVIOR	Loss of control over harmful drug seeking is one of the most intractable aspects of addiction, as human substance abusers continue to pursue drugs despite incurring significant negative consequences(1). Human studies have suggested that deficits in prefrontal cortical function and consequential loss of inhibitory control(2-4) could be crucial in promoting compulsive drug use. However, it remains unknown whether chronic drug use compromises cortical activity and, equally important, whether this deficit promotes compulsive cocaine seeking. Here we use a rat model of compulsive drug seeking(5-8) in which cocaine seeking persists in a subgroup of rats despite delivery of noxious foot shocks. We show that prolonged cocaine self-administration decreases ex vivo intrinsic excitability of deep-layer pyramidal neurons in the prelimbic cortex, which was significantly more pronounced in compulsive drug-seeking animals. Furthermore, compensating for hypoactive prelimbic cortex neurons with in vivo optogenetic prelimbic cortex stimulation significantly prevented compulsive cocaine seeking, whereas optogenetic prelimbic cortex inhibition significantly increased compulsive cocaine seeking. Our results show a marked reduction in prelimbic cortex excitability in compulsive cocaine-seeking rats, and that in vivo optogenetic prelimbic cortex stimulation decreased compulsive drug-seeking behaviours. Thus, targeted stimulation of the prefrontal cortex could serve as a promising therapy for treating compulsive drug use.	[Chen, Billy T.; Yau, Hau-Jie; Hatch, Christina; Kusumoto-Yoshida, Ikue; Bonci, Antonello] NIDA, Intramural Res Program, Baltimore, MD 21224 USA; [Cho, Saemi L.; Hopf, F. Woodward] Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94608 USA; [Hopf, F. Woodward; Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94110 USA; [Bonci, Antonello] Johns Hopkins Sch Med, Solomon H Snyder Neurosci Inst, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Medicine	Chen, BT (corresponding author), NIDA, Intramural Res Program, Baltimore, MD 21224 USA.	billy.chen@nih.gov; antonello.bonci@nih.gov	Core, Vector/CAF-4832-2022	YAU, HAU-JIE/0000-0001-7454-7971	NIDA/IRP; State of California through the University of California at San Francisco; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000579] Funding Source: NIH RePORTER	NIDA/IRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); State of California through the University of California at San Francisco; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Kourrich and Y. Shaham for careful reading of the manuscript. We also thank K. Deisseroth for providingthe ChR2 and eNpHR3.0 vectors. This study was supported by funds from the NIDA/IRP and the State of California through the University of California at San Francisco.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Beck H, 2008, NAT REV NEUROSCI, V9, P357, DOI 10.1038/nrn2371; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Farovik A, 2008, J NEUROSCI, V28, P13428, DOI 10.1523/JNEUROSCI.3662-08.2008; Ghazizadeh A, 2012, J NEUROSCI, V32, P726, DOI 10.1523/JNEUROSCI.3891-11.2012; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Gregoire S, 2012, NEUROBIOL LEARN MEM, V97, P202, DOI 10.1016/j.nlm.2011.12.003; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Jonkman S, 2009, BEHAV NEUROSCI, V123, P875, DOI 10.1037/a0016330; Kasanetz F, 2012, MOL PSYCHIAT; Knackstedt LA, 2007, J PHARMACOL EXP THER, V322, P1103, DOI 10.1124/jpet.107.122861; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Martina M, 1998, J NEUROSCI, V18, P8111; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Pelloux Y, 2007, PSYCHOPHARMACOLOGY, V194, P127, DOI 10.1007/s00213-007-0805-0; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Taverna S, 2005, J NEUROSCI, V25, P9162, DOI 10.1523/JNEUROSCI.2454-05.2005; Tiffany ST, 2000, ADDICTION, V95, pS145, DOI 10.1046/j.1360-0443.95.8s2.3.x; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Yang CR, 1996, J NEUROSCI, V16, P1904; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	30	325	335	4	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					359	+		10.1038/nature12024	http://dx.doi.org/10.1038/nature12024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23552889				2022-12-24	WOS:000317599200037
J	Lloyd, KG; Schreiber, L; Petersen, DG; Kjeldsen, KU; Lever, MA; Steen, AD; Stepanauskas, R; Richter, M; Kleindienst, S; Lenk, S; Schramm, A; Jorgensen, BB				Lloyd, Karen G.; Schreiber, Lars; Petersen, Dorthe G.; Kjeldsen, Kasper U.; Lever, Mark A.; Steen, Andrew D.; Stepanauskas, Ramunas; Richter, Michael; Kleindienst, Sara; Lenk, Sabine; Schramm, Andreas; Jorgensen, Bo Barker			Predominant archaea in marine sediments degrade detrital proteins	NATURE			English	Article							AARHUS BAY; RNA GENES; ONE-CELL; BACTERIA; QUANTIFICATION; CLOSTRIPAIN; METAGENOME; INDICATORS; PHYLOGENY; ALGORITHM	Half of the microbial cells in the Earth's oceans are found in sediments(1). Many of these cells are members of the Archaea(2), single-celled prokaryotes in a domain of life separate from Bacteria and Eukaryota. However, most of these archaea lack cultured representatives, leaving their physiologies and placement on the tree of life uncertain. Here we show that the uncultured miscellaneous crenar-chaeotal group (MCG) and marine benthic group-D (MBG-D) are among the most numerous archaea in the marine sub-sea floor. Single-cell genomic sequencing of one cell of MCG and three cells of MBG-D indicated that they form new branches basal to the archaeal phyla Thaumarchaeota(3) and Aigarchaeota(4), for MCG, and the order Thermoplasmatales, for MBG-D. All four cells encoded extracellular protein-degrading enzymes such as gingipain and clostripain that are known to be effective in environments chemically similar to marine sediments. Furthermore, we found these two types of peptidase to be abundant and active in marine sediments, indicating that uncultured archaea may have a previously undiscovered role in protein remineralization in anoxic marine sediments.	[Lloyd, Karen G.; Schreiber, Lars; Petersen, Dorthe G.; Kjeldsen, Kasper U.; Lever, Mark A.; Schramm, Andreas; Jorgensen, Bo Barker] Aarhus Univ, Dept Biosci, Ctr Geomicrobiol, DK-8000 Aarhus, Denmark; [Lloyd, Karen G.; Steen, Andrew D.] Univ Tennessee, Knoxville, TN 37996 USA; [Stepanauskas, Ramunas] Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA; [Richter, Michael] Ribocon GmbH, D-28359 Bremen, Germany; [Kleindienst, Sara; Lenk, Sabine] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany	Aarhus University; University of Tennessee System; University of Tennessee Knoxville; Bigelow Laboratory for Ocean Sciences; Max Planck Society	Lloyd, KG (corresponding author), Aarhus Univ, Dept Biosci, Ctr Geomicrobiol, DK-8000 Aarhus, Denmark.	klloyd@utk.edu	Jorgensen, Bo B/C-2214-2013; Schramm, Andreas/AAE-1616-2022; Petersen, Dorthe/B-6063-2009; Schramm, Andreas/J-2655-2013; Schreiber, Lars/J-5937-2013; Kleindienst, Sara/O-9908-2016; Kjeldsen, Kasper U/A-4151-2011; Lever, Mark A/C-2134-2011	Jorgensen, Bo B/0000-0001-9398-8027; Schramm, Andreas/0000-0002-7614-9616; Schramm, Andreas/0000-0002-7614-9616; Schreiber, Lars/0000-0003-3411-0083; Kleindienst, Sara/0000-0001-8304-9149; Kjeldsen, Kasper U/0000-0002-7805-5605; Lever, Mark A/0000-0002-2046-8028; Stepanauskas, Ramunas/0000-0003-4458-3108; Lloyd, Karen/0000-0003-0914-6375; Steen, Andrew/0000-0003-4297-4332	Danish National Research Foundation; German Max Planck Society; NSF Center for Dark Energy Biosphere Investigations [NSF-157595]; Danish Council for Independent Research-Natural Sciences; Villum Kann Rasmussen Foundation; EU Marie Curie fellowship; German Research Foundation; USA National Science Foundation [EF-826924, OCE-821374, OCE-1019242]; Directorate For Geosciences [1232982] Funding Source: National Science Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); German Max Planck Society(Max Planck Society); NSF Center for Dark Energy Biosphere Investigations; Danish Council for Independent Research-Natural Sciences(Det Frie Forskningsrad (DFF)); Villum Kann Rasmussen Foundation(Villum Fonden); EU Marie Curie fellowship(European Commission); German Research Foundation(German Research Foundation (DFG)); USA National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors thank the captain and crew of the R/V Tyra for sampling; T. B. Sogaard, A. Stentebjerg and B. Poulsen for technical work; F. Loffler for laboratory space; and D. Kirchman and S. Hallam for sharing their unpublished metagenomic data sets. This work was funded by the Danish National Research Foundation, the German Max Planck Society, NSF Center for Dark Energy Biosphere Investigations NSF-157595 (K. G. L.), The Danish Council for Independent Research-Natural Sciences (D. G. P.), the Villum Kann Rasmussen Foundation, an EU Marie Curie fellowship (M. A. L.), the German Research Foundation (S. L.) and the USA National Science Foundation awards EF-826924, OCE-821374 and OCE-1019242 (R.S.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashelford KE, 2002, NUCLEIC ACIDS RES, V30, P3481, DOI 10.1093/nar/gkf450; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Brochier C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-36; Brochier-Armanet C, 2012, ISME J, V6, P227, DOI [10.1038/ismej.2011.145, 10.1038/ismej.2012.110]; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Coolen MJL, 2000, APPL ENVIRON MICROB, V66, P2589, DOI 10.1128/AEM.66.6.2589-2598.2000; Dale AW, 2008, J MAR RES, V66, P127, DOI 10.1357/002224008784815775; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; HALL DO, 1971, NATURE, V233, P136, DOI 10.1038/233136a0; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Jarrell KF, 2011, MICROBIOL-SGM, V157, P919, DOI 10.1099/mic.0.047837-0; Johnson MK, 1996, CHEM REV, V96, P2817, DOI 10.1021/cr950063d; Jorgensen B. B., 1996, COASTAL ESTUARINE ST, P137, DOI DOI 10.1029/CE052P0137; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KEMBHAVI AA, 1991, FEBS LETT, V283, P277, DOI 10.1016/0014-5793(91)80607-5; KING GM, 1986, APPL ENVIRON MICROB, V51, P373, DOI 10.1128/AEM.51.2.373-380.1986; Kjeldsen KU, 2007, FEMS MICROBIOL ECOL, V60, P287, DOI 10.1111/j.1574-6941.2007.00288.x; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Labrou NE, 2004, EUR J BIOCHEM, V271, P983, DOI 10.1111/j.1432-1033.2004.04000.x; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Li PY, 2012, ENVIRON MICROBIOL, V14, P467, DOI 10.1111/j.1462-2920.2011.02637.x; Lomstein BA, 2012, NATURE, V484, P101, DOI 10.1038/nature10905; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Matte-Tailliez O, 2002, MOL BIOL EVOL, V19, P631, DOI 10.1093/oxfordjournals.molbev.a004122; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Pedersen AGU, 2001, LIMNOL OCEANOGR, V46, P1358, DOI 10.4319/lo.2001.46.6.1358; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R Core Team, 2021, R LANG ENV STAT COMP; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; RAUBER P, 1988, BIOCHEM J, V250, P871, DOI 10.1042/bj2500871; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Reysenbach AL, 2006, NATURE, V442, P444, DOI 10.1038/nature04921; Richter M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-177; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Schippers A, 2010, GEOMICROBIOL J, V27, P170, DOI 10.1080/01490450903456798; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schut GJ, 2001, METHOD ENZYMOL, V331, P144; Stahl D, 1991, DEV APPL NUCL ACID P, P205; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Wakeham SG, 1997, GEOCHIM COSMOCHIM AC, V61, P5363, DOI 10.1016/S0016-7037(97)00312-8; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299	60	374	385	4	256	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					215	+		10.1038/nature12033	http://dx.doi.org/10.1038/nature12033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23535597				2022-12-24	WOS:000317346300040
J	Schonknecht, G; Chen, WH; Ternes, CM; Barbier, GG; Shrestha, RP; Stanke, M; Brautigam, A; Baker, BJ; Banfield, JF; Garavito, RM; Carr, K; Wilkerson, C; Rensing, SA; Gagneul, D; Dickenson, NE; Oesterhelt, C; Lercher, MJ; Weber, APM				Schoenknecht, Gerald; Chen, Wei-Hua; Ternes, Chad M.; Barbier, Guillaume G.; Shrestha, Roshan P.; Stanke, Mario; Braeutigam, Andrea; Baker, Brett J.; Banfield, Jillian F.; Garavito, R. Michael; Carr, Kevin; Wilkerson, Curtis; Rensing, Stefan A.; Gagneul, David; Dickenson, Nicholas E.; Oesterhelt, Christine; Lercher, Martin J.; Weber, Andreas P. M.			Gene Transfer from Bacteria and Archaea Facilitated Evolution of an Extremophilic Eukaryote	SCIENCE			English	Article							GALDIERIA-SULPHURARIA; CYANIDIUM-CALDARIUM; GENOME; ALGA; ENVIRONMENTS; FAMILY	Some microbial eukaryotes, such as the extremophilic red alga Galdieria sulphuraria, live in hot, toxic metal-rich, acidic environments. To elucidate the underlying molecular mechanisms of adaptation, we sequenced the 13.7-megabase genome of G. sulphuraria. This alga shows an enormous metabolic flexibility, growing either photoautotrophically or heterotrophically on more than 50 carbon sources. Environmental adaptation seems to have been facilitated by horizontal gene transfer from various bacteria and archaea, often followed by gene family expansion. At least 5% of protein-coding genes of G. sulphuraria were probably acquired horizontally. These proteins are involved in ecologically important processes ranging from heavy-metal detoxification to glycerol uptake and metabolism. Thus, our findings show that a pan-domain gene pool has facilitated environmental adaptation in this unicellular eukaryote.	[Schoenknecht, Gerald; Ternes, Chad M.] Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA; [Schoenknecht, Gerald; Braeutigam, Andrea; Weber, Andreas P. M.] Univ Dusseldorf, Inst Plant Biochem, D-40225 Dusseldorf, Germany; [Chen, Wei-Hua; Lercher, Martin J.] Univ Dusseldorf, Inst Comp Sci, D-40225 Dusseldorf, Germany; [Chen, Wei-Hua] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Barbier, Guillaume G.; Shrestha, Roshan P.; Wilkerson, Curtis; Weber, Andreas P. M.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Stanke, Mario] Ernst Moritz Arndt Univ Greifswald, Inst Math & Informat, D-17487 Greifswald, Germany; [Baker, Brett J.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Garavito, R. Michael] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Carr, Kevin; Wilkerson, Curtis] Michigan State Univ, Plant Biol Labs, Res Technol Support Facil, E Lansing, MI 48824 USA; [Rensing, Stefan A.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Rensing, Stefan A.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Gagneul, David] Univ Lille 1, UMR USTL INRA Stress Abiot & Differenciat Vegetau, F-59650 Villeneuve Dascq, France; [Dickenson, Nicholas E.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA; [Oesterhelt, Christine] CyanoBiofuels GmbH, D-12489 Berlin, Germany; [Lercher, Martin J.; Weber, Andreas P. M.] Univ Dusseldorf, Cluster Excellence Plant Sci CEPLAS, D-40225 Dusseldorf, Germany; [Barbier, Guillaume G.] Novozymes Inc, Davis, CA 95618 USA; [Shrestha, Roshan P.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Rensing, Stefan A.] Univ Marburg, Fac Biol, D-35032 Marburg, Germany	Oklahoma State University System; Oklahoma State University - Stillwater; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; European Molecular Biology Laboratory (EMBL); Michigan State University; Ernst Moritz Arndt Universitat Greifswald; University of Michigan System; University of Michigan; University of California System; University of California Berkeley; Michigan State University; Michigan State University; University of Freiburg; University of Freiburg; INRAE; Universite de Lille - ISITE; Universite de Lille; Oklahoma State University System; Oklahoma State University - Stillwater; Heinrich Heine University Dusseldorf; University of Cologne; Novozymes; University of California System; University of California San Diego; Scripps Institution of Oceanography; Philipps University Marburg	Schonknecht, G (corresponding author), Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA.	gerald.schoenknecht@okstate.edu; andreas.weber@uni-duesseldorf.de	Baker, Brett/P-1783-2014; Chen, Weihua/GRS-9256-2022; Lercher, Martin/K-7939-2013; Weber, Andreas PM/A-6250-2011; Stanke, Mario/P-7876-2019; Weber, Andreas Paul Michael/O-3043-2019; Schoenknecht, Gerald/L-8848-2013; Bräutigam, Andrea/H-2685-2012	Baker, Brett/0000-0002-5971-1021; Lercher, Martin/0000-0003-3940-1621; Weber, Andreas PM/0000-0003-0970-4672; Stanke, Mario/0000-0001-8696-0384; Weber, Andreas Paul Michael/0000-0003-0970-4672; Schoenknecht, Gerald/0000-0003-3762-4880; Bräutigam, Andrea/0000-0002-5309-0527; Banfield, Jill/0000-0001-8203-8771; Dickenson, Nicholas/0000-0003-1572-6077; Chen, Wei-Hua/0000-0003-2168-6147; Gagneul, David/0000-0002-9288-0986	NSF [EF 0332882, MCB 0925298]; Deutsche Forschungsgemeinschaft (DFG) [CRC TR1, IRTG 1525/1, WE2231/7-1, EXC 1028, CRC 680]; DFG Mercator Fellowship; College of Arts and Sciences, Oklahoma State University (OSU)	NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Mercator Fellowship; College of Arts and Sciences, Oklahoma State University (OSU)	This work was made possible by NSF grant EF 0332882 (to A.P.M.W.). Partial support came from the Deutsche Forschungsgemeinschaft (DFG) (CRC TR1, IRTG 1525/1 and WE2231/7-1 to A.P.M.W., EXC 1028 to M.J.L. and A. P. M. W., CRC 680 to M.J.L., and a DFG Mercator Fellowship to G. S.). G. S. appreciates support from NSF (MCB 0925298) and the College of Arts and Sciences, Oklahoma State University (OSU). We thank M. Hanikenne and E. Koonin for helpful discussion, and A. Doust and P. Pelser for advice on phylogenetic analyses. We are grateful to B. Sears for introduction to and assistance with CsCl purification of bisbenzamide-treated nuclear DNA. Some of the computing for this project was performed at the OSU High Performance Computing Center. Sequence data have been deposited at DNA Data Bank of Japan, EMBL, and GenBank under accession ADNM00000000 (SRA012465). The version described in this paper is the first version, ADNM01000000.	Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; DOEMEL WN, 1971, J GEN MICROBIOL, V67, P17, DOI 10.1099/00221287-67-1-17; ENAMI I, 1986, PLANT CELL PHYSIOL, V27, P1351, DOI 10.1093/oxfordjournals.pcp.a077233; GROSS W, 1995, PLANT CELL PHYSIOL, V36, P633; Gross W, 2000, HYDROBIOLOGIA, V433, P31, DOI 10.1023/A:1004054317446; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Keeling PJ, 2009, CURR OPIN GENET DEV, V19, P613, DOI 10.1016/j.gde.2009.10.001; Koonin EV, 1997, SCIENCE, V275, P1489, DOI 10.1126/science.275.5305.1489; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; McCoy JG, 2009, PROTEINS, V74, P368, DOI 10.1002/prot.22147; Oesterhelt C, 2008, PLANTA, V227, P353, DOI 10.1007/s00425-007-0622-z; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Pinto G., 2007, V11, P487; Reeb V, 2010, CELL ORIG LIFE EXTRE, V13, P409, DOI 10.1007/978-90-481-3795-4_22; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Ye J, 2012, TRENDS PLANT SCI, V17, P155, DOI 10.1016/j.tplants.2011.12.003	19	287	297	8	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2013	339	6124					1207	1210		10.1126/science.1231707	http://dx.doi.org/10.1126/science.1231707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471408	Green Submitted			2022-12-24	WOS:000315709900048
J	Colbert, JA; Adler, JN				Colbert, James A.; Adler, Jonathan N.			Mammography Screening - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809	1	15	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					E12	E12		10.1056/NEJMclde1301407	http://dx.doi.org/10.1056/NEJMclde1301407			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096ET	23445113				2022-12-24	WOS:000315387700017
J	Griffin, WST				Griffin, W. Sue T.			Neuroinflammatory Cytokine Signaling and Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Griffin, W. Sue T.] Univ Arkansas Med Sci, Donald W Reynolds Dept Geriatr, Little Rock, AR 72205 USA; [Griffin, W. Sue T.] Univ Arkansas Med Sci, Inst Aging, Little Rock, AR 72205 USA; [Griffin, W. Sue T.] Cent Arkansas Vet Healthcare Syst, GRECC, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Griffin, WST (corresponding author), Univ Arkansas Med Sci, Donald W Reynolds Dept Geriatr, Little Rock, AR 72205 USA.							Griffin W Sue T, 2010, US Neurol, V6, P19; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965	4	73	76	2	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					770	771		10.1056/NEJMcibr1214546	http://dx.doi.org/10.1056/NEJMcibr1214546			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092CG	23425171				2022-12-24	WOS:000315095800014
J	Stine, NW; Chokshi, DA; Gourevitch, MN				Stine, Nicholas W.; Chokshi, Dave A.; Gourevitch, Marc N.			Improving Population Health in US Cities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Stine, Nicholas W.] New York City Hlth & Hosp Corp, Off Healthcare Improvement, New York, NY 10013 USA; [Stine, Nicholas W.; Gourevitch, Marc N.] NYU, Sch Med, Dept Populat Hlth, New York, NY 10003 USA; [Stine, Nicholas W.; Gourevitch, Marc N.] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Chokshi, Dave A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	New York University; New York University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Stine, NW (corresponding author), New York City Hlth & Hosp Corp, New York, NY 10013 USA.	nicholas.stine@nychhc.org		Chokshi, Dave/0000-0001-7467-4591; Gourevitch, Marc/0000-0001-6865-2126	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000038] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Agency for Healthcare Research and Quality, SERVICE DELIVERY INN; City of Boston Inspectional Services Department, HOUSING DIVISION BRE; Institute of Medicine, 2011, FOR THE PUBLICS HEAL; Institute of Medicine, 2012, PRIMARY CARE AND PUB; Jacobson DM, 2012, COMMISSIONED PAPER; Victor RG, 2011, ARCH INTERN MED, V171, P342, DOI 10.1001/archinternmed.2010.390; Yaggy SD, 2006, GERONTOLOGIST, V46, P271, DOI 10.1093/geront/46.2.271	7	16	16	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					449	450		10.1001/jama.2012.154302	http://dx.doi.org/10.1001/jama.2012.154302			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083LY	23385269	Green Accepted			2022-12-24	WOS:000314466900024
J	Kirk, GD; Mehta, SH; Astemborski, J; Galai, N; Washington, J; Higgins, Y; Balagopal, A; Thomas, DL				Kirk, Gregory D.; Mehta, Shruti H.; Astemborski, Jacquie; Galai, Noya; Washington, Jonathan; Higgins, Yvonne; Balagopal, Ashwin; Thomas, David L.			HIV, Age, and the Severity of Hepatitis C Virus-Related Liver Disease A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							INJECTION-DRUG USERS; HUMAN-IMMUNODEFICIENCY; NATURAL-HISTORY; TRANSIENT ELASTOGRAPHY; TELOMERE LENGTH; UNITED-STATES; INFECTION; FIBROSIS; PROGRESSION; COINFECTION	Background: Persons with HIV infection have been reported to develop age-related diseases at younger ages than those without HIV. Whether this finding is related to HIV infection or failure to control for other risk factors is unknown. Objective: To investigate whether persons with HIV infection develop hepatitis C virus (HCV)-related liver disease at younger ages than similar persons without HIV. Design: Comparison of the severity of liver fibrosis by age among persons who have HCV with and without HIV followed concurrently in the same protocol. Setting: Observational cohort from Baltimore, Maryland, participating in the ALIVE (AIDS Linked to the IntraVenous Experience) study. Participants: 1176 current and former injection drug users with antibodies to HCV. Measurements: Liver fibrosis assessed semiannually from 2006 to 2011 by elastography (FibroScan, Echosens, Paris, France) and using previously validated thresholds for clinically significant fibrosis and cirrhosis; concurrent assessment of medical history, alcohol and illicit drug use, HCV RNA levels, hepatitis B virus surface antigen level, body mass index, and (for those with HIV) CD4(+) lymphocyte count and HIV RNA levels. Results: Among 1176 participants with antibodies to HCV, the median age was 49 years and 34% were coinfected with HIV and HCV. Participants contributed 5634 valid liver fibrosis measurements. The prevalence of clinically significant fibrosis without cirrhosis (12.9% vs. 9.5%) and of cirrhosis (19.5% vs. 11.0%) was greater in persons coinfected with HIV and HCV than in those with only HCV (P < 0.001). Increasing age and HIV infection were independently associated with liver fibrosis, as were daily alcohol use, chronic hepatitis B virus infection, body mass index greater than 25 kg/m(2), and greater plasma HCV RNA levels. When these factors were kept constant, persons with HIV had liver fibrosis measurements equal to those of persons without HIV, who were, on average, 9.2 years older. Limitation: The process of liver fibrosis began before the study in most persons. Conclusion: In this cohort, persons who have HCV with HIV have liver fibrosis stages similar to those without HIV who are nearly a decade older.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Johns Hopkins Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Thomas, DL (corresponding author), Johns Hopkins Sch Med, Div Infect Dis, Room 437,1830 Monument St, Baltimore, MD 21205 USA.		Galai, Noya/HII-8086-2022		National Institute on Drug Abuse; United States Public Health Service, National Institute of Drug Abuse [R01-DA-016078, R01-DA-04334, R01-DA-12568]; American Cancer Society [MRSG-07-284-01-CCE]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004334, R01DA016078, R01DA012568, U01DA036297] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); United States Public Health Service, National Institute of Drug Abuse; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institute on Drug Abuse.; By United States Public Health Service, National Institute of Drug Abuse (R01-DA-016078, R01-DA-04334, and R01-DA-12568). Dr. Kirk was supported by the American Cancer Society (MRSG-07-284-01-CCE). Support of reagents for HCV RNA testing was generously provided by Abbott Molecular.	Alberti A, 2002, ANN INTERN MED, V137, P961, DOI 10.7326/0003-4819-137-12-200212170-00009; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Goedert JJ, 2002, BLOOD, V100, P1584; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hisada M, 2005, HEPATOLOGY, V42, P1446, DOI 10.1002/hep.20938; Hoare M, 2010, J HEPATOL, V53, P252, DOI 10.1016/j.jhep.2010.03.005; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Hulten E, 2009, HEART, V95, P1826, DOI 10.1136/hrt.2009.177774; Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989; Kirk Gregory D, 2011, Proc Am Thorac Soc, V8, P326, DOI 10.1513/pats.201009-061WR; Kirk GD, 2009, CLIN INFECT DIS, V48, P963, DOI 10.1086/597350; Lichterfeld M, 2008, BLOOD, V112, P3679, DOI 10.1182/blood-2008-01-135442; Martin J, 2010, ANN INTERN MED, V153, P477, DOI 10.7326/0003-4819-153-7-201010050-00013; McMahon BJ, 2010, GASTROENTEROLOGY, V138, P922, DOI 10.1053/j.gastro.2009.10.056; Mehta SH, 2012, ANTIVIR THER, V17, P813, DOI 10.3851/IMP2085; Mehta SH, 2011, J INFECT DIS, V203, P587, DOI 10.1093/infdis/jiq112; Moore RD, 1996, ANN INTERN MED, V124, P633, DOI 10.7326/0003-4819-124-7-199604010-00003; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Pradat P, 2007, LIVER INT, V27, P335, DOI 10.1111/j.1478-3231.2006.01430.x; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; SHAKIL AO, 1995, ANN INTERN MED, V123, P330, DOI 10.7326/0003-4819-123-5-199509010-00002; Shiels MS, 2010, ANN INTERN MED, V153, P452, DOI 10.7326/0003-4819-153-7-201010050-00008; Thomas DL, 2000, J INFECT DIS, V181, P844, DOI 10.1086/315314; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; VLAHOV D, 1991, J DRUG ISSUES, V21, P759, DOI 10.1177/002204269102100406; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Wilson LE, 2006, HEPATOLOGY, V43, P788, DOI 10.1002/hep.21091; Wolthers KC, 1996, SCIENCE, V274, P1543, DOI 10.1126/science.274.5292.1543; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	39	135	139	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2013	158	9					658	+		10.7326/0003-4819-158-9-201305070-00604	http://dx.doi.org/10.7326/0003-4819-158-9-201305070-00604			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146WV	23440167	Green Accepted			2022-12-24	WOS:000319126900003
J	Morgan, GA; Campbell, BA; Carter, LM; Plaut, JJ; Phillips, RJ				Morgan, Gareth A.; Campbell, Bruce A.; Carter, Lynn M.; Plaut, Jeffrey J.; Phillips, Roger J.			3D Reconstruction of the Source and Scale of Buried Young Flood Channels on Mars	SCIENCE			English	Article							CERBERUS FOSSAE; STRATIGRAPHY; PLAINS; WATER; LAVA	Outflow channels on Mars are interpreted as the product of gigantic floods due to the catastrophic eruption of groundwater that may also have initiated episodes of climate change. Marte Vallis, the largest of the young martian outflow channels (<500 million years old), is embayed by lava flows that hinder detailed studies and comparisons with older channel systems. Understanding Marte Vallis is essential to our assessment of recent Mars hydrologic activity during a period otherwise considered to be cold and dry. Using data from the Shallow Radar sounder on the Mars Reconnaissance Orbiter, we present a three-dimensional (3D) reconstruction of buried channels on Mars and provide estimates of paleohydrologic parameters. Our work shows that Cerberus Fossae provided the waters that carved Marte Vallis, and it extended an additional 180 kilometers to the east before the emplacement of the younger lava flows. We identified two stages of channel incision and determined that channel depths were more than twice those of previous estimates.	[Morgan, Gareth A.; Campbell, Bruce A.] Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Carter, Lynn M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Plaut, Jeffrey J.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Phillips, Roger J.] SW Res Inst, Planetary Sci Directorate, Boulder, CO USA	Smithsonian Institution; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Morgan, GA (corresponding author), Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA.	morganga@si.edu	Carter, Lynn/D-2937-2012	Carter, Lynn/0000-0002-6245-4142	NASA Mars Reconnaissance Orbiter Project	NASA Mars Reconnaissance Orbiter Project	C. Chazen and T. Watters provided very helpful reviews of earlier versions of the paper. Comments and suggestions by four anonymous referees were extremely beneficial. Thanks are also extended to P. Russell for his technical assistance. Funding for this work was provided by the NASA Mars Reconnaissance Orbiter Project. The SHARAD data and MOLA altimetry are available through NASA's Planetary Data system.	Baker V. R., 1978, CHANNELED SCABLAND G; Berman DC, 2002, ICARUS, V159, P1, DOI 10.1006/icar.2002.6920; Burr DM, 2002, ICARUS, V159, P53, DOI 10.1006/icar.2002.6921; Campbell B, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003177; CARR MH, 1979, J GEOPHYS RES, V84, P2995, DOI 10.1029/JB084iB06p02995; Carrier W. D., 1991, LUNAR SOURCEBOOK, V457-567; Carter LM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041234; Fuller ER, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001842; Fulthorpe CS, 2004, GEOLOGY, V32, P1013, DOI 10.1130/G20822.1; Jaeger WL, 2010, ICARUS, V205, P230, DOI 10.1016/j.icarus.2009.09.011; Leverington DW, 2011, GEOMORPHOLOGY, V132, P51, DOI 10.1016/j.geomorph.2011.05.022; Murray JB, 2005, NATURE, V434, P352, DOI 10.1038/nature03379; Plescia JB, 2003, ICARUS, V164, P79, DOI 10.1016/S0019-1035(03)00139-8; Rotto S., 1995, GEOLOGIC GEOMORPHIC; Scott D. H., 1986, GEOLOGICAL MAP W EQU; Seu R, 2004, PLANET SPACE SCI, V52, P157, DOI 10.1016/j.pss.2003.08.024; Seu R, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002745; Tanaka K.L., 2005, GEOLOGIC MAP NO PLAI; TANAKA KL, 1986, J GEOPHYS RES-SOLID, V91, pE139, DOI 10.1029/JB091iB13p0E139; Ulaby F.T., 1988, MICROWAVE DIELECTRIC; Vaucher J, 2009, ICARUS, V204, P418, DOI 10.1016/j.icarus.2009.06.032; Warner N, 2009, EARTH PLANET SC LETT, V288, P58, DOI 10.1016/j.epsl.2009.09.008	22	22	24	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					607	610		10.1126/science.1234787	http://dx.doi.org/10.1126/science.1234787			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23470730				2022-12-24	WOS:000318268900047
J	Dekkers, MPJ; Barde, YA				Dekkers, Martijn P. J.; Barde, Yves-Alain			Programmed Cell Death in Neuronal Development	SCIENCE			English	Editorial Material							NERVE GROWTH-FACTOR; RAT		[Dekkers, Martijn P. J.; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Dekkers, MPJ (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	yves.barde@unibas.ch		Barde, Yves/0000-0002-7627-461X; Dekkers, Martijn/0000-0002-1627-2882				Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Gartner A., 2008, WORMBOOK; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hatzold J, 2008, PLOS BIOL, V6, P771, DOI 10.1371/journal.pbio.0060084; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; MILLER MW, 1995, J COMP NEUROL, V355, P6, DOI 10.1002/cne.903550104; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Purves D., 1984, PRINCIPLES NEURAL DE, P131; Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010; Sahara S, 2012, J NEUROSCI, V32, P4755, DOI 10.1523/JNEUROSCI.6412-11.2012; Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523; SULSTON J, 1988, NEMATODE CAENORHABDI, P123	14	35	36	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2013	340	6128					39	41		10.1126/science.1236152	http://dx.doi.org/10.1126/science.1236152			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559240				2022-12-24	WOS:000317061100036
J	Kurth, I; Georgescu, RE; O'Donnell, ME				Kurth, Isabel; Georgescu, Roxana E.; O'Donnell, Mike E.			A solution to release twisted DNA during chromosome replication by coupled DNA polymerases	NATURE			English	Article							LAGGING-STRAND SYNTHESIS; SLIDING CLAMPS; TOPOISOMERASE-I; FORK; MECHANISM; PROCESSIVITY; BACTERIAL; DYNAMICS; HOLOENZYME; VIABILITY	Chromosomal replication machines contain coupled DNA polymerases that simultaneously replicate the leading and lagging strands(1). However, coupled replication presents a largely unrecognized topological problem. Because DNA polymerase must travel a helical path during synthesis, the physical connection between leading- and lagging-strand polymerases causes the daughter strands to entwine, or produces extensive build-up of negative supercoils in the newly synthesized DNA(2-4). How DNA polymerases maintain their connection during coupled replication despite these topological challenges is unknown. Here we examine the dynamics of the Escherichia coli replisome, using ensemble and single-molecule methods, and show that the replisome may solve the topological problem independent of topoisomerases. We find that the lagging-strand polymerase frequently releases from an Okazaki fragment before completion, leaving single-strand gaps behind. Dissociation of the polymerase does not result in loss from the replisome because of its contact with the leading-strand polymerase. This behaviour, referred to as 'signal release', had been thought to require a protein, possibly primase, to pry polymerase from incompletely extended DNA fragments(5-7). However, we observe that signal release is independent of primase and does not seem to require a protein trigger at all. Instead, the lagging-strand polymerase is simply less processive in the context of a replisome. Interestingly, when the lagging-strand polymerase is supplied with primed DNA in trans, uncoupling it from the fork, high processivity is restored. Hence, we propose that coupled polymerases introduce topological changes, possibly by accumulation of superhelical tension in the newly synthesized DNA, that cause lower processivity and transient lagging-strand polymerase dissociation from DNA.	[Kurth, Isabel; Georgescu, Roxana E.; O'Donnell, Mike E.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	O'Donnell, ME (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	odonnel@rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health [GM 38839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, R01GM038839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Langston, A. Libchaber and B. Michel for suggestions on the manuscript. We are also grateful to the National Institutes of Health (GM 38839) for supporting this work.	Bailey S, 2006, CELL, V126, P893, DOI 10.1016/j.cell.2006.07.027; BENYAJATI C, 1976, CELL, V9, P393, DOI 10.1016/0092-8674(76)90084-2; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Dorman Charles J., 2006, Science Progress, V89, P151, DOI 10.3184/003685006783238317; Espeli O, 2004, MOL MICROBIOL, V52, P925, DOI 10.1111/j.1365-2958.2004.04047.x; Georgescu RE, 2009, EMBO J, V28, P2981, DOI 10.1038/emboj.2009.233; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hingorani MM, 2000, CURR BIOL, V10, pR25, DOI 10.1016/S0960-9822(99)00252-3; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kornberg A., 1992, DNA REPLICATION; Leu FP, 2003, MOL CELL, V11, P315, DOI 10.1016/S1097-2765(03)00042-X; Li XJ, 2000, J BIOL CHEM, V275, P34757, DOI 10.1074/jbc.M006556200; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; ODONNELL ME, 1985, J BIOL CHEM, V260, P2884; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; Postow L, 1999, BIOESSAYS, V21, P805, DOI 10.1002/(SICI)1521-1878(199910)21:10<805::AID-BIES1>3.0.CO;2-7; Stockum A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-26; Stupina VA, 2005, J BIOL CHEM, V280, P355, DOI 10.1074/jbc.M411924200; Tanner NA, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp006; Travers A, 2007, EMBO REP, V8, P147, DOI 10.1038/sj.embor.7400898; Ullsperger C. J., 1995, UNLINKING DNA TOPOIS, V9; VOLOGODSKII AV, 1979, NUCLEIC ACIDS RES, V6, P967, DOI 10.1093/nar/6.3.967; WU CA, 1992, J BIOL CHEM, V267, P4074; WYMAN C, 1995, CURR BIOL, V5, P334, DOI 10.1016/S0960-9822(95)00065-0; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Yao N, 2000, J BIOL CHEM, V275, P1421, DOI 10.1074/jbc.275.2.1421; Yao NY, 2009, P NATL ACAD SCI USA, V106, P13236, DOI 10.1073/pnas.0906157106	29	31	31	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2013	496	7443					119	+		10.1038/nature11988	http://dx.doi.org/10.1038/nature11988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23535600	Green Accepted			2022-12-24	WOS:000316993400037
J	Schulz, TJ; Huang, P; Huang, TL; Xue, RD; McDougall, LE; Townsend, KL; Cypess, AM; Mishina, Y; Gussoni, E; Tseng, YH				Schulz, Tim J.; Huang, Ping; Huang, Tian Lian; Xue, Ruidan; McDougall, Lindsay E.; Townsend, Kristy L.; Cypess, Aaron M.; Mishina, Yuji; Gussoni, Emanuela; Tseng, Yu-Hua			Brown-fat paucity due to impaired BMP signalling induces compensatory browning of white fat	NATURE			English	Article							ADIPOSE-TISSUE; TRANSCRIPTIONAL CONTROL; ADIPOCYTES; THERMOGENESIS; DISTINCT; REVEALS; MUSCLE; MICE; IDENTIFICATION; ACTIVATION	Maintenance of body temperature is essential for the survival of homeotherms. Brown adipose tissue (BAT) is a specialized fat tissue that is dedicated to thermoregulation(1). Owing to its remarkable capacity to dissipate stored energy and its demonstrated presence in adult humans(2-5), BAT holds great promise for the treatment of obesity and metabolic syndrome(1). Rodent data suggest the existence of two types of brown fat cells: constitutive BAT (cBAT), which is of embryonic origin and anatomically located in the imterscapular region of mice; and recruitable BAT (rBAT), which resides within white adipose tissue (WAT)(6) and skeletal muscle(7), and has alternatively been called beige(8), brite(9) or inducible BAT(10). Bone morphogenetic proteins (BMPs) regulate the formation and thermogenic activity of BAT(10-12). Here we use mouse models to provide evidence for a systemically active regulatory mechanism that controls whole-body BAT activity for thermoregulation and energy homeostasis. Genetic ablation of the type 1A BMP receptor (Bmpr1a) in brown adipogenic progenitor cells leads to a severe paucity of cBAT. This in turn increases sympathetic input to WAT, thereby promoting the formation of rBAT within white fat depots. This previously unknown compensatory mechanism, aimed at restoring total brown-fat-mediated thermogenic capacity in the body, is sufficient to maintain normal temperature homeostasis and resistance to diet-induced obesity. These data suggest an important physiological cross-talk between constitutive and recruitable brown fat cells. This sophisticated regulatory mechanism of body temperature may participate in the control of energy balance and metabolic disease.	[Schulz, Tim J.; Huang, Tian Lian; Xue, Ruidan; McDougall, Lindsay E.; Townsend, Kristy L.; Cypess, Aaron M.; Tseng, Yu-Hua] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02215 USA; [Huang, Ping; Gussoni, Emanuela] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Huang, Ping; Gussoni, Emanuela] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Xue, Ruidan] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Div Endocrinol & Metab, Shanghai 200032, Peoples R China; [Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Tseng, Yu-Hua] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Fudan University; University of Michigan System; University of Michigan; Harvard University	Tseng, YH (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02215 USA.	yu-hua.tseng@joslin.harvard.edu	Schulz, Tim/F-4842-2013; Gussoni, Emanuela/AAL-6150-2021; Tseng, Yu-Hua/G-7003-2015	Schulz, Tim/0000-0002-8413-3972; Gussoni, Emanuela/0000-0002-9915-3677; 	National Institutes of Health (NIH) [R01 DK077097]; Joslin Diabetes Center's Diabetes Research Center (DRC from the NIDDK) [P30 DK036836]; Eli Lilly Research Foundation; Harvard Stem Cell Institute; Mary K. Iacocca Foundation; German Research Foundation (DFG) [SCHU2445/1-1]; American Heart Association [0730285N]; NIH [T32 DK007260, F32 DK091996]; National Natural Science Foundation of China [985III-YFX0302, NSFC81070680]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007260, R01DK077097, K23DK081604, P30DK036836, F32DK091996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047727] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin Diabetes Center's Diabetes Research Center (DRC from the NIDDK); Eli Lilly Research Foundation(Eli Lilly); Harvard Stem Cell Institute; Mary K. Iacocca Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health (NIH) grants R01 DK077097 (Y.-H.T.), and Joslin Diabetes Center's Diabetes Research Center (DRC; P30 DK036836 from the NIDDK), a research grant from the Eli Lilly Research Foundation, and by funding from the Harvard Stem Cell Institute (to Y.-H.T.), T.J.S. was supported by the Mary K. Iacocca Foundation and the German Research Foundation (DFG; SCHU2445/1-1). P.H. was supported by a Scientist Development Grant from the American Heart Association (0730285N). K.L.T. was supported by NIH fellowships (T32 DK007260 and F32 DK091996). R.X. was supported by Project 985III-YFX0302 and NSFC81070680 from the National Natural Science Foundation of China. The authors thank Stryker Regenerative Medicine for the gift of recombinant BMP7. We acknowledge V. Kaartinen, B. Kahn, K. Lyons and P. Soriano for providing floxed Acvr1 mice, FABP4-Cre mice, Bmpr1b heterozygous mice and Myf5-Cre mice, respectively. The authors thank C. R. Kahn, L.J. Goodyear, E. Kokkotou and D. Breault for comments on the manuscript The authors wish to thank J. LaVecchio, G. Buruzula, A. Wakabayashi, A. Pinkhasov, A. Clermont, M. Mulvey, C. Cahill and G. Sankaranarayanan for technical assistance, and E. Caniano for editorial contributions.	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; BUCKINGHAM ME, 1992, CIBA F SYMP, V165, P111; Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Collins Sheila, 2011, Front Endocrinol (Lausanne), V2, P102, DOI 10.3389/fendo.2011.00102; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; ROTHWELL NJ, 1989, AM J PHYSIOL, V257, pR253, DOI 10.1152/ajpregu.1989.257.2.R253; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; SCHMID P, 1991, DEVELOPMENT, V113, P857; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200	30	281	292	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					379	383		10.1038/nature11943	http://dx.doi.org/10.1038/nature11943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23485971	Green Accepted, Green Submitted			2022-12-24	WOS:000316650500045
J	Peplow, M				Peplow, Mark			The accelerator	NATURE			English	Editorial Material																			0	18	18	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					S10	S11		10.1038/495S10a	http://dx.doi.org/10.1038/495S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486095	Bronze			2022-12-24	WOS:000316652300030
J	Cox, PM; Pearson, D; Booth, BB; Friedlingstein, P; Huntingford, C; Jones, CD; Luke, CM				Cox, Peter M.; Pearson, David; Booth, Ben B.; Friedlingstein, Pierre; Huntingford, Chris; Jones, Chris D.; Luke, Catherine M.			Sensitivity of tropical carbon to climate change constrained by carbon dioxide variability	NATURE			English	Article							CYCLE; FEEDBACK; DROUGHT; BIOMASS; RISK	The release of carbon from tropical forests may exacerbate future climate change(1), but the magnitude of the effect in climate models remains uncertain(2). Coupled climate-carbon-cycle models generally agree that carbon storage on land will increase as a result of the simultaneous enhancement of plant photosynthesis and water use efficiency under higher atmospheric CO2 concentrations, but will decrease owing to higher soil and plant respiration rates associated with warming temperatures(3). At present, the balance between these effects varies markedly among coupled climate-carbon-cycle models, leading to a range of 330 gigatonnes in the projected change in the amount of carbon stored on tropical land by 2100. Explanations for this large uncertainty include differences in the predicted change in rainfall in Amazonia(4,5) and variations in the responses of alternative vegetation models to warming(6). Here we identify an emergent linear relationship, across an ensemble of models(7), between the sensitivity of tropical land carbon storage to warming and the sensitivity of the annual growth rate of atmospheric CO2 to tropical temperature anomalies(8). Combined with contemporary observations of atmospheric CO2 concentration and tropical temperature, this relationship provides a tight constraint on the sensitivity of tropical land carbon to climate change. We estimate that over tropical land from latitude 30 degrees north to 30 degrees south, warming alone will release 53 +/- 17 gigatonnes of carbon per kelvin. Compared with the unconstrained ensemble of climate-carbon-cycle projections, this indicates a much lower risk of Amazon forest die-back under CO2-induced climate change if CO2 fertilization effects are as large as suggested by current models(9). Our study, however, also implies greater certainty that carbon will be lost from tropical land if warming arises from reductions in aerosols(10) or increases in other greenhouse gases(11).	[Cox, Peter M.; Friedlingstein, Pierre; Luke, Catherine M.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England; [Pearson, David; Booth, Ben B.; Jones, Chris D.] Hadley Ctr, Met Off, Exeter EX1 3PB, Devon, England; [Huntingford, Chris] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England	University of Exeter; Met Office - UK; Hadley Centre; UK Centre for Ecology & Hydrology (UKCEH)	Cox, PM (corresponding author), Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England.	p.m.cox@exeter.ac.uk	Cox, Peter Michae;/B-3299-2012; Huntingford, Christopher/A-4307-2008; Jones, Chris/I-2983-2014; Friedlingstein, Pierre/H-2700-2014; Kushnir, Yochanan/B-4472-2013	Cox, Peter Michae;/0000-0002-0679-2219; Huntingford, Christopher/0000-0002-5941-7770; Jones, Chris/0000-0002-7141-9285; Friedlingstein, Pierre/0000-0003-3309-4739; 	NERC NCEO; EU; DECC/Defra Met Office Hadley Centre [GA01101]; CEH Science Budget; Newton Institute; NERC [earth010002] Funding Source: UKRI; Natural Environment Research Council [earth010002, ceh010023] Funding Source: researchfish	NERC NCEO(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EU(European Commission); DECC/Defra Met Office Hadley Centre; CEH Science Budget; Newton Institute; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We acknowledge funding from the NERC NCEO programme (P.M.C. and C.M.L.); the EU Greencycles II-project (P.M.C. and P.F.); the EU FP7 'CARBONES' project (D.P. and C.D.J.); the Joint DECC/Defra Met Office Hadley Centre Climate Programme (GA01101)(D.P.,B.B.B.and C.D.J.); the CEH Science Budget(C.H.) and the Newton Institute programme on 'Mathematical and Statistical Approaches to Climate Modelling and Prediction', during which this research was first formulated (P.M.C., B.B.B. and C.H.). We also acknowledge the modelling groups that provided results to C<SUP>4</SUP>MIP.	[Anonymous], 2000, SPECIAL REPORT EMISS; BACASTOW RB, 1976, NATURE, V261, P116, DOI 10.1038/261116a0; Baker TR, 2004, PHILOS T R SOC B, V359, P353, DOI 10.1098/rstb.2003.1422; Booth BBB, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024002; Cox PM, 2008, NATURE, V453, P212, DOI 10.1038/nature06960; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Friedlingstein P, 2003, TELLUS B, V55, P692, DOI 10.1034/j.1600-0889.2003.01461.x; Galbraith D, 2010, NEW PHYTOL, V187, P647, DOI 10.1111/j.1469-8137.2010.03350.x; Hall A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025127; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Huntingford C, 2011, PHILOS T R SOC A, V369, P2026, DOI 10.1098/rsta.2010.0314; Jones CD, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023027; Jupp TE, 2010, NEW PHYTOL, V187, P682, DOI 10.1111/j.1469-8137.2010.03368.x; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; MASARIE KA, 1995, J GEOPHYS RES-ATMOS, V100, P11593, DOI 10.1029/95JD00859; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Rammig A, 2010, NEW PHYTOL, V187, P694, DOI 10.1111/j.1469-8137.2010.03318.x; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Zaehle S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041345	29	460	472	27	679	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					341	344		10.1038/nature11882	http://dx.doi.org/10.1038/nature11882			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23389447	Green Accepted			2022-12-24	WOS:000315312900035
J	Rochman, CM; Browne, MA; Halpern, BS; Hentschel, BT; Hoh, E; Karapanagioti, HK; Rios-Mendoza, LM; Takada, H; Teh, S; Thompson, RC				Rochman, Chelsea M.; Browne, Mark Anthony; Halpern, Benjamin S.; Hentschel, Brian T.; Hoh, Eunha; Karapanagioti, Hrissi K.; Rios-Mendoza, Lorena M.; Takada, Hideshige; Teh, Swee; Thompson, Richard C.			Classify plastic waste as hazardous	NATURE			English	Editorial Material									[Rochman, Chelsea M.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Browne, Mark Anthony] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA	University of California System; University of California Davis; National Center for Ecological Analysis & Synthesis	Rochman, CM (corresponding author), Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA.	cmrochman@ucdavis.edu; browne@nceas.ucsb.edu	Karapanagioti, Hrissi/AAI-1461-2020; Karapanagioti, Hrissi K./AAW-9344-2020; Takada, Hideshige/G-1096-2013	Karapanagioti, Hrissi K./0000-0002-0297-5229; Thompson, Richard/0000-0003-2262-6621; Hoh, Eunha/0000-0002-4075-040X; Browne, Mark Anthony/0000-0002-7508-1015				Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Gaylor MO, 2012, CHEMOSPHERE, V86, P500, DOI 10.1016/j.chemosphere.2011.10.014; Lithner D, 2011, SCI TOTAL ENVIRON, V409, P3309, DOI 10.1016/j.scitotenv.2011.04.038; Mettang T, 1996, NEPHROL DIAL TRANSPL, V11, P2439, DOI 10.1093/oxfordjournals.ndt.a027211; Pauly JL, 1998, CANCER EPIDEM BIOMAR, V7, P419; Rochman C. M., 2012, ENV SCI TECHNOL; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Uhnn A.V., 2011, MAR POLLUT B, V62, P2605; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713	10	811	850	61	642	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					169	171		10.1038/494169a	http://dx.doi.org/10.1038/494169a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23407523	Bronze			2022-12-24	WOS:000315137700015
J	Osnas, JLD; Lichstein, JW; Reich, PB; Pacala, SW				Osnas, Jeanne L. D.; Lichstein, Jeremy W.; Reich, Peter B.; Pacala, Stephen W.			Global Leaf Trait Relationships: Mass, Area, and the Leaf Economics Spectrum	SCIENCE			English	Article							NITROGEN; CANOPY; INVESTMENT; IRRADIANCE; WORLDWIDE; LIGHT; MODEL	The leaf economics spectrum (LES) describes multivariate correlations that constrain leaf traits of plant species primarily to a single axis of variation if data are normalized by leaf mass. We show that these traits are approximately distributed proportional to leaf area instead of mass, as expected for a light-and carbon dioxide-collecting organ. Much of the structure in the mass-normalized LES results from normalizing area-proportional traits by mass. Mass normalization induces strong correlations among area-proportional traits because of large variation among species in leaf mass per area (LMA). The high LMA variance likely reflects its functional relationship with leaf life span. A LES that is independent of mass-or area-normalization and LMA reveals physiological relationships that are inconsistent with those in global vegetation models designed to address climate change.	[Osnas, Jeanne L. D.; Pacala, Stephen W.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08542 USA; [Osnas, Jeanne L. D.; Lichstein, Jeremy W.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2751, Australia	Princeton University; State University System of Florida; University of Florida; University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University	Osnas, JLD (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, 106 Guyot Hall, Princeton, NJ 08542 USA.	jldosnas@gmail.com	Lichstein, Jeremy/GMW-6555-2022	Reich, Peter/0000-0003-4424-662X	NSF [DEB 0620652]	NSF(National Science Foundation (NSF))	The GLOPNET data set is archived in the online supplementary materials in (2) (DOI: 10.1038/nature02403) and is available at www.nature.com/nature/journal/v428/n6985/suppinfo/nature02403.html. J.L.D.O. and S. W. P. articulated the problem and analyses; J.L.D.O., J.W.L., and S. W. P. performed analyses; and J.L.D.O., S. W. P., J.W.L., and P. B. R. interpreted results and wrote the manuscript. P. B. R. thanks the NSF Long Term Ecological Research program (grant DEB 0620652) for support. No competing interests exist between the authors' funding sources and this research.	Aranda I, 2004, ACTA OECOL, V25, P187, DOI 10.1016/j.actao.2004.01.003; Bonan GB, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001360; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Falster DS, 2012, NEW PHYTOL, V193, P409, DOI 10.1111/j.1469-8137.2011.03940.x; FIELD C, 1983, OECOLOGIA, V56, P348, DOI 10.1007/BF00379711; Field C., 1986, EC PLANT FORM FUNCTI, P22; Hurtt GC, 2002, P NATL ACAD SCI USA, V99, P1389, DOI 10.1073/pnas.012249999; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Koike T, 2001, TREE PHYSIOL, V21, P951, DOI 10.1093/treephys/21.12-13.951; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Niinemets U, 1997, PLANT CELL ENVIRON, V20, P845, DOI 10.1046/j.1365-3040.1997.d01-133.x; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 2010, P ROY SOC B-BIOL SCI, V277, P877, DOI 10.1098/rspb.2009.1818; Thornton PE, 2007, J CLIMATE, V20, P3902, DOI 10.1175/JCLI4222.1; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; ZAEHLE S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI DOI 10.1029/2009GB003521	18	263	309	25	440	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					741	744		10.1126/science.1231574	http://dx.doi.org/10.1126/science.1231574			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23539179				2022-12-24	WOS:000318619000038
J	Butler, J; Fonarow, GC; Gheorghiade, M				Butler, Javed; Fonarow, Gregg C.; Gheorghiade, Mihai			Strategies and Opportunities for Drug Development in Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Butler, Javed] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA USA; [Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA	Emory University; University of California System; University of California Los Angeles; Northwestern University; Feinberg School of Medicine	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu	Fonarow, Gregg C/D-5988-2014	Fonarow, Gregg C/0000-0002-3192-8093				Gheorghiade M, 2014, HEART FAIL REV, V19, P135, DOI 10.1007/s10741-012-9361-8; Gheorghiade M, 2013, J AM COLL CARDIOL, V61, P391, DOI 10.1016/j.jacc.2012.09.038; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P2349, DOI 10.1016/j.jacc.2009.01.075	3	38	38	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1593	1594		10.1001/jama.2013.1063	http://dx.doi.org/10.1001/jama.2013.1063			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126FY	23538438				2022-12-24	WOS:000317599500020
J	Gornall, J				Gornall, Jonathan			Doctors and the alcohol industry: an unhealthy mix?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						[Anonymous], 2012, REDUCING HARMFUL USE; Bounds A., 2013, FINANCIAL TIMES; Craig T, 2013, BREWERS GUARDIA 0213; Dingle AE, 1980, COMPAIGN PROHIBITION; Institute of Alcohol Studies, WE AR FUND; Jernigan D, 2013, STATEMENT INT PUBLIC; Jewell J, 2010, CLIN MED, V10, P259, DOI 10.7861/clinmedicine.10-3-259; Mellows P, 2009, PUBLICAN        0202, P18; O'Dowd A, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1659; Rush James, 2013, DAILY MAIL; World Health Organization, 2010, GLOB STRAT RED HARMF	11	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2013	346								f1889	10.1136/bmj.f1889	http://dx.doi.org/10.1136/bmj.f1889			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122SA	23550047				2022-12-24	WOS:000317337200008
J	Caron, JB; Morris, SC; Cameron, CB				Caron, Jean-Bernard; Morris, Simon Conway; Cameron, Christopher B.			Tubicolous enteropneusts from the Cambrian period	NATURE			English	Article							DEUTEROSTOME PHYLOGENY; HEMICHORDATA; EVOLUTION; COMMUNITY; ORIGINS; ORGAN	Hemichordates are a marine group that, apart from one mono-specific pelagic larval form, are represented by the vermiform enteropneusts and minute colonial tube-dwelling pterobranchs. Together with echinoderms, they comprise the clade Ambulacraria(1). Despite their restricted diversity, hemichordates provide important insights into early deuterostome evolution, notably because of their pharyngeal gill slits(2). Hemichordate phylogeny has long remained problematic(3,4), not least because the nature of any transitional form that might serve to link the anatomically disparate enteropneusts and pterobranchs is conjectural. Hence, inter-relationships have also remained controversial. For example, pterobranchs have sometimes been compared to ancestral echinoderms(1). Molecular data identify enteropneusts as paraphyletic, and harrimaniids(5-8) as the sister group of pterobranchs. Recent molecular phylogenies suggest that enteropneusts are probably basal within hemichordates, contrary to previous views(9), but otherwise provide little guidance as to the nature of the primitive hemichordate(7,8). In addition, the hemichordate fossil record is almost entirely restricted to peridermal skeletons of pterobranchs, notably graptolites(10,11). Owing to their low preservational potentials, fossil enteropneusts are exceedingly rare(12-15), and throw no light on either hemichordate phylogeny or the proposed harrimaniid-pterobranch transition. Here we describe an enteropneust, Spartobranchus tenuis (Walcott, 1911), from the Middle Cambrian-period (Series 3, Stage 5) Burgess Shale. It is remarkably similar to the extant harrimaniids, but differs from all known enteropneusts in that it is associated with a fibrous tube that is sometimes branched. Wesuggest that this is the precursor of the pterobranch periderm, and supports the hypothesis that pterobranchs are miniaturized and derived from an enteropneust-like worm(5,6). It also shows that the periderm was acquired before size reduction and acquisition of feeding tentacles, and that coloniality emerged through aggregation of individuals, perhaps similar to the Cambrian rhabdopleurid Fasciculitubus(11). The presence of both suggests that hemichordates originated at the onset of the Cambrian explosion.	[Caron, Jean-Bernard] Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada; [Morris, Simon Conway] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Cameron, Christopher B.] Univ Montreal, Dept Sci Biol, Montreal, PQ H2V 2S9, Canada	Royal Ontario Museum; University of Cambridge; Universite de Montreal	Caron, JB (corresponding author), Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada.	jcaron@rom.on.ca		Caron, Jean-Bernard/0000-0002-1670-5502	Natural Sciences and Engineering Research Council; St John's College, University of Cambridge, UK; Royal Ontario Museum Burgess Shale project [41]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); St John's College, University of Cambridge, UK; Royal Ontario Museum Burgess Shale project	We thank C. Lowe for constructive comments, D. Erwin and M. Florence for access to the Smithsonian Institution collections, Parks Canada for collection and research permits, P. Fenton and V. Brown for assistance, R. Gaines for donation of specimens from Utah, and M. Collins (ARTofFACT) for reconstructions. J.-B.C. and C.B.C. are supported by Natural Sciences and Engineering Research Council Discovery Grants, and S. C. M. is supported by St John's College, University of Cambridge, UK. This is Royal Ontario Museum Burgess Shale project number 41.	Alessandrello Anna, 2004, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V32, P1; Arduini P., 1981, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V122, P104; Bardack David, 1997, P89; Bechly G., 1999, FOSSILS SOLNHOFEN, P76; Cameron CB, 2005, CAN J ZOOL, V83, P196, DOI 10.1139/Z04-190; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Cannon JT, 2009, MOL PHYLOGENET EVOL, V52, P17, DOI 10.1016/j.ympev.2009.03.027; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; Conway Morris S., 1977, SPEC PAP PALAEONTOL, V20, P1; Gonzalez P, 2009, BIOL J LINN SOC, V98, P898, DOI 10.1111/j.1095-8312.2009.01332.x; Hyman L. H., 1959, INVERTEBRATES, V5, P72; Kazmierczak J., 1969, Acta Palaeontologica Polonica, V14, P299; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Mitchell CE, 2013, LETHAIA, V46, P34, DOI 10.1111/j.1502-3931.2012.00319.x; MORRIS SC, 1979, ANNU REV ECOL SYST, V10, P327, DOI 10.1146/annurev.es.10.110179.001551; MORRIS SC, 1986, PALAEONTOLOGY, V29, P423; Osborn KJ, 2012, P ROY SOC B-BIOL SCI, V279, P1646, DOI 10.1098/rspb.2011.1916; Pani AM, 2012, NATURE, V483, P289, DOI 10.1038/nature10838; Rickards Barrie, 2006, National Museum of Wales Geological Series, V25, P5; RICKARDS RB, 1984, ALCHERINGA, V8, P101, DOI 10.1080/03115518408618936; Ruppert EE, 2005, CAN J ZOOL, V83, P8, DOI 10.1139/Z04-158; Stach T, 2011, ACTA ZOOL-STOCKHOLM, V92, P150, DOI 10.1111/j.1463-6395.2010.00462.x; Swalla BJ, 2008, PHILOS T R SOC B, V363, P1557, DOI 10.1098/rstb.2007.2246; Twitchett RJ, 1996, J PALEONTOL, V70, P126; Walcott C.D., 1911, SMITHSONIAN MISCELLA, V57, P109, DOI DOI 10.1126/SCIENCE.1091376; Wetzei W., 1972, Schriften des Naturwissenschaftichen Vereins fuer Schleswig-Holstein, V42, P104; Winchell CJ, 2002, MOL BIOL EVOL, V19, P762, DOI 10.1093/oxfordjournals.molbev.a004134; Worsaae K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048529	28	58	58	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					503	506		10.1038/nature12017	http://dx.doi.org/10.1038/nature12017			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23485974				2022-12-24	WOS:000316682800044
J	Kozauer, N; Katz, R				Kozauer, Nicholas; Katz, Russell			Regulatory Innovation and Drug Development for Early-Stage Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MILD COGNITIVE IMPAIRMENT		[Kozauer, Nicholas; Katz, Russell] US FDA, Div Neurol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Kozauer, N (corresponding author), US FDA, Div Neurol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							Albert M, 2007, NEUROPSYCHOLOGY, V21, P158, DOI 10.1037/0894-4105.21.2.158; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Center for Drug Evaluation and Research, 2013, GUID IND ALZH DIS DE; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6	5	140	144	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1169	1171		10.1056/NEJMp1302513	http://dx.doi.org/10.1056/NEJMp1302513			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116FU	23484795				2022-12-24	WOS:000316869000001
J	Wallace, WHB; Thompson, L; Anderson, RA				Wallace, W. H. B.; Thompson, L.; Anderson, R. A.		Guideline Dev Grp	GUIDELINES Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wallace, W. H. B.] Royal Hosp Sick Children, Dept Haematol & Oncol, Edinburgh EH9 1LF, Midlothian, Scotland; [Thompson, L.] Healthcare Improvement Scotland, Scottish Intercoll Guidelines Network, Edinburgh EH12 9EB, Midlothian, Scotland; [Anderson, R. A.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Wallace, WHB (corresponding author), Royal Hosp Sick Children, Dept Haematol & Oncol, Edinburgh EH9 1LF, Midlothian, Scotland.	hamish.wallace@nhs.net		wallace, william, hamish/0000-0001-8080-5674	MRC [G1002033, G1100357, G1002118] Funding Source: UKRI; Medical Research Council [G1100357, G1002118, G1002033] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], LONG TERM FOLL SURV; Cancer Research UK, CHILH CANC STAT; Children's Oncology Group, 2008, KEEP YOUR HEART HLTH; National Cancer Survivorship Initiative, RISK STRAT PATHW CAR; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Scottish Intercollegiate Guidelines Network, 2004, LONG TERM FOLL SURV; Zeltzer LK, 1997, J CLIN ONCOL, V15, P547, DOI 10.1200/JCO.1997.15.2.547	7	65	66	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2013	346								f1190	10.1136/bmj.f1190	http://dx.doi.org/10.1136/bmj.f1190			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117WT	23535255				2022-12-24	WOS:000316984500001
J	Keren, I; Wu, YX; Inocencio, J; Mulcahy, LR; Lewis, K				Keren, Iris; Wu, Yanxia; Inocencio, Julio; Mulcahy, Lawrence R.; Lewis, Kim			Killing by Bactericidal Antibiotics Does Not Depend on Reactive Oxygen Species	SCIENCE			English	Article							ESCHERICHIA-COLI; PERSISTER CELLS; DEATH; TOLERANCE; RESISTANCE; LETHALITY; MECHANISM; LYSIS	Bactericidal antibiotics kill by modulating their respective targets. This traditional view has been challenged by studies that propose an alternative, unified mechanism of killing, whereby toxic reactive oxygen species (ROS) are produced in the presence of antibiotics. We found no correlation between an individual cell's probability of survival in the presence of antibiotic and its level of ROS. An ROS quencher, thiourea, protected cells from antibiotics present at low concentrations, but the effect was observed under anaerobic conditions as well. There was essentially no difference in survival of bacteria treated with various antibiotics under aerobic or anaerobic conditions. This suggests that ROS do not play a role in killing of bacterial pathogens by antibiotics.	[Keren, Iris; Wu, Yanxia; Inocencio, Julio; Mulcahy, Lawrence R.; Lewis, Kim] Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA	Northeastern University	Lewis, K (corresponding author), Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA.	k.lewis@neu.edu	Wu, yanxia/HGA-0318-2022		NIH [T-R01AI085585-01]; Army Research Office [W9911NF-09-1-0265, 55631-LS-RIP]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085585] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank V. Isabella for helpful discussion of the manuscript. This work was supported by NIH grant T-R01AI085585-01 and by Army Research Office grants W9911NF-09-1-0265 and 55631-LS-RIP.	Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; DAMPER PD, 1981, ANTIMICROB AGENTS CH, V20, P803, DOI 10.1128/AAC.20.6.803; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; DAVIS BD, 1986, P NATL ACAD SCI USA, V83, P6164, DOI 10.1073/pnas.83.16.6164; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Hooper DC, 2001, CLIN INFECT DIS, V32, pS9, DOI 10.1086/319370; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lewis K, 2012, NATURE, V485, P439, DOI 10.1038/485439a; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Liu YL, 2012, ANTIMICROB AGENTS CH, V56, P6048, DOI 10.1128/AAC.00754-12; POOLMAN B, 1993, FEMS MICROBIOL REV, V12, P125, DOI 10.1111/j.1574-6976.1993.tb00015.x; ROWEN RC, 1987, PHARMACOTHERAPY, V7, P92; Sampson TR, 2012, ANTIMICROB AGENTS CH, V56, P5642, DOI 10.1128/AAC.00756-12; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Wiuff C, 2005, ANTIMICROB AGENTS CH, V49, P1483, DOI 10.1128/AAC.49.4.1483-1494.2005	23	358	372	13	219	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1213	1216		10.1126/science.1232688	http://dx.doi.org/10.1126/science.1232688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471410				2022-12-24	WOS:000315709900050
J	Liu, YY; Imlay, JA				Liu, Yuanyuan; Imlay, James A.			Cell Death from Antibiotics Without the Involvement of Reactive Oxygen Species	SCIENCE			English	Article							INTRACELLULAR HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; BACTERICIDAL ANTIBIOTICS; HYDROXYL RADICALS; DNA-DAMAGE; SUPEROXIDE; MECHANISM; ENZYMES	Recent observations have suggested that classic antibiotics kill bacteria by stimulating the formation of reactive oxygen species (ROS). If true, this notion might guide new strategies to improve antibiotic efficacy. In this study, the model was directly tested. Contrary to the hypothesis, antibiotic treatment did not accelerate the formation of hydrogen peroxide in Escherichia coli and did not elevate intracellular free iron, an essential reactant for the production of lethal damage. Lethality persisted in the absence of oxygen, and DNA repair mutants were not hypersensitive, undermining the idea that toxicity arose from oxidative DNA lesions. We conclude that these antibiotic exposures did not produce ROS and that lethality more likely resulted from the direct inhibition of cell-wall assembly, protein synthesis, and DNA replication.	[Liu, Yuanyuan; Imlay, James A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Imlay, JA (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	jimlay@illinois.edu	liu, yuanyuan/GWZ-5838-2022		National Institutes of Health [GM49060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049640, R01GM049640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Hassett (University of Cincinnati) for helpful conversations about this topic, and J. Collins, G. Walker, and members of their laboratories for generously sharing ideas, unpublished data, and strains. We also thank M. Nilges of the Illinois EPR Research Center for assistance. This work was supported by GM49060 from the National Institutes of Health. The authors declare no conflict of interest.	Albesa I, 2004, BIOCHEM BIOPH RES CO, V317, P605, DOI 10.1016/j.bbrc.2004.03.085; ANBAR M, 1967, INT J APPL RADIAT IS, V18, P493, DOI 10.1016/0020-708X(67)90115-9; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Drlica K, 1999, CURR OPIN MICROBIOL, V2, P504, DOI 10.1016/S1369-5274(99)00008-9; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Ikemura K, 2008, J AM CHEM SOC, V130, P14384, DOI 10.1021/ja805735g; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KUO CF, 1987, J BIOL CHEM, V262, P4724; LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Seaver LC, 2004, J BIOL CHEM, V279, P48742, DOI 10.1074/jbc.M408754200; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Wang XH, 2010, J ANTIMICROB CHEMOTH, V65, P520, DOI 10.1093/jac/dkp486; Yamada M, 2012, MOL MICROBIOL, V86, P1364, DOI 10.1111/mmi.12061; Yeom J, 2010, J BIOL CHEM, V285, P22689, DOI 10.1074/jbc.M110.127456; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	29	386	401	12	297	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1210	1213		10.1126/science.1232751	http://dx.doi.org/10.1126/science.1232751			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471409	Green Accepted			2022-12-24	WOS:000315709900049
J	Bava, FA; Eliscovich, C; Ferreira, PG; Minana, B; Ben-Dov, C; Guigo, R; Valcarcel, J; Mendez, R				Bava, Felice-Alessio; Eliscovich, Carolina; Ferreira, Pedro G.; Minana, Belen; Ben-Dov, Claudia; Guigo, Roderic; Valcarcel, Juan; Mendez, Raul			CPEB1 coordinates alternative 3 ' -UTR formation with translational regulation	NATURE			English	Article							MESSENGER-RNAS; UNTRANSLATED REGIONS; CYTOPLASMIC POLYADENYLATION; CHROMOSOME SEGREGATION; CELLS; MECHANISMS; INSIGHTS; COMPLEX	More than half of mammalian genes generate multiple messenger RNA isoforms that differ in their 3' untranslated regions (3' UTRs) and therefore in regulatory sequences(1), often associated with cell proliferation and cancer(2,3); however, the mechanisms coordinating alternative 3'-UTR processing for specific mRNA populations remain poorly defined. Here we report that the cytoplasmic-polyadenylation element binding protein 1 (CPEB1), an RNA-binding protein that regulates mRNA translation(4), also controls alternative 3'-UTR processing. CPEB1 shuttles to the nudeus(5,6), where it co-localizes with splicing factors and mediates shortening of hundreds of mRNA 3' UTRs, thereby modulating their translation efficiency in the cytoplasm. CPEB1-mediated 3'-UTR shortening correlates with cell proliferation and tumorigenesis. CPEB1 binding to pre-mRNAs not only directs the use of alternative polyadenylation sites, but also changes alternative splicing by preventing U2AF65 recruitment. Our results reveal a novel function of CPEB1 in mediating alternative 3'-UTR processing, which is coordinated with regulation of mRNA translation, through its dual nuclear and cytoplasmic functions.	[Bava, Felice-Alessio; Mendez, Raul] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Eliscovich, Carolina; Ferreira, Pedro G.; Minana, Belen; Ben-Dov, Claudia; Guigo, Roderic; Valcarcel, Juan] UPF, Ctr Genom Regulat CRG, Barcelona 08003, Spain; [Valcarcel, Juan; Mendez, Raul] Passeig Lluis Co 23, ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Mendez, R (corresponding author), Inst Res Biomed IRB Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain.	raul.mendez@irbbarcelona.org	minana, belen/K-5530-2015; Valcarcel, Juan/O-9814-2014; Ferreira, Pedro G/J-6379-2013; bava, felice alessio/AAB-5212-2022; Guigo, Roderic/D-1303-2010; Ferreira, Pedro/HDO-1346-2022	minana, belen/0000-0001-7676-5788; Valcarcel, Juan/0000-0001-5398-3571; Ferreira, Pedro G/0000-0003-3838-8664; Guigo, Roderic/0000-0002-5738-4477; Mendez, Raul/0000-0002-1952-6905	Consolider; MICINN; Generalitat de Catalunya; RNAREG; AICR; EURASNET; Fundacion Marcelino Botin; National Institutes of Health; Instituto de Salud Carlos III; "la Caixa" predoctoral fellowship; FCT-Portugal; Spanish MICINN; Worldwide Cancer Research [11-0086] Funding Source: researchfish; ICREA Funding Source: Custom	Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); RNAREG; AICR; EURASNET; Fundacion Marcelino Botin; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); "la Caixa" predoctoral fellowship(La Caixa Foundation); FCT-Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Worldwide Cancer Research; ICREA(ICREA)	We thank A. Nebreda, R. Gomis, T. Yates, M. Fernandez, V. Giangarra, J. P. Tavanez, F. Lai, I. Novoa, J. La Cava and members of the Valcarcel and Mendez laboratories for comments on the manuscript and other contributions. We also thank the Ultrasequencing Units (CRG, IRB) and the Microscopy Units (CRG, IRB) for technical assistance. This work was funded by research grants as follows: from Consolider, MICINN and Generalitat de Catalunya to J.V., R.G. and R.M.; from RNAREG to J.V. and R.M.; from AICR to R.M.; from EURASNET and Fundacion Marcelino Botin to J.V.; and from the National Institutes of Health and Instituto de Salud Carlos III to R.G. F.-A.B. holds a "la Caixa" predoctoral fellowship, and P.G.F was supported by a FCT-Portugal postdoctoral grant and by a Spanish MICINN Consolider grant.	Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Ernoult-Lange M, 2009, MOL BIOL CELL, V20, P176, DOI 10.1091/mbc.E08-09-0904; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lin CL, 2010, RNA, V16, P338, DOI 10.1261/rna.1779810; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; Paronetto MP, 2011, MOL CELL, V43, P353, DOI 10.1016/j.molcel.2011.05.035; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311	23	107	109	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					121	125		10.1038/nature11901	http://dx.doi.org/10.1038/nature11901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23434754				2022-12-24	WOS:000316039800052
J	Hirano, A; Yumimoto, K; Tsunematsu, R; Matsumoto, M; Oyama, M; Kozuka-Hata, H; Nakagawa, T; Lanjakornsiripan, D; Nakayama, KI; Fukada, Y				Hirano, Arisa; Yumimoto, Kanae; Tsunematsu, Ryosuke; Matsumoto, Masaki; Oyama, Masaaki; Kozuka-Hata, Hiroko; Nakagawa, Tomoki; Lanjakornsiripan, Darin; Nakayama, Keiichi I.; Fukada, Yoshitaka			FBXL21 Regulates Oscillation of the Circadian Clock through Ubiquitination and Stabilization of Cryptochromes	CELL			English	Article							F-BOX PROTEINS; PHOSPHORYLATION; DEGRADATION; MAMMALS; MCRY2; MECHANISM; PACEMAKER; REVEALS; RHYTHMS; PERIOD	In the mammalian circadian clockwork, CRY1 and CRY2 repressor proteins are regulated by posttranslational modifications for temporally coordinated transcription of clock genes. Previous studies revealed that FBXL3, an F-box-type E3 ligase, ubiquitinates CRYs and mediates their degradation. Here, we found that FBXL21 also ubiquitinates CRYs but counteracts FBXL3. Fbxl21(-/-) mice exhibited normal periodicity of wheel-running rhythms with compromised organization of daily activities, while an extremely long-period phenotype of Fbxl3(-/-) mice was attenuated in Fbxl3/Fbxl21 double-knockout mice. The double knockout destabilized the behavioral rhythms progressively and sometimes elicited arrhythmicity. Surprisingly, FBXL21 stabilized CRYs and antagonized the destabilizing action by FBXL3. Predominantly cytosolic distribution of FBXL21 contrasts with nuclear localization of FBXL3. These results emphasize the physiological importance of antagonizing actions between FBXL21 and FBXL3 on CRYs, and their combined actions at different subcellular locations stabilize oscillation of the circadian clock.	[Hirano, Arisa; Nakagawa, Tomoki; Lanjakornsiripan, Darin; Fukada, Yoshitaka] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Yumimoto, Kanae; Tsunematsu, Ryosuke; Matsumoto, Masaki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; Kyushu University; University of Tokyo	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp; sfukada@mail.ecc.u-tokyo.ac.jp	吉孝, 深田/G-5090-2014	Oyama, Masaaki/0000-0001-6478-3735; Kozuka-Hata, Hiroko/0000-0002-9286-6594; Matsumoto, Masaki/0000-0002-6987-0288	Global COE program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT, Japan; JSPS	Global COE program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT, Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Kentaro Hirose and Drs. Daisuke Kojima and Masaki Torii for their help with data analysis. We are grateful to Drs. Joseph S. Takahashi and Seung-Hee Yoo for communicating their unpublished results on Fbxl21 and to Drs. Steve A. Kay and Tsuyoshi Hirota for providing us with CRY1-Luc expression vectors. We also thank Jun Nakano and Drs. Hikari Yoshitane and Kimiko Shimizu for critical comments on the manuscript. This work was supported in part by Grants-in-Aid for Scientific research and by the Global COE program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT, Japan. A. H. is supported by JSPS Research Fellowships for Young Scientists.	Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Dardente H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003530; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Ito S, 2012, MOL PLANT, V5, P573, DOI 10.1093/mp/sss013; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kurabayashi N, 2006, CHRONOBIOL INT, V23, P129, DOI 10.1080/07420520500464478; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Nolan PM, 2009, MAMM GENOME, V20, P67, DOI 10.1007/s00335-008-9166-1; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; TAKAHASHI JS, 1995, ANNU REV NEUROSCI, V18, P531, DOI 10.1146/annurev.neuro.18.1.531; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055	33	172	187	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1106	1118		10.1016/j.cell.2013.01.054	http://dx.doi.org/10.1016/j.cell.2013.01.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452856	Bronze			2022-12-24	WOS:000315710300017
J	Pasternak, B; Svanstrom, H; Hviid, A				Pasternak, Bjorn; Svanstrom, Henrik; Hviid, Anders			Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NAUSEA; REGISTRATION; MEDICATIONS; SAFETY	BACKGROUND Ondansetron is frequently used to treat nausea and vomiting during pregnancy, but the safety of this drug for the fetus has not been well studied. METHODS We investigated the risk of adverse fetal outcomes associated with ondansetron administered during pregnancy. From a historical cohort of 608,385 pregnancies in Denmark, women who were exposed to ondansetron and those who were not exposed were included, in a 1: 4 ratio, in propensity-score-matched analyses of spontaneous abortion (1849 exposed women vs. 7396 unexposed women), stillbirth (1915 vs. 7660), any major birth defect (1233 vs. 4932), preterm delivery (1792 vs. 7168), and birth of infants at low birth weight and small for gestational age (1784 vs. 7136). In addition, estimates were adjusted for hospitalization for nausea and vomiting during pregnancy (as a proxy for severity) and the use of other antiemetics. RESULTS Receipt of ondansetron was not associated with a significantly increased risk of spontaneous abortion, which occurred in 1.1% of exposed women and 3.7% of unexposed women during gestational weeks 7 to 12 (hazard ratio, 0.49; 95% confidence interval [CI], 0.27 to 0.91) and in 1.0% and 2.1%, respectively, during weeks 13 to 22 (hazard ratio, 0.60; 95% CI, 0.29 to 1.21). Ondansetron also conferred no significantly increased risk of stillbirth (0.3% for exposed women and 0.4% for unexposed women; hazard ratio, 0.42; 95% CI, 0.10 to 1.73), any major birth defect (2.9% and 2.9%, respectively; prevalence odds ratio, 1.12; 95% CI, 0.69 to 1.82), preterm delivery (6.2% and 5.2%; prevalence odds ratio, 0.90; 95% CI, 0.66 to 1.25), delivery of a low-birth-weight infant (4.1% and 3.7%; prevalence odds ratio, 0.76; 95% CI, 0.51 to 1.13), or delivery of a small-for-gestational-age infant (10.4% and 9.2%; prevalence odds ratio, 1.13; 95% CI, 0.89 to 1.44). CONCLUSIONS Ondansetron taken during pregnancy was not associated with a significantly increased risk of adverse fetal outcomes. (Funded by the Danish Medical Research Council.)	[Pasternak, Bjorn; Svanstrom, Henrik; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Pasternak, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	bjp@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127	Danish Medical Research Council [11-115854]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a grant from the Danish Medical Research Council (11-115854, to Dr. Pasternak).	Anderka M, 2012, BIRTH DEFECTS RES A, V94, P22, DOI 10.1002/bdra.22865; [Anonymous], EUROPEAN SURVEILLANC; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Buhimschi CS, 2009, OBSTET GYNECOL, V113, P166, DOI 10.1097/AOG.0b013e31818d6788; Chan RL, 2010, HUM REPROD, V25, P2907, DOI 10.1093/humrep/deq260; Einarson A, 2004, BJOG-INT J OBSTET GY, V111, P940, DOI 10.1111/j.1471-0528.2004.00236.x; GADSBY R, 1993, BRIT J GEN PRACT, V43, P245; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lacroix R, 2000, AM J OBSTET GYNECOL, V182, P931, DOI 10.1016/S0002-9378(00)70349-8; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Lohse Sarah Rytter, 2010, Clin Epidemiol, V2, P247, DOI 10.2147/CLEP.S13815; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Magee LA, 2002, AM J OBSTET GYNECOL, V186, pS256, DOI 10.1067/mob.2002.122596; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Niebyl JR, 2010, NEW ENGL J MED, V363, P1544, DOI 10.1056/NEJMcp1003896; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; WEIGEL RM, 1989, BRIT J OBSTET GYNAEC, V96, P1312, DOI 10.1111/j.1471-0528.1989.tb03229.x	20	120	126	2	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					814	823		10.1056/NEJMoa1211035	http://dx.doi.org/10.1056/NEJMoa1211035			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096ET	23445092				2022-12-24	WOS:000315387700007
J	Hashem, Y; Georges, AD; Fu, J; Buss, SN; Jossinet, F; Jobe, A; Zhang, Q; Liao, HY; Grassucci, RA; Bajaj, C; Westhof, E; Madison-Antenucci, S; Frank, J				Hashem, Yaser; Georges, Amedee des; Fu, Jie; Buss, Sarah N.; Jossinet, Fabrice; Jobe, Amy; Zhang, Qin; Liao, Hstau Y.; Grassucci, Robert A.; Bajaj, Chandrajit; Westhof, Eric; Madison-Antenucci, Susan; Frank, Joachim			High-resolution cryo-electron microscopy structure of the Trypanosoma brucei ribosome	NATURE			English	Article							EUKARYOTIC RIBOSOME; CRYSTAL-STRUCTURE; ATOMIC STRUCTURES; 80S RIBOSOME; SMALL RNAS; INITIATION; SUBUNIT; PROTEINS; PARASITE; SEQUENCE	Ribosomes, the protein factories of living cells, translate genetic information carried by messenger RNAs into proteins, and are thus involved in virtually all aspects of cellular development and maintenance. The few available structures of the eukaryotic ribosome(1-6) reveal that it is more complex than its prokaryotic counterpart(7,8), owing mainly to the presence of eukaryote-specific ribosomal proteins and additional ribosomal RNA insertions, called expansion segments(9). The structures also differ among species, partly in the size and arrangement of these expansion segments. Such differences are extreme in kinetoplastids, unicellular eukaryotic parasites often infectious to humans. Here we present a high-resolution cryo-electron microscopy structure of the ribosome of Trypanosoma brucei, the parasite that is transmitted by the tsetse fly and that causes African sleeping sickness. The atomic model reveals the unique features of this ribosome, characterized mainly by the presence of unusually large expansion segments and ribosomal-protein extensions leading to the formation of four additional inter-subunit bridges. We also find additional rRNA insertions, including one large rRNA domain that is not found in other eukaryotes. Furthermore, the structure reveals the five cleavage sites of the kinetoplastid large ribosomal subunit (LSU) rRNA chain, which is known to be cleaved uniquely into six pieces(10-12), and suggests that the cleavage is important for the maintenance of the T. brucei ribosome in the observed structure. We discuss several possible implications of the large rRNA expansion segments for the translation-regulation process. The structure could serve as a basis for future experiments aimed at understanding the functional importance of these kinetoplastid-specific ribosomal features in protein-translation regulation, an essential step towards finding effective and safe kinetoplastid-specific drugs.	[Hashem, Yaser; Georges, Amedee des; Grassucci, Robert A.; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst HHMI, New York, NY 10032 USA; [Fu, Jie; Liao, Hstau Y.; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Buss, Sarah N.; Madison-Antenucci, Susan] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY 12201 USA; [Jossinet, Fabrice; Westhof, Eric] Univ Strasbourg, Inst Biol Mol & Cellulaire CNRS, Architecture & Reactivite ARN, F-67084 Strasbourg, France; [Jobe, Amy; Frank, Joachim] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Zhang, Qin; Bajaj, Chandrajit] Univ Texas Austin, Inst Computat Engn & Sci, Dept Comp Sci, Austin, TX 78712 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; State University of New York (SUNY) System; Wadsworth Center; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Columbia University; University of Texas System; University of Texas Austin	Frank, J (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst HHMI, 630 W 168th St, New York, NY 10032 USA.	jf2192@columbia.edu	Georges, Amédée des/C-3588-2014	Georges, Amédée des/0000-0002-9704-3781; Bajaj, Chandrajit/0000-0002-9619-3278; Madison-Antenucci, Susan/0000-0003-1748-9327	Howard Hughes Medical Institute (HHMI); National Institutes of Health (NIH) [R01 GM29169]; L'Agence Nationale de la recherche (ANR) project AMIS ARN [ANR-09-BLAN-0160]; NIH [R01-EB004873, R01-GM074258]; Centers for Disease Control (CDC) Emerging Infectious Diseases (EID) fellowship program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB004873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029169, R01GM074258, T32GM008798] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); L'Agence Nationale de la recherche (ANR) project AMIS ARN(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control (CDC) Emerging Infectious Diseases (EID) fellowship program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is dedicated to the memory of Mariano Levin, who collaborated with J.F. and S.M.A. on the ribosomes from T. cruzi and T. brucei. We thank G. Cardone for assistance in the local resolution computation, and M. Thomas for her assistance with the preparation of figures. We wish to thank N. Williams for an useful discussion about the T brucei LSU rRNA processing. This work was supported by the Howard Hughes Medical Institute (HHMI) and the National Institutes of Health (NIH) R01 GM29169 (to IF.), L'Agence Nationale de la recherche (ANR) project AMIS ARN ANR-09-BLAN-0160 (E.W. and F.J.), as well as NIH R01-EB004873 and R01-GM074258 (to Q.Z. and C.B.). S.N.B. was supported by a Centers for Disease Control (CDC) Emerging Infectious Diseases (EID) fellowship program.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; CAMPBELL DA, 1987, J MOL BIOL, V196, P113, DOI 10.1016/0022-2836(87)90514-6; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Ciganda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030029; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; CORDINGLEY JS, 1980, MOL BIOCHEM PARASIT, V1, P91, DOI 10.1016/0166-6851(80)90003-1; Gao HX, 2005, P NATL ACAD SCI USA, V102, P10206, DOI 10.1073/pnas.0500926102; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jossinet F, 2005, BIOINFORMATICS, V21, P3320, DOI 10.1093/bioinformatics/bti504; Jossinet F, 2010, BIOINFORMATICS, V26, P2057, DOI 10.1093/bioinformatics/btq321; Ayub MJ, 2009, BIOCHEM BIOPH RES CO, V382, P30, DOI 10.1016/j.bbrc.2009.02.095; Klinge S, 2012, TRENDS BIOCHEM SCI, V37, P189, DOI 10.1016/j.tibs.2012.02.007; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Lescrinier EMHP, 2003, J MOL BIOL, V331, P759, DOI 10.1016/S0022-2836(03)00787-3; Liao HY, 2010, I S BIOMED IMAGING, P169, DOI 10.1109/ISBI.2010.5490386; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Michaeli S, 2011, FUTURE MICROBIOL, V6, P459, DOI [10.2217/fmb.11.20, 10.2217/FMB.11.20]; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; SRIVASTAVA S, 1992, J MOL BIOL, V226, P301, DOI 10.1016/0022-2836(92)90946-H; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; WHITE TC, 1986, NUCLEIC ACIDS RES, V14, P9471, DOI 10.1093/nar/14.23.9471; Wilson DN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011536; Yokoyama T, 2008, NUCLEIC ACIDS RES, V36, P3539, DOI 10.1093/nar/gkn224; Zhang Q, 2012, BIOPOLYMERS, V97, P709, DOI 10.1002/bip.22052	30	102	102	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					385	389		10.1038/nature11872	http://dx.doi.org/10.1038/nature11872			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23395961	Green Accepted			2022-12-24	WOS:000315312900045
J	Cohen, D; Swift, G				Cohen, Deborah; Swift, Glenn			Laboratories and regulator misled over antibiotic susceptibility test discs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cohen, Deborah] BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						British In Vitro Diagnostics Association, MICR RES; British Society for Antimicrobial Chemotherapy, 2005, STAND DISC SUSC TEST; MHRA, MED DEV AL OX CEFP C; O'Dowd A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f537; Thermo Scientific, ANT SUSC TEST	5	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2013	346								f837	10.1136/bmj.f837	http://dx.doi.org/10.1136/bmj.f837			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZK	23403982				2022-12-24	WOS:000315088100020
J	Whittle, SL; Richards, BL; Buchbinder, R				Whittle, Samuel L.; Richards, Bethan L.; Buchbinder, Rachelle			Opioid Analgesics for Rheumatoid Arthritis Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK		[Whittle, Samuel L.] Queen Elizabeth Hosp, Rheumatol Unit, Woodville, SA 5011, Australia; [Richards, Bethan L.] Royal Prince Alfred Hosp, Rheumatol Unit, Camperdown, NSW 2050, Australia; [Buchbinder, Rachelle] Monash Univ, Cabrini Hosp, Monash Dept Clin Epidemiol, Dept Epidemiol & Prevent Med,Sch Publ Hlth & Prev, Malvern, Australia	University of Sydney; Cabrini Health; Monash University	Whittle, SL (corresponding author), Queen Elizabeth Hosp, Rheumatol Unit, 28 Woodville Rd, Woodville, SA 5011, Australia.	sam@whit.tl	Whittle, Samuel L/K-7861-2015; Buchbinder, Rachelle/G-2952-2011	Whittle, Samuel L/0000-0001-7417-7691; Buchbinder, Rachelle/0000-0002-0597-0933; Richards, Bethan/0000-0002-9249-8808				Boada JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003580; Grijalva CG, 2008, RHEUMATOLOGY, V47, P1061, DOI 10.1093/rheumatology/ken193; Heiberg T, 2002, ARTHRIT RHEUM-ARTHR, V47, P391, DOI 10.1002/art.10515; Moore RA, 2010, PAIN, V149, P173, DOI 10.1016/j.pain.2009.08.007; Nelson LS, 2012, JAMA-J AM MED ASSOC, V308, P457, DOI 10.1001/jama.2012.8165; Whittle SL, 2012, RHEUMATOLOGY, V51, P1416, DOI 10.1093/rheumatology/kes032; Whittle SL, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003113.pub3	7	18	18	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					485	486		10.1001/jama.2012.193412	http://dx.doi.org/10.1001/jama.2012.193412			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083LY	23385275				2022-12-24	WOS:000314466900030
J	Black, RE				Black, Robert E.			The future of the US response to global HIV/AIDS	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Black, RE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	rblack@jhsph.edu		Black, Robert/0000-0001-9926-7984				amfAR, 2018, ZIMB DAT PEPFAR MON; Office of the Global AIDS Coordinator, 2012, PEPFAR BLUEPR CREAT	2	16	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 31	2013	382	9894					751	753		10.1016/S0140-6736(13)60184-1	http://dx.doi.org/10.1016/S0140-6736(13)60184-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215VP	23434311				2022-12-24	WOS:000324239200008
J	Lujambio, A; Akkari, L; Simon, J; Grace, D; Tschaharganeh, DF; Bolden, JE; Zhao, Z; Thapar, V; Joyce, JA; Krizhanovsky, V; Lowe, SW				Lujambio, Amaia; Akkari, Leila; Simon, Janelle; Grace, Danielle; Tschaharganeh, Darjus F.; Bolden, Jessica E.; Zhao, Zhen; Thapar, Vishal; Joyce, Johanna A.; Krizhanovsky, Valery; Lowe, Scott W.			Non-Cell-Autonomous Tumor Suppression by p53	CELL			English	Article							NF-KAPPA-B; OPPOSING ROLES; LIVER-CANCER; SENESCENCE; EXPRESSION; FIBROBLASTS; LIMITS; MICE; PHENOTYPE; APOPTOSIS	The p53 tumor suppressor can restrict malignant transformation by triggering cell-autonomous programs of cell-cycle arrest or apoptosis. p53 also promotes cellular senescence, a tumor-suppressive program that involves stable cell-cycle arrest and secretion of factors that modify the tissue microenvironment. In the presence of chronic liver damage, we show that ablation of a p53-dependent senescence program in hepatic stellate cells increases liver fibrosis and cirrhosis associated with reduced survival and enhances the transformation of adjacent epithelial cells into hepatocellular carcinoma. p53-expressing senescent stellate cells release factors that skew macrophage polarization toward a tumor-inhibiting M1-state capable of attacking senescent cells in culture, whereas proliferating p53-deficient stellate cells secrete factors that stimulate polarization of macrophages into a tumor-promoting M2-state and enhance the proliferation of premalignant cells. Hence, p53 can act non-cell autonomously to suppress tumorigenesis by promoting an antitumor microenvironment, in part, through secreted factors that modulate macrophage function.	[Lujambio, Amaia; Simon, Janelle; Grace, Danielle; Bolden, Jessica E.; Zhao, Zhen; Thapar, Vishal; Krizhanovsky, Valery; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Lujambio, Amaia; Akkari, Leila; Simon, Janelle; Grace, Danielle; Tschaharganeh, Darjus F.; Bolden, Jessica E.; Zhao, Zhen; Thapar, Vishal; Joyce, Johanna A.; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Krizhanovsky, Valery] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Simon, Janelle; Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center; Weizmann Institute of Science; Howard Hughes Medical Institute	Krizhanovsky, V (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	valery.krizhanovsky@weizmann.ac.il; lowes@mskcc.org	; Krizhanovsky, Valery/D-1336-2010	Lujambio, Amaia/0000-0002-2798-1481; Akkari, Leila/0000-0001-5479-641X; Zhao, Zhen/0000-0001-5271-4759; Krizhanovsky, Valery/0000-0002-3977-5482	NCI [U54 CA148967]; German Research Foundation (DFG); Israel Science Foundation; NIA [AG16379]; NATIONAL CANCER INSTITUTE [P01CA087497, U54CA148967, P30CA008748, P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG016379, R01AG016379] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Research Foundation (DFG)(German Research Foundation (DFG)); Israel Science Foundation(Israel Science Foundation); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully thank Jacqueline Cappellani and Sha Tian for excellent technical assistance; Prem Premsrirut for generating the TG-p53.1224 mouse strain; Orit Pappo for advice in pathological analyses; Vadim Pinskiy and Anna Chuprin for scanning the slides; Carolyn Zawislak for help with NK cell isolation; Anna Sabarovsky for assistance with ultrasound imaging; and Eusebio Manchado, Geulah Livshits, Shane Mayack, and Charles Sherr for constructive criticisms and careful editing of the manuscript. We also thank members of the Lowe laboratory for stimulating discussions. We thank CSHL and MSKCC animal facilities, CSHL histology facility, MSKCC Molecular Cytology Core, and MSKCC Genomics Core. A. L. is funded by EMBO-Long-Term Fellowship; J. A. J. and L. A. are funded by NCI U54 CA148967; D. F. T. is funded by the German Research Foundation (DFG); and V. K. is an incumbent of The Karl and Frances Korn Career Development Chair at Weizmann Institute of Science and is supported by Israel Science Foundation. S. W. L. is the Geoffrey Beene chair for Cancer Biology and is a Howard Hughes Medical Institute investigator. This work was supported by AG16379 grant from the NIA.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Crescenzi E, 2011, ONCOGENE, V30, P2707, DOI 10.1038/onc.2011.1; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Hesse M, 2000, AM J PATHOL, V157, P945, DOI 10.1016/S0002-9440(10)64607-X; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kiaris H, 2005, CANCER RES, V65, P1627, DOI 10.1158/0008-5472.CAN-04-3791; Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Marino S, 2000, GENE DEV, V14, P994; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Oakley F, 2005, AM J PATHOL, V166, P695, DOI 10.1016/S0002-9440(10)62291-2; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Tanikawa C, 2009, ONCOGENE, V28, P3081, DOI 10.1038/onc.2009.154; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670; Zimmermann HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021381	38	486	499	10	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					449	460		10.1016/j.cell.2013.03.020	http://dx.doi.org/10.1016/j.cell.2013.03.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23562644	Green Accepted, Bronze			2022-12-24	WOS:000317349700022
J	Bostrom, P; Frisen, J				Bostrom, Pontus; Frisen, Jonas			New Cells in Old Hearts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIAC REGENERATION; RENEWAL		[Bostrom, Pontus; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet	Bostrom, P (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.							Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Rosenzweig A, 2012, SCIENCE, V338, P1549, DOI 10.1126/science.1228951; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682	5	8	9	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1358	1360		10.1056/NEJMcibr1300157	http://dx.doi.org/10.1056/NEJMcibr1300157			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117YT	23550676				2022-12-24	WOS:000316989900017
J	Wain-Hobson, S				Wain-Hobson, Simon			H5N1 viral-engineering dangers will not go away	NATURE			English	Editorial Material									Fdn Vaccine Res, Washington, DC 20005 USA		Wain-Hobson, S (corresponding author), Fdn Vaccine Res, Washington, DC 20005 USA.	simon.wain-hobson@pasteur.fr							0	11	12	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					411	411		10.1038/495411a	http://dx.doi.org/10.1038/495411a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113QN	23538789	Bronze			2022-12-24	WOS:000316682800006
J	Wang, PY; Ma, WZ; Park, JY; Celi, FS; Arena, R; Choi, JW; Ali, QA; Tripodi, DJ; Zhuang, J; Lago, CU; Strong, LC; Talagala, SL; Balaban, RS; Kang, JG; Hwang, PM				Wang, Ping-yuan; Ma, Wenzhe; Park, Joon-Young; Celi, Francesco S.; Arena, Ross; Choi, Jeong W.; Ali, Qais A.; Tripodi, Dotti J.; Zhuang, Jie; Lago, Cory U.; Strong, Louise C.; Talagala, S. Lalith; Balaban, Robert S.; Kang, Ju-Gyeong; Hwang, Paul M.			Increased Oxidative Metabolism in the Li-Fraumeni Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MITOCHONDRIAL METABOLISM; MUSCLE; CANCER; APOPTOSIS; EXERCISE	There is growing evidence that alterations in metabolism may contribute to tumorigenesis. Here, we report on members of families with the Li-Fraumeni syndrome who carry germline mutations in TP53, the gene encoding the tumor-suppressor protein p53. As compared with family members who are not carriers and with healthy volunteers, family members with these mutations have increased oxidative phosphorylation of skeletal muscle. Basic experimental studies of tissue samples from patients with the Li-Fraumeni syndrome and a mouse model of the syndrome support this in vivo finding of increased mitochondrial function. These results suggest that p53 regulates bioenergetic homeostasis in humans. (Funded by the National Heart, Lung, and Blood Institute and the National Institutes of Health; ClinicalTrials.govnumber, NCT00406445.)	[Wang, Ping-yuan; Ma, Wenzhe; Choi, Jeong W.; Ali, Qais A.; Tripodi, Dotti J.; Zhuang, Jie; Lago, Cory U.; Balaban, Robert S.; Kang, Ju-Gyeong; Hwang, Paul M.] NHLBI, NIH, Bethesda, MD 20892 USA; [Celi, Francesco S.] NIDDKD, NIH, Bethesda, MD 20892 USA; [Talagala, S. Lalith] NINDS, NIH, Bethesda, MD 20892 USA; [Park, Joon-Young] Temple Univ, Philadelphia, PA 19122 USA; [Arena, Ross] Univ New Mexico, Albuquerque, NM 87131 USA; [Strong, Louise C.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of New Mexico; University of Texas System; UTMD Anderson Cancer Center	Hwang, PM (corresponding author), NHLBI, Ctr Mol Med, NIH, Bldg 10CRC 5-5330,10 Ctr Dr, Bethesda, MD 20892 USA.	hwangp@nhlbi.nih.gov	Arena, Ross/AAY-7646-2020; Arena, Ross/A-3141-2008	Arena, Ross/0000-0002-6675-1996; Park, Joon-Young/0000-0002-7705-7086	Division of Intramural Research, National Heart, Lung, and Blood Institute; National Institutes of Health Bench-to-Bedside Award; National Heart, Lung, and Blood Institute; National Institutes of Health; NATIONAL CANCER INSTITUTE [U24CA078142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006051, ZIAHL005101, ZIGHL006020, ZIAHL004601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075001] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health Bench-to-Bedside Award; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Division of Intramural Research, National Heart, Lung, and Blood Institute and by a National Institutes of Health Bench-to-Bedside Award (to Drs. Hwang and Strong).; Funded by the National Heart, Lung, and Blood Institute and the National Institutes of Health.	Argov Z, 2000, MUSCLE NERVE, V23, P1316, DOI 10.1002/1097-4598(200009)23:9<1316::AID-MUS2>3.0.CO;2-I; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Chance B, 2006, NMR BIOMED, V19, P904, DOI 10.1002/nbm.1109; Ertel A, 2012, CELL CYCLE, V11, P253, DOI 10.4161/cc.11.2.19006; Gottlieb E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001040; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lago CU, 2011, ANTIOXID REDOX SIGN, V15, P1739, DOI 10.1089/ars.2010.3650; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Macedo GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047010; MALKIN D, 1993, SCIENCE, V259, P878, DOI 10.1126/science.8438145; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Nakagawa Y, 2005, MED SCI SPORT EXER, V37, P937, DOI 10.1249/01.mss.0000166946.94871.9b; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; SCHNEIDER K, 2010, GENEREVIEWS; Sung HJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1003; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107	26	86	87	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					1027	1032		10.1056/NEJMoa1214091	http://dx.doi.org/10.1056/NEJMoa1214091			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104HF	23484829	Green Accepted			2022-12-24	WOS:000315982100009
J	Johnson, PTJ; Preston, DL; Hoverman, JT; Richgels, KLD				Johnson, Pieter T. J.; Preston, Daniel L.; Hoverman, Jason T.; Richgels, Katherine L. D.			Biodiversity decreases disease through predictable changes in host community competence	NATURE			English	Article							WEST-NILE-VIRUS; SPECIES-DIVERSITY; INFECTIOUS-DISEASE; PARASITE DIVERSITY; RISK; EXTINCTION; ECOSYSTEM; INVASION; DILUTION	Accelerating rates of species extinctions and disease emergence underscore the importance of understanding how changes in bio-diversity affect disease outcomes(1-3). Over the past decade, a growing number of studies have reported negative correlations between host biodiversity and disease risk(4-8), prompting suggestions that biodiversity conservation could promote human and wildlife health(9,10). Yet the generality of the diversity-disease linkage remains conjectural(11-13), in part because empirical evidence of a relationship between host competence (the ability to maintain and transmit infections) and the order in which communities assemble has proven elusive. Here we integrate high-resolution field data with multi-scale experiments to show that host diversity inhibits transmission of the virulent pathogen Ribeiroia ondatrae and reduces amphibian disease as a result of consistent linkages among species richness, host composition and community competence. Surveys of 345 wetlands indicated that community composition changed nonrandomly with species richness, such that highly competent hosts dominated in species-poor assemblages whereas more resistant species became progressively more common in diverse assemblages. As a result, amphibian species richness strongly moderated pathogen transmission and disease pathology among 24,215 examined hosts, with a 78.4% decline in realized transmission in richer assemblages. Laboratory and mesocosm manipulations revealed an approximately 50% decrease in pathogen transmission and host pathology across a realistic diversity gradient while controlling for host density, helping to establish mechanisms underlying the diversity-disease relationship and their consequences for host fitness. By revealing a consistent link between species richness and community competence, these findings highlight the influence of biodiversity on infection risk and emphasize the benefit of a community-based approach to understanding infectious diseases.	[Johnson, Pieter T. J.; Preston, Daniel L.; Richgels, Katherine L. D.] Univ Colorado, Boulder, CO 80309 USA; [Hoverman, Jason T.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	University of Colorado System; University of Colorado Boulder; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Johnson, PTJ (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	pieter.johnson@colorado.edu	Hoverman, Jason/AGR-0056-2022; Hoverman, Jason T/D-1756-2013; Richgels, Katherine/H-3773-2013	Hoverman, Jason/0000-0002-4002-2728; Hoverman, Jason T/0000-0002-4002-2728; Richgels, Katherine/0000-0003-2834-9477; JOHNSON, PIETER/0000-0002-7997-5390	US National Science Foundation [DEB-0841758, DEB-1149308]; National Geographic Society; David and Lucile Packard Foundation	US National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	We thank B. Hoye, J. Koprivnikar, K. Medley, J. Rohr and especially Y. Springer for editorial suggestions; S. Johnson for valuable statistical advice; M. Baragona, I. Buller, K. Gietzen, B. Goodman, J. Jenkins, E. Kellermanns, B. LaFonte, T. McDevitt-Galles,J. McFarland and S. Paull for assistance in collecting data; and East Bay Regional Parks, East Bay Municipal Utility District, Santa Clara County Parks, Hopland Research and Extension Center, Blue Oak Ranch Reserve, California State Parks, The Nature Conservancy, Open Space Authority and Mid-peninsula Open Space for access to properties and logistical support. This work was supported through funds from the US National Science Foundation (DEB-0841758, DEB-1149308), the National Geographic Society, and the David and Lucile Packard Foundation.	Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Clay CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006467; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Graham SP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007873; Haas SE, 2011, ECOL LETT, V14, P1108, DOI 10.1111/j.1461-0248.2011.01679.x; Hamer GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023767; Hechinger RF, 2005, P ROY SOC B-BIOL SCI, V272, P1059, DOI 10.1098/rspb.2005.3070; Johnson PTJ, 2012, P NATL ACAD SCI USA, V109, P9006, DOI 10.1073/pnas.1201790109; Johnson PTJ, 2012, ECOLOGY, V93, P56, DOI 10.1890/11-0636.1; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Raymundo LJ, 2009, P NATL ACAD SCI USA, V106, P17067, DOI 10.1073/pnas.0900365106; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Wood C. L., 2012, TRENDS ECOL EVOL	29	241	246	13	461	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2013	494	7436					230	233		10.1038/nature11883	http://dx.doi.org/10.1038/nature11883			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23407539				2022-12-24	WOS:000315137700038
J	Zanier, K; Charbonnier, S; Sidi, AOMO; McEwen, AG; Ferrario, MG; Poussin-Courmontagne, P; Cura, V; Brimer, N; Babah, KO; Ansari, T; Muller, I; Stote, RH; Cavarelli, J; Pol, SV; Trave, G				Zanier, Katia; Charbonnier, Sebastian; Sidi, Abdellahi Ould M'hamed Ould; McEwen, Alastair G.; Ferrario, Maria Giovanna; Poussin-Courmontagne, Pierre; Cura, Vincent; Brimer, Nicole; Babah, Khaled Ould; Ansari, Tina; Muller, Isabelle; Stote, Roland H.; Cavarelli, Jean; Pol, Scott Vande; Trave, Gilles			Structural Basis for Hijacking of Cellular LxxLL Motifs by Papillomavirus E6 Oncoproteins	SCIENCE			English	Article							PAXILLIN LD MOTIFS; TYPE-1 E6; ASSOCIATION; PROTEINS; BINDING; P53; RECOGNITION; IDENTIFICATION; TRANSFORMATION; DEGRADATION	E6 viral oncoproteins are key players in epithelial tumors induced by papillomaviruses in vertebrates, including cervical cancer in humans. E6 proteins target many host proteins by specifically interacting with acidic LxxLL motifs. We solved the crystal structures of bovine (BPV1) and human (HPV16) papillomavirus E6 proteins bound to LxxLL peptides from the focal adhesion protein paxillin and the ubiquitin ligase E6AP, respectively. In both E6 proteins, two zinc domains and a linker helix form a basic-hydrophobic pocket, which captures helical LxxLL motifs in a way compatible with other interaction modes. Mutational inactivation of the LxxLL binding pocket disrupts the oncogenic activities of both E6 proteins. This work reveals the structural basis of both the multifunctionality and the oncogenicity of E6 proteins.	[Zanier, Katia; Charbonnier, Sebastian; Sidi, Abdellahi Ould M'hamed Ould; Babah, Khaled Ould; Muller, Isabelle; Trave, Gilles] Ecole Super Biotechnol Strasbourg, Biotechnol & Signalisat Cellulaire UMR 7242, F-67412 Illkirch Graffenstaden, France; [McEwen, Alastair G.; Ferrario, Maria Giovanna; Poussin-Courmontagne, Pierre; Cura, Vincent; Stote, Roland H.; Cavarelli, Jean] Univ Strasbourg, IGBMC, INSERM, CNRS,UMR 7104,U964, F-67404 Illkirch Graffenstaden, France; [Brimer, Nicole; Ansari, Tina; Pol, Scott Vande] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Virginia	Cavarelli, J (corresponding author), Univ Strasbourg, IGBMC, INSERM, CNRS,UMR 7104,U964, 1 Rue Laurent Fries,BP 10142, F-67404 Illkirch Graffenstaden, France.	cava@igbmc.fr; vandepol@virginia.edu; gilles.trave@unistra.fr	TRAVE, Gilles/P-8577-2016; Cura, Vincent/P-4587-2016; Pol, Scott Vande/AAO-1068-2020; Cavarelli, Jean/P-3566-2016	Cura, Vincent/0000-0003-2586-510X; Pol, Scott Vande/0000-0002-0587-4802; Cavarelli, Jean/0000-0001-8620-8723; McEwen, Alastair G./0000-0003-4484-3512; Poussin-Courmontagne, Pierre/0000-0003-4813-6882; Ould M'hamed Sidi, Abdellahi/0000-0001-6535-1950; Ferrario, Maria Giovanna/0000-0003-4415-3722	CNRS; Universite de Strasbourg; INSERM; European Commission SPINE2-Complexes project [LSHG-CT-2006-031220]; Association pour la Recherche contre le Cancer (ARC) [3171]; Agence Nationale de la Recherche [ANR-MIME-2007 EPI-HPV-3D]; NIH [R01CA134737, CA120352, CA134737, CA08093]; ANR; ARC; College Doctoral Europeen; NATIONAL CANCER INSTITUTE [R01CA134737, P30CA044579, R01CA120352] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Commission SPINE2-Complexes project(European Commission); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANR(French National Research Agency (ANR)); ARC(Australian Research Council); College Doctoral Europeen; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by institutional support from CNRS, Universite de Strasbourg, INSERM, the European Commission SPINE2-Complexes project (contract no. LSHG-CT-2006-031220) and grants from Association pour la Recherche contre le Cancer (ARC) (no. 3171), Agence Nationale de la Recherche (ANR-MIME-2007 EPI-HPV-3D), and NIH (grant R01CA134737). S. C. was supported by ANR, A.o.M.o.S. by ARC, and K.o.B. by College Doctoral Europeen. S. V. P., N.B., and T. A. were supported by NIH grants (CA120352, CA134737 and CA08093) to S. V. P. and institutional support from the University of Virginia. S. C., K.o.B., and M. G. F. were supported by NIH grant CA134737. MD calculations were performed at the Meso-Centre of the University of Strasbourg. The authors thank members of the European Synchrotron Radiation Facility-European Molecular Biology Laboratory joint Structural Biology groups for the use of beamline facilities and for help during data collection; members of the IGBMC common services for assistance; and B. Kieffer, A. Dejaegere, and all members of the Oncoproteins team for helpful discussions and advice. Coordinates and structure factors have been deposited at the Protein Data Bank with accession codes 3PY7 and 4GIZ. K.Z., S. C., N.B., A.o.M.o.S., T. A., K. o. B., I. M., A. G. McE., P. P.-C., V. C., and S. V. P. performed experiments; M. G. F. and R. H. S. performed computational analysis; and J.C. and A. G. McE. performed structure determination. S. C., K.Z., J.C., S. V. P., and G. T. analyzed the data. G. T., K.Z., S. C., S. V. P., J.C., and R. S. prepared the manuscript. G. T., S. V. P., J.C., and R.S. supervised the work.	Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Brimer N, 2012, ONCOGENE, V31, P4639, DOI 10.1038/onc.2011.589; Charbonnier S, 2011, J MOL BIOL, V406, P745, DOI 10.1016/j.jmb.2011.01.015; Chen JJ, 1998, J BIOL CHEM, V273, P13537, DOI 10.1074/jbc.273.22.13537; Das K, 2000, J VIROL, V74, P812, DOI 10.1128/JVI.74.2.812-816.2000; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Lafont V, 2007, PROTEINS, V67, P418, DOI 10.1002/prot.21259; Lorenz S, 2008, STRUCTURE, V16, P1521, DOI 10.1016/j.str.2008.08.007; Nasir L, 2008, VET DERMATOL, V19, P243, DOI 10.1111/j.1365-3164.2008.00683.x; Ned R, 1997, J VIROL, V71, P4866, DOI 10.1128/JVI.71.6.4866-4870.1997; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Pfister H, 2003, ARCH DERMATOL RES, V295, P273, DOI 10.1007/s00403-003-0435-2; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Sekaric P, 2008, J VIROL, V82, P71, DOI 10.1128/JVI.01776-07; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sidi AOMO, 2011, PROTEIN EXPRES PURIF, V80, P8, DOI 10.1016/j.pep.2011.06.013; Tan MJA, 2012, P NATL ACAD SCI USA, V109, pE1473, DOI 10.1073/pnas.1205991109; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Tong XA, 1997, P NATL ACAD SCI USA, V94, P4412, DOI 10.1073/pnas.94.9.4412; Tumbarello DA, 2002, FEBS LETT, V513, P114, DOI 10.1016/S0014-5793(01)03244-6; Tungteakkhun SS, 2008, ARCH VIROL, V153, P397, DOI 10.1007/s00705-007-0022-5; Vande Pol SB, 1998, ONCOGENE, V16, P43, DOI 10.1038/sj.onc.1201504; Wade R, 2008, J VIROL, V82, P5962, DOI 10.1128/JVI.02747-07; Zanier K, 2005, J MOL BIOL, V349, P401, DOI 10.1016/j.jmb.2005.03.071; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001; Zanier K, 2010, J MOL BIOL, V396, P90, DOI 10.1016/j.jmb.2009.11.022; Zhang Y, 2007, J VIROL, V81, P3618, DOI 10.1128/JVI.02044-06; zur Hausen H, 1999, SEMIN CANCER BIOL, V9, P405, DOI 10.1006/scbi.1999.0144	33	132	137	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					694	698		10.1126/science.1229934	http://dx.doi.org/10.1126/science.1229934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393263	Green Accepted, Green Submitted			2022-12-24	WOS:000314585600042
J	Grossman, D				Grossman, Daniel			Moving Oral Contraceptives Over the Counter as a Strategy to Reduce Unintended Pregnancy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONTRAINDICATIONS		Ibis Reprod Hlth, Oakland, CA 94612 USA		Grossman, D (corresponding author), Ibis Reprod Hlth, 1330 Broadway, Oakland, CA 94612 USA.	DGrossman@ibisreproductivehealth.org						Committee on Gynecologic Practice American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P1527, DOI 10.1097/01.AOG.0000423818.85283.bd; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Grindlay K, 2012, CONTRACEPTION; Grossman D, 2012, CONTRACEPTION, V86, P293, DOI 10.1016/j.contraception.2012.05.033; Grossman D, 2008, OBSTET GYNECOL, V112, P572, DOI 10.1097/AOG.0b013e31818345f0; Hopkins K, 2012, CONTRACEPTION, V86, P376, DOI 10.1016/j.contraception.2012.03.003; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Potter JE, 2011, OBSTET GYNECOL, V117, P551, DOI 10.1097/AOG.0b013e31820afc46; Shah MA, 2001, INT J GYNECOL OBSTET, V73, P243, DOI 10.1016/S0020-7292(01)00375-7; White K, 2012, CONTRACEPTION, V86, P199, DOI 10.1016/j.contraception.2012.01.008	10	5	6	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					839	+		10.7326/0003-4819-158-11-201306040-00629	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00629			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164AA	23529386				2022-12-24	WOS:000320379800007
J	Hoggatt, J; Mohammad, KS; Singh, P; Hoggatt, AF; Chitteti, BR; Speth, JM; Hu, PR; Poteat, BA; Stilger, KN; Ferraro, F; Silberstein, L; Wong, FK; Farag, SS; Czader, M; Milne, GL; Breyer, RM; Serezani, CH; Scadden, DT; Guise, TA; Srour, EF; Pelus, LM				Hoggatt, Jonathan; Mohammad, Khalid S.; Singh, Pratibha; Hoggatt, Amber F.; Chitteti, Brahmananda R.; Speth, Jennifer M.; Hu, Peirong; Poteat, Bradley A.; Stilger, Kayla N.; Ferraro, Francesca; Silberstein, Lev; Wong, Frankie K.; Farag, Sherif S.; Czader, Magdalena; Milne, Ginger L.; Breyer, Richard M.; Serezani, Carlos H.; Scadden, David T.; Guise, Theresa A.; Srour, Edward F.; Pelus, Louis M.			Differential stem- and progenitor-cell trafficking by prostaglandin E-2	NATURE			English	Article							BONE-MARROW NICHE; HEMATOPOIETIC STEM; RECEPTOR; MICROENVIRONMENT; OSTEOPONTIN; IMPACT; SIZE	To maintain lifelong production of blood cells, haematopoietic stem cells (HSCs) are tightly regulated by inherent programs and extrinsic regulatory signals received from their microenvironmental niche. Long-term repopulating HSCs reside in several, perhaps overlapping, niches that produce regulatory molecules and signals necessary for homeostasis and for increased output after stress or injury(1-5). Despite considerable advances in the specific cellular or molecular mechanisms governing HSC-niche interactions, little is known about the regulatory function in the intact mammalian haematopoietic niche. Recently, we and others described a positive regulatory role for prostaglandin E-2 (PGE(2)) on HSC function ex vivo(6,7). Here we show that inhibition of endogenous PGE(2) by nonsteroidal anti-inflammatory drug (NSAID) treatment in mice results in modest HSC egress from the bone marrow. Surprisingly, this was independent of the SDF-1-CXCR4 axis implicated in stem-cell migration. Stem and progenitor cells were found to have differing mechanisms of egress, with HSC transit to the periphery dependent on niche attenuation and reduction in the retentive molecule osteopontin. Haematopoietic grafts mobilized with NSAIDs had superior repopulating ability and long-term engraftment. Treatment of non-human primates and healthy human volunteers confirmed NSAID-mediated egress in other species. PGE(2) receptor knockout mice demonstrated that progenitor expansion and stem/progenitor egress resulted from reduced E-prostanoid 4 (EP4) receptor signalling. These results not only uncover unique regulatory roles for EP4 signalling in HSC retention in the niche, but also define a rapidly translatable strategy to enhance transplantation therapeutically.	[Hoggatt, Jonathan; Mohammad, Khalid S.; Singh, Pratibha; Hoggatt, Amber F.; Speth, Jennifer M.; Hu, Peirong; Stilger, Kayla N.; Czader, Magdalena; Serezani, Carlos H.; Guise, Theresa A.; Srour, Edward F.; Pelus, Louis M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hoggatt, Jonathan; Ferraro, Francesca; Silberstein, Lev; Wong, Frankie K.; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Harvard Med Sch, Ctr Regenerat Med,Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hoggatt, Amber F.] Univ Illinois, Biol Resources Lab, Chicago, IL 60612 USA; [Chitteti, Brahmananda R.; Poteat, Bradley A.; Farag, Sherif S.; Srour, Edward F.] Indiana Univ Sch Med, Div Hematol & Oncol, Indianapolis, IN 46202 USA; [Milne, Ginger L.] Vanderbilt Univ, Div Clin Pharmacol, Eicosanoid Core Lab, Nashville, TN 37232 USA; [Breyer, Richard M.] Vanderbilt Univ, Div Nephrol & Hypertens, Nashville, TN 37232 USA	Indiana University System; Indiana University Bloomington; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Indiana University System; Indiana University Bloomington; Vanderbilt University; Vanderbilt University	Pelus, LM (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.	lpelus@iupui.edu	Mohammad, Khalid/AAE-9569-2022; Singh, Pratibha/AAI-9796-2020; Milne, Ginger/D-7648-2014; Mohammad, Khalid/AFE-4205-2022; serezani, C. Henrique/H-1675-2013	Milne, Ginger/0000-0003-3890-151X; Speth, Jennifer/0000-0002-7724-6995; serezani, C. Henrique/0000-0002-5363-415X	National Institutes of Health (NIH) [HL096305, CA143057, CA069158, HL100402, DK37097]; NIH [DK07519, HL07910, HL087735]; Center of Excellence in Hematology [P01 DK090948]; NATIONAL CANCER INSTITUTE [U01CA143057, P30CA082709, R29CA069158, R01CA069158] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851, U01HL100402, R01HL096305, T32HL087735, T32HL007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090948, T32DK007519, R01DK037097] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Hematology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by National Institutes of Health (NIH) grants HL096305 (L.M.P.), CA143057, CA069158 (T.A.G., K.S.M.), HL100402 (D.T.S.) and DK37097 (R.M.B.). J.H. was supported by NIH training grants DK07519, HL07910 and HL087735. Flow cytometry was performed in the Flow Cytometry Resource Facility of the Indiana University Simon Cancer Center (NCI P30 CA082709). Additional core support was provided by a Center of Excellence in Hematology grant P01 DK090948. The authors would like to thank H. E. Broxmeyer and B. Saez for critically reading the manuscript.	Ahmed Mansoor, 2005, Expert Opin Drug Metab Toxicol, V1, P739, DOI 10.1517/17425255.1.4.739; Bethel Monique, 2011, Curr Osteoporos Rep, V9, P96, DOI 10.1007/s11914-011-0048-1; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chitteti BR, 2010, BLOOD, V115, P3239, DOI 10.1182/blood-2009-09-246173; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christopher MJ, 2011, J EXP MED, V208, P251, DOI 10.1084/jem.20101700; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Guan Y, 2007, J CLIN INVEST, V117, P2496, DOI 10.1172/JCI29838; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hoggatt J, 2011, CURR OPIN HEMATOL, V18, P231, DOI 10.1097/MOH.0b013e3283477962; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kennedy CRJ, 1999, NAT MED, V5, P217, DOI 10.1038/5583; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mundy GR, 2001, SEMIN ONCOL, V28, P35, DOI 10.1053/sonc.2001.24158; Nakamura Y, 2010, BLOOD, V116, P1422, DOI 10.1182/blood-2009-08-239194; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rinder HM, 2002, J CLIN PHARMACOL, V42, P881, DOI 10.1177/009127002401102795; Schneider A, 2004, GENESIS, V40, P7, DOI 10.1002/gene.20048; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	26	106	109	3	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					365	369		10.1038/nature11929	http://dx.doi.org/10.1038/nature11929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23485965	Green Submitted, Green Accepted			2022-12-24	WOS:000316650500042
J	Rutten-Jacobs, LCA; Arntz, RM; Maaijwee, NAM; Schoonderwaldt, HC; Dorresteijn, LD; van Dijk, EJ; de Leeuw, FE				Rutten-Jacobs, Loes C. A.; Arntz, Renate M.; Maaijwee, Noortje A. M.; Schoonderwaldt, Henny C.; Dorresteijn, Lucille D.; van Dijk, Ewoud J.; de Leeuw, Frank-Erik			Long-term Mortality After Stroke Among Adults Aged 18 to 50 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISCHEMIC-STROKE; YOUNG-ADULTS; CEREBRAL INFARCTION; PROGNOSIS; CLASSIFICATION; PREDICTORS; RATIONALE; COMMUNITY; REGISTRY; EVENTS	Importance Long-term data on mortality after first-ever stroke in adults aged 18 through 50 years are scarce and usually restricted to ischemic stroke. Moreover, expected mortality not related to first-ever stroke is not taken in account. Objectives To investigate long-term mortality and cause of death after acute stroke in adults aged 18 through 50 years and to compare this with nationwide age-and sex-matched mortality rates. Design, Setting, and Participants The Follow-Up of Transient Ischemic Attack and Stroke Patients and Unelucidated Risk Factor Evaluation (FUTURE) study, a prospective cohort study of prognosis after transient ischemic attack (TIA), ischemic stroke, or hemorrhagic stroke in adults aged 18 through 50 years admitted to Radboud University Nijmegen Medical Centre, the Netherlands, between January 1, 1980, and November 1, 2010. The survival status of 959 consecutive patients with a first-ever TIA (n=262), ischemic stroke (n=606), or intracerebral hemorrhage (n=91) was assessed as of November 1, 2012. Mean follow-up duration was 11.1 (SD, 8.7) years (median, 8.3 [interquartile range, 4.0-17.4]). Observed mortality was compared with the expected mortality, derived from mortality rates in the general population with similar age, sex, and calendar-year characteristics. Main Outcome Measures Cumulative 20-year mortality among 30-day survivors of stroke. Results At the end of follow-up, 192 patients (20.0%) had died. For each stroke type, observed 20-year mortality among 30-day survivors exceeded expected mortality in the general population. [GRAPHICS] For ischemic stroke, cumulative 20-year mortality among 30-day survivors was higher in men than in women (33.7% [95% CI, 26.1%-41.3%] vs 19.8% [95% CI, 13.8%-25.9%]). The standardized mortality ratio was 4.3 (95% CI, 3.2-5.6) for women and 3.6 (95% CI, 2.8-4.6) for men. For all etiologic subtypes of ischemic stroke, observed mortality exceeded expected mortality. Conclusions and Relevance Among adults aged 18 through 50 years, 20-year mortality following acute stroke was relatively high compared with expected mortality. These findings may warrant further research evaluating secondary prevention strategies in these patients. JAMA. 2013;309(11):1136-1144 www.jama.com	[Rutten-Jacobs, Loes C. A.; Arntz, Renate M.; Maaijwee, Noortje A. M.; Schoonderwaldt, Henny C.; van Dijk, Ewoud J.; de Leeuw, Frank-Erik] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Dorresteijn, Lucille D.] Med Spectrum Twente, Dept Neurol, Nijmegen, Netherlands	Radboud University Nijmegen; Medical Spectrum Twente	de Leeuw, FE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	h.deleeuw@neuro.umcn.nl	de Leeuw, Frank-Erik/E-4795-2012; Rutten-Jacobs, Loes/C-7746-2013; de Leeuw, H.F./L-4479-2015; van Dijk, Ewoud J/J-7951-2012	Rutten-Jacobs, Loes/0000-0003-3223-885X; Rutten-Jacobs, Loes/0000-0001-6275-0462	Dutch Epilepsy Fund [2010-18]; Netherlands Organization for Scientific Research [016.126.351]	Dutch Epilepsy Fund; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Dutch Epilepsy Fund (grant 2010-18) and by a Vidi innovational grant from the Netherlands Organization for Scientific Research (grant 016.126.351).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; Bousser MG, 2009, CEREBROVASC DIS, V27, P509, DOI 10.1159/000212671; Breslow NE, 1987, STATISTICAL METHODS, P1; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Greisenegger S, 2011, J NEUROL, V258, P1105, DOI 10.1007/s00415-010-5893-9; HANKEY GJ, 1991, J NEUROL NEUROSUR PS, V54, P793, DOI 10.1136/jnnp.54.9.793; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; KAPPELLE LJ, 1994, STROKE, V25, P1360, DOI 10.1161/01.STR.25.7.1360; Kasner SE, 1999, STROKE, V30, P1534, DOI 10.1161/01.STR.30.8.1534; Leys D, 2002, NEUROLOGY, V59, P26, DOI 10.1212/WNL.59.1.26; Marini C, 2001, STROKE, V32, P52, DOI 10.1161/01.STR.32.1.52; Naess H, 2004, ACTA NEUROL SCAND, V110, P107, DOI 10.1111/j.1600-0404.2004.00273.x; Nedeltchev K, 2005, J NEUROL NEUROSUR PS, V76, P191, DOI 10.1136/jnnp.2004.040543; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Putaala J, 2009, STROKE, V40, P2698, DOI 10.1161/STROKEAHA.109.554998; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Rutten-Jacobs LCA, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-109; Statistics Netherlands, STATLINE DAT; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Varona JF, 2004, J NEUROL, V251, P1507, DOI 10.1007/s00415-004-0583-0; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Waje-Andreassen U, 2007, ACTA NEUROL SCAND, V116, P150, DOI 10.1111/j.1600-0404.2007.00822.x; Williams LS, 2000, STROKE, V31, P858, DOI 10.1161/01.STR.31.4.858; World Health Organization, 1992, INT STAT CLASS DIS R; World Health Organization (WHO), 2009, CARD DIS	28	144	148	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1136	1144		10.1001/jama.2013.842	http://dx.doi.org/10.1001/jama.2013.842			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FF	23512060	Bronze			2022-12-24	WOS:000316276500027
J	Toll, E				Toll, Elizabeth			278.00 Obesity, Not Otherwise Specified	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Toll, Elizabeth] Brown Univ, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02912 USA; [Toll, Elizabeth] Brown Univ, Dept Internal Med, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University; Brown University	Toll, E (corresponding author), Brown Univ, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02912 USA.	etoll@lifespan.org							0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1123	1124		10.1001/jama.2013.1241	http://dx.doi.org/10.1001/jama.2013.1241			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FF	23512059				2022-12-24	WOS:000316276500025
J	Bavelier, D; Davidson, RJ				Bavelier, Daphne; Davidson, Richard J.			Games to do you good	NATURE			English	Editorial Material									[Bavelier, Daphne] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Bavelier, Daphne] Univ Geneva, Dept Psychol & Educ Sci, CH-1211 Geneva 4, Switzerland; [Davidson, Richard J.] Univ Wisconsin, Ctr Invest Healthy Minds, Madison, WI 53705 USA	University of Rochester; University of Geneva; University of Wisconsin System; University of Wisconsin Madison	Bavelier, D (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	daphne@bcs.rochester.edu; rjdavids@wisc.edu		Davidson, Richard/0000-0002-8506-4964; Bavelier, Daphne/0000-0002-5904-1240				Bavelier D, 2011, NAT REV NEUROSCI, V12, P763, DOI 10.1038/nrn3135; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Green CS, 2012, CURR BIOL, V22, pR197, DOI 10.1016/j.cub.2012.02.012; Greitemeyer T, 2010, J PERS SOC PSYCHOL, V98, P211, DOI 10.1037/a0016997; Klimecki O. M., 2012, CEREBRAL CORTEX; Merry SN, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2598; Rideout V.J., 2010, HENRY J KAIS FAM FOU; Strasburger VC, 2010, PEDIATRICS, V125, P756, DOI 10.1542/peds.2009-2563	9	61	63	4	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					425	426		10.1038/494425a	http://dx.doi.org/10.1038/494425a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099YI	23446401	Green Published, Bronze			2022-12-24	WOS:000315661500015
J	Atun, R; Jaffar, S; Nishtar, S; Knaul, FM; Barreto, ML; Nyirenda, M; Banatvala, N; Piot, P				Atun, Rifat; Jaffar, Shabbar; Nishtar, Sania; Knaul, Felicia M.; Barreto, Mauricio L.; Nyirenda, Moffat; Banatvala, Nicholas; Piot, Peter			Improving responsiveness of health systems to non-communicable diseases	LANCET			English	Editorial Material							FUND-SUPPORTED PROGRAMS; CASE-MANAGEMENT; CERVICAL-CANCER; PRIMARY-CARE; LOW-INCOME; SCALE-UP; HIV; MULTIMORBIDITY; INTERVENTIONS; PREVENTION		[Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Jaffar, Shabbar; Piot, Peter] London Sch Hyg & Trop Med, London WC1, England; [Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Knaul, Felicia M.] Harvard Global Equ Initiat, Boston, MA USA; [Barreto, Mauricio L.] Univ Fed Bahia, Inst Saude Colet, BR-41170290 Salvador, BA, Brazil; [Nyirenda, Moffat] Coll Med, Blantyre, Malawi; [Banatvala, Nicholas] WHO, CH-1211 Geneva, Switzerland	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Universidade Federal da Bahia; University of Malawi; World Health Organization	Atun, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, S Kensington Campus, London SW7 2AZ, England.	r.atun@imperial.ac.uk	Atun, Rifat/AAH-5537-2021; Barreto, Mauricio L/B-1752-2008	Barreto, Mauricio L/0000-0002-0215-4930; Jaffar, Shabbar/0000-0002-9615-1588; Atun, Rifat/0000-0002-1531-5983; Banatvala, Nick/0000-0001-8130-154X; Knaul, Felicia/0000-0002-0512-4788	Medical Research Council [MR/K012126/1] Funding Source: researchfish; Wellcome Trust [098610] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 2011, FHI 360; Aquino R, 2009, AM J PUBLIC HEALTH, V99, P87, DOI 10.2105/AJPH.2007.127480; Atun RA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2165; Atun RA, 2005, THE WORLD BANK REPOR, VI; Atun R, 2012, LANCET, V380, P2044, DOI 10.1016/S0140-6736(12)61460-3; Atun R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-780; Atun R, 2011, JAIDS-J ACQ IMM DEF, V57, pS91, DOI 10.1097/QAI.0b013e3182218441; Atun R, 2010, LANCET, V375, P2169, DOI 10.1016/S0140-6736(10)60493-X; Atun R, 2010, HEALTH POLICY PLANN, V25, P1, DOI 10.1093/heapol/czp053; Atun RA, 2006, HEALTH POLICY, V79, P79, DOI 10.1016/j.healthpol.2005.12.005; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Balabanova D, 2011, GOOD HEALTH AT LOW C; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bloom D., 2011, THE GLOBAL ECONOMIC; Celletti F, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000366082.68321.d6; DEBUSK RF, 1994, ANN INTERN MED, V120, P721, DOI 10.7326/0003-4819-120-9-199405010-00001; Desai M, 2010, HEALTH POLICY PLANN, V25, pi43, DOI 10.1093/heapol/czq057; Dourado I, 2011, MED CARE, V49, P577, DOI 10.1097/MLR.0b013e31820fc39f; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Farzadfar F, 2012, LANCET, V379, P47, DOI 10.1016/S0140-6736(11)61349-4; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Gilmer TP, 2007, HEALTH SERV RES, V42, P1943, DOI 10.1111/j.1475-6773.2007.00701.x; Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Kalk A, 2010, TROP MED INT HEALTH, V15, P94, DOI 10.1111/j.1365-3156.2009.02424.x; Knaul FM, 2012, CLOSING THE CANCER D; Krishnan Anand, 2009, Glob Health Action, V2, DOI 10.3402/gha.v2i0.1990; Lamptey P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001086; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Macinko J, 2010, HEALTH AFFAIR, V29, P2149, DOI 10.1377/hlthaff.2010.0251; Mamo Y, 2007, CLIN MED, V7, P228, DOI 10.7861/clinmedicine.7-3-228; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Knaul FM, 2008, REPROD HEALTH MATTER, V16, P113, DOI 10.1016/S0968-8080(08)32414-8; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Ministry of Health Malawi and WHO Country Office Malawi, MALAWI NATIONAL STEP; Mounier-Jack S, 2010, HEALTH POLICY PLANN, V25, pi37, DOI 10.1093/heapol/czq056; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Mwanahamuntu MH, 2009, AIDS, V23, pN1, DOI 10.1097/QAD.0b013e3283236e11; Mwangemi F, 2010, INTERNATIONAL AIDS C; Narayan KMV, 2011, NEW ENGL J MED, V365, P876, DOI 10.1056/NEJMp1107189; Nishtar S, 2005, AM J PREV MED, V29, P102, DOI 10.1016/j.amepre.2005.07.034; Nishtar S, 2010, 55 WHO; Nishtar S., 2004, NATIONAL ACTION PLAN; Nishtar S, 2010, CHOKED PIPES REFORMI; Nishtar Sania, 2006, Prev Chronic Dis, V3, pA14; Nishtar Sania, 2004, Health Res Policy Syst, V2, P7, DOI 10.1186/1478-4505-2-7; Nishtar S, 2011, LANCET, V378, P648, DOI 10.1016/S0140-6736(11)60606-5; Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; PEPFAR, 2011, COTE DIVOIRE INTEGRA; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Rabkin M, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/137460; Rabkin Miriam, 2012, AIDS, V26 Suppl 1, pS77; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; Rasschaert Freya, 2011, J Int AIDS Soc, V14 Suppl 1, pS3, DOI 10.1186/1758-2652-14-S1-S3; Rocha R, 2012, HEALTH ECON, V19, P126; Rudge JW, 2010, HEALTH POLICY PLANN, V25, pi48, DOI 10.1093/heapol/czq058; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Srikantiah P, 2010, AIDS, V24, pS62, DOI 10.1097/01.aids.0000390091.45435.ea; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Sweeney S, 2012, SEX TRANSM INFECT, V88, P85, DOI 10.1136/sextrans-2011-050199; Tragard A, 2010, HEALTH POLICY PLANN, V25, pi58, DOI 10.1093/heapol/czq061; Ullrich A, 2011, LANCET, V377, P639, DOI 10.1016/S0140-6736(11)60233-X; United Nations General Assembly, 2011, POL DECL HIGH LEV M; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; WHO, 2011, GLOB STAT REP NONC D; WHO, 2010, PACKAGE OF ESSENTIAL; World Health Organization, 2012, PREVENTION CONTROL N; Yap IKS, 2010, J PROTEOME RES, V9, P6647, DOI 10.1021/pr100798r; Ziguras SJ, 2000, PSYCHIAT SERV, V51, P1410, DOI 10.1176/appi.ps.51.11.1410	76	168	168	2	63	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2013	381	9867					690	697		10.1016/S0140-6736(13)60063-X	http://dx.doi.org/10.1016/S0140-6736(13)60063-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	093JY	23410609				2022-12-24	WOS:000315189300039
J	de Leeuw, PW; Postma, CT; Kroon, AA				de Leeuw, Peter W.; Postma, Cornelis T.; Kroon, Abraham A.			Treatment of Atherosclerotic Renal Artery Stenosis Time for a New Approach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RENOVASCULAR DISEASE		[de Leeuw, Peter W.; Kroon, Abraham A.] Univ Hosp Maastricht, Dept Med, NL-6202 AZ Maastricht, Netherlands; [de Leeuw, Peter W.; Kroon, Abraham A.] Cardiovasc Res Inst Maastricht CARIM, NL-6202 AZ Maastricht, Netherlands; [Postma, Cornelis T.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Radboud University Nijmegen	de Leeuw, PW (corresponding author), Univ Hosp Maastricht, Dept Med, POB 5800, NL-6202 AZ Maastricht, Netherlands.	p.deleeuw@maastrichtuniversity.nl	de Leeuw, Peter W./J-4552-2016; Postma, C.T./L-4585-2015	de Leeuw, Peter W./0000-0002-4949-5812; 				Caps MT, 1998, CIRCULATION, V98, P2866, DOI 10.1161/01.CIR.98.25.2866; Dechering DG, 2010, J INTERN MED, V267, P305, DOI 10.1111/j.1365-2796.2009.02144.x; Gross CM, 2001, RADIOLOGY, V220, P751, DOI 10.1148/radiol.2203001444; HAIMOVICI H, 1962, J CARDIOVASC SURG, V3, P259; Koivuviita N, 2012, NEPHROL DIAL TRANSPL, V27, P3843, DOI 10.1093/ndt/gfs301; Nordmann AJ, 2003, AM J MED, V114, P44, DOI 10.1016/S0002-9343(02)01396-7; Schreij G, 1996, J NUCL MED, V37, P594; Wheatley K, 2009, NEW ENGL J MED, V361, P1953, DOI 10.1056/NEJMoa0905368	8	14	14	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					663	664		10.1001/jama.2012.194145	http://dx.doi.org/10.1001/jama.2012.194145			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091EK	23423409				2022-12-24	WOS:000315032000018
J	De, S; Williams, GJ; Hayen, A; Macaskill, P; McCaskill, M; Isaacs, D; Craig, JC				De, Sukanya; Williams, Gabrielle J.; Hayen, Andrew; Macaskill, Petra; McCaskill, Mary; Isaacs, David; Craig, Jonathan C.			Accuracy of the "traffic light" clinical decision rule for serious bacterial infections in young children with fever: a retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FEBRILE INFANTS; OBSERVATION SCALES; LOW-RISK; ILLNESS; PROCALCITONIN; PERFORMANCE; MANAGEMENT; BACTEREMIA; MARKERS	Objectives To determine the accuracy of a clinical decision rule (the traffic light system developed by the National Institute for Health and Clinical Excellence (NICE)) for detecting three common serious bacterial infections (urinary tract infection, pneumonia, and bacteraemia) in young febrile children. Design Retrospective analysis of data from a two year prospective cohort study Setting A paediatric emergency department. Participants 15 781 cases of children under 5 years of age presenting with a febrile illness. Main outcome measures Clinical features were used to categorise each febrile episodes as low, intermediate, or high probability of serious bacterial infection (green, amber, and red zones of the traffic light system); these results were checked (using standard radiological and microbiological tests) for each of the infections of interest and for any serious bacterial infection. Results After combination of the intermediate and high risk categories, the NICE traffic light system had a test sensitivity of 85.8% (95% confidence interval 83.6% to 87.7%) and specificity of 28.5% (27.8% to 29.3%) for the detection of any serious bacterial infection. Of the 1140 cases of serious bacterial infection, 157 (13.8%) were test negative (in the green zone), and, of these, 108 (68.8%) were urinary tract infections. Adding urine analysis (leucocyte esterase or nitrite positive), reported in 3653 (23.1%) episodes, to the traffic light system improved the test performance: sensitivity 92.1% (89.3% to 94.1%), specificity 22.3% (20.9% to 23.8%), and relative positive likelihood ratio 1.10 (1.06 to 1.14). Conclusion The NICE traffic light system failed to identify a substantial proportion of serious bacterial infections, particularly urinary tract infections. The addition of urine analysis significantly improved test sensitivity, making the traffic light system a more useful triage tool for the detection of serious bacterial infections in young febrile children.	[De, Sukanya; Williams, Gabrielle J.; Hayen, Andrew; Macaskill, Petra; Craig, Jonathan C.] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; [Hayen, Andrew] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; [McCaskill, Mary] Childrens Hosp Westmead, Dept Emergency Med, Sydney, NSW 2145, Australia; [Isaacs, David] Childrens Hosp, Dept Infect Dis & Microbiol, Westmead, NSW, Australia; [Craig, Jonathan C.] Childrens Hosp, Dept Nephrol, Westmead, NSW, Australia	University of Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney	De, S (corresponding author), Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia.	sukanya.de@health.nsw.gov.au	Craig, Jonathan/E-2813-2013	Craig, Jonathan/0000-0002-2548-4035; Hayen, Andrew/0000-0003-4046-8030; Macaskill, Petra/0000-0001-5879-6193	National Health and Medical Research Council of Australia [211205, 402764]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This is a sub-study of FEVER, which was funded by the National Health and Medical Research Council of Australia (grant Nos 211205 and 402764). The funding source had no influence on study design; collection, analysis, or interpretation of data; writing the report; or the decision to submit the paper for publication.	Andreola B, 2007, PEDIATR INFECT DIS J, V26, P672, DOI 10.1097/INF.0b013e31806215e3; Armon K, 2001, ARCH DIS CHILD, V84, P390, DOI 10.1136/adc.84.5.390; Avner JR, 2009, ACAD EMERG MED, V16, P258, DOI 10.1111/j.1553-2712.2008.00345.x; BAKER MD, 1990, PEDIATRICS, V85, P1040; Baraff LJ, 2008, PEDIATR ANN, V37, P673, DOI 10.3928/00904481-20081001-01; Berger RMF, 1996, EUR J PEDIATR, V155, P468, DOI 10.1007/BF01955183; Bleeker SE, 2007, ACTA PAEDIATR, V96, P100, DOI 10.1111/j.1651-2227.2006.00033.x; BONADIO WA, 1993, CLIN PEDIATR, V32, P401, DOI 10.1177/000992289303200703; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Browne G J, 2001, Emerg Med (Fremantle), V13, P426, DOI 10.1046/j.1035-6851.2001.00256.x; Considine J, 2004, ANN EMERG MED, V44, P516, DOI 10.1016/j.annemergmed.2004.04.007; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; ESKERUD JR, 1992, FAM PRACT, V9, P263, DOI 10.1093/fampra/9.3.263; Hayen A, 2010, J CLIN EPIDEMIOL, V63, P883, DOI 10.1016/j.jclinepi.2009.08.024; Herr SM, 2001, PEDIATRICS, V108, P866, DOI 10.1542/peds.108.4.866; Hewson PH, 2000, J PAEDIATR CHILD H, V36, P221, DOI 10.1046/j.1440-1754.2000.00483.x; Isaacman DJ, 2000, PEDIATRICS, V106, P977, DOI 10.1542/peds.106.5.977; Jackson MA, 1996, PEDIATR INFECT DIS J, V15, P1049, DOI 10.1097/00006454-199611000-00026; JASKIEWICZ JA, 1994, PEDIATRICS, V94, P390; Macaskill P, 2002, STAT MED, V21, P2527, DOI 10.1002/sim.1227; MCCARTHY PL, 1982, PEDIATRICS, V70, P802; McCarthy PL, 1979, PEDIATR REV, V1, P51; MORLEY CJ, 1991, ARCH DIS CHILD, V66, P100, DOI 10.1136/adc.66.1.100; National Collaborating Centre for Women's and Children's Health, 2007, FEV ILLN CHILDR ASS; Richardson M, 2007, BRIT MED J, V334, P1163, DOI 10.1136/bmj.39218.495255.AE; Thayyil S, 2005, ACTA PAEDIATR, V94, P155, DOI 10.1080/08035250410025140; Thompson M, 2009, ARCH DIS CHILD, V94, P888, DOI 10.1136/adc.2009.159095; Waddle E, 2009, ARCH DIS CHILD, V94, P144, DOI 10.1136/adc.2007.130583; Watt K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012448; Welch SB, 2003, ARCH DIS CHILD, V88, P608, DOI 10.1136/adc.88.7.608; Williams GJ, 2010, LANCET INFECT DIS, V10, P240, DOI 10.1016/S1473-3099(10)70031-1	31	37	38	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2013	346								f866	10.1136/bmj.f866	http://dx.doi.org/10.1136/bmj.f866			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091ZK	23407730	hybrid, Green Published, Green Submitted			2022-12-24	WOS:000315088100022
J	Ohde, T; Yaginuma, T; Niimi, T				Ohde, Takahiro; Yaginuma, Toshinobu; Niimi, Teruyuki			Insect Morphological Diversification Through the Modification of Wing Serial Homologs	SCIENCE			English	Article							TEAD/TEF FAMILY; EVOLUTION; ULTRABITHORAX; INTEGRATION; EXPRESSION; COCKROACH; IDENTITY; ORIGIN; BEETLE	Fossil insects living some 300 million years ago show winglike pads on all thoracic and abdominal segments, which suggests their serial homology. It remains unclear whether winglike structures in nonwinged segments have been lost or modified through evolution. Here, we identified a ventral lateral part of the body wall on the first thoracic segment, the hypomeron, and pupal dorsolateral denticular outgrowths as wing serial homologs in the mealworm beetle Tenebrio molitor. Both domains transform into winglike structures under Hox RNA interference conditions. Gene expression and functional analyses revealed central roles for the key wing selector genes, vestigial and scalloped, in the hypomeron and the denticular outgrowth formation. We propose that modification, rather than loss, of dorsal appendages has provided an additional diversifying mechanism of insect body plan.	[Ohde, Takahiro; Yaginuma, Toshinobu; Niimi, Teruyuki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Niimi, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	niimi@agr.nagoya-u.ac.jp		Niimi, Teruyuki/0000-0003-3981-0177; Ohde, Takahiro/0000-0002-0870-9175	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank M. Morita-Miwa for helping in the early stage of this study; T. Suzuki, M. Kobayashi, M. Ikeda, and L. van de Graaf for helpful discussions; and K. Kawakita for providing potatoes. This study was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science. Sequences are deposited in GenBank (accession nos. AB698919 to AB698923).	Angelini DR, 2005, DEV BIOL, V286, P57, DOI 10.1016/j.ydbio.2005.07.006; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; Eisner Thomas, 1992, Psyche (Cambridge), V99, P265, DOI 10.1155/1992/54859; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; HLAVAC T F, 1972, Psyche (Cambridge), V79, P123, DOI 10.1155/1972/31579; Hrycaj S, 2010, DEV BIOL, V341, P324, DOI 10.1016/j.ydbio.2010.02.018; Ichikawa T, 2009, ZOOL SCI, V26, P525, DOI 10.2108/zsj.26.525; Jockusch EL, 2004, J HERED, V95, P382, DOI 10.1093/jhered/esh064; KERRIDGE S, 1982, J EMBRYOL EXP MORPH, V68, P211; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; KUKALOVAPECK J, 1978, J MORPHOL, V156, P53, DOI 10.1002/jmor.1051560104; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Miko I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030137; Niwa N, 2010, EVOL DEV, V12, P168, DOI 10.1111/j.1525-142X.2010.00402.x; Ohde T, 2009, INSECT MOL BIOL, V18, P571, DOI 10.1111/j.1365-2583.2009.00898.x; Paumard-Rigal S, 1998, DEV GENES EVOL, V208, P440, DOI 10.1007/s004270050201; Prud'homme B, 2011, NATURE, V473, P83, DOI 10.1038/nature09977; ROSS MARY H., 1964, AMER MIDLAND NAT, V71, P161, DOI 10.2307/2422693; Simmonds AJ, 1998, GENE DEV, V12, P3815, DOI 10.1101/gad.12.24.3815; Tanaka A, 1997, ZOOL SCI, V14, P339, DOI 10.2108/zsj.14.339; Tomoyasu Y, 2005, NATURE, V433, P643, DOI 10.1038/nature03272; WILSON MCL, 1971, J STORED PROD RES, V7, P21, DOI 10.1016/0022-474X(71)90034-8; WOOTTON R J, 1972, Palaeontology (Oxford), V15, P662; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yoshizawa K, 2012, SYST ENTOMOL, V37, P2, DOI 10.1111/j.1365-3113.2011.00606.x; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; [No title captured], DOI DOI 10.1111/J.1365-2311.1946.TB00273.X	28	48	49	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					495	498		10.1126/science.1234219	http://dx.doi.org/10.1126/science.1234219			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23493422				2022-12-24	WOS:000318016700047
J	Yosef, N; Shalek, AK; Gaublomme, JT; Jin, HL; Lee, YJ; Awasthi, A; Wu, C; Karwacz, K; Xiao, S; Jorgolli, M; Gennert, D; Satija, R; Shakya, A; Lu, DY; Trombetta, JJ; Pillai, MR; Ratcliffe, PJ; Coleman, ML; Bix, M; Tantin, D; Park, H; Kuchroo, VK; Regev, A				Yosef, Nir; Shalek, Alex K.; Gaublomme, Jellert T.; Jin, Hulin; Lee, Youjin; Awasthi, Amit; Wu, Chuan; Karwacz, Katarzyna; Xiao, Sheng; Jorgolli, Marsela; Gennert, David; Satija, Rahul; Shakya, Arvind; Lu, Diana Y.; Trombetta, John J.; Pillai, Meenu R.; Ratcliffe, Peter J.; Coleman, Mathew L.; Bix, Mark; Tantin, Dean; Park, Hongkun; Kuchroo, Vijay K.; Regev, Aviv			Dynamic regulatory network controlling T(H)17 cell differentiation	NATURE			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTION-FACTOR; GENE-EXPRESSION; T-CELLS; TARGET GENES; PLATFORM; GAMMA; INDUCTION; DISCOVERY; DATABASE	Despite their importance, the molecular circuits that control the differentiation of naive T cells remain largely unknown. Recent studies that reconstructed regulatory networks in mammalian cells have focused on short-term responses and relied on perturbation-based approaches that cannot be readily applied to primary T cells. Here we combine transcriptional profiling at high temporal resolution, novel computational algorithms, and innovative nanowire-based perturbation tools to systematically derive and experimentally validate a model of the dynamic regulatory network that controls the differentiation of mouse T(H)17 cells, a proinflammatory T-cell subset that has been implicated in the pathogenesis of multiple autoimmune diseases. The T(H)17 transcriptional network consists of two self-reinforcing, but mutually antagonistic, modules, with 12 novel regulators, the coupled action of which may be essential for maintaining the balance between T(H)17 and other CD41 T-cell subsets. Our study identifies and validates 39 regulatory factors, embeds them within a comprehensive temporal network and reveals its organizational principles; it also highlights novel drug targets for controlling T(H)17 cell differentiation.	[Yosef, Nir; Gennert, David; Satija, Rahul; Lu, Diana Y.; Trombetta, John J.; Park, Hongkun; Kuchroo, Vijay K.; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Yosef, Nir; Jin, Hulin; Lee, Youjin; Awasthi, Amit; Wu, Chuan; Karwacz, Katarzyna; Xiao, Sheng; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Shalek, Alex K.; Gaublomme, Jellert T.; Jorgolli, Marsela; Park, Hongkun] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Shalek, Alex K.; Gaublomme, Jellert T.; Jorgolli, Marsela; Park, Hongkun] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Shakya, Arvind; Tantin, Dean] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA; [Pillai, Meenu R.; Bix, Mark] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Ratcliffe, Peter J.; Coleman, Mathew L.] Univ Oxford, Oxford OX3 7BN, England; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02140 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard University; Utah System of Higher Education; University of Utah; St Jude Children's Research Hospital; University of Oxford; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Park, H (corresponding author), Broad Inst MIT & Harvard, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	Hongkun_Park@harvard.edu; vkuchroo@rics.bwh.harvard.edu; aregev@broad.mit.edu	Coleman, Mathew L/C-1676-2014; Park, Hongkun/R-9842-2019; Satija, Rahul/AAF-9564-2019; Shalek, Alex/Y-2434-2019; Wu, Chuan/H-6379-2013	Coleman, Mathew L/0000-0001-6020-9023; Park, Hongkun/0000-0001-9576-8829; Shalek, Alex/0000-0001-5670-8778; Ratcliffe, Peter/0000-0002-2853-806X; Shakya, Arvind/0000-0001-7993-6159; Wu, Chuan/0000-0003-2288-353X; Bix, Mark/0000-0003-4617-0497	NHGRI [1P50HG006193-01]; NIH Pioneer Awards [5DP1OD003893-03, DP1OD003958-01]; NIH [NS 30843, NS045937, AI073748, AI45757]; National MS Society [RG2571]; HHMI; Klarman Cell Observatory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757, R01AI100873, P01AI073748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS030843, R01NS030843, R37NS030843, R01NS045937] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958, DP1OD003893] Funding Source: NIH RePORTER; British Heart Foundation [RG/11/1/28684] Funding Source: researchfish	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Pioneer Awards; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National MS Society(National Multiple Sclerosis Society); HHMI(Howard Hughes Medical Institute); Klarman Cell Observatory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation)	We thank L. Gaffney and L. Solomon for artwork, the Broad's Genomics Platform for sequencing, and D. Kozoriz for cell sorting. Work was supported by NHGRI (1P50HG006193-01 to H. P. and A. R.), NIH Pioneer Awards (5DP1OD003893-03 to H. P., DP1OD003958-01 to A. R.), NIH (NS 30843, NS045937, AI073748 and AI45757 to V. K. K.), National MS Society (RG2571 to V. K. K.), HHMI (A. R.), and the Klarman Cell Observatory (A. R.).	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chechik G, 2009, J COMPUT BIOL, V16, P279, DOI 10.1089/cmb.2008.13TT; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Choi SJ, 2005, MOL CELL BIOCHEM, V271, P23, DOI 10.1007/s11010-005-3456-7; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Dardalhon V, 2001, GENE THER, V8, P190, DOI 10.1038/sj.gt.3301378; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hu Si-Ming, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P1185; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Jing Y, 2012, BIOTECHNOL PROGR, V28, P490, DOI 10.1002/btpr.747; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jux B, 2009, J IMMUNOL, V182, P6709, DOI 10.4049/jimmunol.0713344; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McManus MT, 2002, J IMMUNOL, V169, P5754, DOI 10.4049/jimmunol.169.10.5754; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; O'Shea JJ, 2009, MICROBES INFECT, V11, P599, DOI 10.1016/j.micinf.2009.04.007; Okamoto M, 2009, NAT IMMUNOL, V10, P872, DOI 10.1038/ni.1747; Peleg T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000635; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Shalek AK, 2012, NANO LETT, V12, P6498, DOI 10.1021/nl3042917; Shalek AK, 2010, P NATL ACAD SCI USA, V107, P1870, DOI 10.1073/pnas.0909350107; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Teitell MA, 2003, TRENDS IMMUNOL, V24, P546, DOI 10.1016/j.it.2003.08.002; Waldner H, 1997, J IMMUNOL, V159, P3100; Wang VEH, 2004, P NATL ACAD SCI USA, V101, P2005, DOI 10.1073/pnas.0307304101; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilkins MR, 1999, METH MOL B, V112, P531; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wu C, 2013, NATURE; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Zheng GY, 2008, BIOINFORMATICS, V24, P2416, DOI 10.1093/bioinformatics/btn439; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	65	461	481	2	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					461	+		10.1038/nature11981	http://dx.doi.org/10.1038/nature11981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23467089	Green Accepted, Green Submitted			2022-12-24	WOS:000317984400033
J	Liebensteiner, MG; Pinkse, MWH; Schaap, PJ; Stams, AJM; Lomans, BP				Liebensteiner, Martin G.; Pinkse, Martijn W. H.; Schaap, Peter J.; Stams, Alfons J. M.; Lomans, Bart P.			Archaeal (Per)Chlorate Reduction at High Temperature: An Interplay of Biotic and Abiotic Reactions	SCIENCE			English	Article							ARCHAEOGLOBUS-FULGIDUS; PERCHLORATE	Perchlorate and chlorate anions [(per) chlorate] exist in the environment from natural and anthropogenic sources, where they can serve as electron acceptors for bacteria. We performed growth experiments combined with genomic and proteomic analyses of the hyperthermophile Archaeoglobus fulgidus that show (per) chlorate reduction also extends into the archaeal domain of life. The (per) chlorate reduction pathway in A. fulgidus relies on molybdo-enzymes that have similarity with bacterial enzymes; however, chlorite is not enzymatically split into chloride and oxygen. Evidence suggests that it is eliminated by an interplay of abiotic and biotic redox reactions involving sulfur compounds. Biological (per) chlorate reduction by ancient archaea at high temperature may have prevented accumulation of perchlorate in early terrestrial environments and consequently given rise to oxidizing conditions on Earth before the rise of oxygenic photosynthesis.	[Liebensteiner, Martin G.; Stams, Alfons J. M.] Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [Pinkse, Martijn W. H.] Delft Univ Technol, Dept Biotechnol, Analyt Biotechnol Sect, NL-2628 BC Delft, Netherlands; [Pinkse, Martijn W. H.] Netherlands Prote Ctr, NL-2628 BC Delft, Netherlands; [Schaap, Peter J.] Wageningen Univ, Lab Syst & Synthet Biol, NL-6703 HB Wageningen, Netherlands; [Stams, Alfons J. M.] Univ Minho, Ctr Biol Engn, P-4710057 Braga, Portugal; [Lomans, Bart P.] Shell Global Solut Int BV, NL-2288 GS Rijswijk, Netherlands	Wageningen University & Research; Delft University of Technology; Wageningen University & Research; Universidade do Minho; Royal Dutch Shell	Stams, AJM (corresponding author), Wageningen Univ, Microbiol Lab, Dreijenpl 10, NL-6703 HB Wageningen, Netherlands.	Fons.Stams@wur.nl	Stams, Alfons/C-8167-2014	Stams, Alfons/0000-0001-7840-6500; Schaap, Peter/0000-0002-4346-6084	Shell Global Solutions International BV; Technology Foundation STW [08053]; Chemical Sciences division CW of the Netherlands Science Foundation (NWO) [700.55.343]	Shell Global Solutions International BV; Technology Foundation STW(Technologiestichting STW); Chemical Sciences division CW of the Netherlands Science Foundation (NWO)	We thank D. Frigo and M. Golombok for critically reviewing the manuscript and Shell Global Solutions International BV for financial support. A.J.M.S. acknowledges the support of the Technology Foundation STW (project 08053) and the Chemical Sciences division CW (project 700.55.343) of the Netherlands Science Foundation (NWO). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium with the data set identifier PXD000137 and digital object identifier 10.6019/PXD000137. The experiments were conceived by M. G. L., A.J.M.S., and B. P. L. Growth experiments, enzyme activity measurements and chemical analyses were conducted by M. G. L. The proteome analysis was performed by M. W. H. P. Data processing and interpretation of the proteome analysis was done by P.J.S. and M. G. L. The manuscript was written by M. G. L. with input from all other authors.	BEEDER J, 1994, APPL ENVIRON MICROB, V60, P1227, DOI 10.1128/AEM.60.4.1227-1231.1994; Bender KS, 2005, J BACTERIOL, V187, P5090, DOI 10.1128/JB.187.15.5090-5096.2005; Castresana J, 1999, J MOL EVOL, V49, P453, DOI 10.1007/PL00006568; Coates JD, 1999, APPL ENVIRON MICROB, V65, P5234; Coates JD, 2004, NAT REV MICROBIOL, V2, P569, DOI 10.1038/nrmicro926; Coulthurst SJ, 2012, BIOCHEMISTRY-US, V51, P1678, DOI 10.1021/bi201852d; Dasgupta PK, 2005, ENVIRON SCI TECHNOL, V39, P1569, DOI 10.1021/es048612x; Dridge EJ, 2006, BIOCHEM SOC T, V34, P118, DOI 10.1042/BST0340118; Fardeau ML, 2009, GEOMICROBIOL J, V26, P119, DOI 10.1080/01490450802674970; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Kengen SWM, 1999, J BACTERIOL, V181, P6706, DOI 10.1128/JB.181.21.6706-6711.1999; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Kounaves SP, 2010, ENVIRON SCI TECHNOL, V44, P2360, DOI 10.1021/es9033606; Kurakin A, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-4; Mao SC, 2009, J PHYS CHEM A, V113, P1231, DOI 10.1021/jp807802v; ORBAN M, 1982, J PHYS CHEM-US, V86, P431, DOI 10.1021/j100393a001; Parker DR, 2009, ENVIRON CHEM, V6, P10, DOI 10.1071/EN09001; Plummer LN, 2006, ENVIRON SCI TECHNOL, V40, P1757, DOI 10.1021/es051739h; Rikken GB, 1996, APPL MICROBIOL BIOT, V45, P420, DOI 10.1007/s002530050707; Sperling D, 1998, FEMS MICROBIOL LETT, V162, P257, DOI 10.1111/j.1574-6968.1998.tb13007.x; STETTER KO, 1987, SCIENCE, V236, P822, DOI 10.1126/science.236.4803.822; ZELLNER G, 1989, SYST APPL MICROBIOL, V11, P151, DOI 10.1016/S0723-2020(89)80055-4	22	50	50	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					85	87		10.1126/science.1233957	http://dx.doi.org/10.1126/science.1233957			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559251				2022-12-24	WOS:000317061100051
J	Quigley, A; Dong, YY; Pike, ACW; Dong, L; Shrestha, L; Berridge, G; Stansfeld, PJ; Sansom, MSP; Edwards, AM; Bountra, C; von Delft, F; Bullock, AN; Burgess-Brown, NA; Carpenter, EP				Quigley, Andrew; Dong, Yin Yao; Pike, Ashley C. W.; Dong, Liang; Shrestha, Leela; Berridge, Georgina; Stansfeld, Phillip J.; Sansom, Mark S. P.; Edwards, Aled M.; Bountra, Chas; von Delft, Frank; Bullock, Alex N.; Burgess-Brown, Nicola A.; Carpenter, Elisabeth P.			The Structural Basis of ZMPSTE24-Dependent Laminopathies	SCIENCE			English	Article							HETEROZYGOUS ZMPSTE24 MUTATIONS; MANDIBULOACRAL DYSPLASIA; RESTRICTIVE DERMOPATHY; PRELAMIN-A; ZINC METALLOPROTEINASE; LAMIN-A; ACCUMULATION; PHENOTYPE	Mutations in the nuclear membrane zinc metalloprotease ZMPSTE24 lead to diseases of lamin processing (laminopathies), such as the premature aging disease progeria and metabolic disorders. ZMPSTE24 processes prelamin A, a component of the nuclear lamina intermediate filaments, by cleaving it at two sites. Failure of this processing results in accumulation of farnesylated, membrane-associated prelamin A. The 3.4 angstrom crystal structure of human ZMPSTE24 has a seven transmembrane a-helical barrel structure, surrounding a large, water-filled, intramembrane chamber, capped by a zinc metalloprotease domain with the catalytic site facing into the chamber. The 3.8 angstrom structure of a complex with a CSIM tetrapeptide showed that the mode of binding of the substrate resembles that of an insect metalloprotease inhibitor in thermolysin. Laminopathy-associated mutations predicted to reduce ZMPSTE24 activity map to the zinc metalloprotease peptide-binding site and to the bottom of the chamber.	[Quigley, Andrew; Dong, Yin Yao; Pike, Ashley C. W.; Dong, Liang; Shrestha, Leela; Berridge, Georgina; Bountra, Chas; von Delft, Frank; Bullock, Alex N.; Burgess-Brown, Nicola A.; Carpenter, Elisabeth P.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Stansfeld, Phillip J.; Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Edwards, Aled M.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada	University of Oxford; University of Oxford; University of Toronto; Structural Genomics Consortium	Carpenter, EP (corresponding author), Univ Oxford, Struct Genom Consortium, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England.	liz.carpenter@sgc.ox.ac.uk	Stansfeld, Phillip James/AAA-9228-2020; Stansfeld, Phill/C-6213-2011; Sansom, Mark S.P./C-5157-2009	Stansfeld, Phillip James/0000-0001-8800-7669; Stansfeld, Phill/0000-0001-8800-7669; Sansom, Mark S.P./0000-0001-6360-7959; Carpenter, Liz/0000-0001-9138-2937; Pike, Ashley/0000-0001-9661-2607; Edwards, Aled/0000-0002-4782-6016; von Delft, Frank/0000-0003-0378-0017; Quigley, Andrew/0000-0002-5022-9845; Dong, Yin/0000-0001-8600-6988	AbbVie [1097737]; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Eli Lilly Canada; Novartis Research Foundation; Pfizer; Takeda; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust; BBSRC [BB/H000267/1, BB/I019855/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I019855/1, B19456, BB/H000267/1, BBS/B/16011, BEP17032] Funding Source: researchfish	AbbVie(AbbVie); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Eli Lilly Canada(Eli Lilly); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Economic Development and Innovation; Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J. Yang, S. Mukhopadhyay, C. Cooper, S. Goubin, Q. Li, A. Chaikuad, J. Kim, and A. Barr for help with this project, including preparation of insect cell cultures, screening constructs and crystals, purification, and help with crystal optimization. We thank J. Bray for construct design; B. Marsden for bioinformatics support; R. Chalk for mass spectrometry; H. Lingard for help with the mechanism figures; the staff at Diamond Light Source Ltd.; and, in particular, the microfocus beamline I24 staff D. Axford, R. Owen, and G. Evans. The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from AbbVie, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Eli Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, The Canada Foundation for Innovation, the Ontario Ministry of Economic Development and Innovation, and the Wellcome Trust. Atomic coordinates and structure factors have been deposited with the Protein Data Bank under accession codes 4AW6 (P1 crystal form) and 2YPT (peptide complex). The authors declare no competing financial interests.	Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Agarwal AK, 2006, J INVEST MED, V54, P208, DOI 10.2310/6650.2006.05068; Ahmad Z, 2010, AM J MED GENET A, V152A, P2703, DOI 10.1002/ajmg.a.33664; Arolas JL, 2011, ANGEW CHEM INT EDIT, V50, P10357, DOI 10.1002/anie.201103262; Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Barrowman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032120; Barrowman J, 2009, BIOL CHEM, V390, P761, DOI 10.1515/BC.2009.080; Ben Yaou R, 2011, EUR J HUM GENET, V19, P647, DOI 10.1038/ejhg.2010.256; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; Cunningham VJ, 2010, BONE, V47, P591, DOI 10.1016/j.bone.2010.06.004; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Denecke J, 2006, HUM MUTAT, V27, P524, DOI 10.1002/humu.20315; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Dutour A, 2011, HUM MOL GENET, V20, P3779, DOI 10.1093/hmg/ddr294; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Kuzin A. P., 2008, PDB ENTRY 3C37, V3c37, DOI [10.2210/pdb3c37/pdb, DOI 10.2210/PDB3C37/PDB]; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; Michaelis S, 2012, MICROBIOL MOL BIOL R, V76, P626, DOI 10.1128/MMBR.00010-12; Miyoshi Y, 2008, CLIN GENET, V73, P535, DOI 10.1111/j.1399-0004.2008.00992.x; Moulson CL, 2005, J INVEST DERMATOL, V125, P913, DOI 10.1111/j.0022-202X.2005.23846.x; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Rodriguez Sofia, 2010, Curr Aging Sci, V3, P81; Shackleton S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029751; Thill M, 2008, ARCH GYNECOL OBSTET, V278, P201, DOI 10.1007/s00404-008-0676-6; WITT DR, 1986, AM J MED GENET, V24, P631, DOI 10.1002/ajmg.1320240408	31	69	74	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1604	1607		10.1126/science.1231513	http://dx.doi.org/10.1126/science.1231513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539603				2022-12-24	WOS:000316731600048
J	Silverman, E				Silverman, Ed			DRUG COMPANIES Big brand pharma on the hook for generic problems	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												pharmalot@gmail.com							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2013	346								f1978	10.1136/bmj.f1978	http://dx.doi.org/10.1136/bmj.f1978			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117XI	23538929				2022-12-24	WOS:000316986200013
J	Tanji, H; Ohto, U; Shibata, T; Miyake, K; Shimizu, T				Tanji, Hiromi; Ohto, Umeharu; Shibata, Takuma; Miyake, Kensuke; Shimizu, Toshiyuki			Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands	SCIENCE			English	Article							SINGLE-STRANDED RNA; INTERFERING RNA; RECOGNITION; ACTIVATION; RESPONSES; CELLS; TLR7; INDUCTION; VIRUSES	Toll-like receptor 7 (TLR7) and TLR8 recognize single-stranded RNA and initiate innate immune responses. Several synthetic agonists of TLR7-TLR8 display novel therapeutic potential; however, the molecular basis for ligand recognition and activation of signaling by TLR7 or TLR8 is largely unknown. In this study, the crystal structures of unliganded and ligand-induced activated human TLR8 dimers were elucidated. Ligand recognition was mediated by a dimerization interface formed by two protomers. Upon ligand stimulation, the TLR8 dimer was reorganized such that the two C termini were brought into proximity. The loop between leucine-rich repeat 14 (LRR14) and LRR15 was cleaved; however, the N- and C-terminal halves remained associated and contributed to ligand recognition and dimerization. Thus, ligand binding induces reorganization of the TLR8 dimer, which enables downstream signaling processes.	[Tanji, Hiromi; Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shibata, Takuma; Miyake, Kensuke] Univ Tokyo, Dept Microbiol & Immunol, Ctr Expt Med & Syst Biol, Div Innate Immun,Lab Innate Immun,Inst Med Sci,Mi, Tokyo 1088639, Japan; [Tanji, Hiromi; Ohto, Umeharu; Shimizu, Toshiyuki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	University of Tokyo; University of Tokyo; RIKEN	Shimizu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	shimizu@mol.f.u-tokyo.ac.jp	Shibata, Takuma/M-8196-2019		Japanese Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research	The NF-kappa B luciferase reporter plasmid, pELAM1-luc, containing the human E-selectin promoter region was kindly provided by T. Muta. We thank the beamline staffs at Photon Factory and SPring-8 for their assistance with data collection. This work was supported by funding from a Japanese Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid (U.O., K.M., and T.S.), Takeda Science Foundation, and Mochida Memorial Foundation for Medical and Pharmaceutical Research (U.O.). The data presented in this manuscript are tabulated in the main paper and the supplementary materials. The coordinate and structure factor data of human TLR8 (unliganded form), TLR8-CL097, TLR8-CL075, TLR8-R848 (form1), TLR8-R848 (form2), and TLR8-R848 (form3) have been deposited to the Protein Data Bank (PDB) under the PDB IDs 3W3G, 3W3J, 3W3K, 3W3L, 3W3M, and 3W3N, respectively. We all declare that none of the authors have a financial interest related to this work.	Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161; Melchjorsen J, 2005, J VIROL, V79, P12944, DOI 10.1128/JVI.79.20.12944-12951.2005; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sioud M, 2005, J MOL BIOL, V348, P1079, DOI 10.1016/j.jmb.2005.03.013; Sioud M, 2006, EUR J IMMUNOL, V36, P1222, DOI 10.1002/eji.200535708; Triantafilou K, 2005, CELL MICROBIOL, V7, P1117, DOI 10.1111/j.1462-5822.2005.00537.x; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584	24	230	242	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1426	1429		10.1126/science.1229159	http://dx.doi.org/10.1126/science.1229159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520111				2022-12-24	WOS:000316740700041
J	Zhao, W; Li, QT; Ayers, S; Gu, YF; Shi, Z; Zhu, QY; Chen, YD; Wang, HY; Wang, RF				Zhao, Wei; Li, Qingtian; Ayers, Stephen; Gu, Yifeng; Shi, Zhong; Zhu, Qingyuan; Chen, Yidong; Wang, Helen Y.; Wang, Rong-Fu			Jmjd3 Inhibits Reprogramming by Upregulating Expression of INK4a/Arf and Targeting PHF20 for Ubiquitination	CELL			English	Article							PLURIPOTENT STEM-CELLS; CHROMATIN; PROTEIN; WDR5; UTX; IDENTIFICATION; CONTRIBUTES; GENERATION; DISTINCT; FAMILY	Although somatic cell reprogramming to generate inducible pluripotent stem cells (iPSCs) is associated with profound epigenetic changes, the roles and mechanisms of epigenetic factors in this process remain poorly understood. Here, we identify Jmjd3 as a potent negative regulator of reprogramming. Jmjd3-deficient MEFs produced significantly more iPSC colonies than did wild-type cells, whereas ectopic expression of Jmjd3 markedly inhibited reprogramming. We show that the inhibitory effects of Jmjd3 are produced through both histone demethylase-dependent and -independent pathways. The latter pathway involves Jmjd3 targeting of PHF20 for ubiquitination and degradation via recruitment of an E3 ligase, Trim26. Importantly, PHF20-deficient MEFs could not be converted to fully reprogrammed iPSCs, even with knockdown of Jmjd3, Ink4a, or p21, indicating that PHF20 is required for reprogramming. Our findings demonstrate, to the best of our knowledge, a previously unrecognized role of Jmjd3 in cellular reprogramming and provide molecular insight into the mechanisms by which the Jmjd3-PHF20 axis controls this process.	[Zhao, Wei; Li, Qingtian; Gu, Yifeng; Zhu, Qingyuan; Wang, Helen Y.; Wang, Rong-Fu] Methodist Hosp, Res Inst, Ctr Inflammat & Epigenet, Houston, TX 77030 USA; [Ayers, Stephen] Methodist Hosp, Res Inst, Houston, TX 77030 USA; [Shi, Zhong] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Wang, RF (corresponding author), Methodist Hosp, Res Inst, Ctr Inflammat & Epigenet, 6535 Fannin, Houston, TX 77030 USA.	rwang3@tmhs.org	Zhao, Wei/F-4848-2014; Ayers, Stephen D/O-4535-2014	Ayers, Stephen D/0000-0003-1390-8969	National Cancer Institute; NIH [R01CA09327, R01CA101795, R01CA116408, R01CA121191, R01 DA030338]; Cancer Prevention and Research Institute of Texas [RP121048]; Methodist Hospital Research Institute; NATIONAL CANCER INSTITUTE [R01CA116408, R01CA101795, R01CA090327, R01CA121191, P01CA094237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030338] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Methodist Hospital Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Dr. Yi Li at Baylor College of Medicine for providing Tet-O-Myc transgenic mice, Dr. Mark Bedford at M. D. Anderson Cancer Center for PHF20 KO mice, Dr. Dan Liu at Baylor College of Medicine for assistance with shRNA screening, and Dr. Paul Webb for assistance in ChIP-seq experiments. We would also like to thank John Gilbert and Adebusola A. Ajibade for their critical reading of this manuscript. This work was in part supported by grants from National Cancer Institute, NIH (R01CA09327, R01CA101795, R01CA116408, R01CA121191, and R01 DA030338), and Cancer Prevention and Research Institute of Texas (RP121048) to R.-F. W. and from The Methodist Hospital Research Institute.	Adams-Cioaba MA, 2012, FEBS LETT, V586, P859, DOI 10.1016/j.febslet.2012.02.012; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Badeaux AI, 2012, J BIOL CHEM, V287, P429, DOI 10.1074/jbc.M111.271163; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fischer U, 2001, CLIN EXP IMMUNOL, V126, P206, DOI 10.1046/j.1365-2249.2001.01635.x; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li Y, 2013, CELL SIGNAL, V25, P74, DOI 10.1016/j.cellsig.2012.09.009; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park S, 2012, J BIOL CHEM, V287, P11151, DOI 10.1074/jbc.M111.333922; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	121	126	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					1037	1050		10.1016/j.cell.2013.02.006	http://dx.doi.org/10.1016/j.cell.2013.02.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452852	Green Accepted, Bronze			2022-12-24	WOS:000315710300012
J	Beaglehole, R; Bonita, R; Horton, R				Beaglehole, Robert; Bonita, Ruth; Horton, Richard			Independent global accountability for NCDs	LANCET			English	Editorial Material									[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Horton, Richard] The Lancet, London NW1 7BY, England	University of Auckland	Beaglehole, R (corresponding author), Univ Auckland, Auckland 1, New Zealand.	r.beaglehole@auckland.ac.uk						Alleyne G, 2013, LANCET; Beaglehole R, 2012, LANCET, V380, P1283, DOI 10.1016/S0140-6736(12)61692-4; Beyer P, 2016, OPTIONS GLOBAL DEV S; Bonita R, 2013, LANCET; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; Di Cesare M, 2013, LANCET; Moodie R, 2013, LANCET; The NCD Alliance, PROP GLOB COORD MECH; UNAIDS, 2009, 2010 2011 PERF MON F; *UNDP, MILL DEV GOALS; United Nations General Assembly,, 2012, NOT SECR GEN TRANSM; United Nations Secretary-General Ban Kin-moon, 2010, GLOB STRAT WOM CHILD; WHO, 2013, DRAFT PLAN PREV CONT; World Health Organization, 2012, 65 WORLD HLTH ASS DE; World Health Organization (WHO), STEPWISE APPR SURV S	15	25	25	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2013	381	9867					602	605		10.1016/S0140-6736(13)60101-4	http://dx.doi.org/10.1016/S0140-6736(13)60101-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	093JY	23410610				2022-12-24	WOS:000315189300005
J	Ryan, KK; Seeley, RJ				Ryan, Karen K.; Seeley, Randy J.			Food as a Hormone	SCIENCE			English	Editorial Material							ENERGY HOMEOSTASIS; FATTY-ACIDS; PPAR-GAMMA; OBESITY; BALANCE; GPR120		[Ryan, Karen K.; Seeley, Randy J.] Univ Cincinnati, Metab Dis Inst, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati	Ryan, KK (corresponding author), Univ Cincinnati, Metab Dis Inst, Cincinnati, OH 45237 USA.	randy.seeley@uc.edu	Ryan, Karen/A-4626-2014	Ryan, Karen/0000-0003-4563-3744; Seeley, Randy/0000-0002-3721-5625	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL111319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093848] Funding Source: NIH RePORTER; NHLBI NIH HHS [R00 HL111319, K99 HL111319, HL111319] Funding Source: Medline; NIDDK NIH HHS [R01 DK093848, DK093848] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004; Buckley JD, 2010, NUTRIENTS, V2, P1212, DOI 10.3390/nu2121212; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Heppner KM, 2012, ENDOCRINOLOGY, V153, P4687, DOI 10.1210/en.2012-1194; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ryan KK, 2012, CELL METAB, V15, P137, DOI 10.1016/j.cmet.2011.12.013; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552	15	35	39	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					918	919		10.1126/science.1234062	http://dx.doi.org/10.1126/science.1234062			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430646	Green Accepted			2022-12-24	WOS:000315149600038
J	Duttwyler, S; Chen, SM; Takase, MK; Wiberg, KB; Bergman, RG; Ellman, JA				Duttwyler, Simon; Chen, Shuming; Takase, Michael K.; Wiberg, Kenneth B.; Bergman, Robert G.; Ellman, Jonathan A.			Proton Donor Acidity Controls Selectivity in Nonaromatic Nitrogen Heterocycle Synthesis	SCIENCE			English	Article							C-H FUNCTIONALIZATION; ACTIVATION; CASCADE; BONDS	Piperidines are prevalent in natural products and pharmaceutical agents and are important synthetic targets for drug discovery and development. We report on a methodology that provides highly substituted piperidine derivatives with regiochemistry selectively tunable by varying the strength of acid used in the reaction. Readily available starting materials are first converted to dihydropyridines via a cascade reaction initiated by rhodium-catalyzed carbon-hydrogen bond activation. Subsequent divergent regio- and diastereoselective protonation of the dihydropyridines under either kinetic or thermodynamic control provides two distinct iminium ion intermediates that then undergo highly diastereoselective nucleophilic additions. X-ray structural characterization of both the kinetically and thermodynamically favored iminium ions along with density functional theory calculations provide a theoretical underpinning for the high selectivities achieved for the reaction sequences.	[Duttwyler, Simon; Chen, Shuming; Takase, Michael K.; Wiberg, Kenneth B.; Ellman, Jonathan A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Bergman, Robert G.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Bergman, Robert G.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Yale University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ellman, JA (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	jonathan.ellman@yale.edu	Ellman, Jonathan A/C-7732-2013		NIH [GM069559]; Office of Energy Research, Office of Basic Energy Sciences, Chemical Sciences Division, U.S. Department of Energy [DE-AC02-05CH11231]; National Science Foundation [PBZHP2-130-966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069559] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Energy Research, Office of Basic Energy Sciences, Chemical Sciences Division, U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM069559 (to J.A.E.). R. G. B. acknowledges funding from the Director, Office of Energy Research, Office of Basic Energy Sciences, Chemical Sciences Division, U.S. Department of Energy, under contract DE-AC02-05CH11231. S. D. is grateful to the Swiss National Science Foundation for a postdoctoral fellowship (PBZHP2-130-966). Metrical parameters for the structures of compounds 5a, 6a, 7e, 8a, and 8m are available free of charge from the Cambridge Crystallographic Data Centre under reference nos. CCDC 911314-911318.	Anderson P. S., 1964, TETRAHEDRON LETT, V5, P153; Bull JA, 2012, CHEM REV, V112, P2642, DOI 10.1021/cr200251d; Colby DA, 2008, J AM CHEM SOC, V130, P3645, DOI 10.1021/ja7104784; Crabtree RH, 2010, CHEM REV, V110, P575, DOI 10.1021/cr900388d; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Davies HML, 2011, CHEM SOC REV, V40, P1855, DOI 10.1039/c1cs90010b; Davies HML, 2009, CHEM SOC REV, V38, P2981, DOI 10.1039/b918568m; Doyle MP, 2012, ACCOUNTS CHEM RES, V45, P777, DOI 10.1021/ar300096z; Duttwyler S, 2012, J AM CHEM SOC, V134, P4064, DOI 10.1021/ja2119833; Evans D. A., 1984, ASYMMETRIC SYNTHESIS, V3, p[20, 65]; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Grondal C, 2010, NAT CHEM, V2, P167, DOI [10.1038/NCHEM.539, 10.1038/nchem.539]; Guimond N, 2011, J AM CHEM SOC, V133, P6449, DOI 10.1021/ja201143v; HOFFMANN RW, 1989, CHEM REV, V89, P1841, DOI 10.1021/cr00098a009; Liu HJ, 1999, TETRAHEDRON, V55, P3803, DOI 10.1016/S0040-4020(99)00114-3; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Lyle R. E., 1962, TETRAHEDRON LETT, V3, P553; Muller S, 2009, ANGEW CHEM INT EDIT, V48, P9975, DOI 10.1002/anie.200905035; Okamoto Y, 2008, CHEM SOC REV, V37, P2593, DOI 10.1039/b808881k; Ritchie TJ, 2009, DRUG DISCOV TODAY, V14, P1011, DOI 10.1016/j.drudis.2009.07.014; Thompson S, 2011, CHEM SOC REV, V40, P4217, DOI 10.1039/c1cs15022g; Tietze L. F., 2006, DOMINO REACTIONS ORG; Walters WP, 2011, J MED CHEM, V54, P6405, DOI 10.1021/jm200504p; Ward TJ, 2010, ANAL CHEM, V82, P4712, DOI 10.1021/ac1010926; Wasa M, 2010, J AM CHEM SOC, V132, P3680, DOI 10.1021/ja1010866; Yamaguchi J., 2012, ANGEW CHEM INT EDIT, V51, P8690	26	54	55	1	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					678	682		10.1126/science.1230704	http://dx.doi.org/10.1126/science.1230704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393259	Green Accepted			2022-12-24	WOS:000314585600037
J	Arias-Palomo, E; O'Shea, VL; Hood, IV; Berger, JM				Arias-Palomo, Ernesto; O'Shea, Valerie L.; Hood, Iris V.; Berger, James M.			The Bacterial DnaC Helicase Loader Is a DnaB Ring Breaker	CELL			English	Article							ESCHERICHIA-COLI DNAB; PROTEIN-PROTEIN INTERACTIONS; SLIDING CLAMP INTERACTIONS; N-TERMINAL DOMAIN; REPLICATIVE HELICASE; CRYSTAL-STRUCTURE; FUNCTIONAL INTERACTION; HEXAMERIC HELICASE; POLYMERASE CLAMP; QUANTITATIVE-ANALYSIS	Dedicated AAA+ ATPases deposit hexameric ring-shaped helicases onto DNA to promote replication in cellular organisms. To understand how loading occurs, we used electron microscopy and small angle X-ray scattering (SAXS) to determine the ATP-bound structure of the intact E. coli DnaB, DnaC helicase/loader complex. The 480 kDa dodecamer forms a three-tiered assembly, in which DnaC adopts a spiral configuration that remodels N-terminal scaffolding and C-terminal motor regions of DnaB to produce a clear break in the helicase ring. Surprisingly, DnaC's AAA+ fold is dispensable for ring remodeling because the DnaC isolated helicase-binding domain can both load DnaB onto DNA and increase the efficiency by which the helicase acts on substrates in vitro. Our data demonstrate that DnaC opens DnaB by a mechanism akin to that of polymerase clamp loaders and indicate that bacterial replicative helicases, like their eukaryotic counterparts, possess autoregulatory elements that influence how hexameric motor domains are loaded onto and unwind DNA.	[Arias-Palomo, Ernesto; O'Shea, Valerie L.; Hood, Iris V.; Berger, James M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, 229 Stanley Hall, Berkeley, CA 94720 USA.	jmberger@berkeley.edu	Arias Palomo, Ernesto/L-1853-2017; Bustelo, Xose R./A-9526-2010; Garcia, Pedro/L-2808-2017	Bustelo, Xose R./0000-0001-9398-6072; Arias-Palomo, Ernesto/0000-0002-2706-7411; Garcia, Pedro/0000-0001-6717-8717	NIH NRSA postdoctoral fellowship [F32GM090803]; Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I+D+i from the Spanish Ministry of Education; Department of Energy Office of Science Graduate Fellowship; NIGMS [RO1-GM071747]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404, T32GM007232, F32GM090803, R01GM071747] Funding Source: NIH RePORTER	NIH NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I+D+i from the Spanish Ministry of Education; Department of Energy Office of Science Graduate Fellowship(United States Department of Energy (DOE)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to Eva Nogales and her research group, to the staff at beamlines 8.3.1 and 12.3.1 of the Advanced Light Source for help with data collection and analysis, and to the J.M.B. laboratory members for helpful discussions and aid in preparing the manuscript. This work was supported by an NIH NRSA postdoctoral fellowship (F32GM090803) to V.L.O., a postdoctoral fellowship from the Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I+D+i 2008-2011 from the Spanish Ministry of Education to E.A.-P., a Department of Energy Office of Science Graduate Fellowship to I.V.H., and by the NIGMS (RO1-GM071747) to J.M.	Ason B, 2000, J BIOL CHEM, V275, P3006, DOI 10.1074/jbc.275.4.3006; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Barcena M, 2001, EMBO J, V20, P1462, DOI 10.1093/emboj/20.6.1462; BISWAS EE, 1986, BIOCHEMISTRY-US, V25, P7368, DOI 10.1021/bi00371a019; Biswas SB, 2004, BIOCHEM J, V379, P553, DOI 10.1042/BJ20031255; Biswas T, 2008, FEBS J, V275, P3064, DOI 10.1111/j.1742-4658.2008.06460.x; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Chang P, 2000, J BIOL CHEM, V275, P26187, DOI 10.1074/jbc.M001800200; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Davey MJ, 2003, CURR BIOL, V13, pR594, DOI 10.1016/S0960-9822(03)00523-2; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; Galletto R, 2004, BIOCHEMISTRY-US, V43, P10988, DOI 10.1021/bi049377y; Galletto R, 2003, J MOL BIOL, V329, P441, DOI 10.1016/S0022-2836(03)00435-2; Goedken ER, 2005, NAT STRUCT MOL BIOL, V12, P183, DOI 10.1038/nsmb889; Hingorani MM, 1999, EMBO J, V18, P5131, DOI 10.1093/emboj/18.18.5131; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; JARVIS TC, 1989, J BIOL CHEM, V264, P12717; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Kaguni JM, 2011, CURR OPIN CHEM BIOL, V15, P606, DOI 10.1016/j.cbpa.2011.07.016; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 1999, J BIOL CHEM, V274, P6889, DOI 10.1074/jbc.274.11.6889; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kelch BA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-34; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; KOBORI JA, 1982, J BIOL CHEM, V257, P13770; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KOONIN EV, 1992, NUCLEIC ACIDS RES, V20, P1997, DOI 10.1093/nar/20.8.1997; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Latham GJ, 1997, J BIOL CHEM, V272, P31677, DOI 10.1074/jbc.272.50.31677; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Lo YH, 2009, NUCLEIC ACIDS RES, V37, P804, DOI 10.1093/nar/gkn999; Ludlam AV, 2001, J BIOL CHEM, V276, P27345, DOI 10.1074/jbc.M101940200; Lyubimov AY, 2012, P NATL ACAD SCI USA, V109, P11999, DOI 10.1073/pnas.1209406109; MacNeill SA, 2011, BIOCHEM SOC T, V39, P163, DOI 10.1042/BST0390163; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; McGlynn P, 2011, BIOCHEM SOC T, V39, P606, DOI 10.1042/BST0390606; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Nielsen O, 2008, EMBO REP, V9, P151, DOI 10.1038/sj.embor.2008.2; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietroni P, 1997, J BIOL CHEM, V272, P31666, DOI 10.1074/jbc.272.50.31666; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; San Martin C, 1998, STRUCTURE, V6, P501; SANMARTIN MC, 1995, J STRUCT BIOL, V114, P167, DOI 10.1006/jsbi.1995.1016; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Schaeffer PM, 2005, IUBMB LIFE, V57, P5, DOI 10.1080/15216540500058956; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; Seybert A, 2006, EMBO J, V25, P2209, DOI 10.1038/sj.emboj.7601093; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Soultanas P, 2002, NUCLEIC ACIDS RES, V30, P966, DOI 10.1093/nar/30.4.966; Soultanas P, 2012, MOL MICROBIOL, V84, P6, DOI 10.1111/j.1365-2958.2012.08012.x; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TOUGU K, 1994, J BIOL CHEM, V269, P4675; Tsai KL, 2009, J MOL BIOL, V393, P1056, DOI 10.1016/j.jmb.2009.09.002; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; WAHLE E, 1989, J BIOL CHEM, V264, P2469; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921; Yang SX, 2002, J MOL BIOL, V321, P839, DOI 10.1016/S0022-2836(02)00711-8; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103	78	61	61	3	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					438	448		10.1016/j.cell.2013.03.006	http://dx.doi.org/10.1016/j.cell.2013.03.006			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23562643	Green Accepted, Bronze			2022-12-24	WOS:000317349700021
J	Boetius, A; Albrecht, S; Bakker, K; Bienhold, C; Felden, J; Fernandez-Mendez, M; Hendricks, S; Katlein, C; Lalande, C; Krumpen, T; Nicolaus, M; Peeken, I; Rabe, B; Rogacheva, A; Rybakova, E; Somavilla, R; Wenzhofer, F				Boetius, Antje; Albrecht, Sebastian; Bakker, Karel; Bienhold, Christina; Felden, Janine; Fernandez-Mendez, Mar; Hendricks, Stefan; Katlein, Christian; Lalande, Catherine; Krumpen, Thomas; Nicolaus, Marcel; Peeken, Ilka; Rabe, Benjamin; Rogacheva, Antonina; Rybakova, Elena; Somavilla, Raquel; Wenzhoefer, Frank		RV Polarstern ARK27-3-Shipboard Sc	Export of Algal Biomass from the Melting Arctic Sea Ice	SCIENCE			English	Article							PHYTOPLANKTON; SEDIMENT; CLIMATE; OCEAN; DEEP; FATE	In the Arctic, under-ice primary production is limited to summer months and is restricted not only by ice thickness and snow cover but also by the stratification of the water column, which constrains nutrient supply for algal growth. Research Vessel Polarstern visited the ice-covered eastern-central basins between 82 degrees to 89 degrees N and 30 degrees to 130 degrees E in summer 2012, when Arctic sea ice declined to a record minimum. During this cruise, we observed a widespread deposition of ice algal biomass of on average 9 grams of carbon per square meter to the deep-sea floor of the central Arctic basins. Data from this cruise will contribute to assessing the effect of current climate change on Arctic productivity, biodiversity, and ecological function.	[Boetius, Antje; Bienhold, Christina; Fernandez-Mendez, Mar; Hendricks, Stefan; Katlein, Christian; Lalande, Catherine; Krumpen, Thomas; Nicolaus, Marcel; Peeken, Ilka; Rabe, Benjamin; Somavilla, Raquel; Wenzhoefer, Frank] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, D-27515 Bremerhaven, Germany; [Boetius, Antje; Bienhold, Christina; Fernandez-Mendez, Mar] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Boetius, Antje; Felden, Janine; Peeken, Ilka] Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28334 Bremen, Germany; [Albrecht, Sebastian] FIELAX Gesell Wissensch Datenverarbeitung mbH, D-27568 Bremerhaven, Germany; [Bakker, Karel] NIOZ Royal Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands; [Rogacheva, Antonina; Rybakova, Elena] Russian Acad Sci, PP Shirshov Oceanol Inst, Moscow 117997, Russia	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society; University of Bremen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Russian Academy of Sciences; Shirshov Institute of Oceanology	Boetius, A (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, D-27515 Bremerhaven, Germany.	antje.boetius@awi.de	Rabe, Benjamin/G-2999-2011; Somavilla, Raquel/G-2675-2016; Nicolaus, Marcel/A-3658-2013; Martí, Montserrat Roca/AAD-2094-2022; Attard, Karl Michael/ABE-6044-2021; Rybakova, Elena/AAD-1922-2019; Krumpen, Thomas/D-5163-2011; Hendricks, Stefan/D-5168-2011; Katlein, Christian/AAY-8731-2020; Kremenetskaia, Antonina/H-5654-2018; Galgani, Luisa/J-4026-2017; Boetius, Antje/D-5459-2013; Attard, Karl/AAO-8314-2021; Puigcorbé, Viena/I-9349-2016	Rabe, Benjamin/0000-0001-5794-9856; Somavilla, Raquel/0000-0002-8719-4105; Nicolaus, Marcel/0000-0003-0903-1746; Martí, Montserrat Roca/0000-0002-4719-9358; Attard, Karl Michael/0000-0002-8009-5462; Krumpen, Thomas/0000-0001-6234-8756; Hendricks, Stefan/0000-0002-1412-3146; Kremenetskaia, Antonina/0000-0001-8851-3318; Galgani, Luisa/0000-0001-5239-6893; Boetius, Antje/0000-0003-2117-4176; Puigcorbé, Viena/0000-0001-5892-2305; Bienhold, Christina/0000-0003-2269-9468; Degen, Renate/0000-0001-7380-9378; Katlein, Christian/0000-0003-2422-0414; Rybakova, Elena/0000-0001-9695-149X; Fernandez-Mendez, Mar/0000-0002-4968-1156; Peeken, Ilka/0000-0003-1531-1664	PACES (Polar Regions and Coasts in a Changing Earth System) program of the Helmholtz Association; European Research Council [294757]; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie [03F0605E]	PACES (Polar Regions and Coasts in a Changing Earth System) program of the Helmholtz Association; European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie(Federal Ministry of Education & Research (BMBF))	We thank the captain and crew of RV Polarstern expedition IceArc (ARK27-3) as well as our helicopter and meteorology teams for their excellent support with work at sea. This study was funded by the PACES (Polar Regions and Coasts in a Changing Earth System) program of the Helmholtz Association. Additional funds were made available to A.B. by the European Research Council Advanced Investigator grant 294757 and the Leibniz program of the Deutsche Forschungsgemeinschaft, and to B.R. for the Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie project 03F0605E. Supplementary data are available at http://doi.pangaea.de/10.1594/PANGAEA.803293.	Ambrose WG, 2005, POLAR BIOL, V28, P784, DOI 10.1007/s00300-005-0002-8; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Boetius A, 1998, DEEP-SEA RES PT I, V45, P239, DOI 10.1016/S0967-0637(97)00052-6; Bourgain P, 2011, DEEP-SEA RES PT I, V58, P745, DOI 10.1016/j.dsr.2011.05.001; Cooperative Institute for Research in Environmental Sciences at the University of Colorado at Boulder, 2012, NAT SNOW IC DAT CTR; DEMING JW, 1992, NATO ADV SCI I C-MAT, V360, P11; Fahl K, 2007, DEEP-SEA RES PT I, V54, P1256, DOI 10.1016/j.dsr.2007.04.014; Fischer JP, 2009, BIOGEOSCIENCES, V6, P1467, DOI 10.5194/bg-6-1467-2009; Glover AG, 2010, ADV MAR BIOL, V58, P1, DOI [10.1016/B978-0-12-381015-1.00001-0, 10.1016/S0065-2881(10)58001-5]; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; GUTT J, 1995, POLAR BIOL, V15, P247; Hegseth EN, 1998, POLAR RES, V17, P113, DOI 10.1111/j.1751-8369.1998.tb00266.x; Klages M, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P139; Lalande C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040570; LEGENDRE L, 1992, POLAR BIOL, V12, P429; Maslanik J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047735; Melnikov I.A., 1997, ARCTIC SEA ICE SYSTE; MELNIKOV IA, 1987, OCEANOLOGY, V0027; Mundy CJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038837; Nansen F., 1906, VIDENSKAB SELSKAB MN, V1; Nicolaus M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053738; Nicolaus M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006074; Rabe B, 2011, DEEP-SEA RES PT I, V58, P173, DOI 10.1016/j.dsr.2010.12.002; Rosel A, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007869; Rogacheva A, 2012, J MAR BIOL ASSOC UK, V92, P1183, DOI 10.1017/S0025315411000427; Ruhl HA, 2008, P NATL ACAD SCI USA, V105, P17006, DOI 10.1073/pnas.0803898105; Rysgaard S, 2001, MAR ECOL PROG SER, V223, P15, DOI 10.3354/meps223015; SYVERTSEN EE, 1991, POLAR RES, V10, P277, DOI 10.1111/j.1751-8369.1991.tb00653.x; Tremblay JE, 2009, NATO SCI PEACE SECUR, P73, DOI 10.1007/978-1-4020-9460-6_7; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820; Wassmann P, 2006, PROG OCEANOGR, V71, P232, DOI 10.1016/j.pocean.2006.10.003; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Wassmann P, 2010, POLAR BIOL, V33, P1641, DOI 10.1007/s00300-010-0839-3; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Wenzhofer F, 2002, DEEP-SEA RES PT I, V49, P1255, DOI 10.1016/S0967-0637(02)00025-0; Wigham BD, 2003, J MAR BIOL ASSOC UK, V83, P175, DOI 10.1017/S0025315403006957h; Witte U, 2003, NATURE, V424, P763, DOI 10.1038/nature01799	38	283	305	7	310	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1430	1432		10.1126/science.1231346	http://dx.doi.org/10.1126/science.1231346			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23413190				2022-12-24	WOS:000316740700042
J	Melchor, RN; Buchwaldt, R; Bowring, S				Melchor, Ricardo N.; Buchwaldt, Robert; Bowring, Samuel			A Late Eocene date for Late Triassic bird tracks	NATURE			English	Letter							SANTO-DOMINGO; ARGENTINA; FOOTPRINTS; PRECISION		[Melchor, Ricardo N.] INCITAP, CONICET UNLPam, Santa Rosa 6300, Argentina; [Buchwaldt, Robert; Bowring, Samuel] MIT, Dept Earth Atmosphere & Planet Sci, Cambridge, MA 02139 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Massachusetts Institute of Technology (MIT)	Melchor, RN (corresponding author), INCITAP, CONICET UNLPam, Av Uruguay 151, Santa Rosa 6300, Argentina.	melchor@exactas.unlpam.edu.ar	Melchor, Ricardo Nestor/R-8107-2019					BOWRING JF, 2011, GEOCHEM GEOPHYS SYST, V12; CAMINOS R, 1995, REV ASOC GEOL ARGENT, V50, P262; COUGHLIN TJ, 2001, LINK OROG OBL FAULT; De Valais S, 2008, J VERTEBR PALEONTOL, V28, P145, DOI 10.1671/0272-4634(2008)28[145:IOBFAE]2.0.CO;2; Genise JF, 2009, PALAEOGEOGR PALAEOCL, V272, P143, DOI 10.1016/j.palaeo.2008.08.014; Gradstein FM, 2004, EPISODES, V27, P83, DOI 10.18814/epiiugs/2004/v27i2/002; JAFFEY AH, 1971, PHYS REV C, V4, P1889, DOI 10.1103/PhysRevC.4.1889; Mattinson JM, 2005, CHEM GEOL, V220, P47, DOI 10.1016/j.chemgeo.2005.03.011; MCLEAN NM, 2011, GEOCHEM GEOPHYS SYST, V12; Melchor RN, 2006, PALAEOGEOGR PALAEOCL, V239, P253, DOI 10.1016/j.palaeo.2006.01.011; Melchor RN, 2002, NATURE, V417, P936, DOI 10.1038/nature00818; Rioux M, 2012, NAT GEOSCI, V5, P275, DOI [10.1038/ngeo1378, 10.1038/NGEO1378]; Vizan H, 2013, TECTONOPHYSICS, V583, P105, DOI 10.1016/j.tecto.2012.10.026	13	10	12	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					E1	E2		10.1038/nature11931	http://dx.doi.org/10.1038/nature11931			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23518566				2022-12-24	WOS:000316650500050
J	Misteli, T				Misteli, Tom			The Cell Biology of Genomes: Bringing the Double Helix to Life	CELL			English	Article							STOCHASTIC GENE-EXPRESSION; ORGANIZATION; CHROMATIN	The recent ability to routinely probe genome function at a global scale has revolutionized our view of genomes. One of the most important realizations from these approaches is that the functional output of genomes is affected by the nuclear environment in which they exist. Integration of sequence information with molecular and cellular features of the genome promises a fuller understanding of genome function.	NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov			Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Due to space limitations, mostly review articles were cited. Work in the author's laboratory is supported by the Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research.	Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Ecker JR, 2012, NATURE, V489, P52, DOI 10.1038/489052a; Edelman LB, 2012, CURR OPIN GENET DEV, V22, P110, DOI 10.1016/j.gde.2012.01.010; Geyer PK, 2011, CURR OPIN CELL BIOL, V23, P354, DOI 10.1016/j.ceb.2011.03.002; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010	13	50	50	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1209	1212		10.1016/j.cell.2013.02.048	http://dx.doi.org/10.1016/j.cell.2013.02.048			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498929	Green Accepted, Bronze			2022-12-24	WOS:000316192500002
J	Patterson, AP; Tabak, LA; Fauci, AS; Collins, FS; Howard, S				Patterson, Amy P.; Tabak, Lawrence A.; Fauci, Anthony S.; Collins, Francis S.; Howard, Sally			A Framework for Decisions About Research with HPAI H5N1 Viruses	SCIENCE			English	Editorial Material							TRANSMISSION; PAUSE		[Patterson, Amy P.; Tabak, Lawrence A.; Fauci, Anthony S.; Collins, Francis S.] NIH, Bethesda, MD 20892 USA; [Howard, Sally] US Dept HHS, Washington, DC 20201 USA	National Institutes of Health (NIH) - USA	Patterson, AP (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	pattersa@od.nih.gov			Intramural NIH HHS [Z99 OD999999, Z99 AI999999] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000739] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		[Anonymous], 2012, GAIN OF FUNCT RES HI; [Anonymous], 2009, REP TRANSF TASK FORC, P40; Center for Disease Control and Prevention, HIGHL PATH AV INFL A; Centers for Disease Control and Prevention (CDC) HHS, 2012, FED REG, V77, P63783; Food and Agriculture Organization of the United Nations (FAO), 2012, H5N1 HIGHL PATH AV I; Fouchier RAM, 2013, NATURE, V493, P609, DOI 10.1038/nature11858; Fouchier RAM, 2012, SCIENCE, V335, P400, DOI [10.1126/science.1219412, 10.1126/science.335.6067.400]; Fouchier RAM, 2012, NATURE, V481, P443, DOI 10.1038/481443a; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; National Institute of Health, 2013, NIH GUID RES INV REC; Office of Biotechnology Activities NIH, 2012, US GOV POL OV LIF SC	12	20	20	3	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1036	1037		10.1126/science.1236194	http://dx.doi.org/10.1126/science.1236194			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23429700	Green Accepted			2022-12-24	WOS:000315452000025
J	Sakakibara, K; Ando, S; Yip, HK; Tamada, Y; Hiwatashi, Y; Murata, T; Deguchi, H; Hasebe, M; Bowman, JL				Sakakibara, Keiko; Ando, Sayuri; Yip, Hoichong Karen; Tamada, Yosuke; Hiwatashi, Yuji; Murata, Takashi; Deguchi, Hironori; Hasebe, Mitsuyasu; Bowman, John L.			KNOX2 Genes Regulate the Haploid-to-Diploid Morphological Transition in Land Plants	SCIENCE			English	Article							EXPRESSION; PROTEINS; CELL; LOCALIZATION; DNA	Unlike animals, land plants undergo an alternation of generations, producing multicellular bodies in both haploid (1n: gametophyte) and diploid (2n: sporophyte) generations. Plant body plans in each generation are regulated by distinct developmental programs initiated at either meiosis or fertilization, respectively. In mosses, the haploid gametophyte generation is dominant, whereas in vascular plants-including ferns, gymnosperms, and angiosperms-the diploid sporophyte generation is dominant. Deletion of the class 2 KNOTTED1-LIKE HOMEOBOX (KNOX2) transcription factors in the moss Physcomitrella patens results in the development of gametophyte bodies from diploid embryos without meiosis. Thus, KNOX2 acts to prevent the haploid-specific body plan from developing in the diploid plant body, indicating a critical role for the evolution of KNOX2 in establishing an alternation of generations in land plants.	[Sakakibara, Keiko; Deguchi, Hironori] Hiroshima Univ, Dept Biol Sci, Grad Sch Sci, Higashihiroshima 7398526, Japan; [Sakakibara, Keiko; Bowman, John L.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia; [Sakakibara, Keiko; Ando, Sayuri; Hasebe, Mitsuyasu] Japan Sci & Technol Agcy, ERATO, Okazaki, Aichi 4448585, Japan; [Sakakibara, Keiko; Ando, Sayuri; Tamada, Yosuke; Hiwatashi, Yuji; Murata, Takashi; Hasebe, Mitsuyasu] Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Yip, Hoichong Karen; Bowman, John L.] Univ Calif Davis, Sect Plant Biol, Davis, CA 95616 USA; [Tamada, Yosuke; Hiwatashi, Yuji; Murata, Takashi; Hasebe, Mitsuyasu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448585, Japan	Hiroshima University; Monash University; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of California System; University of California Davis; Graduate University for Advanced Studies - Japan	Sakakibara, K (corresponding author), Hiroshima Univ, Dept Biol Sci, Grad Sch Sci, Higashihiroshima 7398526, Japan.	bara@hiroshima-u.ac.jp; john.bowman@monash.edu	Sakakibara, Keiko/Q-5748-2018; Tamada, Yosuke/A-4144-2010	Sakakibara, Keiko/0000-0003-4420-9351; Hasebe, Mitsuyasu/0000-0001-7425-8758; Murata, Takashi/0000-0002-1543-0439; Tamada, Yosuke/0000-0002-4845-4867; Bowman, John/0000-0001-7347-3691; HIWATASHI, YUJI/0000-0002-3996-0549	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) KAKENHI grant; Australian Research Council [FF0561326]; Grants-in-Aid for Scientific Research [24770077] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Australian Research Council(Australian Research Council); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Kabeya for technical assistance of flow cytometry; C. L. Volk Murayama for translation of references; D. R. Smyth, Y. Eshed, M. Shimamura, and T. Nishiyama for critical comments on the manuscript; and the Model Plant Research Facility of the National Institute for Basic Biology for experimental facilities. This research was partly supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); the Japan Society for the Promotion of Science (JSPS) KAKENHI grant (to K. S., Y. T., H. D, and M. H.); and the Australian Research Council grant FF0561326 (J.L.B.). K. S. was a JSPS research fellow. Sequence data associated with this manuscript have been submitted to the DNA Data Bank of Japan.	Allen CE, 1935, BOT REV, V1, P269; [Anonymous], 1894, ANN BOT, DOI DOI 10.1093/OXFORDJOURNALS.AOB.A090708; Bellaoui M, 2001, PLANT CELL, V13, P2455, DOI 10.1105/tpc.13.11.2455; Bower F. O., 1908, ORIGIN LAND FLORA TH; Graham L, 1993, ORIGIN LAND PLANTS; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; Hofmeister W. F. B., 1862, GERMINATION DEV FRUC; Ishikawa M, 2011, PLANT CELL, V23, P2924, DOI 10.1105/tpc.111.088005; JEFFERSON RA, 1987, EMBO J, V6, P3901; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; LEE JHW, 2008, J HYDRO-ENVIRON RES, V2, P133, DOI DOI 10.1016/S1570-6443(08)00079-8; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Mosquna A, 2009, DEVELOPMENT, V136, P2433, DOI 10.1242/dev.035048; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Nishimura Y, 2012, PLANT CELL, V24, P2401, DOI 10.1105/tpc.112.097865; Okano Y, 2009, P NATL ACAD SCI USA, V106, P16321, DOI 10.1073/pnas.0906997106; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Pringsheim N., 1876, MONATSBER K AKAD WIS, V1876, P425; Sakakibara K, 2008, EVOL DEV, V10, P555, DOI 10.1111/j.1525-142X.2008.00271.x; Serikawa KA, 1997, PLANT J, V11, P853, DOI 10.1046/j.1365-313X.1997.11040853.x; Singer SD, 2007, PLANT CELL REP, V26, P1155, DOI 10.1007/s00299-007-0312-0; Smith HMS, 2002, P NATL ACAD SCI USA, V99, P9579, DOI 10.1073/pnas.092271599; STEIL W. N., 1939, BOT REV, V5, P433, DOI 10.1007/BF02878704; Truernit E, 2006, PLANT MOL BIOL, V60, P1, DOI 10.1007/s11103-005-1673-9; Zhao H, 2001, GENE DEV, V15, P2767, DOI 10.1101/gad.919501	26	94	98	2	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1067	1070		10.1126/science.1230082	http://dx.doi.org/10.1126/science.1230082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449590				2022-12-24	WOS:000315452000039
J	Rodriguez, PL; Harada, T; Christian, DA; Pantano, DA; Tsai, RK; Discher, DE				Rodriguez, Pia L.; Harada, Takamasa; Christian, David A.; Pantano, Diego A.; Tsai, Richard K.; Discher, Dennis E.			Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles	SCIENCE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; SIGNAL-REGULATORY PROTEIN; IN-VIVO; CD47; CELLS; MEMBRANE; TARGET; ALPHA; ENGRAFTMENT; ACTIVATION	Foreign particles and cells are cleared from the body by phagocytes that must also recognize and avoid clearance of "self" cells. The membrane protein CD47 is reportedly a "marker of self" in mice that impedes phagocytosis of self by signaling through the phagocyte receptor CD172a. Minimal "Self" peptides were computationally designed from human CD47 and then synthesized and attached to virus-size particles for intravenous injection into mice that express a CD172a variant compatible with hCD47. Self peptides delay macrophage-mediated clearance of nanoparticles, which promotes persistent circulation that enhances dye and drug delivery to tumors. Self-peptide affinity for CD172a is near the optimum measured for human CD172a variants, and Self peptide also potently inhibits nanoparticle uptake mediated by the contractile cytoskeleton. The reductionist approach reveals the importance of human Self peptides and their utility in enhancing drug delivery and imaging.	[Rodriguez, Pia L.; Harada, Takamasa; Christian, David A.; Pantano, Diego A.; Tsai, Richard K.; Discher, Dennis E.] Univ Penn, Mol & Cell Biophys & NanoBioPolymers Lab, Philadelphia, PA 19104 USA; [Discher, Dennis E.] Univ Penn, Pharmacol Sci Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Discher, DE (corresponding author), Univ Penn, Mol & Cell Biophys & NanoBioPolymers Lab, Philadelphia, PA 19104 USA.	discher@seas.upenn.edu	Christian, David/AAE-6425-2019	discher, dennis/0000-0001-6163-2229	NIH [R01-EB007049, R01-HL062352, P01-DK032094, NCATS-8UL1TR000003, P30-DK090969]; NSF (Materials Research Science and Engineering Center, and Nano Science and Engineering Center-Nano Bio Interface Center); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK032094, P30DK090969] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF (Materials Research Science and Engineering Center, and Nano Science and Engineering Center-Nano Bio Interface Center); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The assistance of A. Secreto, J. Glover, and G. Danet-Desnoyers of the Stem Cell Xenograft Core at the University of Pennsylvania is very gratefully acknowledged as is technical assistance of K. Hsu, P. Bhoorasingh, and V. Carnevale. Support from the NIH (R01-EB007049, R01-HL062352, P01-DK032094, NCATS-8UL1TR000003, P30-DK090969) and NSF (Materials Research Science and Engineering Center, and Nano Science and Engineering Center-Nano Bio Interface Center) is also very gratefully acknowledged. P. L. R., D. A. P., and D. E. D. are authors on a patent applied for by the University of Pennsylvania on the Self peptide with first disclosure filed on 16 August 2010.	Armstrong JK, 2007, CANCER-AM CANCER SOC, V110, P103, DOI 10.1002/cncr.22739; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Bentley AA, 2010, MOL BIOL EVOL, V27, P2187, DOI 10.1093/molbev/msq107; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Cameron CM, 2005, VIROLOGY, V337, P55, DOI 10.1016/j.virol.2005.03.037; Cox D, 2001, SEMIN IMMUNOL, V13, P339, DOI 10.1006/smim.2001.0330; Glodek AM, 2010, BLOOD, V116, P6063, DOI 10.1182/blood-2010-04-273904; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hong RL, 1999, CLIN CANCER RES, V5, P3645; KLIBANOV AL, 1991, BIOCHIM BIOPHYS ACTA, V1062, P142, DOI 10.1016/0005-2736(91)90385-L; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; MACDONALD IC, 1991, MICROVASC RES, V42, P60, DOI 10.1016/0026-2862(91)90075-M; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mouro-Chanteloup I, 2003, BLOOD, V101, P338, DOI 10.1182/blood-2002-04-1285; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Photos PJ, 2003, J CONTROL RELEASE, V90, P323, DOI 10.1016/S0168-3659(03)00201-3; Rossin R, 2008, J NUCL MED, V49, P103, DOI 10.2967/jnumed.107.045302; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Stachelek SJ, 2011, BIOMATERIALS, V32, P4317, DOI 10.1016/j.biomaterials.2011.02.053; Strowig T, 2011, P NATL ACAD SCI USA, V108, P13218, DOI 10.1073/pnas.1109769108; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Subramanian S, 2007, J BIOL CHEM, V282, P1805, DOI 10.1074/jbc.M603923200; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Turk MJ, 2004, CANCER LETT, V213, P165, DOI 10.1016/j.canlet.2003.12.028; TURRINI F, 1993, BLOOD, V81, P3146; Wilflingseder D, 2007, J IMMUNOL, V178, P7840, DOI 10.4049/jimmunol.178.12.7840; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109	31	661	727	18	601	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					971	975		10.1126/science.1229568	http://dx.doi.org/10.1126/science.1229568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430657	Green Accepted			2022-12-24	WOS:000315149600053
J	Lee, SJ; McCormick, MS; Lippard, SJ; Cho, US				Lee, Seung Jae; McCormick, Michael S.; Lippard, Stephen J.; Cho, Uhn-Soo			Control of substrate access to the active site in methane monooxygenase	NATURE			English	Article							METHYLOCOCCUS-CAPSULATUS BATH; METHYLOSINUS-TRICHOSPORIUM OB3B; REGULATORY PROTEIN-B; HYDROXYLASE COMPONENT; DIOXYGEN ACTIVATION; CRYSTAL-STRUCTURE; OXYGEN ACTIVATION; OXIDATION	Methanotrophs consume methane as their major carbon source and have an essential role in the global carbon cycle by limiting escape of this greenhouse gas to the atmosphere(1-3). These bacteria oxidize methane to methanol by soluble and particulate methane monooxygenases (MMOs)(1-4). Soluble MMO contains three protein components, a 251-kilodalton hydroxylase (MMOH), a 38.6-kilodalton reductase (MMOR), and a 15.9-kilodalton regulatory protein (MMOB), required to couple electron consumption with substrate hydroxylation at the catalytic diiron centre of MMOH2. Until now, the role of MMOB has remained ambiguous owing to a lack of atomic-level information about the MMOH-MMOB (hereafter termed H-B) complex. Here we remedy this deficiency by providing a crystal structure of H-B, which reveals the manner by which MMOB controls the conformation of residues in MMOH crucial for substrate access to the active site. MMOB docks at the alpha(2)beta(2) interface of alpha(2)beta(2)gamma(2) MMOH, and triggers simultaneous conformational changes in the alpha-subunit that modulate oxygen and methane access as well as proton delivery to the diiron centre. Without such careful control by MMOB of these substrate routes to the diiron active site, the enzyme operates as an NADH oxidase rather than a monooxygenases(5). Biological catalysis involving small substrates is often accomplished in nature by large proteins and protein complexes. The structure presented in this work provides an elegant example of this principle.	[Lee, Seung Jae; McCormick, Michael S.; Lippard, Stephen J.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Cho, Uhn-Soo] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Lippard, SJ (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	lippard@mit.edu; uhnsoo@med.umich.edu		cho, uhn-soo/0000-0002-6992-2455	National Institute of General Medical Sciences [GM 32114]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032114, R01GM032134] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM 32114 from the National Institute of General Medical Sciences to S. J. Lippard. We thank the staff at the Advanced Light Source beamline 8.2.2. in Lawrence Berkeley National Laboratory for the data collection, S. C. Harrison for resources and comments on the manuscript, and T. C. Johnstone, A. D. Liang and T.-T. Lu for discussions.	Bailey LJ, 2008, P NATL ACAD SCI USA, V105, P19194, DOI 10.1073/pnas.0807948105; Blazyk JL, 2005, J AM CHEM SOC, V127, P17364, DOI 10.1021/ja0554054; Brandstetter H, 1999, CHEM BIOL, V6, P441, DOI 10.1016/S1074-5521(99)80062-3; Chang SL, 2001, BIOCHEMISTRY-US, V40, P9539, DOI 10.1021/bi0103462; Coufal DE, 2000, EUR J BIOCHEM, V267, P2174, DOI 10.1046/j.1432-1327.2000.01210.x; Elango N, 1997, PROTEIN SCI, V6, P556; FROLAND WA, 1992, J BIOL CHEM, V267, P17588; Gassner GT, 1999, BIOCHEMISTRY-US, V38, P12768, DOI 10.1021/bi990841m; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Leahy JG, 2003, FEMS MICROBIOL REV, V27, P449, DOI 10.1016/S0168-6445(03)00023-8; Lee SY, 1999, BIOCHEMISTRY-US, V38, P4423, DOI 10.1021/bi982712w; LIU KE, 1995, J AM CHEM SOC, V117, P10174, DOI 10.1021/ja00146a002; LIU Y, 1995, J BIOL CHEM, V270, P24662, DOI 10.1074/jbc.270.42.24662; McCormick MS, 2011, BIOCHEMISTRY-US, V50, P11058, DOI 10.1021/bi201248b; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; PAULSEN KE, 1994, BIOCHEMISTRY-US, V33, P713, DOI 10.1021/bi00169a013; RARDIN RL, 1991, NEW J CHEM, V15, P417; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; Rosenzweig AC, 1997, PROTEINS, V29, P141, DOI 10.1002/(SICI)1097-0134(199710)29:2<141::AID-PROT2>3.3.CO;2-W; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P15392, DOI 10.1021/bi0618969; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Song WJ, 2010, J AM CHEM SOC, V132, P13582, DOI 10.1021/ja1063795; Tinberg CE, 2009, BIOCHEMISTRY-US, V48, P12145, DOI 10.1021/bi901672n; Valentine AM, 1999, J AM CHEM SOC, V121, P3876, DOI 10.1021/ja9839522; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; Walters KJ, 1999, P NATL ACAD SCI USA, V96, P7877, DOI 10.1073/pnas.96.14.7877; Whittington DA, 2001, J AM CHEM SOC, V123, P827, DOI 10.1021/ja003240n; Whittington DA, 2001, BIOCHEMISTRY-US, V40, P3476, DOI 10.1021/bi0022487; Whittington DA, 2001, J AM CHEM SOC, V123, P1794, DOI 10.1021/ja0031725	30	93	104	3	263	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					380	384		10.1038/nature11880	http://dx.doi.org/10.1038/nature11880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23395959	Green Accepted, Green Submitted			2022-12-24	WOS:000315312900044
J	Joynt, KE; Jha, AK				Joynt, Karen E.; Jha, Ashish K.			A Path Forward on Medicare Readmissions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HOSPITAL READMISSION; RATES		[Joynt, Karen E.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Joynt, Karen E.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Joynt, KE (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							Arbaje AI, 2008, GERONTOLOGIST, V48, P495, DOI 10.1093/geront/48.4.495; Glass D, 2012, REFINING HOSP READMI; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333	5	240	241	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1175	1177		10.1056/NEJMp1300122	http://dx.doi.org/10.1056/NEJMp1300122			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116FU	23465069				2022-12-24	WOS:000316869000004
J	Arnoult, L; Su, KFY; Manoel, D; Minervino, C; Magrina, J; Gompel, N; Prud'homme, B				Arnoult, Laurent; Su, Kathy F. Y.; Manoel, Diogo; Minervino, Caroline; Magrina, Justine; Gompel, Nicolas; Prud'homme, Benjamin			Emergence and Diversification of Fly Pigmentation Through Evolution of a Gene Regulatory Module	SCIENCE			English	Article							DROSOPHILA; PATTERNS	The typical pattern of morphological evolution associated with the radiation of a group of related species is the emergence of a novel trait and its subsequent diversification. Yet the genetic mechanisms associated with these two evolutionary steps are poorly characterized. Here, we show that a spot of dark pigment on fly wings emerged from the assembly of a novel gene regulatory module in which a set of pigmentation genes evolved to respond to a common transcriptional regulator determining their spatial distribution. The primitive wing spot pattern subsequently diversified through changes in the expression pattern of this regulator. These results suggest that the genetic changes underlying the emergence and diversification of wing pigmentation patterns are partitioned within genetic networks.	[Arnoult, Laurent; Su, Kathy F. Y.; Manoel, Diogo; Minervino, Caroline; Magrina, Justine; Gompel, Nicolas; Prud'homme, Benjamin] Aix Marseille Univ, CNRS, UMR 7288, Inst Biol Dev Marseille Luminy, F-13288 Marseille 9, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Gompel, N (corresponding author), Aix Marseille Univ, CNRS, UMR 7288, Inst Biol Dev Marseille Luminy, F-13288 Marseille 9, France.	nicolas.gompel@univ-amu.fr; benjamin.prudhomme@univ-amu.fr		Gompel, Nicolas/0000-0003-3358-7963; Manoel, Diogo/0000-0002-0353-1742	French government (Ministere de la Recherche de l'Enseignement Superieur); Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia); GABBA graduate program; Fondation ARC pour la Recherche sur le Cancer; EURYI award; Human Frontier Science Program Career Development Award; Agence Nationale de la Recherche; France-Berkeley Fund; Fondation Schlumberger pour l'Enseignement et la Recherche; CNRS	French government (Ministere de la Recherche de l'Enseignement Superieur); Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); GABBA graduate program; Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); EURYI award(European Science Foundation (ESF)); Human Frontier Science Program Career Development Award; Agence Nationale de la Recherche(French National Research Agency (ANR)); France-Berkeley Fund; Fondation Schlumberger pour l'Enseignement et la Recherche(Schlumberger); CNRS(Centre National de la Recherche Scientifique (CNRS))	We thank A. Kopp, S. B. Carroll, J. David, R. Mann, A. Mazo, M. Yamaguchi, and the Vienna Drosophila RNAi Center (VDRC, Vienna), Bloomington (Indiana), National Center of Genetics (Kyoto), and San Diego Drosophila Stock Centers for flies and antibodies; A. Polette and L. Mille for developing a custom quantification program for wing pigmentation; J.-L. Mari for advice on programming; G. Storelli for help with cloning; A. Defaye for qPCR guidance; J.-Y. Sgro for microarray analysis; A. Kopp, F. Leulier, and J. Cande for helpful comments on the manuscript; Flybase for information support; and Le Calendal for logistical support. L.A. and K.F.Y.S. were supported by fellowships from the French government (Ministere de la Recherche de l'Enseignement Superieur), D.M. by the Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia) and the GABBA graduate program, and K.F.Y.S. by the Fondation ARC pour la Recherche sur le Cancer. This work was funded by a EURYI award, a Human Frontier Science Program Career Development Award, the Agence Nationale de la Recherche, the France-Berkeley Fund, the Fondation Schlumberger pour l'Enseignement et la Recherche, and the CNRS. RNAi lines from the VDRC are covered by a Materiels Transfer Agreement. The microarray data set is accessible in the National Center for Biotechnology Information Gene Expression Omnibus database (accession no. GSE43673). Author contributions: B.P. and N.G. conceived the project; all authors designed the experiments; K.F.Y.S. and D.M. performed the RNAi screen; K.F.Y.S., D.M., and L.A. did the antibody stainings; K.F.Y.S., L.A., D.M., C.M., and B.P. cloned the molecular constructs; and D.M. and B.P. ran the biochemistry experiments. L.A. designed and carried out the shRNA experiments in D. biarmipes, did the qPCR analysis, optimized transgenesis, and developed the wing-peeling technique. L.A. and N.G. quantified the effects on pigmentation; K.F.Y.S., L.A., D.M., J.M., N.G., and B.P. made transgenic flies; L.A., N.G., and K.F.Y.S. took the images; all authors analyzed the data; and B.P. and N.G. wrote the paper, with feedback from L.A. and the other authors.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Campbell G, 1998, DEVELOPMENT, V125, P4483; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Haley B, 2008, DEV BIOL, V321, P482, DOI 10.1016/j.ydbio.2008.06.015; Marcellini S, 2006, PLOS BIOL, V4, P2252, DOI 10.1371/journal.pbio.0040386; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; True JR, 1999, CURR BIOL, V9, P1382, DOI 10.1016/S0960-9822(00)80083-4	11	98	101	5	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 22	2013	339	6126					1423	1426		10.1126/science.1233749	http://dx.doi.org/10.1126/science.1233749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520110				2022-12-24	WOS:000316740700040
J	Lewis, P; Al-Muthanna, AN; Patel, P				Lewis, Philip; Al-Muthanna, Ali Nasser; Patel, Preeti		Baroness Nicholson	Effect of armed conflict on health of Marsh Arabs in southern Iraq	LANCET			English	Editorial Material									[Lewis, Philip; Patel, Preeti] Kings Coll London, Dept War Studies, London WC2R 2LS, England; [Al-Muthanna, Ali Nasser] AMAR Int Charitable Fdn, London, England; [Baroness Nicholson] House Lords, London SW1A 0PW, England	University of London; King's College London	Lewis, P (corresponding author), House Lords, London SW1A 0PW, England.			Patel, Preeti/0000-0003-3875-453X				[Anonymous], 2010, MAN CHANG PRES FUT S, P1; Coast E, 2002, IRAQI MARSHLANDS HUM, P19; Ibrahim MH, 2011, MARSH B, V6, P167; Inter-Agency Information and Analysis Unit, 2011, BASR GOV PROF; Inter-Agency Information and Analysis Unit, 2012, WOM IR FACTSH; Inter-Agency Information and Analysis Unit, 2011, MISS GOV PROF; Inter-Agency Information and Analysis Unit, 2011, THI QAR GOV PROF; Inter-Agency Information and Analysis Unit, 2012, LANDM UN ORDN FACTSH; Inter-Agency Information and Analysis Unit, 2009, MARSHL PRES; IOM, 2012, IR SPEC REP WAT SCAR; Iraq Knowledge Network, 2011, FOOD SEC EXP FACTSH; Iraq Knowledge Network, 2011, ESS SERV FACTSH; Newman SD, 2007, ADV NURS SCI, V30, P315, DOI 10.1097/01.ANS.0000300181.71724.c7; Sluglett P, 2002, IRAQI MARSHLANDS HUM, P223; UN Country Team Iraq, 2010, UN DEV ASS FRAM IR 2; *UNEP, 2007, UNEP IR POST CONFL A; United Nations Committee on Economic Social and Cultural Rights, 2000, RIGHT HIGH ATT STAND; United Nations Integrated Water Task Force for Iraq PaPer, 2011, MAN CHANG MARSHL IR; World Health Organization, 2008, SOCIAL DETERMINANTS	19	0	0	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					959	961		10.1016/S0140-6736(13)60282-2	http://dx.doi.org/10.1016/S0140-6736(13)60282-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23499044				2022-12-24	WOS:000316069700031
J	MacManus, D; Dean, K; Jones, M; Rona, RJ; Greenberg, N; Hull, L; Fahy, T; Wessely, S; Fear, NT				MacManus, Deirdre; Dean, Kimberlie; Jones, Margaret; Rona, Roberto J.; Greenberg, Neil; Hull, Lisa; Fahy, Tom; Wessely, Simon; Fear, Nicola T.			Violent offending by UK military personnel deployed to Iraq and Afghanistan: a data linkage cohort study	LANCET			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; COMBAT; WAR; VETERANS; ALCOHOL; TRAUMA; PTSD; AGGRESSION; HOSTILITY	Background Violent off ending by veterans of the Iraq and Afghanistan conflicts is a cause for concern and there is much public debate about the proportion of ex-military personnel in the criminal justice system for violent offences. Although the psychological effects of conflict are well documented, the potential legacy of violent off ending has yet to be ascertained. We describe our use of criminal records to investigate the effect of deployment, combat, and post-deployment mental health problems on violent off ending among military personnel relative to pre-existing risk factors. Methods In this cohort study, we linked data from 13 856 randomly selected, serving and ex-serving UK military personnel with national criminal records stored on the Ministry of Justice Police National Computer database. We describe off ending during the lifetime of the participants and assess the risk factors for violent off ending. Findings 2139 (weighted 17.0%) of 12 359 male UK military personnel had a criminal record for any offence during their lifetime. Violent off enders (1369 [11.0%]) were the most prevalent off ender types; prevalence was highest in men aged 30 years or younger (521 [20.6%] of 2728) and fell with age (164 [4.7%] of 3027 at age >45 years). Deployment was not independently associated with increased risk of violent off ending, but serving in a combat role conferred an additional risk, even after adjustment for confounders (violent off ending in 137 [6.3%] of 2178 men deployed in a combat role vs 140 (2.4%) of 5797 deployed in a non-combat role; adjusted hazard ratio 1.53, 95% CI 1.15-2.03; p=0.003). Increased exposure to traumatic events during deployment also increased risk of violent off ending (violent off ending in 104 [4.1%] of 2753 men with exposure to two to four traumatic events vs 56 [1.6%] of 2944 with zero to one traumatic event, 1.77, 1.21-2.58, p=0.003; and violent off ending in 122 [5.1%] of 2582 men with exposure to five to 16 traumatic events, 1.65, 1.12-2.40, p=0.01; test for trend, p=0.032). Violent off ending was strongly associated with post-deployment alcohol misuse (violent off ending in 120 [9.0%] of 1363 men with alcohol misuse vs 155 [2.3%] of 6768 with no alcohol misuse; 2.16, 1.62-2.90; p<0.0001), post-traumatic stress disorder (violent off ending in 25 [8.6%] of 344 men with post-traumatic stress disorder vs 221 [3.0%] of 7256 with no symptoms of post-traumatic stress disorder; 2.20, 1.36-3.55; p=0.001), and high levels of self-reported aggressive behaviour (violent off ending in 56 [6.7%] of 856 men with an aggression score of six to 16 vs 22 [1.2%] of 1685 with an aggression score of zero; 2.47, 1.37-4.46; p=0.003). Of the post-traumatic stress disorder symptoms, the hyperarousal cluster was most strongly associated with violent off ending (2.01, 1.50-2.70; p<0.0001). Interpretation Alcohol misuse and aggressive behaviour might be appropriate targets for interventions, but any action must be evidence based. Post-traumatic stress disorder, though less prevalent, is also a risk factor for violence, especially hyperarousal symptoms, so if diagnosed it should be appropriately treated and associated risk monitored.	[MacManus, Deirdre; Jones, Margaret; Rona, Roberto J.; Greenberg, Neil; Hull, Lisa; Wessely, Simon; Fear, Nicola T.] Kings Coll London, Weston Educ Ctr, Kings Ctr Mil Hlth Res, London SE5 8AF, England; [MacManus, Deirdre; Dean, Kimberlie; Fahy, Tom] Kings Coll London, Inst Psychiat, Dept Forens & Neurodev Sci, London SE5 8AF, England; [Dean, Kimberlie] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Greenberg, Neil] Weston Educ Ctr, Acad Ctr Def Mental Hlth, London, England	University of London; King's College London; University of London; King's College London; University of New South Wales Sydney; University of London; King's College London	MacManus, D (corresponding author), Kings Coll London, Inst Psychiat, Dept Forens & Neurodev Sci, PO 23,De Crespigny Pk, London SE5 8AF, England.	deirdre.macmanus@kcl.ac.uk	Wessely, Simon C/A-8713-2008; Fear, Nicola/A-1917-2012	Fear, Nicola/0000-0002-5792-2925; Wessely, Simon Charles/0000-0002-6743-9929; Rona, Roberto/0000-0003-3739-5571; Fahy, Thomas/0000-0003-3019-3547; Jones, Margaret Mary/0000-0002-7450-8195; MacManus, Deirdre/0000-0003-4903-9638; greenberg, neil/0000-0003-4550-2971	Medical Research Council; UK Ministry of Defence; Department of Health through the National Institute for Health Research Comprehensive Biomedical Research Centre; UK Medical Research Council; MRC [G0901999] Funding Source: UKRI; Medical Research Council [G0901999] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Ministry of Defence; Department of Health through the National Institute for Health Research Comprehensive Biomedical Research Centre; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding Medical Research Council and the UK Ministry of Defence.; NG is a full-time member of the UK Armed Forces, and is currently seconded to King's College London. NTF and SW are employed by the Academic Centre for Defence Mental Health, based at King's College London, which receives funding from the UK Ministry of Defence. SW is also an honorary civilian consultant adviser in psychiatry to the British Army and a trustee of Combat Stress, a UK charity that provides service and support for veterans with mental health problems. The authors acknowledge financial support from the Department of Health through the National Institute for Health Research Comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. DM is funded by a Medical Research Council Clinical Research Training Fellowship and undertook this project as part of her PhD studies with the King's Centre for Military Health Research. KD and TF are employed by the Institute of Psychiatry and are forensic psychiatrists who provide supervision and advice about the project; they declare that they have no conflicts of interest.; The UK Medical Research Council and UK Ministry of Defence funded this study.	Alvarey L, 2009, NEW YORK TIMES  0101; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Association of Chief Police Officers, 2012, ACPO CRIM REC OFF AN; Australian Centre for Posttraumatic Mental Health, 2012, SUMM LIT DSM 5 CHANG; Babor TF., 2001, ALCOHOL USE DISORDER; Black DW, 2005, MIL MED, V170, P612, DOI 10.7205/MILMED.170.7.612; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese P., 2004, VALIDATION 90 120 DA; Booth-Kewley S, 2010, AGGRESSIVE BEHAV, V36, P330, DOI 10.1002/ab.20355; Booth-Kewley S, 2010, J NERV MENT DIS, V198, P91, DOI 10.1097/NMD.0b013e3181cc45e9; Brooke C, 2012, MAIL ONLINE LON 0403; Bureau of Justice Statistics, 2004, VET STAT FED PRIS 20; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Elbogen EB, 2010, AM J PSYCHIAT, V167, P1051, DOI 10.1176/appi.ajp.2010.09050739; Fear NT, 2007, ADDICTION, V102, P1749, DOI 10.1111/j.1360-0443.2007.01978.x; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Fontana A, 2005, J NERV MENT DIS, V193, P203, DOI 10.1097/01.nmd.0000154835.92962.e5; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Graham K, 2011, DRUG ALCOHOL REV, V30, P453, DOI 10.1111/j.1465-3362.2011.00340.x; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; House of Commons Defence Select Committee, DUT CAR 3 SESS 2004, V2; Howard League for Penal Reform, 2011, INQ FORM ARM SERV PE; Institute of Medicine, 2010, RET HOM IR AFGH PREL; Iversen A, 2005, EUR J PUBLIC HEALTH, V15, P175, DOI 10.1093/eurpub/cki128; Iversen AC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-68; JOHNSTONE JWC, 1978, SOCIOL SOC RES, V63, P49; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; MacManus D, 2012, PSYCHOL MED, V42, P1663, DOI 10.1017/S0033291711002327; MacManus D, 2012, SOC PSYCH PSYCH EPID, V47, P1353, DOI 10.1007/s00127-011-0443-z; MacManus D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3898; Maden T., 2007, TREATING VIOLENCE GU; Malvern J., 2012, TIMES LONDON    0313; Miller MW, 2004, J ABNORM PSYCHOL, V113, P636, DOI 10.1037/0021-843X.113.4.636; Ministry of Defence, 2000, MIDT REV NDP8, P5; Orth U, 2006, J CONSULT CLIN PSYCH, V74, P698, DOI 10.1037/0022-006X.74.4.698; Prime J., 2001, CRIMINAL CAREERS THO; Savarese VW, 2001, J TRAUMA STRESS, V14, P717, DOI 10.1023/A:1013038021175; Taft CT, 2007, J TRAUMA STRESS, V20, P135, DOI 10.1002/jts.20197; Taft CT, 2007, J ABNORM PSYCHOL, V116, P498, DOI 10.1037/0021-843X.116.3.498; Therneau TM, 2000, MODELING SURVIVAL DA; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tsai J, 2013, PSYCHIAT SERV, V64, P36, DOI [10.1176/appi.ps.001882012, 10.1176/appi.ps.201200188]; Turpin J, 1999, ENCY VIOLENCE PEACE, P144; UK Defence Statistics UK Ministry of Defence, DEF AN STAT ADV	45	134	134	1	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					907	917		10.1016/S0140-6736(13)60354-2	http://dx.doi.org/10.1016/S0140-6736(13)60354-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23499041				2022-12-24	WOS:000316069700026
J	Flesken-Nikitin, A; Hwang, CI; Cheng, CY; Michurina, TV; Enikolopov, G; Nikitin, AY				Flesken-Nikitin, Andrea; Hwang, Chang-Il; Cheng, Chieh-Yang; Michurina, Tatyana V.; Enikolopov, Grigori; Nikitin, Alexander Yu			Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche	NATURE			English	Article							ALDEHYDE DEHYDROGENASE-ACTIVITY; SELF-RENEWAL; ORIGIN; MARKER; CARCINOGENESIS; IDENTIFICATION; CARCINOMAS; P53	Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer deaths among women in the United States, but its pathogenesis is poorly understood(1-3). Some epithelial cancers are known to occur in transitional zones between two types of epithelium, whereas others have been shown to originate in epithelial tissue stem cells'. The stem cell niche of the ovarian surface epithelium (OSE), which is ruptured and regenerates during ovulation, has not yet been defined unequivocally. Here we identify the hilum region of the mouse ovary, the transitional (or junction) area between the OSE, mesothelium and tubal (oviductal) epithelium, as a previously unrecognized stem cell niche of the OSE. We find that cells of the hilum OSE are cycling slowly and express stem and/or progenitor cell markers ALDH1, LGR5, LEF1, CD 133 and CK6B. These cells display long-term stem cell properties ex vivo and in vivo, as shown by our serial sphere generation and long-term lineage-tracing assays. Importantly, the hilum cells show increased transformation potential after inactivation of tumour suppressor genes Trp53 and Rb1, whose pathways are altered frequently in the most aggressive and common type of human EOC, high-grade serous adenocarcinomea(7,8). Our study supports experimentally the idea that susceptibility of transitional zones to malignant transformation may be explained by the presence of stem cell niches in those areas. Identification of a stem cell niche for the OSE may have important implications for understanding EOC pathogenesis.	[Flesken-Nikitin, Andrea; Hwang, Chang-Il; Cheng, Chieh-Yang; Nikitin, Alexander Yu] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Flesken-Nikitin, Andrea; Hwang, Chang-Il; Cheng, Chieh-Yang; Nikitin, Alexander Yu] Cornell Univ, Cornell Stem Cell Program, Ithaca, NY 14853 USA; [Michurina, Tatyana V.; Enikolopov, Grigori] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Michurina, Tatyana V.; Enikolopov, Grigori] Moscow Inst Phys & Technol, NBIC, Moscow 123182, Russia	Cornell University; Cornell University; Cold Spring Harbor Laboratory; Moscow Institute of Physics & Technology	Nikitin, AY (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA.	an58@cornell.edu	Enikolopov, Grigori/P-5731-2019	Enikolopov, Grigori/0000-0001-8178-8917; Hwang, Chang-il/0000-0002-5710-7672	NYSTEM; US National Institutes of Health (NIH); National Cancer Institute (NCI) [CA096823, CA112354]; NYSTEM [CO23050, N1 1G-160]; Marsha Rivkin Center for Ovarian Cancer Research; NIH National Institute of Mental Health [MH092928]; NIH National Institute on Aging [AG040209]; Russian Ministry of Education and Science;  [NIH NICHD T32HD052471]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA096823, R01CA112354, R56CA096823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040209] Funding Source: NIH RePORTER	NYSTEM; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NYSTEM; Marsha Rivkin Center for Ovarian Cancer Research; NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank T. lumbar for critical reading of this manuscript, J. Choi for help with immunostainings, L Sayam (NYSTEM supported" FACS Core) for help with FAGS experiments and F. M. Vermeyfen (Cornell Statistical Consulting Unit) for help with statistical analysis. This work was supported by grants from the US National Institutes of Health (NIH) and National Cancer Institute (NCI) (CA096823 and CA112354), NYSTEM (CO23050 and N1 1G-160) and the Marsha Rivkin Center for Ovarian Cancer Research to A.Yu.N.; the NIH National Institute of Mental Health (MH092928), NIH National Institute on Aging (AG040209), NYSTEM (CO24323) and Russian Ministry of Education and Science to G.E.; and,postdoctoral fellowships to A.F.-N. (NIH NICHD T32HD052471) and C-.I.H. (Cornell Comparative Cancer Biology Training Program).	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Auersperg N, 2008, GYNECOL ONCOL, V110, P452, DOI 10.1016/j.ygyno.2008.05.031; Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Bullough W. S., 1942, JOUR ENDOCRINOL, V3, P141, DOI 10.1677/joe.0.0030141; Burger PE, 2009, STEM CELLS, V27, P2220, DOI 10.1002/stem.135; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Seidman JD, 2011, INT J GYNECOL PATHOL, V30, P4, DOI 10.1097/PGP.0b013e3181f29d2a; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Szabova L, 2012, CANCER RES, V72, P4141, DOI 10.1158/0008-5472.CAN-11-3834; Szotek PP, 2008, P NATL ACAD SCI USA, V105, P12469, DOI 10.1073/pnas.0805012105; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781	30	240	248	4	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					241	245		10.1038/nature11979	http://dx.doi.org/10.1038/nature11979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23467088	Green Accepted			2022-12-24	WOS:000316652300052
J	Parrenin, F; Masson-Delmotte, V; Kohler, P; Raynaud, D; Paillard, D; Schwander, J; Barbante, C; Landais, A; Wegner, A; Jouzel, J				Parrenin, F.; Masson-Delmotte, V.; Koehler, P.; Raynaud, D.; Paillard, D.; Schwander, J.; Barbante, C.; Landais, A.; Wegner, A.; Jouzel, J.			Synchronous Change of Atmospheric CO2 and Antarctic Temperature During the Last Deglacial Warming	SCIENCE			English	Article							ABRUPT CLIMATE-CHANGE; EPICA DOME-C; POLAR ICE; FIRN; AIR; CONSTRAINTS; DELTA-N-15; DIFFERENCE; GREENLAND; CORES	Understanding the role of atmospheric CO2 during past climate changes requires clear knowledge of how it varies in time relative to temperature. Antarctic ice cores preserve highly resolved records of atmospheric CO2 and Antarctic temperature for the past 800,000 years. Here we propose a revised relative age scale for the concentration of atmospheric CO2 and Antarctic temperature for the last deglacial warming, using data from five Antarctic ice cores. We infer the phasing between CO2 concentration and Antarctic temperature at four times when their trends change abruptly. We find no significant asynchrony between them, indicating that Antarctic temperature did not begin to rise hundreds of years before the concentration of atmospheric CO2, as has been suggested by earlier studies.	[Parrenin, F.; Raynaud, D.] Lab Glaciol & Geophys Environm CNRS UJF, Grenoble, France; [Masson-Delmotte, V.; Paillard, D.; Landais, A.; Jouzel, J.] Lab Sci Climat & Environm CEA CNRS UVSQ IPSL, Gif Sur Yvette, France; [Koehler, P.; Wegner, A.] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Schwander, J.] Univ Bern, Inst Phys, Bern, Switzerland; [Barbante, C.] Univ Venice, Dept Environm Sci, I-30123 Venice, Italy; [Barbante, C.] Univ Venice, Inst Dynam Environm Proc CNR, I-30123 Venice, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bern; Universita Ca Foscari Venezia; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Dinamica dei Processi Ambientali (IDPA-CNR); Universita Ca Foscari Venezia	Parrenin, F (corresponding author), Lab Glaciol & Geophys Environm CNRS UJF, Grenoble, France.	parrenin@ujf-grenoble.fr	Masson-Delmotte, Valerie L/G-1995-2011; raynaud, dominique/ABG-4718-2020; Raynaud, Dominique/H-9626-2016; Köhler, Peter/F-7293-2010; Paillard, Didier/G-4776-2012; Parrenin, Frédéric/H-3054-2014; Barbante, Carlo/B-3195-2011	Masson-Delmotte, Valerie L/0000-0001-8296-381X; Köhler, Peter/0000-0003-0904-8484; Paillard, Didier/0000-0002-9995-2794; Parrenin, Frédéric/0000-0002-9489-3991; Barbante, Carlo/0000-0003-4177-2288; LANDAIS, Amaelle/0000-0002-5620-5465	French Agence Nationale de la Recherche [ANR-07-BLAN-0125, ANR-09-SYSC-001]; European Union	French Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union(European Commission)	We thank O. Watanabe, B. Stenni, and EPICA community members for giving access to, respectively, the DF1, TALDICE, and EDML isotopic data; L. Loulergue, D. Buiron, and T. Blunier for giving access to, respectively, the EDC-EDML, TALDICE, and GRIP CH<INF>4</INF> data; G. Dreyfus for giving access to the delta<SUP>15</SUP>N isotopic data; and G. Delaygue, J. Chappellaz, S. Barker, and A. Ganopolski for helpful discussions. This work greatly benefited from constructive comments by two anonymous reviewers. This work had support from the French Agence Nationale de la Recherche (project ANR-07-BLAN-0125 "Dome A" and ANR-09-SYSC-001 "ADAGE"). This work is a contribution to EPICA, a joint European Science Foundation/European Commission scientific program, funded by the European Union and by national contributions from Belgium, Denmark, France, Germany, Italy, the Netherlands, Norway, Sweden, Switzerland, and the United Kingdom. Main logistical support was provided by the Institut Paul Emile Victor and the Programma Nazionale Ricerche in Antartide at Dome C. We thank the technical teams in the field and at the different laboratories. This is EPICA publication no. 291.	Barker S, 2011, SCIENCE, V334, P347, DOI 10.1126/science.1203580; Bazin L., 2012, CLIM PAST DISCUSS, V8, P5963, DOI DOI 10.5194/CPD-8-5963-2012; Caillon N, 2003, SCIENCE, V299, P1728, DOI 10.1126/science.1078758; CRAIG H, 1988, SCIENCE, V242, P1675, DOI 10.1126/science.242.4886.1675; Dreyfus GB, 2010, QUATERNARY SCI REV, V29, P28, DOI 10.1016/j.quascirev.2009.10.012; Fischer H, 1999, SCIENCE, V283, P1712, DOI 10.1126/science.283.5408.1712; Fischer H, 2010, QUATERNARY SCI REV, V29, P193, DOI 10.1016/j.quascirev.2009.06.007; Goujon C, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003319; Horhold MW, 2012, EARTH PLANET SC LETT, V325, P93, DOI 10.1016/j.epsl.2011.12.022; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kohler P, 2011, CLIM PAST, V7, P473, DOI 10.5194/cp-7-473-2011; Kohler P, 2010, QUATERNARY SCI REV, V29, P129, DOI 10.1016/j.quascirev.2009.09.026; Landais A, 2006, QUATERNARY SCI REV, V25, P49, DOI 10.1016/j.quascirev.2005.06.007; Loulergue L, 2007, CLIM PAST, V3, P527, DOI 10.5194/cp-3-527-2007; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Lourantou A, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003545; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Myhre G, 1998, GEOPHYS RES LETT, V25, P2715, DOI 10.1029/98GL01908; Parrenin F, 2007, CLIM PAST, V3, P243, DOI 10.5194/cp-3-243-2007; Parrenin F, 2012, CLIM PAST, V8, P1239, DOI 10.5194/cp-8-1239-2012; Pedro JB, 2012, CLIM PAST, V8, P1213, DOI 10.5194/cp-8-1213-2012; Raisbeck GM, 2007, CLIM PAST, V3, P541, DOI 10.5194/cp-3-541-2007; Severinghaus JP, 2010, EARTH PLANET SC LETT, V293, P359, DOI 10.1016/j.epsl.2010.03.003; Severinghaus JP, 2003, GEOCHIM COSMOCHIM AC, V67, P325, DOI 10.1016/S0016-7037(02)00965-1; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; SOWERS T, 1992, J GEOPHYS RES-ATMOS, V97, P15683, DOI 10.1029/92JD01297; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Veres D., 2012, CLIM PAST DISCUSS, V8, P6011, DOI DOI 10.5194/CPD-8-6011-2012	29	200	210	16	311	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1060	1063		10.1126/science.1226368	http://dx.doi.org/10.1126/science.1226368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449589	Green Submitted			2022-12-24	WOS:000315452000037
J	Telford, MJ				Telford, Maximilian J.			The Animal Tree of Life	SCIENCE			English	Editorial Material							RIBOSOMAL-RNA SEQUENCES; EARLY EMERGENCE		UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England	University of London; University College London	Telford, MJ (corresponding author), UCL, Dept Genet Evolut & Environm, Mortimer St, London WC1E 6BT, England.	m.telford@ucl.ac.uk						Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Balavoine G, 1997, CR ACAD SCI III-VIE, V320, P83, DOI 10.1016/S0764-4469(99)80090-0; Darwin C., 1857, DARWIN CORRES PROJEC; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; FELSENSTEIN J, 1978, SYST ZOOL, V27, P27, DOI 10.2307/2412810; FIELD KG, 1988, SCIENCE, V239, P748, DOI 10.1126/science.3277277; Halanych KM, 1996, BIOL BULL-US, V190, P1, DOI 10.2307/1542669; Holland P. H., 2011, ANIMAL KINGDOM; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; OHAMA T, 1984, NUCLEIC ACIDS RES, V12, P5101, DOI 10.1093/nar/12.12.5101; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Telford MJ, 2011, TRENDS GENET, V27, P186, DOI 10.1016/j.tig.2011.02.003	15	4	4	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					764	766		10.1126/science.1234378	http://dx.doi.org/10.1126/science.1234378			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413342				2022-12-24	WOS:000314874400031
J	Bateson, D; McNamee, K; Briggs, P				Bateson, Deborah; McNamee, Kathleen; Briggs, Paula			Newer non-oral hormonal contraception	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							USERS		[Bateson, Deborah] Family Planning NSW, Sydney, NSW 2131, Australia; [Bateson, Deborah] Univ Sydney, Discipline Obstet Gynaecol & Neonatol, Sydney, NSW 2006, Australia; [McNamee, Kathleen] Family Planning Victoria, Box Hill, Vic 3128, Australia; [McNamee, Kathleen] Monash Med Ctr, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia	University of Sydney; Monash University	Bateson, D (corresponding author), Family Planning NSW, Sydney, NSW 2131, Australia.	deborahb@fpnsw.org.au	Bateson, Deborah/A-4563-2018	Bateson, Deborah/0000-0003-1035-7110				Affandi B, 1998, CONTRACEPTION, V58, p99S, DOI 10.1016/S0010-7824(98)00123-1; [Anonymous], 2011, CONTRACEPTIVE TECHNO; BRACKEN MB, 1990, OBSTET GYNECOL, V76, P552; Curtis Kathryn M., 2010, Morbidity and Mortality Weekly Report, V59, P1; *FAC SEX REPR HEAL, 2009, MAN UNSCH BLEED WOM; Faculty of Sexual and Reproductive Healthcare, 2007, INTR CONTR; Faculty of Sexual and Reproductive Healthcare, RISK VEN THROMB US N; Faculty of Sexual and Reproductive Healthcare, UK MED EL CRIT CONTR; Faculty of Sexual and Reproductive Healthcare clinical guidance, 2011, DRUG INT HORM CONTR; Faculty of Sexual and Reproductive Healthcare of the Royal College of Obstetricians and Gynaecologists, 2010, CONTR WOM AG 40 YEAR; Faculty of Sexual & Reproductive Healthcare, 2011, COMB HORM CONTR; Faculty of Sexual & Reproductive Healthcare, 2008, PROGR ONL INJ CONTR; Faculty of Sexual & Reproductive Healthcare Clinical Effectiveness Unit, 2008, PROG ONL IMPL; Hannaford PC, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c927; Lidegaard O, 2012, NEW ENGL J MED, V366, P2257, DOI 10.1056/NEJMoa1111840; Lidegaard O, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2990; Lopez LM, 2010, COCHRANE DB SYST REV, V3, DOI [DOI 10.10002/14651858.CD003552.PUB3, 10.10002/14651858.CD003552.pub3]; National Institute for Health and Clinical Excellence, 2005, LONG ACT REV CONTR E, V30; National Institute for Health and Clinical Excellence, 2007, HEAV MENSTR BLEED, V44; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; Varma R, 2006, EUR J OBSTET GYN R B, V125, P9, DOI 10.1016/j.ejogrb.2005.10.029	21	2	2	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2013	346								f341	10.1136/bmj.f341	http://dx.doi.org/10.1136/bmj.f341			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZR	23412438				2022-12-24	WOS:000315088800008
J	Sohn, JW; Harris, LE; Berglund, ED; Liu, TM; Vong, L; Lowell, BB; Balthasar, N; Williams, KW; Elmquist, JK				Sohn, Jong-Woo; Harris, Louise E.; Berglund, Eric D.; Liu, Tiemin; Linh Vong; Lowell, Bradford B.; Balthasar, Nina; Williams, Kevin W.; Elmquist, Joel K.			Melanocortin 4 Receptors Reciprocally Regulate Sympathetic and Parasympathetic Preganglionic Neurons	CELL			English	Article							FRAMESHIFT MUTATION; HIPPOCAMPAL SLICES; RAPID INHIBITION; OBESITY; ACTIVATION; NUCLEUS; MICE; EXCITABILITY; PROTEIN; LEPTIN	Melanocortin 4 receptors (MC4Rs) in the central nervous system are key regulators of energy and glucose homeostasis. Notably, obese patients with MC4R mutations are hyperinsulinemic and resistant to obesity-induced hypertension. Although these effects are probably dependent upon the activity of the autonomic nervous system, the cellular effects of MC4Rs on parasympathetic and sympathetic neurons remain undefined. Here, we show that MC4R agonists inhibit parasympathetic preganglionic neurons in the brainstem. In contrast, MC4R agonists activate sympathetic preganglionic neurons in the spinal cord. Deletion of MC4Rs in cholinergic neurons resulted in elevated levels of insulin. Furthermore, re-expression of MC4Rs specifically in cholinergic neurons (including sympathetic preganglionic neurons) restores obesity-associated hypertension in MC4R null mice. These findings provide a cellular correlate of the autonomic side effects associated with MC4R agonists and demonstrate a role for MC4Rs expressed in cholinergic neurons in the regulation of insulin levels and in the development of obesity-induced hypertension.	[Sohn, Jong-Woo; Berglund, Eric D.; Liu, Tiemin; Williams, Kevin W.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Sohn, Jong-Woo; Berglund, Eric D.; Liu, Tiemin; Williams, Kevin W.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Div Hypothalam Res, Dallas, TX 75390 USA; [Harris, Louise E.; Balthasar, Nina] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Linh Vong; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, Boston, MA 02115 USA; [Linh Vong; Lowell, Bradford B.] Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Bristol; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Balthasar, N (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England.	nina.balthasar@bristol.ac.uk; kevin.williams@utsouthwestern.edu	Williams, Kevin W/AAA-4243-2020; Williams, Kevin W/ABD-5818-2021; ç, æ /AAU-6965-2020; Sohn, Jong Woo/D-6700-2014	Williams, Kevin W/0000-0002-8434-8658; Williams, Kevin W/0000-0002-8434-8658; 	American Diabetes Association [07-11-MN-16]; American Heart Association [12POST8860007]; British Heart Foundation [FS/06/057]; Lister Institute for Preventive Medicine; National Institutes of Health [F32 DK092083, K01 DK087780, P01 DK088761, RL1 DK081185, R37 DK053301, F32 DK078478, R01 DK075632, P30 DK046200, P30 DK057521]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK092083, R37DK053301, P30DK057521, P30DK046200, R01DK075632, RL1DK081185, K01DK087780, F32DK078478, R01DK088423, P01DK088761] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); British Heart Foundation(British Heart Foundation); Lister Institute for Preventive Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Diabetes Association 07-11-MN-16 (J.K.E. and T.L.); American Heart Association 12POST8860007 (J.-W.S.); British Heart Foundation FS/06/057 (N.B.); Lister Institute for Preventive Medicine (N.B.); National Institutes of Health F32 DK092083 (E.D.B), K01 DK087780 (K.W.W.), P01 DK088761(J.K.E.), RL1 DK081185 (J.K.E.), R37 DK053301 (J.K.E.), F32 DK078478 (L.V.), and R01 DK075632 (B.B.L.), P30 DK046200 (B.B.L.), and P30 DK057521 (B.B.L.).	Acuna-Goycolea C, 2004, J NEUROSCI, V24, P8141, DOI 10.1523/JNEUROSCI.1607-04.2004; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Diogenes MJ, 2004, J NEUROSCI, V24, P2905, DOI 10.1523/JNEUROSCI.4454-03.2004; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kuo JJ, 2004, HYPERTENSION, V43, P370, DOI 10.1161/01.HYP.0000111836.54204.93; Lin YW, 2003, J NEUROSCI, V23, P4173; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Ni XP, 2006, J HYPERTENS, V24, P2239, DOI 10.1097/01.hjh.0000249702.49854.fa; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Quinn KV, 2004, CIRC RES, V94, P1359, DOI 10.1161/01.RES.0000128513.34817.c4; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Smith MA, 2007, J PHYSIOL-LONDON, V578, P425, DOI 10.1113/jphysiol.2006.119479; Tallam LS, 2005, HYPERTENSION, V46, P326, DOI 10.1161/01.HYP.0000175474.99326.bf; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Wan S, 2007, AM J PHYSIOL-GASTR L, V292, pG1474, DOI 10.1152/ajpgi.00562.2006; Wan S, 2008, J NEUROSCI, V28, P4957, DOI 10.1523/JNEUROSCI.5398-07.2008; Wang LH, 2008, J NEUROSCI, V28, P12445, DOI 10.1523/JNEUROSCI.2951-08.2008; Williams KW, 2007, ENDOCRINOLOGY, V148, P1868, DOI 10.1210/en.2006-1098; Williams KW, 2006, J PHYSIOL-LONDON, V573, P395, DOI 10.1113/jphysiol.2006.106336; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	29	149	150	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					612	619		10.1016/j.cell.2012.12.022	http://dx.doi.org/10.1016/j.cell.2012.12.022			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374353	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000314362800028
J	Pirnot, MT; Rankic, DA; Martin, DBC; MacMillan, DWC				Pirnot, Michael T.; Rankic, Danica A.; Martin, David B. C.; MacMillan, David W. C.			Photoredox Activation for the Direct beta-Arylation of Ketones and Aldehydes	SCIENCE			English	Article							COORDINATION-COMPOUNDS; FUNCTIONALIZATION; 1,4-ADDITION	The direct beta-activation of saturated aldehydes and ketones has long been an elusive transformation. We found that photoredox catalysis in combination with organocatalysis can lead to the transient generation of 5 pi-electron beta-enaminyl radicals from ketones and aldehydes that rapidly couple with cyano-substituted aryl rings at the carbonyl beta-position. This mode of activation is suitable for a broad range of carbonyl beta-functionalization reactions and is amenable to enantioselective catalysis.	[Pirnot, Michael T.; Rankic, Danica A.; Martin, David B. C.; MacMillan, David W. C.] Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu		Martin, David/0000-0002-8084-8225	National Institute of General Medical Sciences [R01 GM103558-01]; Merck; Amgen; Abbott; Bristol-Myers Squibb; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093213, R01GM103558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Merck(Merck & Company); Amgen(Amgen); Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institute of General Medical Sciences grant R01 GM103558-01 and gifts from Merck, Amgen, Abbott, and Bristol-Myers Squibb.	Ano Y, 2011, J AM CHEM SOC, V133, P12984, DOI 10.1021/ja206002m; Dixon IM, 2000, CHEM SOC REV, V29, P385, DOI 10.1039/b000704h; Evans D. A., 2006, ASYMMETRIC SYNTHESIS; Flamigni L, 2007, TOP CURR CHEM, V281, P143, DOI 10.1007/128_2007_131; Gus'kova T.A., 2010, GAUSSIAN 09 REVISION; Ischay MA, 2008, J AM CHEM SOC, V130, P12886, DOI 10.1021/ja805387f; Itooka R, 2003, J ORG CHEM, V68, P6000, DOI 10.1021/jo0207067; KAWANISI M, 1968, TETRAHEDRON, V24, P6557, DOI 10.1016/S0040-4020(01)96868-1; Leskinen MV, 2012, J AM CHEM SOC, V134, P5750, DOI 10.1021/ja300684r; Lopez F, 2004, J AM CHEM SOC, V126, P12784, DOI 10.1021/ja046632t; Mangion D, 2002, ACCOUNTS CHEM RES, V35, P297, DOI 10.1021/ar010108z; McNally A, 2011, SCIENCE, V334, P1114, DOI 10.1126/science.1213920; Mori Y, 2000, J PHYS CHEM A, V104, P4896, DOI 10.1021/jp0007437; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; Narayanam J.M.R., 2011, J AM CHEM SOC COLLEC, V76, P859; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Paras NA, 2002, J AM CHEM SOC, V124, P7894, DOI 10.1021/ja025981p; Renaud V. P., 1990, ANGEW CHEM, V102, P416; Renaudat A, 2010, ANGEW CHEM INT EDIT, V49, P7261, DOI 10.1002/anie.201003544; Wasa M, 2009, J AM CHEM SOC, V131, P9886, DOI 10.1021/ja903573p; Zhang SL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1214	21	389	388	9	374	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1593	1596		10.1126/science.1232993	http://dx.doi.org/10.1126/science.1232993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539600	Green Accepted			2022-12-24	WOS:000316731600045
J	Kettl, P				Kettl, Paul			The NRA Let Me Down	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Philadelphia VA Med Ctr, Philadelphia, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center	Kettl, P (corresponding author), Philadelphia VA Med Ctr, Philadelphia, PA USA.	paul.kettl@va.gov						Hoyert DL, 2012, NATL VITAL STAT REP, V61, P2013; KELLERMANN AL, 1986, NEW ENGL J MED, V314, P1557, DOI 10.1056/NEJM198606123142406	2	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2013	309	12					1239	1240		10.1001/jama.2013.1302	http://dx.doi.org/10.1001/jama.2013.1302			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112WO	23532239				2022-12-24	WOS:000316625200023
J	Sharwood, LN; Elkington, J; Meuleners, L; Ivers, R; Boufous, S; Stevenson, M				Sharwood, Lisa N.; Elkington, Jane; Meuleners, Lynn; Ivers, Rebecca; Boufous, Soufiane; Stevenson, Mark			Use of caffeinated substances and risk of crashes in long distance drivers of commercial vehicles: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SLEEPINESS	Objective To determine whether there is an association between use of substances that contain caffeine and the risk of crash in long distance commercial vehicle drivers. Design Case-control study. Setting New South Wales (NSW) and Western Australia (WA), Australia. Participants 530 long distance drivers of commercial vehicles who were recently involved in a crash attended by police (cases) and 517 control drivers who had not had a crash while driving a commercial vehicle in the past 12 months. Main outcome measure The likelihood of a crash associated with the use of substances containing caffeine after adjustment for factors including age, health disorders, sleep patterns, and symptoms of sleep disorders as well as exposures such as kilometres driven, hours slept, breaks taken, and night driving schedules. Results Forty three percent of drivers reported consuming substances containing caffeine, such as tea, coffee, caffeine tablets, or energy drinks for the express purpose of staying awake. Only 3% reported using illegal stimulants such as amphetamine ("speed"); 3,4 methylenedioxymethamphetamine (ecstasy); and cocaine. After adjustment for potential confounders, drivers who consumed caffeinated substances for this purpose had a 63% reduced likelihood of crashing (odds ratio 0.37, 95% confidence interval 0.27 to 0.50) compared with drivers who did not take caffeinated substances. Conclusions Caffeinated substances are associated with a reduced risk of crashing for long distance commercial motor vehicle drivers. While comprehensive mandated strategies for fatigue management remain a priority, the use of caffeinated substances could be a useful adjunct strategy in the maintenance of alertness while driving.	[Sharwood, Lisa N.; Elkington, Jane; Boufous, Soufiane] George Inst Global Hlth, Camperdown, NSW 2050, Australia; [Ivers, Rebecca] George Inst Global Hlth, Injury Div, Camperdown, NSW 2050, Australia; [Meuleners, Lynn] Curtin Monash Accid Res Ctr, Perth, WA 6845, Australia; [Boufous, Soufiane] Univ New S Wales, Sydney, NSW 2052, Australia; [Stevenson, Mark] Monash Univ, Accid Res Ctr, Monash Injury Res Inst, Clayton, Vic 3800, Australia	George Institute for Global Health; University of Sydney; George Institute for Global Health; University of Sydney; University of New South Wales Sydney; Monash University	Sharwood, LN (corresponding author), 98 Bunnerong Rd, Pagewood, NSW 2035, Australia.	lsharwood@george.org.au	stevenson, mark/AAE-9706-2019; Sharwood, Lisa N/I-5157-2019	stevenson, mark/0000-0003-3166-5876; Sharwood, Lisa N/0000-0001-8977-6144; Ivers, Rebecca/0000-0003-3448-662X; Boufous, Soufiane/0000-0002-5686-1729	Australian Research Council; Australian Government Department of Infrastructure, Transport, Regional Development and Local Government; DiagnoseIT; National Transport Commission; Queensland Transport; Roads and Traffic Authority of New South Wales and Main Roads in Western Australia; NHMRC	Australian Research Council(Australian Research Council); Australian Government Department of Infrastructure, Transport, Regional Development and Local Government(Australian Government); DiagnoseIT; National Transport Commission; Queensland Transport; Roads and Traffic Authority of New South Wales and Main Roads in Western Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded by the Australian Research Council, the Australian Government Department of Infrastructure, Transport, Regional Development and Local Government, DiagnoseIT, the National Transport Commission, Queensland Transport, the Roads and Traffic Authority of New South Wales and Main Roads in Western Australia. LNS is supported by Australian postgraduate awards industry grant (Australian Research Council). MS and RI are supported by NHMRC fellowships.	Addicott MA, 2009, PSYCHOPHARMACOLOGY, V203, P571, DOI 10.1007/s00213-008-1403-5; Australian demographic statistics, 2011, AUSTR DEM STAT; Brice C, 2001, HUM PSYCHOPHARM CLIN, V16, P523, DOI 10.1002/hup.327; Canberra National Information and Referral Service. National health survey, 2009, NAT HLTH SURV SUMM R, P1; Carrier J, 2009, SLEEP MED, V10, P1016, DOI 10.1016/j.sleep.2009.01.001; Connor J, 2001, ACCIDENT ANAL PREV, V33, P31, DOI 10.1016/S0001-4575(00)00013-0; De Valck E, 2001, J SLEEP RES, V10, P203, DOI 10.1046/j.1365-2869.2001.00260.x; Department of Health and Ageing, 2011, AUSTR ALC GUID; Fredholm BB, 1999, PHARMACOL REV, V51, P83; FREWER LJ, 1991, HUM PSYCHOPHARM CLIN, V6, P119, DOI 10.1002/hup.470060206; Hall J, 1995, INT COUNC ALC DRUGS; Heatherley SV, 2011, NUTR NEUROSCI, V14, P89, DOI 10.1179/147683011X13019262348785; Horne JA, 2001, AMINO ACIDS, V20, P83, DOI 10.1007/s007260170068; Horne JA, 1996, PSYCHOPHYSIOLOGY, V33, P306, DOI 10.1111/j.1469-8986.1996.tb00428.x; Howard ME, 2004, AM J RESP CRIT CARE, V170, P1014, DOI 10.1164/rccm.200312-1782oc; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jones I, 1987, EFFECT DRIVER HOURS; Ker K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008508; Mabbott NA, 1999, TRANSPORT RES F-TRAF, V2, P115, DOI DOI 10.1016/S1369-8478(99)00012-1; Magkos F, 2005, CRIT REV FOOD SCI, V45, P535, DOI 10.1080/1040-830491379245; MAISLIN G, 1995, SLEEP, V18, P158, DOI 10.1093/sleep/18.3.158; McCartt AT, 2000, ACCIDENT ANAL PREV, V32, P493, DOI 10.1016/S0001-4575(99)00067-6; Mets MAJ, 2012, PSYCHOPHARMACOLOGY, V222, P337, DOI 10.1007/s00213-012-2647-7; Mets MAJ, 2011, PSYCHOPHARMACOLOGY, V214, P737, DOI 10.1007/s00213-010-2078-2; Philip P, 2006, ANN INTERN MED, V144, P785, DOI 10.7326/0003-4819-144-11-200606060-00004; Schweitzer PK, 2006, SLEEP, V29, P39, DOI 10.1093/sleep/29.1.39; Sharwood LN, 2011, J AUSTRALAS COLL ROA, V22, P24; Spiller G, 1984, METHYLXANTHINE BEVER; Stevenson M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-162; Williamson A, 2007, AM J EPIDEMIOL, V166, P1320, DOI 10.1093/aje/kwm205	30	31	31	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2013	346								f1140	10.1136/bmj.f1140	http://dx.doi.org/10.1136/bmj.f1140			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113LX	23511947	Green Submitted, hybrid			2022-12-24	WOS:000316670500001
J	Gwynne, P				Gwynne, Peter			There's gold in them there bugs	NATURE			English	Editorial Material																		Fairbrother L, 2012, CHEM GEOL, V320, P17, DOI 10.1016/j.chemgeo.2012.05.025; Lengke M, 2006, GEOCHIM COSMOCHIM AC, V70, P3646, DOI 10.1016/j.gca.2006.04.018; Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106	4	18	18	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					S12	S13		10.1038/495S12a	http://dx.doi.org/10.1038/495S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486096	Bronze			2022-12-24	WOS:000316652300031
J	Wang, Q				Wang, Qiang			Nuclear safety lies in greater transparency	NATURE			English	Editorial Material									Chinese Acad Sci Urumqi, Western Res Ctr Energy & Ecoenvironm Policy, Xinjiang Inst Ecol & Geog, Xinjiang, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Wang, Q (corresponding author), Chinese Acad Sci Urumqi, Western Res Ctr Energy & Ecoenvironm Policy, Xinjiang Inst Ecol & Geog, Xinjiang, Peoples R China.	wang_q@ms.xjb.ac.cn	WANG, Qiang/F-4618-2011	WANG, Qiang/0000-0002-8751-8093					0	15	15	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					403	403		10.1038/494403a	http://dx.doi.org/10.1038/494403a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446380	Bronze			2022-12-24	WOS:000315661500004
J	Miller, E; Andrews, N; Stellitano, L; Stowe, J; Marie, A; Shneerson, J; Verity, C				Miller, Elizabeth; Andrews, Nick; Stellitano, Lesley; Stowe, Julia; Marie, Anne; Shneerson, John; Verity, Christopher			Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EPIDEMIOLOGY; COHORT; H1N1	Objective To evaluate the risk of narcolepsy in children and adolescents in England targeted for vaccination with ASO3 adjuvanted pandemic A/H1N1 2009 vaccine (Pandemrix) from October 2009. Design Retrospective analysis. Clinical information and results of sleep tests were extracted from hospital notes between August 2011 and February 2012 and reviewed by an expert panel to confirm the diagnosis. Vaccination and clinical histories were obtained from general practitioners. Setting Sleep centres and paediatric neurology centres in England. Participants Children and young people aged 4-18 with onset of narcolepsy from January 2008. Main outcome measures The odds of vaccination in those with narcolepsy compared with the age matched English population after adjustment for clinical conditions that were indications for vaccination. The incidence of narcolepsy within six months of vaccination compared with the incidence outside this period measured with the self controlled cases series method. Results Case notes for 245 children and young people were reviewed; 75 had narcolepsy (56 with cataplexy) and onset after 1 January 2008. Eleven had been vaccinated before onset; seven within six months. In those with a diagnosis by July 2011 the odds ratio was 14.4 (95% confidence interval 4.3 to 48.5) for vaccination at any time before onset and 16.2 (3.1 to 84.5) for vaccination within six months before onset. The relative incidence from the self controlled cases series analysis in those with a diagnosis by July 2011 with onset from October 2008 to December 2010 was 9.9 (2.1 to 47.9). The attributable risk was estimated as between 1 in 57 500 and 1 in 52 000 doses. Conclusion The increased risk of narcolepsy after vaccination with ASO3 adjuvanted pandemic A/H1N1 2009 vaccine indicates a causal association, consistent with findings from Finland. Because of variable delay in diagnosis, however, the risk might be overestimated by more rapid referral of vaccinated children.	[Miller, Elizabeth; Stellitano, Lesley; Stowe, Julia; Marie, Anne; Verity, Christopher] Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London NW9 5EQ, England; [Andrews, Nick] Hlth Protect Agcy, Stat Modelling & Econ Dept, London NW9 5EQ, England; [Stellitano, Lesley; Marie, Anne; Verity, Christopher] Addenbrookes Hosp, PIND Res Grp, Cambridge CB2 0QQ, England; [Stowe, Julia] UCL, Gen & Adolescent Paediat Unit, Inst Child Hlth, London NW1 2PF, England; [Shneerson, John] Papworth Hosp, Resp Support & Sleep Ctr, Cambridge CB23 3RE, England	Health Protection Agency; Health Protection Agency; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Papworth Hospital	Miller, E (corresponding author), Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London NW9 5EQ, England.	liz.miller@hpa.org.uk		Stowe, Julia/0000-0002-3999-6461	Department of Health; Health Protection Agency; Department of Health research and development directorate [039/0031]	Department of Health; Health Protection Agency; Department of Health research and development directorate	The study was funded by the Department of Health policy research programme and the Health Protection Agency. The views expressed in the publication are those of the authors and not necessarily those of the Department of Health, England. The funding source had no role in data collection, data analysis, data interpretation, or writing of the report. CV, JS, AMW, and LS were supported by a grant from the Department of Health research and development directorate (No 039/0031).	ALLSOPP MR, 1992, ARCH DIS CHILD, V67, P302, DOI 10.1136/adc.67.3.302; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Andrews N, 2012, BIOLOGICALS, V40, P389, DOI 10.1016/j.biologicals.2011.08.010; [Anonymous], 2010, PANDEMIC H1N1 SWINE; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Chief Medical Officer's Update, 2009, H1N1 SWIN FLU VACC P; Dauvilliers Y, 2010, SLEEP, V33, P1428, DOI 10.1093/sleep/33.11.1428; Doherty L, 2010, Ir Med J, V103, P112; Doherty L, 2010, IRAN MED J, V103, P112; European Medicines Agency, 2011, PAND ASS REP; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; Fleming DM, 2010, J PUBLIC HEALTH-UK, V32, P90, DOI 10.1093/pubmed/fdp087; Furuta H, 2001, PSYCHIAT CLIN NEUROS, V55, P241, DOI 10.1046/j.1440-1819.2001.00841.x; Global Advisory Committee on Vaccine Safety, 2011, STAT NARC VACC; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Hardelid P, 2012, VACCINE, V30, P1371, DOI 10.1016/j.vaccine.2011.12.038; Longstreth WT, 2007, SLEEP, V30, P13, DOI 10.1093/sleep/30.1.13; Medical Products Agency, OCC NARC CAT CHILDR; Morrish E, 2004, SLEEP MED, V5, P37, DOI 10.1016/j.sleep.2003.06.002; National Institute for Health and Welfare recommends discontinuation of Pandemrix vaccinations. National Institute for Health and Welfare, 2010, NAT I HLTH WELF REC; National Narcolepsy Study Steering Committee, INV INCR INC NARC CH; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Picchioni D, 2007, NEUROEPIDEMIOLOGY, V29, P185, DOI 10.1159/000111581; Population Estimates Unit, 2009, EST RES POP MID 2009; Salisbury D, 2006, IMMUNISATION INFECT, P193; Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197; Wijnans L, 2013, VACCINE, V31, P1246, DOI 10.1016/j.vaccine.2012.12.015	30	192	194	0	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2013	346								f794	10.1136/bmj.f794	http://dx.doi.org/10.1136/bmj.f794			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BJ	23444425	hybrid			2022-12-24	WOS:000315669400023
J	Dicks, L				Dicks, Lynn			Bees, lies and evidence-based policy	NATURE			English	Editorial Material									Univ Cambridge, Nat Environm Res Council, Cambridge CB2 1TN, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Cambridge	Dicks, L (corresponding author), Univ Cambridge, Nat Environm Res Council, Cambridge CB2 1TN, England.	lvd22@cam.ac.uk	Dicks, Lynn V./AFH-5289-2022	Dicks, Lynn/0000-0002-8304-4468	Natural Environment Research Council [NE/J500665/1] Funding Source: researchfish; NERC [NE/J500665/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))			0	34	34	1	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					283	283		10.1038/494283a	http://dx.doi.org/10.1038/494283a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	095CS	23426287	Bronze			2022-12-24	WOS:000315312900004
J	Gomez, JA; Wapinski, OL; Yang, YW; Bureau, JF; Gopinath, S; Monack, DM; Chang, HY; Brahic, M; Kirkegaard, K				Gomez, J. Antonio; Wapinski, Orly L.; Yang, Yul W.; Bureau, Jean-Francois; Gopinath, Smita; Monack, Denise M.; Chang, Howard Y.; Brahic, Michel; Kirkegaard, Karla			The NeST Long ncRNA Controls Microbial Susceptibility and Epigenetic Activation of the Interferon-gamma Locus	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; THEILERS VIRUS-INFECTION; INTERGENIC NONCODING RNA; GENOME-WIDE ASSOCIATION; T-CELL SUBSET; GENE-EXPRESSION; SALMONELLA-TYPHIMURIUM; IFNG LOCUS; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS	Long noncoding RNAs (IncRNAs) are increasingly appreciated as regulators of cell-specific gene expression. Here, an enhancer-like IncRNA termed NeST (nettoie Salmonella pas Theiler's [cleanup Salmonella not Theiler's]) is shown to be causal for all phenotypes conferred by murine viral susceptibility locus Tmevp3. This locus was defined by crosses between SJL/J and B10.S mice and contains several candidate genes, including NeST. The SJL/J-derived locus confers higher IncRNA expression, increased interferon-gamma (IFN-gamma) abundance in activated CD8(+) T cells, increased Theiler's virus persistence, and decreased Salmonella enterica pathogenesis. Transgenic expression of NeST IncRNA alone was sufficient to confer all phenotypes of the SJL/J locus. NeST RNA was found to bind WDR5, a component of the histone H3 lysine 4 methyltransferase complex, and to alter histone 3 methylation at the IFN-gamma locus. Thus, this IncRNA regulates epigenetic marking of IFN-gamma-encoding chromatin, expression of IFN-gamma, and susceptibility to a viral and a bacterial pathogen.	[Gomez, J. Antonio; Gopinath, Smita; Monack, Denise M.; Brahic, Michel; Kirkegaard, Karla] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Wapinski, Orly L.; Yang, Yul W.; Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Bureau, Jean-Francois] Inst Pasteur, Dept Virol, F-75724 Paris 15, France	Stanford University; Howard Hughes Medical Institute; Stanford University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Kirkegaard, K (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	karlak@stanford.edu		Gopinath, Smita/0000-0003-3672-3780; Monack, Denise/0000-0003-3804-2209	Gates Foundation; Stanford University DARE program; National Science Foundation; Stanford Medical Science Training Program; NIH Training Grant; National Society for Multiple Sclerosis; Scleroderma Research Foundation; NIH Director's Pioneer Award; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000827] Funding Source: NIH RePORTER	Gates Foundation(Bill & Melinda Gates Foundation); Stanford University DARE program; National Science Foundation(National Science Foundation (NSF)); Stanford Medical Science Training Program; NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Society for Multiple Sclerosis; Scleroderma Research Foundation; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Holden Maecker, Roberto Mateo, and Peter Sarnow for comments on the manuscript. We also thank Laura Attardi for experimental advice, Nigel Killeen for plasmids, Mary Vadeboncoeur and Grete Sonderstrup for their transgenics expertise, Shyamalia Roy for Salmonella titering and the Human Immune Monitoring Core for Luminex assays. Individuals involved in this work were supported by scholarships from the Gates Foundation and the Stanford University DARE program (J.A.G.), the National Science Foundation (O.L.W.), the Stanford Medical Science Training Program (Y.W.Y.), and an NIH Training Grant (S.G.). H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute. Research funding was provided by the National Society for Multiple Sclerosis (K.K. and M.B.), the Scleroderma Research Foundation (H.Y.C.), and an NIH Director's Pioneer Award (K.K.).	Arpaia N, 2011, CELL, V144, P675, DOI 10.1016/j.cell.2011.01.031; Balasubramani A, 2010, IMMUNOL REV, V238, P216, DOI 10.1111/j.1600-065X.2010.00961.x; Bihl F, 1999, GENETICS, V152, P385; Brahic M, 2005, ANNU REV MICROBIOL, V59, P279, DOI 10.1146/annurev.micro.59.030804.121242; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; BUREAU JF, 1992, J VIROL, V66, P4698, DOI 10.1128/JVI.66.8.4698-4704.1992; BUREAU JF, 1993, NAT GENET, V5, P87, DOI 10.1038/ng0993-87; Cagliani R, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-171; Chang B, 2008, HUM MOL GENET, V17, P3929, DOI 10.1093/hmg/ddn295; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P17095, DOI 10.1073/pnas.0502129102; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Collier SP, 2012, J IMMUNOL, V189, P2084, DOI 10.4049/jimmunol.1200774; Davila E, 2005, J IMMUNOL, V174, P7292, DOI 10.4049/jimmunol.174.11.7292; Dean M, 2002, ANNU REV GENOM HUM G, V3, P263, DOI 10.1146/annurev.genom.3.022502.103149; Foster N, 2005, J INTERF CYTOK RES, V25, P31, DOI 10.1089/jir.2005.25.31; Frehel C, 2002, CELL MICROBIOL, V4, P541, DOI 10.1046/j.1462-5822.2002.00213.x; Frisullo G, 2010, HUM IMMUNOL, V71, P437, DOI 10.1016/j.humimm.2010.01.024; Goris A, 2002, GENES IMMUN, V3, P470, DOI 10.1038/sj.gene.6363913; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Latiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022688; Levillayer F, 2007, GENETICS, V176, P1835, DOI 10.1534/genetics.107.073536; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Martinat C, 2002, J VIROL, V76, P12823, DOI 10.1128/JVI.76.24.12823-12833.2002; MCALLISTER A, 1989, MICROB PATHOGENESIS, V7, P381, DOI 10.1016/0882-4010(89)90041-7; Miao EA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00085; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; O'Geen H, 2011, METHODS MOL BIOL, V791, P265, DOI 10.1007/978-1-61779-316-5_20; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Orozco G, 2005, HUM IMMUNOL, V66, P1235, DOI 10.1016/j.humimm.2006.02.003; Pereira MSF, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00033; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Rodriguez M, 2003, J VIROL, V77, P12252, DOI 10.1128/JVI.77.22.12252-12265.2003; Rossi CP, 1997, J VIROL, V71, P3336, DOI 10.1128/JVI.71.4.3336-3340.1997; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Singer SM, 1998, DIABETES, V47, P1570, DOI 10.2337/diabetes.47.10.1570; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; SUBBAIAH TV, 1964, NATURE, V201, P1298, DOI 10.1038/2011298a0; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Vigneau S, 2003, J VIROL, V77, P5632, DOI 10.1128/JVI.77.10.5632-5638.2003; Vigneau S, 2001, GENOMICS, V78, P206, DOI 10.1006/geno.2001.6656; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Xystrakis E, 2004, BLOOD, V104, P3294, DOI 10.1182/blood-2004-03-1214; Zhou WS, 2004, P NATL ACAD SCI USA, V101, P2440, DOI 10.1073/pnas.0306002101	61	480	511	5	106	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					743	754		10.1016/j.cell.2013.01.015	http://dx.doi.org/10.1016/j.cell.2013.01.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415224	Green Accepted, Bronze			2022-12-24	WOS:000314945600010
J	Gusarov, I; Gautier, L; Smolentseva, O; Shamovsky, I; Eremina, S; Mironov, A; Nudler, E				Gusarov, Ivan; Gautier, Laurent; Smolentseva, Olga; Shamovsky, Ilya; Eremina, Svetlana; Mironov, Alexander; Nudler, Evgeny			Bacterial Nitric Oxide Extends the Lifespan of C. elegans	CELL			English	Article							HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; OXIDATIVE STRESS; S-NITROSYLATION; RNA-SEQ; LONGEVITY; DISEASE; POPULATIONS; EXTENSION	Nitric oxide (NO) is an important signaling molecule in multicellular organisms. Most animals produce NO from L-arginine via a family of dedicated enzymes known as NO synthases (NOSes). A rare exception is the roundworm Caenorhabditis elegans, which lacks its own NOS. However, in its natural environment, C. elegans feeds on Bacilli that possess functional NOS. Here, we demonstrate that bacterially derived NO enhances C. elegans longevity and stress resistance via a defined group of genes that function under the dual control of HSF-1 and DAF-16 transcription factors. Our work provides an example of interspecies signaling by a small molecule and illustrates the lifelong value of commensal bacteria to their host.	[Gusarov, Ivan; Gautier, Laurent; Smolentseva, Olga; Shamovsky, Ilya; Nudler, Evgeny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Eremina, Svetlana; Mironov, Alexander] State Res Inst Genet & Select Ind Microorganisms, Moscow 117545, Russia	New York University; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	evgeny.nudler@nyumc.org	Eremina, Svetlana/AAT-7430-2021; Gusarov, Ivan/AAJ-6282-2020; Mironov, Alexander/G-8531-2013	Mironov, Alexander/0000-0003-3914-1380; Nudler, Evgeny/0000-0002-8811-3071	BGRF; Dynasty Foundation; Robertson Foundation; NIH	BGRF; Dynasty Foundation; Robertson Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Zuojian Tang, Ekaterina Avetissova, Olga Katkova-Zhukotskaya, and Saamia Alam for technical assistance and the Caenorhabditis Genetics Center (University of Wisconsin) for providing strains. This work was supported by the BGRF, Dynasty Foundation, Robertson Foundation, and NIH (E.N.).	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; BRENNER S, 1974, GENETICS, V77, P71; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Crane BR, 2010, ANNU REV BIOCHEM, V79, P445, DOI 10.1146/annurev-biochem-062608-103436; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; FABIAN TJ, 1994, J GERONTOL, V49, pB145, DOI 10.1093/geronj/49.4.B145; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-26; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Halaschek-Wiener J, 2005, GENOME RES, V15, P603, DOI 10.1101/gr.3274805; Hanafy K A, 2001, Med Sci Monit, V7, P801; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Johnson EG, 2008, CHEM BIOL, V15, P43, DOI 10.1016/j.chembiol.2007.11.014; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kerwin J, 1995, J MED CHEM, V88, P4343; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Kurapati R, 2000, J GERONTOL A-BIOL, V55, pB552, DOI 10.1093/gerona/55.11.B552; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227, DOI 10.7326/0003-4819-120-3-199402010-00009; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; MONCADA S, 1991, EUR J CLIN INVEST, V21, P361, DOI 10.1111/j.1365-2362.1991.tb01383.x; MONCADA S, 1991, PHARMACOL REV, V43, P109; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Olsen A, 2006, BIOGERONTOLOGY, V7, P221, DOI 10.1007/s10522-006-9018-x; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Reece SY, 2009, BIOCHEMISTRY-US, V48, P5483, DOI 10.1021/bi900385g; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Samuelson AV, 2007, GENE DEV, V21, P2976, DOI 10.1101/gad.1588907; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Shatalin K, 2008, P NATL ACAD SCI USA, V105, P1009, DOI 10.1073/pnas.0710950105; SIALA A, 1974, J GEN MICROBIOL, V81, P183, DOI 10.1099/00221287-81-1-183; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; van der Linden AM, 2008, GENETICS, V180, P1475, DOI 10.1534/genetics.108.094771; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; WONG A, 1995, GENETICS, V139, P1247; Xu QB, 1997, J CLIN INVEST, V100, P1089, DOI 10.1172/JCI119619; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5	65	125	129	2	73	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					818	830		10.1016/j.cell.2012.12.043	http://dx.doi.org/10.1016/j.cell.2012.12.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415229	Bronze			2022-12-24	WOS:000314945600016
J	Cavalli, F				Cavalli, Franco			An appeal to world leaders: stop cancer now	LANCET			English	Editorial Material							OFFLINE		Oncol Inst So Switzerland, CH-6500 Bellinzona, Switzerland	Institute of Oncology Research (IOR)	Cavalli, F (corresponding author), Oncol Inst So Switzerland, CH-6500 Bellinzona, Switzerland.	franco.cavalli@eoc.ch						Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Horton R, 2012, LANCET, V380, P1542, DOI 10.1016/S0140-6736(12)61848-0; Horton R, 2012, LANCET, V380, P1457, DOI 10.1016/S0140-6736(12)61810-8; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Sundewall J, 2011, LANCET, V377, P1222, DOI 10.1016/S0140-6736(10)60679-4; Taylor AL, 2011, NEW ENGL J MED, V365, P2348, DOI 10.1056/NEJMp1108658; WHO, WHA65 8 PREV CONTR N; World Health Organization, 2012, CANC FACT SHEET 297	12	25	27	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2013	381	9865					425	426		10.1016/S0140-6736(13)60059-8	http://dx.doi.org/10.1016/S0140-6736(13)60059-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088CH	23388078				2022-12-24	WOS:000314810900005
J	Briesacher, BA; Tjia, J; Peterson, D; Gurwitz, JH				Briesacher, Becky A.; Tjia, Jennifer; Peterson, Daniel; Gurwitz, Jerry H.			Antipsychotic Use Among Nursing Home Residents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							REGULATIONS		Meyers Primary Care Inst, Worcester, MA USA; [Briesacher, Becky A.] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Briesacher, BA (corresponding author), Univ Massachusetts, Sch Med, 377 Plantat St,Biotech 4,Ste 315, Worcester, MA 01605 USA.	becky.briesacher@umassmed.edu	Tjia, Jennifer/Y-2094-2019		AHRQ HHS [R18 HS019351, R18HS019351-01] Funding Source: Medline; NIA NIH HHS [K01 AG031836, K01AG031836] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS019351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG031836] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Briesacher BA, 2005, ARCH INTERN MED, V165, P1280, DOI 10.1001/archinte.165.11.1280; Chen Y, 2010, ARCH INTERN MED, V170, P89, DOI 10.1001/archinternmed.2009.469; Maher AR, 2011, JAMA-J AM MED ASSOC, V306, P1359, DOI 10.1001/jama.2011.1360; ROVNER BW, 1992, AM J PSYCHIAT, V149, P1390; Shorr Ronald I., 1994, JAMA (Journal of the American Medical Association), V271, P358, DOI 10.1001/jama.271.5.358	5	43	44	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					440	442		10.1001/jama.2012.211266	http://dx.doi.org/10.1001/jama.2012.211266			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083LY	23385262	Green Accepted, Bronze			2022-12-24	WOS:000314466900017
J	Smith, R; McCready, T; Yusuf, S				Smith, Richard; McCready, Tara; Yusuf, Salim			Combination Therapy to Prevent Cardiovascular Disease Slow Progress	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Smith, Richard] UnitedHlth Chron Dis Initiat, London, England; [McCready, Tara; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [McCready, Tara; Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON, Canada	McMaster University; Population Health Research Institute; McMaster University	Yusuf, S (corresponding author), McMaster Univ, Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca		Yusuf, Salim/0000-0003-4776-5601				American Heart Association, 2012, PEOPLE MORE LIKELY T; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; Diaz R, 2012, EUROPEAN SOCIETY OF; Dudl RJ, 2009, AM J MANAG CARE, V15, pE88; Elley CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052145; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; The Global Summit on Combination Polypharmacy for Cardiovascular Disease, 2012, THE GLOBAL SUMMIT ON; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	8	15	15	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1595	1596		10.1001/jama.2013.3180	http://dx.doi.org/10.1001/jama.2013.3180			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126FY	23529576				2022-12-24	WOS:000317599500021
J	Creamean, JM; Suski, KJ; Rosenfeld, D; Cazorla, A; DeMott, PJ; Sullivan, RC; White, AB; Ralph, FM; Minnis, P; Comstock, JM; Tomlinson, JM; Prather, KA				Creamean, Jessie M.; Suski, Kaitlyn J.; Rosenfeld, Daniel; Cazorla, Alberto; DeMott, Paul J.; Sullivan, Ryan C.; White, Allen B.; Ralph, F. Martin; Minnis, Patrick; Comstock, Jennifer M.; Tomlinson, Jason M.; Prather, Kimberly A.			Dust and Biological Aerosols from the Sahara and Asia Influence Precipitation in the Western U.S.	SCIENCE			English	Article							ATMOSPHERIC ICE NUCLEI; OROGRAPHIC ENHANCEMENT; LIQUID WATER; MIXED-PHASE; CLOUD; PARTICLES; SUPPRESSION; DEPOSITION; RANGE; RADAR	Winter storms in California's Sierra Nevada increase seasonal snowpack and provide critical water resources and hydropower for the state. Thus, the mechanisms influencing precipitation in this region have been the subject of research for decades. Previous studies suggest Asian dust enhances cloud ice and precipitation, whereas few studies consider biological aerosols as an important global source of ice nuclei (IN). Here, we show that dust and biological aerosols transported from as far as the Sahara were present in glaciated high-altitude clouds coincident with elevated IN concentrations and ice-induced precipitation. This study presents the first direct cloud and precipitation measurements showing that Saharan and Asian dust and biological aerosols probably serve as IN and play an important role in orographic precipitation processes over the western United States.	[Creamean, Jessie M.; Suski, Kaitlyn J.; Cazorla, Alberto; Prather, Kimberly A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Rosenfeld, Daniel] Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel; [DeMott, Paul J.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Sullivan, Ryan C.] Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA; [White, Allen B.; Ralph, F. Martin] NOAA, PSD, ESRL, Boulder, CO 80305 USA; [Ralph, F. Martin; Prather, Kimberly A.] Univ Calif San Diego, SIO, La Jolla, CA 92093 USA; [Minnis, Patrick] NASA, Langley Res Ctr, Hampton, VA 23681 USA; [Comstock, Jennifer M.; Tomlinson, Jason M.] Pacific NW Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99352 USA	University of California System; University of California San Diego; Hebrew University of Jerusalem; Colorado State University; Carnegie Mellon University; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; National Aeronautics & Space Administration (NASA); NASA Langley Research Center; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Prather, KA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	kprather@ucsd.edu	Tomlinson, Jason M/C-6566-2009; Rosenfeld, Daniel/F-6077-2016; Minnis, Patrick/G-1902-2010; Studies, Center for Atmospheric Particle/AAR-6731-2020; Rosenfeld, Daniel/AAJ-4617-2021; DeMott, Paul J/C-4389-2011; Prather, Kim/A-3892-2008; Cazorla, Alberto/G-2097-2017; Sullivan, Ryan/B-4674-2008	Tomlinson, Jason M/0000-0002-0734-3298; Rosenfeld, Daniel/0000-0002-0784-7656; Minnis, Patrick/0000-0002-4733-6148; Rosenfeld, Daniel/0000-0002-0784-7656; DeMott, Paul J/0000-0002-3719-1889; Prather, Kim/0000-0003-3048-9890; Cazorla, Alberto/0000-0002-0901-1609; Sullivan, Ryan/0000-0003-0701-7158; Creamean, Jessie/0000-0003-3819-5600; Comstock, Jennifer/0000-0002-4183-7355	California Energy Commission [CEC 500-09-043]; Atmospheric System Research (ASR)/U.S. Department of Energy (DOE) program; ASR/DOE program [DE-SC0000991/003]; NASA MAPS Program	California Energy Commission; Atmospheric System Research (ASR)/U.S. Department of Energy (DOE) program; ASR/DOE program; NASA MAPS Program	Funding was provided by the California Energy Commission under contract CEC 500-09-043. D. R. was funded under the Atmospheric System Research (ASR)/U.S. Department of Energy (DOE) program. P. M. was supported by the ASR/DOE program under DE-SC0000991/003 and the NASA MAPS Program. J. Mayer, E. Fitzgerald, D. Collins, and J. Cahill provided assistance with UCSD/SIO equipment setup. The authors gratefully acknowledge the NOAA Air Resources Laboratory (ARL) for the provision of the HYSPLIT transport and dispersion model and READY website (www.arl.noaa.gov/ready.php) used in this publication and the Office of Naval Research for provision of NAAPS data. J. Ayers and R. Palikonda (Science Systems and Applications) provided GOES-11 cloud top heights used for HYSPLIT back trajectory analysis and %Ice in cloud. The deployment of the NOAA and UCSD/SIO equipment at the Sugar Pine site involved many field staff, particularly C. King (NOAA/ESRL/PSD). The deployment of the DOE Gulfstream-1 involved many PNNL/Atmospheric Radiation Measurement field staff, particularly E. Dukes, J. Hubbe, C. Kluzek, H. Jonsson, M. Pekour, and B. Schmid. M. Hubbell and B. Svancara flew the G-1 for the CalWater flight campaign. D. Collins and R. Spackman provided insightful discussions during the editing stages of this manuscript. T. Lersch of R. J. Lee provided TEM analyses of collected IN. Data available in this paper are available in the supplementary materials.	Andreae MO, 2008, EARTH-SCI REV, V89, P13, DOI 10.1016/j.earscirev.2008.03.001; Ault AP, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015351; Borys RD, 2000, ATMOS ENVIRON, V34, P2593, DOI 10.1016/S1352-2310(99)00492-6; Choi YS, 2010, P NATL ACAD SCI USA, V107, P11211, DOI 10.1073/pnas.1006241107; CHOULARTON TW, 1986, Q J ROY METEOR SOC, V112, P335, DOI 10.1002/qj.49711247204; DeMott PJ, 2010, P NATL ACAD SCI USA, V107, P11217, DOI 10.1073/pnas.0910818107; DeMott PJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017410; DESHLER T, 1990, J APPL METEOROL, V29, P288, DOI 10.1175/1520-0450(1990)029&lt;0288:PROWOC&gt;2.0.CO;2; Dore AJ, 1999, ATMOS ENVIRON, V33, P3301, DOI 10.1016/S1352-2310(98)00294-5; Draxler R., 2013, HYSPLIT HYBRID SINGL; Fowler D, 1995, WATER AIR SOIL POLL, V85, P2107, DOI 10.1007/BF01186145; Gard E, 1997, ANAL CHEM, V69, P4083, DOI 10.1021/ac970540n; Givati A, 2004, J APPL METEOROL, V43, P1038, DOI [10.1175/1520-0450(2004)043<1038:QPSDTA>2.0.CO;2, 10.1175/1520-0450(2004)043&lt;1038:QPSDTA&gt;2.0.CO;2]; Guan B, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044696; Hallar AG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048166; Hara K, 2012, ATMOS ENVIRON, V47, P20, DOI 10.1016/j.atmosenv.2011.11.050; Hoose C, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024009; HOSLER CL, 1957, J METEOROL, V14, P415, DOI 10.1175/1520-0469(1957)014<0415:OTAOIC>2.0.CO;2; Houze R. A., 1993, CLOUD DYNAMICS; Hsu SC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051962; Husar RB, 2001, J GEOPHYS RES-ATMOS, V106, P18317, DOI 10.1029/2000JD900788; Iannone R, 2011, ATMOS CHEM PHYS, V11, P1191, DOI 10.5194/acp-11-1191-2011; Isono K., 1959, J METEOR SOC JAPAN, V37, P211, DOI DOI 10.2151/JMSJ1923.37.6_211; Korolev A, 2007, J ATMOS SCI, V64, P3372, DOI 10.1175/JAS4035.1; Lau KM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018567; McKendry IG, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007129; MEYERS MP, 1992, J APPL METEOROL, V31, P708, DOI 10.1175/1520-0450(1992)031<0708:NPINPI>2.0.CO;2; Morris CE, 2004, J PHYS IV, V121, P87, DOI 10.1051/jp4:2004121004; Pinsky M, 1998, ATMOS RES, V49, P99, DOI 10.1016/S0169-8095(98)00073-8; Pratt KA, 2009, NAT GEOSCI, V2, P397, DOI 10.1038/NGEO521; Pratt KA, 2009, ANAL CHEM, V81, P1792, DOI 10.1021/ac801942r; Prospero JM, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000095; Reinking RF, 2000, J APPL METEOROL, V39, P733, DOI 10.1175/1520-0450(2000)039<0733:IOSEOG>2.0.CO;2; REYNOLDS DW, 1986, B AM METEOROL SOC, V67, P513, DOI 10.1175/1520-0477(1986)067<0513:AROTSC>2.0.CO;2; Rogers DC, 2001, J ATMOS OCEAN TECH, V18, P725, DOI 10.1175/1520-0426(2001)018<0725:ACFDCF>2.0.CO;2; Rosenfeld D, 2000, SCIENCE, V287, P1793, DOI 10.1126/science.287.5459.1793; Rosenfeld D, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049423; Saleeby SM, 2009, J APPL METEOROL CLIM, V48, P903, DOI 10.1175/2008JAMC1989.1; Sun JM, 2001, J GEOPHYS RES-ATMOS, V106, P10325, DOI 10.1029/2000JD900665; Uno I, 2011, ATMOS CHEM PHYS, V11, P7333, DOI 10.5194/acp-11-7333-2011; Uno I, 2009, NAT GEOSCI, V2, P557, DOI 10.1038/NGEO583; White AB, 2000, J ATMOS OCEAN TECH, V17, P1226, DOI 10.1175/1520-0426(2000)017<1226:ETDROA>2.0.CO;2; White AB, 2003, J HYDROMETEOROL, V4, P264, DOI 10.1175/1525-7541(2003)4<264:CORPOB>2.0.CO;2; Wiacek A, 2010, ATMOS CHEM PHYS, V10, P8649, DOI 10.5194/acp-10-8649-2010	44	400	409	22	414	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1572	1578		10.1126/science.1227279	http://dx.doi.org/10.1126/science.1227279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23449996				2022-12-24	WOS:000316731600040
J	Chen, XG; Taylor, DW; Fowler, CC; Galan, JE; Wang, HW; Wolin, SL				Chen, Xinguo; Taylor, David W.; Fowler, Casey C.; Galan, Jorge E.; Wang, Hong-Wei; Wolin, Sandra L.			An RNA Degradation Machine Sculpted by Ro Autoantigen and Noncoding RNA	CELL			English	Article							5S RIBOSOMAL-RNA; Y-RNAS; POLYNUCLEOTIDE PHOSPHORYLASE; CRYSTAL-STRUCTURE; QUALITY-CONTROL; BINDING; RIBONUCLEOPROTEIN; RECOGNITION; ORTHOLOG; PROTEIN	Many bacteria contain an ortholog of the Ro autoantigen, a ring-shaped protein that binds noncoding RNAs (ncRNAs) called Y RNAs. In the only studied bacterium, Deinococcus radiodurans, the Ro ortholog Rsr functions in heat-stress-induced ribosomal RNA (rRNA) maturation and starvation-induced rRNA decay. However, the mechanism by which this conserved protein and its associated ncRNAs act has been obscure. We report that Rsr and the exoribonuclease polynucleotide phosphorylase (PNPase) form an RNA degradation machine that is scaffolded by Y RNA. Single-particle electron microscopy, followed by docking of atomic models into the reconstruction, suggests that Rsr channels single-stranded RNA into the PNPase cavity. Biochemical assays reveal that Rsr and Y RNA adapt PNPase for effective degradation of structured RNAs. A Ro ortholog and ncRNA also associate with PNPase in Salmonella Typhimurium. Our studies identify another ribonucleoprotein machine and demonstrate that ncRNA, by tethering a protein cofactor, can alter the substrate specificity of an enzyme.	[Chen, Xinguo; Galan, Jorge E.; Wolin, Sandra L.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Taylor, David W.; Wang, Hong-Wei; Wolin, Sandra L.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Fowler, Casey C.; Galan, Jorge E.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Wolin, SL (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	sandra.wolin@yale.edu	Wolin, Sandra/H-2333-2016	Wolin, Sandra/0000-0001-6730-0399; Taylor, David/0000-0002-6198-1194; Fowler, Casey/0000-0001-6494-5650	Smith Family Awards Program for Excellence in Biomedical Research; NIH [R01 AI079022, R01 GM073863]; Molecular Biophysics training grant [5 T32 GM008283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073863, T32GM008283] Funding Source: NIH RePORTER	Smith Family Awards Program for Excellence in Biomedical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biophysics training grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	X.C. identified the Rsr/Y RNA/PNPase RNP, reconstituted it in E. coli, and performed all biochemical experiments. D.W.T. performed the single-particle electron microscopy and three-dimensional reconstruction. C.C.F. prepared S. Typhimurium strains and extracts. All authors contributed to planning experiments and analyzing data. We thank J. Button for assistance in preparing S. Typhimurium strains; A. Carpousis, N. Kucera, A. Ramesh, J. Sacchettini, S. Sim, and E. Wurtmann for reagents; H. Zheng and K. Reinisch for assistance with baculovirus; G. Lander, M. Cianfrocco, and P. Grob for electron microscopy assistance; E. Conti for advice; and S. Baserga, E. De La Cruz, A. Horwich, J. Steitz, E. Ullu, and Y. Zuo for comments on the manuscript. We thank the Yale Center for Cellular and Molecular Imaging and E. Nogales for use of the EM facility at UC-Berkeley. D.W.T is an NSF Graduate Research Fellow. This work was supported by the Smith Family Awards Program for Excellence in Biomedical Research (to H.W.), NIH grants R01 AI079022 (to J.E.G.) and R01 GM073863 (to S.L.W.), and Molecular Biophysics training grant 5 T32 GM008283 (to D.W.T.).	Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Bouffard P, 2000, RNA, V6, P66, DOI 10.1017/S1355838200990277; Chen XG, 2000, GENE DEV, V14, P777; Chen XG, 2003, CURR BIOL, V13, P2206, DOI 10.1016/j.cub.2003.11.028; Chen XG, 2007, GENE DEV, V21, P1328, DOI 10.1101/gad.1548207; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Evguenieva-Hackenberg E, 2010, ADV EXP MED BIOL, V702, P29; Evguenieva-Hackenberg E, 2008, BIOCHEMISTRY-US, V47, P13158, DOI 10.1021/bi8012214; Fabini G, 2001, J BIOL CHEM, V276, P20711, DOI 10.1074/jbc.M101360200; Fouraux MA, 2002, J MOL BIOL, V320, P475, DOI 10.1016/S0022-2836(02)00518-1; Fuchs G, 2006, NAT STRUCT MOL BIOL, V13, P1002, DOI 10.1038/nsmb1156; Genschik P, 1998, J BIOL CHEM, V273, P25516, DOI 10.1074/jbc.273.39.25516; Gorna MW, 2012, Q REV BIOPHYS, V45, P105, DOI 10.1017/S003358351100014X; Green CD, 1998, RNA, V4, P750, DOI 10.1017/S1355838298971667; Hannon GJ, 2006, COLD SPRING HARB SYM, V71, P551, DOI 10.1101/sqb.2006.71.064; Hogg JR, 2007, GENE DEV, V21, P3067, DOI 10.1101/gad.1603907; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Labbe JC, 1999, GENETICS, V151, P143; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mohanty BK, 2011, WIRES RNA, V2, P256, DOI 10.1002/wrna.51; OBRIEN CA, 1994, GENE DEV, V8, P2891, DOI 10.1101/gad.8.23.2891; Perreault J, 2007, MOL BIOL EVOL, V24, P1678, DOI 10.1093/molbev/msm084; Ramesh A, 2007, J BIOL CHEM, V282, P14960, DOI 10.1074/jbc.M611163200; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Shi H, 1996, RNA, V2, P769; Sim S, 2009, MOL BIOL CELL, V20, P1555, DOI 10.1091/mbc.E08-11-1094; Spickler C, 2000, J BACTERIOL, V182, P2422, DOI 10.1128/JB.182.9.2422-2427.2000; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Tanaka N, 2011, J BIOL CHEM, V286, P7727, DOI 10.1074/jbc.C111.219022; Teunissen SWM, 2000, NUCLEIC ACIDS RES, V28, P610, DOI 10.1093/nar/28.2.610; Wurtmann EJ, 2010, P NATL ACAD SCI USA, V107, P4022, DOI 10.1073/pnas.1000307107; Yoshioka C, 2007, J STRUCT BIOL, V159, P335, DOI 10.1016/j.jsb.2007.03.005	37	68	69	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					166	177		10.1016/j.cell.2013.02.037	http://dx.doi.org/10.1016/j.cell.2013.02.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540697	Green Accepted, Bronze			2022-12-24	WOS:000316853700014
J	Epstein, AJ; Srinivas, SK; Nicholson, S; Herrin, J; Asch, DA				Epstein, Andrew J.; Srinivas, Sindhu K.; Nicholson, Sean; Herrin, Jeph; Asch, David A.			Association between physicians' experience after training and maternal obstetrical outcomes: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LEARNING-CURVE; MORTALITY; SURGEONS; CARE	Objective To assess the association between obstetricians' years of experience after training and the maternal complications of their patients during their first 40 years of post-residency practice. Design Retrospective cohort analysis. Setting Obstetrical discharges from acute care hospitals in Florida and New York between academic years 1992 and 2009. Population 6 704 311 deliveries performed by 5175 obstetricians. Main outcome measure Three composite measures of maternal complication rates per physician year from vaginal and cesarean births separately and combined, adjusted for secular trends. Results Obstetricians' maternal complication rates declined during the first three decades after completion of residency. The improvement was largest in the first decade and diminished thereafter. For all deliveries, the change was -0.21 (95% confidence interval -0.23 to -0.19) percentage points per year in the first decade, -0.11 (-0.13 to -0.09) percentage points per year in the second decade, and -0.05 (-0.08 to -0.01) percentage points in the third decade (P<0.001 for second to first decade comparison; P=0.001 for third to second decade comparison). The patterns were comparable for cesarean deliveries and vaginal deliveries and across several sensitivity checks. Conclusions Among obstetricians practicing in Florida and New York, those with more years of experience had fewer maternal complications. This association persisted over the first three decades of practice but diminished in magnitude.	[Epstein, Andrew J.; Asch, David A.] Philadelphia Vet Affairs Med Ctr, Dept Vet Affairs, Ctr Hlth Equity Res & Promot, Philadelphia, PA 19104 USA; [Epstein, Andrew J.; Asch, David A.] Univ Penn, Div Gen Internal Med, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Epstein, Andrew J.; Srinivas, Sindhu K.; Asch, David A.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Srinivas, Sindhu K.] Univ Penn, Dept Obstet & Gynecol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nicholson, Sean] Cornell Univ, Dept Policy Anal & Management, Coll Human Ecol, Ithaca, NY 14853 USA; [Herrin, Jeph] Yale Univ, Sect Cardiovasc Med, Dept Med, Sch Med, New Haven, CT 06510 USA; [Herrin, Jeph] Hlth Res & Educ Trust, Chicago, IL 60606 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Cornell University; Yale University	Epstein, AJ (corresponding author), Philadelphia Vet Affairs Med Ctr, Dept Vet Affairs, Ctr Hlth Equity Res & Promot, 3900 Woodland Ave, Philadelphia, PA 19104 USA.	eandrew@mail.med.upenn.edu		Asch, David/0000-0002-7970-286X; Epstein, Andrew/0000-0001-5078-6564				Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Bridgewater B, 2004, BMJ-BRIT MED J, V329, P421, DOI 10.1136/bmj.38173.577697.55; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Epstein AJ, 2010, J HEALTH ECON, V29, P718, DOI 10.1016/j.jhealeco.2010.06.002; Gawande A. A., 2011, PERSONAL BEST; Gregory KD, 2002, HEALTH SERV RES, V37, P1387, DOI 10.1111/1475-6773.10762; Hopper AN, 2007, POSTGRAD MED J, V83, P777, DOI 10.1136/pgmj.2007.057190; Huesch MD, 2009, HEALTH SERV RES, V44, P1960, DOI 10.1111/j.1475-6773.2009.01018.x; Huesch MD, 2009, HEALTH ECON, V18, P855, DOI 10.1002/hec.1412; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Pisano GP, 2001, MANAGE SCI, V47, P752, DOI 10.1287/mnsc.47.6.752.9811; Rathore SS, 2005, JAMA-J AM MED ASSOC, V293, P1383, DOI 10.1001/jama.293.11.1383; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Srinivas SK, 2010, MED CARE, V48, P487, DOI 10.1097/MLR.0b013e3181d68840; Vickers AJ, 2007, JNCI-J NATL CANCER I, V99, P1171, DOI 10.1093/jnci/djm060; Waljee JF, 2006, ANN SURG, V244, P353, DOI 10.1097/01.sla.0000234803.11991.6d; Waljee Jennifer F, 2007, Adv Surg, V41, P189, DOI 10.1016/j.yasu.2007.05.012	17	17	17	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2013	346								f1596	10.1136/bmj.f1596	http://dx.doi.org/10.1136/bmj.f1596			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117XI	23538919	Green Published, hybrid			2022-12-24	WOS:000316986200003
J	He, Y; Fang, J; Taatjes, DJ; Nogales, E				He, Yuan; Fang, Jie; Taatjes, Dylan J.; Nogales, Eva			Structural visualization of key steps in human transcription initiation	NATURE			English	Article							RNA-POLYMERASE-II; DNA-BINDING DOMAIN; PREINITIATION COMPLEX; ELECTRON-MICROSCOPY; CONFORMATIONAL FLEXIBILITY; SUBUNIT ARCHITECTURE; ANGSTROM RESOLUTION; ACCURATE INITIATION; PROMOTER CLEARANCE; ELONGATION COMPLEX	Eukaryotic transcription initiation requires the assembly of general transcription factors into a pre-initiation complex that ensures the accurate loading of RNA polymerase II (Pol II) at the transcription start site. The molecular mechanism and function of this assembly have remained elusive due to lack of structural information. Here we have used an in vitro reconstituted system to study the stepwise assembly of human TBP, TFIIA, TFIIB, Pol II, TFIIF, TFIIE and TFIIH onto promoter DNA using cryo-electron microscopy. Our structural analyses provide pseudo-atomic models at various stages of transcription initiation that illuminate critical molecular interactions, including how TFIIF engages Pol II and promoter DNA to stabilize both the closed pre-initiation complex and the open-promoter complex, and to regulate start-site selection. Comparison of open versus closed pre-initiation complexes, combined with the localization of the TFIIH helicases XPD and XPB, support a DNA translocation model of XPB and explain its essential role in promoter opening.	[He, Yuan; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA; [Fang, Jie; Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Taatjes, Dylan J.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA; [Nogales, Eva] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Colorado System; University of Colorado Boulder; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Nogales, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA.	ENogales@lbl.gov	He, Yuan/C-7341-2015; He, Yuan/GVT-7268-2022	He, Yuan/0000-0002-1455-3963; He, Yuan/0000-0002-1455-3963	NIGMS [GM63072]; NCI [CA127364]; NATIONAL CANCER INSTITUTE [P01CA112181, R01CA127364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063072] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Inouye for providing us with recombinant TFIIF and TFIIE; P. Grob and T. Houweling for electron microscopy and computer support, respectively; T. Goddard for help with Chimera; and members of the Nogales laboratory for technical advice on image processing. We are thankful to J. Kadonaga, J. Goodrich and M. Cianfrocco for their comments on the manuscript. We thank P. Cooper both for biochemical advice and for her comments on the manuscript. This work was funded by NIGMS (GM63072 to E.N.) and by NCI (CA127364 to D. J. T.). E.N. is a Howard Hughes Medical Institute Investigator.	Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; Andrecka J, 2009, NUCLEIC ACIDS RES, V37, P5803, DOI 10.1093/nar/gkp601; Bernecky C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000603; Bleichenbacher M, 2003, J MOL BIOL, V332, P783, DOI 10.1016/S0022-2836(03)00887-8; BURATOWSKI S, 1991, P NATL ACAD SCI USA, V88, P7509, DOI 10.1073/pnas.88.17.7509; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Fernandez-Tornero C, 2010, EMBO J, V29, P3762, DOI 10.1038/emboj.2010.266; Forget D, 1997, P NATL ACAD SCI USA, V94, P7150, DOI 10.1073/pnas.94.14.7150; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; Ghazy MA, 2004, MOL CELL BIOL, V24, P10975, DOI 10.1128/MCB.24.24.10975-10985.2004; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Goodrich JA, 1996, CELL, V84, P825, DOI 10.1016/S0092-8674(00)81061-2; Groft CM, 1998, P NATL ACAD SCI USA, V95, P9117, DOI 10.1073/pnas.95.16.9117; Grohmann D, 2011, MOL CELL, V43, P263, DOI 10.1016/j.molcel.2011.05.030; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kostek SA, 2006, STRUCTURE, V14, P1691, DOI 10.1016/j.str.2006.09.011; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004; MATSUI T, 1980, J BIOL CHEM, V255, P1992; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Orlicky SM, 2001, J BIOL CHEM, V276, P10097, DOI 10.1074/jbc.M003165200; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Robert F, 1996, J BIOL CHEM, V271, P8517, DOI 10.1074/jbc.271.15.8517; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; SUN ZW, 1995, P NATL ACAD SCI USA, V92, P3127, DOI 10.1073/pnas.92.8.3127; TAN SY, 1994, P NATL ACAD SCI USA, V91, P9808, DOI 10.1073/pnas.91.21.9808; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Yan Q, 1999, J BIOL CHEM, V274, P35668, DOI 10.1074/jbc.274.50.35668	63	192	193	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					481	+		10.1038/nature11991	http://dx.doi.org/10.1038/nature11991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23446344	Green Accepted, Green Submitted			2022-12-24	WOS:000316682800039
J	Detsky, AS; Berwick, DM				Detsky, Allan S.; Berwick, Donald M.			Teaching Physicians to Care Amid Chaos	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DUTY HOURS		[Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Berwick, Donald M.] Harvard Univ, Sch Med, Boston, MA USA; [Berwick, Donald M.] Inst Healthcare Improvement, Cambridge, MA USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Harvard Medical School; Institute for Healthcare Improvement	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Ste 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Arora VM, 2012, JAMA-J AM MED ASSOC, V308, P2195, DOI 10.1001/jama.2012.14584; Cimino JJ, 2013, JAMA-J AM MED ASSOC, V309, P991, DOI 10.1001/jama.2013.890; Hirschtick RE, 2012, JAMA-J AM MED ASSOC, V308, P463, DOI 10.1001/jama.2012.8331; Horwitz LI, 2006, ARCH INTERN MED, V166, P1173, DOI 10.1001/archinte.166.11.1173; Lucas BP, 2012, JAMA-J AM MED ASSOC, V308, P2199, DOI 10.1001/jama.2012.36522; Rafelson WM, 2012, JAMA-J AM MED ASSOC, V308, P579, DOI 10.1001/jama.2012.8727; Rosenbaum L, 2012, NEW ENGL J MED, V367, P2044, DOI 10.1056/NEJMsr1210160; Toll E, 2012, JAMA-J AM MED ASSOC, V307, P2497, DOI 10.1001/jama.2012.4946	8	25	25	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					987	988		10.1001/jama.2013.620	http://dx.doi.org/10.1001/jama.2013.620			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23483169				2022-12-24	WOS:000315938700023
J	Atwood, SX; Li, MC; Lee, A; Tang, JY; Oro, AE				Atwood, Scott X.; Li, Mischa; Lee, Alex; Tang, Jean Y.; Oro, Anthony E.			GLI activation by atypical protein kinase C iota/lambda regulates the growth of basal cell carcinomas	NATURE			English	Article							HEDGEHOG PATHWAY; GENE; RESISTANCE	Growth of basal cell carcinomas (BCCs) requires high levels of hedgehog (HH) signalling through the transcription factor GLI(1). Although inhibitors of membrane protein smoothened (SMO) effectively suppress HH signalling, early tumour resistance illustrates the need for additional downstream targets for therapy(1-6). Here we identify atypical protein kinase C (aPKC-iota/lambda) as a novel GLI regulator in mammals. aPKC-iota/lambda and its polarity signalling partners' co-localize at the centrosome and form a complex with missing-in-metastasis (MIM), a scaffolding protein that potentiates HH signalling(8,9). Genetic or pharmacological loss of aPKC-iota/lambda function blocks HH signalling and proliferation of BCC cells. Prkci is a HH target gene that forms a positive feedback loop with GLI and exists at increased levels in BCCs. Genome-wide transcriptional profiling shows that aPKC-iota/lambda? and SMO control the expression of similar genes in tumour cells. aPKC-iota/lambda functions downstream of SMO to phosphorylate and activate GLI1, resulting in maximal DNA binding and transcriptional activation. Activated aPKC-iota/lambda. is upregulated in SMO-inhibitor-resistant tumours and targeting aPKC-iota/lambda suppresses signalling and growth of resistant BCC cell lines. These results demonstrate that aPKC-iota/lambda is critical for HH-dependent processes and implicates aPKC-iota/lambda as a new, tumour-selective therapeutic target for the treatment of SMO-inhibitor-resistant cancers. [GRAPHICS] .	[Atwood, Scott X.; Li, Mischa; Lee, Alex; Tang, Jean Y.; Oro, Anthony E.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA	Stanford University	Oro, AE (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	satwood@stanford.edu; oro@stanford.edu		Atwood, Scott/0000-0001-7407-9792; Lee, Alexander/0000-0002-4583-0740; Oro, Anthony/0000-0002-6261-138X; Tang, Jean/0000-0002-5510-6502; Li Covington, Mischa/0000-0001-5452-4529	NIH NRSA [1F32CA14208701]; NIH [AR052785, AR046786]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046786, R01AR054780, R01AR052785] Funding Source: NIH RePORTER	NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank K. Qun for bioinformatics assistance, J. Kim for archival BCC tissue, A. Chang and S. Aasi for clinical trial operations, K. Chang for technical assistance, and H. Chang and P. Khavari for reading the manuscript. This work was supported by NIH NRSA 1F32CA14208701 (S.X.A.) and NIH grants AR052785 and AR046786 (A.E.O.).	Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Atwood SX, 2012, J CELL BIOL, V199, P193, DOI 10.1083/jcb.201207140; Atwood SX, 2009, CURR BIOL, V19, P723, DOI 10.1016/j.cub.2009.03.056; Bershteyn M, 2010, DEV CELL, V19, P270, DOI 10.1016/j.devcel.2010.07.009; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Chang ALS, 2012, ARCH DERMATOL, V148, P1324, DOI 10.1001/archdermatol.2012.2354; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Little AS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001752; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang GY, 2011, J INVEST DERMATOL, V131, P2298, DOI 10.1038/jid.2011.204; Winklmayr M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-2; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	21	187	194	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					484	488		10.1038/nature11889	http://dx.doi.org/10.1038/nature11889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446420	Green Accepted, Green Submitted			2022-12-24	WOS:000315661500040
J	Cox, B; Martens, E; Nemery, B; Vangronsveld, J; Nawrot, TS				Cox, Bianca; Martens, Evelyne; Nemery, Benoit; Vangronsveld, Jaco; Nawrot, Tim S.			Impact of a stepwise introduction of smoke-free legislation on the rate of preterm births: analysis of routinely collected birth data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; MYOCARDIAL-INFARCTION; SECONDHAND SMOKE; GESTATIONAL-AGE; PASSIVE SMOKING; PREGNANT-WOMEN; AIR-POLLUTION; EXPOSURE; RISK; ASSOCIATION	Objective To investigate the incidence of preterm delivery in the Belgian population after implementation of smoke-free legislation in three phases (in public places and most workplaces January 2006, in restaurants January 2007, and in bars serving food January 2010). Design Logistic regression analyses on routinely collected birth data from January 2002 to December 2011. Setting Flanders, Belgium. Population All live born singleton births delivered at 24-44 weeks of gestation (n=606 877, with n=448 520 spontaneous deliveries). Main outcome measures Preterm birth (gestational age <37 weeks). Results We found reductions in the risk of preterm birth after the introduction of each phase of the smoking ban. No decreasing trend was evident in the years or months before the bans. We observed a step change in the risk of spontaneous preterm delivery of -3.13% (95% CI -4.37% to -1.87%; P<0.01) on 1 January 2007 (ban on smoking in restaurants), and an annual slope change of -2.65% (-5.11% to -0.13%; P=0.04) after 1 January 2010 (ban on smoking in bars serving food). The analysis for all births gave similar results: a step change of -3.18% (-5.38% to -0.94%; P<0.01) on 1 January 2007, and an annual slope change of -3.50% (-6.35% to -0.57%; P=0.02) after 1 January 2010. These changes could not be explained by personal factors (infant sex, maternal age, parity, socioeconomic status, national origin, level of urbanisation); time related factors (underlying trends, month of the year, day of the week); or population related factors (public holidays, influenza epidemics, and short term changes in apparent temperature and particulate air pollution). Conclusion Our study shows a consistent pattern of reduction in the risk of preterm delivery with successive population interventions to restrict smoking. This finding is not definitive but it supports the notion that smoking bans have public health benefits from early life.	[Cox, Bianca; Vangronsveld, Jaco; Nawrot, Tim S.] Hasselt Univ, Ctr Environm Sci, B-3590 Diepenbeek, Belgium; [Martens, Evelyne] Study Ctr Perinatal Epidemiol, Brussels, Belgium; [Nemery, Benoit; Nawrot, Tim S.] Univ Leuven KU Leuven, Dept Publ Hlth, Louvain, Belgium	Hasselt University; KU Leuven	Nawrot, TS (corresponding author), Hasselt Univ, Ctr Environm Sci, B-3590 Diepenbeek, Belgium.	tim.nawrot@uhasselt.be	Nemery, Benoit/D-1224-2013; Cox, Bianca/A-9480-2015; Vangronsveld, Jaco/ABE-5907-2020; Nemery, Benoit/N-3155-2019; Nawrot, Tim/AAA-4531-2019	Cox, Bianca/0000-0001-9824-6276; Vangronsveld, Jaco/0000-0003-4423-8363; Nemery, Benoit/0000-0003-0571-4689; Nawrot, Tim/0000-0002-3583-3593	Flemish Scientific fund [FWO: G.0.873.11.N.10/1.5.158.09.N.00]; ERC starting grant (ENVIRONAGE); Hasselt University Fund (BOF)	Flemish Scientific fund; ERC starting grant (ENVIRONAGE); Hasselt University Fund (BOF)	The Study Centre for Perinatal Epidemiology is financed and commissioned by the Flemish Centre for Care and Health (Agentschap Zorg en Gezondheid). This study was supported by grants from the Flemish Scientific fund (FWO: G.0.873.11.N.10/1.5.158.09.N.00), ERC starting grant (ENVIRONAGE), and Hasselt University Fund (BOF).	Ahluwalia IB, 1997, AM J EPIDEMIOL, V146, P42; Anonymous, 2009, Morbidity and Mortality Weekly Report, V57, P1373; Ashford KB, 2010, JOGNN-J OBST GYN NEO, V39, P525, DOI 10.1111/j.1552-6909.2010.01169.x; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Basu R, 2010, AM J EPIDEMIOL, V172, P1108, DOI 10.1093/aje/kwq170; Cammu H, 2002, AM J OBSTET GYNECOL, V186, P240, DOI 10.1067/mob.2002.119643; Charafeddine R, 2012, HLTH INTERVIEW SURG; Charrier L, 2010, J PUBLIC HEALTH POL, V31, P51, DOI 10.1057/jphp.2009.43; Crane JMG, 2011, BJOG-INT J OBSTET GY, V118, P865, DOI 10.1111/j.1471-0528.2011.02941.x; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; Dadvand P, 2011, ENVIRON HEALTH PERSP, V119, P1449, DOI 10.1289/ehp.1003241; Dexia Bank NV, 2007, SOC TYP GEM; El-Mohandes AAE, 2010, PEDIATRICS, V125, P721, DOI 10.1542/peds.2009-1809; Engle WA, 2007, PEDIATRICS, V120, P1390, DOI 10.1542/peds.2007-2952; Fantuzzi G, 2007, PAEDIATR PERINAT EP, V21, P194, DOI 10.1111/j.1365-3016.2007.00815.x; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Gallus S, 2007, PREV MED, V45, P198, DOI 10.1016/j.ypmed.2007.03.009; Halleux JM, 2009, SOCIAAL EC ENQUETE 2; Hanke W, 1999, HUM EXP TOXICOL, V18, P265, DOI 10.1191/096032799678840020; Harrel F.E., 2001, REGRESSION MODELING; Haw SJ, 2007, BRIT MED J, V335, P549, DOI 10.1136/bmj.39315.670208.47; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jaakkola JJK, 2001, ENVIRON HEALTH PERSP, V109, P557, DOI 10.2307/3455027; Janssen S, 2008, ATMOS ENVIRON, V42, P4884, DOI 10.1016/j.atmosenv.2008.02.043; Kabir Z, 2009, BJOG-INT J OBSTET GY, V116, P1782, DOI 10.1111/j.1471-0528.2009.02374.x; KALKSTEIN LS, 1986, B AM METEOROL SOC, V67, P842, DOI 10.1175/1520-0477(1986)067<0842:AEOSDI>2.0.CO;2; Keirse MJNC, 2009, PAEDIATR PERINAT EP, V23, P522, DOI 10.1111/j.1365-3016.2009.01067.x; Kharrazi M, 2004, EPIDEMIOLOGY, V15, P660, DOI 10.1097/01.ede.0000142137.39619.60; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lang JM, 1996, EPIDEMIOLOGY, V7, P369, DOI 10.1097/00001648-199607000-00006; Lee BE, 2003, EPIDEMIOLOGY, P14; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; Liu SL, 2003, ENVIRON HEALTH PERSP, V111, P1773, DOI 10.1289/ehp.6251; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Mackay DF, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001175; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McIntire DD, 2008, OBSTET GYNECOL, V111, P35, DOI 10.1097/01.AOG.0000297311.33046.73; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Mons U, 2012, TOB CONTROL; Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9; Sagiv SK, 2005, ENVIRON HEALTH PERSP, V113, P602, DOI 10.1289/ehp.7646; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; Schick S, 2005, TOB CONTROL, V14, P396, DOI 10.1136/tc.2005.011288; Shah NR, 2000, AM J OBSTET GYNECOL, V182, P465, DOI 10.1016/S0002-9378(00)70240-7; Sheldon T, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5503; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Van Casteren V, 2010, ARCH PUBLIC HEALTH, V68, P62, DOI 10.1186/0778-7367-68-2-62; VILLAR J, 1986, EARLY HUM DEV, V14, P307, DOI 10.1016/0378-3782(86)90193-3; Vlaamse Liga tegen Kanker, 2011, GEDW MEER WET; Windham GC, 2000, EPIDEMIOLOGY, V11, P427, DOI 10.1097/00001648-200007000-00011; Xu XP, 1995, ARCH ENVIRON HEALTH, V50, P407, DOI 10.1080/00039896.1995.9935976	52	33	33	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2013	346								f441	10.1136/bmj.f441	http://dx.doi.org/10.1136/bmj.f441			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091ZR	23412829	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000315088800009
J	Patel, K				Patel, Kinesh			End the silence on animal products in drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk						Humane Research Council, 2012, VEG FOODS MARK ASS 2	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2013	346								f722	10.1136/bmj.f722	http://dx.doi.org/10.1136/bmj.f722			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088AR	23386407				2022-12-24	WOS:000314806700009
J	Bennartz, R; Shupe, MD; Turner, DD; Walden, VP; Steffen, K; Cox, CJ; Kulie, MS; Miller, NB; Pettersen, C				Bennartz, R.; Shupe, M. D.; Turner, D. D.; Walden, V. P.; Steffen, K.; Cox, C. J.; Kulie, M. S.; Miller, N. B.; Pettersen, C.			July 2012 Greenland melt extent enhanced by low-level liquid clouds	NATURE			English	Article							ICE-SHEET; ARCTIC SURFACE; SNOW	Melting of the world's major ice sheets can affect human and environmental conditions by contributing to sea-level rise. In July 2012, an historically rare period of extended surface melting was observed across almost the entire Greenland ice sheet(1,2), raising questions about the frequency and spatial extent of such events. Here we show that low-level clouds consisting of liquid water droplets ('liquid clouds'), via their radiative effects, played a key part in this melt event by increasing near-surface temperatures. We used a suite of surface-based observations(3), remote sensing data, and a surface energy-balance model. At the critical surface melt time, the clouds were optically thick enough and low enough to enhance the down-welling infrared flux at the surface. At the same time they were optically thin enough to allow sufficient solar radiation to penetrate through them and raise surface temperatures above the melting point. Outside this narrow range in cloud optical thickness, the radiative contribution to the surface energy budget would have been diminished, and the spatial extent of this melting event would have been smaller. We further show that these thin, low-level liquid clouds occur frequently, both over Greenland and across the Arctic, being present around 30-50 per cent of the time(3-6). Our results may help to explain the difficulties that global climate models have in simulating the Arctic surface energy budget(7-9), particularly as models tend to under-predict the formation of optically thin liquid clouds at supercooled temperatures(6)-a process potentially necessary to account fully for temperature feedbacks in a warming Arctic climate.	[Bennartz, R.] Univ Wisconsin, Madison, WI 53706 USA; [Shupe, M. D.; Steffen, K.] Univ Colorado, CIRES, Boulder, CO 80305 USA; [Shupe, M. D.; Steffen, K.] NOAA, ESRL, Boulder, CO 80305 USA; [Turner, D. D.] NOAA, Natl Severe Storms Lab, Norman, OK 73072 USA; [Walden, V. P.; Cox, C. J.] Univ Idaho, Dept Geog, Moscow, ID 83844 USA; [Steffen, K.] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Kulie, M. S.; Miller, N. B.; Pettersen, C.] Univ Wisconsin, Space Sci & Engn Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Idaho; University of Idaho; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Wisconsin System; University of Wisconsin Madison	Bennartz, R (corresponding author), Univ Wisconsin, Madison, WI 53706 USA.	bennartz@aos.wisc.edu	Bennartz, Ralf/F-3760-2010; Pettersen, Claire/H-2687-2018; Kulie, Mark/C-3289-2011; Steffen, Konrad/C-6027-2013; Shupe, Matthew/F-8754-2011; Cox, Christopher/O-4276-2016; Turner, David D/E-5180-2016	Pettersen, Claire/0000-0002-8685-6242; Kulie, Mark/0000-0003-1400-1007; Steffen, Konrad/0000-0001-8658-1026; Shupe, Matthew/0000-0002-0973-9982; Cox, Christopher/0000-0003-2203-7173; Turner, David D/0000-0003-1097-897X; Bennartz, Ralf/0000-0001-7133-9659	US National Science Foundation, Arctic Observing Network (AON) programme [ARC-0904152, 0856773, 0856559]; Directorate For Geosciences [1314156, 1304692, 0856773, 0856559] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1303879, 1414314] Funding Source: National Science Foundation	US National Science Foundation, Arctic Observing Network (AON) programme(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	ICECAPS is supported by the US National Science Foundation (grants ARC-0904152, 0856773 and 0856559) as part of the Arctic Observing Network (AON) programme. Two-metre temperature and radar measurements were provided by the NOAA Earth System Research Laboratory. Lidar and ceilometer measurements were provided by the Department of Energy Atmospheric Radiation Measurement programme. We thank the extended ICECAPS team of scientists, engineers, students and field technicians for obtaining high-quality atmosphere and cloud observations at Summit.	Bintanja R, 1996, INT J CLIMATOL, V16, P1281, DOI 10.1002/(SICI)1097-0088(199611)16:11<1281::AID-JOC83>3.0.CO;2-A; BRANDT RE, 1993, J GLACIOL, V39, P99, DOI 10.3189/S0022143000015756; Brandt RE, 1997, J GLACIOL, V43, P339, DOI 10.3189/S0022143000003294; Cesana G, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053385; CLAUSEN HB, 1988, ANN GLACIOLOGY, V0010; Cox CJ, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017164; de Boer G, 2012, J CLIMATE, V25, P2676, DOI 10.1175/JCLI-D-11-00228.1; Hudson SR, 2005, J CLIMATE, V18, P1673, DOI 10.1175/JCLI3360.1; Intrieri JM, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000439; Klein SA, 2009, Q J ROY METEOR SOC, V135, P979, DOI 10.1002/qj.416; Mernild SH, 2011, J GLACIOL, V57, P621, DOI 10.3189/002214311797409712; Munneke PK, 2009, CRYOSPHERE, V3, P155; Nghiem SV, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053611; Ohmura A, 2001, J APPL METEOROL, V40, P753, DOI 10.1175/1520-0450(2001)040<0753:PBFTTB>2.0.CO;2; Ohmura A, 1998, B AM METEOROL SOC, V79, P2115, DOI 10.1175/1520-0477(1998)079<2115:BSRNBW>2.0.CO;2; Pavolonis MJ, 2003, J APPL METEOROL, V42, P827, DOI 10.1175/1520-0450(2003)042<0827:ACRFAT>2.0.CO;2; Persson POG, 2012, CLIM DYNAM, V39, P1349, DOI 10.1007/s00382-011-1196-9; Sandvik A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007351; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Shupe MD, 2011, J APPL METEOROL CLIM, V50, P626, DOI 10.1175/2010JAMC2467.1; Shupe MD, 2013, B AM METEOROL SOC, V94, P169, DOI 10.1175/BAMS-D-11-00249.1; Shupe MD, 2004, J CLIMATE, V17, P616, DOI 10.1175/1520-0442(2004)017<0616:CRFOTA>2.0.CO;2; Steffen K, 2001, J GEOPHYS RES-ATMOS, V106, P33951, DOI 10.1029/2001JD900161; Turner DD, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008530; Turner DD, 2007, B AM METEOROL SOC, V88, P177, DOI 10.1175/BAMS-88-2-177; Turner DD, 2007, IEEE T GEOSCI REMOTE, V45, P3680, DOI 10.1109/TGRS.2007.903703	26	217	221	1	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					83	86		10.1038/nature12002	http://dx.doi.org/10.1038/nature12002			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23552947				2022-12-24	WOS:000316993400029
J	Kontoyiannis, DP				Kontoyiannis, Dimitrios P.			Preventing Fungal Disease in Chronically Immunosuppressed Outpatients: Time for Action?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Kontoyiannis, DP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Unit 402, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dkontoyi@mdanderson.org			MD Anderson Cancer Center [CA016672]; Frances King Black Endowed Professorship for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	MD Anderson Cancer Center; Frances King Black Endowed Professorship for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported in part by the MD Anderson Cancer Center (grant CA016672). Dr. Kontoyiannis is the recipient of the Frances King Black Endowed Professorship for Cancer Research.	Bieri S, 2011, EUR J HAEMATOL, V87, P138, DOI 10.1111/j.1600-0609.2011.01638.x; Centers for Disease Control and Prevention (CDC), HEALTHC ASS INF GUID; Centers for Disease Control and Prevention (CDC), HEALTHC ASS INF BAS; Kontoyiannis DP, 2011, BONE MARROW TRANSPL, V46, P165, DOI 10.1038/bmt.2010.256; Lass-Florl C, 2007, J CLIN MICROBIOL, V45, P2686, DOI 10.1128/JCM.00917-07; Panackal AA, 2010, CLIN INFECT DIS, V50, P1588, DOI 10.1086/652761; Partridge-Hinckley K, 2009, MYCOPATHOLOGIA, V168, P329, DOI 10.1007/s11046-009-9247-z; Raad I, 2002, INFECT CONT HOSP EP, V23, P532, DOI 10.1086/502102; Sipsas NV, 2008, INFECTION, V36, P515, DOI 10.1007/s15010-008-8129-5; Warris A, 2010, J HOSP INFECT, V76, P56, DOI 10.1016/j.jhin.2010.03.014	10	5	5	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2013	158	7					555	+		10.7326/0003-4819-158-7-201304020-00007	http://dx.doi.org/10.7326/0003-4819-158-7-201304020-00007			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	123VM	23546567				2022-12-24	WOS:000317419400006
J	Gatsogiannis, C; Lang, AE; Meusch, D; Pfaumann, V; Hofnagel, O; Benz, R; Aktories, K; Raunser, S				Gatsogiannis, Christos; Lang, Alexander E.; Meusch, Dominic; Pfaumann, Vanda; Hofnagel, Oliver; Benz, Roland; Aktories, Klaus; Raunser, Stefan			A syringe-like injection mechanism in Photorhabdus luminescens toxins	NATURE			English	Article							PORE FORMATION; INSECTICIDAL TOXINS; PROTEIN TOXINS; ANTHRAX TOXIN; COMPLEX; BACTERIUM	Photorhabdus luminescens is an insect pathogenic bacterium that is symbiotic with entomopathogenic nematodes(1). On invasion of insect larvae, P. luminescens is released from the nematodes and kills the insect through the action of a variety of virulence factors including large tripartite ABC-type toxin complexes(2) (Tcs). Tcs are typically composed of TcA, TcB and TcC proteins and are biologically active only when complete(3-5). Functioning as ADP-ribosyltransferases, TcC proteins were identified as the actual functional components that induce actin-clustering, defects in phagocytosis and cell death(5-7). However, little is known about the translocation of TcC into the cell by the TcA and TcB components. Here we show that TcA in P. luminescens (TcdA1) forms a transmembrane pore and report its structure in the prepore and pore state determined by cryoelectron microscopy. We find that the TcdA1 prepore assembles as a pentamer forming an alpha-helical, vuvuzela-shaped channel less than 1.5 nanometres in diameter surrounded by a large outer shell. Membrane insertion is triggered not only at low pH as expected, but also at high pH, explaining Tc action directly through the midgut of insects(8). Comparisons with structures of the TcdA1 pore inserted into a membrane and in complex with TcdB2 and TccC3 reveal large conformational changes during membrane insertion, suggesting a novel syringe-like mechanism of protein translocation. Our results demonstrate how ABC-type toxin complexes bridge a membrane to insert their lethal components into the cytoplasm of the host cell. We believe that the proposed mechanism is characteristic of the whole ABC-type toxin family. This explanation of toxin translocation is a step towards understanding the host-pathogen interaction and the complex life cycle of P. luminescens and other pathogens, including human pathogenic bacteria, and serves as a strong foundation for the development of biopesticides.	[Gatsogiannis, Christos; Meusch, Dominic; Hofnagel, Oliver; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Lang, Alexander E.; Pfaumann, Vanda; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxik, D-79104 Freiburg, Germany; [Benz, Roland] Jacobs Univ Bremen, Sch Engn & Sci, D-28759 Bremen, Germany	Max Planck Society; University of Freiburg; Jacobs University	Raunser, S (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany.	stefan.raunser@mpi-dortmund.mpg.de	Aktories, Klaus/CAJ-5682-2022; Raunser, Stefan/AHE-1573-2022; Gatsogiannis, Christos/K-1012-2018	Aktories, Klaus/0000-0002-5397-0436; Gatsogiannis, Christos/0000-0002-4922-4545; Benz, Roland/0000-0002-9510-9265; Raunser, Stefan/0000-0001-9373-3016	Deutsche Forschungsgemeinschaft [RA 1781/1-1, AK 6/22-1]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We are grateful to R. S. Goody for continuous support and for comments on the manuscript. We thank I. Vetter for stimulating discussions. This work was supported by the Deutsche Forschungsgemeinschaft grants RA 1781/1-1 (S. R.) and AK 6/22-1 (K. A.) and by Max Planck Society (S.R.).	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; DOW JAT, 1984, AM J PHYSIOL, V246, pR633, DOI 10.1152/ajpregu.1984.246.4.R633; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; Ffrench-Constant R, 2003, FEMS MICROBIOL REV, V26, P433, DOI 10.1111/j.1574-6976.2003.tb00625.x; ffrench-Constant RH, 2000, CELL MOL LIFE SCI, V57, P828, DOI 10.1007/s000180050044; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Joyce SA, 2006, CURR OPIN MICROBIOL, V9, P127, DOI 10.1016/j.mib.2006.01.004; Katayama H, 2010, P NATL ACAD SCI USA, V107, P3453, DOI 10.1073/pnas.1000100107; Landsberg MJ, 2011, P NATL ACAD SCI USA, V108, P20544, DOI 10.1073/pnas.1111155108; Lang AE, 2011, N-S ARCH PHARMACOL, V383, P227, DOI 10.1007/s00210-010-0579-5; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; MILSTEAD JE, 1979, J INVERTEBR PATHOL, V33, P324, DOI 10.1016/0022-2011(79)90033-8; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramon E, 2007, J BIOL CHEM, V282, P14272, DOI 10.1074/jbc.M611091200; Rusu M, 2012, J STRUCT BIOL, V178, P121, DOI 10.1016/j.jsb.2012.03.001; Sheets JJ, 2011, J BIOL CHEM, V286, P22742, DOI 10.1074/jbc.M111.227009; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	25	91	95	2	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					520	523		10.1038/nature11987	http://dx.doi.org/10.1038/nature11987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23515159				2022-12-24	WOS:000316682800048
J	Jaccard, SL; Hayes, CT; Martinez-Garcia, A; Hodell, DA; Anderson, RF; Sigman, DM; Haug, GH				Jaccard, S. L.; Hayes, C. T.; Martinez-Garcia, A.; Hodell, D. A.; Anderson, R. F.; Sigman, D. M.; Haug, G. H.			Two Modes of Change in Southern Ocean Productivity Over the Past Million Years	SCIENCE			English	Article							CARBON-DIOXIDE CONCENTRATION; SEA-ICE; CO2; MARINE; VARIABILITY; SEDIMENT; RECORDS; IMPACT; EXPORT; CYCLE	Export of organic carbon from surface waters of the Antarctic Zone of the Southern Ocean decreased during the last ice age, coinciding with declining atmospheric carbon dioxide (CO2) concentrations, signaling reduced exchange of CO2 between the ocean interior and the atmosphere. In contrast, in the Subantarctic Zone, export production increased into ice ages coinciding with rising dust fluxes, thus suggesting iron fertilization of subantarctic phytoplankton. Here, a new high-resolution productivity record from the Antarctic Zone is compiled with parallel subantarctic data over the past million years. Together, they fit the view that the combination of these two modes of Southern Ocean change determines the temporal structure of the glacial-interglacial atmospheric CO2 record, including during the interval of "lukewarm" interglacials between 450 and 800 thousand years ago.	[Jaccard, S. L.; Martinez-Garcia, A.; Haug, G. H.] Swiss Fed Inst Technol, Inst Geol, Dept Earth Sci, Zurich, Switzerland; [Hayes, C. T.; Anderson, R. F.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Hodell, D. A.] Univ Cambridge, Dept Earth Sci, Godwin Lab Paleoclimate Res, Cambridge CB2 3EQ, England; [Sigman, D. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Hayes, C. T.; Anderson, R. F.] Columbia Univ, Dept Earth & Environm Sci, New York, NY USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Columbia University; University of Cambridge; Princeton University; Columbia University	Jaccard, SL (corresponding author), Swiss Fed Inst Technol, Inst Geol, Dept Earth Sci, Zurich, Switzerland.	samuel.jaccard@erdw.ethz.ch	Sigman, Daniel M/A-2649-2008; Jaccard, Samuel/G-3447-2014; Hayes, Christopher T/P-3145-2016; Martínez-García, Alfredo/A-6244-2010	Sigman, Daniel M/0000-0002-7923-1973; Jaccard, Samuel/0000-0002-5793-0896; Hayes, Christopher T/0000-0002-5636-2989; Martínez-García, Alfredo/0000-0002-7206-5079; Anderson, Robert/0000-0002-8472-2494; Hodell, David/0000-0001-8537-1588	Swiss National Science Foundation (SNSF); Deutsche Forschungsgemeinschaft (DFG); U.S. National Science Foundation; Comer Science and Education Foundation; Natural Environment Research Council [NE/H009930/1] Funding Source: researchfish; NERC [NE/H009930/1] Funding Source: UKRI	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); U.S. National Science Foundation(National Science Foundation (NSF)); Comer Science and Education Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank S. Stefer for performing the XRF scanning measurements at the University of Bremen. We also acknowledge the Integrated Ocean Drilling Program for providing the samples used in this study and U. Rohl, A. Wulbers and W. Hale for their support at the Bremen IODP core repository. This research used data acquired at the XRF Core Scanner Laboratory at the MARUM - Center for Marine Environmental Sciences, University of Bremen. We further thank E. D. Galbraith as well as three anonymous reviewers, whose comments improved the manuscript. Financial support for this work was provided by the Swiss National Science Foundation (SNSF), the Deutsche Forschungsgemeinschaft (DFG), the U.S. National Science Foundation, and the Comer Science and Education Foundation.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Bereiter B, 2012, P NATL ACAD SCI USA, V109, P9755, DOI 10.1073/pnas.1204069109; Brovkin V, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001380; de Boer AM, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2005PA001242; DiFiore PJ, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003216; Dymond J, 1992, PALEOCEANOGRAPHY, V7, P163, DOI 10.1029/92PA00181; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Hain MP, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003790; Hodell D., 2003, P OC DRILL PROGR SCI, V177; Hodell D. A., 1999, P OC DRILL PROGR IN; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Horn MG, 2011, EARTH PLANET SC LETT, V310, P334, DOI 10.1016/j.epsl.2011.08.016; Jaccard SL, 2010, QUATERNARY SCI REV, V29, P206, DOI 10.1016/j.quascirev.2009.10.007; Keeling RF, 2001, PALEOCEANOGRAPHY, V16, P112, DOI 10.1029/2000PA000529; Keir RS, 1988, PALEOCEANOGRAPHY, V3, P413, DOI 10.1029/PA003i004p00413; Kemp AES, 2010, QUATERNARY SCI REV, V29, P1993, DOI 10.1016/j.quascirev.2010.04.027; Kleiven H. F., 2003, P OC DRILL PROGR SCI, V177; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; Lang N, 2011, CLIM PAST, V7, P361, DOI 10.5194/cp-7-361-2011; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lefevre N, 1999, GLOBAL BIOGEOCHEM CY, V13, P727, DOI 10.1029/1999GB900034; Lourey MJ, 2001, J GEOPHYS RES-OCEANS, V106, P31463, DOI 10.1029/2000JC000287; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Marinov I, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002958; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; Nielsen SHH, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001618; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Russell JL, 2006, J CLIMATE, V19, P6382, DOI 10.1175/JCLI3984.1; Sayles FL, 2001, DEEP-SEA RES PT II, V48, P4323, DOI 10.1016/S0967-0645(01)00091-1; Schneider-Mor A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022543; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Watson AJ, 2006, TELLUS B, V58, P73, DOI 10.1111/j.1600-0889.2005.00167.x; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Zonneveld KAF, 2010, BIOGEOSCIENCES, V7, P483, DOI 10.5194/bg-7-483-2010	37	165	173	2	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1419	1423		10.1126/science.1227545	http://dx.doi.org/10.1126/science.1227545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520109	Green Submitted			2022-12-24	WOS:000316740700039
J	Farrell, L				Farrell, Liam			THE BEST MEDICINE A curious case of childhood obesity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2013	346								f1705	10.1136/bmj.f1705	http://dx.doi.org/10.1136/bmj.f1705			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113LR	23507538				2022-12-24	WOS:000316669700003
J	Appleby, J				Appleby, John			The hospital bed: on its way out?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						[Anonymous], 2012, GUARDIAN; *DEP HLTH, 2007, HOSP ORG SPEC MIX MR; Department of Health, 1992, STAT B, V2, P92; Department of Health, 2012, BED AV OCC OV TIM SE; King Edward's Hospital Fund for London, 1967, DES HOSP BEDST; Lawrence G., 2001, LANCET, DOI [10.1016/S0140-6736(01)05957-8, DOI 10.1016/S0140-6736(01)05957-8]; Lawrence G, 2001, THESIS U LONDON; Organisation for Economic Cooperation and Development, OECD HLTH DAT 2012 F	8	16	16	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2013	346								f1563	10.1136/bmj.f1563	http://dx.doi.org/10.1136/bmj.f1563			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108VM	23482956				2022-12-24	WOS:000316324300013
J	Arie, S				Arie, Sophie			Inquiry launched into newspaper story about babies on "death pathway"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sophiearie@fmail.co.uk						[Anonymous], 2012, BMJ, V345, pe7319, DOI 10.1136/bmj.e7319	1	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2013	346								f1273	10.1136/bmj.f1273	http://dx.doi.org/10.1136/bmj.f1273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	149WE	23447346				2022-12-24	WOS:000319351300004
J	Johnson, RH; Chien, FL; Bleyer, A				Johnson, Rebecca H.; Chien, Franklin L.; Bleyer, Archie			Incidence of Breast Cancer With Distant Involvement Among Women in the United States, 1976 to 2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AGE	Importance Evidence from the US National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) database suggests that the incidence of advanced breast cancer in young women is increasing. Objective To quantify this trend and analyze it as a function of stage at diagnosis, race/ethnicity, residence, and hormone receptor status. Design, Setting, and Patients Breast cancer incidence, incidence trends, and survival rates as a function of age and extent of disease at diagnosis were obtained from 3 SEER registries that provide data spanning 1973-2009, 1992-2009, and 2000-2009. SEER defines localized as disease confined to the breast, regional to contiguous and adjacent organ spread (eg, lymph nodes, chest wall), and distant disease to remote metastases (bone, brain, lung, etc). Main Outcome Measure Breast cancer incidence trends in the United States. Results In the United States, the incidence of breast cancer with distant involvement at diagnosis increased in 25- to 39-year-old women from 1.53 (95% CI, 1.01 to 2.21) per 100 000 in 1976 to 2.90 (95% CI, 2.31 to 3.59) per 100 000 in 2009. This is an absolute difference of 1.37 per 100 000, representing an average compounded increase of 2.07% per year (95% CI, 1.57% to 2.58%; P<.001) over the 34-year interval. No other age group or extent-of-disease subgroup of the same age range had a similar increase. For 25- to 39-year-olds, there was an increased incidence in distant disease among all races and ethnicities evaluated, especially non-Hispanic white and African American, and this occurred in both metropolitan and nonmetropolitan areas. Incidence for women with estrogen receptor-positive subtypes increased more than for women with estrogen receptor-negative subtypes. Conclusion and Relevance Based on SEER data, there was a small but statistically significant increase in the incidence of breast cancer with distant involvement in the United States between 1976 and 2009 for women aged 25 to 39 years, without a corresponding increase in older women. JAMA. 2013;309(8):800-805 www.jama.com	[Johnson, Rebecca H.; Chien, Franklin L.] Univ Washington, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Chien, Franklin L.] Swarthmore Coll, Swarthmore, PA 19081 USA; [Bleyer, Archie] St Charles Hlth Syst, Cent Oregon, Portland, OR USA; [Bleyer, Archie] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Swarthmore College; Oregon Health & Science University	Johnson, RH (corresponding author), Seattle Childrens Hosp, MB 8501,POB 5371, Seattle, WA 98105 USA.	rebecca.johnson@seattlechildrens.com			Seattle Children's Guild Association	Seattle Children's Guild Association	Mr Chien's salary was funded by the Seattle Children's Guild Association Teen Cancer Grant.	Anders CK, 2009, SEMIN ONCOL, V36, P237, DOI 10.1053/j.seminoncol.2009.03.001; [Anonymous], 2000, POP EST STAT INT EST; [Anonymous], SEER DAT 1973 2009 I; Bleyer A, 2008, NAT REV CANCER, V8, P288, DOI 10.1038/nrc2349; Bouchardy C, 2007, BRIT J CANCER, V96, P1743, DOI 10.1038/sj.bjc.6603783; Department of Health and Human Services National Institutes of Health National Cancer Institute LiveStrong Young Adult Alliance, CLOS GAP RES CAR IMP; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; Jung SY, 2012, CANCER CAUSE CONTROL, V23, P103, DOI 10.1007/s10552-011-9859-8; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; National Cancer Institute, 2018, SEER STAT DAT INC SE; People and society: United States, PEOPL SOC US; Welch HG, 2011, OVERDIAGNOSED MAKING, P84	12	219	224	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					800	805		10.1001/jama.2013.776	http://dx.doi.org/10.1001/jama.2013.776			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23443443	Bronze			2022-12-24	WOS:000315332200025
J	Braumuller, H; Wieder, T; Brenner, E; Assmann, S; Hahn, M; Alkhaled, M; Schilbach, K; Essmann, F; Kneilling, M; Griessinger, C; Ranta, F; Ullrich, S; Mocikat, R; Braungart, K; Mehra, T; Fehrenbacher, B; Berdel, J; Niessner, H; Meier, F; van den Broek, M; Haring, HU; Handgretinger, R; Quintanilla-Martinez, L; Fend, F; Pesic, M; Bauer, J; Zender, L; Schaller, M; Schulze-Osthoff, K; Rocken, M				Braumueller, Heidi; Wieder, Thomas; Brenner, Ellen; Assmann, Sonja; Hahn, Matthias; Alkhaled, Mohammed; Schilbach, Karin; Essmann, Frank; Kneilling, Manfred; Griessinger, Christoph; Ranta, Felicia; Ullrich, Susanne; Mocikat, Ralph; Braungart, Kilian; Mehra, Tarun; Fehrenbacher, Birgit; Berdel, Julia; Niessner, Heike; Meier, Friedegund; van den Broek, Maries; Haering, Hans-Ulrich; Handgretinger, Rupert; Quintanilla-Martinez, Leticia; Fend, Falko; Pesic, Marina; Bauer, Juergen; Zender, Lars; Schaller, Martin; Schulze-Osthoff, Klaus; Roecken, Martin			T-helper-1-cell cytokines drive cancer into senescence	NATURE			English	Article							ONCOGENE-INDUCED SENESCENCE; CD4(+) T-CELLS; TUMOR; SURVEILLANCE; REGRESSION; PATHWAY; P53	Cancer control by adaptive immunity involves a number of defined death(1-8) and clearance(9-11) mechanisms. However, efficient inhibition of exponential cancer growth by T cells and interferon-gamma (IFN-gamma) requires additional undefined mechanisms that arrest cancer cell proliferation(1-5,12,13). Here we show that the combined action of the T-helper-1-cell cytokines IFN-gamma and tumour necrosis factor (TNF) directly induces permanent growth arrest in cancers. To safely separate senescence induced by tumour immunity from oncogene-induced senescence(9-11,14-17), we used a mouse model in which the Simian virus 40 large T antigen (Tag) expressed under the control of the rat insulin promoter creates tumours by attenuating p53- and Rb-mediated cell cycle control(18,19). When combined, IFN-gamma and TNF drive Tag-expressing cancers into senescence by inducing permanent growth arrest in G1/G0, activation of p16INK4a (also known as CDKN2A), and downstream Rb hypophosphorylation at serine 795. This cytokine-induced senescence strictly requires STAT1 and TNFR1 (also known as TNFRSF1A) signalling in addition to p16INK4a. In vivo, Tag-specific T-helper 1 cells permanently arrest Tag-expressing cancers by inducing IFN-gamma- and TNFR1-dependent senescence. Conversely, Tnfr1(-/-) Tag-expressing cancers resist cytokine-induced senescence and grow aggressively, even in TNFR1-expressing hosts. Finally, as IFN-gamma and TNF induce senescence in numerous murine and human cancers, this may be a general mechanism for arresting cancer progression.	[Braumueller, Heidi; Wieder, Thomas; Brenner, Ellen; Assmann, Sonja; Hahn, Matthias; Kneilling, Manfred; Griessinger, Christoph; Braungart, Kilian; Mehra, Tarun; Fehrenbacher, Birgit; Berdel, Julia; Niessner, Heike; Meier, Friedegund; Bauer, Juergen; Schaller, Martin; Roecken, Martin] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; [Alkhaled, Mohammed; Schilbach, Karin; Handgretinger, Rupert] Univ Tubingen, Dept Gen Pediat, D-72076 Tubingen, Germany; [Essmann, Frank] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Griessinger, Christoph] Univ Tubingen, Dept Preclin Imaging & Radiopharm, Werner Siemens Fdn, Lab Preclin Imaging & Imaging Technol, D-72076 Tubingen, Germany; [Ranta, Felicia; Ullrich, Susanne; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med 6, D-72076 Tubingen, Germany; [Mocikat, Ralph] Deutsch Forschungszentrum Gesundheit & Umwelt, Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [van den Broek, Maries] Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland; [Handgretinger, Rupert; Fend, Falko; Schulze-Osthoff, Klaus; Roecken, Martin] German Canc Consortium DKTK, Comprehens Canc Ctr Tubingen, D-72070 Tubingen, Germany; [Quintanilla-Martinez, Leticia; Fend, Falko] Univ Tubingen, Dept Pathol, D-72076 Tubingen, Germany; [Pesic, Marina; Zender, Lars] Univ Tubingen, Dept Internal Med 1, Div Mol Oncol Solid Tumors, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Siemens AG; Siemens Germany; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Zurich; University Zurich Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Rocken, M (corresponding author), Univ Tubingen, Dept Dermatol, Liebermeister Str 25, D-72076 Tubingen, Germany.	mrocken@med.uni-tuebingen.de	Alkhaled, Mohammed/D-3026-2016; Schulze-Osthoff, Klaus/N-9025-2013; van den Broek, Maries/L-6532-2019; Essmann, Frank/ABG-7409-2020; van den Broek, Maries/G-4128-2016; Bauer, Jurgen/B-4656-2008	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Essmann, Frank/0000-0003-4369-8456; Rocken, Martin/0000-0003-3795-7001; van den Broek, Maries/0000-0002-9489-3692; Brenner, Ellen/0000-0002-2019-5074; Bauer, Jurgen/0000-0001-8789-1536	Sander Stiftung [2005.043.2, 2005.043.3]; Deutsche Krebshilfe [109037]; IZKF-Promotionskolleg 'Molekulare Medizin' [1886-0-0, PK 2011-3, PK 2012-1]; Deutsche Forschungsgemeinschaft [SFB 685, SFB 773, Wi 1279/3-1]; German Federal Ministry of Education and Research (BMBF)	Sander Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); IZKF-Promotionskolleg 'Molekulare Medizin'; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors thank A. Knuth, H. G. Rammensee, K. Ghoreschi, J. Bruck, G. Riethmuller, G. Stingl, T. Biedermann and A. Yazdi for discussions, T. Haug for technical support in the chromium release assay, R. Dummer for melanoma samples, W. Kempf for technical support in the cell cycle analysis and S. Lowe for the p16-p19 shRNA concept. The technical assistance of S. Weidemann and M. Dierstein is gratefully acknowledged. This work is part of the doctoral thesis of E.B., S.A., M.H., K.B., J.Berdel and C.G., and was supported by the Sander Stiftung (2005.043.2 and 2005.043.3), the Deutsche Krebshilfe (No. 109037), the IZKF-Promotionskolleg 'Molekulare Medizin' 2010 (1886-0-0), 2011 (PK 2011-3) and 2012 (PK 2012-1), the Deutsche Forschungsgemeinschaft (SFB 685, SFB 773 and Wi 1279/3-1) and in part by the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DzD e.V.).	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Zhang B, 2008, J CLIN INVEST, V118, P1398, DOI 10.1172/JCI33522; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Canova C, 2009, CANCER RES, V69, P2956, DOI 10.1158/0008-5472.CAN-08-2604; Casanovas O, 2005, ONCOGENE, V24, P6597, DOI 10.1038/sj.onc.1208823; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Critchley-Thorne RJ, 2009, P NATL ACAD SCI USA, V106, P9010, DOI 10.1073/pnas.0901329106; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Gurzov EN, 2012, ONCOGENE, V31, P1723, DOI 10.1038/onc.2011.353; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Rocken M, 2010, J CLIN INVEST, V120, P1800, DOI 10.1172/JCI43424; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	30	451	467	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					361	365		10.1038/nature11824	http://dx.doi.org/10.1038/nature11824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23376950	Green Accepted			2022-12-24	WOS:000315312900040
J	Kunins, HV; Farley, TA; Dowell, D				Kunins, Hillary V.; Farley, Thomas A.; Dowell, Deborah			Guidelines for Opioid Prescription: Why Emergency Physicians Need Support	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PAIN; MANAGEMENT		[Kunins, Hillary V.; Farley, Thomas A.; Dowell, Deborah] New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA	New York City Department of Health & Mental Hygiene	Kunins, HV (corresponding author), New York City Dept Hlth & Mental Hyg, 42-09 28th St,19th Floor, Queens, NY 11101 USA.							Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Boscarino JA, 2011, J ADDICT DIS, V30, P185, DOI 10.1080/10550887.2011.581961; Chu J, 2013, NEW YORK CITY EMERGE; Franklin GM, 2008, SPINE, V33, P199, DOI 10.1097/BRS.0b013e318160455c; Manchikanti L, 2011, PAIN PHYSICIAN, V14, P91; Mularski RA, 2006, J GEN INTERN MED, V21, P607, DOI 10.1111/j.1525-1497.2006.00415.x; Paone D, 2001, CITY HLTH INFORM, V30, P23; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; PORTER J, 1980, NEW ENGL J MED, V302, P123; Warner Margaret, 2011, NCHS Data Brief, P1; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	11	21	21	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					841	+		10.7326/0003-4819-158-11-201306040-00631	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00631			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164AA	23567824				2022-12-24	WOS:000320379800008
J	Blackburn, TJ; Olsen, PE; Bowring, SA; McLean, NM; Kent, DV; Puffer, J; McHone, G; Rasbury, ET; Et-Touhami, M				Blackburn, Terrence J.; Olsen, Paul E.; Bowring, Samuel A.; McLean, Noah M.; Kent, Dennis V.; Puffer, John; McHone, Greg; Rasbury, E. Troy; Et-Touhami, Mohammed			Zircon U-Pb Geochronology Links the End-Triassic Extinction with the Central Atlantic Magmatic Province	SCIENCE			English	Article							MASS-EXTINCTION; FLOOD BASALTS; SYNCHRONY; ERUPTIONS; ADJACENT; JERSEY; EVENT	The end-Triassic extinction is characterized by major tosses in both terrestrial and marine diversity, setting the stage for dinosaurs to dominate Earth for the next 136 million years. Despite the approximate coincidence between this extinction and flood basalt volcanism, existing geochronotogic dates have insufficient resolution to confirm eruptive rates required to induce major climate perturbations. Here, we present new zircon uranium-lead (U-Pb) geochronotogic constraints on the age and duration of flood basalt volcanism within the Central Atlantic Magmatic Province. This chronology demonstrates synchroneity between the earliest volcanism and extinction, tests and corroborates the existing astrochronologic time scale, and shows that the release of magma and associated atmospheric flux occurred in four pulses over about 600,000 years, indicating expansive volcanism even as the biologic recovery was under way.	[Blackburn, Terrence J.; Bowring, Samuel A.; McLean, Noah M.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Olsen, Paul E.; Kent, Dennis V.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Kent, Dennis V.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08554 USA; [Puffer, John] Rutgers State Univ, Newark Coll Arts & Sci, Dept Earth & Environm Sci, Newark, NJ 07102 USA; [Rasbury, E. Troy] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Et-Touhami, Mohammed] Univ Mohammed Premier Oujda, Dept Sci Terre, Oujda 60000, Morocco	Massachusetts Institute of Technology (MIT); Columbia University; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Mohammed First University of Oujda	Blackburn, TJ (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	tblackburn@ciw.edu	Et-Touhami, Mohammed/AAX-2737-2020	McLean, Noah/0000-0003-0388-1862; Blackburn, Terrence/0000-0003-0029-0709; Rasbury, Troy/0000-0003-0591-4461; Olsen, Paul/0000-0002-5852-6326; Kent, Dennis/0000-0002-7677-2993	U.S. National Science Foundation [EAR-0446880, EAR-0931839, EAR 0753496, EAR 0345664]; Bahamas Petroleum Company	U.S. National Science Foundation(National Science Foundation (NSF)); Bahamas Petroleum Company	We express our gratitude to S. Burgess, N. Youbi, B. Schoene, J. Ramezani, D. Condon, and two anonymous reviewers. We acknowledge that this work owes much to the collective effort of the EARTHTIME community. We also thank Vulcan Materials and Carolina Sunrock LLC for quarry access, G. Fisher of the Alcatel-Lucent EH&S-Americas for Preakness Basalt cores, B. Smith for the Rossville and York Haven diabase samples, and J. Smoot and N. Ratcliff for access to cores and thin sections. We acknowledge support from the U.S. National Science Foundation (grants EAR-0446880 and EAR-0931839 to S.A.B., EAR 0753496 to P.E.O. and D.V.K., and EAR 0345664 to E.T.R.). P.E.O. received support from the Bahamas Petroleum Company. Data presented in this paper are fully documented in the supplementary materials. U-Pb zircon data are deposited at the Geochron database (www.geochron.org) with SESAR IGSNs SAB000002-SAB00000A, available at www.geochron.org/dataset/html/5QlSoX9SCtJbNfOZbNeXtuwSK.	Bartolini A, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003807; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; BERGER A, 1992, SCIENCE, V255, P560, DOI 10.1126/science.255.5044.560; Cirilli S, 2009, EARTH PLANET SC LETT, V286, P514, DOI 10.1016/j.epsl.2009.07.021; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Deenen MHL, 2011, CAN J EARTH SCI, V48, P1282, DOI 10.1139/E11-015; Deenen MHL, 2010, EARTH PLANET SC LETT, V291, P113, DOI 10.1016/j.epsl.2010.01.003; El Hachimi H., 2012, THESIS CADI AYYAD U; GOTTFRIE.D, 1968, GEOCHIM COSMOCHIM AC, V32, P925, DOI 10.1016/0016-7037(68)90059-8; Gottfried D., 1991, 91322C USGS; Gottfried D., 1991, 91322E USGS; Gottfried D., 1991, 91322F USGS; Greene SE, 2012, GEOLOGY, V40, P1043, DOI 10.1130/G33205.1; Grossman J. N., 1991, 91322J USGS; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Hinnov LA, 2007, STRATIGRAPHY, V4, P239; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; Jourdan F, 2009, LITHOS, V110, P167, DOI 10.1016/j.lithos.2008.12.011; Kent DV, 1999, J GEOPHYS RES-SOL EA, V104, P12831, DOI 10.1029/1999JB900076; Kent DV, 2005, SCIENCE, V307, P240, DOI 10.1126/science.1105826; LEMARCHAND F, 1987, GEOCHIM COSMOCHIM AC, V51, P1071, DOI 10.1016/0016-7037(87)90201-8; Marzoli A, 2004, GEOLOGY, V32, P973, DOI 10.1130/G20652.1; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McHone G., 2003, VOLATILE EMISSIONS C, V136, P14; MORTON N, 2008, INT SUBCOMMISSION JU, V35, P74; Olsen PE, 2003, GEOPH MONOG SERIES, V136, P7; Olsen PE, 2002, GEOL SOC AM SPEC PAP, V356, P505; Olsen PE, 1996, PALAEOGEOGR PALAEOCL, V122, P1, DOI 10.1016/0031-0182(95)00171-9; Puffer JH, 2009, J GEOL, V117, P139, DOI 10.1086/595663; Rampino MR, 2011, SCIENCE, V334, DOI 10.1126/science.1208653; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; Ruhl M, 2011, SCIENCE, V333, P430, DOI 10.1126/science.1204255; Schaller MF, 2011, SCIENCE, V331, P1404, DOI 10.1126/science.1199011; Schoene B, 2010, GEOLOGY, V38, P387, DOI 10.1130/G30683.1; Todo R. P., 1992, SPEC PAP GEOL SOC AM, V268, P233; VANHOUTEN FB, 1962, AM J SCI, V260, P561, DOI 10.2475/ajs.260.8.561; von Hillebrandt A., 2009, GEOLOGIE PALONTOLOGI, V253, P163; Whiteside JH, 2007, PALAEOGEOGR PALAEOCL, V244, P345, DOI 10.1016/j.palaeo.2006.06.035; Whiteside JH, 2010, P NATL ACAD SCI USA, V107, P6721, DOI 10.1073/pnas.1001706107	40	336	346	11	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					941	945		10.1126/science.1234204	http://dx.doi.org/10.1126/science.1234204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23519213	Green Submitted			2022-12-24	WOS:000319344100037
J	Bellan, SE; Fiorella, KJ; Melesse, DY; Getz, WM; Williams, BG; Dushoff, J				Bellan, Steve E.; Fiorella, Kathryn J.; Melesse, Dessalegn Y.; Getz, Wayne M.; Williams, Brian G.; Dushoff, Jonathan			Extra-couple HIV transmission in sub-Saharan Africa: a mathematical modelling study of survey data	LANCET			English	Article							DISCORDANT COUPLES; SEXUAL PARTNERSHIPS; PREVENTION; RISK; INFECTIONS; PREVALENCE; EPIDEMIC; MARRIAGE; COHORT	Background The proportion of heterosexual HIV transmission in sub-Saharan Africa that occurs within cohabiting partnerships, compared with that in single people or extra-couple relationships, is widely debated. We estimated the proportional contribution of different routes of transmission to new HIV infections. As plans to use antiretroviral drugs as a strategy for population-level prevention progress, understanding the importance of different transmission routes is crucial to target intervention efforts. Methods We built a mechanistic model of HIV transmission with data from Demographic and Health Surveys (DHS) for 2003-2011, of 27 201 cohabiting couples (men aged 15-59 years and women aged 15-49 years) from 18 sub-Saharan African countries with information about relationship duration, age at sexual debut, and HIV serostatus. We combined this model with estimates of HIV survival times and country-specific estimates of HIV prevalence and coverage of antiretroviral therapy (ART). We then estimated the proportion of recorded infections in surveyed cohabiting couples that occurred before couple formation, between couple members, and because of extra-couple intercourse. Findings In surveyed couples, we estimated that extra-couple transmission accounted for 27-61% of all HIV infections in men and 21-51% of all those in women, with ranges showing intercountry variation. We estimated that in 2011, extra-couple transmission accounted for 32-65% of new incident HIV infections in men in cohabiting couples, and 10-47% of new infections in women in such couples. Our findings suggest that transmission within couples occurs largely from men to women; however, the latter sex have a very high-risk period before couple formation. Interpretation Because of the large contribution of extra-couple transmission to new HIV infections, interventions for HIV prevention should target the general sexually active population and not only serodiscordant couples.	[Bellan, Steve E.; Fiorella, Kathryn J.; Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Melesse, Dessalegn Y.] Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB R3T 2N2, Canada; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa; [Williams, Brian G.] South African Ctr Epidemiol Modeling & Anal, Stellenbosch, South Africa; [Dushoff, Jonathan] McMaster Univ, Dept Biol, Hamilton, ON, Canada	University of California System; University of California Berkeley; University of Manitoba; University of Kwazulu Natal; McMaster University	Bellan, SE (corresponding author), Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA.	steve.bellan@gmail.com	Bellan, Steve/D-6368-2013; Fiorella, Katie/N-9538-2013; Getz, Wayne/I-4521-2013	Bellan, Steve/0000-0002-4110-272X; Fiorella, Katie/0000-0002-8625-2473; Getz, Wayne/0000-0001-8784-9354; Melesse, Dessalegn Y./0000-0003-3917-5329; Williams, Brian/0000-0002-3174-4876	National Institutes of Health [R24TW008822]; Henry Wheeler Center for Emerging and Neglected Diseases; NSF-NIH Ecology of Infectious Diseases program (NSF) [1134964]; African Institute for Mathematical Sciences; South African Centre for Excellence in Epidemiological Modelling and Analysis; Chang-Lin Tien Environmental Fellowship; Andrew and Mary Thompson Rocca Fellowships; University of California; Berkeley Environmental Science, Policy and Management and Entomology Society; National Science Foundation Graduate Research Fellowship Program; UC Global Health Institute One Health Summer Research Program; Sigma Xi; Andrew and Mary Thompson Rocca Pre-Dissertation Research Award in African Studies; Sara's Wish Foundation; Centre for Global Public Health, University of Manitoba, Canada; National Institutes of Health Ecology of Infectious Disease [GM83863]; J S McDonnell Foundation; FOGARTY INTERNATIONAL CENTER [R24TW008822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry Wheeler Center for Emerging and Neglected Diseases; NSF-NIH Ecology of Infectious Diseases program (NSF); African Institute for Mathematical Sciences; South African Centre for Excellence in Epidemiological Modelling and Analysis; Chang-Lin Tien Environmental Fellowship; Andrew and Mary Thompson Rocca Fellowships; University of California(University of California System); Berkeley Environmental Science, Policy and Management and Entomology Society; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); UC Global Health Institute One Health Summer Research Program; Sigma Xi; Andrew and Mary Thompson Rocca Pre-Dissertation Research Award in African Studies; Sara's Wish Foundation; Centre for Global Public Health, University of Manitoba, Canada; National Institutes of Health Ecology of Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J S McDonnell Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The 2011 Clinic on the Meaningful Modeling of Epidemiological Data, where this work was started, was funded by the National Institutes of Health Framework Programs for Global Health Innovations (grant R24TW008822 to Lee Riley), the Henry Wheeler Center for Emerging and Neglected Diseases, the NSF-NIH Ecology of Infectious Diseases program (NSF award 1134964 to Juliet R C Pulliam), the African Institute for Mathematical Sciences, and the South African Centre for Excellence in Epidemiological Modelling and Analysis. This work was partly supported by a Chang-Lin Tien Environmental Fellowship, Andrew and Mary Thompson Rocca Fellowships, University of California, Berkeley Environmental Science, Policy and Management and Entomology Society Travel Grants to SEB; the National Science Foundation Graduate Research Fellowship Program, UC Global Health Institute One Health Summer Research Program, Sigma Xi Grants-in-Aid of Research, Andrew and Mary Thompson Rocca Pre-Dissertation Research Award in African Studies, and Sara's Wish Foundation to KJF; the Centre for Global Public Health, University of Manitoba, Canada support to DYM; National Institutes of Health Ecology of Infectious Disease grant (GM83863) to WMG; and a J S McDonnell Foundation grant to JD. We thank Juliet R C Pulliam, James C Scott, Travis C Porco, John W Hargrove, Alex Welte, and Wim Delva for their help in organising the Meaningful Modeling of Epidemiological Data workshop where this work was started; Damian Kajunguri, Mateusz Plucinski, and Zindoga Mukandavire for their comments on early versions of this work, and Savannah Nuwagaba for work on early formulations of this project; Juliet R C Pulliam, Paul Cross, Ben Bolker, Andy Lyons, and Karen Weinbaum for their feedback.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bongaarts J, 2007, POP STUD-J DEMOG, V61, P73, DOI 10.1080/00324720601048343; Busch Michael P., 1997, American Journal of Medicine, V102, P117, DOI 10.1016/S0002-9343(97)00077-6; CALDWELL JC, 1989, POPUL DEV REV, V15, P185, DOI 10.2307/1973703; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Chemaitelly H, 2013, SEX TRANSM INFECT, V89, P138, DOI 10.1136/sextrans-2012-050651; Chemaitelly H, 2012, SEX TRANSM INFECT, V88, P51, DOI 10.1136/sextrans-2011-050114; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Curran K, 2012, CURR HIV-AIDS REP, V9, P160, DOI 10.1007/s11904-012-0114-z; De Walque D, 2007, POPUL DEV REV, V33, P501, DOI 10.1111/j.1728-4457.2007.00182.x; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Eyawo O, 2010, LANCET INFECT DIS, V10, P770, DOI 10.1016/S1473-3099(10)70189-4; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; Glynn JR, 2003, JAIDS-J ACQ IMM DEF, V33, P526, DOI 10.1097/00126334-200308010-00015; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Hargrove JW, 2011, EPIDEMICS-NETH, V3, P88, DOI 10.1016/j.epidem.2011.02.004; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Ndase P, 2012, JAIDS-J ACQ IMM DEF, V59, P65, DOI 10.1097/QAI.0b013e318237b864; Padian NS, 2012, JAIDS-J ACQ IMM DEF, V60, pS22, DOI 10.1097/QAI.0b013e31825b7100; Shelton JD, 2008, LANCET, V372, P1299, DOI 10.1016/S0140-6736(08)61545-7; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; UNAIDS, 2010, GLOB REP UNAIDS REP; World Health Organization, 2012, GUID OR PREEXP PROPH; Zachariah R, 2010, T ROY SOC TROP MED H, V104, P387, DOI 10.1016/j.trstmh.2010.01.004	32	47	47	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2013	381	9877					1561	1569		10.1016/S0140-6736(12)61960-6	http://dx.doi.org/10.1016/S0140-6736(12)61960-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139UF	23391466	Green Accepted			2022-12-24	WOS:000318609600031
J	Jiang, H; Khan, S; Wang, Y; Charron, G; He, B; Sebastian, C; Du, JT; Kim, R; Ge, E; Mostoslavsky, R; Hang, HC; Hao, Q; Lin, HN				Jiang, Hong; Khan, Saba; Wang, Yi; Charron, Guillaume; He, Bin; Sebastian, Carlos; Du, Jintang; Kim, Ray; Ge, Eva; Mostoslavsky, Raul; Hang, Howard C.; Hao, Quan; Lin, Hening			SIRT6 regulates TNF-alpha secretion through hydrolysis of long-chain fatty acyl lysine	NATURE			English	Article							HISTONE DEACETYLASE; MAMMALIAN-CELLS; PROTEIN; PRECURSOR; ACYLATION; SIRTUINS; INSIGHTS; NAD(+); MICE	The Sir2 family of enzymes or sirtuins are known as nicotinamide adenine dinucleotide (NAD)-dependent deacetylases(1) and have been implicated in the regulation of transcription, genome stability, metabolism and lifespan(2,3). However, four of the seven mammalian sirtuins have very weak deacetylase activity in vitro. Here we show that human SIRT6 efficiently removes long-chain fatty acyl groups, such as myristoyl, from lysine residues. The crystal structure of SIRT6 reveals a large hydrophobic pocket that can accommodate long-chain fatty acyl groups. We demonstrate further that SIRT6 promotes the secretion of tumour necrosis factor-alpha (TNF-alpha) by removing the fatty acyl modification on K19 and K20 of TNF-alpha. Protein lysine fatty acylation has been known to occur in mammalian cells, but the function and regulatory mechanisms of this modification were unknown. Our data indicate that protein lysine fatty acylation is a novel mechanism that regulates protein secretion. The discovery of SIRT6 as an enzyme that controls protein lysine fatty acylation provides new opportunities to investigate the physiological function of a protein post-translational modification that has been little studied until now.	[Jiang, Hong; Khan, Saba; He, Bin; Du, Jintang; Kim, Ray; Ge, Eva; Lin, Hening] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Wang, Yi; Hao, Quan] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Charron, Guillaume; Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10065 USA; [Sebastian, Carlos; Mostoslavsky, Raul] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA	Cornell University; University of Hong Kong; Rockefeller University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lin, HN (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	qhao@hku.hk; hl379@cornell.edu	Sebastian, Carlos/CAG-6271-2022; Hao, Quan/C-4304-2009; Sebastian, Carlos/H-8014-2018	Sebastian, Carlos/0000-0001-6623-8028; Hao, Quan/0000-0002-9642-0514	NIH [R01GM086703, R01GM093072, R01GM087544];  [GRF766510]; NATIONAL CANCER INSTITUTE [R01CA175727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072, R01GM087544, R01GM086703] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH R01GM086703 (H. L.), R01GM093072 (R. M.), Hong Kong GRF766510 (Q. H.) and NIH R01GM087544 (H. C. H.). We thank C. Zhang for help with the cloning of SIRT6 WT and H133Y to generate lentiviral particles and the staff at the Shanghai Synchrotron Radiation Facility for assistance during the data collection.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Sebastian C, 2008, J IMMUNOL, V180, P5898, DOI 10.4049/jimmunol.180.9.5898; Stephens Samuel B., 2008, V419, P197, DOI 10.1007/978-1-59745-033-1_14; STEVENSON FT, 1993, P NATL ACAD SCI USA, V90, P7245, DOI 10.1073/pnas.90.15.7245; STEVENSON FT, 1992, J EXP MED, V176, P1053, DOI 10.1084/jem.176.4.1053; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Wilson JP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001198; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhu AY, 2012, ACS CHEM BIOL, V7, P155, DOI 10.1021/cb200230x	29	470	486	6	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2013	496	7443					110	+		10.1038/nature12038	http://dx.doi.org/10.1038/nature12038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23552949	Green Accepted, Green Submitted			2022-12-24	WOS:000316993400035
J	McMichael, AJ				McMichael, Anthony J.			Globalization, Climate Change, and Human Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INFECTIOUS-DISEASES; POPULATION HEALTH; GLOBAL TRENDS; IMPACTS; EQUITY; POLICY; ENERGY; WORLD; RISK; FOOD		Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia	Australian National University	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, GPO Box 4, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au						[Anonymous], 2007, CONTRIBUTION WORKING; [Anonymous], 2011, WORLD POP PROSP 2010; Bambrick H., 2008, IMPACTS CLIMATE CHAN; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Beddington JR, 2012, SCIENCE, V335, P289, DOI 10.1126/science.1217941; Butler CD, 2010, J PUBLIC HEALTH-UK, V32, P157, DOI 10.1093/pubmed/fdq039; Butler CD, 2010, POSTGRAD MED J, V86, P230, DOI 10.1136/pgmj.2009.082727; Confalonieri U, 2007, CLIMATE CHANGE 2007, P391, DOI DOI 10.1016/J.JHYDR0L.2011.05.013; Costello A, 2009, LANCET, V373, P1693, DOI 10.1016/S0140-6736(09)60929-6; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; Dai A., 2010, DROUGHT GLOBAL WARMI; Drager N, 2007, B WORLD HEALTH ORGAN, V85, P162, DOI 10.2471/BLT.07.041079; Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079; Evengard B, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.11210; Grace K, 2012, APPL GEOGR, V35, P405, DOI 10.1016/j.apgeog.2012.06.017; Haines A, 2004, BMJ-BRIT MED J, V329, P394, DOI 10.1136/bmj.329.7462.394; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Hansen JE, 2008, PALEOCLIMATE IMPLICA; Hernandez MA, 2010, FIRES RUSSIA WHEAT P; Hibbard K. A., 2007, SUSTAINABILITY COLLA, P417; Hunt A, 2011, CLIMATIC CHANGE, V104, P13, DOI 10.1007/s10584-010-9975-6; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Knowlton K, 2007, AM J PUBLIC HEALTH, V97, P2028, DOI 10.2105/AJPH.2006.102947; Labonte R, 2011, ANNU REV PUBL HEALTH, V32, P263, DOI 10.1146/annurev-publhealth-031210-101225; Lee K, 2012, GLOBAL HLTH DIS PROG, P885; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; McMichael AJ, 2011, J INTERN MED, V270, P401, DOI 10.1111/j.1365-2796.2011.02415.x; McMichael AJ, 2011, ANNU REV PUBL HEALTH, V32, P179, DOI 10.1146/annurev-publhealth-031210-101203; McMichael A. J., 2011, CLIMATE CHANGE GLOBA, P114; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Moore S., 2009, CHINA SECURITY, V5, P25; Oceanic National, 2011, STAT CLIM 2011; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Pencheon D, 2009, J HEALTH SERV RES PO, V14, P2, DOI 10.1258/jhsrp.2008.008147; Perdue ML, 2005, AVIAN DIS, V49, P317, DOI 10.1637/7390-060305R.1; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Scheidel A, 2012, GLOBAL ENVIRON CHANG, V22, P588, DOI 10.1016/j.gloenvcha.2011.12.005; Shibuya K, 2003, BMJ-BRIT MED J, V327, P154, DOI 10.1136/bmj.327.7407.154; Smith K. R., 2009, Commonwealth Health Ministers' Update 2009, P59; Tripp JT., 1988, NEW YORK U J INT LAW, V20, P733; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Welton G., 2011, OXFAM RES REPORT IMP; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188	49	310	317	27	296	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1335	1343		10.1056/NEJMra1109341	http://dx.doi.org/10.1056/NEJMra1109341			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117YT	23550671				2022-12-24	WOS:000316989900010
J	Sawyer, DB				Sawyer, Douglas B.			Anthracyclines and Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DOXORUBICIN		Vanderbilt Univ, Med Ctr, Nashville, TN 37240 USA	Vanderbilt University	Sawyer, DB (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37240 USA.							Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; UNVERFERTH BJ, 1983, CANCER, V52, P215, DOI 10.1002/1097-0142(19830715)52:2<215::AID-CNCR2820520206>3.0.CO;2-F; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	3	98	101	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					1154	1156		10.1056/NEJMcibr1214975	http://dx.doi.org/10.1056/NEJMcibr1214975			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108TH	23514294				2022-12-24	WOS:000316318600011
J	Yokobayashi, S; Liang, CY; Kohler, H; Nestorov, P; Liu, ZC; Vidal, M; van Lohuizen, M; Roloff, TC; Peters, AHFM				Yokobayashi, Shihori; Liang, Ching-Yeu; Kohler, Hubertus; Nestorov, Peter; Liu, Zichuan; Vidal, Miguel; van Lohuizen, Maarten; Roloff, Tim C.; Peters, Antoine H. F. M.			PRC1 coordinates timing of sexual differentiation of female primordial germ cells	NATURE			English	Article							RETINOIC ACID; HOX GENES; MICE; MEIOSIS; FATE; MECHANISMS; EXPRESSION	In mammals, sex differentiation of primordial germ cells (PGCs) is determined by extrinsic cues from the environment(1). In mouse female PGCs, expression of stimulated by retinoic acid gene 8 (Stra8) and meiosis are induced in response to retinoic acid provided from the mesonephroi(2-5). Given the widespread role of retinoic add signalling during development(6,7), the molecular mechanisms that enable PGCs to express Stra8 and enter meiosis in a timely manner are unknown(2,8). Here we identify gene-dosage-dependent roles in PGC development for Ring1 and Rnf2, two central components of the Polycomb repressive complex 1 (PRC1)(9,10). Both paralogues are essential for PGC development between days 10.5 and 11.5 of gestation. Rnf2 is subsequently required in female PGCs to maintain high levels of Oct4 (also known as Pou5f1) and Nanog expression(11), and to prevent premature induction of meiotic gene expression and entry into meiotic prophase. Chemical inhibition of retinoic acid signalling partially suppresses precocious Oct4 downregulation and Stra8 activation in Rnf2-deficient female PGCs. Chromatin immunoprecipitation analyses show that Stra8 is a direct target of PRC1 and PRC2 in PGCs. These data demonstrate the importance of PRC1 gene dosage in PGC development and in coordinating the timing of sex differentiation of female PGCs by antagonizing extrinsic retinoic add signalling.	[Yokobayashi, Shihori; Liang, Ching-Yeu; Kohler, Hubertus; Nestorov, Peter; Liu, Zichuan; Roloff, Tim C.; Peters, Antoine H. F. M.] Friedrich Miescher Inst Biomed Res FMI, CH-4058 Basel, Switzerland; [Liang, Ching-Yeu; Nestorov, Peter; Peters, Antoine H. F. M.] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland; [Vidal, Miguel] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [van Lohuizen, Maarten] Netherlands Canc Inst NKI, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [van Lohuizen, Maarten] Netherlands Canc Inst NKI, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Friedrich Miescher Institute for Biomedical Research; University of Basel; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Netherlands Cancer Institute; Netherlands Cancer Institute	Peters, AHFM (corresponding author), Friedrich Miescher Inst Biomed Res FMI, Maulbeerstr 66, CH-4058 Basel, Switzerland.	antoine.peters@fmi.ch	Peters, Antoine/ABA-6283-2020; Vidal, Miguel/M-8861-2016	Peters, Antoine/0000-0002-0311-1887; Vidal, Miguel/0000-0003-4374-6761; Liang, Ching-Yeu/0000-0002-9027-1853	Human Frontier Science Program long-term fellowship; Japan Society for the Promotion of Science postdoctoral fellowship; Novartis Research Foundation; Swiss National Science Foundation [31003A_125386, NRP 63]; SystemsX.ch; Japanese Swiss Science and Technology Cooperation Program; European Network of Excellence; EMBO Young Investigator program	Human Frontier Science Program long-term fellowship(Human Frontier Science Program); Japan Society for the Promotion of Science postdoctoral fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Novartis Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch; Japanese Swiss Science and Technology Cooperation Program; European Network of Excellence(European Commission); EMBO Young Investigator program(European Molecular Biology Organization (EMBO))	We thank A. Nagy and H. Scholer for the Tnap-cre and Oct4(APE)GFP mice, respectively, and M. Griswold for the Stra8 antibody. We are grateful to L. Gelman (microscopy and imaging), L Burger, M. Stadler (bioinformatics), E Cabuy, S. Thiry, K.Jacobeit (functional genomics) nd the FMI animal facilityfor assistance. We thank members of the Peters laboratory, particularly M. Tardat, S. Erkek and M. Gill, for experimental support and discussions. S.Y. is a recipient of a Human Frontier Science Program long-term fellowship and a Japan Society for the Promotion of Science postdoctoral fellowship. Research in the Peters laboratory is supported by the Novartis Research Foundation, the Swiss National Science Foundation (31003A_125386 and NRP 63-Stem Cells and Regenerative Medicine), SystemsX.ch (Cell plasticity), the Japanese Swiss Science and Technology Cooperation Program, the European Network of Excellence 'The Epigenome' and the EMBO Young Investigator program.	Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Bel-Vialar S, 2000, DEV BIOL, V224, P238, DOI 10.1006/dbio.2000.9791; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Deschamps J, 2007, CURR OPIN GENET DEV, V17, P422, DOI 10.1016/j.gde.2007.07.008; Di Carlo A, 2000, DEV BIOL, V226, P209, DOI 10.1006/dbio.2000.9861; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Hogarth CA, 2011, BIOL REPROD, V84, P957, DOI 10.1095/biolreprod.110.088575; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Posfai E, 2012, GENE DEV, V26, P920, DOI 10.1101/gad.188094.112; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Wojtasz L, 2012, GENE DEV, V26, P958, DOI 10.1101/gad.187559.112; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594	27	79	80	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					236	240		10.1038/nature11918	http://dx.doi.org/10.1038/nature11918			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486062	Green Accepted			2022-12-24	WOS:000316652300051
J	Khullar, D; Schroeder, SA; Maa, J				Khullar, Dhruv; Schroeder, Steven A.; Maa, John			Helping Smokers Quit Around the Time of Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTOPERATIVE COMPLICATIONS; SMOKING-CESSATION; INTERVENTION		[Khullar, Dhruv] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Schroeder, Steven A.] Univ Calif San Francisco, Dept Med, Smoking Cessat Leadership Ctr, San Francisco, CA 94131 USA; [Maa, John] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94131 USA	Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Maa, J (corresponding author), Univ Calif San Francisco, Dept Surg, 521 Parnassus Ave,C 341, San Francisco, CA 94131 USA.	john.maa@ucsfmedctr.org						Baumgardner JR, 2012, NEW ENGL J MED, V367, P2068, DOI 10.1056/NEJMp1210319; Chow CK, 2011, ARCH INTERN MED, V171, P989, DOI 10.1001/archinternmed.2011.88; Khullar D, 2012, J AM COLL SURGEONS, V215, P418, DOI 10.1016/j.jamcollsurg.2012.05.023; Lindstrom D, 2008, ANN SURG, V248, P739, DOI 10.1097/SLA.0b013e3181889d0d; Moller AM, 2002, LANCET, V359, P114, DOI 10.1016/S0140-6736(02)07369-5; Myers K, 2011, ARCH INTERN MED, V171, P983, DOI 10.1001/archinternmed.2011.97; Rigotti NA, 2012, JAMA-J AM MED ASSOC, V308, P1573, DOI 10.1001/jama.2012.13043; *US DEP HHS, 2008, TREAT TOB US DEP 200; Vaughan-Sarrazin M, 2011, SURGERY, V149, P474, DOI 10.1016/j.surg.2010.12.004; Warner DO, 2009, ANESTHESIOLOGY, V110, P1223, DOI 10.1097/ALN.0b013e3181a5d03e	10	8	9	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					993	994		10.1001/jama.2013.1702	http://dx.doi.org/10.1001/jama.2013.1702			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23483172				2022-12-24	WOS:000315938700026
J	Hubbard, BP; Gomes, AP; Dai, H; Li, J; Case, AW; Considine, T; Riera, TV; Lee, JE; Yen, ES; Lamming, DW; Pentelute, BL; Schuman, ER; Stevens, LA; Ling, AJY; Armour, SM; Michan, S; Zhao, HZ; Jiang, Y; Sweitzer, SM; Blum, CA; Disch, JS; Ng, PY; Howitz, KT; Rolo, AP; Hamuro, Y; Moss, J; Perni, RB; Ellis, JL; Vlasuk, GP; Sinclair, DA				Hubbard, Basil P.; Gomes, Ana P.; Dai, Han; Li, Jun; Case, April W.; Considine, Thomas; Riera, Thomas V.; Lee, Jessica E.; Yen, Sook E.; Lamming, Dudley W.; Pentelute, Bradley L.; Schuman, Eli R.; Stevens, Linda A.; Ling, Alvin J. Y.; Armour, Sean M.; Michan, Shaday; Zhao, Huizhen; Jiang, Yong; Sweitzer, Sharon M.; Blum, Charles A.; Disch, Jeremy S.; Ng, Pui Yee; Howitz, Konrad T.; Rolo, Anabela P.; Hamuro, Yoshitomo; Moss, Joel; Perni, Robert B.; Ellis, James L.; Vlasuk, George P.; Sinclair, David A.			Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators	SCIENCE			English	Article							SMALL-MOLECULE ACTIVATORS; MITOCHONDRIAL-FUNCTION; DEACETYLASE ACTIVITY; RESVERATROL; SIRTUINS; SURVIVAL; TRANSCRIPTION; ACETYLATION; MODULATION; SRT1720	A molecule that treats multiple age-related diseases would have a major impact on global health and economics. The SIRT1 deacetylase has drawn attention in this regard as a target for drug design. Yet controversy exists around the mechanism of sirtuin-activating compounds (STACs). We found that specific hydrophobic motifs found in SIRT1 substrates such as PGC-1 alpha and FOXO3a facilitate SIRT1 activation by STACs. A single amino acid in SIRT1, Glu(230), located in a structured N-terminal domain, was critical for activation by all previously reported STAC scaffolds and a new class of chemically distinct activators. In primary cells reconstituted with activation-defective SIRT1, the metabolic effects of STACs were blocked. Thus, SIRT1 can be directly activated through an allosteric mechanism common to chemically diverse STACs.	[Hubbard, Basil P.; Gomes, Ana P.; Li, Jun; Lamming, Dudley W.; Ling, Alvin J. Y.; Armour, Sean M.; Michan, Shaday; Sinclair, David A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Gomes, Ana P.; Rolo, Anabela P.] Univ Coimbra, Dept Life Sci, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Dai, Han; Case, April W.; Considine, Thomas; Riera, Thomas V.; Schuman, Eli R.; Blum, Charles A.; Disch, Jeremy S.; Ng, Pui Yee; Perni, Robert B.; Ellis, James L.; Vlasuk, George P.] Sirtris, Cambridge, MA 02139 USA; [Lee, Jessica E.; Yen, Sook E.; Hamuro, Yoshitomo] ExSAR Corp, Monmouth Jct, NJ 08852 USA; [Pentelute, Bradley L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stevens, Linda A.; Moss, Joel] NHLBI, NIH, Cardiovasc & Pulm Branch, Bethesda, MD 20892 USA; [Zhao, Huizhen; Jiang, Yong; Sweitzer, Sharon M.] GlaxoSmithKline, Collegeville, PA 19426 USA; [Howitz, Konrad T.] BIOMOL Res Labs Inc, Plymouth Meeting, PA 19462 USA; [Rolo, Anabela P.] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Sinclair, David A.] Univ New S Wales, Dept Pharmacol, Sydney, NSW 2052, Australia	Harvard University; Harvard Medical School; Universidade de Coimbra; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); GlaxoSmithKline; Universidade de Aveiro; University of New South Wales Sydney	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	david_sinclair@hms.harvard.edu	Li, Jun/B-8055-2014; Li, Jun/AAF-9234-2021; Rolo, Anabela/AAU-6567-2020; Lamming, Dudley/O-7191-2015; Rolo, Anabela/D-6062-2011	Li, Jun/0000-0002-0179-4151; Rolo, Anabela/0000-0003-3535-9630; Lamming, Dudley/0000-0002-0079-4467; Rolo, Anabela/0000-0003-3535-9630; Disch, Jeremy/0000-0002-0357-1672; Sinclair, David/0000-0002-9936-436X; Lee, Jessica/0000-0002-8567-1633; Hubbard, Basil/0000-0003-4353-9674; Riera, Thomas/0000-0001-7427-2728	Glenn Foundation for Medical Research; Ellison Medical Foundation; Juvenile Diabetes Research Foundation; United Mitochondrial Disease Foundation; NIH; NIAID; NSERC fellowship; Portuguese Science and Technology Foundation; Intramural Research Program; NIH/NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019719, R37AG028730, R01AG028730, P01AG027916] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; Ellison Medical Foundation(Lawrence Ellison Foundation); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); United Mitochondrial Disease Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSERC fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); Intramural Research Program; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Glenn Foundation for Medical Research, the Ellison Medical Foundation, the Juvenile Diabetes Research Foundation, the United Mitochondrial Disease Foundation, NIH and NIAID grants, an NSERC fellowship (B. P. H.), the Portuguese Science and Technology Foundation (A. P. G.), the Intramural Research Program, and NIH/NHLBI (L. A. S. and J.M.). D. A. S. is a consultant and inventor on patents licensed to Sirtris, a GSK company. H. D., A. W. C., T. C., T. V. R., E. R. S., H.Z., Y.J., S. M. S., C. A. B., J.S.D., P.Y.N., R. B. P., J.L.E., and G. P. V. are employees of Sirtris, a GSK company. Dedicated to the memories of Jana Perni and Harmon Rasnow. A patent application on the PNC1-OPT sirtuin assay has been filed by Harvard Medical School with D. A. S. and B. P. H. as inventors. Patent applications related to sirtuin activators have been filed by Sirtris and Biomol. Natural Sirt1 activators will be provided upon request. Synthetic STACs are provided under a material transfer agreement from Sirtris.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bernier M, 2011, J BIOL CHEM, V286, P19270, DOI 10.1074/jbc.M110.200311; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Ghosh HS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00150; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kang H, 2011, MOL CELL, V44, P203, DOI 10.1016/j.molcel.2011.07.038; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pan M, 2012, J BIOL CHEM, V287, P2468, DOI 10.1074/jbc.M111.285031; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; SUGAWARA K, 1981, J BIOCHEM-TOKYO, V89, P771, DOI 10.1093/oxfordjournals.jbchem.a133257; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	29	465	482	4	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1216	1219		10.1126/science.1231097	http://dx.doi.org/10.1126/science.1231097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471411	Green Accepted, Green Published			2022-12-24	WOS:000315709900051
J	Nugent, P; Belmabkhout, Y; Burd, SD; Cairns, AJ; Luebke, R; Forrest, K; Pham, T; Ma, SQ; Space, B; Wojtas, L; Eddaoudi, M; Zaworotko, MJ				Nugent, Patrick; Belmabkhout, Youssef; Burd, Stephen D.; Cairns, Amy J.; Luebke, Ryan; Forrest, Katherine; Pham, Tony; Ma, Shengqian; Space, Brian; Wojtas, Lukasz; Eddaoudi, Mohamed; Zaworotko, Michael J.			Porous materials with optimal adsorption thermodynamics and kinetics for CO2 separation	NATURE			English	Article							METAL-ORGANIC FRAMEWORKS; CARBON-DIOXIDE CAPTURE; COORDINATION POLYMER; PORE-SIZE; DESIGN; ADSORBENTS; ISOMERISM; METHANE; 13X	The energy costs associated with the separation and purification of industrial commodities, such as gases, fine chemicals and fresh water, currently represent around 15 per cent of global energy production, and the demand for such commodities is projected to triple by 2050 (ref. 1). The challenge of developing effective separation and purification technologies that have much smaller energy footprints is greater for carbon dioxide (CO2) than for other gases; in addition to its involvement in climate change, CO2, is an impurity in natural gas, biogas (natural gas produced from biomass), syngas (CO/H-2, the main source of hydrogen in refineries) and many other gas streams. In the context of porous crystalline materials that can exploit both equilibrium and kinetic selectivity, size selectivity and targeted molecular recognition are attractive characteristics for CO2 separation and capture, as exemplified by zeolites 5A and 13X (ref. 2), as well as metal-organic materials (MOMs)(3-9). Here we report that a crystal engineering(7) or reticular chemistry(5,9) strategy that controls pore functionality and size in a series of MOMs with coordinately saturated metal centres and periodically arrayed hexafluorosilicate (SiF62-) anions enables a 'sweet spot' of kinetics and thermodynamics that offers high volumetric uptake at low CO2 partial pressure (less than 0.15 bar). Most importantly, such MOMs offer an unprecedented CO2 sorption selectivity over N-2, H-2 and CH4, even in the presence of moisture. These MOMs are therefore relevant to CO2 separation in the context of post-combustion (flue gas, CO2/N-2), pre-combustion (shifted synthesis gas stream, CO2/H-2) and natural gas upgrading (natural gas clean-up, CO2/CH4).	[Nugent, Patrick; Burd, Stephen D.; Forrest, Katherine; Pham, Tony; Ma, Shengqian; Space, Brian; Wojtas, Lukasz; Eddaoudi, Mohamed; Zaworotko, Michael J.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA; [Belmabkhout, Youssef; Cairns, Amy J.; Luebke, Ryan; Eddaoudi, Mohamed] 4700 King Abdullah Univ Sci & Technol KAUST, Div Phys Sci & Engn, Adv Membranes & Porous Mat Ctr, Thuwal 239556900, Saudi Arabia	State University System of Florida; University of South Florida; King Abdullah University of Science & Technology	Eddaoudi, M (corresponding author), Univ S Florida, Dept Chem, 4202 East Fowler Ave, Tampa, FL 33620 USA.	mohamed.eddaoudi@kaust.edu.sa; xtal@usf.edu	Pham, Tony/A-3787-2014; Luebke, Ryan/F-4333-2011; Nugent, Patrick/I-8308-2015; Eddaoudi, Mohamed/D-2298-2009; Ma, Shengqian/B-4022-2012; Space, Brian/AFU-1654-2022; Zaworotko, Michael/A-7448-2009	Luebke, Ryan/0000-0002-1285-3321; Nugent, Patrick/0000-0002-1585-2762; Eddaoudi, Mohamed/0000-0003-1916-9837; Ma, Shengqian/0000-0002-1897-7069; Space, Brian/0000-0003-0246-7408; Zaworotko, Michael/0000-0002-1360-540X; Wojtas, Lukasz/0000-0003-0545-0302	KAUST [FIC/2010/06]; XSEDE [TG-DMR090028]; National Science Foundation/Department of Energy [NSF/CHE-0822838]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Division Of Chemistry [0822838] Funding Source: National Science Foundation	KAUST(King Abdullah University of Science & Technology); XSEDE; National Science Foundation/Department of Energy(National Science Foundation (NSF)United States Department of Energy (DOE)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This publication is based on work supported by KAUST award number FIC/2010/06 (ME. and M.J.Z.) and KAUST start up funds (RE.). B.S. acknowledges computational resources made available by an XSEDE grant (number TG-DMR090028). Single-crystal diffraction experiments on SIFSIX-2-Cu-I were conducted at the Advanced Photon Source on beamline 15ID-B of ChemMatCARS Sector 15, which is principally supported by the National Science Foundation/Department of Energy under grant number NSF/CHE-0822838. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract number DE-AC02-06CH11357.	Belmabkhout Y, 2010, IND ENG CHEM RES, V49, P359, DOI 10.1021/ie900837t; Burd SD, 2012, J AM CHEM SOC, V134, P3663, DOI 10.1021/ja211340t; Caskey SR, 2008, J AM CHEM SOC, V130, P10870, DOI 10.1021/ja8036096; Cavenati S, 2004, J CHEM ENG DATA, V49, P1095, DOI 10.1021/je0498917; Coe BJ, 2004, DALTON T, P2935, DOI 10.1039/b409432h; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Farha OK, 2012, J AM CHEM SOC, V134, P15016, DOI 10.1021/ja3055639; Han SG, 2012, ACS COMB SCI, V14, P263, DOI 10.1021/co3000192; Herm ZR, 2011, J AM CHEM SOC, V133, P5664, DOI 10.1021/ja111411q; Ho MT, 2008, IND ENG CHEM RES, V47, P4883, DOI 10.1021/ie070831e; Jagiello J, 2004, CARBON, V42, P1227, DOI 10.1016/j.carbon.2004.01.022; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Kizzie AC, 2011, LANGMUIR, V27, P6368, DOI 10.1021/la200547k; Lassig D., 2011, ANGEW CHEM, V123, P10528; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Llewellyn PL, 2008, LANGMUIR, V24, P7245, DOI 10.1021/la800227x; Ma SQ, 2007, J AM CHEM SOC, V129, P1858, DOI 10.1021/ja067435s; MacGillivray L. R., 2010, METAL ORGANIC FRAMEW; Merel J, 2008, IND ENG CHEM RES, V47, P209, DOI 10.1021/ie071012x; Moulton B, 2001, CHEM REV, V101, P1629, DOI 10.1021/cr9900432; MYERS AL, 1965, AICHE J, V11, P121, DOI 10.1002/aic.690110125; Noro S, 2000, ANGEW CHEM INT EDIT, V39, P2082; SUBRAMANIAN S, 1995, ANGEW CHEM INT EDIT, V34, P2127, DOI 10.1002/anie.199521271; Sumida K, 2012, CHEM REV, V112, P724, DOI 10.1021/cr2003272; Taylor P, 2010, ENERGY TECHNOLOGY PE; Uemura K, 2009, EUR J INORG CHEM, P2329, DOI 10.1002/ejic.200900144; Vaidhyanathan R, 2010, SCIENCE, V330, P650, DOI 10.1126/science.1194237; Xiang SC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1956; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Yazaydin AO, 2009, CHEM MATER, V21, P1425, DOI 10.1021/cm900049x	30	1683	1720	137	3332	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2013	495	7439					80	84		10.1038/nature11893	http://dx.doi.org/10.1038/nature11893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23446349				2022-12-24	WOS:000316039800043
J	Thompson, LG; Mosley-Thompson, E; Davis, ME; Zagorodnov, VS; Howat, IM; Mikhatenko, VN; Lin, PN				Thompson, L. G.; Mosley-Thompson, E.; Davis, M. E.; Zagorodnov, V. S.; Howat, I. M.; Mikhatenko, V. N.; Lin, P. -N.			Annually Resolved Ice Core Records of Tropical Climate Variability over the Past similar to 1800 Years	SCIENCE			English	Article							INTERTROPICAL CONVERGENCE ZONE; MODELING DELTA-O-18; PRECIPITATION; PACIFIC; TEMPERATURES; ALTIPLANO; HUASCARAN; AMERICA; HISTORY; CAP	Ice cores from low Latitudes can provide a wealth of unique information about past climate in the tropics, but they are difficult to recover and few exist. Here, we report annually resolved ice core records from the Quelccaya ice cap (5670 meters above sea level) in Peru that extend back similar to 1800 years and provide a high-resolution record of climate variability there. Oxygen isotopic ratios (delta O-18) are linked to sea surface temperatures in the tropical eastern Pacific, whereas concentrations of ammonium and nitrate document the dominant role played by the migration of the Intertropical Convergence Zone in the region of the tropical Andes. Quetccaya continues to retreat and thin. Radiocarbon dates on wetland plants exposed along its retreating margins indicate that it has not been smaller for at least six millennia.	[Thompson, L. G.; Mosley-Thompson, E.; Davis, M. E.; Zagorodnov, V. S.; Howat, I. M.; Lin, P. -N.] Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA; [Thompson, L. G.; Howat, I. M.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Mosley-Thompson, E.] Ohio State Univ, Dept Geog, Columbus, OH 43210 USA; [Mikhatenko, V. N.] Russian Acad Sci, Inst Geog, Moscow V71, Russia	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Russian Academy of Sciences	Thompson, LG (corresponding author), Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA.	thompson.3@osu.edu	Mosley-Thompson, Ellen S/Z-2100-2018; Mikhalenko, Vladimir N/A-4253-2014; Howat, Ian M/A-3474-2008	Howat, Ian M/0000-0002-8072-6260	NSF [ATM-0318130]; Ohio State University's Climate, Water and Carbon Program; Div Atmospheric & Geospace Sciences [0823586] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Ohio State University's Climate, Water and Carbon Program; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by NSF Paleoclimate Program award ATM-0318130 and the Ohio State University's Climate, Water and Carbon Program. We thank all the field and laboratory team members, many from the Byrd Polar Research Center, who have worked so diligently over the years to acquire these ice cores and extract their preserved climate histories. We acknowledge the efforts of our Peruvian colleagues from the Servicio Nacional de Meteorologia e Hidrologia, C. Portocarrero, and our mountaineers, led by B. Vicencio, who cooperated with us to make the project possible. Accelerator mass spectrometry <SUP>14</SUP>C measurements were made at the National Ocean Sciences Accelerator Mass Spectrometry Facility (Woods Hole Oceanographic Institution). This is Byrd Polar Research Center Contribution Number 1430. The data are archived at the National Oceanic and Atmospheric Administration World Data Center-A for Paleoclimatology: ftp://ftp.ncdc.noaa.gov/pub/data/paleo/icecore/trop/quelccaya/quelccaya2013.txt.	Baker PA, 2001, SCIENCE, V291, P640, DOI 10.1126/science.291.5504.640; Bird BW, 2011, P NATL ACAD SCI USA, V108, P8583, DOI 10.1073/pnas.1003719108; Black DE, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001427; Boyle EA, 1997, GEOPHYS RES LETT, V24, P273, DOI 10.1029/97GL00081; Bradley RS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037712; Bradley RS, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016546; Buffen AM, 2009, QUATERNARY RES, V72, P157, DOI 10.1016/j.yqres.2009.02.007; Diaz HF, 2011, B AM METEOROL SOC, V92, P1487, DOI 10.1175/BAMS-D-10-05003.1; Dunbar R. B., 1996, CLIMATIC FLUCTUATION, P375; Francou B, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002959; Garreaud R, 2003, PALAEOGEOGR PALAEOCL, V194, P5, DOI 10.1016/S0031-0182(03)00269-4; Haase-Schramm A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000830; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Henderson KA, 1999, J GEOPHYS RES-ATMOS, V104, P31053, DOI 10.1029/1999JD900966; Jomelli V, 2009, PALAEOGEOGR PALAEOCL, V281, P269, DOI 10.1016/j.palaeo.2008.10.033; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kellerhals T, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012603; Klein A.G., 1995, B I FRANCAIS ETUDES, V24, P607; Koutavas A, 2004, ADV GLOB CHANGE RES, V21, P347, DOI 10.1007/978-1-4020-2944-8_12; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Liu KB, 2005, QUATERNARY RES, V64, P272, DOI 10.1016/j.yqres.2005.06.001; Marengo JA, 2004, THEOR APPL CLIMATOL, V78, P79, DOI 10.1007/S00704-004-0045-8; Novello VF, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053936; Pepin NC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034026; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Rein B, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020161; Reuter J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041051; Robertson G. P., 1998, NATURE, V336, P757; Sachs JP, 2009, NAT GEOSCI, V2, P519, DOI 10.1038/ngeo554; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; THOMPSON LG, 1986, SCIENCE, V234, P361, DOI 10.1126/science.234.4774.361; THOMPSON LG, 1985, SCIENCE, V229, P971, DOI 10.1126/science.229.4717.971; THOMPSON LG, 1988, NATURE, V336, P763, DOI 10.1038/336763a0; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; Thompson LG, 2006, P NATL ACAD SCI USA, V103, P10536, DOI 10.1073/pnas.0603900103; Thompson LG, 2011, ANN GLACIOL, V52, P23, DOI 10.3189/172756411799096231; Vuille M, 1999, INT J CLIMATOL, V19, P1579, DOI 10.1002/(SICI)1097-0088(19991130)19:14<1579::AID-JOC441>3.0.CO;2-N; Vuille M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD002039; Xue Y, 2003, J CLIMATE, V16, P1601, DOI 10.1175/1520-0442-16.10.1601	39	167	174	4	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					945	950		10.1126/science.1234210	http://dx.doi.org/10.1126/science.1234210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23558172				2022-12-24	WOS:000319344100038
J	Grohman, JK; Gorelick, RJ; Lickwar, CR; Lieb, JD; Bower, BD; Znosko, BM; Weeks, KM				Grohman, Jacob K.; Gorelick, Robert J.; Lickwar, Colin R.; Lieb, Jason D.; Bower, Brian D.; Znosko, Brent M.; Weeks, Kevin M.			A Guanosine-Centric Mechanism for RNA Chaperone Function	SCIENCE			English	Article							MURINE LEUKEMIA-VIRUS; NUCLEOCAPSID PROTEIN; SHAPE CHEMISTRY; PARAMETERS; DUPLEXES; GENOME; PAIRS	RNA chaperones are ubiquitous, heterogeneous proteins essential for RNA structural biogenesis and function. We investigated the mechanism of chaperone-mediated RNA folding by following the time-resolved dimerization of the packaging domain of a retroviral RNA at nucleotide resolution. In the absence of the nucleocapsid (NC) chaperone, dimerization proceeded through multiple, slow-folding intermediates. In the presence of NC, dimerization occurred rapidly through a single structural intermediate. The RNA binding domain of heterogeneous nuclear ribonucleoprotein A1 protein, a structurally unrelated chaperone, also accelerated dimerization. Both chaperones interacted primarily with guanosine residues. Replacing guanosine with more weakly pairing inosine yielded an RNA that folded rapidly without a facilitating chaperone. These results show that RNA chaperones can simplify RNA folding landscapes by weakening intramolecular interactions involving guanosine and explain many RNA chaperone activities.	[Grohman, Jacob K.; Weeks, Kevin M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Grohman, Jacob K.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Lickwar, Colin R.; Lieb, Jason D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Lickwar, Colin R.; Lieb, Jason D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Bower, Brian D.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Gorelick, Robert J.] SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Znosko, Brent M.] St Louis Univ, Dept Chem, St Louis, MO 63103 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Saint Louis University; Washington University (WUSTL)	Weeks, KM (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	weeks@unc.edu		Lieb, Jason/0000-0001-7601-8061	U.S. National Institutes of Health [GM064803, GM072518, GM031819]; National Cancer Institute [HHSN261200800001E]; SAIC-Frederick, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092, R01GM072518, R01GM064803, R01GM031819] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); SAIC-Frederick, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to D. Grawoig for a critical review of the manuscript and to D. Johnson and C. Hixson for assistance in preparing MuLV NC protein. This work was supported by the U.S. National Institutes of Health (GM064803 to K.M.W., GM072518 to J.D.L., and GM031819 to Jack Griffith and B.D.B) and by the National Cancer Institute (under contract HHSN261200800001E with SAIC-Frederick, Inc. to R.J.G.). Data sets of representative clustered kinetic data are provided in the supplementary materials.	ADAM MA, 1988, J VIROL, V62, P3802, DOI 10.1128/JVI.62.10.3802-3806.1988; Badorrek CS, 2006, BIOCHEMISTRY-US, V45, P12664, DOI 10.1021/bi060521k; Coffin J, 1997, RETROVIRUSES; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Dey A, 2005, BIOCHEMISTRY-US, V44, P3735, DOI 10.1021/bi047639q; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gherghe C, 2010, P NATL ACAD SCI USA, V107, P19248, DOI 10.1073/pnas.1006897107; Gherghe C, 2010, J VIROL, V84, P898, DOI 10.1128/JVI.01602-09; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Hibbert CS, 2004, J VIROL, V78, P10927, DOI 10.1128/JVI.78.20.10927-10938.2004; Li PTX, 2006, P NATL ACAD SCI USA, V103, P15847, DOI 10.1073/pnas.0607202103; Mortimer SA, 2009, NAT PROTOC, V4, P1413, DOI 10.1038/nprot.2009.126; Mortimer SA, 2008, J AM CHEM SOC, V130, P16178, DOI 10.1021/ja8061216; PORTMAN DS, 1994, EMBO J, V13, P213, DOI 10.1002/j.1460-2075.1994.tb06251.x; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Rein A, 2010, RNA BIOL, V7, P700, DOI 10.4161/rna.7.6.13685; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; Woodson SA, 2010, RNA BIOL, V7, P677, DOI 10.4161/rna.7.6.13615; Wright DJ, 2007, BIOCHEMISTRY-US, V46, P4625, DOI 10.1021/bi0616910; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425	22	37	37	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129					190	195		10.1126/science.1230715	http://dx.doi.org/10.1126/science.1230715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23470731	Green Accepted, Green Submitted			2022-12-24	WOS:000317341400054
J	Hsieh, J; Schneider, JW				Hsieh, Jenny; Schneider, Jay W.			Neural Stem Cells, Excited	SCIENCE			English	Editorial Material							SMALL MOLECULES; ADULT; NEUROGENESIS; DIFFERENTIATION; FATE; GABA		[Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Schneider, Jay W.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hsieh, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	jenny.hsieh@utsouthwestern.edu; jay.schneider@utsouthwestern.edu						Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Petrik D, 2012, FASEB J, V26, P3148, DOI 10.1096/fj.11-201426; Sadek H, 2008, P NATL ACAD SCI USA, V105, P6063, DOI 10.1073/pnas.0711507105; Schneider JW, 2008, NAT CHEM BIOL, V4, P408, DOI 10.1038/nchembio.95; Schneider JW, 2012, ACS CHEM NEUROSCI, V3, P557, DOI 10.1021/cn300025a; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wang LP, 2005, MOL CELL NEUROSCI, V29, P181, DOI 10.1016/j.mcn.2005.02.002; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644	16	13	13	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1534	1535		10.1126/science.1237576	http://dx.doi.org/10.1126/science.1237576			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539589				2022-12-24	WOS:000316731600031
J	Gutmann, A				Gutmann, Amy			Safeguarding Children - Pediatric Research on Medical Countermeasures	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gutmann, Amy] Presidential Commiss Study Bioeth Issues, Washington, DC USA; [Gutmann, Amy] Univ Penn, Off President, Philadelphia, PA 19104 USA; [Gutmann, Amy] Univ Penn, Dept Polit Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Gutmann, A (corresponding author), Presidential Commiss Study Bioeth Issues, Washington, DC USA.							National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1977, RES INV CHILDR; Presidential Commission for the Study of Bioethical Issues (PCSBI), 2013, SAF CHILDR PED MED C; White R, 2012, BIOETHICS FORUM 0522	3	6	6	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1171	1173		10.1056/NEJMp1302093	http://dx.doi.org/10.1056/NEJMp1302093			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116FU	23506617				2022-12-24	WOS:000316869000002
J	Cruciat, CM; Dolde, C; de Groot, REA; Ohkawara, B; Reinhard, C; Korswagen, HC; Niehrs, C				Cruciat, Cristina-Maria; Dolde, Christine; de Groot, Reinoud E. A.; Ohkawara, Bisei; Reinhard, Carmen; Korswagen, Hendrik C.; Niehrs, Christof			RNA Helicase DDX3 Is a Regulatory Subunit of Casein Kinase 1 in Wnt-beta-Catenin Signaling	SCIENCE			English	Article							I-EPSILON; WNT/BETA-CATENIN; CELL-MIGRATION; PROMOTES; PATHWAY; FAMILY; EXPRESSION; MUTATIONS; INDUCTION; PROTEINS	Casein kinase 1 (CK1) members play key roles in numerous biological processes. They are considered "rogue" kinases, because their enzymatic activity appears unregulated. Contrary to this notion, we have identified the DEAD-box RNA helicase DDX3 as a regulator of the Wnt-beta-catenin network, where it acts as a regulatory subunit of CK1 epsilon: In a Wnt-dependent manner, DDX3 binds CK1 epsilon and directly stimulates its kinase activity, and promotes phosphorylation of the scaffold protein dishevelled. DDX3 is required for Wnt-beta-catenin signaling in mammalian cells and during Xenopus and Caenorhabditis elegans development. The results also suggest that the kinase-stimulatory function extends to other DDX and CK1 members, opening fresh perspectives for one of the longest-studied protein kinase families.	[Cruciat, Cristina-Maria; Dolde, Christine; Ohkawara, Bisei; Reinhard, Carmen; Niehrs, Christof] Deutsch Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, D-69120 Heidelberg, Germany; [de Groot, Reinoud E. A.; Korswagen, Hendrik C.] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Amsterdam, Netherlands; [de Groot, Reinoud E. A.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Niehrs, Christof] Inst Mol Biol, D-55128 Mainz, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Institute of Molecular Biology (IMB)	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	niehrs@dkfz-heidelberg.de	Korswagen, Hendrik/I-8782-2012	Ohkawara, Bisei/0000-0002-1987-458X; de Groot, Reinoud/0000-0002-1905-6501	Deutsche Forschungsgemeinschaft; Grants-in-Aid for Scientific Research [23710253] Funding Source: KAKEN	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Bienz, H. Clevers, X. He, R. Moon, R. Nusse, Y. H. Wu Lee, and D. Wu for reagents; D. Ingelfinger and M. Boutros for assistance with siRNA screening; and R. Voit for help with kinase assays. We thank G. Roth and Aska Pharmaceuticals Tokyo for generous supply of human chorionic gonadotropin. This work was supported by the Deutsche Forschungsgemeinschaft.	Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; CARMEL G, 1994, J BIOL CHEM, V269, P7304; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Grietzen KF, 1999, J BIOL CHEM, V274, P32063, DOI 10.1074/jbc.274.45.32063; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Hassler C, 2007, DEVELOPMENT, V134, P4255, DOI 10.1242/dev.005942; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Ou GS, 2009, J CELL BIOL, V185, P77, DOI 10.1083/jcb.200812077; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Schroder M, 2010, BIOCHEM PHARMACOL, V79, P297, DOI 10.1016/j.bcp.2009.08.032; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Traut T., 2008, REGULATORY ALLOSTERI; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869	41	153	171	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1436	1441		10.1126/science.1231499	http://dx.doi.org/10.1126/science.1231499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23413191				2022-12-24	WOS:000316740700044
J	McCartney, M				McCartney, Margaret			How do we know whether medical apps work?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Adams S., 2013, DAILY TELEGRAPH; [Anonymous], COMM US PULS OX SPOR; Food and Drug Administration, 2011, GUID IND FO IN PRESS; Iacobucci G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1501; Instant Heart Rate by Azumio, INST HEART RAT; MHRA, FREQ ASK QUEST OTH D; NHS Choices, HLTH APPS LIB; Sharpe R, 2012, LACKING REGULATION M; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; Wolf JA, 2013, JAMA DERMATOL, V149, P422, DOI 10.1001/jamadermatol.2013.2382	10	34	35	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2013	346								f1811	10.1136/bmj.f1811	http://dx.doi.org/10.1136/bmj.f1811			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113MG	23516158				2022-12-24	WOS:000316671500012
J	Lever, MA; Rouxel, O; Alt, JC; Shimizu, N; Ono, SH; Coggon, RM; Shanks, WC; Lapham, L; Elvert, M; Prieto-Mollar, X; Hinrichs, KU; Inagaki, F; Teske, A				Lever, Mark A.; Rouxel, Olivier; Alt, Jeffrey C.; Shimizu, Nobumichi; Ono, Shuhei; Coggon, Rosalind M.; Shanks, Wayne C., III; Lapham, Laura; Elvert, Marcus; Prieto-Mollar, Xavier; Hinrichs, Kai-Uwe; Inagaki, Fumio; Teske, Andreas			Evidence for Microbial Carbon and Sulfur Cycling in Deeply Buried Ridge Flank Basalt	SCIENCE			English	Article							DE-FUCA RIDGE; OCEAN CRUST; SUBSEAFLOOR SEDIMENTS; SULFIDE OXIDATION; SULFATE REDUCTION; DIVERSITY; FLUIDS; DISPROPORTIONATION; FRACTIONATION; COMMUNITY	Sediment-covered basalt on the flanks of mid-ocean ridges constitutes most of Earth's oceanic crust, but the composition and metabolic function of its microbial ecosystem are largely unknown. By drilling into 3.5-million-year-old subseafloor basalt, we demonstrated the presence of methane-and sulfur-cycling microbes on the eastern flank of the Juan de Fuca Ridge. Depth horizons with functional genes indicative of methane-cycling and sulfate-reducing microorganisms are enriched in solid-phase sulfur and total organic carbon, host delta C-13- and delta S-34-isotopic values with a biological imprint, and show clear signs of microbial activity when incubated in the laboratory. Downcore changes in carbon and sulfur cycling show discrete geochemical intervals with chemoautotrophic delta C-13 signatures locally attenuated by heterotrophic metabolism.	[Lever, Mark A.; Teske, Andreas] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA; [Lever, Mark A.; Lapham, Laura] Aarhus Univ, Dept Biosci, Ctr Geomicrobiol, DK-8000 Aarhus C, Denmark; [Rouxel, Olivier; Shimizu, Nobumichi] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Rouxel, Olivier] IFREMER, Ctr Brest, F-29280 Plouzane, France; [Alt, Jeffrey C.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Ono, Shuhei] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Coggon, Rosalind M.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Shanks, Wayne C., III] US Geol Survey, Denver, CO 80225 USA; [Elvert, Marcus; Prieto-Mollar, Xavier; Hinrichs, Kai-Uwe] Univ Bremen, Dept Geosci, Organ Geochem Grp, D-28334 Bremen, Germany; [Elvert, Marcus; Prieto-Mollar, Xavier; Hinrichs, Kai-Uwe] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28334 Bremen, Germany; [Inagaki, Fumio] Japan Agcy Marine Earth Sci & Technol, Kochi Inst Core Sample Res, Geomicrobiol Grp, Nanko Ku, Kochi 7838502, Japan	University of North Carolina; University of North Carolina Chapel Hill; Aarhus University; Woods Hole Oceanographic Institution; Ifremer; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); Imperial College London; United States Department of the Interior; United States Geological Survey; University of Bremen; University of Bremen; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Lever, MA (corresponding author), Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA.	mark.lever@biology.au.dk; teske@email.unc.edu	Lever, Mark A/C-2134-2011; Coggon, Rosalind/M-8816-2017; Lapham, Laura L/A-4035-2011; Teske, Andreas/AAQ-9577-2021; Lapham, Laura Lee/AAD-7655-2022; Facility, NENIMF/B-8811-2015; Inagaki, Fumio/AAI-1156-2019; Hinrichs, Kai-Uwe/C-7675-2009; Rouxel, Olivier J/F-3954-2014	Lever, Mark A/0000-0002-2046-8028; Coggon, Rosalind/0000-0002-9228-9707; Lapham, Laura Lee/0000-0002-7045-1785; Inagaki, Fumio/0000-0003-2887-6525; Hinrichs, Kai-Uwe/0000-0002-0739-9291; Rouxel, Olivier J/0000-0002-1431-222X; Elvert, Marcus/0000-0003-3863-0975	IODP Expedition 301 Scientists; Schlanger Ocean Drilling Fellowship; University of North Carolina Dissertation Completion Fellowship; Marie-Curie Intra-European Fellowship [255135]; Danish National Research Foundation; Max Planck Society; Europole Mer; European Research Council Advanced Grant DARCLIFE; NASA Astrobiology Institute Subsurface Biospheres; Japan Society for the Promotion of Science (JSPS) Funding Program for Next Generation World-Leading Researchers (NEXT Program); National Science Foundation [NSF-OCE 0622949, OCE 1129631, OCE-0753126, NSF-ODP 0727175]; National Science Foundation (NSF-STC for Dark Energy Biosphere Investigations)	IODP Expedition 301 Scientists; Schlanger Ocean Drilling Fellowship; University of North Carolina Dissertation Completion Fellowship; Marie-Curie Intra-European Fellowship(European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Max Planck Society(Max Planck SocietyFoundation CELLEX); Europole Mer; European Research Council Advanced Grant DARCLIFE; NASA Astrobiology Institute Subsurface Biospheres; Japan Society for the Promotion of Science (JSPS) Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation(National Science Foundation (NSF)); National Science Foundation (NSF-STC for Dark Energy Biosphere Investigations)(National Science Foundation (NSF))	We thank B. Jorgensen, M. Sogin, and the IODP Expedition 301 Scientists for advice and support in this project. Funding was obtained from a Schlanger Ocean Drilling Fellowship, a University of North Carolina Dissertation Completion Fellowship, a Marie-Curie Intra-European Fellowship (255135) (all to M. A. L.); the Danish National Research Foundation and the Max Planck Society (both to B. Jorgensen); Europole Mer (to O.R.); the European Research Council Advanced Grant DARCLIFE (to K.-U.H.); the NASA Astrobiology Institute Subsurface Biospheres (to A. T.); the Japan Society for the Promotion of Science (JSPS) Funding Program for Next Generation World-Leading Researchers (NEXT Program) (to F. I.); and the National Science Foundation (NSF-OCE 0622949 and OCE 1129631 to J.C.A.; OCE-0753126 to S.O. and O.R.; and NSF-ODP 0727175 and NSF-STC for Dark Energy Biosphere Investigations to A. T.). We thank three anonymous reviewers for very helpful comments. The geochemical data are available in the supplementary tables. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U. S. government. The functional gene sequence data are available from the GenBank database (accession numbers GU182109 to GU182110 and JX465656 to JX465658).	Bach W, 2003, GEOCHIM COSMOCHIM AC, V67, P3871, DOI 10.1016/S0016-7037(03)00304-1; CANFIELD DE, 1994, SCIENCE, V266, P1973, DOI 10.1126/science.11540246; Cowen JP, 2003, SCIENCE, V299, P120, DOI 10.1126/science.1075653; Dhillon A, 2003, APPL ENVIRON MICROB, V69, P2765, DOI 10.1128/AEM.69.5.2765-2772.2003; Edwards KJ, 2003, GEOCHIM COSMOCHIM AC, V67, P2843, DOI 10.1016/S0016-7037(03)00089-9; Fisher A. T., 2005, P IODP, P1; Fisk MR, 1998, SCIENCE, V281, P978, DOI 10.1126/science.281.5379.978; Friedrich MW, 2005, METHOD ENZYMOL, V397, P428, DOI 10.1016/S0076-6879(05)97026-2; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Lever MA, 2010, GEOMICROBIOL J, V27, P183, DOI 10.1080/01490450903456681; Lin HT, 2012, GEOCHIM COSMOCHIM AC, V85, P213, DOI 10.1016/j.gca.2012.02.017; Lueders T, 2001, ENVIRON MICROBIOL, V3, P194, DOI 10.1046/j.1462-2920.2001.00179.x; Mason OU, 2009, ISME J, V3, P231, DOI 10.1038/ismej.2008.92; McCarthy MD, 2011, NAT GEOSCI, V4, P32, DOI 10.1038/NGEO1015; McCollom TM, 2007, CHEM REV, V107, P382, DOI 10.1021/cr0503660; Ono SH, 2012, GEOCHIM COSMOCHIM AC, V87, P323, DOI 10.1016/j.gca.2012.04.016; Orcutt BN, 2011, ISME J, V5, P692, DOI 10.1038/ismej.2010.157; Rouxel O, 2008, EARTH PLANET SC LETT, V268, P110, DOI 10.1016/j.epsl.2008.01.010; Rudnicki MD, 2001, GEOCHIM COSMOCHIM AC, V65, P777, DOI 10.1016/S0016-7037(00)00579-2; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Schippers A, 2002, GEOCHIM COSMOCHIM AC, V66, P85, DOI 10.1016/S0016-7037(01)00745-1; Sim MS, 2011, SCIENCE, V333, P74, DOI 10.1126/science.1205103; Wagner M., 1998, APPL ENVIRON MICROB, V75, P7086; Walker BD, 2008, MAR CHEM, V108, P123, DOI 10.1016/j.marchem.2007.11.002; Wang FP, 2009, P NATL ACAD SCI USA, V106, P4840, DOI 10.1073/pnas.0810418106; Webster G, 2006, FEMS MICROBIOL ECOL, V58, P65, DOI 10.1111/j.1574-6941.2006.00147.x; Wheat CG, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003057; WHITMAN WB, 2006, PROKARYOTES, V3, P165; Zerkle AL, 2005, AM J SCI, V305, P467, DOI 10.2475/ajs.305.6-8.467; Zhang GS, 2008, ENVIRON MICROBIOL, V10, P1850, DOI 10.1111/j.1462-2920.2008.01606.x	30	150	156	7	266	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1305	1308		10.1126/science.1229240	http://dx.doi.org/10.1126/science.1229240			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493710	Green Submitted, Green Published			2022-12-24	WOS:000316053400034
J	Natalio, F; Corrales, TP; Panthofer, M; Schollmeyer, D; Lieberwirth, I; Muller, WEG; Kappl, M; Butt, HJ; Tremel, W				Natalio, Filipe; Corrales, Tomas P.; Panthoefer, Martin; Schollmeyer, Dieter; Lieberwirth, Ingo; Mueller, Werner E. G.; Kappl, Michael; Butt, Hans-Juergen; Tremel, Wolfgang			Flexible Minerals: Self-Assembled Calcite Spicules with Extreme Bending Strength	SCIENCE			English	Article							URCHIN LARVAL SPICULE; ECHINODERM CALCITE; SPONGE SPICULES; CRYSTAL TEXTURE; CARBONATE; PROTEINS; GROWTH; BIOMINERALIZATION; COMPOSITE; BIOSILICA	Silicatein-alpha is responsible for the biomineralization of silicates in sponges. We used silicatein-alpha to guide the self-assembly of calcite "spicules" similar to the spicules of the calcareous sponge Sycon sp. The self-assembled spicules, 10 to 300 micrometers (mu m) in length and 5 to 10 mu m in diameter, are composed of aligned calcite nanocrystals. The spicules are initially amorphous but transform into calcite within months, exhibiting unusual growth along [100]. They scatter x-rays like twinned calcite crystals. Whereas natural spicules evidence brittle failure, the synthetic spicules show an elastic response, which greatly enhances bending strength. This remarkable feature is linked to a high protein content. With nano-thermogravimetric analysis, we measured the organic content of a single spicule to be 10 to 16%. In addition, the spicules exhibit waveguiding properties even when they are bent.	[Natalio, Filipe; Panthoefer, Martin; Tremel, Wolfgang] Johannes Gutenberg Univ Mainz, Inst Anorgan Chem & Analyt Chem, D-55099 Mainz, Germany; [Natalio, Filipe] Univ Halle Wittenberg, Inst Chem Anorgan Chem, D-06120 Halle, Germany; [Corrales, Tomas P.; Lieberwirth, Ingo; Kappl, Michael; Butt, Hans-Juergen] Max Planck Inst Polymer Res, D-55128 Mainz, Germany; [Schollmeyer, Dieter] Johannes Gutenberg Univ Mainz, Inst Organ Chem, D-55099 Mainz, Germany; [Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Univ Med, Inst Physiol Chem, D-55099 Mainz, Germany	Johannes Gutenberg University of Mainz; Martin Luther University Halle Wittenberg; Max Planck Society; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Tremel, W (corresponding author), Johannes Gutenberg Univ Mainz, Inst Anorgan Chem & Analyt Chem, Duesbergweg 10-14, D-55099 Mainz, Germany.	tremel@uni-mainz.de	Lieberwirth, Ingo/Q-5862-2017; Tremel, Wolfgang/D-8125-2011; Kappl, Michael/A-5697-2009; Butt, Hans-Jürgen/C-4811-2011; Natalio, Filipe/D-4417-2011; Tremel, Wolfgang/AAT-1137-2021; Corrales, Tomas/F-1717-2016; Corrales, Tomas/I-1969-2013; Müller, W. E. G./AAR-8651-2020	Tremel, Wolfgang/0000-0002-4536-994X; Butt, Hans-Jürgen/0000-0001-5391-2618; Müller, W. E. G./0000-0002-8223-3689; Panthofer, Martin/0000-0001-6888-5552; Natalio, Filipe/0000-0002-4166-6947; Corrales, Tomas P./0000-0003-0197-9735	Deutsche Forschungsgemeinschaft [SPP 1420]; Deutscher Akademischer Austauschdienst scholarship; Center for Complex Matter;  [SFB 625]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst scholarship; Center for Complex Matter; 	This work was partially supported by the Deutsche Forschungsgemeinschaft within the SPP 1420. T. P. C. was supported by a Deutscher Akademischer Austauschdienst scholarship. We acknowledge the use of the facilities of the EM Center in Mainz (EZMZ) supported by the Center for Complex Matter and the SFB 625. We are grateful to R. Jung-Pothmann for performing single-crystal x-ray measurements and J. Ally for insightful discussions. The authors declare that they have no competing financial interests.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; AIZENBERG J, 1995, FASEB J, V9, P262, DOI 10.1096/fasebj.9.2.7781928; AIZENBERG J, 1995, CHEM-EUR J, V1, P414, DOI 10.1002/chem.19950010705; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; BERMAN A, 1993, SCIENCE, V259, P776, DOI 10.1126/science.259.5096.776; BERMAN A, 1990, SCIENCE, V250, P664, DOI 10.1126/science.250.4981.664; Carey P. R., 1982, BIOCH APPL RAMAN RES; Colfen H., 2008, MESOCRYSTALS NONCLAS, DOI DOI 10.1002/9780470994603; EANES ED, 1965, NATURE, V208, P365, DOI 10.1038/208365a0; EMLET RB, 1982, BIOL BULL, V163, P264, DOI 10.2307/1541265; Gilbert P.U.P.A., 2011, P199, DOI 10.1007/978-3-642-21230-7_7; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; Johnson M, 2010, ACTA BIOMATER, V6, P2181, DOI 10.1016/j.actbio.2009.12.006; Kuther J, 1998, J MATER CHEM, V8, P641, DOI 10.1039/a705859d; LEVI C, 1989, J MATER SCI LETT, V8, P337, DOI 10.1007/BF00725516; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Miserez A, 2008, ADV FUNCT MATER, V18, P1241, DOI 10.1002/adfm.200701135; Muller WEG, 2005, CELL TISSUE RES, V321, P285, DOI 10.1007/s00441-005-1141-5; Murr MM, 2005, P NATL ACAD SCI USA, V102, P11657, DOI 10.1073/pnas.0503968102; ONEILL PL, 1981, SCIENCE, V213, P646, DOI 10.1126/science.213.4508.646; Pipich V, 2008, J AM CHEM SOC, V130, P6879, DOI 10.1021/ja801798h; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Politi Y, 2008, P NATL ACAD SCI USA, V105, P17362, DOI 10.1073/pnas.0806604105; Rieger J, 1997, TENSIDE SURFACT DET, V34, P430; Sarikaya M, 2001, J MATER RES, V16, P1420, DOI 10.1557/JMR.2001.0198; Schroder HC, 2008, NAT PROD REP, V25, P455, DOI 10.1039/b612515h; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Woesz A, 2006, J MATER RES, V21, P2068, DOI 10.1557/JMR.2006.0251	29	96	96	1	323	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2013	339	6125					1298	1302		10.1126/science.1216260	http://dx.doi.org/10.1126/science.1216260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493708				2022-12-24	WOS:000316053400032
J	Baker, SA; Chen, L; Wilkins, AD; Yu, P; Lichtarge, O; Zoghbi, HY				Baker, Steven Andrew; Chen, Lin; Wilkins, Angela Dawn; Yu, Peng; Lichtarge, Olivier; Zoghbi, Huda Yahya			An AT-Hook Domain in MeCP2 Determines the Clinical Course of Rett Syndrome and Related Disorders	CELL			English	Article							CPG-BINDING PROTEIN-2; METHYL-CPG; MOUSE MODEL; X SYNDROME; CHROMATIN; EXPRESSION; MUTATIONS; DNA; MICE; ENCEPHALOPATHY	Mutations in the X-linked MECP2 cause Rett syndrome, a devastating neurological disorder typified by a period of apparently normal development followed by loss of cognitive and psychomotor skills. Data from rare male patients suggest symptom onset and severity can be influenced by the location of the mutation, with amino acids 270 and 273 marking the difference between neonatal encephalopathy and death, on the one hand, and survival with deficits on the other. We therefore generated two mouse models expressing either MeCP2-R270X or MeCP2-G273X. The mice developed phenotypes at strikingly different rates and showed differential ATRX nuclear localization within the nervous system, over time, coinciding with phenotypic progression. We discovered that MeCP2 contains three AT-hook-like domains over a stretch of 250 amino acids, like HMGA DNA-bending proteins; one conserved AT-hook is disrupted in MeCP2-R270X, lending further support to the notion that one of MeCP2's key functions is to alter chromatin structure.	[Baker, Steven Andrew; Zoghbi, Huda Yahya] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Baker, Steven Andrew] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Chen, Lin; Wilkins, Angela Dawn; Yu, Peng; Lichtarge, Olivier; Zoghbi, Huda Yahya] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zoghbi, Huda Yahya] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Yahya] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Baker, Steven Andrew; Lichtarge, Olivier; Zoghbi, Huda Yahya] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Zoghbi, HY (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Zoghbi, Huda/0000-0002-0700-3349	Howard Hughes Medical Institute; NINDS [NS053862, F30NS066527]; cores of the Baylor College of Medicine IDDRC [HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS053862, R01NS057819, F30NS066527] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); cores of the Baylor College of Medicine IDDRC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Christopher Woodcock for the pUC19-601x12 vector, Chris McGraw, Hsiao-Tuan Chao, Laura Lombardi, and Jeffrey Neul for critical reading of this manuscript, and Gabriele Schuster for pronuclear injections. This work was supported by the Howard Hughes Medical Institute, NINDS grant NS053862 (to H. Y. Z.), the cores of the Baylor College of Medicine IDDRC (HD024064), and NINDS F30NS066527 (to S.A.B.).	Agrawal A, 2011, IEEE ACM T COMPUT BI, V8, P194, DOI 10.1109/TCBB.2009.69; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Brocher J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-64; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Ghosh RP, 2010, BIOCHEMISTRY-US, V49, P4395, DOI 10.1021/bi9019753; Gibbons RJ, 2000, AM J MED GENET, V97, P204, DOI 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Kankirawatana P, 2006, NEUROLOGY, V67, P164, DOI 10.1212/01.wnl.0000223318.28938.45; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Nikitina T, 2007, MOL CELL BIOL, V27, P864, DOI 10.1128/MCB.01593-06; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; Samaco RC, 2012, NAT GENET, V44, P206, DOI 10.1038/ng.1066; Schule B, 2008, CLIN GENET, V74, P116, DOI 10.1111/j.1399-0004.2008.01005.x; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Turner B., 2001, MAPPING PROTEIN DNA; Venancio M, 2007, EUR J HUM GENET, V15, P902, DOI 10.1038/sj.ejhg.5201835; Villard L, 2007, J MED GENET, V44, P417, DOI 10.1136/jmg.2007.049452	38	157	161	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					984	996		10.1016/j.cell.2013.01.038	http://dx.doi.org/10.1016/j.cell.2013.01.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452848	Green Accepted, Bronze			2022-12-24	WOS:000315710300008
J	Snuderl, M; Batista, A; Kirkpatrick, ND; de Almodovar, CR; Riedemann, L; Walsh, EC; Anolik, R; Huang, YH; Martin, JD; Kamoun, W; Knevels, E; Schmidt, T; Farrar, CT; Vakoc, BJ; Mohan, N; Chung, EH; Roberge, S; Peterson, T; Bais, C; Zhelyazkova, BH; Yip, S; Hasselblatt, M; Rossig, C; Niemeyer, E; Ferrara, N; Klagsbrun, M; Duda, DG; Fukumura, D; Xu, L; Carmeliet, P; Jain, RK				Snuderl, Matija; Batista, Ana; Kirkpatrick, Nathaniel D.; de Almodovar, Carmen Ruiz; Riedemann, Lars; Walsh, Elisa C.; Anolik, Rachel; Huang, Yuhui; Martin, John D.; Kamoun, Walid; Knevels, Ellen; Schmidt, Thomas; Farrar, Christian T.; Vakoc, Benjamin J.; Mohan, Nishant; Chung, Euiheon; Roberge, Sylvie; Peterson, Teresa; Bais, Carlos; Zhelyazkova, Boryana H.; Yip, Stephen; Hasselblatt, Martin; Rossig, Claudia; Niemeyer, Elisabeth; Ferrara, Napoleone; Klagsbrun, Michael; Duda, Dan G.; Fukumura, Dai; Xu, Lei; Carmeliet, Peter; Jain, Rakesh K.			Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma	CELL			English	Article							TUMOR-GROWTH; DOSE-ESCALATION; CELL-LINE; PHASE-I; ANGIOGENESIS; CANCER; PLGF; METASTASIS; RESISTANCE; TB-403	Medulloblastoma is the most common pediatric malignant brain tumor. Although current therapies improve survival, these regimens are highly toxic and are associated with significant morbidity. Here, we report that placental growth factor (PlGF) is expressed in the majority of medulloblastomas, independent of their subtype. Moreover, high expression of PlGF receptor neuropilin 1 (Nrp1) correlates with poor overall survival in patients. We demonstrate that PlGF and Nrp1 are required for the growth and spread of medulloblastoma: PlGF/Nrp1 blockade results in direct antitumor effects in vivo, resulting in medulloblastoma regression, decreased metastasis, and increased mouse survival. We reveal that PlGF is produced in the cerebellar stroma via tumor-derived Sonic hedgehog (Shh) and show that PlGF acts through Nrp1-and not vascular endothelial growth factor receptor 1-to promote tumor cell survival. This critical tumor-stroma interaction-mediated by Shh, PlGF, and Nrp1 across medulloblastoma subtypes-supports the development of therapies targeting PlGF/Nrp1 pathway.	[Snuderl, Matija; Zhelyazkova, Boryana H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Batista, Ana; Kirkpatrick, Nathaniel D.; Riedemann, Lars; Walsh, Elisa C.; Anolik, Rachel; Huang, Yuhui; Martin, John D.; Kamoun, Walid; Chung, Euiheon; Roberge, Sylvie; Peterson, Teresa; Niemeyer, Elisabeth; Duda, Dan G.; Fukumura, Dai; Xu, Lei; Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA; [Vakoc, Benjamin J.; Mohan, Nishant] Massachusetts Gen Hosp, Dept Dermatol, Wellman Ctr Photomed, Boston, MA 02114 USA; [Snuderl, Matija; Batista, Ana; Kirkpatrick, Nathaniel D.; Riedemann, Lars; Walsh, Elisa C.; Anolik, Rachel; Huang, Yuhui; Martin, John D.; Kamoun, Walid; Farrar, Christian T.; Vakoc, Benjamin J.; Mohan, Nishant; Chung, Euiheon; Roberge, Sylvie; Peterson, Teresa; Niemeyer, Elisabeth; Klagsbrun, Michael; Duda, Dan G.; Fukumura, Dai; Xu, Lei; Jain, Rakesh K.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [de Almodovar, Carmen Ruiz] Katholieke Univ Leuven, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Louvain, Belgium; [de Almodovar, Carmen Ruiz; Knevels, Ellen; Schmidt, Thomas; Carmeliet, Peter] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Louvain, Belgium; [Farrar, Christian T.] Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Vakoc, Benjamin J.; Mohan, Nishant] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Bais, Carlos; Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA; [Yip, Stephen] Univ British Columbia, Vancouver Gen Hosp, Dept Pathol & Lab Med, Vancouver, BC V5Z 4E6, Canada; [Hasselblatt, Martin] Univ Hosp Munster, Inst Neuropathol, D-48149 Munster, Germany; [Rossig, Claudia] Univ Hosp Munster, Dept Pediat Hematol & Oncol, D-48149 Munster, Germany; [Klagsbrun, Michael] Childrens Hosp Boston, Vasc Biol Program, Dept Surg, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Harvard University; Roche Holding; Genentech; University of British Columbia; University of Munster; University of Munster; Harvard University; Boston Children's Hospital	Jain, RK (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA.	jain@steele.mgh.harvard.edu	Xu, Lei/GRR-9174-2022; Yip, Stephen/E-9994-2012; Jain, Rakesh K/I-1384-2017; Riedemann, Lars/Q-7944-2019; Carmeliet, Peter/AAQ-5140-2020; Chung, Euiheon/A-1801-2009; Riedemann, Lars/J-5725-2014; Martin, John D/L-6892-2016; Schmidt, Thomas/Y-8431-2019; Duda, Dan G/H-8523-2014	Yip, Stephen/0000-0002-8514-9861; Jain, Rakesh K/0000-0001-7571-3548; Carmeliet, Peter/0000-0001-7961-1821; Riedemann, Lars/0000-0002-9510-1845; Martin, John D/0000-0002-9828-8203; Schmidt, Thomas/0000-0002-7166-3675; Duda, Dan G/0000-0001-7065-8797; Farrar, Christian/0000-0001-6623-8220; Snuderl, Matija/0000-0003-0752-0917; Hasselblatt, Martin/0000-0003-2707-8484; Chung, Euiheon/0000-0002-3326-6927; Huang, Yuhui/0000-0003-1985-3575; Ruiz de Almodovar, Carmen/0000-0001-5975-7815	Hoffmann-La Roche; NIH [R01CA163815, P01CA080124, R01CA096915, S10RR027070, R01CA126642, R01CA159258, K25AG029415, R21CA155862, CA37392, CA45548, R01CA163528, P41-EB015903]; Department of Defense (DoD) [W81XWH-10-1-0016]; Belgian Government [IUAP06/30]; Flemish Government; Concerted Research Activities, Stichting Emmanuel van der Schueren (Belgium) [GOA2006/11]; American Cancer Society [120733-RSG-11-073-01-TBG, RSG-12-199-01-TBG]; BrainCare BC; DoD [W81XWH-11-1-0619]; Calabresi Career Development Award [2K12CA090354]; Mildred-Scheel-Fellowship (Deutsche Krebshilfe); Rolf Dierichs Stiftung;  [T32-CA073479]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA126642, R01CA163815, R37CA037392, P01CA045548, R01CA037392, K12CA090354, R21CA155862, P01CA080124, T32CA073479, R01CA159258, R01CA096915, R56CA037392, R01CA163528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG029415] Funding Source: NIH RePORTER	Hoffmann-La Roche(Hoffmann-La Roche); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DoD)(United States Department of Defense); Belgian Government; Flemish Government(European Commission); Concerted Research Activities, Stichting Emmanuel van der Schueren (Belgium); American Cancer Society(American Cancer Society); BrainCare BC; DoD(United States Department of Defense); Calabresi Career Development Award; Mildred-Scheel-Fellowship (Deutsche Krebshilfe)(Deutsche Krebshilfe); Rolf Dierichs Stiftung; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank Drs. J. M. Olson, M. Dewerchin, A. J. Iafrate, E. di Tomaso, M. Ancukiewicz, S. Goel, D. Kodack, K. Munro, B. Seed, R. Wechsler-Reya, and M. Weidner for invaluable suggestions and experimental assistance and Ms. C. J. Smith, A. Khachatryan, K. Kinzel, and B. Riesmeier for technical assistance. This study was supported by a grant from Hoffmann-La Roche and NIH grant R01CA163815 (to R. K. J.). The study was partially supported by NIH grants P01CA080124 (to R. K. J., D. G. D., D. F., and L. X.), R01CA096915 and S10RR027070 (to D. F.), R01CA126642 (to R. K. J.), and R01CA159258 (to D. G. D.); Department of Defense (DoD) Breast Cancer Research Innovator Award W81XWH-10-1-0016 (to R. K. J.); Belgian Government grant IUAP06/30 (to P. C.); Flemish Government long-term structural funding Methusalem (to P. C.); the Concerted Research Activities, Stichting Emmanuel van der Schueren (Belgium), GOA2006/11 (to P. C.); and American Cancer Society grants 120733-RSG-11-073-01-TBG (to D. G. D.) and RSG-12-199-01-TBG (to L. X.). C. T. F. is supported by NIH grants K25AG029415 and R21CA155862. M. K.'s work is supported by NIH grants CA37392 and CA45548. B. J. V.'s work is supported by NIH grants R01CA163528 and P41-EB015903. S. Y.'s work is supported by BrainCare BC. Y. H. is supported by DoD Research Fellowship W81XWH-11-1-0619. N. D. K. was supported by T32-CA073479. M. S. was supported by the Calabresi Career Development Award 2K12CA090354. L. R. received funding from Mildred-Scheel-Fellowship (Deutsche Krebshilfe) and from Rolf Dierichs Stiftung. P. C. has patent applications claiming subject matter related to this report, which may result in royalty payments. R. K. J. is a member of Board of Trustees of H& Q Healthcare Investors and H&Q Life Sciences Investors.	Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Coenegrachts L, 2010, CANCER RES, V70, P6537, DOI 10.1158/0008-5472.CAN-09-4092; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dewerchin M., 2012, PIGF MULTITASKING CY; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Fouladi M, 2005, J CLIN ONCOL, V23, P7152, DOI 10.1200/JCO.2005.01.214; FRIEDMAN HS, 1985, J NEUROPATH EXP NEUR, V44, P592, DOI 10.1097/00005072-198511000-00005; FRIEDMAN HS, 1988, AM J PATHOL, V130, P472; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Goldstein AM, 1997, CANCER CAUSE CONTROL, V8, P865, DOI 10.1023/A:1018464328836; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hatton BA, 2008, CANCER RES, V68, P1768, DOI 10.1158/0008-5472.CAN-07-5092; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Jain RK, 2007, CELL, V131, P443, DOI 10.1016/j.cell.2007.10.023; Lassen U, 2012, BRIT J CANCER, V106, P678, DOI 10.1038/bjc.2011.609; Xu L, 2007, MOL CANCER RES, V5, P873, DOI 10.1158/1541-7786.MCR-06-0141; Martinsson-Niskanen T, 2011, CLIN THER, V33, P1142, DOI 10.1016/j.clinthera.2011.08.007; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Nielsen DL, 2012, EXPERT OPIN BIOL TH, V12, P795, DOI 10.1517/14712598.2012.679655; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Pei YX, 2012, DEVELOPMENT, V139, P1724, DOI 10.1242/dev.050104; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Rutkowski S, 2007, CLIN CANCER RES, V13, P2651, DOI 10.1158/1078-0432.CCR-06-1779; Schmidt T, 2011, CANCER CELL, V19, P740, DOI 10.1016/j.ccr.2011.05.007; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; The WHO, 2020, CLASSIFICATION TUMOU; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; Walter K, 2010, CLIN CANCER RES, V16, P1781, DOI 10.1158/1078-0432.CCR-09-1913; Weekes CD, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3014; Xu L, 2006, CANCER RES, V66, P3971, DOI 10.1158/0008-5472.CAN-04-3085; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Ziche M, 1997, LAB INVEST, V76, P517	39	169	175	3	71	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					1065	1076		10.1016/j.cell.2013.01.036	http://dx.doi.org/10.1016/j.cell.2013.01.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452854	Green Accepted, Bronze			2022-12-24	WOS:000315710300014
J	Tilburt, JC; Cassel, CK				Tilburt, Jon C.; Cassel, Christine K.			Why the Ethics of Parsimonious Medicine Is Not the Ethics of Rationing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Tilburt, Jon C.] Mayo Clin, Div Gen Internal Med, Biomed Eth Res Unit, Ctr Sci Healthcare Delivery, Rochester, MN 55905 USA; [Cassel, Christine K.] Amer Board Internal Med, Philadelphia, PA USA	Mayo Clinic; American Board of Internal Medicine	Tilburt, JC (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	tilburt.jon@mayo.edu						Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Brett AS, 2012, JAMA-J AM MED ASSOC, V307, P149, DOI 10.1001/jama.2011.1999; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; DANIELS N, 1985, JUST HLTH CARE STUDI; GRABER GC, 1989, THEORY PRACTICE MED; Institute of Medicine, 2001, COV MATT INS HLTH CA; Sulmasy DP, 2007, J CLIN ONCOL, V25, P217, DOI 10.1200/JCO.2006.08.0481; UBEL PA, 1995, ARCH INTERN MED, V155, P1837, DOI 10.1001/archinte.155.17.1837	8	44	44	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					773	774		10.1001/jama.2013.368	http://dx.doi.org/10.1001/jama.2013.368			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23443438				2022-12-24	WOS:000315332200019
J	Rohle, D; Popovici-Muller, J; Palaskas, N; Turcan, S; Grommes, C; Campos, C; Tsoi, J; Clark, O; Oldrini, B; Komisopoulou, E; Kunii, K; Pedraza, A; Schalm, S; Silverman, L; Miller, A; Wang, F; Yang, H; Chen, Y; Kernytsky, A; Rosenblum, MK; Liu, W; Biller, SA; Su, SM; Brennan, CW; Chan, TA; Graeber, TG; Yen, KE; Mellinghoff, IK				Rohle, Dan; Popovici-Muller, Janeta; Palaskas, Nicolaos; Turcan, Sevin; Grommes, Christian; Campos, Carl; Tsoi, Jennifer; Clark, Owen; Oldrini, Barbara; Komisopoulou, Evangelia; Kunii, Kaiko; Pedraza, Alicia; Schalm, Stefanie; Silverman, Lee; Miller, Alexandra; Wang, Fang; Yang, Hua; Chen, Yue; Kernytsky, Andrew; Rosenblum, Marc K.; Liu, Wei; Biller, Scott A.; Su, Shinsan M.; Brennan, Cameron W.; Chan, Timothy A.; Graeber, Thomas G.; Yen, Katharine E.; Mellinghoff, Ingo K.			An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells	SCIENCE			English	Article							INTEGRATED GENOMIC ANALYSIS; ACUTE MYELOID-LEUKEMIA; ONCOMETABOLITE 2-HYDROXYGLUTARATE; MUTATIONS; GLIOBLASTOMA; TRANSFORMATION; PHENOTYPE; BRAIN	The recent discovery of mutations in metabolic enzymes has rekindled interest in harnessing the altered metabolism of cancer cells for cancer therapy. One potential drug target is isocitrate dehydrogenase 1 (IDH1), which is mutated in multiple human cancers. Here, we examine the role of mutant IDH1 in fully transformed cells with endogenous IDH1 mutations. A selective R132H-IDH1 inhibitor (AGI-5198) identified through a high-throughput screen blocked, in a dose-dependent manner, the ability of the mutant enzyme (mIDH1) to produce R-2-hydroxyglutarate (R-2HG). Under conditions of near-complete R-2HG inhibition, the mIDH1 inhibitor induced demethylation of histone H3K9me3 and expression of genes associated with gliogenic differentiation. Blockade of mIDH1 impaired the growth of IDH1-mutant-but not IDH1-wild-type-glioma cells without appreciable changes in genome-wide DNA methylation. These data suggest that mIDH1 may promote glioma growth through mechanisms beyond its well-characterized epigenetic effects.	[Rohle, Dan; Palaskas, Nicolaos; Turcan, Sevin; Campos, Carl; Clark, Owen; Oldrini, Barbara; Brennan, Cameron W.; Chan, Timothy A.; Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Rohle, Dan; Mellinghoff, Ingo K.] Weill Cornell Grad Sch Biomed Sci, Dept Pharmacol, New York, NY 10021 USA; [Popovici-Muller, Janeta; Kunii, Kaiko; Schalm, Stefanie; Silverman, Lee; Wang, Fang; Yang, Hua; Chen, Yue; Kernytsky, Andrew; Liu, Wei; Biller, Scott A.; Su, Shinsan M.; Yen, Katharine E.] Agios Pharmaceut, Cambridge, MA 02139 USA; [Grommes, Christian; Miller, Alexandra; Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Rosenblum, Marc K.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pedraza, Alicia; Brennan, Cameron W.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Tsoi, Jennifer; Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Memorial Sloan Kettering Cancer Center; Agios Pharmaceuticals; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles	Yen, KE (corresponding author), Agios Pharmaceut, Cambridge, MA 02139 USA.	katharine.yen@agios.com; mellingi@mskcc.org	Chan, Timothy A/ABD-5850-2021; Turcan, Sevin/AAF-1095-2019; Brennan, Cameron/R-7082-2019	Turcan, Sevin/0000-0002-0885-5607; Brennan, Cameron/0000-0003-4064-8891; Campos, Carl/0000-0002-7616-8518; Graeber, Thomas/0000-0001-8574-9181; Miller, Alexandra/0000-0003-2048-579X; Mellinghoff, Ingo/0000-0002-4347-8149; PALASKAS, NICOLAOS/0000-0003-0783-0683	National Brain Tumor Society; National Institutes of Health [1R01NS080944-01, U54CA143798]; Leon Levy Foundation; James S. McDonnell Foundation; American Brain Tumor Association; Lymphoma Research Foundation; American Cancer Society; American Society of Clinical Oncology; NATIONAL CANCER INSTITUTE [T32CA160001, U54CA143798, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080944] Funding Source: NIH RePORTER	National Brain Tumor Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leon Levy Foundation; James S. McDonnell Foundation; American Brain Tumor Association; Lymphoma Research Foundation; American Cancer Society(American Cancer Society); American Society of Clinical Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. G. Kaelin Jr., for sharing unpublished results. This work was supported by the National Brain Tumor Society (T. G. G., K.E.Y., and I. K. M.), the National Institutes of Health (1R01NS080944-01 and U54CA143798), the Leon Levy Foundation (I. K. M), and the James S. McDonnell Foundation (I. K. M.). C. G. was supported through an American Brain Tumor Association Basic Research Fellowship Award and the Lymphoma Research Foundation. T. G. G. is the recipient of a Research Scholar Award from the American Cancer Society. I. K. M. is the recipient of an Advanced Clinical Research Award in Glioma from the American Society of Clinical Oncology. Agios Pharmaceuticals has filed a patent application on AGI-5198. Microarray data are deposited in the Gene Expression Omnibus (GEO accession no. GSE45200).	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Popovici-Muller J, 2012, ACS MED CHEM LETT, V3, P850, DOI 10.1021/ml300225h; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Sobieszczuk DF, 2010, GENE DEV, V24, P206, DOI 10.1101/gad.554510; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	27	820	896	5	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					626	630		10.1126/science.1236062	http://dx.doi.org/10.1126/science.1236062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23558169	Green Accepted			2022-12-24	WOS:000318268900052
J	Mignot, E				Mignot, Emmanuel			The Perfect Hypnotic?	SCIENCE			English	Editorial Material							OREXIN RECEPTOR ANTAGONISM; CLINICAL-TRIAL; SLEEP; INSOMNIA; ALMOREXANT; NARCOLEPSY; PEPTIDES		Stanford Univ, Ctr Sleep Sci, Palo Alto, CA 94304 USA	Stanford University	Mignot, E (corresponding author), Stanford Univ, Ctr Sleep Sci, Palo Alto, CA 94304 USA.	mignot@stanford.edu						Black SW, 2013, SLEEP, V36, P325, DOI 10.5665/sleep.2442; Born J, 2012, NEURON, V75, P933, DOI 10.1016/j.neuron.2012.09.007; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Drake CL, 2003, DEPRESS ANXIETY, V18, P163, DOI 10.1002/da.10151; Herring WJ, 2012, NEUROLOGY, V79, P2265, DOI 10.1212/WNL.0b013e31827688ee; Hoever P, 2012, CLIN PHARMACOL THER, V91, P975, DOI 10.1038/clpt.2011.370; Hoever P, 2012, J PSYCHOPHARMACOL, V26, P1071, DOI 10.1177/0269881112448946; Nishino S., 2013, ESSENTIALS CLIN PHAR, P531; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Uslaner JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005213; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570	15	11	11	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					36	38		10.1126/science.1237998	http://dx.doi.org/10.1126/science.1237998			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559238				2022-12-24	WOS:000317061100034
J	Schembri, S; Williamson, PA; Short, PM; Singanayagam, A; Akram, A; Taylor, J; Singanayagam, A; Hill, AT; Chalmers, JD				Schembri, Stuart; Williamson, Peter A.; Short, Philip M.; Singanayagam, Aran; Akram, Ahsan; Taylor, Joanne; Singanayagam, Anika; Hill, Adam T.; Chalmers, James D.			Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; OBSTRUCTIVE PULMONARY-DISEASE; SHORT-TERM CLARITHROMYCIN; CORONARY-HEART-DISEASE; ANTIBIOTIC-THERAPY; RANDOMIZED-TRIAL; RISK; EXACERBATIONS; MORTALITY; AZITHROMYCIN	Objective To study the association of clarithromycin with cardiovascular events in the setting of acute exacerbations of chronic obstructive pulmonary disease and community acquired pneumonia. Design Analysis of two prospectively collected datasets. Setting Chronic obstructive pulmonary disease dataset including patients admitted to one of 12 hospitals around the United Kingdom between 2009 and 2011; Edinburgh pneumonia study cohort including patients admitted to NHS Lothian Hospitals between 2005 and 2009. Population 1343 patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease and 1631 patients admitted with community acquired pneumonia. Main outcome measures Hazard ratios for cardiovascular events at one year (defined as hospital admissions with acute coronary syndrome, decompensated cardiac failure, serious arrhythmia, or sudden cardiac death) and admissions for acute coronary syndrome (acute ST elevation myocardial infarction, non-ST elevation myocardial infarction, and unstable angina). Secondary outcomes were all cause and cardiovascular mortality at one year. Results 268 cardiovascular events occurred in the acute exacerbations of chronic obstructive pulmonary disease cohort and 171 in the community acquired pneumonia cohort over one year. After multivariable adjustment, clarithromycin use in acute exacerbations of chronic obstructive pulmonary disease was associated with an increased risk of cardiovascular events and acute coronary syndrome-hazard ratios 1.50 (95% confidence interval 1.13 to 1.97) and 1.67 (1.04 to 2.68). After multivariable adjustment, clarithromycin use in community acquired pneumonia was associated with increased risk of cardiovascular events (hazard ratio 1.68, 1.18 to 2.38) but not acute coronary syndrome (1.65, 0.97 to 2.80). The association between clarithromycin use and cardiovascular events persisted after matching for the propensity to receive clarithromycin. A significant association was found between clarithromycin use and cardiovascular mortality (adjusted hazard ratio 1.52, 1.02 to 2.26) but not all cause mortality (1.16, 0.90 to 1.51) in acute exacerbations of chronic obstructive pulmonary disease. No association was found between clarithromycin use in community acquired pneumonia and all cause mortality or cardiovascular mortality. Longer durations of clarithromycin use were associated with more cardiovascular events. Use of beta lactam antibiotics or doxycycline was not associated with increased cardiovascular events in patients with acute exacerbations of chronic obstructive pulmonary disease, suggesting an effect specific to clarithromycin. Conclusions The use of clarithromycin in the setting of acute exacerbations of chronic obstructive pulmonary disease or community acquired pneumonia may be associated with increased cardiovascular events. These findings require confirmation in other datasets.	[Schembri, Stuart; Short, Philip M.; Chalmers, James D.] Ninewells Hosp, Dundee DD1 9SY, Scotland; [Williamson, Peter A.] Perth Royal Infirm, Perth PH1 1NX, Scotland; [Short, Philip M.; Chalmers, James D.] Univ Dundee, Dundee, Scotland; [Singanayagam, Aran] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Akram, Ahsan; Taylor, Joanne; Hill, Adam T.] Royal Infirm Edinburgh NHS Trust, Edinburgh EH16 4SA, Midlothian, Scotland; [Singanayagam, Anika] Chase Farm & Barnet Hosp NHS Trust, London E1 1BB, England; [Hill, Adam T.] Univ Edinburgh, Edinburgh, Midlothian, Scotland	University of Dundee; University of Dundee; Imperial College London; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh	Chalmers, JD (corresponding author), Ninewells Hosp, Dundee DD1 9SY, Scotland.	jameschalmers1@nhs.net	; Taylor, Joanne K/F-4747-2011	Singanayagam, Aran/0000-0001-9849-0033; Chalmers, James/0000-0001-5514-7868; Singanayagam, Anika/0000-0002-2572-0173; Akram, Ahsan/0000-0003-4605-1682; Taylor, Joanne K/0000-0001-9882-0119				Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Bril F, 2010, CURR DRUG SAF, V5, P85, DOI 10.2174/157488610789869184; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Chalmers JD, 2011, J ANTIMICROB CHEMOTH, V66, P416, DOI 10.1093/jac/dkq426; Chalmers JD, 2010, THORAX, V65, P878, DOI 10.1136/thx.2009.133280; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; el Moussaoui R, 2006, BMJ-BRIT MED J, V332, P1355, DOI 10.1136/bmj.332.7554.1355; Gluud C, 2008, CARDIOLOGY, V111, P280, DOI 10.1159/000128994; Gupta S, 1997, CIRCULATION, V96, P404; Gurfinkel E, 1997, LANCET, V350, P404, DOI 10.1016/S0140-6736(97)07201-2; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Houck PM, 2001, CHEST, V119, P1420, DOI 10.1378/chest.119.5.1420; Jespersen CM, 2006, BRIT MED J, V332, P22, DOI 10.1136/bmj.38666.653600.55; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Levesque L, 2010, BMJ-BRIT MED J, V340, pb508; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388; National Institute for Health and Clinical Excellence, 2010, CHRON OBSTR PULM DIS; National Respiratory Training Centre, 2002, IMP RESP COND GUID P; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Restrepo MI, 2009, EUR RESPIR J, V33, P153, DOI 10.1183/09031936.00054108; Rodriguez A, 2007, CRIT CARE MED, V35, P1493, DOI 10.1097/01.CCM.0000266755.75844.05; Shorr AF, 2011, CHEST, V140, P1177, DOI 10.1378/chest.10-3035; Singanayagam A, 2012, EUR RESPIR J, V39, P187, DOI 10.1183/09031936.00049111; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; White AJ, 2003, THORAX, V58, P73, DOI 10.1136/thorax.58.1.73; Winkel P, 2011, CARDIOLOGY, V118, P63, DOI 10.1159/000324533	31	83	90	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2013	346								f1235	10.1136/bmj.f1235	http://dx.doi.org/10.1136/bmj.f1235			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113MQ	23525864	hybrid, Green Submitted			2022-12-24	WOS:000316672500002
J	Spence, D				Spence, Des			Bad medicine: co-codamol	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						ACMD Advisory Council on the Misuse of Drugs, 2013, ACMD CONS TRAM; All-Party Parliamentary Drugs Misuse Group, 2007, INQ PHYS DEP ADD PRE; Centers for Disease Control and Prevention, 2012, POL IMP PRESCR PAINK; NHS National Treatment Agency for Substance Misuse, ADD MED INV CONF COM; PAGB Proprietary Association of Great Britain, 2012, OTC MED ADD; The NHS Information Centre, PRESCR COST AN ENGL	6	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2013	346								f1821	10.1136/bmj.f1821	http://dx.doi.org/10.1136/bmj.f1821			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113MG	23516162				2022-12-24	WOS:000316671500015
J	Pope, BD; Aparicio, OM; Gilbert, DM				Pope, Benjamin D.; Aparicio, Oscar M.; Gilbert, David M.			SnapShot: Replication Timing	CELL			English	Editorial Material							CHROMOSOME-REPLICATION; KINASES; REVEALS		[Pope, Benjamin D.; Gilbert, David M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Aparicio, Oscar M.] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA	State University System of Florida; Florida State University; University of Southern California	Pope, BD (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.		Pope, Ben/Y-4326-2019	Pope, Ben/0000-0003-1847-9163; Aparicio, Oscar/0000-0002-5591-0277	NCI NIH HHS [F31 CA165863] Funding Source: Medline; NIGMS NIH HHS [P01 GM085354] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F31CA165863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354, R01GM065494] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aparicio OM, 2013, GENE DEV, V27, P117, DOI 10.1101/gad.209999.112; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Maya-Mendoza A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000900; McCune HJ, 2008, GENETICS, V180, P1833, DOI 10.1534/genetics.108.094359; Meister P, 2007, EMBO J, V26, P1315, DOI 10.1038/sj.emboj.7601538; Nordman J, 2012, DEVELOPMENT, V139, P455, DOI 10.1242/dev.061838; Rhind N., 2013, DNA REPLICATION HUMA; Takebayashi S, 2012, P NATL ACAD SCI USA, V109, P12574, DOI 10.1073/pnas.1207185109; Yao NY, 2010, CELL, V141, P1088, DOI 10.1016/j.cell.2010.05.042	10	15	15	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1390	1390	1390.e1	10.1016/j.cell.2013.02.038	http://dx.doi.org/10.1016/j.cell.2013.02.038			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498945	Bronze			2022-12-24	WOS:000316192500018
J	Kirkcaldy, RD; Zaidi, A; Hook, EW; Holmes, KH; Soge, O; del Rio, C; Hall, G; Papp, J; Bolan, G; Weinstock, HS				Kirkcaldy, Robert D.; Zaidi, Akbar; Hook, Edward W., III; Holmes, King H.; Soge, Olusegun; del Rio, Carlos; Hall, Geraldine; Papp, John; Bolan, Gail; Weinstock, Hillard S.			Neisseria gonorrhoeae Antimicrobial Resistance Among Men Who Have Sex With Men and Men Who Have Sex Exclusively With Women: The Gonococcal Isolate Surveillance Project, 2005-2010	ANNALS OF INTERNAL MEDICINE			English	Article							HIGH-LEVEL RESISTANCE; UNITED-STATES; SUSCEPTIBILITY; PENICILLIN; STRAINS; EPIDEMIOLOGY; EMERGENCE; CEFIXIME; PENA	Background: Gonorrhea treatment has been complicated by antimicrobial resistance in Neisseria gonorrhoeae. Gonococcal fluoroquinolone resistance emerged more rapidly among men who have sex with men (MSM) than men who have sex exclusively with women (MSW). Objective: To determine whether N. gonorrhoeae urethral isolates from MSM were more likely than isolates from MSW to exhibit resistance to or elevated minimum inhibitory concentrations (MICs) of antimicrobials used to treat gonorrhea. Design: 6 years of surveillance data from the Gonococcal Isolate Surveillance Project. Setting: Publicly funded sexually transmitted disease clinics in 30 U.S. cities. Patients: Men with a total of 34 600 episodes of symptomatic urethral gonorrhea. Measurements: Percentage of isolates exhibiting resistance or elevated MICs and adjusted odds ratios for resistance or elevated MICs among isolates from MSM compared with isolates from MSW. Results: In all U. S. regions except the West, isolates from MSM were significantly more likely to exhibit elevated MICs of ceftriaxone and azithromycin than isolates from MSW (P < 0.050). Isolates from MSM had a high prevalence of resistance to ciprofloxacin, penicillin, and tetracycline and were significantly more likely to exhibit antimicrobial resistance than isolates from MSW (P < 0.001). Limitations: Sentinel surveillance may not be representative of all patients with gonorrhea. HIV status, travel history, and antimicrobial use data were missing for some patients. Conclusion: Men who have sex with men are vulnerable to the emerging threat of antimicrobial-resistant N. gonorrhoeae. Because antimicrobial susceptibility testing is not routinely done in clinical practice, clinicians should monitor for treatment failures among MSM diagnosed with gonorrhea. Strengthened prevention strategies for MSM and new antimicrobial treatment options are needed.	[Kirkcaldy, Robert D.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Emory Univ, Atlanta, GA 30322 USA; Univ Alabama Birmingham, Birmingham, AL USA; Jefferson Cty Dept Hlth, Birmingham, AL USA; Univ Washington, Seattle, WA 98195 USA; Cleveland Clin, Cleveland, OH 44106 USA	Centers for Disease Control & Prevention - USA; Emory University; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; Cleveland Clinic Foundation	Kirkcaldy, RD (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,Mailstop E-02, Atlanta, GA 30333 USA.	rkirkcaldy@cdc.gov	del Rio, Carlos/B-3763-2012; Papp, John/AAA-3073-2019; Kirkcaldy, Bob/ABB-1483-2020	del Rio, Carlos/0000-0002-0153-3517; Papp, John/0000-0002-7495-5454; Kirkcaldy, Robert/0000-0002-1749-4647	Centers for Disease Control and Prevention; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [H25PS001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial Support: By the Centers for Disease Control and Prevention.	Akasaka S, 2001, J Infect Chemother, V7, P49, DOI 10.1007/s101560170034; Ameyama S, 2002, ANTIMICROB AGENTS CH, V46, P3744, DOI 10.1128/AAC.46.12.3744-3749.2002; Braunstein SL, 2011, SEX TRANSM DIS, V38, P385, DOI 10.1097/OLQ.0b013e31820b8eba; Centers for Disease Control and Prevention, 2012, 2011 SEX TRANSM DIS; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1041; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI, V29, P84; CURRAN JW, 1979, SEX TRANSM DIS, V6, P174, DOI 10.1097/00007435-197904000-00024; del Rio C., 2007, Morbidity and Mortality Weekly Report, V56, P332; del Rio Carlos, 2012, Morbidity and Mortality Weekly Report, V61, P590; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Dowell D, 2012, AM J PUBLIC HEALTH, V102, P148, DOI 10.2105/AJPH.2011.300283; FAGAN D, 1985, GENITOURIN MED, V61, P363; Gaudreau C, 2011, EMERG INFECT DIS, V17, P1747, DOI 10.3201/eid1709.102034; HANDSFIELD HH, 1980, SEX TRANSM DIS, V7, P1, DOI 10.1097/00007435-198001000-00001; Health Protection Agency, 2011, GRASP 2010 REP GON R; Ison CA, 2011, EURO SURVEILL, V16; Johnson LF, 2008, SEX TRANSM DIS, V35, P946, DOI 10.1097/OLQ.0b013e3181812d15; Katz AR, 2012, CLIN INFECT DIS, V54, P841, DOI 10.1093/cid/cir929; Katz Kenneth A., 2011, Morbidity and Mortality Weekly Report, V60, P579; KNAPP JS, 1994, ANTIMICROB AGENTS CH, V38, P2200, DOI 10.1128/AAC.38.9.2200; KNAPP JS, 1987, J INFECT DIS, V155, P819, DOI 10.1093/infdis/155.4.819; Mansergh G, 2001, AM J PUBLIC HEALTH, V91, P953, DOI 10.2105/AJPH.91.6.953; MARTIN JE, 1970, J INFECT DIS, V122, P459, DOI 10.1093/infdis/122.5.459; MCFARLAND L, 1983, J CLIN MICROBIOL, V18, P121, DOI 10.1128/JCM.18.1.121-127.1983; MORSE SA, 1982, INFECT IMMUN, V37, P432, DOI 10.1128/IAI.37.2.432-438.1982; MORSE SA, 1986, ANTIMICROB AGENTS CH, V30, P664, DOI 10.1128/AAC.30.5.664; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; PERINE PL, 1979, SEX TRANSM DIS, V6, P152; Ratelle S., 2004, Morbidity and Mortality Weekly Report, V53, P335; SHAFER WM, 1995, MICROBIOL-UK, V141, P907, DOI 10.1099/13500872-141-4-907; Soge OO, 2012, SEX TRANSM DIS, V39, P877, DOI 10.1097/OLQ.0b013e3182685d2b; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Truong HHM, 2008, J TRAVEL MED, V15, P454, DOI 10.1111/j.1708-8305.2008.00245.x; Unemo M, 2010, EURO SURVEILL, V15; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11; Warner L, 2006, SEX TRANSM DIS, V33, P36, DOI 10.1097/01.olq.0000187908.42622.fd; WATSON RA, 1979, MIL MED, V144, P785; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Yokoi S, 2007, EMERG INFECT DIS, V13, P1275	40	68	70	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	1				321	328		10.7326/0003-4819-158-5-201303050-00004	http://dx.doi.org/10.7326/0003-4819-158-5-201303050-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105HP	23460055	Green Accepted			2022-12-24	WOS:000316057700003
J	Dor, Y; Glaser, B				Dor, Yuval; Glaser, Benjamin			Beta-Cell Dedifferentiation and Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROLIFERATION		[Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Dept Internal Med, Serv Endocrinol, IL-91010 Jerusalem, Israel; [Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Dept Internal Med, Metab Serv, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Dor, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel.		Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000				Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Weinberg N, 2007, DIABETES, V56, P1299, DOI 10.2337/db06-1654	5	57	60	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					572	573		10.1056/NEJMcibr1214034	http://dx.doi.org/10.1056/NEJMcibr1214034			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083VU	23388011				2022-12-24	WOS:000314494100011
J	Satoh, T; Kidoya, H; Naito, H; Yamamoto, M; Takemura, N; Nakagawa, K; Yoshioka, Y; Morii, E; Takakura, N; Takeuchi, O; Akira, S				Satoh, Takashi; Kidoya, Hiroyasu; Naito, Hisamichi; Yamamoto, Masahiro; Takemura, Naoki; Nakagawa, Katsuhiro; Yoshioka, Yoshichika; Morii, Eiichi; Takakura, Nobuyuki; Takeuchi, Osamu; Akira, Shizuo			Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages	NATURE			English	Article							TRIBBLES HOMOLOG; ALTERNATIVE ACTIVATION; MYELOID LEUKEMOGENESIS; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; INFLAMMATION; OBESITY; POLARIZATION; ASSOCIATION	Macrophages consist of at least two subgroups, M1 and M2 (refs 1-3). Whereas M1 macrophages are proinflammatory and have a central role in host defence against bacterial and viral infections(4,5), M2 macrophages are associated with responses to anti-inflammatory reactions, helminth infection, tissue remodelling, fibrosis and tumour progression(6). Trib1 is an adaptor protein involved in protein degradation by interacting with COP1 ubiquitin ligase(7). Genome-wide association studies in humans have implicated TRIB1 in lipid metabolism(8-10). Here we show that Trib1 is critical for the differentiation of F4/80(+)MR(+) tissue-resident macrophages-that share characteristics with M2 macrophages (which we term M2-like macrophages)-and eosinophils but not for the differentiation of M1 myeloid cells. Trib1 deficiency results in a severe reduction of M2-like macrophages in various organs, including bone marrow, spleen, lung and adipose tissues. Aberrant expression of C/EBP alpha in Trib1-deficient bone marrow cells is responsible for the defects in macrophage differentiation. Unexpectedly, mice lacking Trib1 in haematopoietic cells show diminished adipose tissue mass accompanied by evidence of increased lipolysis, even when fed a normal diet. Supplementation of M2-like macrophages rescues the pathophysiology, indicating that a lack of these macrophages is the cause of lipolysis. In response to a high-fat diet, mice lacking Trib1 in haematopoietic cells develop hypertriglyceridaemia and insulin resistance, together with increased proinflammatory cytokine gene induction. Collectively, these results demonstrate that Trib1 is critical for adipose tissue maintenance and suppression of metabolic disorders by controlling the differentiation of tissue-resident M2-like macrophages.	[Satoh, Takashi; Takemura, Naoki; Nakagawa, Katsuhiro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Lab Host Def, WPI Immunol Frontier Res Ctr WPI IFReC, Suita, Osaka 5650871, Japan; [Satoh, Takashi; Takemura, Naoki; Nakagawa, Katsuhiro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Kidoya, Hiroyasu; Naito, Hisamichi; Takakura, Nobuyuki] Osaka Univ, Dept Signal Transduct, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Yamamoto, Masahiro] Osaka Univ, Lab Immunoparasitol, WPI Immunol Frontier Res Ctr WPI IFReC, Suita, Osaka 5650871, Japan; [Yamamoto, Masahiro] Osaka Univ, Dept Immunoparasitol, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Yoshioka, Yoshichika] Osaka Univ, Lab Biofunct Imaging, WPI Immunol Frontier Res Ctr WPI IFReC, Suita, Osaka 5650871, Japan; [Morii, Eiichi] Osaka Univ, Dept Pathol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Takeuchi, Osamu] Kyoto Univ, Lab Infect & Prevent, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Kyoto University	Akira, S (corresponding author), Osaka Univ, Lab Host Def, WPI Immunol Frontier Res Ctr WPI IFReC, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Akira, Shizuo/C-3134-2009	Takeuchi, Osamu/0000-0002-1260-6232; Naito, Hisamichi/0000-0002-0750-1743	Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare in Japan; Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22689016] Funding Source: KAKEN	Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank I. Shimomura and Y. Miyata for providing us with the key protocols for the metabolic experiments; T. Kitamura for providing the PlatE cells; M. Higa, H. Tanaka, N. Miyamoto, K. Miura, D. Ori, T. Uehata and K. Kuniyoshi for assistance with the experiments; and T. Kawai, S. Uematsu, T. Saitoh and Y. Kumagai for discussions. We also thank E. Kamada and M. Kageyama for secretarial assistance, and N. Umano, Y. Matsumoto and M. Kumagai for technical assistance. This work was supported by the Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health, Labour and Welfare in Japan, the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program).	Aung LHH, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-230; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hong S, 2011, J LEUKOCYTE BIOL, V90, P643, DOI 10.1189/jlb.0111043; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Okamoto H, 2007, DIABETES, V56, P1350, DOI 10.2337/db06-1448; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Varbo A, 2011, ARTERIOSCL THROM VAS, V31, P451, DOI 10.1161/ATVBAHA.110.216333; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yamamoto M, 2007, J EXP MED, V204, P2233, DOI 10.1084/jem.20070183; Yokoyama T, 2010, BLOOD, V116, P2768, DOI 10.1182/blood-2009-10-246264	30	217	226	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					524	+		10.1038/nature11930	http://dx.doi.org/10.1038/nature11930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23515163				2022-12-24	WOS:000316682800049
J	Parson, EA; Keith, DW				Parson, Edward A.; Keith, David W.			End the Deadlock on Governance of Geoengineering Research	SCIENCE			English	Editorial Material									[Parson, Edward A.] UCLA Sch Law, Emmett Ctr Climate Change & Law, Los Angeles, CA 90095 USA; [Keith, David W.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University	Parson, EA (corresponding author), UCLA Sch Law, Emmett Ctr Climate Change & Law, Los Angeles, CA 90095 USA.	parson@law.ucla.edu						Asilomar Scientific Organizing Committee, 2010, C REP; Biello D, 2012, SCI AM; Bipartisan Policy Center Task Force on Climate Remediation Research, 2011, GEOENG NAT STRAT PLA; Hamilton Clive, 2011, GUARDIAN; Keith DW, 2010, NATURE, V463, P426, DOI 10.1038/463426a; Keith DW, 2000, ANNU REV ENERG ENV, V25, P245, DOI 10.1146/annurev.energy.25.1.245; Levitt S. D., 2011, SUPERFREAKONOMICS; Lukacs M, 2012, GUARDIAN; NATIONAL RESEARCH COUNCIL, 2010, AM CLIM CHOIC PAN AD, P377; Oxford Geoengineering Programme, 2009, OXF PRINC GEOENG RES; Parson E., 2013, THEORET INQ LAW, V14, P311; Robock A, 2008, B ATOM SCI, V64, P14, DOI 10.1080/00963402.2008.11461140; Solar Radiation Management Governance Initiative, 2011, SOL RAD MAN GOV RES; Wood L., 2002, UCRLJC148012 LAWR LI	15	82	85	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1278	1279		10.1126/science.1232527	http://dx.doi.org/10.1126/science.1232527			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	105GC	23493699				2022-12-24	WOS:000316053400021
J	Roehr, B				Roehr, Bob			Grappling with concussion: discovery, policy, and practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com						Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2013	346								f1693	10.1136/bmj.f1693	http://dx.doi.org/10.1136/bmj.f1693			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108VT	23502708				2022-12-24	WOS:000316325000003
J	Xu, Y; Ma, PJ; Shah, P; Rokas, A; Liu, Y; Johnson, CH				Xu, Yao; Ma, Peijun; Shah, Premal; Rokas, Antonis; Liu, Yi; Johnson, Carl Hirschie			Non-optimal codon usage is a mechanism to achieve circadian clock conditionality	NATURE			English	Article							GENE-EXPRESSION; ESCHERICHIA-COLI; CYANOBACTERIA; SELECTION; BIAS; TEMPERATURE; PROKARYOTES; ADAPTATION; EFFICIENCY; DROSOPHILA	Circadian rhythms are oscillations in biological processes that function as a key adaptation to the daily rhythms of most environments. In the model cyanobacterial circadian clock system, the core oscillator proteins are encoded by the gene cluster kaiABC(1). Genes with high expression and functional importance, such as the kai genes, are usually encoded by optimal codons, yet the codon-usage bias of the kaiBC genes is not optimized for translational efficiency. We discovered a relationship between codon usage and a general property of circadian rhythms called conditionality; namely, that endogenous rhythmicity is robustly expressed under some environmental conditions but not others(2). Despite the generality of circadian conditionality, however, its molecular basis is unknown for any system. Here we show that in the cyanobacterium Synechococcus elongate, non-optimal codon usage was selected as a post-transcriptional. mechanism to switch between circadian and non-circadian regulation of gene expression as an adaptive response to environmental conditions. When the kaiBC sequence was experimentally optimized to enhance expression of the KaiB and KaiC proteins, intrinsic rhythmicity was enhanced at cool temperatures that are experienced by this organism in. its natural habitat. However, fitness at those temperatures was highest in cells hi which the endogenous rhythms were suppressed at cool temperatures as compared with cells exhibiting high-amplitude rhythmicity. These results indicate natural selection against circadian systems in cyanobacteria that are intrinsically robust at cool temperatures. Modulation of circadian amplitude is therefore crucial to its adaptive significance(3). Moreover, these results show the direct effects of codon usage on a complex phenotype and organismal fitness. Our work also challenges the long-standing view of directional selection towards optimal codons(4-7), and provides a key example of natural selection against optimal codons to achieve adaptive responses to environmental changes.	[Xu, Yao; Ma, Peijun; Rokas, Antonis; Johnson, Carl Hirschie] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Shah, Premal] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Vanderbilt University; University of Pennsylvania; University of Texas System; University of Texas Southwestern Medical Center Dallas	Johnson, CH (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	carl.h.johnson@vanderbilt.edu	Rokas, Antonis/A-9775-2008; Johnson, Carl H/I-4655-2014	Rokas, Antonis/0000-0002-7248-6551; Shah, Premal/0000-0002-8424-4218	National Institute of General Medical Science [R01 GM067152, R01 GM088595, GM068496, GM062591]; Welch Foundation [I-1560]; National Science Foundation [DEB-0844968]; Searle Scholars Program; Burroughs Wellcome Fund Career Award; David & Lucille Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM067152, R35GM118118, R01GM107434, R01GM084283, R01GM067152, R01GM062591, R01GM068496, R01GM088595] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); Searle Scholars Program; Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); David & Lucille Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for the suggestions of M. Woelfle and the technical assistance of D. Zelli and C. Chintanaphol. This research was supported by grants from the National Institute of General Medical Science to C.H.J. (R01 GM067152 and R01 GM088595) and to Y.L. (GM068496 and GM062591), the Welch Foundation (I-1560) to Y.L., and the National Science Foundation (DEB-0844968) and the Searle Scholars Program to A.R. P.S. acknowledges support from a Burroughs Wellcome Fund Career Award and a David & Lucille Packard Foundation Fellowship awarded to Joshua B. Plotkin.	AKASHI H, 1994, GENETICS, V136, P927; BULMER M, 1991, GENETICS, V129, P897; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; KONIGSBERG W, 1983, P NATL ACAD SCI-BIOL, V80, P687, DOI 10.1073/pnas.80.3.687; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; Nakajima M, 2010, FEBS LETT, V584, P898, DOI 10.1016/j.febslet.2010.01.016; NJUS D, 1977, J COMP PHYSIOL, V117, P335, DOI 10.1007/BF00691559; Paul S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r70; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Shah P, 2011, P NATL ACAD SCI USA, V108, P10231, DOI 10.1073/pnas.1016719108; Shah P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001128; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Vijayan V, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r47; Vijayan V, 2009, P NATL ACAD SCI USA, V106, P22564, DOI 10.1073/pnas.0912673106; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070	30	129	131	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2013	495	7439					116	120		10.1038/nature11942	http://dx.doi.org/10.1038/nature11942			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23417065	Green Accepted			2022-12-24	WOS:000316039800051
J	Rosenzweig, R; Moradi, S; Zarrine-Afsar, A; Glover, JR; Kay, LE				Rosenzweig, Rina; Moradi, Shoeib; Zarrine-Afsar, Arash; Glover, John R.; Kay, Lewis E.			Unraveling the Mechanism of Protein Disaggregation Through a ClpB-DnaK Interaction	SCIENCE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; MOLECULAR CHAPERONE; THERMUS-THERMOPHILUS; AGGREGATED PROTEINS; FACTOR GRPE; M-DOMAINS; HSP70; ATPASE; THERMOTOLERANCE; SOLUBILIZATION	HSP-100 protein machines, such as ClpB, play an essential role in reactivating protein aggregates that can otherwise be lethal to cells. Although the players involved are known, including the DnaK/DnaJ/GrpE chaperone system in bacteria, details of the molecular interactions are not well understood. Using methyl-transverse relaxation-optimized nuclear magnetic resonance spectroscopy, we present an atomic-resolution model for the ClpB-DnaK complex, which we verified by mutagenesis and functional assays. ClpB and GrpE compete for binding to the DnaK nucleotide binding domain, with GrpE binding inhibiting disaggregation. DnaK, in turn, plays a dual role in both disaggregation and subsequent refolding of polypeptide chains as they emerge from the aggregate. On the basis of a combined structural-biochemical analysis, we propose a model for the mechanism of protein aggregate reactivation by ClpB.	[Rosenzweig, Rina; Moradi, Shoeib; Glover, John R.; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Rosenzweig, Rina; Zarrine-Afsar, Arash; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Rosenzweig, Rina; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Kay, Lewis E.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Rosenzweig, R (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	rina.rosenzweig@utoronto.ca; kay@pound.med.utoronto.ca		Rosenzweig, Rina/0000-0002-4019-5135; Moradi, Shoeib/0000-0003-2808-4579	European Molecular Biology Organization [ALTF-570-2010]; Government of Canada (Banting); Canadian Institutes of Health Research	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Government of Canada (Banting); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank J. Forman-Kay for providing laboratory space and for valuable discussions, R. Muhandiram for NMR support, and M. Latham for helpful discussions. wt-ClpB and GroEL/ES constructs were generously provided by F. Tsai (Baylor College of Medicine, Texas) and A. Horwich (Yale School of Medicine, Connecticut). R. R. acknowledges the European Molecular Biology Organization (ALTF-570-2010) and the Government of Canada (Banting) for postdoctoral fellowships. L. E. K. holds a Canada Research Chair in Biochemistry. This work was supported by a grant from the Canadian Institutes of Health Research. Coordinates for the ClpB-DnaK complex are available as supplementary material.	Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Grimshaw JPA, 2001, J BIOL CHEM, V276, P6098, DOI 10.1074/jbc.M009290200; Groemping Y, 2001, J MOL BIOL, V305, P1173, DOI 10.1006/jmbi.2000.4373; Groemping Y, 2001, J MOL BIOL, V314, P167, DOI 10.1006/jmbi.2001.5116; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Haslberger T, 2008, NAT STRUCT MOL BIOL, V15, P641, DOI 10.1038/nsmb.1425; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Religa TL, 2010, SCIENCE, V328, P98, DOI 10.1126/science.1184991; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schlieker C, 2004, FEBS LETT, V578, P351, DOI 10.1016/j.febslet.2004.11.051; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Tugarinov V, 2004, J BIOMOL NMR, V28, P165, DOI 10.1023/B:JNMR.0000013824.93994.1f; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	30	187	188	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1080	1083		10.1126/science.1233066	http://dx.doi.org/10.1126/science.1233066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23393091				2022-12-24	WOS:000315452000043
J	Balmford, A				Balmford, Andrew			Pollution, Politics, and Vultures	SCIENCE			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DICLOFENAC RESIDUES; GYPS VULTURES; THREAT; INDIA; DECLINE; POPULATION; PAKISTAN		Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England	University of Cambridge	Balmford, A (corresponding author), Dept Zool, Conservat Sci Grp, Downing St, Cambridge CB2 3EJ, England.	a.balmford@zoo.cam.ac.uk		Balmford, Andrew/0000-0002-0144-3589				Chaudhry MJI, 2012, BIRD CONSERV INT, V22, P389, DOI 10.1017/S0959270912000445; Cuthbert R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019069; Cuthbert RJ, 2011, ORYX, V45, P420, DOI 10.1017/S0030605311000135; Gilbert N, 2012, NATURE, V491, P503, DOI 10.1038/491503a; Green RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000686; Markandya A, 2008, ECOL ECON, V67, P194, DOI 10.1016/j.ecolecon.2008.04.020; Naidoo V, 2010, BIOL LETTERS, V6, P339, DOI 10.1098/rsbl.2009.0818; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Prakash V., 2007, J BOMBAY NAT HIST SO, V104, P129; Prakash V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049118; Sharma P, 2012, J RAPTOR RES, V46, P314, DOI 10.3356/JRR-11-66.1; Swan G, 2006, PLOS BIOL, V4, P395, DOI 10.1371/journal.pbio.0040066	12	15	17	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					653	654		10.1126/science.1234193	http://dx.doi.org/10.1126/science.1234193			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085BM	23393251				2022-12-24	WOS:000314585600026
J	Frattaroli, S; Webster, DW; Wintemute, GJ				Frattaroli, Shannon; Webster, Daniel W.; Wintemute, Garen J.			Implementing a Public Health Approach to Gun Violence Prevention: The Importance of Physician Engagement	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Frattaroli, Shannon] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Univ Calif Davis, Davis, CA 95616 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Davis	Frattaroli, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 624 North Broadway, Baltimore, MD 21205 USA.	sfrattar@jhsph.edu						Barry CL, 2013, N ENGL J MED; Centers for Disease Control and Prevention, 2005, WEB BAS INJ STAT QUE; Cook PJ, 1996, GUND AM RESULTS COMP; Davidoff F, 1998, ANN INTERN MED, V128, P234, DOI 10.7326/0003-4819-128-3-199802010-00011; Gun Violence Archive, 2022, SUMM LEDG; Kellermann AL, 1996, NEW ENGL J MED, V335, P1438, DOI 10.1056/NEJM199611073351906; Laine C, 2013, ANN INTERN MED, V158, P493, DOI 10.7326/0003-4819-158-6-201303190-00586; Vittes KA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8672; Wintemute GJ, 2013, NEW ENGL J MED, V368, P397, DOI 10.1056/NEJMp1215491	9	26	27	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2013	158	9					697	+		10.7326/0003-4819-158-9-201305070-00597	http://dx.doi.org/10.7326/0003-4819-158-9-201305070-00597			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146WV	23400374				2022-12-24	WOS:000319126900007
J	Barde, I; Rauwel, B; Marin-Florez, RM; Corsinotti, A; Laurenti, E; Verp, S; Offner, S; Marquis, J; Kapopoulou, A; Vanicek, J; Trono, D				Barde, Isabelle; Rauwel, Benjamin; Marin-Florez, Ray Marcel; Corsinotti, Andrea; Laurenti, Elisa; Verp, Sonia; Offner, Sandra; Marquis, Julien; Kapopoulou, Adamandia; Vanicek, Jiri; Trono, Didier			A KRAB/KAP1-miRNA Cascade Regulates Erythropoiesis Through Stage-Specific Control of Mitophagy	SCIENCE			English	Article							CONTRIBUTES; EXPRESSION; GENE; CELL; REPRESSION; PROTEIN-1; SEQUENCE	During hematopoiesis, lineage- and stage-specific transcription factors work in concert with chromatin modifiers to direct the differentiation of all blood cells. We explored the role of KRAB-containing zinc finger proteins (KRAB-ZFPs) and their cofactor KAP1 in this process. In mice, hematopoietic-restricted deletion of Kap1 resulted in severe hypoproliferative anemia. Kap1-deleted erythroblasts failed to induce mitophagy-associated genes and retained mitochondria. This was due to persistent expression of microRNAs (miRNAs) targeting mitophagy transcripts, itself secondary to a lack of repression by stage-specific KRAB-ZFPs. The KRAB/KAP1-miRNA regulatory cascade is evolutionarily conserved, as it also controls mitophagy during human erythropoiesis. Thus, a multilayered transcription regulatory system is present, in which protein- and RNA-based repressors are superimposed in combinatorial fashion to govern the timely triggering of an important differentiation event.	[Barde, Isabelle; Rauwel, Benjamin; Corsinotti, Andrea; Laurenti, Elisa; Verp, Sonia; Offner, Sandra; Marquis, Julien; Kapopoulou, Adamandia; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Barde, Isabelle; Rauwel, Benjamin; Corsinotti, Andrea; Laurenti, Elisa; Verp, Sonia; Offner, Sandra; Marquis, Julien; Kapopoulou, Adamandia; Trono, Didier] Ecole Polytech Fed Lausanne, Frontiers Genet Program, CH-1015 Lausanne, Switzerland; [Marin-Florez, Ray Marcel; Vanicek, Jiri] Ecole Polytech Fed Lausanne, Sch Basic Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	didier.trono@epfl.ch	Marin, Ray/C-5515-2013; Vanicek, Jiri/I-6479-2013	Marin, Ray/0000-0002-5648-0731; Vanicek, Jiri/0000-0002-2080-4378; Laurenti, Elisa/0000-0002-9917-9092	Swiss National Science Foundation; European Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission)	We thank the staff of our core facilities for technical expertise, and P. Turelli, B. Yazdanpanah, and F. Marzetta (EPFL), P. Malik (Cincinnati Children's Hospital), and G. Ferrari (San Raffaele Telethon Institute for Gene Therapy, Milano) for the kind gift of reagents. Supported by grants from the Swiss National Science Foundation and the European Research Council (D.T.). The cDNA and miRNA microarray and ChIP-seq data are deposited in the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) under accession number GSE44061. D.T. and I.B. are inventors on a patent application submitted by EPFL for the control of mitophagy.	BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; Bojkowska K, 2012, HEPATOLOGY, V56, P1279, DOI 10.1002/hep.25767; Chikuma S, 2012, NAT IMMUNOL, V13, P596, DOI 10.1038/ni.2293; de Sio FRS, 2012, FASEB J, V26, P4561, DOI 10.1096/fj.12-206177; de Sio FRS, 2012, BLOOD, V119, P4675, DOI 10.1182/blood-2011-12-401117; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Jakobsson J, 2008, NEURON, V60, P818, DOI 10.1016/j.neuron.2008.09.036; Lawrie CH, 2010, BRIT J HAEMATOL, V150, P144, DOI 10.1111/j.1365-2141.2009.07978.x; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Marin RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032208; Marin RM, 2011, NUCLEIC ACIDS RES, V39, P19, DOI 10.1093/nar/gkq768; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Quenneville S, 2012, CELL REP, V2, P766, DOI 10.1016/j.celrep.2012.08.043; Rowe HM, 2013, GENOME RES, V23, P452, DOI 10.1101/gr.147678.112; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Xu J, 2012, DEV CELL, V23, P796, DOI 10.1016/j.devcel.2012.09.003; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	27	79	87	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					350	353		10.1126/science.1232398	http://dx.doi.org/10.1126/science.1232398			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23493425	Green Accepted			2022-12-24	WOS:000317657500055
J	Rechel, B; Grundy, E; Robine, JM; Cylus, J; Mackenbach, JP; Knai, C; McKee, M				Rechel, Bernd; Grundy, Emily; Robine, Jean-Marie; Cylus, Jonathan; Mackenbach, Johan P.; Knai, Cecile; McKee, Martin			Ageing in the European Union	LANCET			English	Article							LIFE-COURSE APPROACH; HEALTH-CARE; OLDER-PEOPLE; LAST YEAR; ELDERLY POPULATION; HEART-DISEASE; EXPECTANCY; COSTS; TRENDS; AGE	The ageing of European populations presents health, long-term care, and welfare systems with new challenges. Although reports of ageing as a fundamental threat to the welfare state seem exaggerated, societies have to embrace various policy options to improve the robustness of health, long-term care, and welfare systems in Europe and to help people to stay healthy and active in old age. These policy options include prevention and health promotion, better selfcare, increased coordination of care, improved management of hospital admissions and discharges, improved systems of long-term care, and new work and pension arrangements. Ageing of the health workforce is another challenge, and policies will need to be pursued that meet the particular needs of older workers (ie, those aged 50 years or older) while recruiting young practitioners.	[Rechel, Bernd; Cylus, Jonathan; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, London WC1H 9SH, England; [Rechel, Bernd; Knai, Cecile; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1H 9SH, England; [Grundy, Emily] Univ Cambridge, Cambridge, England; [Robine, Jean-Marie] French Natl Inst Hlth & Med Res INSERM, Paris, France; [Cylus, Jonathan] Univ London London Sch Econ & Polit Sci, European Observ Hlth Syst & Policies, London WC2A 2AE, England; [Mackenbach, Johan P.] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands	European Observatory on Health Systems & Policies; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); European Observatory on Health Systems & Policies; University of London; London School Economics & Political Science; Erasmus University Rotterdam; Erasmus MC	Rechel, B (corresponding author), Univ London London Sch Hyg & Trop Med, 15-17 Tavistock Pl, London WC1H 9SH, England.	bernd.rechel@lshtm.ac.uk	Robine, Jean-Marie/F-5439-2011; Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011; Grundy, Emily/AAC-3260-2019	Robine, Jean-Marie/0000-0002-4111-6195; Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Grundy, Emily/0000-0002-9633-1116; Cylus, Jonathan/0000-0001-8269-1578; Rechel, Bernd/0000-0001-8020-3956; Knai, Cecile/0000-0001-6663-7379	European Observatory on Health Systems and Policies	European Observatory on Health Systems and Policies	This work has been supported by the European Observatory on Health Systems and Policies.	Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; [Anonymous], 2007, TRENDS SEVERE DISABI; [Anonymous], 2006, SECURING GOOD CARE O; Attias-Donfut C., 2003, MYTH GENERATIONAL CO, P22; Beard JR, 2010, PUBLIC HEALTH REV, V32, P427, DOI 10.1007/BF03391610; Bech M, 2011, EUR J HEALTH ECON, V12, P469, DOI 10.1007/s10198-010-0260-4; Borsch-Supan A, 2005, HLTH AGEING RETIREME, P133; Breyer F, 2006, HEALTH POLICY, V75, P178, DOI 10.1016/j.healthpol.2005.03.011; Bronnum-Hansen H, 2005, EUR J PUBLIC HEALTH, V15, P20, DOI 10.1093/eurpub/cki106; Byberg L, 2009, BMJ-BRIT MED J, V338, P688; Calfo S, 2009, LAST YEAR LIFE STUDY; Casey B., 2003, POLICIES AGEING SOC; Chen KM, 2009, INT J NURS STUD, V46, P154, DOI 10.1016/j.ijnurstu.2008.09.005; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Coyte PC, 2008, CAN SITTINGS USED PR; Dale B, 2012, SCAND J CARING SCI, V26, P113, DOI 10.1111/j.1471-6712.2011.00917.x; Daviglus ML, 2005, ARCH INTERN MED, V165, P1028, DOI 10.1001/archinte.165.9.1028; Dormont B., 2009, DEPENSES SANTE AUGME; Doyle Y., 2009, BMJ-BRIT MED J, V339, P892; Doyle YG, 2012, EUR J PUBLIC HEALTH, V22, P71, DOI 10.1093/eurpub/ckq132; Dubois C-A, 2006, HUMAN RESOURCES HLTH, P15; European Commission, 2008, LONG TERM CAR EUR UN; European Commission, 2013, EUR DAT; European Commission, 2008, GREEN PAP EUR WORKF; European Commission, 2006, COMM COMM DEM FUT EU; European Commission, 2009, 2009 AG REP EC BUDG; Eurostat, 2011, ACT AG SOL GEN STAT; Fahy N, 2011, BMJ-BRIT MED J, V342, P3815; Figueras J., 2008, HLTH SYSTEMS HLTH WE; Forster A., 2009, COCHRANE DB SYST REV, V1; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Freedman VA, 2006, GERONTOLOGIST, V46, P124, DOI 10.1093/geront/46.1.124; Fries JF, 2005, AM J PREV MED, V29, P164, DOI 10.1016/j.amepre.2005.07.004; FRIES JF, 1983, MILBANK FUND Q, V61, P397, DOI 10.2307/3349864; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; FUCHS VR, 1984, MILBANK FUND Q, V62, P143; Gandjour A, 2005, J HEALTH ECON, V24, P715, DOI 10.1016/j.jhealeco.2004.11.009; Gandjour A., 2008, HEALTH ECON, V18, P355; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Glei DA, 2010, INT DIFFERENCES MORT, P17; Glymour M, 2012, BMJ-BRIT MED J, V345, P10; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; Hakkinen U, 2008, HEALTH ECON POLICY L, V3, P165, DOI 10.1017/S174413310800443X; Hartman M, 2008, HEALTH AFFAIR, V27, pW1, DOI 10.1377/hlthaff.27.1.w1; Hillman K, 1999, MED J AUSTRALIA, V170, P325, DOI 10.5694/j.1326-5377.1999.tb127789.x; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hubbard RE, 2004, AGE AGEING, V33, P479, DOI 10.1093/ageing/afh164; Jagger C, 2011, GERONTOLOGIST, V51, P250; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Jagger C, 2011, INT HANDB POPUL, V2, P551, DOI 10.1007/978-90-481-9996-9_26; Kardamanidis K, 2007, MED J AUSTRALIA, V187, P383, DOI 10.5694/j.1326-5377.2007.tb01306.x; Kendrick S, 2006, EUR J POPUL, V22, P281, DOI 10.1007/s10680-006-9002-9; King AC, 2010, PUBLIC HEALTH REV, V32, P401, DOI 10.1007/BF03391609; Kohler H-P, 2003, ENCY POPULATION, P405; KRAMER M, 1980, ACTA PSYCHIAT SCAND, V62, P382, DOI 10.1111/j.1600-0447.1980.tb07714.x; Kuh D, 2012, PUBLIC HEALTH, V126, P193, DOI 10.1016/j.puhe.2012.01.025; Kuh D, 2007, J GERONTOL A-BIOL, V62, P717, DOI 10.1093/gerona/62.7.717; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Lievre A, 2007, J NUTR HEALTH AGING, V11, P508; Mackenbach JP, 2011, EUR J EPIDEMIOL, V26, P903, DOI 10.1007/s10654-011-9633-y; Majer IM, 2011, OBESITY, V19, P1451, DOI 10.1038/oby.2011.46; Mangin D, 2007, BMJ-BRIT MED J, V335, P285, DOI 10.1136/bmj.39241.630741.BE1; MANTON KG, 1988, J GERONTOL, V43, pS153, DOI 10.1093/geronj/43.5.S153; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; Matthews RJ, 2006, SOC SCI MED, V62, P2489, DOI 10.1016/j.socscimed.2005.11.019; McGrail K, 2000, AGE AGEING, V29, P249, DOI 10.1093/ageing/29.3.249; Mistry M, 2011, BRIT J CANCER, V105, P1795, DOI 10.1038/bjc.2011.430; MOON L, 2003, STROKE CARE OECD COU; Mura T, 2010, EUR J NEUROL, V17, P252, DOI 10.1111/j.1468-1331.2009.02783.x; Nolte E, 2008, CARING PEOPLE CHRONI; Nusselder WJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-487; Oliveira Martins J, 2006, PROJECTING OECD HLTH; Oliveira Martins J, 2005, IMPACTS AGEING DEMAN; Olshansky S.J., 1991, J AGING HEALTH, V3, P194, DOI DOI 10.1177/089826439100300205; Organisation for Economic Co-operation and Development, 2008, LOOM CRIS HLT WORKF; Organisation for Economic Co-operation and Development, 2011, PENS GLANC; Organisation for Economic Co-operation and Development, 2010, LAB FORC STAT OECD M; Oxley H., 2009, POLICIES HLTH AGEING; Parker M, 2005, J GERONTOL A-BIOL, V60, P933; Parker MG, 2007, GERONTOLOGIST, V47, P150, DOI 10.1093/geront/47.2.150; Polder JJ, 2006, SOC SCI MED, V63, P1720, DOI 10.1016/j.socscimed.2006.04.018; PRESTON SH, 1989, DEMOGRAPHY, V26, P691, DOI 10.2307/2061266; Rathmann W, 2005, GESUNDHEITSWESEN, V67, pS110, DOI 10.1055/s-2005-858227; Rechel B., 2009, INVESTING HOSP FUTUR; Rechel B., 2010, CAN HLTH SYSTEMS RES; Rechel B, 2013, LANCET; Ritsatakis A., 2008, DEMYSTIFYING MYTHS A; Robine JM, 2009, QUAL AGEING OLDER AD, V10, P5, DOI 10.1108/14717794200900012; ROBINE JM, 1992, B WORLD HEALTH ORGAN, V70, P791; Saltman RB, 1997, EUROPEAN HLTH CARE R; Schelleman H, 2004, J HUM HYPERTENS, V18, P317, DOI 10.1038/sj.jhh.1001672; Seeman TE, 2000, AM J HEALTH PROMOT, V14, P362, DOI 10.4278/0890-1171-14.6.362; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Sihvonen AP, 1998, SOC SCI MED, V47, P303, DOI 10.1016/S0277-9536(98)00020-3; Steinberg BA, 2008, AM HEART J, V156, P719, DOI 10.1016/j.ahj.2008.05.020; Stevens JA, 2008, J SAFETY RES, V39, P345, DOI 10.1016/j.jsr.2008.05.002; Suhrcke M, 2006, BRIT MED J, V333, P1017, DOI 10.1136/bmj.38951.614144.68; The Economist, 2009, HEALTHC STRAT AG SOC; Trippel M, 2011, TRULY IMPOSSIBLE EQU; UN, REPL MIGR IS SOL DEC; van Baal PH, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-51; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; van Gool CH, 2011, INT J EPIDEMIOL, V40, P1056, DOI 10.1093/ije/dyr009; Vass M, 2007, Z GERONTOL GERIATR, V40, P209, DOI 10.1007/s00391-007-0470-2; Vickerstaff S., 2011, WORK HLTH WELLBEING; Werblow A, 2007, HEALTH ECON, V16, P1109, DOI 10.1002/hec.1213; Winblad K, 2001, J CLIN EPIDEMIOL, V54, P1019; Wiskow C., 2010, CREATE ATTRACTIVE SU	109	370	373	14	182	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2013	381	9874					1312	1322		10.1016/S0140-6736(12)62087-X	http://dx.doi.org/10.1016/S0140-6736(12)62087-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122XD	23541057				2022-12-24	WOS:000317351000034
J	Keestra, AM; Winter, MG; Auburger, JJ; Frassle, SP; Xavier, MN; Winter, SE; Kim, A; Poon, V; Ravesloot, MM; Waldenmaier, JFT; Tsolis, RM; Eigenheer, RA; Baumler, AJ				Keestra, A. Marijke; Winter, Maria G.; Auburger, Josef J.; Fraessle, Simon P.; Xavier, Mariana N.; Winter, Sebastian E.; Kim, Anita; Poon, Victor; Ravesloot, Marietta M.; Waldenmaier, Julian F. T.; Tsolis, Renee M.; Eigenheer, Richard A.; Bauemler, Andreas J.			Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1	NATURE			English	Article							NF-KAPPA-B; SEROVAR TYPHIMURIUM COLITIS; SALMONELLA-TYPHIMURIUM; CHEMOKINE EXPRESSION; NUCLEAR RESPONSES; SIGNALING PATHWAY; EPITHELIAL-CELLS; HOST-CELLS; ACTIVATION; MODEL	Our innate immune system distinguishes microbes from self by detecting conserved pathogen-associated molecular patterns(1). However, these are produced by all microbes, regardless of their pathogenic potential. To distinguish virulent microbes from those with lower disease-causing potential the innate immune system detects conserved pathogen-induced processes(2), such as the presence of microbial products in the host cytosol, by mechanisms that are not fully resolved. Here we show that NOD1 senses cytosolic microbial products by monitoring the activation state of small Rho GTPases. Activation of RAC1 and CDC42 by bacterial delivery or ectopic expression of SopE, a virulence factor of the enteric pathogen Salmonella, triggered the NOD1 signalling pathway, with consequent RIP2 (also known as RIPK2)-mediated induction of NF-kappa B-dependent inflammatory responses. Similarly, activation of the NOD1 signalling pathway by peptidoglycan required RAC1 activity. Furthermore, constitutively active forms of RAC1, CDC42 and RHOA activated the NOD1 signalling pathway. Our data identify the activation of small Rho GTPases as a pathogen-induced process sensed through the NOD1 signalling pathway.	[Keestra, A. Marijke; Winter, Maria G.; Auburger, Josef J.; Fraessle, Simon P.; Xavier, Mariana N.; Winter, Sebastian E.; Kim, Anita; Poon, Victor; Ravesloot, Marietta M.; Waldenmaier, Julian F. T.; Tsolis, Renee M.; Bauemler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Eigenheer, Richard A.] Univ Calif Davis, UC Davis Genome Ctr, Prote Core Facil, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Baumler, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, 1 Shields Ave, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Winter, Sebastian E/A-4118-2009; Byndloss, Mariana Xavier/ABD-5506-2021; Baumler, Andreas J/H-2301-2011; Keestra-Gounder, A. Marijke/H-4394-2012; Byndloss, Mariana X/D-9890-2014	Winter, Sebastian E/0000-0003-1532-9178; Byndloss, Mariana Xavier/0000-0002-2122-4156; Baumler, Andreas J/0000-0001-9152-7809; Keestra-Gounder, A. Marijke/0000-0002-2231-652X; Byndloss, Mariana X/0000-0002-2122-4156; Tsolis, Renee/0000-0001-9131-6657	Public Health Service Grants [AI044170, AI076246]; American Heart Association [12SDG12220022]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076246, R01AI044170] Funding Source: NIH RePORTER	Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank S.-P. Nuccio for providing PCR primers for the construction of the bacterial strains. This work was supported by Public Health Service Grants AI044170 and AI076246. A. M. K. is supported by the American Heart Association Grant 12SDG12220022.	Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; Argast GM, 2005, MOL CELL BIOCHEM, V268, P129, DOI 10.1007/s11010-005-3701-0; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Boyer L, 2011, IMMUNITY, V35, P536, DOI 10.1016/j.immuni.2011.08.015; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Figueiredo JF, 2009, MICROBES INFECT, V11, P302, DOI 10.1016/j.micinf.2008.12.005; Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x; Fukazawa A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000228; Geddes K, 2010, INFECT IMMUN, V78, P5107, DOI 10.1128/IAI.00759-10; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hobbie S, 1997, J IMMUNOL, V159, P5550; Inohara N, 2000, J BIOL CHEM, V275, P27823; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Keestra AM, 2011, MBIO, V2, DOI 10.1128/mBio.00266-11; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; LAWES M, 1995, J BACTERIOL, V177, P1383, DOI 10.1128/jb.177.5.1383-1387.1995; Le Bourhis L, 2009, INFECT IMMUN, V77, P4480, DOI 10.1128/IAI.00519-09; Lopez CA, 2012, MBIO, V3, DOI 10.1128/mBio.00143-12; Lu WJ, 2006, J IMMUNOL, V176, P3890, DOI 10.4049/jimmunol.176.7.3890; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Muller AJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000795; Sambrook J., 2002, MOL CLONING LAB MANU; Schlumberger MC, 2003, J BIOL CHEM, V278, P27149, DOI 10.1074/jbc.M302475200; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Tattoli I, 2007, SEMIN IMMUNOPATHOL, V29, P289, DOI 10.1007/s00281-007-0083-2; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Wong KW, 2008, J BIOL CHEM, V283, P35954, DOI 10.1074/jbc.M804717200; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176	33	169	178	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					233	+		10.1038/nature12025	http://dx.doi.org/10.1038/nature12025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23542589	Green Submitted, Green Accepted			2022-12-24	WOS:000317346300044
J	Pryor, EE; Horanyi, PS; Clark, KM; Fedoriw, N; Connelly, SM; Koszelak-Rosenblum, M; Zhu, GY; Malkowski, MG; Wiener, MC; Dumont, ME				Pryor, Edward E., Jr.; Horanyi, Peter S.; Clark, Kathleen M.; Fedoriw, Nadia; Connelly, Sara M.; Koszelak-Rosenblum, Mary; Zhu, Guangyu; Malkowski, Michael G.; Wiener, Michael C.; Dumont, Mark E.			Structure of the Integral Membrane Protein CAAX Protease Ste24p	SCIENCE			English	Article							A-FACTOR; SACCHAROMYCES-CEREVISIAE; INHIBITORS BLOCK; THERMOLYSIN; PROTEOLYSIS; MECHANISM; ZMPSTE24; FAMILY; STEP; RAS	Posttranslational lipidation provides critical modulation of the functions of some proteins. Isoprenoids (i.e., farnesyl or geranylgeranyl groups) are attached to cysteine residues in proteins containing C-terminal CAAX sequence motifs (where A is an aliphatic residue and X is any residue). Isoprenylation is followed by cleavage of the AAX amino acid residues and, in some cases, by additional proteolytic cuts. We determined the crystal structure of the CAAX protease Ste24p, a zinc metalloprotease catalyzing two proteolytic steps in the maturation of yeast mating pheromone a-factor. The Ste24p core structure is a ring of seven transmembrane helices enclosing a voluminous cavity containing the active site and substrate-binding groove. The cavity is accessible to the external milieu by means of gaps between splayed transmembrane helices. We hypothesize that cleavage proceeds by means of a processive mechanism of substrate insertion, translocation, and ejection.	[Pryor, Edward E., Jr.; Horanyi, Peter S.; Wiener, Michael C.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Clark, Kathleen M.; Fedoriw, Nadia; Connelly, Sara M.; Wiener, Michael C.; Dumont, Mark E.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Koszelak-Rosenblum, Mary; Zhu, Guangyu; Malkowski, Michael G.] Hauptman Woodward Inst, Buffalo, NY 14203 USA; [Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA; [Dumont, Mark E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Virginia; University of Rochester; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Rochester	Wiener, MC (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA.	mwiener@virginia.edu; mark_dumont@urmc.rochester.edu	Zhu, Guangyu/F-6279-2011	Zhu, Guangyu/0000-0003-4228-135X; Pryor, Edward/0000-0001-8328-9126; Malkowski, Michael/0000-0002-1203-7463	Protein Structure Initiative: Biology grant [U54 GM094611]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094611] Funding Source: NIH RePORTER	Protein Structure Initiative: Biology grant; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Author contributions (authorship of relevant supplementary materials: Materials and Methods sections denoted by *): target selection and yeast homology screening (M.E.D.*); cloning (S. M. C); expression, solubilization, purification, and functional characterization with accompanying fig. S3 (K.M.C.*, N.F.*, M.E.D.*); preliminary crystallization and diffraction screening (M.K.-R., G.Z., M.G.M.*); SmSte24p crystallization (E.E.P.*), SmSte24p crystallography (E.E.P.*, P.S.H.*, M. C. W.). M. C. W. conceptualized and wrote the main paper, with the following exceptions: introduction (M. E. D.), figures and captions (E. E. P, P. S. H., M. C. W.). All authors critically read the manuscript before submission. In particular, M. E. D. contributed substantially to the editing, revision, and improvement of the manuscript. This work was supported by Protein Structure Initiative: Biology grant U54 GM094611 (NIH) for membrane protein structural genomics. Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. We thank P. Loll, R. Nakamoto, and J. Zimmer for useful discussion. Atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession number 4IL3. Vectors and clones are available from the NIH Protein Structure Initiative Materials Repository, under a Materials Transfer Agreement. The authors declare no competing financial interests.	Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Berka K, 2012, NUCLEIC ACIDS RES, V40, pW222, DOI 10.1093/nar/gks363; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Clark KM, 2010, PROTEIN EXPRES PURIF, V71, P207, DOI 10.1016/j.pep.2009.12.012; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Dolence JM, 2000, BIOCHEMISTRY-US, V39, P4096, DOI 10.1021/bi9923611; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; Golde Todd E, 2003, Sci STKE, V2003, pRE4, DOI 10.1126/stke.2003.172.re4; HANGAUER DG, 1984, BIOCHEMISTRY-US, V23, P5730, DOI 10.1021/bi00319a011; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hudon SE, 2008, BIOCHEM BIOPH RES CO, V374, P365, DOI 10.1016/j.bbrc.2008.07.033; Huyer G, 2006, EUKARYOT CELL, V5, P1560, DOI 10.1128/EC.00161-06; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; KESTER WR, 1977, BIOCHEMISTRY-US, V16, P2506, DOI 10.1021/bi00630a030; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Malkowski MG, 2007, P NATL ACAD SCI USA, V104, P6678, DOI 10.1073/pnas.0610337104; MATTHEWS BW, 1972, NATURE-NEW BIOL, V238, P37, DOI 10.1038/newbio238037a0; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; MATTHEWS BW, 1972, NATURE-NEW BIOL, V238, P41, DOI 10.1038/newbio238041a0; Michaelis S, 2012, MICROBIOL MOL BIOL R, V76, P626, DOI 10.1128/MMBR.00010-12; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513; Schmidt WK, 2000, J BIOL CHEM, V275, P6227, DOI 10.1074/jbc.275.9.6227; Tam A, 2001, J BIOL CHEM, V276, P46798, DOI 10.1074/jbc.M106150200; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; Trueblood CE, 2000, MOL CELL BIOL, V20, P4381, DOI 10.1128/MCB.20.12.4381-4392.2000; Urban S, 2010, BIOCHEM J, V425, P501, DOI 10.1042/BJ20090861; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Worman HJ, 2012, J PATHOL, V226, P316, DOI 10.1002/path.2999	34	64	65	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1600	+		10.1126/science.1232048	http://dx.doi.org/10.1126/science.1232048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539602	Green Accepted			2022-12-24	WOS:000316731600047
J	Weintraub, K				Weintraub, Karen			The new gold standard	NATURE			English	Editorial Material							PHOTOTHERMAL THERAPY; DELIVERY; SIRNA											Gad SC, 2012, INT J TOXICOL, V31, P584, DOI 10.1177/1091581812465969; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Huang XH, 2008, LASER MED SCI, V23, P217, DOI 10.1007/s10103-007-0470-x; Huschka R, 2012, ACS NANO, V6, P7681, DOI 10.1021/nn301135w; Jun YW, 2009, P NATL ACAD SCI USA, V106, P17735, DOI 10.1073/pnas.0907367106; Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905; Zhang K, 2012, J AM CHEM SOC, V134, P16488, DOI 10.1021/ja306854d; Zheng D, 2012, P NATL ACAD SCI USA, V109, P11975, DOI 10.1073/pnas.1118425109	8	62	100	3	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					S14	S16		10.1038/495S14a	http://dx.doi.org/10.1038/495S14a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486097	Bronze			2022-12-24	WOS:000316652300032
J	Fung, KY; Mangan, NE; Cumming, H; Horvat, JC; Mayall, JR; Stifter, SA; De Weerd, N; Roisman, LC; Rossjohn, J; Robertson, SA; Schjenken, JE; Parker, B; Gargett, CE; Nguyen, HPT; Carr, DJ; Hansbro, PM; Hertzog, PJ				Fung, Ka Yee; Mangan, Niamh E.; Cumming, Helen; Horvat, Jay C.; Mayall, Jemma R.; Stifter, Sebastian A.; De Weerd, Nicole; Roisman, Laila C.; Rossjohn, Jamie; Robertson, Sarah A.; Schjenken, John E.; Parker, Belinda; Gargett, Caroline E.; Nguyen, Hong P. T.; Carr, Daniel J.; Hansbro, Philip M.; Hertzog, Paul J.			Interferon-epsilon Protects the Female Reproductive Tract from Viral and Bacterial Infection	SCIENCE			English	Article							CELLS; ACTIVATION; INDUCTION; IMMUNITY; RISK; DNA	The innate immune system senses pathogens through pattern-recognition receptors (PRRs) that signal to induce effector cytokines, such as type I interferons (IFNs). We characterized IFN-epsilon as a type I IFN because it signaled via the Ifnar1 and Ifnar2 receptors to induce IFN-regulated genes. In contrast to other type I IFNs, IFN-epsilon was not induced by known PRR pathways; instead, IFN-epsilon was constitutively expressed by epithelial cells of the female reproductive tract (FRT) and was hormonally regulated. Ifn-epsilon-deficient mice had increased susceptibility to infection of the FRT by the common sexually transmitted infections (STIs) herpes simplex virus 2 and Chlamydia muridarum. Thus, IFN-epsilon is a potent antipathogen and immunoregulatory cytokine that may be important in combating STIs that represent a major global health and socioeconomic burden.	[Fung, Ka Yee; Mangan, Niamh E.; Cumming, Helen; Stifter, Sebastian A.; De Weerd, Nicole; Roisman, Laila C.; Hertzog, Paul J.] Monash Univ, Ctr Innate Immun & Infect Dis, Inst Med Res, Clayton, Vic, Australia; [Horvat, Jay C.; Mayall, Jemma R.; Hansbro, Philip M.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Horvat, Jay C.; Mayall, Jemma R.; Hansbro, Philip M.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Roisman, Laila C.; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Robertson, Sarah A.; Schjenken, John E.] Univ Adelaide, Robinson Inst, Adelaide, SA 5005, Australia; [Robertson, Sarah A.; Schjenken, John E.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Parker, Belinda] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Parker, Belinda] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Gargett, Caroline E.; Nguyen, Hong P. T.] Monash Univ, Ritchie Ctr, Monash Inst Med Res, Clayton, Vic, Australia; [Gargett, Caroline E.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; [Carr, Daniel J.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK USA; [Carr, Daniel J.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA	Monash University; University of Sydney; Westmead Institute for Medical Research; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Monash University; Robinson Research Institute; University of Adelaide; University of Adelaide; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Monash University; Monash University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Hertzog, PJ (corresponding author), Monash Univ, Ctr Innate Immun & Infect Dis, Inst Med Res, Clayton, Vic, Australia.	paul.hertzog@monash.edu	Roisman, Laila C./P-9129-2019; Hertzog, Paul J/I-7053-2013; Hansbro, Phil/G-7486-2013; Schjenken, John E/ABB-8754-2021; Robertson, Sarah A/C-8182-2009; de Weerd, Nicole/X-5886-2019; Rossjohn, Jamie/F-9032-2013; Hertzog, Paul J/G-6734-2013; Gargett, Caroline Eve/I-4895-2019; Gargett, Caroline E/Q-7911-2019	Roisman, Laila C./0000-0001-8455-9327; Hertzog, Paul J/0000-0002-1373-8472; Hansbro, Phil/0000-0002-4741-3035; Schjenken, John E/0000-0001-6293-6160; Robertson, Sarah A/0000-0002-9967-0084; de Weerd, Nicole/0000-0002-7985-189X; Rossjohn, Jamie/0000-0002-2020-7522; Hertzog, Paul J/0000-0002-1373-8472; Gargett, Caroline E/0000-0002-3590-2077; Stifter, Sebastian/0000-0002-7825-222X; Horvat, Jay/0000-0002-8526-0631; Carr, Daniel JJ/0000-0003-1954-2478; Mangan, Niamh/0000-0003-3844-0709; Parker, Belinda/0000-0002-8333-1926; Mayall, Jemma/0000-0002-0915-5020	Australian National Health and Medical Research Council; Australian Research Council; NIH [R01 AI053108]; Victorian Government's Operational Infrastructure Support Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053108] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victorian Government's Operational Infrastructure Support Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Mansell, R. Ferrero, and L. Salamonsen for their contributions; N. Bourke and S. Forster for helpful discussions and reading of the manuscript; K. Fitzgerald for reagents; and C. Berry for assistance with viral plaque assays. The data presented in this paper are tabulated in the main text and in the supplementary materials. This work was supported by funding from Australian National Health and Medical Research Council (P.J.H., N. E. M., P. M. H., J.R., C. E. G., and B. P.), the Australian Research Council (P.J.H., N. E. M., J.R.), the NIH via grant R01 AI053108 (D.J.C.), and the Victorian Government's Operational Infrastructure Support Program. P.J.H., N. E. M., K.Y.F., H. C., S. A. S., and N. D. W. hold International Patent Application number PCT/AU2011/000715, "Use of interferon epsilon in methods of diagnosis and treatment."	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Austin BA, 2006, BIOL PROCED ONLINE, V8, P55, DOI 10.1251/bpo118; Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862; Beagley KW, 2009, CRIT REV IMMUNOL, V29, P275, DOI 10.1615/CritRevImmunol.v29.i4.10; Conrady CD, 2011, J VIROL, V85, P1625, DOI 10.1128/JVI.01715-10; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Devitt A, 1996, INFECT IMMUN, V64, P3951, DOI 10.1128/IAI.64.10.3951-3956.1996; Doyle SE, 2003, J IMMUNOL, V170, P3565, DOI 10.4049/jimmunol.170.7.3565; Hardy MP, 2004, GENOMICS, V84, P331, DOI 10.1016/j.ygeno.2004.03.003; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Lad SP, 2005, J IMMUNOL, V174, P7186, DOI 10.4049/jimmunol.174.11.7186; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Nagarajan UM, 2005, J IMMUNOL, V175, P450, DOI 10.4049/jimmunol.175.1.450; Nagarajan UM, 2008, INFECT IMMUN, V76, P4642, DOI 10.1128/IAI.00629-08; PARR MB, 1994, LAB INVEST, V70, P369; Patel MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035654; Salamonsen L., 2008, ENDOMETRIUM MOL CELL; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Thapa M, 2009, J VIROL, V83, P9486, DOI 10.1128/JVI.00854-09; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Tseng CTK, 1998, INFECT IMMUN, V66, P5867, DOI 10.1128/IAI.66.12.5867-5875.1998; Wang CC, 1999, J ACQ IMMUN DEF SYND, V21, P51, DOI 10.1097/00126334-199905010-00007; World Health Organization, 2001, GLOB PREV INC SEL CU	27	154	164	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1088	1092		10.1126/science.1233321	http://dx.doi.org/10.1126/science.1233321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449591	Green Accepted, Green Published			2022-12-24	WOS:000315452000045
J	Sedgwick, P				Sedgwick, Philip			Case-control studies: measures of risk	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Dumville JC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b773; Feldkamp ML, 2008, BMJ-BRIT MED J, V336, P1420, DOI 10.1136/bmj.39567.509074.25; Sedgwick P, 2010, BMJ-BRIT MED J, V341, pc3983; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5980	4	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2013	346								f1185	10.1136/bmj.f1185	http://dx.doi.org/10.1136/bmj.f1185			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096HT	23435603				2022-12-24	WOS:000315395500008
J	Suren, P; Roth, C; Bresnahan, M; Haugen, M; Hornig, M; Hirtz, D; Lie, KK; Lipkin, WI; Magnus, P; Reichborn-Kjennerud, T; Schjolberg, S; Smith, GD; Oyen, AS; Susser, E; Stoltenberg, C				Suren, Pal; Roth, Christine; Bresnahan, Michaeline; Haugen, Margaretha; Hornig, Mady; Hirtz, Deborah; Lie, Kari Kveim; Lipkin, W. Ian; Magnus, Per; Reichborn-Kjennerud, Ted; Schjolberg, Synnve; Smith, George Davey; Oyen, Anne-Siri; Susser, Ezra; Stoltenberg, Camilla			Association Between Maternal Use of Folic Acid Supplements and Risk of Autism Spectrum Disorders in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEURAL-TUBE DEFECTS; NORWEGIAN MOTHER; PREGNANT-WOMEN; COHORT; PREVALENCE; FOLATE; DELAY	Importance Prenatal folic acid supplements reduce the risk of neural tube defects in children, but it has not been determined whether they protect against other neurodevelopmental disorders. Objective To examine the association between maternal use of prenatal folic acid supplements and subsequent risk of autism spectrum disorders (ASDs) (autistic disorder, Asperger syndrome, pervasive developmental disorder-not otherwise specified [PDD-NOS]) in children. Design, Setting, and Patients The study sample of 85 176 children was derived from the population-based, prospective Norwegian Mother and Child Cohort Study (MoBa). The children were born in 2002-2008; by the end of follow-up on March 31, 2012, the age range was 3.3 through 10.2 years (mean, 6.4 years). The exposure of primary interest was use of folic acid from 4 weeks before to 8 weeks after the start of pregnancy, defined as the first day of the last menstrual period before conception. Relative risks of ASDs were estimated by odds ratios (ORs) with 95% CIs in a logistic regression analysis. Analyses were adjusted for maternal education level, year of birth, and parity. Main Outcome Measure Specialist-confirmed diagnosis of ASDs. Results At the end of follow-up, 270 children in the study sample had been diagnosed with ASDs: 114 with autistic disorder, 56 with Asperger syndrome, and 100 with PDD-NOS. In children whose mothers took folic acid, 0.10% (64/61 042) had autistic disorder, compared with 0.21% (50/24 134) in those unexposed to folic acid. The adjusted OR for autistic disorder in children of folic acid users was 0.61 (95% CI, 0.41-0.90). No association was found with Asperger syndrome or PDD-NOS, but power was limited. Similar analyses for prenatal fish oil supplements showed no such association with autistic disorder, even though fish oil use was associated with the same maternal characteristics as folic acid use. Conclusions and Relevance Use of prenatal folic acid supplements around the time of conception was associated with a lower risk of autistic disorder in the MoBa cohort. Although these findings cannot establish causality, they do support prenatal folic acid supplementation. JAMA. 2013;309(6):570-577 www.jama.com	[Suren, Pal; Roth, Christine; Haugen, Margaretha; Lie, Kari Kveim; Magnus, Per; Reichborn-Kjennerud, Ted; Schjolberg, Synnve; Oyen, Anne-Siri; Stoltenberg, Camilla] Norwegian Inst Publ Hlth, N-0403 Oslo, Norway; [Suren, Pal] UCL Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Roth, Christine; Bresnahan, Michaeline; Hornig, Mady; Lipkin, W. Ian; Susser, Ezra] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Bresnahan, Michaeline; Susser, Ezra] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Hirtz, Deborah] NINDS, Bethesda, MD 20892 USA; [Reichborn-Kjennerud, Ted] Univ Oslo, Inst Psychiat, Oslo, Norway; [Smith, George Davey] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Oyen, Anne-Siri] Lovisenberg Hosp, Nic Waals Inst, Oslo, Norway; [Stoltenberg, Camilla] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway	Norwegian Institute of Public Health (NIPH); University of London; University College London; Columbia University; New York State Psychiatry Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Oslo; University of Bristol; University of Bergen	Suren, P (corresponding author), Norwegian Inst Publ Hlth, POB 4404, N-0403 Oslo, Norway.	pal.suren@fhi.no	Davey Smith, George/A-7407-2013; Hornig, Mady/AAE-8431-2020; Lipkin, W. Ian/ABE-6216-2020; Stoltenberg, Camilla/G-5090-2017; Haugen, Margaretha/H-7007-2016	Davey Smith, George/0000-0002-1407-8314; Hornig, Mady/0000-0001-7572-3092; Lipkin, W. Ian/0000-0002-8768-9386; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Haugen, Margaretha/0000-0001-5924-5000; Oyen, Anne-Siri/0000-0002-1637-992X	Norwegian Ministry of Health and Care Services; Norwegian Ministry of Education and Research; Research Council of Norway/FUGE [151918]; National Institute of Neurological Disorders and Stroke (NINDS) [NS47537]; National Institute of Environmental Health Sciences (NIEHS) [NO-ES-75558]; NINDS [NS47537]; Research Council of Norway [185476, 190694]; Medical Research Council [G9815508] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	Norwegian Ministry of Health and Care Services; Norwegian Ministry of Education and Research; Research Council of Norway/FUGE(Research Council of Norway); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Research Council of Norway(Research Council of Norway); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Norwegian Mother and Child Cohort is supported by the Norwegian Ministry of Health and Care Services, the Norwegian Ministry of Education and Research, the Research Council of Norway/FUGE (grant 151918), the National Institute of Neurological Disorders and Stroke (NINDS) (grant NS47537 [Dr Lipkin]), and the National Institute of Environmental Health Sciences (NIEHS) (contract NO-ES-75558). The Autism Birth Cohort study is funded by the NINDS (grant NS47537 [Dr Lipkin]). Dr Suren's salary is funded by the Research Council of Norway (grants 185476 and 190694).	Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Brantsaeter AL, 2008, MATERN CHILD NUTR, V4, P28, DOI 10.1111/j.1740-8709.2007.00103.x; Cordero A., 2010, Morbidity and Mortality Weekly Report, V59, P980; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C, 2012, ARCH GEN PSYCHIAT, V69, P306, DOI 10.1001/archgenpsychiatry.2011.148; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Meltzer HM, 2008, MATERN CHILD NUTR, V4, P14, DOI 10.1111/j.1740-8709.2007.00104.x; MILUNSKY A, 1989, JAMA-J AM MED ASSOC, V262, P2847, DOI 10.1001/jama.262.20.2847; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Roth C, 2011, JAMA-J AM MED ASSOC, V306, P1566, DOI 10.1001/jama.2011.1433; Sadler TW., 2010, LANGMANS MED EMBRYOL, V11th; Schmidt RJ, 2012, AM J CLIN NUTR, V96, P80, DOI 10.3945/ajcn.110.004416; Schmidt RJ, 2011, EPIDEMIOLOGY, V22, P476, DOI 10.1097/EDE.0b013e31821d0e30; Scientific Advisory Committee on Nutrition, FOL DIS PREV; SHAW GM, 1995, EPIDEMIOLOGY, V6, P219, DOI 10.1097/00001648-199505000-00005; Smith GD, 2008, BASIC CLIN PHARMACOL, V102, P245, DOI 10.1111/j.1742-7843.2007.00191.x; Stoltenberg C, 2010, MOL PSYCHIATR, V15, P676, DOI 10.1038/mp.2009.143; Suren P, 2012, PEDIATRICS, V130, pE152, DOI 10.1542/peds.2011-3217; WALD N, 1991, LANCET, V338, P131; WERLER MM, 1993, JAMA-J AM MED ASSOC, V269, P1257, DOI 10.1001/jama.269.10.1257	25	318	346	7	131	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2013	309	6					570	577		10.1001/jama.2012.155925	http://dx.doi.org/10.1001/jama.2012.155925			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087PH	23403681	Green Accepted, Bronze			2022-12-24	WOS:000314773700029
J	MacDougall, AS; McCann, KS; Gellner, G; Turkington, R				MacDougall, A. S.; McCann, K. S.; Gellner, G.; Turkington, R.			Diversity loss with persistent human disturbance increases vulnerability to ecosystem collapse	NATURE			English	Article							BIODIVERSITY; STABILITY; SHIFTS	Long-term and persistent human disturbances have simultaneously altered the stability and diversity of ecological systems, with disturbances directly reducing functional attributes such as invasion resistance, while eliminating the buffering effects of high species diversity(1-4). Theory predicts that this combination of environmental change and diversity loss increases the risk of abrupt and potentially irreversible ecosystem collapse(1-3,5-7), but long-term empirical evidence from natural systems is lacking. Here we demonstrate this relationship in a degraded but species-rich pyrogenic grassland in which the combined effects of fire suppression, invasion and trophic collapse have created a species-poor grassland that is highly productive, resilient to yearly climatic fluctuations, and resistant to invasion, but vulnerable to rapid collapse after the re-introduction of fire. We initially show how human disturbance has created a negative relationship between diversity and function, contrary to theoretical predictions(3,4). Fire prevention since the mid-nineteenth century is associated with the loss of plant species but it has stabilized high-yield annual production and invasion resistance, comparable to a managed high-yield low-diversity agricultural system. In managing for fire suppression, however, a hidden vulnerability to sudden environmental change emerges that is explained by the elimination of the buffering effects of high species diversity. With the re-introduction of fire, grasslands only persist in areas with remnant concentrations of native species, in which a range of rare and mostly functionally redundant plants proliferate after burning and prevent extensive invasion including a rapid conversion towards woodland. This research shows how biodiversity can be crucial for ecosystem stability despite appearing functionally insignificant beforehand, a relationship probably applicable to many ecosystems given the globally prevalent combination of intensive long-term land management and species loss.	[MacDougall, A. S.; McCann, K. S.; Gellner, G.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Turkington, R.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Turkington, R.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada	University of Guelph; University of British Columbia; University of British Columbia	MacDougall, AS (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	amacdo02@uoguelph.ca	MacDougall, Andrew S/F-2037-2011	Gellner, Gabriel/0000-0001-8170-1463	NSERC; World Wildlife Fund Endangered Species Recovery Fund; Mountain Equipment Co-Op Environmental Research Fund; University of Guelph	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); World Wildlife Fund Endangered Species Recovery Fund; Mountain Equipment Co-Op Environmental Research Fund; University of Guelph	We thank I. Banman, T. Ennis and C. Elder; the Garry Oak Ecosystem Recovery Team; the British Columbia Ministry of Forests, Lands, and Natural Resource Operations; the Municipality of North Cowichan, British Columbia; the Maple Bay Fire Department; and the many field technicians over ten years who assisted with this project. All burning was conducted with the assistance and approval of the Municipality of North Cowichan and the BC Ministry of Forests, Lands, and Natural Resource Operations. Thanks also to B. Gilbert, Y. Hautier, E. Harvey, L. Keshet, P. Arcese, M. Fuchs, D. Fraser, R. Hebda, H. Roemer, B. Costanzo, B. Beckwith, G. Douglas, A. Ceska and M. Fairbarns. Funding was provided by NSERC, World Wildlife Fund Endangered Species Recovery Fund, Mountain Equipment Co-Op Environmental Research Fund, and the University of Guelph, with significant in-kind contributions from the Nature Conservancy of Canada.	Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Elton C. S., 1958, ECOLOGY INVASIONS AN; Harley CDG, 2009, P NATL ACAD SCI USA, V106, P11172, DOI 10.1073/pnas.0904946106; Hector A, 2011, NATURE, V472, P45, DOI 10.1038/472045a; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Loreau M., 2010, POPULATIONS ECOSYSTE; MacDougall AS, 2005, ECOLOGY, V86, P3354, DOI 10.1890/04-1733; MacDougall AS, 2004, CONSERV BIOL, V18, P455, DOI 10.1111/j.1523-1739.2004.00483.x; May R. M., 1973, STABILITY COMPLEXITY; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Wohl DL, 2004, ECOLOGY, V85, P1534, DOI 10.1890/03-3050; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; YODZIS P, 1981, NATURE, V289, P674, DOI 10.1038/289674a0	25	185	199	12	557	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					86	89		10.1038/nature11869	http://dx.doi.org/10.1038/nature11869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23389543				2022-12-24	WOS:000314741200039
J	Ko, M; An, J; Bandukwala, HS; Chavez, L; Aijo, T; Pastor, WA; Segal, MF; Li, HM; Koh, KP; Lahdesmaki, H; Hogan, PG; Aravind, L; Rao, A				Ko, Myunggon; An, Jungeun; Bandukwala, Hozefa S.; Chavez, Lukas; Aijo, Tarmo; Pastor, William A.; Segal, Matthew F.; Li, Huiming; Koh, Kian Peng; Lahdesmaki, Harri; Hogan, Patrick G.; Aravind, L.; Rao, Anjana			Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX	NATURE			English	Article							CPG ISLANDS; 5-HYDROXYMETHYLCYTOSINE CONTENT; DNA; BINDING; DIFFERENTIATION; COMPLEX; DATABASE; PATHWAY; RINF	TET (ten-eleven-translocation) proteins are Fe(II)- and alpha-ketogluta-rate-dependent dioxygenases(1-3) that modify the methylation status of DNA by successively oxidizing 5-methylcytosine to 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxycytosine(1,3-5), potential intermediates in the active erasure of DNA-methylation marks(5,6). Here we show that IDAX (also known as CXXC4), a reported inhibitor of Wnt signalling(7) that has been implicated in malignant renal cell carcinoma(8) and colonic villous adenoma(9), regulates TET2 protein expression. IDAX was originally encoded within an ancestral TET2 gene that underwent a chromosomal gene inversion during evolution, thus separating the TET2 CXXC domain from the catalytic domain. The IDAX CXXC domain binds DNA sequences containing unmethylated CpG dinucleotides, localizes to promoters and CpG islands in genomic DNA and interacts directly with the catalytic domain of TET2. Unexpectedly, IDAX expression results in caspase activation and TET2 protein downregulation, in a manner that depends on DNA binding through the IDAX CXXC domain, suggesting that IDAX recruits TET2 to DNA before degradation. IDAX depletion prevents TET2 downregulation in differentiating mouse embryonic stem cells, and short hairpin RNA against IDAX increases TET2 protein expression in the human monocytic cell line U937. Notably, we find that the expression and activity of TET3 is also regulated through its CXXC domain. Taken together, these results establish the separate and linked CXXC domains of TET2 and TET3, respectively, as previously unknown regulators of caspase activation and TET enzymatic activity.	[Ko, Myunggon; An, Jungeun; Bandukwala, Hozefa S.; Chavez, Lukas; Aijo, Tarmo; Pastor, William A.; Segal, Matthew F.; Hogan, Patrick G.; Rao, Anjana] La Jolla Inst Allergy & Immunol, Div Signaling & Gene Express, La Jolla, CA 92037 USA; [Aijo, Tarmo; Lahdesmaki, Harri] Aalto Univ, Sch Sci, Dept Informat & Comp Sci, FI-00076 Aalto, Finland; [Li, Huiming; Koh, Kian Peng; Rao, Anjana] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Li, Huiming; Koh, Kian Peng; Rao, Anjana] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Rao, Anjana] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; Aalto University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Rao, A (corresponding author), La Jolla Inst Allergy & Immunol, Div Signaling & Gene Express, La Jolla, CA 92037 USA.	arao@liai.org	Koh, Kian Peng/S-6279-2016	Koh, Kian Peng/0000-0003-2523-5175; Aijo, Tarmo/0000-0002-3008-4634; Aravind, L/0000-0003-0771-253X; Ko, Myunggon/0000-0002-6007-2570; Chavez, Lukas/0000-0002-8718-8848	National Institutes of Health (NIH) [HD065812, CA151535]; California Institute of Regenerative Medicine and Translational Research [RM-01729]; Leukemia and Lymphoma Society [TRP 6187-12]; NIH [AI40127]; Leukemia and Lymphoma Society; Lady Tata Memorial Trust; GlaxoSmithKline-Immune Disease Institute Alliance; National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065812] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA151535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040127, R01AI044432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine and Translational Research; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Lady Tata Memorial Trust; GlaxoSmithKline-Immune Disease Institute Alliance; National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Seumois, M. Ku and J. Day for help with library preparation, B. Ren for use of his Illumina Hi-Seq 2000, J. A. Zepeda-Martinez for the recombinant Flag-TET2<SUP>CD</SUP>, and members of the Rao laboratory for discussions. This work was supported by National Institutes of Health (NIH) R01 grants HD065812 and CA151535, grant RM-01729 from the California Institute of Regenerative Medicine and Translational Research, grant TRP 6187-12 from the Leukemia and Lymphoma Society (to A. R.) and NIH R01 grant AI40127 (to P. G. H. and A. R). We also gratefully acknowledge a Special Fellow Award from the Leukemia and Lymphoma Society (to M. K.), postdoctoral fellowships from the Lady Tata Memorial Trust and from the GlaxoSmithKline-Immune Disease Institute Alliance (to H. S. B.) and a predoctoral graduate research fellowship from the National Science Foundation (to W.A.P.).	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Haffner MC, 2011, ONCOTARGET, V2, P627; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Huang C. C., 1996, PAC S BIOCOMPUT, P724, DOI DOI 10.1142/9789814531399; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iyer LM, 2011, PROG MOL BIOL TRANSL, V101, P25, DOI 10.1016/B978-0-12-387685-0.00002-0; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Kim MS, 2010, J BIOL CHEM, V285, P14585, DOI 10.1074/jbc.M109.094334; Knappskog S, 2011, ANN ONCOL, V22, P2208, DOI 10.1093/annonc/mdq737; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kojima T, 2009, ONCOGENE, V28, P297, DOI 10.1038/onc.2008.391; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Maiti A, 2011, DNA REPAIR, V10, P545, DOI 10.1016/j.dnarep.2011.03.004; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Nguyen AV, 2010, INT J MOL MED, V26, P121, DOI 10.3892/ijmm_00000443; Pendino F, 2009, BLOOD, V113, P3172, DOI 10.1182/blood-2008-07-170035; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	40	257	266	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					122	+		10.1038/nature12052	http://dx.doi.org/10.1038/nature12052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23563267	Green Accepted			2022-12-24	WOS:000318221500046
J	Pedersen, BP; Kumar, H; Waight, AB; Risenmay, AJ; Roe-Zurz, Z; Chau, BH; Schlessinger, A; Bonomi, M; Harries, W; Sali, A; Johri, AK; Stroud, RM				Pedersen, Bjorn P.; Kumar, Hemant; Waight, Andrew B.; Risenmay, Aaron J.; Roe-Zurz, Zygy; Chau, Bryant H.; Schlessinger, Avner; Bonomi, Massimiliano; Harries, William; Sali, Andrej; Johri, Atul K.; Stroud, Robert M.			Crystal structure of a eukaryotic phosphate transporter	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PIRIFORMOSPORA-INDICA; MOLECULAR-DYNAMICS; FORCE-FIELD; PROTEIN; SPECIFICITY; PREDICTION; MECHANISM; SEQUENCE; CARRIERS	Phosphate is crucial for structural and metabolic needs, including nucleotide and lipid synthesis, signalling and chemical energy storage. Proton-coupled transporters of the major facilitator superfamily (MFS) are essential for phosphate uptake in plants and fungi, and also have a function in sensing external phosphate levels as transceptors(1-5). Here we report the 2.9 angstrom structure of a fungal (Piriformospora indica) high-affinity phosphate transporter, PiPT, in an inward-facing occluded state, with bound phosphate visible in the membrane-buried binding site. The structure indicates both proton and phosphate exit pathways and suggests a modified asymmetrical 'rocker-switch' mechanism of phosphate transport. PiPT is related to several human transporter families, most notably the organic cation and anion transporters of the solute carrier family (SLC22), which are implicated in cancer-drug resistance(6,7). We modelled representative cation and anion SLC22 transporters based on the PiPT structure to surmise the structural basis for substrate binding and charge selectivity in this important family. The PiPT structure demonstrates and expands on principles of substrate transport by the MFS transporters and illuminates principles of phosphate uptake in particular.	[Pedersen, Bjorn P.; Kumar, Hemant; Waight, Andrew B.; Risenmay, Aaron J.; Roe-Zurz, Zygy; Chau, Bryant H.; Harries, William; Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Kumar, Hemant; Johri, Atul K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Schlessinger, Avner; Bonomi, Massimiliano; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Pharmaceut Chem, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Jawaharlal Nehru University, New Delhi; University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	stroud@msg.ucsf.edu	Kumar, Hemant/AAW-6086-2021; Pedersen, Bjørn/H-4128-2017; Kumar, Arun/C-9149-2009; Pedersen, Bjørn/AAT-2409-2021	Pedersen, Bjørn/0000-0001-7860-7230; Kumar, Arun/0000-0001-8422-0219; Pedersen, Bjørn/0000-0001-7860-7230; Bonomi, Massimiliano/0000-0002-7321-0004; HARRIES, WILLIAM/0000-0002-6461-4090; Kumar, Hemant/0000-0001-7698-2301	Carlsberg Foundation; Danish Cancer Society; Woods Whelan foundation; Council of Scientific and Industrial Research, Government of India; Jawaharlal Nehru University, New Delhi; NIH [F32 GM088991, U01 GM61390, U54 GM094625, GM24485, GM073210]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094625, F32GM088991, R01GM024485, U01GM061390, P50GM073210, U19GM061390, R37GM024485] Funding Source: NIH RePORTER	Carlsberg Foundation(Carlsberg Foundation); Danish Cancer Society(Danish Cancer Society); Woods Whelan foundation; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Jawaharlal Nehru University, New Delhi; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Giacomini for discussions about SLC transporters; P. Nissen for comments that improved the manuscript; J. Holton, G. Meigs, C. Ogata and N. Venugopalan for assistance with synchrotron data collection at the Advanced Light Source and Advanced Photon Source; and C. Waddling, P. Wassam and M. Tessema for technical assistance. B. P. P. was supported by a postdoctoral fellowship from the Carlsberg Foundation and later by a fellowship from the Danish Cancer Society; H. K. by a fellowship from Woods Whelan foundation, Council of Scientific and Industrial Research, Government of India, and a travel grant from Jawaharlal Nehru University, New Delhi.; A.Sc. by NIH postdoctoral fellowship F32 GM088991; A. Sa. by NIH grants U54 GM094625 and U01 GM61390; A. K. J. by a Research Assistant Professorship to do work at UCSF from the American Society for Microbiology; and R. M. S. by NIH grants U54 GM094625, GM24485 and GM073210.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feng B, 2001, BIOCHEMISTRY-US, V40, P5511, DOI 10.1021/bi002841o; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; Holyoake J, 2007, STRUCTURE, V15, P873, DOI 10.1016/j.str.2007.06.004; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Keller S, 2006, ACTA CRYSTALLOGR D, V62, P1564, DOI 10.1107/S0907444906040169; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; KRUPKA RM, 1993, BIOCHIM BIOPHYS ACTA, V1183, P105, DOI 10.1016/0005-2728(93)90009-5; Li M, 2009, J MOL BIOL, V385, P820, DOI 10.1016/j.jmb.2008.11.021; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; Madej MG, 2012, P NATL ACAD SCI USA, V109, pE2970, DOI 10.1073/pnas.1211183109; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P2169, DOI 10.1107/S0907444904016038; Morales R, 2006, STRUCTURE, V14, P601, DOI 10.1016/j.str.2005.12.012; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Nussaume L, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00083; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pedersen BP, 2010, ACTA CRYSTALLOGR D, V66, P309, DOI 10.1107/S0907444909053244; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9; Petrek M, 2007, STRUCTURE, V15, P1357, DOI 10.1016/j.str.2007.10.007; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samyn DR, 2012, BIOCHEM J, V445, P413, DOI 10.1042/BJ20112086; Schlessinger A, 2010, PROTEIN SCI, V19, P412, DOI 10.1002/pro.320; Schrodinger LLC, 2012, PYMOL MOL GRAPH SYST; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; van Scheltinga ACT, 2003, ACTA CRYSTALLOGR D, V59, P2017, DOI 10.1107/S090744490302122X; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Varma A, 2012, AGR RES, V1, P117, DOI 10.1007/s40003-012-0019-5; Vyas NK, 2003, STRUCTURE, V11, P765, DOI 10.1016/S0969-2126(03)00109-6; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yadav V, 2010, J BIOL CHEM, V285, P26532, DOI 10.1074/jbc.M110.111021; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	63	159	168	2	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					533	536		10.1038/nature12042	http://dx.doi.org/10.1038/nature12042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23542591	Green Accepted, Green Submitted			2022-12-24	WOS:000317984400047
J	McGuire, AL; McCullough, LB; Evans, JP				McGuire, Amy L.; McCullough, Laurence B.; Evans, James P.			The Indispensable Role of Professional Judgment in Genomic Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McGuire, Amy L.; McCullough, Laurence B.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Evans, James P.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA	Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	McGuire, AL (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, 1 Baylor Plaza,MS420, Houston, TX 77030 USA.	amcguire@bcm.edu			NHGRI NIH HHS [U01 HG006485, U01 HG006487, U01-HG006485, U01 HG006500, U01-HG006500, U01-HG006487] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006500, U01HG006485, U01HG006487] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Beauchamp T., 1986, HIST THEORY INFORM C; Brierley KL, 2012, CANCER J, V18, P303, DOI 10.1097/PPO.0b013e3182609490; Knoppers BM, 2006, EUR J HUM GENET, V14, P1170, DOI 10.1038/sj.ejhg.5201690; Langreth R, 2012, BLOOMBERG NEWS; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880	5	26	26	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1465	1466		10.1001/jama.2013.1438	http://dx.doi.org/10.1001/jama.2013.1438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571582	Green Accepted			2022-12-24	WOS:000317271700021
J	Han, DR; Pal, S; Yang, Y; Jiang, SX; Nangreave, J; Liu, Y; Yan, H				Han, Dongran; Pal, Suchetan; Yang, Yang; Jiang, Shuoxing; Nangreave, Jeanette; Liu, Yan; Yan, Hao			DNA Gridiron Nanostructures Based on Four-Arm Junctions	SCIENCE			English	Article							FOLDING DNA	Engineering wireframe architectures and scaffolds of increasing complexity is one of the important challenges in nanotechnology. We present a design strategy to create gridiron-like DNA structures. A series of four-arm junctions are used as vertices within a network of double-helical DNA fragments. Deliberate distortion of the junctions from their most relaxed conformations ensures that a scaffold strand can traverse through individual vertices in multiple directions. DNA gridirons were assembled, ranging from two-dimensional arrays with reconfigurability to multilayer and three-dimensional structures and curved objects.	[Han, Dongran; Pal, Suchetan; Yang, Yang; Jiang, Shuoxing; Nangreave, Jeanette; Liu, Yan; Yan, Hao] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Han, Dongran; Pal, Suchetan; Yang, Yang; Jiang, Shuoxing; Nangreave, Jeanette; Liu, Yan; Yan, Hao] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Han, DR (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	dongran.han@asu.edu; yan_liu@asu.edu	Yang, Yang/S-4225-2017; Pal, Suchetan/D-3653-2012; Liu, Yan/K-1999-2014; Pal, Suchetan/R-5525-2019	Yang, Yang/0000-0002-2630-6062; Pal, Suchetan/0000-0001-8291-2844; Liu, Yan/0000-0003-0906-2606; Pal, Suchetan/0000-0002-6323-7502	NSF [1104373]; Office of Naval Research [N000140911118]; Army Research Office [W911NF-11-1-0137]; Army Research Office Multidisciplinary University Research Initiative [W911NF-12-1-0420]; National Science Foundation of China [21028005]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001016]; Presidential Strategic Initiative Fund from Arizona State University	NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Army Research Office; Army Research Office Multidisciplinary University Research Initiative(MURI); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Presidential Strategic Initiative Fund from Arizona State University	We thank N. Seeman and R. Sha from New York University for helpful discussions. This work is supported by NSF grant 1104373, Office of Naval Research grant N000140911118, Army Research Office grant W911NF-11-1-0137 to H.Y. and Y.L. and Army Research Office Multidisciplinary University Research Initiative award W911NF-12-1-0420 and National Science Foundation of China grant 21028005 to H.Y. H.Y. and Y.L. are part of the Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award no. DE-SC0001016. H.Y. is supported by the Presidential Strategic Initiative Fund from Arizona State University. The DNA sequences for the nanostructures and additional data described in this work can be found in the online supplementary materials.	Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Mao CD, 1999, J AM CHEM SOC, V121, P5437, DOI 10.1021/ja9900398; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; Miick SM, 1997, P NATL ACAD SCI USA, V94, P9080, DOI 10.1073/pnas.94.17.9080; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244	9	195	210	10	226	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1412	1415		10.1126/science.1232252	http://dx.doi.org/10.1126/science.1232252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520107				2022-12-24	WOS:000316740700037
J	Hemphill, CS; Sampat, B				Hemphill, C. Scott; Sampat, Bhaven			Drug Patents at the Supreme Court	SCIENCE			English	Editorial Material									[Sampat, Bhaven] Columbia Univ, Columbia Law Sch, New York, NY 10032 USA; Columbia Univ, New York, NY 10032 USA	Columbia University; Columbia University	Sampat, B (corresponding author), Columbia Univ, Columbia Law Sch, New York, NY 10032 USA.	bns3@columbia.edu						Correa C.M., 2007, GUIDELINES EXAMINATI; Dickey Bret, 2010, Ann Health Law, V19, P367; European Commission, 2009, PHARM SECT INQ FIN R; FTC, 2013, AGR FIL FTC MED PRES; Gal A., 2013, WATERTIGHT COMPOSITI; Hemphill CS, 2012, J HEALTH ECON, V31, P327, DOI 10.1016/j.jhealeco.2012.01.004; Hemphill CS, 2011, J EMPIR LEGAL STUD, V8, P613, DOI 10.1111/j.1740-1461.2011.01235.x; Hemphill CS, 2009, COLUMBIA LAW REV, V109, P629; IMS Health, 2012, EC AN GEN DRUG US US; Kanter J., 2013, NY TIMES, pB1; Nikhil S., 2007, PREDICTING PARA; PRIEST GL, 1984, J LEGAL STUD, V13, P1, DOI 10.1086/467732; RBC Capital Markets, 2010, PHARM AN LIT SUCC RA	13	24	24	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1386	1387		10.1126/science.1235857	http://dx.doi.org/10.1126/science.1235857			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	114KU	23520096				2022-12-24	WOS:000316740700025
J	Teles, RMB; Graeber, TG; Krutzik, SR; Montoya, D; Schenk, M; Lee, DJ; Komisopoulou, E; Kelly-Scumpia, K; Chun, R; Iyer, SS; Sarno, EN; Rea, TH; Hewison, M; Adams, JS; Popper, SJ; Relman, DA; Stenger, S; Bloom, BR; Cheng, GH; Modlin, RL				Teles, Rosane M. B.; Graeber, Thomas G.; Krutzik, Stephan R.; Montoya, Dennis; Schenk, Mirjam; Lee, Delphine J.; Komisopoulou, Evangelia; Kelly-Scumpia, Kindra; Chun, Rene; Iyer, Shankar S.; Sarno, Euzenir N.; Rea, Thomas H.; Hewison, Martin; Adams, John S.; Popper, Stephen J.; Relman, David A.; Stenger, Steffen; Bloom, Barry R.; Cheng, Genhong; Modlin, Robert L.			Type I Interferon Suppresses Type II Interferon-Triggered Human Anti-Mycobacterial Responses	SCIENCE			English	Article							LISTERIA-MONOCYTOGENES; TUBERCULOSIS; LEPROSY; ACTIVATION; IL-1-BETA; INDUCTION; PROFILES; PATTERNS; PROGRAMS; DISEASE	Type I interferons (IFN-alpha and IFN-beta) are important for protection against many viral infections, whereas type II interferon (IFN-gamma) is essential for host defense against some bacterial and parasitic pathogens. Study of IFN responses in human leprosy revealed an inverse correlation between IFN-beta and IFN-gamma gene expression programs. IFN-gamma and its downstream vitamin D-dependent antimicrobial genes were preferentially expressed in self-healing tuberculoid lesions and mediated antimicrobial activity against the pathogen Mycobacterium leprae in vitro. In contrast, IFN-beta and its downstream genes, including interleukin-10 (IL-10), were induced in monocytes by M. leprae in vitro and preferentially expressed in disseminated and progressive lepromatous lesions. The IFN-gamma-induced macrophage vitamin D-dependent antimicrobial peptide response was inhibited by IFN-beta and by IL-10, suggesting that the differential production of IFNs contributes to protection versus pathogenesis in some human bacterial infections.	[Teles, Rosane M. B.; Krutzik, Stephan R.; Montoya, Dennis; Schenk, Mirjam; Kelly-Scumpia, Kindra; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Los Angeles, CA 90095 USA; [Iyer, Shankar S.; Cheng, Genhong; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Chun, Rene; Hewison, Martin; Adams, John S.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Orthoped Hosp Dept Orthoped Surg, Los Angeles, CA 90095 USA; [Graeber, Thomas G.; Komisopoulou, Evangelia] Univ Calif Los Angeles, Johnson Comprehens Canc Ctr, Dept Mol & Med Pharmacol, Crump Inst Mol Imaging,Inst Mol Med,Calif NanoSys, Los Angeles, CA 90095 USA; [Lee, Delphine J.] John Wayne Canc Inst, Dept Translat Immunol, Santa Monica, CA USA; [Sarno, Euzenir N.] Fundacao Oswaldo Cruz, Dept Mycobacteriosis, Rio De Janeiro, RJ, Brazil; [Rea, Thomas H.] Univ So Calif, Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA; [Popper, Stephen J.; Relman, David A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Popper, Stephen J.; Relman, David A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Stenger, Steffen] Univ Hosp Ulm, Inst Med Microbiol & Hyg, Ulm, Germany; [Bloom, Barry R.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; John Wayne Cancer Institute; Fundacao Oswaldo Cruz; University of Southern California; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Ulm University; Harvard University; Harvard T.H. Chan School of Public Health	Modlin, RL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Los Angeles, CA 90095 USA.	rmodlin@mednet.ucla.edu	Adams, John S/I-3365-2013; Chun, Rene/A-9415-2010; Teles, Rosane/E-9607-2017; Teles, Rosane/AAQ-3436-2020; Modlin, Robert L/M-7941-2014	Adams, John S/0000-0001-9607-5020; Chun, Rene/0000-0002-0190-0807; Teles, Rosane/0000-0003-2908-3244; Teles, Rosane/0000-0003-2908-3244; Modlin, Robert L/0000-0003-4720-031X; Nunes Sarno, Euzenir/0000-0003-0129-2159; Graeber, Thomas/0000-0001-8574-9181; Relman, David A./0000-0001-8331-1354; Schenk, Mirjam/0000-0002-1637-0730	NIH [P50 AR063020, R01 AI022553, R01 AR040312, R01 AI047868, UL1TR000124]; NATIONAL CANCER INSTITUTE [T32CA009120] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047868, R01AI056154, R01AI022553, R37AI047868, R01AI082575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040312, R01AR059126, P50AR063020] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Liu for advice with the M. leprae viability assays and helpful discussion; M. So for help in the bioinformatic analysis; K. Zavala for help with the high-performance liquid chromatography (HPLC) assays; A. Legaspi and A. DeLeon for help with the immunohistochemistry; M. Schibler and the University of California-Los Angeles, California NanoSystems Institute, Advanced Light Microscopy Core Facility for assistance with the confocal studies; D. Elashoff for help with the statistical analysis; and A. Steinmeyer, E. May, and U. Zugel from Bayer Pharma AG for the VDR antagonist ZK 159 222 (VAZ). The live M. leprae was provided by the U.S. National Hansen's Disease Programs through the generous support of the American Leprosy Missions and Society of St. Lazarus of Jerusalem. The data presented in this manuscript are tabulated in the main paper and supplementary materials. Gene expression files containing array data are available under the accession nos. GSE17763 and GSE43700 in the Gene Expression Omnibus (GEO) database. This work was supported in parts by NIH grants (P50 AR063020; R01s AI022553, AR040312, and AI047868; and Clinical and Translational Science Award grant UL1TR000124).	ADAMS JS, 1985, J EXP MED, V161, P755, DOI 10.1084/jem.161.4.755; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; COOPER CL, 1989, J EXP MED, V169, P1565, DOI 10.1084/jem.169.5.1565; Edfeldt K, 2010, P NATL ACAD SCI USA, V107, P22593, DOI 10.1073/pnas.1011624108; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; HERRERA G, 1949, Int J Lepr, V17, P35; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Liu PT, 2012, NAT MED, V18, P267, DOI 10.1038/nm.2584; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Martinez AN, 2009, J CLIN MICROBIOL, V47, P2124, DOI 10.1128/JCM.00512-09; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Montoya D, 2009, CELL HOST MICROBE, V6, P343, DOI 10.1016/j.chom.2009.09.002; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Roy S, 1999, J INFECT DIS, V179, P187, DOI 10.1086/314536; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; YAMAMURA M, 1992, J IMMUNOL, V149, P1470; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582	29	260	262	0	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1448	1453		10.1126/science.1233665	http://dx.doi.org/10.1126/science.1233665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23449998	Green Accepted, Green Published			2022-12-24	WOS:000316740700047
J	Frigola, J; Remus, D; Mehanna, A; Diffley, JFX				Frigola, Jordi; Remus, Dirk; Mehanna, Amina; Diffley, John F. X.			ATPase-dependent quality control of DNA replication origin licensing	NATURE			English	Article							RE-REPLICATION; COMPLEX; HELICASE; CDT1; INITIATION; MECHANISM; SEQUENCE; BINDING; CELLS; ORC6	The regulated loading of the Mcm2-7 DNA helicase (comprising six related subunits, Mcm2 to Mcm7) into pre-replicative complexes at multiple replication origins ensures precise once per cell cycle replication in eukaryotic cells. The origin recognition complex (ORC), Cdc6 and Cdt1 load Mcm2-7 into a double hexamer bound around duplex DNA in an ATP-dependent reaction, but the molecular mechanism of this origin 'licensing' is still poorly understood. Here we show that both Mcm2-7 hexamers in Saccharomyces cerevisiae are recruited to origins by an essential, conserved carboxy-terminal domain of Mcm3 that interacts with and stimulates the ATPase activity of ORC-Cdc6. ATP hydrolysis can promote Mcm2-7 loading, but can also promote Mcm2-7 release if components are missing or if ORC has been inactivated by cyclin-dependent kinase phosphorylation. Our work provides new insights into how origins are licensed and reveals a novel ATPase-dependent mechanism contributing to precise once per cell cycle replication.	[Frigola, Jordi; Remus, Dirk; Mehanna, Amina; Diffley, John F. X.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	John.Diffley@cancer.org.uk	Frigola, Jordi/N-4602-2015	Frigola, Jordi/0000-0002-7231-3853; Diffley, John/0000-0001-5184-7680; Remus, Dirk/0000-0002-5155-181X	Cancer Research UK; Association for International Cancer Research [10-0270]; European Research Council [249883 - EUKDNAREP]; Cancer Research UK [15669] Funding Source: researchfish; Worldwide Cancer Research [10-0270] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Association for International Cancer Research; European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	We are grateful to N. Cook for help with protein purifications, A. Early and L Drury for help with strain constructions, G. Coster for help with Mcm3 complementation, S. Mochida and B. Pfander for vectors and K. Labib for antibodies. We also thank members of the Diffley laboratory for critical reading of the manuscript This work was funded by Cancer Research UK and grants from the Association for International Cancer Research (10-0270) and the European Research Council (249883 - EUKDNAREP).	Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Boos D, 2012, CURR OPIN CELL BIOL, V24, P423, DOI 10.1016/j.ceb.2012.01.011; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Chen SY, 2011, GENE DEV, V25, P363, DOI 10.1101/gad.2011511; Diffley JFX, 2010, COLD SH Q B, V75, P135, DOI 10.1101/sqb.2010.75.062; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee DG, 1997, MOL CELL BIOL, V17, P7159, DOI 10.1128/MCB.17.12.7159; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Pasion SG, 1999, MOL BIOL CELL, V10, P4043, DOI 10.1091/mbc.10.12.4043; Remus D, 2004, EMBO J, V23, P897, DOI 10.1038/sj.emboj.7600077; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Takara TJ, 2011, EMBO J, V30, P4885, DOI 10.1038/emboj.2011.394; Tanaka S, 2010, CHROMOSOMA, V119, P565, DOI 10.1007/s00412-010-0291-8; Tye BK, 2000, J BIOL CHEM, V275, P34833, DOI 10.1074/jbc.R000018200; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304	26	145	147	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					339	343		10.1038/nature11920	http://dx.doi.org/10.1038/nature11920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23474987	Green Accepted			2022-12-24	WOS:000316650500036
J	Meckler, AN; Sigman, DM; Gibson, KA; Francois, R; Martinez-Garcia, A; Jaccard, SL; Rohl, U; Peterson, LC; Tiedemann, R; Haug, GH				Meckler, A. N.; Sigman, D. M.; Gibson, K. A.; Francois, R.; Martinez-Garcia, A.; Jaccard, S. L.; Roehl, U.; Peterson, L. C.; Tiedemann, R.; Haug, G. H.			Deglacial pulses of deep-ocean silicate into the subtropical North Atlantic Ocean	NATURE			English	Article							AFRICAN HUMID PERIOD; SOUTHERN-OCEAN; LAST DEGLACIATION; YOUNGER DRYAS; CIRCULATION; RECORD; TERMINATION; EVENTS; CD/CA; WATER	Growing evidence suggests that the low atmospheric CO2 concentration of the ice ages resulted from enhanced storage of CO2 in the ocean interior, largely as a result of changes in the Southern Ocean(1). Early in the most recent deglaciation, a reduction in North Atlantic overturning circulation seems to have driven CO2 release from the Southern Ocean(2-5), but the mechanism connecting the North Atlantic and the Southern Ocean remains unclear. Biogenic opal export in the low-latitude ocean relies on silicate from the underlying thermocline, the concentration of which is affected by the circulation of the ocean interior. Here we report a record of biogenic opal export from a coastal upwelling system off the coast of northwest Africa that shows pronounced opal maxima during each glacial termination over the past 550,000 years. These opal peaks are consistent with a strong deglacial reduction in the formation of silicate-poor glacial North Atlantic intermediate water(2) (GNAIW). The loss of GNAIW allowed mixing with underlying silicate-rich deep water to increase the silicate supply to the surface ocean. An increase in westerly-wind-driven upwelling in the Southern Ocean in response to the North Atlantic change has been proposed to drive the deglacial rise in atmospheric CO2 (refs 3, 4). However, such a circulation change would have accelerated the formation of Antarctic intermediate water and sub-Antarctic mode water, which today have as little silicate as North Atlantic Deep Water and would have thus maintained low silicate concentrations in the Atlantic thermocline. The deglacial opal maxima reported here suggest an alternative mechanism for the deglacial CO2 release(5,6). Just as the reduction in GNAIW led to upward silicate transport, it should also have allowed the downward mixing of warm, low-density surface water to reach into the deep ocean. The resulting decrease in the density of the deep Atlantic relative to the Southern Ocean surface promoted Antarctic overturning, which released CO2 to the atmosphere.	[Meckler, A. N.; Martinez-Garcia, A.; Jaccard, S. L.; Haug, G. H.] ETH, Inst Geol, CH-8092 Zurich, Switzerland; [Sigman, D. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Gibson, K. A.; Peterson, L. C.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Francois, R.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V6T 1Z4, Canada; [Roehl, U.] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Tiedemann, R.] Alfred Wegener Inst, D-27568 Bremerhaven, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Princeton University; University of Miami; University of British Columbia; University of Bremen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Meckler, AN (corresponding author), ETH, Inst Geol, CH-8092 Zurich, Switzerland.	nele.meckler@erdw.ethz.ch	Meckler, Anna Nele/AAC-2490-2020; Gibson, Kelly/AAB-6615-2020; Röhl, Ursula/G-5986-2011; Jaccard, Samuel/G-3447-2014; Sigman, Daniel M/A-2649-2008; Martínez-García, Alfredo/A-6244-2010	Meckler, Anna Nele/0000-0002-7225-8276; Röhl, Ursula/0000-0001-9469-7053; Jaccard, Samuel/0000-0002-5793-0896; Sigman, Daniel M/0000-0002-7923-1973; Martínez-García, Alfredo/0000-0002-7206-5079; Tiedemann, Ralf/0000-0001-7211-8049	US NSF [OCE-1060947]; DFG-Leibniz Center for Surface Process and Climate Studies at the University of Potsdam; NSERC; CFCAS; Directorate For Geosciences [1003364] Funding Source: National Science Foundation; Division Of Ocean Sciences [1060947] Funding Source: National Science Foundation	US NSF(National Science Foundation (NSF)); DFG-Leibniz Center for Surface Process and Climate Studies at the University of Potsdam; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFCAS; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research used samples provided by the ODP, which is sponsored by the US NSF and participating countries under the management of the Joint Oceanographic Institutions. XRF data were acquired at the XRF Core Scanner Lab at MARUM - Center for Marine Environmental Sciences, University of Bremen, with support from the DFG-Leibniz Center for Surface Process and Climate Studies at the University of Potsdam. Further support was provided by the US NSF through grant OCE-1060947 to D. M. S. and by NSERC and CFCAS to R. F. We thank V. Lukies for XRF scanning technical support and T. Westerhold for help in deriving the new composite depth. M. Soon and T. Kane are acknowledged for opal and excess <SUP>230</SUP>Th measurements, respectively, in core MD03-2705.	Adkins J, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001200; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Bradtmiller LI, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001443; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Came RE, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000888; Came RE, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001450; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; EGLINTON G, 1992, NATURE, V356, P423, DOI 10.1038/356423a0; Gil IM, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001729; Gnanadesikan A, 1999, GEOPHYS RES LETT, V26, P1865, DOI 10.1029/1999GL900379; Harris PG, 1996, NATURE, V383, P63, DOI 10.1038/383063a0; Hayes CT, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002008; Jaccard S. L., 2002, SCIENCE IN PRESS; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Jullien E, 2007, QUATERNARY RES, V68, P379, DOI 10.1016/j.yqres.2007.07.007; Levitus S., 2009, NOAA ATLAS NESDIS, P184; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Marchitto TM, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000598; Marshall J, 2012, NAT GEOSCI, V5, P171, DOI [10.1038/ngeo1391, 10.1038/NGEO1391]; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; MORTLOCK RA, 1989, DEEP-SEA RES, V36, P1415, DOI 10.1016/0198-0149(89)90092-7; Oppo D. W., 2012, NATURE ED KNOWL, V3, P1; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Rickaby REM, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000858; Romero OE, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001601; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Sarnthein M, 1990, PALEOCEANOGRAPHY, V5, P1041, DOI 10.1029/PA005i006p01041; Schlitzer R., 2000, EOS T AGU, V81, P45, DOI DOI 10.1029/00E000028; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Sigman D. M., 2013, GEOPHYS MONOGR SER, P335, DOI [10.1029/173GM21, DOI 10.1029/173GM21]; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Stott L, 2007, SCIENCE, V318, P435, DOI 10.1126/science.1143791; TIEDEMANN R, 1989, P OCEAN DRILLING PRO, V0108; Tjallingii R, 2008, NAT GEOSCI, V1, P670, DOI 10.1038/ngeo289; Toggweiler JR, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001758; Xie RFC, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002337	38	62	66	2	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					495	+		10.1038/nature12006	http://dx.doi.org/10.1038/nature12006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23538831				2022-12-24	WOS:000316682800042
J	Alaei, A; Alaei, K				Alaei, Arash; Alaei, Kamiar			Drug users need more choices at addiction treatment facilities	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Alaei, Arash; Alaei, Kamiar] SUNY Albany, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany	Alaei, A (corresponding author), SUNY Albany, Albany, NY 12222 USA.	aalaei@albany.edu						Amnesty International, 2011, ADD DEATH EX DRUGS O; Mokri A, 2002, ARCH IRAN MED, V5, P184; United Nations Department of Economic and Social Affairs Population Division, 20 MOST POP COUNTR 1	3	0	0	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2013	346								f1520	10.1136/bmj.f1520	http://dx.doi.org/10.1136/bmj.f1520			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113MQ	23525866				2022-12-24	WOS:000316672500011
J	Chandra, V; Huang, PX; Potluri, N; Wu, DL; Kim, YC; Rastinejad, F				Chandra, Vikas; Huang, Pengxiang; Potluri, Nalini; Wu, Dalei; Kim, Youngchang; Rastinejad, Fraydoon			Multidomain integration in the structure of the HNF-4 alpha nuclear receptor complex	NATURE			English	Article							LIGAND-BINDING DOMAIN; PPAR-GAMMA-RXR; TRANSCRIPTION FACTORS; DNA-BINDING; HYPERINSULINEMIC HYPOGLYCEMIA; PHOSPHORYLATION; IDENTIFICATION; MUTATIONS; ELEMENTS; HNF4A	The hepatocyte nuclear factor 4 alpha (HNF-4 alpha; also known as NR2A1) is a member of the nuclear receptor (NR) family of transcription factors, which have conserved DNA-binding domains and ligand-binding domains(1,2). HNF-4 alpha is the most abundant DNA-binding protein in the liver, where some 40% of the actively transcribed genes have a HNF-4 alpha response element(1,3,4). These regulated genes are largely involved in the hepatic gluconeogenic program and lipid metabolism(3,5,6). In the pancreas HNF-4 alpha is also a master regulator, controlling an estimated 11% of islet genes(7). HNF-4 alpha protein mutations are linked to maturity-onset diabetes of the young, type 1 (MODY1) and hyperinsulinaemic hypoglycaemia(8-11). Previous structural analyses of NRs, although productive in elucidating the structure of individual domains, have lagged behind in revealing the connectivity patterns of NR domains. Here we describe the 2.9 angstrom crystal structure of the multidomain human HNF-4 alpha homodimer bound to its DNA response element and coactivatorderived peptides. A convergence zone connects multiple receptor domains in an asymmetric fashion, joining distinct elements from each monomer. An arginine target of PRMT1 methylation protrudes directly into this convergence zone and sustains its integrity. A serine target of protein kinase C is also responsible for maintaining domain-domain interactions. These post-translational modifications lead to changes in DNA binding by communicating through the tightly connected surfaces of the quaternary fold. We find that some MODY1 mutations, positioned on the ligand-binding domain and hinge regions of the receptor, compromise DNA binding at a distance by communicating through the interjunctional surfaces of the complex. The overall domain representation of the HNF-4 alpha homodimer is different from that of the PPAR-gamma-RXR-alpha heterodimer, even when both NR complexes are assembled on the same DNA element. Our findings suggest that unique quaternary folds and interdomain connections in NRs could be exploited by small-molecule allosteric modulators that affect distal functions in these polypeptides.	[Chandra, Vikas; Huang, Pengxiang; Potluri, Nalini; Wu, Dalei; Rastinejad, Fraydoon] Sanford Burnham Med Res Inst, Metab Signaling & Dis Program, Orlando, FL 32827 USA; [Kim, Youngchang] Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA	Sanford Burnham Prebys Medical Discovery Institute; United States Department of Energy (DOE); Argonne National Laboratory	Rastinejad, F (corresponding author), Sanford Burnham Med Res Inst, Metab Signaling & Dis Program, Orlando, FL 32827 USA.	frastinejad@sanfordburnham.org		Kim, Youngchang/0000-0002-1610-4889	National Institutes of Health [R01 DK094147, R01 DK097475]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094147, R01DK097475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01 DK094147 and R01 DK097475.	Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Ellard S, 2006, HUM MUTAT, V27, P854, DOI 10.1002/humu.20357; Fang B, 2012, NUCLEIC ACIDS RES, V40, P5343, DOI 10.1093/nar/gks190; Flanagan SE, 2010, EUR J ENDOCRINOL, V162, P987, DOI 10.1530/EJE-09-0861; Gineste R, 2008, MOL ENDOCRINOL, V22, P2433, DOI 10.1210/me.2008-0092; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Helsen C, 2012, MOL CELL BIOL, V32, P3033, DOI 10.1128/MCB.00151-12; Jiang GQ, 1997, MOL CELL BIOL, V17, P6546, DOI 10.1128/MCB.17.11.6546; Kapoor RR, 2009, ARCH DIS CHILD, V94, P450, DOI 10.1136/adc.2008.148171; Lu P, 2008, J BIOL CHEM, V283, P33685, DOI 10.1074/jbc.M806213200; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Rochel N, 2011, NAT STRUCT MOL BIOL, V18, P564, DOI 10.1038/nsmb.2054; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Wallerman O, 2009, NUCLEIC ACIDS RES, V37, P7498, DOI 10.1093/nar/gkp823; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609	28	126	131	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					394	398		10.1038/nature11966	http://dx.doi.org/10.1038/nature11966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23485969	Green Accepted			2022-12-24	WOS:000316650500048
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Hype and the HIV cure	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2013, TELEGRAPH, DOI DOI 10150905/NSA-SURVEILLANCE-US-BUGGED-EU-OFFICES.HTML; Boseley S, 2013, GUARDIAN; Hodgekiss Anna, 2013, DAILY MAIL; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; NIH News National Institutes of Health, 2013, NIH NEWS        0303; Persaud D, 2013, 20 C RETR OPP INF 3; Pollack A., 2013, NY TIMES; Roehr B, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1487; Sample I., 2013, GUARDIAN	9	1	1	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2013	346								f1599	10.1136/bmj.f1599	http://dx.doi.org/10.1136/bmj.f1599			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108VJ	23479595				2022-12-24	WOS:000316324000006
J	Ferner, R				Ferner, Robin			Divination	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				Australian Government Therapeutic Goods Administration, 2013, LAB PACK PRACT SUMM; Flynn EA, 2006, TROUBLING AMINE; Garrett D, TALL MAN LETT; Kondrak G, 2006, ARTIF INTELL MED, V36, P29, DOI 10.1016/j.artmed.2005.07.005; MACINTYRE IM, 1972, LANCET, V1, P1094; Nelson RL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003431.pub3; Smith VM, 2012, BRIT J DERMATOL, V167, P1048, DOI 10.1111/j.1365-2133.2012.11185.x; Timur, LEVENSHTEIN DISTANCE; US Food and Drug Administration, FDA DRUG SAF COMM ME; US Food and Drug Administration, MED ERR NAM DIFF PRO	10	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2013	346								f1536	10.1136/bmj.f1536	http://dx.doi.org/10.1136/bmj.f1536			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104MT	23471365				2022-12-24	WOS:000315998500004
J	Mo, W; Chen, J; Patel, A; Zhang, L; Chau, V; Li, YJ; Cho, W; Lim, K; Xu, J; Lazar, AJ; Creighton, CJ; Bolshakov, S; McKay, RM; Lev, D; Le, LQ; Parada, LF				Mo, Wei; Chen, Jian; Patel, Amish; Zhang, Liang; Chau, Vincent; Li, Yanjiao; Cho, Woosung; Lim, Kyun; Xu, Jing; Lazar, Alexander J.; Creighton, Chad J.; Bolshakov, Svetlana; McKay, Renee M.; Lev, Dina; Le, Lu Q.; Parada, Luis F.			CXCR4/CXCL12 Mediate Autocrine Cell- Cycle Progression in NF1-Associated Malignant Peripheral Nerve Sheath Tumors	CELL			English	Article							CHEMOKINE RECEPTOR CXCR4; NEUROFIBROMATOSIS TYPE-1; SCHWANN-CELLS; THERAPEUTIC APPROACH; PANCREATIC-CANCER; MAMMALIAN TARGET; EXPRESSION; PROLIFERATION; METASTASIS; SURVIVAL	Malignant peripheral nerve sheath tumors (MPNSTs) are soft tissue sarcomas that arise in connective tissue surrounding peripheral nerves. They occur sporadically in a subset of patients with neurofibromatosis type 1 (NF1). MPNSTs are highly aggressive, therapeutically resistant, and typically fatal. Using comparative transcriptome analysis, we identified CXCR4, a G-protein-coupled receptor, as highly expressed in mouse models of NF1-deficient MPNSTs, but not in nontransformed precursor cells. The chemokine receptor CXCR4 and its ligand, CXCL12, promote MPNST growth by stimulating cyclin D1 expression and cell-cycle progression through PI3-kinase (PI3K) and beta-catenin signaling. Suppression of CXCR4 activity either by shRNA or pharmacological inhibition decreases MPNST cell growth in culture and inhibits tumorigenesis in allografts and in spontaneous genetic mouse models of MPNST. We further demonstrate conservation of these activated molecular pathways in human MPNSTs. Our findings indicate a role for CXCR4 in NF1-associated MPNST development and identify a therapeutic target.	[Mo, Wei; Chen, Jian; Chau, Vincent; Li, Yanjiao; Cho, Woosung; Lim, Kyun; Xu, Jing; McKay, Renee M.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Patel, Amish; Chau, Vincent; Le, Lu Q.] Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA; [Zhang, Liang] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Lazar, Alexander J.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77054 USA; [Bolshakov, Svetlana; Lev, Dina] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77054 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Le, LQ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA.	lu.le@utsouthwestern.edu; luis.parada@utsouthwestern.edu	Parada, luis F/B-9400-2014; Lazar, Alexander J/A-3416-2008	Lazar, Alexander J/0000-0002-6395-4499; Le, Lu/0000-0003-2817-5382; Patel, Amish/0000-0002-4214-2619	National Cancer Institute [R01 CA166593]; Department of Defense [W81XWH-12-1-0161, W81XWH-11-1-0184]; National Institutes of Health [P50NS052606]; Career Award for Medical Scientists from the Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [R01CA166593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS052606] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Karen Cichowski for the generous gift of the human MPNST cell lines. This work was partially supported by funding from the National Cancer Institute (grant R01 CA166593 to L. Q. L.), Department of Defense (grant W81XWH-12-1-0161 to L. Q. L. and Postdoctoral Fellowship Award grant W81XWH-11-1-0184 to W. M.), and the National Institutes of Health (grant P50NS052606 to L. F. P.). L. Q. L. is a Disease-Oriented Clinical Scholar and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. L. F. P. is an American Cancer Society Research Professor.	Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bertolini F, 2002, CANCER RES, V62, P3106; Bian XW, 2007, NEUROSURGERY, V61, P570, DOI 10.1227/01.NEU.0000290905.53685.A2; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Ferner RE, 2007, EUR J HUM GENET, V15, P131, DOI 10.1038/sj.ejhg.5201676; Ghadimi MP, 2012, CLIN CANCER RES, V18, P2545, DOI 10.1158/1078-0432.CCR-11-2592; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Johannessen CM, 2008, CURR BIOL, V18, P56, DOI 10.1016/j.cub.2007.11.066; Johansson G, 2008, MOL CANCER THER, V7, P1237, DOI 10.1158/1535-7163.MCT-07-2335; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Kijima T, 2002, CANCER RES, V62, P6304; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Laverdiere C, 2005, CLIN CANCER RES, V11, P2561, DOI 10.1158/1078-0432.CCR-04-1089; Le LQ, 2007, ONCOGENE, V26, P4609, DOI 10.1038/sj.onc.1210261; Le LQ, 2011, CANCER RES, V71, P4686, DOI 10.1158/0008-5472.CAN-10-4577; Le LQ, 2009, CELL STEM CELL, V4, P453, DOI 10.1016/j.stem.2009.03.017; Lee MH, 2003, CANCER METAST REV, V22, P435, DOI 10.1023/A:1023785332315; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mantripragada KK, 2008, CLIN CANCER RES, V14, P1015, DOI 10.1158/1078-0432.CCR-07-1305; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Oh JW, 2001, J IMMUNOL, V166, P2695, DOI 10.4049/jimmunol.166.4.2695; Peled A, 2012, EXPERT OPIN INV DRUG, V21, P341, DOI 10.1517/13543784.2012.656197; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Rubin JB, 2005, NAT REV CANCER, V5, P557, DOI 10.1038/nrc1653; Schrader AJ, 2002, BRIT J CANCER, V86, P1250, DOI 10.1038/sj.bjc.6600221; Sehgal A, 1998, J SURG ONCOL, V69, P99, DOI 10.1002/(SICI)1096-9098(199810)69:2<99::AID-JSO10>3.0.CO;2-M; Sengupta R, 2012, CANCER RES, V72, P122, DOI 10.1158/0008-5472.CAN-11-1701; Serra E, 2000, HUM MOL GENET, V9, P3055, DOI 10.1093/hmg/9.20.3055; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Srivastava AK, 1998, MOL CELL BIOCHEM, V182, P135, DOI 10.1023/A:1006857527588; Taichman RS, 2002, CANCER RES, V62, P1832; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Wang Y, 2012, CELL, V150, P816, DOI 10.1016/j.cell.2012.06.034; Wang Z, 2008, BRIT J CANCER, V99, P1695, DOI 10.1038/sj.bjc.6604745; Warrington NM, 2007, CANCER RES, V67, P8588, DOI 10.1158/0008-5472.CAN-06-2220; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zheng H, 2008, CANCER CELL, V13, P117, DOI 10.1016/j.ccr.2008.01.002; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452; Zhu Y, 2001, EXP CELL RES, V264, P19, DOI 10.1006/excr.2000.5138; Zou CYY, 2009, MOL CANCER THER, V8, P1157, DOI 10.1158/1535-7163.MCT-08-1008	48	114	120	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1077	1090		10.1016/j.cell.2013.01.053	http://dx.doi.org/10.1016/j.cell.2013.01.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23434321	Bronze, Green Accepted			2022-12-24	WOS:000315710300015
J	Chiyaka, C; Tatem, AJ; Cohen, JM; Gething, PW; Johnston, G; Gosling, R; Laxminarayan, R; Hay, SI; Smith, DL				Chiyaka, C.; Tatem, A. J.; Cohen, J. M.; Gething, P. W.; Johnston, G.; Gosling, R.; Laxminarayan, R.; Hay, S. I.; Smith, D. L.			The Stability of Malaria Elimination	SCIENCE			English	Editorial Material							FEASIBILITY; POPULATION; STRATEGIES		[Chiyaka, C.; Tatem, A. J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Tatem, A. J.] Univ Southampton, Dept Geog & Environm, Southampton SO17 1BJ, Hants, England; [Tatem, A. J.; Hay, S. I.; Smith, D. L.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Cohen, J. M.] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Gething, P. W.; Hay, S. I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Johnston, G.; Smith, D. L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Johnston, G.; Smith, D. L.] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD 21205 USA; [Gosling, R.] Univ Calif San Francisco, Malaria Eliminat Initiat, Global Hlth Grp, San Francisco, CA 94105 USA; [Hay, S. I.; Smith, D. L.] Ctr Dis Dynam Econ & Policy, Washington, DC 20036 USA	State University System of Florida; University of Florida; University of Southampton; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Oxford; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco	Smith, DL (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	dlsmith@jhsph.edu	Gething, Peter/ABD-2110-2020; Smith, David L/L-8850-2013; Laxminarayan, Ramanan/ABD-5050-2021; Hay, Simon Iain/F-8967-2015; Gething, Peter/GQR-1884-2022	Smith, David L/0000-0003-4367-3849; Hay, Simon Iain/0000-0002-0611-7272; Gething, Peter/0000-0001-6759-5449; Chi-Johnston, Geoffrey/0000-0002-0397-3508; Cohen, Justin/0000-0003-4481-6784; Tatem, Andrew/0000-0002-7270-941X	Medical Research Council [MR/K00669X/1] Funding Source: Medline; NIAID NIH HHS [U19AI089674] Funding Source: Medline; Wellcome Trust [095066] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER; MRC [MR/K00669X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Breman JG, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000405; Bretscher MT, 2011, EPIDEMICS-NETH, V3, P109, DOI 10.1016/j.epidem.2011.03.002; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Feachem RGA, 2010, LANCET, V376, P1517, DOI 10.1016/S0140-6736(10)61500-0; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; GRAMICCIA G, 1988, PRINCIPLES PRACTICE, V2, P1335; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P613; MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P369; Moonen B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-322; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Pigott DM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-246; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Smith DL, 2011, SCIENCE, V332, P1384, DOI 10.1126/science.1201398; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; *UCSF GLOB HLTH GR, 2012, ATL MAL EL COUNTR; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; *WHO, 1957, 6 WHO EXP COMM MAL; Yekutiel P, 1980, ERADICATION INFECT D, P34; Zanzibar Malaria Control Program, 2009, MAL EL ZANZ FEAS ASS	25	36	36	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					909	910		10.1126/science.1229509	http://dx.doi.org/10.1126/science.1229509			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092UX	23430640				2022-12-24	WOS:000315149600032
J	Bindman, AB; Blum, JD; Kronick, R				Bindman, Andrew B.; Blum, Jonathan D.; Kronick, Richard			Medicare's Transitional Care Payment - A Step toward the Medical Home	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bindman, Andrew B.; Kronick, Richard] US Dept HHS, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA; [Blum, Jonathan D.] US Dept HHS, Ctr Medicare & Medicaid Serv, Washington, DC 20201 USA; [Bindman, Andrew B.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Centers for Medicare & Medicaid Services; University of California System; University of California San Francisco	Bindman, AB (corresponding author), US Dept HHS, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA.							[Anonymous], 2012, GAO REPORT THE OBAMA; Centers for Medicare & Medicaid Services (CMS) HHS, 2012, Fed Regist, V77, P68891; Grumbach K, 2010, OUTCOMES OF IMPLEMEN; Hesselink G, 2012, ANN INTERN MED, V157, P417, DOI 10.7326/0003-4819-157-6-201209180-00006; The Commonwealth Fund Commission on a High Performance Health System, 2009, THE PATH TO A HIGH P	5	34	36	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					692	694		10.1056/NEJMp1214122	http://dx.doi.org/10.1056/NEJMp1214122			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	092CG	23425161	Green Published			2022-12-24	WOS:000315095800002
J	Horikawa, T; Tamaki, M; Miyawaki, Y; Kamitani, Y				Horikawa, T.; Tamaki, M.; Miyawaki, Y.; Kamitani, Y.			Neural Decoding of Visual Imagery During Sleep	SCIENCE			English	Article							EYE-MOVEMENTS; BRAIN; REM; REPRESENTATION; ACTIVATION; OBJECT; CORTEX	Visual imagery during sleep has long been a topic of persistent speculation, but its private nature has hampered objective analysis. Here we present a neural decoding approach in which machine-learning models predict the contents of visual imagery during the sleep-onset period, given measured brain activity, by discovering links between human functional magnetic resonance imaging patterns and verbal reports with the assistance of lexical and image databases. Decoding models trained on stimulus-induced brain activity in visual cortical areas showed accurate classification, detection, and identification of contents. Our findings demonstrate that specific visual experience during sleep is represented by brain activity patterns shared by stimulus perception, providing a means to uncover subjective contents of dreaming using objective neural measurement.	[Horikawa, T.; Tamaki, M.; Miyawaki, Y.; Kamitani, Y.] ATR Computat Neurosci Labs, Kyoto 6190288, Japan; [Horikawa, T.; Kamitani, Y.] Nara Inst Sci & Technol, Nara 6300192, Japan; [Miyawaki, Y.] Natl Inst Informat & Commun Technol, Kyoto 6190288, Japan	Nara Institute of Science & Technology; National Institute of Information & Communications Technology (NICT) - Japan	Kamitani, Y (corresponding author), ATR Computat Neurosci Labs, Kyoto 6190288, Japan.	kmtn@atr.jp		Horikawa, Tomoyasu/0000-0002-6524-9398; Miyawaki, Yoichi/0000-0001-9581-926X; Tamaki, Masako/0000-0001-7621-8039	Strategic Research Program for Brain Science (MEXT); Strategic Information and Communications R&D Promotion Programme (SOUMU); National Institute of Information and Communications Technology; Nissan Science Foundation; Ministry of Internal Affairs and Communications	Strategic Research Program for Brain Science (MEXT); Strategic Information and Communications R&D Promotion Programme (SOUMU); National Institute of Information and Communications Technology; Nissan Science Foundation; Ministry of Internal Affairs and Communications	We thank Y. Onuki, T. Beck, Y. Fujiwara, G. Pandey, and T. Kubo for assistance with early experiments and M. Takemiya and P. Sukhanov for comments on the manuscript. This work was supported by grants from the Strategic Research Program for Brain Science (MEXT), the Strategic Information and Communications R&D Promotion Programme (SOUMU), the National Institute of Information and Communications Technology, the Nissan Science Foundation, and the Ministry of Internal Affairs and Communications (Novel and innovative R&D making use of brain structures).	[Anonymous], 1994, SLEEP ONSET NORMAL A, DOI DOI 10.1037/10166-014; Braun AR, 1998, SCIENCE, V279, P91, DOI 10.1126/science.279.5347.91; DEMENT W, 1957, J EXP PSYCHOL, V53, P339, DOI 10.1037/h0048189; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Dresler M, 2011, CURR BIOL, V21, P1833, DOI 10.1016/j.cub.2011.09.029; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fellbaum C., 1998, WORDNET ELECT LEXICA; Finke RA., 1989, PRINCIPLES MENTAL IM; FOULKES DAVID, 1965, J ABNORM PSYCHOL, V70, P231, DOI 10.1037/h0022217; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hobson JA, 2009, NAT REV NEUROSCI, V10, P803, DOI 10.1038/nrn2716; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Maquet P, 2000, J SLEEP RES, V9, P207; Marzano C, 2011, J NEUROSCI, V31, P6674, DOI 10.1523/JNEUROSCI.0412-11.2011; Miyauchi S, 2009, EXP BRAIN RES, V192, P657, DOI 10.1007/s00221-008-1579-2; Miyawaki Y, 2008, NEURON, V60, P915, DOI 10.1016/j.neuron.2008.11.004; Nir Y, 2010, TRENDS COGN SCI, V14, P88, DOI 10.1016/j.tics.2009.12.001; Oudiette D, 2012, CONSCIOUS COGN, V21, P1129, DOI 10.1016/j.concog.2012.04.010; Stickgold R, 2000, SCIENCE, V290, P350, DOI 10.1126/science.290.5490.350; Stokes M, 2009, J NEUROSCI, V29, P1565, DOI 10.1523/JNEUROSCI.4657-08.2009; Vapnik V., 1998, STAT LEARNING THEORY; VOGEL GW, 1972, ARCH GEN PSYCHIAT, V26, P449; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yotsumoto Y, 2009, CURR BIOL, V19, P1278, DOI 10.1016/j.cub.2009.06.011	29	272	281	3	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					639	642		10.1126/science.1234330	http://dx.doi.org/10.1126/science.1234330			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23558170				2022-12-24	WOS:000318268900055
J	Hoogland, JL				Hoogland, John L.			Prairie Dogs Disperse When All Close Kin Have Disappeared	SCIENCE			English	Article							GROUND-SQUIRRELS; NATAL DISPERSAL; PHILOPATRY; COMPETITION; COOPERATION; EVOLUTION; CYNOMYS; MAMMALS	Because competition decreases inclusive fitness among kin, Hamilton and May predicted that the presence of nearby kin should induce the dispersal of individuals from the natal territory, independent of pressures to avoid inbreeding. Many studies support this landmark prediction, but research over 31 years with prairie dogs reveals the opposite pattern: Young females are 12.5 times more likely to disperse in the absence of mother and siblings for one species, and 5.5 times more likely for another species. Such striking patterns probably occur because cooperation among kin is more important than competition among kin for young prairie dogs. The inability to cooperate with close kin, due to their absence, prompts a search for a new territory where cooperation might be less crucial for survival and reproduction.	Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA	University System of Maryland; University of Maryland Center for Environmental Science	Hoogland, JL (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA.	hoogland@al.umces.edu	Hoogland, John/B-3950-2015; Hoogland, John/AAC-9808-2021		Colorado Parks and Wildlife; Denver Zoological Foundation; Environmental Defense; Eppley Foundation; Harry Frank Guggenheim Foundation; National Fish and Wildlife Foundation; National Geographic Society; NSF; Princeton University; Ted Turner Foundation; UMCES; University of Michigan; University of Minnesota	Colorado Parks and Wildlife; Denver Zoological Foundation; Environmental Defense; Eppley Foundation; Harry Frank Guggenheim Foundation; National Fish and Wildlife Foundation; National Geographic Society(National Geographic Society); NSF(National Science Foundation (NSF)); Princeton University(Princeton University); Ted Turner Foundation; UMCES; University of Michigan(University of Michigan System); University of Minnesota(University of Minnesota System)	I thank J. Hoogland for encouraging me to reexamine my information on dispersal; my 150+ research assistants over the 31 years of research (especially my four offspring); and D. Boesch, K. Fuller, R. Gardner, R. Morgan, and L. Pitelka of the University of the Maryland Center for Environmental Science (UMCES) for the opportunity for long-term comparative research. Financial support was provided by Colorado Parks and Wildlife, the Denver Zoological Foundation, Environmental Defense, the Eppley Foundation, the Harry Frank Guggenheim Foundation, the National Fish and Wildlife Foundation, the National Geographic Society, NSF, Princeton University, the Ted Turner Foundation, UMCES, and the Universities of Michigan and Minnesota. For help with the manuscript, I thank R. Alexander, D. Blumstein, D. Bowler, C. Brown, J. Clobert, T. H. Clutton-Brock, A. Davis-Robosky, F. S. Dobson, L. Handley, K. Holekamp, A. Hoogland, S. Keller, X. Lambin, M. Oli, P. Sherman, N. Solomon, and D. Van Vuren. Data for this report are archived as supplementary materials on Science Online.	Armitage KB, 2011, ECOLOGY, V92, P218, DOI 10.1890/10-0109.1; Arnaud CM, 2012, MOL ECOL, V21, P493, DOI 10.1111/j.1365-294X.2011.05219.x; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Clutton-Brock TH, 2012, MOL ECOL, V21, P472, DOI 10.1111/j.1365-294X.2011.05232.x; Cote J, 2007, P NATL ACAD SCI USA, V104, P9703, DOI 10.1073/pnas.0703601104; Davis AR, 2012, BEHAV ECOL, V23, P18, DOI 10.1093/beheco/arr144; Dobson FS, 1998, BEHAV ECOL, V9, P622, DOI 10.1093/beheco/9.6.622; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; HOLEKAMP KE, 1986, ECOL MONOGR, V56, P365, DOI 10.2307/1942552; Hoogland J. L., 1995, BLACK TAILED PRAIRIE; HOOGLAND JL, 1982, SCIENCE, V215, P1639, DOI 10.1126/science.215.4540.1639; HOOGLAND JL, 1979, BEHAVIOUR, V69, P1, DOI 10.1163/156853979X00377; Hoogland JL, 1999, J MAMMAL, V80, P243, DOI 10.2307/1383224; Hoogland John L., 2007, P438; Hoogland JL, 2009, BEHAV ECOL SOCIOBIOL, V63, P1621, DOI 10.1007/s00265-009-0763-0; JACQUOT JJ, 1995, BEHAV ECOL SOCIOBIOL, V37, P407, DOI 10.1007/BF00170588; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Lambin Xavier, 2001, P110; Mitani J., 2012, EVOLUTION PRIMATE SO; Moore JC, 2006, BIOL LETT-UK, V2, P17, DOI 10.1098/rsbl.2005.0370; Platt TG, 2009, TRENDS ECOL EVOL, V24, P370, DOI 10.1016/j.tree.2009.02.009; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Stenseth N. C., 2012, ANIMAL DISPERSAL SMA; WASER PM, 1983, Q REV BIOL, V58, P355, DOI 10.1086/413385; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507	29	41	43	1	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2013	339	6124					1205	1207		10.1126/science.1231689	http://dx.doi.org/10.1126/science.1231689			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471407				2022-12-24	WOS:000315709900047
J	Zhou, M; Guo, JH; Cha, J; Chae, M; Chen, S; Barral, JM; Sachs, MS; Liu, Y				Zhou, Mian; Guo, Jinhu; Cha, Joonseok; Chae, Michael; Chen, She; Barral, Jose M.; Sachs, Matthew S.; Liu, Yi			Non-optimal codon usage affects expression, structure and function of clock protein FRQ	NATURE			English	Article							NEUROSPORA CIRCADIAN CLOCK; FEEDBACK LOOPS; PHOSPHORYLATION; TRANSLATION; GENE; LUCIFERASE; MECHANISM; FREQUENCY; RHYTHMS; SYSTEM	Codon-usage bias has been observed in almost all genomes and is thought to result from selection for efficient and accurate translation of highly expressed genes(1-3). Codon usage is also implicated in the control of transcription, splicing and RNA structure(4-6). Many genes exhibit little codon-usage bias, which is thought to reflect a lack of selection for messenger RNA translation. Alternatively, however, non-optimal codon usage may be of biological importance. The rhythmic expression and the proper function of the Neurospora FREQUENCY (FRQ) protein are essential for circadian clock function. Here we show that, unlike most genes in Neurospora, frq exhibits non-optimal codon usage across its entire open reading frame. Optimization of frq codon usage abolishes both overt and molecular circadian rhythms. Codon optimization not only increases FRQ levels but, unexpectedly, also results in conformational changes in FRQ protein, altered FRQ phosphorylation profile and stability, and impaired functions in the circadian feedback loops. These results indicate that non-optimal codon usage of frq is essential for its circadian clock function. Our study provides an example of how non-optimal codon usage functions to regulate protein expression and to achieve optimal protein structure and function.	[Zhou, Mian; Guo, Jinhu; Cha, Joonseok; Chae, Michael; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Chen, She] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Barral, Jose M.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Barral, Jose M.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Sachs, Matthew S.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institute of Biological Sciences, Beijing; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Texas A&M University System; Texas A&M University College Station	Liu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Yi.Liu@UTsouthwestern.edu	Cha, Joonseok/AAE-9918-2020	Chae, Michael/0000-0002-5594-4450; Cha, Joonseok/0000-0001-9362-5285; Sachs, Matthew/0000-0001-9891-9223	National Institutes of Health [GM068496, GM062591, GM47498]; Welch Foundation [I-1560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087, R01GM084283, R35GM118118, R01GM047498, R29GM047498, R01GM068496, R01GM062591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Yuan and Q. Ye,for technical assistance, J. Dunlap for providing the pfrq-luc-I construct and M. Rosbash for suggesting the temperature experiments. We apologize to those colleagues whose studies we could not cite owing to space limitations. This work was supported by grants from the National Institutes of Health to Y.L. (GM068496 & GM062591) and M.S.S. (GM47498), and from the Welch Foundation (I-1560) to Y.L.	Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Colot HV, 2005, MOL BIOL CELL, V16, P5563, DOI 10.1091/mbc.E05-08-0756; Diernfellner A, 2007, FEBS LETT, V581, P5759, DOI 10.1016/j.febslet.2007.11.043; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Gooch VD, 2008, EUKARYOT CELL, V7, P28, DOI 10.1128/EC.00257-07; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Huang GC, 2006, EMBO J, V25, P5349, DOI 10.1038/sj.emboj.7601397; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Johnson CH, 2011, ANNU REV BIOPHYS, V40, P143, DOI 10.1146/annurev-biophys-042910-155317; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Morgan LW, 2003, FUNGAL GENET BIOL, V38, P327, DOI 10.1016/S1087-1845(02)00562-5; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070	29	266	273	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					111	115		10.1038/nature11833	http://dx.doi.org/10.1038/nature11833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23417067	Green Accepted			2022-12-24	WOS:000316039800050
J	Fields, E; Chard, J; James, D; Treasure, T				Fields, Ella; Chard, Jiri; James, David; Treasure, Tom		Guideline Dev Grp	GUIDELINES Fertility (update): summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fields, Ella; Chard, Jiri; James, David] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Treasure, Tom] UCL, London WC1H 0BT, England	University of London; University College London	Chard, J (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	jchard@ncc-wch.org.uk	iheozor-ejiofor, zipporah/N-3012-2013	iheozor-ejiofor, zipporah/0000-0003-2597-3266				Brkovich AM, 1998, J PSYCHOSOM OBST GYN, V19, P218, DOI 10.3109/01674829809025700; Human Fertilisation and Embryology Authority, 2012, COD PRACT; Human Fertilisation and Embryology Authority, 2011, FERT TREATM 2010 TRE; Human Fertilisation and Embryology Authority, 2008, LONG TERM AN HFEA RE; Human Fertilisation and Embryology Authority, 2006, FACTS FIG; National Institute for Health and Clinical Excellence, 2013, NAT I HLTH CLIN EXC, V156; National Institute for Health and Clinical Excellence, 2004, NAT I HLTH CLIN EXC, V11	7	22	22	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2013	346								f650	10.1136/bmj.f650	http://dx.doi.org/10.1136/bmj.f650			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096HL	23427132				2022-12-24	WOS:000315394700010
J	Yildirim, E; Kirby, JE; Brown, DE; Mercier, FE; Sadreyev, RI; Scadden, DT; Lee, JT				Yildirim, Eda; Kirby, James E.; Brown, Diane E.; Mercier, Francois E.; Sadreyev, Ruslan I.; Scadden, David T.; Lee, Jeannie T.			Xist RNA Is a Potent Suppressor of Hematologic Cancer in Mice	CELL			English	Article							X-CHROMOSOME INACTIVATION; HEMATOPOIETIC STEM; DOSAGE COMPENSATION; MYELOID-LEUKEMIA; C-KIT; CELLS; GENE; MAINTENANCE; EXPRESSION; LOCALIZATION	X chromosome aneuploidies have long been associated with human cancers, but causality has not been established. In mammals, X chromosome inactivation (XCI) is triggered by Xist RNA to equalize gene expression between the sexes. Here we delete Xist in the blood compartment of mice and demonstrate that mutant females develop a highly aggressive myeloproliferative neoplasm and myelodysplastic syndrome (mixed MPN/MDS) with 100% penetrance. Significant disease components include primary myelofibrosis, leukemia, histiocytic sarcoma, and vasculitis. Xist-deficient hematopoietic stem cells (HSCs) show aberrant maturation and age-dependent loss. Reconstitution experiments indicate that MPN/MDS and myelofibrosis are of hematopoietic rather than stromal origin. We propose that Xist loss results in X reactivation and consequent genome-wide changes that lead to cancer, thereby causally linking the X chromosome to cancer in mice. Thus, Xist RNA not only is required to maintain XCI but also suppresses cancer in vivo.	[Yildirim, Eda; Sadreyev, Ruslan I.; Lee, Jeannie T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA; [Yildirim, Eda; Sadreyev, Ruslan I.; Lee, Jeannie T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02114 USA; [Brown, Diane E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Comparat Med, Boston, MA 02114 USA; [Mercier, Francois E.; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Brown, Diane E.; Sadreyev, Ruslan I.; Lee, Jeannie T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02114 USA; [Yildirim, Eda; Sadreyev, Ruslan I.; Lee, Jeannie T.] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02114 USA; [Kirby, James E.] Harvard Univ, Dept Pathol, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02114 USA; [Mercier, Francois E.; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Mercier, Francois E.; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard University	Lee, JT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu	Kirby, James/K-4438-2019	Yildirim, Eda/0000-0002-4796-3854	MGH ECOR Medical Discovery Fund; Clinician-Scientist Training Award from the Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851] Funding Source: NIH RePORTER	MGH ECOR Medical Discovery Fund; Clinician-Scientist Training Award from the Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to members of the Lee lab for stimulating discussions. We thank R. Jaenisch for Xist<SUP>2lox</SUP>/Xist<SUP>2lox</SUP> mice, G. Pihan and A. Sohani for hematopathology advice, H. Hock for advice on Vav-Cre mice, W. Press for maintenance of Xist<SUP>2lox</SUP>/Xist<SUP>2lox</SUP> mice colony, the MGH CCM-Clinical Pathology laboratory for assistance on hematological analysis, D. Dombkowski for FACS assistance, and A.J. Zall for survival bleed collections. This work was supported by the MGH ECOR Medical Discovery Fund (E.Y.), Clinician-Scientist Training Award from the Canadian Institutes of Health Research (F.E.M.),	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Anguera MC, 2012, CELL STEM CELL, V11, P75, DOI 10.1016/j.stem.2012.03.008; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Bennett JM, 2009, HAEMATOL-HEMATOL J, V94, P264, DOI 10.3324/haematol.13755; Brecqueville M, 2012, GENE CHROMOSOME CANC, V51, P743, DOI 10.1002/gcc.21960; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; DEWALD GW, 1989, CANCER GENET CYTOGEN, V42, P173, DOI 10.1016/0165-4608(89)90085-X; DIERLAMM J, 1995, BRIT J HAEMATOL, V91, P885, DOI 10.1111/j.1365-2141.1995.tb05405.x; DOLL D C, 1987, Hematologic Pathology, V1, P183; Feldman AL, 2004, LANCET ONCOL, V5, P248, DOI 10.1016/S1470-2045(04)01428-7; Fentiman IS, 2006, LANCET, V367, P595, DOI 10.1016/S0140-6736(06)68226-3; HARRISON DE, 1980, BLOOD, V55, P77; Heinonen K, 1999, MED PEDIATR ONCOL, V32, P360, DOI 10.1002/(SICI)1096-911X(199905)32:5<360::AID-MPO9>3.0.CO;2-7; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang S, 1998, EMBO J, V17, P4358, DOI 10.1093/emboj/17.15.4358; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Kawakami T, 2003, J UROLOGY, V169, P1546, DOI 10.1097/01.ju.0000044927.23323.5a; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LAURENCET FM, 1994, LEUKEMIA, V8, P502; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Li L, 2011, BLOOD, V118, P4935, DOI 10.1182/blood-2011-01-328096; Liao DZJ, 2003, CANCER INVEST, V21, P641, DOI 10.1081/CNV-120022385; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Mazumdar M, 2011, NUCLEUS-AUSTIN, V2, P591, DOI 10.4161/nucl.2.6.18044; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; MOORE K L, 1955, Br J Cancer, V9, P246, DOI 10.1038/bjc.1955.21; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Muramatsu H, 2012, SEMIN ONCOL, V39, P67, DOI 10.1053/j.seminoncol.2011.11.004; Namekawa SH, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.195; Namekawa SH, 2010, MOL CELL BIOL, V30, P3187, DOI 10.1128/MCB.00227-10; OKADA S, 1992, BLOOD, V80, P3044; Pageau GJ, 2007, NAT REV CANCER, V7, P628, DOI 10.1038/nrc2172; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Paulsson K, 2010, HUM MOL GENET, V19, P1507, DOI 10.1093/hmg/ddq024; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Percy D.H., 2007, MOUSE; RACK KA, 1994, HUM MOL GENET, V3, P1053, DOI 10.1093/hmg/3.7.1053; SANDBERG AA, 1983, CYTOGENETICS MAMMA B, P459; Savarese F, 2006, MOL CELL BIOL, V26, P7167, DOI 10.1128/MCB.00810-06; Schmitt A, 2001, EXP HEMATOL, V29, P1295, DOI 10.1016/S0301-472X(01)00733-0; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Suttie AW, 2006, TOXICOL PATHOL, V34, P466, DOI 10.1080/01926230600867750; Tefferi A, 2011, AM J HEMATOL, V86, P1018, DOI 10.1002/ajh.22210; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yamamoto K, 2002, CANCER GENET CYTOGEN, V134, P84, DOI 10.1016/S0165-4608(01)00603-3; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	63	351	364	2	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					727	742		10.1016/j.cell.2013.01.034	http://dx.doi.org/10.1016/j.cell.2013.01.034			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415223	Green Accepted, Bronze			2022-12-24	WOS:000314945600009
J	Costa, Y; Ding, JJ; Theunissen, TW; Faiola, F; Hore, TA; Shliaha, PV; Fidalgo, M; Saunders, A; Lawrence, M; Dietmann, S; Das, S; Levasseur, DN; Li, Z; Xu, MJ; Reik, W; Silva, JCR; Wang, JL				Costa, Yael; Ding, Junjun; Theunissen, Thorold W.; Faiola, Francesco; Hore, Timothy A.; Shliaha, Pavel V.; Fidalgo, Miguel; Saunders, Arven; Lawrence, Moyra; Dietmann, Sabine; Das, Satyabrata; Levasseur, Dana N.; Li, Zhe; Xu, Mingjiang; Reik, Wolf; Silva, Jose C. R.; Wang, Jianlong			NANOG-dependent function of TET1 and TET2 in establishment of pluripotency	NATURE			English	Article							CELL SELF-RENEWAL; 5-HYDROXYMETHYLCYTOSINE; PROTEIN; DNA; CONVERSION; NETWORK; GENES	Molecular control of the pluripotent state is thought to reside in a core circuitry of master transcription factors including the homeodomain-containing protein NANOG(1,2), which has an essential role in establishing ground state pluripotency during somatic cell reprogramming(3,4). Whereas the genomic occupancy of NANOG has been extensively investigated, comparatively little is known about NANOG-associated proteins(5) and their contribution to the NANOG-mediated reprogramming process. Using enhanced purification techniques and a stringent computational algorithm, we identify 27 high-confidence protein interaction partners of NANOG in mouse embryonic stem cells. These consist of 19 previously unknown partners of NANOG that have not been reported before, including the ten-eleven translocation (TET) family methylcytosine hydroxylase TET1. We confirm physical association of NANOG with TET1, and demonstrate that TET1, in synergy with NANO G, enhances the efficiency of reprogramming. We also find physical associatinn and reprogramming synergy of TET2 with NANOG, and demonstrate that knockdown of TET2 abolishes the reprogramming synergy of NANOG with a catalytically deficient mutant of TET1. These results indicate that the physical interaction between NANOG and TET1/TET2 proteins facilitates reprogramming in a manner that is dependent on the catalytic activity of TET1/TET2. TET1 and NANOG co-occupy genomic loci of genes associated with both maintenance of pluripotency and lineage commitment in embryonic stem cells, and TET1 binding is reduced upon NANOG depletion. Co-expression of NANOG and TET1 increases 5-hydroxymethylcytosine levels at the top-ranked common target loci Esrrb and Oct4 (also called Pou5f1), resulting in priming of their expression before reprogramming to naive pluripotency. We propose that TET1 is recruited by NANOG to enhance the expression of a subset of key reprogramming target genes. These results provide an insight into the reprogramming mechanism of NANOG and uncover a new role for 5-methykytosine hydroxylases in the establishment of naive pluripotency.	[Costa, Yael; Theunissen, Thorold W.; Lawrence, Moyra; Dietmann, Sabine; Silva, Jose C. R.] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England; [Ding, Junjun; Faiola, Francesco; Fidalgo, Miguel; Saunders, Arven; Wang, Jianlong] Mt Sinai Sch Med, Black Family Stem Cell Inst, Grad Sch Biol Sci, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Theunissen, Thorold W.; Lawrence, Moyra; Silva, Jose C. R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Hore, Timothy A.; Reik, Wolf] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Shliaha, Pavel V.] Univ Cambridge, Cambridge Ctr Prote, Cambridge Syst Biol Ctr, Cambridge CB2 1QR, England; [Das, Satyabrata; Levasseur, Dana N.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Li, Zhe; Xu, Mingjiang] Indiana Univ, Dept Pediat, Indianapolis, IN 46202 USA; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England	University of Cambridge; Icahn School of Medicine at Mount Sinai; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; University of Iowa; Indiana University System; Indiana University-Purdue University Indianapolis; University of Cambridge	Wang, JL (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, Grad Sch Biol Sci, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	jcs64@cam.ac.uk; jianlong.wang@mssm.edu	Lawrence, Moyra/AAC-6198-2019; Fidalgo, Miguel/I-7006-2019; Das, Satyabrata/J-2629-2019; Faiola, Francesco/Q-4218-2018; Ding, Junjun/F-8618-2015; Silva, Jose C R/X-5140-2019; Reik, Wolf/I-6794-2012; Wang, Jianlong/GQR-1191-2022; Silva, Jose/G-1920-2014; Ding, Junjun/C-4098-2012; Wang, Jianlong/AAG-9425-2020	Lawrence, Moyra/0000-0001-9386-5633; Fidalgo, Miguel/0000-0003-1134-2674; Faiola, Francesco/0000-0002-3512-8253; Silva, Jose C R/0000-0001-5487-1117; Wang, Jianlong/0000-0002-1317-6457; Silva, Jose/0000-0001-5487-1117; Ding, Junjun/0000-0002-9936-882X; Theunissen, Thorold/0000-0001-6943-7858; Reik, Wolf/0000-0003-0216-9881; Dietmann, Sabine./0000-0001-6672-8457; Costa, Yael/0000-0002-3327-4580; Shliaha, Pavel/0000-0003-3092-0724; Hore, Timothy/0000-0002-6735-225X	NIH [1R01-GM095942-01A1]; New York state Department of Health (NYSTEM) [C026420]; Black Family Stem Cell Institute; Wellcome Trust [WT086692MA, WT079249]; Isaac Newton Trust [11.19(ad)]; BBSRC; MRC; Wellcome Trust; EU; Biotechnology and Biological Sciences Research Council [BB/H008071/1] Funding Source: researchfish; Medical Research Council [G0700098] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095942] Funding Source: NIH RePORTER; BBSRC [BB/H008071/1] Funding Source: UKRI; MRC [G0700098] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York state Department of Health (NYSTEM); Black Family Stem Cell Institute; Wellcome Trust(Wellcome TrustEuropean Commission); Isaac Newton Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank W. Mansfield for blastocyst injections, A. Radzisheuskaya for cell culture assistance, and R. Jaenisch for Tet1<SUP>-/-</SUP> embryonic stem cells. This study was supported by a grant from the NIH (1R01-GM095942-01A1), a grant from New York state Department of Health (NYSTEM#C026420), and a seed fund from the Black Family Stem Cell Institute to J.W., by the Wellcome Trust Fellowship (WT086692MA) and the Isaac Newton Trust Grant (11.19(ad)) to J.C.R.S., who is a Wellcome Trust Career Development Fellow, by the BBSRC, the MRC, the Wellcome Trust, and EU Epigenesys and BLUEPRINT to W.R., and by the Wellcome Trust Fellowship WT079249 to T.W.T.	Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Das S, 2011, J BIOL CHEM, V286, P42690, DOI 10.1074/jbc.M111.290189; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kallin EM, 2012, MOL CELL, V48, P266, DOI 10.1016/j.molcel.2012.08.007; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Pereira C. F., 2009, CURR PROTOC STEM CEL, V9; Rees J. S., 2011, MOL CELL PROTEOMICS; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	26	307	321	1	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					370	374		10.1038/nature11925	http://dx.doi.org/10.1038/nature11925			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23395962	Green Published, Green Accepted			2022-12-24	WOS:000316650500043
J	Martin, EG; Schackman, BR				Martin, Erika G.; Schackman, Bruce R.			Updating the HIV-Testing Guidelines - A Modest Change with Major Consequences	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[Martin, Erika G.] SUNY Albany, Rockefeller Coll Publ Affairs & Policy, Albany, NY 12222 USA; [Martin, Erika G.] SUNY Albany, Nelson A Rockefeller Inst Govt, Albany, NY 12222 USA; [Schackman, Bruce R.] Weill Cornell Med Coll, Dept Publ Hlth, Div Hlth Policy, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Cornell University	Martin, EG (corresponding author), SUNY Albany, Rockefeller Coll Publ Affairs & Policy, Albany, NY 12222 USA.		Schackman, Bruce R./J-8208-2019	Schackman, Bruce R./0000-0002-1132-2932; Martin, Erika/0000-0003-2607-8933				Branson B, 2007, J MED VIROL, V79, pS6, DOI 10.1002/jmv.20972; Chou R, 2012, ANN INTERN MED, V157, P706, DOI 10.7326/0003-4819-157-10-201211200-00007; Martin EG, 2012, JAIDS-J ACQ IMM DEF, V60, P72, DOI 10.1097/QAI.0b013e31824c0dd4; Martin EG, 2010, VALUE HEALTH, V13, P893, DOI 10.1111/j.1524-4733.2010.00763.x	4	21	21	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					884	886		10.1056/NEJMp1214630	http://dx.doi.org/10.1056/NEJMp1214630			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BG	23425132				2022-12-24	WOS:000315669100002
J	Treasure, T; Utley, M				Treasure, Tom; Utley, Martin			Surgical removal of asymptomatic pulmonary metastases: time for better evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COLORECTAL-CANCER; LUNG METASTASECTOMY; OSTEOGENIC-SARCOMA; EUROPEAN-SOCIETY; RADICAL SURGERY; MESOTHELIOMA; RESECTIONS		[Treasure, Tom; Utley, Martin] UCL, Clin Operat Res Unit, London, England	University of London; University College London	Treasure, T (corresponding author), UCL, Clin Operat Res Unit, London, England.	tom.treasure@gmail.com		Utley, Martin/0000-0001-9928-1516				Antunes M, 1999, EUR J CARDIO-THORAC, V15, P592, DOI 10.1016/S1010-7940(99)00098-6; Aradhana G, 2022, P 2022 IEEE INT C CO, P25; Beattie E J Jr, 1984, Cancer, V54, P2729, DOI 10.1002/1097-0142(19841201)54:2+<2729::AID-CNCR2820541420>3.0.CO;2-U; BEATTIE EJ, 1991, J SURG ONCOL, V46, P154, DOI 10.1002/jso.2930460305; Burt BM, 2011, ANN THORAC SURG, V92, P1202, DOI 10.1016/j.athoracsur.2011.05.052; Fiorentino F, 2010, J ROY SOC MED, V103, P60, DOI 10.1258/jrsm.2009.090299; Gelderblom H, 2011, EUR J CANCER, V47, P895, DOI 10.1016/j.ejca.2010.11.036; Gonzalez M, 2013, ANN SURG ONCOL, V20, P572, DOI 10.1245/s10434-012-2726-3; Internullo E, 2008, J THORAC ONCOL, V3, P1257, DOI 10.1097/JTO.0b013e31818bd9da; Lilford RJ, 1995, BMJ-BRIT MED J, V311, P1621, DOI 10.1136/bmj.311.7020.1621; Martini N, 1971, Ann Thorac Surg, V12, P271; Nauenheim KS, 2007, DIFFICULT DECISIONS, P151; Russell RCG, 2012, BRIT J SURG, V99, P449, DOI 10.1002/bjs.8695; Treasure T, 2004, BMJ-BRIT MED J, V328, P237, DOI 10.1136/bmj.328.7434.237; Treasure T, 2008, CANCER IMAGING, V8, P121, DOI 10.1102/1470-7330.2008.0017; Treasure T, 2007, J THORAC CARDIOV SUR, V133, P1414, DOI 10.1016/j.jtcvs.2007.02.014; Treasure T, 2007, BMJ-BRIT MED J, V334, P831, DOI 10.1136/bmj.39161.403218.AD; Treasure T, 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2011-000725, 10.1136/bmjopen-2012-001736]; Treasure T, 2012, J ROY SOC MED, V105, P140, DOI 10.1258/jrsm.2011.110307; Treasure T, 2012, THORAX, V67, P185, DOI 10.1136/thoraxjnl-2011-200015; Treasure T, 2011, LANCET ONCOL, V12, P763, DOI 10.1016/S1470-2045(11)70149-8; Utley M, 2010, J THORAC ONCOL, V5, pS200, DOI 10.1097/JTO.0b013e3181dd0a8d; Van Raemdonck D, 2010, J THORAC ONCOL, V5, pS127, DOI 10.1097/JTO.0b013e3181dcf59c	23	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2013	346								f824	10.1136/bmj.f824	http://dx.doi.org/10.1136/bmj.f824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096HP	23430330				2022-12-24	WOS:000315395100004
J	Marx, V				Marx, Vivien			TRACKING METASTASIS AND TRICKING CANCER	NATURE			English	Editorial Material																		Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Paget S, 1889, LANCET, V133, P571, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217	6	54	72	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					131	+		10.1038/494131a	http://dx.doi.org/10.1038/494131a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23389545	Bronze			2022-12-24	WOS:000314741200051
J	Gulati, R; Gore, JL; Etzioni, R				Gulati, Roman; Gore, John L.; Etzioni, Ruth			Comparative Effectiveness of Alternative Prostate-Specific Antigen-Based Prostate Cancer Screening Strategies Model Estimates of Potential Benefits and Harms	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES TASK-FORCE; QUALITY-OF-LIFE; RANDOMIZED PROSTATE; FOLLOW-UP; MORTALITY; TRIAL; POPULATION; US; VIEWPOINT; BIOPSIES	Background: The U.S. Preventive Services Task Force recently concluded that the harms of existing prostate-specific antigen (PSA) screening strategies outweigh the benefits. Objective: To evaluate comparative effectiveness of alternative PSA screening strategies. Design: Microsimulation model of prostate cancer incidence and mortality quantifying harms and lives saved for alternative PSA screening strategies. Data Sources: National and trial data on PSA growth, screening and biopsy patterns, incidence, treatment distributions, treatment efficacy, and mortality. Target Population: A contemporary cohort of U.S. men. Time Horizon: Lifetime. Perspective: Societal. Intervention: 35 screening strategies that vary by start and stop ages, screening intervals, and thresholds for biopsy referral. Outcome Measures: PSA tests, false-positive test results, cancer detected, overdiagnoses, prostate cancer deaths, lives saved, and months of life saved. Results of Base-Case Analysis: Without screening, the risk for prostate cancer death is 2.86%. A reference strategy that screens men aged 50 to 74 years annually with a PSA threshold for biopsy referral of 4 mu g/L reduces the risk for prostate cancer death to 2.15%, with risk for overdiagnosis of 3.3%. A strategy that uses higher PSA thresholds for biopsy referral in older men achieves a similar risk for prostate cancer death (2.23%) but reduces the risk for overdiagnosis to 2.3%. A strategy that screens biennially with longer screening intervals for men with low PSA levels achieves similar risks for prostate cancer death (2.27%) and overdiagnosis (2.4%), but reduces total tests by 59% and false-positive results by 50%. Results of Sensitivity Analysis: Varying incidence inputs or reducing the survival improvement due to screening did not change conclusions. Limitation: The model is a simplification of the natural history of prostate cancer, and improvement in survival due to screening is uncertain. Conclusion: Compared with standard screening, PSA screening strategies that use higher thresholds for biopsy referral for older men and that screen men with low PSA levels less frequently can reduce harms while preserving lives. Primary Funding Source: National Cancer Institute and Centers for Disease Control and Prevention. Ann Intern Med. 2013;158:145-153.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Etzioni, R (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave N,M2-B230,POB 19024, Seattle, WA 98109 USA.	retzioni@fhcrc.org	Gulati, Roman/AAE-4298-2019	Gulati, Roman/0000-0002-7592-6567; Gore, John/0000-0002-2847-5062	National Cancer Institute [R01 CA131874, U01 CA88160]; National Cancer Institute and the Centers for Disease Control and Prevention [U01 CA157224]; NATIONAL CANCER INSTITUTE [R01CA131874, U01CA088160, U01CA157224] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute and the Centers for Disease Control and Prevention; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By awards R01 CA131874 and U01 CA88160 (National Cancer Institute) and U01 CA157224 (National Cancer Institute and the Centers for Disease Control and Prevention).	Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Babaian RJ, 2000, J UROLOGY, V163, P152, DOI 10.1016/S0022-5347(05)67993-1; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Carter HB, 1997, JAMA-J AM MED ASSOC, V277, P1456, DOI 10.1001/jama.277.18.1456; Catalona WJ, 2006, ANN INTERN MED, V144, P441, DOI 10.7326/0003-4819-144-6-200603210-00012; Ciatto S, 2003, BJU INT, V92, P97, DOI 10.1111/j.1464-410X.2003.04407.x; Cooperberg MR, 2010, CANCER-AM CANCER SOC, V116, P5226, DOI 10.1002/cncr.25456; Crawford ED, 2011, J CLIN ONCOL, V29, P355, DOI 10.1200/JCO.2010.30.5979; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Eichler K, 2006, J UROLOGY, V175, P1605, DOI 10.1016/S0022-5347(05)00957-2; Etzioni R, 1999, J UROLOGY, V162, P741, DOI 10.1097/00005392-199909010-00032; Etzioni R, 2009, 2 GEN M INT MICR ASS; Etzioni R, 2012, CANCER; Glied S, 2010, ANNU REV PUBL HEALTH, V31, P439, DOI 10.1146/annurev.publhealth.012809.103542; Gore JL, 2001, J UROLOGY, V165, P1554, DOI 10.1016/S0022-5347(05)66347-1; Gulati R, 2012, CANCER CAUSE CONTROL, V23, P827, DOI 10.1007/s10552-012-9951-8; Gulati R, 2011, J CLIN EPIDEMIOL, V64, P1412, DOI 10.1016/j.jclinepi.2011.06.011; Gulati R, 2010, BIOSTATISTICS, V11, P707, DOI 10.1093/biostatistics/kxq036; Heijnsdijk EAM, 2012, NEW ENGL J MED, V367, P595, DOI 10.1056/NEJMoa1201637; Hoffman RM, 2006, ANN INTERN MED, V144, P438, DOI 10.7326/0003-4819-144-6-200603210-00011; Kawachi MH, 2010, J NATL COMPR CANC NE, V8, P240, DOI 10.6004/jnccn.2010.0016; Loeb S, 2012, NAT REV UROL, V9, P183, DOI 10.1038/nrurol.2012.34; Loeb S, 2011, J CLIN ONCOL, V29, P464, DOI 10.1200/JCO.2010.30.6373; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mariotto AB, 2007, CANCER-AM CANCER SOC, V109, P1877, DOI 10.1002/cncr.22607; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; National Cancer Institute, 2012, DEVCAN PROB DEV DYIN; National Center for Health Statistics, VIT STAT US A, VII; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; Pinsky PF, 2005, J UROLOGY, V173, P746, DOI 10.1097/01.ju.0000152697.25708.71; Presti JC, 2000, J UROLOGY, V163, P163, DOI 10.1016/S0022-5347(05)67995-5; Ross KS, 2000, JAMA-J AM MED ASSOC, V284, P1399, DOI 10.1001/jama.284.11.1399; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sox HC, 2012, NEW ENGL J MED, V367, P669, DOI 10.1056/NEJMe1207165; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Tsodikov A, 2006, STAT MED, V25, P2846, DOI 10.1002/sim.2257; Vickers AJ, 2009, NAT REV UROL, V6, P301, DOI 10.1038/nrurol.2009.95; Weinstein M C, 2001, Value Health, V4, P348, DOI 10.1046/j.1524-4733.2001.45061.x; Welch HG, 2011, JAMA-J AM MED ASSOC, V306, P2649, DOI 10.1001/jama.2011.1898; Wever EM, 2011, MED DECIS MAKING, V31, P550, DOI 10.1177/0272989X10396717; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Wu GHM, 2012, EUR UROL, V61, P1011, DOI 10.1016/j.eururo.2012.01.008; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	45	118	121	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3					145	+		10.7326/0003-4819-158-3-201302050-00003	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00003			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087JP	23381039	Green Accepted			2022-12-24	WOS:000314757900001
J	Tanaka, Y; Hipolito, CJ; Maturana, AD; Ito, K; Kuroda, T; Higuchi, T; Katoh, T; Kato, HE; Hattori, M; Kumazaki, K; Tsukazaki, T; Ishitani, R; Suga, H; Nureki, O				Tanaka, Yoshiki; Hipolito, Christopher J.; Maturana, Andres D.; Ito, Koichi; Kuroda, Teruo; Higuchi, Takashi; Katoh, Takayuki; Kato, Hideaki E.; Hattori, Motoyuki; Kumazaki, Kaoru; Tsukazaki, Tomoya; Ishitani, Ryuichiro; Suga, Hiroaki; Nureki, Osamu			Structural basis for the drug extrusion mechanism by a MATE multidrug transporter	NATURE			English	Article							IN-VITRO SELECTION; VIBRIO-PARAHAEMOLYTICUS; STAPHYLOCOCCUS-AUREUS; EFFLUX PROTEIN; NORM; RESISTANCE; FAMILY; ANTIPORTER; METFORMIN; HOMOLOG	Multidrug and toxic compound extrusion(MATE) family transporters are conserved in the three primary domains of life (Archaea, Bacteria and Eukarya), and export xenobiotics using an electro-chemical gradient of H+ or Na+ across the membrane(1,2). MATE transporters confer multidrug resistance to bacterial pathogens(3-6) and cancer cells(7), thus causing critical reductions in the therapeutic efficacies of antibiotics and anti-cancer drugs, respectively. Therefore, the development of MATE inhibitors has long been awaited in the field of clinical medicine(8,9). Here we present the crystal structures of the H+-driven MATE transporter from Pyrococcus furiosus in two distinct apo-form conformations, and in complexes with a derivative of the antibacterial drug norfloxacin and three in vitro selected thioether-macrocyclic peptides, at 2.1-3.0 angstrom resolutions. The structures, combined with functional analyses, show that the protonation of Asp 41 on the amino (N)-terminal lobe induces the bending of TM1, which in turn collapses the N-lobe cavity, thereby extruding the substrate drug to the extracellular space. Moreover, the macrocyclic peptides bind the central cleft in distinct manners, which correlate with their inhibitory activities. The strongest inhibitory peptide that occupies the N-lobe cavity may pave the way towards the development of efficient inhibitors against MATE transporters.	[Tanaka, Yoshiki; Kato, Hideaki E.; Hattori, Motoyuki; Kumazaki, Kaoru; Tsukazaki, Tomoya; Ishitani, Ryuichiro; Nureki, Osamu] RIKEN Adv Sci Inst, Wako, Saitama 3510198, Japan; [Tanaka, Yoshiki; Kato, Hideaki E.; Hattori, Motoyuki; Kumazaki, Kaoru; Tsukazaki, Tomoya; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Hipolito, Christopher J.; Higuchi, Takashi; Katoh, Takayuki; Suga, Hiroaki] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Maturana, Andres D.] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ito, Koichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan; [Kuroda, Teruo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Genome Appl Microbiol, Okayama 7008530, Japan; [Hattori, Motoyuki; Tsukazaki, Tomoya] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	RIKEN; University of Tokyo; University of Tokyo; Nagoya University; University of Tokyo; Okayama University; Japan Science & Technology Agency (JST)	Nureki, O (corresponding author), RIKEN Adv Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hsuga@chem.s.u-tokyo.ac.jp; nureki@biochem.s.u-tokyo.ac.jp	KURODA, Teruo/B-2028-2011; NUREKI, OSAMU/G-4960-2014; Tsukazaki, Tomoya/N-2299-2019; Kato, Hideaki/AAQ-4323-2020; Hattori, Motoyuki/B-6069-2014	Tsukazaki, Tomoya/0000-0002-6386-723X; Kato, Hideaki/0000-0002-1941-5535; Katoh, Takayuki/0000-0001-6550-6203; Hattori, Motoyuki/0000-0002-5327-5337; Tanaka, Yoshiki/0000-0001-6960-5276; Ito, Koichi/0000-0002-2042-405X	Japan Society for the Promotion of Science (JSPS); Core Research for Evolutional Science and Technology Program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of Japan Science and Technology Agency; MEXT [24227004, 22687007, P11344]; JSPS [21000005]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology Program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of Japan Science and Technology Agency; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to the beam-line staff at BL32XU of SPring-8 for assistance in data collection (proposals 2011B1062, 2012A1087 and 2012B1161), and the RIKEN BioResource Center (Ibaraki, Japan) for providing the P. furiosus genomic DNA. We are also grateful to N. Dohmae and Y. Sugita (RIKEN Advanced Science Institute, Japan) for discussions. This work was supported by the Japan Society for the Promotion of Science (JSPS) through its 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)' to O.N.; by the Core Research for Evolutional Science and Technology Program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of Japan Science and Technology Agency to O.N.; and by a Grant-in-Aid for Scientific Research (S) (24227004) and a Grant-in-Aid for Young Scientists (A) (22687007) from MEXT to O.N. and R. I., respectively. This work was also supported by a JSPS Grant-in-Aid for the Specially Promoted Research (21000005) and MEXT Platform for Drug Discovery, Informatics, and Structural Life Science to H. S., and a Grant-in-Aid for JSPS post-doctoral fellows to C.J.H. (P11344).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Becker MSL, 2009, DIABETES, V58, P745, DOI 10.2337/db08-1028; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherezov V, 2011, CURR OPIN STRUC BIOL, V21, P559, DOI 10.1016/j.sbi.2011.06.007; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Hayashi Y, 2012, ACS CHEM BIOL, V7, P607, DOI 10.1021/cb200388k; He GX, 2004, J BACTERIOL, V186, P262, DOI 10.1128/JB.186.1.262-265.2004; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Hipolito CJ, 2012, CURR OPIN CHEM BIOL, V16, P196, DOI 10.1016/j.cbpa.2012.02.014; Hirata K, 2010, AIP CONF PROC, V1234, P901, DOI 10.1063/1.3463362; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; Ito S, 2010, J PHARMACOL EXP THER, V333, P341, DOI 10.1124/jpet.109.163642; Kaatz GW, 2005, ANTIMICROB AGENTS CH, V49, P1857, DOI 10.1128/AAC.49.5.1857-1864.2005; KOGA H, 1980, J MED CHEM, V23, P1358, DOI 10.1021/jm00186a014; Kuo MMC, 2007, J BIOL CHEM, V282, P24294, DOI 10.1074/jbc.M703618200; Kusuhara H, 2011, CLIN PHARMACOL THER, V89, P837, DOI 10.1038/clpt.2011.36; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Li XZ, 2003, ANTIMICROB AGENTS CH, V47, P27, DOI 10.1128/AAC.47.1.27-33.2003; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; McAleese F, 2005, ANTIMICROB AGENTS CH, V49, P1865, DOI 10.1128/AAC.49.5.1865-1871.2005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minematsu T, 2011, MOL CANCER THER, V10, P531, DOI 10.1158/1535-7163.MCT-10-0731; Morimoto J, 2012, ANGEW CHEM INT EDIT, V51, P3423, DOI 10.1002/anie.201108118; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Morita Y, 2000, J BACTERIOL, V182, P6694, DOI 10.1128/JB.182.23.6694-6697.2000; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Otsuka M, 2005, J BACTERIOL, V187, P1552, DOI 10.1128/JB.187.5.1552-1558.2005; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Tsuda M, 2007, AM J PHYSIOL-RENAL, V292, pF593, DOI 10.1152/ajprenal.00312.2006; TSUJIMOTO K, 1988, BIOCHEM BIOPH RES CO, V155, P123, DOI 10.1016/S0006-291X(88)81058-1; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wasaznik A, 2009, POSTEP HIG MED DOSW, V63, P123; Xu HL, 2008, J APPL CRYSTALLOGR, V41, P644, DOI 10.1107/S0021889808007966; Yamagishi Y, 2011, CHEM BIOL, V18, P1562, DOI 10.1016/j.chembiol.2011.09.013; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	42	193	196	0	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					247	+		10.1038/nature12014	http://dx.doi.org/10.1038/nature12014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23535598				2022-12-24	WOS:000317346300047
J	Rasmussen, J				Rasmussen, Jill			Would doctors routinely asking older patients about their memory improve dementia outcomes? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Clin Commissioning Grp, E Surrey CR3 5QX, Caterham, England		Rasmussen, J (corresponding author), Clin Commissioning Grp, E Surrey CR3 5QX, Caterham, England.	jill.Rasmussen@virgin.net						All Party Parliamentary Group on Dementia, 2012, UNL DIAGN; Alzheimer's Society, DEM 2012 NAT CHALL; Ballard C, 2006, J QUAL RES DEMENTIA, V2, P14; Ballard C, 2013, HELPING YOU ASSESS C; Burns A, 2009, BMJ, V338, P405; De Mendonca Lima CA, 2012, COMPANION PRIMARY CA, P571; Department of Health, 2009, CLIN HLTH EC CAS EAR; Department of Health, 2012, PRIM MIN CHALL DEM D; Department of Health, 2009, LIVING WELL DEMENTIA; Greaves N., 2011, J CARE SERVICES MANA, V5, P49, DOI DOI 10.1179/175016811X12883685967016; NHS Public Health Resource Unit, 2009, APPR SCREEN ALZH DIS; NICE, 2011, NICE SCIE GUID SUPP; Woods B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005562.pub2	13	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2013	346								f1780	10.1136/bmj.f1780	http://dx.doi.org/10.1136/bmj.f1780			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117WO	23532870				2022-12-24	WOS:000316984000015
J	McShane, M				McShane, Martin			Should GPs be fined for rises in avoidable emergency admissions to hospital? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Natl Commissioning Board, Leeds LS2 7UE, W Yorkshire, England		McShane, M (corresponding author), Natl Commissioning Board, Leeds LS2 7UE, W Yorkshire, England.	martin.mcshane@btinternet.com						Bardsley M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002007; Department of Health, 2012, BAS SPEND EST NEW NH; Francis R., 2013, FINAL REPORT MIDSTAF; Imison C, 2012, OLDER PEOPLE EMERGEN	4	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2013	346								f1389	10.1136/bmj.f1389	http://dx.doi.org/10.1136/bmj.f1389			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104MN	23463139				2022-12-24	WOS:000315997600017
J	Clevers, H; Batlle, E				Clevers, Hans; Batlle, Eduard			SnapShot: The Intestinal Crypt	CELL			English	Editorial Material							LGR5 STEM-CELLS; WNT RECEPTORS; HOMEOSTASIS		[Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Batlle, Eduard] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Batlle, Eduard] ICREA, Barcelona 08010, Spain	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Clevers, H (corresponding author), KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.		Batlle, Eduard/K-8080-2014	Batlle, Eduard/0000-0003-2422-0326	ICREA Funding Source: Custom	ICREA(ICREA)		Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Buczacki SJ, 2013, NATURE; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464	10	39	40	2	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1198	+		10.1016/j.cell.2013.02.030	http://dx.doi.org/10.1016/j.cell.2013.02.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452862	Bronze			2022-12-24	WOS:000315710300027
J	Ward, AB; Sali, A; Wilson, IA				Ward, Andrew B.; Sali, Andrej; Wilson, Ian A.			Integrative Structural Biology	SCIENCE			English	Editorial Material							MODEL		[Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Int AIDS Vaccine Initiat, Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94158 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Scripps Research Institute	Ward, AB (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, Int AIDS Vaccine Initiat, Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.	abward@scripps.edu	Ward, Andrew B/F-9203-2014; Ward, Andrew/ABD-7728-2021; Cheng, Yushao/E-6256-2011	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; 	NIAID NIH HHS [UM1 AI100663, P01 AI082362] Funding Source: Medline; NIGMS NIH HHS [U54 GM094586] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, P01AI082362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Lander GC, 2012, CURR OPIN STRUC BIOL, V22, P627, DOI 10.1016/j.sbi.2012.07.006; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Loquet A, 2012, NATURE, V486, P276, DOI 10.1038/nature11079; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Sgourakis NG, 2011, J AM CHEM SOC, V133, P6288, DOI 10.1021/ja111318m; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673	12	170	172	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					913	915		10.1126/science.1228565	http://dx.doi.org/10.1126/science.1228565			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430643	Green Accepted			2022-12-24	WOS:000315149600035
J	Jiang, JS; Miracco, EJ; Hong, K; Eckert, B; Chan, H; Cash, DD; Min, BS; Zhou, ZH; Collins, K; Feigon, J				Jiang, Jiansen; Miracco, Edward J.; Hong, Kyungah; Eckert, Barbara; Chan, Henry; Cash, Darian D.; Min, Bosun; Zhou, Z. Hong; Collins, Kathleen; Feigon, Juli			The architecture of Tetrahymena telomerase holoenzyme	NATURE			English	Article							RNA-BINDING DOMAIN; STEM-LOOP IV; MOLECULAR-STRUCTURE DETERMINATION; CATALYTIC SUBUNIT TERT; N-TERMINAL DOMAIN; REVERSE-TRANSCRIPTASE; ELECTRON-MICROSCOPY; STRUCTURAL BASIS; PROTEIN P65; XPLOR-NIH	Telomerase adds telomeric repeats to chromosome ends using an internal RNA template and a specialized telomerase reverse transcriptase (TERT), thereby maintaining genome integrity. Little is known about the physical relationships among protein and RNA subunits within a biologically functional holoenzyme. Here we describe the architecture of Tetrahymena thermophila telomerase holoenzyme determined by electron microscopy. Six of the seven proteins and the TERT-binding regions of telomerase RNA (TER) have been localized by affinity labelling. Fitting with high-resolution structures reveals the organization of TERT, TER and p65 in the ribonucleoprotein (RNP) catalytic core. p50 has an unanticipated role as a hub between the RNP catalytic core, p75-p19-p45 subcomplex, and the DNA-binding Teb1. A complete in vitro holoenzyme reconstitution assigns function to these interactions in processive telomeric repeat synthesis. These studies provide the first view of the extensive network of subunit associations necessary for telomerase holoenzyme assembly and physiological function.	[Jiang, Jiansen; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Jiang, Jiansen; Miracco, Edward J.; Chan, Henry; Cash, Darian D.; Feigon, Juli] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Jiang, Jiansen; Zhou, Z. Hong; Feigon, Juli] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA; [Hong, Kyungah; Eckert, Barbara; Min, Bosun; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Berkeley	Feigon, J (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	hong.zhou@ucla.edu; kcollins@berkeley.edu; feigon@mbi.ucla.edu	Zhou, Z Hong/HDN-0747-2022; Jiang, Jiansen/J-2057-2015	Jiang, Jiansen/0000-0002-1692-7906	NSF [MCB1022379]; NIH [GM48123, GM54198, GM071940, AI069015, 1S10RR23057]; Ruth L. Kirschstein NRSA postdoctoral fellowship [GM101874]; Ruth L. Kirschstein NRSA pre-doctoral training grant fellowship [GM007185]; CNSI; UCLA; Div Of Molecular and Cellular Bioscience [1022379] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054198, F32GM101874, R01GM071940, T32GM007185, R01GM048123] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NRSA pre-doctoral training grant fellowship; CNSI; UCLA(University of California System); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from NSF MCB1022379 and NIH GM48123 to J.F., NIH GM54198 to K. C., GM071940 and AI069015 to Z.H.Z., Ruth L. Kirschstein NRSA postdoctoral fellowship GM101874 to E.J.M., and Ruth L. Kirschstein NRSA pre-doctoral training grant GM007185 fellowship for H. C. and D. D. C. We acknowledge the use of instruments at the Electron Imaging Center for NanoMachines supported by NIH (1S10RR23057 to ZHZ) and CNSI at UCLA.	Akiyama BM, 2012, RNA, V18, P653, DOI 10.1261/rna.031377.111; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blackburn EH, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003558; Bley CJ, 2011, P NATL ACAD SCI USA, V108, P20333, DOI 10.1073/pnas.1100270108; Bryan TM, 2000, MOL CELL, V6, P493, DOI 10.1016/S1097-2765(00)00048-4; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen Y, 2006, EMBO J, V25, P3156, DOI 10.1038/sj.emboj.7601195; Cole DI, 2012, J AM CHEM SOC, V134, P20070, DOI 10.1021/ja305636u; Collins K, 2011, CURR OPIN CHEM BIOL, V15, P643, DOI 10.1016/j.cbpa.2011.07.011; Couvillion MT, 2012, METHOD CELL BIOL, V109, P347, DOI 10.1016/B978-0-12-385967-9.00012-8; Cunningham DD, 2005, MOL CELL BIOL, V25, P4442, DOI 10.1128/MCB.25.11.4442-4454.2005; Eckert B, 2012, J BIOL CHEM, V287, P12805, DOI 10.1074/jbc.M112.339853; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Friedman KL, 1999, GENE DEV, V13, P2863, DOI 10.1101/gad.13.21.2863; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Jacks A, 2003, STRUCTURE, V11, P833, DOI 10.1016/S0969-2126(03)00121-7; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Lai CK, 2003, MOL CELL, V11, P1673, DOI 10.1016/S1097-2765(03)00232-6; Lai CK, 2002, GENE DEV, V16, P415, DOI 10.1101/gad.962602; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; Lee J, 2010, NUCLEIC ACIDS RES, V38, P2279, DOI 10.1093/nar/gkp1173; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mason DX, 2003, MOL CELL BIOL, V23, P5606, DOI 10.1128/MCB.23.16.5606-5613.2003; Min BS, 2010, J BIOL CHEM, V285, P16434, DOI 10.1074/jbc.M110.119172; Min BS, 2009, MOL CELL, V36, P609, DOI 10.1016/j.molcel.2009.09.041; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mitchell M, 2010, NAT STRUCT MOL BIOL, V17, P513, DOI 10.1038/nsmb.1777; O'Connor CM, 2006, MOL CELL BIOL, V26, P2029, DOI 10.1128/MCB.26.6.2029-2036.2006; O'Connor CM, 2005, J BIOL CHEM, V280, P17533, DOI 10.1074/jbc.M501211200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Richards RJ, 2006, RNA, V12, P1475, DOI 10.1261/rna.112306; Richards RJ, 2006, NUCLEIC ACIDS RES, V34, P816, DOI 10.1093/nar/gkj481; Robart AR, 2011, MOL CELL, V42, P308, DOI 10.1016/j.molcel.2011.03.012; Romi E, 2007, P NATL ACAD SCI USA, V104, P8791, DOI 10.1073/pnas.0703157104; Rosenfeld KK, 2011, J MOL BIOL, V410, P77, DOI 10.1016/j.jmb.2011.04.040; Rouda S, 2007, STRUCTURE, V15, P1403, DOI 10.1016/j.str.2007.09.007; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sexton AN, 2012, J BIOL CHEM, V287, P34455, DOI 10.1074/jbc.M112.394767; Singh M, 2012, MOL CELL, V47, P16, DOI 10.1016/j.molcel.2012.05.018; Steczkiewicz K, 2011, P NATL ACAD SCI USA, V108, P9443, DOI 10.1073/pnas.1015399108; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; Talley JM, 2011, J BIOL CHEM, V286, P26431, DOI 10.1074/jbc.M111.228635; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; Ulyanov NB, 2007, NUCLEIC ACIDS RES, V35, P6150, DOI 10.1093/nar/gkm660; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Witkin KL, 2004, GENE DEV, V18, P1107, DOI 10.1101/gad.1201704; Wu JY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1033; Yen WF, 2011, P NATL ACAD SCI USA, V108, P20370, DOI 10.1073/pnas.1017855108; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zeng ZX, 2011, P NATL ACAD SCI USA, V108, P20357, DOI 10.1073/pnas.1113624108	65	84	90	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					187	+		10.1038/nature12062	http://dx.doi.org/10.1038/nature12062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23552895	Green Accepted, Green Submitted			2022-12-24	WOS:000317346300034
J	Avorn, J				Avorn, Jerry			Approval of a Tuberculosis Drug Based on a Paradoxical Surrogate Measure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Avorn, J (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA.	javorn@medsoc.harvard.edu						[Anonymous], 2012, JANSS BRIEF DOC TMC2; Carome M., 2012, COMMUNICATION; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; Cox EM., 2012, COMMUNICATION; Hirschler B, 2012, REUTERS; Kesselheim AS, 2008, NEW ENGL J MED, V359, P1981, DOI 10.1056/NEJMp0806684; Ridley DB, 2006, HEALTH AFFAIR, V25, P313, DOI 10.1377/hlthaff.25.2.313; US Food and Drug Administration, 2012, BRIEF PACK NDA 204 3	8	55	57	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1349	1350		10.1001/jama.2013.623	http://dx.doi.org/10.1001/jama.2013.623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EC	23430122				2022-12-24	WOS:000316934500020
J	Inokuma, Y; Yoshioka, S; Ariyoshi, J; Arai, T; Hitora, Y; Takada, K; Matsunaga, S; Rissanen, K; Fujita, M				Inokuma, Yasuhide; Yoshioka, Shota; Ariyoshi, Junko; Arai, Tatsuhiko; Hitora, Yuki; Takada, Kentaro; Matsunaga, Shigeki; Rissanen, Kari; Fujita, Makoto			X-ray analysis on the nanogram to microgram scale using porous complexes	NATURE			English	Article							ABSOLUTE-CONFIGURATION; GUEST EXCHANGE; CRYSTAL; MOLECULES; NETWORK; INCLUSION; FRAMEWORK; SANTONIN; CITRUS	X-ray single-crystal diffraction (SCD) analysis has the intrinsic limitation that the target molecules must be obtained as single crystals. Here we report a protocol for SCD analysis that does not require the crystallization of the sample. In our method, tiny crystals of porous complexes are soaked in a solution of the target, such that the complexes can absorb the target molecules. Crystallographic analysis clearly determines the absorbed guest structures along with the host frameworks. Because the SCD analysis is carried out on only one tiny crystal of the complex, the required sample mass is of the nanogram-microgram order. We demonstrate that as little as about 80 nanograms of a sample is enough for the SCD analysis. In combination with high-performance liquid chromatography, our protocol allows the direct characterization of multiple fractions, establishing a prototypical means of liquid chromatography SCD analysis. Furthermore, we unambiguously determined the structure of a scarce marine natural product using only 5 micrograms of the compound.	[Inokuma, Yasuhide; Yoshioka, Shota; Ariyoshi, Junko; Arai, Tatsuhiko; Fujita, Makoto] Univ Tokyo, Dept Appl Chem, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Hitora, Yuki; Takada, Kentaro; Matsunaga, Shigeki] Univ Tokyo, Lab Aquat Nat Prod Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Rissanen, Kari] Univ Jyvaskyla, Dept Chem, NanoSci Ctr, Jyvaskyla 40014, Finland	University of Tokyo; University of Tokyo; University of Jyvaskyla	Fujita, M (corresponding author), Univ Tokyo, Dept Appl Chem, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.	mfujita@appchem.t.u-tokyo.ac.jp	Inokuma, Yasuhide/AAQ-9803-2020; Takada, Kentaro/AAH-7191-2020; Rissanen, Kari T/B-5688-2008	Inokuma, Yasuhide/0000-0001-6558-3356; Takada, Kentaro/0000-0003-3835-1482; Rissanen, Kari T/0000-0002-7282-8419; Hitora, Yuki/0000-0003-4271-2543; Fujita, Makoto/0000-0001-6105-7340	CREST project of the Japan Science and Technology Agency;  [24000009];  [23750146]; Grants-in-Aid for Scientific Research [12J07872] Funding Source: KAKEN	CREST project of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Specially Promoted Research (24000009) and Young Scientists (B) (23750146), and by the CREST project of the Japan Science and Technology Agency. The experiment involving X-ray crystallography with 80 ng of guest molecules was performed using VariMax optics with a RAPID image plate detector system, courtesy of Rigaku Corporation. We thank M. Yamasaki and H. Sato for support for X-ray measurements.	Ahuja S, 2003, HDB ISOLATION CHARAC; [Anonymous], 2009, ISOLATION IDENTIFICA; Batten SR, 1998, ANGEW CHEM INT EDIT, V37, P1460, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1460::AID-ANIE1460>3.0.CO;2-Z; BIJVOET JM, 1951, NATURE, V168, P271, DOI 10.1038/168271a0; Biradha K, 2002, ANGEW CHEM INT EDIT, V41, P3392, DOI 10.1002/1521-3773(20020916)41:18<3392::AID-ANIE3392>3.0.CO;2-V; CAHN RS, 1966, ANGEW CHEM INT EDIT, V5, P385, DOI 10.1002/anie.196603851; Chen BL, 2010, ACCOUNTS CHEM RES, V43, P1115, DOI 10.1021/ar100023y; COREY EJ, 1955, J AM CHEM SOC, V77, P1044, DOI 10.1021/ja01609a076; Croue J.-P., 1999, CHARACTERIZATION NAT, P73; Deschamps JR, 2010, LIFE SCI, V86, P585, DOI 10.1016/j.lfs.2009.02.028; Ferey G, 2008, CHEM SOC REV, V37, P191, DOI 10.1039/b618320b; Flack HD, 1999, ACTA CRYSTALLOGR A, V55, P908, DOI 10.1107/S0108767399004262; Freedman TB, 2003, CHIRALITY, V15, P743, DOI 10.1002/chir.10287; FUJITA M, 1994, J AM CHEM SOC, V116, P1151, DOI 10.1021/ja00082a055; FUJITA M, 1995, NATURE, V378, P469, DOI 10.1038/378469a0; Green CO, 2007, BIOMED CHROMATOGR, V21, P48, DOI 10.1002/bmc.718; Halder GJ, 2005, J AM CHEM SOC, V127, P7891, DOI 10.1021/ja042420k; Han S, 2010, J AGR FOOD CHEM, V58, P9488, DOI 10.1021/jf102730b; Haneda T, 2007, ANGEW CHEM INT EDIT, V46, P6643, DOI 10.1002/anie.200700999; Hitora Y, 2011, TETRAHEDRON, V67, P4530, DOI 10.1016/j.tet.2011.04.085; INAYAMA S, 1980, J CHEM SOC CHEM COMM, P495, DOI 10.1039/c39800000495; Inokuma Y, 2011, J AM CHEM SOC, V133, P19691, DOI 10.1021/ja209290t; Inokuma Y, 2011, NAT CHEM, V3, P349, DOI [10.1038/NCHEM.1031, 10.1038/nchem.1031]; Inokuma Y, 2010, NAT CHEM, V2, P780, DOI [10.1038/nchem.742, 10.1038/NCHEM.742]; Kawano M, 2007, COORDIN CHEM REV, V251, P2592, DOI 10.1016/j.ccr.2007.07.022; Kim H, 2006, CHEM COMMUN, P2759, DOI 10.1039/b604925g; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Kitaura R, 2002, SCIENCE, V298, P2358, DOI 10.1126/science.1078481; Kondo M, 1997, ANGEW CHEM INT EDIT, V36, P1725, DOI 10.1002/anie.199717251; Li JR, 2009, CHEM SOC REV, V38, P1477, DOI 10.1039/b802426j; Li QW, 2009, SCIENCE, V325, P855, DOI 10.1126/science.1175441; Li-Ling Ooi, 2010, PRINCIPLES XRAY CRYS; Ohara K, 2010, J AM CHEM SOC, V132, P30, DOI 10.1021/ja908794n; Ohashi Y, 2008, MODELS, MYSTERIES AND MAGIC OF MOLECULES, P109, DOI 10.1007/978-1-4020-5941-4_5; Ohmori O, 2004, J AM CHEM SOC, V126, P16292, DOI 10.1021/ja046478a; Seco JM, 2004, CHEM REV, V104, P17, DOI 10.1021/cr000665j; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; TAKAYANAGI H, 1991, ANAL SCI, V7, P183, DOI 10.2116/analsci.7.183; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Yoshizawa M, 2009, ANGEW CHEM INT EDIT, V48, P3418, DOI 10.1002/anie.200805340	40	590	603	14	651	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					461	+		10.1038/nature11990	http://dx.doi.org/10.1038/nature11990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23538828				2022-12-24	WOS:000316682800036
J	Thompson, H; Tucker, AS				Thompson, Hannah; Tucker, Abigail S.			Dual Origin of the Epithelium of the Mammalian Middle Ear	SCIENCE			English	Article							EUSTACHIAN-TUBE; NEURAL CREST; EVOLUTION	The air-filled cavity and ossicles of the mammalian middle ear conduct sound to the cochlea. Using transgenic mice, we show that the mammalian middle ear develops through cavitation of a neural crest mass. These cells, which previously underwent an epithelial-to-mesenchymal transformation upon leaving the neural tube, undergo a mesenchymal-to-epithelial transformation to form a lining continuous with the endodermally derived auditory tube. The epithelium derived from endodermal cells, which surrounds the auditory tube and eardrum, develops cilia, whereas the neural crest-derived epithelium does not. Thus, the cilia critical to clearing pathogenic infections from the middle ear are distributed according to developmental derivations. A different process of cavitation appears evident in birds and reptiles, indicating that this dual epithelium may be unique to mammals.	[Thompson, Hannah; Tucker, Abigail S.] Kings Coll London, Guys Hosp, Dept Craniofacial Dev & Stem Cell Biol, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Tucker, AS (corresponding author), Kings Coll London, Guys Hosp, Dept Craniofacial Dev & Stem Cell Biol, London SE1 9RT, England.	abigail.tucker@kcl.ac.uk	Tucker, Abigail S/K-1788-2016	Tucker, Abigail S/0000-0001-8871-6094	Medical Research Council [G1001232]; MRC [G1001232] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank A. Warley and G. Vizcay in the Centre for Ultrastructural Imaging at King's College London for help with the SEM and J. Green for his helpful critique of the manuscript. We also thank H. Lickert and M. A. Basson for the Sox17-2AiCre line. This work was funded by a project grant from the Medical Research Council (G1001232). Sox17-2Aicre transgenic mice are available for noncommercial use subject to a material transfer agreement with Helmholtz Zentrum Munchen, German Research Centre for Environmental Health (GmbH), through H. Lickert.	Anthwal N, 2013, J ANAT, V222, P147, DOI 10.1111/j.1469-7580.2012.01526.x; BUCH NH, 1964, ARCHIV OTOLARYNGOL, V79, P472, DOI 10.1001/archotol.79.5.472; Chai Y, 2000, DEVELOPMENT, V127, P1671; Engert S, 2009, GENESIS, V47, P603, DOI 10.1002/dvg.20540; GIANNESSI F, 1993, J ANAT, V183, P103; HAYE R, 1974, CELL TISSUE RES, V148, P431; Hilding D A, 1980, Am J Otolaryngol, V1, P97, DOI 10.1016/S0196-0709(80)80002-0; Indra AK, 2000, HORM RES, V54, P296, DOI 10.1159/000053275; Jaisinghani VJ, 1999, AM J OTOLARYNG, V20, P363, DOI 10.1016/S0196-0709(99)90075-3; JOHNSTON MC, 1979, EXP EYE RES, V29, P27, DOI 10.1016/0014-4835(79)90164-7; Kaufmann MH, 1992, ATLAS MOUSE DEV; Kontges G, 1996, DEVELOPMENT, V122, P3229; KUIJPERS W, 1984, HISTOCHEM J, V16, P807, DOI 10.1007/BF01002787; Lim D J, 1967, Acta Otolaryngol, V63, P425, DOI 10.3109/00016486709128777; MAROVITZ WF, 1971, ANN OTO RHINOL LARYN, V80, P384, DOI 10.1177/000348947108000313; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; PARK K, 1992, AM J OTOLARYNG, V13, P93, DOI 10.1016/0196-0709(92)90005-E; PROCTOR B, 1964, J Laryngol Otol, V78, P631, DOI 10.1017/S002221510006254X; Richter CA, 2010, HUM MOL GENET, V19, P1551, DOI 10.1093/hmg/ddq028; SADE J, 1966, ARCHIV OTOLARYNGOL, V84, P137; SCHWARZBART A, 1959, J Laryngol Otol, V73, P45, DOI 10.1017/S0022215100054906; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takechi M, 2010, J EXP ZOOL PART B, V314B, P417, DOI 10.1002/jez.b.21347; Varshney S, 2010, INDIAN J OTOLARYNGOL, V62, P421, DOI 10.1007/s12070-010-0116-3; Wittmaack K., 1918, NORMALE PATHOLOGISCH	25	63	65	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1453	1456		10.1126/science.1232862	http://dx.doi.org/10.1126/science.1232862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520114	Green Published			2022-12-24	WOS:000316740700048
J	Burns, T; Rugkasa, J; Molodynski, A; Dawson, J; Yeeles, K; Vazquez-Montes, M; Voysey, M; Sinclair, J; Priebe, S				Burns, Tom; Rugkasa, Jorun; Molodynski, Andrew; Dawson, John; Yeeles, Ksenija; Vazquez-Montes, Maria; Voysey, Merryn; Sinclair, Julia; Priebe, Stefan			Community treatment orders for patients with psychosis (OCTET): a randomised controlled trial	LANCET			English	Article							INVOLUNTARY OUTPATIENT COMMITMENT	Background Compulsory supervision outside hospital has been developed internationally for the treatment of mentally ill people following widespread deinstitutionalisation but its efficacy has not yet been proven. Community treatment orders (CTOs) for psychiatric patients became available in England and Wales in 2008. We tested whether CTOs reduce admissions compared with use of Section 17 leave when patients in both groups receive equivalent levels of clinical contact but different lengths of compulsory supervision. Methods OCTET is a non-blinded, parallel-arm randomised controlled trial. We postulated that patients with a diagnosis of psychosis discharged from hospital on CTOs would have a lower rate of readmission over 12 months than those discharged on the pre-existing Section 17 leave of absence. Eligible patients were those involuntarily admitted to hospital with a diagnosis of psychosis, aged 18-65 years, who were deemed suitable for supervised outpatient care by their clinicians. Consenting patients were randomly assigned (1:1 ratio) to be discharged from hospital either on CTO or Section 17 leave. Randomisation used random permuted blocks with lengths of two, four, and six, and stratified for sex, schizophrenic diagnosis, and duration of illness. Research assistants, treating clinicians, and patients were aware of assignment to randomisation group. The primary outcome measure was whether or not the patient was admitted to hospital during the 12-month follow-up period, analysed with a log-binomial regression model adjusted for stratification factors. We did all analyses by intention to treat. This trial is registered, number ISRCTN73110773. Findings Of 442 patients assessed, 336 patients were randomly assigned to be discharged from hospital either on CTO (167 patients) or Section 17 leave (169 patients). One patient withdrew directly after randomisation and two were ineligible, giving a total sample of 333 patients (166 in the CTO group and 167 in the Section 17 group). At 12 months, despite the fact that the length of initial compulsory outpatient treatment differed significantly between the two groups (median 183 days CTO group vs 8 days Section 17 group, p<0.001) the number of patients readmitted did not differ between groups (59 [36%] of 166 patients in the CTO group vs 60 [36%] of 167 patients in the Section 17 group; adjusted relative risk 1.0 [95% CI 0.75-1.33]). Interpretation In well coordinated mental health services the imposition of compulsory supervision does not reduce the rate of readmission of psychotic patients. We found no support in terms of any reduction in overall hospital admission to justify the significant curtailment of patients' personal liberty.	[Burns, Tom; Rugkasa, Jorun; Yeeles, Ksenija] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Vazquez-Montes, Maria] Univ Oxford, Dept Primary Hlth Care Sci, Oxford OX3 7JX, England; [Voysey, Merryn] Univ Oxford, Ctr Stat Med, Oxford OX3 7JX, England; [Rugkasa, Jorun] Akershus Univ Hosp, Hlth Serv Res Unit, Lorenskog, Norway; [Molodynski, Andrew] Oxford Hlth NHS Fdn Trust, Oxford, England; [Dawson, John] Univ Otago, Fac Law, Otago, New Zealand; [Sinclair, Julia] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Priebe, Stefan] Queen Mary Univ London, Unit Social & Community Psychiat, London, England	University of Oxford; University of Oxford; University of Oxford; University of Oslo; University of Otago; University of Southampton; University of London; Queen Mary University London	Burns, T (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	tom.burns@psych.ox.ac.uk	Rugkåsa, Jorun/ABI-6495-2020; Dawson, John/HDM-6702-2022; Sinclair, Julia/AAD-8049-2019	Sinclair, Julia/0000-0002-1905-2025; Rugkasa, Jorun/0000-0001-5842-2845; molodynski, andrew/0000-0002-3820-5955; Houston, Mary/0000-0002-8837-4503; Priebe, Stefan/0000-0001-9864-3394; Voysey, Merryn/0000-0001-6324-6559; Yeeles, Ksenija/0000-0002-7757-0154	National Institute of Health Research [RP-PG-0606-1006]; National Institute for Health Research [RP-PG-0606-1006] Funding Source: researchfish	National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The trial is funded by a Programme Grant for Applied Research from the National Institute of Health Research (RP-PG-0606-1006). It is adopted into the UKCRN and MHRN portfolios, and is registered with ISRCTN [ISRCTN73110773]. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Appelbaum PS, 2001, PSYCHIATR SERV, V52, P347, DOI 10.1176/appi.ps.52.3.347; Burns T, 2009, PSYCHOL MED, V39, P1583, DOI 10.1017/S0033291709005352; Burns T, 2010, PSYCHIATR BULL, V34, P361, DOI 10.1192/pb.bp.110.030254; Churchill R, 2007, INT EXPERIENCES USIN; Dawson J, 2011, MED LAW REV, V19, P1, DOI 10.1093/medlaw/fwq030; Dawson J., 2005, COMMUNITY TREATMENT; Dawson John, 2002, Med Law Rev, V10, P308, DOI 10.1093/medlaw/10.3.308; Gledhill K., 2007, J MENT HEALTH, VL, P149; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Kisely S, 2005, COCHRANE DB SYST REV, V3; Lukoff D, 1986, SCHIZOPHRENIA B, V12, P594, DOI DOI 10.1093/SCHBUL/12.4.578; Munetz MR, 2003, J AM ACAD PSYCHIATRY, V31, P173; Priebe S, 2005, BMJ-BRIT MED J, V330, P123, DOI 10.1136/bmj.38296.611215.AE; Romans S, 2004, AUST NZ J PSYCHIAT, V38, P836, DOI 10.1080/j.1440-1614.2004.01470.x; Royal College of Psychiatrists, 1993, CR18 ROYAL COLL PSYC; Steadman HJ, 2001, PSYCHIATR SERV, V52, P330, DOI 10.1176/appi.ps.52.3.330; Swartz MS, 1997, J MENT HEALTH ADMIN, V24, P35; Swartz MS, 1999, AM J PSYCHIAT, V156, P1968; Torrey E, 2008, SHORTAGE PUBLIC HOSP	19	232	234	0	43	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 11	2013	381	9878					1627	1633		10.1016/S0140-6736(13)60107-5	http://dx.doi.org/10.1016/S0140-6736(13)60107-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146SX	23537605	Green Published			2022-12-24	WOS:000319112400029
J	Yoo, SH; Mohawk, JA; Siepka, SM; Shan, YL; Huh, SK; Hong, HK; Kornblum, I; Kumar, V; Koike, N; Xu, M; Nussbaum, J; Liu, XR; Chen, Z; Chen, ZJJ; Green, CB; Takahashi, JS				Yoo, Seung-Hee; Mohawk, Jennifer A.; Siepka, Sandra M.; Shan, Yongli; Huh, Seong Kwon; Hong, Hee-Kyung; Kornblum, Izabela; Kumar, Vivek; Koike, Nobuya; Xu, Ming; Nussbaum, Justin; Liu, Xinran; Chen, Zheng; Chen, Zhijian J.; Green, Carla B.; Takahashi, Joseph S.			Competing E3 Ubiquitin Ligases Govern Circadian Periodicity by Degradation of CRY in Nucleus and Cytoplasm	CELL			English	Article							F-BOX PROTEINS; REV-ERB-ALPHA; CLOCK PROTEIN; CELL-CYCLE; IN-VIVO; REVEALS; UBIQUITYLATION; CRYPTOCHROME; MAMMALS; IDENTIFICATION	Period determination in the mammalian circadian clock involves the turnover rate of the repressors CRY and PER. We show that CRY ubiquitination engages two competing E3 ligase complexes that either lengthen or shorten circadian period in mice. Cloning of a short-period circadian mutant, Past-time, revealed a glycine to glutamate missense mutation in Fbxl21, an F-box protein gene that is a paralog of Fbxl3 that targets the CRY proteins for degradation. While loss of function of FBXL3 leads to period lengthening, mutation of Fbxl21 causes period shortening. FBXL21 forms an SCF E3 ligase complex that slowly degrades CRY in the cytoplasm but antagonizes the stronger E3 ligase activity of FBXL3 in the nucleus. FBXL21 plays a dual role: protecting CRY from FBXL3 degradation in the nucleus and promoting CRY degradation within the cytoplasm. Thus, the balance and cellular compartmentalization of competing E3 ligases for CRY determine circadian period of the clock in mammals.	[Yoo, Seung-Hee; Mohawk, Jennifer A.; Shan, Yongli; Huh, Seong Kwon; Kumar, Vivek; Koike, Nobuya; Liu, Xinran; Green, Carla B.; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Yoo, Seung-Hee; Mohawk, Jennifer A.; Kornblum, Izabela; Kumar, Vivek; Chen, Zhijian J.; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Xu, Ming; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Siepka, Sandra M.; Hong, Hee-Kyung] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Nussbaum, Justin; Green, Carla B.] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Chen, Zheng] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Northwestern University; University of Virginia; University of Texas System; University of Texas Health Science Center Houston	Takahashi, JS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	joseph.takahashi@utsouthwestern.edu	Takahashi, Joseph S/E-8482-2012; Koike, Nobuya/G-1116-2016; Takahashi, Joseph S./Y-2781-2019; Chen, Zhijian/C-6039-2012; Kumar, Vivek/P-8749-2014	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Chen, Zhijian/0000-0002-8475-8251; Chen, Jake/0000-0001-8829-7504; Kumar, Vivek/0000-0001-6643-7465; Shan, Yongli/0000-0002-5870-2107	NIH [U01 MH61915, R01 MH078024, P50 MH074924, R01 GM090247, R01 GM63692, F32 DA024556]; Howard Hughes Medical Institute; Welch Foundation [I-1389]; American Heart Association [11SDG7600045]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090247, R01GM063692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924, U01MH061915, R01MH078024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA024556] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Welch Foundation(The Welch Foundation); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Choogon Lee for generously providing the anti-PER1 antibody, Homin Kim for LRR3 modeling, Junghea Park, Weimin Song, and Yoga Chelliah for excellent technical support, and Yi Liu for editorial comments on the paper. Research was supported by NIH grants (U01 MH61915, P50 MH074924, and R01 MH078024 to J. S. T.; P50 MH074924 and R01 GM090247 to C. B. G.; R01 GM63692 to Z. J. C.; F32 DA024556 to V. K.), the Howard Hughes Medical Institute (J. S. T. and Z. J. C.), the Welch Foundation (I-1389 to Z. J. C.), and the American Heart Association (11SDG7600045 to Z. C.). J. S. T. and Z. J. C. are Investigators, J. A. M. is an Associate, I. K. is a Laboratory Manager, and S.-H. Y., S. M. S., H.-K. H., and V. K. were Associates at the Howard Hughes Medical Institute.	Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Dardente H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003530; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hong HK, 2007, PLOS GENET, V3, P324, DOI 10.1371/journal.pgen.0030033; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Khan SK, 2012, J BIOL CHEM, V287, P25917, DOI 10.1074/jbc.M112.368001; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Maywood ES, 2011, J NEUROSCI, V31, P1539, DOI 10.1523/JNEUROSCI.4107-10.2011; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Pines J, 2005, NAT CELL BIOL, V7, P731, DOI 10.1038/ncb0805-731; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Tong X, 2012, J BIOL CHEM, V287, P25280, DOI 10.1074/jbc.M112.340786; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng XZ, 2012, TRENDS NEUROSCI, V35, P574, DOI 10.1016/j.tins.2012.05.007	36	223	238	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1091	1105		10.1016/j.cell.2013.01.055	http://dx.doi.org/10.1016/j.cell.2013.01.055			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452855	Green Accepted, Bronze			2022-12-24	WOS:000315710300016
J	Bor, J; Herbst, AJ; Newell, ML; Barnighausen, T				Bor, Jacob; Herbst, Abraham J.; Newell, Marie-Louise; Baernighausen, Till			Increases in Adult Life Expectancy in Rural South Africa: Valuing the Scale-Up of HIV Treatment	SCIENCE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; TREATMENT PROGRAM; COHORT PROFILE; MORTALITY; HEALTH; DELIVERY; DECLINE; TRENDS; LEVEL	The scale-up of antiretroviral therapy (ART) is expected to raise adult life expectancy in populations with high HIV prevalence. Using data from a population cohort of over 101,000 individuals in rural KwaZulu-Natal, South Africa, we measured changes in adult life expectancy for 2000-2011. In 2003, the year before ART became available in the public-sector health system, adult life expectancy was 49.2 years; by 2011, adult life expectancy had increased to 60.5 years-an 11.3-year gain. Based on standard monetary valuation of life, the survival benefits of ART far outweigh the costs of providing treatment in this community. These gains in adult life expectancy signify the social value of ART and have implications for the investment decisions of individuals, governments, and donors.	[Bor, Jacob; Herbst, Abraham J.; Newell, Marie-Louise; Baernighausen, Till] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, ZA-3935 Mtubatuba, KwaZulu Natal, South Africa; [Bor, Jacob; Baernighausen, Till] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Newell, Marie-Louise] UCL, Inst Child Hlth, London WC1N 1EH, England	University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; University of London; University College London	Bor, J (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, POB 198, ZA-3935 Mtubatuba, KwaZulu Natal, South Africa.	jbor@hsph.harvard.edu	Bärnighausen, Till/Y-2388-2019; Herbst, Abraham J/E-4848-2010; Newell, Marie-Louise/AAE-8222-2019	Herbst, Abraham J/0000-0002-5436-9386; Newell, Marie-Louise/0000-0002-1074-7699	Wellcome Trust (Africa Centre for Health and Population Studies); National Institutes of Health [R01 HD058482-01, 1R01MH083539-01]; Harvard Global Health Institute and Harvard Center for Population and Development Studies; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083539] Funding Source: NIH RePORTER	Wellcome Trust (Africa Centre for Health and Population Studies); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Global Health Institute and Harvard Center for Population and Development Studies; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank all the respondents who gave their time to this research and the staff of the Africa Centre for Health and Population Studies and the Hlabisa HIV Care and Treatment Programme. In particular, we thank all data collection and database management coordinators, supervisors, and managers (T. Mutevedzi, C. Newell, Z. Gqwede, H. Madida, L. Sithole, P. Dlamini, P. Gwala, T. Mngomezulu, N. Ntombela, N. Myeni, B. Ntimane), as well as all fieldworkers, verbal autopsy nurses, surveillance trackers, data capturers, document management clerks, and quality controllers. We also thank our funders: the Wellcome Trust (Africa Centre for Health and Population Studies); National Institutes of Health grants R01 HD058482-01 and 1R01MH083539-01 (T. B.); and the Harvard Global Health Institute and Harvard Center for Population and Development Studies (J.B.). Data are archived and accessible at no cost from the Africa Centre for Health and Population Studies. The authors report no conflicts of interest.	Actuarial Society of South Africa, 2011, 2008 AIDS AND DEMOGR; Barnighausen T, 2012, P NATL ACAD SCI USA, V109, P21271, DOI 10.1073/pnas.1209017110; Barnighausen T, 2012, SEX TRANSM INFECT, V88, DOI 10.1136/sextrans-2011-050303; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Barnighausen T, 2009, AIDS RES HUM RETROV, V25, P405, DOI 10.1089/aid.2008.0211; Baranov V., 2012, PAPER PRESENTED AT T; Barnett T., 2002, AIDS IN THE TWENTY F; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Bor J, 2012, HEALTH AFFAIR, V31, P1459, DOI 10.1377/hlthaff.2012.0407; Bor J, 2011, TROP MED INT HEALTH, V16, P988, DOI 10.1111/j.1365-3156.2011.02795.x; Condliffe K., 2012, PAPER PRESENTED AT T; Day C., 2011, THE DISTRICT HEALTH; Department of Health, 2010, CLINICAL GUIDELINES; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Efron B, 1993, MONOGRAPHS ON STATIS, V57; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fortson JG, 2011, REV ECON STAT, V93, P1, DOI 10.1162/REST_a_00067; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; Herbst AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-47; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Jayachandran S, 2009, Q J ECON, V124, P349, DOI 10.1162/qjec.2009.124.1.349; Johnson LF, 2012, S AFR J HIV MED, P22; Kalbfleisch J. D., 2002, STATISTICAL ANALYSIS; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Klein JP, 2003, SURVIVAL ANALYSIS TE; Mahy M, 2010, SEX TRANSM INFECT, V86, pI67, DOI 10.1136/sti.2010.046060; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Muhwava W, 2008, MONOGRAPH SERIES, V2; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Nash D, 2011, AIDS, V25, P1523, DOI 10.1097/QAD.0b013e32834811b2; Nyirenda M, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000299413.82893.2b; Piot P, 2000, SCIENCE, V288, P2176, DOI 10.1126/science.288.5474.2176; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Statistics South Africa, 2011, MIDYEAR POPULATION E; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; UNAIDS, 2010, UNAIDS REPORT ON THE; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD POPULATION PRO; World DataBank, 2012, WORLD DEVELOPMENT IN; World Health Organization, 2012, WORLD HEALTH STATIST; Zaba B, 2012, TROP MED INT HEALTH, V17, pe3, DOI 10.1111/j.1365-3156.2011.02943.x; Zaidi J., 2012, LATE BREAKING ABSTRA	47	407	417	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2013	339	6122					961	965		10.1126/science.1230413	http://dx.doi.org/10.1126/science.1230413			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092UX	23430655	Green Accepted			2022-12-24	WOS:000315149600051
J	Noordally, ZB; Ishii, K; Atkins, KA; Wetherill, SJ; Kusakina, J; Walton, EJ; Kato, M; Azuma, M; Tanaka, K; Hanaoka, M; Dodd, AN				Noordally, Zeenat B.; Ishii, Kenyu; Atkins, Kelly A.; Wetherill, Sarah J.; Kusakina, Jelena; Walton, Eleanor J.; Kato, Maiko; Azuma, Miyuki; Tanaka, Kan; Hanaoka, Mitsumasa; Dodd, Antony N.			Circadian Control of Chloroplast Transcription by a Nuclear-Encoded Timing Signal	SCIENCE			English	Article							PLASTID SIGMA-FACTOR; LIGHT-RESPONSIVE PROMOTER; ARABIDOPSIS-THALIANA; RNA-POLYMERASE; HIGHER-PLANTS; KEY PATHWAYS; CLOCK; PSBD; GENE; RHYTHMS	Circadian timekeeping in plants increases photosynthesis and productivity. There are circadian oscillations in the abundance of many chloroplast-encoded transcripts, but it is not known how the circadian clock regulates chloroplast transcription or the photosynthetic apparatus. We show that, in Arabidopsis, nuclear-encoded SIGMA FACTOR5 (SIG5) controls circadian rhythms of transcription of several chloroplast genes, revealing one pathway by which the nuclear-encoded circadian oscillator controls rhythms of chloroplast gene expression. We also show that SIG5 mediates the circadian gating of light input to a chloroplast-encoded gene. We have identified an evolutionarily conserved mechanism that communicates circadian timing information between organelles with distinct genetic systems and have established a new level of integration between eukaryotic circadian clocks and organelles of endosymbiotic origin.	[Noordally, Zeenat B.] Univ Edinburgh, SynthSys, Edinburgh EH9 3JD, Midlothian, Scotland; [Ishii, Kenyu; Kato, Maiko; Hanaoka, Mitsumasa] Chiba Univ, Grad Sch Hort, Matsudo, Chiba 2718510, Japan; [Atkins, Kelly A.; Wetherill, Sarah J.; Walton, Eleanor J.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Kusakina, Jelena; Dodd, Antony N.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Azuma, Miyuki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Tanaka, Kan] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	University of Edinburgh; Chiba University; University of York - UK; University of Bristol; University of Tokyo; Tokyo Institute of Technology	Dodd, AN (corresponding author), Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England.	antony.dodd@bristol.ac.uk	Hanaoka, Mitsumasa/M-9904-2015; Tanaka, Kan/E-3724-2015	Tanaka, Kan/0000-0001-7560-7884; Noordally, Zeenat/0000-0003-2817-1330	Royal Society; Royal Society Anglo-Japanese Daiwa Foundation; Biotechnology and Biological Sciences Research Council [BB/I005811/1]; Nuffield Foundation; University of York; Special Coordination Fund for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan [21770034, 24117505, 24770037, 23120505, 24248061]; Japan Society for the Promotion of Science [21770034, 24117505, 24770037, 23120505, 24248061]; Sumitomo Foundation; Grants-in-Aid for Scientific Research [24117505] Funding Source: KAKEN; Biotechnology and Biological Sciences Research Council [1107454, BB/I005811/2] Funding Source: researchfish; BBSRC [BB/I005811/1, BB/I005811/2] Funding Source: UKRI	Royal Society(Royal Society of London); Royal Society Anglo-Japanese Daiwa Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Nuffield Foundation; University of York(European Commission); Special Coordination Fund for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	A.N.D. thanks the Royal Society for awarding a University Research Fellowship. Funding comprised a Royal Society Research Grant; a Royal Society Anglo-Japanese Daiwa Foundation International Joint Project (A.N.D. and M. H.); Biotechnology and Biological Sciences Research Council grant BB/I005811/1 (A.N.D.); the Nuffield Foundation (A.N.D. and K. A. A.); the University of York (A.N.D.); a Special Coordination Fund for Promoting Science and Technology (M. H.); Grants-in-Aid [21770034, 24117505, and 24770037 (M. H.); 23120505 and 24248061 (K. T.)] from the Ministry of Education, Culture, Sports, Science and Technology of Japan or Japan Society for the Promotion of Science, and the Sumitomo Foundation (M. H.). We thank A. Hall for delayed fluorescence advice and luciferase reporters; S. Penfield for period mutants; S. Kay for COSOPT; M. Kobayashi for technique development; and A. Webb, A. Hetherington, and K. Franklin for constructive criticism. The data described are in the main and supplementary figures. There are no conflicts of interest.	Dalchau N, 2011, P NATL ACAD SCI USA, V108, P5104, DOI 10.1073/pnas.1015452108; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Favory JJ, 2005, NUCLEIC ACIDS RES, V33, P5991, DOI 10.1093/nar/gki908; Gould PD, 2009, PLANT J, V58, P893, DOI 10.1111/j.1365-313X.2009.03819.x; Hanano S, 2006, GENES CELLS, V11, P1381, DOI 10.1111/j.1365-2443.2006.01026.x; Hanaoka M, 2012, INT J MOL SCI, V13, P12182, DOI 10.3390/ijms131012182; Hanaoka M, 2012, J BIOL CHEM, V287, P26321, DOI 10.1074/jbc.M111.338251; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hassidim M, 2007, PLANT J, V51, P551, DOI 10.1111/j.1365-313X.2007.03160.x; Hoffer PH, 1997, PLANT PHYSIOL, V115, P213, DOI 10.1104/pp.115.1.213; Hotta CT, 2007, PLANT CELL ENVIRON, V30, P333, DOI 10.1111/j.1365-3040.2006.01627.x; Ichikawa K, 2008, FEBS LETT, V582, P405, DOI 10.1016/j.febslet.2007.12.034; Ishizaki Y, 2005, PLANT J, V42, P133, DOI 10.1111/j.1365-313X.2005.02362.x; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Kanamaru K, 2004, BIOSCI BIOTECH BIOCH, V68, P2215, DOI 10.1271/bbb.68.2215; Kanamaru K, 2001, PLANT CELL PHYSIOL, V42, P1034, DOI 10.1093/pcp/pce155; Mas P, 2008, TRENDS CELL BIOL, V18, P273, DOI 10.1016/j.tcb.2008.03.005; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Mochizuki T, 2004, FEBS LETT, V571, P26, DOI 10.1016/j.febslet.2004.06.052; Nagashima A, 2004, PLANT CELL PHYSIOL, V45, P357, DOI 10.1093/pcp/pch050; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Onda Y, 2008, PLANT J, V55, P968, DOI 10.1111/j.1365-313X.2008.03567.x; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Shimizu M, 2010, P NATL ACAD SCI USA, V107, P10760, DOI 10.1073/pnas.0911692107; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; STREHLER BL, 1951, J GEN PHYSIOL, V34, P809, DOI 10.1085/jgp.34.6.809; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Tsinoremas NF, 1996, EMBO J, V15, P2488, DOI 10.1002/j.1460-2075.1996.tb00606.x; Tsunoyama Y, 2004, P NATL ACAD SCI USA, V101, P3304, DOI 10.1073/pnas.0308362101; Yao JL, 2003, PLANT PHYSIOL, V132, P739, DOI 10.1104/pp.102.017913	33	89	93	1	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1316	1319		10.1126/science.1230397	http://dx.doi.org/10.1126/science.1230397			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493713				2022-12-24	WOS:000316053400037
J	Malchow, S; Leventhal, DS; Nishi, S; Fischer, BI; Shen, L; Paner, GP; Amit, AS; Kang, C; Geddes, JE; Allison, JP; Socci, ND; Savage, PA				Malchow, Sven; Leventhal, Daniel S.; Nishi, Saki; Fischer, Benjamin I.; Shen, Lynn; Paner, Gladell P.; Amit, Ayelet S.; Kang, Chulho; Geddes, Jenna E.; Allison, James P.; Socci, Nicholas D.; Savage, Peter A.			Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells	SCIENCE			English	Article							PROSTATE-CANCER; SELF-ANTIGEN; EXPRESSION; SELECTION; GENES	Despite considerable interest in the modulation of tumor-associated Foxp3+ regulatory T cells (T-regs) for therapeutic benefit, little is known about the developmental origins of these cells and the nature of the antigens that they recognize. We identified an endogenous population of antigen-specific T-regs (termed MJ23 T-regs) found recurrently enriched in the tumors of mice with oncogene-driven prostate cancer. MJ23 T-regs were not reactive to a tumor-specific antigen but instead recognized a prostate-associated antigen that was present in tumor-free mice. MJ23 T-regs underwent autoimmune regulator (Aire)-dependent thymic development in both male and female mice. Thus, Aire-mediated expression of peripheral tissue antigens drives the thymic development of a subset of organ-specific T-regs, which are likely coopted by tumors developing within the associated organ.	[Malchow, Sven; Leventhal, Daniel S.; Nishi, Saki; Fischer, Benjamin I.; Shen, Lynn; Paner, Gladell P.; Amit, Ayelet S.; Savage, Peter A.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Kang, Chulho] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Geddes, Jenna E.; Allison, James P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Dept Immunol, New York, NY 10021 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core, New York, NY 10021 USA	University of Chicago; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Savage, PA (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	psavage@bsd.uchicago.edu		Allison, James/0000-0001-8980-5697	Cancer Research Institute Investigator Award; Cancer Research Foundation Young Investigator Award; American Cancer Society Institutional Research Grant [IRG-58-004]; University of Chicago Comprehensive Cancer Center [P30 CA14599]; MSKCC Comprehensive Cancer Center [P30 CA008748]; Howard Hughes Medical Institute;  [R01 (1R01CA160371-01)]; NATIONAL CANCER INSTITUTE [R01CA160371, P30CA008748, P30CA014599] Funding Source: NIH RePORTER	Cancer Research Institute Investigator Award; Cancer Research Foundation Young Investigator Award; American Cancer Society Institutional Research Grant(American Cancer Society); University of Chicago Comprehensive Cancer Center; MSKCC Comprehensive Cancer Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Bendelac, T. Gajewski, R. Gottschalk, and S. Quezada for critical reading of the manuscript; A. Rudensky for Foxp3<SUP>gfp</SUP> reporter mice (6); C. Benoist for cassette vectors for TCR alpha and TCR beta transgenic mice (23); L. Degenstein for transgenic mouse production; and A. Thomas and N.-L. Yin for deep TCR sequence analysis. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was partially funded by the following sources (to P. A. S.): R01 (1R01CA160371-01), a Cancer Research Institute Investigator Award, a Cancer Research Foundation Young Investigator Award, an American Cancer Society Institutional Research Grant (IRG-58-004), and the University of Chicago Comprehensive Cancer Center (including Support Grant P30 CA14599). N.D.S. was supported by MSKCC Comprehensive Cancer Center (Support Grant P30 CA008748). J.P.A. was supported by funding from the Howard Hughes Medical Institute.	Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Magurran A E, 1988, ECOLOGICAL DIVERSITY; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032	23	224	229	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2013	339	6124					1219	1224		10.1126/science.1233913	http://dx.doi.org/10.1126/science.1233913			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471412	Green Accepted			2022-12-24	WOS:000315709900052
J	Wright, GA; Baker, DD; Palmer, MJ; Stabler, D; Mustard, JA; Power, EF; Borland, AM; Stevenson, PC				Wright, G. A.; Baker, D. D.; Palmer, M. J.; Stabler, D.; Mustard, J. A.; Power, E. F.; Borland, A. M.; Stevenson, P. C.			Caffeine in Floral Nectar Enhances a Pollinator's Memory of Reward	SCIENCE			English	Article							MUSHROOM BODY; PLASTICITY; EVOLUTION; HONEYBEES; COFFEE; BEES	Plant defense compounds occur in floral nectar, but their ecological role is not well understood. We provide evidence that plant compounds pharmacologically alter pollinator behavior by enhancing their memory of reward. Honeybees rewarded with caffeine, which occurs naturally in nectar of Coffea and Citrus species, were three times as likely to remember a learned floral scent as were honeybees rewarded with sucrose alone. Caffeine potentiated responses of mushroom body neurons involved in olfactory learning and memory by acting as an adenosine receptor antagonist. Caffeine concentrations in nectar did not exceed the bees' bitter taste threshold, implying that pollinators impose selection for nectar that is pharmacologically active but not repellent. By using a drug to enhance memories of reward, plants secure pollinator fidelity and improve reproductive success.	[Wright, G. A.; Stabler, D.; Power, E. F.] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Baker, D. D.; Stabler, D.; Power, E. F.; Borland, A. M.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Palmer, M. J.] Univ Dundee, Ninewells Med Sch, Med Res Inst, Div Neurosci, Dundee DD1 9SY, Scotland; [Mustard, J. A.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Stevenson, P. C.] Royal Bot Gardens, Jodrell Lab, Richmond TW9 3AB, Surrey, England; [Stevenson, P. C.] Univ Greenwich, Nat Resources Inst, Chatham ME4 4TB, Kent, England	Newcastle University - UK; Newcastle University - UK; University of Dundee; Arizona State University; Arizona State University-Tempe; Royal Botanic Gardens, Kew; University of Greenwich	Wright, GA (corresponding author), Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	jeri.wright@ncl.ac.uk	stevenson, philip c/E-8741-2013; Stevenson, Philip C/E-8822-2013	stevenson, philip c/0000-0002-0736-3619; Stevenson, Philip C/0000-0002-0736-3619; Palmer, Mary/0000-0002-5539-6052; Mustard, Julie A/0000-0002-1412-1140; Power, Eileen/0000-0002-5941-4676; Borland, Anne/0000-0003-4560-9998	Linnean Society of London; UK government Insect Pollinators Initiative [BB/I000968/1];  [BB/1000313/1]; BBSRC [BB/I000445/1, BB/I000968/1, BB/I000313/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000313/1, BB/I000445/1, BB/I000968/1] Funding Source: researchfish	Linnean Society of London; UK government Insect Pollinators Initiative; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank staff at Centro Agronomico Tropicale de Investigacion et Ensenanza in Costa Rica for access to the Coffea collections and at Technological Education Institute of Crete for access to Citrus orchards; M. Thomson, K. Smith, F. Marion-Poll, and A. Popescu for help with the data collection; M. Thompson for beekeeping; and J. Harvey and C. Connolly for project support. This work was funded in part by the Linnean Society of London and by a UK government Insect Pollinators Initiative grant BB/I000968/1 to G.A.W. and a separate grant to C. Connolly (BB/1000313/1). Methods and additional data are available in the online supplementary materials. All data are archived on the Natural Environment Research Council Environmental Information Data Centre.	Ashihara H, 2001, TRENDS PLANT SCI, V6, P407, DOI 10.1016/S1360-1385(01)02055-6; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Chittka L, 1997, BEHAV ECOL, V8, P239, DOI 10.1093/beheco/8.3.239; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; Galili DS, 2011, J NEUROSCI, V31, P7240, DOI 10.1523/JNEUROSCI.6667-10.2011; Harborne J. B., 1993, INTRO ECOLOGICAL BIO, V4th; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hollingsworth RG, 2002, NATURE, V417, P915, DOI 10.1038/417915a; Hopkins R, 2012, SCIENCE, V335, P1090, DOI 10.1126/science.1215198; Kretschmar JA, 1999, PHYTOCHEMISTRY, V52, P19, DOI 10.1016/S0031-9422(99)00119-3; KUNIN WE, 1993, ECOLOGY, V74, P2145, DOI 10.2307/1940859; Menzel R, 2005, J EXP BIOL, V208, P4317, DOI 10.1242/jeb.01908; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Mustard JA, 2012, BEHAV BRAIN RES, V232, P217, DOI 10.1016/j.bbr.2012.04.014; Nehlig A, 1999, NEUROSCI BIOBEHAV R, V23, P563, DOI 10.1016/S0149-7634(98)00050-5; OKAMOTO M, 1994, PHARMACOL TOXICOL, V75, P1, DOI 10.1111/j.1600-0773.1994.tb00316.x; Oleskevich S, 1997, J NEUROPHYSIOL, V78, P528, DOI 10.1152/jn.1997.78.1.528; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; Roubik DW, 2002, NATURE, V417, P708, DOI 10.1038/417708a; Rudolph T, 2010, ACTA ANAESTH SCAND, V54, P521, DOI 10.1111/j.1399-6576.2009.02201.x; Simons SB, 2012, NAT NEUROSCI, V15, P23, DOI 10.1038/nn.2962; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Sperlagh B, 2011, CURR TOP MED CHEM, V11, P1034, DOI 10.2174/156802611795347564; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Sullivan RJ, 2008, P ROY SOC B-BIOL SCI, V275, P1231, DOI 10.1098/rspb.2007.1673; Szyszka P, 2011, J NEUROSCI, V31, P7229, DOI 10.1523/JNEUROSCI.6668-10.2011; Szyszka P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.003.2008; Wright GA, 2010, CURR BIOL, V20, P2234, DOI 10.1016/j.cub.2010.11.040; Wright GA, 2009, FUNCT ECOL, V23, P841, DOI 10.1111/j.1365-2435.2009.01627.x	31	190	196	13	370	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1202	1204		10.1126/science.1228806	http://dx.doi.org/10.1126/science.1228806			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471406	Green Submitted, Green Accepted			2022-12-24	WOS:000315709900046
J	Seed, KD; Lazinski, DW; Calderwood, SB; Camilli, A				Seed, Kimberley D.; Lazinski, David W.; Calderwood, Stephen B.; Camilli, Andrew			A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity	NATURE			English	Article							CAS SYSTEMS; PHAGE; INTERFERENCE; ARCHAEA; DEFENSE; RNA; DNA; RESISTANCE; EVOLUTION; PATHOGEN	Bacteriophages (or phages) are the most abundant biological entities on earth, and are estimated to outnumber their bacterial prey by tenfold(1). The constant threat of phage predation has led to the evolution of a broad range of bacterial immunity mechanisms that in turn result in the evolution of diverse phage immune evasion strategies, leading to a dynamic co-evolutionary arms race(2,3). Although bacterial innate immune mechanisms against phage abound, the only documented bacterial adaptive immune system is the CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins) system, which provides sequence-specific protection from invading nudeic acids, including phage(4-11). Here we show a remarkable turn of events, in which a phage-encoded CRISPR/Cas system is used to counteract a phage inhibitory chromosomal island of the bacterial host. A successful lytic infection by the phage is dependent on sequence identity between CRISPR spacers and the target chromosomal island. In the absence of such targeting, the phage-encoded CRISPR/Cas system can acquire new spacers to evolve rapidly and ensure effective targeting of the chromosomal island to restore phage replication.	[Seed, Kimberley D.; Lazinski, David W.; Camilli, Andrew] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA; [Seed, Kimberley D.; Lazinski, David W.; Camilli, Andrew] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Calderwood, Stephen B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Calderwood, Stephen B.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Howard Hughes Medical Institute; Tufts University; Tufts University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Camilli, A (corresponding author), Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA.	andrew.camilli@tufts.edu			US National Institutes of Health [AI055058, AI045746, AI058935]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055058, R01AI045746, U01AI058935] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the Tufts University Core Facility for sequencing and computational support. This work was supported by US National Institutes of Health grants AI055058 (A.C.), AI045746 (A.C.) and AI058935 (S.B.C.). A.C. is a Howard Hughes Medical Institute Investigator.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; De Souza Silva O, 2010, PLASMID, V64, P186, DOI 10.1016/j.plasmid.2010.08.001; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P6119, DOI 10.1073/pnas.0502069102; Garcia-Heredia I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033802; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lazinski DW, 2013, BIOTECHNIQUES, V54, P25, DOI 10.2144/000113981; Longini IM, 2002, J INFECT DIS, V186, P246, DOI 10.1086/341206; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Ram G, 2012, P NATL ACAD SCI USA, V109, P16300, DOI 10.1073/pnas.1204615109; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Seed KD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002917; Seed KD, 2011, MBIO, V2, DOI 10.1128/mBio.00334-10; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002	30	220	252	0	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					489	491		10.1038/nature11927	http://dx.doi.org/10.1038/nature11927			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446421	Green Submitted, Green Accepted			2022-12-24	WOS:000315661500041
J	Tanser, F; Barnighausen, T; Grapsa, E; Zaidi, J; Newell, ML				Tanser, Frank; Baernighausen, Till; Grapsa, Erofili; Zaidi, Jaffer; Newell, Marie-Louise			High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa	SCIENCE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; COHORT PROFILE; PREVENTION; POPULATION; INFECTIONS; IMPACT; EPIDEMIOLOGY; PREVALENCE; COMMUNITY; PROGRAM	The landmark HIV Prevention Trials Network (HPTN) 052 trial in HIV-discordant couples demonstrated unequivocally that treatment with antiretroviral therapy (ART) substantially lowers the probability of HIV transmission to the HIV-uninfected partner. However, it has been vigorously debated whether substantial population-level reductions in the rate of new HIV infections could be achieved in "real-world" sub-Saharan African settings where stable, cohabiting couples are often not the norm and where considerable operational challenges exist to the successful and sustainable delivery of treatment and care to large numbers of patients. We used data from one of Africa's largest population-based prospective cohort studies (in rural KwaZulu-Natal, South Africa) to follow up a total of 16,667 individuals who were HIV-uninfected at baseline, observing individual HIV seroconversions over the period 2004 to 2011. Holding other key HIV risk factors constant, individual HIV acquisition risk declined significantly with increasing ART coverage in the surrounding local community. For example, an HIV-uninfected individual living in a community with high ART coverage (30 to 40% of all HIV-infected individuals on ART) was 38% less likely to acquire HIV than someone living in a community where ART coverage was low (<10% of all HIV-infected individuals on ART).	[Tanser, Frank; Baernighausen, Till; Grapsa, Erofili; Zaidi, Jaffer; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa; [Baernighausen, Till] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Newell, Marie-Louise] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England	University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; University of London; University College London	Tanser, F (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa.	tanserf@africacentre.ac.za	Tanser, Frank/ABE-8326-2021; Newell, Marie-Louise/AAE-8222-2019; Bärnighausen, Till/Y-2388-2019	Newell, Marie-Louise/0000-0002-1074-7699; Tanser, Frank/0000-0001-9797-0000	National Institute of Child Health and Human Development [1R01-HD058482-01]; Wellcome Trust, UK [082384/Z/07/Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust, UK(Wellcome Trust); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by grant 1R01-HD058482-01 from the National Institute of Child Health and Human Development. Funding for the Africa Centre's Demographic Surveillance Information System and Population-Based HIV Survey was received from the Wellcome Trust, UK (grant 082384/Z/07/Z).	Anglemyer A, 2011, COCHRANE DB SYST REV, V2011; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Budtz-Jorgensen E, 2003, STAT MED, V22, P3089, DOI 10.1002/sim.1541; Castel A., 2011, 18 ANN C RETR OPP IN; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Granich R, 2011, CURR HIV RES, V9, P446, DOI 10.2174/157016211798038597; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Hontelez JAC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021919; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Law MG, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-10; McGrath N, 2012, 19 INT AIDS C WASH D; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Shelton JD, 2011, SCIENCE, V334, P1645, DOI 10.1126/science.1212353; Smith K, 2011, CURR OPIN HIV AIDS, V6, P315, DOI 10.1097/COH.0b013e32834788e7; South African National Department of Health, 2010, NAT ANT TREATM GUID; SUSSER M, 1991, AM J EPIDEMIOL, V133, P635, DOI 10.1093/oxfordjournals.aje.a115939; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; UNAIDS, 2012, TOG WE WILL END AIDS; United Nations General Assembly, 2011, POL DECL HIV AIDS IN; Venkatesh KK, 2011, AIDS, V25, P1939, DOI 10.1097/QAD.0b013e32834b4ced; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649	33	584	590	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					966	971		10.1126/science.1228160	http://dx.doi.org/10.1126/science.1228160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430656	Green Accepted			2022-12-24	WOS:000315149600052
J	Wippich, F; Bodenmiller, B; Trajkovska, MG; Wanka, S; Aebersold, R; Pelkmans, L				Wippich, Frank; Bodenmiller, Bernd; Trajkovska, Maria Gustafsson; Wanka, Stefanie; Aebersold, Ruedi; Pelkmans, Lucas			Dual Specificity Kinase DYRK3 Couples Stress Granule Condensation/Dissolution to mTORC1 Signaling	CELL			English	Article							RNA-BINDING PROTEINS; GERMLINE P GRANULES; PHASE-TRANSITIONS; GENE-EXPRESSION; FAMILY KINASE; PHOSPHORYLATION; RAPAMYCIN; TARGET; CELLS; PHOSPHOPROTEOME	Cytosolic compartmentalization through liquid-liquid unmixing, such as the formation of RNA granules, is involved in many cellular processes and might be used to regulate signal transduction. However, specific molecular mechanisms by which liquid-liquid unmixing and signal transduction are coupled remain unknown. Here, we show that during cellular stress the dual specificity kinase DYRK3 regulates the stability of P-granule-like structures and mTORC1 signaling. DYRK3 displays a cyclic partitioning mechanism between stress granules and the cytosol via a low-complexity domain in its N terminus and its kinase activity. When DYRK3 is inactive, it prevents stress granule dissolution and the release of sequestered mTORC1. When DYRK3 is active, it allows stress granule dissolution, releasing mTORC1 for signaling and promoting its activity by directly phosphorylating the mTORC1 inhibitor PRAS40. This mechanism links cytoplasmic compartmentalization via liquid phase transitions with cellular signaling.	[Wippich, Frank; Bodenmiller, Bernd; Trajkovska, Maria Gustafsson; Wanka, Stefanie; Pelkmans, Lucas] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Wippich, Frank; Aebersold, Ruedi] Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pelkmans, L (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	lucas.pelkmans@imls.uzh.ch		Pelkmans, Lucas/0000-0002-6754-9730; Wippich, Frank/0000-0003-2633-9777	Swiss National Science Foundation; Boehringer Ingelheim Fonds; University of Zurich; European Union; SystemsX.ch RTD project PhosphoNetX	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Boehringer Ingelheim Fonds(Boehringer Ingelheim); University of Zurich; European Union(European Commission); SystemsX.ch RTD project PhosphoNetX	We thank Prisca Liberali for help with the compound screen, Herbert Polzhofer for cloning GFP-DYRK3, Lilli Stergiou for help with the initial phase of this project, and all members of the Pelkmans lab for helpful discussions. We further thank Paul Anderson, Nancy Kedersha, Markku Varjosalo, and Edward Chan for reagents used in this study. F.W. is supported by a ProDoc fellowship from the Swiss National Science Foundation and is a member of the Life Science Zurich Graduate School. B.B. was supported by fellowships of the Boehringer Ingelheim Fonds and the Swiss National Science Foundation. L.P. is supported by the University of Zurich, the Swiss National Science Foundation, and the European Union. This work was supported by the SystemsX.ch RTD project PhosphoNetX.	Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Creasy C., 2007, BLOOD, V110, P510; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; Hachet O, 2011, CELL, V145, P1116, DOI 10.1016/j.cell.2011.05.014; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Hyman AA, 2012, SCIENCE, V337, P1047, DOI 10.1126/science.1223728; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Taminato A, 2002, MOL BIOL CELL, V13, P2266, DOI 10.1091/mbc.01-11-0555; Voronina E, 2010, DEVELOPMENT, V137, P1441, DOI 10.1242/dev.047654; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang DY, 2005, GENOMICS, V85, P117, DOI 10.1016/j.ygeno.2004.08.021; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	45	356	367	1	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					791	805		10.1016/j.cell.2013.01.033	http://dx.doi.org/10.1016/j.cell.2013.01.033			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415227	Bronze			2022-12-24	WOS:000314945600014
J	Buchholz, VR; Flossdorf, M; Hensel, I; Kretschmer, L; Weissbrich, B; Graf, P; Verschoor, A; Schiemann, M; Hofer, T; Busch, DH				Buchholz, Veit R.; Flossdorf, Michael; Hensel, Inge; Kretschmer, Lorenz; Weissbrich, Bianca; Graef, Patricia; Verschoor, Admar; Schiemann, Matthias; Hoefer, Thomas; Busch, Dirk H.			Disparate Individual Fates Compose Robust CD8(+) T Cell Immunity	SCIENCE			English	Article							TRANSCRIPTION FACTOR; CUTTING EDGE; MEMORY; EFFECTOR; PRECURSOR; SUBSETS; STEM; DIFFERENTIATION; EXPANSION; DIVISION	A core feature of protective T cell responses to infection is the robust expansion and diversification of naive antigen-specific T cell populations into short-lived effector and long-lived memory subsets. By means of in vivo fate mapping, we found a striking variability of immune responses derived from individual CD8(+) T cells and show that robust acute and recall immunity requires the initial recruitment of multiple precursors. Unbiased mathematical modeling identifies the random integration of multiple differentiation and division events as the driving force behind this variability. Within this probabilistic framework, cell fate is specified along a linear developmental path that progresses from slowly proliferating long-lived to rapidly expanding short-lived subsets. These data provide insights into how complex biological systems implement stochastic processes to guarantee robust outcomes.	[Buchholz, Veit R.; Hensel, Inge; Kretschmer, Lorenz; Weissbrich, Bianca; Graef, Patricia; Verschoor, Admar; Schiemann, Matthias; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Flossdorf, Michael; Hoefer, Thomas] German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany; [Flossdorf, Michael; Hoefer, Thomas] Heidelberg Univ, BioQuant Ctr, D-69120 Heidelberg, Germany; [Busch, Dirk H.] TUM, Helmholtz Ctr Munich Neuherberg, Clin Cooperat Grp Antigen Specif Immunotherapy &, D-81675 Munich, Germany; [Busch, Dirk H.] TUM, Inst Adv Study, Focus Grp Clin Cell Proc & Purificat, D-81675 Munich, Germany; [Busch, Dirk H.] Natl Ctr Infect Res DZIF, D-81675 Munich, Germany	Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; German Center for Infection Research	Hofer, T (corresponding author), German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany.	t.hoefer@dkfz-heidelberg.de; dirk.busch@mikrobio.med.tum.de	Höfer, Thomas/G-5665-2013; Buchholz, Veit R./AAF-6966-2021	Höfer, Thomas/0000-0003-3560-8780; Buchholz, Veit R./0000-0003-0441-3913	Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer; EU-FP7 SYBILLA [201106]; BMBF ForSysPartner [0315267E]; National Science Foundation [NSF PHY11-25915];  [SFB TR 36 (TP-B10/13)];  [SFB 1054 (TP-B09)];  [SFB 914 (TP-B04)]	Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer; EU-FP7 SYBILLA; BMBF ForSysPartner(Federal Ministry of Education & Research (BMBF)); National Science Foundation(National Science Foundation (NSF)); ; ; 	The authors thank L. Henkel for cell sorting; A. Muschaweckh and I. Drexler for providing Vaccinia-OVA and MVA-OVA; and K. Kerksiek, H. Wagner, C. Stemberger, F. Anderl, S. Dreher, and T. G. Grunewald for helpful discussion and/or critically reading the manuscript. The authors declare no conflict of interest. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by the SFB TR 36 (TP-B10/13, TP-Z1), the SFB 1054 (TP-B09), the SFB 914 (TP-B04), the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer, EU-FP7 SYBILLA (201106), BMBF ForSysPartner (0315267E), and by the National Science Foundation under grant NSF PHY11-25915.	Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; D'Souza WN, 2006, J IMMUNOL, V177, P777, DOI 10.4049/jimmunol.177.2.777; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	23	272	273	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					630	635		10.1126/science.1235454	http://dx.doi.org/10.1126/science.1235454			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23493420				2022-12-24	WOS:000318268900053
J	Kim, JH; Resende, R; Wennekes, T; Chen, HM; Bance, N; Buchini, S; Watts, AG; Pilling, P; Streltsov, VA; Petric, M; Liggins, R; Barrett, S; McKimm-Breschkin, JL; Niikura, M; Withers, SG				Kim, Jin-Hyo; Resende, Ricardo; Wennekes, Tom; Chen, Hong-Ming; Bance, Nicole; Buchini, Sabrina; Watts, Andrew G.; Pilling, Pat; Streltsov, Victor A.; Petric, Martin; Liggins, Richard; Barrett, Susan; McKimm-Breschkin, Jennifer L.; Niikura, Masahiro; Withers, Stephen G.			Mechanism-Based Covalent Neuraminidase Inhibitors with Broad-Spectrum Influenza Antiviral Activity	SCIENCE			English	Article							VIRUS NEURAMINIDASE; DRUG DESIGN; H1N1 VIRUS; RESISTANT; SIALIDASE; 4-GUANIDINO-NEU5AC2EN; SENSITIVITY; OSELTAMIVIR; MUTATIONS; VARIANT	Influenza antiviral agents play important roles in modulating disease severity and in controlling pandemics while vaccines are prepared, but the development of resistance to agents like the commonly used neuraminidase inhibitor oseltamivir may limit their future utility. We report here on a new class of specific, mechanism-based anti-influenza drugs that function through the formation of a stabilized covalent intermediate in the influenza neuraminidase enzyme, and we confirm this mode of action with structural and mechanistic studies. These compounds function in cell-based assays and in animal models, with efficacies comparable to that of the neuraminidase inhibitor zanamivir and with broad-spectrum activity against drug-resistant strains in vitro. The similarity of their structure to that of the natural substrate and their mechanism-based design make these attractive antiviral candidates.	[Kim, Jin-Hyo; Resende, Ricardo; Wennekes, Tom; Chen, Hong-Ming; Buchini, Sabrina; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Bance, Nicole; Niikura, Masahiro] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Watts, Andrew G.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Pilling, Pat; Streltsov, Victor A.; Barrett, Susan; McKimm-Breschkin, Jennifer L.] CSIRO, Parkville, Vic 3052, Australia; [Petric, Martin] British Columbia Ctr Dis Control, Prov Hlth Serv Author, Vancouver, BC V5Z 4R4, Canada; [Liggins, Richard] CDRD, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; Simon Fraser University; University of Bath; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca	Watts, Andrew/D-2802-2014; Streltsov, Victor/M-9446-2019; Wennekes, Tom/ABD-1448-2021; McKimm-Breschkin, Jennifer L/D-1880-2013; Wennekes, Tom/H-8271-2012; Pilling, Patricia/AAT-7845-2021	Streltsov, Victor/0000-0002-7846-4396; Wennekes, Tom/0000-0002-2368-7728; Wennekes, Tom/0000-0002-2368-7728; McKimm-Breschkin, Jennifer/0000-0002-2345-6786; Watts, Andrew/0000-0003-4299-2717; Barrett, Susan/0000-0003-1132-5268	Canadian Institutes for Health Research; Pfizer CDRD Innovation Fund; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund; Tier 1 Canada Research Chair; Korea Research Foundation [KRF-2005-214-C00215]; Michael Smith Foundation for Health Research; Netherlands Organization for Scientific Research (NWO); Medical Research Council UK [G0600514]; National Health and Medical Research Council Australia [595625]; Medical Research Council [G0600514] Funding Source: researchfish; MRC [G0600514] Funding Source: UKRI	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer CDRD Innovation Fund; Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; Tier 1 Canada Research Chair(Canada Research Chairs); Korea Research Foundation(National Research Foundation of Korea); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Canadian Institutes for Health Research, the Pfizer CDRD Innovation Fund, the Canadian Foundation for Innovation, and the British Columbia Knowledge Development Fund for support of this work. S. G. W. is supported by a Tier 1 Canada Research Chair. J.-H.K. was supported by fellowships from the Korea Research Foundation (KRF-2005-214-C00215) and the Michael Smith Foundation for Health Research. T. W. was supported by the Netherlands Organization for Scientific Research (NWO) through a Rubicon fellowship. Parts of this work were funded by grant G0600514 from the Medical Research Council UK to A. G. W. and J.L.M.-B. and Pandemic influenza grant 595625 from the National Health and Medical Research Council Australia to J.L.M.-B. The authors acknowledge the use of the MX1 beamline at the Australian Synchrotron, Victoria, Australia. The data presented in this paper were tabulated in the main paper and the supplementary materials. Coordinates of the complex have been deposited in the Protein Data Bank with code 3W09. Patent protection for compounds described has been sought by the University of British Columbia under the following applications: PCT/CA2010/001063 "2,3-Fluorinated Glycosides as Neuraminidase Inhibitors and their Use as Anti-Virals" (S. G. W., A. G. W., J.-H.K., and T. W.); PCT/CA2013/050034 "3' Equatorial-Fluorine-Substituted Neuraminidase Inhibitor Compounds, Compositions and Methods for the Use Thereof as Anti-Virals" (S.G.W., H.-M.C., and R.R).	Barrett S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023627; Blick TJ, 1995, VIROLOGY, V214, P475, DOI 10.1006/viro.1995.0058; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Chavas LMG, 2010, J MED CHEM, V53, P2998, DOI 10.1021/jm100078r; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Eshaghi A, 2011, EMERG INFECT DIS, V17, P1472, DOI 10.3201/eid1708.102004; Gubareva LV, 1997, J VIROL, V71, P3385, DOI 10.1128/JVI.71.5.3385-3390.1997; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; Newstead SL, 2008, J BIOL CHEM, V283, P9080, DOI 10.1074/jbc.M710247200; Nguyen HT, 2010, CLIN INFECT DIS, V51, P983, DOI 10.1086/656439; Tashiro M, 2009, ANTIVIR THER, V14, P751, DOI 10.3851/IMP1194; van der Vries E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002914; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; VONITZSTEIN M, 1993, CARBOHYD RES, V244, P181, DOI 10.1016/0008-6215(93)80014-6; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	20	144	151	4	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					71	75		10.1126/science.1232552	http://dx.doi.org/10.1126/science.1232552			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23429702	Green Accepted			2022-12-24	WOS:000317061100047
J	Ling, HQ; Zhao, SC; Liu, DC; Wang, JY; Sun, H; Zhang, C; Fan, HJ; Li, D; Dong, LL; Tao, Y; Gao, C; Wu, HL; Li, YW; Cui, Y; Guo, XS; Zheng, SS; Wang, B; Yu, K; Liang, QS; Yang, WL; Lou, XY; Chen, J; Feng, MJ; Jian, JB; Zhang, XF; Luo, GB; Jiang, Y; Liu, JJ; Wang, ZB; Sha, YH; Zhang, BR; Wu, HJ; Tang, DZ; Shen, QH; Xue, PY; Zou, SH; Wang, XJ; Liu, X; Wang, FM; Yang, YP; An, XL; Dong, ZY; Zhang, KP; Zhang, XQ; Luo, MC; Dvorak, J; Tong, YP; Wang, J; Yang, HM; Li, ZS; Wang, DW; Zhang, AM; Wang, J				Ling, Hong-Qing; Zhao, Shancen; Liu, Dongcheng; Wang, Junyi; Sun, Hua; Zhang, Chi; Fan, Huajie; Li, Dong; Dong, Lingli; Tao, Yong; Gao, Chuan; Wu, Huilan; Li, Yiwen; Cui, Yan; Guo, Xiaosen; Zheng, Shusong; Wang, Biao; Yu, Kang; Liang, Qinsi; Yang, Wenlong; Lou, Xueyuan; Chen, Jie; Feng, Mingji; Jian, Jianbo; Zhang, Xiaofei; Luo, Guangbin; Jiang, Ying; Liu, Junjie; Wang, Zhaobao; Sha, Yuhui; Zhang, Bairu; Wu, Huajun; Tang, Dingzhong; Shen, Qianhua; Xue, Pengya; Zou, Shenhao; Wang, Xiujie; Liu, Xin; Wang, Famin; Yang, Yanping; An, Xueli; Dong, Zhenying; Zhang, Kunpu; Zhang, Xiangqi; Luo, Ming-Cheng; Dvorak, Jan; Tong, Yiping; Wang, Jian; Yang, Huanming; Li, Zhensheng; Wang, Daowen; Zhang, Aimin; Wang, Jun			Draft genome of the wheat A-genome progenitor Triticum urartu	NATURE			English	Article							EVOLUTION; GENE; IDENTIFICATION; LOCI; MAP	Bread wheat (Triticum aestivum, AABBDD) is one of the most widely cultivated and consumed food crops in the world. However, the complex polyploid nature of its genome makes genetic and functional analyses extremely challenging. The A genome, as a basic genome of bread wheat and other polyploid wheats, for example, T. turgidum (AABB), T. timopheevii (AAGG) and T. zhukovskyi (AAGGA(m)A(m)), is central to wheat evolution, domestication and genetic improvement(1). The progenitor species of the A genome is the diploid wild einkorn wheat T. urartu(2), which resembles cultivated wheat more extensively than do Aegilops speltoides (the ancestor of the B genome(3)) and Ae. tauschii (the donor of the D genome(4)), especially in the morphology and development of spike and seed. Here we present the generation, assembly and analysis of a whole-genome shotgun draft sequence of the T. urartu genome. We identified protein-coding gene models, performed genome structure analyses and assessed its utility for analysing agronomically important genes and for developing molecular markers. Our T. urartu genome assembly provides a diploid reference for analysis of polyploid wheat genomes and is a valuable resource for the genetic improvement of wheat.	[Ling, Hong-Qing; Liu, Dongcheng; Wang, Junyi; Sun, Hua; Fan, Huajie; Dong, Lingli; Wu, Huilan; Li, Yiwen; Cui, Yan; Zheng, Shusong; Wang, Biao; Yu, Kang; Yang, Wenlong; Lou, Xueyuan; Zhang, Xiaofei; Luo, Guangbin; Zhang, Bairu; Tang, Dingzhong; Shen, Qianhua; Xue, Pengya; Zou, Shenhao; Liu, Xin; Wang, Famin; Yang, Yanping; An, Xueli; Dong, Zhenying; Zhang, Kunpu; Zhang, Xiangqi; Tong, Yiping; Li, Zhensheng; Wang, Daowen; Zhang, Aimin] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China; [Zhao, Shancen; Wang, Junyi; Zhang, Chi; Li, Dong; Tao, Yong; Gao, Chuan; Guo, Xiaosen; Liang, Qinsi; Chen, Jie; Feng, Mingji; Jian, Jianbo; Jiang, Ying; Liu, Junjie; Wang, Zhaobao; Sha, Yuhui; Wang, Jian; Yang, Huanming; Wang, Jun] BGI Shenzhen, Shenzhen 518038, Peoples R China; [Zhao, Shancen] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Zhao, Shancen] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Wu, Huajun; Wang, Xiujie] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Luo, Ming-Cheng; Dvorak, Jan] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Beijing Genomics Institute (BGI); Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of California System; University of California Davis; University of Copenhagen; King Abdulaziz University	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518038, Peoples R China.	hqling@genetics.ac.cn; zsli@genetics.ac.cn; dwwang@genetics.ac.cn; amzhang@genetics.ac.cn; wangj@genomics.cn	Tang, Dingzhong/AAZ-2500-2020; Shen, Qian-Hua/D-2734-2013; Sun, Hua/O-6729-2018; Wang, Xiu-Jie/L-1312-2019; wang, junyi/GYA-3213-2022; Ling, Hong-Qing/ABC-9451-2020; Liang, Qinsi/AAK-5234-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Tang, Dingzhong/0000-0001-8850-8754; Shen, Qian-Hua/0000-0002-9446-3086; Sun, Hua/0000-0003-2169-0808; Jian, Jianbo/0000-0003-2187-5490; Luo, Ming-Cheng/0000-0002-9744-5887; zhang, xiaofei/0000-0003-4516-9179; Wang, Jun/0000-0002-8540-8931; wang, dao wen/0000-0002-6230-8735; Wang, Jun/0000-0002-2113-5874	Ministry of Science and Technology of China [2010DFB33540, 2011CB100304, 2011AA100104, 2009CB118300]; Ministry of Science and Technology of China [2010DFB33540, 2011CB100304, 2011AA100104, 2009CB118300]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank L. Goodman for assistance in editing the manuscript, and M. Bevan and Y.-B. Xue for critical reading of the manuscript. This work was supported by grants from the Ministry of Science and Technology of China (the special fund for the State Key Laboratory of Plant Cell and Chromosome Engineering, 2010DFB33540, 2011CB100304, 2011AA100104 and 2009CB118300).	BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; DVORAK J, 1993, GENOME, V36, P21, DOI 10.1139/g93-004; DVORAK J, 1990, P NATL ACAD SCI USA, V87, P9640, DOI 10.1073/pnas.87.24.9640; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; FAOSTAT, 2011, FAOSTAT; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Hernandez P, 2012, PLANT J, V69, P377, DOI 10.1111/j.1365-313X.2011.04808.x; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Ling H.-Q, 2013, GIGASCIENCE; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; MCFADDEN ES, 1946, J HERED, V37, P81, DOI 10.1093/oxfordjournals.jhered.a105590; Ozkan H, 2010, AOB PLANTS, DOI 10.1093/aobpla/plq015; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Peng JHH, 2011, MOL BREEDING, V28, P281, DOI 10.1007/s11032-011-9608-4; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Zhang LY, 2010, J INTEGR PLANT BIOL, V52, P996, DOI 10.1111/j.1744-7909.2010.00967.x	26	539	616	10	339	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					87	90		10.1038/nature11997	http://dx.doi.org/10.1038/nature11997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23535596	hybrid, Green Published			2022-12-24	WOS:000316993400030
J	Li, C; Zhang, TN; Goldman, DI				Li, Chen; Zhang, Tingnan; Goldman, Daniel I.			A Terradynamics of Legged Locomotion on Granular Media	SCIENCE			English	Article							HYDRODYNAMICS	The theories of aero- and hydrodynamics predict animal movement and device design in air and water through the computation of lift, drag, and thrust forces. Although models of terrestrial legged locomotion have focused on interactions with solid ground, many animals move on substrates that flow in response to intrusion. However, locomotor-ground interaction models on such flowable ground are often unavailable. We developed a force model for arbitrarily-shaped legs and bodies moving freely in granular media, and used this "terradynamics" to predict a small legged robot's locomotion on granular media using various leg shapes and stride frequencies. Our study reveals a complex but generic dependence of stresses in granular media on intruder depth, orientation, and movement direction and gives insight into the effects of leg morphology and kinematics on movement.	[Li, Chen; Zhang, Tingnan; Goldman, Daniel I.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Li, Chen] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University System of Georgia; Georgia Institute of Technology; University of California System; University of California Berkeley	Goldman, DI (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	daniel.goldman@physics.gatech.edu	Li, Chen/A-4003-2013	Li, Chen/0000-0001-7516-3646	Burroughs Wellcome Fund; Army Research Laboratory Micro Autonomous Systems and Technology Collaborative Technology Alliance; Army Research Office; NSF; Miller Institute for Basic Research in Science of the University of California, Berkeley	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Army Research Laboratory Micro Autonomous Systems and Technology Collaborative Technology Alliance; Army Research Office; NSF(National Science Foundation (NSF)); Miller Institute for Basic Research in Science of the University of California, Berkeley	We thank Y. Ding, P. Umbanhowar, N. Gravish, G. Meirion-Griffith, S. Sharpe, H. Komsuoglu, D. Koditschek, and R. Full for discussions; J. Shen for assistance with robot modification; P. Masarati for multibody dynamic simulator support; S. Sharpe for measuring the angle of repose of 3-mm glass spheres and assistance with photography; P. Umbanhowar and H. Marvi for natural sand collection; and all the members of the Complex Rheology And Biomechanics Lab at Georgia Tech for general assistance. This work was supported by the Burroughs Wellcome Fund, the Army Research Laboratory Micro Autonomous Systems and Technology Collaborative Technology Alliance, the Army Research Office, and the NSF Physics of Living Systems program. C.L. was partially supported by a Miller Research Fellowship from the Miller Institute for Basic Research in Science of the University of California, Berkeley. The authors declare that they have no competing interests. C.L. designed the study, performed resistive force measurements, and performed robot experiments; C.L. and T.Z. performed model calculations; T.Z. performed robot simulation; D.I.G. oversaw the study; and C.L. and D.I.G. wrote the paper.	Bagnold RA, 2005, PHYS BLOWN SAND DESE; Bekker M, 1960, OFF THE ROAD LOCOMOT; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Brand LR, 1996, J PALEONTOL, V70, P1004, DOI 10.1017/S0022336000038701; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; Chaudhuri B, 2006, POWDER TECHNOL, V165, P105, DOI 10.1016/j.powtec.2006.04.001; Cho GC, 2006, J GEOTECH GEOENVIRON, V132, P591, DOI 10.1061/(ASCE)1090-0241(2006)132:5(591); Clack J. A., 2012, GAINING GROUND ORIGI; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Ding Y, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028001; Dudley R, 2002, BIOMECHANICS INSECT; Etkin B., 1972, DYNAMICS ATMOSPHERIC, V2nd ed.; FANCY SG, 1985, J WILDLIFE MANAGE, V49, P987, DOI 10.2307/3801384; Fearing R. S., 2000, IEEE INT C ROB AUT, V2000, P1509; Haynes G.C., 2011, 2011 IEEE SAF SEC RE, V2011, P134; Holmes P, 2006, SIAM REV, V48, P207, DOI 10.1137/S0036144504445133; Kamrin K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.178301; Lauder GV, 2007, J EXP BIOL, V210, P2767, DOI 10.1242/jeb.000265; Lauder GV, 2002, INTEGR COMP BIOL, V42, P1009, DOI 10.1093/icb/42.5.1009; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; Li C, 2012, J EXP BIOL, V215, P3293, DOI 10.1242/jeb.061937; Li C, 2009, P NATL ACAD SCI USA, V106, P3029, DOI 10.1073/pnas.0809095106; Maladen RD, 2009, SCIENCE, V325, P314, DOI 10.1126/science.1172490; Nedderman R.M., 1992, STATICS KINEMATICS G; Newman J.N., 2017, MARINE HYDRODYNAMICS; Pennycuick C.J., 1975, AVIAN BIOL, P1, DOI DOI 10.1016/B978-0-12-249405-5.50009-4; Raibert M., 2008, IFAC P, V41, P10822, DOI [10.3182/20080706-5-KR-1001.01833, DOI 10.3182/20080706-5-KR-1001.01833]; Spenko M., 2010, IEEE AER C, V2010, P1; Vitt LJ, 2001, COPEIA, P401, DOI 10.1643/0045-8511(2001)001[0401:LOTLLT]2.0.CO;2; Vogel S, 2020, LIFE MOVING FLUIDS P; Wang ZJ, 2005, ANNU REV FLUID MECH, V37, P183, DOI 10.1146/annurev.fluid.36.050802.121940; Zhang TN, 2013, INT J ROBOT RES, V32, P859, DOI 10.1177/0278364913481690	32	244	253	13	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1408	1412		10.1126/science.1229163	http://dx.doi.org/10.1126/science.1229163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520106	Green Submitted			2022-12-24	WOS:000316740700036
J	Taruno, A; Vingtdeux, V; Ohmoto, M; Ma, ZM; Dvoryanchikov, G; Li, A; Adrien, L; Zhao, HT; Leung, S; Abernethy, M; Koppel, J; Davies, P; Civan, MM; Chaudhari, N; Matsumoto, I; Hellekant, G; Tordoff, MG; Marambaud, P; Foskett, JK				Taruno, Akiyuki; Vingtdeux, Valerie; Ohmoto, Makoto; Ma, Zhongming; Dvoryanchikov, Gennady; Li, Ang; Adrien, Leslie; Zhao, Haitian; Leung, Sze; Abernethy, Maria; Koppel, Jeremy; Davies, Peter; Civan, Mortimer M.; Chaudhari, Nirupa; Matsumoto, Ichiro; Hellekant, Goeran; Tordoff, Michael G.; Marambaud, Philippe; Foskett, J. Kevin			CALHM1 ion channel mediates purinergic neurotransmission of sweet, bitter and umami tastes	NATURE			English	Article							MODULATOR 1 CALHM1; A-BETA LEVELS; ALZHEIMERS-DISEASE; P2X RECEPTORS; ATP RELEASE; POLYMORPHISM; HOMEOSTASIS; CELLS; COMMUNICATION; HEMICHANNELS	Recognition of sweet, bitter and umami tastes requires the non-vesicular release from taste bud cells of ATP, which acts as a neurotransmitter to activate afferent neural gustatory pathways(1). However, how ATP is released to fulfil this function is not fully understood. Here we show that calcium homeostasis modulator 1 (CALHM1), a voltage-gated ion channel(2,3), is indispensable for taste-stimuli-evoked ATP release from sweet-, bitter- and umami-sensing taste bud cells. Calhm1 knockout mice have severely impaired perceptions of sweet, bitter and umami compounds, whereas their recognition of sour and salty tastes remains mostly normal. Calhm1 deficiency affects taste perception without interfering with taste cell development or integrity. CALHM1 is expressed specifically in sweet/bitter/umami-sensing type II taste bud cells. Its heterologous expression induces a novel ATP permeability that releases ATP from cells in response to manipulations that activate the CALHM1 ion channel. Knockout of Calhm1 strongly reduces voltage-gated currents in type II cells and taste-evoked ATP release from taste buds without affecting the excitability of taste cells by taste stimuli. Thus, CALHM1 is a voltage-gated ATP-release channel required for sweet, bitter and umami taste perception.	[Taruno, Akiyuki; Ma, Zhongming; Li, Ang; Civan, Mortimer M.; Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Vingtdeux, Valerie; Adrien, Leslie; Zhao, Haitian; Koppel, Jeremy; Davies, Peter; Marambaud, Philippe] Feinstein Inst Med Res, Study Alzheimers Dis, Litwin Zucker Res Ctr, Manhasset, NY 11030 USA; [Ohmoto, Makoto; Matsumoto, Ichiro; Tordoff, Michael G.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Dvoryanchikov, Gennady; Chaudhari, Nirupa] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Leung, Sze; Abernethy, Maria; Hellekant, Goeran] Univ Minnesota, Sch Med, Dept Biomed Sci, Duluth, MN 55812 USA; [Davies, Peter] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Civan, Mortimer M.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Chaudhari, Nirupa] Univ Miami, Miller Sch Med, Program Neurosci, Miami, FL 33136 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Northwell Health; Monell Chemical Senses Center; University of Miami; University of Minnesota System; University of Minnesota Duluth; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; University of Miami; University of Pennsylvania	Marambaud, P (corresponding author), Feinstein Inst Med Res, Study Alzheimers Dis, Litwin Zucker Res Ctr, Manhasset, NY 11030 USA.	pmaramba@nshs.edu; foskett@mail.med.upenn.edu	Vingtdeux, Valerie/C-2463-2012; Foskett, Kevin/R-2549-2019; Taruno, Akiyuki/AAP-5755-2021	Vingtdeux, Valerie/0000-0003-4550-503X; Taruno, Akiyuki/0000-0002-2342-0265; Foskett, J. Kevin/0000-0002-8854-0268; Marambaud, Philippe/0000-0002-8983-1497; Tordoff, Michael/0000-0003-1977-9520	KeySpan award; US NIH [GM56328, MH059937, NS072775, DC10393, EY13624, R03DC011143, P30 EY001583, P30DC011735]; University of Minnesota; NATIONAL EYE INSTITUTE [R01EY013624, P30EY001583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056328, R01GM056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006308, R01DC010393, R03DC011143, P30DC011735] Funding Source: NIH RePORTER	KeySpan award; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a KeySpan award to P.M., several US NIH grants (GM56328, MH059937, NS072775 to J.K.F.; DC10393 to M.G.T.; EY13624 to M.M.C.; R03DC011143 to I.M.; Core Grant P30 EY001583 to the University of Pennsylvania; Core Grant P30DC011735 to the Monell Chemical Senses Center) and the University of Minnesota's Undergraduate Research Opportunities Program to S.L. and M.A. A.T. and M.O. are JSPS Fellows. We thank R. F. Margolskee for the TRPM5-GFP mice and Y. Ninomiya for comments on the manuscript	BURNSTOCK G, 1990, ANN NY ACAD SCI, V603, P31; Burnstock G, 2011, ADV PHARMACOL, V61, P333, DOI 10.1016/B978-0-12-385526-8.00011-4; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Chizh BA, 2001, PHARMACOL REV, V53, P553; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Cotrina ML, 1998, J NEUROSCI, V18, P8794; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; EVANS RJ, 1992, NATURE, V357, P503, DOI 10.1038/357503a0; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Koppel J, 2011, MOL MED, V17, P974, DOI 10.2119/molmed.2011.00154; Lambert JC, 2010, J ALZHEIMERS DIS, V22, P247, DOI 10.3233/JAD-2010-100933; Ma ZM, 2012, P NATL ACAD SCI USA, V109, pE1963, DOI 10.1073/pnas.1204023109; Matsumoto I, 2011, NAT NEUROSCI, V14, P685, DOI 10.1038/nn.2820; Moyer BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007682; Romanov RA, 2006, NEUROSCI LETT, V395, P249, DOI 10.1016/j.neulet.2005.10.085; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Romanov RA, 2012, J CELL SCI, V125, P5514, DOI 10.1242/jcs.111062; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Siebert AP, 2013, J BIOL CHEM, V288, P6140, DOI 10.1074/jbc.M112.409789; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Vandenbeuch A, 2010, J NEUROSCI, V30, P14695, DOI 10.1523/JNEUROSCI.1570-10.2010; Wynn G, 2003, GASTROENTEROLOGY, V125, P1398, DOI 10.1016/j.gastro.2003.07.008; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	27	290	305	21	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					223	226		10.1038/nature11906	http://dx.doi.org/10.1038/nature11906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23467090	Green Accepted			2022-12-24	WOS:000316652300048
J	Vincent, JL; Opal, SM; Marshall, JC; Tracey, KJ				Vincent, Jean-Louis; Opal, Steven M.; Marshall, John C.; Tracey, Kevin J.			Sepsis definitions: time for change	LANCET			English	Editorial Material									[Vincent, Jean-Louis] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, B-1070 Brussels, Belgium; [Opal, Steven M.] Brown Univ, Mem Hosp Rhode Isl, Warren Alpert Med Sch, Div Infect Dis, Pawtucket, RI 02860 USA; [Marshall, John C.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Dept Surg, Toronto, ON M5B 1W8, Canada; [Tracey, Kevin J.] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY USA	Universite Libre de Bruxelles; Brown University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Northwell Health	Vincent, JL (corresponding author), Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium.	jlvincen@ulb.ac.be		Tracey, Kevin J/0000-0003-1884-6314; Vincent, Jean-Louis/0000-0001-6011-6951	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR018535] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR018535] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Czura CJ, 2011, MOL MED, V17, P2, DOI 10.2119/molmed.2010.00001.commentary; Lai NA, 2011, CRIT CARE RESUSC, V13, P146; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Sprung CL, 2006, INTENS CARE MED, V32, P421, DOI 10.1007/s00134-005-0039-8; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	9	427	478	3	63	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2013	381	9868					774	775		10.1016/S0140-6736(12)61815-7	http://dx.doi.org/10.1016/S0140-6736(12)61815-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098TC	23472921	Green Accepted			2022-12-24	WOS:000315570900031
J	MacNeil, LT; Watson, E; Arda, HE; Zhu, LJ; Walhout, AJM				MacNeil, Lesley T.; Watson, Emma; Arda, H. Efsun; Zhu, Lihua Julie; Walhout, Albertha J. M.			Diet-Induced Developmental Acceleration Independent of TOR and Insulin in C. elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; NUTRIENT RESPONSE; NUCLEAR RECEPTORS; GROWTH; GENES; INHIBITION; METABOLISM; NUTRITION; DISCOVERY	Dietary composition has major effects on physiology. Here, we show that developmental rate, reproduction, and lifespan are altered in C. elegans fed Comamonas DA1877 relative to those fed a standard E. coli OP50 diet. We identify a set of genes that change in expression in response to this diet and use the promoter of one of these (acdh-1) as a dietary sensor. Remarkably, the effects on transcription and development occur even when Comamonas DA1877 is diluted with another diet, suggesting that Comamonas DA1877 generates a signal that is sensed by the nematode. Surprisingly, the developmental effect is independent from TOR and insulin signaling. Rather, Comamonas DA1877 affects cyclic gene expression during molting, likely through the nuclear hormone receptor NHR-23. Altogether, our findings indicate that different bacteria elicit various responses via distinct mechanisms, which has implications for diseases such as obesity and the interactions between the human microbiome and intestinal cells.	[MacNeil, Lesley T.; Watson, Emma; Arda, H. Efsun; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA; [MacNeil, Lesley T.; Watson, Emma; Arda, H. Efsun; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Zhu, Lihua Julie] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Walhout, AJM (corresponding author), Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA.	marian.walhout@umassmed.edu		Zhu, Lihua/0000-0001-7416-0590; Walhout, Marian/0000-0001-5587-3608	NIH Office of Research Infrastructure Programs [P40 OD010440]; NIH grant [DK068429]; CIHR postdoctoral fellowship; American Heart Association fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068429] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); American Heart Association fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Walhout laboratory and Amy Walker for discussion and critical reading of the manuscript. We thank Heidi Tissenbaum for RNAi clones and discussions. We thank Victor Ambros for discussions. Some nematode strains used in this work were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by NIH grant DK068429 to A.J.M.W., a CIHR postdoctoral fellowship to L.T.M., and an American Heart Association fellowship to E.W.	ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; Arda HE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.23; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; Avery L., 2012, C ELEGANS RES COMMUN, DOI 10.xxx/wormbook.1.7.1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRENNER S, 1974, GENETICS, V77, P71; Coolon JD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000503; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; EVANS TC, 2006, C ELEGANS RES COMMUN; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Gravato-Nobre MJ, 2005, CELL MICROBIOL, V7, P741, DOI 10.1111/j.1462-5822.2005.00523.x; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Korta DZ, 2012, DEVELOPMENT, V139, P859, DOI 10.1242/dev.074047; Kostrouchova M, 1998, DEVELOPMENT, V125, P1617; Kouns NA, 2011, BIOCHEM BIOPH RES CO, V413, P515, DOI 10.1016/j.bbrc.2011.08.124; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Narasimhan SD, 2009, CURR BIOL, V19, pR657, DOI 10.1016/j.cub.2009.06.013; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Pardee K, 2011, SUBCELL BIOCHEM, V52, P123, DOI 10.1007/978-90-481-9069-0_6; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1050, DOI [10.1038/NMETH.1764, 10.1038/nmeth.1764]; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sommer RJ, 2011, CURR BIOL, V21, pR758, DOI 10.1016/j.cub.2011.06.034; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Sutphin George L, 2009, J Vis Exp, DOI 10.3791/1152; Tan MW, 2011, CELL MICROBIOL, V13, P497, DOI 10.1111/j.1462-5822.2011.01570.x; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tawe WN, 1998, NUCLEIC ACIDS RES, V26, P1621, DOI 10.1093/nar/26.7.1621; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Watson E, 2013, CELL, V153, P253, DOI 10.1016/j.cell.2013.02.050	44	157	162	1	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					240	252		10.1016/j.cell.2013.02.049	http://dx.doi.org/10.1016/j.cell.2013.02.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540701	Green Accepted, Bronze			2022-12-24	WOS:000316853700020
J	Habib, SJ; Chen, BC; Tsai, FC; Anastassiadis, K; Meyer, T; Betzig, E; Nusse, R				Habib, Shukry J.; Chen, Bi-Chang; Tsai, Feng-Chiao; Anastassiadis, Konstantinos; Meyer, Tobias; Betzig, Eric; Nusse, Roel			A Localized Wnt Signal Orients Asymmetric Stem Cell Division in Vitro	SCIENCE			English	Article							BETA-CATENIN; GROUND-STATE; CENTROSOME; PLURIPOTENCY; SPINDLE; NANOG	Developmental signals such as Wnts are often presented to cells in an oriented manner. To examine the consequences of local Wnt signaling, we immobilized Wnt proteins on beads and introduced them to embryonic stem cells in culture. At the single-cell level, the Wnt-bead induced asymmetric distribution of Wnt-beta-catenin signaling components, oriented the plane of mitotic division, and directed asymmetric inheritance of centrosomes. Before cytokinesis was completed, the Wnt-proximal daughter cell expressed high levels of nuclear beta-catenin and pluripotency genes, whereas the distal daughter cell acquired hallmarks of differentiation. We suggest that a spatially restricted Wnt signal induces an oriented cell division that generates distinct cell fates at predictable positions relative to the Wnt source.	[Habib, Shukry J.; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol, Stanford, CA 94305 USA; [Habib, Shukry J.; Chen, Bi-Chang; Betzig, Eric] Janelia Farm Res Campus, Ashburn, VA 20147 USA; [Tsai, Feng-Chiao; Meyer, Tobias] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Anastassiadis, Konstantinos] Tech Univ Dresden, BIOTEC, D-01307 Dresden, Germany	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Technische Universitat Dresden	Habib, SJ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol, 265 Campus Dr, Stanford, CA 94305 USA.	shabib@stanford.edu; rnusse@stanford.edu	Chen, Bi-Chang/F-3480-2014; Anastassiadis, Konstantinos/A-8944-2010	Chen, Bi-Chang/0000-0002-1876-7432; Anastassiadis, Konstantinos/0000-0002-9814-0559; Meyer, Tobias/0000-0003-4339-3804; Habib, Shukry/0000-0003-3132-2216; Tsai, Feng-Chiao/0000-0001-9615-6023	Howard Hughes Medical Institute; California Institute for Regenerative Medicine [RC1-00133-1, RB4-05825, TR1-02149]; NIH [GM063702, NS069375]; Center for Regenerative Therapies Dresden; Deutsche Forschungsgemeinschaft (DFG); Siebel scholarship;  [DFG-SPP1356]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179, R01GM063702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Regenerative Therapies Dresden; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Siebel scholarship; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by the Howard Hughes Medical Institute and by grants RC1-00133-1, RB4-05825, and TR1-02149 from the California Institute for Regenerative Medicine to R.N.; by NIH grant GM063702 to T.M.; and by the Center for Regenerative Therapies Dresden and grant DFG-SPP1356 to K.A. We thank the Stanford Neuroscience Microscopy Service, supported by NIH NS069375. Patent applications are pending for the Bessel beam plane illumination microscopy (by E.B.) and for the Wnt, DKK, and R spondin1 immobilization technology and their applications (by S.J.H. and R.N.). We also thank M. Drukker, T. Schroeder, and T. Stearns for discussions. We appreciate discussions and comments on the manuscript by C. Logan and J. Nelson. S.J.H. was supported by a fellowship from the Deutsche Forschungsgemeinschaft (DFG) and a Siebel scholarship.	Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mogensen MM, 2000, J CELL SCI, V113, P3013; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Sugioka K, 2011, CELL, V146, P941, DOI 10.1016/j.cell.2011.07.043; Surani A, 2012, NATURE, V487, P43, DOI 10.1038/487043a; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Walston T, 2004, DEV CELL, V7, P831, DOI 10.1016/j.devcel.2004.10.008; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Werts AD, 2011, SEMIN CELL DEV BIOL, V22, P842, DOI 10.1016/j.semcdb.2011.07.011; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2008, J CELL BIOL, V180, P261, DOI 10.1083/jcb.200707083; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	29	222	230	5	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1445	1448		10.1126/science.1231077	http://dx.doi.org/10.1126/science.1231077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520113	Green Accepted			2022-12-24	WOS:000316740700046
J	Ast, T; Cohen, G; Schuldiner, M				Ast, Tslil; Cohen, Galit; Schuldiner, Maya			A Network of Cytosolic Factors Targets SRP-Independent Proteins to the Endoplasmic Reticulum	CELL			English	Article							TAIL-ANCHORED PROTEINS; SIGNAL RECOGNITION PARTICLE; POLYPEPTIDE TRANSLOCATION; MEMBRANE INSERTION; MAMMALIAN-CELLS; ER MEMBRANE; IN-VIVO; YEAST; PATHWAY; TRANSPORT	Translocation into the endoplasmic reticulum (ER) is an initial and crucial biogenesis step for all secreted and endomembrane proteins in eukaryotes. ER insertion can take place through the well-characterized signal recognition particle (SRP)-dependent pathway or the less-studied route of SRP-independent translocation. To better understand the prevalence of the SRP-independent pathway, we systematically defined the translocational dependence of the yeast secretome. By combining hydropathy-based analysis and microscopy, we uncovered that a previously unappreciated fraction of the yeast secretome translocates without the aid of the SRP. Furthermore, we validated a family of SRP-independent substrates-the glycosylphosphatidylinositol (GPI)-anchored proteins. Studying this family, we identified a determinant for ER targeting and uncovered a network of cytosolic proteins that facilitate SRP-independent targeting and translocation. These findings highlight the underappreciated complexity of SRP-independent translocation, which enables this pathway to efficiently cope with its extensive substrate flux.	[Ast, Tslil; Cohen, Galit; Schuldiner, Maya] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Schuldiner, M (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	maya.schuldiner@weizmann.ac.il	Schuldiner, Maya/C-9488-2009	Ast, Tslil/0000-0002-6927-6238; Schuldiner, Maya/0000-0001-9947-115X	Israeli Science Foundation (ISF); Miel du Botton Aynsley fund; ERC-StG [260395]; Adam's Fellowship Program	Israeli Science Foundation (ISF)(Israel Science Foundation); Miel du Botton Aynsley fund; ERC-StG; Adam's Fellowship Program	We are extremely grateful to Shifra Ben-Dor, Silvia Gabriela Chuartzman, and Michal Breker for technical assistance. We would like to thank Howard Riezman and Vladimir Denic for their aid and expertise. We are grateful to Yves Bourbonnais, Morihisa Fujita, Marco A. M. Prado, Tommer Ravid, Randy Schekman, Blanche Schwappach, and Peter Walter for providing us with antibodies, plasmids, and yeast strains. We wish to thank Eitan Bibi and Shulamit Michaeli for helpful discussions and Oren Schuldiner, Yifat Cohen, Shachar Dagan, and Idan Frumkin for critical reading of the manuscript. The microscopic system was purchased through the support of the Israeli Science Foundation (ISF) Legacy Heritage fund and the generous donation of the J&R foundation and the Estate of Lela London. This study was supported by a grant from the Miel du Botton Aynsley fund as well as an ERC-StG-2010 260395. Tslil Ast is supported by the Adam's Fellowship Program.	Becker J, 1996, MOL CELL BIOL, V16, P4378; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Brachmann CB, 1998, YEAST, V14, P115; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Favaloro V, 2010, J CELL SCI, V123, P1522, DOI 10.1242/jcs.055970; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goldshmidt H, 2008, J BIOL CHEM, V283, P32085, DOI 10.1074/jbc.M801499200; Hatsuzawa K, 1997, J BIOCHEM-TOKYO, V121, P270; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Hines JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001309; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Johnson N, 2012, J CELL SCI, V125, P3612, DOI 10.1242/jcs.102608; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; MULLER G, 1987, EMBO J, V6, P2099, DOI 10.1002/j.1460-2075.1987.tb02476.x; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Perrett S, 2008, CURR OPIN STRUC BIOL, V18, P52, DOI 10.1016/j.sbi.2007.12.005; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Prilusky J, 2009, P NATL ACAD SCI USA, V106, P6662, DOI 10.1073/pnas.0902029106; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shi YF, 2011, MOL BIOL CELL, V22, P4093, DOI 10.1091/mbc.E11-05-0440; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Webb TR, 2008, J CELL SCI, V121, P3140, DOI 10.1242/jcs.035550; Yan W, 1998, J MOL BIOL, V275, P25, DOI 10.1006/jmbi.1997.1447	52	116	118	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1134	1145		10.1016/j.cell.2013.02.003	http://dx.doi.org/10.1016/j.cell.2013.02.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452858	Bronze			2022-12-24	WOS:000315710300019
J	Cang, CL; Zhou, YD; Navarro, B; Seo, YJ; Aranda, K; Shi, L; Battaglia-Hsu, S; Nissim, I; Clapham, DE; Ren, DJ				Cang, Chunlei; Zhou, Yandong; Navarro, Betsy; Seo, Young-jun; Aranda, Kimberly; Shi, Lucy; Battaglia-Hsu, Shyuefang; Nissim, Itzhak; Clapham, David E.; Ren, Dejian			mTOR Regulates Lysosomal ATP-Sensitive Two-Pore Na+ Channels to Adapt to Metabolic State	CELL			English	Article							CALCIUM-CHANNELS; RAG GTPASES; SODIUM; ACTIVATION; NUTRIENT; AUTOPHAGY; PROTEINS; TARGETS; SENSOR; CELLS	Survival in the wild requires organismal adaptations to the availability of nutrients. Endosomes and lysosomes are key intracellular organelles that couple nutrition and metabolic status to cellular responses, but how they detect cytosolic ATP levels is not well understood. Here, we identify an endolysosomal ATP-sensitive Na+ channel (lysoNa(ATP)). The channel is a complex formed by two-pore channels (TPC1 and TPC2), ion channels previously thought to be gated by nicotinic acid adenine dinucleotide phosphate (NAADP), and the mammalian target of rapamycin (mTOR). The channel complex detects nutrient status, becomes constitutively open upon nutrient removal and mTOR translocation off the lysosomal membrane, and controls the lysosome's membrane potential, pH stability, and amino acid homeostasis. Mutant mice lacking lysoNa(ATP) have much reduced exercise endurance after fasting. Thus, TPCs make up an ion channel family that couples the cell's metabolic state to endolysosomal function and are crucial for physical endurance during food restriction.	[Cang, Chunlei; Zhou, Yandong; Seo, Young-jun; Aranda, Kimberly; Shi, Lucy; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Navarro, Betsy; Clapham, David E.] Childrens Hosp, Dept Cardiol, Howard Hughes Med Inst, Boston, MA 02115 USA; [Battaglia-Hsu, Shyuefang] Univ Lorraine, Fac Med, INSERM, U954, F-54505 Vandoeuvre Les Nancy, France; [Nissim, Itzhak] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Div Child Dev & Metab Dis,Dept Pediat Biochem & B, Philadelphia, PA 19104 USA	University of Pennsylvania; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Ren, DJ (corresponding author), Univ Penn, Dept Biol, 415 S Univ Ave, Philadelphia, PA 19104 USA.	dren@sas.upenn.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019; Cang, Chunlei/D-9185-2019	Clapham, David/0000-0002-4459-9428; Cang, Chunlei/0000-0002-3302-0927; Shi, Lucy/0000-0002-4652-6089	American Heart Association; NIH [DK-053761]; University of Pennsylvania Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053761, R56DK053761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074257, R01NS055293] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Ren lab for discussion, Amita Tiyaboonchai for starting our interest in macrophages, Drs. Morris Birnbaum and Russell Miller for AMPK1/2 dKO MEF cells, Dr. Sara Cherry for the use of plate reader, Dr. Jie Chen for mTOR and S6K1 clones, and Dr. Denia Ramirez-Montealegre for advice on amino acid efflux assay. This work was supported, in part, by funding from American Heart Association, NIH, and the University of Pennsylvania Research Foundation. Embryonic stem cell injections were performed in the Gene Manipulation Facility of the Children's Hospital Boston (tpc1) and the Transgenic and the Chimeric Mouse Facility at University of Pennsylvanian (tpc2). Amino acid measurement was performed by Ilana Nissim in the Metabolomic Core Facility, Children's Hospital of Philadelphia Research Institute (supported, in part, by NIH grant number DK-053761). C.C. designed experiments and contributed all of the patch-clamp recordings. Y.Z. did protein chemistry experiments, immunocytochemistry, and lysosomal pH imaging. Y.-j.S. performed protein chemistry and ATP measurements. Y.S. and I.N. did amino acid analysis. C.C. and Y.Z. performed amino acid efflux assay. D.R. initiated the project, designed experiments, developed cDNA constructs and the mouse models, and performed the behavior studies. B.N. and S.B.-H. performed pilot studies. K.A. and L.S. developed reagents. D.R. and D.E.C. supervised the projects. C.C., D.E.C., and D.R. wrote the manuscript.	Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; BERTL A, 1992, SCIENCE, V258, P873, DOI 10.1126/science.1439795; BRADY LJ, 1978, J NUTR, V108, P648, DOI 10.1093/jn/108.4.648; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Challet E, 1997, BEHAV BRAIN RES, V84, P275, DOI 10.1016/S0166-4328(97)83335-9; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Foster DB, 2008, BIOCHEM BIOPH RES CO, V366, P649, DOI 10.1016/j.bbrc.2007.11.154; Glick D, 2012, MOL CELL BIOL, V32, P2570, DOI 10.1128/MCB.00167-12; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; Grimm C, 2012, J BIOL CHEM, V287, P22701, DOI 10.1074/jbc.M112.368876; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; JONES BN, 1983, J CHROMATOGR, V266, P471, DOI 10.1016/S0021-9673(01)90918-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Laplante M., 2012, COLD SPRING HARB PER, V4, P4; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; McTaggart JS, 2010, J PHYSIOL-LONDON, V588, P3201, DOI 10.1113/jphysiol.2010.191767; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	51	251	256	2	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					778	790		10.1016/j.cell.2013.01.023	http://dx.doi.org/10.1016/j.cell.2013.01.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23394946	Bronze, Green Accepted			2022-12-24	WOS:000314945600013
J	Ogo, S; Ichikawa, K; Kishima, T; Matsumoto, T; Nakai, H; Kusaka, K; Ohhara, T				Ogo, Seiji; Ichikawa, Koji; Kishima, Takahiro; Matsumoto, Takahiro; Nakai, Hidetaka; Kusaka, Katsuhiro; Ohhara, Takashi			A Functional [NiFe]Hydrogenase Mimic That Catalyzes Electron and Hydride Transfer from H-2	SCIENCE			English	Article							HYDROGENASE	Chemists have long sought to mimic enzymatic hydrogen activation with structurally simpler compounds. Here, we report a functional [NiFe]-based model of [NiFe] hydrogenase enzymes. This complex heterolytically activates hydrogen to form a hydride complex that is capable of reducing substrates by either hydride ion or electron transfer. Structural investigations were performed by a range of techniques, including x-ray diffraction and neutron scattering, resulting in crystal structures and the finding that the hydrido ligand is predominantly associated with the Fe center. The ligand's hydridic character is manifested in its reactivity with strong acid to liberate H-2.	[Ogo, Seiji; Matsumoto, Takahiro; Nakai, Hidetaka] Kyushu Univ, World Premier Int Res Ctr Initiat, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan; [Ogo, Seiji; Ichikawa, Koji; Kishima, Takahiro; Matsumoto, Takahiro; Nakai, Hidetaka] Kyushu Univ, Grad Sch Engn, Dept Chem & Biochem, Nishi Ku, Fukuoka 8190395, Japan; [Ogo, Seiji] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan; [Kusaka, Katsuhiro] Ibaraki Univ, Frontier Res Ctr Appl Atom Sci, Tokai, Ibaraki 3191106, Japan; [Ohhara, Takashi] Comprehens Res Org Sci & Soc, Res Ctr Neutron Sci & Technol, Tokai, Ibaraki 3191106, Japan	Kyushu University; Kyushu University; Japan Science & Technology Agency (JST); Ibaraki University	Ogo, S (corresponding author), Kyushu Univ, World Premier Int Res Ctr Initiat, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, 744 Moto Oka, Fukuoka 8190395, Japan.	ogotcm@mail.cstm.kyushu-u.ac.jp	Matsumoto, Takahiro/AAF-6046-2021	Ohhara, Takashi/0000-0002-1215-6032; Nakai, Hidetaka/0000-0002-8548-1987; Matsumoto, Takahiro/0000-0002-8985-0006	WPI; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [23655053, 24750058, 24109016]; Basic Research Programs CREST Type, "Development of the Foundation for Nano-Interface Technology" from JST, Japan; Grants-in-Aid for Scientific Research [24681016, 24109016] Funding Source: KAKEN	WPI; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Basic Research Programs CREST Type, "Development of the Foundation for Nano-Interface Technology" from JST, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the WPI; grants-in-aid 23655053, 24750058, and 24109016 (Scientific Research on Innovative Areas "Stimuli-responsive Chemical Species") from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; and the Basic Research Programs CREST Type, "Development of the Foundation for Nano-Interface Technology" from JST, Japan. Crystallographic data for [1](BPh<INF>4</INF>)<INF>2</INF>, [2](BPh<INF>4</INF>), and [Ni<SUP>II</SUP>(X')Fe<SUP>II</SUP>(Br)<INF>2</INF>] have been deposited with the Cambridge Crystallographic Data Center under reference numbers CCDC-904876 (x-ray diffraction, 1), 904877 (x-ray diffraction, 2), 904874 (neutron scattering, 2), and 904875 {x-ray diffraction, [Ni<SUP>II</SUP>(X')Fe<SUP>II</SUP>(Br)<INF>2</INF>]}, respectively.	Barton BE, 2009, J AM CHEM SOC, V131, P6942, DOI 10.1021/ja902570u; Cammack R., 2001, HYDROGEN FUEL LEARNI; Gloaguen F, 2009, CHEM SOC REV, V38, P100, DOI 10.1039/b801796b; Higuchi Y, 1999, STRUCT FOLD DES, V7, P549, DOI 10.1016/S0969-2126(99)80071-9; Kubas GJ, 2007, CHEM REV, V107, P4152, DOI 10.1021/cr050197j; Ogo S, 2007, SCIENCE, V316, P585, DOI 10.1126/science.1138751; Ogo S, 2009, CHEM COMMUN, P3317, DOI 10.1039/b900297a; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q; Tye JW, 2005, P NATL ACAD SCI USA, V102, P16911, DOI 10.1073/pnas.0508740102	9	197	198	2	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					682	684		10.1126/science.1231345	http://dx.doi.org/10.1126/science.1231345			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393260				2022-12-24	WOS:000314585600038
J	Bryant, JM; Grogono, DM; Greaves, D; Foweraker, J; Roddick, I; Inns, T; Reacher, M; Haworth, CS; Curran, MD; Harris, SR; Peacock, SJ; Parkhill, J; Floto, RA				Bryant, Josephine M.; Grogono, Dorothy M.; Greaves, Daniel; Foweraker, Juliet; Roddick, Iain; Inns, Thomas; Reacher, Mark; Haworth, Charles S.; Curran, Martin D.; Harris, Simon R.; Peacock, Sharon J.; Parkhill, Julian; Floto, R. Andres			Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study	LANCET			English	Article							NONTUBERCULOUS MYCOBACTERIA; LUNG-TRANSPLANT; SP-NOV; MASSILIENSE; EPIDEMIOLOGY; GENE; PREVALENCE; RESISTANCE; INFECTION; BOLLETII	Background Increasing numbers of individuals with cystic fibrosis are becoming infected with the multidrug-resistant non-tuberculous mycobacterium (NTM) Mycobacterium abscessus, which causes progressive lung damage and is extremely challenging to treat. How this organism is acquired is not currently known, but there is growing concern that person-to-person transmission could occur. We aimed to define the mechanisms of acquisition of M abscessus in individuals with cystic fibrosis. Method Whole genome sequencing and antimicrobial susceptibility testing were done on 168 consecutive isolates of M abscessus from 31 patients attending an adult cystic fibrosis centre in the UK between 2007 and 2011. In parallel, we undertook detailed environmental testing for NTM and defined potential opportunities for transmission between patients both in and out of hospital using epidemiological data and social network analysis. Findings Phylogenetic analysis revealed two clustered outbreaks of near-identical isolates of the M abscessus subspecies massiliense (from 11 patients), differing by less than ten base pairs. This variation represents less diversity than that seen within isolates from a single individual, strongly indicating between-patient transmission. All patients within these clusters had numerous opportunities for within-hospital transmission from other individuals, while comprehensive environmental sampling, initiated during the outbreak, failed to detect any potential point source of NTM infection. The clusters of M abscessus subspecies massiliense showed evidence of transmission of mutations acquired during infection of an individual to other patients. Thus, isolates with constitutive resistance to amikacin and clarithromycin were isolated from several individuals never previously exposed to long-term macrolides or aminoglycosides, further indicating cross-infection. Interpretation Whole genome sequencing has revealed frequent transmission of multidrug resistant NTM between patients with cystic fibrosis despite conventional cross-infection measures. Although the exact transmission route is yet to be established, our epidemiological analysis suggests that it could be indirect.	[Grogono, Dorothy M.; Foweraker, Juliet; Haworth, Charles S.; Floto, R. Andres] Papworth Hosp, Cambridge Ctr Lung Infect, Cambridge CB3 8RE, England; [Floto, R. Andres] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Greaves, Daniel; Peacock, Sharon J.; Floto, R. Andres] Univ Cambridge, Dept Med, Cambridge CB2 0XY, England; [Curran, Martin D.] Addenbrookes Hosp, Hlth Protect Agcy, Cambridge, England; [Inns, Thomas] HPA, Norfolk, Suffolk, England; [Inns, Thomas] Hlth Protect Agcy, Field Epidemiol Training Programme, London, England	Papworth Hospital; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Health Protection Agency; University of Cambridge; Health Protection Agency; Health Protection Agency	Floto, RA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	parkhill@sanger.ac.uk; arf27@cam.ac.uk	Harris, Simon R/K-1318-2013; Grogono, Dorothy/Y-3306-2019; Peacock, Sharon J/ABE-6331-2020; Parkhill, Julian/G-4703-2011; Bryant, Josephine/ABC-8288-2021; Reacher, Mark/Y-6979-2018	Harris, Simon R/0000-0003-1512-6194; Parkhill, Julian/0000-0002-7069-5958; Reacher, Mark/0000-0001-6871-7903; Bryant, Josephine/0000-0002-0149-5768; Grogono, Dorothy/0000-0002-3423-3158; Inns, Thomas/0000-0002-1218-958X; Peacock, Sharon/0000-0002-1718-2782	Illumina Inc.; Wellcome Trust [098051, 084953]; Papworth Hospital; NIHR Cambridge Biomedical Research Centre; UK Health Protection Agency; Medical Research Council; UKCRC Translational Infection Research Initiative; MRC [G1000803] Funding Source: UKRI; Medical Research Council [G1000803, 974668] Funding Source: researchfish	Illumina Inc.; Wellcome Trust(Wellcome Trust); Papworth Hospital; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); UK Health Protection Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UKCRC Translational Infection Research Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JP has received funding for conference travel and accommodation from Illumina Inc. The other authors declare that they have no confl icts of interest.; This work was supported by The Wellcome Trust (grant numbers 098051 [JMB, SH, JP] and RAF [084953]), Papworth Hospital (DMG, CSH, JF, RAF), NIHR Cambridge Biomedical Research Centre (SP, RAF), The UK Health Protection Agency (JF, MDC, SP), Medical Research Council (JMB), and the UKCRC Translational Infection Research Initiative (SP, JP).	Adekambi T, 2006, INT J SYST EVOL MICR, V56, P133, DOI 10.1099/ijs.0.63969-0; Adekambi T, 2004, J CLIN MICROBIOL, V42, P5493, DOI 10.1128/JCM.42.12.5493-5501.2004; Aitken ML, 2012, AM J RESP CRIT CARE, V185, P231, DOI 10.1164/ajrccm.185.2.231; CF Foundation Patient Registry, 2011, ANN DAT REP CTR DIR; Chan ED, 2010, AM J RESP CELL MOL, V43, P387, DOI 10.1165/rcmb.2009-0276TR; Cystic Fibrosis Trust, 2004, PSEUD AER INF PEOPL; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Esther CR, 2010, J CYST FIBROS, V9, P117, DOI 10.1016/j.jcf.2009.12.001; Falkinham JO, 2011, EMERG INFECT DIS, V17, P419, DOI 10.3201/eid1703.101510; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Harris KA, 2012, J CLIN MICROBIOL, V50, P1758, DOI 10.1128/JCM.00155-12; Huang WC, 2010, J MED MICROBIOL, V59, P1203, DOI 10.1099/jmm.0.020586-0; Iseman MD, 2008, AM J RESP CRIT CARE, V178, P999, DOI 10.1164/rccm.200808-1258ED; Jarand J, 2011, CLIN INFECT DIS, V52, P565, DOI 10.1093/cid/ciq237; Jeon K, 2009, AM J RESP CRIT CARE, V180, P896, DOI 10.1164/rccm.200905-0704OC; Kim HY, 2010, MICROBIOL IMMUNOL, V54, P347, DOI 10.1111/j.1348-0421.2010.00221.x; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Leao SC, 2011, INT J SYST EVOL MICR, V61, P2311, DOI 10.1099/ijs.0.023770-0; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Orens JB, 2006, J HEART LUNG TRANSPL, V25, P745, DOI 10.1016/j.healun.2006.03.011; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Roux AL, 2009, J CLIN MICROBIOL, V47, P4124, DOI 10.1128/JCM.01257-09; Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004; Sermet-Gaudelus I, 2003, EMERG INFECT DIS, V9, P1587, DOI 10.3201/eid0912.020774; Stout JE, 2012, AM J RESP CRIT CARE, V186, P822, DOI 10.1164/rccm.201208-1500ED; Thomson RM, 2010, EMERG INFECT DIS, V16, P1576, DOI 10.3201/eid1610.091201; Wallace RJ, 1996, ANTIMICROB AGENTS CH, V40, P1676, DOI 10.1128/AAC.40.7.1676; Wallace RJ, 1998, ANNU REV MICROBIOL, V52, P453, DOI 10.1146/annurev.micro.52.1.453; WENDT SL, 1980, AM REV RESPIR DIS, V122, P259; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104	36	439	450	3	85	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2013	381	9877					1551	1560		10.1016/S0140-6736(13)60632-7	http://dx.doi.org/10.1016/S0140-6736(13)60632-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139UF	23541540	Bronze, Green Published			2022-12-24	WOS:000318609600030
J	Jae, LT; Raaben, M; Riemersma, M; van Beusekom, E; Blomen, VA; Velds, A; Kerkhoven, RM; Carette, JE; Topaloglu, H; Meinecke, P; Wessels, MW; Lefeber, DJ; Whelan, SP; van Bokhoven, H; Brummelkamp, TR				Jae, Lucas T.; Raaben, Matthijs; Riemersma, Moniek; van Beusekom, Ellen; Blomen, Vincent A.; Velds, Arno; Kerkhoven, Ron M.; Carette, Jan E.; Topaloglu, Haluk; Meinecke, Peter; Wessels, Marja W.; Lefeber, Dirk J.; Whelan, Sean P.; van Bokhoven, Hans; Brummelkamp, Thijn R.			Deciphering the Glycosylome of Dystroglycanopathies Using Haploid Screens for Lassa Virus Entry	SCIENCE			English	Article							ALPHA-DYSTROGLYCAN; HUMAN-CELLS; MUTATIONS; RECEPTOR; ISPD; IDENTIFICATION; DISRUPTION; REQUIRES	Glycosylated alpha-dystroglycan (alpha-DG) serves as cellular entry receptor for multiple pathogens, and defects in its glycosylation cause hereditary Walker-Warburg syndrome (WWS). At least eight proteins are critical to glycosylate alpha-DG, but many genes mutated in WWS remain unknown. To identify modifiers of alpha-DG, we performed a haploid screen for Lassa virus entry, a hemorrhagic fever virus causing thousands of deaths annually that hijacks glycosylated alpha-DG to enter cells. In complementary screens, we profiled cells for absence of alpha-DG carbohydrate chains or biochemically related glycans. This revealed virus host factors and a suite of glycosylation units, including all known Walker-Warburg genes and five additional factors critical for the modification of alpha-DG. Our findings accentuate the complexity of this posttranslational feature and point out genes defective in dystroglycanopathies.	[Jae, Lucas T.; Blomen, Vincent A.; Velds, Arno; Kerkhoven, Ron M.; Brummelkamp, Thijn R.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Raaben, Matthijs; Whelan, Sean P.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Riemersma, Moniek; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Neurol, NL-6525 GA Nijmegen, Netherlands; [Riemersma, Moniek; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Lab Genet Endocrine & Metab Dis, NL-6525 GA Nijmegen, Netherlands; [Riemersma, Moniek; van Beusekom, Ellen; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Carette, Jan E.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Topaloglu, Haluk] Hacettepe Univ, Childrens Hosp, TR-06100 Ankara, Turkey; [Meinecke, Peter] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [Wessels, Marja W.] Erasmus MC, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; [Brummelkamp, Thijn R.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria	Netherlands Cancer Institute; Harvard University; Harvard Medical School; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Stanford University; Hacettepe University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Erasmus University Rotterdam; Erasmus MC; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Whelan, SP (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	sean_whelan@hms.harvard.edu; H.vanBokhoven@gen.umcn.nl; t.brummelkamp@nki.nl	Jae, Lucas/AAH-5342-2020; Bokhoven, J.H.L.M. van van/H-8015-2014; Lefeber, Dirk DJ/A-2146-2014; TOPALOGLU, HALUK AYDIN/I-9318-2013; van Beusekom, Ellen/AAF-2687-2019; Jae, Lucas/AAY-3438-2021; blomen, vincent/AAE-1477-2020; van Bokhoven, Hans/D-8764-2012	Jae, Lucas/0000-0002-3531-1760; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Raaben, Matthijs/0000-0001-5989-289X; Whelan, Sean/0000-0003-1564-8590; Carette, Jan/0000-0002-5187-8070; Velds, Arno/0000-0003-4333-8872	Netherlands Genomics Initiative (NGI); Netherlands Organization for Scientific Research [Vidi-91711316]; European Research Council (ERC) [ERC- 2012-StG 309634]; Prinses Beatrix Fonds [W.OR09-15]; European Union [241995 GENCODYS]; NIH [AI081842, AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI081842, R01AI081842, U54AI057159] Funding Source: NIH RePORTER	Netherlands Genomics Initiative (NGI); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC)European Commission); Prinses Beatrix Fonds; European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Sixma, J. Roix, S. Mukherjee, S. Hill, and S. Nijman for discussions and S. Radoshitzky and M. Farzan for providing the plasmid encoding the LASV glycoprotein. Supported by The Netherlands Genomics Initiative (NGI), Netherlands Organization for Scientific Research (Vidi-91711316), and the European Research Council (ERC) starting grant (ERC- 2012-StG 309634) to T. R. B., Prinses Beatrix Fonds (W.OR09-15) to D. J. L. and H. V. B., European Union Framework Programme 7 Health Programme (241995 GENCODYS) to H. V. B., and NIH grants AI081842 and AI057159 to S. P. W. T. R. B. is a cofounder of Haplogen GmbH, S. P. W. is inventor on a patent describing the reverse-genetics system for VSV (International Patent no: 5,789,229), J. E. C. and T. R. B. are inventors on a patent on mutagenesis in haploid or near-haploid cells (U. S. Patent Application no: 2012/0190,011), and materials will be made available to the academic community under a Materials Transfer Agreement. The study was approved by the ethical board of the Radboud University Nijmegen Medical Centre, Commissie Mensgebonden Onderzoek Regio Arnhem-Nijmegen Approval 2011/155 (9612-1812). Deep sequencing data have been deposited in the NCBI Sequence Read Archive (www.ncbi.nlm.nih.gov/sra) under accession number SRP018361.	Buysse K., 2013, HUM MOL GENET; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; Eckhardt M, 1996, P NATL ACAD SCI USA, V93, P7572, DOI 10.1073/pnas.93.15.7572; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Hari R. J. L, 2005, CHEM BIOL HEPARIN HE; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kunz S, 2005, J VIROL, V79, P14282, DOI 10.1128/JVI.79.22.14282-14296.2005; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Vogel P, 2012, VET PATHOL, V49, P166, DOI 10.1177/0300985811415708; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	24	214	222	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					479	483		10.1126/science.1233675	http://dx.doi.org/10.1126/science.1233675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23519211	Green Accepted			2022-12-24	WOS:000318016700042
J	Bhatt, S; Gething, PW; Brady, OJ; Messina, JP; Farlow, AW; Moyes, CL; Drake, JM; Brownstein, JS; Hoen, AG; Sankoh, O; Myers, MF; George, DB; Jaenisch, T; Wint, GRW; Simmons, CP; Scott, TW; Farrar, JJ; Hay, SI				Bhatt, Samir; Gething, Peter W.; Brady, Oliver J.; Messina, Jane P.; Farlow, Andrew W.; Moyes, Catherine L.; Drake, John M.; Brownstein, John S.; Hoen, Anne G.; Sankoh, Osman; Myers, Monica F.; George, Dylan B.; Jaenisch, Thomas; Wint, G. R. William; Simmons, Cameron P.; Scott, Thomas W.; Farrar, Jeremy J.; Hay, Simon I.			The global distribution and burden of dengue	NATURE			English	Article							PLASMODIUM-FALCIPARUM; YELLOW-FEVER; DISEASE; TRANSMISSION; ENDEMICITY; VACCINE; VECTOR; VIRUS	Dengue is a systemic viral infection transmitted between humans by Aedes mosquitoes(1). For some patients, dengue is a life-threatening illness(2). There are currently no licensed vaccines or specific therapeutics, and substantial vector control efforts have not stopped its rapid emergence and global spread(3). The contemporary worldwide distribution of the risk of dengue virus infection(4) and its public health burden are poorly known(2,5). Here we undertake an exhaustive assembly of known records of dengue occurrence worldwide, and use a formal modelling framework to map the global distribution of dengue risk. We then pair the resulting risk map with detailed longitudinal information from dengue cohort studies and population surfaces to infer the public health burden of dengue in 2010. We predict dengue to be ubiquitous throughout the tropics, with local spatial variations in risk influenced strongly by rainfall, temperature and the degree of urbanization. Using cartographic approaches, we estimate there to be 390 million (95% credible interval 284-528) dengue infections per year, of which 96 million (67-136) manifest apparently (any level of disease severity). This infection total is more than three times the dengue burden estimate of the World Health Organization(2). Stratification of our estimates by country allows comparison with national dengue reporting, after taking into account the probability of an apparent infection being formally reported. The most notable differences are discussed. These new risk maps and infection estimates provide novel insights into the global, regional and national public health burden imposed by dengue. We anticipate that they will provide a starting point for a wider discussion about the global impact of this disease and will help to guide improvements in disease control strategies using vaccine, drug and vector control methods, and in their economic evaluation.	[Bhatt, Samir; Gething, Peter W.; Brady, Oliver J.; Messina, Jane P.; Farlow, Andrew W.; Moyes, Catherine L.; Drake, John M.; Myers, Monica F.; Wint, G. R. William; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Brady, Oliver J.] Oxitec Ltd, Abingdon OX14 4RX, Oxon, England; [Drake, John M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Brownstein, John S.] Harvard Univ, Sch Med, Dept Phys, Boston, MA 02115 USA; [Brownstein, John S.] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Hoen, Anne G.] Dartmouth Coll, Geisel Sch Med, Dept Community & Family Med, Hanover, NH 03755 USA; [Sankoh, Osman] INDEPTH Network Secretariat, East Legon, Accra, Ghana; [Sankoh, Osman] Univ Witwatersrand, Sch Publ Hlth, ZA-2000 Johannesburg, South Africa; [Sankoh, Osman] Heidelberg Univ, Inst Publ Hlth, D-69120 Heidelberg, Germany; [George, Dylan B.; Scott, Thomas W.; Hay, Simon I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Jaenisch, Thomas] Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, INF 324, D-69120 Heidelberg, Germany; [Wint, G. R. William] Univ Oxford, Dept Zool, ERGO, Oxford OX1 3PS, England; [Simmons, Cameron P.; Farrar, Jeremy J.] Oxford Univ Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Simmons, Cameron P.; Farrar, Jeremy J.] Univ Oxford, Churchill Hosp, Ctr Trop Med, Oxford OX3 7LJ, England; [Scott, Thomas W.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Farrar, Jeremy J.] Natl Univ Singapore, Dept Med, Singapore 119228, Singapore	University of Oxford; University System of Georgia; University of Georgia; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Dartmouth College; INDEPTH Network; University of Witwatersrand; Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Ruprecht Karls University Heidelberg; University of Oxford; University of Oxford; University of California System; University of California Davis; National University of Singapore	Hay, SI (corresponding author), Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Tinbergen Bldg,South Parks Rd, Oxford OX1 3PS, England.	simon.hay@zoo.ox.ac.uk	Brady, Oliver/P-9421-2019; Sankoh, Osman/ABB-3755-2020; Simmons, Cameron P/ABA-3896-2021; Jaenisch, Thomas/H-3473-2017; Farrar, Jeremy J./HGA-7610-2022; Gething, Peter/ABD-2110-2020; Gething, Peter/GQR-1884-2022; Hay, Simon Iain/F-8967-2015; Bhatt, Samir/ABE-7938-2020	Brady, Oliver/0000-0002-3235-2129; Sankoh, Osman/0000-0003-4405-9808; Simmons, Cameron P/0000-0002-9039-7392; Gething, Peter/0000-0001-6759-5449; Hay, Simon Iain/0000-0002-0611-7272; Drake, John/0000-0003-4646-1235; Moyes, Catherine/0000-0002-8028-4079; Farrar, Jeremy/0000-0002-2700-623X; Bhatt, Samir/0000-0002-0891-4611; Wint, William/0000-0003-0916-0847	Wellcome Trust [095066, 084368]; BBSRC Industrial CASE studentship; International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS) [21803]; EU [2011-261504 EDENEXT]; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Biotechnology and Biological Sciences Research Council [1090403] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091980, R01AI069341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083224] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC Industrial CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS); EU(European Commission); RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.I.H. is funded by a Senior Research Fellowship from the Wellcome Trust (095066) which also supports S. B. and P. W. G. C. P. S. is also funded by a Senior Research Fellowship from the Wellcome Trust (084368). O.J.B. is funded by a BBSRC Industrial CASE studentship. J.P.M., A. W. F., T.J., G. R. W. W., C. P. S., T. W. S. and S. I. H. received funding from, and with S. B., P. W. G., O.J.B. and J.J.F. acknowledge the contribution of, the International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS, 21803, http://www.idams.eu). This work was funded in part by EU grant 2011-261504 EDENEXT and the paper is catalogued by the EDENEXT Steering Committee as EDENEXT. S. I. H. and T. W. S. also acknowledge funding support from the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health.	Anders KL, 2012, LANCET INFECT DIS, V12, P977, DOI 10.1016/S1473-3099(12)70246-3; [Anonymous], 2009, WHOHTMNTDDEN20091; Bambrick H., 2009, TROPIKA; BEATTY ME, 2009, AM J TROP MED HYG S, V81, P231; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Chakravarti A, 2012, T ROY SOC TROP MED H, V106, P273, DOI 10.1016/j.trstmh.2011.12.007; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2012, LANCET, V380, P1535, DOI 10.1016/S0140-6736(12)61510-4; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042; Kakkar M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8574; MONATH TP, 1994, SEMIN VIROL, V5, P133, DOI 10.1006/smvy.1994.1014; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Rodhain F, 1996, B SOC PATHOL EXOT, V89, P87; Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; TDR/World Health Organization, 2006, TDRSWG08 WHO; World Health Organization, 2012, INT TRAV HLTH SIT 1	30	5348	5604	46	1281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					504	507		10.1038/nature12060	http://dx.doi.org/10.1038/nature12060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23563266	Green Submitted, Green Accepted			2022-12-24	WOS:000317984400041
J	Itoh, Y; Brocker, MJ; Sekine, S; Hammond, G; Suetsugu, S; Soll, D; Yokoyama, S				Itoh, Yuzuru; Broecker, Markus J.; Sekine, Shun-ichi; Hammond, Gifty; Suetsugu, Shiro; Soell, Dieter; Yokoyama, Shigeyuki			Decameric SelA.tRNA(Sec) Ring Structure Reveals Mechanism of Bacterial Selenocysteine Formation	SCIENCE			English	Article							TRANSFER-RNA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; IDENTIFICATION; COMPLEX; KINASE	The 21st amino acid, selenocysteine (Sec), is synthesized on its cognate transfer RNA (tRNA(Sec)). In bacteria, SelA synthesizes Sec from Ser-tRNA(Sec), whereas in archaea and eukaryotes SepSecS forms Sec from phosphoserine (Sep) acylated to tRNA(Sec). We determined the crystal structures of Aquifex aeolicus SelA complexes, which revealed a ring-shaped homodecamer that binds 10 tRNA(Sec) molecules, each interacting with four SelA subunits. The SelA N-terminal domain binds the tRNA(Sec)-specific D-arm structure, thereby discriminating Ser-tRNA(Sec) from Ser-tRNA(Ser). A large cleft is created between two subunits and accommodates the 3'-terminal region of Ser-tRNA(Sec). The SelA structures together with in vivo and in vitro enzyme assays show decamerization to be essential for SelA function. SelA catalyzes pyridoxal 5'-phosphate-dependent Sec formation involving Arg residues nonhomologous to those in SepSecS. Different protein architecture and substrate coordination of the bacterial enzyme provide structural evidence for independent evolution of the two Sec synthesis systems present in nature.	[Itoh, Yuzuru; Sekine, Shun-ichi; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Itoh, Yuzuru; Sekine, Shun-ichi; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Itoh, Yuzuru; Sekine, Shun-ichi; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Itoh, Yuzuru; Suetsugu, Shiro] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Membrane & Cytoskeleton Dynam, Bunkyo Ku, Tokyo 1130032, Japan; [Broecker, Markus J.; Hammond, Gifty; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA	RIKEN; University of Tokyo; University of Tokyo; University of Tokyo; Yale University; Yale University	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	dieter.soll@yale.edu; yokoyama@riken.jp	Suetsugu, Shiro/ABB-6033-2020; Suetsugu, Shiro/B-3300-2010; Yokoyama, Shigeyuki/N-6911-2015; Itoh, Yuzuru/M-1454-2017; Sekine, Shun-ichi/N-5450-2015; Suetsugu, Shiro/AAF-4427-2019	Suetsugu, Shiro/0000-0002-4612-0628; Yokoyama, Shigeyuki/0000-0003-3133-7338; Sekine, Shun-ichi/0000-0001-8174-8704; Suetsugu, Shiro/0000-0002-4612-0628; Itoh, Yuzuru/0000-0001-7802-5572	Japan Society for the Promotion of Science (JSPS); Alexander von Humboldt Foundation (Bonn, Germany); JSPS; Ministry of Education, Culture, Sports, Science and Technology; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-98ER20311]; National Institute of General Medical Sciences [GM22854]; Defense Advanced Research Projects Agency [N66001-12-C-4020, N66001-12-C-4211]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854, R37GM022854] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alexander von Humboldt Foundation (Bonn, Germany)(Alexander von Humboldt Foundation); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Y.I. was supported by research fellowships from the Japan Society for the Promotion of Science (JSPS). M.J.B. holds a Feodor Lynen Postdoctoral Fellowship of the Alexander von Humboldt Foundation (Bonn, Germany). We thank the staff members of SPring-8 BL41XU and the Photon Factory beam lines for assistance with our data collection, A. Ishii and T. Nakayama for assistance in the manuscript preparation, and M. Simonovic (University of Illinois, Chicago) for critical discussions. We are grateful to the National BioResource Project in Japan for providing the ASKA E. coli K12 ORF library. This work was supported in part by JSPS Grants-in-Aid for Scientific Research (A) to S.Y. and (C) to S. S. and the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology (to S.Y.). D. S. acknowledges support from the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy (DE-FG02-98ER20311) for funding the genetic experiments; the National Institute of General Medical Sciences (GM22854); and Defense Advanced Research Projects Agency (contracts N66001-12-C-4020 and N66001-12-C-4211). The plasmids for protein expression and tRNA transcription are available from S.Y. under a material transfer agreement with RIKEN. The atomic coordinates and structure factors have been deposited in the Protein Data Bank (PDB IDs 3W1H, 3W1I, 3W1J, and 3W1K).	BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; BOCK A, 2005, AMINOACYL TRNA SYNTH, P320; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Chiba S, 2010, MOL CELL, V39, P410, DOI 10.1016/j.molcel.2010.07.018; CONE JE, 1976, P NATL ACAD SCI USA, V73, P2659, DOI 10.1073/pnas.73.8.2659; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; ENGELHARDT H, 1992, MOL MICROBIOL, V6, P3461, DOI 10.1111/j.1365-2958.1992.tb01781.x; Fischer N, 2007, BIOL CHEM, V388, P1061, DOI 10.1515/BC.2007.108; Itoh Y, 2009, NUCLEIC ACIDS RES, V37, P6259, DOI 10.1093/nar/gkp648; Palioura S, 2009, SCIENCE, V325, P321, DOI 10.1126/science.1173755; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; SCHON A, 1989, NUCLEIC ACIDS RES, V17, P7159, DOI 10.1093/nar/17.18.7159; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104	14	40	44	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					75	78		10.1126/science.1229521	http://dx.doi.org/10.1126/science.1229521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559248	Green Accepted			2022-12-24	WOS:000317061100048
J	Ben-Sahra, I; Howell, JJ; Asara, JM; Manning, BD				Ben-Sahra, Issam; Howell, Jessica J.; Asara, John M.; Manning, Brendan D.			Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1	SCIENCE			English	Article							PHOSPHATE SYNTHETASE; PROTEIN-KINASE; CELL-GROWTH; SUBSTRATE; BIOSYNTHESIS; ACTIVATION; MECHANISM; COMPLEX; TARGET	Cellular growth signals stimulate anabolic processes. The mechanistic target of rapamycin complex 1 (mTORC1) is a protein kinase that senses growth signals to regulate anabolic growth and proliferation. Activation of mTORC1 led to the acute stimulation of metabolic flux through the de novo pyrimidine synthesis pathway. mTORC1 signaling posttranslationally regulated this metabolic pathway via its downstream target ribosomal protein S6 kinase 1 (S6K1), which directly phosphorylates S1859 on CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, dihydroorotase), the enzyme that catalyzes the first three steps of de novo pyrimidine synthesis. Growth signaling through mTORC1 thus stimulates the production of new nucleotides to accommodate an increase in RNA and DNA synthesis needed for ribosome biogenesis and anabolic growth.	[Ben-Sahra, Issam; Howell, Jessica J.; Manning, Brendan D.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct,Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Manning, BD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956; Ben-Sahra, Issam/0000-0001-9333-4162; Howell, Jessica/0000-0002-9736-5211	LAM Foundation; NIH [F32-DK095508, P01-CA120964, R01-CA122617]; Dana Farber/Harvard Cancer Center [P30-CA006516]; Sanofi Innovation Award; NATIONAL CANCER INSTITUTE [P30CA006516, R01CA122617, P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095508] Funding Source: NIH RePORTER	LAM Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Farber/Harvard Cancer Center; Sanofi Innovation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Yuan and S. Breitkopf for technical assistance with MS/MS and D. Patterson, D. Kwiatkowski, and M. Zbinden for cell lines. This work was supported in part by a grant from the LAM Foundation (I.B.-S.); NIH grants F32-DK095508 (J.J.H.), P01-CA120964 (B. D. M. and J.M.A.), and R01-CA122617 (B. D. M.); Dana Farber/Harvard Cancer Center grant P30-CA006516 (J.M.A.); and a Sanofi Innovation Award (B. D. M.). I.B.-S. and J.J.H. conceived and performed all experiments, analyzed all experimental data, and prepared the manuscript. J.M.A. performed and analyzed the MS/MS experiments. B. D. M. directed the research, reviewed all experimental data, and prepared the manuscript. All authors have reviewed the manuscript and declare no competing financial interests.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; CARREY EA, 1985, EMBO J, V4, P3735, DOI 10.1002/j.1460-2075.1985.tb04142.x; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; FLOTOW H, 1992, J BIOL CHEM, V267, P3074; Graves LM, 2000, NATURE, V403, P328, DOI 10.1038/35002111; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Iadevaia V, 2012, BIOCHEM SOC T, V40, P168, DOI 10.1042/BST20110682; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Mori M, 1978, Methods Enzymol, V51, P111; MUSMANNO LA, 1992, SOMAT CELL MOLEC GEN, V18, P309, DOI 10.1007/BF01235754; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Williamson RA, 1996, TRANSPLANT P, V28, P3088; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	18	467	486	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2013	339	6125					1323	1328		10.1126/science.1228792	http://dx.doi.org/10.1126/science.1228792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23429703	Green Accepted			2022-12-24	WOS:000316053400039
J	Gulati, A; Jabbour, A; Ismail, TF; Guha, K; Khwaja, J; Raza, S; Morarji, K; Brown, TDH; Ismail, NA; Dweck, MR; Di Pietro, E; Roughton, M; Wage, R; Daryani, Y; O'Hanlon, R; Sheppard, MN; Alpendurada, F; Lyon, AR; Cook, SA; Cowie, MR; Assomull, RG; Pennell, DJ; Prasad, SK				Gulati, Ankur; Jabbour, Andrew; Ismail, Tevfik F.; Guha, Kaushik; Khwaja, Jahanzaib; Raza, Sadaf; Morarji, Kishen; Brown, Tristan D. H.; Ismail, Nizar A.; Dweck, Marc R.; Di Pietro, Elisa; Roughton, Michael; Wage, Ricardo; Daryani, Yousef; O'Hanlon, Rory; Sheppard, Mary N.; Alpendurada, Francisco; Lyon, Alexander R.; Cook, Stuart A.; Cowie, Martin R.; Assomull, Ravi G.; Pennell, Dudley J.; Prasad, Sanjay K.			Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; HEART-FAILURE; RISK STRATIFICATION; MYOCARDIAL FIBROSIS; TASK-FORCE; PRACTICE GUIDELINES; RHYTHM SOCIETY; PREVENTION; THERAPY	Importance Risk stratification of patients with nonischemic dilated cardiomyopathy is primarily based on left ventricular ejection fraction (LVEF). Superior prognostic factors may improve patient selection for implantable cardioverter-defibrillators (ICDs) and other management decisions. Objective To determine whether myocardial fibrosis (detected by late gadolinium enhancement cardiovascular magnetic resonance [LGE-CMR] imaging) is an independent and incremental predictor of mortality and sudden cardiac death (SCD) in dilated cardiomyopathy. Design, Setting, and Patients Prospective, longitudinal study of 472 patients with dilated cardiomyopathy referred to a UK center for CMR imaging between November 2000 and December 2008 after presence and extent of midwall replacement fibrosis were determined. Patients were followed up through December 2011. Main Outcome Measures Primary end point was all-cause mortality. Secondary end points included cardiovascular mortality or cardiac transplantation; an arrhythmic composite of SCD or aborted SCD (appropriate ICD shock, nonfatal ventricular fibrillation, or sustained ventricular tachycardia); and a composite of HF death, HF hospitalization, or cardiac transplantation. Results Among the 142 patients with midwall fibrosis, there were 38 deaths (26.8%) vs 35 deaths (10.6%) among the 330 patients without fibrosis (hazard ratio [HR], 2.96 [95% CI, 1.87-4.69]; absolute risk difference, 16.2% [95% CI, 8.2%-24.2%]; P<.001) during a median follow-up of 5.3 years (2557 patient-years of follow-up). The arrhythmic composite was reached by 42 patients with fibrosis (29.6%) and 23 patients without fibrosis (7.0%) (HR, 5.24 [95% CI, 3.15-8.72]; absolute risk difference, 22.6% [95% CI, 14.6%-30.6%]; P<.001). After adjustment for LVEF and other conventional prognostic factors, both the presence of fibrosis (HR, 2.43 [95% CI, 1.503.92]; P<.001) and the extent (HR, 1.11 [95% CI, 1.06-1.16]; P<.001) were independently and incrementally associated with all-cause mortality. Fibrosis was also independently associated with cardiovascular mortality or cardiac transplantation (by fibrosis presence: HR, 3.22 [95% CI, 1.95-5.31], P<.001; and by fibrosis extent: HR, 1.15 [95% CI, 1.10-1.20], P<.001), SCD or aborted SCD (by fibrosis presence: HR, 4.61 [95% CI, 2.75-7.74], P<.001; and by fibrosis extent: HR, 1.10 [95% CI, 1.051.16], P<.001), and the HF composite (by fibrosis presence: HR, 1.62 [95% CI, 1.002.61], P=.049; and by fibrosis extent: HR, 1.08 [95% CI, 1.04-1.13], P<.001). Addition of fibrosis to LVEF significantly improved risk reclassification for all-cause mortality and the SCD composite (net reclassification improvement: 0.26 [95% CI, 0.11-0.41]; P=. 001 and 0.29 [95% CI, 0.11-0.48]; P=. 002, respectively). Conclusions and Relevance Assessment of midwall fibrosis with LGE-CMR imaging provided independent prognostic information beyond LVEF in patients with nonischemic dilated cardiomyopathy. The role of LGE-CMR in the risk stratification of dilated cardiomyopathy requires further investigation. JAMA.2013;309(9):896-908 www.jama.com	[Ismail, Tevfik F.; Guha, Kaushik; Sheppard, Mary N.; Lyon, Alexander R.; Cook, Stuart A.; Cowie, Martin R.; Pennell, Dudley J.; Prasad, Sanjay K.] Royal Brompton Hosp, London SW3 6NP, England; [Ismail, Tevfik F.; Guha, Kaushik; Sheppard, Mary N.; Lyon, Alexander R.; Cook, Stuart A.; Cowie, Martin R.; Pennell, Dudley J.; Prasad, Sanjay K.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Dweck, Marc R.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Cook, Stuart A.] Natl Heart Ctr Singapore, Singapore, Singapore	Royal Brompton Hospital; Imperial College London; University of Edinburgh; National Heart Centre Singapore	Prasad, SK (corresponding author), Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, Sydney St, London SW3 6NP, England.	s.prasad@rbht.nhs.uk	Ismail, Tevfik F/AAG-3303-2020; Cook, Stuart/G-9567-2011; Dweck, Marc/AAY-1509-2021; Sheppard, Mary N/AAB-3364-2019; Cowie, Martin R/AAQ-2818-2020	Ismail, Tevfik F/0000-0002-1691-7599; Sheppard, Mary N/0000-0003-2724-3881; Cowie, Martin R/0000-0001-7457-2552; Khwaja, Jahanzaib/0000-0002-4993-7828; dweck, marc/0000-0001-9847-5917; Cook, Stuart/0000-0001-6628-194X; Pennell, Dudley/0000-0001-5523-1314; Ismail, Nizar/0000-0001-5640-9938	National Institute for Health Research; CORDA; Rosetrees Trust; National Health and Medical Research Council of Australia; Victor Chang Cardiac Research Institute; St Vincent's Clinic Foundation; British Heart Foundation; Biotronik; Boston Scientific; Servier; Fondation Leducq; Medtronic; ResMed; Pfizer; Bayer; Novartis; Bayer Schering; National Institute for Health Research Cardiovascular Biomedical Research Unit at the Royal Brompton; Harefield NHS Foundation Trust; Imperial College, London, England; British Heart Foundation [FS/11/67/28954] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); CORDA; Rosetrees Trust(Rosetrees Trust); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victor Chang Cardiac Research Institute; St Vincent's Clinic Foundation; British Heart Foundation(British Heart Foundation); Biotronik; Boston Scientific(Boston Scientific); Servier(Servier); Fondation Leducq(Leducq Foundation); Medtronic(Medtronic); ResMed; Pfizer(Pfizer); Bayer(Bayer AG); Novartis(Novartis); Bayer Schering(Bayer AG); National Institute for Health Research Cardiovascular Biomedical Research Unit at the Royal Brompton; Harefield NHS Foundation Trust; Imperial College, London, England; British Heart Foundation(British Heart Foundation)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gulati reported receiving grant support from the National Institute for Health Research, CORDA, and Rosetrees Trust. Dr Jabbour reported receiving grant support from the National Health and Medical Research Council of Australia, Victor Chang Cardiac Research Institute, and St Vincent's Clinic Foundation. Dr T. Ismail reported receiving grant support from the British Heart Foundation. Dr Guha reported receiving an unrestricted educational grant from Biotronik; payment for an editorial from Boston Scientific; and sponsored attendance by Biotronik and Boston Scientific at national and international conferences. Dr Lyon reported receiving institutional grants from British Heart Foundation, CORDA, and Rosetrees Trust; serving on advisory boards for Roche Pharmaceuticals and Servier; serving as a consultant to Servier and Celladon Inc; receiving an educational grant from Servier; receiving speakers fees from Servier; and receiving travel reimbursement from AstraZeneca, Boston Scientific, and Servier. Dr Cook reported receiving grants from the British Heart Foundation and Fondation Leducq; and serving as a consultant for GlaxoSmithKline. Dr Cowie reported serving as a consultant to GE Healthcare, Servier, Bayer, ResMed, Roche Diagnostics, Pfizer, Boehringer Ingelheim, Novartis, Medtronic, and Boston Scientific; receiving grants from Medtronic and ResMed; and receiving speakers fees from Servier, Pfizer, Bayer, Medtronic, Boston Scientific, Biotronik, Novartis, and ResMed. Dr Assomull reported receiving grant support from the British Heart Foundation. Dr Pennell reported receiving grant support from the National Institute for Health Research and the British Heart Foundation; serving as a consultant to Siemens, Novartis, ApoPharma, AMAG, and Bayer; and serving as the director and owning stock in Cardiovascular Imaging Solutions. Dr Prasad reported receiving grant support from the British Heart Foundation, CORDA, and Rosetrees Trust, and the National Institute for Health Research; and receiving speaking fees from Bayer Schering. No other authors reported disclosures.; This work was supported by the National Institute for Health Research Cardiovascular Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, England.	Aleksova A, 2011, HEART LUNG, V40, P454, DOI 10.1016/j.hrtlng.2010.06.001; Aleksova A, 2009, J CARDIOVASC MED, V10, P699, DOI 10.2459/JCM.0b013e32832bba35; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Baig MK, 1998, AM HEART J, V135, pS216, DOI 10.1016/S0002-8703(98)70252-2; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cygankiewicz I, 2009, AM J CARDIOL, V103, P1003, DOI 10.1016/j.amjcard.2008.11.061; de Leeuw N, 2001, TRANSPLANT INT, V14, P299, DOI 10.1007/s001470100339; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Desai AS, 2004, JAMA-J AM MED ASSOC, V292, P2874, DOI 10.1001/jama.292.23.2874; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dickstein K, 2010, EUR J HEART FAIL, V12, P1143, DOI [10.1093/eurjhf/hfq192, 10.1093/europace/euq392]; Epstein AE, 2013, CIRCULATION, V127, pE283, DOI 10.1161/CIR.0b013e318276ce9b; European Heart Rhythm Association, 2006, J Am Coll Cardiol, V48, pe247, DOI 10.1016/j.jacc.2006.07.010; Ezekowitz JA, 2007, ANN INTERN MED, V147, P251, DOI 10.7326/0003-4819-147-4-200708210-00007; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; Goldberger JJ, 2008, CIRCULATION, V118, P1497, DOI 10.1161/CIRCULATIONAHA.107.189375; Goldberger JJ, 2011, CIRCULATION, V123, P2423, DOI 10.1161/CIRCULATIONAHA.110.959734; Greenberg H, 2004, J AM COLL CARDIOL, V43, P1459, DOI 10.1016/j.jacc.2003.11.038; Grimm W, 2003, CIRCULATION, V108, P2883, DOI 10.1161/01.CIR.0000100721.52503.85; Grzybowski J, 1996, J Card Fail, V2, P77, DOI 10.1016/S1071-9164(96)80026-1; Hsia Henry H, 2002, Card Electrophysiol Rev, V6, P472, DOI 10.1023/A:1021109130276; Hundley WG, 2010, CIRCULATION, V121, P2462, DOI 10.1161/CIR.0b013e3181d44a8f; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Iles L, 2011, J AM COLL CARDIOL, V57, P821, DOI 10.1016/j.jacc.2010.06.062; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Lehrke S, 2011, HEART, V97, P727, DOI 10.1136/hrt.2010.205542; Leyva F, 2012, J AM COLL CARDIOL, V60, P1659, DOI 10.1016/j.jacc.2012.05.054; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Mahrholdt H, 2005, EUR HEART J, V26, P1461, DOI 10.1093/eurheartj/ehi258; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; McCrohon A, 2003, CIRCULATION, V108, P54, DOI 10.1161/01.CIR.0000078641.19365.4C; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Mishkin JD, 2009, J AM COLL CARDIOL, V54, P1993, DOI 10.1016/j.jacc.2009.07.039; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pennell DJ, 2010, CIRCULATION, V121, P692, DOI 10.1161/CIRCULATIONAHA.108.811547; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; RIHAL CS, 1994, CIRCULATION, V90, P2772, DOI 10.1161/01.CIR.90.6.2772; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Stecker EC, 2011, J INTERV CARD ELECTR, V31, P101, DOI 10.1007/s10840-010-9535-z; Tung R, 2008, J AM COLL CARDIOL, V52, P1111, DOI 10.1016/j.jacc.2008.05.058; UK Department of Health, SENS DRINK REP INT W; White SK, 2012, HEART, V98, P773, DOI 10.1136/heartjnl-2011-301515; Wu KC, 2008, J AM COLL CARDIOL, V51, P2414, DOI 10.1016/j.jacc.2008.03.018	46	685	712	1	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					896	908		10.1001/jama.2013.1363	http://dx.doi.org/10.1001/jama.2013.1363			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23462786	Bronze			2022-12-24	WOS:000315632700025
J	Burns, MB; Lackey, L; Carpenter, MA; Rathore, A; Land, AM; Leonard, B; Refsland, EW; Kotandeniya, D; Tretyakova, N; Nikas, JB; Yee, D; Temiz, NIA; Donohue, DE; McDougle, RM; Brown, WL; Law, EK; Harris, RS				Burns, Michael B.; Lackey, Lela; Carpenter, Michael A.; Rathore, Anurag; Land, Allison M.; Leonard, Brandon; Refsland, Eric W.; Kotandeniya, Delshanee; Tretyakova, Natalia; Nikas, Jason B.; Yee, Douglas; Temiz, Nuri I. A.; Donohue, Duncan E.; McDougle, Rebecca M.; Brown, William L.; Law, Emily K.; Harris, Reuben S.			APOBEC3B is an enzymatic source of mutation in breast cancer	NATURE			English	Article							FOREIGN DNA; LANDSCAPE; AID	Several mutations are required for cancer development, and genome sequencing has revealed that many cancers, including breast cancer, have somatic mutation spectra dominated by C-to-T transitions(1-9). Most of these mutations occur at hydrolytically disfavoured(10) non-methylated cytosines throughout the genome, and are sometimes clustered(8). Here we show that the DNA cytosine deaminase APOBEC3B is a probable source of these mutations. APOBEC3B messenger RNA is upregulated in most primary breast tumours and breast cancer cell lines. Tumours that express high levels of APOBEC3B have twice as many mutations as those that express low levels and are more likely to have mutations in TP53. Endogenous APOBEC3B protein is predominantly nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-line extracts. Knockdown experiments show that endogenous APOBEC3B correlates with increased levels of genomic uracil, increased mutation frequencies, and C-to-T transitions. Furthermore, induced APOBEC3B overexpression causes cell cycle deviations, cell death, DNA fragmentation, gamma-H2AX accumulation and C-to-T mutations. Our data suggest a model in which APOBEC3B-catalysed deamination provides a chronic source of DNA damage in breast cancers that could select TP53 inactivation and explain how some tumours evolve rapidly and manifest heterogeneity.	[Burns, Michael B.; Lackey, Lela; Carpenter, Michael A.; Rathore, Anurag; Land, Allison M.; Refsland, Eric W.; McDougle, Rebecca M.; Brown, William L.; Law, Emily K.; Harris, Reuben S.] Univ Minnesota, Biochem Mol Biol & Biophys Dept, Minneapolis, MN 55455 USA; [Burns, Michael B.; Lackey, Lela; Carpenter, Michael A.; Rathore, Anurag; Land, Allison M.; Leonard, Brandon; Refsland, Eric W.; Kotandeniya, Delshanee; Tretyakova, Natalia; Nikas, Jason B.; Yee, Douglas; McDougle, Rebecca M.; Brown, William L.; Law, Emily K.; Harris, Reuben S.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Burns, Michael B.; Lackey, Lela; Carpenter, Michael A.; Rathore, Anurag; Land, Allison M.; Leonard, Brandon; Refsland, Eric W.; McDougle, Rebecca M.; Brown, William L.; Law, Emily K.; Harris, Reuben S.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Burns, Michael B.; Lackey, Lela; Carpenter, Michael A.; Rathore, Anurag; Land, Allison M.; Leonard, Brandon; Refsland, Eric W.; McDougle, Rebecca M.; Brown, William L.; Law, Emily K.; Harris, Reuben S.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Leonard, Brandon; Harris, Reuben S.] Univ Minnesota, Microbiol Canc Biol & Immunol Grad Program, Minneapolis, MN 55455 USA; [Kotandeniya, Delshanee; Tretyakova, Natalia] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Temiz, Nuri I. A.; Donohue, Duncan E.] SAIC Frederick Inc, In Silico Res Ctr Excellence, Adv Biomed Comp Ctr, Informat Syst Program,Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Harris, RS (corresponding author), Univ Minnesota, Biochem Mol Biol & Biophys Dept, Minneapolis, MN 55455 USA.	rsh@umn.edu	Nikas, Jason B./K-7060-2014; Brown, William/GXN-2777-2022	Nikas, Jason B./0000-0001-9703-0422; Donohue, Duncan/0000-0002-3137-8773; Burns, Michael/0000-0001-9791-4359; Lackey, Lela/0000-0003-2163-4005; Yee, Douglas/0000-0002-3387-4009; Carpenter, Michael/0000-0001-9524-5323	Academic Health Center; National Institutes of Health (NIH) [P30 CA77598, P50 CA101955, KL2 RR033182]; Cancer Biology Training Grant [NIH NCI T32 CA009138]; Department of Defense Breast Cancer Research Program Predoctoral Fellowship [BC101124]; National Science Foundation Predoctoral Fellowship; Institute for Molecular Virology Training Grant NIH [T32 AI083196]; NIH [F32 GM095219, F31 DA033186, R01 AI064046, NIH P01 GM091743, 1UL1RR033183]; CIHR; National Cancer Institute, NIH, CBIIT/caBIG ISRCE [09-260]; Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE [T32CA009138, P30CA077598, P50CA101955] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033183, KL2RR033182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI083196, R01AI064046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM091743, F32GM095219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA033186] Funding Source: NIH RePORTER	Academic Health Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Biology Training Grant; Department of Defense Breast Cancer Research Program Predoctoral Fellowship(United States Department of Defense); National Science Foundation Predoctoral Fellowship(National Science Foundation (NSF)); Institute for Molecular Virology Training Grant NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); National Cancer Institute, NIH, CBIIT/caBIG ISRCE; Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Hultquist and R. Vogel for statistics, T. Hwang for bioinformatic assistance, V. Polunovsky for hTERT-HMECs, V. Simon for shRNA, S. Kaufmann, C. Lange and D. Largaespada for consultation, and the Masonic Cancer Center Breast Cancer Research Fund for purchasing the ATCC breast cancer panel. Tissues were obtained from the Masonic Cancer Center Tissue Procurement Facility, which is part of BioNet, supported by the Academic Health Center and National Institutes of Health (NIH) grants P30 CA77598 (D.Y.), P50 CA101955 (D. Buchsbaum) and KL2 RR033182 (B. Blazar). M.B.B. was supported in part by a Cancer Biology Training Grant (NIH NCI T32 CA009138) and a Department of Defense Breast Cancer Research Program Predoctoral Fellowship (BC101124). L.L. was supported in part by a National Science Foundation Predoctoral Fellowship and by a position on the Institute for Molecular Virology Training Grant NIH T32 AI083196. MAC. was supported by an NIH postdoctoral fellowship (F32 GM095219). A.M.L. was supported by a CIHR postdoctoral fellowship. E.W.R. was supported by a position on the Institute for Molecular Virology Training Grant NIH T32 AI083196 and subsequently by an NIH predoctoral fellowship (F31 DA033186). Computational analyses (N.A.T. and D.E.D.) were supported by federal funds from the National Cancer Institute, NIH, CBIIT/caBIG ISRCE yellow task 09-260. The Harris laboratory was supported in part by NIH R01 AI064046, NIH P01 GM091743, the Children's Cancer Research Fund, and a seed grant from the University of Minnesota Clinical and Translational Science Institute (supported by NIH 1UL1RR033183).	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lackey L, 2012, J MOL BIOL, V419, P301, DOI 10.1016/j.jmb.2012.03.011; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; LOEB LA, 1974, CANCER RES, V34, P2311; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Zhang J, 2011, DISCRETE DYN NAT SOC, V2011, DOI [10.1155/2011/958381, 10.1093/database/bar026]	27	559	573	2	106	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					366	370		10.1038/nature11881	http://dx.doi.org/10.1038/nature11881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23389445	Green Accepted			2022-12-24	WOS:000315312900041
J	Wang, C; Jiang, Y; Ma, JM; Wu, HX; Wacker, D; Katritch, V; Han, GW; Liu, W; Huang, XP; Vardy, E; McCorvy, JD; Gao, X; Zhou, XE; Melcher, K; Zhang, CH; Bai, F; Yang, HY; Yang, LL; Jiang, HL; Roth, BL; Cherezov, V; Stevens, RC; Xu, HE				Wang, Chong; Jiang, Yi; Ma, Jinming; Wu, Huixian; Wacker, Daniel; Katritch, Vsevolod; Han, Gye Won; Liu, Wei; Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Gao, Xiang; Zhou, X. Edward; Melcher, Karsten; Zhang, Chenghai; Bai, Fang; Yang, Huaiyu; Yang, Linlin; Jiang, Hualiang; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.; Xu, H. Eric			Structural Basis for Molecular Recognition at Serotonin Receptors	SCIENCE			English	Article							AGONIST; FENFLURAMINE; PHARMACOLOGY; MUTATION; LIGANDS; TARGETS; BINDING	Serotonin or 5-hydroxytryptamine (5-HT) regulates a wide spectrum of human physiology through the 5-HT receptor family. We report the crystal structures of the human 5-HT1B G protein-coupled receptor bound to the agonist antimigraine medications ergotamine and dihydroergotamine. The structures reveal similar binding modes for these ligands, which occupy the orthosteric pocket and an extended binding pocket close to the extracellular loops. The orthosteric pocket is formed by residues conserved in the 5-HT receptor family, clarifying the family-wide agonist activity of 5-HT. Compared with the structure of the 5-HT2B receptor, the 5-HT1B receptor displays a 3 angstrom outward shift at the extracellular end of helix V, resulting in a more open extended pocket that explains subtype selectivity. Together with docking and mutagenesis studies, these structures provide a comprehensive structural basis for understanding receptor-ligand interactions and designing subtype-selective serotonergic drugs.	[Wang, Chong; Jiang, Yi; Ma, Jinming; Wu, Huixian; Wacker, Daniel; Katritch, Vsevolod; Han, Gye Won; Liu, Wei; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Jiang, Yi; Zhang, Chenghai; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Mat Med Ctr, Van Andel Res Inst,CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Ma, Jinming; Gao, Xiang; Zhou, X. Edward; Melcher, Karsten; Zhang, Chenghai; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, NIMH,Psychoact Drug Screening Program, Chapel Hill, NC 27599 USA; [Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Roth, Bryan L.] Univ N Carolina, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Bai, Fang] Dalian Univ Technol, Fac Chem Environm & Biol Sci & Technol, State Key Lab Technol, Dept Engn Mech, Dalian 116023, Peoples R China; [Yang, Huaiyu; Yang, Linlin; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	Scripps Research Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Dalian University of Technology; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Stevens, RC (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu; eric.xu@vai.org	Stevens, Raymond/K-7272-2015; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8673-2022; Roth, Bryan/ABE-7032-2020; Wu, Huixian/N-6353-2014; Han, Gye Won/GLQ-8724-2022; Melcher, Karsten/AAZ-3861-2020; Cherezov, Vadim/L-9812-2013; Katritch, Vsevolod/Q-8357-2016; Xu, H. Eric/ABD-7487-2021; Katritch, Vsevolod/Y-2721-2019; Ma, Jinming/D-5613-2015; Ma, Jinming/N-3704-2014; Roth, Bryan L/F-3928-2010	Stevens, Raymond/0000-0002-4522-8725; Roth, Bryan/0000-0002-0561-6520; Wu, Huixian/0000-0003-1357-9747; Han, Gye Won/0000-0003-4107-835X; Melcher, Karsten/0000-0002-9125-4027; Cherezov, Vadim/0000-0002-5265-3914; Katritch, Vsevolod/0000-0003-3883-4505; Ma, Jinming/0000-0002-0019-8219; Ma, Jinming/0000-0002-7171-1059; Xu, H. Eric/0000-0002-6829-8144; Bai, Fang/0000-0003-1468-5568	National Institute of General Medical Sciences (NIGMS) PSI: Biology grant [U54 GM094618, GPCR-118]; NIH Common Fund in Structural Biology grant [P50 GM073197]; Jay and Betty Van Andel Foundation [R01 DK071662]; Ministry of Science and Technology (China) [2012ZX09301001-005, 2012CB910403]; Amway (China) [R01 MH61887, U19 MH82441, R01 DA27170]; National Institute of Mental Health Psychoactive Drug Screening Program; Michael Hooker Chair of Pharmacology; Boehringer Ingelheim Fonds Ph.D. Fellowship; National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]; Office of Science of the U.S. Department of Energy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618, P50GM073197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441, R01MH061887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027170] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) PSI: Biology grant; NIH Common Fund in Structural Biology grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; Ministry of Science and Technology (China)(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); Amway (China); National Institute of Mental Health Psychoactive Drug Screening Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael Hooker Chair of Pharmacology; Boehringer Ingelheim Fonds Ph.D. Fellowship(Boehringer Ingelheim); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of General Medical Sciences (NIGMS) PSI: Biology grant U54 GM094618 for biological studies and structure production (target GPCR-118) (V. K., V. C., and R. C. S.); NIH Common Fund in Structural Biology grant P50 GM073197 for technology development (V. C. and R. C. S.); the Jay and Betty Van Andel Foundation, R01 DK071662, Ministry of Science and Technology (China) grants 2012ZX09301001-005 and 2012CB910403, and Amway (China) (H. E. X.); R01 MH61887, U19 MH82441, R01 DA27170, and the National Institute of Mental Health Psychoactive Drug Screening Program (X.-P. H., E. V., J.D.M., and B. L. R.); and the Michael Hooker Chair of Pharmacology (B. L. R.). D. W. is supported by a Boehringer Ingelheim Fonds Ph.D. Fellowship. We thank J. Velasquez for help on molecular biology; T. Trinh, K. Allin, and M. Chu for help on baculovirus expression; I. Wilson for careful review and scientific feedback on the manuscript; K. Kadyshevskaya for assistance with figure preparation; A. Walker for assistance with manuscript preparation; J. Smith, R. Fischetti, and N. Sanishvili for assistance in development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source (APS), which is supported by National Cancer Institute grant Y1-CO-1020 and NIGMS grant Y1-GM-1104; and Z. Wawrzak and J. S. Brunzelle for assistance in data collection at the beamlines of sector 21 (Life Sciences Collaborative Access Team), which is funded in part by the Michigan Economic Development Corporation and Michigan Technology Tri-Corridor Grant 085P1000817. Use of the APS was supported by the Office of Science of the U.S. Department of Energy. The coordinates and the structure factors have been deposited in the Protein Data Bank (PDB) under accession codes 4IAR (5-HT<INF>1B</INF>/ERG) and 4IAQ (5-HT<INF>1B</INF>/DHE). R.C.S. is a founder and paid consultant for Receptos, a GPCR structure-based drug discovery company.	ADHAM N, 1994, NEUROPHARMACOLOGY, V33, P387, DOI 10.1016/0028-3908(94)90068-X; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Braden MR, 2007, MOL PHARMACOL, V72, P1200, DOI 10.1124/mol.107.039255; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Goldenberg Marvin M, 2012, P T, V37, P499; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; HOYER D, 1994, PHARMACOL REV, V46, P157; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kroeze Wesley K., 2002, Current Topics in Medicinal Chemistry, V2, P507, DOI 10.2174/1568026023393796; Mehrotra S, 2008, N-S ARCH PHARMACOL, V378, P371, DOI 10.1007/s00210-008-0322-7; NELSON DL, 1993, J PHARMACOL EXP THER, V265, P1272; OKSENBERG D, 1992, NATURE, V360, P161, DOI 10.1038/360161a0; Roth BL, 2004, PSYCHOPHARMACOLOGY, V174, P17, DOI 10.1007/s00213-003-1683-8; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Rothman RB, 2002, ANN INTERN MED, V136, P779, DOI 10.7326/0003-4819-136-10-200205210-00016; Rothman RB, 2002, PHARMACOL BIOCHEM BE, V71, P825, DOI 10.1016/S0091-3057(01)00669-4; Rothman RB, 2000, CIRCULATION, V102, P2836; Setola V, 2005, MOL PHARMACOL, V68, P20, DOI 10.1124/mol.104.009266; Shapiro DA, 2000, MOL PHARMACOL, V58, P877, DOI 10.1124/mol.58.5.877; Smith BM, 2008, J MED CHEM, V51, P305, DOI 10.1021/jm0709034; Villalon Carlos M., 2003, Current Vascular Pharmacology, V1, P71, DOI 10.2174/1570161033386826; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	27	372	381	7	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					610	614		10.1126/science.1232807	http://dx.doi.org/10.1126/science.1232807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23519210	Green Accepted, Green Submitted			2022-12-24	WOS:000318268900048
J	Lauberth, SM; Nakayama, T; Wu, XL; Ferris, AL; Tang, ZY; Hughes, SH; Roeder, RG				Lauberth, Shannon M.; Nakayama, Takahiro; Wu, Xiaolin; Ferris, Andrea L.; Tang, Zhanyun; Hughes, Stephen H.; Roeder, Robert G.			H3K4me3 Interactions with TAF3 Regulate Preinitiation Complex Assembly and Selective Gene Activation	CELL			English	Article							RNA-POLYMERASE-II; CHROMATIN IN-VITRO; HISTONE MODIFICATIONS; CORE PROMOTER; DEPENDENT TRANSCRIPTION; BINDING MODULES; DNA-DAMAGE; P53; APOPTOSIS; TRIMETHYLATION	Histone modifications regulate chromatin-dependent processes, yet the mechanisms by which they contribute to specific outcomes remain unclear. H3K4me3 is a prominent histone mark that is associated with active genes and promotes transcription through interactions with effector proteins that include initiation factor TFIID. We demonstrate that H3K4me3-TAF3 interactions direct global TFIID recruitment to active genes, some of which are p53 targets. Further analyses show that (1) H3K4me3 enhances p53-dependent transcription by stimulating preinitiation complex (PIC) formation; (2) H3K4me3, through TAF3 interactions, can act either independently or cooperatively with the TATA box to direct PIC formation and transcription; and (3) H3K4me3-TAF3/TFIID interactions regulate gene-selective functions of p53 in response to genotoxic stress. Our findings indicate a mechanism by which H3K4me3 directs PIC assembly for the rapid induction of specific p53 target genes.	[Lauberth, Shannon M.; Nakayama, Takahiro; Tang, Zhanyun; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA; [Wu, Xiaolin] SAIC Frederick Inc, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Ferris, Andrea L.; Hughes, Stephen H.] NCI, HIV Drug Resistance Program, Ctr Canc Res, Frederick, MD 21702 USA	Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA.	roeder@rockefeller.edu		Lauberth, Shannon/0000-0003-4131-8536	NRSA [CA 09673]; NIH, Center for Cancer Research, National Cancer Institute; NIH [CA129325, DK071900]; Leukemia and Lymphoma Society [7132-08]; NATIONAL CANCER INSTITUTE [ZIABC011426, R01CA129325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Tomoyoshi Nakadai and Zhu Xie for technical assistance and Sohail Malik, Beth Moorefield, Christina Hughes, and Michael Rauchman for insightful discussions of the project. This work was supported by NRSA Training Grant CA 09673 to S. L., the Intramural Research Program of the NIH, Center for Cancer Research, National Cancer Institute to S. H. H., and by grants from the NIH (CA129325 and DK071900) and the Leukemia and Lymphoma Society (7132-08) to R.G.R.	An WJ, 2004, METHOD ENZYMOL, V377, P460; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Ferris AL, 2010, P NATL ACAD SCI USA, V107, P3135, DOI 10.1073/pnas.0914142107; Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001; Hart DO, 2009, DEV DYNAM, V238, P2540, DOI 10.1002/dvdy.22083; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hsu JY, 2008, GENE DEV, V22, P2353, DOI 10.1101/gad.1681808; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin JJ, 2011, GENE DEV, V25, P2198, DOI 10.1101/gad.17554711; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; OSHEAGREENFIELD A, 1992, J BIOL CHEM, V267, P1391; Prives C, 1999, J PATHOL, V187, P112; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vermeulen M, 2010, EPIGENOMICS-UK, V2, P395, DOI 10.2217/EPI.10.11; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	43	249	256	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					1021	1036		10.1016/j.cell.2013.01.052	http://dx.doi.org/10.1016/j.cell.2013.01.052			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452851	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000315710300011
J	Spruijt, CG; Gnerlich, F; Smits, AH; Pfaffeneder, T; Jansen, PWTC; Bauer, C; Munzel, M; Wagner, M; Muller, M; Khan, F; Eberl, HC; Mensinga, A; Brinkman, AB; Lephikov, K; Muller, U; Walter, J; Boelens, R; van Ingen, H; Leonhardt, H; Carell, T; Vermeulen, M				Spruijt, Cornelia G.; Gnerlich, Felix; Smits, Arne H.; Pfaffeneder, Toni; Jansen, Pascal W. T. C.; Bauer, Christina; Muenzel, Martin; Wagner, Mirko; Mueller, Markus; Khan, Fariha; Eberl, H. Christian; Mensinga, Anneloes; Brinkman, Arie B.; Lephikov, Konstantin; Mueller, Udo; Walter, Joern; Boelens, Rolf; van Ingen, Hugo; Leonhardt, Heinrich; Carell, Thomas; Vermeulen, Michiel			Dynamic Readers for 5-(Hydroxy)Methylcytosine and Its Oxidized Derivatives	CELL			English	Article							EMBRYONIC STEM-CELLS; HEMI-METHYLATED DNA; ONCOMETABOLITE 2-HYDROXYGLUTARATE; INTERACTION PROTEOMICS; MAMMALIAN DNA; PROTEIN; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; QUANTIFICATION; CHROMATIN	Tet proteins oxidize 5-methylcytosine (mC) to generate 5-hydroxymethyl (hmC), 5-formyl (fC), and 5-carboxylcytosine (caC). The exact function of these oxidative cytosine bases remains elusive. We applied quantitative mass-spectrometry-based proteomics to identify readers for mC and hmC in mouse embryonic stem cells (mESC), neuronal progenitor cells (NPC), and adult mouse brain tissue. Readers for these modifications are only partially overlapping, and some readers, such as Rfx proteins, display strong specificity. Interactions are dynamic during differentiation, as for example evidenced by the mESC-specific binding of Klf4 to mC and the NPC-specific binding of Uhrf2 to hmC, suggesting specific biological roles for mC and hmC. Oxidized derivatives of mC recruit distinct transcription regulators as well as a large number of DNA repair proteins in mouse ES cells, implicating the DNA damage response as a major player in active DNA demethylation.	[Spruijt, Cornelia G.; Smits, Arne H.; Jansen, Pascal W. T. C.; Mensinga, Anneloes; Vermeulen, Michiel] UMC Utrecht, Dept Mol Canc Res Prote & Chromatin Biol, NL-3584 CG Utrecht, Netherlands; [Gnerlich, Felix; Pfaffeneder, Toni; Muenzel, Martin; Wagner, Mirko; Mueller, Markus; Carell, Thomas] Univ Munich, Fak Chem & Pharm, Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Bauer, Christina; Mueller, Udo; Leonhardt, Heinrich] Univ Munich, Fak Biol, Ctr Integrated Prot Sci, D-82152 Planegg Martinsried, Germany; [Khan, Fariha] Pir Mehr Ali Shah Arid Agr Univ Rawalpindi, Univ Inst Biochem & Biotechnol, Rawalpindi, Pakistan; [Khan, Fariha; Boelens, Rolf; van Ingen, Hugo] Univ Utrecht, Bijvoet Ctr Biomol Res, NMR Spect Res Grp, NL-3584 CH Utrecht, Netherlands; [Eberl, H. Christian] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Brinkman, Arie B.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands; [Lephikov, Konstantin; Walter, Joern] Univ Saarland, D-66123 Saarbrucken, Germany	Utrecht University; Utrecht University Medical Center; University of Munich; University of Munich; Arid Agriculture University; Utrecht University; Max Planck Society; Radboud University Nijmegen; Saarland University	Carell, T (corresponding author), Univ Munich, Fak Chem & Pharm, Ctr Integrated Prot Sci, Marchioninistr 15, D-81377 Munich, Germany.	thomas.carell@lmu.de; m.vermeulen-3@umcutrecht.nl	Leonhardt, Heinrich/B-2791-2014; van Ingen, Hugo/Q-2883-2016; Lepikhov, Konstantin/AAN-3634-2021; Walter, Jörn/AFN-6428-2022; Muenzel, Martin/B-3360-2011; Vermeulen, Michiel/C-8883-2013; Pfaffeneder, Toni/D-6171-2014; Boelens, Rolf/B-4702-2009; Khan, Fariha/V-8742-2019; Brinkman, Arie/V-1533-2018; Carell, Thomas/G-4799-2012	van Ingen, Hugo/0000-0002-0808-3811; Walter, Jörn/0000-0003-0563-7417; Vermeulen, Michiel/0000-0003-0836-6894; Boelens, Rolf/0000-0002-6939-8913; Brinkman, Arie/0000-0002-9875-1835; Carell, Thomas/0000-0001-7898-2831; Spruijt, Cornelia/0000-0002-1789-670X; Muenzel, Martin/0000-0002-4504-8281; Eberl, H. Christian/0000-0002-4159-5958; Muller, Markus/0000-0002-3579-3317; Smits, Arne H/0000-0001-5011-0898; Bauer, Christina/0000-0001-9511-2491	DFG Normalverfahren [CA275/8-4, SFB 749, SFB 646]; Volkswagen Foundation; Deutsche Forschungsgemeinschaft (DFG) [SFB 646, SPP 1463]; Fonds der Chemischen Industrie; International Research Support Initiative Program from the Higher Education Commission, Pakistan; Dutch Science Foundation Chemical Sciences, NWO-CW; DFG [WA1029/6, SPP1356]; Netherlands Organization for Scientific Research (NWO-VIDI); ERC	DFG Normalverfahren(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); International Research Support Initiative Program from the Higher Education Commission, Pakistan; Dutch Science Foundation Chemical Sciences, NWO-CW; DFG(German Research Foundation (DFG)); Netherlands Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission)	We would like to thank Dr. Jiemin Wong for providing constructs. We are very thankful to Dr. Nikolay Outchkourov for providing NPCs, and we thank Tony Hyman and Ina Poser for providing the BAC-GFP WDR76 cell line. We would also like to thank Deepani Poramba Liyanage for support. Furthermore, we would like to thank all group members that contributed to fruitful discussions and Susan Kloet for critical reading of the manuscript. We thank the PRIDE team for their help uploading the raw mass spec data. Work in the Vermeulen lab is supported by a grant from the Netherlands Organization for Scientific Research (NWO-VIDI) and an ERC Starting Grant. The Carell group thanks the DFG Normalverfahren CA275/8-4, SFB 749, SFB 646, and the Volkswagen Foundation for financial support. Work in the Leonhardt group is supported by the SFB 646 and SPP 1463 grants from The Deutsche Forschungsgemeinschaft (DFG). M. Munzel and T. P. thank the Fonds der Chemischen Industrie for predoctoral fellowships. F. K. is supported through the International Research Support Initiative Program from the Higher Education Commission, Pakistan. H. v. I. is supported by a Veni fellowship from the Dutch Science Foundation Chemical Sciences, NWO-CW. K. L. and J. W. thank the DFG (WA1029/6) for support through SPP1356.	Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bartels SJJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025884; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bertonati C, 2009, PROTEINS, V75, P760, DOI 10.1002/prot.22287; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Defossez PA, 2011, PROG MOL BIOL TRANSL, V101, P377, DOI 10.1016/B978-0-12-387685-0.00012-3; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Eberl HC, 2013, MOL CELL, V49, P368, DOI 10.1016/j.molcel.2012.10.026; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hubner NC, 2011, METHODS, V53, P453, DOI 10.1016/j.ymeth.2010.12.016; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jones DL, 2011, J NEUROPHYSIOL, V105, P1984, DOI 10.1152/jn.00056.2011; KASTAN MB, 1991, CANCER RES, V51, P6304; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Konstandin N, 2011, LEUKEMIA, V25, P1649, DOI 10.1038/leu.2011.134; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Myant K, 2011, GENOME RES, V21, P83, DOI 10.1101/gr.108498.110; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Potts RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024515; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sengupta PK, 1999, J BIOL CHEM, V274, P36649, DOI 10.1074/jbc.274.51.36649; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Toyota H, 2012, CELL MOL BIOL LETT, V17, P36, DOI 10.2478/s11658-011-0034-8; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang B, 2011, J COMP NEUROL, V519, P2320, DOI 10.1002/cne.22618; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176	51	723	745	6	178	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1146	1159		10.1016/j.cell.2013.02.004	http://dx.doi.org/10.1016/j.cell.2013.02.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23434322	Bronze			2022-12-24	WOS:000315710300020
J	Johnson, AMF; Olefsky, JM				Johnson, Andrew M. F.; Olefsky, Jerrold M.			The Origins and Drivers of Insulin Resistance	CELL			English	Review							DIET-INDUCED OBESITY; HIGH-FAT DIET; NECROSIS-FACTOR-ALPHA; KILLER T-CELLS; ADIPOSE-TISSUE; GUT MICROBIOTA; METABOLIC-SYNDROME; PPAR-GAMMA; MOLECULAR-MECHANISMS; GLUCOSE-TOLERANCE	Obesity-induced insulin resistance is the major determinant of metabolic syndrome, which precedes the development of type 2 diabetes mellitus and is thus the driving force behind the emerging diabetes epidemic. The precise causes of insulin resistance are varied, and the relative importance of each is a matter of ongoing research. Here, we offer a Perspective on the heterogeneous etiology of insulin resistance, focusing in particular on the role of inflammation, lipid metabolism, and the gastrointestinal microbiota.	[Johnson, Andrew M. F.; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu			 [DK033651];  [DK074868];  [DK-063491];  [DK-09062]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009062, P30DK063491, R01DK033651, P01DK074868, R37DK033651] Funding Source: NIH RePORTER	; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DK033651, DK074868, DK-063491, and DK-09062.	Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bernstein LE, 2006, ARCH INTERN MED, V166, P902, DOI 10.1001/archinte.166.8.902; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Boden G, 2002, AM J PHYSIOL-ENDOC M, V283, pE12, DOI 10.1152/ajpendo.00429.2001; Burcelin R, 2012, SEMIN IMMUNOL, V24, P67, DOI 10.1016/j.smim.2011.11.011; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Forsythe LKS, 2008, NUTR RES REV, V21, P117, DOI 10.1017/S0954422408138732; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Gordon JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004347; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; Li JV, 2011, GUT, V60, P1214, DOI 10.1136/gut.2010.234708; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Neyrinck AM, 2009, BIOCHEM BIOPH RES CO, V385, P351, DOI 10.1016/j.bbrc.2009.05.070; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Saltiel AR, 2012, CELL METAB, V15, P798, DOI 10.1016/j.cmet.2012.03.001; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Simon GM, 2012, P NATL ACAD SCI USA, V109, P11133, DOI 10.1073/pnas.1208669109; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Strissel KJ, 2010, OBESITY, V18, P1918, DOI 10.1038/oby.2010.1; Teixeira-Lemos E, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-12; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Asseldonk EJP, 2011, J CLIN ENDOCR METAB, V96, P2119, DOI 10.1210/jc.2010-2992; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	99	417	457	13	299	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					673	684		10.1016/j.cell.2013.01.041	http://dx.doi.org/10.1016/j.cell.2013.01.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415219	Bronze			2022-12-24	WOS:000314945600004
J	Sarraf, SA; Raman, M; Guarani-Pereira, V; Sowa, ME; Huttlin, EL; Gygi, SP; Harper, JW				Sarraf, Shireen A.; Raman, Malavika; Guarani-Pereira, Virginia; Sowa, Mathew E.; Huttlin, Edward L.; Gygi, Steven P.; Harper, J. Wade			Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization	NATURE			English	Article							PHOSPHORYLATION ANALYSIS; PROTEIN-PHOSPHORYLATION; PINK1; DEGRADATION; MITOPHAGY; ACTIVATION; PROTEASOME; PROMOTES; VDAC1	The PARKIN ubiquitin ligase (also known as PARK2) and its regulatory kinase PINK1 (also known as PARK6), often mutated in familial early-onset Parkinson's disease, have central roles in mitochondrial homeostasis and mitophagy(1-3). Whereas PARKIN is recruited to the mitochondrial outer membrane (MOM) upon depolarization via PINK1 action and can ubiquitylate porin, mitofusin and Miro proteins on the MOM1,4-11, the full repertoire of PARKIN substrates-the PARKIN-dependent ubiquitylome-remains poorly defined. Here we use quantitative diGly capture proteomics (diGly)(12,13) to elucidate the ubiquitylation site specificity and topology of PARKIN-dependent target modification in response to mitochondrial depolarization. Hundreds of dynamically regulated ubiquitylation sites in dozens of proteins were identified, with strong enrichment for MOM proteins, indicating that PARKIN dramatically alters the ubiquitylation status of the mitochondrial proteome. Using complementary interaction proteomics, we found depolarization-dependent PARKIN association with numerous MOM targets, autophagy receptors, and the proteasome. Mutation of the PARKIN active site residue C431, which has been found mutated in Parkinson's disease patients, largely disrupts these associations. Structural and topological analysis revealed extensive conservation of PARKIN-dependent ubiquitylation sites on cytoplasmic domains in vertebrate and Drosophila melanogaster MOM proteins. These studies provide a resource for understanding how the PINK1-PARKIN pathway re-sculpts the proteome to support mitochondrial homeostasis.	[Sarraf, Shireen A.; Raman, Malavika; Guarani-Pereira, Virginia; Sowa, Mathew E.; Huttlin, Edward L.; Gygi, Steven P.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu		Harper, Jeffrey/0000-0002-6944-7236; Huttlin, Edward/0000-0002-1822-1173; raman, malavika/0000-0002-4773-8673; Sarraf, Shireen/0000-0001-8489-6198	NIH [GM070565, GM095567, GM067945, CA139885]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL CANCER INSTITUTE [F32CA139885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945, R01GM095567, R01GM070565] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation for Parkinson's Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Kim for LC-MS and for development of QdiGly profiling, R. Kunz for peptide purification, J. Lydeard, S. Hayes and A. White for proteomics, M. Comb and S. Beausoleil (Cell Signaling Technologies) for antibodies, Nikon Imaging Center (Harvard Medical School) for microscopy, and D. Finley and B. Schulman for discussions. Supported by NIH grants GM070565 and GM095567 to J.W.H., GM067945 to S.P.G., CA139885 to M.R., and the Michael J. Fox Foundation for Parkinson's Research to J.W.H.	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020655; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Narendra D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011338; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Onoue K, 2012, J CELL SCI; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sun Y, 2012, J BIOL CHEM, V287, P40652, DOI 10.1074/jbc.M112.419721; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	33	677	686	9	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					372	+		10.1038/nature12043	http://dx.doi.org/10.1038/nature12043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23503661	Green Accepted, Green Submitted			2022-12-24	WOS:000317599200040
J	Makino, DL; Baumgartner, M; Conti, E				Makino, Debora Lika; Baumgaertner, Marc; Conti, Elena			Crystal structure of an RNA-bound 11-subunit eukaryotic exosome complex	NATURE			English	Article							HUMAN PM-SCL; YEAST EXOSOME; ARCHAEAL EXOSOME; CORE EXOSOME; DEGRADATION; SUBUNIT; EXORIBONUCLEASE; RECONSTITUTION; PURIFICATION; RECRUITMENT	The exosome is the major 3'-5' RNA-degradation complex in eukaryotes. The ubiquitous core of the yeast exosome (Exo-10) is formed by nine catalytically inert subunits (Exo-9) and a single active RNase, Rrp44. In the nucleus, the Exo-10 core recruits another nuclease, Rrp6. Here we crystallized an approximately 440-kilodalton complex of Saccharomyces cerevisiae Exo-10 bound to a carboxy-terminal region of Rrp6 and to an RNA duplex with a 3'-overhang of 31 ribonucleotides. The 2.8 angstrom resolution structure shows how RNA is funnelled into the Exo-9 channel in a single-stranded conformation by an unwinding pore. Rrp44 adopts a closed conformation and captures the RNA 3'-end that exits from the side of Exo-9. Exo-9 subunits bind RNA with-sequence-unspecific interactions reminiscent of archaeal exosomes. The substrate binding and channelling mechanisms of 3'-5' RNA degradation complexes are conserved in all kingdoms of life.	[Makino, Debora Lika; Baumgaertner, Marc; Conti, Elena] MPI Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Conti, E (corresponding author), MPI Biochem, Dept Struct Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	conti@biochem.mpg.de		Conti, Elena/0000-0003-1254-5588	Max Planck Gesellschaft; ERC [294371]; Deutsche Forschungsgemeinschaft [SFB646, SFB1035, GRK1721, CIPSM]; Max Planck Institute Biochemistry Core Facility and Crystallization Facility	Max Planck Gesellschaft(Max Planck Society); ERC(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Institute Biochemistry Core Facility and Crystallization Facility	We would like to thank the Max Planck Institute Biochemistry Core Facility and Crystallization Facility; the staff members at beamlines X10SA (Swiss Light Source) and ID23-2 (European Synchrotron Radiation Facility)for support; F. Bonneau for the assay in Supplementary Fig. 6; J. Ebert, J. Basquin and F. Bonneau for initial materials and reagents; and P. Birle and T. Krywcun for technical assistance. We also thank members of our laboratory for discussions and critical reading of the manuscript This study was supported by the Max Planck Gesellschaft, the ERC Advanced Investigator Grant 294371 and the Deutsche Forschungsgemeinschaft (SFB646, SFB1035, GRK1721 and CIPSM) to E.C.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Cristodero M, 2008, MOL BIOCHEM PARASIT, V159, P24, DOI 10.1016/j.molbiopara.2007.12.012; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Greimann JC, 2008, METHOD ENZYMOL, V448, P185, DOI 10.1016/S0076-6879(08)02610-4; Hardwick SW, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120028; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Lorentzen E, 2007, EMBO REP, V8, P470, DOI 10.1038/sj.embor.7400945; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P399, DOI 10.1016/S0968-0004(97)01117-1; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Malet H, 2010, EMBO REP, V11, P936, DOI 10.1038/embor.2010.164; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Navarro MVAS, 2008, J BIOL CHEM, V283, P14120, DOI 10.1074/jbc.M801005200; Noguchi E, 1996, EMBO J, V15, P5595, DOI 10.1002/j.1460-2075.1996.tb00944.x; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schneider C, 2012, MOL CELL, V48, P422, DOI 10.1016/j.molcel.2012.08.013; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012	28	170	170	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					70	75		10.1038/nature11870	http://dx.doi.org/10.1038/nature11870			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23376952				2022-12-24	WOS:000316039800041
J	Sevenster, D; Beckers, T; Kindt, M				Sevenster, Dieuwke; Beckers, Tom; Kindt, Merel			Prediction Error Governs Pharmacologically Induced Amnesia for Learned Fear	SCIENCE			English	Article							MEMORY RECONSOLIDATION; PROTEIN-SYNTHESIS; EXTINCTION; RESPONSES	Although reconsolidation opens up new avenues to erase excessive fear memory, subtle boundary conditions put constraints on retrieval-induced plasticity. Reconsolidation may only take place when memory reactivation involves an experience that engages new learning (prediction error). Thus far, it has not been possible to determine the optimal degree of novelty required for destabilizing the memory. The occurrence of prediction error could only be inferred from the observation of a reconsolidation process itself. Here, we provide a noninvasive index of memory destabilization that is independent from the occurrence of reconsolidation. Using this index, we show in humans that prediction error is (i) a necessary condition for reconsolidation of associative fear memory and (ii) determined by the interaction between original learning and retrieval. Insight into the process of memory updating is crucial for understanding the optimal and boundary conditions on reconsolidation and provides a clear guide for the development of reconsolidation-based treatments.	[Sevenster, Dieuwke; Beckers, Tom; Kindt, Merel] Univ Amsterdam, Dept Clin Psychol, NL-1018 XA Amsterdam, Netherlands; [Sevenster, Dieuwke; Beckers, Tom; Kindt, Merel] Cognit Sci Ctr Amsterdam, NL-1018 WS Amsterdam, Netherlands; [Beckers, Tom] Katholieke Univ Leuven, Dept Psychol, Univ Leuven, B-3000 Louvain, Belgium	University of Amsterdam; KU Leuven	Kindt, M (corresponding author), Univ Amsterdam, Dept Clin Psychol, Weesperpl 4, NL-1018 XA Amsterdam, Netherlands.	m.kindt@uva.nl	Beckers, Tom/C-6164-2008	Beckers, Tom/0000-0002-9581-1505	Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The authors thank B. Molenkamp for his technical assistance. This study was funded by a Vici grant (M. K.) from the Netherlands Organization for Scientific Research. T. B. is supported by a Vidi grant from the Netherlands Organization for Scientific Research. D. S. collected and analyzed the data. D. S. and M. K. wrote the manuscript.	Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Biedenkapp JC, 2004, BEHAV NEUROSCI, V118, P956, DOI 10.1037/0735-7044.118.5.956; Bos MGN, 2012, BIOL PSYCHOL, V89, P598, DOI 10.1016/j.biopsycho.2012.01.007; Finnie PSB, 2012, NEUROSCI BIOBEHAV R, V36, P1667, DOI 10.1016/j.neubiorev.2012.03.008; Hupbach A, 2008, LEARN MEMORY, V15, P574, DOI 10.1101/lm.1022308; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Sevenster D, 2012, NEUROBIOL LEARN MEM, V97, P338, DOI 10.1016/j.nlm.2012.01.009; Soeter M, 2010, NEUROBIOL LEARN MEM, V30, P4990; Soeter M, 2012, NEUROPSYCHOPHARMACOL, V37, P1204, DOI 10.1038/npp.2011.307; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500	16	207	214	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					830	833		10.1126/science.1231357	http://dx.doi.org/10.1126/science.1231357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	088YS	23413355				2022-12-24	WOS:000314874400052
J	Shimozono, S; Iimura, T; Kitaguchi, T; Higashijima, S; Miyawaki, A				Shimozono, Satoshi; Iimura, Tadahiro; Kitaguchi, Tetsuya; Higashijima, Shin-ichi; Miyawaki, Atsushi			Visualization of an endogenous retinoic acid gradient across embryonic development	NATURE			English	Article							BINDING PROTEINS; HINDBRAIN DEVELOPMENT; MORPHOGEN GRADIENT; GENE-EXPRESSION; DISTINCT ROLES; ZEBRAFISH; BOUNDARY; FGF8; PATTERN; DIFFERENTIATION	In vertebrate development, the body plan is determined by primordial morphogen gradients that suffuse the embryo. Retinoic acid (RA) is an important morphogen involved in patterning the anterior-posterior axis of structures, including the hindbrain(1-6) and paraxial mesoderm(7,8). RA diffuses over long distances, and its activity is spatially restricted by synthesizing and degrading enzymes(9). However, gradients of endogenous morphogens in live embryos have not been directly observed; indeed, their existence, distribution and requirement for correct patterning remain controversial(10). Here we report a family of genetically encoded indicators for RA that we have termed GEPRAs (genetically encoded probes for RA). Using the principle of fluorescence resonance energy transfer we engineered the ligand-binding domains of RA receptors to incorporate cyan-emitting and yellow-emitting fluorescent proteins as fluorescence resonance energy transfer donor and acceptor, respectively, for the reliable detection of ambient free RA. We created three GEPRAs with different affinities for RA, enabling the quantitative measurement of physiological RA concentrations. Live imaging of zebrafish embryos at the gastrula and somitogenesis stages revealed a linear concentration gradient of endogenous RA in a two-tailed source-sink arrangement across the embryo. Modelling of the observed linear RA gradient suggests that the rate of RA diffusion exceeds the spatiotemporal dynamics of embryogenesis, resulting in stability to perturbation. Furthermore, we used GEPRAs in combination with genetic and pharmacological perturbations to resolve competing hypotheses on the structure of the RA gradient during hindbrain formation and somitogenesis. Live imaging of endogenous concentration gradients across embryonic development will allow the precise assignment of molecular mechanisms to developmental dynamics and will accelerate the application of approaches based on morphogen gradients to tissue engineering and regenerative medicine.	[Shimozono, Satoshi; Iimura, Tadahiro; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama 3510198, Japan; [Kitaguchi, Tetsuya; Miyawaki, Atsushi] JST, ERATO, Life Funct & Dynam, Wako, Saitama 3510198, Japan; [Higashijima, Shin-ichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan	RIKEN; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB)	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsushi@brain.riken.jp	KITAGUCHI, TETSUYA/AAR-1895-2021; Iimura, Tadahiro/P-3550-2018; Kitaguchi, Tetsuya/F-5260-2017; Miyawaki, Atsushi/K-3569-2014	KITAGUCHI, TETSUYA/0000-0001-6701-1933; Iimura, Tadahiro/0000-0002-1431-0689; Kitaguchi, Tetsuya/0000-0001-6701-1933; Miyawaki, Atsushi/0000-0002-2329-3235; Higashijima, Shin-ichi/0000-0001-6350-4992	Japan Ministry of Education, Culture, Sports, Science and Technology; Human Frontier Science Program	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program)	The authors thank Y. Wada, R. Aoki, M. Sugiyama, F. Picazo and members of the Brain Science Institute Research Resource Center for technical assistance; C. Yokoyama and A. Terashima for critical reading of the manuscript; the FANTOM Consortium for the cDNA clones; and the Zebrafish International Resource Center for the transgenic zebrafish. This work was partly supported by grants from Japan Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research on Priority Areas 'Fluorescence Live Imaging' and 'Cell Innovation' and the Human Frontier Science Program.	Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Begemann G, 2004, DEV BIOL, V271, P119, DOI 10.1016/j.ydbio.2004.03.033; Brand M, 1996, DEVELOPMENT, V123, P179; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; Diez del Corral R, 2003, NEURON, V40, P65; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; EICHELE G, 1987, J CELL BIOL, V105, P1917, DOI 10.1083/jcb.105.4.1917; Emoto Y, 2005, DEV BIOL, V278, P415, DOI 10.1016/j.ydbio.2004.11.023; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Gustafson AL, 1996, MECH DEVELOP, V58, P27, DOI 10.1016/S0925-4773(96)00554-0; Hamade A, 2006, DEV BIOL, V289, P127, DOI 10.1016/j.ydbio.2005.10.019; Haugland R.P., 1999, FLUORESCENT LUMINESC, P40; Hernandez RE, 2007, DEVELOPMENT, V134, P177, DOI 10.1242/dev.02706; Kudoh T, 2002, DEVELOPMENT, V129, P4335; Maves L, 2005, DEV BIOL, V285, P593, DOI 10.1016/j.ydbio.2005.07.015; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Muller P, 2012, SCIENCE, V336, P721, DOI 10.1126/science.1221920; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; NORRIS AW, 1994, BBA-PROTEIN STRUCT M, V1209, P10, DOI 10.1016/0167-4838(94)90130-9; Perz-Edwards A, 2001, DEV BIOL, V229, P89, DOI 10.1006/dbio.2000.9979; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Sawada A, 2001, DEVELOPMENT, V128, P4873; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Sirbu IO, 2005, DEVELOPMENT, V132, P2611, DOI 10.1242/dev.01845; Stern CD, 1998, CELL, V94, P143, DOI 10.1016/S0092-8674(00)81412-9; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; White RJ, 2008, DEV DYNAM, V237, P2775, DOI 10.1002/dvdy.21695; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; Zhang ZP, 2000, ARCH BIOCHEM BIOPHYS, V380, P339, DOI 10.1006/abbi.2000.1932	37	140	144	0	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					363	+		10.1038/nature12037	http://dx.doi.org/10.1038/nature12037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23563268				2022-12-24	WOS:000317599200038
J	Naik, SH; Perie, L; Swart, E; Gerlach, C; van Rooij, N; de Boer, RJ; Schumacher, TN				Naik, Shalin H.; Perie, Leila; Swart, Erwin; Gerlach, Carmen; van Rooij, Nienke; de Boer, Rob J.; Schumacher, Ton N.			Diverse and heritable lineage imprinting of early haematopoietic progenitors	NATURE			English	Article							DENDRITIC-CELL-DEVELOPMENT; STEM-CELLS; IN-VIVO; T-CELLS; COMMITMENT; SUBTYPES; PROMISCUITY; COMPARTMENT; SUBSETS; SYSTEM	Haematopoietic stem cells (HSCs) and their subsequent progenitors produce blood cells, but the precise nature and kinetics of this production is a contentious issue. In one model, lymphoid and myeloid production branch after the lymphoid-primed multipotent progenitor (LMPP)(1), with both branches subsequently producing dendritic cells(2). However, this model is based mainly on in vitro clonal assays and population-based tracking in vivo, which could miss in vivo single-cell complexity(3-7). Here we avoid these issues by using a new quantitative version of 'cellular barcoding'(8-10) to trace the in vivo fate of hundreds of LMPPs and HSCs at the single-cell level. These data demonstrate that LMPPs are highly heterogeneous in the cell types that they produce, separating into combinations of lymphoid-, myeloid-and dendritic-cell-biased producers. Conversely, although we observe a known lineage bias of some HSCs11-14, most cellular output is derived from a small number of HSCs that each generates all cell types. Crucially, in vivo analysis of the output of sibling cells derived from single LMPPs shows that they often share a similar fate, suggesting that the fate of these progenitors was imprinted. Furthermore, as this imprinting is also observed for dendritic-cell-biased LMPPs, dendritic cells may be considered a distinct lineage on the basis of separate ancestry. These data suggest a 'graded commitment' model of haematopoiesis, in which heritable and diverse lineage imprinting occurs earlier than previously thought.	[Naik, Shalin H.; Perie, Leila; Swart, Erwin; Gerlach, Carmen; van Rooij, Nienke; Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Perie, Leila; de Boer, Rob J.] Univ Utrecht, NL-3584 CH Utrecht, Netherlands	Netherlands Cancer Institute; Utrecht University	Naik, SH (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	naik.s@wehi.edu.au; t.schumacher@nki.nl	Naik, Shalin/AFD-5605-2022; de Boer, Rob/B-6050-2011; Schumacher, Ton/Y-2432-2019	de Boer, Rob/0000-0002-2130-691X; Schumacher, Ton/0000-0003-0517-8804; Perie, Leila/0000-0003-0798-4498; Naik, Shalin/0000-0003-0299-3301; Gerlach, Carmen/0000-0001-7889-2393	ERC grant LIFE-HIS-T and HFSP [RGP0060/2012]; National Health and Medical Research Council Australia; Marie Curie Incoming International FP6 Fellowship; Leukemia and Lymphoma Society; Marie Curie Intra European FP7 Fellowship; Bettencourt Schueller Fondation	ERC grant LIFE-HIS-T and HFSP; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Marie Curie Incoming International FP6 Fellowship; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Marie Curie Intra European FP7 Fellowship; Bettencourt Schueller Fondation	We thank G. Filion, U. Braunschweig, L. Pagie, M. Hauptmann, P. Lio, R. van der Wath and the NKI Genomics Facility for computational assistance; J. van Heijst, J. Rohr and J. Urbanus for useful discussions; http://www.josharris.com for illustrations in Fig. 1a and Supplementary Fig. 1; NKI cytometry and animal facilities; D. Leone, Z. Ping and M. Lodder for technical assistance; and P. Hodgkin, K. Duffy and J. Coquet for critical reading of the manuscript. This work was supported by ERC grant LIFE-HIS-T and HFSP grant RGP0060/2012, S.H.N. was supported by the National Health and Medical Research Council Australia, Marie Curie Incoming International FP6 Fellowship, and the Leukemia and Lymphoma Society; and L. P. was supported by a Marie Curie Intra European FP7 Fellowship and the Bettencourt Schueller Fondation.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2005, ANN NY ACAD SCI, V1044, P125, DOI 10.1196/annals.1349.016; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Ceredig R, 2009, NAT REV IMMUNOL, V9, P293, DOI 10.1038/nri2525; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Goncalves MAFV, 2008, MOL THER, V16, P741, DOI 10.1038/mt.2008.16; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LEMISCHKA IR, 1992, CURR TOP MICROBIOL, V177, P59; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Muller-Sieburg CE, 2006, CELL CYCLE, V5, P394, DOI 10.4161/cc.5.4.2487; Naik SH, 2008, IMMUNOL CELL BIOL, V86, P439, DOI 10.1038/icb.2008.28; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2009, CELL BIO RES PROG, P79; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Reeves JP, 2001, CURR PROTOC IMMUNOL, V10, P1; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Schumacher TNM, 2010, NAT REV IMMUNOL, V10, P621, DOI 10.1038/nri2822; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; van Heijst JWJ, 2009, SCIENCE, V325, P1265, DOI 10.1126/science.1175455; Welner RS, 2008, NAT REV IMMUNOL, V8, P95, DOI 10.1038/nri2234	30	267	270	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					229	+		10.1038/nature12013	http://dx.doi.org/10.1038/nature12013			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23552896				2022-12-24	WOS:000317346300043
J	Ostroumov, EE; Mulvaney, RM; Cogdell, RJ; Scholes, GD				Ostroumov, Evgeny E.; Mulvaney, Rachel M.; Cogdell, Richard J.; Scholes, Gregory D.			Broadband 2D Electronic Spectroscopy Reveals a Carotenoid Dark State in Purple Bacteria	SCIENCE			English	Article							BACTERIOCHLOROPHYLL ENERGY-TRANSFER; BETA-CAROTENE; RHODOBACTER-SPHAEROIDES; ULTRAFAST DYNAMICS; TARGET ANALYSIS; EXCITED-STATES; LH2 COMPLEXES; PHOTOSYNTHESIS; SPECTRA; SPHEROIDENE	Although the energy transfer processes in natural light-harvesting systems have been intensively studied for the past 60 years, certain details of the underlying mechanisms remain controversial. We performed broadband two-dimensional (2D) electronic spectroscopy measurements on light-harvesting proteins from purple bacteria and isolated carotenoids in order to characterize in more detail the excited-state manifold of carotenoids, which channel energy to bacteriochlorophyll molecules. The data revealed a well-resolved signal consistent with a previously postulated carotenoid dark state, the presence of which was confirmed by global kinetic analysis. The results point to this state's role in mediating energy flow from carotenoid to bacteriochlorophyll.	[Ostroumov, Evgeny E.; Scholes, Gregory D.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Mulvaney, Rachel M.; Cogdell, Richard J.] Univ Glasgow, Inst Biomed & Life Sci, Glasgow Biomed Res Ctr, Glasgow G12 8TA, Lanark, Scotland	University of Toronto; University of Glasgow	Scholes, GD (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.	greg.scholes@utoronto.ca			Natural Sciences and Engineering Research Council of Canada; U.S. Defense Advanced Research Projects Agency (QuBE); U.S. Air Force Office of Scientific Research [FA9550-10-1-0260]; Biotechnology and Biological Sciences Research Council; U.S. Department of Energy Office of Basic Energy Sciences, Photosynthetic Antenna Research Center (PARC) Energy Frontier Research Center [DE-SC0001035]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); U.S. Defense Advanced Research Projects Agency (QuBE); U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. Department of Energy Office of Basic Energy Sciences, Photosynthetic Antenna Research Center (PARC) Energy Frontier Research Center(United States Department of Energy (DOE))	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the U.S. Defense Advanced Research Projects Agency (QuBE), and the U.S. Air Force Office of Scientific Research (grant FA9550-10-1-0260) to G. D. S.; a research scholarship from the Biotechnology and Biological Sciences Research Council to R. M. M.; and the U.S. Department of Energy Office of Basic Energy Sciences, as part of the Photosynthetic Antenna Research Center (PARC) Energy Frontier Research Center, grant DE-SC0001035 to R.J.C., which allowed R. M. M. and R.J.C. to be involved in both the preparation of the biological material and the initial measurements. We thank D. B. Turner for assistance with 2DES setup and J. M. Anna for helpful discussions.	Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429; Christensson N, 2010, J PHYS CHEM LETT, V1, P3366, DOI 10.1021/jz101409r; Chumanov G, 2000, PHOTOCHEM PHOTOBIOL, V71, P589, DOI 10.1562/0031-8655(2000)071<0589:RRASER>2.0.CO;2; Cong H, 2008, J PHYS CHEM B, V112, P10689, DOI 10.1021/jp711946w; Frank HA, 1997, J PHYS CHEM A, V101, P149, DOI 10.1021/jp962373l; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; GELDOF PA, 1971, CHEM PHYS LETT, V10, P549, DOI 10.1016/0009-2614(71)87035-5; Herzberg G, 1933, Z PHYS CHEM B-CHEM E, V21, P410; Hiller R., 2004, PHOTOCHEMISTRY CAROT, V8, P81; Holzwarth AR, 1996, BIOPHYSICAL TECHNIQU, P75, DOI DOI 10.1007/0-306-47960-5_; Jonas DM, 2003, ANNU REV PHYS CHEM, V54, P425, DOI 10.1146/annurev.physchem.54.011002.103907; Kleinschmidt M, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3062842; Kosumi D, 2006, CHEM PHYS LETT, V425, P66, DOI 10.1016/j.cplett.2006.05.023; Kosumi D, 2011, ANGEW CHEM INT EDIT, V50, P1097, DOI 10.1002/anie.201003771; Kosumi D, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201000684; Krueger BP, 1998, J PHYS CHEM B, V102, P2284, DOI 10.1021/jp973062t; Krueger BP, 1998, J PHYS CHEM B, V102, P5378, DOI 10.1021/jp9811171; Macpherson AN, 2001, BIOPHYS J, V80, P923, DOI 10.1016/S0006-3495(01)76071-7; Maiuri M, 2012, PHYS CHEM CHEM PHYS, V14, P6312, DOI 10.1039/c2cp23585d; Mameloot M., 1992, METHOD ENZYMOL, V210, P314; MCCLURE DS, 1954, J CHEM PHYS, V22, P1668, DOI 10.1063/1.1739870; Niedzwiedzki D, 2007, J PHYS CHEM B, V111, P5984, DOI 10.1021/jp070500f; Ostroumov E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108302; Polivka T, 2004, CHEM REV, V104, P2021, DOI 10.1021/cr020674n; Polivka T, 2010, ACCOUNTS CHEM RES, V43, P1125, DOI 10.1021/ar100030m; Polli D, 2006, BIOPHYS J, V90, P2486, DOI 10.1529/biophysj.105.069286; Ritz T, 2000, PHOTOSYNTH RES, V66, P125, DOI 10.1023/A:1010750332320; Robert B, 2009, PHOTOSYNTH RES, V101, P147, DOI 10.1007/s11120-009-9440-4; TAVAN P, 1987, PHYS REV B, V36, P4337, DOI 10.1103/PhysRevB.36.4337; Telfer Alison, 2008, V4, P265, DOI 10.1007/978-3-7643-7499-0_14; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; Walla PJ, 2000, P NATL ACAD SCI USA, V97, P10808, DOI 10.1073/pnas.190230097; Wohlleben W, 2004, J PHYS CHEM B, V108, P3320, DOI 10.1021/jp036145k; Wohlleben W, 2003, BIOPHYS J, V85, P442, DOI 10.1016/S0006-3495(03)74489-0; Yoshizawa M, 2006, LASER PHYS, V16, P325, DOI 10.1134/S1054660X06020204; Zhang JP, 2000, CHEM PHYS LETT, V331, P154, DOI 10.1016/S0009-2614(00)01165-9	36	122	123	0	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					52	56		10.1126/science.1230106	http://dx.doi.org/10.1126/science.1230106			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559244	Green Published			2022-12-24	WOS:000317061100041
J	Li, TQ; Patz, A; Mouchliadis, L; Yan, JQ; Lograsso, TA; Perakis, IE; Wang, JG				Li, Tianqi; Patz, Aaron; Mouchliadis, Leonidas; Yan, Jiaqiang; Lograsso, Thomas A.; Perakis, Ilias E.; Wang, Jigang			Femtosecond switching of magnetism via strongly correlated spin-charge quantum excitations	NATURE			English	Article							TRANSITION-METAL OXIDES; PHASE-SEPARATION; DENSITY-WAVE; ULTRAFAST; MANGANITE; PULSES; STATE; ORDER	The technological demand to push the gigahertz (10(9) hertz) switching speed limit of today's magnetic memory and logic devices into the terahertz (10(12) hertz) regime underlies the entire field of spin-electronics and integrated multi-functional devices. This challenge is met by all-optical magnetic switching based on coherent spin manipulation(1). By analogy to femtosecond chemistry and photosynthetic dynamics(2)-in which photoproducts of chemical and biochemical reactions can be influenced by creating suitable superpositions of molecular states-femtosecond-laser-excited coherence between electronic states can switch magnetic order by 'suddenly' breaking the delicate balance between competing phases of correlated materials: for example, manganites exhibiting colossal magneto-resistance suitable for applications(3,4). Here we show femtosecond (10(-15) seconds) photo-induced switching from anti-ferromagnetic to ferromagnetic ordering in Pr0.7Ca0.3MnO3, by observing the establishment (within about 120 femtoseconds) of a huge temperature-dependent magnetization with photo-excitation threshold behaviour absent in the optical reflectivity. The development of ferromagnetic correlations during the femtosecond laser pulse reveals an initial quantum coherent regime of magnetism, distinguished from the picosecond (10(-12) seconds) lattice-heating regime characterized by phase separation without threshold behaviour(5,6). Our simulations reproduce the nonlinear femtosecond spin generation and underpin fast quantum spin-flip fluctuations correlated with coherent superpositions of electronic states to initiate local ferromagnetic correlations. These results merge two fields, femtosecond magnetism in metals and band insulators(1,7-9), and non-equilibrium phase transitions of strongly correlated electrons(10-17), in which local interactions exceeding the kinetic energy produce a complex balance of competing orders.	[Li, Tianqi; Patz, Aaron; Wang, Jigang] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Li, Tianqi; Patz, Aaron; Yan, Jiaqiang; Lograsso, Thomas A.; Wang, Jigang] US DOE, Ames Lab, Ames, IA 50011 USA; [Mouchliadis, Leonidas; Perakis, Ilias E.] Univ Crete, Dept Phys, Iraklion 71003, Crete, Greece; [Mouchliadis, Leonidas; Perakis, Ilias E.] Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion 71110, Crete, Greece	Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; University of Crete; Foundation for Research & Technology - Hellas (FORTH)	Wang, JG (corresponding author), Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA.	ilias@physics.uoc.gr; jgwang@iastate.edu	Lograsso, Thomas A/B-9064-2014; Mouchliadis, Leonidas/AAG-8074-2019; Perakis, Ilias/ABC-5659-2020; Li, Tianqi/C-5142-2014; Perakis, Ilias/G-9186-2011	Li, Tianqi/0000-0002-5238-8540; Yan, Jiaqiang/0000-0001-6625-4706	National Science Foundation [DMR-1055352]; US Department of Energy-Basic Energy Sciences [DE-AC02-7CH11358]; Project BIOSOLENUTI [FP7-REGPOT-2008-1, 229927]; EU Social Fund; National resources through the THALES program NANOPHOS	National Science Foundation(National Science Foundation (NSF)); US Department of Energy-Basic Energy Sciences(United States Department of Energy (DOE)); Project BIOSOLENUTI; EU Social Fund; National resources through the THALES program NANOPHOS(Thales Group)	This work was supported by the National Science Foundation (contract no. DMR-1055352). Material synthesis at the Ames Laboratory was supported by the US Department of Energy-Basic Energy Sciences (contract no. DE-AC02-7CH11358). L. M. acknowledges FP7-REGPOT-2008-1, Project BIOSOLENUTI no. 229927 for financial support. L. M. and I. E. P. were partially supported by the EU Social Fund and National resources through the THALES program NANOPHOS.	Axt VM, 1998, REV MOD PHYS, V70, P145, DOI 10.1103/RevModPhys.70.145; Bigot JY, 2009, NAT PHYS, V5, P515, DOI 10.1038/NPHYS1285; Boeglin C, 2010, NATURE, V465, P458, DOI 10.1038/nature09070; Brumer P, 2011, PHYS TODAY, V64, P11, DOI 10.1063/PT.3.1345; Cepas O, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.035218; Dagotto E, 2001, PHYS REP, V344, P1, DOI 10.1016/S0370-1573(00)00121-6; Ehrke H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.217401; Fausti D, 2011, SCIENCE, V331, P189, DOI 10.1126/science.1197294; Fiebig M, 2000, APPL PHYS B-LASERS O, V71, P211, DOI 10.1007/s003400000338; Gedik N, 2007, SCIENCE, V316, P425, DOI 10.1126/science.1138834; Ichikawa H, 2011, NAT MATER, V10, P101, DOI 10.1038/nmat2929; Kagan MY, 1999, EUR PHYS J B, V12, P217, DOI 10.1007/s100510050998; Kapetanakis MD, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3634031; Kapetanakis MD, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.047404; Karadimitriou ME, 2011, J PHYS CHEM B, V115, P5634, DOI 10.1021/jp1118794; Kim KW, 2012, NAT MATER, V11, P497, DOI [10.1038/nmat3294, 10.1038/NMAT3294]; Kimel AV, 2005, NATURE, V435, P655, DOI [10.1038/nature03564, 10.1038/nature03S64]; Kirilyuk A, 2010, REV MOD PHYS, V82, P2731, DOI 10.1103/RevModPhys.82.2731; Liu MK, 2012, NATURE, V487, P345, DOI 10.1038/nature11231; MATSUBARA M, 2007, PHYS REV LETT, V99, DOI DOI 10.1103/PHYSREVLETT.99.207401; McGill SA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.075117; Mertelj T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.113103; Miyasaka K, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.012401; Rini M, 2007, NATURE, V449, P72, DOI 10.1038/nature06119; Schmitt F, 2008, SCIENCE, V321, P1649, DOI 10.1126/science.1160778; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Wang J, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3058765; WANG J, 2007, PHYS REV LETT, V98, DOI DOI 10.1103/PHYSREVLETT.98.217401; Yamaguchi S, 1998, PHYS REV B, V58, P6862, DOI 10.1103/PhysRevB.58.6862; Zhang GP, 2009, NAT PHYS, V5, P499, DOI 10.1038/NPHYS1315	30	133	136	7	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2013	496	7443					69	73		10.1038/nature11934	http://dx.doi.org/10.1038/nature11934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23552945				2022-12-24	WOS:000316993400026
J	Zheng, XT; O'Connor, J; Huchzermeyer, F; Wang, XL; Wang, Y; Wang, M; Zhou, ZH				Zheng, Xiaoting; O'Connor, Jingmai; Huchzermeyer, Fritz; Wang, Xiaoli; Wang, Yan; Wang, Min; Zhou, Zhonghe			Preservation of ovarian follicles reveals early evolution of avian reproductive behaviour	NATURE			English	Article							ALLIGATOR-MISSISSIPPIENSIS; DINOSAUR; CHINA; GROWTH; GENDER; SIZE	The two groups of archosaurs, crocodilians and birds, form an extant phylogenetic bracket for understanding the reproductive behaviour of dinosaurs. This behaviour is inferred from preserved nests and eggs, and even gravid individuals(1). Data indicate that many 'avian' traits were already present in Paraves-the clade that includes birds and their close relatives-and that the early evolution of the modern avian form of reproduction was already well on its way(2,3). Like living neornithine birds, non-avian maniraptorans had daily oviposition and asymmetrical eggs with complex shell microstructure, and were known to protect their clutches(4-6). However, like crocodilians, non-avian maniraptorans had two active oviducts (one present in living birds), relatively smaller eggs, and may not have turned their eggs in the way that living birds do(1,6). Here we report on the first discovery of fossilized mature or nearly mature ovarian follicles, revealing a previously undocumented stage in dinosaur reproduction: reproductively active females near ovulation. Preserved in a specimen of the long bony-tailed Jeholornis and two enantiornithine birds from the Early Cretaceous period lacustrine Jehol Biota in northeastern China, these discoveries indicate that basal birds only had one functional ovary, but retained primitive morphologies as a result of their lower metabolic rate relative to living birds. They also indicate that basal birds reached sexual maturity before skeletal maturity, as in crocodiles and paravian dinosaurs. Differences in follicular morphology between Jeholornis and the enantiornithines are interpreted as forming an evolutionary gradient from the reproductive condition in paravian dinosaurs towards neornithine birds. Furthermore, differences between the two enantiornithines indicate that this lineage might also have evolved advanced reproductive traits in parallel to the neornithine lineage.	[Zheng, Xiaoting; Wang, Xiaoli; Wang, Yan] Linyi Univ, Inst Geol & Paleontol, Linyi 276000, Shandong, Peoples R China; [Zheng, Xiaoting] Tianyu Nat Hist Museum Shandong, Pingyi 273300, Shandong, Peoples R China; [O'Connor, Jingmai; Wang, Min; Zhou, Zhonghe] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origin, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Huchzermeyer, Fritz] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, ZA-0110 Onderstepoort, South Africa	Linyi University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Pretoria	O'Connor, J (corresponding author), Linyi Univ, Inst Geol & Paleontol, Linyi 276000, Shandong, Peoples R China.	jingmai.oconnor@gmail.com; zhouzhonghe@ivpp.ac.cn	Xiaoli, Wang/H-1079-2014; Wang, Min/AAH-6782-2020	Wang, Min/0000-0001-8506-1213	National Basic Research Program of China (973 Program) [2012CB821906]; National Natural Science Foundation of China [41172020]; Chinese Academy of Sciences	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The specimens reported here are deposited in the Tianyu Natural History Museum, Shandong, China. We thank A. Shi for helping with illustrations, S. Zhang for help with the histological analysis and E. O'Connor for estimating body mass. The research was supported by the National Basic Research Program of China (973 Program, 2012CB821906), the National Natural Science Foundation of China (41172020) and the Chinese Academy of Sciences.	ASTHEIMER LB, 1989, COPEIA, P221, DOI 10.2307/1445632; Chiappe LM, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3594[1:JBFTEC]2.0.CO;2; Chiappe Luis M, 2008, Biol Lett, V4, P719, DOI 10.1098/rsbl.2008.0409; Clark James M., 1999, American Museum Novitates, V3265, P1; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Farlow JO, 2005, J VERTEBR PALEONTOL, V25, P354, DOI 10.1671/0272-4634(2005)025[0354:FDABSO]2.0.CO;2; GILBERT AB, 1979, FORM FUNCTION BIRDS, V1, P237; GILL F. B., 2007, ORNITHOLOGY, P399; Girling JE, 2002, J EXP ZOOL, V293, P141, DOI 10.1002/jez.10105; GODFRAY HCJ, 1991, ANNU REV ECOL SYST, V22, P409, DOI 10.1146/annurev.es.22.110191.002205; LANCE VA, 1989, AM ZOOL, V29, P999; Liu Di, 2012, Vertebrata Palasiatica, V50, P39; Lu JC, 2011, SCIENCE, V331, P321, DOI 10.1126/science.1197323; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; O'Connor JK., 2011, LIVING DINOSAURS EVO, P39, DOI [10.1002/9781119990475.ch3, DOI 10.1002/9781119990475.CH3]; OConnor, 2009, THESIS U SO CALIFORN; Richardson K. C., 2002, CROCODILES INSIDE OU, P96; Sato T, 2005, SCIENCE, V308, P375, DOI 10.1126/science.1110578; Schweitzer MH, 2007, BONE, V40, P1152, DOI 10.1016/j.bone.2006.10.029; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; TAYLOR TG, 1970, SCI AM, V222, P88, DOI 10.1038/scientificamerican0370-88; Thorbjarnarson JB, 1996, HERPETOLOGICA, V52, P8; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Zelenitsky D., 2006, P 2006 GOS INT DIN S, V22, P209; Zheng XT, 2011, P NATL ACAD SCI USA, V108, P15904, DOI 10.1073/pnas.1112694108; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2004, SCIENCE, V306, P653, DOI 10.1126/science.1100000	29	65	71	2	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					507	511		10.1038/nature11985	http://dx.doi.org/10.1038/nature11985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23503663	Green Submitted			2022-12-24	WOS:000316682800045
J	Kloosterman, B; Abelenda, JA; Gomez, MDC; Oortwijn, M; de Boer, JM; Kowitwanich, K; Horvath, BM; van Eck, HJ; Smaczniak, C; Prat, S; Visser, RGF; Bachem, CWB				Kloosterman, Bjorn; Abelenda, Jose A.; Carretero Gomez, Maria del Mar; Oortwijn, Marian; de Boer, Jan M.; Kowitwanich, Krissana; Horvath, Beatrix M.; van Eck, Herman J.; Smaczniak, Cezary; Prat, Salome; Visser, Richard G. F.; Bachem, Christian W. B.			Naturally occurring allele diversity allows potato cultivation in northern latitudes	NATURE			English	Article							FLOWERING-TIME; ARABIDOPSIS; CONSTANS; TUBERIZATION; GENE; PLANTS; FKF1	Potato (Solanum tuberosum L.) originates from the Andes and evolved short-day-dependent tuber formation as a vegetative propagation strategy. Here we describe the identification of a central regulator underlying a major-effect quantitative trait locus for plant maturity and initiation of tuber development. We show that this gene belongs to the family of DOF (DNA-binding with one finger) transcription factors' and regulates tuberization and plant life cycle length, by acting as a mediator between the circadian clock and the StSP6A mobile tuberization signal(2). We also show that natural allelic variants evade post-translational light regulation, allowing cultivation outside the geographical centre of origin of potato. Potato is a member of the Solanaceae family and is one of the world's most important food crops. This annual plant originates from the Andean regions of South America(3). Potato develops tubers from underground stems called stolons. Its equatorial origin makes potato essentially short-day dependent for tuberization and potato will not make tubers in the long-day conditions of spring and summer in the northern latitudes. When introduced in temperate zones, wild material will form tubers in the course of the autumnal shortening of day-length. Thus, one of the first selected traits in potato leading to a European potato type(4) is likely to have been long-day acclimation for tuberization. Potato breeders can exploit the naturally occurring variation in tuberization onset and life cycle length, allowing varietal breeding for different latitudes, harvest times and markets.	[Kloosterman, Bjorn; Carretero Gomez, Maria del Mar; Oortwijn, Marian; de Boer, Jan M.; Kowitwanich, Krissana; van Eck, Herman J.; Visser, Richard G. F.; Bachem, Christian W. B.] Wageningen UR, Dept Plant Sci, Lab Plant Breeding, NL-6700 AJ Wageningen, Netherlands; [Abelenda, Jose A.; Prat, Salome] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol & Plantas, E-28049 Madrid, Spain; [Horvath, Beatrix M.] Univ Utrecht, NL-3508 TC Utrecht, Netherlands; [van Eck, Herman J.; Visser, Richard G. F.] Ctr BioSyst Genom, NL-6700 AB Wageningen, Netherlands; [Smaczniak, Cezary] Wageningen UR, Dept Plant Sci, Mol Biol Lab, NL-6700 AJ Wageningen, Netherlands	Wageningen University & Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Utrecht University; Centre for BioSystems Genomics; Wageningen University & Research	Bachem, CWB (corresponding author), Wageningen UR, Dept Plant Sci, Lab Plant Breeding, POB 386, NL-6700 AJ Wageningen, Netherlands.	Christian.Bachem@wur.nl	Abelenda, Jose A/L-8315-2017; Prat, Salome/L-9240-2014; van Eck, Herman/C-5940-2008; Visser, Richard GF/B-3423-2012; Smaczniak, Cezary/K-1774-2014	Abelenda, Jose A/0000-0001-7952-4891; Prat, Salome/0000-0003-2684-5485; van Eck, Herman/0000-0002-6530-0616; Visser, Richard GF/0000-0002-0213-4016; Smaczniak, Cezary/0000-0002-4663-8275; Bachem, Christian/0000-0002-3077-6833	Technology Foundation STW [WGC.7795, WPB.5283]; FP6 integrated Project [EU-Sol PL016214]; Almeria University Fund	Technology Foundation STW(Technologiestichting STW); FP6 integrated Project(European Commission); Almeria University Fund	We would like to thank K. Kaufman, G. Angenent, N. Mansoori Zangir, J. Uitdewilligen and R. Hutten for help and advice in the planning and execution of the project. Thanks also go to V. Ghasemi Omran and I. Pereira-Bertram for their expert technical assistance and to T. Bisseling for critical reading of the manuscript. We gratefully acknowledge the Dutch potato breeding companies, Argrico Research B.V., HZPC Holland B.V. and Meijer B.V. for the execution of the field trials. The project was supported by the Technology Foundation STW (grant no. WGC.7795 and WPB.5283) and FP6 integrated Project EU-Sol PL016214. M.d.M.C.G. received additional support from Almeria University Fund.	Abelenda JA, 2011, CURR OPIN BIOTECH, V22, P287, DOI 10.1016/j.copbio.2010.11.013; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Gonzalez-Schain ND, 2012, PLANT J, V70, P678, DOI 10.1111/j.1365-313X.2012.04909.x; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Inui H, 2010, FEBS LETT, V584, P2393, DOI 10.1016/j.febslet.2010.04.031; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Lifschitz E, 2006, J EXP BOT, V57, P3405, DOI 10.1093/jxb/erl106; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Rodriguez-Falcon M, 2006, ANNU REV PLANT BIOL, V57, P151, DOI 10.1146/annurev.arplant.57.032905.105224; Salaman Redcliffe N., 1989, HIST SOCIAL INFLUENC; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Song YH, 2012, SCIENCE, V336, P1045, DOI 10.1126/science.1219644; Spooner DM, 2005, P NATL ACAD SCI USA, V102, P14694, DOI 10.1073/pnas.0507400102; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Takase T, 2011, PLANT J, V67, P608, DOI 10.1111/j.1365-313X.2011.04618.x; Visker MHPW, 2003, THEOR APPL GENET, V106, P317, DOI 10.1007/s00122-002-1021-2; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	23	219	232	7	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					246	250		10.1038/nature11912	http://dx.doi.org/10.1038/nature11912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23467094				2022-12-24	WOS:000316652300053
J	Basler, M; Ho, BT; Mekalanos, JJ				Basler, Marek; Ho, Brian T.; Mekalanos, John J.			Tit-for-Tat: Type VI Secretion System Counterattack during Bacterial Cell-Cell Interactions	CELL			English	Article							PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION; ESCHERICHIA-COLI; TARGET-CELLS; INHIBITION; GROWTH; ACTIVATION; TRANSPORT; APPARATUS; DYNAMICS	The bacterial type VI secretion system (T6SS) is a dynamic organelle that bacteria use to target prey cells for inhibition via translocation of effector proteins. Time-lapse fluorescence microscopy has documented striking dynamics of opposed T6SS organelles in adjacent sister cells of Pseudomonas aeruginosa. Such cell-cell interactions have been termed "T6SS dueling" and likely reflect a biological process that is driven by T6SS antibacterial attack. Here, we show that T6SS dueling behavior strongly influences the ability of P. aeruginosa to prey upon heterologous bacterial species. We show that, in the case of P. aeruginosa, T6SS-dependent killing of either Vibrio cholerae or Acinetobacter baylyi is greatly stimulated by T6SS activity occurring in those prey species. Our data suggest that, in P. aeruginosa, T6SS organelle assembly and lethal counterattack are regulated by a signal that corresponds to the point of attack of the T6SS apparatus elaborated by a second aggressive T6SS(+) bacterial cell.	[Basler, Marek; Ho, Brian T.; Mekalanos, John J.] Harvard Univ, Dept Microbiol & Immunobiol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mekalanos, JJ (corresponding author), Harvard Univ, Dept Microbiol & Immunobiol, Sch Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	john_mekalanos@hms.harvard.edu	Ho, Brian/M-1976-2019; Basler, Marek/A-3559-2012	Ho, Brian/0000-0003-4979-780X; Basler, Marek/0000-0001-5414-2088	NIAID [AI-018045, AI-26289]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI018045, R01AI018045, R37AI018045, R01AI026289] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Casey Gifford for constructing pEXG2-Delta tagT plasmid. We also thank Russell Vance and Stephen Lory for helpful discussions and Tom Bernhardt and David Rudner for access to microscopic resources and tips for optimal use. This work was supported by NIAID grants AI-018045 and AI-26289 to J.J.M.	Aoki SK, 2009, J BACTERIOL, V191, P1777, DOI 10.1128/JB.01437-08; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Casabona M.G, 2012, ENV MICROBIOL; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Ding JJ, 2012, J BIOL CHEM, V287, P26911, DOI 10.1074/jbc.M112.368043; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gibbs KA, 2008, SCIENCE, V321, P256, DOI 10.1126/science.1160033; Gibbs KA, 2011, J BACTERIOL, V193, P3286, DOI 10.1128/JB.01167-10; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Hsu FS, 2009, MOL MICROBIOL, V72, P1111, DOI 10.1111/j.1365-2958.2009.06701.x; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Li M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002613; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Metzgar D, 2004, NUCLEIC ACIDS RES, V32, P5780, DOI 10.1093/nar/gkh881; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Silverman JM, 2011, MOL MICROBIOL, V82, P1277, DOI 10.1111/j.1365-2958.2011.07889.x; URATANI Y, 1984, J BACTERIOL, V157, P632, DOI 10.1128/JB.157.2.632-636.1984; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	39	321	334	3	121	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					884	894		10.1016/j.cell.2013.01.042	http://dx.doi.org/10.1016/j.cell.2013.01.042			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415234	Green Accepted, Bronze			2022-12-24	WOS:000314945600021
J	Edwards, KM; Zhu, YW; Griffin, MR; Weinberg, GA; Hall, CB; Szilagyi, PG; Staat, MA; Iwane, M; Prill, MM; Williams, JV				Edwards, Kathryn M.; Zhu, Yuwei; Griffin, Marie R.; Weinberg, Geoffrey A.; Hall, Caroline B.; Szilagyi, Peter G.; Staat, Mary A.; Iwane, Marika; Prill, Mila M.; Williams, John V.		New Vaccine Surveillance Network	Burden of Human Metapneumovirus Infection in Young Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; OBSTRUCTIVE PULMONARY-DISEASE; LUNG-TRANSPLANT RECIPIENTS; POLYMERASE-CHAIN-REACTION; TERM-CARE FACILITY; HOSPITALIZED CHILDREN; TRACT INFECTIONS; HEMATOLOGIC MALIGNANCIES; INFLUENZA-VIRUS; VIRAL LOAD	BACKGROUND The inpatient and outpatient burden of human metapneumovirus (HMPV) infection among young children has not been well established. METHODS We conducted prospective, population-based surveillance for acute respiratory illness or fever among inpatient and outpatient children less than 5 years of age in three U.S. counties from 2003 through 2009. Clinical and demographic data were obtained from parents and medical records, HMPV was detected by means of a reverse-transcriptase polymerase-chain-reaction assay, and population-based rates of hospitalization and estimated rates of outpatient visits associated with HMPV infection were determined. RESULTS HMPV was detected in 200 of 3490 hospitalized children (6%), 222 of 3257 children in outpatient clinics (7%), 224 of 3001 children in the emergency department (7%), and 10 of 770 asymptomatic controls (1%). Overall annual rates of hospitalization associated with HMPV infection were 1 per 1000 children less than 5 years of age, 3 per 1000 infants less than 6 months of age, and 2 per 1000 children 6 to 11 months of age. Children hospitalized with HMPV infection, as compared with those hospitalized without HMPV infection, were older and more likely to receive a diagnosis of pneumonia or asthma, to require supplemental oxygen, and to have a longer stay in the intensive care unit. The estimated annual burden of outpatient visits associated with HMPV infection was 55 clinic visits and 13 emergency department visits per 1000 children. The majority of HMPV-positive inpatient and outpatient children had no underlying medical conditions, although premature birth and asthma were more frequent among hospitalized children with HMPV infection than among those without HMPV infection. CONCLUSIONS HMPV infection is associated with a substantial burden of hospitalizations and outpatient visits among children throughout the first 5 years of life, especially during the first year. Most children with HMPV infection were previously healthy.	[Edwards, Kathryn M.; Williams, John V.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Zhu, Yuwei] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA; [Griffin, Marie R.] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA; [Williams, John V.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Weinberg, Geoffrey A.; Hall, Caroline B.; Szilagyi, Peter G.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Hall, Caroline B.] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; [Staat, Mary A.] Cincinnati Childrens Hosp, Dept Pediat, Cincinnati, OH USA; [Iwane, Marika; Prill, Mila M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Rochester; University of Rochester; Cincinnati Children's Hospital Medical Center; Centers for Disease Control & Prevention - USA	Williams, JV (corresponding author), Vanderbilt Univ, Med Ctr, D-7235 Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	john.williams@vanderbilt.edu	Williams, John/ABE-3227-2020; Weinberg, Geoffrey A./W-7510-2019; Williams, John/F-6962-2010	Williams, John/0000-0001-8377-5175; Weinberg, Geoffrey A./0000-0002-3900-379X; Williams, John/0000-0001-8377-5175	Centers for Disease Control and Prevention; National Institutes of Health; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [U01IP000022, U01IP000147, U01IP000017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085062, R21AI082417] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Centers for Disease Control and Prevention and the National Institutes of Health.)	Ali SA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-332; Anderson Evan J, 2012, J Pediatric Infect Dis Soc, V1, P212, DOI 10.1093/jpids/pis069; Biacchesi S, 2004, J VIROL, V78, P12877, DOI 10.1128/JVI.78.23.12877-12887.2004; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Boivin G, 2007, CLIN INFECT DIS, V44, P1152, DOI 10.1086/513204; Bosis S, 2008, J CLIN VIROL, V42, P286, DOI 10.1016/j.jcv.2008.03.029; Cane PA, 2003, BONE MARROW TRANSPL, V31, P309, DOI 10.1038/sj.bmt.1703849; Dollner H, 2004, PEDIATR INFECT DIS J, V23, P436, DOI [10.1097/01.inf.000126401.21779.7, 10.1097/01.inf.0000126401.21779.74]; Ebihara T, 2004, J CLIN MICROBIOL, V42, P126, DOI 10.1128/JCM.42.1.126-132.2004; Englund JA, 2006, ANN INTERN MED, V144, P344, DOI 10.7326/0003-4819-144-5-200603070-00010; Esper F, 2004, J INFECT DIS, V189, P1388, DOI 10.1086/382482; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Freymuth F, 2003, PEDIATR INFECT DIS J, V22, P92, DOI 10.1097/00006454-200301000-00024; Gerna G, 2007, J CLIN VIROL, V40, P236, DOI 10.1016/j.jcv.2007.08.001; Gray GC, 2006, J CLIN VIROL, V37, P269, DOI 10.1016/j.jcv.2006.08.016; Griffin Marie R, 2004, Pediatr Infect Dis J, V23, pS188, DOI 10.1097/01.inf.0000144660.53024.64; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hamelin ME, 2005, J VIROL, V79, P8894, DOI 10.1128/JVI.79.14.8894-8903.2005; Hopkins P, 2008, AM J RESP CRIT CARE, V178, P876, DOI 10.1164/rccm.200711-1657OC; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Kuiken T, 2004, AM J PATHOL, V164, P1893, DOI 10.1016/S0002-9440(10)63750-9; Kunz AN, 2008, EUR J CLIN MICROBIOL, V27, P1245, DOI 10.1007/s10096-008-0558-7; Larcher C, 2005, J HEART LUNG TRANSPL, V24, P1891, DOI 10.1016/j.healun.2005.02.014; Liao RS, 2012, J CLIN VIROL, V53, P171, DOI 10.1016/j.jcv.2011.10.010; Madhi SA, 2007, PEDIATR INFECT DIS J, V26, P693, DOI 10.1097/INF.0b013e3180621192; Martin ET, 2008, DIAGN MICR INFEC DIS, V62, P382, DOI 10.1016/j.diagmicrobio.2008.08.002; Martinello RA, 2006, J INFECTION, V53, P248, DOI 10.1016/j.jinf.2005.11.010; Martino R, 2005, BIOL BLOOD MARROW TR, V11, P781, DOI 10.1016/j.bbmt.2005.07.007; McAdam AJ, 2004, J INFECT DIS, V190, P20, DOI 10.1086/421120; Miller EK, 2009, J ALLERGY CLIN IMMUN, V123, P98, DOI 10.1016/j.jaci.2008.10.007; Morrow BM, 2006, J PAEDIATR CHILD H, V42, P174, DOI 10.1111/j.1440-1754.2006.00825.x; Mullins JA, 2004, EMERG INFECT DIS, V10, P700, DOI 10.3201/eid1004.030555; Noyola DE, 2005, J MED MICROBIOL, V54, P969, DOI 10.1099/jmm.0.46052-0; Osterhaus A, 2003, LANCET, V361, P890, DOI 10.1016/S0140-6736(03)12785-7; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Pelletier G, 2002, EMERG INFECT DIS, V8, P976, DOI 10.3201/eid0809.020238; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Shahda S, 2011, TRANSPL INFECT DIS, V13, P324, DOI 10.1111/j.1399-3062.2010.00575.x; Sivaprakasam V, 2007, J CLIN VIROL, V39, P234, DOI 10.1016/j.jcv.2007.03.011; Skiadopoulos MH, 2004, J VIROL, V78, P6927, DOI 10.1128/JVI.78.13.6927-6937.2004; Sumino KC, 2005, J INFECT DIS, V192, P1052, DOI 10.1086/432728; Talbot HK, 2009, PEDIATR INFECT DIS J, V28, P682, DOI 10.1097/INF.0b013e31819d0d27; van den Hoogen BG, 2003, J INFECT DIS, V188, P1571, DOI 10.1086/379200; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Vicente D, 2004, EMERG INFECT DIS, V10, P1338, DOI 10.3201/eid1007.030633; Walsh EE, 2008, ARCH INTERN MED, V168, P2489, DOI 10.1001/archinte.168.22.2489; Weinberg GA, 2009, J PEDIATR-US, V154, P694, DOI 10.1016/j.jpeds.2008.11.034; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Williams JV, 2010, J INFECT DIS, V201, P1890, DOI 10.1086/652782; Williams JV, 2005, J INFECT DIS, V192, P1061, DOI 10.1086/432732; Williams JV, 2005, J INFECT DIS, V192, P1149, DOI 10.1086/444392; Williams JV, 2005, J VIROL, V79, P10944, DOI 10.1128/JVI.79.17.10944-10951.2005; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Wyde PR, 2005, ANTIVIR RES, V66, P57, DOI 10.1016/j.antiviral.2004.12.009	55	197	214	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					633	643		10.1056/NEJMoa1204630	http://dx.doi.org/10.1056/NEJMoa1204630			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194VA	23406028	Green Accepted			2022-12-24	WOS:000322659600008
J	Lu, XW; Wontakal, SN; Kavi, H; Kim, BJ; Guzzardo, PM; Emelyanov, AV; Xu, N; Hannon, GJ; Zavadil, J; Fyodorov, DV; Skoultchi, AI				Lu, Xingwu; Wontakal, Sandeep N.; Kavi, Harsh; Kim, Byung Ju; Guzzardo, Paloma M.; Emelyanov, Alexander V.; Xu, Na; Hannon, Gregory J.; Zavadil, Jiri; Fyodorov, Dmitry V.; Skoultchi, Arthur I.			Drosophila H1 Regulates the Genetic Activity of Heterochromatin by Recruitment of Su(var)3-9	SCIENCE			English	Article							LINKER HISTONE H1; TRANSPOSABLE ELEMENTS; MELANOGASTER; CHROMATIN; GENOME; PHOSPHORYLATION; GERMLINE; BINDING; REPEATS; RNAS	Eukaryotic genomes harbor transposable elements and other repetitive sequences that must be silenced. Small RNA interference pathways play a major role in their repression. Here, we reveal another mechanism for silencing these sequences in Drosophila. Depleting the linker histone H1 in vivo leads to strong activation of these elements. H1-mediated silencing occurs in combination with the heterochromatin-specific histone H3 lysine 9 methyltransferase Su(var)3-9. H1 physically interacts with Su(var) 3-9 and recruits it to chromatin in vitro, which promotes H3 methylation. We propose that H1 plays a key role in silencing by tethering Su(var) 3-9 to heterochromatin. The tethering function of H1 adds to its established role as a regulator of chromatin compaction and accessibility.	[Lu, Xingwu; Wontakal, Sandeep N.; Kavi, Harsh; Kim, Byung Ju; Emelyanov, Alexander V.; Xu, Na; Fyodorov, Dmitry V.; Skoultchi, Arthur I.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Guzzardo, Paloma M.; Hannon, Gregory J.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Zavadil, Jiri] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Zavadil, Jiri] NYU, Langone Med Ctr, NYU Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Zavadil, Jiri] Int Agcy Res Canc, Mechanisms Carcinogenesis Sect, F-69372 Lyon 08, France	Yeshiva University; Albert Einstein College of Medicine; Cold Spring Harbor Laboratory; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; World Health Organization; International Agency for Research on Cancer (IARC)	Fyodorov, DV (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.	dmitry.fyodorov@einstein.yu.edu; arthur.skoultchi@einstein.yu.edu	Hannon, Gregory/AAB-3568-2019; KAVI, HARSH/B-5391-2014; Zavadil, Jiri/ABG-1780-2020	Zavadil, Jiri/0000-0003-0640-5562	NIH [GM074233, GM093190, CA079057]; National Cancer Institute, NIH, Cancer Center Grant [2P30CA13330];  [5T32GM0728]; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA079057, R56CA079057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074233, R37GM062534, R01GM093190] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH, Cancer Center Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Elgin, A. Imhof, T. Kornberg, and G. Reuter for fly stocks and DNA constructs; J. Kadonaga, M. Khuong, and T. Kusch for purified recombinant GAL4-VP16 and MBP-TRR; A. Lusser for critical reading of the manuscript; and E. Vershilova for technical assistance. This work was supported by grants from the NIH to D. V. F. (GM074233) and A. I. S. (GM093190 and CA079057). A. I. S. also receives support from National Cancer Institute, NIH, Cancer Center Grant 2P30CA13330. S.N.W. was supported by 5T32GM0728. Data have been deposited in the GEO database and assigned Series accession no. GSE44148.	Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Dimitri P, 1997, GENETICA, V100, P85, DOI 10.1023/A:1018304922862; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; GRIGORYEV SA, 1990, NUCLEIC ACIDS RES, V18, P7397, DOI 10.1093/nar/18.24.7397; Hale TK, 2006, MOL CELL, V22, P693, DOI 10.1016/j.molcel.2006.04.016; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; KAMAKAKA RT, 1990, EMBO J, V9, P3997, DOI 10.1002/j.1460-2075.1990.tb07621.x; KAMINKER JS, 2002, GENOME BIOL, V0003; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Kotelnikov RN, 2009, NUCLEIC ACIDS RES, V37, P3254, DOI 10.1093/nar/gkp167; LIVAK KJ, 1990, GENETICS, V124, P303; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Lu XW, 2009, GENE DEV, V23, P452, DOI 10.1101/gad.1749309; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Trojer P, 2009, J BIOL CHEM, V284, P8395, DOI 10.1074/jbc.M807818200; Vujatovic O, 2012, NUCLEIC ACIDS RES, V40, P5402, DOI 10.1093/nar/gks224; WEINTRAUB H, 1984, CELL, V38, P17, DOI 10.1016/0092-8674(84)90522-1; Wolffe A., 1995, CHROMATIN STRUCTURE	25	69	71	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					78	81		10.1126/science.1234654	http://dx.doi.org/10.1126/science.1234654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559249	Green Accepted			2022-12-24	WOS:000317061100049
J	Irannejad, R; Tomshine, JC; Tomshine, JR; Chevalier, M; Mahoney, JP; Steyaert, J; Rasmussen, SGF; Sunahara, RK; El-Samad, H; Huang, B; von Zastrow, M				Irannejad, Roshanak; Tomshine, Jin C.; Tomshine, Jon R.; Chevalier, Michael; Mahoney, Jacob P.; Steyaert, Jan; Rasmussen, Soren G. F.; Sunahara, Roger K.; El-Samad, Hana; Huang, Bo; von Zastrow, Mark			Conformational biosensors reveal GPCR signalling from endosomes	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; CAMP; ENDOCYTOSIS; DESENSITIZATION; ACTIVATION; BINDING; DOMAIN	A long-held tenet of molecular pharmacology is that canonical signal transduction mediated by G-protein-coupled receptor (GPCR) coupling to heterotrimeric G proteins is confined to the plasma membrane. Evidence supporting this traditional view is based on analytical methods that provide limited or no subcellular resolution(1). It has been subsequently proposed that signalling by internalized GPCRs is restricted to G-protein-independent mechanisms such as scaffolding by arrestins(2,3), or GPCR activation elicits a discrete formof persistent G protein signalling(4-9), or that internalized GPCRs can indeed contribute to the acute G-protein-mediated response(10). Evidence supporting these various latter hypotheses is indirect or subject to alternative interpretation, and it remains unknown if endosome-localized GPCRs are even present in an active form. Here we describe the application of conformation-specific single-domain antibodies (nanobodies) to directly probe activation of the beta(2)-adrenoceptor, a prototypical GPCR(11), and its cognate G protein, G(s) (ref. 12), in living mammalian cells. We show that the adrenergic agonist isoprenaline promotes receptor and G protein activation in the plasma membrane as expected, but also in the early endosome membrane, and that internalized receptors contribute to the overall cellular cyclic AMP response within several minutes after agonist application. These findings provide direct support for the hypothesis that canonical GPCR signalling occurs from endosomes as well as the plasma membrane, and suggest a versatile strategy for probing dynamic conformational change in vivo.	[Irannejad, Roshanak; Tomshine, Jin C.; Tomshine, Jon R.; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Chevalier, Michael; El-Samad, Hana; Huang, Bo] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Mahoney, Jacob P.; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Steyaert, Jan] Vrije Univ Brussel, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Steyaert, Jan] VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Rasmussen, Soren G. F.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Huang, Bo] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); University of Copenhagen; University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA.	Mark.VonZastrow@ucsf.edu	Sunahara, Roger/AAJ-8667-2020; Steyaert, Jan/H-4662-2011; steyaert, jan/GQP-7811-2022	Steyaert, Jan/0000-0002-3825-874X; Rasmussen, Soren/0000-0002-1853-1841; Tomshine, Jonathan/0000-0001-6633-8678	National Institute on Drug Abuse of the US National Institutes of Health [DA010711, DA012864, F32 DA029993]; American Heart Association; National Institute of General Medical Sciences [GM083118, T32 GM007767]; Lundbeck Foundation; FWO-Vlaanderen grants [FWO551, FWO646]; Innoviris-Brussels [BRGEOZ132]; Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118, T32GM007767, R01GM068603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS053709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010711, F32DA029993, R01DA012864, R37DA010711, P01DA010154, R29DA010711] Funding Source: NIH RePORTER; Lundbeck Foundation [R37-2009-3457] Funding Source: researchfish	National Institute on Drug Abuse of the US National Institutes of Health; American Heart Association(American Heart Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Lundbeck Foundation(Lundbeckfonden); FWO-Vlaanderen grants; Innoviris-Brussels(Innoviris); Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Lundbeck Foundation(Lundbeckfonden)	We thank B. Kobilka, P. Robinson, A. Kruse, E. Pardon, P. Temkin, M. Puthenveedu, A. Henry, A. Marley and K. Thorn for assistance, advice and discussion. These studies were supported by the National Institute on Drug Abuse of the US National Institutes of Health (DA010711 and DA012864 to M.v.Z. and F32 DA029993 to J.C.T.). R. I. is supported by the American Heart Association. R. K. S. and J.P.M. are supported by the National Institute of General Medical Sciences (GM083118 to R. K. S. and T32 GM007767 to J.P.M.). S. G. F. R. is supported by the Lundbeck Foundation. J.S. is supported by FWO-Vlaanderen grants (FWO551 and FWO646) and Innoviris-Brussels (BRGEOZ132). B. H. is supported by a Packard Fellowship for Science and Engineering.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Calebiro D, 2010, J MOL ENDOCRINOL, V45, P1, DOI 10.1677/JME-10-0014; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; CAMPBELL PT, 1991, MOL PHARMACOL, V39, P192; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GILMAN AG, 1991, HARVEY LECT, V85, P153; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Jameson EE, 2005, J BIOL CHEM, V280, P7712, DOI 10.1074/jbc.M413810200; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; LEE E, 1994, METHOD ENZYMOL, V237, P146; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Luttrell LM, 2002, J CELL SCI, V115, P455; McEwen DP, 2001, ANAL BIOCHEM, V291, P109, DOI 10.1006/abio.2001.5011; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Werthmann RC, 2012, FASEB J, V26, P2043, DOI 10.1096/fj.11-195248; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892	41	525	539	5	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					534	+		10.1038/nature12000	http://dx.doi.org/10.1038/nature12000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23515162	Green Accepted, Green Published			2022-12-24	WOS:000316682800051
J	Amador, A; Perl, YS; Mindlin, GB; Margoliash, D				Amador, Ana; Sanz Perl, Yonatan; Mindlin, Gabriel B.; Margoliash, Daniel			Elemental gesture dynamics are encoded by song premotor cortical neurons	NATURE			English	Article							BRAIN-STEM; GENERATION; INTEGRATION; MECHANISMS; FREQUENCY; RESPONSES; NUCLEUS; NETWORK; SLEEP; MODEL	Quantitative biomechanical models can identify control parameters that are used during movements, and movement parameters that are encoded by premotor neurons. We fit a mathematical dynamical systems model including subsyringeal pressure, syringeal biomechanics and upper-vocal-tract filtering to the songs of zebra finches. This reduces the dimensionality of singing dynamics, described as trajectories (motor 'gestures') in a space of syringeal pressure and tension. Here we assess model performance by characterizing the auditory response 'replay' of song premotor HVC neurons to the presentation of song variants in sleeping birds, and by examining HVC activity in singing birds. HVC projection neurons were excited and interneurons were suppressed within a few milliseconds of the extreme time points of the gesture trajectories. Thus, the HVC precisely encodes vocal motor output through activity at the times of extreme points of movement trajectories. We propose that the sequential activity of HVC neurons is used as a 'forward' model, representing the sequence of gestures in song to make predictions on expected behaviour and evaluate feedback.	[Amador, Ana; Margoliash, Daniel] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Sanz Perl, Yonatan; Mindlin, Gabriel B.] Univ Buenos Aires, FCEN, Dept Phys, RA-1428 Buenos Aires, DF, Argentina	University of Chicago; University of Buenos Aires	Margoliash, D (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1027 East 57th St, Chicago, IL 60637 USA.	dan@bigbird.uchicago.edu		Sanz Perl, Yonatan/0000-0002-1270-5564; Amador, Ana/0000-0002-1040-2359; Mindlin, Gabo/0000-0002-7808-5708	Human Frontiers Science Program cross-disciplinary fellowship; ANCyT; CONICET; UBA; NIDCD; NSF/CRCNS;  [NIDCD006876]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006876] Funding Source: NIH RePORTER	Human Frontiers Science Program cross-disciplinary fellowship; ANCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBA(University of Buenos Aires); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NSF/CRCNS(National Science Foundation (NSF)NSF - Office of the Director (OD)); ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to R. H. R. Hahnloser for help-with the microdrives and techniques used to record from singing birds. We thank H. D. I. Abarbanel, T. Q. Gentner, H. C. Nusbaum and S. E Palmer for valuable comments on the manuscript. This work was supported by a Human Frontiers Science Program cross-disciplinary fellowship award to A.A., NIDCD006876, ANCyT, CONICET and UBA awards to G.B.M. and Y.S.P., and NIDCD and NSF/CRCNS awards to D.M.	Amador A, 2008, J NEUROPHYSIOL, V99, P2383, DOI 10.1152/jn.01002.2007; Amador A, 2008, CHAOS, V18, DOI 10.1063/1.3041023; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Coleman MJ, 2007, J NEUROSCI, V27, P10024, DOI 10.1523/JNEUROSCI.2215-07.2007; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Elemans CPH, 2010, J NEUROSCI, V30, P13246, DOI 10.1523/JNEUROSCI.1130-10.2010; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fiete IR, 2004, J NEUROPHYSIOL, V92, P2274, DOI 10.1152/jn.01133.2003; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HARTLEY RS, 1989, J COMP PHYSIOL A, V165, P15, DOI 10.1007/BF00613795; Hatsopoulos NG, 2007, J NEUROSCI, V27, P5105, DOI 10.1523/JNEUROSCI.3570-06.2007; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Laje R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051921; Leyton ASF, 1917, Q J EXP PHYSIOL, V11, P135, DOI 10.1113/expphysiol.1917.sp000240; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; Mindlin GB, 2005, PHYS BIRDSONG; Mulliken GH, 2008, P NATL ACAD SCI USA, V105, P8170, DOI 10.1073/pnas.0802602105; Nick TA, 2005, J NEUROBIOL, V62, P469, DOI 10.1002/neu.20115; Nishikawa K, 2007, INTEGR COMP BIOL, V47, P16, DOI 10.1093/icb/icm024; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Prather JF, 2009, NAT NEUROSCI, V12, P221, DOI 10.1038/nn.2246; Riede T, 2006, P NATL ACAD SCI USA, V103, P5543, DOI 10.1073/pnas.0601262103; Roberts TF, 2008, J NEUROSCI, V28, P3479, DOI 10.1523/JNEUROSCI.0177-08.2008; Perl YS, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051909; Shank SS, 2009, NATURE, V458, P73, DOI 10.1038/nature07615; Sitt JD, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011905; Suthers RA, 2002, P NATL ACAD SCI USA, V99, P5680, DOI 10.1073/pnas.042103199; Suthers RA, 1999, PHILOS T ROY SOC B, V354, P927, DOI 10.1098/rstb.1999.0444; VU ET, 1994, J NEUROSCI, V14, P6924; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; WILLIAMS H, 1993, J NEUROBIOL, V24, P903, DOI 10.1002/neu.480240704; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	40	127	127	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2013	495	7439					59	64		10.1038/nature11967	http://dx.doi.org/10.1038/nature11967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23446354	Green Accepted			2022-12-24	WOS:000316039800039
J	Grossman, SR; Andersen, KG; Shlyakhter, I; Tabrizi, S; Winnicki, S; Yen, A; Park, DJ; Griesemer, D; Karlsson, EK; Wong, SH; Cabili, M; Adegbola, RA; Bamezai, RNK; Hill, AVS; Vannberg, FO; Rinn, JL; Lander, ES; Schaffner, SF; Sabeti, PC				Grossman, Sharon R.; Andersen, Kristian G.; Shlyakhter, Ilya; Tabrizi, Shervin; Winnicki, Sarah; Yen, Angela; Park, Daniel J.; Griesemer, Dustin; Karlsson, Elinor K.; Wong, Sunny H.; Cabili, Moran; Adegbola, Richard A.; Bamezai, Rameshwar N. K.; Hill, Adrian V. S.; Vannberg, Fredrik O.; Rinn, John L.; Lander, Eric S.; Schaffner, Stephen F.; Sabeti, Pardis C.		1000 Genomes Project	Identifying Recent Adaptations in Large-Scale Genomic Data	CELL			English	Article							RECENT POSITIVE SELECTION; HUMAN GENE-EXPRESSION; LARGE NONCODING RNAS; CHRONIC HEPATITIS-B; WIDE ASSOCIATION; POSTTRANSLATIONAL MODIFICATION; POPULATION GENOMICS; NATURAL-SELECTION; SUSCEPTIBILITY; VARIANTS	Although several hundred regions of the human genome harbor signals of positive natural selection, few of the relevant adaptive traits and variants have been elucidated. Using full-genome sequence variation from the 1000 Genomes (1000G) Project and the composite of multiple signals (CMS) test, we investigated 412 candidate signals and leveraged functional annotation, protein structure modeling, epigenetics, and association studies to identify and extensively annotate candidate causal variants. The resulting catalog provides a tractable list for experimental follow-up; it includes 35 high-scoring nonsynonymous variants, 59 variants associated with expression levels of a nearby coding gene or lincRNA, and numerous variants associated with susceptibility to infectious disease and other phenotypes. We experimentally characterized one candidate nonsynonymous variant in Toll-like receptor 5 (TLR5) and show that it leads to altered NF-kappa B signaling in response to bacterial flagellin.	[Grossman, Sharon R.; Andersen, Kristian G.; Shlyakhter, Ilya; Tabrizi, Shervin; Winnicki, Sarah; Yen, Angela; Park, Daniel J.; Karlsson, Elinor K.; Cabili, Moran; Rinn, John L.; Lander, Eric S.; Schaffner, Stephen F.; Sabeti, Pardis C.] Broad Inst & Harvard, Cambridge, MA 02142 USA; [Grossman, Sharon R.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Yen, Angela] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Grossman, Sharon R.; Griesemer, Dustin] Harvard Univ, Sch Med, Div Hlth Sci & Technol, Boston, MA 02115 USA; [Cabili, Moran; Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Andersen, Kristian G.; Shlyakhter, Ilya; Tabrizi, Shervin; Winnicki, Sarah; Park, Daniel J.; Griesemer, Dustin; Karlsson, Elinor K.; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [Wong, Sunny H.; Hill, Adrian V. S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Adegbola, Richard A.] MRC Labs, Fajara, Gambia; [Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India; [Vannberg, Fredrik O.] Georgia Inst Technol, Ctr Integrat Genom, Sch Biol, Atlanta, GA 30332 USA; [Rinn, John L.] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Sabeti, Pardis C.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Cambridge, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; University of Oxford; Wellcome Centre for Human Genetics; MRC Laboratory Molecular Biology; Jawaharlal Nehru University, New Delhi; University System of Georgia; Georgia Institute of Technology; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Grossman, SR (corresponding author), Broad Inst & Harvard, Cambridge, MA 02142 USA.	grossman@broadinstitute.org; psabeti@oeb.harvard.edu	Wong, Sunny H/N-3754-2015; Andersen, Kristian/D-5006-2009; Sabeti, Pardis/GQH-8610-2022; Schaffner, Stephen F/D-1189-2011	Wong, Sunny H/0000-0002-3354-9310; Andersen, Kristian/0000-0001-6431-5982; Rinn, John/0000-0002-7231-7539; Tabrizi, Shervin/0000-0003-2780-8432; Grossman, Sharon/0000-0001-6422-1134; Karlsson, Elinor/0000-0002-4343-3776; Schaffner, Stephen/0000-0001-6699-3568	Burroughs Wellcome Fund Career Award; Packard Foundation Fellowship in Science and Engineering; Broad Institute SPARC award; NIH Innovator Award [1DP2OD006514-01, BAA-NIAID-DAIT-NIHAI2009061]; NIGMS [T32GM007753]; Carlsberg Foundation fellowship; NSF; American Cancer Society Fellowship; Wellcome Trust; UK Medical Research Council; UK National Institute for Health Research; European Commission; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006514] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); Packard Foundation Fellowship in Science and Engineering; Broad Institute SPARC award; NIH Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Carlsberg Foundation fellowship; NSF(National Science Foundation (NSF)); American Cancer Society Fellowship(American Cancer Society); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research(National Institute for Health Research (NIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	P.C.S. and her lab are supported by a Burroughs Wellcome Fund Career Award, a Packard Foundation Fellowship in Science and Engineering, a Broad Institute SPARC award, an NIH Innovator Award 1DP2OD006514-01, and BAA-NIAID-DAIT-NIHAI2009061. S.R.G. is supported by NIGMS T32GM007753, K.G.A. by a Carlsberg Foundation fellowship, D.J.P. by NSF, and E.K.K. by an American Cancer Society Fellowship. The mycobacterial disease studies analyzed were supported by funding from the Wellcome Trust, the UK Medical Research Council, the UK National Institute for Health Research, and the European Commission; we thank the many collaborators who contributed to generating these data sets. We would like to thank S. Hart for help with figures, C. Edwards for reviews of the text, and L. Ward and C. O'Dushlaine for technical guidance.	Abu-Maziad A, 2010, PEDIATR RES, V68, P323, DOI 10.1203/00006450-201011001-00632; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Gusev A, 2012, MOL BIOL EVOL, V29, P473, DOI 10.1093/molbev/msr133; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koedel U, 2000, J INFECT DIS, V182, P1437, DOI 10.1086/315877; Kunz S, 2005, J VIROL, V79, P14282, DOI 10.1128/JVI.79.22.14282-14296.2005; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu W, 2004, INT J TUBERC LUNG D, V8, P428; Loizou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018670; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Okugawa S, 2006, CELL MICROBIOL, V8, P1571, DOI 10.1111/j.1462-5822.2006.00731.x; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Png E, 2011, HUM MOL GENET, V20, P3893, DOI 10.1093/hmg/ddr302; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vernot B, 2012, GENOME RES, V22, P1689, DOI 10.1101/gr.134890.111; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WANG YX, 1995, HUM MOL GENET, V4, P657, DOI 10.1093/hmg/4.4.657; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	54	237	241	1	171	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					703	713		10.1016/j.cell.2013.01.035	http://dx.doi.org/10.1016/j.cell.2013.01.035			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415221	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000314945600007
J	Oh, YS; Gao, P; Lee, KW; Ceglia, I; Seo, JS; Zhang, X; Ahn, JH; Chait, BT; Patel, DJ; Kim, Y; Greengard, P				Oh, Yong-Seok; Gao, Pu; Lee, Ko-Woon; Ceglia, Ilaria; Seo, Ji-Seon; Zhang, Xiaozhu; Ahn, Jung-Hyuck; Chait, Brian T.; Patel, Dinshaw J.; Kim, Yong; Greengard, Paul			SMARCA3, a Chromatin-Remodeling Factor, Is Required for p11-Dependent Antidepressant Action	CELL			English	Article							HILAR MOSSY CELLS; HIPPOCAMPAL NEUROGENESIS; TRANSCRIPTION FACTOR; DENTATE GYRUS; ANIMAL-MODEL; P11; EXPRESSION; DEPRESSION; NEURONS; COMPLEX	p11, through unknown mechanisms, is required for behavioral and cellular responses to selective serotonin reuptake inhibitors (SSRIs). We show that SMARCA3, a chromatin-remodeling factor, is a target for the p11/annexin A2 heterotetrameric complex. Determination of the crystal structure indicates that SMARCA3 peptide binds to a hydrophobic pocket in the heterotetramer. Formation of this complex increases the DNA-binding affinity of SMARCA3 and its localization to the nuclear matrix fraction. In the dentate gyrus, both p11 and SMARCA3 are highly enriched in hilar mossy cells and basket cells. The SSRI fluoxetine induces expression of p11 in both cell types and increases the amount of the ternary complex of p11/annexin A2/SMARCA3. SSRI-induced neurogenesis and behavioral responses are abolished by constitutive knockout of SMARCA3. Our studies indicate a central role for a chromatin-remodeling factor in the SSRI/p11 signaling pathway and suggest an approach to the development of improved antidepressant therapies.	[Oh, Yong-Seok; Lee, Ko-Woon; Ceglia, Ilaria; Seo, Ji-Seon; Zhang, Xiaozhu; Kim, Yong; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA; [Gao, Pu; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Ahn, Jung-Hyuck] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul 158710, South Korea	Rockefeller University; Rockefeller University; Memorial Sloan Kettering Cancer Center; Ewha Womans University	Kim, Y (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA.	kimyo@rockefeller.edu; greengard@rockefeller.edu	Seo, Ji-Seon/AAM-5949-2020	Oh, Yong-Seok/0000-0002-9039-2014; Kim, Yong/0000-0002-1387-2962; Ceglia, Ilaria/0000-0003-0692-9518	DOD/USAMRAA Grant [W81XWH-09-1-0392, W81XWH-09-1-0402]; JPB Foundation; Fisher Center Foundation; NIH [MH090963, DA10044, AG09464]; Maloris Foundation; Abby Rockefeller Mauze Trust; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	DOD/USAMRAA Grant; JPB Foundation; Fisher Center Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maloris Foundation; Abby Rockefeller Mauze Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by DOD/USAMRAA Grant W81XWH-09-1-0392 to Y.K.; DOD/USAMRAA Grant W81XWH-09-1-0402 to P. Greengard; the JPB Foundation to P. Greengard; the Fisher Center Foundation to P. Greengard; NIH grants (MH090963, DA10044, and AG09464) to Y.K. and P. Greengard; and the Maloris Foundation and the Abby Rockefeller Mauze Trust to D.J.P. We thank the staff at beamline 24ID-C of the Advanced Photon Source at the Argonne National Laboratory and beamline X29 of the National Synchrotron Light Source at the Brookhaven National Laboratory for assistance with data collection. We thank Daesoo Kim, Eric Schmidt, Jennifer Wagner-Schmidt, and Yotam Sagi for their helpful advice and discussion, and Elisabeth Griggs for technical assistance. We would like to thank Ji-Eun Kim for the mass spectrometry analysis. Finally, we would like to acknowledge Rada Norinsky and the Rockefeller University Transgenics Services Laboratory for their excellent IVF services; and Henry Zebroski III and Nagarajan Chandramouli from The Rockefeller University Proteomics Resource Center.	Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Barlow CA, 2010, TRENDS CELL BIOL, V20, P25, DOI 10.1016/j.tcb.2009.09.009; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Bjarkam CR, 2003, HIPPOCAMPUS, V13, P21, DOI 10.1002/hipo.10042; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Das S, 2010, BIOCHEMISTRY-US, V49, P2216, DOI 10.1021/bi9013038; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Debauve G, 2008, CELL MOL LIFE SCI, V65, P591, DOI 10.1007/s00018-007-7392-4; Ding H, 1996, DNA CELL BIOL, V15, P429, DOI 10.1089/dna.1996.15.429; Egeland M, 2010, BIOL PSYCHIAT, V67, P1048, DOI 10.1016/j.biopsych.2010.01.024; GAGE FH, 1980, BRAIN RES BULL, V5, P771, DOI 10.1016/0361-9230(80)90220-8; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Hanson ND, 2011, NEUROPSYCHOPHARMACOL, V36, P2589, DOI 10.1038/npp.2011.220; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Henze DA, 2007, PROG BRAIN RES, V163, P199, DOI 10.1016/S0079-6123(07)63012-X; Houser CR, 2007, PROG BRAIN RES, V163, P217, DOI 10.1016/S0079-6123(07)63013-1; Jost M, 1996, BBA-MOL CELL RES, V1313, P283, DOI 10.1016/0167-4889(96)00101-2; KATZ RJ, 1982, PHARMACOL BIOCHEM BE, V16, P965, DOI 10.1016/0091-3057(82)90053-3; KUBE E, 1992, J BIOL CHEM, V267, P14175; Liu J, 2007, MOL CELL BIOCHEM, V303, P211, DOI 10.1007/s11010-007-9477-7; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Rando OJ, 2002, P NATL ACAD SCI USA, V99, P2824, DOI 10.1073/pnas.032662899; Rescher U, 2008, PFLUG ARCH EUR J PHY, V455, P575, DOI 10.1007/s00424-007-0313-4; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rezvanpour A, 2009, PROTEIN SCI, V18, P2528, DOI 10.1002/pro.267; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SCHARFMAN HE, 1995, J NEUROPHYSIOL, V74, P179, DOI 10.1152/jn.1995.74.1.179; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Warner-Schmidt JL, 2010, BIOL PSYCHIAT, V68, P528, DOI 10.1016/j.biopsych.2010.04.029; Zaidi SK, 2007, NAT REV CANCER, V7, P454, DOI 10.1038/nrc2149; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	44	65	67	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					831	843		10.1016/j.cell.2013.01.014	http://dx.doi.org/10.1016/j.cell.2013.01.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415230	Green Accepted, Bronze			2022-12-24	WOS:000314945600017
J	Gerlach, C; Rohr, JC; Perie, L; van Rooij, N; van Heijst, JWJ; Velds, A; Urbanus, J; Naik, SH; Jacobs, H; Beltman, JB; de Boer, RJ; Schumacher, TNM				Gerlach, Carmen; Rohr, Jan C.; Perie, Leila; van Rooij, Nienke; van Heijst, Jeroen W. J.; Velds, Arno; Urbanus, Jos; Naik, Shalin H.; Jacobs, Heinz; Beltman, Joost B.; de Boer, Rob J.; Schumacher, Ton N. M.			Heterogeneous Differentiation Patterns of Individual CD8(+) T Cells	SCIENCE			English	Article							INFECTION; EFFECTOR; FATES; ACTIVATION; PRECURSOR; DIVISION; SUBSETS	Upon infection, antigen-specific CD8(+) T lymphocyte responses display a highly reproducible pattern of expansion and contraction that is thought to reflect a uniform behavior of individual cells. We tracked the progeny of individual mouse CD8(+) T cells by in vivo lineage tracing and demonstrated that, even for T cells bearing identical T cell receptors, both clonal expansion and differentiation patterns are heterogeneous. As a consequence, individual naive T lymphocytes contributed differentially to short-and long-term protection, as revealed by participation of their progeny during primary versus recall infections. The discordance in fate of individual naive T cells argues against asymmetric division as a singular driver of CD8(+) T cell heterogeneity and demonstrates that reproducibility of CD8(+) T cell responses is achieved through population averaging.	[Gerlach, Carmen; Rohr, Jan C.; Perie, Leila; van Rooij, Nienke; van Heijst, Jeroen W. J.; Urbanus, Jos; Naik, Shalin H.; Beltman, Joost B.; Schumacher, Ton N. M.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Rohr, Jan C.] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency CCI, Freiburg, Germany; [Rohr, Jan C.] Univ Freiburg, D-79106 Freiburg, Germany; [Perie, Leila; Beltman, Joost B.; de Boer, Rob J.] Univ Utrecht, Utrecht, Netherlands; [Velds, Arno] Netherlands Canc Inst, Cent Genom Facil, NL-1066 CX Amsterdam, Netherlands; [Jacobs, Heinz] Netherlands Canc Inst, Div Biol Stress Responses, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; University of Freiburg; University of Freiburg; Utrecht University; Netherlands Cancer Institute; Netherlands Cancer Institute	Schumacher, TNM (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	t.schumacher@nki.nl	de Boer, Rob/B-6050-2011; Naik, Shalin/AFD-5605-2022; Schumacher, Ton/Y-2432-2019	de Boer, Rob/0000-0002-2130-691X; Schumacher, Ton/0000-0003-0517-8804; Jacobs, Heinz/0000-0001-6227-9850; Velds, Arno/0000-0003-4333-8872; Perie, Leila/0000-0003-0798-4498; Naik, Shalin/0000-0003-0299-3301; Gerlach, Carmen/0000-0001-7889-2393	European Research Council AdG Life-his-T; Walter-Hitzig fellowship from the CCI [BMBF 01EO0803]; Deutsche Forschungsgemeinschaft [DFG RO 4120/1-1]; Marie Curie Intra European Fellowship; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni grant [916.86.080]; Leukemia and Lymphoma Society Career Development Fellowship	European Research Council AdG Life-his-T; Walter-Hitzig fellowship from the CCI; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Marie Curie Intra European Fellowship(European Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni grant; Leukemia and Lymphoma Society Career Development Fellowship(Leukemia and Lymphoma Society)	The authors thank A. Pfauth and F. van Diepen for cell sorting; E. Borg for technical assistance; D. Zehn for provision of LM-OVA (T4); S. Harkema for helpful discussions; and G. Bendle, M. C. Wolkers, and E. A. Moseman for critically reading the manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The authors declare no conflict of interest. This research was funded by European Research Council AdG Life-his-T to T.N.M.S., a Walter-Hitzig fellowship from the CCI (BMBF 01EO0803), a Deutsche Forschungsgemeinschaft (DFG RO 4120/1-1) research fellowship to J.C.R., a Marie Curie Intra European Fellowship to L. P., a Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni grant (916.86.080) to J.B.B., and a Leukemia and Lymphoma Society Career Development Fellowship to S.H.N.	Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; D'Souza WN, 2006, J IMMUNOL, V177, P777, DOI 10.4049/jimmunol.177.2.777; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Obar JJ, 2010, INT IMMUNOL, V22, P619, DOI 10.1093/intimm/dxq053; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Schlub TE, 2009, EUR J IMMUNOL, V39, P67, DOI 10.1002/eji.200838554; Schumacher TNM, 2010, NAT REV IMMUNOL, V10, P621, DOI 10.1038/nri2822; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; van Heijst JWJ, 2009, SCIENCE, V325, P1265, DOI 10.1126/science.1175455; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548	18	245	250	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					635	639		10.1126/science.1235487	http://dx.doi.org/10.1126/science.1235487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23493421				2022-12-24	WOS:000318268900054
J	Tannahill, GM; Curtis, AM; Adamik, J; Palsson-McDermott, EM; McGettrick, AF; Goel, G; Frezza, C; Bernard, NJ; Kelly, B; Foley, NH; Zheng, L; Gardet, A; Tong, Z; Jany, SS; Corr, SC; Haneklaus, M; Caffrey, BE; Pierce, K; Walmsley, S; Beasley, FC; Cummins, E; Nizet, V; Whyte, M; Taylor, CT; Lin, H; Masters, SL; Gottlieb, E; Kelly, VP; Clish, C; Auron, PE; Xavier, RJ; O'Neill, LAJ				Tannahill, G. M.; Curtis, A. M.; Adamik, J.; Palsson-McDermott, E. M.; McGettrick, A. F.; Goel, G.; Frezza, C.; Bernard, N. J.; Kelly, B.; Foley, N. H.; Zheng, L.; Gardet, A.; Tong, Z.; Jany, S. S.; Corr, S. C.; Haneklaus, M.; Caffrey, B. E.; Pierce, K.; Walmsley, S.; Beasley, F. C.; Cummins, E.; Nizet, V.; Whyte, M.; Taylor, C. T.; Lin, H.; Masters, S. L.; Gottlieb, E.; Kelly, V. P.; Clish, C.; Auron, P. E.; Xavier, R. J.; O'Neill, L. A. J.			Succinate is an inflammatory signal that induces IL-1 beta through HIF-1 alpha	NATURE			English	Article							RECEPTOR GPR91; HYPOXIA; ACTIVATION; LINKS; INHIBITION; METABOLISM; MECHANISM; PROMOTER; MUTATION; PROVIDES	Macrophages activated by the Gram-negative bacterial product lipopolysaccharide switch their core metabolism from oxidative phosphorylation to glycolysis(1). Here we show that inhibition of glycolysis with 2-deoxyglucose suppresses lipopolysaccharide-induced interleukin-1 beta but not tumour-necrosis factor-a in mouse macrophages. A comprehensive metabolic map of lipopolysaccharide-activated macrophages shows upregulation of glycolytic and down-regulation of mitochondrial genes, which correlates directly with the expression profiles of altered metabolites. Lipopolysaccharide strongly increases the levels of the tricarboxylic-acid cycle intermediate succinate. Glutamine-dependent anerplerosis is the principal source of succinate, although the 'GABA (gamma-aminobutyric acid) shunt' pathway also has a role. Lipopolysaccharide-induced succinate stabilizes hypoxia-inducible factor-1 alpha, an effect that is inhibited by 2-deoxyglucose, with interleukin-1 beta as an important target. Lipopolysaccharide also increases succinylation of several proteins. We therefore identify succinate as a metabolite in innate immune signalling, which enhances interleukin-1 beta production during inflammation.	[Tannahill, G. M.; Curtis, A. M.; Palsson-McDermott, E. M.; McGettrick, A. F.; Bernard, N. J.; Kelly, B.; Foley, N. H.; Jany, S. S.; Corr, S. C.; Haneklaus, M.; Kelly, V. P.; O'Neill, L. A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Adamik, J.; Auron, P. E.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Goel, G.; Xavier, R. J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Richard B Simches Res Ctr, Boston, MA 02114 USA; [Frezza, C.; Zheng, L.; Gottlieb, E.] Beatson Inst Canc Res, Apoptosis & Tumour Physiol Lab, Glasgow G61 1BD, Lanark, Scotland; [Frezza, C.; Xavier, R. J.] Hutchison MRC Res Ctr, Med Res Council Canc Cell Unit, Cambridge CB2 0X2, England; [Gardet, A.; Pierce, K.; Clish, C.] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Tong, Z.; Lin, H.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Caffrey, B. E.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Walmsley, S.; Whyte, M.] Univ Sheffield, Dept Infect & Immun, Acad Unit Resp Med, Sheffield S10 2RX, S Yorkshire, England; [Beasley, F. C.; Nizet, V.] Univ Calif San Diego, Ctr Neural Circuits & Behav, Div Pediat, V Nizet Lab, La Jolla, CA 92093 USA; [Cummins, E.; Taylor, C. T.] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [Masters, S. L.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic 3052, Australia	Trinity College Dublin; Duquesne University; Harvard University; Massachusetts General Hospital; Beatson Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cornell University; Trinity College Dublin; University of Sheffield; University of California System; University of California San Diego; University College Dublin; Walter & Eliza Hall Institute	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland.	laoneill@tcd.ie	Nizet, Victor/AAF-3190-2019; Kelly, Vincent P/I-2151-2017; Clish, Clary B/ABB-9374-2021; Masters, Seth L/N-2886-2013; Gottlieb, Eyal/G-6450-2010; Haneklaus, Moritz/AAE-4728-2020; Clish, Clary/AAB-7124-2019; Cummins, Eoin/S-7554-2019; Frezza, Christian/G-2174-2010	Kelly, Vincent P/0000-0001-7067-5407; Clish, Clary B/0000-0001-8259-9245; Masters, Seth L/0000-0003-4763-576X; Gottlieb, Eyal/0000-0002-9770-0956; Cummins, Eoin/0000-0002-9346-8299; Frezza, Christian/0000-0002-3293-7397; Walmsley, Sarah/0000-0001-9584-174X; Bernard, Nicholas/0000-0002-9483-7922; Curtis, Annie/0000-0002-9601-9624; Zheng, Liang/0000-0002-5346-4111; Kelly, Beth/0000-0002-3195-6860; Nizet, Victor/0000-0003-3847-0422; Corr, Sinead/0000-0001-9930-5039; Adamik, Juraj/0000-0002-3604-158X	European Research Council; Science Foundation Ireland; Health Research Board; European Union FP7 programme 'TIMER'; Wellcome Trust; National Institutes of Health; Helmsley Trust; Nestle Research Centre; VESKI; Duquesne University Hunkele Dreaded Disease Award; Interleukin Foundation; National Health and Medical Research Council; MRC [MC_UP_1101/3] Funding Source: UKRI; Medical Research Council [MC_UP_1101/3] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R56AI090863, R01AI093451] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; European Union FP7 programme 'TIMER'; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Trust; Nestle Research Centre(Nestle SA); VESKI; Duquesne University Hunkele Dreaded Disease Award; Interleukin Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the European Research Council, Science Foundation Ireland, the Health Research Board, European Union FP7 programme 'TIMER', Wellcome Trust, National Institutes of Health, Helmsley Trust, Nestle Research Centre, VESKI, The Duquesne University Hunkele Dreaded Disease Award, The Interleukin Foundation and the National Health and Medical Research Council for funding. We also thank R. Thompson for assistance with Hif1a<SUP>-/-</SUP> mice and M. Murphy for discussions.	Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Choi S, 2002, J MED CHEM, V45, P4531, DOI 10.1021/jm020134i; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Doyle SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1706; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hobert JA, 2012, GENET MED, V14, P616, DOI 10.1038/gim.2011.63; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Pan H, 2012, BIOCHEM BIOPH RES CO, V420, P685, DOI 10.1016/j.bbrc.2012.03.069; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Pistollato F, 2010, BIOCHEM PHARMACOL, V80, P1517, DOI 10.1016/j.bcp.2010.08.003; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; ROTSTEIN OD, 1985, ARCH SURG-CHICAGO, V120, P146; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Sadagopan N, 2007, AM J HYPERTENS, V20, P1209, DOI 10.1016/j.amjhyper.2007.05.010; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sumbayev VV, 2008, FEBS LETT, V582, P319, DOI 10.1016/j.febslet.2007.12.024; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Walker SD, 2011, ACTA NEUROL SCAND, V124, P72, DOI 10.1111/j.1600-0404.2011.01602.x; Walmsley SR, 2011, J CLIN INVEST, V121, P1053, DOI 10.1172/JCI43273; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Yan Y, 2007, AM J PHYSIOL-GASTR L, V292, pG535, DOI 10.1152/ajpgi.00385.2006; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang WD, 2006, J NEUROIMMUNOL, V174, P63, DOI 10.1016/j.jneuroim.2006.01.014	30	2017	2102	26	378	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					238	+		10.1038/nature11986	http://dx.doi.org/10.1038/nature11986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23535595	Green Accepted, Green Submitted			2022-12-24	WOS:000317346300045
J	Clarke, D; Whitney, H; Sutton, G; Robert, D				Clarke, Dominic; Whitney, Heather; Sutton, Gregory; Robert, Daniel			Detection and Learning of Floral Electric Fields by Bumblebees	SCIENCE			English	Article							ELECTROSTATIC FORCES; FLOWERS; COLOR; BEES; CUE	Insects use several senses to forage, detecting floral cues such as color, shape, pattern, and volatiles. We report a formerly unappreciated sensory modality in bumblebees (Bombus terrestris), detection of floral electric fields. These fields act as floral cues, which are affected by the visit of naturally charged bees. Like visual cues, floral electric fields exhibit variations in pattern and structure, which can be discriminated by bumblebees. We also show that such electric field information contributes to the complex array of floral cues that together improve a pollinator's memory of floral rewards. Because floral electric fields can change within seconds, this sensory modality may facilitate rapid and dynamic communication between flowers and their pollinators.	[Clarke, Dominic; Whitney, Heather; Sutton, Gregory; Robert, Daniel] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol	Robert, D (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	d.robert@bristol.ac.uk			Leverhulme Trust [RPG 173]; European Research Council; Association for the Study of Animal Behaviour; Royal Society of London	Leverhulme Trust(Leverhulme Trust); European Research Council(European Research Council (ERC)European Commission); Association for the Study of Animal Behaviour; Royal Society of London(Royal Society of London)	This work was sponsored by a grant from the Leverhulme Trust (RPG 173). H. W. is supported by the European Research Council and Association for the Study of Animal Behaviour. D. R. is supported by the Royal Society of London. The authors declare no conflict of interest. All data are available in the supplementary materials. We thank K. Strickland for help with data collection and C. Evans for illustrative work. We thank A. Radford, J. Matthews, and S. Rands for reading the manuscript and helpful feedback.	Aristotle, 1970, HIST ANIMALIUM; Bowker GE, 2007, ATMOS ENVIRON, V41, P1587, DOI 10.1016/j.atmosenv.2006.10.047; COLIN ME, 1991, J BIOELECTRICITY, V10, P17, DOI 10.3109/15368379109031397; CORBET SA, 1982, PLANT CELL ENVIRON, V5, P125, DOI 10.1111/1365-3040.ep11571488; Erikson E. H., 1983, HDB POLLINATION BIOL; FROMM J, 1995, PLANT PHYSIOL, V109, P375, DOI 10.1104/pp.109.2.375; GANMOR S, 1995, CAN AGR ENG, V37, P189; Leonard AS, 2011, FUNCT ECOL, V25, P1293, DOI 10.1111/j.1365-2435.2011.01885.x; Leonard AS, 2011, CURR ZOOL, V57, P215, DOI 10.1093/czoolo/57.2.215; Leonard AS, 2011, J EXP BIOL, V214, P113, DOI 10.1242/jeb.047407; Raguso RA, 2004, CURR OPIN PLANT BIOL, V7, P434, DOI 10.1016/j.pbi.2004.05.010; Rycroft MJ, 2000, J ATMOS SOL-TERR PHY, V62, P1563, DOI 10.1016/S1364-6826(00)00112-7; Simon R, 2011, SCIENCE, V333, P631, DOI 10.1126/science.1204210; Stankovic B, 1997, PLANT PHYSIOL, V115, P1083, DOI 10.1104/pp.115.3.1083; Stout JC, 2001, ANIM BEHAV, V62, P183, DOI 10.1006/anbe.2001.1729; Vaknin Y, 2000, PLANT SYST EVOL, V222, P133, DOI 10.1007/BF00984099; von Arx M, 2012, P NATL ACAD SCI USA, V109, P9471, DOI 10.1073/pnas.1121624109; WASER NM, 1983, NATURE, V302, P422, DOI 10.1038/302422a0; Wedzony M, 1998, ACTA PHYSIOL PLANT, V20, P291, DOI 10.1007/s11738-998-0061-x; WEISS MR, 1995, AM J BOT, V82, P167, DOI 10.2307/2445525; Whitney HM, 2009, SCIENCE, V323, P130, DOI 10.1126/science.1166256; Willmer P, 2009, CURR BIOL, V19, P919, DOI 10.1016/j.cub.2009.03.070; Yes'kov Ye. K., 1976, Biophysics, V21, P1124	23	157	166	4	364	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2013	340	6128					66	69		10.1126/science.1230883	http://dx.doi.org/10.1126/science.1230883			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23429701				2022-12-24	WOS:000317061100045
J	Zhang, SJ; Ye, J; Miao, CL; Tsao, A; Cerniauskas, I; Ledergerber, D; Moser, MB; Moser, EI				Zhang, Sheng-Jia; Ye, Jing; Miao, Chenglin; Tsao, Albert; Cerniauskas, Ignas; Ledergerber, Debora; Moser, May-Britt; Moser, Edvard I.			Optogenetic Dissection of Entorhinal-Hippocampal Functional Connectivity	SCIENCE			English	Article							GRID CELLS; SPATIAL REPRESENTATION; PATH-INTEGRATION; PLACE FIELDS; NEURONAL POPULATIONS; GABAERGIC NEURONS; CORTICAL-NEURONS; CORTEX; MAP; ACTIVATION	We used a combined optogenetic-electrophysiological strategy to determine the functional identity of entorhinal cells with output to the place-cell population in the hippocampus. Channelrhodopsin-2 (ChR2) was expressed selectively in the hippocampus-targeting subset of entorhinal projection neurons by infusing retrogradely transportable ChR2-coding recombinant adeno-associated virus in the hippocampus. Virally transduced ChR2-expressing cells were identified in medial entorhinal cortex as cells that fired at fixed minimal latencies in response to local flashes of light. A large number of responsive cells were grid cells, but short-latency firing was also induced in border cells and head-direction cells, as well as cells with irregular or nonspatial firing correlates, which suggests that place fields may be generated by convergence of signals from a broad spectrum of entorhinal functional cell types.	[Zhang, Sheng-Jia] Norwegian Univ Sci & Technol, Norwegian Brain Ctr, Kavli Inst Syst Neurosci, N-7491 Trondheim, Norway; Norwegian Univ Sci & Technol, Norwegian Brain Ctr, Ctr Neural Computat, N-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Zhang, SJ (corresponding author), Norwegian Univ Sci & Technol, Norwegian Brain Ctr, Kavli Inst Syst Neurosci, Olav Kyrres Gate 9, N-7491 Trondheim, Norway.	sheng-jia.zhang@ntnu.no; edvard.moser@ntnu.no	Ye, Jing/M-3366-2017	Ye, Jing/0000-0002-6364-4124	European Research Council (CIRCUIT) [232608]; Louis-Jeantet Prize for Medicine; Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway	European Research Council (CIRCUIT); Louis-Jeantet Prize for Medicine; Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway	The work was supported by an Advanced Investigator Grant from the European Research Council (CIRCUIT grant agreement no. 232608), the Louis-Jeantet Prize for Medicine, the Kavli Foundation, and the Centre of Excellence scheme of the Research Council of Norway. We thank M. P. Witter for discussion; A. M. Amundsgard, A. Buroy, K. Haugen, K. Jenssen, E. Krakvik, R. Skjerpeng, H. Waade, J. Wu, and Q. Zhang for technical assistance; K. Deisseroth for providing ChR2-H134R and eNpHR3.0 plasmids; and E. Boyden for providing Arch plasmid. S.-J.Z., J.Y., M.-B.M., and E. I. M. planned and designed the study; S.-J.Z. designed and performed all molecular biology, modified and made all viruses, and performed all surgeries; J.Y., C. M., I. C., S.-J.Z., and D. L. performed experimental recordings; J.Y. performed analyses and made figures; A. T., C. M., and J.Y. designed the laser system; A. T. made stimulation and shuffle programs; M.-B.M. and E. I. M. supervised experiments and analyses; and E. I. M. wrote the paper with input from all authors. The molecular biology sections were written by S.-J.Z, with some support from E. I. M. All authors discussed analyses and results.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Barry C, 2006, REV NEUROSCIENCE, V17, P71; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; FOX SE, 1981, EXP BRAIN RES, V41, P399; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; GERMROTH P, 1989, BRAIN RES, V494, P187, DOI 10.1016/0006-8993(89)90162-5; Gothard KM, 1996, J NEUROSCI, V16, P8027; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kaspar BK, 2002, MOL THER, V5, P50, DOI 10.1006/mthe.2001.0520; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; Monaco JD, 2011, J NEUROSCI, V31, P9414, DOI 10.1523/JNEUROSCI.1433-11.2011; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Muller R. U., 1991, BRAIN SPACE, P296; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Rivard B, 2004, J GEN PHYSIOL, V124, P9, DOI 10.1085/jgp.200409015; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2010, J NEUROPHYSIOL, V103, P3167, DOI 10.1152/jn.00932.2009; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Skaggs WE, 1993, ADV NEURAL INFORM PR, V5, P1030, DOI DOI 10.1109/PROC.1977.10559; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Terrazas A, 2005, J NEUROSCI, V25, P8085, DOI 10.1523/JNEUROSCI.0693-05.2005; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; WITTER MP, 1988, NEUROSCIENCE, V24, P519, DOI 10.1016/0306-4522(88)90347-8; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	61	159	164	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2013	340	6128					44	U17	1232627	10.1126/science.1232627	http://dx.doi.org/10.1126/science.1232627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151YZ	23559255				2022-12-24	WOS:000319497600001
J	Bonnet, J; Yin, P; Ortiz, ME; Subsoontorn, P; Endy, D				Bonnet, Jerome; Yin, Peter; Ortiz, Monica E.; Subsoontorn, Pakpoom; Endy, Drew			Amplifying Genetic Logic Gates	SCIENCE			English	Article							RECOMBINATION DIRECTIONALITY; CELLS; CIRCUITS; SYSTEMS; DESIGN; PARTS	Organisms must process information encoded via developmental and environmental signals to survive and reproduce. Researchers have also engineered synthetic genetic logic to realize simpler, independent control of biological processes. We developed a three-terminal device architecture, termed the transcriptor, that uses bacteriophage serine integrases to control the flow of RNA polymerase along DNA. Integrase-mediated inversion or deletion of DNA encoding transcription terminators or a promoter modulates transcription rates. We realized permanent amplifying AND, NAND, OR, XOR, NOR, and XNOR gates actuated across common control signal ranges and sequential logic supporting autonomous cell-cell communication of DNA encoding distinct logic-gate states. The single-layer digital logic architecture developed here enables engineering of amplifying logic gates to control transcription rates within and across diverse organisms.	[Bonnet, Jerome; Yin, Peter; Ortiz, Monica E.; Subsoontorn, Pakpoom; Endy, Drew] Dept Bioengn, Stanford, CA 94305 USA		Endy, D (corresponding author), Dept Bioengn, Y2E2-269B,473 Via Ortega, Stanford, CA 94305 USA.	endy@stanford.edu	Bonnet, Jerome/D-3041-2014; Bonnet, Jerome/AAT-5600-2020	Bonnet, Jerome/0000-0002-8420-9359; Bonnet, Jerome/0000-0002-8420-9359; Endy, Drew/0000-0001-6952-8098	NSF Synthetic Biology Engineering Research Center; Stanford Center for Longevity; Stanford Bio-X; Townshend/Lamarre Family Foundation; Siebel Foundation	NSF Synthetic Biology Engineering Research Center; Stanford Center for Longevity; Stanford Bio-X; Townshend/Lamarre Family Foundation; Siebel Foundation	We thank M. Juul, T. Knight, S. Kushner, C. Smolke, B. Townshend, the Endy and Smolke labs, and the Stanford Shared FACS Facility. Funding was provided by the NSF Synthetic Biology Engineering Research Center, Stanford Center for Longevity, Stanford Bio-X, the Townshend/Lamarre Family Foundation, and the Siebel Foundation. DNA sequences are available in GenBank (accession nos. KC529324 to KC529332). DNA constructs will be made available via Addgene.	Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; BARDEEN J, 1948, PHYS REV, V74, P230, DOI 10.1103/PhysRev.74.230; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Benenson Y, 2012, NAT REV GENET, V13, P455, DOI 10.1038/nrg3197; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; Brown WRA, 2011, METHODS, V53, P372, DOI 10.1016/j.ymeth.2010.12.031; Burrill DR, 2010, CELL, V140, P13, DOI 10.1016/j.cell.2009.12.034; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Hatfull GF, 2012, J VIROL, V86, P2382, DOI 10.1128/JVI.06870-11; Lewis JA, 2001, NUCLEIC ACIDS RES, V29, P2205, DOI 10.1093/nar/29.11.2205; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Miyamoto T, 2013, ACS SYNTH BIOL, V2, P72, DOI 10.1021/sb3001112; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Ortiz ME, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-16; Pasotti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039407; Qi L, 2012, NAT BIOTECHNOL, V30, P1002, DOI 10.1038/nbt.2355; Siuti P, 2013, NAT BIOTECHNOL; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Varadarajan PA, 2009, IEEE T NANOBIOSCI, V8, P281, DOI 10.1109/TNB.2009.2028687; Wadey C., 2005, ADVENTURES SYNTHETIC; Wang BJ, 2012, TRENDS MICROBIOL, V20, P376, DOI 10.1016/j.tim.2012.05.001; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527	25	319	330	17	370	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					599	603		10.1126/science.1232758	http://dx.doi.org/10.1126/science.1232758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23539178				2022-12-24	WOS:000318268900045
J	Kern, J; Alonso-Mori, R; Tran, R; Hattne, J; Gildea, RJ; Echols, N; Glockner, C; Hellmich, J; Laksmono, H; Sierra, RG; Lassalle-Kaiser, B; Koroidov, S; Lampe, A; Han, GY; Gul, S; DiFiore, D; Milathianaki, D; Fry, AR; Miahnahri, A; Schafer, DW; Messerschmidt, M; Seibert, MM; Koglin, JE; Sokaras, D; Weng, TC; Sellberg, J; Latimer, MJ; Grosse-Kunstleve, RW; Zwart, PH; White, WE; Glatzel, P; Adams, PD; Bogan, MJ; Williams, GJ; Boutet, S; Messinger, J; Zouni, A; Sauter, NK; Yachandra, VK; Bergmann, U; Yano, J				Kern, Jan; Alonso-Mori, Roberto; Tran, Rosalie; Hattne, Johan; Gildea, Richard J.; Echols, Nathaniel; Gloeckner, Carina; Hellmich, Julia; Laksmono, Hartawan; Sierra, Raymond G.; Lassalle-Kaiser, Benedikt; Koroidov, Sergey; Lampe, Alyssa; Han, Guangye; Gul, Sheraz; DiFiore, Doerte; Milathianaki, Despina; Fry, Alan R.; Miahnahri, Alan; Schafer, Donald W.; Messerschmidt, Marc; Seibert, M. Marvin; Koglin, Jason E.; Sokaras, Dimosthenis; Weng, Tsu-Chien; Sellberg, Jonas; Latimer, Matthew J.; Grosse-Kunstleve, Ralf W.; Zwart, Petrus H.; White, William E.; Glatzel, Pieter; Adams, Paul D.; Bogan, Michael J.; Williams, Garth J.; Boutet, Sebastien; Messinger, Johannes; Zouni, Athina; Sauter, Nicholas K.; Yachandra, Vittal K.; Bergmann, Uwe; Yano, Junko			Simultaneous Femtosecond X-ray Spectroscopy and Diffraction of Photosystem II at Room Temperature	SCIENCE			English	Article							OXYGEN-EVOLVING COMPLEX; CRYSTAL-STRUCTURE; SYNTHETIC MODEL; MN4CA CLUSTER; RESOLUTION; WATER; TRANSITION; LIGATION; DIOXYGEN; CORE	Intense femtosecond x-ray pulses produced at the Linac Coherent Light Source (LCLS) were used for simultaneous x-ray diffraction (XRD) and x-ray emission spectroscopy (XES) of microcrystals of photosystem II (PS II) at room temperature. This method probes the overall protein structure and the electronic structure of the Mn4CaO5 cluster in the oxygen-evolving complex of PS II. XRD data are presented from both the dark state (S-1) and the first illuminated state (S-2) of PS II. Our simultaneous XRD-XES study shows that the PS II crystals are intact during our measurements at the LCLS, not only with respect to the structure of PS II, but also with regard to the electronic structure of the highly radiation-sensitive Mn4CaO5 cluster, opening new directions for future dynamics studies.	[Kern, Jan; Tran, Rosalie; Hattne, Johan; Gildea, Richard J.; Echols, Nathaniel; Lassalle-Kaiser, Benedikt; Lampe, Alyssa; Han, Guangye; Gul, Sheraz; Grosse-Kunstleve, Ralf W.; Zwart, Petrus H.; Adams, Paul D.; Sauter, Nicholas K.; Yachandra, Vittal K.; Yano, Junko] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Kern, Jan; Alonso-Mori, Roberto; Milathianaki, Despina; Fry, Alan R.; Miahnahri, Alan; Schafer, Donald W.; Messerschmidt, Marc; Seibert, M. Marvin; Koglin, Jason E.; White, William E.; Bogan, Michael J.; Williams, Garth J.; Boutet, Sebastien; Bergmann, Uwe] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Gloeckner, Carina; Hellmich, Julia; DiFiore, Doerte; Zouni, Athina] Tech Univ Berlin, Max Volmer Lab Biophys Chem, D-10623 Berlin, Germany; [Laksmono, Hartawan; Sierra, Raymond G.; Bogan, Michael J.] SLAC Natl Accelerator Lab, PULSE Inst, Menlo Pk, CA 94025 USA; [Koroidov, Sergey; Messinger, Johannes] Umea Univ, Kemiskt Biologiskt Ctr, Inst Kemi, Umea, Sweden; [Sokaras, Dimosthenis; Weng, Tsu-Chien; Sellberg, Jonas; Latimer, Matthew J.] SLAC Natl Accelerator Lab, SSRL, Menlo Pk, CA 94025 USA; [Sellberg, Jonas] Stockholm Univ, AlbaNova, Dept Phys, S-10691 Stockholm, Sweden; [Glatzel, Pieter] European Synchrotron Radiat Facil, F-38043 Grenoble 9, France	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Technical University of Berlin; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Umea University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stockholm University; European Synchrotron Radiation Facility (ESRF)	Yachandra, VK (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	vkyachandra@lbl.gov; bergmann@slac.stanford.edu; jyano@lbl.gov	Koroidov, Sergey/U-1115-2018; Sellberg, Jonas A/C-6506-2009; Messerschmidt, Marc/Y-8929-2019; Gildea, Richard/J-6862-2012; Glatzel, Pieter/E-9958-2010; Sauter, Nicholas K/K-3430-2012; Messerschmidt, Marc/F-3796-2010; Zwart, Peter/F-7123-2013; Milathianaki, Despina/AAG-5381-2021; Lassalle, Benedikt/I-3748-2015; alonso-mori, roberto/G-2638-2013; Adams, Paul David/A-1977-2013; Sokaras, Dimosthenis/G-6037-2010; Messinger, Johannes/AAC-4221-2019; Kern, Jan/G-2586-2013	Koroidov, Sergey/0000-0003-4823-2188; Sellberg, Jonas A/0000-0003-2793-5052; Messerschmidt, Marc/0000-0002-8641-3302; Gildea, Richard/0000-0001-5038-6958; Glatzel, Pieter/0000-0001-6532-8144; Messerschmidt, Marc/0000-0002-8641-3302; Lassalle, Benedikt/0000-0003-2141-2496; alonso-mori, roberto/0000-0002-5357-0934; Adams, Paul David/0000-0001-9333-8219; Sokaras, Dimosthenis/0000-0001-8117-1933; Messinger, Johannes/0000-0003-2790-7721; Seibert, Mark Marvin/0000-0003-0251-0744; Hattne, Johan/0000-0002-8936-0912; Kern, Jan/0000-0002-7272-1603	Office of Science, Office of Basic Energy Sciences (OBES), Division of Chemical Sciences, Geosciences, and Biosciences (CSGB) of the Department of Energy (DOE) [DE-AC02-05CH11231]; Laboratory Directed Research and Development award; NIH [GM055302, P41GM103393, GM095887, GM102520]; Deutsche Forschungsgemeinschaft Cluster of Excellence "UniCat"; Alexander von Humboldt Foundation; Solar Fuels Strong Research Environment (Umeal University); Artificial Leaf Project (K&A Wallenberg Foundation); LCLS; AMOS program; CSGB Division; OBES; DOE; SLAC Laboratory Directed Research and Development Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102520, R01GM055302, R01GM095887, R56GM055302, P41GM103393] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences (OBES), Division of Chemical Sciences, Geosciences, and Biosciences (CSGB) of the Department of Energy (DOE)(United States Department of Energy (DOE)); Laboratory Directed Research and Development award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Cluster of Excellence "UniCat"; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Solar Fuels Strong Research Environment (Umeal University); Artificial Leaf Project (K&A Wallenberg Foundation); LCLS; AMOS program; CSGB Division; OBES; DOE(United States Department of Energy (DOE)); SLAC Laboratory Directed Research and Development Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this paper to G. Renger (1937-2013) for his enthusiasm and support. This work was supported by the Director, Office of Science, Office of Basic Energy Sciences (OBES), Division of Chemical Sciences, Geosciences, and Biosciences (CSGB) of the Department of Energy (DOE) under contract DE-AC02-05CH11231 (J.Y. and V.K.Y.) for x-ray methodology and instrumentation; a Laboratory Directed Research and Development award to N.K.S; NIH grant GM055302 (V.K.Y.) for PS II biochemistry, structure, and mechanism and NIH grant P41GM103393 (U. B.); and grants GM095887 and GM102520 (N.K.S.) for data-processing methods. We thank the Deutsche Forschungsgemeinschaft Cluster of Excellence "UniCat," coordinated by the Technische Universitat Berlin and Sfb1078, TP A5 (A.Z.); the Alexander von Humboldt Foundation (J.K.); and the Solar Fuels Strong Research Environment (Umeal University), the Artificial Leaf Project (K&A Wallenberg Foundation), and Vetenskapsradet and Energimyndigheten (J.M.) for supporting this project. The injector work was supported by LCLS (M.J.B., D. W. S.) and the AMOS program, CSGB Division, OBES, DOE (M.J.B), and through the SLAC Laboratory Directed Research and Development Program (M.J.B., H. L.). Experiments were carried out at the LCLS at SLAC National Accelerator Laboratory operated by Stanford University on behalf of DOE, OBES. We thank K. Sauer for continuing scientific discussions. The atomic coordinates and structure factors have been deposited in the Protein Data Bank (www.pdb.org) with ID codes 4IXQ (dark state, S1) and 4IXR (first illuminated state, S2). See the supplementary materials for author contributions and full acknowledgments.	Alonso-Mori R, 2012, P NATL ACAD SCI USA, V109, P19103, DOI 10.1073/pnas.1211384109; Alonso-Mori R, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4737630; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Corbett MC, 2007, ACTA CRYSTALLOGR D, V63, P951, DOI 10.1107/S0907444907035160; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Glatzel P, 2005, COORDIN CHEM REV, V249, P65, DOI 10.1016/j.ccr.2004.04.011; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hart P, 2012, PROC SPIE, V8504, DOI 10.1117/12.930924; Hunter MS, 2011, BIOPHYS J, V100, P198, DOI 10.1016/j.bpj.2010.10.049; Kanady JS, 2011, SCIENCE, V333, P733, DOI 10.1126/science.1206036; Kern J, 2012, P NATL ACAD SCI USA, V109, P9721, DOI 10.1073/pnas.1204598109; Kirian RA, 2011, ACTA CRYSTALLOGR A, V67, P131, DOI 10.1107/S0108767310050981; Lizasa M, 2010, BIOCHEMISTRY-US, V49, P3074, DOI 10.1021/bi1002647; Meharenna YT, 2010, BIOCHEMISTRY-US, V49, P2984, DOI 10.1021/bi100238r; Messinger J, 2001, J AM CHEM SOC, V123, P7804, DOI 10.1021/ja004307+; Mukherjee S, 2012, P NATL ACAD SCI USA, V109, P2257, DOI 10.1073/pnas.1115290109; Pushkar Y, 2010, ANGEW CHEM INT EDIT, V49, P800, DOI 10.1002/anie.200905366; Renger G, 2012, ADV PHOTOSYNTH RESP, V34, P359, DOI 10.1007/978-94-007-1579-0_17; Sierra RG, 2012, ACTA CRYSTALLOGR D, V68, P1584, DOI 10.1107/S0907444912038152; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2008, INORG CHEM, V47, P1711, DOI 10.1021/ic7016837; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	29	322	343	19	373	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					491	495		10.1126/science.1234273	http://dx.doi.org/10.1126/science.1234273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23413188	Green Accepted			2022-12-24	WOS:000318016700046
J	Jasechko, S; Sharp, ZD; Gibson, JJ; Birks, SJ; Yi, Y; Fawcett, PJ				Jasechko, Scott; Sharp, Zachary D.; Gibson, John J.; Birks, S. Jean; Yi, Yi; Fawcett, Peter J.			Terrestrial water fluxes dominated by transpiration	NATURE			English	Article							EVAPOTRANSPIRATION; CARBON; ISOTOPE; CLIMATE; VAPOR; EVAPORATION; VEGETATION; BALANCE; SIZE	Renewable fresh water over continents has input from precipitation and losses to the atmosphere through evaporation and transpiration. Global-scale estimates of transpiration from climate models are poorly constrained owing to large uncertainties in stomatal conductance and the lack of catchment-scale measurements required for model calibration, resulting in a range of predictions spanning 20 to 65 per cent of total terrestrial evapotranspiration (14,000 to 41,000 km(3) per year) (refs 1-5). Here we use the distinct isotope effects of transpiration and evaporation to show that transpiration is by far the largest water flux from Earth's continents, representing 80 to 90 per cent of terrestrial evapotranspiration. On the basis of our analysis of a global data set of large lakes and rivers, we conclude that transpiration recycles 62,000 +/- 8,000 km(3) of water per year to the atmosphere, using half of all solar energy absorbed by land surfaces in the process. We also calculate CO2 uptake by terrestrial vegetation by connecting transpiration losses to carbon assimilation using water-use efficiency ratios of plants, and show the global gross primary productivity to be 129 +/- 32 gigatonnes of carbon per year, which agrees, within the uncertainty, with previous estimates(6). The dominance of transpiration water fluxes in continental evapotranspiration suggests that, from the point of view of water resource forecasting, climate model development should prioritize improvements in simulations of biological fluxes rather than physical (evaporation) fluxes.	[Jasechko, Scott; Sharp, Zachary D.; Fawcett, Peter J.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Gibson, John J.; Birks, S. Jean; Yi, Yi] Alberta Innovates Technol Futures, Victoria, BC V8Z 7X8, Canada; [Gibson, John J.; Yi, Yi] Univ Victoria, Dept Geog, Victoria, BC V8W 3R4, Canada; [Birks, S. Jean] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada	University of New Mexico; Alberta Innovates; University of Victoria; University of Waterloo	Jasechko, S (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA.	jasechko@unm.edu	yi, yi/HHY-7381-2022; Gibson, John/D-1897-2009	Gibson, John/0000-0001-5952-0228; Jasechko, Scott/0000-0001-6470-7708	Caswell Silver Foundation through the University of New Mexico	Caswell Silver Foundation through the University of New Mexico	We thank T. W. D. Edwards, T. Gleeson and M. C. Molles Jr for comments on the manuscript, and are grateful to O. Kwiecien, D. G. Miralles, B. K. Nyarko, K. Yoshimura and F. Yuan for providing access to isotope and gridded data sets. Support for this work was provided by a graduate fellowship awarded to S.J. by the Caswell Silver Foundation through the University of New Mexico.	Alton P, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003540; Beer C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029006; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; BUCK AL, 1981, J APPL METEOROL, V20, P1527, DOI 10.1175/1520-0450(1981)020<1527:NEFCVP>2.0.CO;2; Cao L, 2010, P NATL ACAD SCI USA, V107, P9513, DOI 10.1073/pnas.0913000107; Craig H., 1965, DEUTERIUM OXYGEN 18, P9, DOI DOI 10.1109/ISSRE.1993.624301; Dai A, 2002, J HYDROMETEOROL, V3, P660, DOI 10.1175/1525-7541(2002)003<0660:EOFDFC>2.0.CO;2; Dawson TE, 1996, TREE PHYSIOL, V16, P263; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Gerten D, 2005, PHYS CHEM EARTH, V30, P334, DOI 10.1016/J.PCE.2005.06.002; Gibson JJ, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002997; Global Energy and Water Cycle Experiment, 2012, INT SAT LAND SURF CL; Gonfiantini R., 1986, TERRESTRIAL ENV B, V2, P113, DOI [DOI 10.1016/B978-0-444-42225-5.50008-5, 10.1016/B978-0-444-42225-5.50008-5]; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HORITA J, 1994, GEOCHIM COSMOCHIM AC, V58, P3425, DOI 10.1016/0016-7037(94)90096-5; Ito A, 2012, J HYDROMETEOROL, V13, P681, DOI 10.1175/JHM-D-10-05034.1; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Lawrence DM, 2007, J HYDROMETEOROL, V8, P862, DOI 10.1175/JHM596.1; Miralles DG, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013530; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Reynolds JF, 2000, PLANT ECOL, V150, P145, DOI 10.1023/A:1026530522612; ROZANSKI K, 1993, CLIMATE CHANGE CONTI; Trenberth KE, 2009, B AM METEOROL SOC, V90, P311, DOI 10.1175/2008BAMS2634.1; Welp LR, 2008, PLANT CELL ENVIRON, V31, P1214, DOI 10.1111/j.1365-3040.2008.01826.x; Williams DG, 2004, AGR FOREST METEOROL, V125, P241, DOI 10.1016/j.agrformet.2004.04.008; Yakir D, 1996, NATURE, V380, P515, DOI 10.1038/380515a0; Yoshimura K, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010074	30	719	749	44	747	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					347	+		10.1038/nature11983	http://dx.doi.org/10.1038/nature11983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23552893				2022-12-24	WOS:000317599200034
J	Watson, E; MacNeil, LT; Arda, HE; Zhu, LJ; Walhout, AJM				Watson, Emma; MacNeil, Lesley T.; Arda, H. Efsun; Zhu, Lihua Julie; Walhout, Albertha J. M.			Integration of Metabolic and Gene Regulatory Networks Modulates the C. elegans Dietary Response	CELL			English	Article							NUCLEAR HORMONE-RECEPTORS; ONE-HYBRID ASSAYS; EXPRESSION; DISEASES	Expression profiles are tailored according to dietary input. However, the networks that control dietary responses remain largely uncharacterized. Here, we combine forward and reverse genetic screens to delineate a network of 184 genes that affect the C. elegans dietary response to Comamonas DA1877 bacteria. We find that perturbation of a mitochondrial network composed of enzymes involved in amino acid metabolism and the TCA cycle affects the dietary response. In humans, mutations in the corresponding genes cause inborn diseases of amino acid metabolism, most of which are treated by dietary intervention. We identify several transcription factors (TFs) that mediate the changes in gene expression upon metabolic network perturbations. Altogether, our findings unveil a transcriptional response system that is poised to sense dietary cues and metabolic imbalances, illustrating extensive communication between metabolic networks in the mitochondria and gene regulatory networks in the nucleus.	[Watson, Emma; MacNeil, Lesley T.; Arda, H. Efsun; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA; [Watson, Emma; MacNeil, Lesley T.; Arda, H. Efsun; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Zhu, Lihua Julie] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Walhout, AJM (corresponding author), Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA.	marian.walhout@umassmed.edu		Walhout, Marian/0000-0001-5587-3608; Zhu, Lihua/0000-0001-7416-0590	National Institutes of Health (NIH) grant [DK068429]; CIHR postdoctoral fellowship; AHA Founders Affiliate Predoctoral Fellowship [11PRE6590003]; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068429] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); AHA Founders Affiliate Predoctoral Fellowship; NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Walhout laboratory, Amy Walker, and Victor Ambros for discussions and critical reading of the manuscript. We thank Jean Francois Rual and Marc Vidal (CCSB at the Dana-Farber Cancer Institute) for a copy of the ORFeome RNAi library and L. Safak Yilmaz for help with the creation of Figure 3. This work was supported by the National Institutes of Health (NIH) grant DK068429 to A.J.M.W. L.T.M. was supported by a CIHR postdoctoral fellowship. E.W. was supported by an AHA Founders Affiliate Predoctoral Fellowship (11PRE6590003). Some nematode strains used in this work were provided by the CGC, which is funded by the NIH National Center for Research Resources (NCRR).	Acosta P., 2010, NUTR MANAGEMENT PATI; Arda HE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.23; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; BRENNER S, 1974, GENETICS, V77, P71; Carsten LD, 2005, MOL ECOL, V14, P3203, DOI 10.1111/j.1365-294X.2005.02654.x; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Du D, 2010, MOL BIOL REP, V37, P1867, DOI 10.1007/s11033-009-9622-3; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Gubelmann C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar040; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049; Martinez NJ, 2008, GENOME RES, V18, P2005, DOI 10.1101/gr.083055.108; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1059, DOI [10.1038/NMETH.1748, 10.1038/nmeth.1748]; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1050, DOI [10.1038/NMETH.1764, 10.1038/nmeth.1764]; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Sarin S, 2010, GENETICS, V185, P417, DOI 10.1534/genetics.110.116319; Saudubray JM, 2006, J INHERIT METAB DIS, V29, P261, DOI 10.1007/s10545-006-0358-0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Taubert S, 2011, MOL CELL ENDOCRINOL, V334, P49, DOI 10.1016/j.mce.2010.04.021; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Weisfeld-Adams JD, 2010, MOL GENET METAB, V99, P116, DOI 10.1016/j.ymgme.2009.09.008; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	37	81	86	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					253	266		10.1016/j.cell.2013.02.050	http://dx.doi.org/10.1016/j.cell.2013.02.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540702	Green Accepted, Bronze			2022-12-24	WOS:000316853700021
J	Hamasaki, M; Furuta, N; Matsuda, A; Nezu, A; Yamamoto, A; Fujita, N; Oomori, H; Noda, T; Haraguchi, T; Hiraoka, Y; Amano, A; Yoshimori, T				Hamasaki, Maho; Furuta, Nobumichi; Matsuda, Atsushi; Nezu, Akiko; Yamamoto, Akitsugu; Fujita, Naonobu; Oomori, Hiroko; Noda, Takeshi; Haraguchi, Tokuko; Hiraoka, Yasushi; Amano, Atsuo; Yoshimori, Tamotsu			Autophagosomes form at ER-mitochondria contact sites	NATURE			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE; LC3; DISSECTION; PROTEINS; ATG14L; CELLS	Autophagy is a tightly regulated intracellular bulk degradation/recycling system that has fundamental roles in cellular homeostasis(1). Autophagy is initiated by isolation membranes, which form and elongate as they engulf portions of the cytoplasm and organelles. Eventually isolation membranes dose to form double membrane-bound autophagosomes and fuse with lysosomes to degrade their contents. The physiological role of autophagy has been determined since its discovery, but the origin of autophagosomal membranes has remained unclear. At present, there is much controversy about the organelle from which the membranes originate-the endoplasmic reticulum (ER), mitochondria and plasma membrane(1,2). Here we show that autophagosomes form at the ER-mitochondria contact site in mammalian cells. Imaging data reveal that the pre-autophagosome/autophagosome marker ATG14 (also known as ATG14L) relocalizes to the ER-mitochondria contact site after starvation, and the autophagosome-formation marker ATG5 also localizes at the site until formation is complete. Subcellular fractionation showed that ATG14 co-fractionates in the mitochondria-associated ER membrane(3-5) fraction under starvation conditions. Disruption of the ER-mitochondria contact site prevents the formation of ATG14 puncta. The ER-resident SNARE protein syntaxin 17 (STX17) binds ATG14 and recruits it to the ER-mitochondria contact site. These results provide new insight into organelle biogenesis by demonstrating that the ER-mitochondria contact site is important in autophagosome formation.	[Hamasaki, Maho; Nezu, Akiko; Fujita, Naonobu; Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; [Hamasaki, Maho; Nezu, Akiko; Fujita, Naonobu; Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Frontier Biosci, Lab Intracellular Membrane Dynam, Suita, Osaka 5650871, Japan; [Furuta, Nobumichi; Amano, Atsuo] Osaka Univ, Grad Sch Dent, Ctr Oral Frontier Sci, Dept Oral Frontier Biol, Suita, Osaka 5650871, Japan; [Matsuda, Atsushi; Haraguchi, Tokuko; Hiraoka, Yasushi] Natl Inst Informat & Commun Technol, Nishi Ku, Kobe, Hyogo 6512492, Japan; [Matsuda, Atsushi; Haraguchi, Tokuko; Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Nucl Dynam Grp, Suita, Osaka 5650871, Japan; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Fac Biosci, Dept Cell Biol, Nagahama, Shiga 5260829, Japan; [Oomori, Hiroko] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Amano, Atsuo] Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; Osaka University; Osaka University	Yoshimori, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Genet, 2-2 Yaniadaoka, Suita, Osaka 5650871, Japan.	amanoa@dent.osaka-u.ac.jp; tamyoshi@fbs.osaka-u.ac.jp	Yoshimori, Tamotsu/K-9626-2014; Hiraoka, Yasushi/B-5111-2009; Noda, Takeshi/B-7240-2008; Fujita, Naonobu/A-1218-2010	Yoshimori, Tamotsu/0000-0001-9787-3788; Hiraoka, Yasushi/0000-0001-9407-8228; Noda, Takeshi/0000-0003-3581-7961; Fujita, Naonobu/0000-0003-1914-8438; Hamasaki, Maho/0000-0002-5646-5136; Matsuda, Atsushi/0000-0003-0510-213X	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank all members of the Amano and Yoshimori laboratories for discussions. We thank O. Kunitaki and K. Miura for continuous help throughout the research. We also thank P. Karagiannis for proofreading. This research was supported by grants-in-aid for Scientific Research (A) and (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kageyama S, 2011, MOL BIOL CELL, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Steegmaier M, 2000, MOL BIOL CELL, V11, P2719, DOI 10.1091/mbc.11.8.2719; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Yamamoto A, 2010, METHODS MOL BIOL, V657, P225, DOI 10.1007/978-1-60761-783-9_18; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180	26	1124	1167	9	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					389	393		10.1038/nature11910	http://dx.doi.org/10.1038/nature11910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23455425				2022-12-24	WOS:000316650500047
J	Leder, K; Torresi, J; Libman, MD; Cramer, JP; Castelli, F; Schlagenhauf, P; Wilder-Smith, A; Wilson, ME; Keystone, JS; Schwartz, E; Barnett, ED; von Sonnenburg, F; Brownstein, JS; Cheng, AC; Sotir, MJ; Esposito, DH; Freedman, DO				Leder, Karin; Torresi, Joseph; Libman, Michael D.; Cramer, Jakob P.; Castelli, Francesco; Schlagenhauf, Patricia; Wilder-Smith, Annelies; Wilson, Mary E.; Keystone, Jay S.; Schwartz, Eli; Barnett, Elizabeth D.; von Sonnenburg, Frank; Brownstein, John S.; Cheng, Allen C.; Sotir, Mark J.; Esposito, Douglas H.; Freedman, David O.		GeoSentinel Surveillance Network	GeoSentinel Surveillance of Illness in Returned Travelers, 2007-2011	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; VISITING FRIENDS; INTERNATIONAL TRAVELERS; HEALTH-PROBLEMS; LARGE COHORT; MALARIA; DIARRHEA; FEVER; RISK; EPIDEMIOLOGY	Background: International travel continues to increase, particularly to Asia and Africa. Clinicians are increasingly likely to be consulted for advice before travel or by ill returned travelers. Objective: To describe typical diseases in returned travelers according to region, travel reason, and patient demographic characteristics; describe the pattern of low-frequency travel-associated diseases; and refine key messages for care before and after travel. Design: Descriptive, using GeoSentinel records. Setting: 53 tropical or travel disease units in 24 countries. Patients: 42 173 ill returned travelers seen between 2007 and 2011. Measurements: Frequencies of demographic characteristics, regions visited, and illnesses reported. Results: Asia (32.6%) and sub-Saharan Africa (26.7%) were the most common regions where illnesses were acquired. Three quarters of travel-related illness was due to gastrointestinal (34.0%), febrile (23.3%), and dermatologic (19.5%) diseases. Only 40.5% of all ill travelers reported pretravel medical visits. The relative frequency of many diseases varied with both travel destination and reason for travel, with travelers visiting friends and relatives in their country of origin having both a disproportionately high burden of serious febrile illness and very low rates of advice before travel (18.3%). Life-threatening diseases, such as Plasmodium falciparum malaria, melioidosis, and African trypanosomiasis, were reported. Limitations: Sentinel surveillance data collected by specialist clinics do not reflect healthy returning travelers or those with mild or self-limited illness. Data cannot be used to infer quantitative risk for illness. Conclusion: Many illnesses may have been preventable with appropriate advice, chemoprophylaxis, or vaccination. Clinicians can use these 5-year GeoSentinel data to help tailor more efficient pretravel preparation strategies and evaluate possible differential diagnoses of ill returned travelers according to destination and reason for travel.	Univ Melbourne, Monash Univ, Austin Hosp, Victorian Infect Dis Serv,Royal Melbourne Hosp, Melbourne, Vic, Australia; Alfred Hosp, Melbourne, Vic, Australia; McGill Univ, Ctr Trop Dis, Montreal, PQ, Canada; Toronto Gen Hosp, Trop Dis Unit, Toronto, ON, Canada; Univ Toronto, Toronto, ON, Canada; Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; Univ Munich, Munich, Germany; Univ Brescia, Brescia, Italy; Univ Zurich, World Hlth Org Collaborating Ctr Travelers Hlth, Ctr Travel Med, Zurich, Switzerland; Harvard Univ, Sch Publ Hlth, Boston Childrens Hosp, Maxwell Finland Lab Infect Dis,Boston Med Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Chaim Sheba Med Ctr, Ctr Geog Med, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, IL-69978 Tel Aviv, Israel; Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; Univ Alabama Birmingham, Gorgas Ctr Geog Med, Birmingham, AL USA	Florey Institute of Neuroscience & Mental Health; Monash University; Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Munich; University of Brescia; University of Zurich; World Health Organization; Boston Medical Center; Harvard University; Boston Children's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Chaim Sheba Medical Center; Tel Aviv University; Centers for Disease Control & Prevention - USA; University of Alabama System; University of Alabama Birmingham	Leder, K (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Alfred Ctr, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	karin.leder@monash.edu	Leder, Karin/AAD-2388-2019; Parola, Philippe/AAY-4346-2021; Wilder-Smith, Annelies/F-8751-2015; Leder, Karin/H-4979-2014; Gkrania-Klotsas, Effrossyni/AAT-8424-2021; Freedman, David O./AAV-2999-2020	Leder, Karin/0000-0003-1368-1039; Parola, Philippe/0000-0002-1061-1927; Gkrania-Klotsas, Effrossyni/0000-0002-0930-8330; Freedman, David O./0000-0002-5642-5257; Okhuysen, Pablo/0000-0002-1596-3411; Perez-Molina, Jose Antonio/0000-0001-8735-4124; Torresi, Joseph/0000-0002-8212-0887; Aoun, Olivier/0000-0001-9554-8439; Schlagenhauf, Patricia/0000-0002-1075-7010; Mendelson, Marc/0000-0001-6668-3893; Ursing, Johan/0000-0002-5508-9327; Castelli, Francesco/0000-0001-9161-7804; Kain, Kevin/0000-0001-6068-1272; Wilder-Smith, Annelies/0000-0003-0362-5375; Cheng, Allen/0000-0003-3152-116X; Barnett, Elizabeth/0000-0003-4822-5949	Centers for Disease Control and Prevention; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U50CI000359] Funding Source: NIH RePORTER; MRC [G0701652] Funding Source: UKRI	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Centers for Disease Control and Prevention.	Angell SY, 2005, ANN INTERN MED, V142, P67, DOI 10.7326/0003-4819-142-1-200501040-00013; [Anonymous], 2012, Wkly Epidemiol Rec, V87; Ansart S, 2007, AM J TROP MED HYG, V76, P184, DOI 10.4269/ajtmh.2007.76.184; Askling HH, 2005, EMERG INFECT DIS, V11, P436, DOI 10.3201/eid1103.040677; Bacaner N, 2004, JAMA-J AM MED ASSOC, V291, P2856, DOI 10.1001/jama.291.23.2856; Behrens RH, 2013, TRAVEL MED, P297; Boggild AK, 2012, J TRAVEL MED, V19, P4, DOI 10.1111/j.1708-8305.2011.00579.x; Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Castelli F, 2001, J TRAVEL MED, V8, pS26, DOI 10.1111/j.1708-8305.2001.tb00543.x; CAUMES E, 1995, CLIN INFECT DIS, V20, P542, DOI 10.1093/clinids/20.3.542; Centers for Disease Control and Prevention, 2012, CDC HLTH INF INT TRA; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1605; Connor BA, 2005, CLIN INFECT DIS, V41, pS577, DOI 10.1086/432956; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Dupont Andrew W, 2007, Curr Gastroenterol Rep, V9, P378, DOI 10.1007/s11894-007-0046-8; El Hajj L, 2004, INT J DERMATOL, V43, P120, DOI 10.1111/j.1365-4632.2004.01991.x; Field VK, 2010, HLTH INFORM OVERSEAS; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Fulford Martha, 2005, Curr Infect Dis Rep, V7, P48, DOI 10.1007/s11908-005-0023-z; Gautret P, 2007, VACCINE, V25, P2656, DOI 10.1016/j.vaccine.2006.12.034; Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2; Guse CE, 2007, J TRAVEL MED, V14, P279, DOI 10.1111/j.1708-8305.2007.00133.x; Hagmann S, 2010, J TRAVEL MED, V17, P193, DOI 10.1111/j.1708-8305.2010.00399.x; Hakanen A, 2003, EMERG INFECT DIS, V9, P267; HARGARTEN SW, 1991, ANN EMERG MED, V20, P622, DOI 10.1016/S0196-0644(05)82379-0; Herbinger KH, 2011, TROP MED INT HEALTH, V16, P1457, DOI 10.1111/j.1365-3156.2011.02840.x; Herbinger KH, 2012, J TRAVEL MED, V19, P150, DOI 10.1111/j.1708-8305.2011.00589.x; Heukelbach J, 2008, LANCET INFECT DIS, V8, P302, DOI 10.1016/S1473-3099(08)70098-7; Hill DR, 2000, AM J TROP MED HYG, V62, P585, DOI 10.4269/ajtmh.2000.62.585; Hill DR, 2000, J TRAVEL MED, V7, P259, DOI 10.2310/7060.2000.00075; Jensenius M, 2009, EMERG INFECT DIS, V15, P1791, DOI 10.3201/eid1511.090677; Joseph CA, 2010, EUROSURVEILLANCE, V15, P5; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Lalloo DG, 2008, BMJ-BRIT MED J, V336, P1362, DOI 10.1136/bmj.a153; LANGE WR, 1992, ARCH INTERN MED, V152, P2049, DOI 10.1001/archinte.152.10.2049; LaRocque RC, 2012, CLIN INFECT DIS, V54, P455, DOI 10.1093/cid/cir839; Leder K, 2004, CLIN INFECT DIS, V39, P1104, DOI 10.1086/424510; Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893; Lederman ER, 2008, INT J INFECT DIS, V12, P593, DOI 10.1016/j.ijid.2007.12.008; Lindgren E, 2012, SCIENCE, V336, P418, DOI 10.1126/science.1215735; Loutan L, 2003, INT J ANTIMICROB AG, V21, P158, DOI 10.1016/S0924-8579(02)00367-9; MacPherson DW, 2007, J TRAVEL MED, V14, P77, DOI 10.1111/j.1708-8305.2007.00107.x; Meltzer E, 2012, AM J TROP MED HYG, V87, P264, DOI 10.4269/ajtmh.2012.11-0512; Migchelsen SJ, 2011, INT J INFECT DIS, V15, pE517, DOI 10.1016/j.ijid.2011.03.018; Moore SJ, 2012, INFECT DIS CLIN N AM, V26, P655, DOI 10.1016/j.idc.2012.07.002; Morris-Jones R, 2012, INFECT DIS CLIN N AM, V26, P675, DOI 10.1016/j.idc.2012.05.010; O'Brien DP, 2006, J TRAVEL MED, V13, P145, DOI 10.1111/j.1708-8305.2006.00033.x; Odolini S, 2012, CLIN MICROBIOL INFEC, V18, P468, DOI 10.1111/j.1469-0691.2011.03596.x; PROCIV P, 1995, MED J AUSTRALIA, V163, P27, DOI 10.5694/j.1326-5377.1995.tb126084.x; Ryan ET, 2002, NEW ENGL J MED, V347, P505, DOI 10.1056/NEJMra020118; Siikamaki HM, 2011, J TRAVEL MED, V18, P239, DOI 10.1111/j.1708-8305.2011.00532.x; Solomon M, 2011, AM J TROP MED HYG, V85, P868, DOI 10.4269/ajtmh.2011.10-0471; Steffen R, 2004, J TRAVEL MED, V11, P231, DOI 10.2310/7060.2004.19007; Steffen R, 1999, JAMA-J AM MED ASSOC, V281, P811, DOI 10.1001/jama.281.9.811; STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84; Thabane M, 2007, ALIMENT PHARM THER, V26, P535, DOI 10.1111/j.1365-2036.2007.03399.x; Thabane M, 2009, WORLD J GASTROENTERO, V15, P3591, DOI 10.3748/wjg.15.3591; Tonellato DJ, 2009, J TRAVEL MED, V16, P304, DOI 10.1111/j.1708-8305.2009.00318.x; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; United Nations World Tourism Organization, 2011, UNWTO TOUR HIGHL 201; Vlieghe ER, 2008, J TRAVEL MED, V15, P419, DOI 10.1111/j.1708-8305.2008.00236.x; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; Wilson ME, 2007, CURR OPIN INFECT DIS, V20, P449; Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173; World Health Organization, 2012, INT TRAV HLTH 2012; Zaki SA, 2011, J INFECT DEV COUNTR, V5, P324, DOI 10.3855/jidc.1405	68	305	312	1	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6					456	+		10.7326/0003-4819-158-6-201303190-00005	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-00005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292YJ	23552375	Green Accepted			2022-12-24	WOS:000329938300001
J	Linnen, CR; Poh, YP; Peterson, BK; Barrett, RDH; Larson, JG; Jensen, JD; Hoekstra, HE				Linnen, Catherine R.; Poh, Yu-Ping; Peterson, Brant K.; Barrett, Rowan D. H.; Larson, Joanna G.; Jensen, Jeffrey D.; Hoekstra, Hopi E.			Adaptive Evolution of Multiple Traits Through Multiple Mutations at a Single Gene	SCIENCE			English	Article							AGOUTI; ADAPTATION; MICE; SELECTION	The identification of precise mutations is required for a complete understanding of the underlying molecular and evolutionary mechanisms driving adaptive phenotypic change. Using plasticine models in the field, we show that the light coat color of deer mice that recently colonized the light-colored soil of the Nebraska Sand Hills provides a strong selective advantage against visually hunting predators. Color variation in an admixed population suggests that this light Sand Hills phenotype is composed of multiple traits. We identified distinct regions within the Agouti locus associated with each color trait and found that only haplotypes associated with light trait values have evidence of selection. Thus, local adaptation is the result of independent selection on many mutations within a single locus, each with a specific effect on an adaptive phenotype, thereby minimizing pleiotropic consequences.	[Linnen, Catherine R.] Univ Kentucky, Dept Biol, Lexington, KY 40506 USA; [Poh, Yu-Ping; Peterson, Brant K.; Barrett, Rowan D. H.; Larson, Joanna G.; Hoekstra, Hopi E.] Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Peterson, Brant K.; Hoekstra, Hopi E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Poh, Yu-Ping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA USA; [Jensen, Jeffrey D.] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Poh, Yu-Ping; Jensen, Jeffrey D.] SIB, Lausanne, Switzerland	University of Kentucky; Harvard University; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Linnen, CR (corresponding author), Univ Kentucky, Dept Biol, 200A Thomas Hunt Morgan Bldg, Lexington, KY 40506 USA.	catherine.linnen@uky.edu; hoekstra@oeb.harvard.edu	Hoekstra, Hopi E/I-6690-2012; Jensen, Jeffrey/S-1084-2016	Hoekstra, Hopi E/0000-0003-1431-1769; Jensen, Jeffrey/0000-0002-4786-8064; Larson, Joanna/0000-0002-1401-7837; Peterson, Brant/0000-0002-0433-3035; Barrett, Rowan/0000-0003-3044-2531	NIH; Jane Coffins Child Postdoctoral Fellowship; Swiss National Science Foundation; European Research Council; Defense Advanced Research Projects Agency; Natural Sciences and Engineering Research Council of Canada Banting Postdoctoral Fellowship; Foundational Questions in Evolutionary Biology Postdoctoral Fellowship; MCZ Museum of Comparative Zoology (MCZ); Harvard University; National Science Foundation [DEB-0749958]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffins Child Postdoctoral Fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Natural Sciences and Engineering Research Council of Canada Banting Postdoctoral Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Foundational Questions in Evolutionary Biology Postdoctoral Fellowship; MCZ Museum of Comparative Zoology (MCZ); Harvard University; National Science Foundation(National Science Foundation (NSF))	We thank K. Duryea and G. Goncalves for laboratory assistance; J. Chupasko, E. Kay, E. Kingsley, M. Manceau, and J. Weber for field assistance; J. Demboski and the Denver Museum of Nature and Science for logistical support; and J. Chupasko for curation assistance. C. R. L. was supported by a Ruth Kirschstein National Research Service Award from NIH; B. K. P. by a Jane Coffins Child Postdoctoral Fellowship; J. D. J. and Y-P.P. by grants from the Swiss National Science Foundation, the European Research Council, and Defense Advanced Research Projects Agency; R. D. H. B. by a Natural Sciences and Engineering Research Council of Canada Banting Postdoctoral Fellowship and a Foundational Questions in Evolutionary Biology Postdoctoral Fellowship. Laboratory and fieldwork was funded by Putnam Expedition Grants from the MCZ Museum of Comparative Zoology (MCZ), the Swiss National Science Foundation, Harvard University, and the National Science Foundation (DEB-0749958 to H. E. H.). P. maniculatus were collected under the Nebraska Game and Parks Commission Scientific and Educational Permit 901, and voucher specimens were deposited in the MCZ's Mammal Department. Sequence data were deposited in the NCBI Short Read Archive (accession no. SRP017939).	BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; Darwin C., 1859, ORIGIN SPECIES MEANS; Dice L. R., 1941, Contributions from the Laboratory of Vertebrate Genetics University of Michigan, Vno. 15, P1; Dice Lee R., 1947, CONIR LAB VERTEBRATE BIOL UNIV MICHIGAN, V34, P1; Domingues VS, 2012, EVOLUTION, V66, P3209, DOI 10.1111/j.1558-5646.2012.01669.x; Fisher R.A., 1930, GENETICAL THEORY NAT; Frankel N, 2011, NATURE, V474, P598, DOI 10.1038/nature10200; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Jackson PJ, 2006, CHEM BIOL, V13, P1297, DOI 10.1016/j.chembiol.2006.10.006; Kingsley EP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006435; Laurie CC, 2007, PLOS GENET, V3, P1487, DOI 10.1371/journal.pgen.0030144; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; Loope D.B., 2000, GREAT PLAINS RES, V10, P5; Meiklejohn CD, 2004, GENETICS, V168, P265, DOI 10.1534/genetics.103.025494; Nadeau NJ, 2010, TRENDS GENET, V26, P484, DOI 10.1016/j.tig.2010.08.004; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Prasad KVSK, 2012, SCIENCE, V337, P1081, DOI 10.1126/science.1221636; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Vignieri SN, 2010, EVOLUTION, V64, P2153, DOI 10.1111/j.1558-5646.2010.00976.x; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667	24	210	213	0	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1312	1316		10.1126/science.1233213	http://dx.doi.org/10.1126/science.1233213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493712	Green Accepted			2022-12-24	WOS:000316053400036
J	Burrell, RA; McClelland, SE; Endesfelder, D; Groth, P; Weller, MC; Shaikh, N; Domingo, E; Kanu, N; Dewhurst, SM; Gronroos, E; Chew, SK; Rowan, AJ; Schenk, A; Sheffer, M; Howell, M; Kschischo, M; Behrens, A; Helleday, T; Bartek, J; Tomlinson, IR; Swanton, C				Burrell, Rebecca A.; McClelland, Sarah E.; Endesfelder, David; Groth, Petra; Weller, Marie-Christine; Shaikh, Nadeem; Domingo, Enric; Kanu, Nnennaya; Dewhurst, Sally M.; Gronroos, Eva; Chew, Su Kit; Rowan, Andrew J.; Schenk, Arne; Sheffer, Michal; Howell, Michael; Kschischo, Maik; Behrens, Axel; Helleday, Thomas; Bartek, Jiri; Tomlinson, Ian R.; Swanton, Charles			Replication stress links structural and numerical cancer chromosomal instability	NATURE			English	Article							DNA-DAMAGE RESPONSE; SEGREGATION ERRORS; EVOLUTION; ORIGINS	Cancer chromosomal instability (CIN) results in an increased rate of change of chromosome number and structure and generates intratumour heterogeneity(1,2). CIN is observed in most solid tumours and is associated with both poor prognosis and drug resistance(3,4). Understanding a mechanistic basis for CIN is therefore paramount. Here we find evidence for impaired replication fork progression and increased DNA replication stress in CIN+ colorectal cancer (CRC) cells relative to CIN- CRC cells, with structural chromosome abnormalities precipitating chromosome missegregation in mitosis. We identify three new CIN-suppressor genes (PIGN (also known as MCD4), MEX3C (RKHD2) and ZNF516 (KIAA0222)) encoded on chromosome 18q that are subject to frequent copy number loss in CIN+ CRC. Chromosome 18q loss was temporally associated with aneuploidy onset at the adenoma-carcinoma transition. CIN-suppressor gene silencing leads to DNA replication stress, structural chromosome abnormalities and chromosome missegregation. Supplementing cells with nucleosides, to alleviate replication-associated damage(5), reduces the frequency of chromosome segregation errors after CIN-suppressor gene silencing, and attenuates segregation errors and DNA damage in CIN+ cells. These data implicate a central role for replication stress in the generation of structural and numerical CIN, which may inform new therapeutic approaches to limit intratumour heterogeneity.	[Burrell, Rebecca A.; McClelland, Sarah E.; Endesfelder, David; Shaikh, Nadeem; Kanu, Nnennaya; Dewhurst, Sally M.; Gronroos, Eva; Chew, Su Kit; Rowan, Andrew J.; Howell, Michael; Behrens, Axel; Swanton, Charles] Canc Res UK London Res Inst, London WC2A 3LY, England; [Endesfelder, David; Schenk, Arne; Kschischo, Maik] Univ Appl Sci Koblenz, Dept Math & Technol, D-53424 Remagen, Germany; [Groth, Petra; Weller, Marie-Christine; Helleday, Thomas] Karolinska lnstitutet, Sci Life Lab, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, S-17121 Stockholm, Sweden; [Domingo, Enric; Tomlinson, Ian R.] Wellcome Trust Ctr Human Genet, Mol & Populat Genet & NIHR Biomed Res Ctr, Oxford OX3 7BN, England; [Chew, Su Kit; Swanton, Charles] UCL Canc Inst, London WC1E 6BT, England; [Sheffer, Michal] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Bartek, Jiri] Danish Canc Soc, Res Ctr, DK-2100 Copenhagen, Denmark; [Bartek, Jiri] Palacky Univ Olomouc, Inst Mol & Translat Med, CZ-77515 Olomouc, Czech Republic	Cancer Research UK; Karolinska Institutet; University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London; Weizmann Institute of Science; Danish Cancer Society; Palacky University Olomouc	Swanton, C (corresponding author), Canc Res UK London Res Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England.	charles.swanton@cancer.org.uk	Gronroos, Eva/E-9351-2013; Gronroos, Eva/P-6951-2015; Bartek, Jiri/G-5870-2014; Domingo, Enric/A-9099-2018; Helleday, Thomas/D-5224-2013	Domingo, Enric/0000-0003-4390-8767; Shaikh, Nadeem/0000-0003-1797-2271; Behrens, Axel/0000-0002-1557-1143; Helleday, Thomas/0000-0002-7384-092X; Gronroos, Eva/0000-0001-8303-5409; Howell, Michael/0000-0003-0912-0079; Swanton, Charles/0000-0002-4299-3018; Sheffer, Michal/0000-0001-5934-9950	Cancer Research UK; Medical Research Council; EU; Prostate Cancer Foundation; Breast Cancer Research Foundation; Oxford Biomedical Research Centre; Danish Cancer Society; Lundbeck Foundation; European Commission; Swedish Cancer Society; Swedish Research Council; Torsten and Ragnar Soderberg Foundation; Cancer Research UK [16459, 15679] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); Prostate Cancer Foundation; Breast Cancer Research Foundation; Oxford Biomedical Research Centre; Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg Foundation; Cancer Research UK(Cancer Research UK)	We thank A. Straube for reagents. C.S. is a senior Medical Research Council clinical research fellow and is funded by Cancer Research UK, the Medical Research Council, EU FP7 (projects PREDICT and RESPONSIFY), Prostate Cancer Foundation, and the Breast Cancer Research Foundation. We thank A. Futreal and The Wellcome Trust Sanger Centre and The Cancer Genome Atlas Research Network for providing genomics data. I.P.T. is supported by the Oxford Biomedical Research Centre and Cancer Research UK. J.B. is funded by the Danish Cancer Society, the Lundbeck Foundation, and the European Commission (FP7 projects DDResponse, Biomedreg and Infla-Care). T.H. is funded by the Swedish Cancer Society, the Swedish Research Council and the Torsten and Ragnar Soderberg Foundation.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bunz F, 2002, CANCER RES, V62, P1129; Chan KL, 2009, CELL CYCLE, V8, P3065, DOI 10.4161/cc.8.19.9513; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Dereli-Oz A, 2011, MOL ONCOL, V5, P308, DOI 10.1016/j.molonc.2011.05.002; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gisselsson D, 2008, CHROMOSOMA, V117, P511, DOI 10.1007/s00412-008-0169-1; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Ichijima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008821; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pampalona J, 2010, GENE CHROMOSOME CANC, V49, P368, DOI 10.1002/gcc.20749; Pasello G, 2009, MODERN PATHOL, V22, P58, DOI 10.1038/modpathol.2008.150; Rowan A, 2005, CLIN GASTROENTEROL H, V3, P1115, DOI 10.1016/S1542-3565(05)00618-X; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2011, CHROMOSOME RES, V19, P433, DOI 10.1007/s10577-010-9179-y; Tort F, 2006, CANCER RES, V66, P10258, DOI 10.1158/0008-5472.CAN-06-2178; Yatsuoka T, 2000, AM J GASTROENTEROL, V95, P2080	27	518	532	2	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					492	496		10.1038/nature11935	http://dx.doi.org/10.1038/nature11935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446422	Green Accepted			2022-12-24	WOS:000315661500042
J	Auyeung, VC; Ulitsky, I; McGeary, SE; Bartel, DP				Auyeung, Vincent C.; Ulitsky, Igor; McGeary, Sean E.; Bartel, David P.			Beyond Secondary Structure: Primary-Sequence Determinants License Pri-miRNA Hairpins for Processing	CELL			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; CHRONIC LYMPHOCYTIC-LEUKEMIA; IN-VITRO SELECTION; MESSENGER-RNA; SR PROTEINS; MICROPROCESSOR COMPLEX; DROSHA-DGCR8 COMPLEX; MICRORNA PRECURSORS; MAMMALIAN-CELLS; MOLECULAR-BASIS	To use microRNAs to downregulate mRNA targets, cells must first process these similar to 22 nt RNAs from primary transcripts (pri-miRNAs). These transcripts form RNA hairpins important for processing, but additional determinants must distinguish pri-miRNAs from the many other hairpin-containing transcripts expressed in each cell. Illustrating the complexity of this recognition, we show that most Caenorhabditis elegans pri-miRNAs lack determinants required for processing in human cells. To find these determinants, we generated many variants of four human pri-miRNAs, sequenced millions that retained function, and compared them with the starting variants. Our results confirmed the importance of pairing in the stem and revealed three primary-sequence determinants, including an SRp20-binding motif (CNNC) found downstream of most pri-miRNA hairpins in bilaterian animals, but not in nematodes. Adding this and other determinants to C. elegans pri-miRNAs imparted efficient processing in human cells, thereby confirming the importance of primary-sequence determinants for distinguishing pri-miRNAs from other hairpin-containing transcripts.	[Auyeung, Vincent C.; Ulitsky, Igor; McGeary, Sean E.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Auyeung, Vincent C.; Ulitsky, Igor; McGeary, Sean E.; Bartel, David P.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Auyeung, Vincent C.; Ulitsky, Igor; McGeary, Sean E.; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Auyeung, Vincent C.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu	Ulitsky, Igor/HCH-7453-2022	Ulitsky, Igor/0000-0003-0555-6561; Auyeung, Vincent/0000-0001-6273-1595	NIH [GM067031, T32GM007753]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031, T32GM007753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Shechner, C. Jan, O. Rissland, D. Weinberg, J. Ruby, J. Nam, and V.N. Kim for valuable discussions; O. Rissland for comments on this manuscript; L. Schoenfeld and J. Lassar for technical assistance; J. Stevenin for 9G8 antibody; V.N. Kim and T. Tuschl for plasmids; the Whitehead Institute Genome Technology Core for sequencing; and E. Spooner for mass spectrometry. This work was supported by NIH grants GM067031 and T32GM007753. D.B. is an Investigator of the Howard Hughes Medical Institute.	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bedard KM, 2007, EMBO J, V26, P459, DOI 10.1038/sj.emboj.7601494; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; CAVALOC Y, 1994, EMBO J, V13, P2639, DOI 10.1002/j.1460-2075.1994.tb06554.x; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Chung WJ, 2011, GENOME RES, V21, P286, DOI 10.1101/gr.113050.110; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Feng Y, 2011, BBA-GENE REGUL MECH, V1809, P700, DOI 10.1016/j.bbagrm.2011.05.015; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385; HEINRICHS V, 1995, EMBO J, V14, P3987, DOI 10.1002/j.1460-2075.1995.tb00070.x; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jia R, 2010, INT J BIOL SCI, V6, P806; Jumaa H, 1999, CURR BIOL, V9, P899, DOI 10.1016/S0960-9822(99)80394-7; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lamontagne B, 2004, J BIOL CHEM, V279, P2231, DOI 10.1074/jbc.M309324200; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2007, METHOD ENZYMOL, V427, P89, DOI 10.1016/S0076-6879(07)27005-3; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; PAN T, 1992, BIOCHEMISTRY-US, V31, P3887, DOI 10.1021/bi00131a001; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Schaal TD, 1999, MOL CELL BIOL, V19, P1705; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Swartz JE, 2007, J BIOL CHEM, V282, P19844, DOI 10.1074/jbc.M701660200; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021; WYATT JR, 1992, GENE DEV, V6, P2542, DOI 10.1101/gad.6.12b.2542; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; ZAHLER AM, 1993, MOL CELL BIOL, V13, P4023, DOI 10.1128/MCB.13.7.4023; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	63	276	291	1	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					844	858		10.1016/j.cell.2013.01.031	http://dx.doi.org/10.1016/j.cell.2013.01.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415231	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000314945600018
J	Landau, DA; Carter, SL; Stojanov, P; McKenna, A; Stevenson, K; Lawrence, MS; Sougnez, C; Stewart, C; Sivachenko, A; Wang, LL; Wan, YZ; Zhang, WD; Shukla, SA; Vartanov, A; Fernandes, SM; Saksena, G; Cibulskis, K; Tesar, B; Gabriel, S; Hacohen, N; Meyerson, M; Lander, ES; Neuberg, D; Brown, JR; Getz, G; Wu, CJ				Landau, Dan A.; Carter, Scott L.; Stojanov, Petar; McKenna, Aaron; Stevenson, Kristen; Lawrence, Michael S.; Sougnez, Carrie; Stewart, Chip; Sivachenko, Andrey; Wang, Lili; Wan, Youzhong; Zhang, Wandi; Shukla, Sachet A.; Vartanov, Alexander; Fernandes, Stacey M.; Saksena, Gordon; Cibulskis, Kristian; Tesar, Bethany; Gabriel, Stacey; Hacohen, Nir; Meyerson, Matthew; Lander, Eric S.; Neuberg, Donna; Brown, Jennifer R.; Getz, Gad; Wu, Catherine J.			Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; COPY-NUMBER ALTERATION; B-CELL LYMPHOMA; CLONAL EVOLUTION; SOMATIC MUTATIONS; GENOMIC ABERRATIONS; MULTIPLE-MYELOMA; CANCER GENES; PROGRESSION; HETEROGENEITY	Clonal evolution is a key feature of cancer progression and relapse. We studied intratumoral heterogeneity in 149 chronic lymphocytic leukemia (CLL) cases by integrating whole-exome sequence and copy number to measure the fraction of cancer cells harboring each somatic mutation. We identified driver mutations as predominantly clonal (e.g., MYD88, trisomy 12, and del(13q)) or subclonal (e.g., SF3B1 and TP53), corresponding to earlier and later events in CLL evolution. We sampled leukemia cells from 18 patients at two time points. Ten of twelve CLL cases treated with chemotherapy (but only one of six without treatment) underwent clonal evolution, predominantly involving subclones with driver mutations (e.g., SF3B1 and TP53) that expanded over time. Furthermore, presence of a subclonal driver mutation was an independent risk factor for rapid disease progression. Our study thus uncovers patterns of clonal evolution in CLL, providing insights into its stepwise transformation, and links the presence of subclones with adverse clinical outcomes.	[Landau, Dan A.; Wang, Lili; Wan, Youzhong; Zhang, Wandi; Shukla, Sachet A.; Wu, Catherine J.] Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA; [Landau, Dan A.; Stojanov, Petar; Wang, Lili; Wan, Youzhong; Zhang, Wandi; Vartanov, Alexander; Fernandes, Stacey M.; Tesar, Bethany; Brown, Jennifer R.; Wu, Catherine J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Stevenson, Kristen; Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Landau, Dan A.; Carter, Scott L.; Stojanov, Petar; McKenna, Aaron; Lawrence, Michael S.; Sougnez, Carrie; Stewart, Chip; Sivachenko, Andrey; Shukla, Sachet A.; Saksena, Gordon; Cibulskis, Kristian; Gabriel, Stacey; Hacohen, Nir; Meyerson, Matthew; Lander, Eric S.; Getz, Gad] Broad Inst, Cambridge, MA 02139 USA; [Landau, Dan A.] Yale Canc Ctr, Dept Hematol, New Haven, CT 06510 USA; [Landau, Dan A.] Univ Paris Diderot, F-75013 Paris, France; [Brown, Jennifer R.; Wu, Catherine J.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA; [Hacohen, Nir] Harvard Univ, Div Allergy Immunol & Rheumatol, Dept Med, Massachusetts Gen Hosp,Med Sch, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Getz, G (corresponding author), Broad Inst, Cambridge, MA 02139 USA.	gadgetz@broadinstitute.org; cwu@partners.org	Stojanov, Petar/GQI-4462-2022; Cibulskis, Kristian/AAC-7380-2019; Lawrence, Michael/AAC-8202-2020	Stojanov, Petar/0000-0001-7815-776X; Cibulskis, Kristian/0000-0003-1343-1582; Meyerson, Matthew/0000-0002-9133-8108; Vartanov, Alexander/0000-0001-5744-4882	American Society of Hematology (ASH) Research Award for Fellows-in-Training; ACS Postdoctoral Fellowship; NIH [K23 CA115682]; Melton and Rosenbach Funds; Blavatnik Family Foundation; AACR (SU2C Innovative Research Grant); NHLBI [1RO1HL103532-01]; NCI [1R01CA155010-01A1]; Damon-Runyon Cancer Research Foundation [CI-38-07]; NATIONAL CANCER INSTITUTE [R01CA155010, K23CA115682] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103532] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	American Society of Hematology (ASH) Research Award for Fellows-in-Training; ACS Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melton and Rosenbach Funds; Blavatnik Family Foundation; AACR (SU2C Innovative Research Grant); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon-Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	D.A.L. dedicates this manuscript to the loving memory of his mother Nina, who passed away during the final stages of this work. We thank all members of the Broad Institute's Biological Samples, Genetic Analysis, and Genome Sequencing Platforms, who made this work possible (NHGRI-U54HG003067). D.A.L. is supported by an American Society of Hematology (ASH) Research Award for Fellows-in-Training and an ACS Postdoctoral Fellowship. J.R.B. is supported by NIH K23 CA115682, the Melton and Rosenbach Funds, and is an ASH Scholar and a LLS Clinical Research Scholar. C.J.W. acknowledges support from the Blavatnik Family Foundation, AACR (SU2C Innovative Research Grant), NHLBI (1RO1HL103532-01), NCI (1R01CA155010-01A1), and is a clinical investigator supported in part by the Damon-Runyon Cancer Research Foundation (CI-38-07).	Alami R, 2003, P NATL ACAD SCI USA, V100, P5920, DOI 10.1073/pnas.0736105100; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BOS JL, 1989, CANCER RES, V49, P4682; Brown JR, 2012, CLIN CANCER RES, V18, P3791, DOI 10.1158/1078-0432.CCR-11-2342; Carter S.L., 2011, NATURE PRECEDINGS; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cibulskis K., 2013, NAT BIOTECH; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Deutsch AJA, 2007, BLOOD, V109, P3500, DOI 10.1182/blood-2006-06-030494; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dohner Hartmut, 2005, Clin Adv Hematol Oncol, V3, P103; Egan JB, 2012, BLOOD, V120, P1060, DOI 10.1182/blood-2012-01-405977; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Geisler C, 1999, JNCI-J NATL CANCER I, V91, P861; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Grubor V, 2009, BLOOD, V113, P1294, DOI 10.1182/blood-2008-05-158865; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hosgood HD, 2009, LEUKEMIA RES, V33, P1609, DOI 10.1016/j.leukres.2009.03.013; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Marechal Y, 2011, IMMUNOBIOLOGY, V216, P103, DOI 10.1016/j.imbio.2010.03.012; Masica DL, 2011, CANCER RES, V71, P4550, DOI 10.1158/0008-5472.CAN-11-0180; McCarthy H, 2003, BLOOD, V101, P4903, DOI 10.1182/blood-2002-09-2906; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nowak MA, 2004, SCIENCE, V303, P793, DOI 10.1126/science.1093411; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Schuh A, 2012, BLOOD, V120, P4191, DOI 10.1182/blood-2012-05-433540; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shanafelt TD, 2008, J CLIN ONCOL, V26, pE5, DOI 10.1200/JCO.2008.16.7874; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stilgenbauer S, 2007, HAEMATOLOGICA, V92, P1242, DOI 10.3324/haematol.10720; Unoki M, 2003, ONCOGENE, V22, P2172, DOI 10.1038/sj.onc.1206222; Vincent TL, 2008, INT J ONCOL, V32, P729; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wu CJ, 2012, BLOOD, V120, P4117, DOI 10.1182/blood-2012-09-452805	59	989	1008	4	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					714	726		10.1016/j.cell.2013.01.019	http://dx.doi.org/10.1016/j.cell.2013.01.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415222	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000314945600008
J	Canzio, D; Liao, MF; Naber, N; Pate, E; Larson, A; Wu, SP; Marina, DB; Garcia, JF; Madhani, HD; Cooke, R; Schuck, P; Cheng, YF; Narlikar, GJ				Canzio, Daniele; Liao, Maofu; Naber, Nariman; Pate, Edward; Larson, Adam; Wu, Shenping; Marina, Diana B.; Garcia, Jennifer F.; Madhani, Hiten D.; Cooke, Roger; Schuck, Peter; Cheng, Yifan; Narlikar, Geeta J.			A conformational switch in HP1 releases auto-inhibition to drive heterochromatin assembly	NATURE			English	Article							HISTONE H3; SHADOW DOMAIN; SELF-ASSOCIATION; FAMILY PROTEINS; LYSINE 9; CHROMODOMAIN; METHYLATION; PARTICLE; BINDING; VISUALIZATION	A hallmark of histone H3 lysine 9 (H3K9)-methylated heterochromatin, conserved from the fission yeast Schizosaccharomyces pombe to humans, is its ability to spread to adjacent genomic regions(1-6). Central to heterochromatin spread is heterochromatin protein 1 (HP1), which recognizes H3K9-methylated chromatin, oligomerizes and forms a versatile platform that participates in diverse nuclear functions, ranging from gene silencing to chromosome segregation(1-6). How HP1 proteins assemble on methylated nucleosomal templates and how the HP1-nucleosome complex achieves functional versatility remain poorly understood. Here we show that binding of the key S. pombe HP1 protein, Swi6, to methylated nucleosomes drives a switch from an auto-inhibited state to a spreading-competent state. In the auto-inhibited state, a histonemimic sequence in one Swi6 monomer blocks methyl-mark recognition by the chromodomain of another monomer. Auto-inhibition is relieved by recognition of two template features, the H3K9 methyl mark and nucleosomal DNA. Cryo-electron-microscopy-based reconstruction of the Swi6-nucleosome complex provides the overall architecture of the spreading-competent state in which two unbound chromodomain sticky ends appear exposed. Disruption of the switch between the auto-inhibited and spreading-competent states disrupts heterochromatin assembly and gene silencing in vivo. These findings are reminiscent of other conditionally activated polymerization processes, such as actin nucleation, and open up a new class of regulatory mechanisms that operate on chromatin in vivo.	[Canzio, Daniele; Liao, Maofu; Naber, Nariman; Larson, Adam; Wu, Shenping; Marina, Diana B.; Garcia, Jennifer F.; Madhani, Hiten D.; Cooke, Roger; Cheng, Yifan; Narlikar, Geeta J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Canzio, Daniele] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94158 USA; [Pate, Edward] Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Larson, Adam; Marina, Diana B.; Garcia, Jennifer F.] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA; [Schuck, Peter] Nat Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington State University; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Narlikar, GJ (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	geeta.narlikar@ucsf.edu	Schuck, Peter/AAA-6888-2020; Garcia, Jennifer/HDN-4569-2022; Liao, Maofu/AAD-7333-2021	Schuck, Peter/0000-0002-8859-6966; Liao, Maofu/0000-0002-3481-450X; Garcia, Jennifer/0000-0002-0620-0594; Cheng, Yifan/0000-0001-9535-0369; Madhani, Hiten/0000-0001-7400-6657	Hillblom foundation; American Cancer Society; Leukemia and Lymphoma Society; National Institutes of Health (NIH) [R01GM071801, AR053720]; UCSF Program for Breakthrough Biomedical Research; NIBIB, NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053720, R01AR062279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071801] Funding Source: NIH RePORTER	Hillblom foundation; American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Program for Breakthrough Biomedical Research; NIBIB, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Tretyakova for preparation of histone proteins and J. Leonard for sample preparation for cryo-electron microscopy of nucleosome alone. We thank W. Lim, M. Simon, K. Armache, J. Zalatan, L. Racki and members of the Narlikar laboratory for discussions. D.C. would like to thank I. Ortiz Torres and K. M. Kuchenbecker for scientific discussions and members of the Schuck laboratory for advice on AUC approaches. This work was supported by a grant from the Hillblom foundation to D.C., by grants from the American Cancer Society and Leukemia and Lymphoma Society to G.J.N., National Institutes of Health (NIH) grant R01GM071801 to H.D.M. and by a New Technology Award to Y.C. from the UCSF Program for Breakthrough Biomedical Research. P.S. was supported by the Intramural Research Program of the NIBIB, NIH. N.N. and E.P. were supported by the NIH grant AR053720.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRIGON RP, 1975, BIOCHEMISTRY-US, V14, P4567, DOI 10.1021/bi00692a002; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Keller C, 2012, MOL CELL; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Leroy G, 2009, MOL CELL PROTEOMICS, V8, P2432, DOI 10.1074/mcp.M900160-MCP200; Li XM, 2010, J STRUCT BIOL, V172, P407, DOI 10.1016/j.jsb.2010.06.010; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mendez DL, 2011, CHEMBIOCHEM, V12, P1084, DOI 10.1002/cbic.201000598; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mullins RD, 2000, CURR OPIN CELL BIOL, V12, P91, DOI 10.1016/S0955-0674(99)00061-7; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Purcell TJ, 2011, J MOL BIOL, V407, P79, DOI 10.1016/j.jmb.2010.11.053; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Richart AN, 2012, J BIOL CHEM, V287, P18730, DOI 10.1074/jbc.M111.337204; Rougemaille M, 2008, J BIOL CHEM, V283, P25770, DOI 10.1074/jbc.C800140200; Ruan JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035376; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Sadaie M, 2008, MOL CELL BIOL, V28, P6973, DOI 10.1128/MCB.00791-08; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Simon M.D., 2010, CURR PROTOCOLS MOL B, VChapter 21, pUNIT 21.18.1, DOI [10.1002/0471142727.mb2118s90, DOI 10.1002/0471142727.MB2118S90]; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000; Yamada T, 1999, J BIOCHEM, V125, P832, DOI 10.1093/oxfordjournals.jbchem.a022356; Zhao T, 2000, J BIOL CHEM, V275, P28332	40	96	97	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					377	+		10.1038/nature12032	http://dx.doi.org/10.1038/nature12032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23485968	Green Accepted			2022-12-24	WOS:000317599200041
J	Garibaldi, LA; Steffan-Dewenter, I; Winfree, R; Aizen, MA; Bommarco, R; Cunningham, SA; Kremen, C; Carvalheiro, LG; Harder, LD; Afik, O; Bartomeus, I; Benjamin, F; Boreux, V; Cariveau, D; Chacoff, NP; Dudenhoffer, JH; Freitas, BM; Ghazoul, J; Greenleaf, S; Hipolito, J; Holzschuh, A; Howlett, B; Isaacs, R; Javorek, SK; Kennedy, CM; Krewenka, KM; Krishnan, S; Mandelik, Y; Mayfield, MM; Motzke, I; Munyuli, T; Nault, BA; Otieno, M; Petersen, J; Pisanty, G; Potts, SG; Rader, R; Ricketts, TH; Rundlof, M; Seymour, CL; Schuepp, C; Szentgyorgyi, H; Taki, H; Tscharntke, T; Vergara, CH; Viana, BF; Wanger, TC; Westphal, C; Williams, N; Klein, AM				Garibaldi, Lucas A.; Steffan-Dewenter, Ingolf; Winfree, Rachael; Aizen, Marcelo A.; Bommarco, Riccardo; Cunningham, Saul A.; Kremen, Claire; Carvalheiro, Luisa G.; Harder, Lawrence D.; Afik, Ohad; Bartomeus, Ignasi; Benjamin, Faye; Boreux, Virginie; Cariveau, Daniel; Chacoff, Natacha P.; Dudenhoeffer, Jan H.; Freitas, Breno M.; Ghazoul, Jaboury; Greenleaf, Sarah; Hipolito, Juliana; Holzschuh, Andrea; Howlett, Brad; Isaacs, Rufus; Javorek, Steven K.; Kennedy, Christina M.; Krewenka, Kristin M.; Krishnan, Smitha; Mandelik, Yael; Mayfield, Margaret M.; Motzke, Iris; Munyuli, Theodore; Nault, Brian A.; Otieno, Mark; Petersen, Jessica; Pisanty, Gideon; Potts, Simon G.; Rader, Romina; Ricketts, Taylor H.; Rundlof, Maj; Seymour, Colleen L.; Schueepp, Christof; Szentgyoergyi, Hajnalka; Taki, Hisatomo; Tscharntke, Teja; Vergara, Carlos H.; Viana, Blandina F.; Wanger, Thomas C.; Westphal, Catrin; Williams, Neal; Klein, Alexandra M.			Wild Pollinators Enhance Fruit Set of Crops Regardless of Honey Bee Abundance	SCIENCE			English	Article							BIODIVERSITY	The diversity and abundance of wild insect pollinators have declined in many agricultural landscapes. Whether such declines reduce crop yields, or are mitigated by managed pollinators such as honey bees, is unclear. We found universally positive associations of fruit set with flower visitation by wild insects in 41 crop systems worldwide. In contrast, fruit set increased significantly with flower visitation by honey bees in only 14% of the systems surveyed. Overall, wild insects pollinated crops more effectively; an increase in wild insect visitation enhanced fruit set by twice as much as an equivalent increase in honey bee visitation. Visitation by wild insects and honey bees promoted fruit set independently, so pollination by managed honey bees supplemented, rather than substituted for, pollination by wild insects. Our results suggest that new practices for integrated management of both honey bees and diverse wild insect assemblages will enhance global crop yields.	[Garibaldi, Lucas A.] UNRN, Mitre 630, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Garibaldi, Lucas A.] Consejo Nacl Invest Cient & Tecn, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Steffan-Dewenter, Ingolf; Holzschuh, Andrea] Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, D-97074 Wurzburg, Germany; [Winfree, Rachael; Benjamin, Faye; Cariveau, Daniel] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Aizen, Marcelo A.] Univ Nacl Comahue, CRUB, Lab Ecotono, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Aizen, Marcelo A.] Inst Invest Biodiversidad & Medioambiente INIBIOM, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Bommarco, Riccardo; Rundlof, Maj] Swedish Univ Agr Sci, Dept Ecol, SE-75007 Uppsala, Sweden; [Cunningham, Saul A.] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Kremen, Claire; Greenleaf, Sarah] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Carvalheiro, Luisa G.] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Carvalheiro, Luisa G.] Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands; [Harder, Lawrence D.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Afik, Ohad; Mandelik, Yael; Pisanty, Gideon] Hebrew Univ Jerusalem, Dept Entomol, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Bartomeus, Ignasi] Rutgers State Univ, Dept Entomol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Boreux, Virginie; Klein, Alexandra M.] Leuphana Univ, Inst Ecol, D-21335 Luneburg, Germany; [Boreux, Virginie; Ghazoul, Jaboury; Krishnan, Smitha] ETH, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland; [Chacoff, Natacha P.] Univ Nacl Tucuman, Inst Ecol Reg, Fac Ciencias Nat, RA-4017 Yerba Buena, Tucuman, Argentina; [Chacoff, Natacha P.] Univ Nacl Tucuman, IML, RA-4017 Yerba Buena, Tucuman, Argentina; [Dudenhoeffer, Jan H.] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [Freitas, Breno M.] Univ Fed Ceara, Dept Zootecnia CCA, BR-60356000 Fortaleza, Ceara, Brazil; [Hipolito, Juliana; Viana, Blandina F.] Univ Fed Bahia, Dept Zool, Inst Biol, BR-40170110 Salvador, BA, Brazil; [Howlett, Brad] New Zealand Inst Plant & Food Res, Christchurch, New Zealand; [Isaacs, Rufus] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Javorek, Steven K.] Agr & Agri Food Canada, Atlantic Food & Hort Res Ctr, Kentville, NS, Canada; [Kennedy, Christina M.] Nature Conservancy, Dev Design Program, Ft Collins, CO 80524 USA; [Krewenka, Kristin M.; Motzke, Iris; Tscharntke, Teja; Wanger, Thomas C.; Westphal, Catrin] Univ Gottingen, Dept Crop Sci, D-37077 Gottingen, Germany; [Mayfield, Margaret M.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Mayfield, Margaret M.] Univ Queensland, Ctr Ecol, Brisbane, Qld, Australia; [Munyuli, Theodore] DS Bukavu, CRSN Lwiro, Natl Ctr Res Nat Sci, Dept Biol, Sud Kivu, DEM REP CONGO; [Nault, Brian A.; Petersen, Jessica] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Potts, Simon G.] Univ Reading, Sch Agr Policy & Dev, Reading RG6 6AR, Berks, England; [Rader, Romina] Stockholm Univ, Dept Phys Geog & Quaternary Geol, SE-10691 Stockholm, Sweden; [Ricketts, Taylor H.] Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05401 USA; [Rundlof, Maj] Lund Univ, Dept Biol, SE-22362 Lund, Sweden; [Seymour, Colleen L.] South African Natl Inst Biodivers, Appl Biodivers Res Div, ZA-7735 Claremont, South Africa; [Schueepp, Christof] Univ Bern, Inst Ecol & Evolut, CH-3012 Bern, Switzerland; [Schueepp, Christof] Univ Koblenz Landau, D-76829 Landau, Germany; [Szentgyoergyi, Hajnalka] Jagiellonian Univ, Inst Environm Sci, PL-30387 Krakow, Poland; [Taki, Hisatomo] Forestry & Forest Prod Res Inst, Dept Forest Entomol, Tsukuba, Ibaraki 3058687, Japan; [Vergara, Carlos H.] Univ Americas Puebla, Dept Ciencias Quim Biol, Cholula, Mexico; [Williams, Neal] Univ Calif Davis, Dept Entomol, Davis, CA 96616 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Wurzburg; Rutgers State University New Brunswick; Universidad Nacional del Comahue; Swedish University of Agricultural Sciences; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California Berkeley; University of Leeds; Naturalis Biodiversity Center; University of Calgary; Hebrew University of Jerusalem; Rutgers State University New Brunswick; Leuphana University Luneburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidad Nacional de Tucuman; Universidad Nacional de Tucuman; Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; Universidade Federal do Ceara; Universidade Federal da Bahia; New Zealand Institute for Plant & Food Research Ltd; Michigan State University; Agriculture & Agri Food Canada; Nature Conservancy; University of Gottingen; University of Queensland; University of Queensland; Cornell University; University of Reading; Stockholm University; University of Vermont; Lund University; University of Bern; University of Koblenz & Landau; Jagiellonian University; Forestry & Forest Products Research Institute - Japan; Universidad Americas Puebla (UDLAP); University of California System; University of California Davis	Garibaldi, LA (corresponding author), UNRN, Mitre 630, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	lgaribaldi@unrn.edu.ar	Hipólito, Juliana/AAQ-1457-2020; Isaacs, Rufus/AAF-4646-2019; rader, romina/AAL-8067-2020; Westphal, Catrin/F-9560-2015; Carvalheiro, Luisa/D-9414-2012; Cunningham, Saul A/B-9947-2009; Howlett, Brad/F-1150-2018; Felipe Viana, Blandina Felipe/AAH-2606-2022; Freitas, Breno M/F-9509-2012; Potts, Simon/ABF-9221-2020; Szentgyörgyi, Hajnalka/AAK-2579-2020; Rader, Romina/X-6428-2019; Holzschuh, Andrea/X-8989-2018; Rundlöf, Maj/AAB-7401-2022; Viana, Blandina/M-6537-2013; Bommarco, Riccardo/E-7109-2016; Mayfield, Margaret M/B-7386-2012; Cariveau, Daniel/AAB-9336-2020; Potts, Simon G/C-7250-2008; Krishnan, Smitha/O-2282-2017; Klein, Alexandra-Maria/J-5871-2016; Tscharntke, Teja/N-5123-2014; Ghazoul, Jaboury/B-2121-2018; Harder, Lawrence/H-9715-2012; Chacoff, Natacha/K-7595-2019; Felipe Viana, Blandina Felipe/AFM-0275-2022; Garibaldi, Lucas A/D-7302-2013	Hipólito, Juliana/0000-0002-0721-3143; Isaacs, Rufus/0000-0001-7523-4643; Westphal, Catrin/0000-0002-2615-1339; Carvalheiro, Luisa/0000-0001-7655-979X; Cunningham, Saul A/0000-0003-0703-6893; Howlett, Brad/0000-0002-0694-135X; Felipe Viana, Blandina Felipe/0000-0002-4924-1257; Freitas, Breno M/0000-0002-9932-2207; Potts, Simon/0000-0002-2045-980X; Szentgyörgyi, Hajnalka/0000-0002-5753-800X; Rader, Romina/0000-0001-9056-9118; Holzschuh, Andrea/0000-0002-5235-4746; Rundlöf, Maj/0000-0003-3014-1544; Viana, Blandina/0000-0002-4924-1257; Bommarco, Riccardo/0000-0001-8888-0476; Mayfield, Margaret M/0000-0002-5101-6542; Potts, Simon G/0000-0002-2045-980X; Krishnan, Smitha/0000-0002-2851-6813; Klein, Alexandra-Maria/0000-0003-2139-8575; Harder, Lawrence/0000-0002-2303-5076; Chacoff, Natacha/0000-0002-1115-6989; Felipe Viana, Blandina Felipe/0000-0002-4924-1257; Otieno, Mark/0000-0002-8509-3298; Krewenka, Kristin/0000-0002-1913-1057; Garibaldi, Lucas Alejandro/0000-0003-0725-4049; Seymour, Colleen/0000-0002-6729-2576; Steffan-Dewenter, Ingolf/0000-0003-1359-3944; Dudenhoffer, Jan-Hendrik/0000-0003-1548-1436; Kennedy, Christina/0000-0001-8902-8728; Bartomeus, Ignasi/0000-0001-7893-4389; Aizen, Marcelo/0000-0001-9079-9749	Division Of Environmental Biology [0918442] Funding Source: National Science Foundation; Office Of The Director [1101317] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))		Aebil A, 2012, TRENDS ECOL EVOL, V27, P142, DOI 10.1016/j.tree.2011.11.017; Aizen MA, 2007, ECOLOGY, V88, P271, DOI 10.1890/06-1017; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chacoff NP, 2008, P ROY SOC B-BIOL SCI, V275, P907, DOI 10.1098/rspb.2007.1547; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Goodwin RM, 2011, NEW ZEAL J CROP HORT, V39, P7, DOI 10.1080/01140671.2010.520164; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein Alexandra-Maria, 2009, P195; Kremen C, 2011, CONSERV BIOL, V25, P607, DOI 10.1111/j.1523-1739.2011.01657.x; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Morris WF, 2010, ECOLOGY, V91, P1276, DOI 10.1890/08-2278.1; MORSE RA, 1991, TRENDS ECOL EVOL, V6, P337, DOI 10.1016/0169-5347(91)90043-W; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Roberts L, 2011, SCIENCE, V333, P540, DOI 10.1126/science.333.6042.540; Rucker RR, 2012, AM J AGR ECON, V94, P956, DOI 10.1093/ajae/aas031; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Wratten SD, 2012, AGR ECOSYST ENVIRON, V159, P112, DOI 10.1016/j.agee.2012.06.020	28	1329	1397	36	1416	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1608	+		10.1126/science.1230200	http://dx.doi.org/10.1126/science.1230200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23449997	Green Published, Green Submitted			2022-12-24	WOS:000316731600049
J	Raj, VS; Mou, HH; Smits, SL; Dekkers, DHW; Muller, MA; Dijkman, R; Muth, D; Demmers, JAA; Zaki, A; Fouchier, RAM; Thiel, V; Drosten, C; Rottier, PJM; Osterhaus, ADME; Bosch, BJ; Haagmans, BL				Raj, V. Stalin; Mou, Huihui; Smits, Saskia L.; Dekkers, Dick H. W.; Mueller, Marcel A.; Dijkman, Ronald; Muth, Doreen; Demmers, Jeroen A. A.; Zaki, Ali; Fouchier, Ron A. M.; Thiel, Volker; Drosten, Christian; Rottier, Peter J. M.; Osterhaus, Albert D. M. E.; Bosch, Berend Jan; Haagmans, Bart L.			Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC	NATURE			English	Article							ACUTE-RESPIRATORY-SYNDROME; ANGIOTENSIN-CONVERTING ENZYME-2; SARS CORONAVIRUS; AMINOPEPTIDASE-N; PATHOGENESIS; MECHANISMS; RESERVOIRS; BATS	Most human coronaviruses cause mild upper respiratory tract disease but may be associated with more severe pulmonary disease in immunocompromised individuals'. However, SARS coronavirus caused severe lower respiratory disease with nearly 10% mortality and evidence of systemic spread(2). Recently, another coronavirus (human coronavirus-Erasmus Medical Center (hCoV-EMC)) was identified in patients with severe and sometimes lethal lower respiratory tract infection(3,4). Viral genome analysis revealed close relatedness to coronaviruses found in bats'. Here we identify dipeptidyl peptidase 4 (DPP4; also known as CD26) as a functional receptor for hCoV-EMC. DPP4 specifically co-purified with the receptor-binding Si domain of the hCoV-EMC spike protein from lysates of susceptible Huh-7 cells. Antibodies directed against DPP4 inhibited hCoV-EMC infection of primary human bronchial epithelial cells and Huh-7 cells. Expression of human and bat (Pipistrellus pipistrellus) DPP4 in non-susceptible COS-7 cells enabled infection by hCoV-EMC. The use of the evolutionarily conserved DPP4 protein from different species as a functional receptor provides clues about the host range potential of hCoV-EMC. In addition, it will contribute critically to our understanding of the pathogenesis and epidemiology of this emerging human coronavirus, and may facilitate the development of intervention strategies.	[Raj, V. Stalin; Smits, Saskia L.; Fouchier, Ron A. M.; Osterhaus, Albert D. M. E.; Haagmans, Bart L.] Erasmus MC, Dept Virosci, NL-3000 CA Rotterdam, Netherlands; [Mou, Huihui; Rottier, Peter J. M.; Bosch, Berend Jan] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, NL-3508 TD Utrecht, Netherlands; [Smits, Saskia L.] Viroclin Biosci BV, NL-3029 AK Rotterdam, Netherlands; [Dekkers, Dick H. W.; Demmers, Jeroen A. A.] Erasmus MC, Prote Dept, NL-3000 CA Rotterdam, Netherlands; [Mueller, Marcel A.; Muth, Doreen; Drosten, Christian] Univ Bonn, Med Ctr, Inst Virol, D-53105 Bonn, Germany; [Dijkman, Ronald; Thiel, Volker] Kantonal Hosp St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland; [Zaki, Ali] Dr Soliman Fakeeh Hosp, Virol Lab, Jeddah, Saudi Arabia; [Thiel, Volker] Univ Zurich, Vetsuisse Fac, CH-8057 Zurich, Switzerland	Erasmus University Rotterdam; Erasmus MC; Utrecht University; Erasmus University Rotterdam; Erasmus MC; University of Bonn; Kantonsspital St. Gallen; University of Zurich	Bosch, BJ (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, NL-3508 TD Utrecht, Netherlands.	b.j.bosch@uu.nl; b.haagmans@erasmusmc.nl	Bosch, Berend/ABD-8740-2021; Haagmans, Bart/E-9791-2015; Fouchier, Ron A/A-1911-2014; Smits, Saskia/A-2953-2014; Demmers, Jeroen AA/F-4046-2016; Thiel, Volker/AAI-2391-2019; Müller, Marcel A./O-2425-2019; Raj, Victor Stalin/E-9670-2016	Haagmans, Bart/0000-0001-6221-2015; Fouchier, Ron A/0000-0001-8095-2869; Demmers, Jeroen AA/0000-0002-8757-9611; Müller, Marcel A./0000-0003-2242-5117; Thiel, Volker/0000-0002-5783-0887; Raj, Victor Stalin/0000-0003-2250-8481; Dijkman, Ronald/0000-0003-0320-2743; Osterhaus, Albert/0000-0002-6074-1172	European Union FP7 [223498]; ANTIGONE [278976]; Swiss National Science Foundation [31003A_132898]; 3R Research Foundation Switzerland [128-11]; German Research Foundation (DFG) [DR 772/3-1, KAl241/18-1]; German Ministry of Education and Research (BMBF SARS II)	European Union FP7(European Commission); ANTIGONE; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 3R Research Foundation Switzerland; German Research Foundation (DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF SARS II)(Federal Ministry of Education & Research (BMBF))	We thank E. Snijder for peoviding the anti-SARS-CoV NSP4 antibody, and E. Kindler, H. Jonsdottir, R. Rodriguez, T. Bestebroer, S. Pas, G. Arron, M. van Velzen and W. Ouwendijk for techn ical assistance. This work was supported by a fellowship from China Scholarship Council to H.M. The study was financed by the European Union FP7 project EMPERIE (contract number 223498), ANTIGONE (contract number 278976), the Swiss National Science Foundation (31003A_132898) and the 3R Research Foundation Switzerland (Project 128-11). C.D. was supported by the German Research Foundation (DFG grant DR 772/3-1, KAl241/18-1) and the German Ministry of Education and Research (BMBF SARS II).	Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; SCHULTZE B, 1992, J GEN VIROL, V73, P901, DOI 10.1099/0022-1317-73-4-901; Sims AC, 2008, VIRUS RES, V133, P33, DOI 10.1016/j.virusres.2007.03.013; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; World Health Organization, 2013, INT SURV REC HUM INF; Wu KL, 2012, J BIOL CHEM, V287, P8904, DOI 10.1074/jbc.M111.325803; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	23	1316	1413	4	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					251	254		10.1038/nature12005	http://dx.doi.org/10.1038/nature12005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486063	Green Published, Bronze			2022-12-24	WOS:000316652300054
J	Schmitz, RJ; Schultz, MD; Urich, MA; Nery, JR; Pelizzola, M; Libiger, O; Alix, A; McCosh, RB; Chen, HM; Schork, NJ; Ecker, JR				Schmitz, Robert J.; Schultz, Matthew D.; Urich, Mark A.; Nery, Joseph R.; Pelizzola, Mattia; Libiger, Ondrej; Alix, Andrew; McCosh, Richard B.; Chen, Huaming; Schork, Nicholas J.; Ecker, Joseph R.			Patterns of population epigenomic diversity	NATURE			English	Article							GENOME-WIDE ASSOCIATION; DNA METHYLATION; ARABIDOPSIS-THALIANA; EPIGENETIC MUTATION; NATURAL VARIATION; GENE; ELEMENTS; MODEL; DEMETHYLATION; PLANTS	Natural epigenetic variation provides a source for the generation of phenotypic diversity, but to understand its contribution to such diversity, its interaction with genetic variation requires further investigation. Here we report population-wide DNA sequencing of genomes, transcriptomes and methylomes of wild Arabidopsis thaliana accessions. Single cytosine methylation polymorphisms are not linked to genotype. However, the rate of linkage disequilibrium decay amongst differentially methylated regions targeted by RNA-directed DNA methylation is similar to the rate for single nucleotide polymorphisms. Association analyses of these RNA-directed DNA methylation regions with genetic variants identified thousands of methylation quantitative trait loci, which revealed the population estimate of genetically dependent methylation variation. Analysis of invariably methylated transposons and genes across this population indicates that loci targeted by RNA-directed DNA methylation are epigenetically activated in pollen and seeds, which facilitates proper development of these structures.	[Schmitz, Robert J.; Urich, Mark A.; Alix, Andrew; McCosh, Richard B.; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Schmitz, Robert J.; Schultz, Matthew D.; Urich, Mark A.; Nery, Joseph R.; Pelizzola, Mattia; Chen, Huaming; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Schultz, Matthew D.] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Libiger, Ondrej; Schork, Nicholas J.] Scripps Res Inst, Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Libiger, Ondrej; Schork, Nicholas J.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; Salk Institute	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	ecker@salk.edu	Schmitz, Robert/AAY-7659-2020; Nery, Joseph/AAE-8422-2019; Ecker, Joseph R/B-9144-2008	Schmitz, Robert/0000-0001-7538-6663; Nery, Joseph/0000-0003-0153-5659; Ecker, Joseph R/0000-0001-5799-5895; Schork, Nicholas/0000-0003-0920-5013; McCosh, Richard/0000-0003-2404-2603; Chen, Huaming/0000-0001-5289-7882; Pelizzola, Mattia/0000-0001-6672-9636	NIH [F32HG004830, K99GM100000]; NSF IGERT [DGE-0504645]; NIH/NCRR [UL1 RR025774]; NSF [MCB-0929402, MCB-1122246]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3034]; Div Of Molecular and Cellular Bioscience [1122246] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG004830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM100000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF IGERT(National Science Foundation (NSF)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Luo, R. Dowen and N. Krogan for critical reading of this manuscript; B. Coullahan for technical assistance with SOLiD RNA-seq; O. Loudet for seeds; and S. Ossowski, K. Schneeberger and D. Weigel for assistance in establishing a variant calling pipeline. R.J.S. was supported by NIH postdoctoral fellowships F32HG004830 and K99GM100000. M.D.S. was supported by an NSF IGERT training grant (DGE-0504645). O.L. and N.J.S. were supported by NIH/NCRR grant number UL1 RR025774. This work was supported by the NSF (MCB-0929402 and MCB-1122246), the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation (grant GBMF3034 to J.R.E.). J.R.E. is a HHMI-GBMF Investigator.	Ahmed I, 2011, NUCLEIC ACIDS RES, V39, P6919, DOI 10.1093/nar/gkr324; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; Calarco JP, 2012, CELL, V151, P194, DOI 10.1016/j.cell.2012.09.001; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Genereux DP, 2005, P NATL ACAD SCI USA, V102, P5802, DOI 10.1073/pnas.0502036102; Ibarra CA, 2012, SCIENCE, V337, P1360, DOI 10.1126/science.1224839; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schultz MD, 2012, TRENDS GENET, V28, P583, DOI 10.1016/j.tig.2012.10.012; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; Woo HR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-92; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	37	360	379	1	219	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					193	198		10.1038/nature11968	http://dx.doi.org/10.1038/nature11968			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23467092	Green Accepted, hybrid			2022-12-24	WOS:000316652300042
J	Bressan, M; Liu, G; Mikawa, T				Bressan, Michael; Liu, Gary; Mikawa, Takashi			Early Mesodermal Cues Assign Avian Cardiac Pacemaker Fate Potential in a Tertiary Heart Field	SCIENCE			English	Article							CELLS	Cardiac pacemaker cells autonomously generate electrical impulses that initiate and maintain the rhythmic contraction of the heart. Although the majority of heart cells are thought to originate from the primary and secondary heart fields, we found that chick pacemaker cells arise from a discrete region of mesoderm outside of these fields. Shortly after gastrulation, canonical Wnts promote the recruitment of mesodermal cells within this region into the pacemaker lineage. These findings suggest that cardiac pacemaker cells are physically segregated and molecularly programmed in a tertiary heart field prior to the onset of cardiac morphogenesis.	[Bressan, Michael; Liu, Gary; Mikawa, Takashi] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Mikawa, T (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	takashi.mikawa@ucsf.edu			NIH [R01HL093566, R01HL112268, T32HL007544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007544, R01HL093566, R01HL112268, R37HL078921] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank T. Kornberg, D. Stainier, S. Coughlin, and R. Shaw for their comments, and Mikawa lab members for their suggestions. All data reported in this paper can be found in the main text or supplementary materials. Supported by NIH grants R01HL093566 and R01HL112268 (T. M.) and T32HL007544 (M.B.).	Abu-Issa R, 2008, DEV BIOL, V319, P223, DOI 10.1016/j.ydbio.2008.04.014; Ammirabile G, 2012, CARDIOVASC RES, V93, P291, DOI 10.1093/cvr/cvr314; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hoff EC, 1939, AM HEART J, V17, P470, DOI 10.1016/S0002-8703(39)90597-1; KAMINO K, 1981, NATURE, V290, P595, DOI 10.1038/290595a0; Keith A, 1907, J ANAT PHYSIOL, V41, P172; LINTS TJ, 1993, DEVELOPMENT, V119, P419; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Manisastry SM, 2006, DEV DYNAM, V235, P2160, DOI 10.1002/dvdy.20878; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Mommersteeg MTM, 2007, CIRC RES, V100, P354, DOI 10.1161/01.RES.0000258019.74591.b3; Rawles Mary E., 1943, PHYSIOL ZOOL, V16, P22; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; STALSBERG H, 1969, DEV BIOL, V19, P128, DOI 10.1016/0012-1606(69)90052-9; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; VANMIEROP LH, 1967, AM J PHYSIOL, V212, P407, DOI 10.1152/ajplegacy.1967.212.2.407; Vinogradova TM, 2010, CIRC RES, V107, P767, DOI 10.1161/CIRCRESAHA.110.220517; Wang J, 2010, P NATL ACAD SCI USA, V107, P9753, DOI 10.1073/pnas.0912585107; Yuan SP, 2000, ANAT REC, V260, P204, DOI 10.1002/1097-0185(20001001)260:2<204::AID-AR90>3.0.CO;2-5	25	100	100	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					744	748		10.1126/science.1232877	http://dx.doi.org/10.1126/science.1232877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23519212	Green Accepted			2022-12-24	WOS:000318619000039
J	Meijer, HA; Kong, YW; Lu, WT; Wilczynska, A; Spriggs, RV; Robinson, SW; Godfrey, JD; Willis, AE; Bushell, M				Meijer, H. A.; Kong, Y. W.; Lu, W. T.; Wilczynska, A.; Spriggs, R. V.; Robinson, S. W.; Godfrey, J. D.; Willis, A. E.; Bushell, M.			Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Mediated Gene Regulation	SCIENCE			English	Article							DEADENYLATION; INITIATION; INHIBITION; CCR4-NOT; GW182	MicroRNAs (miRNAs) control gene expression through both translational repression and degradation of target messenger RNAs (mRNAs). However, the interplay between these processes and the precise molecular mechanisms involved remain unclear. Here, we show that translational inhibition is the primary event required for mRNA degradation. Translational inhibition depends on miRNAs impairing the function of the eIF4F initiation complex. We define the RNA helicase eIF4A2 as the key factor of eIF4F through which miRNAs function. We uncover a correlation between the presence of miRNA target sites in the 3' untranslated region (3'UTR) of mRNAs and secondary structure in the 5'UTR and show that mRNAs with unstructured 5'UTRs are refractory to miRNA repression. These data support a linear model for miRNA-mediated gene regulation in which translational repression via eIF4A2 is required first, followed by mRNA destabilization.	[Meijer, H. A.; Kong, Y. W.; Lu, W. T.; Wilczynska, A.; Spriggs, R. V.; Robinson, S. W.; Godfrey, J. D.; Willis, A. E.; Bushell, M.] MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester	Bushell, M (corresponding author), MRC, Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	mb446@le.ac.uk	Lu, Wei-Ting/N-9398-2013	Lu, Wei-Ting/0000-0002-1405-4806; Kong, Yi Wen/0000-0002-4223-971X; Willis, Anne/0000-0002-1470-8531; Wilczynska, Ania/0000-0003-4548-9367	MRC, UK; BBSRC [BB/F02326X/2, BB/F011806/2, BB/F019017/2, BB/F019017/1, BB/F011806/1] Funding Source: UKRI; MRC [MC_UP_A600_1024, MC_UP_A600_1023, MC_EX_G0902052] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019017/2, BB/B500915/1, BB/F019017/1, BB/F02326X/2, BB/F011806/1, BB/F011806/2] Funding Source: researchfish; Medical Research Council [MC_UP_A600_1023, MC_EX_G0902052, MC_UP_A600_1024] Funding Source: researchfish	MRC, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank E. Smith, M. Stoneley, T. Poyry, E. Jan, C. Jopling, T. Achsel, M. Hentze, and J. Pelletier for helpful comments and reagents. This work was funded by the MRC, UK. M. B. is an MRC Senior Fellow, and A. E. W. is a Biotechnology and Biological Sciences Research Council Professorial Fellow.	Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Cooke A, 2010, J BIOL CHEM, V285, P28506, DOI 10.1074/jbc.M110.150763; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Galicia-Vazquez G, 2012, RNA, V18, P1373, DOI 10.1261/rna.033209.112; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mishima Y, 2012, P NATL ACAD SCI USA, V109, P1104, DOI 10.1073/pnas.1113350109; Moretti F, 2012, NAT STRUCT MOL BIOL, V19, P603, DOI 10.1038/nsmb.2309; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Petit AP, 2012, NUCLEIC ACIDS RES, V40, P11058, DOI 10.1093/nar/gks883; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zdanowicz A, 2009, MOL CELL, V35, P881, DOI 10.1016/j.molcel.2009.09.009	20	236	251	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2013	340	6128					82	85		10.1126/science.1231197	http://dx.doi.org/10.1126/science.1231197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559250				2022-12-24	WOS:000317061100050
J	Cheng, L; Huang, Z; Zhou, WC; Wu, QL; Donnola, S; Liu, JK; Fang, XG; Sloan, AE; Mao, YB; Lathia, JD; Min, W; McLendon, RE; Rich, JN; Bao, SD				Cheng, Lin; Huang, Zhi; Zhou, Wenchao; Wu, Qiulian; Donnola, Shannon; Liu, James K.; Fang, Xiaoguang; Sloan, Andrew E.; Mao, Yubin; Lathia, Justin D.; Min, Wang; McLendon, Roger E.; Rich, Jeremy N.; Bao, Shideng			Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth	CELL			English	Article							ADHESION MOLECULE-1 PROMOTER; MESENCHYMAL DIFFERENTIATION; PROGENITOR CELLS; EXPRESSION; BRAIN; ANGIOGENESIS; ABNORMALITIES; LINEAGE; CLONING; CANCER	Glioblastomas (GBMs) are highly vascular and lethal brain tumors that display cellular hierarchies containing self-renewing tumorigenic glioma stem cells (GSCs). Because GSCs often reside in perivascular niches and may undergo mesenchymal differentiation, we interrogated GSC potential to generate vascular pericytes. Here, we show that GSCs give rise to pericytes to support vessel function and tumor growth. In vivo cell lineage tracing with constitutive and lineage-specific fluorescent reporters demonstrated that GSCs generate the majority of vascular pericytes. Selective elimination of GSC-derived pericytes disrupts the neovasculature and potently inhibits tumor growth. Analysis of human GBM specimens showed that most pericytes are derived from neoplastic cells. GSCs are recruited toward endothelial cells via the SDF-1/CXCR4 axis and are induced to become pericytes predominantly by transforming growth factor beta. Thus, GSCs contribute to vascular pericytes that may actively remodel perivascular niches. Therapeutic targeting of GSC-derived pericytes may effectively block tumor progression and improve antiangiogenic therapy.	[Cheng, Lin; Huang, Zhi; Zhou, Wenchao; Wu, Qiulian; Donnola, Shannon; Fang, Xiaoguang; Lathia, Justin D.; Rich, Jeremy N.; Bao, Shideng] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44195 USA; [Liu, James K.] Cleveland Clin, Dept Neurosurg, Cleveland, OH 44195 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Brain Tumor & Neurooncol Ctr, Univ Hosp, Cleveland, OH 44106 USA; [Mao, Yubin] Xiamen Univ, Dept Pathol, Coll Med, Xiamen 361005, Fujian, Peoples R China; [Min, Wang] Yale Univ, Dept Pathol, Sch Med, New Haven, CT 06520 USA; [McLendon, Roger E.] Duke Univ, Dept Pathol, Med Ctr, Durham, NC 27710 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; University Hospitals of Cleveland; Xiamen University; Yale University; Duke University	Bao, SD (corresponding author), Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44195 USA.	baos@ccf.org	Rich, Jeremy/AAM-1445-2021; Sloan, Andrew/AAE-9842-2020; Lathia, Justin/AHB-8296-2022; Fang, Xiaoguang/N-2313-2014; Zhou, Wenchao/ABE-9015-2020	Liu, James/0000-0002-1907-7150	Cleveland Clinic Foundation; National Institutes of Health [NS070315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070315] Funding Source: NIH RePORTER	Cleveland Clinic Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Brain Tumor and Neuro-Oncology Centers at Cleveland Clinic, University Hospitals, and Duke Medical Center for providing GBM specimens. We also thank Dr. Dolores Hambardzumyan for providing the genetically engineered mouse GBMs. We are grateful to Cathy Shemo at the Flow Cytometry Core and Judith Drazba at the Imaging Core for their help. This work was supported by the Cleveland Clinic Foundation and National Institutes of Health R01 grant NS070315 (to S.B.).	Almendro N, 1996, J IMMUNOL, V157, P5411; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DeCarvalho AC, 2010, STEM CELLS, V28, P181, DOI 10.1002/stem.264; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Ehtesham M, 2009, CANCER LETT, V274, P305, DOI 10.1016/j.canlet.2008.09.034; Folkins C, 2009, CANCER RES, V69, P7243, DOI 10.1158/0008-5472.CAN-09-0167; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Gerhardt H, 2000, DEV DYNAM, V218, P472, DOI 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#; Gumina RJ, 1997, BLOOD, V89, P1260, DOI 10.1182/blood.V89.4.1260; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Ii M, 2009, CIRC RES, V105, P860, DOI 10.1161/CIRCRESAHA.109.199299; Keogh MC, 1999, GENE THER, V6, P616, DOI 10.1038/sj.gt.3300866; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Komatani H, 2009, INT J ONCOL, V34, P665, DOI 10.3892/ijo_00000192; Kulla A, 2003, ACTA NEUROPATHOL, V105, P328, DOI 10.1007/s00401-003-0681-6; LI ZL, 1991, J BIOL CHEM, V266, P6562; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Morishita R, 2007, J NEUROCHEM, V101, P1031, DOI 10.1111/j.1471-4159.2006.04405.x; NAKANO Y, 1991, GENE, V99, P285; Norden AD, 2009, NAT REV NEUROL, V5, P610, DOI 10.1038/nrneurol.2009.159; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Ricci-Vitiani L, 2008, CELL DEATH DIFFER, V15, P1491, DOI 10.1038/cdd.2008.72; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rius C, 1998, BLOOD, V92, P4677; Rodriguez FJ, 2012, ONCOTARGET, V3, P98; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Song N, 2009, CANCER RES, V69, P6057, DOI 10.1158/0008-5472.CAN-08-2007; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	46	559	583	9	150	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					139	152		10.1016/j.cell.2013.02.021	http://dx.doi.org/10.1016/j.cell.2013.02.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540695	Green Accepted, Bronze			2022-12-24	WOS:000316853700012
J	Hanada, T; Weitzer, S; Mair, B; Bernreuther, C; Wainger, BJ; Ichida, J; Hanada, R; Orthofer, M; Cronin, SJ; Komnenovic, V; Minis, A; Sato, F; Mimata, H; Yoshimura, A; Tamir, I; Rainer, J; Kofler, R; Yaron, A; Eggan, KC; Woolf, CJ; Glatzel, M; Herbst, R; Martinez, J; Penninger, JM				Hanada, Toshikatsu; Weitzer, Stefan; Mair, Barbara; Bernreuther, Christian; Wainger, Brian J.; Ichida, Justin; Hanada, Reiko; Orthofer, Michael; Cronin, Shane J.; Komnenovic, Vukoslav; Minis, Adi; Sato, Fuminori; Mimata, Hiromitsu; Yoshimura, Akihiko; Tamir, Ido; Rainer, Johannes; Kofler, Reinhard; Yaron, Avraham; Eggan, Kevin C.; Woolf, Clifford J.; Glatzel, Markus; Herbst, Ruth; Martinez, Javier; Penninger, Josef M.			CLP1 links tRNA metabolism to progressive motor-neuron loss	NATURE			English	Article							3-END FORMATION; PHOSPHORYLATION; ENDONUCLEASE; STRESS; ENZYME; MOUSE; HCLP1; SITE; IA	CLP1 was the first mammalian RNA kinase to be identified. However, determining its in vivo function has been elusive. Here we generated kinase-dead Clp1 (Clp1(K/K)) mice that show a progressive loss of spinal motor neurons associated with axonal degeneration in the peripheral nerves and denervation of neuromuscular junctions, resulting in impaired motor function, muscle weakness, paralysis and fatal respiratory failure. Transgenic rescue experiments show that CLP1 functions in motor neurons. Mechanistically, loss of CLP1 activity results in accumulation of a novel set of small RNA fragments, derived from aberrant processing of tyrosine pre-transfer RNA. These tRNA fragments sensitize cells to oxidative-stress-induced p53 (also known as TRP53) activation and p53-dependent cell death. Genetic inactivation of p53 rescues Clp1(K/K) mice from the motor neuron loss, muscle denervation and respiratory failure. Our experiments uncover a mechanistic link between tRNA processing, formation of a new RNA species and progressive loss of lower motor neurons regulated by p53.	[Hanada, Toshikatsu; Weitzer, Stefan; Mair, Barbara; Hanada, Reiko; Orthofer, Michael; Komnenovic, Vukoslav; Martinez, Javier; Penninger, Josef M.] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Bernreuther, Christian; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, D-20246 Hamburg, Germany; [Wainger, Brian J.; Cronin, Shane J.; Woolf, Clifford J.] Boston Childrens Hosp, Program Neurobiol, Boston, MA 02115 USA; [Wainger, Brian J.; Cronin, Shane J.; Woolf, Clifford J.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Wainger, Brian J.] Massachusetts Gen Hosp, Department Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Ichida, Justin; Eggan, Kevin C.] Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Howard Hughes Med Inst, Boston, MA 02115 USA; [Minis, Adi; Yaron, Avraham] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Sato, Fuminori; Mimata, Hiromitsu] Oita Univ, Dept Urol, Fac Med, Oita 8795593, Japan; [Yoshimura, Akihiko] Keio Univ, Dept Microbiol & Immunol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Tamir, Ido] Campus Sci Support Facil GmbH, A-1030 Vienna, Austria; [Rainer, Johannes; Kofler, Reinhard] Med Univ Innsbruck, Div Mol Pathophysiol, Bioctr, A-6020 Innsbruck, Austria; [Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Herbst, Ruth] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute; Weizmann Institute of Science; Oita University; Keio University; Medical University of Innsbruck; Harvard University; Harvard Medical School; Medical University of Vienna	Martinez, J (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at; josef.penninger@imba.oeaw.ac.at	Wainger, Brian/L-7553-2017; Sato, Fuminori/O-4449-2015; Minis, Adi/AAJ-6098-2020; Woolf, Clifford/A-9784-2010; Glatzel, Markus/G-3356-2011; Penninger, Josef M/I-6860-2013; Eggan, Kevin/P-7119-2018; Yoshimura, Akihiko/K-5515-2013; Glatzel, Markus/V-8844-2019	Minis, Adi/0000-0001-8532-313X; Glatzel, Markus/0000-0002-7720-8817; Penninger, Josef M/0000-0002-8194-3777; Glatzel, Markus/0000-0002-7720-8817; Martinez, Javier/0000-0001-9152-7323; Mair, Barbara/0000-0001-6982-2529; Herbst, Ruth/0000-0002-7764-5363; Rainer, Johannes/0000-0002-6977-7147	Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA); Austrian Ministry of Sciences; Austrian Academy of Sciences; AustroMouse network of Genome Research in Austria (GEN-AU); Apoptosis systems biology applied to cancer and AIDS (ApoSys); European Research Council Advanced Grant from the European Union; IMBA; GEN-AU (AustroMouse); Japan Society for the Promotion of Science; Astellas Foundation; National Institutes of Health (NIH) [K99NS077435-01A1]; German Research Foundation (DFG) [FG885, GRK 1459]; Landesexzellenzinitiative Hamburg (Neurodapt); Austrian Science Fund [P19223, P21667]; NIH [NS038253]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS077435, R01NS038253, K99NS077435] Funding Source: NIH RePORTER	Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA); Austrian Ministry of Sciences; Austrian Academy of Sciences; AustroMouse network of Genome Research in Austria (GEN-AU); Apoptosis systems biology applied to cancer and AIDS (ApoSys); European Research Council Advanced Grant from the European Union; IMBA; GEN-AU (AustroMouse); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation(Astellas Pharmaceuticals); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); Landesexzellenzinitiative Hamburg (Neurodapt); Austrian Science Fund(Austrian Science Fund (FWF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Meixner, M. Foong, T. Nakashima, H. C. Theussl, J. R. Wojciechowski, A. Bichl, the mouse pathology unit of the Universitatsklinikum Hamburg-Eppendorf, and G. P. Resch for discussions and technical support. We also thank T. Buerckstuemmer for providing the pRV-NTAP vector. J. M. P. is supported by grants from the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), the Austrian Ministry of Sciences, the Austrian Academy of Sciences, AustroMouse network of Genome Research in Austria (GEN-AU), Apoptosis systems biology applied to cancer and AIDS (ApoSys) and a European Research Council Advanced Grant from the European Union. J. M., S. W. and B. M. are supported by IMBA and GEN-AU (AustroMouse). T. H. is supported by the Japan Society for the Promotion of Science and the Astellas Foundation. J. K. I. was supported by National Institutes of Health (NIH) grant K99NS077435-01A1. M. G. is supported by grants from the German Research Foundation (DFG) (FG885 and GRK 1459), the Landesexzellenzinitiative Hamburg (Neurodapt). R. H. was supported by the Austrian Science Fund (P19223, P21667). C. J. W. is supported by the NIH (NS038253).	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Atkin JD, 2005, NEUROMUSCULAR DISORD, V15, P377, DOI 10.1016/j.nmd.2005.02.005; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Ghazy MA, 2012, NUCLEIC ACIDS RES, V40, P1214, DOI 10.1093/nar/gkr801; Haddad R, 2012, NUCLEIC ACIDS RES, V40, P1226, DOI 10.1093/nar/gkr800; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Herbst R, 2009, NEUROMUSCULAR DISORD, V19, P366, DOI 10.1016/j.nmd.2009.02.011; Holbein S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029139; Hurto RL, 2011, ADV EXP MED BIOL, V722, P137, DOI 10.1007/978-1-4614-0332-6_9; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jain R, 2009, RNA, V15, P923, DOI 10.1261/rna.1492809; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Ramirez A, 2008, RNA, V14, P1737, DOI 10.1261/rna.1142908; Sanchez-Carbente MR, 2005, CELL DEATH DIFFER, V12, P279, DOI 10.1038/sj.cdd.4401560; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; Tuck AC, 2011, TRENDS GENET, V27, P422, DOI 10.1016/j.tig.2011.06.001; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410	27	150	159	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					474	480		10.1038/nature11923	http://dx.doi.org/10.1038/nature11923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23474986	Green Accepted			2022-12-24	WOS:000316682800038
J	Li, J; D'Angiolella, V; Seeley, ES; Kim, S; Kobayashi, T; Fu, WX; Campos, EI; Pagano, M; Dynlacht, BD				Li, Ji; D'Angiolella, Vincenzo; Seeley, E. Scott; Kim, Sehyun; Kobayashi, Tetsuo; Fu, Wenxiang; Campos, Eric I.; Pagano, Michele; Dynlacht, Brian David			USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110	NATURE			English	Article							LINDAU TUMOR-SUPPRESSOR; CHROMOSOMAL INSTABILITY; DRUG TARGETS; CELLS; ABNORMALITIES; DEGRADATION; CARCINOMA	Centrosome duplication is critical for cell division, and genome instability can result if duplication is not restricted to a single round per cell cycle. Centrosome duplication is controlled in part by CP110, a centriolar protein that positively regulates centriole duplication while restricting centriole elongation and ciliogenesis. Maintenance of normal CP110 levels is essential, as excessive CP110 drives centrosome over-duplication and suppresses ciliogenesis, whereas its depletion inhibits centriole amplification and leads to highly elongated centrioles and aberrant assembly of cilia in growing cells(1,2). CP110 levels are tightly controlled, partly through ubiquitination by the ubiquitin ligase complex SCFcyclin (F) during G2 and M phases of the cell cycle(3). Here, using human cells, we report a new mechanism for the regulation of centrosome duplication that requires USP33, a deubiquitinating enzyme that is able to regulate CP110 levels. USP33 interacts with CP110 and localizes to centrioles primarily in S and G2/M phases, the periods during which centrioles duplicate and elongate. USP33 potently and specifically deubiquitinates CP110, but not other cyclin-F substrates. USP33 activity antagonizes SCFcyclin F-mediated ubiquitination and promotes the generation of supernumerary centriolar foci, whereas ablation of USP33 destabilizes CP110 and thereby inhibits centrosome amplification and mitotic defects. To our knowledge, we have identified the first centriolar deubiquitinatimg enzyme whose expression regulates centrosome homeostasis by countering cyclin-F-mediated destruction of a key substrate. Our results point towards potential therapeutic strategies for inhibiting tumorigenesis associated with centrosome amplification.	[Li, Ji; D'Angiolella, Vincenzo; Kim, Sehyun; Kobayashi, Tetsuo; Fu, Wenxiang; Pagano, Michele; Dynlacht, Brian David] NYU, Sch Med, Smilow Res Ctr, Dept Pathol, New York, NY 10016 USA; [Li, Ji; D'Angiolella, Vincenzo; Kim, Sehyun; Kobayashi, Tetsuo; Fu, Wenxiang; Pagano, Michele; Dynlacht, Brian David] NYU, Sch Med, Smilow Res Ctr, Inst Canc, New York, NY 10016 USA; [Seeley, E. Scott] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Campos, Eric I.] NYU, Sch Med, Smilow Res Ctr, Dept Biochem, New York, NY 10016 USA; [Pagano, Michele] NYU, Sch Med, Smilow Res Ctr, Dept Pathol,Howard Hughes Med Inst, New York, NY 10016 USA	New York University; New York University; University of California System; University of California San Francisco; New York University; Howard Hughes Medical Institute; New York University	Dynlacht, BD (corresponding author), NYU, Sch Med, Smilow Res Ctr, Dept Pathol, 522 1st Ave, New York, NY 10016 USA.	Brian.Dynlacht@nyumc.org	Li, Ji/J-6026-2014	pagano, michele/0000-0003-3210-2442; Campos, Eric I./0000-0001-8152-3994	National Institutes of Health [5R01HD069647-02]; March of Dimes [FY11-432]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069647] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA076584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Hajdu, G. Miller, L. Chiriboga, H. Court, C. Zambirinis, E. Bekes, L Taylor, S. Krauter, M. Philips and D. Bar-Sagi for help with staining and analysis of pancreatic cancer samples. We thank F. Liang, Y. Deng, C. Petzold and K. Dancel for help with correlative electron microscopy. We thank J. Jastrab and S. Vijayakumar for initial experiments pertaining to the USP20-CP110 interaction. We thank J. Pollack for providing pancreatic cell lines. We thank G. Wu, S. Shenoy, R. Baer and T. Huang for providing plasmids. We thank members of the Dynlacht laboratory and T. Huang for advice. B.D.D. was supported by National Institutes of Health grant 5R01HD069647-02 and March of Dimes grant FY11-432. M.P. is an Investigator with the Howard Hughes Medical Institute.	Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Curcio-Morelli C, 2003, J CLIN INVEST, V112, P189, DOI 10.1172/JCI200318348; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Li J, 2012, EMBO REP, V13, P547, DOI 10.1038/embor.2012.40; Li ZB, 2002, BIOCHEM BIOPH RES CO, V294, P700, DOI 10.1016/S0006-291X(02)00534-X; Li ZB, 2002, J BIOL CHEM, V277, P4656, DOI 10.1074/jbc.M108269200; Sato N, 1999, CLIN CANCER RES, V5, P963; Sato N, 2001, CANCER GENET CYTOGEN, V126, P13, DOI 10.1016/S0165-4608(00)00384-8; Shono M, 2001, LAB INVEST, V81, P945, DOI 10.1038/labinvest.3780306; Sippl W, 2011, FUTURE ONCOL, V7, P619, DOI [10.2217/FON.11.39, 10.2217/fon.11.39]; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Thorne C, 2011, TRAFFIC, V12, P1563, DOI 10.1111/j.1600-0854.2011.01261.x	20	95	102	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					255	259		10.1038/nature11941	http://dx.doi.org/10.1038/nature11941			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486064	Green Accepted			2022-12-24	WOS:000316652300055
J	Winther, AML; Bublitz, M; Karlsen, JL; Moller, JV; Hansen, JB; Nissen, P; Buch-Pedersen, MJ				Winther, Anne-Marie L.; Bublitz, Maike; Karlsen, Jesper L.; Moller, Jesper V.; Hansen, John B.; Nissen, Poul; Buch-Pedersen, Morten J.			The sarcolipin-bound calcium pump stabilizes calcium sites exposed to the cytoplasm	NATURE			English	Article							SARCOPLASMIC-RETICULUM; CA-2+ PUMP; PHOSPHOLAMBAN; CA2+-ATPASE; CA2+; BINDING; MECHANISM; ATPASE; PHOSPHORYLATION; ASSOCIATION	The contraction and relaxation of muscle cells is controlled by the successive rise and fall of cytosolic Ca2+, initiated by the release of Ca2+ from the sarcoplasmic reticulum and terminated by re-sequestration of Ca2+ into the sarcoplasmic reticulum. as the main mechanism of Ca2+ removal. Re-sequestration requires active transport and is catalysed by the sarcoplasmic reticulum Ca2+-ATPase (SERCA), which has a key role in defining the contractile properties of skeletal and heart muscle tissue. The activity of SERCA is regulated by two small, homologous membrane proteins called phospholamban (PLB, also known as PLN) and sarcolipin (SLN)(1,2). Detailed structural information explaining this regulatory mechanism has been lacking, and the structural features defining the pathway through which cytoplasmic Ca2+ enters the intramembranous binding sites of SERCA have remained unknown. Here we report the crystal structure of rabbit SERCA1a (also known as ATP2A1) in complex with SLN at 3.1 angstrom resolution. The regulatory SLN traps the Ca2+-ATPase in a previously undescribed E1 state, with exposure of the Ca2+ sites through an open cytoplasmic pathway stabilized by Mg2+. The structure suggests a mechanism for selective Ca2+ loading and activation of SERCA, and provides new insight into how SLN and PLB inhibition arises from stabilization of this E1 intermediate state without bound Ca2+. These findings may prove useful in studying how autoinhibitory domains of other ion pumps modulate transport across biological membranes.	[Winther, Anne-Marie L.; Hansen, John B.; Buch-Pedersen, Morten J.] Pcovery, DK-1871 Frederiksberg, Denmark; [Winther, Anne-Marie L.; Bublitz, Maike; Karlsen, Jesper L.; Moller, Jesper V.; Nissen, Poul] Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPkin, DK-8000 Aarhus C, Denmark; [Winther, Anne-Marie L.; Bublitz, Maike; Karlsen, Jesper L.; Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Moller, Jesper V.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	Danmarks Grundforskningsfond; Aarhus University; Aarhus University	Nissen, P (corresponding author), Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPkin, DK-8000 Aarhus C, Denmark.	pn@mb.au.dk; mbp@pcovery.com		Bublitz, Maike/0000-0003-3161-418X; Lund Winther, Anne-Marie/0000-0002-5776-0989; Nissen, Poul/0000-0003-0948-6628	Danish Council for Independent Research (Technology and Production Sciences); Danish National Advanced Technology Foundation; ERC; Danish Research Council for Strategic Research	Danish Council for Independent Research (Technology and Production Sciences)(Det Frie Forskningsrad (DFF)); Danish National Advanced Technology Foundation; ERC(European Research Council (ERC)European Commission); Danish Research Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	We thank the staff at beamlines 911-3 at MaxLab and X06SA at the Swiss Light Source. We are grateful to N. Hogholm Jonassen, C. Olesen, B. Nielsen and A.-M. Nielsen for assistance with experimental procedures, and to H. Tidow and P. Gourdon for discussions on autoinhibition. We also thank P. Vangheluwe, H. Young, M. le Maire and E. Carafoli for discussions on PLB and SLN. A.-M.L.W. was supported by postdoctoral fellowships from the Danish Council for Independent Research (Technology and Production Sciences) and the Danish National Advanced Technology Foundation. P.N. is supported by an ERC advanced research grant (BIOMEMOS). Further support was obtained from the Fungalfight and Spotlight projects of the Danish Research Council for Strategic Research.	Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bhupathy P, 2009, J MOL CELL CARDIOL, V47, P723, DOI 10.1016/j.yjmcc.2009.07.014; Buffy JJ, 2006, J MOL BIOL, V358, P420, DOI 10.1016/j.jmb.2006.02.005; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; DUPONT Y, 1982, BIOCHIM BIOPHYS ACTA, V688, P75, DOI 10.1016/0005-2736(82)90580-6; Einholm AP, 2007, J BIOENERG BIOMEMBR, V39, P357, DOI 10.1007/s10863-007-9106-x; Fuzesi M, 2005, J BIOL CHEM, V280, P18291, DOI 10.1074/jbc.M500080200; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; HENDERSON IMJ, 1994, BIOCHEM J, V297, P625, DOI 10.1042/bj2970625; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Lamberth S, 2000, HELV CHIM ACTA, V83, P2141, DOI 10.1002/1522-2675(20000906)83:9<2141::AID-HLCA2141>3.0.CO;2-W; Mascioni A, 2002, BIOCHEMISTRY-US, V41, P475, DOI 10.1021/bi011243m; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Peinelt C, 2002, BIOPHYS J, V82, P170, DOI 10.1016/S0006-3495(02)75384-8; Smith GA, 2001, BIOCHEM J, V354, P539, DOI 10.1042/0264-6021:3540539; TADA M, 1989, BIOESSAYS, V10, P157, DOI 10.1002/bies.950100505; Tidow H, 2012, NATURE, V491, P468, DOI 10.1038/nature11539; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	30	147	153	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					265	269		10.1038/nature11900	http://dx.doi.org/10.1038/nature11900			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23455424				2022-12-24	WOS:000316652300057
J	Kacsoh, BZ; Lynch, ZR; Mortimer, NT; Schlenke, TA				Kacsoh, Balint Z.; Lynch, Zachary R.; Mortimer, Nathan T.; Schlenke, Todd A.			Fruit Flies Medicate Offspring After Seeing Parasites	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; ALCOHOL-DEHYDROGENASE; SELF-MEDICATION; CENTRAL COMPLEX; ETHANOL; RECEPTOR; CONSUMPTION; SIMULANS; MEMORY; SITES	Hosts have numerous defenses against parasites, of which behavioral immune responses are an important but underappreciated component. Here we describe a behavioral immune response that Drosophila melanogaster uses against endoparasitoid wasps. We found that when flies see wasps, they switch to laying eggs in alcohol-laden food sources that protect hatched larvae from infection. This change in oviposition behavior, mediated by neuropeptide F, is retained long after wasps are removed. Flies respond to diverse female larval endoparasitoids but not to males or pupal endoparasitoids, showing that they maintain specific wasp search images. Furthermore, the response evolved multiple times across the genus Drosophila. Our data reveal a behavioral immune response based on anticipatory medication of offspring and outline a nonassociative memory paradigm based on innate parasite recognition by the host.	[Kacsoh, Balint Z.; Lynch, Zachary R.; Mortimer, Nathan T.; Schlenke, Todd A.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Schlenke, TA (corresponding author), Emory Univ, Dept Biol, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	tschlen@emory.edu	Kacsoh, Balint/AAF-2165-2019	Kacsoh, Balint/0000-0001-9171-0611; Mortimer, Nathan/0000-0003-3787-9445; Schlenke, Todd/0000-0003-3091-3057; Lynch, Zachary/0000-0002-8802-3164	NIH [AI081879]; Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS Core Facilities [P30NS055077]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS Core Facilities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Shen for NPF antiserum; P. Shen, K. Moberg, and S. Sanyal for Drosophila strains; and J. van Alphen and B. Wertheim for wasp strains. This work was supported by NIH grant AI081879 to T. A. S. and the Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS Core Facilities grant, P30NS055077. Data are deposited in the Dryad Repository: http://dx.doi.org/10.5061/dryad.j5g7m.	Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; CHAWLA SS, 1981, CAN ENTOMOL, V113, P315, DOI 10.4039/Ent113315-4; de Roode Jacobus C., 2012, Insects, V3, P789, DOI 10.3390/insects3030789; ENGLAND BP, 1990, J BIOL CHEM, V265, P5086; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Fleury F, 2009, ADV PARASIT, V70, P3, DOI 10.1016/S0065-308X(09)70001-6; GIBSON JB, 1981, OECOLOGIA, V51, P191, DOI 10.1007/BF00540600; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; HARVEY PH, 1991, NATURE, V351, P619, DOI 10.1038/351619a0; Kacsoh BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034721; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Lefevre T, 2012, BIOL LETTERS, V8, P230, DOI 10.1098/rsbl.2011.0725; Lefevre T, 2010, ECOL LETT, V13, P1485, DOI 10.1111/j.1461-0248.2010.01537.x; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; MCKECHNIE SW, 1984, INSECT BIOCHEM, V14, P231, DOI 10.1016/0020-1790(84)90034-9; Menzel R, 1985, EXPT BEHAV ECOLOGY, P55; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; PARSONS PA, 1979, AUST J ZOOL, V27, P747, DOI 10.1071/ZO9790747; PIETREWICZ AT, 1979, SCIENCE, V204, P1332, DOI 10.1126/science.204.4399.1332; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; von Lintig J, 2001, P NATL ACAD SCI USA, V98, P1130, DOI 10.1073/pnas.031576398; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102	26	112	118	5	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					947	950		10.1126/science.1229625	http://dx.doi.org/10.1126/science.1229625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430653	Green Accepted			2022-12-24	WOS:000315149600046
J	Russell, AB; LeRoux, M; Hathazi, K; Agnello, DM; Ishikawa, T; Wiggins, PA; Wai, SN; Mougous, JD				Russell, Alistair B.; LeRoux, Michele; Hathazi, Krisztina; Agnello, Danielle M.; Ishikawa, Takahiko; Wiggins, Paul A.; Wai, Sun Nyunt; Mougous, Joseph D.			Diverse type VI secretion phospholipases are functionally plastic antibacterial effectors	NATURE			English	Article							COMPLETE GENOME SEQUENCE; PSEUDOMONAS-AERUGINOSA; MEMBRANE-LIPIDS; VIRULENCE; EXPRESSION; PROTEIN; SYSTEM; IDENTIFICATION; PREDICTION; SURVIVAL	Membranes allow the compartmentalization of biochemical processes and are therefore fundamental to life. The conservation of the cellular membrane, combined with its accessibility to secreted proteins, has made it a common target of factors mediating antagonistic interactions between diverse organisms. Here we report the discovery of a diverse superfamily of bacterial phospholipase enzymes. Within this superfamily, we defined enzymes with phospholipase A(1) and A(2) activity, which are common in host-cell-targeting bacterial toxins and the venoms of certain insects and reptiles(1,2). However, we find that the fundamental role of the superfamily is to mediate antagonistic bacterial interactions as effectors of the type VI secretion system (T6SS) translocation apparatus; accordingly, we name these proteins type VI lipase effectors. Our analyses indicate that PldA of Pseudomonas aeruginosa, a eukaryotic-like phospholipase D-3, is a member of the type VI lipase effector superfamily and the founding substrate of the haemolysin co-regulated protein secretion island II T6SS (H2-T6SS). Although previous studies have specifically implicated PldA and the H2-T6SS in pathogenesis(3-5), we uncovered a specific role for the effector and its secretory machinery in intra-and interspecies bacterial interactions. Furthermore, we find that this effector achieves its antibacterial activity by degrading phosphatidylethanolamine, the major component of bacterial membranes. The surprising finding that virulence-associated phospholipases can serve as specific antibacterial effectors suggests that interbacterial interactions are a relevant factor driving the continuing evolution of pathogenesis.	[Russell, Alistair B.; LeRoux, Michele; Agnello, Danielle M.; Mougous, Joseph D.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [LeRoux, Michele; Mougous, Joseph D.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Hathazi, Krisztina; Ishikawa, Takahiko; Wai, Sun Nyunt] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; [Hathazi, Krisztina; Ishikawa, Takahiko; Wai, Sun Nyunt] Umea Univ, Lab Mol Infect Med Sweden MIMS, SE-90187 Umea, Sweden; [Wiggins, Paul A.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Wiggins, Paul A.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Umea University; Umea University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mougous, JD (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	mougous@u.washington.edu		LeRoux, Michele/0000-0003-2075-4208; Russell, Alistair/0000-0002-5342-2309; Wiggins, Paul/0000-0002-8316-4339; Wai, Sun Nyunt/0000-0003-4793-4671	National Institutes of Health (NIH) [AI080609, AI057141, AI105268, GM07270]; Cystic Fibrosis Foundation [CFR565-CR07]; National Science Foundation [PHY-084845, MCB-1151043, DGE-0718124]; Swedish Research Council [2010-3073, 2007-8673 UCMR Linnaeus, 2006-7431 MIMS]; Faculty of Medicine, Umea University; University of Washington Royalty Research Fund; Sloan Foundation; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141, R01AI080609, R21AI105268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Science Foundation(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Faculty of Medicine, Umea University; University of Washington Royalty Research Fund(University of Washington); Sloan Foundation(Alfred P. Sloan Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Kulasekara, B. E. Uhlin and members of the Mougous and Wai laboratories for discussions, J. Woodward for sharing chemistry expertise, the Manoil laboratory for sharing B. thailandensis transposon mutants, and the Parsek laboratory and K. Korotkov for sharing reagents. This work was supported by grants from the National Institutes of Health (NIH) (AI080609, AI057141 and AI105268), Cystic Fibrosis Foundation (CFR565-CR07), the National Science Foundation (PHY-084845 and MCB-1151043), the Swedish Research Council (2010-3073, 2007-8673 UCMR Linnaeus and 2006-7431 MIMS), and the Faculty of Medicine, Umea University. A. B. R. was supported by a Graduate Research Fellowship from the National Science Foundation (DGE-0718124), M. L. was supported by the NIH Cellular and Molecular Training Grant (GM07270), P. A. W. received support from the University of Washington Royalty Research Fund and the Sloan Foundation, and J. D. M. holds an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Aloulou A, 2012, METHODS MOL BIOL, V861, P63, DOI 10.1007/978-1-61779-600-5_4; Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Barret M, 2011, MICROBIOL-SGM, V157, P1726, DOI 10.1099/mic.0.048645-0; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Chandler JR, 2009, J BACTERIOL, V191, P5901, DOI 10.1128/JB.00591-09; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hsu FS, 2009, MOL MICROBIOL, V72, P1111, DOI 10.1111/j.1365-2958.2009.06701.x; Imperi F, 2009, PROTEOMICS, V9, P1901, DOI 10.1002/pmic.200800618; Ishikawa T, 2012, INFECT IMMUN, V80, P575, DOI 10.1128/IAI.05510-11; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim HS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-174; Korotkov K. V., 2013, J STRUCT BIOL; LeRoux M, 2012, P NATL ACAD SCI USA, V109, P19804, DOI 10.1073/pnas.1213963109; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Mougous JD, 2004, NAT STRUCT MOL BIOL, V11, P721, DOI 10.1038/nsmb802; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sana TG, 2012, J BIOL CHEM, V287, P27095, DOI 10.1074/jbc.M112.376368; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schmiel DH, 1999, MICROBES INFECT, V1, P1103, DOI 10.1016/S1286-4579(99)00205-1; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Termine E, 2009, INT MICROBIOL, V12, P7, DOI 10.2436/20.1501.01.76; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Valeru SP, 2009, INFECT IMMUN, V77, P935, DOI 10.1128/IAI.00929-08; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; VONTIGERSTROM RG, 1989, CAN J MICROBIOL, V35, P511, DOI 10.1139/m89-079; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wilderman PJ, 2001, MOL MICROBIOL, V39, P291, DOI 10.1046/j.1365-2958.2001.02282.x; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998	48	243	249	4	142	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					508	+		10.1038/nature12074	http://dx.doi.org/10.1038/nature12074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23552891	Green Accepted			2022-12-24	WOS:000317984400042
J	Pernigo, S; Lamprecht, A; Steiner, RA; Dodding, MP				Pernigo, Stefano; Lamprecht, Anneri; Steiner, Roberto A.; Dodding, Mark P.			Structural Basis for Kinesin-1: Cargo Recognition	SCIENCE			English	Article							LIGHT-CHAIN; DYNEIN; TRANSPORT; PROTEINS; SEQUENCE; AVIDITY; BINDING	Kinesin-mediated cargo transport is required for many cellular functions and plays a key role in pathological processes. Structural information on how kinesins recognize their cargoes is required for a molecular understanding of this fundamental and ubiquitous process. Here, we present the crystal structure of the tetratricopeptide repeat domain of kinesin light chain 2 in complex with a cargo peptide harboring a "tryptophan-acidic" motif derived from SKIP (SifA-kinesin interacting protein), a critical host determinant in Salmonella pathogenesis and a regulator of lysosomal positioning. Structural data together with biophysical, biochemical, and cellular assays allow us to propose a framework for intracellular transport based on the binding by kinesin-1 of W-acidic cargo motifs through a combination of electrostatic interactions and sequence-specific elements, providing direct molecular evidence of the mechanisms for kinesin-1: cargo recognition.	[Pernigo, Stefano; Lamprecht, Anneri; Steiner, Roberto A.; Dodding, Mark P.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; King's College London	Steiner, RA (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England.	roberto.steiner@kcl.ac.uk; mark.dodding@kcl.ac.uk	Steiner, Roberto/AAZ-9582-2021	Steiner, Roberto/0000-0001-7084-9745; Dodding, Mark/0000-0001-8091-6534	Wellcome Trust; London Law Trust; British Heart Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); London Law Trust; British Heart Foundation(British Heart Foundation)	Scientists of I24 beamline (Diamond Light Source, Didcot, UK) are gratefully acknowledged for their support during data collection. ARL8b-HA and myc-SKIP were a kind gift from S. Munro, (Laboratory of Molecular Biology-Medical Research Council, Cambridge). We thank T. Blundell and R. Nookala (University of Cambridge) for useful discussions. Coordinates and structure factor files for have been deposited in the Protein Data Bank under accession number 3ZFW. The authors declare no competing financial interests. M.P.D and A.L. are supported by a Wellcome Trust Research Career Development Fellowship to M.P.D. and a London Law Trust Medal Fellowship to M.P.D. S.P. is supported by a British Heart Foundation grant awarded to R.A.S.	Aoyama T, 2009, J CELL SCI, V122, P4177, DOI 10.1242/jcs.048579; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dodding MP, 2011, EMBO J, V30, P4523, DOI 10.1038/emboj.2011.326; Dodding MP, 2011, EMBO J, V30, P3527, DOI 10.1038/emboj.2011.283; Gindhart Joseph G., 2006, Briefings in Functional Genomics & Proteomics, V5, P74, DOI 10.1093/bfgp/ell002; Hammond JW, 2008, TRAFFIC, V9, P725, DOI 10.1111/j.1600-0854.2008.00722.x; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Kawano T, 2012, TRAFFIC, V13, P834, DOI 10.1111/j.1600-0854.2012.01350.x; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; Mack ET, 2012, J AM CHEM SOC, V134, P333, DOI 10.1021/ja2073033; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Morgan GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000785; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Radnai L, 2010, J BIOL CHEM, V285, P38649, DOI 10.1074/jbc.M110.165894; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Zhu HZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033943	21	56	59	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					356	359		10.1126/science.1234264	http://dx.doi.org/10.1126/science.1234264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23519214	Green Accepted			2022-12-24	WOS:000317657500057
J	Bell, KJL; Hayen, A; Irwig, L; Takahashi, O; Ohde, S; Glasziou, P				Bell, Katy J. L.; Hayen, Andrew; Irwig, Les; Takahashi, Osamu; Ohde, Sachiko; Glasziou, Paul			When to remeasure cardiovascular risk in untreated people at low and intermediate risk: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To estimate the probability of becoming high risk for cardiovascular disease among people at low and intermediate risk and not being treated for high blood pressure or lipid levels. Design Observational study. Setting General communities in Japan and the United States. Participants 13 757 participants of the Tokyo health check-up study and 3855 of the Framingham studies aged 30-74 years with complete data on risk equation covariates, not receiving blood pressure or cholesterol lowering treatment, and with an estimated risk of cardiovascular disease <20% within 10 years. We stratified participants on the basis of baseline risk: <5%, 5-<10%, 10-<15%, and15-<20%. We used follow-up measurements from the Tokyo study done annually over three years (2006-10) and follow-up visits in the Framingham study done between eight (1968-75) and 19 years (1990-1995) after baseline. Main outcome measure Estimated 10 year risk of a cardiovascular event >20% using the Framingham equation. Results At baseline most participants had <5% risk (60.6% of Tokyo cohort and 45.7% of Framingham cohort) or 5-<10% risk (24.0% and 28.0%, respectively) of a cardiovascular event within 10 years. There was <10% probability of crossing the treatment threshold at 19, 8, and 3 years for baseline risk groups <5%, 5-<10%, and 10-<15%, respectively, and >10% probability of crossing the treatment threshold at one year for the 15-<20% baseline risk group. Conclusions Decisions on the frequency of remeasuring for cardiovascular risk should be made on the basis of baseline risk. Repeat risk estimation before 8-10 years is not warranted for most people initially not requiring treatment. However, remeasurement within a year seems warranted in those with an initial 15-<20% risk.	[Bell, Katy J. L.; Glasziou, Paul] Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia; [Hayen, Andrew] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; [Irwig, Les] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; [Takahashi, Osamu; Ohde, Sachiko] St Lukes Life Sci Inst, Ctr Clin Epidemiol, Tokyo, Japan; [Takahashi, Osamu] St Lukes Int Hosp, Tokyo, Japan	Bond University; University of New South Wales Sydney; University of Sydney; St. Luke's International Hospital	Bell, KJL (corresponding author), Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia.	katy.bell@sydney.edu.au	Glasziou, Paul/A-7832-2008; Bell, Katy/B-9650-2013; Ohde, Sachiko/AAC-6496-2019	Glasziou, Paul/0000-0001-7564-073X; Bell, Katy/0000-0002-0137-3218; Ohde, Sachiko/0000-0001-9137-0047; Hayen, Andrew/0000-0003-4046-8030	Australian National Health and Medical Research Council [633003, APP1013390]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study received no specific funding. The authors have received funding from the Australian National Health and Medical Research Council (Program Grant No 633003, Early Career Fellowship No. APP1013390). The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Cupples LA, 1987, FRAMINGHAM HEART STU; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Glasziou PP, 2008, ANN INTERN MED, V148, P656, DOI 10.7326/0003-4819-148-9-200805060-00005; Graham I, 2007, EUR J CARDIOV PREV R, V14, pE1, DOI 10.1097/01.hjr.0000277984.31558.c4; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Keenan K, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1492; National Heart Lung and Blood Institute, 2011, CARD RISK RED GUID A; National Vascular Disease Prevention Alliance, 2009, GUID ASS ABS CARD DI; National Vascular Disease Prevention Alliance (NVDPA), 2012, GUIDELINES MANAGEMEN; New Zealand Guideline Group, 2003, ASS MAN CARD RISK; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Scottish Intercollegiate Guidelines Network, 2007, RISK EST PREV CARD D; Takahashi O, 2012, J HUM HYPERTENS, V26, P540, DOI 10.1038/jhh.2011.72; Takahashi O, 2010, DIABETES CARE, V33, P2016, DOI 10.2337/dc10-0588; Takahashi O, 2010, HEART, V96, P448, DOI 10.1136/hrt.2009.172619; US Department of Health and Human Services National Institutes of Health National Institutes of Diabetes and Digestive and Kidney diseases, 2011, DIAGN DIAB; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; World Health Organization, 2007, PREV CARD DIS GUID A	20	15	15	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2013	346								f1895	10.1136/bmj.f1895	http://dx.doi.org/10.1136/bmj.f1895			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122SG	23553971	Green Published, hybrid			2022-12-24	WOS:000317337800001
J	Kadoch, C; Crabtree, GR				Kadoch, Cigall; Crabtree, Gerald R.			Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial Sarcoma	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; NEURAL DEVELOPMENT; SWI/SNF COMPLEXES; SOFT-TISSUE; GENES; SYT; POLYCOMB; GENOME; CELLS; SSX	Recent exon sequencing studies have revealed that over 20% of human tumors have mutations in subunits of mSWI/SNF (BAF) complexes. To investigate the underlying mechanism, we studied human synovial sarcoma (SS), in which transformation results from the translocation of exactly 78 amino acids of SSX to the SS18 subunit of BAF complexes. We demonstrate that the SS18-SSX fusion protein competes for assembly with wild-type SS18, forming an altered complex lacking the tumor suppressor BAF47 (hSNF5). The altered complex binds the Sox2 locus and reverses polycomb-mediated repression, resulting in Sox2 activation. Sox2 is uniformly expressed in SS tumors and is essential for proliferation. Increasing the concentration of wild-type SS18 leads to reassembly of wild-type complexes retargeted away from the Sox2 locus, polycomb-mediated repression of Sox2, and cessation of proliferation. This mechanism of transformation depends on only two amino acids of SSX, providing a potential foundation for therapeutic intervention.	[Kadoch, Cigall] Stanford Univ, Program Canc Biol, Sch Med, Stanford, CA 94305 USA; [Kadoch, Cigall; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Kadoch, Cigall; Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Kadoch, Cigall; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	crabtree@stanford.edu		Crabtree, Robert/0000-0002-6639-8707	National Institutes of Health (NIH) [HD55391, RO1NS046789, R01CA163195]; National Science Foundation (Graduate Research Fellowship Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA163915, T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (Graduate Research Fellowship Program)(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the National Institutes of Health (NIH) (HD55391, RO1NS046789, and R01CA163195) (to G.R.C.). G.R.C. is an Investigator of the Howard Hughes Medical Institute. C.K. is supported by the National Science Foundation (Graduate Research Fellowship Program). The authors are grateful to Kazuyuki Itoh, Norifume Naka, and Satoshi Takenaka (Osaka University, Japan) for kindly providing the Aska-SS and Yamato-SS cell lines and cDNA clone of the SS18-SSX fusion. We are also grateful to Clara Lee for technical assistance and N. Hathaway, O. Bell, A. Shalizi, and J. Ronan for helpful discussions and their critical review of the manuscript.	Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Brodin B, 2001, GENE, V268, P173, DOI 10.1016/S0378-1119(01)00412-7; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; DELEEUW B, 1995, HUM MOL GENET, V4, P1097, DOI 10.1093/hmg/4.6.1097; dosSantos NR, 1997, HUM MOL GENET, V6, P1549, DOI 10.1093/hmg/6.9.1549; Garcia CB, 2012, ONCOGENE, V31, P2323, DOI 10.1038/onc.2011.418; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hiraga H, 1998, DIAGN MOL PATHOL, V7, P102, DOI 10.1097/00019606-199804000-00007; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; LIMON J, 1991, GENE CHROMOSOME CANC, V3, P338, DOI 10.1002/gcc.2870030504; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Naka N, 2010, STEM CELLS, V28, P1119, DOI 10.1002/stem.452; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Sandberg AA, 2002, CANCER GENET CYTOGEN, V132, P1, DOI 10.1016/S0165-4608(01)00528-3; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Smith HA, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/150591; Takenaka S, 2010, INT J ONCOL, V36, P823, DOI 10.3892/ijo_00000559; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tea JS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-5; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; WEISS SW, 2001, ENZINGER WEISSS SOFT; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	44	289	300	4	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					71	85		10.1016/j.cell.2013.02.036	http://dx.doi.org/10.1016/j.cell.2013.02.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540691	Green Accepted, Bronze			2022-12-24	WOS:000316853700007
J	Shnyrova, AV; Bashkirov, PV; Akimov, SA; Pucadyil, TJ; Zimmerberg, J; Schmid, SL; Frolov, VA				Shnyrova, Anna V.; Bashkirov, Pavel V.; Akimov, Sergey A.; Pucadyil, Thomas J.; Zimmerberg, Joshua; Schmid, Sandra L.; Frolov, Vadim A.			Geometric Catalysis of Membrane Fission Driven by Flexible Dynamin Rings	SCIENCE			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; CONSTRICTION; REVEALS; FUSION; SHAPE	Biological membrane fission requires protein-driven stress. The guanosine triphosphatase (GTPase) dynamin builds up membrane stress by polymerizing into a helical collar that constricts the neck of budding vesicles. How this curvature stress mediates nonleaky membrane remodeling is actively debated. Using lipid nanotubes as substrates to directly measure geometric intermediates of the fission pathway, we found that GTP hydrolysis limits dynamin polymerization into short, metastable collars that are optimal for fission. Collars as short as two rungs translated radial constriction to reversible hemifission via membrane wedging of the pleckstrin homology domains (PHDs) of dynamin. Modeling revealed that tilting of the PHDs to conform with membrane deformations creates the low-energy pathway for hemifission. This local coordination of dynamin and lipids suggests how membranes can be remodeled in cells.	[Shnyrova, Anna V.; Frolov, Vadim A.] Univ Basque Country, CSIC, Biophys Unit, Leioa, Spain; [Shnyrova, Anna V.; Frolov, Vadim A.] Univ Basque Country, Dept Biochem & Mol Biol, Leioa, Spain; [Bashkirov, Pavel V.; Akimov, Sergey A.] Russian Acad Sci, AN Frumkin Inst Phys Chem & Electrochem, Moscow 119071, Russia; [Akimov, Sergey A.] Natl Univ Sci & Technol MISiS, Moscow 119049, Russia; [Pucadyil, Thomas J.] Indian Inst Sci Educ & Res, Pune, Maharashtra, India; [Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Schmid, Sandra L.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Frolov, Vadim A.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Russian Academy of Sciences; Frumkin Institute of Physical Chemistry & Electrochemistry; National University of Science & Technology (MISIS); Indian Institute of Science Education & Research (IISER) Pune; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Texas System; University of Texas Southwestern Medical Center Dallas; Basque Foundation for Science	Frolov, VA (corresponding author), Univ Basque Country, CSIC, Biophys Unit, Leioa, Spain.	vadim.frolov@ehu.es	Frolov, Vadim/ABH-3889-2020; Bashkirov, Pavel V/Y-8464-2018; Akimov, Sergey A/L-2001-2013; Akimov, Sergey/AFV-4270-2022; Akimov, Sergey A./I-6432-2015; Pucadyil, Thomas/AAJ-3974-2020	Frolov, Vadim/0000-0002-0653-5669; Akimov, Sergey/0000-0002-7916-6032; Pucadyil, Thomas/0000-0002-2907-9889; Schmid, Sandra/0000-0002-1690-7024; Bashkirov, Pavel/0000-0003-2250-9759; Shnyrova, Anna/0000-0002-5329-348X	Spanish Ministry of Economy and Competitiveness [BFU2012-34885]; Basque Government [IE12-332]; Russian Foundation for Basic Research [11-04-02087]; Russian Academy of Science; Ministry of Education and Science of the Russian Federation [14.740.11.1409]; National Institute of Child Health and Human Development; NIH [GM42455]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER	Spanish Ministry of Economy and Competitiveness(Spanish Government); Basque Government(Basque Government); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Science(Russian Academy of Sciences); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Rizo-Rey and P. Kuzmin for critical reading of the manuscript. This work was in part supported by Spanish Ministry of Economy and Competitiveness grant BFU2012-34885 (V.A.F.); the Basque Government Program Etortek, grant IE12-332 (V.A.F); Russian Foundation for Basic Research grant 11-04-02087 (P.V.B.); the Russian Academy of Science program "Molecular and Cell Biology" (P.V.B. and S.A.A.); the Ministry of Education and Science of the Russian Federation, grant 14.740.11.1409 (P.V.B.); the Intramural Program of the National Institute of Child Health and Human Development (J.Z); and NIH grant GM42455 (S.L.S.). Additional data are presented in the supplementary materials.	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Frolov VA, 2003, P NATL ACAD SCI USA, V100, P8698, DOI 10.1073/pnas.1432962100; Frolov VA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004747; Frolov VA, 2010, FEBS LETT, V584, P1824, DOI 10.1016/j.febslet.2010.01.039; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; LEIKIN SL, 1987, J THEOR BIOL, V129, P411, DOI 10.1016/S0022-5193(87)80021-8; Mattheyses AL, 2011, TRAFFIC, V12, P1394, DOI 10.1111/j.1600-0854.2011.01235.x; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2011, CURR TOP MEMBR, V68, P33, DOI 10.1016/B978-0-12-385891-7.00002-7; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramachandran R, 2009, MOL BIOL CELL, V20, P4630, DOI 10.1091/mbc.E09-08-0683; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Shlomovitz R, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/065008; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354	28	92	93	1	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1433	1436		10.1126/science.1233920	http://dx.doi.org/10.1126/science.1233920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520112	Green Accepted			2022-12-24	WOS:000316740700043
J	Ding, L; Morrison, SJ				Ding, Lei; Morrison, Sean J.			Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches	NATURE			English	Article							B-CELL; STEM/PROGENITOR CELLS; CRE RECOMBINASE; FACTOR-I; MICE; IDENTIFICATION; LYMPHOPOIESIS; OSTEOBLASTS; MAINTENANCE; EXPRESSION	Although haematopoietic stem cells (HSCs) are commonly assumed to reside within a specialized microenvironment, or niche(1), most published experimental manipulations of the HSC niche have affected the function of diverse restricted progenitors. This raises the fundamental question, of whether HSCs1 and restricted progenitors(2,3) reside within distinct, specialized niches or whether they share a common niche. Here we assess the physiological sources of the chemokine CXCL12 for HSC and restricted progenitor maintenance. Cxcl12(DsRed) knock-in mice (DsRed-Express2 recombined into the Cxcl12 locus) showed that Cxcl12 was primarily expressed by perivascular stromal cells and, at lower levels, by endothelial cells, osteoblasts and some haematopoietic cells. Conditional deletion of Cxcl12 from haematopoietic cells or nestin-cre-expressing cells had little or no effect on HSCs or restricted progenitors. Deletion of Cxcl12 from endothelial cells depleted HSCs but not myeloerythroid or lymphoid progenitors. Deletion of Cxcl12 from perivascular stromal cells depleted HSCs and certain restricted progenitors and mobilized these cells into circulation. Deletion of Cxcl12 from osteoblasts depleted certain early lymphoid progenitors but not HSCs or myeloerythroid progenitors, and did not mobilize these cells into circulation. Different stem and progenitor cells thus reside in distinct cellular niches in bone marrow: HSCs occupy a perivascular niche and early lymphoid progenitors occupy an endosteal niche.	[Ding, Lei; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Childrens Res Inst, Howard Hughes Med Inst, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Childrens Res Inst, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	sean.morrison@utsouthwestern.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute (HHMI); US National Heart, Lung and Blood Institute [5R01-HL097760]; Helen Hay Whitney Foundation; HHMI; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097760] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); US National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Helen Hay Whitney Foundation; HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Howard Hughes Medical Institute (HHMI) and the US National Heart, Lung and Blood Institute (5R01-HL097760). L.D. was supported by a Helen Hay Whitney Foundation Fellowship and by the HHMI. We thank M. White and D. Adams for flow cytometry, E. Hughes and T. Saunders at the University of Michigan transgenic core for helping to generate Cxcl12<SUP>DsRed</SUP> and Cxcl12<SUP>fl</SUP> mice, and S. Grove, R. Coolon, S. Manning, M. Gross and K. Correll for managing the mouse colony.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Greenbaum A., 2013, NATURE; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	30	788	816	7	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					231	235		10.1038/nature11885	http://dx.doi.org/10.1038/nature11885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23434755	Green Accepted			2022-12-24	WOS:000316652300050
J	Niehuis, O; Buellesbach, J; Gibson, JD; Pothmann, D; Hanner, C; Mutti, NS; Judson, AK; Gadau, J; Ruther, J; Schmitt, T				Niehuis, Oliver; Buellesbach, Jan; Gibson, Joshua D.; Pothmann, Daniela; Hanner, Christian; Mutti, Navdeep S.; Judson, Andrea K.; Gadau, Juergen; Ruther, Joachim; Schmitt, Thomas			Behavioural and genetic analyses of Nasonia shed light on the evolution of sex pheromones	NATURE			English	Article							WASP; BIOSYNTHESIS; GENOMES	Sex pheromones play a pivotal role in the communication of many sexually reproducing organisms(1). Accordingly, speciation is often accompanied by pheromone diversification enabling proper mate finding and recognition(2). Current theory implies that chemical signals are under stabilizing selection by the receivers who thereby maintain the integrity of the signals(3). How the tremendous diversity of sex pheromones seen today evolved is poorly understood(4,5). Here we unravel the genetics of a newly evolved pheromone phenotype in wasps and present results from behavioural experiments indicating how the evolution of a new pheromone component occurred in an established sender-receiver system. We show that male Nasonia vitripennis evolved an additional pheromone compound differing only in its stereochemistry from a pre-existing one. Comparative behavioural studies show that conspecific females responded neutrally to the new pheromone phenotype when it evolved. Genetic mapping and gene knockdown show that a cluster of three closely linked genes accounts for the ability to produce this new pheromone phenotype. Our data suggest that new pheromone compounds can persist in a sender's population, without being selected against by the receiver and without the receiver having a pre-existing preference for the new pheromone phenotype, by initially remaining unperceived. Out results thus contribute valuable new insights into the evolutionary mechanisms underlying the diversification of sex pheromones: Furthermore, they indicate that the genetic basis of new pheromone compounds can be simple, allowing them to persist long enough in a population for receivers to evolve chemosensory adaptations for their exploitation.	[Niehuis, Oliver] Zool Res Museum Alexander Koenig, Ctr Mol Biodivers Res, D-53113 Bonn, Germany; [Niehuis, Oliver; Buellesbach, Jan; Gibson, Joshua D.; Mutti, Navdeep S.; Judson, Andrea K.; Gadau, Juergen] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Buellesbach, Jan; Hanner, Christian; Schmitt, Thomas] Univ Freiburg, D-79104 Freiburg, Germany; [Buellesbach, Jan; Schmitt, Thomas] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Pothmann, Daniela; Ruther, Joachim] Univ Regensburg, Dept Zool, D-93053 Regensburg, Germany; [Mutti, Navdeep S.] DuPont Pioneer Agr Biotechnol, DuPont Expt Stn, Wilmington, DE 19880 USA; [Schmitt, Thomas] Tech Univ Darmstadt, Ecol Network Grp, D-64287 Darmstadt, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Arizona State University; Arizona State University-Tempe; University of Freiburg; University of Freiburg; University of Regensburg; DuPont; Technical University of Darmstadt	Niehuis, O (corresponding author), Zool Res Museum Alexander Koenig, Ctr Mol Biodivers Res, D-53113 Bonn, Germany.	o.niehuis.zfmk@uni-bonn.de	Schmitt, Thomas/H-3033-2013; Ruther, Joachim/AAE-3568-2019; Buellesbach, Jan/AAR-5635-2020	Ruther, Joachim/0000-0002-1295-347X; Gibson, Joshua/0000-0002-0193-2307; Buellesbach, Jan/0000-0001-8493-692X	Alexander von Humboldt foundation; Excellence Initiative of the German Research Foundation (Spemann Graduate School) [GSC-4]; German Research Foundation (DFG) [RU 717/10-1]	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); Excellence Initiative of the German Research Foundation (Spemann Graduate School); German Research Foundation (DFG)(German Research Foundation (DFG))	We thank J. H. Werren for providing laboratory strains of Nasonia and Trichomalopsis and D. Wheeler for discussion on the gene expression data. G. Amdam and J. Liebig allowed us to use their research facilities for conducting the gene expression studies, knockdown experiments and gas chromatography analyses. We thank D. D. McKenna and R. S. Peters for comments on an earlier draft of this paper. O.N. acknowledges the Alexander von Humboldt foundation for a Feodor Lynen postdoctoral research stipend. J.B. and TS. were supported by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School). parts of this research were supported by the German Research Foundation (DFG) grant RU 717/10-1 to J.R.	Abdel-Latief M, 2008, P NATL ACAD SCI USA, V105, P8914, DOI 10.1073/pnas.0801559105; Albre J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002489; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Butlin RK, 1997, INSECT PHEROMONE RESEARCH, P548; Cho H, 2003, ARCH BIOCHEM BIOPHYS, V419, P139, DOI 10.1016/j.abb.2003.09.019; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Lienard MA, 2010, P NATL ACAD SCI USA, V107, P10955, DOI 10.1073/pnas.1000823107; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Munoz-Torres MC, 2011, NUCLEIC ACIDS RES, V39, pD658, DOI 10.1093/nar/gkq1145; Niehuis O, 2011, HEREDITY, V107, P61, DOI 10.1038/hdy.2010.157; Niehuis O, 2008, GENETICS, V178, P413, DOI 10.1534/genetics.107.080523; Niehuis O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008597; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; Ruther J, 2008, J CHEM ECOL, V34, P99, DOI 10.1007/s10886-007-9411-1; Ruther J, 2007, J EXP BIOL, V210, P2163, DOI 10.1242/jeb.02789; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Steiger S, 2011, P ROY SOC B-BIOL SCI, V278, P970, DOI 10.1098/rspb.2010.2285; Steiner S, 2009, J CHEM ECOL, V35, P416, DOI 10.1007/s10886-009-9624-6; Symonds MRE, 2008, TRENDS ECOL EVOL, V23, P220, DOI 10.1016/j.tree.2007.11.009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanner ME, 2002, ACCOUNTS CHEM RES, V35, P237, DOI 10.1021/ar000056y; WERREN JH, 2009, COLD SPRING HARB PRO, V2009, DOI DOI 10.1101/PDB.EMO134; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wyatt T. D., 2003, PHEROMONES ANIMAL BE, P37; Xue BY, 2007, P NATL ACAD SCI USA, V104, P4467, DOI 10.1073/pnas.0700422104	29	90	91	0	160	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					345	348		10.1038/nature11838	http://dx.doi.org/10.1038/nature11838			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23407492				2022-12-24	WOS:000315312900036
J	Pauly, D; Hilborn, R; Branch, TA				Pauly, Daniel; Hilborn, Ray; Branch, Trevor A.			Does catch reflect abundance?	NATURE			English	Editorial Material							GLOBAL FISHERIES; OCEAN; US		[Pauly, Daniel] Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada; [Hilborn, Ray; Branch, Trevor A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of British Columbia; University of Washington; University of Washington Seattle	Pauly, D (corresponding author), Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada.	d.pauly@fisheries.ubc.ca; rayh@uw.edu; tbranch@uw.edu	Hilborn, Ray W/D-6332-2013; Pauly, Daniel Marc/AAY-2316-2021	Pauly, Daniel/0000-0003-3756-4793				Branch TA, 2011, CONSERV BIOL, V25, P777, DOI 10.1111/j.1523-1739.2011.01687.x; Froese R, 2012, MAR BIOL, V159, P1283, DOI 10.1007/s00227-012-1909-6; Grainger R.J., 1996, CHRONICLES MARINE FI; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Kleisner K, 2012, FISH FISH; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Pauly D, 1996, FISH RES, V25, P25, DOI 10.1016/0165-7836(95)00436-X; Sumaila UR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040542; Walters C, 1996, REV FISH BIOL FISHER, V6, P125; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zeller D, 2011, FISH RES, V108, P356, DOI 10.1016/j.fishres.2010.10.024; Zeller D, 2007, FISH B-NOAA, V105, P266	13	210	217	1	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					303	306		10.1038/494303a	http://dx.doi.org/10.1038/494303a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	095CS	23426308				2022-12-24	WOS:000315312900015
J	Visel, A; Taher, L; Girgis, H; May, D; Golonzhka, O; Hoch, RV; McKinsey, GL; Pattabiraman, K; Silberberg, SN; Blow, MJ; Hansen, DV; Nord, AS; Akiyama, JA; Holt, A; Hosseini, R; Phouanenavong, S; Plajzer-Frick, I; Shoukry, M; Afzal, V; Kaplan, T; Kriegstein, AR; Rubin, EM; Ovcharenko, I; Pennacchio, LA; Rubenstein, JLR				Visel, Axel; Taher, Leila; Girgis, Hani; May, Dalit; Golonzhka, Olga; Hoch, Renee V.; McKinsey, Gabriel L.; Pattabiraman, Kartik; Silberberg, Shanni N.; Blow, Matthew J.; Hansen, David V.; Nord, Alex S.; Akiyama, Jennifer A.; Holt, Amy; Hosseini, Roya; Phouanenavong, Sengthavy; Plajzer-Frick, Ingrid; Shoukry, Malak; Afzal, Veena; Kaplan, Tommy; Kriegstein, Arnold R.; Rubin, Edward M.; Ovcharenko, Ivan; Pennacchio, Len A.; Rubenstein, John L. R.			A High-Resolution Enhancer Atlas of the Developing Telencephalon	CELL			English	Article							RECOMBINASE ACTIVITY; EXPRESSION; DATABASE; AUTISM; ASSOCIATION; PHENOTYPE; REVEALS; LOCI	The mammalian telencephalon plays critical roles in cognition, motor function, and emotion. Though many of the genes required for its development have been identified, the distant-acting regulatory sequences orchestrating their in vivo expression are mostly unknown. Here, we describe a digital atlas of in vivo enhancers active in subregions of the developing telencephalon. We identified more than 4,600 candidate embryonic forebrain enhancers and studied the in vivo activity of 329 of these sequences in transgenic mouse embryos. We generated serial sets of histological brain sections for 145 reproducible forebrain enhancers, resulting in a publicly accessible web-based data collection comprising more than 32,000 sections. We also used epigenomic analysis of human and mouse cortex tissue to directly compare the genome-wide enhancer architecture in these species. These data provide a primary resource for investigating gene regulatory mechanisms of telencephalon development and enable studies of the role of distant-acting enhancers in neurodevelopmental disorders.	[Visel, Axel; May, Dalit; Nord, Alex S.; Akiyama, Jennifer A.; Holt, Amy; Hosseini, Roya; Phouanenavong, Sengthavy; Plajzer-Frick, Ingrid; Shoukry, Malak; Afzal, Veena; Rubin, Edward M.; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Visel, Axel; Blow, Matthew J.; Rubin, Edward M.; Pennacchio, Len A.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Taher, Leila; Girgis, Hani; Ovcharenko, Ivan] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Golonzhka, Olga; Hoch, Renee V.; McKinsey, Gabriel L.; Pattabiraman, Kartik; Silberberg, Shanni N.; Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Hansen, David V.; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell Res, San Francisco, CA 94143 USA; [Hansen, David V.; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Kaplan, Tommy] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kaplan, Tommy] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Hebrew University of Jerusalem	Visel, A (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, MS 84-171, Berkeley, CA 94720 USA.	avisel@lbl.gov	Visel, Axel/A-9398-2009; Kaplan, Tommy/T-2528-2017; Blow, Matthew/G-6369-2012	Visel, Axel/0000-0002-4130-7784; Kaplan, Tommy/0000-0002-1892-5461; Blow, Matthew/0000-0002-8844-9149; Taher, Leila/0000-0002-2013-5426; Nord, Alexander/0000-0003-4259-7514; Hansen, David/0000-0001-9679-7189; Hoch, Renee/0000-0003-0042-3751; Pennacchio, Len/0000-0002-8748-3732	NINDS [R01NS062859A, R01NS34661, R01NS075998]; NHGRI [R01HG003988]; Nina Ireland; Weston Havens Foundation; NIMH [R01MH081880, R37MH049428]; CIRM [RB2-1602]; NARSAD; Intramural Research Program of the NIH; National Library of Medicine; Department of Energy [DE-AC02-05CH11231];  [T32 GM007449];  [T32 GMO7618];  [F32 MH081431]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007449, T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049428, R01MH081880, F32MH081431, R01MH049428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099099, R01NS034661, R01NS075998, R01NS062859] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200881] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Nina Ireland; Weston Havens Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); CIRM(California Institute for Regenerative Medicine); NARSAD(NARSAD); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Department of Energy(United States Department of Energy (DOE)); ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors thank Julian Golder and Noah Efron for help with digital image acquisition and data processing; Bing Ren and Zirong Li for help with chromatin immunoprecipitation from embryonic mouse tissue; Inna Dubchak, Simon Minovitsky, and Alexandre Poliakov for website support; and staff at San Francisco General Hospital Women's Options Center for their consideration in allowing us to access donated fetal tissue. A.V. and L.A.P. were supported by NINDS grant R01NS062859A and by NHGRI grant R01HG003988. J.L.R.R. was supported by the Nina Ireland, Weston Havens Foundation, NINDS grant R01NS34661, NIMH grant R01MH081880, and NIMH grant R37MH049428. J.L.R.R. and A.R.K were supported by CIRM RB2-1602. G.M. and S.N.S. were supported by T32 GM007449, K.P. was supported by T32 GMO7618, R.H. was supported by F32 MH081431, and O.G. was supported by NARSAD. A.R.K. was supported by NINDS grant R01NS075998. I.O. was supported by the Intramural Research Program of the NIH, National Library of Medicine. Research was conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231, University of California.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Colasante G, 2008, J NEUROSCI, V28, P10674, DOI 10.1523/JNEUROSCI.1283-08.2008; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Cummings MP, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-137; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Farah MH, 2000, DEVELOPMENT, V127, P693; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Kurokawa D, 2004, DEVELOPMENT, V131, P3307, DOI 10.1242/dev.01219; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Long JE, 2009, J COMP NEUROL, V512, P556, DOI 10.1002/cne.21854; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Poitras L, 2010, DEVELOPMENT, V137, P3089, DOI 10.1242/dev.051052; Portales-Casamar E, 2010, P NATL ACAD SCI USA, V107, P16589, DOI 10.1073/pnas.1009158107; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shim SB, 2012, NATURE, V486, P74, DOI 10.1038/nature11094; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052	55	166	166	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					895	908		10.1016/j.cell.2012.12.041	http://dx.doi.org/10.1016/j.cell.2012.12.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23375746	Green Accepted, Bronze			2022-12-24	WOS:000314945600022
J	Lewis, PW; Muller, MM; Koletsky, MS; Cordero, F; Lin, S; Banaszynski, LA; Garcia, BA; Muir, TW; Becher, OJ; Allis, CD				Lewis, Peter W.; Mueller, Manuel M.; Koletsky, Matthew S.; Cordero, Francisco; Lin, Shu; Banaszynski, Laura A.; Garcia, Benjamin A.; Muir, Tom W.; Becher, Oren J.; Allis, C. David			Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma	SCIENCE			English	Article							HISTONE MARKS; BINDING	Sequencing of pediatric gliomas has identified missense mutations Lys27Met (K27M) and Gly34Arg/Val (G34R/V) in genes encoding histone H3.3 (H3F3A) and H3.1 (HIST3H1B). We report that human diffuse intrinsic pontine gliomas (DIPGs) containing the K27M mutation display significantly lower overall amounts of H3 with trimethylated lysine 27 (H3K27me3) and that histone H3K27M transgenes are sufficient to reduce the amounts of H3K27me3 in vitro and in vivo. We find that H3K27M inhibits the enzymatic activity of the Polycomb repressive complex 2 through interaction with the EZH2 subunit. In addition, transgenes containing lysine-to-methionine substitutions at other known methylated lysines (H3K9 and H3K36) are sufficient to cause specific reduction in methylation through inhibition of SET-domain enzymes. We propose that K-to-M substitutions may represent a mechanism to alter epigenetic states in a variety of pathologies.	[Lewis, Peter W.; Koletsky, Matthew S.; Banaszynski, Laura A.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Mueller, Manuel M.; Muir, Tom W.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Cordero, Francisco; Becher, Oren J.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Pediat, Durham, NC 27710 USA; [Cordero, Francisco; Becher, Oren J.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Pathol, Durham, NC 27710 USA; [Lin, Shu; Garcia, Benjamin A.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Rockefeller University; Princeton University; Duke University; Duke University; University of Pennsylvania; Pennsylvania Medicine	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	alliscd@rockefeller.edu	Muir, Tom/AHD-0860-2022; Mueller, Manuel M/D-5562-2017; Müller, Manuel/F-7399-2014; Becher, Oren/AAI-7495-2020	Muir, Tom/0000-0001-9635-0344; Mueller, Manuel M/0000-0001-6701-0893; Müller, Manuel/0000-0001-6701-0893; Becher, Oren/0000-0003-4016-8492; Lewis, Peter/0000-0002-9816-7823	NIH Innovator grant, Office of the Director, NIH [DP2OD007447]; U.S. Department of Defense; Pediatric Brain Tumor Foundation; Damon Runyon Foundation; Rory David Deutsch Foundation; Cristian Rivera Foundation; NIH [GM040922]; Starr Cancer Consortium [SCC I6-A614]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107047, R01GM040922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	NIH Innovator grant, Office of the Director, NIH; U.S. Department of Defense(United States Department of Defense); Pediatric Brain Tumor Foundation; Damon Runyon Foundation; Rory David Deutsch Foundation; Cristian Rivera Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	B.A.G. acknowledges funding from NIH Innovator grant (DP2OD007447), Office of the Director, NIH. O.J. B. is supported by the U.S. Department of Defense; The Pediatric Brain Tumor Foundation; and the Damon Runyon, Rory David Deutsch, and Cristian Rivera Foundations. C. D. A. acknowledges funding from NIH (GM040922) and Starr Cancer Consortium (grant SCC I6-A614). We thank D. Reinberg for reagents, and EMD Millipore for its role in H3K27M antibody generation.	Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Elsasser SJ, 2011, SCIENCE, V331, P1145, DOI 10.1126/science.1203280; Karytinos A, 2009, J BIOL CHEM, V284, P17775, DOI 10.1074/jbc.M109.003087; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208	13	804	825	4	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					857	861		10.1126/science.1232245	http://dx.doi.org/10.1126/science.1232245			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23539183	Green Accepted			2022-12-24	WOS:000318997400042
J	Jennings, JH; Sparta, DR; Stamatakis, AM; Ung, RL; Pleil, KE; Kash, TL; Stuber, GD				Jennings, Joshua H.; Sparta, Dennis R.; Stamatakis, Alice M.; Ung, Randall L.; Pleil, Kristen E.; Kash, Thomas L.; Stuber, Garret D.			Distinct extended amygdala circuits for divergent motivational states	NATURE			English	Article							VENTRAL TEGMENTAL AREA; STRIA TERMINALIS; BED NUCLEUS; INDUCED REINSTATEMENT; DOPAMINE NEURONS; GABA NEURONS; REWARD; ACTIVATION; AFFERENTS; BEHAVIOR	The co-morbidity of anxiety and dysfunctional reward processing in illnesses such as addiction(1) and depression(2) suggests that common neural circuitry contributes to these disparate neuropsychiatric symptoms. The extended amygdala, including the bed nucleus of the stria terminalis (BNST), modulates fear and anxiety(3,4), but also projects to the ventral tegmental area (VTA)(5,6), a region implicated in reward and aversion(7-13), thus providing a candidate neural substrate for integrating diverse emotional states. However, the precise functional connectivity between distinct BNST projection neurons and their postsynaptic targets in the VTA, as well as the role of this circuit in controlling motivational states, have not been described. Here we record and manipulate the activity of genetically and neurochemically identified VTA-projecting BNST neurons in freely behaving mice. Collectively, aversive stimuli exposure produced heterogeneous firing patterns in VTA-projecting BNST neurons. By contrast, in vivo optically identified glutamatergic projection neurons displayed a net enhancement of activity to aversive stimuli, whereas the firing rate of identified GABAergic (gamma-aminobutyric acid-containing) projection neurons was suppressed. Channelrhodopsin-2-assisted circuit mapping revealed that both BNST glutamatergic and GABAergic projections preferentially innervate postsynaptic non-dopaminergic VTA neurons, thus providing a mechanistic framework for in vivo circuit perturbations. In vivo photostimulation of BNST glutamatergic projections resulted in aversive and anxiogenic behavioural phenotypes. Conversely, activation of BNST GABAergic projections produced rewarding and anxiolytic phenotypes, which were also recapitulated by direct inhibition of VTA GABAergic neurons. These data demonstrate that functionally opposing BNST to VTA circuits regulate rewarding and aversive motivational states, and may serve as a crucial circuit node for bidirectionally normalizing maladaptive behaviours.	[Jennings, Joshua H.; Sparta, Dennis R.; Stamatakis, Alice M.; Ung, Randall L.; Stuber, Garret D.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Jennings, Joshua H.; Stamatakis, Alice M.; Kash, Thomas L.; Stuber, Garret D.] Univ N Carolina, Neurobiol Curriculum, Chapel Hill, NC 27599 USA; [Sparta, Dennis R.; Pleil, Kristen E.; Kash, Thomas L.; Stuber, Garret D.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA; [Pleil, Kristen E.; Kash, Thomas L.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Kash, Thomas L.; Stuber, Garret D.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Stuber, Garret D.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stuber, GD (corresponding author), Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA.	gstuber@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; Core, Vector/CAF-4832-2022; Kash, Thomas/G-9625-2013; Stuber, Garret/E-1160-2011	Stuber, Garret/0000-0003-1730-4855; Ung, Randall/0000-0002-5303-3741	Whitehall Foundation; Foundation of Hope; National Institutes of Health [DA029325, DA032750, AA018610, AA007573, NS007431, DA034472, AA021043]; UNC NIAAA alcohol research center [AA011605]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, T32NS007431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007573, F32AA021043, P50AA011605, F32AA018610, P60AA011605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032750, R37DA032750, R21DA029325, F31DA034472] Funding Source: NIH RePORTER	Whitehall Foundation; Foundation of Hope; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC NIAAA alcohol research center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Patel, J. Phillips and S. Maciver for assistance; V. Gukassyan and the UNC Neuroscience Center Microscopy Core (P30 NS045892), and members of the Stuber laboratory for discussion. We thank K. Deisseroth for viral constructs and the UNC Vector Core Facility for viral packaging. We thank B. Lowell and L. Vong for providing the Vgat-ires-cre and Vglut2-ires-cre mice. This study was supported by The Whitehall Foundation, The Foundation of Hope, National Institutes of Health grants DA029325 and DA032750 (to G. D. S.), AA018610 and AA007573 (to D. R. S.), NS007431 and DA034472 (to A. M. S.) and AA021043 (to K. P.), and the UNC NIAAA alcohol research center (AA011605).	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Briand LA, 2010, J NEUROSCI, V30, P16149, DOI 10.1523/JNEUROSCI.2827-10.2010; Christianson JP, 2011, BIOL PSYCHIAT, V70, P458, DOI 10.1016/j.biopsych.2011.04.004; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Dong HW, 2004, J COMP NEUROL, V468, P277, DOI 10.1002/cne.10949; Dumont EC, 2004, J NEUROSCI, V24, P8198, DOI 10.1523/JNEUROSCI.0425-04.2004; Erb S, 2001, Stress, V4, P289; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; FULLER JH, 1976, BRAIN RES, V112, P283, DOI 10.1016/0006-8993(76)90284-5; Geisler S, 2005, J COMP NEUROL, V490, P270, DOI 10.1002/cne.20668; Georges F, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0003.2001; Hammack SE, 2007, J NEUROPHYSIOL, V98, P638, DOI 10.1152/jn.00382.2007; Jalabert M, 2009, PROG NEURO-PSYCHOPH, V33, P1336, DOI 10.1016/j.pnpbp.2009.07.010; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Kudo T, 2012, J NEUROSCI, V32, P18035, DOI 10.1523/JNEUROSCI.4057-12.2012; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Mahler SV, 2012, J NEUROSCI, V32, P13309, DOI 10.1523/JNEUROSCI.2277-12.2012; Nagy FZ, 2008, J NEUROPHYSIOL, V100, P3429, DOI 10.1152/jn.90936.2008; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Poulos AM, 2010, P NATL ACAD SCI USA, V107, P14881, DOI 10.1073/pnas.1005754107; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Walker DL, 2008, BRAIN STRUCT FUNCT, V213, P29, DOI 10.1007/s00429-008-0183-3	32	443	483	3	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					224	+		10.1038/nature12041	http://dx.doi.org/10.1038/nature12041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23515155	Green Accepted, Green Submitted			2022-12-24	WOS:000317346300042
J	Xiong, Y; McCormack, M; Li, L; Hall, Q; Xiang, CB; Sheen, J				Xiong, Yan; McCormack, Matthew; Li, Lei; Hall, Qi; Xiang, Chengbin; Sheen, Jen			Glucose-TOR signalling reprograms the transcriptome and activates meristems	NATURE			English	Article							E2F TARGET GENES; ARABIDOPSIS; ROOT; GROWTH; RAPAMYCIN; PROLIFERATION; EXPRESSION; NUTRIENT; ENERGY; DIFFERENTIATION	Meristems encompass stem/progenitor cells that sustain postembryonic growth of all plant organs. How meristems are activated and sustained by nutrient signalling remains enigmatic in photosynthetic plants. Combining chemical manipulations and chemical genetics at the photoautotrophic transition checkpoint, we reveal that shoot photosynthesis-derived glucose drives target-of-rapamycin (TOR) signalling relays through glycolysis and mitochondrial bioenergetics to control root meristem activation, which is decoupled from direct glucose sensing, growth-hormone signalling and stem-cell maintenance. Surprisingly, glucose-TOR signalling dictates transcriptional reprogramming of remarkable gene sets involved in central and secondary metabolism, cell cycle, transcription, signalling, transport and protein folding. Systems, cellular and genetic analyses uncover TOR phosphorylation of E2Fa transcription factor for an unconventional activation of S-phase genes, and glucose-signalling defects in e2fa root meristems. Our findings establish pivotal roles of glucose-TOR signalling in unprecedented transcriptional networks wiring central metabolism and biosynthesis for energy and biomass production, and integrating localized stem/progenitor-cell proliferation through inter-organ nutrient coordination to control developmental transition and growth.	[Xiong, Yan; McCormack, Matthew; Li, Lei; Hall, Qi; Sheen, Jen] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Xiong, Yan; McCormack, Matthew; Li, Lei; Hall, Qi; Sheen, Jen] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xiong, Yan; McCormack, Matthew; Li, Lei; Hall, Qi; Sheen, Jen] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Xiang, Chengbin] Univ Sci & Technol China, Sch Life Sci, Hefei 230023, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Xiong, Y (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	xiong@molbio.mgh.harvard.edu; sheen@molbio.mgh.harvard.edu	Li, Lei/F-9826-2015	Xiong, Yan/0000-0003-0676-8267	MGH Tosteson Postdoctoral Fellowship; Chinese Academy of Sciences [KSCX3-YW-N-007]; NSF; NIH; WJC Special Project RDA-Korea [PJ009106]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070567, R01GM060493] Funding Source: NIH RePORTER	MGH Tosteson Postdoctoral Fellowship; Chinese Academy of Sciences(Chinese Academy of Sciences); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WJC Special Project RDA-Korea; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Dai and J. Avruch for S6K antibodies and advice, J. L. Celenza for stimulating discussion, M. D. Curtis and Y. J. Niu for the oestradiol-inducible binary vector, L. Li and J. Bush for seeds and plants, B. Muller for TCS::GFP, J. Friml for DR5::GFP, N. S. Gray and D. M. Sabatini for torin1, and J. F. Li, H. Lee and M. Ramon for critical reading of the manuscript. Y. X. is supported by the MGH Tosteson Postdoctoral Fellowship. C. X. is supported by Chinese Academy of Sciences (KSCX3-YW-N-007). The Research is supported by the NSF, NIH and WJC Special Project (PJ009106) RDA-Korea to J.S.	Aichinger E, 2012, ANNU REV PLANT BIOL, V63, P615, DOI 10.1146/annurev-arplant-042811-105555; Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Chaudhuri B, 2008, PLANT J, V56, P948, DOI 10.1111/j.1365-313X.2008.03652.x; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; de Jager SM, 2009, PLANT MOL BIOL, V71, P345, DOI 10.1007/s11103-009-9527-5; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; Gonzali S, 2006, J PLANT RES, V119, P115, DOI 10.1007/s10265-005-0251-1; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Kotogany E, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-5; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li YH, 2006, GENOME RES, V16, P414, DOI 10.1101/gr.4237406; Liu QS, 2012, J BIOL CHEM, V287, P9742, DOI 10.1074/jbc.M111.304485; Magyar Z, 2012, EMBO J, V31, P1480, DOI 10.1038/emboj.2012.13; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; Menges M, 2003, PLANT MOL BIOL, V53, P423, DOI 10.1023/B:PLAN.0000019059.56489.ca; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Moreau M, 2012, PLANT CELL, V24, P463, DOI 10.1105/tpc.111.091306; Moubayidin L, 2010, CURR BIOL, V20, P1138, DOI 10.1016/j.cub.2010.05.035; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Naouar N, 2009, PLANT J, V57, P184, DOI 10.1111/j.1365-313X.2008.03662.x; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Sanz L, 2011, PLANT CELL, V23, P641, DOI 10.1105/tpc.110.080002; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Vandepoele K, 2005, PLANT PHYSIOL, V139, P316, DOI 10.1104/pp.105.066290; Vernoux T, 2000, PLANT CELL, V12, P97, DOI 10.1105/tpc.12.1.97; Xiong Y, 2012, J BIOL CHEM, V287, P2836, DOI 10.1074/jbc.M111.300749; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang ZW, 2010, FEBS LETT, V584, P3573, DOI 10.1016/j.febslet.2010.07.024	42	449	466	15	279	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					181	+		10.1038/nature12030	http://dx.doi.org/10.1038/nature12030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23542588	Green Submitted, Green Accepted			2022-12-24	WOS:000317346300033
J	Son, J; Lyssiotis, CA; Ying, H; Wang, X; Hua, S; Ligorio, M; Perera, RM; Ferrone, CR; Mullarky, E; Ng, SC; Kang, Y; Fleming, JB; Bardeesy, N; Asara, JM; Haigis, MC; DePinho, RA; Cantley, LC; Kimmelman, AC				Son, Jaekyoung; Lyssiotis, Costas A.; Ying, Haoqiang; Wang, Xiaoxu; Hua, Sujun; Ligorio, Matteo; Perera, Rushika M.; Ferrone, Cristina R.; Mullarky, Edouard; Ng Shyh-Chang; Kang, Ya'an; Fleming, Jason B.; Bardeesy, Nabeel; Asara, John M.; Haigis, Marcia C.; DePinho, Ronald A.; Cantley, Lewis C.; Kimmelman, Alec C.			Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway	NATURE			English	Article							MASS-SPECTROMETRY; TRANSFORMED-CELLS; ADDICTION; GLUCOSE	Cancer cells have metabolic dependencies that distinguish them from their normal counterparts(1). Among these dependencies is an increased use of the amino acid glutamine to fuel anabolic processes(2). Indeed, the spectrum of glutamine-dependent tumours and the mechanisms whereby glutamine supports cancer metabolism remain areas of active investigation. Here we report the identification of a non-canonical pathway of glutamine use in human pancreatic ductal adenocarcinoma (PDAC) cells that is required for tumour growth. Whereas most cells use glutamate dehydrogenase (GLUD1) to convert glutamine-derived glutamate into alpha-ketoglutarate in the mitochondria to fuel the tricarboxylic acid cycle, PDAC relies on a distinct pathway in which glutamine-derived aspartate is transported into the cytoplasm where it can be converted into oxaloacetate by aspartate transaminase (GOT1). Subsequently, this oxaloacetate is converted into malate and then pyruvate, ostensibly increasing the NADPH/NADP(+) ratio which can potentially maintain the cellular redox state. Importantly, PDAC cells are strongly dependent on this series of reactions, as glutamine deprivation or genetic inhibition of any enzyme in this pathway leads to an increase in reactive oxygen species and a reduction in reduced glutathione. Moreover, knockdown of any component enzyme in this series of reactions also results in a pronounced suppression of PDAC growth in vitro and in vivo. Furthermore, we establish that the reprogramming of glutamine metabolism is mediated by oncogenic KRAS, the signature genetic alteration in PDAC, through the transcriptional upregulation and repression of key metabolic enzymes in this pathway. The essentiality of this pathway in PDAC and the fact that it is dispensable in normal cells may provide novel therapeutic approaches to treat these refractory tumours.	[Son, Jaekyoung; Wang, Xiaoxu; Kimmelman, Alec C.] Dana Farber Canc Inst, Dept Radiat Oncol, Div Genom Stabil & DNA Repair, Boston, MA 02215 USA; [Lyssiotis, Costas A.; Mullarky, Edouard; Ng Shyh-Chang; Cantley, Lewis C.] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02215 USA; [Lyssiotis, Costas A.; Mullarky, Edouard; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Ying, Haoqiang; Hua, Sujun; DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Ligorio, Matteo; Ferrone, Cristina R.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Perera, Rushika M.; Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Ng Shyh-Chang] Childrens Hosp, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Stem Cell Program, Boston, MA 02130 USA; [Ng Shyh-Chang] Dana Farber Canc Inst, Boston, MA 02130 USA; [Kang, Ya'an; Fleming, Jason B.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Haigis, Marcia C.] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Cantley, LC (corresponding author), Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02215 USA.	lec2014@med.cornell.edu; Alec_Kimmelman@DFCI.harvard.edu	Ying, Haoqiang/AAK-4325-2020; Cantley, Lewis C/D-1800-2014; Lyssiotis, Costas A/AAI-1923-2019	Cantley, Lewis C/0000-0002-1298-7653; Lyssiotis, Costas A/0000-0001-9309-6141; DePinho, Ronald/0000-0002-5625-577X; Shyh-Chang, Ng/0000-0003-3138-9525	Dana Farber Cancer Institute; National Cancer Institute [R01 CA157490]; Kimmel Scholar Award; AACR-PanCAN Career Development Award; NIH [T32 CA009382-26, P01 CA117969, 5P01CA120964-05]; Dana-Farber/Harvard Cancer Center Support Grant [5P30CA006516-46]; NATIONAL CANCER INSTITUTE [P01CA117969, R01CA157490, P01CA120964, T32CA009382, P30CA006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	Dana Farber Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kimmel Scholar Award; AACR-PanCAN Career Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber/Harvard Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank D. Anastasiou for advice and helpful comments on the manuscript; M. Yuan and S. Breitkopf for technical help with mass spectrometry experiments; J. Erickson, R. Cerione and J. Escobedo for the GLS inhibitors. Grant support derives from the Dana Farber Cancer Institute (A. C. K.), National Cancer Institute Grant R01 CA157490 (A. C. K.), Kimmel Scholar Award (A. C. K.), AACR-PanCAN Career Development Award (A. C. K.), NIH grants T32 CA009382-26 (H.Y.) and P01 CA117969 (L. C. C. and R. A. D.). C. A. L. is the Amgen Fellow of the Damon Runyon Cancer Research Foundation (DRG-2056-10). NIH grants 5P01CA120964-05 and Dana-Farber/Harvard Cancer Center Support Grant 5P30CA006516-46 (J.M.A.).	Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Huypens P, 2011, DIABETOLOGIA, V54, P135, DOI 10.1007/s00125-010-1923-5; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	25	1214	1266	21	395	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					101	+		10.1038/nature12040	http://dx.doi.org/10.1038/nature12040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23535601	Green Submitted, Green Accepted			2022-12-24	WOS:000316993400033
J	Xing, WM; Busino, L; Hinds, TR; Marionni, ST; Saifee, NH; Bush, MF; Pagano, M; Zheng, N				Xing, Weiman; Busino, Luca; Hinds, Thomas R.; Marionni, Samuel T.; Saifee, Nabiha H.; Bush, Matthew F.; Pagano, Michele; Zheng, Ning			SCFFBXL3 ubiquitin ligase targets cryptochromes at their cofactor pocket	NATURE			English	Article							CIRCADIAN CLOCK; CRYSTAL-STRUCTURE; MAMMALIAN CRY1; PHOTOLYASE; MECHANISM; PHOSPHORYLATION; IDENTIFICATION; COORDINATION; DEGRADATION; OSCILLATION	The cryptochrome (CRY) flavoproteins act as blue-light receptors in plants and insects, but perform light-independent functions at the core of the mammalian circadian clock. To drive clock oscillations, mammalian CRYs associate with the Period proteins (PERs) and together inhibit the transcription of their own genes. The SCFFBXL3 ubiquitin ligase complex controls this negative feedback loop by promoting CRY ubiquitination and degradation. However, the molecular mechanisms of their interactions and the functional role of flavin adenine dinucleotide (FAD) binding in CRYs remain poorly understood. Here we report crystal structures of mammalian CRY2 in its apo, FAD-bound and FBXL3-SKP1-complexed forms. Distinct from other cryptochromes of known structures, mammalian CRY2 binds FAD dynamically with an open cofactor pocket. Notably, the F-box protein FBXL3 captures CRY2 by simultaneously occupying its FAD-binding pocket with a conserved carboxy-terminal tail and burying its PER-binding interface. This novel F-box-protein-substrate bipartite interaction is susceptible to disruption by both FAD and PERs, suggesting a new avenue for pharmacological targeting of the complex and a multifaceted regulatory mechanism of CRY ubiquitination.	[Xing, Weiman; Hinds, Thomas R.; Saifee, Nabiha H.; Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Xing, Weiman; Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Busino, Luca; Pagano, Michele] NYU, Sch Med, Dept Pathol, NYU Canc Inst, New York, NY 10016 USA; [Marionni, Samuel T.; Bush, Matthew F.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Pagano, Michele] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; New York University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; New York University	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	nzheng@u.washington.edu	Bush, Matthew F./Y-2079-2019	Bush, Matthew F./0000-0003-3526-4973; Huq Saifee, Nabiha/0000-0003-1646-9201; pagano, michele/0000-0003-3210-2442; Xing, Weiman/0000-0002-6238-0075	Howard Hughes Medical Institute; National Institutes of Health [R01-CA107134, 5T32-HL007151, R01-GM057587, R37-CA-076584, R21-CA161108]; University of Washington; NATIONAL CANCER INSTITUTE [R21CA161108, R01CA107134, R37CA076584, K99CA166181] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline staff of the Advanced Light Source at the University of California at Berkeley for help with data collection, and members of the Zheng laboratory for discussion. This work is supported by the Howard Hughes Medical Institute (N. Z. and M. P.), the National Institutes of Health (R01-CA107134 to N. Z., 5T32-HL007151 to L. B., and R01-GM057587, R37-CA-076584 and R21-CA161108 to M. P.), and the University of Washington (S.T.M. and M.F.B.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; Liu B, 2010, CURR OPIN PLANT BIOL, V13, P578, DOI 10.1016/j.pbi.2010.09.005; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozber N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-69; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sanada K, 2004, GENES CELLS, V9, P697, DOI 10.1111/j.1356-9597.2004.00758.x; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yang HQ, 2001, PLANT CELL, V13, P2573, DOI 10.1105/tpc.13.12.2573; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhu HS, 2006, CURR BIOL, V16, P730, DOI 10.1016/j.cub.2006.03.026; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	42	156	162	0	75	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					64	+		10.1038/nature11964	http://dx.doi.org/10.1038/nature11964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23503662	Green Accepted			2022-12-24	WOS:000316993400025
J	Konopacky, QM; Barman, TS; Macintosh, BA; Marois, C				Konopacky, Quinn M.; Barman, Travis S.; Macintosh, Bruce A.; Marois, Christian			Detection of Carbon Monoxide and Water Absorption Lines in an Exoplanet Atmosphere	SCIENCE			English	Article							MU-M; FIELD SPECTROGRAPH; PLANET FORMATION; LAMBDA-BOOTIS; GIANT PLANETS; T DWARFS; HR; MASSES; COOL; TEMPERATURE	Determining the atmospheric structure and chemical composition of an exoplanet remains a formidable goal. Fortunately, advancements in the study of exoplanets and their atmospheres have come in the form of direct imaging-spatially resolving the planet from its parent star-which enables high-resolution spectroscopy of self-luminous planets in jovian-like orbits. Here, we present a spectrum with numerous, well-resolved molecular lines from both water and carbon monoxide from a massive planet orbiting less than 40 astronomical units from the star HR 8799. These data reveal the planet's chemical composition, atmospheric structure, and surface gravity, confirming that it is indeed a young planet. The spectral lines suggest an atmospheric carbon-to-oxygen ratio that is greater than that of the host star, providing hints about the planet's formation.	[Konopacky, Quinn M.] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Barman, Travis S.] Lowell Observ, Flagstaff, AZ 86001 USA; [Konopacky, Quinn M.; Macintosh, Bruce A.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Marois, Christian] Natl Res Council Canada, Dominion Astrophys Observ, Victoria, BC V9E 2E7, Canada	University of Toronto; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; National Research Council Canada	Konopacky, QM (corresponding author), Univ Toronto, Dunlap Inst Astron & Astrophys, 50 St George St, Toronto, ON M5S 3H4, Canada.	konopacky@di.utoronto.ca		Konopacky, Quinn/0000-0002-9936-6285; Macintosh, Bruce/0000-0003-1212-7538	U.S. Department of Energy by LLNL [DE-AC52-07NA27344]; NASA; Keck Principal Investigator Data Analysis Fund; NASA High-End Computing Program through the NASA Advanced Supercomputing Division at Ames Research Center; David Dunlap family; University of Toronto; W. M. Keck Foundation	U.S. Department of Energy by LLNL; NASA(National Aeronautics & Space Administration (NASA)); Keck Principal Investigator Data Analysis Fund; NASA High-End Computing Program through the NASA Advanced Supercomputing Division at Ames Research Center; David Dunlap family; University of Toronto(University of Toronto); W. M. Keck Foundation(W.M. Keck Foundation)	We thank A. Conrad, S. Dahm, J. Lyke, H. Tran, H. Hershley, J. McIlroy, J. Rivera, and the entire Keck staff for maximizing our observing efficiency; J. Larkin and S. Wright for their assistance with OSIRIS data reduction; and R. Murray-Clay and K. Oberg for assistance with abundance values. Portions of this work were performed under the auspices of the U.S. Department of Energy by LLNL under contract no. DE-AC52-07NA27344. Support for this work was provided by NASA Origins of the Solar System grants to LLNL and Lowell Observatory and from the Keck Principal Investigator Data Analysis Fund, managed by NExScI on behalf of NASA. Support was also provided by the NASA High-End Computing Program through the NASA Advanced Supercomputing Division at Ames Research Center. Q.M.K. is a Dunlap Fellow at the Dunlap Institute for Astronomy and Astrophysics, University of Toronto. The Dunlap Institute is funded through an endowment established by the David Dunlap family and the University of Toronto. The W. M. Keck Observatory is operated as a scientific partnership among the California Institute of Technology, the University of California, and NASA. The Keck Observatory was made possible by the generous financial support of the W. M. Keck Foundation. We also wish to recognize the very important cultural role and reverence that the summit of Mauna Kea has always had within the indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain. All authors contributed equally to this work.	Asplund M, 2005, ASTR SOC P, V336, P25; Baines EK, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/57; Baraffe I, 2003, ASTRON ASTROPHYS, V402, P701, DOI 10.1051/0004-6361:20030252; Barman TS, 2011, ASTROPHYS J LETT, V735, DOI 10.1088/2041-8205/735/2/L39; Barman TS, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/65; Borysov A, 2002, MOL PHYS, V100, P3585, DOI 10.1080/00268970210161430; Boss AP, 1997, SCIENCE, V276, P1836, DOI 10.1126/science.276.5320.1836; Bowler BP, 2010, ASTROPHYS J, V723, P850, DOI 10.1088/0004-637X/723/1/850; Currie T, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/128; Fegley B, 1996, ASTROPHYS J, V472, pL37, DOI 10.1086/310356; Fortney JJ, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/2/L27; Galicher R, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L41; Gray RO, 2002, ASTRON J, V124, P989, DOI 10.1086/341609; Helled R, 2010, ICARUS, V207, P503, DOI 10.1016/j.icarus.2009.11.023; Krabbe A, 2004, P SOC PHOTO-OPT INS, V5492, P1403, DOI 10.1117/12.552592; Larkin J, 2006, NEW ASTRON REV, V50, P362, DOI 10.1016/j.newar.2006.02.005; Madhusudhan N, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/34; Marley MS, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/135; Marois C, 2008, SCIENCE, V322, P1348, DOI 10.1126/science.1166585; Marois C, 2010, NATURE, V468, P1080, DOI 10.1038/nature09684; Metchev SA, 2006, ASTROPHYS J, V651, P1166, DOI 10.1086/507836; Oberg KI, 2011, ASTROPHYS J LETT, V743, DOI 10.1088/2041-8205/743/1/L16; Patience J, 2010, ASTRON ASTROPHYS, V517, DOI 10.1051/0004-6361/201014173; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Rafikov RR, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/86; Rothman LS, 2008, J QUANT SPECTROSC RA, V109, P881, DOI 10.1016/j.jqsrt.2008.02.002; Sadakane K, 2006, PUBL ASTRON SOC JPN, V58, P1023, DOI 10.1093/pasj/58.6.1023; Saumon D, 2008, ASTROPHYS J, V689, P1327, DOI 10.1086/592734; Skemer AJ, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/14; Smith MD, 1998, ICARUS, V132, P176, DOI 10.1006/icar.1997.5886; Stephens DC, 2009, ASTROPHYS J, V702, P154, DOI 10.1088/0004-637X/702/1/154; Sudol JJ, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/38; Warmbier R, 2009, ASTRON ASTROPHYS, V495, P655, DOI 10.1051/0004-6361:200810983; Wenger C, 1998, J QUANT SPECTROSC RA, V59, P471, DOI 10.1016/S0022-4073(97)00106-4; Wilson HF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.111101; Wizinowich PL, 2006, PROC SPIE, V6272, pU79, DOI 10.1117/12.672104; Zuckerman B, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/61	38	239	239	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1398	1401		10.1126/science.1232003	http://dx.doi.org/10.1126/science.1232003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23493423	Green Submitted			2022-12-24	WOS:000316740700033
J	Qi, LS; Larson, MH; Gilbert, LA; Doudna, JA; Weissman, JS; Arkin, AP; Lim, WA				Qi, Lei S.; Larson, Matthew H.; Gilbert, Luke A.; Doudna, Jennifer A.; Weissman, Jonathan S.; Arkin, Adam P.; Lim, Wendell A.			Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression	CELL			English	Article							FLUORESCENT PROTEIN; ADAPTIVE IMMUNITY; TRANSCRIPTION; BACTERIA; SYSTEMS; INTERFERENCE; EVOLUTION; CLEAVAGE; ARCHAEA; COMPLEX	Targeted gene regulation on a genome-wide scale is a powerful strategy for interrogating, perturbing, and engineering cellular systems. Here, we develop a method for controlling gene expression based on Cas9, an RNA-guided DNA endonuclease from a type II CRISPR system. We show that a catalytically dead Cas9 lacking endonuclease activity, when coexpressed with a guide RNA, generates a DNA recognition complex that can specifically interfere with transcriptional elongation, RNA polymerase binding, or transcription factor binding. This system, which we call CRISPR interference (CRISPRi), can efficiently repress expression of targeted genes in Escherichia coli, with no detectable off-target effects. CRISPRi can be used to repress multiple target genes simultaneously, and its effects are reversible. We also show evidence that the system can be adapted for gene repression in mammalian cells. This RNA-guided DNA recognition platform provides a simple approach for selectively perturbing gene expression on a genome-wide scale.	[Qi, Lei S.; Lim, Wendell A.] Univ Calif San Francisco, UCSF Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Qi, Lei S.; Larson, Matthew H.; Gilbert, Luke A.; Weissman, Jonathan S.; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Larson, Matthew H.; Gilbert, Luke A.; Weissman, Jonathan S.; Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Qi, Lei S.; Larson, Matthew H.; Gilbert, Luke A.; Doudna, Jennifer A.; Weissman, Jonathan S.; Arkin, Adam P.; Lim, Wendell A.] Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Doudna, Jennifer A.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Qi, LS (corresponding author), Univ Calif San Francisco, UCSF Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA.	stanley.qi@ucsf.edu	Arkin, Adam/M-9941-2019; Wilson, Matthew H/K-3193-2013; Arkin, Adam P/A-6751-2008; Gilbert, Luke/AAC-5300-2019; Larson, Matthew/C-8289-2014; Qi, Lei S/AAC-5088-2019	Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931; Larson, Matthew/0000-0002-6778-2604; Qi, Lei S/0000-0002-3965-3223; Gilbert, Luke/0000-0001-5854-0825; Weissman, Jonathan/0000-0003-2445-670X	NIH [P50 GM081879]; Howard Hughes Medical Institute; NSF SynBERC [EEC-0540879]; Howard Hughes Collaborative Initiative Award; Ruth L. Kirschstein National Research Service Award; UCSF Center for Systems and Synthetic Biology; NATIONAL CANCER INSTITUTE [U01CA168370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100611, P50GM081879] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF SynBERC(National Science Foundation (NSF)); Howard Hughes Collaborative Initiative Award(Howard Hughes Medical Institute); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Center for Systems and Synthetic Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Martin Jinek for discussion and distribution of Cas9 and dCas9 genes and Connie Lee for discussion and critical reading of the manuscript. The authors also thank Leonardo Morsut and Esteban Toro for technical advice and help. L. S. Q. acknowledges support from the UCSF Center for Systems and Synthetic Biology. This work was supported by NIH P50 GM081879 (L. S. Q. and W. A. L.), Howard Hughes Medical Institute (L. A. G., J. A. D., J. S. W., and W. A. L.), NSF SynBERC EEC-0540879 (A. P. A. and W. A. L.), a Howard Hughes Collaborative Initiative Award (J. S. W.), and a Ruth L. Kirschstein National Research Service Award (M. H. L.). J. A. D. is a founder of Caribou Biosciences and a member of its scientific advisory board. None of the other authors have a financial interest related to this work. The authors have filed a patent related to this work.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cho SW, 2013, NAT BIOTECHNOL; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hwang W.Y., 2013, NAT BIOTECHNOL; Jiang W., 2013, NAT BIOTECHNOL; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NUDLER E, 1994, SCIENCE, V265, P793, DOI 10.1126/science.8047884; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Qi L, 2012, NAT BIOTECHNOL, V30, P1002, DOI 10.1038/nbt.2355; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	29	2727	3207	63	1149	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1173	1183		10.1016/j.cell.2013.02.022	http://dx.doi.org/10.1016/j.cell.2013.02.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452860	Green Accepted, Bronze			2022-12-24	WOS:000315710300022
J	Bloom, JS; Ehrenreich, IM; Loo, WT; Lite, TLV; Kruglyak, L				Bloom, Joshua S.; Ehrenreich, Ian M.; Loo, Wesley T.; Thuy-Lan Vo Lite; Kruglyak, Leonid			Finding the sources of missing heritability in a yeast cross	NATURE			English	Article							GENETIC INTERACTIONS; COMPLEX DISEASES; HUMAN HEIGHT; VARIANTS; TRAITS; EXPRESSION; EVOLUTION	For many traits, including susceptibility to common diseases in humans, causal loci uncovered by genetic-mapping studies explain only a minority of the heritable contribution to trait variation. Multiple explanations for this 'missing heritability' have been proposed(1). Here we use a large cross between two yeast strains to accurately estimate different sources of heritable variation for 46 quantitative traits, and to detect underlying loci with high statistical power. We find that the detected loci explain nearly the entire additive contribution to heritable variation for the traits studied. We also show that the contribution to heritability of gene-gene interactions varies among traits, from near zero to approximately 50 per cent. Detected two-locus interactions explain only a minority of this contribution. These results substantially advance our understanding of the missing heritability problem and have important implications	[Bloom, Joshua S.; Ehrenreich, Ian M.; Loo, Wesley T.; Thuy-Lan Vo Lite; Kruglyak, Leonid] Princeton Uniyers, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08540 USA; [Bloom, Joshua S.; Loo, Wesley T.; Thuy-Lan Vo Lite] Princeton Univ, Dept Mol Biol, Princeton, NJ 08540 USA; [Ehrenreich, Ian M.] Univ So Calif, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; [Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; [Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08540 USA	Princeton University; University of Southern California; Princeton University; Howard Hughes Medical Institute; Princeton University	Kruglyak, L (corresponding author), Princeton Uniyers, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08540 USA.	leonid@genomics.princeton.edu		Loo, Wesley/0000-0002-8281-8599	National Institutes of Health (NIH) [R37 MH59520, R01 GM102308]; James S. McDonnell Centennial Fellowship; Howard Hughes Medical Institute; National Science Foundation (NSF); NIH postdoctoral fellowship [F32 HG51762]; NIH grant [P50 GM071508]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG005176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102308, P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Centennial Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Botstein, M. McClean, E. Andersen, F. Albert, S. Treusch, R. Ghosh and X. Wang for comments on the manuscript, Y. Jia and S. Schrader for technical assistance and E. Lander for discussions. This work was supported by National Institutes of Health (NIH) grants R37 MH59520 and R01 GM102308, a James S. McDonnell Centennial Fellowship, and the Howard Hughes Medical Institute (L.K.), a National Science Foundation (NSF) fellowship (J.S.B.), NIH postdoctoral fellowship F32 HG51762 (I.M.E.) and NIH grant P50 GM071508 to the Center for Quantitative Biology at the Lewis-Sigler Institute of Princeton University.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Aylor DL, 2011, GENOME RES, V21, P1213, DOI 10.1101/gr.111310.110; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Ehrenreich IM, 2009, COLD SH Q B, V74, P145, DOI 10.1101/sqb.2009.74.013; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Falconer D. S, 1996, INTRO QUANTITATIVE G; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hill WG, 2010, PHILOS T R SOC B, V365, P73, DOI 10.1098/rstb.2009.0203; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	30	272	276	3	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2013	494	7436					234	237		10.1038/nature11867	http://dx.doi.org/10.1038/nature11867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23376951	Green Submitted, Green Accepted			2022-12-24	WOS:000315137700039
J	Liao, HX; Lynch, R; Zhou, TQ; Gao, F; Alam, SM; Boyd, SD; Fire, AZ; Roskin, KM; Schramm, CA; Zhang, ZH; Zhu, J; Shapiro, L; Mullikin, JC; Gnanakaran, S; Hraber, P; Wiehe, K; Kelsoe, G; Yang, G; Xia, SM; Montefiori, DC; Parks, R; Lloyd, KE; Scearce, RM; Soderberg, KA; Cohen, M; Kamanga, G; Louder, MK; Tran, LM; Chen, Y; Cai, FP; Chen, SR; Moquin, S; Du, XL; Joyce, MG; Srivatsan, S; Zhang, BS; Zheng, AQ; Shaw, GM; Hahn, BH; Kepler, TB; Korber, BTM; Kwong, PD; Mascola, JR; Haynes, BF				Liao, Hua-Xin; Lynch, Rebecca; Zhou, Tongqing; Gao, Feng; Alam, S. Munir; Boyd, Scott D.; Fire, Andrew Z.; Roskin, Krishna M.; Schramm, Chaim A.; Zhang, Zhenhai; Zhu, Jiang; Shapiro, Lawrence; Mullikin, James C.; Gnanakaran, S.; Hraber, Peter; Wiehe, Kevin; Kelsoe, Garnett; Yang, Guang; Xia, Shi-Mao; Montefiori, David C.; Parks, Robert; Lloyd, Krissey E.; Scearce, Richard M.; Soderberg, Kelly A.; Cohen, Myron; Kamanga, Gift; Louder, Mark K.; Tran, Lillian M.; Chen, Yue; Cai, Fangping; Chen, Sheri; Moquin, Stephanie; Du, Xiulian; Joyce, M. Gordon; Srivatsan, Sanjay; Zhang, Baoshan; Zheng, Anqi; Shaw, George M.; Hahn, Beatrice H.; Kepler, Thomas B.; Korber, Bette T. M.; Kwong, Peter D.; Mascola, John R.; Haynes, Barton F.		NISC Comparative Sequencing Progra	Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus	NATURE			English	Article							B-CELL RESPONSES; HUMAN MONOCLONAL-ANTIBODIES; IN-SITU PROTEOLYSIS; CD4 BINDING-SITE; CONFORMATIONAL EPITOPE; POTENT NEUTRALIZATION; ENVELOPE GLYCOPROTEIN; SUBTYPE-B; CRYSTALLIZATION; EVOLUTION	Current human immunodeficiency virus-1 (HIV-1) vaccines elicit strain-specific neutralizing antibodies. However, cross-reactive neutralizing antibodies arise in approximately 20% of HIV-1-infected individuals, and details of their generation could provide a blueprint for effective vaccination. Here we report the isolation, evolution and structure of a broadly neutralizing antibody from an African donor followed from the time of infection. The mature antibody, CH103, neutralized approximately 55% of HIV-1 isolates, and its co-crystal structure with the HIV-1 envelope protein gp120 revealed a new loop-based mechanism of CD4-binding-site recognition. Virus and antibody gene sequencing revealed concomitant virus evolution and antibody maturation. Notably, the unmutated common ancestor of the CH103 lineage avidly bound the transmitted/founder HIV-1 envelope glycoprotein, and evolution of antibody neutralization breadth was preceded by extensive viral diversification in and near the CH103 epitope. These data determine the viral and antibody evolution leading to induction of a lineage of HIV-1 broadly neutralizing antibodies, and provide insights into strategies to elicit similar antibodies by vaccination.	[Liao, Hua-Xin; Gao, Feng; Alam, S. Munir; Wiehe, Kevin; Kelsoe, Garnett; Yang, Guang; Xia, Shi-Mao; Montefiori, David C.; Parks, Robert; Lloyd, Krissey E.; Scearce, Richard M.; Soderberg, Kelly A.; Chen, Yue; Cai, Fangping; Chen, Sheri; Haynes, Barton F.] Duke Univ, Sch Med, Dept Med, Human Vaccine Inst, Durham, NC 27710 USA; [Liao, Hua-Xin; Gao, Feng; Alam, S. Munir; Wiehe, Kevin; Kelsoe, Garnett; Yang, Guang; Xia, Shi-Mao; Montefiori, David C.; Parks, Robert; Lloyd, Krissey E.; Scearce, Richard M.; Soderberg, Kelly A.; Chen, Yue; Cai, Fangping; Chen, Sheri; Haynes, Barton F.] Duke Univ, Sch Med, Dept Immunol, Human Vaccine Inst, Durham, NC 27710 USA; [Liao, Hua-Xin; Gao, Feng; Alam, S. Munir; Wiehe, Kevin; Kelsoe, Garnett; Yang, Guang; Xia, Shi-Mao; Montefiori, David C.; Parks, Robert; Lloyd, Krissey E.; Scearce, Richard M.; Soderberg, Kelly A.; Chen, Yue; Cai, Fangping; Chen, Sheri; Haynes, Barton F.] Duke Ctr HIV AIDS Vaccine Immunol & Immunogen Dis, Durham, NC 27710 USA; [Lynch, Rebecca; Zhou, Tongqing; Zhu, Jiang; Shapiro, Lawrence; Louder, Mark K.; Tran, Lillian M.; Moquin, Stephanie; Du, Xiulian; Joyce, M. Gordon; Srivatsan, Sanjay; Zhang, Baoshan; Zheng, Anqi; Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Boyd, Scott D.; Fire, Andrew Z.; Roskin, Krishna M.] Stanford Univ, Dept Pathol, Palo Alto, CA 94305 USA; [Schramm, Chaim A.; Zhang, Zhenhai; Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Mullikin, James C.] NIH, NISC Comparat Sequencing Program, Bethesda, MD 20892 USA; [Mullikin, James C.] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Gnanakaran, S.; Hraber, Peter; Korber, Bette T. M.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87544 USA; [Cohen, Myron] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Cohen, Myron] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Cohen, Myron] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Kamanga, Gift] Univ North Carolina Project, Kamuzu Cent Hosp, Lilongwe, Malawi; [Shaw, George M.; Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Shaw, George M.; Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Kepler, Thomas B.] Boston Univ, Dept Microbiol, Boston, MA 02215 USA	Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stanford University; Columbia University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); United States Department of Energy (DOE); Los Alamos National Laboratory; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Boston University	Liao, HX (corresponding author), Duke Univ, Sch Med, Dept Med, Human Vaccine Inst, Durham, NC 27710 USA.	hliao@duke.edu; barton.haynes@duke.edu	Zhou, Tongqing/A-6880-2010; Zhang, Zhenhai/GRX-5887-2022; Alam, S. Munir/AAC-6711-2019; Mascola, John/AAI-7193-2021; Shapiro, Lawrence/AAE-7172-2019	Zhou, Tongqing/0000-0002-3935-4637; Zhang, Zhenhai/0000-0002-4310-0525; Hraber, Peter/0000-0002-2920-4897; Gnanakaran, S/0000-0002-9368-3044; Fire, Andrew/0000-0001-6217-8312; Kelsoe, Garnett/0000-0002-8770-040X; Hahn, Beatrice/0000-0002-9400-9887; Moquin, Stephanie/0000-0002-8696-4315; Kepler, Thomas/0000-0002-1383-6865; Korber, Bette/0000-0002-2026-5757	National Institutes of Allergy and Infectious Diseases (NIAID); intramural National Institutes of Health (NIH); NIH, NIAID [AI067854, AI100645]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, U01AI067854, UM1AI100645, ZIAAI005022, U19AI067854, ZIAAI005089] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); intramural National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Allergy and Infectious Diseases (NIAID) and by intramural National Institutes of Health (NIH) support for the NIAID Vaccine Research Center, by grants from the NIH, NIAID, AI067854 (the Center for HIV/AIDS Vaccine Immunology) and AI100645 (the Center for Vaccine Immunology-Immunogen Discovery). The authors thank J. Pritchett, H. Chen, D. Pause, M. Cooper, E. Solomon, J. Blinn, K. Yarborough, E. Friberg, M. Smith, A. Hogan, C. Peckels, A. Foulger and T. Jeffries for technical assistance, and J. Kircherr and C. Andrews for project management. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38. The opinions herein are those of the authors and should not be construed as official or representing the views of the US Department of Health and Human Services, National Institute for Allergy and Infectious Diseases.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2011, J VIROL, V85, P11725, DOI 10.1128/JVI.05680-11; Andre S, 1998, J VIROL, V72, P1497; Bai Y, 2007, ACTA CRYSTALLOGR F, V63, P135, DOI 10.1107/S1744309107002904; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Chen W., 2008, AIDS RES HUMAN RETRO, V24; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes Barton F., 2005, Human Antibodies, V14, P59; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Kabat EA, 1991, SEQUENCES PROTEINS I; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Lutteke T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-69; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; Malherbe DC, 2011, J VIROL, V85, P5262, DOI 10.1128/JVI.02419-10; Mandel CR, 2006, ACTA CRYSTALLOGR F, V62, P1041, DOI 10.1107/S1744309106038152; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moir S, 2008, J INFECT DIS, V197, P572, DOI 10.1086/526789; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Moore PL, 2009, CURR OPIN HIV AIDS, V4, P358, DOI 10.1097/COH.0b013e32832ea7e8; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sattentau Quentin J, 2010, F1000 Biol Rep, V2, P60, DOI 10.3410/B2-60; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109; Stamatatos L, 2012, CURR OPIN IMMUNOL, V24, P316, DOI 10.1016/j.coi.2012.04.006; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wolinsky SM, 1996, SCIENCE, V274, P1010, DOI 10.1126/science.274.5289.1010; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zar JH, 1974, BIOSTATISTICAL ANAL; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	71	718	766	5	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					469	+		10.1038/nature12053	http://dx.doi.org/10.1038/nature12053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23552890	Green Accepted, Green Submitted			2022-12-24	WOS:000317984400034
J	Kind, J; Pagie, L; Ortabozkoyun, H; Boyle, S; de Vries, SS; Janssen, H; Amendola, M; Nolen, LD; Bickmore, WA; van Steensel, B				Kind, Jop; Pagie, Ludo; Ortabozkoyun, Havva; Boyle, Shelagh; de Vries, Sandra S.; Janssen, Hans; Amendola, Mario; Nolen, Leisha D.; Bickmore, Wendy A.; van Steensel, Bas			Single-Cell Dynamics of Genome-Nuclear Lamina Interactions	CELL			English	Article							HISTONE H3; CHROMATIN DYNAMICS; EARLY G1; METHYLATION; G9A; HETEROCHROMATIN; MITOSIS; GENES; POSITIONS; DOMAINS	The nuclear lamina (NL) interacts with hundreds of large genomic regions termed lamina associated domains (LADs). The dynamics of these interactions and the relation to epigenetic modifications are poorly understood. We visualized the fate of LADs in single cells using a "molecular contact memory" approach. In each nucleus, only similar to 30% of LADs are positioned at the periphery; these LADs are in intermittent molecular contact with the NL but remain constrained to the periphery. Upon mitosis, LAD positioning is not detectably inherited but instead is stochastically reshuffled. Contact of individual LADs with the NL is linked to transcriptional repression and H3K9 dimethylation in single cells. Furthermore, we identify the H3K9 methyltransferase G9a as a regulator of NL contacts. Collectively, these results highlight principles of the dynamic spatial architecture of chromosomes in relation to gene regulation.	[Kind, Jop; Pagie, Ludo; Ortabozkoyun, Havva; de Vries, Sandra S.; Amendola, Mario; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Janssen, Hans] Netherlands Canc Inst, Electron Microscopy Facil, NL-1066 CX Amsterdam, Netherlands; [Boyle, Shelagh; Nolen, Leisha D.; Bickmore, Wendy A.] Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	Netherlands Cancer Institute; Netherlands Cancer Institute; University of Edinburgh	Kind, J (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.kind@nki.nl; b.v.steensel@nki.nl	t, lf/AAJ-4924-2020; amendola, mario/I-1728-2017; Bickmore, Wendy/C-7314-2013	amendola, mario/0000-0002-1188-8856; Bickmore, Wendy/0000-0001-6660-7735	EMBO LTF; NWO-ALW VENI; NWO-ALW VICI; ERC Advanced grant [293662, 249956]; MRC; Medical Research Council [MC_PC_U127527202] Funding Source: researchfish; MRC [MC_PC_U127527202] Funding Source: UKRI	EMBO LTF(European Molecular Biology Organization (EMBO)); NWO-ALW VENI(Netherlands Organization for Scientific Research (NWO)); NWO-ALW VICI(Netherlands Organization for Scientific Research (NWO)); ERC Advanced grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Wouter Meuleman for help with FISH probe pool design; Federica Morettini for the scoring of FISH images; the NKI Genomics Core Facility for microarray hybridizations and RNA-seq; and the Wolthuis and Neefjes laboratories for reagents. This work was supported by EMBO LTF and NWO-ALW VENI (J.K.), NWO-ALW VICI and ERC Advanced grant 293662 (B.v.S.), and MRC and ERC Advanced grant 249956 (W.A.B.).	Abney JR, 1997, J CELL BIOL, V137, P1459, DOI 10.1083/jcb.137.7.1459; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Boyle S, 2011, CHROMOSOME RES, V19, P901, DOI 10.1007/s10577-011-9245-0; Carpenter AE, 2005, MOL CELL BIOL, V25, P958, DOI 10.1128/MCB.25.3.958-968.2005; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; de Oca RM, 2011, NUCLEUS-PHILA, V2, P580, DOI 10.4161/nucl.2.6.17960; Dialynas G, 2010, DEVELOPMENT, V137, P3067, DOI 10.1242/dev.048231; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hermann A, 2003, BIOTECHNIQUES, V34, P924, DOI 10.2144/03345bm05; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lionnet T, 2012, EMBO REP, V13, P313, DOI 10.1038/embor.2012.31; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Nemeth A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000889; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Quinn AM, 2010, MOL BIOSYST, V6, P782, DOI 10.1039/b921912a; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Shevelyov YY, 2012, CURR ISSUES MOL BIOL, V14, P27; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Siwek W, 2012, NUCLEIC ACIDS RES, V40, P7563, DOI 10.1093/nar/gks428; Strickfaden H, 2010, NUCLEUS-PHILA, V1, P284, DOI 10.4161/nucl.1.3.11969; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Tumbar T, 2001, NAT CELL BIOL, V3, P134, DOI 10.1038/35055033; van Koningsbruggen S, 2010, MOL BIOL CELL, V21, P3735, DOI 10.1091/mbc.E10-06-0508; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wu R, 2005, MOL BIOL CELL, V16, P2872, DOI 10.1091/mbc.e04-11-0997; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106	49	434	447	1	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					178	192		10.1016/j.cell.2013.02.028	http://dx.doi.org/10.1016/j.cell.2013.02.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23523135	Bronze			2022-12-24	WOS:000316853700015
J	Morita, M; Kuba, K; Ichikawa, A; Nakayama, M; Katahira, J; Iwamoto, R; Watanebe, T; Sakabe, S; Daidoji, T; Nakamura, S; Kadowaki, A; Ohto, T; Nakanishi, H; Taguchi, R; Nakaya, T; Murakami, M; Yoneda, Y; Arai, H; Kawaoka, Y; Penninger, JM; Arita, M; Imai, Y				Morita, Masayuki; Kuba, Keiji; Ichikawa, Akihiko; Nakayama, Mizuho; Katahira, Jun; Iwamoto, Ryo; Watanebe, Tokiko; Sakabe, Saori; Daidoji, Tomo; Nakamura, Shota; Kadowaki, Ayumi; Ohto, Takayo; Nakanishi, Hiroki; Taguchi, Ryo; Nakaya, Takaaki; Murakami, Makoto; Yoneda, Yoshihiro; Arai, Hiroyuki; Kawaoka, Yoshihiro; Penninger, Josef M.; Arita, Makoto; Imai, Yumiko			The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza	CELL			English	Article							MESSENGER-RNA EXPORT; NUCLEAR-PORE COMPLEX; INFLAMMATION; RESOLUTION; PATHWAYS; REVEALS; MICE; SEQ; EXPRESSION; DEPENDENCE	Influenza A viruses are a major cause of mortality. Given the potential for future lethal pandemics, effective drugs are needed for the treatment of severe influenza such as that caused by H5N1 viruses. Using mediator lipidomics and bioactive lipid screen, we report that the omega-3 polyunsaturated fatty acid (PUFA)-derived lipid mediator protectin D1 (PD1) markedly attenuated influenza virus replication via RNA export machinery. Production of PD1 was suppressed during severe influenza and PD1 levels inversely correlated with the pathogenicity of H5N1 viruses. Suppression of PD1 was genetically mapped to 12/15-lipoxygenase activity. Importantly, PD1 treatment improved the survival and pathology of severe influenza in mice, even under conditions where known antiviral drugs fail to protect from death. These results identify the endogenous lipid mediator PD1 as an innate suppressor of influenza virus replication that protects against lethal influenza virus infection.	[Morita, Masayuki; Kuba, Keiji; Ichikawa, Akihiko; Nakayama, Mizuho; Kadowaki, Ayumi; Ohto, Takayo; Imai, Yumiko] Akita Univ, Dept Biol Informat & Expt Therapeut, Grad Sch Med, Akita 0108543, Japan; [Katahira, Jun; Yoneda, Yoshihiro] Osaka Univ, Biomol Networks Labs, Biomol Dynam Lab, Grad Sch Frontier Biosci, Osaka 5650871, Japan; [Nakamura, Shota] Osaka Univ, Dept Infect Metagen, Microbial Dis Res Inst, Osaka 5650871, Japan; [Iwamoto, Ryo; Arai, Hiroyuki; Arita, Makoto] Univ Tokyo, Dept Hlth Chem, Tokyo 1130033, Japan; [Iwamoto, Ryo] Univ Tokyo, Business Acad Collaborat Lab, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Watanebe, Tokiko; Sakabe, Saori; Kawaoka, Yoshihiro] Univ Tokyo, Div Virol, Dept Microbiol & Immunol, Tokyo 1130033, Japan; [Watanebe, Tokiko; Sakabe, Saori; Kawaoka, Yoshihiro] Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Tokyo 1130033, Japan; [Nakanishi, Hiroki; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Tokyo 1130033, Japan; [Watanebe, Tokiko; Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan; [Arita, Makoto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Watanebe, Tokiko; Sakabe, Saori; Kawaoka, Yoshihiro] Univ Wisconsin, Influenza Res Inst, Madison, WI 53711 USA; [Daidoji, Tomo; Nakaya, Takaaki] Kyoto Prefectural Univ Med, Dept Infect Dis, Kyoto 6028566, Japan; [Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Biomembrane Signaling Project, Tokyo 1568506, Japan; [Penninger, Josef M.] Austrian Acad Sci, IMBA Inst Mol Biotechnol, A-1030 Vienna, Austria	Akita University; Osaka University; Osaka University; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Wisconsin System; University of Wisconsin Madison; Kyoto Prefectural University of Medicine; Tokyo Metropolitan Institute of Medical Science; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Imai, Y (corresponding author), Akita Univ, Dept Biol Informat & Expt Therapeut, Grad Sch Med, Akita 0108543, Japan.	imai@med.akita-u.ac.jp	Penninger, Josef M/I-6860-2013; Imai, Yumiko/GXW-1144-2022; Nakamura, Shota/E-3033-2010	Penninger, Josef M/0000-0002-8194-3777; Nakamura, Shota/0000-0003-2058-5942; Katahira, Jun/0000-0001-5188-0368; Arita, Makoto/0000-0001-9902-0463; Nakanishi, Hiroki/0000-0002-5108-1598	Funding Program for Next Generation World-Leading Researchers (NEXT Program, JSPS); Center of Education and Research for the Advanced Genome-Based Medicine-For Personalized Medicine and the Control of Worldwide Infectious Diseases; Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology; ERATO (Japan Science and Technology Agency); Public Health Service research grants from the National Institute of Allergy and Infectious Diseases; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science, and Technology of Japan; IMBA; Advanced ERC grant; European Union; Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industry; Grants-in-Aid for Scientific Research [24619007] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers (NEXT Program, JSPS); Center of Education and Research for the Advanced Genome-Based Medicine-For Personalized Medicine and the Control of Worldwide Infectious Diseases; Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology; ERATO (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); Public Health Service research grants from the National Institute of Allergy and Infectious Diseases; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); IMBA; Advanced ERC grant; European Union(European Commission); Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all members of our laboratories for helpful discussions. We gratefully thank Ms. Michiko Kamio for technical assistance on LC-MS/MS analyses. Y.I. and K.K. are supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program, JSPS). Y.K. is supported by the "Center of Education and Research for the Advanced Genome-Based Medicine-For Personalized Medicine and the Control of Worldwide Infectious Diseases,'' by a grant-in-aid for Specially Promoted Research and by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, by ERATO (Japan Science and Technology Agency), and by Public Health Service research grants from the National Institute of Allergy and Infectious Diseases. M.A. is supported by a grant-in-aid from the Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO), and a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. J.M.P. is supported by IMBA and an Advanced ERC grant by the European Union. H.A. and M.A. are supported in part by the Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industry.	Amorim MJ, 2007, TRAFFIC, V8, P1, DOI 10.1111/j.1600-0854.2006.00507.x; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Arya V, 2010, CLIN PHARMACOL THER, V88, P587, DOI 10.1038/clpt.2010.187; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; Chanez P, 2002, AM J RESP CELL MOL, V27, P655, DOI 10.1165/rcmb.F253; Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Herold A, 2001, RNA, V7, P1768; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; Ho DN, 2002, P NATL ACAD SCI USA, V99, P1888, DOI 10.1073/pnas.042698599; Ichikawa A, 2013, AM J RESP CRIT CARE, V187, P65, DOI 10.1164/rccm.201203-0508OC; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Isobe Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00270; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kumar A, 2011, J ANTIMICROB CHEMOTH, V66, P959, DOI 10.1093/jac/dkr090; Kumar S, 2010, PEDIATR INFECT DIS J, V29, P591, DOI 10.1097/INF.0b013e3181d73e32; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Liker E, 2000, EMBO J, V19, P5587, DOI 10.1093/emboj/19.21.5587; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Monette A, 2011, J CELL BIOL, V193, P619, DOI 10.1083/jcb.201008064; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; PAPAYIANNI A, 1995, KIDNEY INT, V47, P1295, DOI 10.1038/ki.1995.184; Read EKC, 2010, J GEN VIROL, V91, P1290, DOI 10.1099/vir.0.018564-0; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rodriguez-Navarro S, 2011, CURR OPIN CELL BIOL, V23, P302, DOI 10.1016/j.ceb.2010.12.002; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Schneider J, 2009, VACCINE, V27, P6312, DOI 10.1016/j.vaccine.2009.01.015; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Serhan CN, 2003, CHEM IMMUNOL, V83, P115; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Sly PD, 2003, J APPL PHYSIOL, V94, P1460, DOI 10.1152/japplphysiol.00596.2002; Smith JH, 2011, VIRAL IMMUNOL, V24, P131, DOI 10.1089/vim.2010.0085; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stewart M, 2010, TRENDS BIOCHEM SCI, V35, P609, DOI 10.1016/j.tibs.2010.07.001; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Yatherajam G, 2011, J VIROL, V85, P1429, DOI 10.1128/JVI.02108-10	51	314	324	4	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 28	2013	153	1					112	125		10.1016/j.cell.2013.02.027	http://dx.doi.org/10.1016/j.cell.2013.02.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23477864	Bronze			2022-12-24	WOS:000316853700010
J	Kafri, R; Levy, J; Ginzberg, MB; Oh, S; Lahav, G; Kirschner, MW				Kafri, Ran; Levy, Jason; Ginzberg, Miriam B.; Oh, Seungeun; Lahav, Galit; Kirschner, Marc W.			Dynamics extracted from fixed cells reveal feedback linking cell growth to cell cycle	NATURE			English	Article							MASS	Biologists have long been concerned about what constrains variation in cell size, but progress in this field has been slow and stymied by experimental limitations'. Here we describe a new method, ergodic rate analysis (ERA), that uses single-cell measurements of fixed steady-state populations to accurately infer the rates of molecular events, including rates of cell growth. ERA exploits the fact that the number of cells in a particular state is related to the average transit time through that state(2). With this method, it is possible to calculate full time trajectories of any feature that can be labelled in fixed cells, for example levels of phosphoproteins or total cellular mass. Using ERA we find evidence for a size-discriminatory process at the G1/S transition that acts to decrease cell-to-cell size variation.	[Kafri, Ran; Ginzberg, Miriam B.; Oh, Seungeun; Lahav, Galit; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Levy, Jason] Univ Ottawa, Dept Math & Stat, Ottawa, ON K1N 6N5, Canada	Harvard University; Harvard Medical School; University of Ottawa	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu		Oh, Seungeun/0000-0002-4064-9301; Ginzberg, Miriam/0000-0001-8431-3714	National Institute of General Medical Sciences [GM26875]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083303, R01GM026875, R37GM026875] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Klein, Y. Merbl, S. Tal and J. Toettcher for consistent and valuable insights at the beginning of and throughout this project. We thank J. Waters and the staff of The Nikon Imaging Center at Harvard Medical School for help and support. We especially thank R. Ward for her critique of the paper and the National Institute of General Medical Sciences (GM26875) for support of this work.	Deen, 2012, ANAL TRANSPORT PHENO; HENDRIX RW, 1974, NATURE, V247, P145, DOI 10.1038/247145a0; Jacobberger JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030870; KILLANDER D, 1965, EXP CELL RES, V40, P12, DOI 10.1016/0014-4827(65)90285-5; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Mitchison JM, 2003, INT REV CYTOL, V226, P165, DOI 10.1016/S0074-7696(03)01004-0; MITCHISON JM, 1971, BIOL CELL CYCLE, P128; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Son S, 2012, NAT METHODS, V9, P910, DOI 10.1038/nmeth.2133; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294	11	146	146	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					480	483		10.1038/nature11897	http://dx.doi.org/10.1038/nature11897			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446419	Green Accepted			2022-12-24	WOS:000315661500039
J	Kwak, H; Fuda, NJ; Core, LJ; Lis, JT				Kwak, Hojoong; Fuda, Nicholas J.; Core, Leighton J.; Lis, John T.			Precise Maps of RNA Polymerase Reveal How Promoters Direct Initiation and Pausing	SCIENCE			English	Article							TRANSCRIPTION ELONGATION; DROSOPHILA-MELANOGASTER; NUCLEOSOME ORGANIZATION; HSP70 PROMOTER; CORE PROMOTER; TATA ELEMENT; IN-VIVO; GENES; DOWNSTREAM; RESOLUTION	Transcription regulation occurs frequently through promoter-associated pausing of RNA polymerase II (Pol II). We developed a precision nuclear run-on and sequencing (PRO-seq) assay to map the genome-wide distribution of transcriptionally engaged Pol II at base pair resolution. Pol II accumulates immediately downstream of promoters, at intron-exon junctions that are efficiently used for splicing, and over 3' polyadenylation sites. Focused analyses of promoters reveal that pausing is not fixed relative to initiation sites, nor is it specified directly by the position of a particular core promoter element or the first nucleosome. Core promoter elements function beyond initiation, and when optimally positioned they act collectively to dictate the position and strength of pausing. This "complex interaction" model was tested with insertional mutagenesis of the Drosophila Hsp70 core promoter.	[Kwak, Hojoong; Fuda, Nicholas J.; Core, Leighton J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Core, LJ (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	ljc37@cornell.edu; jtl10@cornell.edu			NIH [GM25232, HG004845]; Howard Hughes Medical Institute fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025232, R01GM025232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute fellowship(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants GM25232 and HG004845 (J.T.L.) and a Howard Hughes Medical Institute fellowship (H. K.). Sequence data are in the Gene Expression Omnibus (GEO) database under accession number GSE42117. Part of this work is included in a broader U.S. patent application (12/554,472, "Genome-wide Method for Mapping of Engaged RNA Polymerases Quantitatively and at High Resolution"), which refers to variants of the method that we use here.	Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; EMANUEL PA, 1993, P NATL ACAD SCI USA, V90, P8449, DOI 10.1073/pnas.90.18.8449; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sharma S., 2012, THESIS CORNELL U ITH; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Wu CH, 2001, MOL CELL BIOL, V21, P1593, DOI 10.1128/MCB.21.5.1593-1602.2001; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	29	424	428	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					950	953		10.1126/science.1229386	http://dx.doi.org/10.1126/science.1229386			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430654	Green Accepted			2022-12-24	WOS:000315149600047
J	Henschke, CI; Yip, R; Yankelevitz, DF; Smith, JP				Henschke, Claudia I.; Yip, Rowena; Yankelevitz, David F.; Smith, James P.		Int Early Lung Canc Action Program	Definition of a Positive Test Result in Computed Tomography Screening for Lung Cancer A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							BASE-LINE	Background: Low-dose computed tomography screening for lung cancer can reduce mortality among high-risk persons, but "false-positive" findings may result in unnecessary evaluations with attendant risks. The effect of alternative thresholds for defining a positive result on the rates of positive results and cancer diagnoses is unknown. Objective: To assess the frequency of positive results and potential delays in diagnosis in the baseline round of screening by using more restrictive thresholds. Design: Prospective cohort study. Setting: Multi-institutional International Early Lung Cancer Action Program. Patients: 21 136 participants with baseline computed tomography performed between 2006 and 2010. Measurements: The frequency of solid and part-solid pulmonary nodules and the rate of lung cancer diagnosis by using current (5 mm) and more restrictive thresholds of nodule diameter. Results: The frequency of positive results in the baseline round by using the current definition of positive result (any parenchymal, solid or part-solid, noncalcified nodule >= 5.0 mm) was 16% (3396/21 136). When alternative threshold values of 6.0, 7.0, 8.0 and 9.0 mm were used, the frequencies of positive results were 10.2% (95% CI, 9.8% to 10.6%), 7.1% (CI, 6.7% to 7.4%), 5.1% (CI, 4.8% to 5.4%), and 4.0% (CI, 3.7% to 4.2%), respectively. Use of these alternative definitions would have reduced the work-up by 36%, 56%, 68%, and 75%, respectively. Concomitantly, lung cancer diagnostics would have been delayed by at most 9 months for 0%, 5.0% (CI, 1.1% to 9.0%), 5.9% (CI, 1.7 to 10.1%), and 6.7% (CI, 2.2% to 11.2%) of the cases of cancer, respectively. Limitation: This was a retrospective analysis and thus whether delays in diagnosis would have altered outcomes cannot be determined. Conclusion: These findings suggest that using a threshold of 7 or 8 mm to define positive results in the baseline round of computed tomography screening for lung cancer should be prospectively evaluated to determine whether the benefits of decreasing further work-up outweigh the consequent delay in diagnosis in some patients.	Mt Sinai Med Ctr, New York, NY 10029 USA; Mt Sinai Sch Med, New York, NY 10029 USA; Weill Cornell Med Coll, New York, NY 10065 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cornell University	Henschke, CI (corresponding author), Mt Sinai Sch Med, Dept Radiol, 1 Gustave L Levy Pl, New York, NY 10029 USA.	Claudia.Henschke@mountsinai.org	Zulueta, Javier J/H-5127-2011	Zulueta, Javier J/0000-0003-3182-3555; Aye, Ralph/0000-0003-3726-6673	Flight Attendant Medical Research Institute; American Legacy Foundation; Department of Energy [DE-FG02-96SF21260]; Israel Cancer Association; Rogers Family Fund; Yad-Hanadiv Foundation; Jacob and Malka Goldfarb Charitable Foundation; Auen/Berger Foundation; Princess Margaret Foundation; Berger Foundation; Mills Peninsula Hospital Foundation; Columbia University Medical Center; Mount Sinai Medical Center; Weill Medical College of Cornell University; Cornell University; New York Presbyterian Hospital; Swedish Hospital; Christiana Care Helen F. Graham Cancer Center; Holy Cross Hospital; Eisenhower Hospital; Jackson Memorial Hospital Health System; Evanston Northwestern Healthcare	Flight Attendant Medical Research Institute; American Legacy Foundation; Department of Energy(United States Department of Energy (DOE)); Israel Cancer Association; Rogers Family Fund; Yad-Hanadiv Foundation; Jacob and Malka Goldfarb Charitable Foundation; Auen/Berger Foundation; Princess Margaret Foundation; Berger Foundation; Mills Peninsula Hospital Foundation; Columbia University Medical Center; Mount Sinai Medical Center; Weill Medical College of Cornell University(General Electric); Cornell University; New York Presbyterian Hospital; Swedish Hospital; Christiana Care Helen F. Graham Cancer Center; Holy Cross Hospital; Eisenhower Hospital; Jackson Memorial Hospital Health System; Evanston Northwestern Healthcare	In part by the Flight Attendant Medical Research Institute, the American Legacy Foundation, Department of Energy (DE-FG02-96SF21260), Israel Cancer Association, The Rogers Family Fund, Yad-Hanadiv Foundation, Jacob and Malka Goldfarb Charitable Foundation, Auen/Berger Foundation, Princess Margaret Foundation, Berger Foundation, Mills Peninsula Hospital Foundation, Columbia University Medical Center, Mount Sinai Medical Center, Weill Medical College of Cornell University, Cornell University, New York Presbyterian Hospital, Swedish Hospital, Christiana Care Helen F. Graham Cancer Center, Holy Cross Hospital, Eisenhower Hospital, Jackson Memorial Hospital Health System, and Evanston Northwestern Healthcare.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; [Anonymous], 2010, NY TIMES, pA34; Carter D, 2007, LUNG CANCER, V56, P193, DOI 10.1016/j.lungcan.2006.12.001; Harris G, 2010, NY TIMES, P1; Henschke CI, 2004, RADIOLOGY, V231, P164, DOI 10.1148/radiol.2311030634; Henschke CI, 2002, LUNG CANCER-J IASLC, V35, P143, DOI 10.1016/S0169-5002(01)00416-0; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke CI., INT EARLY LUNG CANC; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Henschke CI, 2012, RADIOLOGY, V263, P578, DOI 10.1148/radiol.12102489; International Early Lung Cancer Action Program Investigators, INT EARL LUNG CANC A; Libby DM, 2006, CHEST, V129, P1039, DOI 10.1378/chest.129.4.1039; Miettinen OS, 2011, EPIDEMIOLOGIC RES TE; New York Early Cancer Action Inv, 2007, RADIOLOGY, V243, P239, DOI 10.1148/radiol.2431060467; Parker-Pope T, 2010, NY TIMES, pD5; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Vazquez M, 2009, LUNG CANCER, V64, P148, DOI 10.1016/j.lungcan.2008.08.009	18	155	161	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4					246	252		10.7326/0003-4819-158-4-201302190-00004	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420233				2022-12-24	WOS:000315580300015
J	Meyers, MA; McKittrick, J; Chen, PY				Meyers, Marc Andre; McKittrick, Joanna; Chen, Po-Yu			Structural Biological Materials: Critical Mechanics-Materials Connections	SCIENCE			English	Review							SACRIFICIAL BONDS; COLLAGEN FIBRILS; MINERAL BRIDGES; TOUGHNESS; BEHAVIOR; NACRE; FRACTURE; DESIGN; MODEL; DEFORMATION	Spider silk is extraordinarily strong, mollusk shells and bone are tough, and porcupine quills and feathers resist buckling. How are these notable properties achieved? The building blocks of the materials listed above are primarily minerals and biopolymers, mostly in combination; the first weak in tension and the second weak in compression. The intricate and ingenious hierarchical structures are responsible for the outstanding performance of each material. Toughness is conferred by the presence of controlled interfacial features (friction, hydrogen bonds, chain straightening and stretching); buckling resistance can be achieved by filling a slender column with a lightweight foam. Here, we present and interpret selected examples of these and other biological materials. Structural bio-inspired materials design makes use of the biological structures by inserting synthetic materials and processes that augment the structures' capability while retaining their essential features. In this Review, we explain this idea through some unusual concepts.	[Meyers, Marc Andre; McKittrick, Joanna] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Meyers, Marc Andre; McKittrick, Joanna] Univ Calif San Diego, Mat Sci & Engn Program, La Jolla, CA 92093 USA; [Meyers, Marc Andre] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA; [Chen, Po-Yu] Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu 30013, Taiwan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Tsing Hua University	Meyers, MA (corresponding author), Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA.	mameyers@ucsd.edu	Meyers, Marc A/A-2970-2016	Meyers, Marc A/0000-0003-1698-5396; McKittrick, Joanna/0000-0002-1442-3472	NSF [1006931]; National Science Council, Taiwan [NSC-100-2218-E-007-016-MY3, NSC-101-2628-E-007-017-MY3]	NSF(National Science Foundation (NSF)); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	We thank W. Yang and C.-H. Lu for help with the figures. This work is funded by the NSF, Ceramics Program grant 1006931 (M. A. M. and J.M.), and the National Science Council, Taiwan, grants NSC-100-2218-E-007-016-MY3 and NSC-101-2628-E-007-017-MY3 (P.-Y.C.).	Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Aizenberg J, 2010, MRS BULL, V35, P323, DOI 10.1557/mrs2010.555; Aladin DMK, 2010, J ORTHOP RES, V28, P497, DOI 10.1002/jor.21010; [Anonymous], 2010, CELLULAR MAT NATURE; ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6; Arzt E, 2006, MAT SCI ENG C-BIO S, V26, P1245, DOI 10.1016/j.msec.2005.08.033; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; Chan EP, 2007, MRS BULL, V32, P496, DOI 10.1557/mrs2007.84; Chen PY, 2009, ACTA BIOMATER, V5, P693, DOI 10.1016/j.actbio.2008.09.011; Chen PY, 2008, ACTA BIOMATER, V4, P587, DOI 10.1016/j.actbio.2007.12.010; Chen PY, 2012, PROG MATER SCI, V57, P1492, DOI 10.1016/j.pmatsci.2012.03.001; Chiadini F, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/2/026002; Currey J, 2001, NATURE, V414, P699, DOI 10.1038/414699a; Currey J., 2002, BONE STRUCTURE MECH; CURREY JD, 1984, PHILOS T ROY SOC B, V304, P509, DOI 10.1098/rstb.1984.0042; Erb RM, 2012, SCIENCE, V335, P199, DOI 10.1126/science.1210822; Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339; Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428; Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966; Fung Y.C., 1993, BIOMECHANICS MECH PR; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u; Gibson LJ, 1997, CELLULAR SOLIDS STRU; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Jin K, 2012, LANGMUIR, V28, P5737, DOI 10.1021/la204040p; KARAM GN, 1995, INT J SOLIDS STRUCT, V32, P1259, DOI 10.1016/0020-7683(94)00147-O; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; Launey ME, 2010, ACTA BIOMATER, V6, P1505, DOI 10.1016/j.actbio.2009.11.026; Launey ME, 2010, ANNU REV MATER RES, V40, P25, DOI [10.1146/annurev-matsci-070909-104427, 10.1146/annurev-matsci-070909-10442]; Lee SJ, 2005, FLUID DYN RES, V37, P246, DOI 10.1016/j.fluiddyn.2005.05.002; Lin AYM, 2009, J MECH BEHAV BIOMED, V2, P607, DOI 10.1016/j.jmbbm.2009.04.003; Lingham-Soliar T, 2010, P ROY SOC B-BIOL SCI, V277, P1161, DOI 10.1098/rspb.2009.1980; Melnick CA, 1996, J MATER RES, V11, P2903, DOI 10.1557/JMR.1996.0367; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; Miserez A, 2009, NAT MATER, V8, P910, DOI [10.1038/NMAT2547, 10.1038/nmat2547]; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; Nalla RK, 2005, BIOMATERIALS, V26, P217, DOI 10.1016/j.biomaterials.2004.02.017; Nikolov S, 2010, ADV MATER, V22, P519, DOI 10.1002/adma.200902019; Oeffner J, 2012, J EXP BIOL, V215, P785, DOI 10.1242/jeb.063040; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Porter MM, 2012, MAT SCI ENG A-STRUCT, V556, P741, DOI 10.1016/j.msea.2012.07.058; PURSLOW PP, 1978, J EXP BIOL, V72, P251; Qiao L, 2008, J INORG MATER, V23, P337, DOI 10.3724/SP.J.1077.2008.00337; Raabe D, 2005, ACTA MATER, V53, P4281, DOI 10.1016/j.actamat.2005.05.027; Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3; Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i; Seki Y, 2005, ACTA MATER, V53, P5281, DOI 10.1016/j.actamat.2005.04.048; Sethi S, 2008, NANO LETT, V8, P822, DOI 10.1021/nl0727765; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; Song F, 2001, ACTA MECH SINICA, V17, P251; Sun TL, 2005, ACCOUNTS CHEM RES, V38, P644, DOI 10.1021/ar040224c; Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a; Timoshenko S., 1936, THEORY ELASTIC STABI; Vincent J. F. V., 1991, STRUCTURAL BIOMATERI; Viswanath PR, 2002, PROG AEROSP SCI, V38, P571, DOI 10.1016/S0376-0421(02)00048-9; Yang W, 2013, ACTA BIOMATER, V9, P5297, DOI 10.1016/j.actbio.2012.09.004	57	667	688	69	1212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					773	779		10.1126/science.1220854	http://dx.doi.org/10.1126/science.1220854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413348				2022-12-24	WOS:000314874400037
J	Burnaevskiy, N; Fox, TG; Plymire, DA; Ertelt, JM; Weigele, BA; Selyunin, AS; Way, SS; Patrie, SM; Alto, NM				Burnaevskiy, Nikolay; Fox, Thomas G.; Plymire, Daniel A.; Ertelt, James M.; Weigele, Bethany A.; Selyunin, Andrey S.; Way, Sing Sing; Patrie, Steven M.; Alto, Neal M.			Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ	NATURE			English	Article							PROTEIN; EFFECTOR; COMPLEX; GTPASE; IDENTIFICATION; INACTIVATION; AUTOPHAGY; SEQUENCE; GLYCINE; FAMILY	Protein N-myristoylation is a 14-carbon fatty-acid modification that is conserved across eukaryotic species and occurs on nearly 1% of the cellular proteome(1,2). The ability of the myristoyl group to facilitate dynamic protein-protein and protein-membrane interactions (known as the myristoyl switch) makes it an essential feature of many signal transduction systems(3). Thus pathogenic strategies that facilitate protein demyristoylation would markedly alter the signalling landscape of infected host cells. Here we describe an irreversible mechanism of protein demyristoylation catalysed by invasion plasmid antigen J (IpaJ), a previously uncharacterized Shigella flexneri type III effector protein with cysteine protease activity. A yeast genetic screen for IpaJ substrates identified ADP-ribosylation factor (ARF)1p and ARF2p, small molecular mass GTPases that regulate cargo transport through the Golgi apparatus(4). Mass spectrometry showed that IpaJ cleaved the peptide bond between N-myristoylated glycine-2 and asparagine-3 of human ARF1, thereby providing a new mechanism for host secretory inhibition by a bacterial pathogen(5,6). We further demonstrate that IpaJ cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. Taken together, these findings show a previously unrecognized pathogenic mechanism for the site-specific elimination of N-myristoyl protein modification.	[Burnaevskiy, Nikolay; Weigele, Bethany A.; Selyunin, Andrey S.; Alto, Neal M.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Fox, Thomas G.] Indiana Univ Sch Med, Sect Pediat Infect Dis, Dept Pediat, Indianapolis, IN 46202 USA; [Plymire, Daniel A.; Patrie, Steven M.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Ertelt, James M.; Way, Sing Sing] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University Bloomington; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Alto, NM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	neal.alto@utsouthwestern.edu		Way, Sing Sing/0000-0001-8948-1952; Fox, Thomas/0000-0002-3418-3832	Cancer Prevention and Research Institute of Texas [RP120613]; Howard Hughes Medical Institute; National Institutes of Health (NIAID) [5T32AI007520, RO1AI083359]; Burroughs Wellcome Fund; National Institutes of Health (NIGMS) [R01GM100486]; Welch Foundation [I-1704]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083359, R01AI100934, T32AI007520, R01AI087830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100486] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our colleagues at University of Texas Southwestern Medical Center, specifically K. Orth, Y. M. Chook and J. Seeman, for discussions in preparing this manuscript. We are particularly indebted to L. Kinch, N. Grishin, D. Mitchel, X. Guo, D. Trudgian and S. Perelman for their contributions. We acknowledge the services of the University of Texas Southwestern Medical Center proteomics core, supported by a Cancer Prevention and Research Institute of Texas grant RP120613. A. S. S. was supported by the Howard Hughes Medical Institute International Student Research fellowship. B. A. W. was supported by a National Institutes of Health training grant (NIAID; 5T32AI007520) and S. S. W. by the Burroughs Wellcome Fund. This work was supported by grants from the National Institutes of Health (NIAID; RO1AI083359 and NIGMS; R01GM100486), the Welch Foundation (I-1704) and the Burroughs Wellcome Fund to N.M.A.	Alto NM, 2008, METHOD ENZYMOL, V439, P131, DOI 10.1016/S0076-6879(07)00410-7; Ashida H, 2011, CURR OPIN IMMUNOL, V23, P448, DOI 10.1016/j.coi.2011.06.001; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Buysse JM, 1997, MICROB PATHOGENESIS, V23, P357, DOI 10.1006/mpat.1997.0164; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Franco M, 1996, J BIOL CHEM, V271, P1573, DOI 10.1074/jbc.271.3.1573; HERMAN PK, 1991, CELL, V64, P425, DOI 10.1016/0092-8674(91)90650-N; Kahn RA, 2009, FEBS LETT, V583, P3872, DOI 10.1016/j.febslet.2009.10.066; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; Kelleher NL, 2004, ANAL CHEM, V76, p196A, DOI 10.1021/ac0415657; Liu MQ, 2002, PLASMID, V48, P59, DOI 10.1016/S0147-619X(02)00008-2; Liu YZ, 2010, NAT STRUCT MOL BIOL, V17, P876, DOI 10.1038/nsmb.1853; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Maurer-Stroh S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r21; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Michiels J, 2001, TRENDS MICROBIOL, V9, P164, DOI 10.1016/S0966-842X(01)01979-5; Mounier J, 2012, CELL HOST MICROBE, V12, P381, DOI 10.1016/j.chom.2012.07.010; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Phalipon A, 2003, CRIT REV IMMUNOL, V23, P371, DOI 10.1615/CritRevImmunol.v23.i56.20; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Roth MJ, 2011, ANAL CHEM, V83, P9586, DOI 10.1021/ac202339x; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Shima DT, 1997, J CELL BIOL, V137, P1211, DOI 10.1083/jcb.137.6.1211; Slagowski NL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040009; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Sze SK, 2002, P NATL ACAD SCI USA, V99, P1774, DOI 10.1073/pnas.251691898; Way SS, 1998, INFECT IMMUN, V66, P1342, DOI 10.1128/IAI.66.4.1342-1348.1998	36	103	106	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					106	+		10.1038/nature12004	http://dx.doi.org/10.1038/nature12004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23535599	Green Accepted			2022-12-24	WOS:000316993400034
J	Klein, F; Diskin, R; Scheid, JF; Gaebler, C; Mouquet, H; Georgiev, IS; Pancera, M; Zhou, TQ; Incesu, RB; Fu, BZ; Gnanapragasam, PNP; Oliveira, TY; Seaman, MS; Kwong, PD; Bjorkman, PJ; Nussenzweig, MC				Klein, Florian; Diskin, Ron; Scheid, Johannes F.; Gaebler, Christian; Mouquet, Hugo; Georgiev, Ivelin S.; Pancera, Marie; Zhou, Tongqing; Incesu, Reha-Baris; Fu, Brooks Zhongzheng; Gnanapragasam, Priyanthi N. P.; Oliveira, Thiago Y.; Seaman, Michael S.; Kwong, Peter D.; Bjorkman, Pamela J.; Nussenzweig, Michel C.			Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization	CELL			English	Article							HUMAN MONOCLONAL-ANTIBODIES; CHIMERIC VIRUS; 3-DIMENSIONAL STRUCTURE; ANTIGEN; EPITOPE; BREADTH; COMPLEX; DOMAIN; GLYCOPROTEIN; COMBINATION	Broadly neutralizing antibodies (bNAbs) to HIV-1 can prevent infection and are therefore of great importance for HIV-1 vaccine design. Notably, bNAbs are highly somatically mutated and generated by a fraction of HIV-1-infected individuals several years after infection. Antibodies typically accumulate mutations in the complementarity determining region (CDR) loops, which usually contact the antigen. The CDR loops are scaffolded by canonical framework regions (FWRs) that are both resistant to and less tolerant of mutations. Here, we report that in contrast to most antibodies, including those with limited HIV-1 neutralizing activity, most bNAbs require somatic mutations in their FWRs. Structural and functional analyses reveal that somatic mutations in FWR residues enhance breadth and potency by providing increased flexibility and/or direct antigen contact. Thus, in bNAbs, FWRs play an essential role beyond scaffolding the CDR loops and their unusual contribution to potency and breadth should be considered in HIV-1 vaccine design.	[Klein, Florian; Scheid, Johannes F.; Gaebler, Christian; Mouquet, Hugo; Incesu, Reha-Baris; Oliveira, Thiago Y.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Diskin, Ron; Fu, Brooks Zhongzheng; Gnanapragasam, Priyanthi N. P.; Bjorkman, Pamela J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Bjorkman, Pamela J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Diskin, Ron] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Scheid, Johannes F.] Charite, D-10117 Berlin, Germany; [Gaebler, Christian] Tech Univ Dresden, Fac Med Carl Gustav Carus, D-01307 Dresden, Germany; [Georgiev, Ivelin S.; Pancera, Marie; Zhou, Tongqing; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Incesu, Reha-Baris] Univ Klinikum Hamburg Eppendorf, D-20246 Hamburg, Germany; [Oliveira, Thiago Y.] Univ Sao Paulo, Dept Genet, Med Sch Ribeirao Preto, Natl Inst Sci & Technol Stem Cells & Cell Therapy, BR-14051140 Ribeirao Preto, SP, Brazil; [Oliveira, Thiago Y.] Ctr Cell Based Therapy, BR-14051140 Ribeirao Preto, SP, Brazil; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Weizmann Institute of Science; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Hamburg; University Medical Center Hamburg-Eppendorf; Universidade de Sao Paulo; Harvard University; Beth Israel Deaconess Medical Center	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Mouquet, Hugo/M-2750-2014; Oliveira, Thiago Y/ABF-5186-2020; Zhou, Tongqing/A-6880-2010; Oliveira, Thiago Y/HGA-3848-2022; Nussenzweig, Michel/AAE-7292-2019; Gaebler, Christian/GWZ-2628-2022	Mouquet, Hugo/0000-0002-4230-610X; Oliveira, Thiago Y/0000-0002-2654-0879; Zhou, Tongqing/0000-0002-3935-4637; Oliveira, Thiago Y/0000-0002-2654-0879; Gaebler, Christian/0000-0001-7295-8128	German Research Foundation (DFG) [KL 2389/1-1]; Stavros Niarchos Foundation; Robert Mapplethorpe Foundation; German National Academic Foundation; Vaccine Research Center, NIAID, NIH; Bill and Melinda Gates Foundation [1032144, 38660, OPP1033115]; CHAVI-ID Award [UM1AI100663]; NIH grant [AI081677]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, P01AI100148, ZICAI005112, P01AI081677, ZIAAI005022] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Stavros Niarchos Foundation; Robert Mapplethorpe Foundation; German National Academic Foundation; Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); CHAVI-ID Award; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Louise Scharf for her help on generating structural images and Kai-Hui Yao for technical assistance. We thank Paola Marchovecchio and Han Gan for preparation of 3BNC60<SUP>P61A</SUP> as well as the members of the Nussenzweig and Bjorkman laboratory for helpful discussions. We also thank R. Wyatt for the YU2-gp140 plasmid; Davide Corti and Antonio Lanzavecchia for the HJ16 plasmids, and Francine McCutchan, Beatrice Hahn, David Montefiori, Michael Thomson, Ronald Swanstrom, Lynn Morris, Jerome Kim, Linqi Zhang, Dennis Ellenberger, and Carolyn Williamson for contributing HIV-1 envelope plasmids used in neutralization assays. F.K. was supported by the German Research Foundation (DFG, KL 2389/1-1), the Stavros Niarchos Foundation and the Robert Mapplethorpe Foundation. C.G. and R.-B.I. were supported by The German National Academic Foundation. I.G., M.P., T.Z., and P.D.K. were supported by intramural funding to the Vaccine Research Center, NIAID, NIH. M.S.S., P.J.B., and M.C.N. were supported by the Bill and Melinda Gates Foundation (M.S.S., Comprehensive Antibody Vaccine Immune Monitoring Consortium grant 1032144; P.J.B. and M.C.N., Collaboration for AIDS Vaccine Discovery grants 38660 [P.J.B.] and OPP1033115 [M.C.N.]). M.C.N is supported by the CHAVI-ID Award UM1AI100663 and The NIH grant AI081677. M.C.N. and P.J.B. are HHMI investigators.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; Giudicelli V, 2006, NUCLEIC ACIDS RES, V34, pD781, DOI 10.1093/nar/gkj088; GORNY MK, 1993, J IMMUNOL, V150, P635; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huber M, 2010, J VIROL, V84, P10700, DOI 10.1128/JVI.01111-10; Jolly C J, 1996, Semin Immunol, V8, P159, DOI 10.1006/smim.1996.0020; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kabat EA, 1991, SEQUENCES PROTEINS I; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pietzsch J, 2010, J EXP MED, V207, P1995, DOI 10.1084/jem.20101176; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; STANFIELD RL, 1990, SCIENCE, V248, P712, DOI 10.1126/science.2333521; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; Walker LM, 2011, P NATL ACAD SCI USA, V108, P20125, DOI 10.1073/pnas.1117531108; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, VIRUSES-BASEL, V1, P802, DOI 10.3390/v1030802; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	62	356	375	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					126	138		10.1016/j.cell.2013.03.018	http://dx.doi.org/10.1016/j.cell.2013.03.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540694	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000316853700011
J	Alivisatos, AP; Chun, MY; Church, GM; Deisseroth, K; Donoghue, JP; Greenspan, RJ; McEuen, PL; Roukes, ML; Sejnowski, TJ; Weiss, PS; Yuste, R				Alivisatos, A. Paul; Chun, Miyoung; Church, George M.; Deisseroth, Karl; Donoghue, John P.; Greenspan, Ralph J.; McEuen, Paul L.; Roukes, Michael L.; Sejnowski, Terrence J.; Weiss, Paul S.; Yuste, Rafael			The Brain Activity Map	SCIENCE			English	Editorial Material									[Alivisatos, A. Paul] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Alivisatos, A. Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chun, Miyoung] Kavli Fdn, Oxnard, CA 93030 USA; [Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Church, George M.] Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Donoghue, John P.] Vet Affairs Med Ctr, Rehabil Res & Dev Serv, Providence, RI 02908 USA; [Donoghue, John P.] Brown Univ, Dept Neurosci, Brown Inst Brain Sci, Providence, RI 02912 USA; [Donoghue, John P.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Greenspan, Ralph J.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA; [McEuen, Paul L.] Cornell Univ, Dept Phys, Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14850 USA; [Roukes, Michael L.] CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA; [Roukes, Michael L.] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Roukes, Michael L.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Roukes, Michael L.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; [Sejnowski, Terrence J.] Salk Inst Biol Studies, Computat Neurobiol Lab, HHMI, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Weiss, Paul S.] Univ Calif Los Angeles, Dept Chem & Biochem, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Weiss, Paul S.] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Yuste, Rafael] Columbia Univ, Kavli Inst Brain Sci, Dept Biol Sci & Neurosci, HHMI, New York, NY 10027 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; Brown University; University of California System; University of California San Diego; Cornell University; California Institute of Technology; California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University; Howard Hughes Medical Institute	Alivisatos, AP (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.	alivis@berkeley.edu; terry@salk.edu; rafaelyuste@columbia.edu	Alivisatos, Paul/N-8863-2015; Sejnowski, Terrence/AAV-5558-2021; Weiss, Paul/P-8016-2019; Weiss, Paul S/A-2575-2011	Alivisatos, Paul/0000-0001-6895-9048; Weiss, Paul/0000-0001-5527-6248; Weiss, Paul S/0000-0001-5527-6248; church, george/0000-0001-6232-9969	Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [DP1 EY024503] Funding Source: Medline; NIGMS NIH HHS [DP1 GM105376] Funding Source: Medline; NATIONAL EYE INSTITUTE [DP1EY024503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105376] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Andrews AM, 2012, ACS NANO, V6, P8463, DOI 10.1021/nn304724q; Battelle, 2011, EC IMP HUM GEN PROJ; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Koch C, 2012, NATURE, V483, P397, DOI 10.1038/483397a; Lozano AM, 2012, J NEUROSURG, V116, P315, DOI 10.3171/2011.10.JNS102122	6	144	152	4	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1284	1285		10.1126/science.1236939	http://dx.doi.org/10.1126/science.1236939			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23470729	Green Accepted			2022-12-24	WOS:000316053400025
J	Winthrop, KL; Baddley, JW; Chen, L; Liu, LY; Grijalva, CG; Delzell, E; Beukelman, T; Patkar, NM; Xie, FL; Saag, KG; Herrinton, LJ; Solomon, DH; Lewis, JD; Curtis, JR				Winthrop, Kevin L.; Baddley, John W.; Chen, Lang; Liu, Liyan; Grijalva, Carlos G.; Delzell, Elizabeth; Beukelman, Timothy; Patkar, Nivedita M.; Xie, Fenglong; Saag, Kenneth G.; Herrinton, Lisa J.; Solomon, Daniel H.; Lewis, James D.; Curtis, Jeffrey R.			Association Between the Initiation of Anti-Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; INFECTION; SAFETY; VACCINATION; IMPACT; RATES	Importance Herpes zoster reactivation disproportionately affects patients with rheumatoid arthritis (RA). It is unclear whether anti-tumor necrosis factor (anti-TNF) therapy elevates herpes zoster risk. Objectives To ascertain whether initiation of anti-TNF therapy compared with non-biologic comparators is associated with increased herpes zoster risk. Design, Setting, and Patients We identified new users of anti-TNF therapy among cohorts of patients with RA, inflammatory bowel disease, and psoriasis, psoriatic arthritis, or ankylosing spondylitis from 1998 through 2007 within a large US multi-institutional collaboration combining data from Kaiser Permanente Northern California, Pharmaceutical Assistance Contract for the Elderly, Tennessee Medicaid, and national Medicaid/Medicare programs. We compared herpes zoster incidence between new anti-TNF users (n=33,324) and patients initiating nonbiologic disease-modifying antirheumatic drugs (DMARDs) (n=25 742) within each inflammatory disease cohort (last participant follow-up December 31, 2007). Within these cohorts, we used Cox regression models to compare propensity score-adjusted herpes zoster incidence between new anti-TNF and nonbiologic DMARD users while controlling for baseline corticosteroid use. Main Outcome Measures Incidence of herpes zoster cases occurring after initiation of new anti-TNF or nonbiologic DMARD therapy. Results Among 33 324 new users of anti-TNF therapy, we identified 310 herpes zoster cases. Crude incidence rates among anti-TNF users were 12.1 per 1000 patient-years (95% CI, 10.7-13.6) for RA, 11.3 per 1000 patient-years (95% CI, 7.7-16.7) for inflammatory bowel disease, and 4.4 per 1000 patient-years (95% CI, 2.8-7.0) for psoriasis, psoriatic arthritis, or ankylosing spondylitis. Baseline use of corticosteroids of 10 mg/d or greater among all disease indications was associated with elevated risk (adjusted hazard ratio [HR], 2.13 [95% CI, 1.64-2.75]) compared with no baseline use. For patients with RA, adjusted incidence rates were similar between anti-TNF and nonbiologic DMARD initiators (adjusted HR, 1.00 [95% CI, 0.77-1.29]) and comparable between all 3 anti-TNF therapies studied. Across all disease indications, the adjusted HR was 1.09 (95% CI, 0.88-1.36). Conclusion and Relevance Among patients with RA and other inflammatory diseases, those who initiated anti-TNF therapies were not at higher risk of herpes zoster compared with patients who initiated nonbiologic treatment regimens. JAMA. 2013;309(9):887-895 www.jama.com	[Winthrop, Kevin L.] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97239 USA; [Winthrop, Kevin L.] Oregon Hlth & Sci Univ, Div Publ Hlth & Prevent Med, Portland, OR 97239 USA; [Winthrop, Kevin L.] Oregon Hlth & Sci Univ, Div Ophthalmol, Portland, OR 97239 USA; [Baddley, John W.; Chen, Lang; Delzell, Elizabeth; Beukelman, Timothy; Patkar, Nivedita M.; Xie, Fenglong; Saag, Kenneth G.; Curtis, Jeffrey R.] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA; [Liu, Liyan; Herrinton, Lisa J.] Kaiser Permanente No Calif, Ctr Hlth Res, Oakland, CA USA; [Grijalva, Carlos G.] Vanderbilt Univ, Dept Prevent Med, Nashville, TN USA; [Solomon, Daniel H.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Lewis, James D.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Alabama System; University of Alabama Birmingham; Kaiser Permanente; Vanderbilt University; Harvard University; Brigham & Women's Hospital; University of Pennsylvania	Winthrop, KL (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, 3375 SW Terwilliger Blvd, Portland, OR 97239 USA.	Winthrop@ohsu.edu		Grijalva, Carlos/0000-0002-2329-7797; Beukelman, Timothy/0000-0001-9463-6306	Pfizer; Amgen; National Institutes of Health; Novartis; Genentech; Horizon; Merck; Apollo Health Resources Ltd; Centocor; Procter and Gamble; Lilly; Consortium of Rheumatology Researchers of North America Inc.; Takeda; Shire; Roche/Genentech; UCB Pharma; Bristol-Myers Squibb; Crescendo; Abbott; US Food and Drug Administration (FDA); US Department of Health and Human Services (DHHS); Agency for Healthcare Research and Quality (AHRQ) [U18 HS17919]; AHRQ [1K08HS017552-01, R01HS018517]; National Institutes of Health (NIH) [AR053351]; NIH via the University of Alabama at Birmingham Center for Clinical and Translational Science [5KL2 RR025776-03]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [5P60AR56116]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS017919, K08HS017552, R01HS018517] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR053351, K24AR052361, P60AR056116] Funding Source: NIH RePORTER	Pfizer(Pfizer); Amgen(Amgen); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); Genentech(Roche HoldingGenentech); Horizon; Merck(Merck & Company); Apollo Health Resources Ltd; Centocor; Procter and Gamble(Procter & Gamble); Lilly(Eli Lilly); Consortium of Rheumatology Researchers of North America Inc.; Takeda(Takeda Pharmaceutical Company Ltd); Shire; Roche/Genentech(Roche HoldingGenentech); UCB Pharma(UCB Pharma SA); Bristol-Myers Squibb(Bristol-Myers Squibb); Crescendo(European Commission); Abbott(Abbott Laboratories); US Food and Drug Administration (FDA)(United States Department of Health & Human Services); US Department of Health and Human Services (DHHS); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH via the University of Alabama at Birmingham Center for Clinical and Translational Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Winthrop reported that he has consulted for Genentech, Abbott, Pfizer, UCB Pharma, and Amgen and received research grant support from Pfizer. Dr Baddley reported that he has consulted for Pfizer and Merck. Dr Delzell reported that she has received research and other support from Amgen. Dr Grijalva reported that he has received research grant support from National Institutes of Health. Dr Beukelman reported that he has received research support from Pfizer and National Institutes of Health and consultant fees from Novartis and Genentech. Dr Saag reported that he has received research support from Amgen, Genentech, Horizon, Merck, National Institutes of Health, and Apollo Health Resources Ltd, consulted for Amgen, Abbott, Ardea, Lilly, Merck, Regeneron, Savient, and URL Pharma, and has served on the board for National Osteoporosis Foundation. Dr Herrinton reported that she has received research support from Centocor, Genentech, and Procter and Gamble and has served as an expert witness for Hoffman La Roche. Dr Solomon reported that he has received research support from Amgen, Lilly, and the Consortium of Rheumatology Researchers of North America Inc. He serves in unpaid roles on trials funded by Pfizer and Novartis. Dr Lewis reported that he has received research support from Centocor, Takeda, and Shire and consultant honoraria from Abbott, Amgen, Millennium Pharmaceuticals, Prometheus, and Pfizer. Dr Curtis reported that he has received consultant fees from Roche/Genentech, UCB Pharma, Centocor, Consortium of Rheumatology Researchers of North America Inc, Amgen, Pfizer, Bristol-Myers Squibb, Crescendo, and Abbott. No other disclosures were reported.; This work was supported by the US Food and Drug Administration (FDA), US Department of Health and Human Services (DHHS), and by grant U18 HS17919 from the Agency for Healthcare Research and Quality (AHRQ), administered through the AHRQ Centers for Education and Research on Therapeutics Program. Dr Winthrop's work on this article was funded by grant 1K08HS017552-01 from AHRQ. Dr Curtis was supported by grant AR053351 from the National Institutes of Health (NIH) and by grant R01HS018517 from AHRQ. Dr Beukelman was supported by grant 5KL2 RR025776-03 from NIH via the University of Alabama at Birmingham Center for Clinical and Translational Science. Dr Grijalva was supported by grant 5P60AR56116 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.	Buttgereit F, 2002, ANN RHEUM DIS, V61, P718, DOI 10.1136/ard.61.8.718; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Grijalva CG, 2011, JAMA-J AM MED ASSOC, V306, P2331, DOI 10.1001/jama.2011.1692; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Herrinton LJ, 2011, PHARMACOEPIDEM DR S, V20, P1199, DOI 10.1002/pds.2196; Lin YC, 2012, ORAL ONCOL, V48, P535, DOI 10.1016/j.oraloncology.2012.01.008; McDonald JR, 2009, CLIN INFECT DIS, V48, P1364, DOI 10.1086/598331; Mullooly JP, 2005, EPIDEMIOL INFECT, V133, P245, DOI 10.1017/S095026880400281X; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Salmon-Ceron D, 2011, ANN RHEUM DIS, V70, P616, DOI 10.1136/ard.2010.137422; Schmader KE, 2002, CLIN J PAIN, V18, P350, DOI 10.1097/00002508-200211000-00002; Schmader KE, 2007, CLIN J PAIN, V23, P490, DOI 10.1097/AJP.0b013e318065b6c9; Schmader KE, 2012, CLIN INFECT DIS, V54, P922, DOI 10.1093/cid/cir970; Schmajuk G, 2011, JAMA-J AM MED ASSOC, V305, P480, DOI 10.1001/jama.2011.67; Smitten AL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1431, DOI 10.1002/art.23112; Strangfeld A, 2011, ANN RHEUM DIS, V70, P1914, DOI 10.1136/ard.2011.151043; Strangfeld A, 2009, JAMA-J AM MED ASSOC, V301, P737, DOI 10.1001/jama.2009.146; Winthrop KL, 2010, ANN RHEUM DIS, V69, P1735, DOI 10.1136/ard.2010.133843; Winthrop KL, 2009, NAT REV RHEUMATOL, V5, P405, DOI 10.1038/nrrheum.2009.105; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341; Zhang J, 2012, JAMA-J AM MED ASSOC, V308, P43, DOI 10.1001/jama.2012.7304; Zhang J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3497	23	139	146	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					887	895		10.1001/jama.2013.1099	http://dx.doi.org/10.1001/jama.2013.1099			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23462785	Green Accepted, Green Published			2022-12-24	WOS:000315632700024
J	Dumesic, PA; Natarajan, P; Chen, CB; Drinnenberg, IA; Schiller, BJ; Thompson, J; Moresco, JJ; Yates, JR; Bartel, DP; Madhani, HD				Dumesic, Phillip A.; Natarajan, Prashanthi; Chen, Changbin; Drinnenberg, Ines A.; Schiller, Benjamin J.; Thompson, James; Moresco, James J.; Yates, John R., III; Bartel, David P.; Madhani, Hiten D.			Stalled Spliceosomes Are a Signal for RNAi-Mediated Genome Defense	CELL			English	Article							TRANSPOSABLE ELEMENTS; C-ELEGANS; GENE; PROTEIN; INTRON; YEAST; INTERFERENCE; EXPRESSION; EVOLUTION; INTERACTS	Using the yeast Cryptococcus neoformans, we describe a mechanism by which transposons are initially targeted for RNAi-mediated genome defense. We show that intron-containing mRNA precursors template siRNA synthesis. We identify a Spliceosome-Coupled And Nuclear RNAi (SCANR) complex required for siRNA synthesis and demonstrate that it physically associates with the spliceosome. We find that RNAi target transcripts are distinguished by suboptimal introns and abnormally high occupancy on spliceosomes. Functional investigations demonstrate that the stalling of mRNA precursors on spliceosomes is required for siRNA accumulation. Lariat debranching enzyme is also necessary for siRNA production, suggesting a requirement for processing of stalled splicing intermediates. We propose that recognition of mRNA precursors by the SCANR complex is in kinetic competition with splicing, thereby promoting siRNA production from transposon transcripts stalled on spliceosomes. Disparity in the strength of expression signals encoded by transposons versus host genes offers an avenue for the evolution of genome defense.	[Dumesic, Phillip A.; Natarajan, Prashanthi; Chen, Changbin; Schiller, Benjamin J.; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Drinnenberg, Ines A.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Thompson, James; Moresco, James J.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Whitehead Institute; Scripps Research Institute	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com		Moresco, James/0000-0003-1178-1642; Madhani, Hiten/0000-0001-7400-6657	National Center for Research Resources [5P41RR011823-17]; National Institute of General Medical Sciences [8 P41 GM103533-17]; National Institute on Aging [R01AG027463-04]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM061835, R01GM071801, P41GM103533, T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027463] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Madhani and Guthrie labs, P. O'Farrell, J. Reuter, and S. Coyle for critical reading of the manuscript and helpful discussions; N. Nguyen for media preparation; and X. Wang and J. Heitman for strains and plasmids. Mass spectrometry experiments were supported by the National Center for Research Resources (5P41RR011823-17), the National Institute of General Medical Sciences (8 P41 GM103533-17), and the National Institute on Aging (R01AG027463-04). P. A. D. and H. D. M. designed the study. C. C., I. A. D., and D. P. B. performed high-throughput sequencing shown in Figure 1. J. T., J. J. M., and J. R. Y. performed mass spectrometry analyses shown in Figures 2, 3, and 4. P. N. performed subcellular localization of tagged proteins shown in Figures 2, 3, 4, and S1. B. J. S. performed bioinformatic analyses shown in Figures 1, 5, and 7 and Tables S1 and S2. P. A. D. performed experiments shown in Figures 2, 3, 4, 5, 6, 7, S2, S3, and S4. P. A. D. and H. D. M. wrote the manuscript. All authors contributed to editing the manuscript.	Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Belancio VP, 2008, GENE, V411, P38, DOI 10.1016/j.gene.2007.12.022; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Burns C, 2005, FUNGAL GENET BIOL, V42, P191, DOI 10.1016/j.fgb.2004.11.005; Cam HP, 2009, CELL, V136, P610, DOI 10.1016/j.cell.2009.02.004; CELLINI A, 1986, EMBO J, V5, P1023, DOI 10.1002/j.1460-2075.1986.tb04317.x; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Chua K, 2001, MOL CELL BIOL, V21, P1509, DOI 10.1128/MCB.21.5.1509-1514.2001; Chun CD, 2010, METHOD ENZYMOL, V470, P797, DOI 10.1016/S0076-6879(10)70033-1; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Conley AB, 2008, TRENDS GENET, V24, P53, DOI 10.1016/j.tig.2007.11.008; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; GIERL A, 1990, TRENDS GENET, V6, P155, DOI 10.1016/0168-9525(90)90150-5; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Hogg R, 2010, BIOCHEM SOC T, V38, P1110, DOI 10.1042/BST0381110; Hughes SS, 2008, MOL BIOL EVOL, V25, P247, DOI 10.1093/molbev/msm220; Irimia M, 2007, TRENDS GENET, V23, P321, DOI 10.1016/j.tig.2007.04.001; Janbon G, 2010, FUNGAL GENET BIOL, V47, P1070, DOI 10.1016/j.fgb.2010.10.005; Kapitonov VV, 2004, DNA CELL BIOL, V23, P311, DOI 10.1089/104454904323090949; Kelly WG, 2007, CHROMOSOME RES, V15, P633, DOI 10.1007/s10577-007-1143-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Khurana JS, 2011, CELL, V147, P1551, DOI 10.1016/j.cell.2011.11.042; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lu SH, 2003, RNA, V9, P618, DOI 10.1261/rna.5260303; Lugones LG, 1999, MOL MICROBIOL, V32, P681, DOI 10.1046/j.1365-2958.1999.01373.x; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mayas RM, 2010, P NATL ACAD SCI USA, V107, P10020, DOI 10.1073/pnas.0906022107; MENSSEN A, 1990, EMBO J, V9, P3051, DOI 10.1002/j.1460-2075.1990.tb07501.x; Nam K, 1997, MOL CELL BIOL, V17, P809, DOI 10.1128/MCB.17.2.809; Nolan T, 2008, NUCLEIC ACIDS RES, V36, P532, DOI 10.1093/nar/gkm1071; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; PURUGGANAN M, 1992, GENETICA, V86, P295, DOI 10.1007/BF00133728; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; She XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000624; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Tabach Y., 2012, NATURE; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; Wang XY, 2010, GENE DEV, V24, P2566, DOI 10.1101/gad.1970910; Warf MB, 2012, GENOME RES, V22, P1488, DOI 10.1101/gr.134841.111; Warnecke T, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r29; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	50	117	121	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					957	968		10.1016/j.cell.2013.01.046	http://dx.doi.org/10.1016/j.cell.2013.01.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23415457	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000315710300006
J	Consani, C; Aubock, G; van Mourik, F; Chergui, M				Consani, Cristina; Auboeck, Gerald; van Mourik, Frank; Chergui, Majed			Ultrafast Tryptophan-to-Heme Electron Transfer in Myoglobins Revealed by UV 2D Spectroscopy	SCIENCE			English	Article							RESONANCE ENERGY-TRANSFER; PICOSECOND FLUORESCENCE; DYNAMICS; PROTEINS; FEMTOSECOND; HEMOGLOBIN; SOLVATION; COMPLEXES; COHERENCE; BINDING	Tryptophan is commonly used to study protein structure and dynamics, such as protein folding, as a donor in fluorescence resonant energy transfer (FRET) studies. By using ultra-broadband ultrafast two-dimensional (2D) spectroscopy in the ultraviolet (UV) and transient absorption in the visible range, we have disentangled the excited state decay pathways of the tryptophan amino acid residues in ferric myoglobins (MbCN and metMb). Whereas the more distant tryptophan (Trp(7)) relaxes by energy transfer to the heme, Trp(14) excitation predominantly decays by electron transfer to the heme. The excited Trp(14)-> heme electron transfer occurs in <40 picoseconds with a quantum yield of more than 60%, over an edge-to-edge distance below similar to 10 angstroms, outcompeting the FRET process. Our results raise the question of whether such electron transfer pathways occur in a larger class of proteins.	[Consani, Cristina; Auboeck, Gerald; van Mourik, Frank; Chergui, Majed] Ecole Polytech Fed Lausanne, Lab Ultrafast Spect, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Chergui, M (corresponding author), Ecole Polytech Fed Lausanne, Lab Ultrafast Spect, CH-1015 Lausanne, Switzerland.	majed.chergui@epfl.ch		Consani, Cristina/0000-0002-4244-7324; Aubock, Gerald/0000-0001-8462-6825	National Center of Competence in Research-Molecular Ultrafast Science and Technology of the Swiss National Science Foundation;  [206021-121300]	National Center of Competence in Research-Molecular Ultrafast Science and Technology of the Swiss National Science Foundation; 	This work was supported by contract 206021-121300 and the National Center of Competence in Research-Molecular Ultrafast Science and Technology of the Swiss National Science Foundation.	Aubock G, 2012, OPT LETT, V37, P2337, DOI 10.1364/OL.37.002337; Balabin IA, 2012, J COMPUT CHEM, V33, P906, DOI 10.1002/jcc.22927; Baldwin J, 2000, J AM CHEM SOC, V122, P12195, DOI 10.1021/ja001278u; Balzani V., 2001, ELECT TRANSFER CHEM; BERATAN DN, 1991, SCIENCE, V252, P1285, DOI 10.1126/science.1656523; Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429; Chang CW, 2010, P NATL ACAD SCI USA, V107, P2914, DOI 10.1073/pnas.1000001107; CHEN LXQ, 1987, CHEM PHYS LETT, V139, P55, DOI 10.1016/0009-2614(87)80150-1; Cordes M, 2009, CHEM SOC REV, V38, P892, DOI 10.1039/b805743p; DOSREMEDIOS CG, 1995, J STRUCT BIOL, V115, P175, DOI 10.1006/jsbi.1995.1042; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Gruia F, 2008, BIOPHYS J, V94, P2252, DOI 10.1529/biophysj.107.122119; GU YG, 1993, J AM CHEM SOC, V115, P4993, DOI 10.1021/ja00065a007; Hamm P., 2011, CONCEPTS METHODS 2D; Helbing J, 2004, BIOPHYS J, V87, P1881, DOI 10.1529/biophysj.103.036236; HOCHSTRASSER RM, 1984, P NATL ACAD SCI-BIOL, V81, P4399, DOI 10.1073/pnas.81.14.4399; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MAYO SL, 1986, SCIENCE, V233, P948, DOI 10.1126/science.3016897; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PETRICH JW, 1991, BIOCHEMISTRY-US, V30, P3975, DOI 10.1021/bi00230a025; PETRICH JW, 1988, BIOPHYS J, V53, pA281; PETRICH JW, 1987, BIOCHEMISTRY-US, V26, P2711, DOI 10.1021/bi00384a010; Prytkova TR, 2007, SCIENCE, V315, P622, DOI 10.1126/science.1134862; Qiu WH, 2008, CHEM PHYS, V350, P154, DOI 10.1016/j.chemphys.2008.01.061; Reddy KS, 1996, BIOCHEMISTRY-US, V35, P5562, DOI 10.1021/bi952596m; Shih C, 2008, SCIENCE, V320, P1760, DOI 10.1126/science.1158241; Stevens JA, 2012, J PHYS CHEM A, V116, P2610, DOI 10.1021/jp206106j; Stevens JA, 2010, J PHYS CHEM B, V114, P1498, DOI 10.1021/jp910013f; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; WEBER G, 1959, DISCUSS FARADAY SOC, P134; WILLIS KJ, 1990, BIOCHEMISTRY-US, V29, P5270, DOI 10.1021/bi00474a008; Zhang LY, 2006, J PHYS CHEM B, V110, P18097, DOI 10.1021/jp063025e	35	106	107	1	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1586	1589		10.1126/science.1230758	http://dx.doi.org/10.1126/science.1230758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23393092				2022-12-24	WOS:000316731600043
J	Quill, TE; Abernethy, AP				Quill, Timothy E.; Abernethy, Amy P.			Generalist plus Specialist Palliative Care - Creating a More Sustainable Model	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Quill, Timothy E.] Univ Rochester, Med Ctr, Dept Med, Palliat Care Div, Rochester, NY 14642 USA; [Abernethy, Amy P.] Duke Univ, Med Ctr, Duke Ctr Learning Hlth Care, Durham, NC USA; [Abernethy, Amy P.] Duke Univ, Med Ctr, Duke Canc Care Res Program, Durham, NC USA	University of Rochester; Duke University; Duke University	Quill, TE (corresponding author), Univ Rochester, Med Ctr, Dept Med, Palliat Care Div, Rochester, NY 14642 USA.			Abernethy, Amy/0000-0001-6930-8722				Back AL, 2009, J CLIN ONCOL, V27, P1137, DOI 10.1200/JCO.2008.20.2408; Kamal AH, 2012, J PAIN SYMPTOM MANAG; Morrison RS, 2011, HEALTH AFFAIR, V30, P454, DOI 10.1377/hlthaff.2010.0929; Quill Timothy E, 2003, J Palliat Med, V6, P365, DOI 10.1089/109662103322144682; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	5	850	852	3	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1173	1175		10.1056/NEJMp1215620	http://dx.doi.org/10.1056/NEJMp1215620			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116FU	23465068				2022-12-24	WOS:000316869000003
J	Mori, K; Weng, SM; Arzberger, T; May, S; Rentzsch, K; Kremmer, E; Schmid, B; Kretzschmar, HA; Cruts, M; Van Broeckhoven, C; Haass, C; Edbauer, D				Mori, Kohji; Weng, Shih-Ming; Arzberger, Thomas; May, Stephanie; Rentzsch, Kristin; Kremmer, Elisabeth; Schmid, Bettina; Kretzschmar, Hans A.; Cruts, Marc; Van Broeckhoven, Christine; Haass, Christian; Edbauer, Dieter			The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL DEMENTIA; HEXANUCLEOTIDE REPEAT; EXPANSION; IDENTIFICATION; INITIATION; FTD; ALS	Expansion of a GGGGCC hexanucleotide repeat upstream of the C9orf72 coding region is the most common cause of familial frontotemporal lobar degeneration and amyotrophic lateral sclerosis (FTLD/ALS), but the pathomechanisms involved are unknown. As in other FTLD/ALS variants, characteristic intracellular inclusions of misfolded proteins define C9orf72 pathology, but the core proteins of the majority of inclusions are still unknown. Here, we found that most of these characteristic inclusions contain poly-(Gly-Ala) and, to a lesser extent, poly-(Gly-Pro) and poly-(Gly-Arg) dipeptide-repeat proteins presumably generated by non-ATG-initiated translation from the expanded GGGGCC repeat in three reading frames. These findings directly link the FTLD/ALS-associated genetic mutation to the predominant pathology in patients with C9orf72 hexanucleotide expansion.	[Mori, Kohji; Haass, Christian; Edbauer, Dieter] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Weng, Shih-Ming; May, Stephanie; Rentzsch, Kristin; Schmid, Bettina; Haass, Christian; Edbauer, Dieter] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Arzberger, Thomas; Kretzschmar, Hans A.] Univ Munich, Ctr Neuropathol & Prion Res, D-81377 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Schmid, Bettina; Haass, Christian; Edbauer, Dieter] Univ Munich, Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Cruts, Marc; Van Broeckhoven, Christine] Univ Antwerp VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, B-2610 Antwerp, Belgium; [Cruts, Marc; Van Broeckhoven, Christine] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2610 Antwerp, Belgium	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp	Edbauer, D (corresponding author), Univ Munich, Adolf Butenandt Inst, Schillerstr 44, D-80336 Munich, Germany.	dieter.edbauer@dzne.de	Edbauer, Dieter/M-9906-2019; Cruts, Marc/J-6161-2013; Van Broeckhoven, Christine/G-8362-2017; Mori, Kohji/AAM-8471-2020; Van Broeckhoven, Christine/M-7853-2019	Edbauer, Dieter/0000-0002-7186-4653; Cruts, Marc/0000-0002-1338-992X; Van Broeckhoven, Christine/0000-0003-0183-7665; Mori, Kohji/0000-0003-2629-0723; Van Broeckhoven, Christine/0000-0003-0183-7665	Centres of Excellence in Neurodegeneration Research (CoEN); Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF); Alexander von Humboldt Foundation; Helmholtz Young Investigator program; MetLife Foundation Award; Belgian Science Policy Office Interuniversity Attraction Poles program; Foundation for Alzheimer Research (SAO/FRA); Medical Foundation Queen Elisabeth; Flemish Government Methusalem excellence program; Research Foundation Flanders (FWO); University Research Fund of the University of Antwerp	Centres of Excellence in Neurodegeneration Research (CoEN); Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Helmholtz Young Investigator program; MetLife Foundation Award; Belgian Science Policy Office Interuniversity Attraction Poles program; Foundation for Alzheimer Research (SAO/FRA); Medical Foundation Queen Elisabeth; Flemish Government Methusalem excellence program; Research Foundation Flanders (FWO)(FWO); University Research Fund of the University of Antwerp	We thank I. Pigur for technical assistance, M. Neumann for genotyping of some of the LMU cases, and J. Banzhaf-Strathmann, F. van Bebber, E. Bentmann, D. Dormann, J. Herms, A. Hruscha, G. Kleinberger, J. McCarter, D. Orozco, and B. Schwenk for critical comments. This project was supported by a grant from the Centres of Excellence in Neurodegeneration Research (CoEN) to M. C., C. H., C. V. B., B. S., and D. E., and the Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF) to C. H. K. M. was supported by a postdoctoral fellowship from the Alexander von Humboldt Foundation. D. E. was supported by the Helmholtz Young Investigator program. We thank all clinicians recruiting brain donors, in particular H.-H. Klunemann (Bezirksklinikum Regensburg) and, most notably, all brain donors and their next of kin. We acknowledge the Antwerp biobank of the Institute Born-Bunge for brain samples, as well as T. Van Langenhove, J. van der Zee, S. Engelborghs, P. P. De Deyn, A. Sieben, and J.-J. Martin for genetic, clinical, and pathological diagnoses. The Antwerp site is supported by the MetLife Foundation Award (to C. V. B.), the Belgian Science Policy Office Interuniversity Attraction Poles program, the Foundation for Alzheimer Research (SAO/FRA), the Medical Foundation Queen Elisabeth, the Flemish Government Methusalem excellence program, the Research Foundation Flanders (FWO), and the University Research Fund of the University of Antwerp. A patent application concerning DPR-based diagnosis and therapy of neurodegenerative disorders has been filed by K. M., S.-M. W., T. A., K. R., E. K., C.H., and D.E.	Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Bigio EH, 2013, NEUROPATHOLOGY, V33, P122, DOI 10.1111/j.1440-1789.2012.01332.x; Boxer AL, 2011, J NEUROL NEUROSUR PS, V82, P196, DOI 10.1136/jnnp.2009.204081; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Josephs KA, 2011, ACTA NEUROPATHOL, V122, P137, DOI 10.1007/s00401-011-0839-6; KREMMER E, 1995, VIROLOGY, V208, P336, DOI 10.1006/viro.1995.1157; Li H, 2003, HUM MOL GENET, V12, P2021, DOI 10.1093/hmg/ddg218; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Mahoney CJ, 2012, BRAIN, V135, P736, DOI 10.1093/brain/awr361; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Pearson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002018; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; van der Zee J, 2013, HUM MUTAT, V34, P363, DOI 10.1002/humu.22244; Whitwell JL, 2012, BRAIN, V135, P794, DOI 10.1093/brain/aws001; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	20	842	862	5	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1335	1338		10.1126/science.1232927	http://dx.doi.org/10.1126/science.1232927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23393093				2022-12-24	WOS:000316053400042
J	Merbl, Y; Refour, P; Patel, H; Springer, M; Kirschner, MW				Merbl, Yifat; Refour, Phillipe; Patel, Hevan; Springer, Michael; Kirschner, Marc W.			Profiling of Ubiquitin-like Modifications Reveals Features of Mitotic Control	CELL			English	Article							PROTEIN FAT10; TRANSCRIPTIONAL ACTIVITY; PROTEASOMAL DEGRADATION; AURORA-B; SUMOYLATION; SUMO; IDENTIFICATION; EXPRESSION; APOPTOSIS; DISEASE	Ubiquitin and ubiquitin-like (Ubl) protein modifications affect protein stability, activity, and localization, but we still lack broad understanding of the functions of Ubl modifications. We have profiled the protein targets of ubiquitin and six additional Ubls in mitosis using a functional assay that utilizes active mammalian cell extracts and protein microarrays and identified 1,500 potential substrates; 80-200 protein targets were exclusive to each Ubl. The network structure is nonrandom, with most targets mapping to a single Ubl. There are distinct molecular functions for each Ubl, suggesting divergent biological roles. Analysis of differential profiles between mitosis and G1 highlighted a previously underappreciated role for the Ubl, FAT10, in mitotic regulation. In addition to its role as a resource for Ubl modifications, our study provides a systematic approach to analyze changes in posttranslational modifications at various cellular states.	[Merbl, Yifat; Refour, Phillipe; Patel, Hevan; Springer, Michael; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave,Warren Alpert 536, Boston, MA 02115 USA.	marc@hms.harvard.edu		Merbl, Yifat/0000-0002-3465-2221	NIH [GM039023]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039023] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jennifer Waters and the Nikon Imaging Center at Harvard Medical School for help with light microscope. We thank Anthony Hyman and Ina Poser for providing BAC clones. We thank Einav Laser for her support and Allon Klein, Shay Tal, Ana Hernandez, and Shai Shen-Orr for important scientific discussions and for their advice. We thank Kai Li, Sean Irwin, Tao Wu, and Weiping Wang for technical support. We thank Becky Ward and Shay Tal for critically reading this manuscript and for their insightful comments. This work was supported by the NIH grant GM039023.	Aichem A, 2012, J CELL SCI, V125, P4576, DOI 10.1242/jcs.107789; Aichem A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1012; Ban R, 2011, GENES CELLS, V16, P652, DOI 10.1111/j.1365-2443.2011.01521.x; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Buchsbaum S, 2012, MOL BIOL CELL, V23, P225, DOI 10.1091/mbc.E11-07-0609; Canaan A, 2006, MOL CELL BIOL, V26, P5180, DOI 10.1128/MCB.00966-05; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Edelmann MJ, 2008, BBA-MOL BASIS DIS, V1782, P809, DOI 10.1016/j.bbadis.2008.08.010; Fernandez-Miranda G, 2010, J CELL SCI, V123, P2823, DOI 10.1242/jcs.065565; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hattori N, 2004, LANCET, V364, P722, DOI 10.1016/S0140-6736(04)16901-8; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Lee PCW, 2011, MOL CELL, V43, P392, DOI 10.1016/j.molcel.2011.05.034; Li TW, 2011, ARCH BIOCHEM BIOPHYS, V509, P164, DOI 10.1016/j.abb.2011.02.017; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Park KM, 2007, MOL CELLS, V23, P170; Pelzer C, 2010, SUBCELL BIOCHEM, V54, P238, DOI 10.1007/978-1-4419-6676-6_19; Qing X, 2011, EXP MOL PATHOL, V90, P51, DOI 10.1016/j.yexmp.2010.09.005; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Ren JW, 2006, J BIOL CHEM, V281, P11413, DOI 10.1074/jbc.M507218200; Ross MJ, 2006, J AM SOC NEPHROL, V17, P996, DOI 10.1681/ASN.2005070692; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Snyder A, 2009, J VIROL, V83, P11983, DOI 10.1128/JVI.00034-09; Storey JD, 2007, BIOSTATISTICS, V8, P414, DOI 10.1093/biostatistics/kxl019; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Yang SH, 2006, E SCHERING RES FDN W, V57, P193; Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848; Zhang DW, 2006, ONCOGENE, V25, P2318, DOI 10.1038/sj.onc.1209220	50	73	78	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1160	1172		10.1016/j.cell.2013.02.007	http://dx.doi.org/10.1016/j.cell.2013.02.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452859	Green Accepted, Bronze			2022-12-24	WOS:000315710300021
J	Renne, PR; Deino, AL; Hilgen, FJ; Kuiper, KF; Mark, DF; Mitchell, WS; Morgan, LE; Mundil, R; Smit, J				Renne, Paul R.; Deino, Alan L.; Hilgen, Frederik J.; Kuiper, Klaudia F.; Mark, Darren F.; Mitchell, William S., III; Morgan, Leah E.; Mundil, Roland; Smit, Jan			Time Scales of Critical Events Around the Cretaceous-Paleogene Boundary	SCIENCE			English	Article							TERTIARY BOUNDARY; MASS EXTINCTION; CHICXULUB CRATER; ASTEROID IMPACT; HELL CREEK; TERRESTRIAL; CLIMATE; AGES; CONSEQUENCES; VOLCANISM	Mass extinctions manifest in Earth's geologic record were turning points in biotic evolution. We present 40Ar/39Ar data that establish synchrony between the Cretaceous-Paleogene boundary and associated mass extinctions with the Chicxulub bolide impact to within 32,000 years. Perturbation of the atmospheric carbon cycle at the boundary likely lasted less than 5000 years, exhibiting a recovery time scale two to three orders of magnitude shorter than that of the major ocean basins. Low-diversity mammalian fauna in the western Williston Basin persisted for as little as 20,000 years after the impact. The Chicxulub impact likely triggered a state shift of ecosystems already under near-critical stress.	[Renne, Paul R.; Deino, Alan L.; Mundil, Roland] Berkeley Geochronol Ctr BGC, Berkeley, CA 94709 USA; [Renne, Paul R.; Mitchell, William S., III] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Hilgen, Frederik J.] Univ Utrecht, Dept Earth Sci, Fac Geosci, NL-3584 CD Utrecht, Netherlands; [Kuiper, Klaudia F.; Smit, Jan] Vrije Univ Amsterdam, Inst Earth Sci, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands; [Mark, Darren F.; Morgan, Leah E.] Scottish Univ Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland; [Mitchell, William S., III] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Berkeley Geochronolgy Center; University of California System; University of California Berkeley; Utrecht University; Vrije Universiteit Amsterdam; Scottish Universities Research & Reactor Center; University of California System; University of California Berkeley	Renne, PR (corresponding author), Berkeley Geochronol Ctr BGC, 2455 Ridge Rd, Berkeley, CA 94709 USA.	prenne@bgc.org		Renne, Paul/0000-0003-1769-5235; Mitchell, William/0000-0002-0845-7051; Smit, Jan/0000-0002-6070-4865; Hilgen, Frits/0000-0002-5683-259X; Morgan, Leah/0000-0001-9930-524X	Ann and Gordon Getty Foundation; U.C. Berkeley's Esper S. Larsen Jr. Fund; NSF [EAR 0844098, EAR 0451802]; Natural Environment Research Council of the Argon Isotope Facility at the Scottish Universities Environmental Research Centre; Marie Curie Foundation; Marie Curie Fellowship program; Netherlands Organisation for Scientific Research [863.07.009]; Natural Environment Research Council [aif10001] Funding Source: researchfish; NERC [aif10001] Funding Source: UKRI	Ann and Gordon Getty Foundation; U.C. Berkeley's Esper S. Larsen Jr. Fund; NSF(National Science Foundation (NSF)); Natural Environment Research Council of the Argon Isotope Facility at the Scottish Universities Environmental Research Centre; Marie Curie Foundation(European Commission); Marie Curie Fellowship program(European Commission); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Ann and Gordon Getty Foundation, U.C. Berkeley's Esper S. Larsen Jr. Fund, and NSF (grants EAR 0844098 and EAR 0451802) for support of B.G.C.'s work; the Natural Environment Research Council for continued funding of the Argon Isotope Facility at the Scottish Universities Environmental Research Centre; the GTSNext project of the Marie Curie Foundation; the Marie Curie Fellowship program for support of L.E.M.; the Netherlands Organisation for Scientific Research (grant 863.07.009) for support of K.F.K.; F. Maurrasse for providing the tektites; W. Alvarez, A. Barnosky, W. Clemens, T. White, and G. Wilson for discussion and comments on the manuscript; and three anonymous reviewers for helpful suggestions. Data are available in the supplementary materials.	ALVAREZ LW, 1983, P NATL ACAD SCI USA, V80, P627, DOI 10.1073/pnas.80.2.627; Archibald JD, 2010, SCIENCE, V328, P973, DOI 10.1126/science.328.5981.973-a; Arens NC, 2008, PALEOBIOLOGY, V34, P456, DOI 10.1666/07034.1; Arens NC, 2000, PALAIOS, V15, P314, DOI 10.2307/3515539; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; BAADSGAARD H, 1988, CAN J EARTH SCI, V25, P1088, DOI 10.1139/e88-106; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barrera E, 1999, GEOL S AM S, P245; Chenet AL, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005644; Clemens WA, 2002, GEOL S AM S, P217; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Courtillot V, 2010, SCIENCE, V328, P973, DOI 10.1126/science.328.5981.973-b; D'Hondt S, 2005, ANNU REV ECOL EVOL S, V36, P295, DOI 10.1146/annurev.ecolsys.35.021103.105715; Dalrymple GB, 1993, US GEOL SURV B, V2065, p1 ; HILDEBRAND AR, 1991, GEOLOGY, V19, P867, DOI 10.1130/0091-7613(1991)019<0867:CCAPCT>2.3.CO;2; Husson D, 2011, EARTH PLANET SC LETT, V305, P328, DOI 10.1016/j.epsl.2011.03.008; Keller G, 2008, CRETACEOUS RES, V29, P754, DOI 10.1016/j.cretres.2008.05.030; Keller G, 2007, EARTH PLANET SC LETT, V255, P339, DOI 10.1016/j.epsl.2006.12.026; Keller G, 2010, SCIENCE, V328, P974, DOI 10.1126/science.328.5981.974-a; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Li LQ, 1998, MAR MICROPALEONTOL, V33, P55, DOI 10.1016/S0377-8398(97)00027-3; MAURRASSE FJMR, 1991, SCIENCE, V252, P1690, DOI 10.1126/science.252.5013.1690; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Murphy EC, 2002, GEOL S AM S, P9; Renne PR, 2011, GEOCHIM COSMOCHIM AC, V75, P5097, DOI 10.1016/j.gca.2011.06.021; Robinson N, 2009, EARTH PLANET SC LETT, V281, P159, DOI 10.1016/j.epsl.2009.02.019; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Self S, 2006, PHILOS T R SOC A, V364, P2073, DOI 10.1098/rsta.2006.1814; SIGURDSSON H, 1991, NATURE, V353, P839, DOI 10.1038/353839a0; SMIT J, 1990, GEOL MIJNBOUW, V69, P187; SMIT J, 1984, SCIENCE, V223, P1177, DOI 10.1126/science.223.4641.1177; SWISHER CC, 1992, SCIENCE, V257, P954, DOI 10.1126/science.257.5072.954; SWISHER CC, 1993, CAN J EARTH SCI, V30, P1981, DOI 10.1139/e93-174; Tobin TS, 2012, PALAEOGEOGR PALAEOCL, V350, P180, DOI 10.1016/j.palaeo.2012.06.029; Westerhold T, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004096; Wilf P, 2003, P NATL ACAD SCI USA, V100, P599, DOI 10.1073/pnas.0234701100; Wilson Gregory P., 2005, Journal of Mammalian Evolution, V12, P53, DOI 10.1007/s10914-005-6943-4	39	372	388	5	292	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					684	687		10.1126/science.1230492	http://dx.doi.org/10.1126/science.1230492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393261				2022-12-24	WOS:000314585600039
J	Smoller, JW; Craddock, N; Kendler, K; Lee, PH; Neale, BM; Nurnberger, JI; Ripke, S; Santangelo, S; Sullivan, PF; Purcell, S; Anney, R; Buitelaar, J; Fanous, A; Faraone, SV; Hoogendijk, W; Lesch, KP; Levinson, DF; Perlis, RH; Rietschel, M; Riley, B; Sonuga-Barke, E; Schachar, R; Schulze, TG; Thapar, A; Neale, M; Bender, P; Cichon, S; Daly, MJ; Kelsoe, J; Lehner, T; O'Donovan, M; Gejman, P; Sebat, J; Sklar, P; Devlin, B				Smoller, Jordan W.; Craddock, Nicholas; Kendler, Kenneth; Lee, Phil Hyoun; Neale, Benjamin M.; Nurnberger, John I.; Ripke, Stephan; Santangelo, Susan; Sullivan, Patrick F.; Purcell, Shaun; Anney, Richard; Buitelaar, Jan; Fanous, Ayman; Faraone, Stephen V.; Hoogendijk, Witte; Lesch, Klaus-Peter; Levinson, Douglas F.; Perlis, Roy H.; Rietschel, Marcella; Riley, Brien; Sonuga-Barke, Edmund; Schachar, Russell; Schulze, Thomas G.; Thapar, Anita; Neale, Michael; Bender, Patrick; Cichon, Sven; Daly, Mark J.; Kelsoe, John; Lehner, Thomas; O'Donovan, Mick; Gejman, Pablo; Sebat, Jonathan; Sklar, Pamela; Devlin, Bernie		Psychiatric Genomics Consortium	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis	LANCET			English	Article							AUTISM SPECTRUM DISORDERS; BIPOLAR DISORDER; GENETIC-CONTROL; SCHIZOPHRENIA; ASSOCIATION; METAANALYSIS; CACNA1C; EXPRESSION; TWIN	Background Findings from family and twin studies suggest that genetic contributions to psychiatric disorders do not in all cases map to present diagnostic categories. We aimed to identify specific variants underlying genetic effects shared between the five disorders in the Psychiatric Genomics Consortium: autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia. Methods We analysed genome-wide single-nucleotide polymorphism (SNP) data for the five disorders in 33 332 cases and 27 888 controls of European ancestory. To characterise allelic effects on each disorder, we applied a multinomial logistic regression procedure with model selection to identify the best-fitting model of relations between genotype and phenotype. We examined cross-disorder effects of genome-wide significant loci previously identified for bipolar disorder and schizophrenia, and used polygenic risk-score analysis to examine such effects from a broader set of common variants. We undertook pathway analyses to establish the biological associations underlying genetic overlap for the five disorders. We used enrichment analysis of expression quantitative trait loci (eQTL) data to assess whether SNPs with cross-disorder association were enriched for regulatory SNPs in post-mortem brain-tissue samples. Findings SNPs at four loci surpassed the cutoff for genome-wide significance (p<5x10(-8)) in the primary analysis: regions on chromosomes 3p21 and 10q24, and SNPs within two L-type voltage-gated calcium channel subunits, CACNA1C and CACNB2. Model selection analysis supported effects of these loci for several disorders. Loci previously associated with bipolar disorder or schizophrenia had variable diagnostic specificity. Polygenic risk scores showed cross-disorder associations, notably between adult-onset disorders. Pathway analysis supported a role for calcium channel signalling genes for all five disorders. Finally, SNPs with evidence of cross-disorder association were enriched for brain eQTL markers. Interpretation Our findings show that specific SNPs are associated with a range of psychiatric disorders of childhood onset or adult onset. In particular, variation in calcium-channel activity genes seems to have pleiotropic effects on psychopathology. These results provide evidence relevant to the goal of moving beyond descriptive syndromes in psychiatry, and towards a nosology informed by disease cause.	[Smoller, Jordan W.] Massachusetts Gen Hosp, Simches Res Bldg, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Smoller, JW (corresponding author), Massachusetts Gen Hosp, Simches Res Bldg, Boston, MA 02114 USA.	jsmoller@hms.harvard.edu	Medland, Sarah E/C-7630-2013; Daly, Mark J/B-2453-2017; Ruderfer, Douglas M/M-5795-2016; Visscher, Peter/ABB-6151-2020; Degenhardt, Franziska/H-4169-2017; Schalling, Martin/F-1518-2015; Jamain, Stéphane/L-1822-2019; Mahon, Pamela Belmonte/O-9806-2018; Franke, Barbara/D-4836-2009; Meier, Sandra/AAB-1242-2021; Lohoff, Falk W/M-7951-2016; Fanous, Ayman H/O-1263-2017; Kuntsi, Jonna/G-9750-2011; van Grootheest, Gerard/C-6942-2014; Lesch, Klaus-Peter/J-4906-2013; Etain, Bruno/L-6647-2017; Zhang, Peng/N-2920-2014; Pickard, Benjamin S/K-3923-2014; Bergen, Sarah/I-8313-2012; Hansen, Thomas Folkmann/O-5965-2014; Hartmann, Annette/AAS-6331-2021; O'Donovan, Michael C/P-7005-2018; Hickie, Ian B/K-8975-2015; Thapar, Anita/AAH-5555-2020; BELLIVIER, FRANK/H-5197-2012; McQuillin, Andrew/C-1623-2008; Faraone, Stephen/AAE-7334-2019; Jamain, Stéphane/P-3710-2017; Middeldorp, Christel M/L-7728-2017; Neale, Michael/AAD-5056-2020; Mattheisen, Manuel/B-4949-2012; van Os, Jim/C-2113-2014; McMahon, Francis J/A-7290-2009; Ripke, Stephan/AAK-5486-2021; Holmans, Peter/F-4518-2015; Kendler, Kenneth/AAF-2876-2019; Wray, Naomi/C-8639-2015; Kähler, Anna K/J-2874-2012; Greenwood, Tiffany/F-6356-2012; Mattingsdal, Morten/Q-9367-2016; Sonuga-Barke, Edmund j/D-9137-2011; de Geus, Eco J.C./M-9318-2015; Breen, Gerome D/A-5540-2010; Melle, Ingrid S/B-4858-2011; Mattheisen, Manuel/S-3725-2019; Nolen, Willem A/E-9006-2014; Konte, Bettina/AAT-1142-2021; Sigurdsson, Engilbert/D-2486-2014; Andreassen, Ole A./AAY-7531-2020; Nyholt, Dale/J-3174-2017	Medland, Sarah E/0000-0003-1382-380X; Daly, Mark J/0000-0002-0949-8752; Ruderfer, Douglas M/0000-0002-2365-386X; Visscher, Peter/0000-0002-2143-8760; Schalling, Martin/0000-0001-5011-2922; Mahon, Pamela Belmonte/0000-0002-3947-441X; Franke, Barbara/0000-0003-4375-6572; Kuntsi, Jonna/0000-0002-0113-8162; van Grootheest, Gerard/0000-0003-4350-6661; Lesch, Klaus-Peter/0000-0001-8348-153X; Etain, Bruno/0000-0002-5377-1488; Zhang, Peng/0000-0003-1182-1392; Pickard, Benjamin S/0000-0002-2374-6329; Bergen, Sarah/0000-0002-5888-0034; Hansen, Thomas Folkmann/0000-0001-6703-7762; O'Donovan, Michael C/0000-0001-7073-2379; Hickie, Ian B/0000-0001-8832-9895; Thapar, Anita/0000-0002-3689-737X; McQuillin, Andrew/0000-0003-1567-2240; Faraone, Stephen/0000-0002-9217-3982; Jamain, Stéphane/0000-0002-4321-4100; Middeldorp, Christel M/0000-0002-6218-0428; Mattheisen, Manuel/0000-0002-8442-493X; McMahon, Francis J/0000-0002-9469-305X; Holmans, Peter/0000-0003-0870-9412; Wray, Naomi/0000-0001-7421-3357; Greenwood, Tiffany/0000-0002-6080-6503; Mattingsdal, Morten/0000-0003-4440-0324; de Geus, Eco J.C./0000-0001-6022-2666; Breen, Gerome D/0000-0003-2053-1792; Melle, Ingrid S/0000-0002-9783-548X; Mattheisen, Manuel/0000-0002-8442-493X; Konte, Bettina/0000-0001-5287-308X; Sigurdsson, Engilbert/0000-0001-9404-7982; Nothen, Markus/0000-0002-8770-2464; Andreassen, Ole A./0000-0002-4461-3568; Agartz, Ingrid/0000-0002-9839-5391; Stefansson, Hreinn/0000-0002-9331-6666; Nyholt, Dale/0000-0001-7159-3040; BELLIVIER, FRANK/0000-0002-3660-6640; Anney, Richard/0000-0002-6083-407X; KELLER, MATTHEW/0000-0002-6075-9882; Tozzi, Federica/0000-0002-3536-2920; Craig, Ian/0000-0002-4063-1005; Hamilton, Steven/0000-0001-8106-6260; lichtenstein, paul/0000-0003-3037-5287; MacIntyre, Donald J/0000-0001-6963-1335; Willemsen, Gonneke/0000-0003-3755-0236; Zammit, Stanley/0000-0002-2647-9211; Posthuma, Danielle/0000-0001-7582-2365; Backlund, Lena/0000-0001-9399-5024; Morken, Gunnar/0000-0003-1972-5901	NIMH [U01 MH085520]; National Institutes of Health (USA); National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH094614, K99MH101367, R01MH106595, ZIAMH002843, R01MH083094, R01MH094400, U01MH094421, R01MH100027, R01MH077139, U01MH085520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688] Funding Source: NIH RePORTER; Medical Research Council [G1000718, G0801418B, G0701420, G9817803B] Funding Source: researchfish; MRC [G0701420, G1000708, G1000718] Funding Source: UKRI	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	National Institute of Mental Health.r We thank the study participants, and the research staff at the many study sites. This work was supported by NIMH grant U01 MH085520. Numerous grants from the National Institutes of Health (USA), and similar numbers of government grants from other countries, and substantial private and foundation support enabled this work.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96; Breen G, 2011, NAT GENET, V43, P3, DOI 10.1038/ng0111-3; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Erk S, 2010, ARCH GEN PSYCHIAT, V67, P803, DOI 10.1001/archgenpsychiatry.2010.94; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; Huang J, 2010, AM J PSYCHIAT, V167, P1254, DOI 10.1176/appi.ajp.2010.09091335; Kendler KS, 2005, PSYCHIAT GENETICS RE; King BH, 2011, BRAIN RES, V1380, P34, DOI 10.1016/j.brainres.2010.11.031; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Liao P, 2010, PFLUG ARCH EUR J PHY, V460, P353, DOI 10.1007/s00424-009-0753-0; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Liu Y, 2011, MOL PSYCHIATR, V16, P2, DOI 10.1038/mp.2009.107; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; Muhleisen TW, 2012, SCHIZOPHR RES, V138, P69, DOI 10.1016/j.schres.2012.03.007; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nyegaard M, 2010, MOL PSYCHIATR, V15, P119, DOI 10.1038/mp.2009.69; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Quen Jacques M., 1990, PSYCHIAT TXB STUDENT; Rapoport J, 2009, J AM ACAD CHILD PSY, V48, P10, DOI 10.1097/CHI.0b013e31818b1c63; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rommelse NNJ, 2010, EUR CHILD ADOLES PSY, V19, P281, DOI 10.1007/s00787-010-0092-x; Ronald A, 2008, J CHILD PSYCHOL PSYC, V49, P535, DOI 10.1111/j.1469-7610.2007.01857.x; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Thimm M, 2011, PSYCHOL MED, V41, P1551, DOI 10.1017/S0033291710002217; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294; Williams NM, 2012, AM J PSYCHIAT, V169, P195, DOI 10.1176/appi.ajp.2011.11060822; Wray NR, 2012, EUR J HUM GENET, V20, P668, DOI 10.1038/ejhg.2011.257; Zeng Z, 2011, MOL PSYCHIATR, V16, P473, DOI 10.1038/mp.2010.86; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	50	1945	1965	15	523	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1371	1379		10.1016/S0140-6736(12)62129-1	http://dx.doi.org/10.1016/S0140-6736(12)62129-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130EF	23453885	Green Submitted, Green Accepted			2022-12-24	WOS:000317894800034
J	Xu, W; Sudhof, TC				Xu, Wei; Suedhof, Thomas C.			A Neural Circuit for Memory Specificity and Generalization	SCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; MIDLINE THALAMUS; SYNAPTIC-TRANSMISSION; INHIBITORY SYNAPSES; PATTERN SEPARATION; NUCLEUS REUNIENS; SPATIAL MEMORY; PLACE CELLS; HIPPOCAMPUS; CONTEXT	Increased fear memory generalization is associated with posttraumatic stress disorder, but the circuit mechanisms that regulate memory specificity remain unclear. Here, we define a neural circuit-composed of the medial prefrontal cortex, the nucleus reuniens (NR), and the hippocampus-that controls fear memory generalization. Inactivation of prefrontal inputs into the NR or direct silencing of NR projections enhanced fear memory generalization, whereas constitutive activation of NR neurons decreased memory generalization. Direct optogenetic activation of phasic and tonic action-potential firing of NR neurons during memory acquisition enhanced or reduced memory generalization, respectively. We propose that the NR determines the specificity and generalization of memory attributes for a particular context by processing information from the medial prefrontal cortex en route to the hippocampus.	[Xu, Wei] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Xu, W (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, 265 Campus Dr, Palo Alto, CA 94304 USA.	weixu@stanford.edu; tcs1@stanford.edu		xu, wei/0000-0003-0987-2481	Simons Foundation [177850]; National Institute of Mental Health [P50 MH086403]; National Institute of Neurological Disorders and Stroke [NS077906]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086403, K99MH099153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077906] Funding Source: NIH RePORTER	Simons Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the following colleagues for providing plasmids and advice: M. Fuccillo and J. Ko (neuroligin-2 knockdown constructs), J. Burre (EGFP-synaptobrevin-2 construct), C. Acuna and R. Tsien (ChIEF-tdTomato), S. Lammel (advice on optogenetics), and K. Diesseroth (WGA-cre plasmid). This study was supported by grants from the Simons Foundation (177850), the National Institute of Mental Health (P50 MH086403), and the National Institute of Neurological Disorders and Stroke (NS077906).	Braz JM, 2002, P NATL ACAD SCI USA, V99, P15148, DOI 10.1073/pnas.222546999; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Dolleman-van der Weel MJ, 2009, BRAIN STRUCT FUNCT, V213, P329, DOI 10.1007/s00429-008-0200-6; DollemanVanderWeel MJ, 1997, J NEUROSCI, V17, P5640; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; FREEMAN FG, 1973, PHYSIOL BEHAV, V11, P273, DOI 10.1016/0031-9384(73)90362-4; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; GROENEWEGEN HJ, 1994, TRENDS NEUROSCI, V17, P52, DOI 10.1016/0166-2236(94)90074-4; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Kumaran D, 2012, PSYCHOL REV, V119, P573, DOI 10.1037/a0028681; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Loureiro M, 2012, J NEUROSCI, V32, P9947, DOI 10.1523/JNEUROSCI.0410-12.2012; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; McTighe SM, 2010, SCIENCE, V330, P1408, DOI 10.1126/science.1194780; Milanovic S, 1998, BRAIN RES, V784, P37, DOI 10.1016/S0006-8993(97)01266-3; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; Morales GJ, 2007, P ANN INT IEEE EMBS, P2480, DOI 10.1109/IEMBS.2007.4352831; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; PERKINS CC, 1958, J COMP PHYSIOL PSYCH, V51, P596, DOI 10.1037/h0042550; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; SWANSON LW, 1981, BRAIN RES, V217, P150, DOI 10.1016/0006-8993(81)90192-X; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Vertes RP, 2007, BRAIN RES BULL, V71, P601, DOI 10.1016/j.brainresbull.2006.12.002; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Watson JB, 2000, AM PSYCHOL, V55, P313, DOI 10.1037/0003-066X.55.3.313; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907; Wiltgen BJ, 2010, CURR BIOL, V20, P1336, DOI 10.1016/j.cub.2010.06.068; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Xu W, 2012, NEURON, V73, P990, DOI 10.1016/j.neuron.2011.12.036; Zhang YC, 2012, J NEUROPHYSIOL, V107, P3181, DOI 10.1152/jn.00072.2012; Zhou JL, 1996, LEARN MOTIV, V27, P400, DOI 10.1006/lmot.1996.0023	40	392	406	8	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2013	339	6125					1290	1295		10.1126/science.1229534	http://dx.doi.org/10.1126/science.1229534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493706	Green Accepted			2022-12-24	WOS:000316053400030
J	Greenbaum, A; Hsu, YMS; Day, RB; Schuettpelz, LG; Christopher, MJ; Borgerding, JN; Nagasawa, T; Link, DC				Greenbaum, Adam; Hsu, Yen-Michael S.; Day, Ryan B.; Schuettpelz, Laura G.; Christopher, Matthew J.; Borgerding, Joshua N.; Nagasawa, Takashi; Link, Daniel C.			CXCL12 in early mesenchymal progenitors is. required for haematopoietic stem-cell maintenance	NATURE			English	Article							BONE-MARROW; MICE; REGENERATION; ENGRAFTMENT; QUIESCENCE; EXPRESSION; REVEALS; CXCR4; FETAL	Haematopoietic stem cells (HSCs) primarily reside in the bone marrow where signals generated by stromal cells regulate their self-renewal, proliferation and trafficking. Endosteal osteoblasts(1,2) and perivascular stromal cells including endothelial cells(3), CXCL12-abundant reticular cells(4,5), leptin-receptor-positive stromal cells(6), and nestin-green fluorescent protein (GFP) -positive mesenchymal progenitors(7) have all been implicated in HSC maintenance. However, it is unclear whether specific haematopoietic progenitor cell (HPC) subsets reside in distinct niches defined by the surrounding stromal cells and the regulatory molecules they produce. CXCL12 (chemokine (C-X-C motif) ligand 12) regulates both HSCs and lymphoid progenitors and is expressed by all of these stromal cell populations(7-11). Here we selectively deleted Cxcl12 from candidate niche stromal cell populations and characterized the effect on HPCs. Deletion of Cxcl12 from mineralizing osteoblasts has no effect on HSCs or lymphoid progenitors. Deletion of Cxcl12 from osterix-expressing stromal cells, which include CXCL12-abundant reticular cells and osteoblasts, results in constitutive HPC mobilization and a loss of B-lymphoid progenitors, but HSC function is normal. Cxcl12 deletion from endothelial cells results in a modest loss of long-term repopulating activity. Strikingly, deletion of Cxcl12 from nestin-negative mesenchymal progenitors using Prx1-cre (Pod also known as Prrx1) is associated with a marked loss of HSCs, long-term repopulating activity, HSC quiescence and common lymphoid progenitors. These data suggest that osterix-expressing stromal cells comprise a distinct niche that supports B-lymphoid progenitors and retains HPCs in the bone marrow, and that expression of CXCL12 from stromal cells in the perivascular region, including endothelial cells and mesenchymal progenitors, supports HSCs.	[Greenbaum, Adam; Day, Ryan B.; Christopher, Matthew J.; Borgerding, Joshua N.; Link, Daniel C.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Hsu, Yen-Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Schuettpelz, Laura G.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Nagasawa, Takashi] Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Kyoto 6068507, Japan; [Nagasawa, Takashi] Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol, Tokyo 1020075, Japan	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Kyoto University; Japan Science & Technology Agency (JST)	Link, DC (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	dlink@dom.wustl.edu	Greenbaum, Adam/S-4034-2016	Day, Ryan/0000-0002-4376-4663; Greenbaum, Adam/0000-0002-1634-4743; Nagasawa, Takashi/0000-0002-1085-0960	NIH [RO1 HL60772, F30 HL097423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL112552, F30HL097423, R01HL060772] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22390096] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Woloszynek, F. Liu, A. Khalaf and M. Romine for technical assistance; G. Callis, S. Oh and M. Vig for technical advice; J. Tucker-Davis for animal care; and T. Clemens for the Oc-cre mice. This work was supported by NIH grants RO1 HL60772 (D.C.L.) and F30 HL097423 (A.G.).	Ara T, 2003, J IMMUNOL, V170, P4649, DOI 10.4049/jimmunol.170.9.4649; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bonig H, 2004, BLOOD, V104, P2299, DOI 10.1182/blood-2004-04-1605; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ding L., 2013, NATURE; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lehmann S, 2007, LEUKEMIA, V21, P1931, DOI 10.1038/sj.leu.2404852; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Zhan M, 2004, BIOCHEM BIOPH RES CO, V317, P198, DOI 10.1016/j.bbrc.2004.03.034; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	29	852	883	10	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					227	230		10.1038/nature11926	http://dx.doi.org/10.1038/nature11926			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23434756	Green Accepted			2022-12-24	WOS:000316652300049
J	Baradaran, R; Berrisford, JM; Minhas, GS; Sazanov, LA				Baradaran, Rozbeh; Berrisford, John M.; Minhas, Gurdeep S.; Sazanov, Leonid A.			Crystal structure of the entire respiratory complex I	NATURE			English	Article							NADH-QUINONE OXIDOREDUCTASE; ELECTRON-TRANSPORT CHAIN; THERMUS-THERMOPHILUS; HYDROPHILIC DOMAIN; ESCHERICHIA-COLI; MITOCHONDRIA; SUBUNITS; UBIQUINONE; STOICHIOMETRY; MECHANISM	Complex I is the first and largest enzyme of the respiratory chain and has a central role in cellular energy production through the coupling of NADH:ubiquinone electron transfer to proton translocation. It is also implicated in many common human neurodegenerative diseases. Here, we report the first crystal structure of the entire, intact complex I (from Thermus thermophilus) at 3.3 angstrom resolution. The structure of the 536-kDa complex comprises 16 different subunits, with a total of 64 transmembrane helices and 9 iron-sulphur clusters. The core fold of subunit Nqo8 (ND1 in humans) is, unexpectedly, similar to a half-channel of the antiporter-like subunits. Small subunits nearby form a linked second half-channel, which completes the fourth proton-translocation pathway (present in addition to the channels in three antiporter-like subunits). The quinone-binding site is unusually long, narrow and enclosed. The quinone headgroup binds at the deep end of this chamber, near iron-sulphur cluster N2. Notably, the chamber is linked to the fourth channel by a 'funnel' of charged residues. The link continues over the entire membrane domain as a flexible central axis of charged and polar residues, and probably has a leading role in the propagation of conformational changes, aided by coupling elements. The structure suggests that a unique, out-of-the-membrane quinone-reaction chamber enables the redox energy to drive concerted long-range conformational changes in the four antiporter-like domains, resulting in translocation of four protons per cycle.	[Baradaran, Rozbeh; Berrisford, John M.; Minhas, Gurdeep S.; Sazanov, Leonid A.] Wellcome Trust Res Labs, MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England	Wellcome Trust Sanger Institute	Sazanov, LA (corresponding author), Wellcome Trust Res Labs, MRC, Mitochondrial Biol Unit, MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	sazanov@mrc-mbu.cam.ac.uk	Sazanov, Leonid A/ABF-2125-2021	Sazanov, Leonid A/0000-0002-0977-7989; Berrisford, John/0000-0003-4442-5871	Medical Research Council; MRC [MC_U105674180] Funding Source: UKRI; Medical Research Council [MC_U105674180] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council. We thank the European Synchrotron Radiation Facility (ESRF) and the Swiss Light Source (SLS) for provision of synchrotron radiation facilities. We are grateful to the staff of beamlines ID29, ID23-2 (ESRF) and X06SA (SLS) for assistance.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Angerer H, 2012, BBA-BIOENERGETICS, V1817, P1776, DOI 10.1016/j.bbabio.2012.03.021; Angerer H, 2011, BIOCHEM J, V437, P279, DOI 10.1042/BJ20110359; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Berrisford JM, 2008, BIOCHEMISTRY-US, V47, P10262, DOI 10.1021/bi801160u; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Efremov RG, 2012, BBA-BIOENERGETICS, V1817, P1785, DOI 10.1016/j.bbabio.2012.02.015; Efremov RG, 2011, CURR OPIN STRUC BIOL, V21, P532, DOI 10.1016/j.sbi.2011.07.002; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Galkin A, 2006, BBA-BIOENERGETICS, V1757, P1575, DOI 10.1016/j.bbabio.2006.10.001; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; Kashani-Poor N, 2001, J BIOL CHEM, V276, P24082, DOI 10.1074/jbc.M102296200; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Moser CC, 2006, BBA-BIOENERGETICS, V1757, P1096, DOI 10.1016/j.bbabio.2006.04.015; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nouws J, 2012, BRAIN, V135, P12, DOI 10.1093/brain/awr261; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 2010, FEBS LETT, V584, P4131, DOI 10.1016/j.febslet.2010.08.039; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Sazanov L. A, 2012, STRUCTURAL PERSPECTI; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; Sekiguchi K, 2009, BBA-BIOENERGETICS, V1787, P1106, DOI 10.1016/j.bbabio.2009.02.016; Verkhovsky M, 2012, BBA-BIOENERGETICS, V1817, P1550, DOI 10.1016/j.bbabio.2012.04.013; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yip CY, 2011, J BIOL CHEM, V286, P5023, DOI 10.1074/jbc.M110.194993; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F	45	555	562	11	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					443	448		10.1038/nature11871	http://dx.doi.org/10.1038/nature11871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23417064	Green Accepted			2022-12-24	WOS:000315661500030
J	Kim, S; Brostromer, E; Xing, D; Jin, JS; Chong, SS; Ge, H; Wang, SY; Gu, C; Yang, LJ; Gao, YQ; Su, XD; Sun, YJ; Xie, XS				Kim, Sangjin; Brostroemer, Erik; Xing, Dong; Jin, Jianshi; Chong, Shasha; Ge, Hao; Wang, Siyuan; Gu, Chan; Yang, Lijiang; Gao, Yi Qin; Su, Xiao-dong; Sun, Yujie; Xie, X. Sunney			Probing Allostery Through DNA	SCIENCE			English	Article							T7 RNA-POLYMERASE; GLUCOCORTICOID-RECEPTOR; CRYSTAL-STRUCTURE; BINDING; PROTEIN; ENDONUCLEASE; REPRESSOR; PROMOTER; OPERATOR; MODEL	Allostery is well documented for proteins but less recognized for DNA-protein interactions. Here, we report that specific binding of a protein on DNA is substantially stabilized or destabilized by another protein bound nearby. The ternary complex's free energy oscillates as a function of the separation between the two proteins with a periodicity of similar to 10 base pairs, the helical pitch of B-form DNA, and a decay length of similar to 15 base pairs. The binding affinity of a protein near a DNA hairpin is similarly dependent on their separation, which-together with molecular dynamics simulations-suggests that deformation of the double-helical structure is the origin of DNA allostery. The physiological relevance of this phenomenon is illustrated by its effect on gene expression in live bacteria and on a transcription factor's affinity near nucleosomes.	[Kim, Sangjin; Brostroemer, Erik; Chong, Shasha; Wang, Siyuan; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Xing, Dong; Jin, Jianshi; Ge, Hao; Su, Xiao-dong; Sun, Yujie; Xie, X. Sunney] Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China; [Jin, Jianshi] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Ge, Hao] Peking Univ, Beijing Int Ctr Math Res, Beijing 100871, Peoples R China; [Gu, Chan; Yang, Lijiang; Gao, Yi Qin] Peking Univ, Coll Chem & Mol Engn, Inst Theoret & Computat Chem, Beijing 100871, Peoples R China	Harvard University; Peking University; Peking University; Peking University; Peking University	Su, XD (corresponding author), Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China.	xdsu@pku.edu.cn; sun_yujie@pku.edu.cn; xie@chemistry.harvard.edu	Yang, Lijiang/AAS-2662-2020; gao, yi/HCI-8298-2022	Kim, Sangjin/0000-0002-8444-7891; Wang, Siyuan (Steven)/0000-0001-6550-4064; Jin, Jianshi/0000-0003-4697-8760; Gu, Chan/0000-0002-4212-2394; Chong, Shasha/0000-0002-5372-311X	NIH; Peking University; Thousand Youth Talents Program; Major State Basic Research Development Program [2011CB809100]; National Natural Science Foundation of China [31170710, 31271423, 21125311]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peking University(Peking University); Thousand Youth Talents Program; Major State Basic Research Development Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Wood for his early involvement and J. Hynes, A. Szabo, C. Bustamante, and J. Gelles for helpful discussions. This work is supported by NIH Director's Pioneer Award to X. S. X., Peking University for BIOPIC, Thousand Youth Talents Program for Y.S., as well as the Major State Basic Research Development Program (2011CB809100), National Natural Science Foundation of China (31170710, 31271423, 21125311).	Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Daber R, 2007, J MOL BIOL, V370, P609, DOI 10.1016/j.jmb.2007.04.028; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Garcia HG, 2012, CELL REP, V2, P150, DOI 10.1016/j.celrep.2012.06.004; HOGAN M, 1979, NATURE, V278, P521, DOI 10.1038/278521a0; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kalodimos CG, 2002, EMBO J, V21, P2866, DOI 10.1093/emboj/cdf318; Kim SJ, 2007, NAT METHODS, V4, P397, DOI 10.1038/NMETH1037; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Koslover EF, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.178102; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Miller J.H., 1972, EXPT MOL GENETICS; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moretti R, 2008, ACS CHEM BIOL, V3, P220, DOI 10.1021/cb700258r; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; NEWMAN M, 1995, SCIENCE, V269, P656, DOI 10.1126/science.7624794; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Parekh BS, 1996, P NATL ACAD SCI USA, V93, P1173, DOI 10.1073/pnas.93.3.1173; POHL F, 1972, P NATL ACAD SCI USA, V69, P3805, DOI 10.1073/pnas.69.12.3805; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rudnick J, 1999, BIOPHYS J, V76, P1725, DOI 10.1016/S0006-3495(99)77334-0; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; Ujvari A, 2000, J MOL BIOL, V295, P1173, DOI 10.1006/jmbi.1999.3418; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x	33	170	171	2	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					816	819		10.1126/science.1229223	http://dx.doi.org/10.1126/science.1229223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413354	Green Accepted, Green Submitted			2022-12-24	WOS:000314874400048
J	Xiao, R; Zhang, B; Dong, YM; Gong, JK; Xu, T; Liu, JF; Xu, XZS				Xiao, Rui; Zhang, Bi; Dong, Yongming; Gong, Jianke; Xu, Tao; Liu, Jianfeng; Xu, X. Z. Shawn			A Genetic Program Promotes C. elegans Longevity at Cold Temperatures via a Thermosensitive TRP Channel	CELL			English	Article							RESTRICTION-INDUCED LONGEVITY; LIFE-SPAN; CAENORHABDITIS-ELEGANS; DAF-16; RECEPTOR; EXPRESSION; IDENTIFICATION; DIAPAUSE; KINASE; METABOLISM	Both poikilotherms and homeotherms live longer at lower body temperatures, highlighting a general role of temperature reduction in lifespan extension. However, the underlying mechanisms remain unclear. One prominent model is that cold temperatures reduce the rate of chemical reactions, thereby slowing the rate of aging. This view suggests that cold-dependent lifespan extension is simply a passive thermodynamic process. Here, we challenge this view in C. elegans by showing that genetic programs actively promote longevity at cold temperatures. We find that TRPA-1, a cold-sensitive TRP channel, detects temperature drop in the environment to extend lifespan. This effect requires cold-induced, TRPA-1-mediated calcium influx and a calcium-sensitive PKC that signals to the transcription factor DAF-16/FOXO. Human TRPA1 can functionally substitute for worm TRPA-1 in promoting longevity. Our results reveal a previously unrecognized function for TRP channels, link calcium signaling to longevity, and, importantly, demonstrate that genetic programs contribute to lifespan extension at cold temperatures.	[Xiao, Rui; Zhang, Bi; Dong, Yongming; Gong, Jianke; Xu, X. Z. Shawn] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Xu, X. Z. Shawn] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Zhang, Bi; Gong, Jianke; Xu, Tao; Liu, Jianfeng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Xu, Tao] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Huazhong University of Science & Technology; Chinese Academy of Sciences; Institute of Biophysics, CAS	Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu	Dong, Yongming/H-9502-2013; Liu, Jianfeng/E-2786-2012	Dong, Yongming/0000-0002-6510-0913; Xiao, Rui/0000-0001-5541-6685; Zhang, Bi/0000-0002-3961-5227	AHA postdoctoral fellowship; Program of Introducing Talents of Discipline to Universities from the Ministry of Education of China; NIGMS; NIA; NSFC; Pew scholar program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000114, R01AG036956] Funding Source: NIH RePORTER	AHA postdoctoral fellowship(American Heart Association); Program of Introducing Talents of Discipline to Universities from the Ministry of Education of China; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NSFC(National Natural Science Foundation of China (NSFC)); Pew scholar program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Ao-Lin Hsu for providing reagents and critically reading the manuscript, Jiandie Lin, Xiaowei Chen, and Zhaoyu Li for technical assistance, and Sean Curran and Gary Ruvkun for daf-16 strains. Some strains were obtained from the CGC and Knockout Consortiums in the US and Japan. R.X. was supported by an AHA postdoctoral fellowship. This work was supported by the Program of Introducing Talents of Discipline to Universities from the Ministry of Education of China (J.L.) and grants from the NIGMS (X.Z.S.X.), NIA (Ao-Lin Hsu), NSFC (T.X. and X.Z.S.X.), and Pew scholar program (X.Z.S.X.).	AAMODT EJ, 1991, SCIENCE, V252, P579, DOI 10.1126/science.2020855; Alam H, 2010, CELL METAB, V12, P30, DOI 10.1016/j.cmet.2010.05.004; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Antebi A, 2000, GENE DEV, V14, P1512; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Conti B, 2008, CELL MOL LIFE SCI, V65, P1626, DOI 10.1007/s00018-008-7536-1; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Earley S, 2009, CIRC RES, V104, P987, DOI 10.1161/CIRCRESAHA.108.189530; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; FIRE A, 1989, EMBO J, V8, P3419, DOI 10.1002/j.1460-2075.1989.tb08506.x; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hsu AL, 2009, NEUROBIOL AGING, V30, P1498, DOI 10.1016/j.neurobiolaging.2007.12.007; Jia KL, 2002, DEVELOPMENT, V129, P221; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Lee BH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000213; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Loeb J, 1916, P NATL ACAD SCI USA, V2, P456, DOI 10.1073/pnas.2.8.456; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Satterlee JS, 2004, CURR BIOL, V14, P62, DOI 10.1016/j.cub.2003.12.030; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Stokes A, 2006, CELL SIGNAL, V18, P1584, DOI 10.1016/j.cellsig.2005.12.009; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wu DQ, 2009, AGING CELL, V8, P666, DOI 10.1111/j.1474-9726.2009.00523.x; Xiao R, 2009, PFLUG ARCH EUR J PHY, V458, P851, DOI 10.1007/s00424-009-0678-7	59	152	160	1	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					806	817		10.1016/j.cell.2013.01.020	http://dx.doi.org/10.1016/j.cell.2013.01.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415228	Bronze, Green Accepted			2022-12-24	WOS:000314945600015
J	Adair, LS; Fall, CHD; Osmond, C; Stein, AD; Martorell, R; Ramirez-Zea, M; Sachdev, HS; Dahly, DL; Bas, I; Norris, SA; Micklesfield, L; Hallal, P; Victora, CG				Adair, Linda S.; Fall, Caroline H. D.; Osmond, Clive; Stein, Aryeh D.; Martorell, Reynaldo; Ramirez-Zea, Manuel; Sachdev, Harshpal Singh; Dahly, Darren L.; Bas, Isabelita; Norris, Shane A.; Micklesfield, Lisa; Hallal, Pedro; Victora, Cesar G.		COHORTS Grp	Associations of linear growth and relative weight gain during early life with adult health and human capital in countries of low and middle income: findings from five birth cohort studies	LANCET			English	Article							BODY-MASS INDEX; CATCH-UP GROWTH; EARLY-CHILDHOOD; BLOOD-PRESSURE; PROFILE; NUTRITION; SIZE; PATTERNS; UNDERNUTRITION; METABOLISM	Background Fast weight gain and linear growth in children in low-income and middle-income countries are associated with enhanced survival and improved cognitive development, but might increase risk of obesity and related adult cardiometabolic diseases. We investigated how linear growth and relative weight gain during infancy and childhood are related to health and human capital outcomes in young adults. Methods We used data from five prospective birth cohort studies from Brazil, Guatemala, India, the Philippines, and South Africa. We investigated body-mass index, systolic and diastolic blood pressure, plasma glucose concentration, height, years of attained schooling, and related categorical indicators of adverse outcomes in young adults. With linear and logistic regression models, we assessed how these outcomes relate to birthweight and to statistically independent measures representing linear growth and weight gain independent of linear growth (relative weight gain) in three age periods: 0-2 years, 2 years to mid-childhood, and mid-childhood to adulthood. Findings We obtained data for 8362 participants who had at least one adult outcome of interest. A higher birthweight was consistently associated with an adult body-mass index of greater than 25 kg/m(2) (odds ratio 1.28, 95% CI 1.21-1.35) and a reduced likelihood of short adult stature (0.49, 0.44-0.54) and of not completing secondary school (0.82, 0.78-0.87). Faster linear growth was strongly associated with a reduced risk of short adult stature (age 2 years: 0.23, 0.20-0.52; mid-childhood: 0.39, 0.36-0.43) and of not completing secondary school (age 2 years: 0.74, 0.67-0.78; mid-childhood: 0.87, 0.83-0.92), but did raise the likelihood of overweight (age 2 years: 1.24, 1.17-1.31; mid-childhood: 1.12, 1.06-1.18) and elevated blood pressure (age 2 years: 1.12, 1.06-1.19; mid-childhood: 1.07, 1.01-1.13). Faster relative weight gain was associated with an increased risk of adult overweight (age 2 years: 1.51, 1.43-1.60; mid-childhood: 1.76, 1.69-1.91) and elevated blood pressure (age 2 years: 1.07, 1.01-1.13; mid-childhood: 1.22, 1.15-1.30). Linear growth and relative weight gain were not associated with dysglycaemia, but a higher birthweight was associated with decreased risk of the disorder (0.89, 0.81-0.98). Interpretation Interventions in countries of low and middle income to increase birthweight and linear growth during the first 2 years of life are likely to result in substantial gains in height and schooling and give some protection from adult chronic disease risk factors, with few adverse trade-offs.	[Adair, Linda S.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27516 USA; [Fall, Caroline H. D.; Osmond, Clive] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Stein, Aryeh D.; Martorell, Reynaldo] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Ramirez-Zea, Manuel] Inst Nutr Cent Amer & Panama, Unit Nutr & Chron Dis, Guatemala City, Guatemala; [Sachdev, Harshpal Singh] Sitaram Bhartia Inst Sci & Res, New Delhi, India; [Dahly, Darren L.] Univ Leeds, Ctr Biostat & Epidemiol, Leeds, W Yorkshire, England; [Bas, Isabelita] Univ San Carlos, Off Populat Studies Fdn, Cebu, Philippines; [Norris, Shane A.; Micklesfield, Lisa] Univ Witwatersrand, Fac Hlth Sci, Dept Pediat, MRC,Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Hallal, Pedro; Victora, Cesar G.] Univ Fed Pelotas, Pelotas, Brazil	University of North Carolina; University of North Carolina Chapel Hill; University of Southampton; Emory University; Rollins School Public Health; Institute of Nutrition of Central America & Panama (INCAP); Sitaram Bhartia Institute of Science & Research; University of Leeds; University of San Carlos; University of Witwatersrand; Universidade Federal de Pelotas	Adair, LS (corresponding author), Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27516 USA.	linda_adair@unc.edu	Victora, Cesar Gomes/Y-2455-2019; Martorell, Reynaldo/I-2539-2012; Horta, Bernardo/A-7604-2008; Hallal, Pedro C/A-3249-2011; Norris, Shane/C-4664-2014; Victora, Cesar G/D-4476-2013; Micklesfield, Lisa/AAR-8262-2021	Victora, Cesar Gomes/0000-0002-2465-2180; Horta, Bernardo/0000-0001-9843-412X; Hallal, Pedro C/0000-0003-1470-6461; Norris, Shane/0000-0001-7124-3788; Victora, Cesar G/0000-0002-2465-2180; Micklesfield, Lisa/0000-0002-4994-0779; Dahly, Darren/0000-0003-0110-324X; Stein, Aryeh/0000-0003-1138-6458; Osmond, Clive/0000-0002-9054-4655; Sachdev, Harshpal Singh/0000-0002-4956-9391; Addo, O.Yaw/0000-0003-1269-759X; Fall, Caroline/0000-0003-4402-5552	Wellcome Trust; Bill & Melinda Gates Foundation; MRC [G1001333, MC_UP_A620_1016, G0902101, MC_UU_12011/4, MC_UU_12011/3] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; Medical Research Council [G0902101, MC_UU_12011/3, MC_UU_12011/4, G1001333, MC_UP_A620_1016] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Wellcome Trust and Bill & Melinda Gates Foundation.	Adair LS, 2011, INT J EPIDEMIOL, V40, P619, DOI 10.1093/ije/dyq085; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Carba DB, 2009, ECON HUM BIOL, V7, P7, DOI 10.1016/j.ehb.2009.01.010; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Demerath EW, 2009, OBESITY, V17, P2060, DOI 10.1038/oby.2009.105; Dulloo AG, 2008, BEST PRACT RES CL EN, V22, P155, DOI 10.1016/j.beem.2007.08.001; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Eriksson JG, 2007, HYPERTENSION, V49, P1415, DOI 10.1161/HYPERTENSIONAHA.106.085597; Hales CN, 2003, J PHYSIOL-LONDON, V547, P5, DOI 10.1113/jphysiol.2002.024406; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; International Diabetes Federation (IDF), 2006, IDF CONS WORLDW DEF; Jones A, 2012, HYPERTENSION, V59, P919, DOI 10.1161/HYPERTENSIONAHA.111.187716; Keijzer-Veen MG, 2005, J CLIN EPIDEMIOL, V58, P1320, DOI 10.1016/j.jclinepi.2005.04.004; Kumar Gautam, 2004, Prehosp Emerg Care, V8, P378, DOI 10.1016/j.prehos.2004.06.010; Kuzawa CW, 2012, AM J HUM BIOL, V24, P5, DOI 10.1002/ajhb.21227; Law CM, 2002, CIRCULATION, V105, P1088, DOI 10.1161/hc0902.104677; Leunissen RWJ, 2009, CLIN ENDOCRINOL, V70, P245, DOI 10.1111/j.1365-2265.2008.03320.x; Li HJ, 2003, AM J CLIN NUTR, V77, P1498, DOI 10.1093/ajcn/77.6.1498; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; Menezes AMB, 2012, J EPIDEMIOL COMMUN H, V66, P149, DOI 10.1136/jech.2010.124842; Norris SA, 2012, DIABETES CARE, V35, P72, DOI 10.2337/dc11-0456; Ong Ken K, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P30, DOI 10.1097/MED.0b013e328013da6c; Petersen JR, 2008, CLIN CHIM ACTA, V396, P10, DOI 10.1016/j.cca.2008.06.010; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; Richter LM, 2012, INT J EPIDEMIOL, V41, P621, DOI 10.1093/ije/dyq251; Roberfroid D, 2012, AM J CLIN NUTR, V95, P916, DOI 10.3945/ajcn.111.029033; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Stein AD, 2008, INT J EPIDEMIOL, V37, P716, DOI 10.1093/ije/dyn028; Stein AD, 2010, AM J HUM BIOL, V22, P353, DOI 10.1002/ajhb.20998; Stettler N, 2010, CURR OPIN CLIN NUTR, V13, P294, DOI 10.1097/MCO.0b013e328337d7b9; Thomas D, 2002, B WORLD HEALTH ORGAN, V80, P106; Tu Yu-Kang, 2006, Epidemiol Perspect Innov, V3, P9, DOI 10.1186/1742-5573-3-9; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; Victora CG, 2001, INT J EPIDEMIOL, V30, P1325, DOI 10.1093/ije/30.6.1325; W.H. Organization, 1999, DEFINITION DIAGNOSIS; World Health Organization/United Nations Children's Fund, 2012, COUNTD 2015 BUILD FU	39	489	500	7	105	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2013	382	9891					525	534		10.1016/S0140-6736(13)60103-8	http://dx.doi.org/10.1016/S0140-6736(13)60103-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201SD	23541370	Green Published			2022-12-24	WOS:000323162400031
J	Jardine, J; Julien, JP; Menis, S; Ota, T; Kalyuzhniy, O; McGuire, A; Sok, D; Huang, PS; MacPherson, S; Jones, M; Nieusma, T; Mathison, J; Baker, D; Ward, AB; Burton, DR; Stamatatos, L; Nemazee, D; Wilson, IA; Schief, WR				Jardine, Joseph; Julien, Jean-Philippe; Menis, Sergey; Ota, Takayuki; Kalyuzhniy, Oleksandr; McGuire, Andrew; Sok, Devin; Huang, Po-Ssu; MacPherson, Skye; Jones, Meaghan; Nieusma, Travis; Mathison, John; Baker, David; Ward, Andrew B.; Burton, Dennis R.; Stamatatos, Leonidas; Nemazee, David; Wilson, Ian A.; Schief, William R.			Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors	SCIENCE			English	Article							STRUCTURAL BASIS; ANTIBODIES; POTENT; BROAD; NEUTRALIZATION; VIRUSES; ENV	Vaccine development to induce broadly neutralizing antibodies (bNAbs) against HIV-1 is a global health priority. Potent VRC01-class bNAbs against the CD4 binding site of HIV gp120 have been isolated from HIV-1-infected individuals; however, such bNAbs have not been induced by vaccination. Wild-type gp120 proteins lack detectable affinity for predicted germline precursors of VRC01-class bNAbs, making them poor immunogens to prime a VRC01-class response. We employed computation-guided, in vitro screening to engineer a germline-targeting gp120 outer domain immunogen that binds to multiple VRC01-class bNAbs and germline precursors, and elucidated germline binding crystallographically. When multimerized on nanoparticles, this immunogen (eOD-GT6) activates germline and mature VRC01-class B cells. Thus, eOD-GT6 nanoparticles have promise as a vaccine prime. In principle, germline-targeting strategies could be applied to other epitopes and pathogens.	[Jardine, Joseph; Menis, Sergey; Ota, Takayuki; Kalyuzhniy, Oleksandr; Sok, Devin; MacPherson, Skye; Jones, Meaghan; Mathison, John; Burton, Dennis R.; Nemazee, David; Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Jardine, Joseph; Julien, Jean-Philippe; Menis, Sergey; Kalyuzhniy, Oleksandr; Sok, Devin; MacPherson, Skye; Jones, Meaghan; Nieusma, Travis; Ward, Andrew B.; Burton, Dennis R.; Wilson, Ian A.; Schief, William R.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Jardine, Joseph; Julien, Jean-Philippe; Menis, Sergey; Kalyuzhniy, Oleksandr; Sok, Devin; MacPherson, Skye; Nieusma, Travis; Ward, Andrew B.; Burton, Dennis R.; Wilson, Ian A.; Schief, William R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Jardine, Joseph; Menis, Sergey; Kalyuzhniy, Oleksandr; Huang, Po-Ssu; MacPherson, Skye; Jones, Meaghan; Baker, David; Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Julien, Jean-Philippe; Nieusma, Travis; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [McGuire, Andrew; Stamatatos, Leonidas] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02129 USA; [Stamatatos, Leonidas] Univ Washington, Dept Global Hlth, Seattle, WA 98109 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; University of Washington; University of Washington Seattle; Scripps Research Institute; Center for Infectious Disease Research; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Washington; University of Washington Seattle; Scripps Research Institute	Schief, WR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	schief@scripps.edu	Cheng, Yushao/E-6256-2011; Ota, Takayuki/Q-5528-2017; Ward, Andrew B/F-9203-2014; Ward, Andrew/ABD-7728-2021; Schief, William/ABF-3645-2020; Baker, David/K-8941-2012	Ota, Takayuki/0000-0001-6249-0664; Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Schief, William/0000-0002-1120-0150; Baker, David/0000-0001-7896-6217; Huang, Possu/0000-0002-7948-2895; Julien, Jean-Philippe/0000-0001-7602-3995; Spencer, Skye/0000-0001-9570-9634; McGuire, Andrew/0000-0003-1841-6859; Kalyuzhniy, Oleksandr/0000-0002-5273-1951	IAVI Neutralizing Antibody Center, CHAVI-ID [UM1 AI100663]; NIH [AI84817, AI081625, AI33292]; NIH National Research Service Award [T32CA080416]; Canadian Institutes of Health Research; Creative and Novel Ideas in HIV Research grant [P30 AI027767-24]; NIH Interdisciplinary Training Program in Immunology [5T32AI007606-10]; Ragon Institute; DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program [P41RR001209]; National Institute of General Medical Sciences (NIGMS); DOE, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI084817, R01AI073148, R37AI033292, T32AI007606, UM1AI100663, P30AI027767, R01AI081625, R01AI033292, R01AI084817, P01AI094419] Funding Source: NIH RePORTER	IAVI Neutralizing Antibody Center, CHAVI-ID; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Creative and Novel Ideas in HIV Research grant; NIH Interdisciplinary Training Program in Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH's National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Mascola and X. Wu for providing sequences of mature PGV19 and PGV20; R. Wyatt for providing the YU2 gp140 trimer; C. Sundling and G. Karlsson Hedestam for the sequence of the Rhe1 VH gene; A. Bradley, R. L. Stanfield, and D. C. Diwanji for technical assistance and insightful discussions; and M. Azoitei, R. Jacak, and D. Kulp for comments on the manuscript. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. Coordinates and structure factors for GL-VRC01 Fab, eOD-GT6, and GL-VRC01+eODGT6 structures have been deposited with the PDB under accession codes 4JPI, 4JPJ, and 4JPK, respectively. The International AIDS Vaccine Initiative (IAVI) has filed a patent relating to immunogens in this manuscript: PCT Application PCT/US12/60062, titled "Engineered Outer Domain (EOD) of HIV GP120 and Mutants Thereof," with inventors W. R. S., J. J., S. M., and P.-S.H. Materials and information will be provided under a material transfer agreement. This work was supported by IAVI Neutralizing Antibody Center, CHAVI-ID (UM1 AI100663); NIH grants AI84817 (I. A. W.), AI081625 (L. S.), and AI33292 (D. R. B.); NIH National Research Service Award Training Grant fellowship T32CA080416 (J. J.); Canadian Institutes of Health Research fellowship (J.-P.J.); Creative and Novel Ideas in HIV Research grant P30 AI027767-24 (T.O.); NIH Interdisciplinary Training Program in Immunology 5T32AI007606-10 (D. S.); and the Ragon Institute. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a directorate of the SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program (P41RR001209); and the National Institute of General Medical Sciences (NIGMS). Use of the Advanced Photon Source was supported by the DOE, Basic Energy Sciences, Office of Science, under contract DE-AC02-06CH11357. GM/CA CAT has been funded in whole or in part with federal funds from the National Cancer Institute (grant Y1-CO-1020) and NIGMS (grant Y1-GM-1104). This is manuscript 23050 from The Scripps Research Institute.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; Knight KL, 1997, CURR OPIN IMMUNOL, V9, P228, DOI 10.1016/S0952-7915(97)80140-9; Kong L, 2012, P NATL ACAD SCI USA, V109, P9499, DOI 10.1073/pnas.1202924109; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Ota T, 2012, J IMMUNOL, V189, P4816, DOI 10.4049/jimmunol.1202165; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang P, 2009, P NATL ACAD SCI USA, V106, P7537, DOI 10.1073/pnas.0902749106; Zhang XF, 2001, J MOL BIOL, V306, P1099, DOI 10.1006/jmbi.2000.4435; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	29	501	531	3	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					711	716		10.1126/science.1234150	http://dx.doi.org/10.1126/science.1234150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23539181	Green Accepted			2022-12-24	WOS:000318619000030
J	Gilmour, JP; Smith, LD; Heyward, AJ; Baird, AH; Pratchett, MS				Gilmour, James P.; Smith, Luke D.; Heyward, Andrew J.; Baird, Andrew H.; Pratchett, Morgan S.			Recovery of an Isolated Coral Reef System Following Severe Disturbance	SCIENCE			English	Article							COMMUNITIES; RESILIENCE; MANAGEMENT; DECLINE	Coral reef recovery from major disturbance is hypothesized to depend on the arrival of propagules from nearby undisturbed reefs. Therefore, reefs isolated by distance or current patterns are thought to be highly vulnerable to catastrophic disturbance. We found that on an isolated reef system in north Western Australia, coral cover increased from 9% to 44% within 12 years of a coral bleaching event, despite a 94% reduction in larval supply for 6 years after the bleaching. The initial increase in coral cover was the result of high rates of growth and survival of remnant colonies, followed by a rapid increase in juvenile recruitment as colonies matured. We show that isolated reefs can recover from major disturbance, and that the benefits of their isolation from chronic anthropogenic pressures can outweigh the costs of limited connectivity.	[Gilmour, James P.; Smith, Luke D.; Heyward, Andrew J.] Univ Western Australia, Oceans Inst, AIMS, Perth, WA 6009, Australia; [Baird, Andrew H.; Pratchett, Morgan S.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	Australian Institute of Marine Science; University of Western Australia; James Cook University	Gilmour, JP (corresponding author), Univ Western Australia, Oceans Inst, AIMS, Perth, WA 6009, Australia.	j.gilmour@aims.gov.au	Baird, Andrew Hamilton/C-8449-2009; Pratchett, Morgan S/A-9256-2010; Pratchett, Morgan/AAW-5179-2020	Baird, Andrew Hamilton/0000-0001-8504-4077; Pratchett, Morgan S/0000-0002-1862-8459; Pratchett, Morgan/0000-0002-1862-8459	Australian Federal Government through the Australian Institute of Marine Science; Browse LNG Development Joint Venture Participants, through the operator Woodside Energy Limited	Australian Federal Government through the Australian Institute of Marine Science; Browse LNG Development Joint Venture Participants, through the operator Woodside Energy Limited	The field work at Scott Reef was supported by crews of the AIMS Research Vessels Lady Basten, Cape Ferguson, and Solander. We thank K. Brooks, M. Case, J. Colquhoun, K. Cook, D. Ceccarelli, A. Cheal, J. Eagle, K. Fitzgerald, E. Gates, A. Halford, O. Hunt, D. Hoey, K. Markey, D. McKinney, S. Neale, R. Ninio, B. Radford, M. Rees, G. Suosaari, A. Thompson, M. Travers, and J. Underwood for help with data collection or analyses; J. Lough for help with sea surface temperature data; and K. Cook, A. McNeil, J. Oliver, and three anonymous reviewers for their comments. This research was jointly supported by the Australian Federal Government through the Australian Institute of Marine Science and the Browse LNG Development Joint Venture Participants, through the operator Woodside Energy Limited. J. P. G., L. D. S., and A. J. H. designed the experiments and collected and managed the data. J. P. G., L. D. S., A. H. B., and M. S. P. analyzed and interpreted the data, and all authors wrote the paper. Data used in this paper can be accessed at the AIMS Data Catalogue at http://data.aims.gov.au/metadataviewer/uuid/efc0b6f4-1eb1-48f0-8673-b161d68f0f2f.	Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; Done T, 2007, CORAL REEFS, V26, P789, DOI 10.1007/s00338-007-0265-3; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Gilmour JP, 2009, MAR BIOL, V156, P1297, DOI 10.1007/s00227-009-1171-8; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Lotze HK, 2011, TRENDS ECOL EVOL, V26, P595, DOI 10.1016/j.tree.2011.07.008; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; NOAA, 2013, COR REEF WATCH COR B; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Underwood JN, 2009, ECOL APPL, V19, P18, DOI 10.1890/07-1461.1; Van Woesik R, 2000, BIODIVERS CONSERV, V9, P1219, DOI 10.1023/A:1008913219660; Wilkinson C, 2000, STATUS CORAL REEFS W; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilkinson C., 2004, STATUS CORAL REEFS W; WITTENBERG M, 1992, MAR BIOL, V112, P131, DOI 10.1007/BF00349736	29	359	364	4	305	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2013	340	6128					69	71		10.1126/science.1232310	http://dx.doi.org/10.1126/science.1232310			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559247				2022-12-24	WOS:000317061100046
J	Burkle, LA; Marlin, JC; Knight, TM				Burkle, Laura A.; Marlin, John C.; Knight, Tiffany M.			Plant-Pollinator Interactions over 120 Years: Loss of Species, Co-Occurrence, and Function	SCIENCE			English	Article							HABITAT FRAGMENTATION; NETWORK STRUCTURE; LIFE-HISTORY; PHENOLOGY; RESPONSES; WORLD	Using historic data sets, we quantified the degree to which global change over 120 years disrupted plant-pollinator interactions in a temperate forest understory community in Illinois, USA. We found degradation of interaction network structure and function and extirpation of 50% of bee species. Network changes can be attributed to shifts in forb and bee phenologies resulting in temporal mismatches, nonrandom species extinctions, and loss of spatial co-occurrences between extant species in modified landscapes. Quantity and quality of pollination services have declined through time. The historic network showed flexibility in response to disturbance; however, our data suggest that networks will be less resilient to future changes.	[Burkle, Laura A.; Knight, Tiffany M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Burkle, Laura A.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Marlin, John C.] Univ Illinois, Illinois Sustainable Technol Ctr, Champaign, IL 61820 USA	Washington University (WUSTL); Montana State University System; Montana State University Bozeman; University of Illinois System; University of Illinois Urbana-Champaign	Burkle, LA (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	laura.burkle@montana.edu			NSF [DEB 0934376, 06-520 DRL-0739874]; NSF	NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	M. Bujnak, A. David, M. Dust, J. Hopwood, M. Jean, R. Jean, S. Mulhern, Z. Portman, and J. Wray provided exceptional help in the field and laboratory. M. Arduser and J. Gibbs aided in bee identification. Historic data and specimen access were provided by J. Memmott and P. Tinerella, respectively. Access to current data is available at http://datadryad.org. We are grateful to Beaver Dam State Park, Moores Cemetery Woods, Bethel Ridge Cemetery, Culp Conservancy Woods, E. Swiatkowsk, and the Parlodi family for field site access. Funding was provided by NSF DEB 0934376 and NSF 06-520 DRL-0739874. Three anonymous reviewers provided comments on earlier drafts.	Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Bartomeus I, 2011, P NATL ACAD SCI USA, V108, P20645, DOI 10.1073/pnas.1115559108; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 1996, J ANIM ECOL, V65, P465, DOI 10.2307/5781; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Cagnolo L, 2009, CONSERV BIOL, V23, P1167, DOI 10.1111/j.1523-1739.2009.01214.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Encinas-Viso F, 2012, ECOL LETT, V15, P198, DOI 10.1111/j.1461-0248.2011.01726.x; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; Inouye DW, 2003, AM J BOT, V90, P905, DOI 10.3732/ajb.90.6.905; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Marlin JC, 2001, CONSERV ECOL, V5, part. no.; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Miller-Rushing AJ, 2008, J ECOL, V96, P1289, DOI 10.1111/j.1365-2745.2008.01436.x; Miller-Rushing AJ, 2008, ECOLOGY, V89, P332, DOI 10.1890/07-0068.1; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Penuelas J, 2002, GLOBAL CHANGE BIOL, V8, P531, DOI 10.1046/j.1365-2486.2002.00489.x; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Robertson C., 1929, FLOWERS INSECTS LIST; ROBERTSON CHARLES, 1926, PSYCHE, V33, P116, DOI 10.1155/1926/95452; ROBERTSON CHARLES, 1929, PSYCHE, V36, P112; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024	31	631	668	32	921	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1611	1615		10.1126/science.1232728	http://dx.doi.org/10.1126/science.1232728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23449999	Green Submitted			2022-12-24	WOS:000316731600050
J	Clemmensen, KE; Bahr, A; Ovaskainen, O; Dahlberg, A; Ekblad, A; Wallander, H; Stenlid, J; Finlay, RD; Wardle, DA; Lindahl, BD				Clemmensen, K. E.; Bahr, A.; Ovaskainen, O.; Dahlberg, A.; Ekblad, A.; Wallander, H.; Stenlid, J.; Finlay, R. D.; Wardle, D. A.; Lindahl, B. D.			Roots and Associated Fungi Drive Long-Term Carbon Sequestration in Boreal Forest	SCIENCE			English	Article							LITTER DECOMPOSITION; ISOTOPE PATTERNS; NITROGEN UPTAKE; N-15 ABUNDANCE; ISLAND AREA; SOIL; ECTOMYCORRHIZAL; RATES; ERGOSTEROL; PROFILES	Boreal forest soils function as a terrestrial net sink in the global carbon cycle. The prevailing dogma has focused on aboveground plant litter as a principal source of soil organic matter. Using C-14 bomb-carbon modeling, we show that 50 to 70% of stored carbon in a chronosequence of boreal forested islands derives from roots and root-associated microorganisms. Fungal biomarkers indicate impaired degradation and preservation of fungal residues in late successional forests. Furthermore, 454 pyrosequencing of molecular barcodes, in conjunction with stable isotope analyses, highlights root-associated fungi as important regulators of ecosystem carbon dynamics. Our results suggest an alternative mechanism for the accumulation of organic matter in boreal forests during succession in the long-term absence of disturbance.	[Clemmensen, K. E.; Dahlberg, A.; Stenlid, J.; Finlay, R. D.; Lindahl, B. D.] Swedish Univ Agr Sci, Uppsala BioCtr, Dept Forest Mycol & Plant Pathol, SE-75007 Uppsala, Sweden; [Bahr, A.; Wallander, H.] Lund Univ, Microbial Ecol Grp, Dept Biol, SE-22100 Lund, Sweden; [Ovaskainen, O.] Univ Helsinki, Dept Biosci, FI-00014 Helsinki, Finland; [Dahlberg, A.] Swedish Univ Agr Sci, Swedish Species Informat Ctr, SE-75007 Uppsala, Sweden; [Ekblad, A.] Univ Orebro, Sch Sci & Technol, SE-70182 Orebro, Sweden; [Wardle, D. A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, SE-90183 Umea, Sweden	Swedish University of Agricultural Sciences; Lund University; University of Helsinki; Swedish University of Agricultural Sciences; Orebro University; Swedish University of Agricultural Sciences	Clemmensen, KE (corresponding author), Swedish Univ Agr Sci, Uppsala BioCtr, Dept Forest Mycol & Plant Pathol, Box 7026, SE-75007 Uppsala, Sweden.	karina.clemmensen@slu.se	Clemmensen, Karina Engelbrecht/C-9555-2014; Lindahl, Björn D./AAH-4538-2019; Wardle, David A./F-6031-2011; Ekblad, Alf/AAG-2632-2019; Finlay, Roger D/B-4731-2009; Finlay, Roger/Q-7796-2019; Ovaskainen, Otso/D-9119-2012; Stenlid, Jan/K-5909-2019; Ovaskainen, Otso/AGN-4838-2022	Clemmensen, Karina Engelbrecht/0000-0002-9627-6428; Wardle, David A./0000-0002-0476-7335; Finlay, Roger D/0000-0002-3652-2930; Finlay, Roger/0000-0002-3652-2930; Ovaskainen, Otso/0000-0001-9750-4421; Ovaskainen, Otso/0000-0001-9750-4421; Stenlid, Jan/0000-0002-5344-2094; Wallander, Hakan/0000-0002-9220-4590	7th European Community Framework Program; Lammska Stiftelsen; research center LUCCI at Lund University; FORMAS [2007-1365, 2011-1747]; Wallenberg Scholar award; European Research Council [205905]; KoN; Swedish University of Agricultural Sciences	7th European Community Framework Program(European Commission); Lammska Stiftelsen; research center LUCCI at Lund University; FORMAS(Swedish Research Council Formas); Wallenberg Scholar award; European Research Council(European Research Council (ERC)European Commission); KoN; Swedish University of Agricultural Sciences	The molecular data are archived at the Sequence Read Archive under accession number SRP016090 (www.ncbi.nlm.nih.gov/sra). This research was supported by the 7th European Community Framework Program (a Marie Curie Intra-European Fellowship to K. E. C.), Lammska Stiftelsen, the research center LUCCI at Lund University, FORMAS grants (2007-1365 and 2011-1747 to B. D. L.), a Wallenberg Scholar award to D. A. W., the European Research Council (grant 205905 to O.O.), and KoN grants to R. D. F. and J.S. by the Swedish University of Agricultural Sciences. We gratefully acknowledge M. Brandstrom-Durling for development of the SCATA bioinformatics pipeline, T. Nasholm for help with the chitin analyses, G. Nyakatura at LGC Genomics for assistance with sequencing, and G. Possnert at the Tandem Laboratory for help with <SUP>14</SUP>C dating.	Alberton O, 2007, PLANT SOIL, V296, P159, DOI 10.1007/s11104-007-9306-5; BONAN GB, 1989, ANNU REV ECOL SYST, V20, P1, DOI 10.1146/annurev.es.20.110189.000245; Bostrom B, 2007, OECOLOGIA, V153, P89, DOI 10.1007/s00442-007-0700-8; Brovkin V, 2012, BIOGEOSCIENCES, V9, P565, DOI 10.5194/bg-9-565-2012; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Dijkstra FA, 2007, ECOL LETT, V10, P1046, DOI 10.1111/j.1461-0248.2007.01095.x; Drake JE, 2011, ECOL LETT, V14, P349, DOI 10.1111/j.1461-0248.2011.01593.x; Ehleringer JR, 2000, ECOL APPL, V10, P412, DOI 10.1890/1051-0761(2000)010[0412:CIRIBC]2.0.CO;2; Ekblad A, 1998, NEW PHYTOL, V138, P143, DOI 10.1046/j.1469-8137.1998.00891.x; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Gaudinski JB, 2000, BIOGEOCHEMISTRY, V51, P33, DOI 10.1023/A:1006301010014; Godbold DL, 2006, PLANT SOIL, V281, P15, DOI 10.1007/s11104-005-3701-6; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Heinemeyer A, 2007, GLOBAL CHANGE BIOL, V13, P1786, DOI 10.1111/j.1365-2486.2007.01383.x; Hobbie EA, 2004, NEW PHYTOL, V161, P371, DOI 10.1111/j.1469-8137.2004.00970.x; Hobbie EA, 2009, BIOGEOCHEMISTRY, V95, P355, DOI 10.1007/s10533-009-9328-6; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hogberg P, 1996, OECOLOGIA, V108, P207, DOI 10.1007/BF00334643; Hogberg P, 2011, NEW PHYTOL, V189, P515, DOI 10.1111/j.1469-8137.2010.03485.x; Hyodo F, 2009, RAPID COMMUN MASS SP, V23, P1892, DOI 10.1002/rcm.4095; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jonsson M, 2010, BIOL LETTERS, V6, P116, DOI 10.1098/rsbl.2009.0613; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Makkonen M, 2012, ECOL LETT, V15, P1033, DOI 10.1111/j.1461-0248.2012.01826.x; Phillips RP, 2012, ECOL LETT, V15, P1042, DOI 10.1111/j.1461-0248.2012.01827.x; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Taylor AFS, 2003, NEW PHYTOL, V159, P757, DOI 10.1046/j.1469-8137.2003.00838.x; Wallander H, 2010, NEW PHYTOL, V187, P1124, DOI 10.1111/j.1469-8137.2010.03324.x; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Wardle DA, 2012, J ECOL, V100, P16, DOI 10.1111/j.1365-2745.2011.01907.x; Yuan JP, 2008, APPL MICROBIOL BIOT, V80, P459, DOI 10.1007/s00253-008-1589-9	33	862	926	82	1535	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1615	1618		10.1126/science.1231923	http://dx.doi.org/10.1126/science.1231923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539604				2022-12-24	WOS:000316731600051
J	Memczak, S; Jens, M; Elefsinioti, A; Torti, F; Krueger, J; Rybak, A; Maier, L; Mackowiak, SD; Gregersen, LH; Munschauer, M; Loewer, A; Ziebold, U; Landthaler, M; Kocks, C; le Noble, F; Rajewsky, N				Memczak, Sebastian; Jens, Marvin; Elefsinioti, Antigoni; Torti, Francesca; Krueger, Janna; Rybak, Agnieszka; Maier, Luisa; Mackowiak, Sebastian D.; Gregersen, Lea H.; Munschauer, Mathias; Loewer, Alexander; Ziebold, Ulrike; Landthaler, Markus; Kocks, Christine; le Noble, Ferdinand; Rajewsky, Nikolaus			Circular RNAs are a large class of animal RNAs with regulatory potency	NATURE			English	Article							BINDING PROTEIN; MESSENGER-RNA; NONCODING RNA; GENE; TRANSCRIPTS; EXPRESSION; MICRORNAS; SEQUENCE; DIFFERENTIATION; DISCOVERY	Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.	[Memczak, Sebastian; Jens, Marvin; Elefsinioti, Antigoni; Torti, Francesca; Krueger, Janna; Rybak, Agnieszka; Maier, Luisa; Mackowiak, Sebastian D.; Gregersen, Lea H.; Munschauer, Mathias; Loewer, Alexander; Ziebold, Ulrike; Landthaler, Markus; Kocks, Christine; le Noble, Ferdinand; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Rajewsky, N (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	rajewsky@mdc-berlin.de	Mackowiak, Sebastian D/S-3266-2017; Gregersen, Lea H/AAI-2386-2021; Munschauer, Mathias/AAK-2789-2020; Landthaler, Markus/A-1427-2010; Ziebold, Ulrike/N-4487-2013; le Noble, Ferdinand/L-7867-2017; Loewer, Alexander/AAL-6943-2021	Mackowiak, Sebastian D/0000-0003-1673-5389; Gregersen, Lea H/0000-0002-1205-604X; Munschauer, Mathias/0000-0001-6143-4548; Landthaler, Markus/0000-0002-1075-8734; Loewer, Alexander/0000-0002-8819-3040; Jens, Marvin/0000-0002-6660-8743; Rybak-Wolf, Agnieszka/0000-0002-1192-5290; Rajewsky, Nikolaus/0000-0002-4785-4332; Memczak, Sebastian/0000-0001-9518-7135	Max-Delbruck-Center (MDC); MDC-NYU; BMBF [1210182]; DFG [KFO218]; Helmholtz Association for the 'MDC Systems Biology Network', MSBN; BMBF support for the DZHK; Center for Stroke Research Berlin; BMBF for the Berlin Institute for Medical Systems Biology [0315362C]	Max-Delbruck-Center (MDC); MDC-NYU; BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Helmholtz Association for the 'MDC Systems Biology Network', MSBN(Helmholtz Association); BMBF support for the DZHK; Center for Stroke Research Berlin; BMBF for the Berlin Institute for Medical Systems Biology(Federal Ministry of Education & Research (BMBF))	We thank M. Feldkamp and C. Langnick (laboratory of W. Chen)for Illumina sequencing runs. We thank J. Kjems for sending us a plasmid encoding circular human CDR1as for our zebrafish experiments. We thank K. Meier for technical assistance with zebrafish experiments and A. Sporbert from the confocal imaging facility. We thank A. Ivanov for assisting in bioinformatic analysis. N.R. thanks E. Westhof for useful discussions. We acknowledge the following funding sources: PhD program of the Max-Delbruck-Center (MDC) (S.M., F.T., L.H.G.); the MDC-NYU exchange program (MM.); BMBF project 1210182, 'MiRNAs as therapeutic targets' (A.E); DFG for KFO218 (U.Z.); Helmholtz Association for the 'MDC Systems Biology Network', MSBN (S.D.M.); BMBF support for the DZHK (F.I.N. and N.R.); Center for Stroke Research Berlin (J.K., F.I.N.). Funding for the group of M.L. is supported by BMBF-funding for the Berlin Institute for Medical Systems Biology (0315362C).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chacon MR, 2012, DEVELOPMENT, V139, P3200, DOI 10.1242/dev.080564; Chao CW, 1998, MOL MED, V4, P614, DOI 10.1007/BF03401761; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Danan M, 2012, NUCLEIC ACIDS RES, V40, P3131, DOI 10.1093/nar/gkr1009; DROPCHO EJ, 1987, P NATL ACAD SCI USA, V84, P4552, DOI 10.1073/pnas.84.13.4552; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; GRABOWSKI PJ, 1981, CELL, V23, P467, DOI 10.1016/0092-8674(81)90142-2; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Huang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027288; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; IWAI Y, 1993, J IMMUNOL, V150, P4386; Jacobs T, 2007, J NEUROSCI, V27, P8604, DOI 10.1523/JNEUROSCI.0765-07.2007; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kaufman M.H., 1999, ANATOMICAL BASIS MOU; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852; Schambra U., 2008, PRENATAL MOUSE BRAIN; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Suzuki H, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl151; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Vivancos AP, 2010, GENOME RES, V20, P989, DOI 10.1101/gr.094318.109; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	51	4889	5272	50	1159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					333	338		10.1038/nature11928	http://dx.doi.org/10.1038/nature11928			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23446348				2022-12-24	WOS:000316650500035
J	Robitaille, AM; Christen, S; Shimobayashi, M; Cornu, M; Fava, LL; Moes, S; Prescianotto-Baschong, C; Sauer, U; Jenoe, P; Hall, MN				Robitaille, Aaron M.; Christen, Stefan; Shimobayashi, Mitsugu; Cornu, Marion; Fava, Luca L.; Moes, Suzette; Prescianotto-Baschong, Cristina; Sauer, Uwe; Jenoe, Paul; Hall, Michael N.			Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis	SCIENCE			English	Article							NUCLEOTIDE BIOSYNTHESIS; PHOSPHATE SYNTHETASE; GROWTH; KINASE; PHOSPHORYLATION; PROLIFERATION; ASSOCIATION; FIBROBLASTS; MECHANISM; RIBOSOME	The Ser-Thr kinase mammalian target of rapamycin (mTOR) controls cell growth and metabolism by stimulating glycolysis and synthesis of proteins and lipids. To further understand the central role of mTOR in cell physiology, we used quantitative phosphoproteomics to identify substrates or downstream effectors of the two mTOR complexes. mTOR controlled the phosphorylation of 335 proteins, including CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase). CAD catalyzes the first three steps in de novo pyrimidine synthesis. mTORC1 indirectly phosphorylated CAD-S1859 through S6 kinase (S6K). CAD-S1859 phosphorylation promoted CAD oligomerization and thereby stimulated de novo synthesis of pyrimidines and progression through S phase of the cell cycle in mammalian cells. Thus, mTORC1 also stimulates the synthesis of nucleotides to control cell proliferation.	[Robitaille, Aaron M.; Shimobayashi, Mitsugu; Cornu, Marion; Fava, Luca L.; Moes, Suzette; Prescianotto-Baschong, Cristina; Jenoe, Paul; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Christen, Stefan; Sauer, Uwe] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	m.hall@unibas.ch	Sauer, Uwe/Y-3556-2019; Fava, Luca/E-2876-2017	Fava, Luca/0000-0002-6741-1723; Shimobayashi, Mitsugu/0000-0002-6936-0990; Robitaille, Aaron Mark/0000-0003-2774-2066; Hall, Michael N/0000-0002-2998-0757	Werner Siemens Foundation; Societe Francophone du Diabete-Association de Langue Francaise pour L'Etude du Diabete et des Maladies Metaboliques; Swiss Cancer League; Louis Jeantet Foundation; Swiss National Science Foundation; SystemsX.ch project YeastX	Werner Siemens Foundation; Societe Francophone du Diabete-Association de Langue Francaise pour L'Etude du Diabete et des Maladies Metaboliques; Swiss Cancer League; Louis Jeantet Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch project YeastX	We acknowledge support from the Werner Siemens Foundation (A. M. R.), the Societe Francophone du Diabete-Association de Langue Francaise pour L'Etude du Diabete et des Maladies Metaboliques (M. C.), the Swiss Cancer League, the Louis Jeantet Foundation, the Swiss National Science Foundation, and the SystemsX.ch project YeastX. We declare no conflicts of interest. The phosphoproteomic data, including UniProt accession numbers reported in this paper, are deposited in the supplementary materials.	Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; CARREY EA, 1985, EMBO J, V4, P3735, DOI 10.1002/j.1460-2075.1985.tb04142.x; Cybulski N, 2012, METHODS MOL BIOL, V821, P267, DOI 10.1007/978-1-61779-430-8_16; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Espeillac C, 2011, J CLIN INVEST, V121, P2821, DOI 10.1172/JCI44203; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Graves LM, 2000, NATURE, V403, P328, DOI 10.1038/35002111; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LEE L, 1985, P NATL ACAD SCI USA, V82, P6802, DOI 10.1073/pnas.82.20.6802; MITCHELL AD, 1975, EXP CELL RES, V93, P105, DOI 10.1016/0014-4827(75)90428-0; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Ruhl M, 2012, BIOTECHNOL BIOENG, V109, P763, DOI 10.1002/bit.24344; SMITH ML, 1979, J CELL PHYSIOL, V101, P293, DOI 10.1002/jcp.1041010210; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang PF, 2009, BIOCHEMISTRY-US, V48, P766, DOI 10.1021/bi801831r; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	23	339	351	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1320	1323		10.1126/science.1228771	http://dx.doi.org/10.1126/science.1228771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23429704				2022-12-24	WOS:000316053400038
J	Zheng, XT; Zhou, ZH; Wang, XL; Zhang, FC; Zhang, XM; Wang, Y; Wei, GJ; Wang, S; Xu, X				Zheng, Xiaoting; Zhou, Zhonghe; Wang, Xiaoli; Zhang, Fucheng; Zhang, Xiaomei; Wang, Yan; Wei, Guangjin; Wang, Shuo; Xu, Xing			Hind Wings in Basal Birds and the Evolution of Leg Feathers	SCIENCE			English	Article							INTEGUMENTARY STRUCTURES; 4-WINGED DINOSAURS; LONG FEATHERS; ORIGIN; CHINA; PALEONTOLOGY; THEROPOD; SCALES; FLIGHT	Recent discoveries of large leg feathers in some theropods have implications for our understanding of the evolution of integumentary features on the avialan leg, and particularly of their relevance for the origin of avialan flight. Here we report 11 basal avialan specimens that will greatly improve our knowledge of leg integumentary features among early birds. In particular, they provide solid evidence for the existence of enlarged leg feathers on a variety of basal birds, suggest that extensively scaled feet might have appeared secondarily at an early stage in ornithuromorph evolution, and demonstrate a distal-to-proximal reduction pattern for leg feathers in avialan evolution.	[Zheng, Xiaoting; Wang, Xiaoli; Wang, Yan; Wei, Guangjin; Xu, Xing] Linyi Univ, Inst Geol & Palaeontol, Linyi 276005, Shandong, Peoples R China; [Zheng, Xiaoting; Zhang, Xiaomei] Shandong Tianyu Museum Nat, Pingyi 273300, Shandong, Peoples R China; [Zhou, Zhonghe; Zhang, Fucheng; Wang, Shuo; Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing 100044, Peoples R China; [Wang, Shuo] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Linyi University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zheng, XT (corresponding author), Linyi Univ, Inst Geol & Palaeontol, Shuangling Rd, Linyi 276005, Shandong, Peoples R China.	xingxu@vip.sina.com	Wang, Shuo/AAX-8516-2020; Xiaoli, Wang/H-1079-2014	Wang, Shuo/0000-0002-4076-0202; 	National Natural Sciences Foundation of China (NNSFC) [41172016, 41120124002, 41125008]; National Basic Research Program of China [2012CB821900]; Chinese Academy of Sciences [KZCX2-EW-105]	National Natural Sciences Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	Support for this research was provided by the National Natural Sciences Foundation of China (NNSFC grant nos. 41172016, 41120124002, and 41125008), the National Basic Research Program of China (grant no. 2012CB821900), and the Chinese Academy of Sciences (grant no. KZCX2-EW-105). We thank K. Padian and C. Sullivan for critical comments; C.-M. Chuong and T. Stidham for discussions; R. Li and H. Zang for illustrations; X. Ding for preparation of some of the specimens; and O. Rauhut, M. Koebl-Ebert, and M. Roeper for access to Archaeopteryx specimens.	Alexander DE, 2010, P NATL ACAD SCI USA, V107, P2972, DOI 10.1073/pnas.0911852107; Beebee C. W., 1915, Zoologica New York, V2; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Gatesy SM, 1996, EVOLUTION, V50, P331, DOI 10.1111/j.1558-5646.1996.tb04496.x; Hall J., 2012, J VERTEBR PALEONTOL, V32, p105B; Harris MP, 2004, DEV DYNAM, V231, P22, DOI 10.1002/dvdy.20096; Hou L.-H., 2003, FOSSIL BIRDS CHINA; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji S, 2007, ACTA GEOL SIN-ENGL, V81, P8; KELSO LEON, 1936, AUK, V53, P51; Koehl MAR, 2011, INTEGR COMP BIOL, V51, P1002, DOI 10.1093/icb/icr112; Logan M, 2003, DEVELOPMENT, V130, P6401, DOI 10.1242/dev.00956; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; Lucas A., 1972, AVIAN ANATOMY INTEGU; Norell M, 2002, NATURE, V416, P36, DOI 10.1038/416036a; Padian K, 2005, NATURE, V438, pE3, DOI 10.1038/nature04354; Padian K, 2003, BIOSCIENCE, V53, P450; Prin F, 2004, INT J DEV BIOL, V48, P137, DOI 10.1387/ijdb.15272378; Prum RO, 2003, NATURE, V421, P323, DOI 10.1038/421323a; Sawyer RH, 2003, J EXP ZOOL PART B, V298B, P57, DOI 10.1002/jez.b.26; Widelitz RB, 2000, DEV BIOL, V219, P98, DOI 10.1006/dbio.1999.9580; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu X., 2002, DEINONYCHOSAURIAN FO; Xu X, 2012, NATURE, V484, P92, DOI 10.1038/nature10906; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; Zhang FC, 2004, NATURE, V431, P925, DOI 10.1038/431925a; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2005, P NATL ACAD SCI USA, V102, P18998, DOI 10.1073/pnas.0507106102; Zhou ZH, 2005, NATURE, V438, pE4, DOI 10.1038/nature04356; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	37	75	84	2	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2013	339	6125					1309	1312		10.1126/science.1228753	http://dx.doi.org/10.1126/science.1228753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493711				2022-12-24	WOS:000316053400035
J	Domnisoru, C; Kinkhabwala, AA; Tank, DW				Domnisoru, Cristina; Kinkhabwala, Amina A.; Tank, David W.			Membrane potential dynamics of grid cells	NATURE			English	Article							HIPPOCAMPAL PLACE CELLS; SPATIAL REPRESENTATION; ENTORHINAL CORTEX; PATH-INTEGRATION; THETA RHYTHM; PHASE PRECESSION; INTERFERENCE; OSCILLATIONS; MODELS; PERIODICITY	During navigation, grid cells increase their spike rates in firing fields arranged on a markedly regular triangular lattice, whereas their spike timing is often modulated by theta oscillations. Oscillatory interference models of grid cells predict theta amplitude modulations of membrane potential during firing field traversals, whereas competing attractor network models predict slow depolarizing ramps. Here, using in vivo whole-cell recordings, we tested these models by directly measuring grid cell intracellular potentials in mice running along linear tracks in virtual reality. Grid cells had large and reproducible ramps of membrane potential depolarization that were the characteristic signature tightly correlated with firing fields. Grid cells also demonstrated intracellular theta oscillations that influenced their spike timing. However, the properties of theta amplitude modulations were not consistent with the view that they determine firing field locations. Our results support cellular and network mechanisms in which grid fields are produced by slow ramps, as in attractor models, whereas theta oscillations control spike timing.	[Domnisoru, Cristina; Kinkhabwala, Amina A.; Tank, David W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Domnisoru, Cristina; Kinkhabwala, Amina A.; Tank, David W.] Princeton Univ, Bezos Ctr Neural Circuit Dynam, Princeton, NJ 08544 USA; [Domnisoru, Cristina; Kinkhabwala, Amina A.; Tank, David W.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Domnisoru, Cristina; Kinkhabwala, Amina A.; Tank, David W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University; Princeton University	Tank, DW (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	dwtank@princeton.edu			NINDS [5RC1NS068148-02, 1R37NS081242-01]; NIMH [5R01MH083686-04]; NIH [F32NS070514-01A1]; NSF; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068148, F32NS070514, R37NS081242] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Harvey, R. Low, A. Miri, S. Lewallen, J. Rickgauer, D. Little, a Barson, D. Aronov, W. Bialek, I. Fiete and G. Buzsaki for helpful discussions. This work was supported by NINDS grant 5RC1NS068148-02 and 1R37NS081242-01, NIMH grant 5R01MH083686-04, NIH Postdoctoral Fellowship grant F32NS070514-01A1 (A.A.K.), and an NSF Graduate Research Fellowship (C.D.).	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Barry C, 2012, NATURE, V488, pE1, DOI 10.1038/nature11276; Barry C, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00030, 10.3389/fncir.2012.00005]; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2008, HIPPOCAMPUS, V18, P1230, DOI 10.1002/hipo.20472; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Giocomo LM, 2011, CURR BIOL, V21, pR962, DOI 10.1016/j.cub.2011.10.024; Giocomo LM, 2011, CELL, V147, P1159, DOI 10.1016/j.cell.2011.08.051; Giocomo LM, 2011, NEURON, V71, P589, DOI 10.1016/j.neuron.2011.07.023; Giocomo LM, 2008, HIPPOCAMPUS, V18, P1186, DOI 10.1002/hipo.20501; Guanella A, 2007, INT J NEURAL SYST, V17, P231, DOI 10.1142/S0129065707001093; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Kinkhabwala A. A., 2011, SPATIAL PATTERNING G; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011; Welinder PE, 2008, HIPPOCAMPUS, V18, P1283, DOI 10.1002/hipo.20519; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Zilli EA, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00016	41	205	209	3	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					199	204		10.1038/nature11973	http://dx.doi.org/10.1038/nature11973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23395984	Green Accepted			2022-12-24	WOS:000316652300043
J	Boon, RA; Iekushi, K; Lechner, S; Seeger, T; Fischer, A; Heydt, S; Kaluza, D; Treguer, K; Carmona, G; Bonauer, A; Horrevoets, AJG; Didier, N; Girmatsion, Z; Biliczki, P; Ehrlich, JR; Katus, HA; Muller, OJ; Potente, M; Zeiher, AM; Hermeking, H; Dimmeler, S				Boon, Reinier A.; Iekushi, Kazuma; Lechner, Stefanie; Seeger, Timon; Fischer, Ariane; Heydt, Susanne; Kaluza, David; Treguer, Karine; Carmona, Guillaume; Bonauer, Angelika; Horrevoets, Anton J. G.; Didier, Nathalie; Girmatsion, Zenawit; Biliczki, Peter; Ehrlich, Joachim R.; Katus, Hugo A.; Mueller, Oliver J.; Potente, Michael; Zeiher, Andreas M.; Hermeking, Heiko; Dimmeler, Stefanie			MicroRNA-34a regulates cardiac ageing and function	NATURE			English	Article							MYOCARDIAL-INFARCTION; HEART FUNCTION; APOPTOSIS; P53; ANGIOGENESIS; PHOSPHATASE; ACTIVATION; SENESCENCE; EXPRESSION; COMPONENT	Ageing is the predominant risk factor for cardiovascular diseases(1) and contributes to a significantly worse outcome in patients with acute myocardial infarction(2). MicroRNAs (miRNAs) have emerged as crucial regulators of cardiovascular function and some miRNAs have key roles in ageing(3,4). We propose that altered expression of miRNAs in the heart during ageing contributes to the age-dependent decline in cardiac function. Here we show that miR-34a is induced in the ageing heart and that in vivo silencing or genetic deletion of miR-34a reduces age-associated cardiomyocyte cell death. Moreover, miR-34a inhibition reduces cell death and fibrosis following acute myocardial infarction and improves recovery of myocardial function. Mechanistically, we identified PNUTS (also known as PPP1R10) as a novel direct miR-34a target, which reduces telomere shortening, DNA damage responses and cardiomyocyte apoptosis, and improves functional recovery after acute myocardial infarction. Together, these results identify age-induced expression of miR-34a and inhibition of its target PNUTS as a key mechanism that regulates cardiac contractile function during ageing and after acute myocardial infarction, by inducing DNA damage responses and telomere attrition.	[Boon, Reinier A.; Iekushi, Kazuma; Seeger, Timon; Fischer, Ariane; Heydt, Susanne; Kaluza, David; Treguer, Karine; Carmona, Guillaume; Bonauer, Angelika; Potente, Michael; Dimmeler, Stefanie] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany; [Lechner, Stefanie; Hermeking, Heiko] Univ Munich, Inst Pathol, D-80337 Munich, Germany; [Seeger, Timon; Girmatsion, Zenawit; Biliczki, Peter; Ehrlich, Joachim R.; Potente, Michael; Zeiher, Andreas M.] Goethe Univ Frankfurt, Dept Cardiol, D-60590 Frankfurt, Germany; [Horrevoets, Anton J. G.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands; [Didier, Nathalie] Univ Paris 06, INSERM, Myol Grp, Inst Myol,UMR S787, Paris, France; [Katus, Hugo A.; Mueller, Oliver J.] Univ Heidelberg Hosp, D-69120 Heidelberg, Germany; [Katus, Hugo A.; Mueller, Oliver J.; Zeiher, Andreas M.; Dimmeler, Stefanie] German Ctr Cardiovasc Res DZHK, D-13347 Berlin, Germany	Goethe University Frankfurt; University of Munich; Goethe University Frankfurt; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research	Dimmeler, S (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany.	dimmeler@em.uni-frankfurt.de	Müller, Oliver/AAA-4399-2021; Boon, Reinier A/E-8423-2011; Müller, Oliver J./H-4739-2016	Müller, Oliver/0000-0001-8223-2638; Boon, Reinier A/0000-0001-7944-9748; Dimmeler, Stefanie/0000-0002-1045-2436; Potente, Michael/0000-0002-5689-0036; DIDIER, Nathalie/0000-0003-4144-7581	Netherlands Organization for Scientific Research (NWO); Japanese Heart Foundation; Excellence Cluster Cardiopulmonary System [Exc 147-1]; European Research Council; German Center for Cardiovascular Research DZHK; European Union [241440]; German Centre for Cardiovascular Research (DZHK); German Ministry of Education and Research (BMBF); ERC; DFG; Deutsche Krebshilfe; Rudolf-Bartling-Stiftung	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Japanese Heart Foundation; Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Center for Cardiovascular Research DZHK; European Union(European Commission); German Centre for Cardiovascular Research (DZHK); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); ERC(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Rudolf-Bartling-Stiftung	We thank M. Muhly-Reinholz, A. Knau, B. Zimmermann, N. Reinfeld and F. Gehring for technical assistance, F. W. Alt for providing SIRT1 mutant mice and D. Sassoon and G. Marazzi for conceptual advice. R.A.B. was supported by the Netherlands Organization for Scientific Research (NWO) and K.I. by a Research Grant Abroad of the Japanese Heart Foundation. This study was supported by a start-up grant of the Excellence Cluster Cardiopulmonary System (Exc 147-1) to R.A.B., by the European Research Council (Advanced grant "Angiomirs") and the German Center for Cardiovascular Research DZHK and the European Union FP7 project Endostem (Grant no. 241440) to S.D. H.A.K. and O.J.M. are supported by the German Centre for Cardiovascular Research (DZHK) and by the German Ministry of Education and Research (BMBF). M.P. is supported by the Max Planck Society, the Fondation Leducq (ARTEMIS) and an ERC Starting Grant (ANGIOMET). H.H. is supported by the DFG, the Deutsche Krebshilfe and the Rudolf-Bartling-Stiftung.	Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; De Leon G, 2008, CANCER BIOL THER, V7, P833, DOI 10.4161/cbt.7.6.5839; Dimmeler S., 2013, EMBO MOL MED; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Hsu CP, 2010, CIRCULATION, V122, P2170, DOI 10.1161/CIRCULATIONAHA.110.958033; Ito T, 2010, BIOCHEM BIOPH RES CO, V398, P735, DOI 10.1016/j.bbrc.2010.07.012; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kim H, 2009, NAT STRUCT MOL BIOL, V16, P372, DOI 10.1038/nsmb.1575; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lakatta Edward G, 2002, Heart Fail Rev, V7, P29; Landsverk HB, 2010, EMBO REP, V11, P868, DOI 10.1038/embor.2010.134; Oh H, 2003, P NATL ACAD SCI USA, V100, P5378, DOI 10.1073/pnas.0836098100; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Shukla PC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1601; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Almen GC, 2011, AGING CELL, V10, P769, DOI 10.1111/j.1474-9726.2011.00714.x; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wellenius GA, 2008, AM HEART J, V156, P483, DOI 10.1016/j.ahj.2008.04.009; Xu QF, 2012, J AM COLL CARDIOL, V59, P2107, DOI 10.1016/j.jacc.2012.02.033; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Zhao T, 2010, AM J PHYSIOL-ENDOC M, V299, pE110, DOI 10.1152/ajpendo.00192.2010	26	569	594	3	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					107	110		10.1038/nature11919	http://dx.doi.org/10.1038/nature11919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23426265				2022-12-24	WOS:000316039800049
J	Hao, YH; Doyle, JM; Ramanathan, S; Gomez, TS; Jia, D; Xu, M; Chen, ZJJ; Billadeau, DD; Rosen, MK; Potts, PR				Hao, Yi-Heng; Doyle, Jennifer M.; Ramanathan, Saumya; Gomez, Timothy S.; Jia, Da; Xu, Ming; Chen, Zhijian J.; Billadeau, Daniel D.; Rosen, Michael K.; Potts, Patrick Ryan			Regulation of WASH-Dependent Actin Polymerization and Protein Trafficking by Ubiquitination	CELL			English	Article							ALDRICH-SYNDROME PROTEIN; RET FINGER PROTEIN; ARP2/3 COMPLEX; WAVE COMPLEX; MAGEL2 GENE; RETROMER; ACTIVATION; MECHANISMS; CANCER; FAMILY	Endosomal protein trafficking is an essential cellular process that is deregulated in several diseases and targeted by pathogens. Here, we describe a role for ubiquitination in this process. We find that the E3 RING ubiquitin ligase, MAGE-L2-TRIM27, localizes to endosomes through interactions with the retromer complex. Knockdown of MAGE-L2-TRIM27 or the Ube2O E2 ubiquitin-conjugating enzyme significantly impaired retromer-mediated transport. We further demonstrate that MAGE-L2-TRIM27 ubiquitin ligase activity is required for nucleation of endosomal F-actin by the WASH regulatory complex, a known regulator of retromer-mediated transport. Mechanistic studies showed that MAGE-L2-TRIM27 facilitates K63-linked ubiquitination of WASH K220. Significantly, disruption of WASH ubiquitination impaired endosomal F-actin nucleation and retromer-dependent transport. These findings provide a cellular and molecular function for MAGE-L2-TRIM27 in retrograde transport, including an unappreciated role of K63-linked ubiquitination and identification of an activating signal of the WASH regulatory complex.	[Hao, Yi-Heng; Doyle, Jennifer M.; Ramanathan, Saumya; Potts, Patrick Ryan] UT Southwestern Dallas, Dept Physiol, Dallas, TX 75390 USA; [Jia, Da; Rosen, Michael K.] UT Southwestern Dallas, Dept Biophys, Dallas, TX 75390 USA; [Xu, Ming; Chen, Zhijian J.] UT Southwestern Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.; Rosen, Michael K.] UT Southwestern Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Potts, Patrick Ryan] UT Southwestern Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Gomez, Timothy S.; Billadeau, Daniel D.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Gomez, Timothy S.; Billadeau, Daniel D.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA	Howard Hughes Medical Institute; Mayo Clinic; Mayo Clinic	Potts, PR (corresponding author), UT Southwestern Dallas, Dept Physiol, Dallas, TX 75390 USA.	ryan.potts@utsouthwestern.edu	Potts, Patrick R/P-4707-2018; Chen, Zhijian/C-6039-2012; 高, 雨莉/HGU-8187-2022	Potts, Patrick R/0000-0002-2024-8885; Chen, Zhijian/0000-0002-8475-8251; Jia, Da/0000-0002-2205-1998	Cancer Prevention and Research Initiative of Texas [R1117]; Department of Defense [CA110261]; Howard Hughes Medical Institute; Mayo Foundation; Michael L. Rosenberg Scholar in Medical Research fund; NIH [R01-AI065474, R01-GM063692, R01-GM56322]; Sara and Frank McKnight Fellowship; Welch Foundation [I-1544, I-1389]; NATIONAL CANCER INSTITUTE [R01CA110261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056322, R01GM063692] Funding Source: NIH RePORTER	Cancer Prevention and Research Initiative of Texas; Department of Defense(United States Department of Defense); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mayo Foundation; Michael L. Rosenberg Scholar in Medical Research fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sara and Frank McKnight Fellowship; Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Mitsuaki Tabuchi (Kawasaki Medical School, Japan) for providing the retromer construct. We also thank Potts lab members for helpful discussions and critical reading of the manuscript. This work was supported by the Cancer Prevention and Research Initiative of Texas R1117 (P. R. P.), Department of Defense CA110261 (P. R. P.), Howard Hughes Medical Institute (M. K. R.), Mayo Foundation (D. D. B.), Michael L. Rosenberg Scholar in Medical Research fund (P. R. P.), NIH R01-AI065474 (D. D. B.), NIH R01-GM063692 (Z. J. C.), NIH R01-GM56322 (M. K. R.), Sara and Frank McKnight Fellowship (P. R. P.), and Welch Foundation I-1544 (M. K. R.) and I-1389 (Z.J.C.).	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bischof JM, 2007, HUM MOL GENET, V16, P2713, DOI 10.1093/hmg/ddm225; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Boudinot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022022; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Duleh S.N., 2012, REGULATION INTEGRIN; Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Gomez TS, 2012, MOL BIOL CELL, V23, P3215, DOI 10.1091/mbc.E12-02-0101; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Harbers M, 2001, J BIOL CHEM, V276, P48596, DOI 10.1074/jbc.M108077200; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Krutzfeldt M, 2005, MOL CELL, V18, P213, DOI 10.1016/j.molcel.2005.03.009; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Liu R, 2009, DEVELOPMENT, V136, P2849, DOI 10.1242/dev.035246; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Saenko V, 2003, MUTAT RES-FUND MOL M, V527, P81, DOI 10.1016/S0027-5107(03)00056-3; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Small SA, 2008, ARCH NEUROL-CHICAGO, V65, P323, DOI 10.1001/archneurol.2007.64; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Zech T, 2011, J CELL SCI, V124, P3753, DOI 10.1242/jcs.080986; Zha FK, 2006, J IMMUNOL, V176, P1072, DOI 10.4049/jimmunol.176.2.1072; Zoumpoulidou G, 2012, JNCI-J NATL CANCER I, V104, P941, DOI 10.1093/jnci/djs224	46	162	171	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					1051	1064		10.1016/j.cell.2013.01.051	http://dx.doi.org/10.1016/j.cell.2013.01.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452853	Green Accepted, Bronze			2022-12-24	WOS:000315710300013
J	Walters, C; Berjak, P; Pammenter, N; Kennedy, K; Raven, P				Walters, Christina; Berjak, Patricia; Pammenter, Norman; Kennedy, Kathryn; Raven, Peter			Preservation of Recalcitrant Seeds	SCIENCE			English	Editorial Material							CRYOPRESERVATION		[Walters, Christina] ARS, USDA, Natl Ctr Genet Resources Preservat, Ft Collins, CO 80521 USA; [Berjak, Patricia; Pammenter, Norman] Univ KwaZulu Natal, Sch Life Sci, ZA-4001 Durban, South Africa; [Kennedy, Kathryn] Ctr Plant Conservat, St Louis, MO 63166 USA; [Raven, Peter] Missouri Bot Garden, St Louis, MO 63166 USA	United States Department of Agriculture (USDA); University of Kwazulu Natal; Missouri Botanical Gardens	Walters, C (corresponding author), ARS, USDA, Natl Ctr Genet Resources Preservat, Ft Collins, CO 80521 USA.	christina.walters@ars.usda.gov		Walters, Christina/0000-0002-9035-945X				Benson EE, 2008, CRIT REV PLANT SCI, V27, P141, DOI 10.1080/07352680802202034; Berjak P, 2008, ANN BOT-LONDON, V101, P213, DOI 10.1093/aob/mcm168; Berjak P, 2011, SEED SCI RES, V21, P187, DOI 10.1017/S0960258511000110; Daws MI, 2006, ANN BOT-LONDON, V97, P667, DOI 10.1093/aob/mcl022; Dickie John B., 2002, P239, DOI 10.1079/9780851995342.0239; Engelmann F, 2011, METHODS MOL BIOL, V710, P155, DOI 10.1007/978-1-61737-988-8_13; Hamilton KN, 2013, PLANT SPEC BIOL, V28, P51, DOI 10.1111/j.1442-1984.2011.00353.x; Hong T.D., 1996, IPGRI TECHNICAL B, V1; Kramer AT, 2009, TRENDS PLANT SCI, V14, P599, DOI 10.1016/j.tplants.2009.08.005; Li DZ, 2009, TRENDS PLANT SCI, V14, P614, DOI 10.1016/j.tplants.2009.09.005; NORMAH M N, 1986, Pertanika, V9, P299; Pence VC, 2011, IN VITRO CELL DEV-PL, V47, P176, DOI 10.1007/s11627-010-9323-6; Pennisi E, 2010, SCIENCE, V329, P1274, DOI 10.1126/science.329.5997.1274; Reed BM, 2011, IN VITRO CELL DEV-PL, V47, P1, DOI 10.1007/s11627-010-9337-0; Richards CM, 2009, TREE GENET GENOMES, V5, P339, DOI 10.1007/s11295-008-0190-9; Towill LE, 2004, SCI PRAC ECOL REST, P180; Tweddle JC, 2003, J ECOL, V91, P294, DOI 10.1046/j.1365-2745.2003.00760.x; Walters Christina, 2008, P465, DOI 10.1007/978-0-387-72276-4_18; Walters Christina, 2008, Biodiversity (Ottawa), V9, P68; Weisenberger L., 2008, POLISH J NAT SCI S, V5, P281	20	113	124	7	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2013	339	6122					915	916		10.1126/science.1230935	http://dx.doi.org/10.1126/science.1230935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430644				2022-12-24	WOS:000315149600036
J	Petry, S; Groen, AC; Ishihara, K; Mitchison, TJ; Vale, RD				Petry, Sabine; Groen, Aaron C.; Ishihara, Keisuke; Mitchison, Timothy J.; Vale, Ronald D.			Branching Microtubule Nucleation in Xenopus Egg Extracts Mediated by Augmin and TPX2	CELL			English	Article							MITOTIC SPINDLE FORMATION; TUBULIN RING COMPLEX; GTP-BOUND RAN; GAMMA-TUBULIN; SELF-ORGANIZATION; AURORA-A; IMPORTIN-ALPHA; HUMAN-CELLS; IN-VITRO; GENERATION	The microtubules that comprise mitotic spindles in animal cells are nucleated at centrosomes and by spindle assembly factors that are activated in the vicinity of chromatin. Indirect evidence has suggested that microtubules also might be nucleated from pre-existing microtubules throughout the spindle, but this process has not been observed directly. Here, we demonstrate microtubule nucleation from the sides of existing microtubules in meiotic Xenopus egg extracts. Daughter microtubules grow at a low branch angle and with the same polarity as mother filaments. Branching microtubule nucleation requires gamma-tubulin and augmin and is stimulated by factors previously implicated in chromatin-stimulated nucleation, guanosine triphosphate(GTP)-bound Ran and its effector, TPX2. Because of the rapid amplification of microtubule numbers and the preservation of microtubule polarity, microtubule-dependent microtubule nucleation is well suited for spindle assembly and maintenance.	[Petry, Sabine; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Petry, Sabine; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Petry, Sabine; Groen, Aaron C.; Ishihara, Keisuke; Mitchison, Timothy J.; Vale, Ronald D.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Groen, Aaron C.; Ishihara, Keisuke; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Marine Biological Laboratory - Woods Hole; Harvard University; Harvard Medical School	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu	Ishihara, Keisuke/I-5656-2019	Ishihara, Keisuke/0000-0002-8481-8680	NIH [GM38499, GM39565]; Evans Foundation Fellowship at MBL; Life Science Research Foundation fellowship; HHMI; K99 NIH grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM100013, R37GM038499, R01GM039565, R37GM039565, R01GM038499] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Evans Foundation Fellowship at MBL; Life Science Research Foundation fellowship; HHMI(Howard Hughes Medical Institute); K99 NIH grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Steve Ross and Nikon, Inc., for generously providing a microscope to conduct initial studies at the MBL, Woods Hole. We thank Rebecca Heald, Kara Helmke, and Jeremy Wilbur (UC Berkeley) for generous help with Xenopus egg extracts, providing vectors, and suggestions. We also thank Chris Field and Ani Nguyen (Harvard Medical School) for help with Xenopus egg extracts, and Jim and Cathy Galbraith (NIH) and Nico Stuurman (UCSF) for microscopy assistance. This work was supported by NIH grants GM38499 to R.D.V. and GM39565 to T.J.M., an Evans Foundation Fellowship at MBL to R.D.V. and T.J.M., and a Life Science Research Foundation fellowship sponsored by HHMI and a K99 NIH grant to S.P.	Athale CA, 2008, SCIENCE, V322, P1243, DOI 10.1126/science.1161820; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; BRINKLEY BR, 1985, ANNU REV CELL BIOL, V1, P145, DOI 10.1146/annurev.cellbio.1.1.145; Brugues J, 2012, CELL, V149, P554, DOI 10.1016/j.cell.2012.03.027; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Bucciarelli E, 2009, CURR BIOL, V19, P1839, DOI 10.1016/j.cub.2009.09.043; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Chan J, 2009, PLANT CELL, V21, P2298, DOI 10.1105/tpc.109.069716; Clausen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000244; Dinarina A, 2009, CELL, V138, P502, DOI 10.1016/j.cell.2009.05.027; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Edelstein A., 2010, CURR PROTOCOLS MOL B, V98; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Greenan G, 2010, CURR BIOL, V20, P353, DOI 10.1016/j.cub.2009.12.050; Groen AC, 2009, MOL BIOL CELL, V20, P2766, DOI 10.1091/mbc.E09-01-0043; Groen AC, 2004, CURR BIOL, V14, P1801, DOI 10.1016/j.cub.2004.10.002; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Ho CMK, 2011, PLANT CELL, V23, P2606, DOI 10.1105/tpc.111.086892; Hotta T, 2012, PLANT CELL, V24, P1494, DOI 10.1105/tpc.112.096610; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; KARSENTI E, 1984, J CELL BIOL, V98, P1730, DOI 10.1083/jcb.98.5.1730; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Keating TJ, 2000, NAT CELL BIOL, V2, P352, DOI 10.1038/35014045; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Nakaoka Y, 2012, PLANT CELL, V24, P1478, DOI 10.1105/tpc.112.098509; Needleman DJ, 2010, MOL BIOL CELL, V21, P323, DOI 10.1091/mbc.E09-09-0816; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Petry S, 2011, P NATL ACAD SCI USA, V108, P14473, DOI 10.1073/pnas.1110412108; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Uehara R, 2010, J CELL BIOL, V191, P259, DOI 10.1083/jcb.201004150; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Zhang H, 2011, CHROMOSOME RES, V19, P335, DOI 10.1007/s10577-011-9190-y; Zhu H, 2008, J CELL BIOL, V183, P835, DOI 10.1083/jcb.200807046	61	219	222	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					768	777		10.1016/j.cell.2012.12.044	http://dx.doi.org/10.1016/j.cell.2012.12.044			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415226	Bronze, Green Accepted			2022-12-24	WOS:000314945600012
J	Leffler, EM; Gao, ZY; Pfeifer, S; Segurel, L; Auton, A; Venn, O; Bowden, R; Bontrop, R; Wall, JD; Sella, G; Donnelly, P; McVean, G; Przeworski, M				Leffler, Ellen M.; Gao, Ziyue; Pfeifer, Susanne; Segurel, Laure; Auton, Adam; Venn, Oliver; Bowden, Rory; Bontrop, Ronald; Wall, Jeffrey D.; Sella, Guy; Donnelly, Peter; McVean, Gilean; Przeworski, Molly			Multiple Instances of Ancient Balancing Selection Shared Between Humans and Chimpanzees	SCIENCE			English	Article							NATURAL-SELECTION; COLOR POLYMORPHISM; RESISTANCE; EVOLUTION; HOST	Instances in which natural selection maintains genetic variation in a population over millions of years are thought to be extremely rare. We conducted a genome-wide scan for long-lived balancing selection by looking for combinations of SNPs shared between humans and chimpanzees. In addition to the major histocompatibility complex, we identified 125 regions in which the same haplotypes are segregating in the two species, all but two of which are noncoding. In six cases, there is evidence for an ancestral polymorphism that persisted to the present in humans and chimpanzees. Regions with shared haplotypes are significantly enriched for membrane glycoproteins, and a similar trend is seen among shared coding polymorphisms. These findings indicate that ancient balancing selection has shaped human variation and point to genes involved in host-pathogen interactions as common targets.	[Leffler, Ellen M.; Segurel, Laure; Przeworski, Molly] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Gao, Ziyue] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Pfeifer, Susanne; Bowden, Rory; Donnelly, Peter; McVean, Gilean] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Segurel, Laure; Przeworski, Molly] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Auton, Adam; Venn, Oliver; Bowden, Rory; Donnelly, Peter; McVean, Gilean] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Bontrop, Ronald] Biomed Primate Res Ctr, Dept Comparat Genet & Refinement, NL-2288 GJ Rijswijk, Netherlands; [Wall, Jeffrey D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Sella, Guy; Przeworski, Molly] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Sella, Guy] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Ecol Evolut & Behav, IL-91904 Jerusalem, Israel	University of Chicago; University of Chicago; University of Oxford; Howard Hughes Medical Institute; University of Chicago; University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California San Francisco; University of Chicago; Hebrew University of Jerusalem	Leffler, EM (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	emleffler@uchicago.edu; mfp@uchicago.edu	Bontrop, Ronald E/J-3628-2012; Leffler, Ellen/I-3010-2019	Bontrop, Ronald E/0000-0003-0874-6467; Leffler, Ellen/0000-0002-1614-9366; Donnelly, Peter/0000-0001-9495-3408; Segurel, Laure/0000-0001-7339-0976; Pfeifer, Susanne/0000-0003-1378-2913; McVean, Gil/0000-0002-5012-4162	NIH [T32 GM007197, HG005226, GM72861]; Israel Science Foundation [1492/10]; Wolfson Royal Society Merit Award; Wellcome Trust Senior Investigator award [095552/Z/11/Z]; Wellcome Trust [090532/Z/09/Z, 075491/Z/04/B, 086084/Z/08/Z]; Howard Hughes Medical Institute Early Career Scientist; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197, R01GM072861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Wolfson Royal Society Merit Award(Royal Society of London); Wellcome Trust Senior Investigator award(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute Early Career Scientist(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Conrad, Y. Lee, M. Nobrega, J. Pickrell, and H. Shim as well as A. Kermany, A. Venkat, and other members of the PPS labs for helpful discussions; I. Aneas, M. Caliskan, M. Nobrega, and C. Ober for their assistance with experiments; and G. Coop for discussions and comments on an earlier version of this manuscript. E. M. L. was supported in part by NIH training grant T32 GM007197. This work was supported by NIH HG005226 to J. D. W.; Israel Science Foundation grant 1492/10 to G. S.; a Wolfson Royal Society Merit Award, a Wellcome Trust Senior Investigator award (095552/Z/11/Z), and Wellcome Trust grants 090532/Z/09/Z and 075491/Z/04/B to P. D.; Wellcome Trust grant 086084/Z/08/Z to G. M.; and NIH grant GM72861 to M. P. M. P. is a Howard Hughes Medical Institute Early Career Scientist. The data set of shared SNPs is available from http://przeworski.uchicago.edu/wordpress/?page_id=20. Data from the validation experiment are available from GenBank under accession nos. KC541701 to KC542146. The biological material obtained from the San Diego Zoo and used in this study is subject to a materials tranfer agreement.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Day CJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00009; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; Franchini Massimo, 2007, Thromb J, V5, P14; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Ghosh R, 2012, SCIENCE, V335, P574, DOI 10.1126/science.1214318; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Gigord LDB, 2001, P NATL ACAD SCI USA, V98, P6253, DOI 10.1073/pnas.111162598; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Hiwatashi T, 2010, MOL BIOL EVOL, V27, P453, DOI 10.1093/molbev/msp262; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; HUDSON RR, 1988, GENETICS, V120, P831; Johnsen JM, 2009, MOL BIOL EVOL, V26, P567, DOI 10.1093/molbev/msn284; KLEIN J, 1993, ANNU REV IMMUNOL, V11, P269, DOI 10.1146/annurev.immunol.11.1.269; Ko WY, 2011, AM J HUM GENET, V88, P741, DOI 10.1016/j.ajhg.2011.05.005; KUDO S, 1990, J BIOL CHEM, V265, P1102; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Monnier J, 2008, FEBS J, V275, P4014, DOI 10.1111/j.1742-4658.2008.06559.x; Nagakubo D, 2003, J IMMUNOL, V171, P553, DOI 10.4049/jimmunol.171.2.553; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; REID DG, 1987, BIOL J LINN SOC, V30, P1, DOI 10.1111/j.1095-8312.1987.tb00284.x; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Segurel L, 2012, P NATL ACAD SCI USA, V109, P18493, DOI 10.1073/pnas.1210603109; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; TAKAHATA N, 1990, P NATL ACAD SCI USA, V87, P2419, DOI 10.1073/pnas.87.7.2419; Tellier A, 2007, P R SOC B, V274, P809, DOI 10.1098/rspb.2006.0281; Videira PA, 2008, GLYCOCONJUGATE J, V25, P259, DOI 10.1007/s10719-007-9092-6; Wiuf C, 2004, GENETICS, V168, P2363, DOI 10.1534/genetics.104.029488; Wright S, 1939, GENETICS, V24, P538; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	39	192	196	1	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1578	1582		10.1126/science.1234070	http://dx.doi.org/10.1126/science.1234070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23413192	Green Accepted, Green Submitted			2022-12-24	WOS:000316731600041
J	Levy, C; Zoltowski, BD; Jones, AR; Vaidya, AT; Top, D; Widom, J; Young, MW; Scrutton, NS; Crane, BR; Leys, D				Levy, Colin; Zoltowski, Brian D.; Jones, Alex R.; Vaidya, Anand T.; Top, Deniz; Widom, Joanne; Young, Michael W.; Scrutton, Nigel S.; Crane, Brian R.; Leys, David			Updated structure of Drosophila cryptochrome	NATURE			English	Letter									[Levy, Colin; Jones, Alex R.; Scrutton, Nigel S.; Leys, David] Univ Manchester, Manchester Inst Biotechnol, Fac Life Sci, Manchester M1 7DN, Lancs, England; [Zoltowski, Brian D.; Vaidya, Anand T.; Widom, Joanne; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Top, Deniz; Young, Michael W.] Rockefeller Univ, Lab Genet, New York, NY 10065 USA	University of Manchester; Cornell University; Rockefeller University	Levy, C (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Fac Life Sci, 131 Princess St, Manchester M1 7DN, Lancs, England.	bc69@cornell.edu	Jones, Alex/AFQ-8212-2022; , 机智的马小跳和机智的羊不愁/ABC-5169-2020	Vaidya, Anand/0000-0002-5812-5266; Jones, Alex/0000-0001-6021-7824; Levy, Colin/0000-0002-9724-310X; Top, Deniz/0000-0002-1042-8460	EPSRC [EP/J020192/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J020192/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054339, R01GM079679] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM079679, R37 GM054339] Funding Source: Medline	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afonine P. V., 2005, CCP4 NEWSLETT; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	2	69	71	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					E3	E4		10.1038/nature11995	http://dx.doi.org/10.1038/nature11995			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23518567	Green Accepted			2022-12-24	WOS:000316650500051
J	Mercier, R; Kawai, Y; Errington, J				Mercier, Romain; Kawai, Yoshikazu; Errington, Jeff			Excess Membrane Synthesis Drives a Primitive Mode of Cell Proliferation	CELL			English	Article							CARRIER PROTEIN SYNTHASE; FATTY-ACID BIOSYNTHESIS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; L-FORM; LIPID BIOSYNTHESIS; DIVISION; WALL; TRANSCRIPTION; PROTOPLAST	The peptidoglycan cell wall is a hallmark of the bacterial subkingdom. Surprisingly, many modern bacteria retain the ability to switch into a wall-free state called the L-form. L-form proliferation is remarkable in being independent of the normally essential FtsZ-based division machinery and in occurring by membrane blebbing and tubulation. We show that mutations leading to excess membrane synthesis are sufficient to drive L-form division in Bacillus subtilis. Artificially increasing the cell surface area to volume ratio in wild-type protoplasts generates similar shape changes and cell division. Our findings show that simple biophysical processes could have supported efficient cell proliferation during the evolution of early cells and provide an extant biological model for studying this problem.	[Mercier, Romain; Kawai, Yoshikazu; Errington, Jeff] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England	Newcastle University - UK	Errington, J (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	jeff.errington@ncl.ac.uk	Mercier, Romain/E-3642-2012; Errington, Jeff/G-1832-2011	Errington, Jeff/0000-0002-6977-9388	European Research Council [250363]; EMBO Long Term Fellowship; Marie-Curie Intra-European Fellowship	European Research Council(European Research Council (ERC)European Commission); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Marie-Curie Intra-European Fellowship(European Commission)	We thank Henrik Strahl for technical support and extensive discussions and Patricia Dominguez-Cuevas, Waldemar Vollmer, and Ling Juan Wu for critical reading of the manuscript. We thank Donald Zeigler (BGSC) for strain OBS20. This work was funded by European Research Council Advanced Investigator grant 250363 ("OPAL"; to J. E.). R. M. was supported by EMBO Long Term and Marie-Curie Intra-European Fellowships.	Adams DW, 2011, MOL MICROBIOL, V80, P68, DOI 10.1111/j.1365-2958.2011.07559.x; Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Allan EJ, 2009, ADV APPL MICROBIOL, V68, P1, DOI 10.1016/S0065-2164(09)01201-5; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Bendezu FO, 2008, J BACTERIOL, V190, P1792, DOI 10.1128/JB.01322-07; BOURNE N, 1986, J GEN MICROBIOL, V132, P251; Bozic B, 2007, EUR PHYS J E, V24, P79, DOI 10.1140/epje/i2007-10217-1; Briers Y, 2012, BIOESSAYS, V34, P1078, DOI 10.1002/bies.201200080; Briers Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038514; Chen IA, 2009, CURR BIOL, V19, pR327, DOI 10.1016/j.cub.2009.03.002; Choi KH, 2000, J BACTERIOL, V182, P365, DOI 10.1128/JB.182.2.365-370.2000; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Dell'Era S, 2009, MOL MICROBIOL, V73, P306, DOI 10.1111/j.1365-2958.2009.06774.x; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Dominguez-Cuevas P, 2012, MOL MICROBIOL, V83, P52, DOI 10.1111/j.1365-2958.2011.07920.x; Errington J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120143; Hamoen LW, 2002, NUCLEIC ACIDS RES, V30, P5517, DOI 10.1093/nar/gkf698; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Ishikawa S, 2006, MOL MICROBIOL, V60, P1364, DOI 10.1111/j.1365-2958.2006.05184.x; KANDLER G, 1954, ARCH MIKROBIOL, V21, P178, DOI 10.1007/BF01816378; Leaver M, 2009, NATURE, V457, P849, DOI 10.1038/nature07742; Luisi PL, 2008, J PHYS CHEM B, V112, P14655, DOI 10.1021/jp8028598; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Mercier R, 2012, CELL REP, V1, P417, DOI 10.1016/j.celrep.2012.03.008; Moche M, 1999, J BIOL CHEM, V274, P6031, DOI 10.1074/jbc.274.10.6031; Peterlin P, 2009, CHEM PHYS LIPIDS, V159, P67, DOI 10.1016/j.chemphyslip.2009.03.005; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Sambrook J., 2002, MOL CLONING LAB MANU; Schujman GE, 1998, MOL MICROBIOL, V29, P1215, DOI 10.1046/j.1365-2958.1998.01004.x; Schujman GE, 2003, DEV CELL, V4, P663, DOI 10.1016/S1534-5807(03)00123-0; Schujman GE, 2006, EMBO J, V25, P4074, DOI 10.1038/sj.emboj.7601284; Siddiqui RA, 2006, FEMS MICROBIOL LETT, V258, P305, DOI 10.1111/j.1574-6968.2006.00237.x; Svetina S, 2009, CHEMPHYSCHEM, V10, P2769, DOI 10.1002/cphc.200900577; Terasawa H, 2012, P NATL ACAD SCI USA, V109, P5942, DOI 10.1073/pnas.1120327109; Zhu TF, 2009, J AM CHEM SOC, V131, P5705, DOI 10.1021/ja900919c	35	128	129	1	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					997	1007		10.1016/j.cell.2013.01.043	http://dx.doi.org/10.1016/j.cell.2013.01.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452849	Bronze			2022-12-24	WOS:000315710300009
J	Lawlor, DA; Wills, AK; Fraser, A; Sayers, A; Fraser, WD; Tobias, JH				Lawlor, Debbie A.; Wills, Andrew K.; Fraser, Abigail; Sayers, Adrian; Fraser, William D.; Tobias, Jonathan H.			Association of maternal vitamin D status during pregnancy with bone-mineral content in off spring: a prospective cohort study	LANCET			English	Article							D DEFICIENCY; CHILDHOOD; BODY; MASS; PREVENTION	Background Maternal vitamin D status in pregnancy is a suggested determinant of bone-mineral content (BMC) in off spring, but has been assessed in small studies. We investigated this association in a large prospective study. Methods Eligible participants were mother-and-singleton-off spring pairs who had participated in the Avon Longitudinal Study of Parents and Children, and in which the mother had recorded measurements of 25(OH) D concentration in pregnancy and the off spring had undergone dual-energy x-ray absorptiometry at age 9-10 years. 25(OH) D concentrations in pregnancy were assessed per 10.0 nmol/L and classified as sufficient (more than 50.00 nmol/L), insufficient (49.99-27.50 nmol/L), or deficient (lower than 27.50 nmol/L). Associations between maternal serum 25(OH) D concentrations and off spring total body less head (TBLH) and spinal BMC were assessed by trimester. Results 3960 mother-and-off spring pairs, mainly of white European origin, were assessed (TBLH BMC n=3960, spinal BMC n=3196). Mean off spring age was 9.9 years. 2644 (67%) mothers had sufficient, 1096 (28%) insufficient, and 220 (6%) deficient 25(OH) D concentrations in pregnancy, but TBLH and spinal BMC did not differ between off spring of mothers in the lower two groups versus sufficient 25(OH) D concentration. No associations with off spring BMC were found for any trimester, including the third trimester, which is thought to be most relevant (TBLH BMC confounder-adjusted mean difference -0.03 g per 10.0 nmol/L, 95% CI -1.71 to 1.65; spinal BMC 0.04 g per 10.0 nmol/L, 95% CI -0.12 to 0.21). Conclusions We found no relevant association between maternal vitamin D status in pregnancy and off spring BMC in late childhood.	[Lawlor, Debbie A.; Wills, Andrew K.; Fraser, Abigail] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England; [Lawlor, Debbie A.; Wills, Andrew K.; Fraser, Abigail; Sayers, Adrian] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Fraser, William D.] Univ Bristol, Sch Clin Sci, Bristol BS8 2BN, Avon, England; [Tobias, Jonathan H.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of Bristol; University of Bristol; University of Bristol; University of East Anglia	Lawlor, DA (corresponding author), Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Oakfield House, Bristol BS8 2BN, Avon, England.	d.a.lawlor@bristol.ac.uk	Wills, Andrew/AAO-5279-2020; Tobias, Jon/E-2832-2014; Sayers, Adrian/AAU-8134-2020	Tobias, Jon/0000-0002-7475-3932; Sayers, Adrian/0000-0001-7452-5043; Fraser, Abigail/0000-0002-7741-9470; Lawlor, Debbie A/0000-0002-6793-2262; Wills, Andrew/0000-0002-9751-4707	UK Medical Research Council; Wellcome Trust; University of Bristol; Medical Research Council [G0701594, G0701603, G0600705] Funding Source: researchfish; MRC [G0600705, G0701594, G0701603] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UK Medical Research Council, Wellcome Trust, and University of Bristol.	Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Dawodu A, 2007, ARCH DIS CHILD, V92, P737, DOI 10.1136/adc.2007.122689; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Gartner LM, 2003, PEDIATRICS, V111, P908, DOI 10.1542/peds.111.4.908; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Lapillonne A, 1997, ACTA PAEDIATR, V86, P196, DOI 10.1111/j.1651-2227.1997.tb08868.x; Macdonald-Wallis C, 2010, AM J CLIN NUTR, V92, P872, DOI 10.3945/ajcn.2010.29501; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Salle BL, 2000, AM J CLIN NUTR, V71, p1317S, DOI 10.1093/ajcn/71.5.1317s; Sayers A, 2012, OSTEOPOROSIS INT, V23, P2117, DOI 10.1007/s00198-011-1813-9; Sayers A, 2009, J CLIN ENDOCR METAB, V94, P765, DOI 10.1210/jc.2008-2146; Thomas SDC, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000236; Tolppanen AM, 2012, J CLIN ENDOCR METAB, V97, P1202, DOI 10.1210/jc.2011-2516; Viljakainen HT, 2011, OSTEOPOROSIS INT, V22, P883, DOI 10.1007/s00198-010-1499-4; Viljakainen HT, 2010, J CLIN ENDOCR METAB, V95, P1749, DOI 10.1210/jc.2009-1391; Weaver CM, 2007, J BONE MINER RES, V22, pV45, DOI 10.1359/JBMR.07S201; Weiler H, 2005, CAN MED ASSOC J, V172, P757, DOI 10.1503/cmaj.1040508; Yu CKH, 2011, FETAL DIAGN THER, V30, P94, DOI 10.1159/000324340	20	110	111	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 22	2013	381	9884					2176	2183		10.1016/S0140-6736(12)62203-X	http://dx.doi.org/10.1016/S0140-6736(12)62203-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KH	23518316	Green Published, Bronze			2022-12-24	WOS:000320925600034
J	Cornulier, T; Yoccoz, NG; Bretagnolle, V; Brommer, JE; Butet, A; Ecke, F; Elston, DA; Framstad, E; Henttonen, H; Hornfeldt, B; Huitu, O; Imholt, C; Ims, RA; Jacob, J; Jedrzejewska, B; Millon, A; Petty, SJ; Pietiainen, H; Tkadlec, E; Zub, K; Lambin, X				Cornulier, Thomas; Yoccoz, Nigel G.; Bretagnolle, Vincent; Brommer, Jon E.; Butet, Alain; Ecke, Frauke; Elston, David A.; Framstad, Erik; Henttonen, Heikki; Hornfeldt, Birger; Huitu, Otso; Imholt, Christian; Ims, Rolf A.; Jacob, Jens; Jedrzejewska, Bogumila; Millon, Alexandre; Petty, Steve J.; Pietiainen, Hannu; Tkadlec, Emil; Zub, Karol; Lambin, Xavier			Europe-Wide Dampening of Population Cycles in Keystone Herbivores	SCIENCE			English	Article							GREY-SIDED VOLE; DENSITY-DEPENDENCE; LEMMING CYCLES; MICROTUS-AGRESTIS; CLIMATE-CHANGE; DYNAMICS; COMPETITION; PREDATORS; OUTBREAKS; HOKKAIDO	Suggestions of collapse in small herbivore cycles since the 1980s have raised concerns about the loss of essential ecosystem functions. Whether such phenomena are general and result from extrinsic environmental changes or from intrinsic process stochasticity is currently unknown. Using a large compilation of time series of vole abundances, we demonstrate consistent cycle amplitude dampening associated with a reduction in winter population growth, although regulatory processes responsible for cyclicity have not been lost. The underlying syndrome of change throughout Europe and grass-eating vole species suggests a common climatic driver. Increasing intervals of low-amplitude small herbivore population fluctuations are expected in the future, and these may have cascading impacts on trophic webs across ecosystems.	[Cornulier, Thomas; Millon, Alexandre; Petty, Steve J.; Lambin, Xavier] Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 3TZ, Scotland; [Yoccoz, Nigel G.; Ims, Rolf A.] Univ Tromso, Dept Arctic & Marine Biol, N-9037 Tromso, Norway; [Bretagnolle, Vincent] CNRS, UPR 1934, Ctr Etud Biol Chize, F-79360 Beauvoir Sur Niort, France; [Brommer, Jon E.; Pietiainen, Hannu] Univ Helsinki, Dept Biosci, FI-00014 Helsinki, Finland; [Butet, Alain] Univ Rennes 1, UEB, UMR CNRS Ecobio 6553, Observ Sci Univ Rennes, F-35042 Rennes, France; [Ecke, Frauke; Hornfeldt, Birger] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Ecke, Frauke] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, S-75007 Uppsala, Sweden; [Elston, David A.] Biomath & Stat Scotland, Aberdeen AB15 8QH, Scotland; [Framstad, Erik] Norwegian Inst Nat Res, N-0349 Oslo, Norway; [Henttonen, Heikki] Finnish Forest Res Inst, Vantaa Unit, FI-01301 Vantaa, Finland; [Huitu, Otso] Finnish Forest Res Inst, Suonenjoki Unit, FI-77600 Suonenjoki, Finland; [Imholt, Christian; Jacob, Jens] Fed Res Ctr Cultivated Plants, Inst Plant Protect Hort & Forests, Julius Kuhn Inst, D-48161 Munster, Germany; [Jedrzejewska, Bogumila; Zub, Karol] Polish Acad Sci, Mammal Res Inst, PL-17230 Bialowieza, Poland; [Petty, Steve J.] Ctr Human & Ecol Sci, No Res Stn, Roslin EH25 9SY, Midlothian, Scotland; [Tkadlec, Emil] Palacky Univ Olomouc, Dept Ecol & Environm Sci, Olomouc 77146, Czech Republic; [Tkadlec, Emil] Acad Sci Czech Republic, Inst Vertebrate Biol, Prague 67502, Czech Republic	University of Aberdeen; UiT The Arctic University of Tromso; Centre National de la Recherche Scientifique (CNRS); University of Helsinki; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; James Hutton Institute; Norwegian Institute Nature Research; Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke); Julius Kuhn-Institut; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Palacky University Olomouc; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Lambin, X (corresponding author), Univ Aberdeen, Sch Biol Sci, Zool Bldg,Tillydrone Ave, Aberdeen AB24 3TZ, Scotland.	x.lambin@abdn.ac.uk	Cornulier, Thomas/G-6841-2014; Cornulier, Thomas/AAC-9753-2022; Millon, Alexandre/R-6464-2017; Lambin, Xavier/E-8284-2011; Tkadlec, Emil/A-6230-2014; Ecke, Frauke/AAW-6468-2021; Brommer, Jon E/C-3613-2008; Zub, Karol/ABG-4802-2020; Jacob, Jens/C-2189-2013; Millon, Alexandre/AAF-8624-2020; Elston, David A/H-8199-2013; Jacob, Jens/AAZ-7850-2020; Yoccoz, Nigel/C-8561-2014	Cornulier, Thomas/0000-0003-2738-4801; Millon, Alexandre/0000-0002-9475-4123; Lambin, Xavier/0000-0003-4643-2653; Ecke, Frauke/0000-0003-4208-345X; Brommer, Jon E/0000-0002-2435-2612; Zub, Karol/0000-0001-7235-2206; Millon, Alexandre/0000-0002-9475-4123; Jacob, Jens/0000-0002-5136-6606; Yoccoz, Nigel/0000-0003-2192-1039; Tkadlec, Emil/0000-0003-3782-8867	Natural Environment Research Council; Research Council of Norway; Agence Nationale de la Recherche; Scottish Government; NERC [NE/G002045/1] Funding Source: UKRI; Natural Environment Research Council [NE/G002045/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Research Council of Norway(Research Council of Norway); Agence Nationale de la Recherche(French National Research Agency (ANR)); Scottish Government; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by the national funders Natural Environment Research Council, Research Council of Norway, and Agence Nationale de la Recherche, part of the 2008 ERA-Net BiodivERsA call for research proposals. D. A. E. was funded by the Scottish Government. We thank R. B. O'Hara and F. Barraquand for useful methodological inputs and all the contributors to vole sampling over decades. General correspondence should be addressed to X. L. and specific requests to T. C. (cornulier@abdn.ac.uk). Raw data are available in supplementary text section IX). Authors declare no conflicts of interest. A. B., B. H., B.J., C. I., E. F., E. T., F. E., H. H., H. P., J.E.B., J.J., K.Z., O.H., S.J.P., V. B., and X. L. led the data collection; T. C., N.G.Y., R. A. I., A. M., and X. L. conceived the ideas for the paper and its structure; T. C., N.G.Y., D. A. E., and X. L. designed the analyses; T. C. and X. L. wrote the manuscript; and all authors discussed the results and commented on the manuscript.	Bell JR, 2012, ECOL LETT, V15, P310, DOI 10.1111/j.1461-0248.2011.01739.x; Bety J, 2002, J ANIM ECOL, V71, P88, DOI 10.1046/j.0021-8790.2001.00581.x; Bierman SM, 2006, AM NAT, V167, P583, DOI 10.1086/501076; Brommer JE, 2010, GLOBAL CHANGE BIOL, V16, P577, DOI 10.1111/j.1365-2486.2009.02012.x; Ecke F, 2006, LANDSCAPE ECOL, V21, P485, DOI 10.1007/s10980-005-2376-y; Fleming RA, 2002, ECOL MODEL, V149, P127, DOI 10.1016/S0304-3800(01)00519-1; Hansen TF, 1999, AM NAT, V154, P129, DOI 10.1086/303229; Hansen TF, 1999, P NATL ACAD SCI USA, V96, P986, DOI 10.1073/pnas.96.3.986; Hanski I, 1996, J ANIM ECOL, V65, P220, DOI 10.2307/5725; HANSSON L, 1983, OIKOS, V40, P258, DOI 10.2307/3544590; Hornfeldt B, 2004, OIKOS, V107, P376, DOI 10.1111/j.0030-1299.2004.13348.x; Hornfeldt B, 2005, P ROY SOC B-BIOL SCI, V272, P2045, DOI 10.1098/rspb.2005.3141; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Ims RA, 2011, P NATL ACAD SCI USA, V108, P1970, DOI 10.1073/pnas.1012714108; Johnson DM, 2010, P NATL ACAD SCI USA, V107, P20576, DOI 10.1073/pnas.1010270107; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Korslund L, 2006, J ANIM ECOL, V75, P156, DOI 10.1111/j.1365-2656.2005.01031.x; Olofsson J, 2012, NAT CLIM CHANGE, V2, P880, DOI 10.1038/NCLIMATE1537; Royama T., 1992, ANAL POPULATION DYNA, P55; Saitoh T, 2006, CLIM RES, V32, P109, DOI 10.3354/cr032109; Schmidt NM, 2012, P ROY SOC B-BIOL SCI, V279, P4417, DOI 10.1098/rspb.2012.1490; Smith MJ, 2006, AM NAT, V167, P695, DOI 10.1086/503119; Stenseth NC, 1999, OIKOS, V87, P427, DOI 10.2307/3546809; Stenseth NC, 2003, P NATL ACAD SCI USA, V100, P11478, DOI 10.1073/pnas.1935306100; Stenseth NC, 2003, FRONT ECOL ENVIRON, V1, P367, DOI 10.2307/3868189; Strann KB, 2002, ECOGRAPHY, V25, P81, DOI 10.1034/j.1600-0587.2002.250109.x; Summers RW, 1998, ECOGRAPHY, V21, P573, DOI 10.1111/j.1600-0587.1998.tb00549.x; Turchin P, 2000, NATURE, V405, P562, DOI 10.1038/35014595	29	185	193	3	329	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					63	66		10.1126/science.1228992	http://dx.doi.org/10.1126/science.1228992			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559246				2022-12-24	WOS:000317061100044
J	Shukla, R; Upton, KR; Munoz-Lopez, M; Gerhardt, DJ; Fisher, ME; Nguyen, T; Brennan, PM; Baillie, JK; Collino, A; Ghisletti, S; Sinha, S; Iannelli, F; Radaelli, E; Dos Santos, A; Rapoud, D; Guettier, C; Samuel, D; Natoli, G; Carninci, P; Ciccarelli, FD; Garcia-Perez, JL; Faivre, J; Faulkner, GJ				Shukla, Ruchi; Upton, Kyle R.; Munoz-Lopez, Martin; Gerhardt, Daniel J.; Fisher, Malcolm E.; Thu Nguyen; Brennan, Paul M.; Baillie, J. Kenneth; Collino, Agnese; Ghisletti, Serena; Sinha, Shruti; Iannelli, Fabio; Radaelli, Enrico; Dos Santos, Alexandre; Rapoud, Delphine; Guettier, Catherine; Samuel, Didier; Natoli, Gioacchino; Carninci, Piero; Ciccarelli, Francesca D.; Luis Garcia-Perez, Jose; Faivre, Jamila; Faulkner, Geoffrey J.			Endogenous Retrotransposition Activates Oncogenic Pathways in Hepatocellular Carcinoma	CELL			English	Article							HEPATITIS-B-VIRUS; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; SOMATIC RETROTRANSPOSITION; LINE-1 RETROTRANSPOSITION; L1 RETROTRANSPOSITION; IDENTIFICATION; GENE; TRANSCRIPTION; LANDSCAPE	LINE-1 (L1) retrotransposons are mobile genetic elements comprising similar to 17% of the human genome. New L1 insertions can profoundly alter gene function and cause disease, though their significance in cancer remains unclear. Here, we applied enhanced retrotransposon capture sequencing (RC-seq) to 19 hepatocellular carcinoma (HCC) genomes and elucidated two archetypal L1-mediated mechanisms enabling tumorigenesis. In the first example, 4/19 (21.1%) donors presented germline retrotransposition events in the tumor suppressor mutated in colorectal cancers (MCC). MCC expression was ablated in each case, enabling oncogenic beta-catenin/Wnt signaling. In the second example, suppression of tumorigenicity 18 (ST18) was activated by a tumor-specific L1 insertion. Experimental assays confirmed that the L1 interrupted a negative feedback loop by blocking ST18 repression of its enhancer. ST18 was also frequently amplified in HCC nodules from Mdr2(-/-) mice, supporting its assignment as a candidate liver oncogene. These proof-of-principle results substantiate L1-mediated retrotransposition as an important etiological factor in HCC.	[Shukla, Ruchi; Fisher, Malcolm E.; Baillie, J. Kenneth; Faulkner, Geoffrey J.] Univ Edinburgh, Div Genet & Genom, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Shukla, Ruchi; Fisher, Malcolm E.; Baillie, J. Kenneth; Faulkner, Geoffrey J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush EH25 9RG, Midlothian, Scotland; [Upton, Kyle R.; Gerhardt, Daniel J.; Thu Nguyen; Faulkner, Geoffrey J.] Mater Med Res Inst, Canc Biol Program, South Brisbane, Qld 4101, Australia; [Munoz-Lopez, Martin; Luis Garcia-Perez, Jose] Pfizer Univ Granada, Dept Human DNA Variabil, Granada 18007, Spain; [Munoz-Lopez, Martin; Luis Garcia-Perez, Jose] Andalusian Govt Ctr Genom & Oncol GENYO, Granada 18007, Spain; [Brennan, Paul M.] Univ Edinburgh, Western Gen Hosp, Edinburgh Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Collino, Agnese; Ghisletti, Serena; Sinha, Shruti; Iannelli, Fabio; Natoli, Gioacchino; Ciccarelli, Francesca D.] European Inst Oncol IEO, Dept Expt Oncol, I-20139 Milan, Italy; [Radaelli, Enrico] Univ Milan, DIVET, Sch Vet Med, I-20133 Milan, Italy; [Dos Santos, Alexandre; Rapoud, Delphine; Guettier, Catherine; Samuel, Didier; Faivre, Jamila] INSERM, U785, Ctr Hepatobiliaire, F-94800 Villejuif, France; [Dos Santos, Alexandre; Rapoud, Delphine; Guettier, Catherine; Samuel, Didier; Faivre, Jamila] Univ Paris 11, Fac Med, F-94800 Villejuif, France; [Carninci, Piero] RIKEN, Yokohama Inst, Omics Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Faulkner, Geoffrey J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Mater Research; Pfizer; University of Granada; University of Edinburgh; IRCCS European Institute of Oncology (IEO); University of Milan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; RIKEN; University of Queensland	Faulkner, GJ (corresponding author), Univ Edinburgh, Div Genet & Genom, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland.	faulknergj@gmail.com	Ghisletti, Serena/AAO-6437-2021; Faulkner, Geoffrey J/M-3168-2014; Baillie, Kenneth/AEK-6650-2022; Dos Santos, Alexandre/S-1933-2018; Baillie, John Kenneth/F-3124-2011; Natoli, gioacchino/ABB-8679-2020; Shukla, Ruchi/AAD-7610-2020; Fisher, Malcolm Edgar/GQH-8954-2022; Natoli, gioacchino/J-2100-2018; Carninci, Piero/K-1568-2014; Upton, Kyle R./M-4772-2014; Ciccarelli, Francesca/D-5380-2014	Faulkner, Geoffrey J/0000-0001-5769-4494; Baillie, Kenneth/0000-0001-5258-793X; Baillie, John Kenneth/0000-0001-5258-793X; Fisher, Malcolm Edgar/0000-0003-1074-8103; Carninci, Piero/0000-0001-7202-7243; Upton, Kyle R./0000-0003-1101-8081; Ciccarelli, Francesca/0000-0002-9325-0900; Natoli, Gioacchino/0000-0003-0711-2411; Munoz-Lopez, Martin/0000-0002-2137-6539; Brennan, Paul/0000-0002-7347-830X; Ghisletti, Serena/0000-0002-7087-5553; Garcia-Perez, Jose Luis/0000-0002-8132-9849; Iannelli, Fabio/0000-0002-2777-1417	European Union's Seventh Framework Programme (FP7) underpinning the MODHEP consortium [259743]; Wellcome Trust Clinical Fellowships through the Edinburgh Clinical Academic Track (ECAT) [090385/Z/09/Z, 090386/Z/09/Z]; Howard Hughes Medical Institute [IECS-55007420]; Institut National de la Sante et de la Recherche Medicale (INSERM); Association pour la Recherche contre le Cancer [ARC 4866]; Institut National du Cancer (INCa PAIR-CHC); New Investigator Award from the British BBSRC [BB/H005935/1]; C.J. Martin Overseas Based Biomedical Fellowship from the Australian NHMRC [575585];  [FP7-PEOPLE-2007-4-3-IRG];  [CICE-FEDER-P09-CTS-4980];  [PeS-FEDER-PI-002];  [FIS-FEDER-PI11/01489]; BBSRC [BBS/E/D/20310000, BB/H005935/1, BB/I024801/1] Funding Source: UKRI; MRC [MR/K001744/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I024801/1, BBS/E/D/20310000, BB/H005935/1] Funding Source: researchfish; Medical Research Council [MR/K001744/1] Funding Source: researchfish	European Union's Seventh Framework Programme (FP7) underpinning the MODHEP consortium; Wellcome Trust Clinical Fellowships through the Edinburgh Clinical Academic Track (ECAT); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer (INCa PAIR-CHC)(Institut National du Cancer (INCA) France); New Investigator Award from the British BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); C.J. Martin Overseas Based Biomedical Fellowship from the Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ; ; ; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Professor Haig Kazazian, Professor Bert Vogelstein, Dr. Bruno Amati, and Dr. Alister Funnell for helpful discussion. We thank Professor Daniel Azoulay, Professor Denis Castaing, Professor Rene Adam and Dr. Eric Vibert (Centre Hepatobiliaire, Villejuif), and the Tissue Biobank Group (AP-HP and Universite Paris-Sud) for providing HCC specimens. We thank Dr. Christine Beck and Professor John Moran for providing the genomic coordinates of a recently published full-length L1 insertion cohort (Beck et al., 2010). Research performed in the laboratories of D.S., G.N., P.C., F.D.C., J.F., and G.J.F. was funded by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 259743 underpinning the MODHEP consortium. J.K.B. and P.M.B. were supported by Wellcome Trust Clinical Fellowships (090385/Z/09/Z and 090386/Z/09/Z, respectively) through the Edinburgh Clinical Academic Track (ECAT). J.L.G.P was supported by FP7-PEOPLE-2007-4-3-IRG, CICE-FEDER-P09-CTS-4980, PeS-FEDER-PI-002, FIS-FEDER-PI11/01489, and the Howard Hughes Medical Institute (IECS-55007420). J.F. acknowledges the support of the Institut National de la Sante et de la Recherche Medicale (INSERM), the Association pour la Recherche contre le Cancer (ARC 4866), and the Institut National du Cancer (INCa 2009-PAIR-CHC). G.J.F. acknowledges the support of a New Investigator Award from the British BBSRC (BB/H005935/1) and a C.J. Martin Overseas Based Biomedical Fellowship from the Australian NHMRC (575585).	Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Faulkner GJ, 2011, FEBS LETT, V585, P1589, DOI 10.1016/j.febslet.2011.03.061; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; FORNACE AJ, 1986, NUCLEIC ACIDS RES, V14, P5793, DOI 10.1093/nar/14.14.5793; Fukuyama R, 2008, ONCOGENE, V27, P6044, DOI 10.1038/onc.2008.204; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang YH, 1996, J BIOL CHEM, V271, P10723, DOI 10.1074/jbc.271.18.10723; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; Kohonen-Corish MRJ, 2007, ONCOGENE, V26, P4435, DOI 10.1038/sj.onc.1210210; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Liu J, 1997, GENE CHROMOSOME CANC, V18, P232, DOI 10.1002/(SICI)1098-2264(199703)18:3<232::AID-GCC10>3.0.CO;2-K; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Matsumine A, 1996, J BIOL CHEM, V271, P10341, DOI 10.1074/jbc.271.17.10341; MIKI Y, 1992, CANCER RES, V52, P643; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ostertag EM, 2001, GENOME RES, V11, P2059, DOI 10.1101/gr.205701; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; RHODES SJ, 1993, GENE DEV, V7, P913, DOI 10.1101/gad.7.6.913; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Senda T, 1999, J HISTOCHEM CYTOCHEM, V47, P1149, DOI 10.1177/002215549904700907; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Steinbach D, 2006, CLIN CANCER RES, V12, P2434, DOI 10.1158/1078-0432.CCR-05-2552; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Tateishi R, 2012, NAT REV GASTRO HEPAT, V9, P69, DOI 10.1038/nrgastro.2011.255; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Unitt E, 2005, HEPATOLOGY, V41, P722, DOI 10.1002/hep.20644; Van Nhieu JT, 1999, AM J PATHOL, V155, P703, DOI 10.1016/S0002-9440(10)65168-1; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366	59	261	268	4	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					101	111		10.1016/j.cell.2013.02.032	http://dx.doi.org/10.1016/j.cell.2013.02.032			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540693	hybrid, Green Published			2022-12-24	WOS:000316853700009
J	Sundaram, GM; Common, JEA; Gopal, FE; Srikanta, S; Lakshman, K; Lunny, DP; Lim, TC; Tanavde, V; Lane, EB; Sampath, P				Sundaram, Gopinath M.; Common, John E. A.; Gopal, Felicia E.; Srikanta, Satyanarayana; Lakshman, Krishnaswamy; Lunny, Declan P.; Lim, Thiam C.; Tanavde, Vivek; Lane, E. Birgitte; Sampath, Prabha			'See-saw' expression of microRNA-198 and FSTL1 from a single transcript in wound healing	NATURE			English	Article							DIABETIC FOOT ULCERS; CELL-MIGRATION; KERATINOCYTES; PATHWAY	Post-transcriptional switches are flexible effectors of dynamic changes in gene expression(1). Here we report a new post-transcriptional switch that dictates the spatiotemporal and mutually exclusive expression of two alternative gene products from a single transcript. Expression of primate-specific exonic microRNA-198 (miR-198)(2), located in the 3'-untranslated region of follistatin-like 1 (FSTL1)(3) messenger RNA, switches to expression of the linked open reading frame of FSTL1 upon wounding in a human ex vivo organ culture system. We show that binding of a KH-type splicing regulatory protein (KSRP, also known as KHSRP) to the primary transcript determines the fate of the transcript and is essential for the processing of miR-198: transforming growth factor-beta signalling switches off miR-198 expression by downregulating KSRP, and promotes FSTL1 protein expression. We also show that FSTL1 expression promotes keratinocyte migration, whereas miR-198 expression has the opposite effect by targeting and inhibiting DIAPH1, PLAU and LAMC2. A clear inverse correlation between the expression pattern of FSTL1 (pro-migratory) and miR-198 (anti-migratory) highlights the importance of this regulatory switch in controlling context-specific gene expression to orchestrate wound re-epithelialization. The deleterious effect of failure of this switch is apparent in non-healing chronic diabetic ulcers, in which expression of miR-198 persists, FSTL1 is absent, and keratinocyte migration, re-epithelialization and wound healing all fail to occur.	[Sundaram, Gopinath M.; Common, John E. A.; Gopal, Felicia E.; Lunny, Declan P.; Tanavde, Vivek; Lane, E. Birgitte; Sampath, Prabha] ASTAR, Inst Med Biol, Singapore 138648, Singapore; [Srikanta, Satyanarayana; Lakshman, Krishnaswamy] Jnana Sanjeevini Diabet Ctr, Bangalore 560078, Karnataka, India; [Lim, Thiam C.] Natl Univ Hlth Syst, Div Plast Reconstruct & Aesthet Surg, Singapore 119074, Singapore; [Lim, Thiam C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 119228, Singapore; [Tanavde, Vivek] ASTAR, Bioinformat Inst, Singapore 138671, Singapore; [Lane, E. Birgitte] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 119074, Singapore; [Lane, E. Birgitte; Sampath, Prabha] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; National University of Singapore	Sampath, P (corresponding author), ASTAR, Inst Med Biol, Singapore 138648, Singapore.	prabha.sampath@imb.a-star.edu.sg	Tanavde, Vivek/B-4758-2011; Lim, Thiam Chye/B-5323-2011; Common, John/Q-6412-2018; Sundaram, Gopi/AAE-5427-2020	Tanavde, Vivek/0000-0001-7404-5568; Common, John/0000-0002-3280-7365; Sundaram, Gopi/0000-0002-8074-6624	A*STAR Investigatorship award; Biomedical Research Council of Singapore; Skin Biology Cluster Platform, A*STAR	A*STAR Investigatorship award(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Skin Biology Cluster Platform, A*STAR(Agency for Science Technology & Research (A*STAR))	This work was supported by an A*STAR Investigatorship award to P.S., the Biomedical Research Council of Singapore and the Skin Biology Cluster Platform, A*STAR. We thank T. Kamala, S. Nama, M. Hisyam and C. Vaz for experimental support and B. Knowles for critical reading of the manuscript.	Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Banerjee J, 2011, PHYSIOL GENOMICS, V43, P543, DOI 10.1152/physiolgenomics.00157.2010; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Daniel RJ, 2002, J INVEST DERMATOL, V119, P1304, DOI 10.1046/j.1523-1747.2002.19533.x; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; He YH, 2011, AM J PATHOL, V178, P975, DOI 10.1016/j.ajpath.2010.11.053; Hinske LCG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-533; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Jude EB, 2002, DIABETIC MED, V19, P440, DOI 10.1046/j.1464-5491.2002.00692.x; Kroeze KL, 2012, J INVEST DERMATOL, V132, P216, DOI 10.1038/jid.2011.245; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Marutsuka K, 1998, CORONARY ARTERY DIS, V9, P177, DOI 10.1097/00019501-199809040-00002; Pastar I, 2010, MOL MED, V16, P92, DOI 10.2119/molmed.2009.00149; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Tan S, 2011, FEBS LETT, V585, P2229, DOI 10.1016/j.febslet.2011.05.042; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Usui ML, 2008, J HISTOCHEM CYTOCHEM, V56, P687, DOI 10.1369/jhc.2008.951194; Usui ML, 2005, WOUND REPAIR REGEN, V13, P468, DOI 10.1111/j.1067-1927.2005.00067.x; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Zorio E., 2008, CURR MED CHEM, V15, P923	28	148	159	3	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					103	106		10.1038/nature11890	http://dx.doi.org/10.1038/nature11890			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23395958				2022-12-24	WOS:000316039800048
J	Biggs, D; Courchamp, F; Martin, R; Possingham, HP				Biggs, Duan; Courchamp, Franck; Martin, Rowan; Possingham, Hugh P.			Legal Trade of Africa's Rhino Horns	SCIENCE			English	Editorial Material							CONSERVATION		[Biggs, Duan; Possingham, Hugh P.] Univ Queensland, Australian Res Council Ctr Excellence Environm De, Ctr Biodivers & Conservat Sci, Brisbane, Qld 4072, Australia; [Courchamp, Franck] Univ Paris Sud, UMR CNRS 8079, Orsay, France	University of Queensland; UDICE-French Research Universities; Universite Paris Saclay	Biggs, D (corresponding author), Univ Queensland, Australian Res Council Ctr Excellence Environm De, Ctr Biodivers & Conservat Sci, Brisbane, Qld 4072, Australia.	ancientantwren@gmail.com	POSSINGHAM, HUGH/R-8310-2019; Possingham, Hugh/B-1337-2008; Biggs, Duan/F-9445-2011; Courchamp, Franck/ABE-7204-2020	POSSINGHAM, HUGH/0000-0001-7755-996X; Possingham, Hugh/0000-0001-7755-996X; Courchamp, Franck/0000-0001-7605-4548; Biggs, Duan/0000-0003-3177-4677				Brown G., 2001, PROTECTING ENDANGERE, P32; Bulte EH, 2005, CONSERV BIOL, V19, P1222, DOI 10.1111/j.1523-1739.2005.00149.x; Burn RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024165; Child B, 2012, S AFR J SCI, V108, P1, DOI 10.4102/sajs.v108i7/8.1338; CITES, 2011, 61 M STAND COMM GEN; CITES, 1992, 8 M COP KYT JAP 2 13, P16; Costello C, 2012, NATURE, V481, P139, DOI 10.1038/481139a; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Cussen M, 2000, AM J ECON SOCIOL, V59, P525, DOI 10.1111/1536-7150.00041; Daly B. G., 2011, PERSPECTIVE DEHORNIN; Damania R, 2007, ECOL ECON, V62, P461, DOI 10.1016/j.ecolecon.2006.07.007; Ferreira SM, 2012, PACHYDERM, P52; Ferreira SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045989; Fischer C, 2010, REV ENV ECON POLICY, V4, P103, DOI 10.1093/reep/rep023; IUCN, 2019, IUCN RED LIST THREAT; Leader-Williams N., 1992, WORLD TRADE RHINO HO; LINDSAY P., 2011, STUDY DEHORNING AFRI; Loh Jonathan, 1994, Traffic Bulletin, V14, P55; Marshall Leon, 2012, NEWSWATCH       1211; Martin R., 2012, LEGAL TRADE RHINO HO; Martin R. B., 2010, WHITE RHINO CONSERVA; Milliken T., 2009, AFRICAN ASIAN RHINOC; Milliken T., 2012, S AFRICA VIET NAM RH; MILNERGULLAND EJ, 1992, P ROY SOC B-BIOL SCI, V249, P83, DOI 10.1098/rspb.1992.0087; Nowell K, 2012, SPECIES TRADE CONSER; Peake D.A., 2012, DECISION MAKING MECH; Rivalan P, 2007, NATURE, V447, P529, DOI 10.1038/447529a; Ruggiero V., 1998, NEW EUROPEAN CRIMONO; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; Wasser S, 2010, SCIENCE, V327, P1331, DOI 10.1126/science.1187811; Webb G.W, 2002, CROC P 16 WORK M CRO, P1	32	154	155	1	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1038	1039		10.1126/science.1229998	http://dx.doi.org/10.1126/science.1229998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	097CQ	23449582				2022-12-24	WOS:000315452000026
J	Karpova, A; Mikhaylova, M; Bera, S; Bar, J; Reddy, PP; Behnisch, T; Rankovic, V; Spilker, C; Bethge, P; Sahin, J; Kaushik, R; Zuschratter, W; Kahne, T; Naumann, M; Gundelfinger, ED; Kreutz, MR				Karpova, Anna; Mikhaylova, Marina; Bera, Sujoy; Baer, Julia; Reddy, Pasham Parameshwar; Behnisch, Thomas; Rankovic, Vladan; Spilker, Christina; Bethge, Philipp; Sahin, Jale; Kaushik, Rahul; Zuschratter, Werner; Kaehne, Thilo; Naumann, Michael; Gundelfinger, Eckart D.; Kreutz, Michael R.			Encoding and Transducing the Synaptic or Extrasynaptic Origin of NMDA Receptor Signals to the Nucleus	CELL			English	Article							NEUROFILAMENT TRIPLET PROTEINS; CREB PHOSPHORYLATION; ALPHA-INTERNEXIN; TRANSLOCATION; ACTIVATION; EXPRESSION; PLASTICITY; SUBUNIT; PATHWAY; CASCADE	The activation of N-methyl-D-aspartate-receptors (NMDARs) in synapses provides plasticity and cell survival signals, whereas NMDARs residing in the neuronal membrane outside synapses trigger neuro-degeneration. At present, it is unclear how these opposing signals are transduced to and discriminated by the nucleus. In this study, we demonstrate that Jacob is a protein messenger that encodes the origin of synaptic versus extrasynaptic NMDAR signals and delivers them to the nucleus. Exclusively synaptic, but not extrasynaptic, NMDAR activation induces phosphorylation of Jacob at serine-180 by ERK1/2. Long-distance trafficking of Jacob from synaptic, but not extrasynaptic, sites depends on ERK activity, and association with fragments of the intermediate filament alpha-internexin hinders dephosphorylation of the Jacob/ERK complex during nuclear transit. In the nucleus, the phosphorylation state of Jacob determines whether it induces cell death or promotes cell survival and enhances synaptic plasticity.	[Karpova, Anna; Mikhaylova, Marina; Bera, Sujoy; Baer, Julia; Reddy, Pasham Parameshwar; Rankovic, Vladan; Spilker, Christina; Bethge, Philipp; Sahin, Jale; Kaushik, Rahul; Kreutz, Michael R.] Leibniz Inst Neurobiol, RG Neuroplast, D-39118 Magdeburg, Germany; [Zuschratter, Werner] Leibniz Inst Neurobiol, Special Lab Electron & Laserscanning Microscopy, D-39118 Magdeburg, Germany; [Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany; [Mikhaylova, Marina] Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands; [Behnisch, Thomas] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Behnisch, Thomas] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [Kaehne, Thilo; Naumann, Michael] Univ Magdeburg, Inst Expt Internal Med, D-39120 Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Utrecht University; Fudan University; Fudan University; Otto von Guericke University	Kreutz, MR (corresponding author), Leibniz Inst Neurobiol, RG Neuroplast, D-39118 Magdeburg, Germany.	kreutz@lin-magdeburg.de	Kaushik, Rahul/AAF-2376-2020; Behnisch, Thomas/G-3688-2018; Naumann, Michael/B-5285-2011; Kaehne, Thilo/E-4858-2012; Mikhaylova, Marina/AAM-4368-2020; Rankovic, Vladan/S-4353-2019	Kaushik, Rahul/0000-0002-4944-8549; Behnisch, Thomas/0000-0002-7842-3252; Naumann, Michael/0000-0002-8060-2313; Mikhaylova, Marina/0000-0001-7646-1346; Rankovic, Vladan/0000-0003-0285-5232; Spilker, Christina/0000-0002-7996-7673	DFG [SFB 779 TPB8, SFB854 TP7, TP4, TP8, GRK1167, Kr1879/3-1, TPZ]; DIP grant; EU FP7 MC-ITN NPlast; European Regional Development Fund (ERDF); Vorhaben: CBBS; NSFC [31271197]; Schram Foundation; European Molecular Biology Organization (EMBO) [EMBO ALTF 884-2011]; Marie Curie Actions (EMBOCOFUND) [GA-2010-267146]	DFG(German Research Foundation (DFG)); DIP grant; EU FP7 MC-ITN NPlast; European Regional Development Fund (ERDF)(European Commission); Vorhaben: CBBS; NSFC(National Natural Science Foundation of China (NSFC)); Schram Foundation; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Marie Curie Actions (EMBOCOFUND)	We want to thank C. Borutzki, M. Marunde, and S. Hochmuth for technical assistance; N. Ziv for helpful discussion; J. Lindquist for proofreading: M. Tsuda, A. Fejtova, D. Ivanova, J. Wiedemann, and U. Thomas for providing constructs; M. Hupe for assistance in alpha-internexin experiments; A. C. Lehmann for help with cloning; and Y. Chen and P. Yuan Xiang for assistance in electrophysiology. This work was supported by the DFG (SFB 779 TPB8 to M. R. K.; TPZ to T. K. and M. N.; SFB854 TP7 to M. R. K.; TP4 to M. N.; TP8 to E. D. G.; GRK1167 and Kr1879/3-1 to M. R. K.); DIP grant to E. D. G. and M. R. K.; EU FP7 MC-ITN NPlast to M. R. K.; European Regional Development Fund (ERDF 2007-2013); Vorhaben: CBBS to A. K. and C. S.; NSFC 31271197 to T. B.; and the Schram Foundation to M. R. K. M. M. is the recipient of a European Molecular Biology Organization (EMBO) long-term fellowship (EMBO ALTF 884-2011) and is supported by Marie Curie Actions (EMBOCOFUND2010, GA-2010-267146).	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Behnisch T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017276; Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; El Gaamouch F, 2012, J NEUROSCI, V32, P10767, DOI 10.1523/JNEUROSCI.5622-11.2012; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harris AZ, 2008, J NEUROPHYSIOL, V99, P524, DOI 10.1152/jn.01169.2007; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Jeffrey RA, 2009, J NEUROSCI, V29, P15613, DOI 10.1523/JNEUROSCI.3314-09.2009; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kindler S, 2009, J BIOL CHEM, V284, P25431, DOI 10.1074/jbc.M109.022137; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; Ronicke R, 2011, NEUROBIOL AGING, V32, P2219, DOI 10.1016/j.neurobiolaging.2010.01.011; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Wang CC, 2011, NEURON, V72, P789, DOI 10.1016/j.neuron.2011.09.023; Wiegert JS, 2007, J BIOL CHEM, V282, P29621, DOI 10.1074/jbc.M701448200; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011	36	136	136	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					1119	1133		10.1016/j.cell.2013.02.002	http://dx.doi.org/10.1016/j.cell.2013.02.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452857	Bronze			2022-12-24	WOS:000315710300018
J	Nathan, JA; Spinnenhim, V; Schmidtke, G; Basler, M; Groettrup, M; Goldberg, AL				Nathan, James A.; Spinnenhim, Valentina; Schmidtke, Gunter; Basler, Michael; Groettrup, Marcus; Goldberg, Alfred L.			Immuno- and Constitutive Proteasomes Do Not Differ in Their Abilities to Degrade Ubiquitinated Proteins	CELL			English	Article							26S PROTEASOMES; PEPTIDASE ACTIVITIES; OXIDATIVE-STRESS; TRIMS PRECURSORS; CELL-PROTEINS; INTERFERON; IMMUNOPROTEASOME; ISG15; AMINOPEPTIDASE; EXPRESSION	Immunoproteasomes are alternative forms of proteasomes that have an enhanced ability to generate antigenic peptides. Recently, Seifert and colleagues reported surprising observations concerning the functions of immunoproteasomes and cellular responses to interferon-gamma: (1) that immunoproteasomes degrade ubiquitinated proteins faster than the constitutive proteasomes, (2) that polyubiquitin conjugates accumulate after interferon-gamma treatment but then are preferentially degraded by immunoproteasomes, and (3) that immunoproteasome deficiency causes the formation of inclusions and more severe experimental autoimmune encephalomyelitis (EAE). In contrast, we find that polyubiquitin conjugates do not transiently accumulate following IFN gamma-treatment and that immunoproteasomes do not prevent the formation of intracellular inclusions or protect against EAE. Furthermore, purified 26S constitutive and immunoproteasomes bind ubiquitin conjugates similarly and degrade them at similar rates. We conclude that, although immunoproteasomes can increase the generation of peptides appropriate for MHC class I presentation, they do not degrade ubiquitinated proteins more efficiently than constitutive particles.	[Nathan, James A.; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Nathan, James A.] Addenbrookes Hosp, NIHR Cambridge Biomed Res Ctr, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Spinnenhim, Valentina; Schmidtke, Gunter; Basler, Michael; Groettrup, Marcus] Univ Konstanz, Dept Biol, Div Immunol, D-78457 Constance, Germany; [Basler, Michael; Groettrup, Marcus] Univ Konstanz, Biotechnol Inst Thurgau, CH-8280 Kreuzlingen, Switzerland	Harvard University; Harvard Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Konstanz	Groettrup, M (corresponding author), Univ Konstanz, Dept Biol, Div Immunol, D-78457 Constance, Germany.	marcus.groettrup@uni-konstanz.de; alfred_goldberg@hms.harvard.edu	Groettrup, Marcus/AAT-2623-2020	Basler, Michael/0000-0002-9428-2349; Nathan, James Alexander/0000-0002-0248-1632	National Institute of General Medical Sciences [5R01 GM51923]; ALS Association [K2Y740]; Fidelity Biosciences Research Initiative; German Research Foundation [GR 1517/12-1]; Swiss Multiple Sclerosis Society; Swiss National Science Foundation [31003A_138451]; Medical Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER; MRC [G0802822] Funding Source: UKRI; Medical Research Council [G0802822] Funding Source: researchfish	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ALS Association; Fidelity Biosciences Research Initiative; German Research Foundation(German Research Foundation (DFG)); Swiss Multiple Sclerosis Society; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	These studies were made possible by grants from the National Institute of General Medical Sciences (5R01 GM51923), the ALS Association (K2Y740), the Fidelity Biosciences Research Initiative, the German Research Foundation (GR 1517/12-1), the Swiss Multiple Sclerosis Society, and the Swiss National Science Foundation (31003A_138451). J. A. N. has been supported by the Medical Research Council with a Clinician Scientist Fellowship. V. S. is a member of the Konstanz Research School Chemical Biology. Confocal microscopy images were acquired at the Bioimaging Center of the University of Konstanz. We acknowledge that Ulrike Seifert and Peter-Michael Kloetzel, who supervised V. S. as a diploma student, agreed to the reference of the part of her diploma thesis work that is mentioned in this manuscript.	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Basler M, 2006, J IMMUNOL, V176, P6665, DOI 10.4049/jimmunol.176.11.6665; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Espejo C, 2002, EXP NEUROL, V177, P21, DOI 10.1006/exnr.2002.7982; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Frausto RF, 2007, J NEUROIMMUNOL, V192, P124, DOI 10.1016/j.jneuroim.2007.09.024; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; GROETTRUP M, 1995, J BIOL CHEM, V270, P23808, DOI 10.1074/jbc.270.40.23808; Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lam YA, 2005, METHOD ENZYMOL, V398, P379, DOI 10.1016/S0076-6879(05)98031-2; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; van Deventer S, 2010, CELL, V142, P517, DOI 10.1016/j.cell.2010.08.002; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	38	74	74	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					1184	1194		10.1016/j.cell.2013.01.037	http://dx.doi.org/10.1016/j.cell.2013.01.037			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452861	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000315710300023
J	Fan, Y; Li, H; Miguez-Macho, G				Fan, Y.; Li, H.; Miguez-Macho, G.			Global Patterns of Groundwater Table Depth	SCIENCE			English	Article							SPECIES DISTRIBUTION; WATER; FORESTS; VEGETATION; DIVERSITY; ECOLOGY; GROWTH; AMAZON; PLANTS; DRY	Shallow groundwater affects terrestrial ecosystems by sustaining river base-flow and root-zone soil water in the absence of rain, but little is known about the global patterns of water table depth and where it provides vital support for land ecosystems. We present global observations of water table depth compiled from government archives and literature, and fill in data gaps and infer patterns and processes using a groundwater model forced by modern climate, terrain, and sea level. Patterns in water table depth explain patterns in wetlands at the global scale and vegetation gradients at regional and local scales. Overall, shallow groundwater influences 22 to 32% of global land area, including similar to 15% as groundwater-fed surface water features and 7 to 17% with the water table or its capillary fringe within plant rooting depths.	[Fan, Y.; Li, H.] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08854 USA; [Miguez-Macho, G.] Univ Santiago de Compostela, Nonlinear Phys Grp, Fac Phys, Galicia, Spain	Rutgers State University New Brunswick; Universidade de Santiago de Compostela	Fan, Y (corresponding author), Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08854 USA.	yingfan@rci.rutgers.edu	Miguez-Macho, Gonzalo/AAA-3295-2019; Miguez-Macho, Gonzalo/K-7008-2017	Miguez-Macho, Gonzalo/0000-0002-4259-7883; Miguez-Macho, Gonzalo/0000-0002-4259-7883	U.S. National Science Foundation [NSF-AGS-1045110, NSF-OCE-10409088]; U.S. Environmental Protection Agency [EPA-STAR-RD834190]; European Commission FP7 (GLOWASIS); Rutgers University Board of Trustees [651201]; Climate Simulation Laboratory at NCAR's Computational and Information Systems Laboratory; National Science Foundation; Directorate For Geosciences [1049088] Funding Source: National Science Foundation; Div Atmospheric & Geospace Sciences [1045110] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); European Commission FP7 (GLOWASIS); Rutgers University Board of Trustees; Climate Simulation Laboratory at NCAR's Computational and Information Systems Laboratory; National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank many individuals for making and providing observations (full acknowledgement is in the supplementary materials) and P. Doll for providing recharge estimates. Funding comes from U.S. National Science Foundation (NSF-AGS-1045110 and NSF-OCE-10409088), U.S. Environmental Protection Agency (EPA-STAR-RD834190), European Commission FP7 (GLOWASIS), and a Rutgers University Board of Trustees grant (651201). Computation used the Extreme Science and Engineering Discovery Environment (XSEDE) supported by U.S. National Science Foundation (NSF-OCI-1053575) and the Climate Simulation Laboratory at NCAR's Computational and Information Systems Laboratory, sponsored by the National Science Foundation and other agencies. Observations, code, and model results are accessible at https://glowasis.deltares.nl/thredds/catalog/opendap/opendap/Equilibrium_Water_Table/catalog.html.	Arndt SK, 2004, OECOLOGIA, V141, P385, DOI 10.1007/s00442-004-1655-7; Bakker MR, 2006, PLANT SOIL, V286, P37, DOI 10.1007/s11104-006-9024-4; Bobrov AA, 1999, PROTIST, V150, P125, DOI 10.1016/S1434-4610(99)70016-7; Carter JL, 2009, TREE PHYSIOL, V29, P1407, DOI 10.1093/treephys/tpp076; Doll P, 2008, HYDROL EARTH SYST SC, V12, P863, DOI 10.5194/hess-12-863-2008; Dwire KA, 2006, WETLANDS, V26, P131, DOI 10.1672/0277-5212(2006)26[131:PSDIRT]2.0.CO;2; Elmore AJ, 2003, ECOL APPL, V13, P443, DOI 10.1890/1051-0761(2003)013[0443:RPOPCR]2.0.CO;2; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Fan Y, 2011, CLIM DYNAM, V37, P253, DOI 10.1007/s00382-010-0829-8; Faure H, 2002, GLOBAL PLANET CHANGE, V33, P47, DOI 10.1016/S0921-8181(02)00060-7; Giordano M, 2009, ANNU REV ENV RESOUR, V34, P153, DOI 10.1146/annurev.environ.030308.100251; Gleeson T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045565; Green TR, 2011, J HYDROL, V405, P532, DOI 10.1016/j.jhydrol.2011.05.002; Grogan James, 2006, Acta Amaz., V36, P483, DOI 10.1590/S0044-59672006000400009; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; HUGHES FMR, 1988, J BIOGEOGR, V15, P127, DOI 10.2307/2845053; Jirka S, 2007, J VEG SCI, V18, P183, DOI 10.1111/j.1654-1103.2007.tb02529.x; Jobbagy EG, 2011, ECOL APPL, V21, P678, DOI 10.1890/09-1427.1; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; MacDonald AM, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024009; Martre D. C., 1999, WATER SA, V25, P137; Miguez-Macho G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017540; Miguez-Macho G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017539; Mishra HS, 1999, IRRIGATION SCI, V18, P117, DOI 10.1007/s002710050052; Orellana F, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000383; Paine CET, 2009, J TROP ECOL, V25, P171, DOI 10.1017/S0266467408005798; Pelissier R, 2002, PLANT ECOL, V162, P143, DOI 10.1023/A:1020399603500; Rossatto DR, 2012, ENVIRON EXP BOT, V77, P259, DOI 10.1016/j.envexpbot.2011.11.025; Sobrado MA, 2010, J TROP ECOL, V26, P215, DOI 10.1017/S0266467409990538; Stave J, 2005, FOREST ECOL MANAG, V212, P367, DOI 10.1016/j.foreco.2005.03.023; Stromberg JC, 1996, ECOL APPL, V6, P113, DOI 10.2307/2269558; Taylor R. G., 2012, NAT CLIM CHANGE, V3; WINTER TC, 1998, 1139 USGS	33	559	578	39	568	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					940	943		10.1126/science.1229881	http://dx.doi.org/10.1126/science.1229881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430651				2022-12-24	WOS:000315149600044
J	Lee, Y; Rubio, MC; Alassimone, J; Geldner, N				Lee, Yuree; Rubio, Maria C.; Alassimone, Julien; Geldner, Niko			A Mechanism for Localized Lignin Deposition in the Endodermis	CELL			English	Article							CELL-WALL; HYDROGEN-PEROXIDE; SUPEROXIDE-DISMUTASE; EXTRACELLULAR-MATRIX; CROSS-LINKING; ARABIDOPSIS; ROS; EXPRESSION; PROTEIN; GROWTH	The precise localization of extracellular matrix and cell wall components is of critical importance for multicellular organisms. Lignin is a major cell wall modification that often forms intricate subcellular patterns that are central to cellular function. Yet the mechanisms of lignin polymerization and the subcellular precision of its formation remain enigmatic. Here, we show that the Casparian strip, a lignin-based, paracellular diffusion barrier in plants, forms as a precise, median ring by the concerted action of a specific, localized NADPH oxidase, brought into proximity of localized peroxidases through the action of Casparian strip domain proteins (CASPs). Our findings in Arabidopsis provide a simple mechanistic model of how plant cells regulate lignin formation with subcellular precision. We speculate that scaffolding of NADPH oxidases to the downstream targets of the reactive oxygen species (ROS) that they produce might be a widespread mechanism to ensure specificity and subcellular precision of ROS action within the extracellular matrix.	[Lee, Yuree; Rubio, Maria C.; Alassimone, Julien; Geldner, Niko] Univ Lausanne, Dept Plant Mol Biol, UNIL Sorge, CH-1015 Lausanne, Switzerland; [Rubio, Maria C.] CSIC, Dept Nutr Vegetal, Estn Expt Aula Dei, Zaragoza 50080, Spain	University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Aula Dei (EEAD)	Geldner, N (corresponding author), Univ Lausanne, Dept Plant Mol Biol, UNIL Sorge, Biophore Bldg, CH-1015 Lausanne, Switzerland.	niko.geldner@unil.ch	Geldner, Niko/Y-2481-2019; Rubio, Maria Carmen/L-6350-2014; Rubio-Gámez, M Carmen/U-8822-2019	Rubio, Maria Carmen/0000-0002-9378-7775; Rubio-Gámez, M Carmen/0000-0002-1874-5129; Alassimone, Julien/0000-0002-8118-2605; Lee, Yuree/0000-0002-4663-6974; Geldner, Niko/0000-0002-2300-9644	European Research Council; Swiss National Science Foundation; European Molecular Biology Organization long-term fellowship	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO))	We wish to thank M.A. Torres for providing mutant lines and P.N. Benfey for providing microarray data for analysis. We thank E.M.N. Dohmann, E.E. Farmer, S. Naseer, D.E. Salt, and J.E.M. Vermeer for critically reading the manuscript. This work was funded by a European Research Council Young Investigator grant and grants from the Swiss National Science Foundation to N.G. and a European Molecular Biology Organization long-term fellowship to Y.L. Electron microscopy and confocal microscopy were done using expertise and equipment of the Electron Microscopy Facility (EMF) and the Cellular Imaging Facility (CIF) at the University of Lausanne.	Alassimone J, 2010, P NATL ACAD SCI USA, V107, P5214, DOI 10.1073/pnas.0910772107; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Barcelo AR, 1998, PLANTA, V207, P207, DOI 10.1007/s004250050474; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berthet S, 2011, PLANT CELL, V23, P1124, DOI 10.1105/tpc.110.082792; Bestwick CS, 1997, PLANT CELL, V9, P209, DOI 10.1105/tpc.9.2.209; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Boisson-Dernier A, 2009, DEVELOPMENT, V136, P3279, DOI 10.1242/dev.040071; BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Fagerstedt KV, 2010, J INTEGR PLANT BIOL, V52, P186, DOI 10.1111/j.1744-7909.2010.00928.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Jammes F, 2009, P NATL ACAD SCI USA, V106, P20520, DOI 10.1073/pnas.0907205106; Jiang CF, 2012, EMBO J, V31, P4359, DOI 10.1038/emboj.2012.273; Karkonen A, 2010, J INTEGR PLANT BIOL, V52, P176, DOI 10.1111/j.1744-7909.2010.00913.x; Karlsson M, 2005, J EXP BOT, V56, P2085, DOI 10.1093/jxb/eri207; Karpinska B, 2001, PLANT PHYSIOL, V126, P1668, DOI 10.1104/pp.126.4.1668; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Liu CJ, 2012, MOL PLANT, V5, P304, DOI 10.1093/mp/ssr121; Martiniere A, 2011, PLANT J, V66, P354, DOI 10.1111/j.1365-313X.2011.04497.x; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Miyazaki S, 2009, CURR BIOL, V19, P1327, DOI 10.1016/j.cub.2009.06.064; Moller IM, 2010, TRENDS PLANT SCI, V15, P370, DOI 10.1016/j.tplants.2010.04.008; Monshausen GB, 2007, P NATL ACAD SCI USA, V104, P20996, DOI 10.1073/pnas.0708586104; Moribe H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002957; Naseer S, 2012, P NATL ACAD SCI USA, V109, P10101, DOI 10.1073/pnas.1205726109; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Oda Y, 2012, SCIENCE, V337, P1333, DOI 10.1126/science.1222597; Oda Y, 2012, CURR OPIN PLANT BIOL, V15, P38, DOI 10.1016/j.pbi.2011.10.005; Pesquet E, 2010, CURR BIOL, V20, P744, DOI 10.1016/j.cub.2010.02.057; Roppolo D, 2011, NATURE, V473, P380, DOI 10.1038/nature10070; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Swanson S, 2010, PHYSIOL PLANTARUM, V138, P384, DOI 10.1111/j.1399-3054.2009.01313.x; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; Vanholme R, 2010, TRENDS BIOTECHNOL, V28, P543, DOI 10.1016/j.tibtech.2010.07.008	42	317	328	3	170	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					402	412		10.1016/j.cell.2013.02.045	http://dx.doi.org/10.1016/j.cell.2013.02.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23541512	Bronze, Green Submitted			2022-12-24	WOS:000317349700018
J	Brunton, BW; Botvinick, MM; Brody, CD				Brunton, Bingni W.; Botvinick, Matthew M.; Brody, Carlos D.			Rats and Humans Can Optimally Accumulate Evidence for Decision-Making	SCIENCE			English	Article							DRIFT-DIFFUSION MODEL; VISUAL FIXATIONS; AUDITORY-CORTEX; CHOICE; ACCURACY; TIME; DISCRIMINATION; SPEED; INTEGRATION; REFLECTS	The gradual and noisy accumulation of evidence is a fundamental component of decision-making, with noise playing a key role as the source of variability and errors. However, the origins of this noise have never been determined. We developed decision-making tasks in which sensory evidence is delivered in randomly timed pulses, and analyzed the resulting data with models that use the richly detailed information of each trial's pulse timing to distinguish between different decision-making mechanisms. This analysis allowed measurement of the magnitude of noise in the accumulator's memory, separately from noise associated with incoming sensory evidence. In our tasks, the accumulator's memory was noiseless, for both rats and humans. In contrast, the addition of new sensory evidence was the primary source of variability. We suggest our task and modeling approach as a powerful method for revealing internal properties of decision-making processes.	[Brunton, Bingni W.; Botvinick, Matthew M.; Brody, Carlos D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Brunton, Bingni W.; Brody, Carlos D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Botvinick, Matthew M.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Brody, Carlos D.] Howard Hughes Med Inst, Chevy Chase, MD USA	Princeton University; Princeton University; Princeton University; Howard Hughes Medical Institute	Brody, CD (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	brody@princeton.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Brunton B. W., 2009, ANN M SOC NEUR CHIC; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Krajbich I, 2011, P NATL ACAD SCI USA, V108, P13852, DOI 10.1073/pnas.1101328108; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Link SW, 1992, WAVE THEORY DIFFEREN; MacKay D. J. C., 2003, INFORM THEORY INFERE; Milosavljevic M, 2010, JUDGM DECIS MAK, V5, P437; Neri P, 1999, NATURE, V401, P695, DOI 10.1038/44409; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Paninski L, 2004, NEURAL COMPUT, V16, P2533, DOI 10.1162/0899766042321797; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Sanders JI, 2012, J NEUROPHYSIOL, V108, P3416, DOI 10.1152/jn.00669.2012; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Zariwala H., 2007, THESIS STONY BROOK U	28	312	313	6	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					95	98		10.1126/science.1233912	http://dx.doi.org/10.1126/science.1233912			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559254				2022-12-24	WOS:000317061100054
J	Ko, H; Cossell, L; Baragli, C; Antolik, J; Clopath, C; Hofer, SB; Mrsic-Flogel, TD				Ko, Ho; Cossell, Lee; Baragli, Chiara; Antolik, Jan; Clopath, Claudia; Hofer, Sonja B.; Mrsic-Flogel, Thomas D.			The emergence of functional microcircuits in visual cortex	NATURE			English	Article							BIDIRECTIONAL SYNAPTIC PLASTICITY; RECEPTIVE-FIELDS; CORTICAL-NEURONS; ORIENTATION SELECTIVITY; HORIZONTAL CONNECTIONS; PYRAMIDAL NEURONS; STRIATE CORTEX; IN-VIVO; NETWORKS; MODEL	Sensory processing occurs in neocortical microcircuits in which synaptic connectivity is highly structured(1-4) and excitatory neurons form subnetworks that process related sensory information(5,6). However, the developmental mechanisms underlying the formation of functionally organized connectivity in cortical microcircuits remain unknown. Here we directly relate patterns of excitatory synaptic connectivity to visual response properties of neighbouring layer 2/3 pyramidal neurons in mouse visual cortex at different postnatal ages, using two-photon calcium imaging in vivo and multiple whole-cell recordings in vitro. Although neural responses were already highly selective for visual stimuli at eye opening, neurons responding to similar visual features were not yet preferentially connected, indicating that the emergence of feature selectivity does not depend on the precise arrangement of local synaptic connections. After eye opening, local connectivity reorganized extensively: more connections formed selectively between neurons with similar visual responses and connections were eliminated between visually unresponsive neurons, but the overall connectivity rate did not change. We propose a sequential model of cortical microcircuit development based on activity-dependent mechanisms of plasticity whereby neurons first acquire feature preference by selecting feedforward inputs before the onset of sensory experience-a process that may be facilitated by early electrical coupling between neuronal subsets(7-9)-and then patterned input drives the formation of functional subnetworks through a redistribution of recurrent synaptic connections.	[Ko, Ho; Cossell, Lee; Baragli, Chiara; Antolik, Jan; Hofer, Sonja B.; Mrsic-Flogel, Thomas D.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6DE, England; [Clopath, Claudia] Columbia Univ, Ctr Theoret Neurosci, New York, NY 10032 USA	University of London; University College London; Columbia University	Hofer, SB (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, 21 Univ St, London WC1E 6DE, England.	s.hofer@ucl.ac.uk; t.mrsic-flogel@ucl.ac.uk	Ko, Ho/AAH-2755-2020; Ko, Ho/I-7513-2016; Antolík, Ján/ABA-4973-2021	Ko, Ho/0000-0002-0254-3274; Ko, Ho/0000-0002-0254-3274; Antolík, Ján/0000-0002-7223-4426; Hofer, Sonja/0000-0003-4921-8521; Mrsic-Flogel, Tom/0000-0002-8947-408X	Wellcome Trust; Medical Research Council; European Research Council; 7th Framework of European Commission 'EuroV1sion' grant; Swiss National Science Foundation [PA00P3_139703]	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); 7th Framework of European Commission 'EuroV1sion' grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank C. Akerman, D. Attwell, R. Froemke, M. Hausser, C. Levelt, C. Lohmann, T. Margrie, J. Sjostrom and members of the Mrsic-Flogel laboratory for advice and comments on the manuscript. We thank D. Farquarson, D. Halpin, A. Hogben of the University College London machine shop for custom parts. The work was supported by the Wellcome Trust (T.D.M.-F., S. B. H., C. B.), the Medical Research Council (L. C.), the European Research Council and the 7th Framework of European Commission 'EuroV1sion' grant (T.D.M.-F.), and the Swiss National Science Foundation (C. C., grant no. PA00P3_139703).	Agresti A., 2002, CATEGORICAL DATA ANA, P181; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Badel L, 2008, J NEUROPHYSIOL, V99, P656, DOI 10.1152/jn.01107.2007; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; CALLAWAY EM, 1990, J NEUROSCI, V10, P1134; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Frick A, 2007, J PHYSIOL-LONDON, V585, P103, DOI 10.1113/jphysiol.2007.141788; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Innocenti GM, 2005, NAT REV NEUROSCI, V6, P955, DOI 10.1038/nrn1790; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; O'Connor DH, 2005, J NEUROPHYSIOL, V94, P1565, DOI 10.1152/jn.00047.2005; Ohtsuki G, 2012, NEURON, V75, P65, DOI 10.1016/j.neuron.2012.05.023; Ostojic S, 2009, J COMPUT NEUROSCI, V26, P369, DOI 10.1007/s10827-008-0117-3; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Purves D, 1996, TRENDS NEUROSCI, V19, P460, DOI 10.1016/S0166-2236(96)20038-4; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2004, J PHYSIOL-LONDON, V558, P717, DOI 10.1113/jphysiol.2004.065771; Rochefort NL, 2011, NEURON, V71, P425, DOI 10.1016/j.neuron.2011.06.013; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; Smyth D, 2003, J NEUROSCI, V23, P4746; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379	47	249	250	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					96	+		10.1038/nature12015	http://dx.doi.org/10.1038/nature12015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23552948	Green Accepted			2022-12-24	WOS:000316993400032
J	Kim, HJ; Kim, NC; Wang, YD; Scarborough, EA; Moore, J; Diaz, Z; MacLea, KS; Freibaum, B; Li, SQ; Molliex, A; Kanagaraj, AP; Carter, R; Boylan, KB; Wojtas, AM; Rademakers, R; Pinkus, JL; Greenberg, SA; Trojanowski, JQ; Traynor, BJ; Smith, BN; Topp, S; Gkazi, AS; Miller, J; Shaw, CE; Kottlors, M; Kirschner, J; Pestronk, A; Li, YR; Ford, AF; Gitler, AD; Benatar, M; King, OD; Kimonis, VE; Ross, ED; Weihl, CC; Shorter, J; Taylor, JP				Kim, Hong Joo; Kim, Nam Chul; Wang, Yong-Dong; Scarborough, Emily A.; Moore, Jennifer; Diaz, Zamia; MacLea, Kyle S.; Freibaum, Brian; Li, Songqing; Molliex, Amandine; Kanagaraj, Anderson P.; Carter, Robert; Boylan, Kevin B.; Wojtas, Aleksandra M.; Rademakers, Rosa; Pinkus, Jack L.; Greenberg, Steven A.; Trojanowski, John Q.; Traynor, Bryan J.; Smith, Bradley N.; Topp, Simon; Gkazi, Athina-Soragia; Miller, Jack; Shaw, Christopher E.; Kottlors, Michael; Kirschner, Janbernd; Pestronk, Alan; Li, Yun R.; Ford, Alice Flynn; Gitler, Aaron D.; Benatar, Michael; King, Oliver D.; Kimonis, Virginia E.; Ross, Eric D.; Weihl, Conrad C.; Shorter, James; Taylor, J. Paul			Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS	NATURE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA-BINDING PROTEINS; DROSOPHILA MODEL; SACCHAROMYCES-CEREVISIAE; FRONTOTEMPORAL DEMENTIA; MULTIPLE ALIGNMENT; STRESS GRANULES; VCP MUTATIONS; TDP-43; DISEASE	Algorithms designed to identify canonical yeast prions predict that around 250 human proteins, including several RNA-binding proteins associated with neurodegenerative disease, harbour a distinctive prion-like domain (PrLD) enriched in uncharged polar amino acids and glycine. PrLDs in RNA-binding proteins are essential for the assembly of ribonucleoprotein granules. However, the interplay between human PrLD function and disease is not understood. Here we define pathogenic mutations in PrLDs of heterogeneous nuclear ribonucleoproteins (hnRNPs) A2B1 and A1 in families with inherited degeneration affecting muscle, brain, motor neuron and bone, and in one case of familial amyotrophic lateral sclerosis. Wild-type hnRNPA2 (the most abundant isoform of hnRNPA2B1) and hnRNPA1 show an intrinsic tendency to assemble into self-seeding fibrils, which is exacerbated by the disease mutations. Indeed, the pathogenic mutations strengthen a 'steric zipper' motif in the PrLD, which accelerates the formation of self-seeding fibrils that cross-seed polymerization of wild-type hnRNP. Notably, the disease mutations promote excess incorporation of hnRNPA2 and hnRNPA1 into stress granules and drive the formation of cytoplasmic inclusions in animal models that recapitulate the human pathology. Thus, dysregulated polymerization caused by a potent mutant steric zipper motif in a PrLD can initiate degenerative disease. Related proteins with PrLDs should therefore be considered candidates for initiating and perhaps propagating proteinopathies of muscle, brain, motor neuron and bone.	[Kim, Hong Joo; Kim, Nam Chul; Moore, Jennifer; Freibaum, Brian; Li, Songqing; Molliex, Amandine; Kanagaraj, Anderson P.; Taylor, J. Paul] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38120 USA; [Wang, Yong-Dong] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38120 USA; [Scarborough, Emily A.; Diaz, Zamia; Ford, Alice Flynn; Shorter, James] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [MacLea, Kyle S.; Ross, Eric D.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Carter, Robert] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38120 USA; [Boylan, Kevin B.; Wojtas, Aleksandra M.; Rademakers, Rosa] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Pinkus, Jack L.; Greenberg, Steven A.] Harvard Univ, Brigham & Womens Hosp, Dept Neurol, Sch Med, Boston, MA 02115 USA; [Trojanowski, John Q.; Smith, Bradley N.] Univ Penn, Dept Pathol & Lab Med, Inst Aging, Philadelphia, PA 19104 USA; [Trojanowski, John Q.; Smith, Bradley N.] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Philadelphia, PA 19104 USA; [Traynor, Bryan J.] NIA, Neuromuscular Dis Res Grp, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Topp, Simon; Gkazi, Athina-Soragia; Miller, Jack; Shaw, Christopher E.] Kings Coll London, Ctr Neurodegenerat Res, Dept Clin Neurosci, Inst Psychiat, London SE5 8AF, England; [Kottlors, Michael; Kirschner, Janbernd] Univ Childrens Hosp Freiburg, Div Neuropediat & Muscle Disorders, D-79106 Freiburg, Germany; [Pestronk, Alan; Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Li, Yun R.] Univ Penn, Med Sci Training Program, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gitler, Aaron D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Benatar, Michael] Univ Miami, Neurol Dept, Miller Sch Med, Miami, FL 33136 USA; [King, Oliver D.] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Kimonis, Virginia E.] Univ Calif Irvine, Dept Pediat, Div Genet & Metab, Irvine, CA 92696 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Colorado State University; St Jude Children's Research Hospital; Mayo Clinic; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; King's College London; University of Freiburg; Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; Stanford University; University of Miami; Boston Biomedical Research Institute; University of California System; University of California Irvine	Taylor, JP (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38120 USA.	jshorter@mail.med.upenn.edu; JPaul.Taylor@STJUDE.ORG	KANAGARAJ, A/GZG-4720-2022; Smith, Bradley/H-6107-2013; Benatar, Michael/AAF-6605-2019; Taylor, J. Paul/N-2482-2018; Kirschner, Janbernd/Q-1493-2019; MacLea, Kyle/S-3269-2019; Shorter, James/ABE-7307-2020; Wang, Yong-Dong/K-3563-2013; Kirschner, Janbernd/H-7418-2016; Traynor, Bryan J/G-5690-2010	Benatar, Michael/0000-0003-4241-5135; Taylor, J. Paul/0000-0002-5794-0349; Kirschner, Janbernd/0000-0003-1618-7386; MacLea, Kyle/0000-0001-7086-1074; Shorter, James/0000-0001-5269-8533; Kirschner, Janbernd/0000-0003-1618-7386; Ross, Eric/0000-0002-6473-9977; Shaw, Christopher/0000-0003-0251-0146; Kim, Hong Joo/0000-0002-9157-1612; Li, Yun Rose/0000-0002-8077-4975; Kim, Nam Chul/0000-0003-1332-3071; Gitler, Aaron/0000-0001-8603-1526; , Palsamy Kanagaraj/0000-0003-3297-3125; topp, simon/0000-0002-5200-3284	ALSAC; Packard Foundation; National Institutes of Health (NIH) [NS053825]; ALS Association; NIH [AG032953, DP2OD002177, NS067354, AG031867]; Ellison Medical Foundation; National Science Foundation [MCB-1023771]; Direct For Biological Sciences [1023771] Funding Source: National Science Foundation; MRC [G0900688, MC_G1000733] Funding Source: UKRI; Medical Research Council [MC_G1000733, G0500289B, G0900688] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067354, R01NS053825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG032953, R01AG031867, ZIAAG000933, K02AG042095] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002177] Funding Source: NIH RePORTER	ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); Packard Foundation(The David & Lucile Packard Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the patients whose participation made this work possible. We thank the St Jude Pediatric Cancer Genome Project and J. Zhang in particular for providing access to control sequencing data. We thank C. Gellera, B. Baloh, M. Harms, S. Krause, G. Dreyfuss and T. Cundy for sharing reagents. We thank S. Donkervoort and S. Mumm for coordinating samples, and A. Taylor for editorial assistance. J.P.T. was supported by ALSAC, the Packard Foundation and the National Institutes of Health (NIH) (NS053825); J.P.T. and M. B. were supported by the ALS Association; J.Q.T. was supported by the NIH (AG032953); J.S. was supported by the NIH (DP2OD002177 and NS067354) and the Ellison Medical Foundation; E. D. R. was supported by the National Science Foundation (MCB-1023771). C. C. W. was supported by the NIH (AG031867).	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Chung PYJ, 2011, MOL GENET METAB, V103, P287, DOI 10.1016/j.ymgme.2011.03.021; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Goode MG, 2007, BIOINFORMATICS, V23, P1553, DOI 10.1093/bioinformatics/btm128; Guthrie C., 2002, METHODS EZYMOLOGY GU, V169; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kottlors M, 2010, J NEUROL SCI, V291, P79, DOI 10.1016/j.jns.2009.12.008; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Nalbandian A, 2011, J MOL NEUROSCI, V45, P522, DOI 10.1007/s12031-011-9627-y; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Neumann M, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001136; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; Ross CD, 2009, GENETICS, V183, P929, DOI 10.1534/genetics.109.109322; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Salajegheh M, 2009, MUSCLE NERVE, V40, P19, DOI 10.1002/mus.21386; Shi Z, 2012, EUR J NEUROL, V19, P501, DOI 10.1111/j.1468-1331.2011.03575.x; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Zwickl D., 2006, GARLI GENETIC ALGORI	37	933	953	6	296	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					467	+		10.1038/nature11922	http://dx.doi.org/10.1038/nature11922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23455423	Green Submitted, Green Accepted			2022-12-24	WOS:000316682800037
J	Parks, JM; Johs, A; Podar, M; Bridou, R; Hurt, RA; Smith, SD; Tomanicek, SJ; Qian, Y; Brown, SD; Brandt, CC; Palumbo, AV; Smith, JC; Wall, JD; Elias, DA; Liang, LY				Parks, Jerry M.; Johs, Alexander; Podar, Mircea; Bridou, Romain; Hurt, Richard A., Jr.; Smith, Steven D.; Tomanicek, Stephen J.; Qian, Yun; Brown, Steven D.; Brandt, Craig C.; Palumbo, Anthony V.; Smith, Jeremy C.; Wall, Judy D.; Elias, Dwayne A.; Liang, Liyuan			The Genetic Basis for Bacterial Mercury Methylation	SCIENCE			English	Article							SP NOV.; PRINCIPAL METHYLATORS; REDUCING BACTERIA; ACETYL-COENZYME; GEN. NOV.; SULFATE; METHYLTETRAHYDROFOLATE; PATHWAYS; ELECTRON; ACETATE	Methylmercury is a potent neurotoxin produced in natural environments from inorganic mercury by anaerobic bacteria. However, until now the genes and proteins involved have remained unidentified. Here, we report a two-gene cluster, hgcA and hgcB, required for mercury methylation by Desulfovibrio desulfuricans ND132 and Geobacter sulfurreducens PCA. In either bacterium, deletion of hgcA, hgcB, or both genes abolishes mercury methylation. The genes encode a putative corrinoid protein, HgcA, and a 2[4Fe-4S] ferredoxin, HgcB, consistent with roles as a methyl carrier and an electron donor required for corrinoid cofactor reduction, respectively. Among bacteria and archaea with sequenced genomes, gene orthologs are present in confirmed methylators but absent in nonmethylators, suggesting a common mercury methylation pathway in all methylating bacteria and archaea sequenced to date.	[Parks, Jerry M.; Podar, Mircea; Hurt, Richard A., Jr.; Brown, Steven D.; Brandt, Craig C.; Palumbo, Anthony V.; Smith, Jeremy C.; Elias, Dwayne A.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Johs, Alexander; Tomanicek, Stephen J.; Qian, Yun; Liang, Liyuan] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Podar, Mircea] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Bridou, Romain; Smith, Steven D.; Wall, Judy D.] Univ Missouri, Div Biochem, Columbia, MO 65211 USA; [Brown, Steven D.; Smith, Jeremy C.; Elias, Dwayne A.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Missouri System; University of Missouri Columbia; University of Tennessee System; University of Tennessee Knoxville	Elias, DA (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	eliasda@ornl.gov; liangl@ornl.gov	Elias, Dwayne/GZL-8202-2022; Parks, Jerry M./B-7488-2009; smith, jeremy c/B-7287-2012; Johs, Alexander/F-1229-2011; Elias, Dwayne A/B-5190-2011; Brown, Steven D/A-6792-2011; Palumbo, Anthony V/A-4764-2011; Bridou, Romain/S-2454-2016; Liang, Liyuan/O-7213-2014; Podar, Mircea/B-7299-2012	Parks, Jerry M./0000-0002-3103-9333; smith, jeremy c/0000-0002-2978-3227; Johs, Alexander/0000-0003-0098-2254; Elias, Dwayne A/0000-0002-4469-6391; Brown, Steven D/0000-0002-9281-3898; Palumbo, Anthony V/0000-0002-1102-3975; Liang, Liyuan/0000-0003-1338-0324; Podar, Mircea/0000-0003-2776-0205	U.S. Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research, through the Mercury Scientific Focus Area Program at Oak Ridge National Laboratory (ORNL); DOE [DE-AC05-00OR22725]	U.S. Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research, through the Mercury Scientific Focus Area Program at Oak Ridge National Laboratory (ORNL)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	We thank S. Miller, C. Gilmour, and T. Barkay for helpful discussions, and K. Rush, X. Yin, G. Christensen, and Q. Gui for experimental assistance. Supported by the U.S. Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research, through the Mercury Scientific Focus Area Program at Oak Ridge National Laboratory (ORNL). ORNL is managed by UT Battelle, LLC, for DOE under contract DE-AC05-00OR22725. All other data are available online in the supplementary materials. Author contributions: J.M.P., A.J., R. B., J.C.S., A. V. P., D. A. E., S. D. B., M. P., J.D.W., and L. L. designed the research. M. P., S. D. B., and C. C. B. performed the comparative genomic analyses. A.J. and J.M.P. performed the bioinformatics and biochemical interpretations. R. B., R. A. H., S. D. S., S.J.T., A.J., and Y.Q. performed the experiments. J.M.P., A.J., R. B., J.C.S., D. A. E., J.D.W., and L.L. wrote the paper.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Brown SD, 2011, J BACTERIOL, V193, P2078, DOI 10.1128/JB.00170-11; Cardiano P, 2011, J CHEM ENG DATA, V56, P4741, DOI 10.1021/je200735r; CHOI SC, 1994, APPL ENVIRON MICROB, V60, P1342, DOI 10.1128/AEM.60.4.1342-1346.1994; CHOI SC, 1994, APPL ENVIRON MICROB, V60, P4072, DOI 10.1128/AEM.60.11.4072-4077.1994; COMPEAU GC, 1985, APPL ENVIRON MICROB, V50, P498, DOI 10.1128/AEM.50.2.498-502.1985; DESIMONE RE, 1973, BIOCHIM BIOPHYS ACTA, V304, P851, DOI 10.1016/0304-4165(73)90232-8; Doukov T, 2000, STRUCTURE, V8, P817, DOI 10.1016/S0969-2126(00)00172-6; Doukov TI, 2002, SCIENCE, V298, P567, DOI 10.1126/science.1075843; DRAKE HL, 1981, J BIOL CHEM, V256, P1137; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; Ekstrom EB, 2003, APPL ENVIRON MICROB, V69, P5414, DOI 10.1128/AEM.69.9.5414-5422.2003; Fleming EJ, 2006, APPL ENVIRON MICROB, V72, P457, DOI 10.1128/AEM.72.1.457-464.2006; GILMOUR CC, 1992, ENVIRON SCI TECHNOL, V26, P2281, DOI 10.1021/es00035a029; Gilmour CC, 2011, APPL ENVIRON MICROB, V77, P3938, DOI 10.1128/AEM.02993-10; Goetzl S, 2011, J MOL BIOL, V411, P96, DOI 10.1016/j.jmb.2011.05.025; Hamelin S, 2011, ENVIRON SCI TECHNOL, V45, P7693, DOI 10.1021/es2010072; HILL HAO, 1970, J CHEM SOC CHEM COMM, P341, DOI 10.1039/c29700000341; Hintelmann H, 2010, METAL IONS LIFE SCI, V7, P365, DOI 10.1039/BK9781847551771-00365; Kerin EJ, 2006, APPL ENVIRON MICROB, V72, P7919, DOI 10.1128/AEM.01602-06; Kung Y, 2012, NATURE, V484, P265, DOI 10.1038/nature10916; RAGSDALE SW, 1987, J BIOL CHEM, V262, P14289; Ranchou-Peyruse M, 2009, GEOMICROBIOL J, V26, P1, DOI 10.1080/01490450802599227; Schaefer JK, 2011, P NATL ACAD SCI USA, V108, P8714, DOI 10.1073/pnas.1105781108; SCHRAUZE.GN, 1970, J AM CHEM SOC, V92, P3509, DOI 10.1021/ja00714a070; Slobodkina GB, 2012, INT J SYST EVOL MICR, V62, P2463, DOI 10.1099/ijs.0.038372-0; Svetlitchnaia T, 2006, P NATL ACAD SCI USA, V103, P14331, DOI 10.1073/pnas.0601420103; WOOD JM, 1968, NATURE, V220, P173, DOI 10.1038/220173a0; WOOD JM, 1974, SCIENCE, V183, P1049, DOI 10.1126/science.183.4129.1049; Yu RQ, 2012, ENVIRON SCI TECHNOL, V46, P2684, DOI 10.1021/es2033718; Zhang GS, 2008, APPL ENVIRON MICROB, V74, P6114, DOI 10.1128/AEM.01146-08	31	563	593	60	847	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2013	339	6125					1332	1335		10.1126/science.1230667	http://dx.doi.org/10.1126/science.1230667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23393089				2022-12-24	WOS:000316053400041
J	Karatas, H; Erdener, SE; Gursoy-Ozdemir, Y; Lule, S; Eren-Kocak, E; Sen, ZD; Dalkara, T				Karatas, Hulya; Erdener, Sefik Evren; Gursoy-Ozdemir, Yasemin; Lule, Sevda; Eren-Kocak, Emine; Sen, Zumrut Duygu; Dalkara, Turgay			Spreading Depression Triggers Headache by Activating Neuronal Panx1 Channels	SCIENCE			English	Article							MENINGEAL NOCICEPTORS; CHROMATIN PROTEIN; MIGRAINE AURA; EXPRESSION; HMGB1; MECHANISMS; PAIN; DEGRANULATION; SENSITIZATION; INFLAMMASOME	The initial phase in the development of a migraine is still poorly understood. Here, we describe a previously unknown signaling pathway between stressed neurons and trigeminal afferents during cortical spreading depression (CSD), the putative cause of migraine aura and headache. CSD caused neuronal Pannexin1 (Panx1) megachannel opening and caspase-1 activation followed by high-mobility group box 1 (HMGB1) release from neurons and nuclear factor kappa B activation in astrocytes. Suppression of this cascade abolished CSD-induced trigeminovascular activation, dural mast cell degranulation, and headache. CSD-induced neuronal megachannel opening may promote sustained activation of trigeminal afferents via parenchymal inflammatory cascades reaching glia limitans. This pathway may function to alarm an organism with headache when neurons are stressed.	[Karatas, Hulya; Erdener, Sefik Evren; Gursoy-Ozdemir, Yasemin; Lule, Sevda; Eren-Kocak, Emine; Sen, Zumrut Duygu; Dalkara, Turgay] Hacettepe Univ, Inst Neurol Sci & Psychiat, TR-06100 Ankara, Turkey; [Karatas, Hulya; Erdener, Sefik Evren; Gursoy-Ozdemir, Yasemin; Dalkara, Turgay] Hacettepe Univ, Dept Neurol, Fac Med, TR-06100 Ankara, Turkey; [Eren-Kocak, Emine; Sen, Zumrut Duygu] Hacettepe Univ, Dept Psychiat, Fac Med, TR-06100 Ankara, Turkey	Hacettepe University; Hacettepe University; Hacettepe University	Dalkara, T (corresponding author), Hacettepe Univ, Inst Neurol Sci & Psychiat, TR-06100 Ankara, Turkey.	tdalkara@hacettepe.edu.tr	Lule, Sevda/N-8229-2017; Karatas, Hulya/J-1459-2013; Gursoy-Ozdemir, Yasemin/X-2778-2019; ERDENER, SEFIK EVREN/I-9202-2013; Erdener, Sefik Evren/B-2924-2014	Lule, Sevda/0000-0001-7066-6471; Karatas, Hulya/0000-0003-4838-6320; Gursoy-Ozdemir, Yasemin/0000-0002-0860-8964; ERDENER, SEFIK EVREN/0000-0002-5141-7899; Erdener, Sefik Evren/0000-0002-5141-7899; Dalkara, Turgay/0000-0003-3943-7819	Turkish Academy of Sciences; Hacettepe University Research Fund [08-D07-101-011]; Brain Research Association	Turkish Academy of Sciences(Turkish Academy of Sciences); Hacettepe University Research Fund(Hacettepe University); Brain Research Association	We are grateful to M. A. Moskowitz for helpful discussions, K. Kilic and E. Lule for their expert help with the figures, and to A. Can for his help with confocal microscopy. This work was supported by the Turkish Academy of Sciences (T. D.), Hacettepe University Research Fund 08-D07-101-011 (Y.G.-O.), and the Brain Research Association (H. K.).	Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Dalkara T, 2006, NEUROL SCI, V27, pS86, DOI 10.1007/s10072-006-0577-z; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Goadsby PJ, 2007, TRENDS MOL MED, V13, P39, DOI 10.1016/j.molmed.2006.11.005; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Jander S, 2001, J CEREBR BLOOD F MET, V21, P218, DOI 10.1097/00004647-200103000-00005; Kunkler PE, 2004, J CEREBR BLOOD F MET, V24, P829, DOI 10.1097/01.WCB.0000126566.34753.30; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Levy D, 2007, PAIN, V130, P166, DOI 10.1016/j.pain.2007.03.012; Levy D, 2012, CURR PAIN HEADACHE R, V16, P270, DOI 10.1007/s11916-012-0255-1; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; MARKOWITZ S, 1989, BRAIN RES, V477, P157, DOI 10.1016/0006-8993(89)91403-0; MOSKOWITZ MA, 1984, ANN NEUROL, V16, P157, DOI 10.1002/ana.410160202; MOSKOWITZ MA, 1993, J NEUROSCI, V13, P1167, DOI 10.1523/jneurosci.13-03-01167.1993; Moskowitz MA, 2008, HEADACHE, V48, P688, DOI 10.1111/j.1526-4610.2008.01110.x; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; OLESEN J, 1990, ANN NEUROL, V28, P791, DOI 10.1002/ana.410280610; Olesen J, 2009, LANCET NEUROL, V8, P679, DOI 10.1016/S1474-4422(09)70090-0; Pedrazzi M, 2007, J IMMUNOL, V179, P8525, DOI 10.4049/jimmunol.179.12.8525; Pisetsky DS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2440; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Strassman AM, 1996, NATURE, V384, P560, DOI 10.1038/384560a0; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Zhang XC, 2011, ANN NEUROL, V69, P855, DOI 10.1002/ana.22329; Zhang XC, 2010, J NEUROSCI, V30, P8807, DOI 10.1523/JNEUROSCI.0511-10.2010	29	301	304	6	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1092	1095		10.1126/science.1231897	http://dx.doi.org/10.1126/science.1231897			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449592				2022-12-24	WOS:000315452000046
J	Collins, JJ; Wang, B; Lambrus, BG; Tharp, ME; Iyer, H; Newmark, PA				Collins, James J., III; Wang, Bo; Lambrus, Bramwell G.; Tharp, Marla E.; Iyer, Harini; Newmark, Phillip A.			Adult somatic stem cells in the human parasite Schistosoma mansoni	NATURE			English	Article							DNA-SYNTHESIS; PLANARIAN; REGENERATION; GROWTH; PLURIPOTENCY; REGULATORS; GENOME; MODEL; SEX	Schistosomiasis is among the most prevalent human parasitic diseases, affecting more than 200 million people worldwide(1). The aetiological agents of this disease are trematode flatworms (Schistosoma) that live and lay eggs within the vasculature of the host. These eggs lodge in host tissues, causing inflammatory responses that are the primary cause of morbidity. Because these parasites can live and reproduce within human hosts for decades', elucidating the mechanisms that promote their longevity is of fundamental importance. Although adult pluripotent stem cells, called neoblasts, drive long-term homeostatic tissue maintenance in long-lived free-living flatworms(3,4) (for example, planarians), and neoblast-like cells have been described in some parasitic tapeworms', little is known about whether similar cell types exist in any trematode species. Here we describe a population of neoblast-like cells in the trematode Schistosoma mansoni. These cells resemble planarian neoblasts morphologically and share their ability to proliferate and differentiate into derivatives of multiple germ layers. Capitalizing on available genomic resources(6,7) and RNA-seq-based gene expression profiling, we find that these schistosome neoblast-like cells express a fibroblast growth factor receptor orthologue. Using RNA interference we demonstrate that this gene is required for the maintenance of these neoblast-like cells. Our observations indicate that adaptation of developmental strategies shared by free-living ancestors to modern-day schistosomes probably contributed to the success of these animals as long-lived obligate parasites. We expect that future studies deciphering the function of these neoblast-like cells will have important implications for understanding the biology of these devastating parasites.	[Collins, James J., III; Wang, Bo; Lambrus, Bramwell G.; Tharp, Marla E.; Iyer, Harini; Newmark, Phillip A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Collins, James J., III; Wang, Bo; Lambrus, Bramwell G.; Tharp, Marla E.; Iyer, Harini; Newmark, Phillip A.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Collins, James J., III; Newmark, Phillip A.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Wang, Bo] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Newmark, PA (corresponding author), Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA.	pnewmark@life.illinois.edu		Newmark, Phillip/0000-0003-0793-022X; Tharp, Marla/0000-0002-0653-1123	NIAID [HHSN272201000005I]; NIH [F32 HD062124, R21 AI099642]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD062124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099642] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Roberts-Galbraith, M. Issigonis and L. Rouhana for comments on the manuscript; R. King for sharing the cathepsin B plasmid and unpublished protocols; and A. Hernandez for assistance with Illumina sequencing. Schistosome-infected mice were provided by the NIAID Schistosomiasis Resource Center and the Biomedical Research Institute through NIAID contract no. HHSN272201000005I. This work was supported by: NIH F32 HD062124 (JJ.C.) and NIH R21 AI099642 (PAN.). PAN. is an investigator of the Howard Hughes Medical Institute.	BAGUNA J, 1981, HYDROBIOLOGIA, V84, P181, DOI 10.1007/BF00026179; Basch P, 1991, SCHISTOSOMES DEV REP; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Brehm K, 2010, PARASITOLOGY, V137, P537, DOI 10.1017/S0031182009991727; Caffrey CR, 2004, TRENDS PARASITOL, V20, P241, DOI 10.1016/j.pt.2004.03.004; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Collins JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001009; Collins JJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000509; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; DENHOLLANDER JE, 1984, PARASITOLOGY, V88, P463, DOI 10.1017/S0031182000054731; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Forsthoefel DJ, 2011, DEV BIOL, V356, P445, DOI 10.1016/j.ydbio.2011.05.669; Juliano C, 2010, SCIENCE, V329, P640, DOI 10.1126/science.1194037; Labbe RM, 2012, STEM CELLS, V30, P1734, DOI 10.1002/stem.1144; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; NOLLEN PM, 1976, J PARASITOL, V62, P227, DOI 10.2307/3279273; Onal P, 2012, EMBO J, V31, P2755, DOI 10.1038/emboj.2012.110; Ogawa K, 2002, DEV GROWTH DIFFER, V44, P191; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Protasio AV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001455; Rouhana L, 2010, DEV BIOL, V341, P429, DOI 10.1016/j.ydbio.2010.02.037; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Severinghaus AE, 1928, Q J MICROSC SCI, V71, P653; SHAW MK, 1987, PARASITOLOGY, V94, P243, DOI 10.1017/S0031182000053920; Skinner DE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001686; Solana J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r19; Wagner DE, 2012, CELL STEM CELL, V10, P299, DOI 10.1016/j.stem.2012.01.016; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983	30	142	142	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					476	479		10.1038/nature11924	http://dx.doi.org/10.1038/nature11924			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23426263	Green Accepted			2022-12-24	WOS:000315661500038
J	Oka, Y; Butnaru, M; von Buchholtz, L; Ryba, NJP; Zuker, CS				Oka, Yuki; Butnaru, Matthew; von Buchholtz, Lars; Ryba, Nicholas J. P.; Zuker, Charles S.			High salt recruits aversive taste pathways	NATURE			English	Article							CARBONIC-ANHYDRASE; IN-VIVO; AMILORIDE; CELLS; RECEPTORS; BITTER; DISCRIMINATION; TRANSDUCTION; SPECIFICITY; SUPPRESSION	In the tongue, distinct classes of taste receptor cells detect the five basic tastes; sweet, sour, bitter, sodium salt and umami(1,2). Among these qualities, bitter and sour stimuli are innately aversive, whereas sweet and umami are appetitive and generally attractive to animals. By contrast, salty taste is unique in that increasing salt concentration fundamentally transforms an innately appetitive stimulus into a powerfully aversive one(3-7). This appetitive-aversive balance helps to maintain appropriate salt consumption(3,4,6,8), and represents an important part of fluid and electrolyte homeostasis. We have shown previously that the appetitive responses to NaCl are mediated by taste receptor cells expressing the epithelial sodium channel, ENaCs8, but the cellular substrate for salt aversion was unknown. Here we examine the cellular and molecular basis for the rejection of high concentrations of salts. We show that high salt recruits the two primary aversive taste pathways by activating the sour- and bitter-taste-sensing cells. We also demonstrate that genetic silencing of these pathways abolishes behavioural aversion to concentrated salt, without impairing salt attraction. Notably, mice devoid of salt-aversion pathways show unimpeded, continuous attraction even to very high concentrations of NaCl. We propose that the 'co-opting' of sour and bitter neural pathways evolved as a means to ensure that high levels of salt reliably trigger robust behavioural rejection, thus preventing its potentially detrimental effects on health.	[Oka, Yuki; Butnaru, Matthew; Zuker, Charles S.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Oka, Yuki; Butnaru, Matthew; Zuker, Charles S.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Oka, Yuki; Butnaru, Matthew; Zuker, Charles S.] Columbia Univ, Dept Neurosci, Columbia Coll Phys & Surg, New York, NY 10032 USA; [von Buchholtz, Lars; Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zuker, CS (corresponding author), Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA.	nick.ryba@nih.gov; cz2195@columbia.edu		Oka, Yuki/0000-0003-2686-0677; Ryba, Nicholas/0000-0002-2060-8393	Japan Society for Promotion of Science; National Institutes of Health and National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health and National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank E. Vitalis and N. Propp for the generation and maintenance of mouse lines, and K. Mueller for the construction of T2R-Sapphire lines. We also thank J. Chandrashekar, W. Sly and A. Waheed for advice and discussions, and K. Scott and members of our laboratories for comments. Y.O. was supported by the Japan Society for Promotion of Science. This research was supported in part by the intramural research program of the National Institutes of Health and National Institute of Dental and Craniofacial Research (to N.J.P.R.). C.S.Z. is an investigator of the Howard Hughes Medical Institute.	Baird TT, 1997, BIOCHEMISTRY-US, V36, P2669, DOI 10.1021/bi962663s; BEAUCHAMP GK, 1990, AM J CLIN NUTR, V51, P881, DOI 10.1093/ajcn/51.5.881; Breslin PAS, 1995, CHEM SENSES, V20, P609, DOI 10.1093/chemse/20.6.609; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Contreras RJ, 1989, NEURAL MECHANISMS TA, P119; Doolin RE, 1996, J GEN PHYSIOL, V107, P545, DOI 10.1085/jgp.107.4.545; DUNCAN C. J., 1962, PHYSIOL ZOOL, V35, P120; Eylam S, 2005, AM J PHYSIOL-REG I, V288, pR1361, DOI 10.1152/ajpregu.00796.2004; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P661, DOI 10.1016/S0006-2952(00)00357-9; Hallock RM, 2009, CHEM SENSES, V34, P799, DOI 10.1093/chemse/bjp069; Halpern BP, 1998, NEUROSCI BIOBEHAV R, V23, P5, DOI 10.1016/S0149-7634(97)00063-8; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hellekant G, 1997, PHYSIOL BEHAV, V61, P829, DOI 10.1016/S0031-9384(96)00562-8; HETTINGER TP, 1990, BRAIN RES, V513, P24, DOI 10.1016/0006-8993(90)91085-U; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Ohkuri T, 2012, CHEM SENSES, V37, P523, DOI 10.1093/chemse/bjs004; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Spector AC, 1996, J NEUROSCI, V16, P8115; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ugawa S, 2005, CHEM SENSES, V30, pI195, DOI 10.1093/chemse/bjh181; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; ZHU XL, 1990, J BIOL CHEM, V265, P8795	30	213	225	3	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					472	475		10.1038/nature11905	http://dx.doi.org/10.1038/nature11905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23407495	Green Accepted			2022-12-24	WOS:000315661500037
J	Zhao, YL; Temperton, B; Thrash, JC; Schwalbach, MS; Vergin, KL; Landry, ZC; Ellisman, M; Deerinck, T; Sullivan, MB; Giovannoni, SJ				Zhao, Yanlin; Temperton, Ben; Thrash, J. Cameron; Schwalbach, Michael S.; Vergin, Kevin L.; Landry, Zachary C.; Ellisman, Mark; Deerinck, Tom; Sullivan, Matthew B.; Giovannoni, Stephen J.			Abundant SAR11 viruses in the ocean	NATURE			English	Article							MARINE; POPULATION; DIVERSITY; DYNAMICS	Several reports proposed that the extraordinary dominance of the SAR11 bacterial clade in ocean ecosystems could be a consequence of unusual mechanisms of resistance to bacteriophage infection, including 'cryptic escape' through reduced cell size(1) and/or K-strategist defence specialism(2). Alternatively, the evolution of high surface-to-volume ratios coupled with minimal genomes containing high-affinity transporters enables unusually efficient metabolism for oxidizing dissolved organic matter in the world's oceans that could support vast population sizes despite phage susceptibility. These ideas are important for understanding plankton ecology because they emphasize the potentially important role of top-down mechanisms in predation, thus determining the size of SAR11 populations and their concomitant role in biogeochemical cycling. Here we report the isolation of diverse SAR11 viruses belonging to two virus families in culture, for which we propose the name 'pelagiphage', after their host. Notably; the pelagiphage genomes were highly represented in marine viral metagenomes, demonstrating their importance in nature. One of the new phages, HTVC010P, represents a new podovirus subfamily more abundant than any seen previously, in all data sets tested, and may represent one of the most abundant virus subfamilies in the biosphere. This discovery disproves the theory that SAR11 cells are immune to viral predation and is consistent with the interpretation that the success of this highly abundant microbial clade is the result of successfully evolved adaptation to resource competition.	[Zhao, Yanlin; Temperton, Ben; Thrash, J. Cameron; Vergin, Kevin L.; Landry, Zachary C.; Giovannoni, Stephen J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Schwalbach, Michael S.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Ellisman, Mark; Deerinck, Tom] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, San Diego, CA 92093 USA; [Sullivan, Matthew B.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	Oregon State University; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego; University of Arizona	Giovannoni, SJ (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu	Temperton, Ben/AAE-2785-2021; Sullivan, Matthew B/H-3256-2011	Sullivan, Matthew B/0000-0003-4040-9831; Thrash, Cameron/0000-0003-0896-9986; VERGIN, KEVIN/0000-0002-8972-2813; Temperton, Ben/0000-0002-3667-8302	Gordon and Betty Moore Foundation Marine Microbiology Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation Marine Microbiology Initiative(Gordon and Betty Moore Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the Tucson Marine Phage Lab and B. Hurwitz for early access to the Pacific-Ocean virome datasets and J. Yan for her assistance in isolating HTVC011P. This work was supported by an investigator award to S.J.G. from the Gordon and Betty Moore Foundation Marine Microbiology Initiative.	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172; Chow CET, 2012, ENVIRON MICROBIOL, V14, P2171, DOI 10.1111/j.1462-2920.2012.02744.x; Duhaime MB, 2012, ENVIRON MICROBIOL, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Fuhrman JA, 2003, BIOL BULL-US, V204, P192, DOI 10.2307/1543557; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12; Hurwitz B. L., 2013, PLOS ONE IN PRESS; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; Kunin V, 2008, GENOME RES, V18, P293, DOI 10.1101/gr.6835308; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Malmstrom RR, 2005, APPL ENVIRON MICROB, V71, P2979, DOI 10.1128/AEM.71.6.2979-2986.2005; Marston MF, 2012, P NATL ACAD SCI USA, V109, P4544, DOI 10.1073/pnas.1120310109; Parsons RJ, 2012, ISME J, V6, P273, DOI 10.1038/ismej.2011.101; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2009, ENVIRON MICROBIOL, V11, P2935, DOI 10.1111/j.1462-2920.2009.02081.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Suttle CA, 2010, MANUAL AQUATIC VIRAL, P92, DOI DOI 10.4319/MAVE.2010.978-0-9845591-0-7.92; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vergin KL, 2007, ENVIRON MICROBIOL, V9, P2430, DOI 10.1111/j.1462-2920.2007.01361.x; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wang LR, 2011, P NATL ACAD SCI USA, V108, P2963, DOI 10.1073/pnas.1017261108; Wilhelm LJ, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-27; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530	30	224	227	8	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					357	360		10.1038/nature11921	http://dx.doi.org/10.1038/nature11921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23407494				2022-12-24	WOS:000315312900039
J	Ren, XF; Farias, GG; Canagarajah, BJ; Bonifacino, JS; Hurley, JH				Ren, Xuefeng; Farias, Ginny G.; Canagarajah, Bertram J.; Bonifacino, Juan S.; Hurley, James H.			Structural Basis for Recruitment and Activation of the AP-1 Clathrin Adaptor Complex by Arf1	CELL			English	Article							ADP-RIBOSYLATION FACTOR; CARGO-SORTING SIGNALS; GTP-BINDING PROTEIN; COATED VESICLES; MEMBRANE RECRUITMENT; GOLGI MEMBRANES; AP2 COMPLEX; HIV-1 NEF; RECOGNITION; SUBUNIT	AP-1 is a clathrin adaptor complex that sorts cargo between the trans-Golgi network and endosomes. AP-1 recruitment to these compartments requires Arf1-GTP. The crystal structure of the tetrameric core of AP-1 in complex with Arf1-GTP, together with biochemical analyses, shows that Arf1 activates cargo binding by unlocking AP-1. Unlocking is driven by two molecules of Arf1 that bridge two copies of AP-1 at two interaction sites. The GTP-dependent switch I and II regions of Arf1 bind to the N terminus of the beta 1 subunit of one AP-1 complex, while the back side of Arf1 binds to the central part of the gamma subunit trunk of a second AP-1 complex. A third Arf1 interaction site near the N terminus of the gamma subunit is important for recruitment, but not activation. These observations lead to a model for the recruitment and activation of AP-1 by Arf1.	[Ren, Xuefeng; Farias, Ginny G.; Bonifacino, Juan S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Canagarajah, Bertram J.; Hurley, James H.] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bonifacino, JS (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	bonifacinoj@helix.nih.gov; james.hurley@nih.gov		Bonifacino, Juan S./0000-0002-5673-6370	U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NICHD; NIDDK, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036130] Funding Source: NIH RePORTER	U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Mardones for assistance with constructs and W. Yang for critically reading the manuscript. Crystallographic data were collected at Southeast Regional Collaborative Access Team 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. This research was supported by the Intramural Programs of NICHD (J.S.B.) and NIDDK (J.H.H.), NIH.	AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Brunger AT, 2012, STRUCTURE, V20, P957, DOI 10.1016/j.str.2012.04.020; Carvajal-Gonzalez JM, 2012, P NATL ACAD SCI USA, V109, P3820, DOI 10.1073/pnas.1117949109; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farias GG, 2012, NEURON, V75, P810, DOI 10.1016/j.neuron.2012.07.007; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Huang FT, 2001, TRAFFIC, V2, P345, DOI 10.1034/j.1600-0854.2001.25020506.x; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; LeBorgne R, 1996, J BIOL CHEM, V271, P2162; Lee I, 2008, ARCH BIOCHEM BIOPHYS, V479, P63, DOI 10.1016/j.abb.2008.08.009; Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037; Liang JO, 1997, J BIOL CHEM, V272, P33001, DOI 10.1074/jbc.272.52.33001; Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montagnac G, 2011, CURR BIOL, V21, P574, DOI 10.1016/j.cub.2011.02.034; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Peden AA, 2001, J BIOL CHEM, V276, P49183, DOI 10.1074/jbc.M106646200; Poupart ME, 2007, CELL SIGNAL, V19, P2370, DOI 10.1016/j.cellsig.2007.07.015; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Seaman MNJ, 1996, J BIOL CHEM, V271, P25446, DOI 10.1074/jbc.271.41.25446; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Shiba T, 2003, NAT STRUCT BIOL, V10, P386, DOI 10.1038/nsb920; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Yu XC, 2012, CELL, V148, P530, DOI 10.1016/j.cell.2012.01.015	48	102	105	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					755	767		10.1016/j.cell.2012.12.042	http://dx.doi.org/10.1016/j.cell.2012.12.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415225	Bronze, Green Accepted			2022-12-24	WOS:000314945600011
J	O'Leary, MA; Bloch, JI; Flynn, JJ; Gaudin, TJ; Giallombardo, A; Giannini, NP; Goldberg, SL; Kraatz, BP; Luo, ZX; Meng, J; Ni, XJ; Novacek, MJ; Perini, FA; Randall, ZS; Rougier, GW; Sargis, EJ; Silcox, MT; Simmons, NB; Spaulding, M; Velazco, PM; Weksler, M; Wible, JR; Cirranello, AL				O'Leary, Maureen A.; Bloch, Jonathan I.; Flynn, John J.; Gaudin, Timothy J.; Giallombardo, Andres; Giannini, Norberto P.; Goldberg, Suzann L.; Kraatz, Brian P.; Luo, Zhe-Xi; Meng, Jin; Ni, Xijun; Novacek, Michael J.; Perini, Fernando A.; Randall, Zachary S.; Rougier, Guillermo W.; Sargis, Eric J.; Silcox, Mary T.; Simmons, Nancy B.; Spaulding, Michelle; Velazco, Paul M.; Weksler, Marcelo; Wible, John R.; Cirranello, Andrea L.			The Placental Mammal Ancestor and the Post-K-Pg Radiation of Placentals	SCIENCE			English	Article							EVOLUTION; CLASSIFICATION; PHYLOGENETICS; EXTINCTION; ANTIQUITY; ORIGINS; PLANT; BATS; END	To discover interordinal relationships of living and fossil placental mammals and the time of origin of placentals relative to the Cretaceous-Paleogene (K-Pg) boundary, we scored 4541 phenomic characters de novo for 86 fossil and living species. Combining these data with molecular sequences, we obtained a phylogenetic tree that, when calibrated with fossils, shows that crown clade Placentalia and placental orders originated after the K-Pg boundary. Many nodes discovered using molecular data are upheld, but phenomic signals overturn molecular signals to show Sundatheria (Dermoptera + Scandentia) as the sister taxon of Primates, a close link between Proboscidea (elephants) and Sirenia (sea cows), and the monophyly of echolocating Chiroptera (bats). Our tree suggests that Placentalia first split into Xenarthra and Epitheria; extinct New World species are the oldest members of Afrotheria.	[O'Leary, Maureen A.; Cirranello, Andrea L.] SUNY Stony Brook, Sch Med, Dept Anat Sci, Stony Brook, NY 11794 USA; [Bloch, Jonathan I.; Randall, Zachary S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [O'Leary, Maureen A.; Flynn, John J.; Giallombardo, Andres; Goldberg, Suzann L.; Kraatz, Brian P.; Meng, Jin; Ni, Xijun; Novacek, Michael J.; Perini, Fernando A.; Spaulding, Michelle; Weksler, Marcelo; Cirranello, Andrea L.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Gaudin, Timothy J.] Univ Tennessee, Dept Biol & Environm Sci, Chattanooga, TN 37403 USA; [Giannini, Norberto P.; Simmons, Nancy B.; Velazco, Paul M.] Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA; [Kraatz, Brian P.] Western Univ Hlth Sci, Dept Anat, Pomona, CA 91766 USA; [Luo, Zhe-Xi] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; [Rougier, Guillermo W.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Sargis, Eric J.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Silcox, Mary T.] Univ Toronto, Dept Anthropol, Scarborough, ON M1C 1A4, Canada; [Spaulding, Michelle; Wible, John R.] Carnegie Museum Nat Hist, Sect Mammals, Pittsburgh, PA 15206 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; University of Florida; American Museum of Natural History (AMNH); University of Tennessee System; University of Tennessee at Chattanooga; American Museum of Natural History (AMNH); Western University of Health Sciences; University of Louisville; Yale University; University of Toronto; University Toronto Scarborough	O'Leary, MA (corresponding author), SUNY Stony Brook, Sch Med, Dept Anat Sci, HSC T-8 040, Stony Brook, NY 11794 USA.	maureen.oleary@stonybrook.edu	Weksler, Marcelo/A-7420-2010; Perini, Fernando/I-1452-2012; Luo, Zhe-XI/AAU-2263-2021; Velazco, Paúl/P-7283-2019	Weksler, Marcelo/0000-0001-8111-4779; Perini, Fernando/0000-0002-4336-9284; Velazco, Paúl/0000-0001-7195-7422; Simmons, Nancy B./0000-0001-8807-7499; Silcox, Mary/0000-0002-4174-9435; Giannini, Norberto/0000-0002-8402-0126; Bloch, Jonathan/0000-0003-1484-6931	NSF [0743309, 0827993]; "Assembling the Tree of Life" program of the Divisions of Environmental Biology and Earth Sciences [0629959, 0629836, 0629811]; Division Of Environmental Biology [0946430] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); "Assembling the Tree of Life" program of the Divisions of Environmental Biology and Earth Sciences; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Asher, L. Jurgielewicz, M. Marotta, S. Parent, E. Seiffert, and E. Woodruff for data collection; K. Johnson for paleobotanical contributions; K. de Queiroz and A. Turner for discussion; and S. Kaufman, K. Alphonse, M. Passarotti, and D. Ferguson for software development. Artist C. Buell drew Fig. 2A and L. Betti-Nash all other figures. Research assistance came from P. Bowden, D. Malinzak, S. B. McLaren, N. Milbrodt, R. Morgan, and J. Morgan Scott. Data are archived in the supplementary materials and in Project 773 of the public repository MorphoBank.org. Supported by NSF grants 0743309 and 0827993, and by 0629959, 0629836, and 0629811 from the "Assembling the Tree of Life" program of the Divisions of Environmental Biology and Earth Sciences.	Agnolin FL, 2011, MAMM BIOL, V76, P101, DOI 10.1016/j.mambio.2010.12.001; [Anonymous], 1999, WALKERS MAMMALS WORL; Archibald J. David, 2001, Journal of Mammalian Evolution, V8, P107, DOI 10.1023/A:1011317930838; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Asher Robert J., 2003, Journal of Mammalian Evolution, V10, P131, DOI 10.1023/A:1025504124129; Berggren WA, 2005, J FORAMIN RES, V35, P279, DOI 10.2113/35.4.279; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; De Queiroz K, 2007, SYST BIOL, V56, P956, DOI 10.1080/10635150701656378; Eberle Jaelyn J., 2003, Rocky Mountain Geology, V38, P143, DOI 10.2113/gsrocky.38.1.143; Gaudin TJ, 2009, J MAMM EVOL, V16, P235, DOI 10.1007/s10914-009-9119-9; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Lofgren Donald L., 2004, P43; LUCKETT WP, 1993, MAMMAL PHYLOGENY, P182; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; Martin T, 2011, J VERTEBR PALEONTOL, V31, P153; McKenna M. C., 1975, PHYLOGENY PRIMATES, P21, DOI DOI 10.1007/978-1-4684-2166-8_2; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Miller-Butterworth CM, 2007, MOL BIOL EVOL, V24, P1553, DOI 10.1093/molbev/msm076; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Norell Mark A., 1992, P89; Novacek MJ, 1999, ANN MO BOT GARD, V86, P230, DOI 10.2307/2666178; NOVACEK MJ, 1986, B AM MUS NAT HIST, V183, P1; O'Leary MA, 2004, ASSEMBLING THE TREE OF LIFE, P490; O'Leary MA, 2011, CLADISTICS, V27, P529, DOI 10.1111/j.1096-0031.2011.00355.x; Owen Richard, 1868, ANATOMY VERTEBRATES, V3; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Rose KD, 2008, P ROY SOC B-BIOL SCI, V275, P1203, DOI 10.1098/rspb.2007.1661; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Sole F, 2009, ZOOL J LINN SOC-LOND, V156, P827, DOI 10.1111/j.1096-3642.2008.00501.x; Springer Mark S., 1997, Journal of Mammalian Evolution, V4, P285, DOI 10.1023/A:1027378615412; Springer MS, 2001, SCIENCE, V291, P1709, DOI 10.1126/science.1059434; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Wible JR, 2009, B AM MUS NAT HIST, P1, DOI 10.1206/623.1; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103; Wilf P, 2004, PALEOBIOLOGY, V30, P347, DOI 10.1666/0094-8373(2004)030<0347:LPEATE>2.0.CO;2; Wilf P, 2006, SCIENCE, V313, P1112, DOI 10.1126/science.1129569	42	763	791	4	457	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					662	667		10.1126/science.1229237	http://dx.doi.org/10.1126/science.1229237			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393258	Green Published			2022-12-24	WOS:000314585600033
J	Baarlink, C; Wang, HC; Grosse, R				Baarlink, Christian; Wang, Haicui; Grosse, Robert			Nuclear Actin Network Assembly by Formins Regulates the SRF Coactivator MAL	SCIENCE			English	Article							SERUM RESPONSE FACTOR; AUTOREGULATORY DOMAIN; GENE-TRANSCRIPTION; DYNAMICS; MDIA1	Formins are potent activators of actin filament assembly in the cytoplasm. In turn, cytoplasmic actin polymerization can promote release of actin from megakaryocytic acute leukemia (MAL) protein for serum response factor (SRF) transcriptional activity. We found that formins polymerized actin inside the mammalian nucleus to drive serum-dependent MAL-SRF activity. Serum stimulated rapid assembly of actin filaments within the nucleus in a formin-dependent manner. The endogenous formin mDia was regulated with an optogenetic tool, which allowed for photoreactive release of nuclear formin autoinhibition. Activated mDia promoted rapid and reversible nuclear actin network assembly, subsequent MAL nuclear accumulation, and SRF activity. Thus, a dynamic polymeric actin structure within the nucleus is part of the serum response.	[Baarlink, Christian; Wang, Haicui; Grosse, Robert] Univ Marburg, Inst Pharmacol, BPC, D-35032 Marburg, Germany	Philipps University Marburg	Grosse, R (corresponding author), Univ Marburg, Inst Pharmacol, BPC, D-35032 Marburg, Germany.	robert.grosse@staff.uni-marburg.de		Grosse, Robert/0000-0002-3380-5273	Deutsche Forschungsgemeinschaft [GR 2111/2-1, SFB 593]; Deutsche Krebshilfe e.V. [108293]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe e.V.(Deutsche Krebshilfe)	We thank J. V. Small for advice on rapid actin fixation, L. O. Essen and C. Taxis for advice on using the LOV-domain, M. Innocenti for mDia2 antibodies, B. Di Ventura for critical reading of the manuscript, and laboratory members for discussions. This work was funded by grants from the Deutsche Forschungsgemeinschaft (GR 2111/2-1 and SFB 593) and the Deutsche Krebshilfe e.V. (108293) to R. G. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Baarlink C, 2010, CELL, V142, DOI 10.1016/j.cell.2010.06.030; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Copeland SJ, 2007, J BIOL CHEM, V282, P30120, DOI 10.1074/jbc.M703834200; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Gauvin TJ, 2009, BIOCHEMISTRY-US, V48, P9327, DOI 10.1021/bi901354z; Gieni RS, 2009, BIOCHEM CELL BIOL, V87, P283, DOI 10.1139/O08-133; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Jockusch BM, 2006, TRENDS CELL BIOL, V16, P391, DOI 10.1016/j.tcb.2006.06.006; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Miki T, 2009, J BIOL CHEM, V284, P5753, DOI 10.1074/jbc.M806191200; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Vartiainen MK, 2008, FEBS LETT, V582, P2033, DOI 10.1016/j.febslet.2008.04.010; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	20	238	242	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					864	867		10.1126/science.1235038	http://dx.doi.org/10.1126/science.1235038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23558171				2022-12-24	WOS:000318997400044
J	Perrat, PN; DasGupta, S; Wang, J; Theurkauf, W; Weng, ZP; Rosbash, M; Waddell, S				Perrat, Paola N.; DasGupta, Shamik; Wang, Jie; Theurkauf, William; Weng, Zhiping; Rosbash, Michael; Waddell, Scott			Transposition-Driven Genomic Heterogeneity in the Drosophila Brain	SCIENCE			English	Article							L1 RETROTRANSPOSITION; TRANSPOSABLE ELEMENTS; MELANOGASTER; CELLS; MEMORY; RNAS; PATHWAY; EVOLUTION; GERMLINE; NEURONS	Recent studies in mammals have documented the neural expression and mobility of retrotransposons and have suggested that neural genomes are diverse mosaics. We found that transposition occurs among memory-relevant neurons in the Drosophila brain. Cell type-specific gene expression profiling revealed that transposon expression is more abundant in mushroom body (MB) alpha beta neurons than in neighboring MB neurons. The Piwi-interacting RNA (piRNA) proteins Aubergine and Argonaute 3, known to suppress transposons in the fly germline, are expressed in the brain and appear less abundant in alpha beta MB neurons. Loss of piRNA proteins correlates with elevated transposon expression in the brain. Paired-end deep sequencing identified more than 200 de novo transposon insertions in alpha beta neurons, including insertions into memory-relevant loci. Our observations indicate that genomic heterogeneity is a conserved feature of the brain.	[Perrat, Paola N.; DasGupta, Shamik; Waddell, Scott] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [DasGupta, Shamik; Waddell, Scott] Univ Oxford, Ctr Neural Circuits & Behav, Oxford OX1 3TA, England; [Wang, Jie; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Theurkauf, William] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Rosbash, Michael] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; [Rosbash, Michael] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02454 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Oxford; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Brandeis University; Howard Hughes Medical Institute; Brandeis University	Waddell, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	scott.waddell@cncb.ox.ac.uk		Waddell, Scott/0000-0003-4503-6229; DasGupta, Shamik/0000-0001-5803-8982; DasGupta, Shamik/0000-0001-5566-7548; Theurkauf, William/0000-0001-7342-1912	Wellcome Trust; Gatsby Charitable Foundation; Oxford Martin School; NlH [MH069883, MH081982]; NIH [NS044232, NS045713, R01HD049116]; Ellison Medical Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069883, R01MH081982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232, P30NS045713] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; Oxford Martin School; NlH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Data are available through ArrayExpress (www.ebi.ac.uk/arrayexpress) and NCBI Short Read (www.ncbi.nlm.nih.gov/sites/sra) archives as E-MEXP-3798 and SRP017718, respectively. We thank A. Vodala, J. Menet, K. Abruzzi, and N. Francis for advice with techniques. Supported by a Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences, the Gatsby Charitable Foundation, Oxford Martin School and grants MH069883 and MH081982 from NlH (S. W.), NIH grants NS044232 and NS045713 and the Ellison Medical Foundation (M. R.), and NIH grant R01HD049116 (Z.W. and W.T.).	Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Blum AL, 2009, CURR BIOL, V19, P1341, DOI 10.1016/j.cub.2009.07.016; BOZZETTI MP, 1995, P NATL ACAD SCI USA, V92, P6067, DOI 10.1073/pnas.92.13.6067; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Gage FH, 2012, SCI AM, V306, P26, DOI 10.1038/scientificamerican0312-26; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hovhanyan A, 2009, J NEUROGENET, V23, P42, DOI 10.1080/01677060802471700; JAKUBCZAK JL, 1991, P NATL ACAD SCI USA, V88, P3295, DOI 10.1073/pnas.88.8.3295; KAMINKER JS, 2002, GENOME BIOL, V0003; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Khurana JS, 2011, CELL, V147, P1551, DOI 10.1016/j.cell.2011.11.042; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; Moreau-Fauvarque C, 1998, MECH DEVELOP, V78, P47, DOI 10.1016/S0925-4773(98)00147-6; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011; SCHUPBACH T, 1991, GENETICS, V129, P1119; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Tan Y, 2010, NEURON, V67, P810, DOI 10.1016/j.neuron.2010.08.020; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; Trannoy S, 2011, CURR BIOL, V21, P1647, DOI 10.1016/j.cub.2011.08.032; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155	44	161	168	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2013	340	6128					91	95		10.1126/science.1231965	http://dx.doi.org/10.1126/science.1231965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559253	Green Accepted			2022-12-24	WOS:000317061100053
J	Holmes, DL; Lancaster, AK; Lindquist, S; Halfmann, R				Holmes, Daniel L.; Lancaster, Alex K.; Lindquist, Susan; Halfmann, Randal			Heritable Remodeling of Yeast Multicellularity by an Environmentally Responsive Prion	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PSEUDOHYPHAL GROWTH; DRUG-RESISTANCE; GENE-EXPRESSION; TRANSCRIPTION; EVOLUTION; PROTEIN; HSP104; PSI+; FLOCCULATION	Prion proteins undergo self-sustaining conformational conversions that heritably alter their activities. Many of these proteins operate at pivotal positions in determining how genotype is translated into phenotype. But the breadth of prion influences on biology and their evolutionary significance are just beginning to be explored. We report that a prion formed by the Mot3 transcription factor, [MOT3(+)], governs the acquisition of facultative multicellularity in the budding yeast Saccharomyces cerevisiae. The traits governed by [MOT3(+)] involved both gains and losses of Mot3 regulatory activity. [MOT3(+)]-dependent expression of FLO11, a major determinant of cell-cell adhesion, produced diverse lineage-specific multicellular phenotypes in response to nutrient deprivation. The prions themselves were induced by ethanol and eliminated by hypoxia-conditions that occur sequentially in the natural respiro-fermentative cycles of yeast populations. These data demonstrate that prions can act as environmentally responsive molecular determinants of multicellularity and contribute to the natural morphological diversity of budding yeast.	[Holmes, Daniel L.; Halfmann, Randal] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Lancaster, Alex K.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Halfmann, R (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	randal.halfmann@utsouthwestern.edu	Lancaster, Alexander K/K-2855-2013	Lancaster, Alexander K/0000-0002-0002-9263; Holmes, Daniel/0000-0002-0489-4043; Halfmann, Randal/0000-0002-6592-1471	NIH Director's Early Independence Award Program [DP5-OD009152-01]; Sara and Frank McKnight Fellowship; G. Harold and Leila Y. Mathers Foundation; HHMI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009152] Funding Source: NIH RePORTER	NIH Director's Early Independence Award Program; Sara and Frank McKnight Fellowship; G. Harold and Leila Y. Mathers Foundation; HHMI(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported primarily by the NIH Director's Early Independence Award Program, grant number DP5-OD009152-01 (to R.H.) and by the Sara and Frank McKnight Fellowship (R.H.). S.L. is a Howard Hughes Medical Institute (HHMI) investigator. This work was supported by grants from the G. Harold and Leila Y. Mathers Foundation and HHMI (to S.L.). We thank Cintia Hongay for fruitful early discussions about Mot3, Oliver King for assistance with the prion prediction algorithm, and Sunil Laxman and members of the S.L. lab for critical reading of the manuscript. We thank Gerry Fink and Fred Winston for yeast strains Sigma 1278b and FY2609, respectively, and Mikko Taipale for unpublished plasmids.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Barrales RR, 2012, GENETICS, V191, P791, DOI 10.1534/genetics.112.140301; Bauer F. F., 2000, South African Journal of Enology and Viticulture, V21, P27; Beardmore RE, 2011, NATURE, V472, P342, DOI 10.1038/nature09905; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Bruckner S, 2012, FEMS MICROBIOL REV, V36, P25, DOI 10.1111/j.1574-6976.2011.00275.x; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bumgarner SL, 2012, MOL CELL, V45, P470, DOI 10.1016/j.molcel.2011.11.029; Carter GW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100137; Casalone E, 2005, RES MICROBIOL, V156, P191, DOI 10.1016/j.resmic.2004.09.008; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Granek JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000823; Griswold CK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000517; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Hongay C, 2002, EMBO J, V21, P4114, DOI 10.1093/emboj/cdf415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; INGLEDEW WM, 1987, AM J ENOL VITICULT, V38, P246; Koonin EV, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-27; Koschwanez JH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001122; Kryndushkin DS, 2011, GENETICS, V188, P339, DOI 10.1534/genetics.111.127779; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; Kuthan M, 2003, MOL MICROBIOL, V47, P745, DOI 10.1046/j.1365-2958.2003.03332.x; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Liu HP, 1996, GENETICS, V144, P967; MacLean R, 2008, HEREDITY, V100, P471, DOI 10.1038/sj.hdy.6801073x; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Octavio LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000673; OUGH CS, 1974, AM J ENOL VITICULT, V25, P7; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Ratcliff WC, 2012, P NATL ACAD SCI USA, V109, P1595, DOI 10.1073/pnas.1115323109; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Rogoza T, 2010, P NATL ACAD SCI USA, V107, P10573, DOI 10.1073/pnas.1005949107; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Satpute-Krishnan P, 2005, NATURE, V437, P262, DOI 10.1038/nature03981; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sertil O, 2003, NUCLEIC ACIDS RES, V31, P5831, DOI 10.1093/nar/gkg792; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Toombs JA, 2012, P NATL ACAD SCI USA, V109, P6519, DOI 10.1073/pnas.1119366109; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Turkel S, 1999, FOLIA MICROBIOL, V44, P372, DOI 10.1007/BF02903707; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Vachova L, 2011, J CELL BIOL, V194, P679, DOI 10.1083/jcb.201103129; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Verstrepen KJ, 2003, APPL MICROBIOL BIOT, V61, P197, DOI 10.1007/s00253-002-1200-8; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2011, PRION, V5, P258, DOI [10.4161/pri.5.4.17748, 10.4161/pri.17748]; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; WRIGHT RM, 1993, CURR GENET, V23, P388, DOI 10.1007/BF00312623; Zupan J, 2010, YEAST, V27, P217, DOI 10.1002/yea.1746	72	127	131	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					153	165		10.1016/j.cell.2013.02.026	http://dx.doi.org/10.1016/j.cell.2013.02.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540696	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000316853700013
J	Giovanoli, S; Engler, H; Engler, A; Richetto, J; Voget, M; Willi, R; Winter, C; Riva, MA; Mortensen, PB; Schedlowski, M; Meyer, U				Giovanoli, Sandra; Engler, Harald; Engler, Andrea; Richetto, Juliet; Voget, Mareike; Willi, Roman; Winter, Christine; Riva, Marco A.; Mortensen, Preben B.; Schedlowski, Manfred; Meyer, Urs			Stress in Puberty Unmasks Latent Neuropathological Consequences of Prenatal Immune Activation in Mice	SCIENCE			English	Article							CHILDHOOD ADVERSITIES; PSYCHIATRIC-DISORDERS; SCHIZOPHRENIA; EXPOSURE; AUTISM; RISK; PHYSIOLOGY	Prenatal infection and exposure to traumatizing experiences during peripuberty have each been associated with increased risk for neuropsychiatric disorders. Evidence is lacking for the cumulative impact of such prenatal and postnatal environmental challenges on brain functions and vulnerability to psychiatric disease. Here, we show in a translational mouse model that combined exposure to prenatal immune challenge and peripubertal stress induces synergistic pathological effects on adult behavioral functions and neurochemistry. We further demonstrate that the prenatal insult markedly increases the vulnerability of the pubescent offspring to brain immune changes in response to stress. Our findings reveal interactions between two adverse environmental factors that have individually been associated with neuropsychiatric disease and support theories that mental illnesses with delayed onsets involve multiple environmental hits.	[Giovanoli, Sandra; Meyer, Urs] Swiss Fed Inst Technol, Physiol & Behav Lab, CH-8603 Schwerzenbach, Switzerland; [Engler, Harald; Engler, Andrea; Schedlowski, Manfred] Univ Duisburg Essen, Inst Med Psychol & Behav Immunobiol, Univ Hosp Essen, D-45122 Essen, Germany; [Richetto, Juliet; Riva, Marco A.] Univ Milan, Ctr Neuropharmacol, Dept Pharmacol Sci, I-20133 Milan, Italy; [Richetto, Juliet; Riva, Marco A.] Univ Milan, Ctr Excellence Neurodegenerat Dis, Dept Pharmacol & Biomol Sci, I-20133 Milan, Italy; [Voget, Mareike] Charite, Int Grad Program Med Neurosci, D-10117 Berlin, Germany; [Voget, Mareike; Winter, Christine] Tech Univ Dresden, Dept Psychiat, D-01062 Dresden, Germany; [Willi, Roman] F Hoffmann La Roche Ltd, Neurosci Discovery, CH-4070 Basel, Switzerland; [Mortensen, Preben B.] Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark; [Mortensen, Preben B.] IPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, DK-8000 Aarhus, Denmark	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Duisburg Essen; University of Milan; University of Milan; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Roche Holding; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH)	Meyer, U (corresponding author), Swiss Fed Inst Technol, Physiol & Behav Lab, CH-8603 Schwerzenbach, Switzerland.	urmeyer@ethz.ch	Richetto, Juliet/AAC-7285-2021; Richetto, Juliet/Q-2865-2016; Riva, Marco Andrea/N-7418-2017; Meyer, Urs/C-4602-2016; Mortensen, Preben B/D-2358-2015; Engler, Harald/H-8773-2017	Richetto, Juliet/0000-0002-8313-3348; Richetto, Juliet/0000-0002-8313-3348; Riva, Marco Andrea/0000-0002-1699-5060; Meyer, Urs/0000-0001-7244-0345; Mortensen, Preben B/0000-0002-5230-9865; Engler, Harald/0000-0001-6329-1990; Willi, Roman/0000-0001-9612-9877	European Union [259679]; Lundbeck Foundation; Stanley Medical Research Institute; European Research Council; German Research Foundation [FOR 1581, SCHE 341/19-1, FOR 751, EN 814/1-2]	European Union(European Commission); Lundbeck Foundation(Lundbeckfonden); Stanley Medical Research Institute; European Research Council(European Research Council (ERC)European Commission); German Research Foundation(German Research Foundation (DFG))	We thank L. Weber and T. Wirth for their technical assistance in the immunohistochemical and flow cytometric analyses; U. Stadlbauer and M. Labouesse for assisting behavioral experimentation and animal care; and the laboratory animal technician team, Schwerzenbach, for animal husbandry. We also thank J. Feldon for his past mentoring and W. Langhans for the continuous infrastructural support. This work was supported by the European Union Seventh Framework Programme (FP7/2007-2011) under Grant Agreement no. 259679 awarded to U. M., and by the Lundbeck Foundation, the Stanley Medical Research Institute, and a European Research Council Advanced Grant awarded to P. B. M., and partially by the German Research Foundation (FOR 1581, SCHE 341/19-1; FOR 751, EN 814/1-2). All authors declare that they have no conflicts of interest to disclose. R. W. is employed by F. Hoffmann-La Roche, Ltd.	Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Brown AS, 2011, SCHIZOPHRENIA BULL, V37, P284, DOI 10.1093/schbul/sbq146; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Clarke MC, 2009, AM J PSYCHIAT, V166, P1025, DOI 10.1176/appi.ajp.2009.08010031; Fisher HL, 2010, PSYCHOL MED, V40, P1967, DOI 10.1017/S0033291710000231; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Franklin TB, 2012, NEURON, V75, P747, DOI 10.1016/j.neuron.2012.08.016; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Herbert MR, 2010, CURR OPIN NEUROL, V23, P103, DOI 10.1097/WCO.0b013e328336a01f; Holmes WC, 1998, JAMA-J AM MED ASSOC, V280, P1855, DOI 10.1001/jama.280.21.1855; Hsiao EY, 2012, P NATL ACAD SCI USA, V109, P12776, DOI 10.1073/pnas.1202556109; Maynard TM, 2001, SCHIZOPHRENIA BULL, V27, P457, DOI 10.1093/oxfordjournals.schbul.a006887; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Selten JP, 2010, SCHIZOPHRENIA BULL, V36, P219, DOI 10.1093/schbul/sbp147; Spear LP, 2009, DEV PSYCHOPATHOL, V21, P87, DOI 10.1017/S0954579409000066; Tsuchiya KJ, 2003, BIPOLAR DISORD, V5, P231, DOI 10.1034/j.1399-5618.2003.00038.x; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050	24	332	337	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1095	1099		10.1126/science.1228261	http://dx.doi.org/10.1126/science.1228261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449593	Green Published			2022-12-24	WOS:000315452000047
J	Davies, SC; Fowler, T; Watson, J; Livermore, DM; Walker, D				Davies, Sally C.; Fowler, Tom; Watson, John; Livermore, David M.; Walker, David			Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance	LANCET			English	Editorial Material									[Davies, Sally C.; Fowler, Tom; Walker, David] Dept Hlth, Off Chief Med Officer, London SW1A 2NS, England; [Fowler, Tom] Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, Birmingham B15 2TT, W Midlands, England; [Watson, John] Hlth Protect Agcy, Hlth Protect Serv HPA Colindale, London, England; [Livermore, David M.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of Birmingham; Health Protection Agency; University of East Anglia	Fowler, T (corresponding author), Dept Hlth, Off Chief Med Officer, London SW1A 2NS, England.	Tom.Fowler@nhs.net	Staves, Peter/C-8219-2014; Fowler, Tom/AGT-1933-2022	Fowler, Tom/0000-0002-7258-2279				Chisholm SA, 2010, J ANTIMICROB CHEMOTH, V65, P2141, DOI 10.1093/jac/dkq289; Davies S. C, 2014, ANN REPORT CHIEF MED; Department of Health. Department for Environment Food and Rural Affairs, 2013, UK ANT RES IN PRESS; Ghafur A, 2013, INDIAN J CANCER, V50, P71, DOI 10.4103/0019-509X.104065; Unemo M, 2012, FUTURE MICROBIOL, V7, P1401, DOI [10.2217/fmb.12.117, 10.2217/FMB.12.117]	5	143	146	5	44	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 11	2013	381	9878					1606	1609		10.1016/S0140-6736(13)60604-2	http://dx.doi.org/10.1016/S0140-6736(13)60604-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146SX	23489756				2022-12-24	WOS:000319112400008
J	Mozaffarian, D; Lemaitre, RN; King, IB; Song, XL; Huang, HY; Sacks, FM; Rimm, EB; Wang, ML; Siscovick, DS				Mozaffarian, Dariush; Lemaitre, Rozenn N.; King, Irena B.; Song, Xiaoling; Huang, Hongyan; Sacks, Frank M.; Rimm, Eric B.; Wang, Molin; Siscovick, David S.			Plasma Phospholipid Long-Chain omega-3 Fatty Acids and Total and Cause-Specific Mortality in Older Adults A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							POLYUNSATURATED FATTY-ACIDS; NONFATAL MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE EVENTS; PROPORTIONAL HAZARDS MODEL; CORONARY-HEART-DISEASE; GAMMA-LINOLENIC ACID; ALL-CAUSE MORTALITY; ACUTE LUNG INJURY; FISH CONSUMPTION; EICOSAPENTAENOIC ACID	Background: Long-chain omega-3 polyunsaturated fatty acids (omega 3-PUFAs), including eicosapentaenoic acid (EPA) (20:5 omega-3), docosapentaenoic acid (DPA) (22:5 omega-3), and docosahexaenoic acid (DHA) (22:6 omega-3), have been shown to reduce cardiovascular risk, but effects on cause-specific and total mortality and potential dose-responses remain controversial. Most observational studies have assessed self-reported dietary intake and most randomized trials have tested effects of adding supplements to dietary intake and evaluated secondary prevention, thus limiting inference for dietary omega 3-PUFAs or primary prevention. Objective: To investigate associations of plasma phospholipid EPA, DPA, DHA, and total omega 3-PUFA levels with total and cause-specific mortality among healthy older adults not receiving supplements. Design: Prospective cohort study. Setting: 4 U.S. communities. Participants: 2692 U.S. adults aged 74 years (+/- 5 years) without prevalent coronary heart disease (CHD), stroke, or heart failure at baseline. Measurements: Phospholipid fatty acid levels and cardiovascular risk factors were measured in 1992. Relationships with total and cause-specific mortality and incident fatal or nonfatal CHD and stroke through 2008 were assessed. Results: During 30 829 person-years, 1625 deaths (including 570 cardiovascular deaths), 359 fatal and 371 nonfatal CHD events, and 130 fatal and 276 nonfatal strokes occurred. After adjustment, higher plasma levels of omega 3-PUFA biomarkers were associated with lower total mortality, with extreme-quintile hazard ratios of 0.83 for EPA (95% CI, 0.71 to 0.98; P for trend = 0.005), 0.77 for DPA (CI, 0.66 to 0.90; P for trend = 0.008), 0.80 for DHA (CI, 0.67 to 0.94; P for trend = 0.006), and 0.73 for total omega 3-PUFAs (CI, 0.61 to 0.86; P for trend < 0.001). Lower risk was largely attributable to fewer cardiovascular than noncardiovascular deaths. Individuals in the highest quintile of phospholipid omega 3-PUFA level lived an average of 2.22 more years (CI, 0.75 to 3.13 years) after age 65 years than did those in the lowest quintile. Limitation: Temporal changes in fatty acid levels and misclassification of causes of death may have resulted in underestimated associations, and unmeasured or imperfectly measured covariates may have caused residual confounding. Conclusion: Higher circulating individual and total omega 3-PUFA levels are associated with lower total mortality, especially CHD death, in older adults.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ New Mexico, Albuquerque, NM 87131 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Washington, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of New Mexico; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Mozaffarian, D (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/ABC-2822-2020		National Institutes of Health; National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201200036C, N01-HC-85239, N01-HC-85079, N01-HC-85080, N01-HC-85081, N01-HC-85082, N01-HC-85083, N01-HC-85084, N01-HC-85085, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HL080295]; Office of Dietary Supplements of the National Institutes of Health [R01-HL-085710]; National Institute on Aging [AG-023629, AG-15928, AG-20098, AG-027058]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085081, N01HC075150, N01HC085082, N01HC085083, N01HC035129, N01HC085084, N01HC015103, N01HC045133, N01HC085085, N01HC085086, N01HC085080, N01HC085079, N01HC055222] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085710, U01HL080295, R01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027058, R56AG020098, R56AG023629, R01AG020098, R01AG015928, R01AG023629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Dietary Supplements of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health.; This investigation was supported by the National Heart, Lung, and Blood Institute (NHLBI) and the Office of Dietary Supplements of the National Institutes of Health (R01-HL-085710). The CHS was supported by NHLBI contracts HHSN268201200036C, N01-HC-85239, N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, and N01-HC-45133 and NHLBI grant HL080295, with additional contribution from the National Institute of Neurological Disorders and Stroke. Additional support was provided through AG-023629, AG-15928, AG-20098, and AG-027058 from the National Institute on Aging. See www.chs-nhlbi.org/pi.htm.	Aarsetoey H, 2009, J NUTR, V139, P507, DOI 10.3945/jn.108.096446; Anandan C, 2009, ALLERGY, V64, P840, DOI 10.1111/j.1398-9995.2009.02042.x; Breslow NE, 1972, J R STAT SOC B, V34, P216, DOI DOI 10.1111/J.2517-6161.1972.TB00900.X; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Cox D. R., 1984, ANAL SURVIVAL DATA; CUSHMAN M, 1995, CLIN CHEM, V41, P264; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Erkkila AT, 2003, AM J CLIN NUTR, V78, P65, DOI 10.1093/ajcn/78.1.65; Folsom AR, 2004, AM J EPIDEMIOL, V160, P1005, DOI 10.1093/aje/kwh307; Fotuhi M, 2009, NAT CLIN PRACT NEURO, V5, P140, DOI 10.1038/ncpneuro1044; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Geffken DF, 2001, AM J EPIDEMIOL, V153, P242, DOI 10.1093/aje/153.3.242; Harris WS, 2004, CIRCULATION, V110, P1645, DOI 10.1161/01.CIR.0000142292.10048.B2; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Johnston CS, 2001, J AM COLL NUTR, V20, P623, DOI 10.1080/07315724.2001.10719159; Kumanyika S, 1996, J AM DIET ASSOC, V96, P137, DOI 10.1016/S0002-8223(96)00042-9; Kumanyika SK, 1997, AM J CLIN NUTR, V65, P1123; Lee SH, 2009, CIRC J, V73, P2250, DOI 10.1253/circj.CJ-09-0327; Lemaitre RN, 2003, AM J CLIN NUTR, V77, P319, DOI 10.1093/ajcn/77.2.319; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lindberg M, 2008, AM J CLIN NUTR, V88, P722, DOI 10.1093/ajcn/88.3.722; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Mayurasakorn K, 2011, CURR OPIN CLIN NUTR, V14, P158, DOI 10.1097/MCO.0b013e328342cba5; Mozaffarian D, 2005, J AM COLL CARDIOL, V45, P2015, DOI 10.1016/j.jacc.2005.03.038; Mozaffarian D, 2005, ARCH INTERN MED, V165, P200, DOI 10.1001/archinte.165.2.200; Mozaffarian D, 2003, CIRCULATION, V107, P1372, DOI 10.1161/01.CIR.0000055315.79177.16; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Mozaffarian D, 2012, J NUTR, V142, p614S, DOI 10.3945/jn.111.149633; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Mozaffarian D, 2011, ANN INTERN MED, V155, P160, DOI 10.7326/0003-4819-155-3-201108020-00006; Mukamal KJ, 2006, J AM GERIATR SOC, V54, P30, DOI 10.1111/j.1532-5415.2005.00561.x; Pontes-Arruda A, 2008, JPEN-PARENTER ENTER, V32, P596, DOI 10.1177/0148607108324203; Pontes-Arruda A, 2011, CRIT CARE, V15, DOI 10.1186/cc10267; Pottala JV, 2010, CIRC-CARDIOVASC QUAL, V3, P406, DOI 10.1161/CIRCOUTCOMES.109.896159; Psaty Bruce M., 1995, Annals of Epidemiology, V5, P270, DOI 10.1016/1047-2797(94)00092-8; Rice TW, 2011, JAMA-J AM MED ASSOC, V306, P1574, DOI 10.1001/jama.2011.1435; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Roberts LJ, 2007, FREE RADICAL BIO MED, V43, P1388, DOI 10.1016/j.freeradbiomed.2007.06.019; ROSNER B, 1992, AM J EPIDEMIOL, V136, P1400, DOI 10.1093/oxfordjournals.aje.a116453; Saini A, 2011, EUR J CLIN MICROBIOL, V30, P393, DOI 10.1007/s10096-010-1099-4; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Siscovick DS, 2003, CIRCULATION, V107, P2632, DOI 10.1161/01.CIR.0000074779.11379.62; Sun Q, 2008, AM J CLIN NUTR, V88, P216, DOI 10.1093/ajcn/88.1.216; Tiesset H, 2011, J NUTR, V141, P1101, DOI 10.3945/jn.110.134585; Virtanen JK, 2009, CIRCULATION, V120, P2315, DOI 10.1161/CIRCULATIONAHA.109.852657; Virtanen JK, 2008, AM J CLIN NUTR, V88, P1618, DOI 10.3945/ajcn.2007.25816; World Cancer Research Fund American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACTIV; Wu JHY, 2012, CIRCULATION, V125, P1084, DOI 10.1161/CIRCULATIONAHA.111.062653; Yamagishi K, 2008, J AM COLL CARDIOL, V52, P988, DOI 10.1016/j.jacc.2008.06.018; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Yuan JM, 2001, AM J EPIDEMIOL, V154, P809, DOI 10.1093/aje/154.9.809; Zheng JS, 2012, PUBLIC HEALTH NUTR, V15, P725, DOI 10.1017/S1368980011002254; Zucker DM, 2008, STAT MED, V27, P1911, DOI 10.1002/sim.3159; Zucker DM, 2004, BIOMETRICS, V60, P324, DOI 10.1111/j.0006-341X.2004.00176.x	58	215	221	0	62	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2013	158	7					515	+		10.7326/0003-4819-158-7-201304020-00003	http://dx.doi.org/10.7326/0003-4819-158-7-201304020-00003			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	123VM	23546563	Green Accepted			2022-12-24	WOS:000317419400002
J	Bouchard, KE; Mesgarani, N; Johnson, K; Chang, EF				Bouchard, Kristofer E.; Mesgarani, Nima; Johnson, Keith; Chang, Edward F.			Functional organization of human sensorimotor cortex for speech articulation	NATURE			English	Article							HUMAN MOTOR CORTEX; LARYNX AREA; REPRESENTATION; DYNAMICS; VOCALIZATION; GENERATION; MOVEMENT	Speaking is one of the most complex actions that we perform, but nearly all of us learn to do it effortlessly. Production of fluent speech requires the precise, coordinated movement of multiple articulators (for example, the lips, jaw, tongue and larynx) over rapid time scales. Here we used high-resolution, multi-electrode cortical recordings during the production of consonant-vowel syllables to determine the organization of speech sensorimotor cortex in humans. We found speech-articulator representations that are arranged somatotopically on ventral pre- and post-central gyri, and that partially overlap at individual electrodes. These representations were coordinated temporally as sequences during syllable production. Spatial patterns of cortical activity showed an emergent, population-level representation, which was organized by phonetic features. Over tens of milliseconds, the spatial patterns transitioned between distinct representations for different consonants and vowels. These results reveal the dynamic organization of speech sensorimotor cortex during the generation of multi-articulator movements that underlies our ability to speak.	[Bouchard, Kristofer E.; Mesgarani, Nima; Chang, Edward F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Bouchard, Kristofer E.; Mesgarani, Nima; Chang, Edward F.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Bouchard, Kristofer E.; Mesgarani, Nima; Chang, Edward F.] Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94158 USA; [Johnson, Keith] Univ Calif Berkeley, Dept Linguist, Berkeley, CA 94720 USA; [Chang, Edward F.] Univ Calif San Francisco, UCSF Epilepsy Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Chang, EF (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave, San Francisco, CA 94143 USA.	ChangEd@neurosurg.ucsf.edu	Johnson, Keith/AAM-6322-2020	Johnson, Keith/0000-0002-2569-8121	US National Institutes of Health [R00-NS065120, DP2-OD00862, R01-DC012379]; Ester A. and Joseph Klingenstein Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS065120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012379] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008627] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ester A. and Joseph Klingenstein Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Ren for technical help with data collection and pre-processing, and M. Babiak for audio transcription. J. Houde, C. Niziolek, S. Lisberger, K. Chaisanguanthum, C. Cheung and I. Garner provided helpful comments on the manuscript. E.F.C. was funded by the US National Institutes of Health grants R00-NS065120, DP2-OD00862 and R01-DC012379, and the Ester A. and Joseph Klingenstein Foundation.	Afshar A, 2011, NEURON, V71, P555, DOI 10.1016/j.neuron.2011.05.047; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Brodmann K., 1994, VERGLEICHENDE LOKALI; Browman CP, 1989, HASKINS LAB STATUS R, V99, P69; Brown S, 2008, CEREB CORTEX, V18, P837, DOI 10.1093/cercor/bhm131; Brown S, 2009, BRAIN COGNITION, V70, P31, DOI 10.1016/j.bandc.2008.12.006; Chomsky, 1991, SOUND PATTERN ENGLIS; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Clements G. Nick, 1995, HDB PHONOLOGICAL THE, P245; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; DELL GS, 1993, COGNITIVE SCI, V17, P149, DOI 10.1207/s15516709cog1702_1; Edwards E, 2010, NEUROIMAGE, V50, P291, DOI 10.1016/j.neuroimage.2009.12.035; FOERSTER O, 1931, LANCET, V2, P309; Fowler C., 1980, LANGUAGE PRODUCTION, P373; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; GRACCO VL, 1985, J NEUROPHYSIOL, V54, P418, DOI 10.1152/jn.1985.54.2.418; GRACCO VL, 1994, J NEUROSCI, V14, P6585; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; HAST MH, 1974, BRAIN RES, V73, P229, DOI 10.1016/0006-8993(74)91046-4; Hatsopoulos NG, 2011, NEURON, V72, P477, DOI 10.1016/j.neuron.2011.10.020; Jakobson R., 1969, PRELIMINARIES SPEECH; JURGENS U, 1974, BRAIN RES, V81, P564, DOI 10.1016/0006-8993(74)90853-1; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Keating P.A., 1990, WINDOW MODEL COARTIC; Kent R. D., 1983, PRODUCTION SPEECH; KUYPERS HGJ, 1958, BRAIN, V81, P364, DOI 10.1093/brain/81.3.364; Ladefoged Peter., 2010, COURSE PHONETICS; Levelt W.J., 1993, SPEAKING INTENTION A; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; MCCARTHY G, 1993, J NEUROSURG, V79, P874, DOI 10.3171/jns.1993.79.6.0874; MCCARTHY JJ, 1988, PHONETICA, V45, P84, DOI 10.1159/000261820; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Penfield W., 1959, SPEECH BRAIN MECH; Pruszynski JA, 2011, NATURE, V478, P387, DOI 10.1038/nature10436; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Saltzman E., 1989, ECOL PSYCHOL, V1, P333, DOI [10.1207/s15326969eco0104_2, DOI 10.1207/S15326969EC00104_]; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Schulz GM, 2005, CEREB CORTEX, V15, P1835, DOI 10.1093/cercor/bhi061; Sherrington Charles Scott, 1911, INTEGRATIVE ACTION N; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Terumitsu M, 2006, NEUROREPORT, V17, P1091, DOI 10.1097/01.wnr.0000224778.97399.c4; Tremblay S, 2003, NATURE, V423, P866, DOI 10.1038/nature01710	47	328	333	5	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					327	332		10.1038/nature11911	http://dx.doi.org/10.1038/nature11911			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23426266	Green Accepted, Green Submitted			2022-12-24	WOS:000316650500034
J	Findlay, GM; Smith, MJ; Lanner, F; Hsiung, MS; Gish, GD; Petsalaki, E; Cockburn, K; Kaneko, T; Huang, HM; Bagshaw, RD; Ketela, T; Tucholska, M; Taylor, L; Bowtell, DD; Moffat, J; Ikura, M; Li, SSC; Sidhu, SS; Rossant, J; Pawson, T				Findlay, Greg M.; Smith, Matthew J.; Lanner, Fredrik; Hsiung, Marilyn S.; Gish, Gerald D.; Petsalaki, Evangelia; Cockburn, Katie; Kaneko, Tomonori; Huang, Haiming; Bagshaw, Richard D.; Ketela, Troy; Tucholska, Monika; Taylor, Lorne; Bowtell, David D.; Moffat, Jason; Ikura, Mitsuhiko; Li, Shawn S. C.; Sidhu, Sachdev S.; Rossant, Janet; Pawson, Tony			Interaction Domains of Sos1/Grb2 Are Finely Tuned for Cooperative Control of Embryonic Stem Cell Fate	CELL			English	Article							RAS ACTIVATOR SON; SRC SH2 DOMAIN; REAL-TIME NMR; COMPARATIVE GENOMICS; NUCLEOTIDE EXCHANGE; VISCERAL ENDODERM; NOONAN-SYNDROME; HISTONE DOMAIN; BINDING; SEVENLESS	Metazoan evolution involves increasing protein domain complexity, but how this relates to control of biological decisions remains uncertain. The Ras guanine nucleotide exchange factor (RasGEF) Sos1 and its adaptor Grb2 are multidomain proteins that couple fibroblast growth factor (FGF) signaling to activation of the Ras-Erk pathway during mammalian development and drive embryonic stem cells toward the primitive endoderm (PrE) lineage. We show that the ability of Sos1/Grb2 to appropriately regulate pluripotency and differentiation factors and to initiate PrE development requires collective binding of multiple Sos1/Grb2 domains to their protein and phospholipid ligands. This provides a cooperative system that only allows lineage commitment when all ligand-binding domains are occupied. Furthermore, our results indicate that the interaction domains of Sos1 and Grb2 have evolved so as to bind ligands not with maximal strength but with specificities and affinities that maintain cooperativity. This optimized system ensures that PrE lineage commitment occurs in a timely and selective manner during embryogenesis.	[Findlay, Greg M.; Hsiung, Marilyn S.; Gish, Gerald D.; Petsalaki, Evangelia; Bagshaw, Richard D.; Tucholska, Monika; Taylor, Lorne; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Smith, Matthew J.; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Toronto, ON M5S 1A8, Canada; [Smith, Matthew J.; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Sidhu, Sachdev S.; Rossant, Janet; Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Lanner, Fredrik; Cockburn, Katie; Rossant, Janet] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; [Kaneko, Tomonori; Li, Shawn S. C.] Univ Western Ontario, Siebens Drake Med Res Inst, London, ON N6A 5C1, Canada; [Huang, Haiming; Ketela, Troy; Moffat, Jason; Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Huang, Haiming; Ketela, Troy; Moffat, Jason; Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Bowtell, David D.] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Western University (University of Western Ontario); University of Toronto; University of Toronto; Peter Maccallum Cancer Center	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.	pawson@lunenfeld.ca	Bowtell, David/H-1007-2016; Petsalaki, Evangelia/ABC-3561-2020; Smith, Matthew J/AAI-8060-2020; Bagshaw, Rick/B-7739-2009; Pawson, Tony J/E-4578-2013; Gish, Gerald D/C-7228-2017; Moffat, Jason/AAC-1110-2020	Bowtell, David/0000-0001-9089-7525; Petsalaki, Evangelia/0000-0002-8294-2995; Smith, Matthew J/0000-0003-2896-9350; Bagshaw, Rick/0000-0001-5013-4291; Moffat, Jason/0000-0002-5663-8586; Cockburn, Katie/0000-0002-2997-0153; Lanner, Fredrik/0000-0002-2771-7445; Kaneko, Tomonori/0000-0001-5448-9639; Findlay, Greg/0000-0002-7222-4965	Terry Fox Foundation/CIHR [TFF-105268]; CCSRI; ORF; CIHR [MOP-6849, FRN-77803, MOP-93684]; CRS; CFI; CBCF; OICR; Terry Fox Research Institute	Terry Fox Foundation/CIHR(Canadian Institutes of Health Research (CIHR)); CCSRI; ORF; CIHR(Canadian Institutes of Health Research (CIHR)); CRS; CFI(Canada Foundation for Innovation); CBCF; OICR; Terry Fox Research Institute	The authors thank Ivica Letunic, Derek Ceccarelli, Bernard Liu, and Geraldine Mbamalu for technical input. We also thank Edvard Smith, Cheryl Seguin, Michael Kofler, Oliver Rocks, Nicolas Bisson, John Kuriyan, and Jody Gureasko for helpful discussions. G. M. F. and T. P. conceived the study, interpreted the data, and wrote the paper. Experiments were performed primarily by G. M. F. and by M. J. S., F. L., M. S. H., G. D. G., and M. T. T. Kaneko, H. H., R. D. B., T. Ketela, J. M., M. I., S. S. C. L., S. S. S., and J. R. provided conceptual insights and reagents. Mass spectrometry was supported by AB SCIEX. This work was supported by grants to T. P. from the Terry Fox Foundation/CIHR (#TFF-105268), the CCSRI, and the ORF; to T. P., J. R., and S. S. S. from the CIHR (#MOP-6849, #FRN-77803, and #MOP-93684); and to M. I. from the CRS. A 600 MHz NMR spectrometer was funded by the CFI. Support for the lentiviral shRNA platform was from the CFI, ORF, OICR, and the Terry Fox Research Institute. M. J. S. is supported by a CBCF fellowship.	Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Bisson N, 2011, NAT BIOTECHNOL, V29, P653, DOI 10.1038/nbt.1905; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen RH, 1997, EMBO J, V16, P1351, DOI 10.1093/emboj/16.6.1351; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Findlay GM, 2008, NAT STRUCT MOL BIOL, V15, P538, DOI 10.1038/nsmb0608-538; Gasmi-Seabrook GMC, 2010, J BIOL CHEM, V285, P5137, DOI 10.1074/jbc.M109.064691; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Gureasko J, 2010, P NATL ACAD SCI USA, V107, P3430, DOI 10.1073/pnas.0913915107; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hirasawa R, 2009, GENE EXPR PATTERNS, V9, P27, DOI 10.1016/j.gep.2008.09.002; Howard PL, 2003, P NATL ACAD SCI USA, V100, P11267, DOI 10.1073/pnas.1934711100; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Kaneko T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003021; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kimber MS, 2000, MOL CELL, V5, P1043, DOI 10.1016/S1097-2765(00)80269-5; Koonin EV, 2000, CELL, V101, P573, DOI 10.1016/S0092-8674(00)80867-3; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kubiseski TJ, 1997, J BIOL CHEM, V272, P1799, DOI 10.1074/jbc.272.3.1799; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Marshall CB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000029; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Yadav KK, 2010, P NATL ACAD SCI USA, V107, P3436, DOI 10.1073/pnas.0914315107	41	45	45	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					1008	1020		10.1016/j.cell.2013.01.056	http://dx.doi.org/10.1016/j.cell.2013.01.056			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452850	Bronze			2022-12-24	WOS:000315710300010
J	Van de Vosse, DW; Wan, YK; Lapetina, DL; Chen, WM; Chiang, JH; Aitchison, JD; Wozniak, RW				Van de Vosse, David W.; Wan, Yakun; Lapetina, Diego L.; Chen, Wei-Ming; Chiang, Jung-Hsien; Aitchison, John D.; Wozniak, Richard W.			A Role for the Nucleoporin Nup170p in Chromatin Structure and Gene Silencing	CELL			English	Article							NUCLEAR-PORE COMPLEX; YEAST TELOMERES; REMODELER RSC; EXPRESSION; GENOME; LOCALIZATION; ARCHITECTURE; PROTEINS; REVEALS; SIR4	Embedded in the nuclear envelope, nuclear pore complexes (NPCs) not only regulate nuclear transport but also interface with transcriptionally active euchromatin, largely silenced heterochromatin, as well as the boundaries between these regions. It is unclear what functional role NPCs play in establishing or maintaining these distinct chromatin domains. We report that the yeast NPC protein Nup170p interacts with regions of the genome that contain ribosomal protein and subtelomeric genes, where it functions in nucleosome positioning and as a repressor of transcription. We show that the role of Nup170p in subtelomeric gene silencing is linked to its association with the RSC chromatin-remodeling complex and the silencing factor Sir4p, and that the binding of Nup170p and Sir4p to subtelomeric chromatin is cooperative and necessary for the association of telomeres with the nuclear envelope. Our results establish the NPC as an active participant in silencing and the formation of peripheral heterochromatin.	[Van de Vosse, David W.; Lapetina, Diego L.; Wozniak, Richard W.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Wan, Yakun; Chen, Wei-Ming; Aitchison, John D.] Inst Syst Biol, Seattle, WA 98109 USA; [Wan, Yakun] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Chen, Wei-Ming; Chiang, Jung-Hsien] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 701, Taiwan; [Aitchison, John D.] Seattle Biomed Res Inst, Seattle, WA 98109 USA	University of Alberta; Institute for Systems Biology (ISB); Southeast University - China; National Cheng Kung University; Center for Infectious Disease Research	Aitchison, JD (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	john.aitchison@systemsbiology.org; rick.wozniak@ualberta.ca		Chiang, Jung-Hsien/0000-0002-4657-6705	CIHR [MOP 36519, MOP 106502]; AIHS; HHMI; NIH [P50 GM076547, U54 GM103511]; CIHR Canada Graduate Doctoral Scholarship; National Natural Science Foundation of China [31071146, 31271365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103511, U01GM098256, P50GM076547] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); AIHS; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR Canada Graduate Doctoral Scholarship(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. M. Gasser, D. E. Gottschling, C. Boone, S. L. Jaspersen, R. Rachubinski, and B. R. Cairns for providing reagents. We thank T. Makio for construction of the TMY1452 and TMY1798 strains, and Y. Sydorskyy and N. Arens for technical assistance. We also thank E. Hurt, L. Cairo, N. Adames, S. Danziger, and members of the Wozniak and Aitchison laboratories for thoughtful discussions. We thank Allison Kudla for the graphical abstract. Funds for this work were provided to R. W. W. by the CIHR (MOP 36519 MOP 106502), AIHS, and HHMI, and to J. D. A. by the NIH (P50 GM076547 and U54 GM103511). D. W. V. d. V. was supported by a CIHR Canada Graduate Doctoral Scholarship, and Y. W. was supported by the National Natural Science Foundation of China (31071146 and 31271365).	AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; Aitchison JD, 2012, GENETICS, V190, P855, DOI 10.1534/genetics.111.127803; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bosio MC, 2011, TRANSCR-AUSTIN, V2, P71, DOI 10.4161/trns.2.2.14486; BUCK SW, 1995, GENE DEV, V9, P370, DOI 10.1101/gad.9.3.370; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; de Vosse DWV, 2011, WIRES SYST BIOL MED, V3, P147, DOI 10.1002/wsbm.101; DIFFLEY JFX, 1989, NATURE, V342, P24, DOI 10.1038/342024a0; Dilworth DJ, 2005, J CELL BIOL, V171, P955, DOI 10.1083/jcb.200509061; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Ebrahimi H, 2008, GENE DEV, V22, P3363, DOI 10.1101/gad.486208; Ehrentraut S, 2010, P NATL ACAD SCI USA, V107, P5522, DOI 10.1073/pnas.0909169107; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Gasser SM, 2004, COLD SPRING HARB SYM, P327; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Hediger F, 2002, J STRUCT BIOL, V140, P79, DOI 10.1016/S1047-8477(02)00533-6; Hiraga S, 2006, EMBO J, V25, P1505, DOI 10.1038/sj.emboj.7601038; Hiraga S, 2008, J CELL BIOL, V183, P641, DOI 10.1083/jcb.200806065; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Kehat I, 2011, J CELL BIOL, V193, P21, DOI 10.1083/jcb.201101046; Kerscher O, 2001, GENETICS, V157, P1543; Laroche T, 2000, J STRUCT BIOL, V129, P159, DOI 10.1006/jsbi.2000.4240; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; Lusk CP, 2002, J CELL BIOL, V159, P267, DOI 10.1083/jcb.200203079; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Mitchell JM, 2010, J CELL BIOL, V191, P505, DOI 10.1083/jcb.201007098; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Ptak C, 2009, TRAFFIC, V10, P1619, DOI 10.1111/j.1600-0854.2009.00978.x; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Shim EY, 2005, MOL CELL BIOL, V25, P3934, DOI 10.1128/MCB.25.10.3934-3944.2005; Shulga N, 2000, J CELL BIOL, V149, P1027, DOI 10.1083/jcb.149.5.1027; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Taddei A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000612; Talamas JA, 2011, J CELL BIOL, V194, P27, DOI 10.1083/jcb.201012154; Therizols P, 2006, J CELL BIOL, V172, P189, DOI 10.1083/jcb.200505159; Titus LC, 2010, MOL BIOL CELL, V21, P1072, DOI 10.1091/mbc.E09-07-0615; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wan YK, 2009, MOL CELL BIOL, V29, P2346, DOI 10.1128/MCB.01233-08; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Yoshida T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000910; Young TJ, 2012, BBA-GENE REGUL MECH, V1819, P303, DOI 10.1016/j.bbagrm.2011.10.006; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	56	97	97	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					969	983		10.1016/j.cell.2013.01.049	http://dx.doi.org/10.1016/j.cell.2013.01.049			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452847	Green Accepted, Bronze			2022-12-24	WOS:000315710300007
J	Murtaza, M; Dawson, SJ; Tsui, DWY; Gale, D; Forshew, T; Piskorz, AM; Parkinson, C; Chin, SF; Kingsbury, Z; Wong, ASC; Marass, F; Humphray, S; Hadfield, J; Bentley, D; Chin, TM; Brenton, JD; Caldas, C; Rosenfeld, N				Murtaza, Muhammed; Dawson, Sarah-Jane; Tsui, Dana W. Y.; Gale, Davina; Forshew, Tim; Piskorz, Anna M.; Parkinson, Christine; Chin, Suet-Feung; Kingsbury, Zoya; Wong, Alvin S. C.; Marass, Francesco; Humphray, Sean; Hadfield, James; Bentley, David; Chin, Tan Min; Brenton, James D.; Caldas, Carlos; Rosenfeld, Nitzan			Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA	NATURE			English	Article							TUMOR-CELLS; EVOLUTION; MUTATIONS; HETEROGENEITY; ACTIVATION	Cancers acquire resistance to systemic treatment as a result of clonal evolution and selection(1,2). Repeat biopsies to study genomic evolution as a result of therapy are difficult, invasive and may be confounded by intra-tumour heterogeneity(3,4). Recent studies have shown that genomic alterations in solid cancers can be characterized by massively parallel sequencing of circulating cell-free tumour DNA released from cancer cells into plasma, representing a noninvasive liquid biopsy(5-7). Here we report sequencing of cancer exomes in serial plasma samples to track genomic evolution of metastatic cancers in response to therapy. Six patients with advanced breast, ovarian and lung cancers were followed over 1-2 years. For each case, exome sequencing was performed on 2-5 plasma samples (19 in total) spanning multiple courses of treatment, at selected time points when the allele fraction of tumour mutations in plasma was high, allowing improved sensitivity. For two cases, synchronous biopsies were also analysed, confirming genome-wide representation of the tumour genome in plasma. Quantification of allele fractions in plasma identified increased representation of mutant alleles in association with emergence of therapy resistance. These included an activating mutation in PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) following treatment with paclitaxel(8); a truncating mutation in RB1 (retinoblastoma 1) following treatment with cisplatin(9); a truncating mutation in MED1 (mediator complex subunit 1) following treatment with tamoxifen and trastuzumab(10,11), and following subsequent treatment with lapatinib(12,13), a splicing mutation in GAS6 (growth arrest-specific 6) in the same patient; and a resistance-conferring mutation in EGFR (epidermal growth factor receptor; T790M) following treatment with gefitinib(14). These results establish proof of principle that exome-wide analysis of circulating tumour DNA could complement current invasive biopsy approaches to identify mutations associated with acquired drug resistance in advanced cancers. Serial analysis of cancer genomes in plasma constitutes a new paradigm for the study of clonal evolution in human cancers.	[Murtaza, Muhammed; Dawson, Sarah-Jane; Tsui, Dana W. Y.; Gale, Davina; Forshew, Tim; Piskorz, Anna M.; Parkinson, Christine; Chin, Suet-Feung; Marass, Francesco; Hadfield, James; Brenton, James D.; Caldas, Carlos; Rosenfeld, Nitzan] Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Murtaza, Muhammed; Dawson, Sarah-Jane; Tsui, Dana W. Y.; Gale, Davina; Forshew, Tim; Piskorz, Anna M.; Parkinson, Christine; Chin, Suet-Feung; Marass, Francesco; Hadfield, James; Brenton, James D.; Caldas, Carlos; Rosenfeld, Nitzan] Univ Cambridge, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Dawson, Sarah-Jane; Parkinson, Christine; Brenton, James D.; Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Dawson, Sarah-Jane; Parkinson, Christine; Brenton, James D.; Caldas, Carlos] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 2QQ, England; [Kingsbury, Zoya] Illumina Inc, Saffron Walden CB10 1XL, England; [Wong, Alvin S. C.; Chin, Tan Min] Natl Univ Hlth Syst, Natl Univ Canc Inst, Dept Haematol Oncol, Singapore 119074, Singapore; [Chin, Tan Min] Natl Univ Singapore, Ctr Translat Med, Canc Sci Inst, Singapore 117599, Singapore; [Brenton, James D.; Caldas, Carlos] Cambridge Expt Canc Med Ctr, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; CRUK Cambridge Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Illumina; National University of Singapore; National University of Singapore	Brenton, JD (corresponding author), Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.	james.brenton@cruk.cam.ac.uk; carlos.caldas@cruk.cam.ac.uk; nitzan.rosenfeld@cruk.cam.ac.uk	ravegnini, gloria/K-1330-2016; Marass, Francesco/U-5220-2019; Brenton, James D/B-3174-2008; Caldas, Carlos/U-7250-2019; Hadfield, James/A-1874-2013	ravegnini, gloria/0000-0002-7774-402X; Marass, Francesco/0000-0002-8993-7320; Brenton, James D/0000-0002-5738-6683; Caldas, Carlos/0000-0003-3547-1489; Murtaza, Muhammed/0000-0001-7557-2861; Dawson, Sarah-Jane/0000-0002-8276-0374; Forshew, Tim/0000-0003-2093-7020; Hadfield, James/0000-0001-9868-4989; chin, suet-feung/0000-0001-5697-1082	NIHR Cambridge Biomedical Research Centre; Cancer Science Institute; National University of Singapore; Hematology-Oncology Research Group, National University Health System, Singapore; Cancer Research UK; University of Cambridge; National Institute for Health Research Cambridge Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Hutchison Whampoa Limited; National Medical Research Council, Singapore; Australian NHMRC/RG Menzies Early Career Fellowship; Cancer Research UK [16942, 11906, 15601, 22310] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Science Institute; National University of Singapore(National University of Singapore); Hematology-Oncology Research Group, National University Health System, Singapore; Cancer Research UK(Cancer Research UK); University of Cambridge(University of Cambridge); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Hutchison Whampoa Limited; National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian NHMRC/RG Menzies Early Career Fellowship; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank J. Langmore and K. Solomon (Rubicon Genomics) for early access to library preparation products. We thank L. Jones, S. Richardson, C. Hodgkin and H. Biggs for recruiting patients into the DETECT and CTCR-OVO4 studies, all medical and ancillary staff in the breast and gynaecological cancer clinic and patients for consenting to participate. We thank the Human Research Tissue Bank at Addenbrooke's Hospital which is supported by the NIHR Cambridge Biomedical Research Centre. We thank the Cancer Science Institute, National University of Singapore, and the Hematology-Oncology Research Group, National University Health System, Singapore for their support. We acknowledge the support of Cancer Research UK, the University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge Experimental Cancer Medicine Centre, Hutchison Whampoa Limited, and the National Medical Research Council, Singapore. S.-J.D. is supported by an Australian NHMRC/RG Menzies Early Career Fellowship that is administered through the Peter MacCallum Cancer Centre, Victoria, Australia.	Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Chang H, 2011, BREAST CANCER RES TR, V125, P55, DOI 10.1007/s10549-010-0825-z; Cui JJ, 2012, CANCER RES, V72, P5625, DOI 10.1158/0008-5472.CAN-12-1305; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; Nagalingam A, 2012, CARCINOGENESIS, V33, P918, DOI 10.1093/carcin/bgs105; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Punnoose EA, 2012, CLIN CANCER RES, V18, P2391, DOI 10.1158/1078-0432.CCR-11-3148; Sato K, 2012, EMBO J, V31, P3524, DOI 10.1038/emboj.2012.197; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; VanderWeele DJ, 2004, MOL CANCER THER, V3, P1605; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu CC, 2011, BIOCHEM BIOPH RES CO, V405, P168, DOI 10.1016/j.bbrc.2011.01.001; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	29	1206	1311	5	384	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					108	112		10.1038/nature12065	http://dx.doi.org/10.1038/nature12065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23563269				2022-12-24	WOS:000318221500043
J	Kim, SY; Adhikari, A; Lee, SY; Marshel, JH; Kim, CK; Mallory, CS; Lo, M; Pak, S; Mattis, J; Lim, BK; Malenka, RC; Warden, MR; Neve, R; Tye, KM; Deisseroth, K				Kim, Sung-Yon; Adhikari, Avishek; Lee, Soo Yeun; Marshel, James H.; Kim, Christina K.; Mallory, Caitlin S.; Lo, Maisie; Pak, Sally; Mattis, Joanna; Lim, Byung Kook; Malenka, Robert C.; Warden, Melissa R.; Neve, Rachael; Tye, Kay M.; Deisseroth, Karl			Diverging neural pathways assemble a behavioural state from separable features in anxiety	NATURE			English	Article							VENTRAL TEGMENTAL AREA; ELEVATED PLUS-MAZE; STRIA TERMINALIS; BED NUCLEUS; ELECTRICAL-STIMULATION; PROJECTIONS; RESPONSES; FEAR; AMYGDALA; BRAIN	Behavioural states in mammals, such as the anxious state, are characterized by several features that are coordinately regulated by diverse nervous system outputs, ranging from behavioural choice patterns to changes in physiology (in anxiety, exemplified respectively by risk-avoidance and respiratory rate alterations)(1,2). Here we investigate if and how defined neural projections arising from a single coordinating brain region in mice could mediate diverse features of anxiety. Integrating behavioural assays, in vivo and in vitro electrophysiology, respiratory physiology and optogenetics, we identify a surprising new role for the bed nucleus of the stria terminalis (BNST) in the coordinated modulation of diverse anxiety features. First, two BNST subregions were unexpectedly found to exert opposite effects on the anxious state: oval BNST activity promoted several independent anxious state features, whereas anterodorsal BNST-associated activity exerted anxiolytic influence for the same features. Notably, we found that three distinct anterodorsal BNST efferent projections-to the lateral hypothalamus, parabrachial nucleus and ventral tegmental area-each implemented an independent feature of anxiolysis: reduced risk-avoidance, reduced respiratory rate, and increased positive valence, respectively. Furthermore, selective inhibition of corresponding circuit elements in freely moving mice showed opposing behavioural effects compared with excitation, and in vivo recordings during free behaviour showed native spiking patterns in anterodorsal BNST neurons that differentiated safe and anxiogenic environments. These results demonstrate that distinct BNST subregions exert opposite effects in modulating anxiety, establish separable anxiolytic roles for different anterodorsal BNST projections, and illustrate circuit mechanisms underlying selection of features for the assembly of the anxious state.	[Kim, Sung-Yon; Adhikari, Avishek; Lee, Soo Yeun; Marshel, James H.; Kim, Christina K.; Mallory, Caitlin S.; Lo, Maisie; Pak, Sally; Mattis, Joanna; Warden, Melissa R.; Tye, Kay M.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kim, Sung-Yon; Kim, Christina K.; Mallory, Caitlin S.; Mattis, Joanna; Deisseroth, Karl] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Lee, Soo Yeun; Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Lim, Byung Kook; Malenka, Robert C.; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Neve, Rachael; Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Tye, Kay/J-6158-2013; Adhikari, Avishek/A-3339-2012; Marshel, James/W-2792-2019; Adhikari, Avishek/AAF-4444-2021; Core, Vector/CAF-4832-2022; Kim, Sung-Yon/AAO-8405-2020; Adhikari, Avishek/N-1284-2015; Warden, Melissa R/M-9300-2016	Tye, Kay/0000-0002-2435-0182; Adhikari, Avishek/0000-0002-9187-9211; Marshel, James/0000-0003-3517-8493; Adhikari, Avishek/0000-0002-9187-9211; Kim, Sung-Yon/0000-0003-0791-7308; Adhikari, Avishek/0000-0002-9187-9211; Warden, Melissa R/0000-0003-2240-3997; Lim, Byungkook/0000-0002-3766-5415; Mattis, Joanna/0000-0003-0341-1270; Kim, Christina/0000-0002-1466-7098; Mallory, Caitlin/0000-0003-2865-0235	Samsung Scholarship; US National Institute of Mental Health (NIMH); Berry Fellowship; NARSAD; Wiegers Family Fund; NIMH; US National Institute on Drug Abuse (NIDA); DARPA REPAIR Program; Keck Foundation; McKnight Foundation; Gatsby Charitable Foundation; Snyder Foundation; Woo Foundation; Tarlton Foundation; Albert Yu and Mary Bechman Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH088010] Funding Source: NIH RePORTER	Samsung Scholarship(Samsung); US National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Berry Fellowship; NARSAD(NARSAD); Wiegers Family Fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA REPAIR Program; Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Gatsby Charitable Foundation; Snyder Foundation; Woo Foundation; Tarlton Foundation; Albert Yu and Mary Bechman Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Davis, D. Walker, D. Pare, D. Rainnie, H. Shin, K. Thompson, P. Anikeeva, T. Davidson, I. Goshen, A. Andalman, L. Gunaydin, A. Bryant, C. Lee, J. Mirzabekov and the entire Deisseroth laboratory for discussions. Supported by a Samsung Scholarship (to S.-Y.K.), the US National Institute of Mental Health (NIMH; to R. C. M.), and a Berry Fellowship (to A. A.). K. D. and M. R. W. are NARSAD grant awardees, and K. D. was supported by the Wiegers Family Fund, the NIMH, the US National Institute on Drug Abuse (NIDA), the DARPA REPAIR Program, the Keck Foundation, the McKnight Foundation, the Gatsby Charitable Foundation, the Snyder Foundation, the Woo Foundation, the Tarlton Foundation, and the Albert Yu and Mary Bechman Foundation. All tools and methods are distributed and supported freely (http://www.optogenetics.org).	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; CHAMBERLIN NL, 1994, J NEUROSCI, V14, P6500; Dabrowska J, 2011, PSYCHONEUROENDOCRINO, V36, P1312, DOI 10.1016/j.psyneuen.2011.03.003; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dong HW, 2006, J COMP NEUROL, V494, P142, DOI 10.1002/cne.20788; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dong HW, 2004, J COMP NEUROL, V468, P277, DOI 10.1002/cne.10949; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; DUNN JD, 1995, J COMP NEUROL, V352, P227, DOI 10.1002/cne.903520206; DUNN JD, 1987, BRAIN RES, V407, P327, DOI 10.1016/0006-8993(87)91111-5; Duvarci S, 2009, J NEUROSCI, V29, P10357, DOI 10.1523/JNEUROSCI.2119-09.2009; Georges F, 2002, J NEUROSCI, V22, P5173, DOI 10.1523/JNEUROSCI.22-12-05173.2002; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; MARTIN B, 1961, PSYCHOL BULL, V58, P234, DOI 10.1037/h0045492; Poulin JF, 2009, PROG NEURO-PSYCHOPH, V33, P1356, DOI 10.1016/j.pnpbp.2009.06.021; Sartor GC, 2012, EUR J NEUROSCI, V36, P3549, DOI 10.1111/j.1460-9568.2012.08277.x; Schwerdtfeger RMH, 2008, PHYSIOL BEHAV, V93, P697, DOI 10.1016/j.physbeh.2007.11.011; Singewald N, 2003, BIOL PSYCHIAT, V53, P275, DOI 10.1016/S0006-3223(02)01574-3; Straube T, 2007, NEUROIMAGE, V37, P1427, DOI 10.1016/j.neuroimage.2007.06.023; SUESS WM, 1980, PSYCHOPHYSIOLOGY, V17, P535, DOI 10.1111/j.1469-8986.1980.tb02293.x; TERREBERRY RR, 1995, SLEEP, V18, P139, DOI 10.1093/sleep/18.3.139; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; Walker DL, 2009, PROG NEURO-PSYCHOPH, V33, P1291, DOI 10.1016/j.pnpbp.2009.06.022; WOODS JH, 1992, PHARMACOL REV, V44, P151; Yassa MA, 2012, J PSYCHIATR RES, V46, P1045, DOI 10.1016/j.jpsychires.2012.04.013	30	379	411	3	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					219	223		10.1038/nature12018	http://dx.doi.org/10.1038/nature12018			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23515158	Green Accepted			2022-12-24	WOS:000317346300041
J	Cooper, KL; Oh, S; Sung, Y; Dasari, RR; Kirschner, MW; Tabin, CJ				Cooper, Kimberly L.; Oh, Seungeun; Sung, Yongjin; Dasari, Ramachandra R.; Kirschner, Marc W.; Tabin, Clifford J.			Multiple phases of chondrocyte enlargement underlie differences in skeletal proportions	NATURE			English	Article							LONGITUDINAL BONE-GROWTH; PLATE CHONDROCYTES; VOLUME INCREASE; FACTOR-I; HYPERTROPHY; PERFORMANCE; MECHANISMS; HINDLIMB; RATS; AGE	The wide diversity of skeletal proportions in mammals is evident upon a survey of any natural history museum's collections and allows us to distinguish between species even when reduced to their calcified components. Similarly, each individual is comprised of a variety of bones of differing lengths. The largest contribution to the lengthening of a skeletal element, and to the differential elongation of elements, comes from a dramatic increase in the volume of hypertrophic chondrocytes in the growth plate as they undergo terminal differentiation(1-7). However, the mechanisms of chondrocyte volume enlargement have remained a mystery(8-11). Here we use quantitative phase microscopy(12) to show that mammalian chondrocytes undergo three distinct phases of volume increase, including a phase of massive cell swelling in which the cellular dry mass is significantly diluted. In light of the tight fluid regulatory mechanisms known to control volume in many cell types(13), this is a remarkable mechanism for increasing cell size and. regulating growth rate. It is, however, the duration of the final phase of volume enlargement by proportional dry mass increase at low density that varies most between rapidly and slowly elongating growth plates. Moreover, we find that this third phase is locally regulated through a mechanism dependent on insulin-like growth factor. This study provides a framework for understanding how skeletal size is regulated and for exploring how cells sense, modify and establish a volume set point.	[Cooper, Kimberly L.; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Oh, Seungeun; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Sung, Yongjin; Dasari, Ramachandra R.] MIT, George R Harrison Spect Lab, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Cooper, KL (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	kcooper@genetics.med.harvard.edu		Oh, Seungeun/0000-0002-4064-9301; Sung, Yongjin/0000-0001-6371-8771	NIH [P01DK056246, R01GM026875, P41RR02594]; National Science Foundation (NSF) [DBI0754339]; Hamamatsu Corporation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Hamamatsu Corporation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank T. J. Mitchison, C. E. Farnum and members of the Developmental Bone Morphogenesis program project grant (National Institutes of Health (NIH)) for helpful discussions. We also thank the Nikon Imaging Center at Harvard Medical School for technical support, A. Luyten and R. Shivdasani for providing mouse megakaryocytes and P. Ramirez for jerboa care. This work was supported by NIH grants P01DK056246 to C.J.T.; R01GM026875 to M.W.K.; and by NIH grant P41RR02594, National Science Foundation (NSF) grant DBI0754339 and support from the Hamamatsu Corporation to R.R.D.	BARER R, 1953, NATURE, V172, P1097, DOI 10.1038/1721097a0; BARER R, 1952, NATURE, V169, P366, DOI 10.1038/169366b0; BREUR GJ, 1991, J ORTHOPAED RES, V9, P348, DOI 10.1002/jor.1100090306; BUCKWALTER JA, 1986, J BONE JOINT SURG AM, V68A, P243, DOI 10.2106/00004623-198668020-00010; Bush PG, 2008, J CELL PHYSIOL, V214, P621, DOI 10.1002/jcp.21249; Bush PG, 2010, J BONE MINER RES, V25, P1594, DOI 10.1002/jbmr.47; Cooper K. L, 2011, COLD SPRING HARB PRO; Farnum CE, 2002, BONE, V30, P574, DOI 10.1016/S8756-3282(01)00710-4; Farnum CE, 2008, CELLS TISSUES ORGANS, V187, P35, DOI 10.1159/000109962; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; HUNZIKER EB, 1989, J PHYSIOL-LONDON, V414, P55, DOI 10.1113/jphysiol.1989.sp017676; HUNZIKER EB, 1987, J BONE JOINT SURG AM, V69A, P162, DOI 10.2106/00004623-198769020-00002; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuhn JL, 1996, J ORTHOPAED RES, V14, P706, DOI 10.1002/jor.1100140505; Lowe LA, 2000, GENESIS, V26, P118, DOI 10.1002/(SICI)1526-968X(200002)26:2<118::AID-GENE5>3.0.CO;2-S; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Serrat MA, 2007, ANAT REC, V290, P375, DOI 10.1002/ar.20480; Wang J, 1999, FASEB J, V13, P1985, DOI 10.1096/fasebj.13.14.1985; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613; Wilsman NJ, 2008, J ORTHOP RES, V26, P1457, DOI 10.1002/jor.20547; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324	23	216	221	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					375	378		10.1038/nature11940	http://dx.doi.org/10.1038/nature11940			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23485973	Green Accepted, Green Submitted			2022-12-24	WOS:000316650500044
J	Diard, M; Garcia, V; Maier, L; Remus-Emsermann, MNP; Regoes, RR; Ackermann, M; Hardt, WD				Diard, Mederic; Garcia, Victor; Maier, Lisa; Remus-Emsermann, Mitja N. P.; Regoes, Roland R.; Ackermann, Martin; Hardt, Wolf-Dietrich			Stabilization of cooperative virulence by the expression of an avirulent phenotype	NATURE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION SYSTEM; BACTERIAL VIRULENCE; MULTIPLE INFECTION; SOCIAL EVOLUTION; DYNAMICS; PATHOGENICITY; POPULATIONS; MICROBIOTA	Pathogens often infect hosts through collective actions: they secrete growth-promoting compounds or virulence factors, or evoke host reactions that fuel the colonization of the host. Such behaviours are vulnerable to the rise of mutants that benefit from the collective action without contributing to it; how these behaviours can be evolutionarily stable is not well understood(1). We address this question using the intestinal pathogen Salmonella enterica serovar Typhimurium (hereafter termed S. typhimurium), which manipulates its host to induce inflammation, and thereby outcompetes the commensal microbiota(2,3). Notably, the virulence factors needed for host manipulation are expressed in a bistable fashion, leading to a slow-growing subpopulation that expresses virulence genes, and a fast-growing subpopulation that is phenotypically avirulent(4,5). Here we show that the expression of the genetically identical but phenotypically avirulent subpopulation is essential for the evolutionary stability of virulence in this pathogen. Using a combination of mathematical modelling, experimental evolution and competition experiments we found that within-host evolution leads to the emergence of mutants that are genetically avirulent and fast-growing. These mutants are defectors that exploit inflammation without contributing to it. In infection experiments initiated with wild-type S. typhimurium, defectors increase only slowly in frequency. In a genetically modified S. typhimurium strain in which the phenotypically avirulent subpopulation is reduced in size, defectors rise more rapidly, inflammation ceases prematurely, and S. typhimurium is quickly cleared from the gut. Our results establish that host manipulation by S. typhimurium is a cooperative trait that is vulnerable to the rise of avirulent defectors; the expression of a phenotypically avirulent subpopulation that grows as fast as defectors slows down this process, and thereby promotes the evolutionary stability of virulence. This points to a key role of bistable virulence gene expression in stabilizing cooperative virulence and may lead the way to new approaches, for controlling pathogens.	[Diard, Mederic; Maier, Lisa; Remus-Emsermann, Mitja N. P.; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Garcia, Victor; Regoes, Roland R.] ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Ackermann, Martin] Swiss Fed Inst Technol, Dept Environm Syst Sci, CH-8600 Dubendorf, Switzerland; [Ackermann, Martin] Dept Environm Microbiol Eawag, CH-8600 Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Regoes, RR (corresponding author), ETH, Inst Integrat Biol, Univ Str 16, CH-8092 Zurich, Switzerland.	roland.regoes@env.ethz.ch; martin.ackermann@env.ethz.ch; wolf-dietrich.hardt@micro.biol.ethz.ch	Diard, Mederic/AAA-3067-2020; Remus-Emsermann, Mitja NP/R-3776-2016; Garcia, Victor/H-4403-2019; Regoes, Roland R/A-6538-2008; Maier, Lisa/ABH-1893-2021; Ackermann, Martin/V-4554-2017	Remus-Emsermann, Mitja NP/0000-0002-6378-9526; Regoes, Roland R/0000-0001-8319-5293; Maier, Lisa/0000-0002-6473-4762; Ackermann, Martin/0000-0003-0087-4819; Hardt, Wolf-Dietrich/0000-0002-9892-6420; Mederic R.J., Diard/0000-0003-0851-4391	Fondation pour la Recherche Medicale; Swiss National Science Foundation	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank E Slack, R. Kummerli, M. Sellin and L. Robert for comments on the manuscript, G. Paul for input on the modelling, and Hardt laboratory members for discussions. M.D. was supported in part by the Fondation pour la Recherche Medicale. M.A., R.R.R. and W.-D.H. were supported by grants from the Swiss National Science Foundation.	Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; Baxter MA, 2003, INFECT IMMUN, V71, P1295, DOI 10.1128/IAI.71.3.1295-1305.2003; Brown SP, 2008, ECOL LETT, V11, P44, DOI 10.1111/j.1461-0248.2007.01125.x; Brown SP, 1999, P ROY SOC B-BIOL SCI, V266, P1899, DOI 10.1098/rspb.1999.0864; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Buckling A, 2008, HEREDITY, V100, P484, DOI 10.1038/sj.hdy.6801093; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Cremer J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00281; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Golubeva YA, 2012, GENETICS, V190, P79, DOI 10.1534/genetics.111.132779; Harrison F, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-21; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Lysenko ES, 2010, CURR BIOL, V20, P1222, DOI 10.1016/j.cub.2010.05.051; Raymond B, 2012, SCIENCE, V337, P85, DOI 10.1126/science.1218196; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Suar M, 2009, INFECT IMMUN, V77, P3569, DOI 10.1128/IAI.00511-09; vanBaalen M, 1995, AM NAT, V146, P881, DOI 10.1086/285830; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	24	200	200	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					353	356		10.1038/nature11913	http://dx.doi.org/10.1038/nature11913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23426324				2022-12-24	WOS:000315312900038
J	Winter, SE; Winter, MG; Xavier, MN; Thiennimitr, P; Poon, V; Keestra, AM; Laughlin, RC; Gomez, G; Wu, J; Lawhon, SD; Popova, IE; Parikh, SJ; Adams, LG; Tsolis, RM; Stewart, VJ; Baumler, AJ				Winter, Sebastian E.; Winter, Maria G.; Xavier, Mariana N.; Thiennimitr, Parameth; Poon, Victor; Keestra, A. Marijke; Laughlin, Richard C.; Gomez, Gabriel; Wu, Jing; Lawhon, Sara D.; Popova, Ina E.; Parikh, Sanjai J.; Adams, L. Garry; Tsolis, Renee M.; Stewart, Valley J.; Baeumler, Andreas J.			Host-Derived Nitrate Boosts Growth of E. coli in the Inflamed Gut	SCIENCE			English	Article							CROHNS-DISEASE; NITRIC-OXIDE; MICROBIOTA; OXIDATION; DISRUPTS; FLORA	Changes in the microbial community structure are observed in individuals with intestinal inflammatory disorders. These changes are often characterized by a depletion of obligate anaerobic bacteria, whereas the relative abundance of facultative anaerobic Enterobacteriaceae increases. The mechanisms by which the host response shapes the microbial community structure, however, remain unknown. We show that nitrate generated as a by-product of the inflammatory response conferred a growth advantage to the commensal bacterium Escherichia coli in the large intestine of mice. Mice deficient in inducible nitric oxide synthase did not support the growth of E. coli by nitrate respiration, suggesting that the nitrate generated during inflammation was host-derived. Thus, the inflammatory host response selectively enhances the growth of commensal Enterobacteriaceae by generating electron acceptors for anaerobic respiration.	[Winter, Sebastian E.; Winter, Maria G.; Xavier, Mariana N.; Thiennimitr, Parameth; Poon, Victor; Keestra, A. Marijke; Tsolis, Renee M.; Baeumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Thiennimitr, Parameth] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand; [Laughlin, Richard C.; Gomez, Gabriel; Wu, Jing; Lawhon, Sara D.; Adams, L. Garry] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA; [Popova, Ina E.; Parikh, Sanjai J.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Stewart, Valley J.] Univ Calif Davis, Coll Biol Sci, Dept Microbiol, Davis, CA 95616 USA	University of California System; University of California Davis; Chiang Mai University; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Davis; University of California System; University of California Davis	Baumler, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, 1 Shields Ave, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Keestra-Gounder, A. Marijke/H-4394-2012; Thiennimitr, Parameth/AAH-1761-2019; Winter, Sebastian E/A-4118-2009; Byndloss, Mariana X/D-9890-2014; Jung, Kirsten/K-4196-2014; Parikh, Sanjai J/F-3476-2011; Lawhon, Sara D./G-5147-2011; Byndloss, Mariana Xavier/ABD-5506-2021; Baumler, Andreas J/H-2301-2011	Keestra-Gounder, A. Marijke/0000-0002-2231-652X; Winter, Sebastian E/0000-0003-1532-9178; Byndloss, Mariana X/0000-0002-2122-4156; Jung, Kirsten/0000-0003-0779-6841; Parikh, Sanjai J/0000-0002-5260-0417; Lawhon, Sara D./0000-0001-9154-8909; Byndloss, Mariana Xavier/0000-0002-2122-4156; Baumler, Andreas J/0000-0001-9152-7809; Laughlin, Richard/0000-0002-3321-8642; Tsolis, Renee/0000-0001-9131-6657; Popova, Inna/0000-0002-2004-1411; Thiennimitr, Parameth/0000-0002-6339-8744	California Agricultural Experiment Station; Public Health Service [AI090387, AI076246, AI088122]; Faculty of Medicine, Chiang Mai University, Thailand; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI090387, R01AI076246, R21AI088122, R21AI107393] Funding Source: NIH RePORTER	California Agricultural Experiment Station; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Faculty of Medicine, Chiang Mai University, Thailand; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Muller for providing Il10<SUP>flox</SUP>/<SUP>flox</SUP> Cd4-cre mice and E. Romao for technical assistance. The data reported in the manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by the California Agricultural Experiment Station (I.E.P. and S.J.P.) and Public Health Service grants AI090387 (R.M.T), AI076246 (L.G.A and A.J.B.), and AI088122 (A.J.B.). P.T. was supported by a scholarship from the Faculty of Medicine, Chiang Mai University, Thailand.	Balagam B, 2008, INORG CHEM, V47, P1173, DOI 10.1021/ic701402h; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Enocksson A, 2004, CLIN DIAGN LAB IMMUN, V11, P250, DOI 10.1128/CDLI.11.2.250-254.2004; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gennis R. B., 1996, CELLULAR MOL BIOL, V1, P217; GIAFFER MH, 1991, J MED MICROBIOL, V35, P238, DOI 10.1099/00222615-35-4-238; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Hoffman LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000712; KROOK A, 1981, J CLIN PATHOL, V34, P645, DOI 10.1136/jcp.34.6.645; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; LUNDBERG JON, 1994, LANCET, V344, P1673, DOI 10.1016/S0140-6736(94)90460-X; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Pils MC, 2011, INFLAMM BOWEL DIS, V17, P2038, DOI 10.1002/ibd.21587; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Singer II, 1996, GASTROENTEROLOGY, V111, P871, DOI 10.1016/S0016-5085(96)70055-0; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222	21	560	575	11	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					708	711		10.1126/science.1232467	http://dx.doi.org/10.1126/science.1232467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393266	Green Accepted			2022-12-24	WOS:000314585600046
J	Alkema, L; Kantorova, V; Menozzi, C; Biddlecom, A				Alkema, Leontine; Kantorova, Vladimira; Menozzi, Clare; Biddlecom, Ann			National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis	LANCET			English	Article							MODEL	Background Expansion of access to contraception and reduction of unmet need for family planning are key components to improve reproductive health, but scarce data and variability in data sources create difficulties in monitoring of progress for these outcomes. We estimated and projected indicators of contraceptive prevalence and unmet need for family planning from 1990 to 2015. Methods We obtained data from nationally representative surveys, for women aged 15-49 years who were married or in a union. Estimates were based on 930 observations of contraceptive prevalence between 1950 and 2011 from 194 countries or areas, and 306 observations of unmet need for family planning from 111 countries or areas. We used a Bayesian hierarchical model combined with country-specific time trends to yield estimates of these indicators and uncertainty assessments. The model accounted for differences by data source, sample population, and contraceptive methods included in the measure. Findings Worldwide, contraceptive prevalence increased from 54.8% (95% uncertainty interval 52.3-57.1) in 1990, to 63.3% (60.4-66.0) in 2010, and unmet need for family planning decreased from 15.4% (14.1-16.9) in 1990, to 12.3% (10.9-13.9) in 2010. Almost all subregions, except for those where contraceptive prevalence was already high in 1990, had an increase in contraceptive prevalence and a decrease in unmet need for family planning between 1990 and 2010, although the pace of change over time varied between countries and subregions. In 2010, 146 million (130-166 million) women worldwide aged 15-49 years who were married or in a union had an unmet need for family planning. The absolute number of married women who either use contraception or who have an unmet need for family planning is projected to grow from 900 million (876-922 million) in 2010 to 962 million (927-992 million) in 2015, and will increase in most developing countries. Interpretation Trends in contraceptive prevalence and unmet need for family planning, and the projected growth in the number of potential contraceptive users indicate that increased investment is necessary to meet demand for contraceptive methods and improve reproductive health worldwide.	[Alkema, Leontine] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Alkema, Leontine] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Kantorova, Vladimira; Menozzi, Clare; Biddlecom, Ann] United Nations Populat Div, Dept Econ & Social Affairs, New York, NY 10017 USA	National University of Singapore; National University of Singapore	Biddlecom, A (corresponding author), United Nations Populat Div, Dept Econ & Social Affairs, DC2-1988, New York, NY 10017 USA.	biddlecom@un.org	Alkema, Leontine/K-1585-2013	Alkema, Leontine/0000-0001-8806-5957; Biddlecom, Ann/0000-0001-9385-2592; Kantorova, Vladimira/0000-0002-2960-5930	United Nations Population Division; United Nations Population Division, Department of Economic and Social Affairs; National University of Singapore	United Nations Population Division; United Nations Population Division, Department of Economic and Social Affairs; National University of Singapore(National University of Singapore)	LA received consulting fees from the United Nations Population Division for the study. We declare that we have no conflicts of interest.; Funding sources were the United Nations Population Division, Department of Economic and Social Affairs, and a research grant from the National University of Singapore. VK, CM, and AB are staff members of the United Nations Population Division, Department of Economic and Social Affairs. LA is a staff member of the National University of Singapore. The views expressed herein are those of the authors and do not necessarily reflect the views of the United Nations. We thank the numerous survey participants and the staff involved in the collection and publication of the data that we analysed; Kyaw Kyaw Lay for research assistance in implementing the programmes and computing regional aggregates; and Akinrinola Bankole, Le Bao, John Casterline, Alex Cook, Trevor Croft, Patrick Gerland, Petra Nahmias, John Ross, Susheela Singh, John Stover, Mary Beth Weinberger, Hania Zlotnik, and four anonymous reviewers for detailed comments on previous versions of the report.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Bongaarts J, 2002, STUD FAMILY PLANN, V33, P24, DOI 10.1111/j.1728-4465.2002.00024.x; Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; Carr B, 2012, LANCET, V380, P80, DOI 10.1016/S0140-6736(12)60905-2; Casterline JB, 2001, DIFFUSION PROCESSES AND FERTILITY TRANSITION: SELECTED PERSPECTIVES, P1; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; Family Planning Summit Metrics Group, 2012, TECHN NOT DAT SOURC; FishelJoy D, 2012, DHS ANAL STUDIES, V25; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gelman A., 2004, BAYESIAN DATA ANAL; Khan S, 2007, DHS COMP REPORTS, V16; LINDLEY DV, 1972, J ROY STAT SOC B, V34, P1; Marchetti C, 1996, TECHNOL FORECAST SOC, V52, P1, DOI 10.1016/0040-1625(96)00001-7; MAULDIN WP, 1988, STUD FAMILY PLANN, V19, P335, DOI 10.2307/1966628; Moreland RS, 2006, ACHIEVING MILLENNIUM; Plummer M., 2003, P 3 INT WORKSH DISTR; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Ross J, 2011, INT PERSPECT SEX R H, V37, P125, DOI 10.1363/3712511; Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8; Singh S, 2012, ADDING IT COSTS BENE; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; United Nations, 2012, MILLENNIUM DEV GOALS; United Nations Department of Economic and Social Affairs, 2012, WORLD CONTR US 2012; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD CONTR US 2010; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	27	303	309	2	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2013	381	9878					1642	1652		10.1016/S0140-6736(12)62204-1	http://dx.doi.org/10.1016/S0140-6736(12)62204-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146SX	23489750				2022-12-24	WOS:000319112400031
J	Kleinewietfeld, M; Manzel, A; Titze, J; Kvakan, H; Yosef, N; Linker, RA; Muller, DN; Hafler, DA				Kleinewietfeld, Markus; Manzel, Arndt; Titze, Jens; Kvakan, Heda; Yosef, Nir; Linker, Ralf A.; Muller, Dominik N.; Hafler, David A.			Sodium chloride drives autoimmune disease by the induction of pathogenic T(H)17 cells	NATURE			English	Article							THREONINE PROTEIN-KINASE; T-CELLS; OSMOTIC-STRESS; TRANSCRIPTIONAL TARGET; P38 MAPK; TGF-BETA; SGK; GENE; INFLAMMATION; ACTIVATION	There has been a marked increase in the incidence of autoimmune diseases in the past half-century. Although the underlying genetic basis of this class of diseases has recently been elucidated, implicating predominantly immune-response genes(1), changes in environmental factors must ultimately be driving this increase. The newly identified population of interleukin (IL)-17-producing CD4(+) helper T cells (T(H)17 cells) has a pivotal role in autoimmune diseases(2). Pathogenic IL-23-dependent T(H)17 cells have been shown to be critical for the development of experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis, and genetic risk factors associated with multiple sclerosis are related to the IL-23-T(H)17 pathway(1,2). However, little is known about the environmental factors that directly influence T(H)17 cells. Here we show that increased salt (sodium chloride, NaCl) concentrations found locally under physiological conditions in vivo markedly boost the induction of murine and human T(H)17 cells. High-salt conditions activate the p38/MAPK pathway involving nuclear factor of activated T cells 5 (NFAT5; also called TONEBP) and serum/glucocorticoid-regulated kinase 1 (SGK1) during cytokine-induced T(H)17 polarization. Gene silencing or chemical inhibition of p38/MAPK, NFAT5 or SGK1 abrogates the high-salt-induced T(H)17 cell development. The T(H)17 cells generated under high-salt conditions display a highly pathogenic and stable phenotype characterized by the upregulation of the pro-inflammatory cytokines GM-CSF, TNF-alpha and IL-2. Moreover, mice fed with a high-salt diet develop a more severe form of EAE, in line with augmented central nervous system infiltrating and peripherally induced antigen-specific T(H)17 cells. Thus, increased dietary salt intake might represent an environmental risk factor for the development of autoimmune diseases through the induction of pathogenic T(H)17 cells.	[Kleinewietfeld, Markus; Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Kleinewietfeld, Markus; Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Kleinewietfeld, Markus; Yosef, Nir; Hafler, David A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Manzel, Arndt; Linker, Ralf A.] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [Manzel, Arndt] Ruhr Univ Bochum, Int Grad Sch Neurosci, D-44801 Bochum, Germany; [Titze, Jens] Vanderbilt Univ, Div Clin Pharmacol, Nashville, TN 37232 USA; [Titze, Jens] Univ Erlangen Nurnberg, Interdisciplinary Ctr Clin Res, D-91054 Erlangen, Germany; [Titze, Jens] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Kvakan, Heda; Muller, Dominik N.] Expt & Clin Res Ctr, D-13125 Berlin, Germany; [Kvakan, Heda] Helios Klinikum Berlin Buch, D-13125 Berlin, Germany; [Muller, Dominik N.] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany	Yale University; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Erlangen Nuremberg; Ruhr University Bochum; Vanderbilt University; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Helios Kliniken; University of Erlangen Nuremberg	Kleinewietfeld, M (corresponding author), Yale Univ, Sch Med, Dept Neurol, 15 York St, New Haven, CT 06520 USA.	markus.kleinewietfeld@yale.edu; david.hafler@yale.edu	Linker, Ralf/AAD-8884-2020; Kleinewietfeld, Markus/AAI-4497-2021; Titze, Jens/GXV-1636-2022	Kleinewietfeld, Markus/0000-0002-2832-3149; Titze, Jens/0000-0001-8463-8404; Muller, Dominik N/0000-0003-3650-5644	National MS Society Collaborative Research Center [CA1061-A-18]; National Institutes of Health [P01 AI045757, U19 AI046130, U19 AI070352, P01 AI039671]; National Institute of Neurological Disorders and Stroke [NS2427]; Penates Foundation; Nancy Taylor Foundation for Chronic Diseases, Inc.; ELAN programme, University of Erlangen; German Research Foundation (DFG); German Center for Cardiovascular Research (DZHK); Interdisciplinary Center for Clinical Research at University of Erlangen; German Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091568, U01AI102011, P01AI039671, U19AI070352, P01AI045757, U19AI046130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024247] Funding Source: NIH RePORTER	National MS Society Collaborative Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Penates Foundation; Nancy Taylor Foundation for Chronic Diseases, Inc.; ELAN programme, University of Erlangen; German Research Foundation (DFG)(German Research Foundation (DFG)); German Center for Cardiovascular Research (DZHK); Interdisciplinary Center for Clinical Research at University of Erlangen; German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank S. Bhela, M. Zaidi, P. Quass, M. Mroz and S. Seubert for technical assistance and F. C. Luft for critical reading of the manuscript. We are grateful to J.-P. David and S. Teufel for providing Mx-Cre1 p38 alpha<SUP>fl/fl</SUP> mice. This work was supported by a National MS Society Collaborative Research Center Award CA1061-A-18, National Institutes of Health Grants P01 AI045757, U19 AI046130, U19 AI070352, and P01 AI039671, and by a Jacob Javits Merit award (NS2427) from the National Institute of Neurological Disorders and Stroke, the Penates Foundation and the Nancy Taylor Foundation for Chronic Diseases, Inc. (to D. A. H.). R. A. L. was supported by the ELAN programme, University of Erlangen. D.N.M. was supported by the German Research Foundation (DFG) and the German Center for Cardiovascular Research (DZHK). J.T. was supported by the Interdisciplinary Center for Clinical Research at University of Erlangen and the German Research Foundation.	Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Astier AL, 2010, J IMMUNOL, V184, P685, DOI 10.4049/jimmunol.0902443; Bell LM, 2000, J BIOL CHEM, V275, P25262, DOI 10.1074/jbc.M002076200; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Ortells MC, 2012, NUCLEIC ACIDS RES, V40, P4368, DOI 10.1093/nar/gks038; Chen SC, 2009, J CLIN INVEST, V119, P1647, DOI 10.1172/JCI35314; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JUNGER WG, 1994, CIRC SHOCK, V42, P190; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; McGuire S, 2010, ADV NUTR, V1, P49, DOI 10.3945/an.110.1002; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shapiro L, 1995, P NATL ACAD SCI USA, V92, P12230, DOI 10.1073/pnas.92.26.12230; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; Waldegger S, 1999, GASTROENTEROLOGY, V116, P1081, DOI 10.1016/S0016-5085(99)70011-9; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; Waldegger S, 2000, CELL PHYSIOL BIOCHEM, V10, P203, DOI 10.1159/000016351; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wenzel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003742; Woehrle T, 2010, J LEUKOCYTE BIOL, V88, P1181, DOI 10.1189/jlb.0410211; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	38	864	892	7	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					518	+		10.1038/nature11868	http://dx.doi.org/10.1038/nature11868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23467095	Green Accepted			2022-12-24	WOS:000317984400044
J	Darby, SC; Ewertz, M; McGale, P; Bennet, AM; Blom-Goldman, U; Bronnum, D; Correa, C; Cutter, D; Gagliardi, G; Gigante, B; Jensen, MB; Nisbet, A; Peto, R; Rahimi, K; Taylor, C; Hall, P				Darby, Sarah C.; Ewertz, Marianne; McGale, Paul; Bennet, Anna M.; Blom-Goldman, Ulla; Bronnum, Dorthe; Correa, Candace; Cutter, David; Gagliardi, Giovanna; Gigante, Bruna; Jensen, Maj-Britt; Nisbet, Andrew; Peto, Richard; Rahimi, Kazem; Taylor, Carolyn; Hall, Per			Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CAUSE-SPECIFIC MORTALITY; CARDIOVASCULAR-DISEASES; MYOCARDIAL-INFARCTION; SURVIVORS; COHORT	BACKGROUND Radiotherapy for breast cancer often involves some incidental exposure of the heart to ionizing radiation. The effect of this exposure on the subsequent risk of ischemic heart disease is uncertain. METHODS We conducted a population-based case-control study of major coronary events (i.e., myocardial infarction, coronary revascularization, or death from ischemic heart disease) in 2168 women who underwent radiotherapy for breast cancer between 1958 and 2001 in Sweden and Denmark; the study included 963 women with major coronary events and 1205 controls. Individual patient information was obtained from hospital records. For each woman, the mean radiation doses to the whole heart and to the left anterior descending coronary artery were estimated from her radiotherapy chart. RESULTS The overall average of the mean doses to the whole heart was 4.9 Gy (range, 0.03 to 27.72). Rates of major coronary events increased linearly with the mean dose to the heart by 7.4% per gray (95% confidence interval, 2.9 to 14.5; P<0.001), with no apparent threshold. The increase started within the first 5 years after radiotherapy and continued into the third decade after radiotherapy. The proportional increase in the rate of major coronary events per gray was similar in women with and women without cardiac risk factors at the time of radiotherapy. CONCLUSIONS Exposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the subsequent rate of ischemic heart disease. The increase is proportional to the mean dose to the heart, begins within a few years after exposure, and continues for at least 20 years. Women with preexisting cardiac risk factors have greater absolute increases in risk from radiotherapy than other women. (Funded by Cancer Research UK and others.)	[Darby, Sarah C.; McGale, Paul; Cutter, David; Peto, Richard; Taylor, Carolyn] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Rahimi, Kazem] Univ Oxford, George Ctr Healthcare Innovat, Oxford, England; [Nisbet, Andrew] Royal Surrey Cty Hosp, Dept Med Phys, Guildford, Surrey, England; [Nisbet, Andrew] Univ Surrey, Guildford GU2 5XH, Surrey, England; [Ewertz, Marianne] Univ Southern Denmark, Inst Clin Res, Odense Univ Hosp, Dept Oncol, Odense, Denmark; [Bronnum, Dorthe] Aalborg Hosp, Dept Oncol, Aalborg, Denmark; [Jensen, Maj-Britt] Rigshosp, Danish Breast Canc Cooperat Grp, DK-2100 Copenhagen, Denmark; [Bennet, Anna M.; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Gigante, Bruna] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden; [Gigante, Bruna] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Div Cardiovasc Med, Stockholm, Sweden; [Blom-Goldman, Ulla] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden; [Gagliardi, Giovanna] Karolinska Univ Hosp, Dept Med Phys, Stockholm, Sweden; [Taylor, Carolyn] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA	University of Oxford; University of Oxford; Royal Surrey County Hospital; University of Surrey; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital; Danish Breast Cancer Cooperative Group (DBCG); Rigshospitalet; University of Copenhagen; Karolinska Institutet; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Darby, SC (corresponding author), Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	sarah.darby@ctsu.ox.ac.uk	Cutter, David/AAU-6599-2021; Rahimi, Kazem/Q-1279-2015; Nisbet, Andrew/AAK-9799-2021; Nisbet, Andrew/A-9651-2013; Rahimi, Kazem/AAA-4250-2022; Gigante, Bruna/I-9252-2012	Cutter, David/0000-0001-7307-7488; Rahimi, Kazem/0000-0002-4807-4610; Nisbet, Andrew/0000-0002-0652-808X; Nisbet, Andrew/0000-0002-0652-808X; Gigante, Bruna/0000-0003-4508-7990; Bennet-Bark, Anna/0000-0003-2704-2625; Bronnum, Dorthe Scavenius/0000-0002-2723-9148; Ewertz, Marianne/0000-0002-5965-969X	Cancer Research UK; British Heart Foundation; U.K. Medical Research Council; European Commission [FI6R-012796]; U.K. Department of Health [RRX 108]; British Heart Foundation Centre for Research Excellence [CRE RE/08/004]; Oxford National Institute for Health Research Biomedical Research Centre; Medical Research Council [MC_U137686858] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); U.K. Department of Health; British Heart Foundation Centre for Research Excellence; Oxford National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by funding to the Oxford University Clinical Trial Service Unit from Cancer Research UK, the British Heart Foundation, and the U.K. Medical Research Council and by grants from the European Commission (FI6R-012796), the U.K. Department of Health (RRX 108), the British Heart Foundation Centre for Research Excellence (CRE RE/08/004, to Dr. Cutter), and the Oxford National Institute for Health Research Biomedical Research Centre (to Dr. Rahimi).	Abe O, 2005, LANCET, V366, P2087; Aleman BMP, 2003, J CLIN ONCOL, V21, P3431, DOI 10.1200/JCO.2003.07.131; American Cancer Society, 2012, BREAST CANC FACTS FI; Ares C, 2010, INT J RADIAT ONCOL, V76, P685, DOI 10.1016/j.ijrobp.2009.02.062; Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1; Aznar MC, 2011, BRIT J RADIOL, V84, P743, DOI 10.1259/bjr/12497075; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Borger JH, 2007, INT J RADIAT ONCOL, V69, P1131, DOI 10.1016/j.ijrobp.2007.04.042; Bouillon K, 2011, J AM COLL CARDIOL, V57, P445, DOI 10.1016/j.jacc.2010.08.638; Carr ZA, 2005, INT J RADIAT ONCOL, V61, P842, DOI 10.1016/j.ijrobp.2004.07.708; Cutter D, 2013, CANC HEART, P88; CUZICK J, 1994, J CLIN ONCOL, V12, P447, DOI 10.1200/JCO.1994.12.3.447; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Ferlay J, 2010, IARC CANCERBASE; Gagliardi G, 2010, INT J RADIAT ONCOL, V76, pS77, DOI 10.1016/j.ijrobp.2009.04.093; Gulyban A, 2008, STRAHLENTHER ONKOL, V184, P262, DOI 10.1007/s00066-008-1770-1; HANCOCK SL, 1993, JAMA-J AM MED ASSOC, V270, P1949, DOI 10.1001/jama.270.16.1949; Hooning MJ, 2007, JNCI-J NATL CANCER I, V99, P365, DOI 10.1093/jnci/djk064; Jagsi R, 2010, INT J RADIAT ONCOL, V78, P1594, DOI 10.1016/j.ijrobp.2010.04.072; Jones B, 2001, CLIN ONCOL-UK, V13, P71, DOI 10.1053/clon.2001.9221; Kleinbaum DG, 1998, APPL REGRESSION ANAL; Lohr F, 2009, INT J RADIAT ONCOL, V74, P73, DOI 10.1016/j.ijrobp.2008.07.018; McGale P, 2008, INT J EPIDEMIOL, V37, P518, DOI 10.1093/ije/dyn067; McGale P, 2011, RADIOTHER ONCOL, V100, P167, DOI 10.1016/j.radonc.2011.06.016; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; PRESTON D. L., 1993, EPICURE USERS GUIDE; RODRIGUES L, 1990, INT J EPIDEMIOL, V19, P205, DOI 10.1093/ije/19.1.205; Schubert LK, 2011, RADIOTHER ONCOL, V100, P241, DOI 10.1016/j.radonc.2011.01.004; Schultz-Hector S, 2007, INT J RADIAT ONCOL, V67, P10, DOI 10.1016/j.ijrobp.2006.08.071; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Smolina K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8059; StataCorp, 2011, STAT STAT SOFTW REL, P173; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Taylor CW, 2008, INT J RADIAT ONCOL, V72, P501, DOI 10.1016/j.ijrobp.2007.12.058; Taylor CW, 2007, INT J RADIAT ONCOL, V69, P1484, DOI 10.1016/j.ijrobp.2007.05.034; Taylor CW, 2011, RADIOTHER ONCOL, V100, P176, DOI 10.1016/j.radonc.2011.01.020; Taylor CW, 2009, RADIOTHER ONCOL, V90, P127, DOI 10.1016/j.radonc.2008.09.029; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050	41	2223	2310	5	190	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					987	998		10.1056/NEJMoa1209825	http://dx.doi.org/10.1056/NEJMoa1209825			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104HF	23484825	Green Published, Bronze			2022-12-24	WOS:000315982100005
J	Wang, F; Travins, J; DeLaBarre, B; Penard-Lacronique, V; Schalm, S; Hansen, E; Straley, K; Kernytsky, A; Liu, W; Gliser, C; Yang, H; Gross, S; Artin, E; Saada, V; Mylonas, E; Quivoron, C; Popovici-Muller, J; Saunders, JO; Salituro, FG; Yan, SQ; Murray, S; Wei, WT; Gao, Y; Dang, L; Dorsch, M; Agresta, S; Schenkein, DP; Biller, SA; Su, SM; de Botton, S; Yen, KE				Wang, Fang; Travins, Jeremy; DeLaBarre, Byron; Penard-Lacronique, Virginie; Schalm, Stefanie; Hansen, Erica; Straley, Kimberly; Kernytsky, Andrew; Liu, Wei; Gliser, Camelia; Yang, Hua; Gross, Stefan; Artin, Erin; Saada, Veronique; Mylonas, Elena; Quivoron, Cyril; Popovici-Muller, Janeta; Saunders, Jeffrey O.; Salituro, Francesco G.; Yan, Shunqi; Murray, Stuart; Wei, Wentao; Gao, Yi; Dang, Lenny; Dorsch, Marion; Agresta, Sam; Schenkein, David P.; Biller, Scott A.; Su, Shinsan M.; de Botton, Stephane; Yen, Katharine E.			Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation	SCIENCE			English	Article							ONCOMETABOLITE 2-HYDROXYGLUTARATE; HEMATOPOIETIC PROGENITORS; ISOCITRATE DEHYDROGENASE; MUTATION; SUFFICIENT	A number of human cancers harbor somatic point mutations in the genes encoding isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2). These mutations alter residues in the enzyme active sites and confer a gain-of-function in cancer cells, resulting in the accumulation and secretion of the oncometabolite (R)-2-hydroxyglutarate (2HG). We developed a small molecule, AGI-6780, that potently and selectively inhibits the tumor-associated mutant IDH2/R140Q. A crystal structure of AGI-6780 complexed with IDH2/R140Q revealed that the inhibitor binds in an allosteric manner at the dimer interface. The results of steady-state enzymology analysis were consistent with allostery and slow-tight binding by AGI-6780. Treatment with AGI-6780 induced differentiation of TF-1 erythroleukemia and primary human acute myelogenous leukemia cells in vitro. These data provide proof-of-concept that inhibitors targeting mutant IDH2/R140Q could have potential applications as a differentiation therapy for cancer.	[Wang, Fang; Travins, Jeremy; DeLaBarre, Byron; Schalm, Stefanie; Hansen, Erica; Straley, Kimberly; Kernytsky, Andrew; Liu, Wei; Gliser, Camelia; Yang, Hua; Gross, Stefan; Artin, Erin; Popovici-Muller, Janeta; Saunders, Jeffrey O.; Salituro, Francesco G.; Murray, Stuart; Dang, Lenny; Dorsch, Marion; Agresta, Sam; Schenkein, David P.; Biller, Scott A.; Su, Shinsan M.; Yen, Katharine E.] Agios Pharmaceut, Cambridge, MA 02139 USA; [Penard-Lacronique, Virginie; Mylonas, Elena; Quivoron, Cyril; de Botton, Stephane] INSERM, U985, F-94805 Villejuif, France; [Penard-Lacronique, Virginie; Saada, Veronique; Mylonas, Elena; Quivoron, Cyril; de Botton, Stephane] Inst Gustave Roussy, F-94805 Villejuif, France; [Penard-Lacronique, Virginie; Mylonas, Elena; Quivoron, Cyril; de Botton, Stephane] Univ Paris 11, F-91405 Orsay, France; [Yan, Shunqi] Schrodinger Inc, New York, NY 10036 USA; [Wei, Wentao] Viva Biotech, Shanghai 201201, Peoples R China; [Gao, Yi] Shanghai ChemPartner Co, Pudong New Area, Shanghai 201203, Peoples R China	Agios Pharmaceuticals; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Yen, KE (corresponding author), Agios Pharmaceut, Cambridge, MA 02139 USA.	katharine.yen@agios.com	Penard-Lacronique, Virginie/R-1938-2019; Penard-Lacronique, Virginie/E-5729-2016	Penard-Lacronique, Virginie/0000-0001-9435-7331; Penard-Lacronique, Virginie/0000-0001-9435-7331; Dang, Lenny/0000-0002-2073-6109; Quivoron, Cyril/0000-0002-9871-0187; Mylonas, Elena/0000-0001-6831-969X; Veronique, SAADA/0000-0001-8021-9050; DE BOTTON, stephane/0000-0002-8126-4942				Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Fathi AT, 2012, BLOOD, V120, P4649, DOI 10.1182/blood-2012-06-438267; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Huss R, 2000, STEM CELLS, V18, P252, DOI 10.1634/stemcells.18-4-252; Jin GL, 2013, CANCER RES, V73, P496, DOI 10.1158/0008-5472.CAN-12-2852; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Peng YJ, 2008, PROTEIN SCI, V17, P1542, DOI 10.1110/ps.035675.108; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Pronier E, 2011, BLOOD, V118, P2551, DOI 10.1182/blood-2010-12-324707; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang B, 2010, CELL RES, V20, P1188, DOI 10.1038/cr.2010.145; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444	22	583	634	3	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					622	626		10.1126/science.1234769	http://dx.doi.org/10.1126/science.1234769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23558173				2022-12-24	WOS:000318268900051
J	Shilagardi, K; Li, S; Luo, FB; Marikar, F; Duan, R; Jin, P; Kim, JH; Murnen, K; Chen, EH				Shilagardi, Khurts; Li, Shuo; Luo, Fengbao; Marikar, Faiz; Duan, Rui; Jin, Peng; Kim, Ji Hoon; Murnen, Katherine; Chen, Elizabeth H.			Actin-Propelled Invasive Membrane Protrusions Promote Fusogenic Protein Engagement During Cell-Cell Fusion	SCIENCE			English	Article							MYOBLAST FUSION; S2 CELLS; INTEGRINS; IDENTIFICATION; CYTOSKELETON; DYNAMICS; EFF-1; FUSE; WASP; SNS	Cell-cell fusion is critical for the conception, development, and physiology of multicellular organisms. Although cellular fusogenic proteins and the actin cytoskeleton are implicated in cell-cell fusion, it remains unclear whether and how they coordinate to promote plasma membrane fusion. We reconstituted a high-efficiency, inducible cell fusion culture system in the normally nonfusing Drosophila S2R+ cells. Both fusogenic proteins and actin cytoskeletal rearrangements were necessary for cell fusion, and in combination they were sufficient to impart fusion competence. Localized actin polymerization triggered by specific cell-cell or cell-matrix adhesion molecules propelled invasive cell membrane protrusions, which in turn promoted fusogenic protein engagement and plasma membrane fusion. This de novo cell fusion culture system reveals a general role for actin-propelled invasive membrane protrusions in driving fusogenic protein engagement during cell-cell fusion.	[Shilagardi, Khurts; Li, Shuo; Luo, Fengbao; Marikar, Faiz; Duan, Rui; Jin, Peng; Kim, Ji Hoon; Murnen, Katherine; Chen, Elizabeth H.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Chen, EH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	echen@jhmi.edu	duan, rui/AAK-8037-2020; Duan, Rui/I-9015-2018	Duan, Rui/0000-0001-5035-5633	National Institutes of Health [R01 GM098816]; Packard Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Beachy for the S2R+ cell line and G. Seydoux for the C. elegans cDNA; M. Delannoy at Johns Hopkins Microscope Facility for advice on cell culture TEM and immunoEM; J. Reidler, J. Hill, and J. DeWitt at Nikon Instruments Inc. for advice on STORM; and S. Craig, J. Nathans, E. Olson, D. Pan, D. Robinson, G. Seydoux, J. Yang, and members of the Chen lab for discussions and critical reading of the manuscript. K.S. was a postdoctoral fellow of the American Heart Association. Supported by the National Institutes of Health (R01 GM098816) and the Packard Foundation (E.H.C.).	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Avinoam O, 2011, CURR TOP MEMBR, V68, P209, DOI 10.1016/B978-0-12-385891-7.00009-X; Avinoam O, 2011, SCIENCE, V332, P589, DOI 10.1126/science.1202333; Bour BA, 2000, GENE DEV, V14, P1498; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Chen EH, 2011, CURR TOP MEMBR, V68, P235, DOI [10.1016/B978-0-12-385891-7.00010-6, 1016/B978-0-12-385891-7.00010-6]; Duan R, 2012, J CELL BIOL, V199, P169, DOI 10.1083/jcb.201204065; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Fenichel P, 1998, HUM REPROD, V13, P31, DOI 10.1093/humrep/13.suppl_4.31; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; GOTWALS PJ, 1994, CURR OPIN CELL BIOL, V6, P734, DOI 10.1016/0955-0674(94)90101-5; Haralalka S, 2011, DEVELOPMENT, V138, P1551, DOI 10.1242/dev.057653; Islam R, 2003, DEVELOPMENT, V130, P2051, DOI 10.1242/dev.00415; ITO M, 1994, J IMMUNOL, V153, P3256; Jin P, 2011, DEV CELL, V20, P623, DOI 10.1016/j.devcel.2011.04.007; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1; Mohler WA, 2002, DEV CELL, V2, P355, DOI 10.1016/S1534-5807(02)00129-6; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Richardson BE, 2007, DEVELOPMENT, V134, P4357, DOI 10.1242/dev.010678; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schafer G, 2007, DEV BIOL, V304, P664, DOI 10.1016/j.ydbio.2007.01.015; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Sens KL, 2010, J CELL BIOL, V191, P1013, DOI 10.1083/jcb.201006006; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353	33	92	94	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					359	363		10.1126/science.1234781	http://dx.doi.org/10.1126/science.1234781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23470732	Green Accepted			2022-12-24	WOS:000317657500058
J	Apps, R; Qi, Y; Carlson, JM; Chen, HY; Gao, XJ; Thomas, R; Yuki, Y; Del Prete, GQ; Goulder, P; Brumme, ZL; Brumme, CJ; John, M; Mallal, S; Nelson, G; Bosch, R; Heckerman, D; Stein, JL; Soderberg, KA; Moody, MA; Denny, TN; Zeng, X; Fang, JY; Moffett, A; Lifson, JD; Goedert, JJ; Buchbinder, S; Kirk, GD; Fellay, J; McLaren, P; Deeks, SG; Pereyra, F; Walker, B; Michael, NL; Weintrob, A; Wolinsky, S; Liao, W; Carrington, M				Apps, Richard; Qi, Ying; Carlson, Jonathan M.; Chen, Haoyan; Gao, Xiaojiang; Thomas, Rasmi; Yuki, Yuko; Del Prete, Greg Q.; Goulder, Philip; Brumme, Zabrina L.; Brumme, Chanson J.; John, Mina; Mallal, Simon; Nelson, George; Bosch, Ronald; Heckerman, David; Stein, Judy L.; Soderberg, Kelly A.; Moody, M. Anthony; Denny, Thomas N.; Zeng, Xue; Fang, Jingyuan; Moffett, Ashley; Lifson, Jeffrey D.; Goedert, James J.; Buchbinder, Susan; Kirk, Gregory D.; Fellay, Jacques; McLaren, Paul; Deeks, Steven G.; Pereyra, Florencia; Walker, Bruce; Michael, Nelson L.; Weintrob, Amy; Wolinsky, Steven; Liao, Wilson; Carrington, Mary			Influence of HLA-C Expression Level on HIV Control	SCIENCE			English	Article							INFLAMMATORY-BOWEL-DISEASE; T-CELL RESPONSES; DETERMINANTS; ASSOCIATIONS; METAANALYSIS; ALLELES; SYNAPSE; ESCAPE; NUMBER	A variant upstream of human leukocyte antigen C (HLA-C) shows the most significant genome-wide effect on HIV control in European Americans and is also associated with the level of HLA-C expression. We characterized the differential cell surface expression levels of all common HLA-C allotypes and tested directly for effects of HLA-C expression on outcomes of HIV infection in 5243 individuals. Increasing HLA-C expression was associated with protection against multiple outcomes independently of individual HLA allelic effects in both African and European Americans, regardless of their distinct HLA-C frequencies and linkage relationships with HLA-B and HLA-A. Higher HLA-C expression was correlated with increased likelihood of cytotoxic T lymphocyte responses and frequency of viral escape mutation. In contrast, high HLA-C expression had a deleterious effect in Crohn's disease, suggesting a broader influence of HLA expression levels in human disease.	[Apps, Richard; Qi, Ying; Gao, Xiaojiang; Thomas, Rasmi; Yuki, Yuko; Carrington, Mary] SAIC Frederick Inc, Frederick Natl Lab Canc Res, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21702 USA; [Apps, Richard; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Goulder, Philip; Pereyra, Florencia; Walker, Bruce; Carrington, Mary] Massachusetts Gen Hosp, MIT, Ragon Inst, Boston, MA 02114 USA; [Apps, Richard; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Goulder, Philip; Pereyra, Florencia; Walker, Bruce; Carrington, Mary] Harvard Univ, Boston, MA 02114 USA; [Carlson, Jonathan M.; Heckerman, David; Zeng, Xue] Microsoft Res, ESci Grp, Los Angeles, CA 90024 USA; [Chen, Haoyan; Fang, Jingyuan; Liao, Wilson] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94115 USA; [Chen, Haoyan; Lifson, Jeffrey D.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Dept Gastroenterol,Ren Ji Hosp, Shanghai 200001, Peoples R China; [Del Prete, Greg Q.] SAIC Frederick Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD 21702 USA; [Goulder, Philip] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Goulder, Philip] Univ Oxford, Dept Paediat, Oxford OX1 3SY, England; [Brumme, Zabrina L.; Brumme, Chanson J.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Brumme, Zabrina L.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [John, Mina; Mallal, Simon] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia; [Nelson, George] SAIC Frederick Inc, Frederick Natl Lab Canc Res, Ctr Canc Res Genet Core, Basic Res Program, Frederick, MD 21702 USA; [Bosch, Ronald] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Stein, Judy L.; Soderberg, Kelly A.; Moody, M. Anthony; Denny, Thomas N.] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Zeng, Xue] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Dermatol, Beijing 100053, Peoples R China; [Moffett, Ashley] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Goedert, James J.] NCI, Div Canc Epidemiol & Genet, Infect & Immunoepidemiol Branch, Bethesda, MD 20892 USA; [Buchbinder, Susan] San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; [Kirk, Gregory D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Fellay, Jacques; McLaren, Paul] Univ Lausanne Hosp, Inst Microbiol, CH-1015 Lausanne, Switzerland; [Fellay, Jacques; McLaren, Paul] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94105 USA; [Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Weintrob, Amy] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20817 USA; [Wolinsky, Steven] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Microsoft; University of California System; University of California San Francisco; Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Kwazulu Natal; University of Oxford; B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Murdoch University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Harvard T.H. Chan School of Public Health; Duke University; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); San Francisco Department of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of California System; University of California San Francisco; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Uniformed Services University of the Health Sciences - USA; Northwestern University; Feinberg School of Medicine	Carrington, M (corresponding author), SAIC Frederick Inc, Frederick Natl Lab Canc Res, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21702 USA.	carringm@mail.nih.gov	Fellay, Jacques/A-6681-2009; Moffett, Ashley/J-9754-2013; Del Prete, Gregory/C-2030-2012; Mallal, Simon Alexander/HDM-9561-2022; Wolinsky, Steven/B-2893-2012; Moody, M/AAB-6947-2020; ZENG, XUE/AAE-2915-2021; Thomas, Rasmi/AAI-4921-2020	Fellay, Jacques/0000-0002-8240-939X; Mallal, Simon Alexander/0000-0002-7036-1309; Moody, M/0000-0002-3890-5855; McLaren, Paul/0000-0001-6019-7018; fang, jingyuan/0000-0003-2282-0248; Brumme, Chanson/0000-0003-2722-5288; Denny, Thomas/0000-0002-7364-8276; Liao, Wilson/0000-0001-7883-6439; Wolinsky, Steven/0000-0002-9625-6697; Brumme, Zabrina/0000-0002-8157-1037	National Institutes of Health (NIH) [HHSN261200800001E, N02-CP-55504, RO1-AI046995, R01-DA04334, R01-DA12568, R01-AI060460]; Bill & Melinda Gates Foundation [38599]; Mark and Lisa Schwartz Foundation; Wellcome Trust; NIH National Institute of Allergy and Infectious Diseases (NIAID) Center for HIV/AIDS Vaccine Immunology [U01-AI-067854]; Australian National Health and Medical Research Council [384702]; National Institutes of Health [K08AR057763, R01-DA-04334, R01-DA-12568]; Creative and Novel Ideas in HIV Research Program [P30 AI027767-24]; Swiss National Science Foundation [33CSC0-108787]; NIAID; National Cancer Institute; National Heart, Lung, and Blood Institute [UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041];  [RO1 AI087145];  [K24AI069994];  [P30 AI027763];  [UL1 RR024131];  [P30 MH62246];  [R24 AI067039]; NATIONAL CANCER INSTITUTE [ZIABC010791, ZIACP010214, ZICBC011237] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131, M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, R01AI046995, U01AI035040, U01AI035043, U01AI035041, R24AI067039, U01AI035042, R01AI087145, U01AI037613, R01AI060460, U01AI035039, U01AI037984, P30AI027767, K24AI069994, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065174, K08AR057763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004334, R01DA012568, U01DA036297] Funding Source: NIH RePORTER; British Heart Foundation [PG/09/077/27964] Funding Source: researchfish	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Mark and Lisa Schwartz Foundation; Wellcome Trust(Wellcome Trust); NIH National Institute of Allergy and Infectious Diseases (NIAID) Center for HIV/AIDS Vaccine Immunology; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creative and Novel Ideas in HIV Research Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); British Heart Foundation(British Heart Foundation)	This study makes use of data generated by the Wellcome Trust Case Control Consortium (WTCCC); a full list of investigators who contributed to the generation of this data is available at www.wtccc.org.uk. The data reported in this paper are tabulated in the main paper and supplementary materials. Data and materials will be shared subject to institutional review board (IRB) provisions regarding patient privacy. Please contact the corresponding author. Those interested in obtaining Center for HIV/AIDS Vaccine Immunology (CHAVI) samples used in this study should contact M. C. and M. A. M. A Simple Letter Agreement for the Transfer of Materials will be executed between the institutions involved, and an IRB approval/exemption should be obtained by the recipient institution when appropriate. Clinical specimens from the Multicenter AIDS Cohort Study (MACS) are subject to the terms and conditions of the MACS Master Material Transfer Agreement for Non-Profit Institutions. The project has been funded in part with federal funds from the National Institutes of Health (NIH) under contracts HHSN261200800001E, N02-CP-55504, RO1-AI046995, R01-DA04334, R01-DA12568, and R01-AI060460. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services or the Department of Defense, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government. This research was supported in part by grants from the Bill & Melinda Gates Foundation as part of the Collaboration for AIDS Vaccine Discovery and grant ID38599, the Mark and Lisa Schwartz Foundation, the Wellcome Trust, the NIH National Institute of Allergy and Infectious Diseases (NIAID) Center for HIV/AIDS Vaccine Immunology (U01-AI-067854), and the Australian National Health and Medical Research Council (Program Grant 384702). Further funding was from the National Institutes of Health grant K08AR057763 and the Creative and Novel Ideas in HIV Research Program through a supplement to the University of Alabama at the Birmingham Center For AIDS Research funding (P30 AI027767-24), made possible by collaborative efforts of the Office of AIDS Research, NIAID, and the International AIDS Society. We thank M. Trubey and A. Lara for cytometry assistance and all the patients and investigators contributing to samples studied in the WTCCC, CHAVI, Multicenter Hemophilia Cohort Study, San Francisco City Clinic Cohort, Massachusetts General Hospital Controller Cohort, United States Military HIV Natural History Study, DC Gay Cohort Study, British Columbia HOMER cohort, Western Australian HIV Cohort Study, US AIDS Clinical Trials Group, Durban, AIDS Linked to Intravenous Experience (supported by National Institutes of Health grants R01-DA-04334 and R01-DA-12568), Swiss HIV Cohort Study (supported by the Swiss National Science Foundation grant number 33CSC0-108787), Study on the Consequences of Protease Inhibitor Era (supported by grants RO1 AI087145, K24AI069994, P30 AI027763, UL1 RR024131, P30 MH62246, and R24 AI067039), and MACS cohorts (funded by NIAID, with supplemental funding from the National Cancer Institute and the National Heart, Lung, and Blood Institute [grants UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, and UO1-AI-35041].	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bashirova AA, 2011, ANNU REV IMMUNOL, V29, P295, DOI 10.1146/annurev-immunol-031210-101332; Blais ME, 2012, J IMMUNOL, V188, P4663, DOI 10.4049/jimmunol.1103472; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Corrah TW, 2011, J VIROL, V85, P3367, DOI 10.1128/JVI.02276-10; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Heckerman D, 2007, J COMPUT BIOL, V14, P736, DOI 10.1089/cmb.2007.R013; KAGEYAMA S, 1995, J IMMUNOL, V154, P567; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOEFFLER HP, 1984, P NATL ACAD SCI-BIOL, V81, P4080, DOI 10.1073/pnas.81.13.4080; Newman B, 2004, AM J GASTROENTEROL, V99, P306, DOI 10.1111/j.1572-0241.2004.04038.x; O'hUigin C, 2011, AM J HUM GENET, V89, P424, DOI 10.1016/j.ajhg.2011.07.024; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Stokkers PCF, 1999, GUT, V45, P395, DOI 10.1136/gut.45.3.395; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Wright JK, 2010, J VIROL, V84, P10820, DOI 10.1128/JVI.01084-10	25	283	286	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					87	91		10.1126/science.1232685	http://dx.doi.org/10.1126/science.1232685			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559252	Green Submitted, Green Accepted			2022-12-24	WOS:000317061100052
J	Villar, G; Graham, AD; Bayley, H				Villar, Gabriel; Graham, Alexander D.; Bayley, Hagan			A Tissue-Like Printed Material	SCIENCE			English	Article							MICROFLUIDIC DEVICE; DROPLET NETWORKS; LIPID-BILAYERS; WATER DROPLETS; PERMEABILITY	Living cells communicate and cooperate to produce the emergent properties of tissues. Synthetic mimics of cells, such as liposomes, are typically incapable of cooperation and therefore cannot readily display sophisticated collective behavior. We printed tens of thousands of picoliter aqueous droplets that become joined by single lipid bilayers to form a cohesive material with cooperating compartments. Three-dimensional structures can be built with heterologous droplets in software-defined arrangements. The droplet networks can be functionalized with membrane proteins; for example, to allow rapid electrical communication along a specific path. The networks can also be programmed by osmolarity gradients to fold into otherwise unattainable designed structures. Printed droplet networks might be interfaced with tissues, used as tissue engineering substrates, or developed as mimics of living tissue.	[Villar, Gabriel; Graham, Alexander D.; Bayley, Hagan] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	University of Oxford	Bayley, H (corresponding author), Univ Oxford, Dept Chem, Oxford OX1 3TA, England.	hagan.bayley@chem.ox.ac.uk	Taylor, Graham/A-4027-2012	Bayley, Hagan/0000-0003-2499-6116	National Institutes of Health; European Commission's Seventh Framework Programme Revolutionary Approaches and Devices for Nucleic Acid Analysis Consortium; Engineering and Physical Sciences Research Council Life Sciences Interface Doctoral Training Centre studentship; Biotechnology and Biological Sciences Research Council Doctoral Training Programme in Molecular Biochemistry and Chemical Biology studentship; Biotechnology and Biological Sciences Research Council [1112403] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission's Seventh Framework Programme Revolutionary Approaches and Devices for Nucleic Acid Analysis Consortium; Engineering and Physical Sciences Research Council Life Sciences Interface Doctoral Training Centre studentship; Biotechnology and Biological Sciences Research Council Doctoral Training Programme in Molecular Biochemistry and Chemical Biology studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank Q. Li for the alpha HL protein and A. Wainman for assistance with confocal microscopy. This work was supported by grants from the National Institutes of Health and the European Commission's Seventh Framework Programme Revolutionary Approaches and Devices for Nucleic Acid Analysis Consortium. G. V. was supported by an Engineering and Physical Sciences Research Council Life Sciences Interface Doctoral Training Centre studentship. A. D. G. was supported by a Biotechnology and Biological Sciences Research Council Doctoral Training Programme in Molecular Biochemistry and Chemical Biology studentship. The authors have submitted a patent application related to this work. The authors declare no competing financial interests. G. V., A. D. G., and H. B. planned the research. G. V. and A. D. G. designed the experimental system and performed the experiments. G. V. wrote the software, performed the modeling, and analyzed the data. G. V. and H. B. wrote the paper.	Bai YP, 2010, LAB CHIP, V10, P1281, DOI 10.1039/b925133b; BOROSKE E, 1981, BIOPHYS J, V34, P95, DOI 10.1016/S0006-3495(81)84839-4; Dixit SS, 2012, LANGMUIR, V28, P7442, DOI 10.1021/la3005739; Dixit SS, 2010, LANGMUIR, V26, P6193, DOI 10.1021/la1010067; Eisenstein M, 2012, NAT METHODS, V9, P13, DOI 10.1038/nmeth.1842; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Funakoshi K, 2006, ANAL CHEM, V78, P8169, DOI 10.1021/ac0613479; Holden MA, 2007, J AM CHEM SOC, V129, P8650, DOI 10.1021/ja072292a; HU ZB, 1995, SCIENCE, V269, P525, DOI 10.1126/science.269.5223.525; Kim J, 2012, SCIENCE, V335, P1201, DOI 10.1126/science.1215309; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Liang HY, 2011, P NATL ACAD SCI USA, V108, P5516, DOI 10.1073/pnas.1007808108; Maglia G, 2009, NAT NANOTECHNOL, V4, P437, DOI [10.1038/NNANO.2009.121, 10.1038/nnano.2009.121]; Malmstadt N, 2006, NANO LETT, V6, P1961, DOI 10.1021/nl0611034; Nakagawa S, 2010, CURR OPIN STRUC BIOL, V20, P423, DOI 10.1016/j.sbi.2010.05.003; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Needham D, 2011, NAT NANOTECHNOL, V6, P761, DOI 10.1038/nnano.2011.218; Poulin P, 1998, LANGMUIR, V14, P6341, DOI 10.1021/la9801413; Poulos JL, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3167283; Sarles SA, 2010, ANAL CHEM, V82, P959, DOI 10.1021/ac902555z; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; Stanley CE, 2010, CHEM COMMUN, V46, P1620, DOI 10.1039/b924897h; Thiam AR, 2012, LANGMUIR, V28, P6291, DOI 10.1021/la3003349; Thutupalli S, 2011, SOFT MATTER, V7, P1312, DOI 10.1039/c0sm00312c; Villar G, 2011, NAT NANOTECHNOL, V6, P803, DOI [10.1038/nnano.2011.183, 10.1038/NNANO.2011.183]; Xu J, 2010, ADV MATER, V22, P120, DOI 10.1002/adma.200901945; Zagnoni M, 2010, LAB CHIP, V10, P3069, DOI [10.1039/c01c00219d, 10.1039/c0lc00219d]	27	402	412	11	544	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					48	52		10.1126/science.1229495	http://dx.doi.org/10.1126/science.1229495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559243	Green Accepted			2022-12-24	WOS:000317061100040
J	Hurd, MD; Martorell, P; Delavande, A; Mullen, KJ; Langa, KM				Hurd, Michael D.; Martorell, Paco; Delavande, Adeline; Mullen, Kathleen J.; Langa, Kenneth M.			Monetary Costs of Dementia in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALZHEIMERS-DISEASE; PREVALENCE; HEALTH; DEMOGRAPHICS; CARE	Background Dementia affects a large and growing number of older adults in the United States. The monetary costs attributable to dementia are likely to be similarly large and to continue to increase. Methods In a subsample (856 persons) of the population in the Health and Retirement Study (HRS), a nationally representative longitudinal study of older adults, the diagnosis of dementia was determined with the use of a detailed in-home cognitive assessment that was 3 to 4 hours in duration and a review by an expert panel. We then imputed cognitive status to the full HRS sample (10,903 persons, 31,936 person-years) on the basis of measures of cognitive and functional status available for all HRS respondents, thereby identifying persons in the larger sample with a high probability of dementia. The market costs associated with care for persons with dementia were determined on the basis of self-reported out-of-pocket spending and the utilization of nursing home care; Medicare claims data were used to identify costs paid by Medicare. Hours of informal (unpaid) care were valued either as the cost of equivalent formal (paid) care or as the estimated wages forgone by informal caregivers. Results The estimated prevalence of dementia among persons older than 70 years of age in the United States in 2010 was 14.7%. The yearly monetary cost per person that was attributable to dementia was either $56,290 (95% confidence interval [CI], $42,746 to $69,834) or $41,689 (95% CI, $31,017 to $52,362), depending on the method used to value informal care. These individual costs suggest that the total monetary cost of dementia in 2010 was between $157 billion and $215 billion. Medicare paid approximately $11 billion of this cost. Conclusions Dementia represents a substantial financial burden on society, one that is similar to the financial burden of heart disease and cancer. (Funded by the National Institute on Aging.)	[Hurd, Michael D.; Martorell, Paco; Delavande, Adeline; Mullen, Kathleen J.] RAND, Santa Monica, CA 90401 USA; [Hurd, Michael D.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Hurd, Michael D.] Network Studies Pens Aging & Retirement, Tillburg, Netherlands; [Delavande, Adeline] Univ Essex, Colchester CO4 3SQ, Essex, England; [Langa, Kenneth M.] Univ Michigan, Div Gen Med, Vet Affairs Ann Arbor Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Healthcare Policy, Ann Arbor, MI 48109 USA	RAND Corporation; National Bureau of Economic Research; University of Essex; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hurd, MD (corresponding author), RAND, Ctr Aging, 1776 Main St, Santa Monica, CA 90401 USA.	mhurd@rand.org		Langa, Kenneth/0000-0002-2798-1836; Delavande, Adeline/0000-0001-8691-6359	National Institute on Aging [R01AG030155, U01 AG09740]; Social Security Administration; NATIONAL INSTITUTE ON AGING [U01AG009740, R01AG030155] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Social Security Administration; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a grant from the National Institute on Aging (R01AG030155). The Health and Retirement Study is conducted by the Institute for Social Research at the University of Michigan, with grants from the National Institute on Aging (U01 AG09740) and the Social Security Administration.	Abraham KG, 2005, MARKET DESIGNING NON, P55; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2012, NAT PLAN AD IN PRESS; [Anonymous], 2012, TOT EXP PERC DISTR S; [Anonymous], 2010, MARK SURV LONG TERM; [Anonymous], 2004, STAT LONG TERM HLTH; [Anonymous], 2005, STAT LONG TERM HLTH; Association A.s., 2010, ALZHEIMERS DEMENT, P158, DOI [10.1016/j.jalz.2010.01.009, DOI 10.1016/J.JALZ.2010.01.009]; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; BDO Siedman Eljay American Health Care Association, 2007, REP SHORTF MED FUND; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Delavande A, 2013, ALZHEIMERS DEMENT, V9, P19, DOI 10.1016/j.jalz.2011.11.003; Eljay American Health Care Association, 2009, REP SHORTF MED FUND; Eljay American Health Care Association, 2008, REP SHORTF MED FUND; Eljay American Health Care Association, 2010, REP SHORTF MED FUND; Grabowski DC, 2004, HLTH AFFAIRS MILLW S; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Johnston J, 1997, NEUROPSY NEUROPSY BE, P11; JORM AF, 1995, PSYCHOL MED, V25, P437; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Langa KM, 2005, NEUROEPIDEMIOLOGY, V25, P181, DOI 10.1159/000087448; Langa KM, 2001, J GEN INTERN MED, V16, P770, DOI 10.1111/j.1525-1497.2001.10123.x; Norgard TM, 1997, J GERONTOL B-PSYCHOL, V52, P93, DOI 10.1093/geronb/52B.Special_Issue.93; Ofstedal M, 2005, DOCUMENTATION COGNIT, DOI DOI 10.1371/journal.pone.0144722; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; PLASSMAN BL, 1994, NEUROPSY NEUROPSY BE, V7, P235; Plassman Brenda L, 2006, Alzheimers Dement, V2, P2, DOI 10.1016/j.jalz.2005.11.001; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103; Wilson RS, 2011, ALZHEIMERS DEMENT, V7, P74, DOI 10.1016/j.jalz.2010.11.006	30	862	873	2	96	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1326	1334		10.1056/NEJMsa1204629	http://dx.doi.org/10.1056/NEJMsa1204629			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117YT	23550670	Green Accepted			2022-12-24	WOS:000316989900009
J	Hansen, TB; Jensen, TI; Clausen, BH; Bramsen, JB; Finsen, B; Damgaard, CK; Kjems, J				Hansen, Thomas B.; Jensen, Trine I.; Clausen, Bettina H.; Bramsen, Jesper B.; Finsen, Bente; Damgaard, Christian K.; Kjems, Jorgen			Natural RNA circles function as efficient microRNA sponges	NATURE			English	Article							MESSENGER-RNAS; MOUSE TESTIS; TARGET; GENE; CIRCULARIZATION; IDENTIFICATION; GLIOBLASTOMA; TRANSCRIPT; EXPRESSION; RECEPTOR	MicroRNAs (miRNAs) are important post-transcriptional regulators of gene expression that act by direct base pairing to target sites within untranslated regions of messenger RNAs1. Recently, miRNA activity has been shown to be affected by the presence of miRNA sponge transcripts, the so-called competing endogenous RNA in humans and target mimicry in plants(2-7). We previously identified a highly expressed circular RNA (circRNA) in human and mouse brain(8). Here we show that this circRNA acts as a miR-7 sponge; we term this circular transcript ciRS-7 (circular RNA sponge for miR-7). ciRS-7 contains more than 70 selectively conserved miRNA target sites, and it is highly and widely associated with Argonaute (AGO) proteins in a miR-7-dependent manner. Although the circRNA is completely resistant to miRNA-mediated target destabilization, it strongly suppresses miR-7 activity, resulting in increased levels of miR-7 targets. In the mouse brain, we observe overlapping co-expression of ciRS-7 and miR-7, particularly in neocortical and hippocampal neurons, suggesting a high degree of endogenous interaction. We further show that the testis-specific circRNA, sex-determining region Y (Sry)(9), serves as a miR-138 sponge, suggesting that miRNA sponge effects achieved by circRNA formation are a general phenomenon. This study serves as the first, to our knowledge, functional analysis of a naturally expressed circRNA.	[Hansen, Thomas B.; Jensen, Trine I.; Bramsen, Jesper B.; Damgaard, Christian K.; Kjems, Jorgen] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Clausen, Bettina H.; Finsen, Bente] Univ Southern Denmark, Inst Mol Med, DK-5000 Odense C, Denmark; [Bramsen, Jesper B.; Kjems, Jorgen] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark	Aarhus University; University of Southern Denmark; Aarhus University	Kjems, J (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, CF Mollers Alle 3, DK-8000 Aarhus C, Denmark.	tbh@mb.au.dk; jk@mb.au.dk	Kjems, Jorgen/I-3490-2016; Damgaard, Christian/AAP-3147-2021; Damgaard, Christian/AAR-4075-2020; Damgaard, Christian K/G-7360-2015; ravegnini, gloria/K-1330-2016	Kjems, Jorgen/0000-0003-4128-9317; Damgaard, Christian/0000-0003-4940-0868; ravegnini, gloria/0000-0002-7774-402X; Hansen, Thomas/0000-0002-7573-9657; Ilso Jensen, Trine/0000-0002-9224-5376; Clausen, Bettina Hjelm/0000-0003-3302-2022; Finsen, Bente/0000-0002-8323-9329	SIROCCO EU consortium; Lundbeck Foundation; Danish Council for Independent Research - Natural Sciences; Lundbeck Foundation [R83-2011-8232] Funding Source: researchfish	SIROCCO EU consortium; Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research - Natural Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	We thank C. Bus and R. Rosendahl for technical assistance and R. M. Zadegan for art work. We also thank the G. Hannon laboratory for providing us with the Myc-tagged AGO2 expression vector, J. Lykke-Andersen for the DCP1A antibody, and K. L. Lambertsen and C. U. von Linstow for their assistance with confocal microscopy. This work was supported by the SIROCCO EU consortium, the Lundbeck Foundation, and the Danish Council for Independent Research - Natural Sciences. T.B.H. and B.H.C. were supported by the Lundbeck Foundation.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Dubin RA, 1995, GENE, V167, P245, DOI 10.1016/0378-1119(95)00639-7; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Iioka H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1316; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Pasman Z, 1996, RNA, V2, P603; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029	25	4898	5273	44	1076	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					384	388		10.1038/nature11993	http://dx.doi.org/10.1038/nature11993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23446346				2022-12-24	WOS:000316650500046
J	Clair, C; Rigotti, NA; Porneala, B; Fox, CS; D'Agostino, RB; Pencina, MJ; Meigs, JB				Clair, Carole; Rigotti, Nancy A.; Porneala, Bianca; Fox, Caroline S.; D'Agostino, Ralph B., Sr.; Pencina, Michael J.; Meigs, James B.			Association of Smoking Cessation and Weight Change With Cardiovascular Disease Among Adults With and Without Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; CIGARETTE-SMOKING; RISK-FACTORS; MORTALITY; WOMEN; POPULATION; MELLITUS; OUTCOMES	Importance Smoking cessation reduces the risks of cardiovascular disease (CVD), but weight gain that follows quitting smoking may weaken the CVD benefit of quitting. Objective To test the hypothesis that weight gain following smoking cessation does not attenuate the benefits of smoking cessation among adults with and without diabetes. Design, Setting, and Participants Prospective community-based cohort study using data from the Framingham Offspring Study collected from 1984 through 2011. At each 4-year examination, self-reported smoking status was assessed and categorized as smoker, recent quitter (-4 years), long-term quitter (-4 years), and nonsmoker. Pooled Cox proportional hazards models were used to estimate the association between quitting smoking and 6-year CVD events and to test whether 4-year change in weight following smoking cessation modified the association between smoking cessation and CVD events. Main Outcome Measure Incidence over 6 years of total CVD events, comprising coronary heart disease, cerebrovascular events, peripheral artery disease, and congestive heart failure. Results After a mean follow-up of 25 (SD, 9.6) years, 631 CVD events occurred among 3251 participants. Median 4-year weight gain was greater for recent quitters without diabetes (2.7 kg [interquartile range {IQR}, -0.5 to 6.4]) and with diabetes (3.6 kg [IQR, -1.4 to 8.2]) than for long-term quitters (0.9 kg [IQR, -1.4 to 3.2] and 0.0 kg [IQR, -3.2 to 3.2], respectively, P < .001). Among participants without diabetes, age-and sex-adjusted incidence rate of CVD was 5.9 per 100 person-examinations (95% CI, 4.9-7.1) in smokers, 3.2 per 100 person-examinations (95% CI, 2.1-4.5) in recent quitters, 3.1 per 100 person-examinations (95% CI, 2.6-3.7) in long-term quitters, and 2.4 per 100 person-examinations (95% CI, 2.0-3.0) in nonsmokers. After adjustment for CVD risk factors, compared with smokers, recent quitters had a hazard ratio (HR) for CVD of 0.47 (95% CI, 0.23-0.94) and long-term quitters had an HR of 0.46 (95% CI, 0.34-0.63); these associations had only a minimal change after further adjustment for weight change. Among participants with diabetes, there were similar point estimates that did not reach statistical significance. Conclusions and Relevance In this community-based cohort, smoking cessation was associated with a lower risk of CVD events among participants without diabetes, and weight gain that occurred following smoking cessation did not modify this association. This supports a net cardiovascular benefit of smoking cessation, despite subsequent weight gain. JAMA. 2013;309(10):1014-1021 www.jama.com	[Clair, Carole; Rigotti, Nancy A.] Massachusetts Gen Hosp, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA; [Clair, Carole; Rigotti, Nancy A.; Porneala, Bianca; Meigs, James B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gen Med, Boston, MA USA; [Fox, Caroline S.] NHLBI, NIH, Framingham Heart Study, Framingham, MA USA; [D'Agostino, Ralph B., Sr.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Pencina, Michael J.] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Pencina, Michael J.] Harvard Clin Res Inst, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Harvard University; Harvard Medical School	Clair, C (corresponding author), Univ Lausanne, Dept Ambulatory Care & Community Med, 44 Bugnon Ave, CH-1011 Lausanne, Switzerland.	carole.willi@gmail.com	Meigs, James/P-3927-2019; Clair, Carole/AAF-6675-2021; Clair, Carole/D-9786-2014	Meigs, James/0000-0002-2439-2657; Clair, Carole/0000-0001-5281-0943; Clair, Carole/0000-0001-5281-0943; Pencina, Michael/0000-0001-5798-8855	UpToDate Inc; Swiss National Science Foundation [PBLAP3-127728/1]; SICPA Foundation; National Heart, Lung, and Blood Institute (NHLBI) [5K24HL4440-10]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K24 DK080140]; Swiss National Science Foundation; NHLBI Framingham Heart Study [N01-HC-25195]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006094] Funding Source: NIH RePORTER	UpToDate Inc; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SICPA Foundation; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NHLBI Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Rigotti reported serving as an unpaid consultant to Pfizer and Allere Wellbeing Inc; conducting research projects sponsored by Pfizer and Nabi Biopharmaceuticals; and receiving royalties from UpToDate Inc for chapters related to smoking cessation. Dr Pencina reported serving as a data and safety monitoring board member for Thoracos. No other authors reported disclosures.; Dr Clair was supported by a grant from the Swiss National Science Foundation (PBLAP3-127728/1) and by a grant from the SICPA Foundation. Dr Rigotti was supported by National Heart, Lung, and Blood Institute (NHLBI) grant 5K24HL4440-10. Dr Meigs was supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant K24 DK080140.; The Swiss National Science Foundation, SICPA Foundation, and NIDDK had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript. The Framingham Heart Study is supported by the NHLBI Framingham Heart Study (contract N01-HC-25195 [Drs D'Agostino and Pencina]). The NHLBI approved the manuscript.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Al-Delaimy WK, 2002, ARCH INTERN MED, V162, P273, DOI 10.1001/archinte.162.3.273; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004, 10.2337/dc12-s011]; Benowitz NL, 2003, PROG CARDIOVASC DIS, V46, P91, DOI 10.1016/S0033-0620(03)00087-2; Berlin I, 2008, DIABETES METAB, V34, P307, DOI 10.1016/j.diabet.2008.01.008; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Chaturvedi N, 1997, DIABETES CARE, V20, P1266, DOI 10.2337/diacare.20.8.1266; Chiolero A, 2006, PREV MED, V42, P348, DOI 10.1016/j.ypmed.2006.01.011; CUPPLES LA, 1987, NIH PUBLICATION, P87; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Eliasson B, 1997, EUR J CLIN INVEST, V27, P450, DOI 10.1046/j.1365-2362.1997.1330680.x; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Feldstein AC, 2008, DIABETES CARE, V31, P1960, DOI 10.2337/dc08-0426; Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x; Gepner AD, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.023; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Johnson HM, 2010, J AM COLL CARDIOL, V55, P1988, DOI 10.1016/j.jacc.2010.03.002; KAWACHI I, 1993, ANN INTERN MED, V119, P992, DOI 10.7326/0003-4819-119-10-199311150-00005; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; MOY CS, 1990, CIRCULATION, V82, P37, DOI 10.1161/01.CIR.82.1.37; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Pisinger C, 2007, PREV MED, V44, P290, DOI 10.1016/j.ypmed.2006.11.015; Tamura U, 2010, J ATHEROSCLER THROMB, V17, P12, DOI 10.5551/jat.1800; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; US Surgeon General, 1990, HLTH BEN SMOK CESS; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	26	162	163	1	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					1014	1021		10.1001/jama.2013.1644	http://dx.doi.org/10.1001/jama.2013.1644			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23483176	Green Accepted			2022-12-24	WOS:000315938700030
J	Lai, F; Orom, UA; Cesaroni, M; Beringer, M; Taatjes, DJ; Blobel, GA; Shiekhattar, R				Lai, Fan; Orom, Ulf A.; Cesaroni, Matteo; Beringer, Malte; Taatjes, Dylan J.; Blobel, Gerd A.; Shiekhattar, Ramin			Activating RNAs associate with Mediator to enhance chromatin architecture and transcription	NATURE			English	Article							OPITZ-KAVEGGIA-SYNDROME; LONG NONCODING RNAS; GENE-EXPRESSION; HISTONE H3; GENOME; IDENTIFICATION; MED12; MUTATION; COMPLEX	Recent advances in genomic research have revealed the existence of a large number of transcripts devoid of protein-coding potential in multiple organisms(1-8). Although the functional role for long non-coding RNAs (lncRNAs) has been best defined in epigenetic phenomena such as X-chromosome inactivation and imprinting, different classes of lncRNAs may have varied biological functions(8-13). We and others have identified a class of lncRNAs, termed ncRNA-activating (ncRNA-a), that function to activate their neighbouring genes using a cis-mediated mechanism(5,14-16). To define the precise mode by which such enhancer-like RNAs function, we depleted factors with known roles in transcriptional activation and assessed their role in RNA-dependent activation. Here we report that depletion of the components of the co-activator complex, Mediator, specifically and potently diminished the ncRNA-induced activation of transcription in a heterologous reporter assay using human HEK293 cells. In vivo, Mediator is recruited to ncRNA-a target genes and regulates their expression. We show that ncRNA-a interact with Mediator to regulate its chromatin localization and kinase activity towards histone H3 serine 10. The Mediator complex harbouring disease-causing MED12 mutations(17,18) displays diminished ability to associate with activating ncRNAs. Chromosome conformation capture confirmed the presence of DNA looping between the ncRNA-a loci and its targets. Importantly, depletion of Mediator subunits or ncRNA-a reduced the chromatin looping between the two loci. Our results identify the human Mediator complex as the transducer of activating ncRNAs and highlight the importance of Mediator and activating ncRNA association in human disease.	[Lai, Fan; Cesaroni, Matteo; Shiekhattar, Ramin] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Orom, Ulf A.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Beringer, Malte] Ctr Regulacio Genom, Barcelona 08003, Spain; [Beringer, Malte] UPF, Barcelona 08003, Spain; [Taatjes, Dylan J.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA	The Wistar Institute; Max Planck Society; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Colorado System; University of Colorado Boulder; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	shiekhattar@wistar.org	Beringer, Malte/AAC-5734-2020; Beringer, Malte/N-3766-2015; Lai, Fan/ABD-2862-2021	Beringer, Malte/0000-0003-1958-9786; Orom, Ulf/0000-0002-0643-0592; Lai, Fan/0000-0002-0568-2616	NIH [P30 CA 010815]; NCI [R01 CA127364];  [5R37DK058044]; NATIONAL CANCER INSTITUTE [R01CA127364, P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058044, R01DK058044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Shiekhattar laboratory members for support and discussions. We thank W. Dang (Blobel laboratory) and I. Tempera for suggestions and technical help on 3C experiments. R.S. was partially supported by a cancer core grant from NIH (P30 CA 010815). D.J.T. was supported by a grant from the NCI (R01 CA127364). GAB. was supported by 5R37DK058044.	Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; Lee JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003749; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Rump P, 2011, CLIN GENET, V79, P183, DOI 10.1111/j.1399-0004.2010.01449.x; Sopher BL, 2011, NEURON, V70, P1071, DOI 10.1016/j.neuron.2011.05.027; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	27	623	646	3	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					497	501		10.1038/nature11884	http://dx.doi.org/10.1038/nature11884			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23417068	Green Accepted, Green Published			2022-12-24	WOS:000315661500043
J	Markoff, L				Markoff, Lewis			Yellow Fever Outbreak in Sudan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Ctr Biol Evaluat & Res, Lab Vector Borne Virus Dis, Bethesda, MD USA	US Food & Drug Administration (FDA)	Markoff, L (corresponding author), US FDA, Ctr Biol Evaluat & Res, Lab Vector Borne Virus Dis, Bethesda, MD USA.							[Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P477; Centers for Disease Control and Prevention, YELL FEV SUD TRAV HL; Ellis BR, 2008, REV MED VIROL, V18, P331, DOI 10.1002/rmv.584; Monath TP, 2012, EXPERT REV VACCINES, V11, P427, DOI [10.1586/ERV.12.6, 10.1586/erv.12.6]; World Health Organization, YELL FEV SUD UPD	5	34	36	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					689	691		10.1056/NEJMp1300772	http://dx.doi.org/10.1056/NEJMp1300772			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	092CG	23387798				2022-12-24	WOS:000315095800001
J	Brodin, T; Fick, J; Jonsson, M; Klaminder, J				Brodin, T.; Fick, J.; Jonsson, M.; Klaminder, J.			Dilute Concentrations of a Psychiatric Drug Alter Behavior of Fish from Natural Populations	SCIENCE			English	Article							RISK TRADE-OFF; ENVIRONMENTAL RISK; PERSONALITY; BOLDNESS; PHARMACEUTICALS; PLASTICITY; PREDATORS; MORTALITY; PRODUCTS; ECOLOGY	Environmental pollution by pharmaceuticals is increasingly recognized as a major threat to aquatic ecosystems worldwide. A variety of pharmaceuticals enter waterways by way of treated wastewater effluents and remain biochemically active in aquatic systems. Several ecotoxicological studies have been done, but generally, little is known about the ecological effects of pharmaceuticals. Here we show that a benzodiazepine anxiolytic drug (oxazepam) alters behavior and feeding rate of wild European perch (Perca fluviatilis) at concentrations encountered in effluent-influenced surface waters. Individuals exposed to water with dilute drug concentrations (1.8 micrograms liter(-1)) exhibited increased activity, reduced sociality, and higher feeding rate. As such, our results show that anxiolytic drugs in surface waters alter animal behaviors that are known to have ecological and evolutionary consequences.	[Brodin, T.; Jonsson, M.; Klaminder, J.] Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden; [Fick, J.] Umea Univ, Dept Chem, S-90187 Umea, Sweden	Umea University; Umea University	Brodin, T (corresponding author), Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden.	tomas.brodin@emg.umu.se	Jonsson, Micael/E-6839-2012; Berglund Fick, Jerker/HDO-5788-2022	Fick, Jerker/0000-0002-3949-7371; Brodin, Tomas/0000-0003-1086-7567	Umea University; Swedish Research Council Vetenskapsradet; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; strong research environment, "The environment's chemistry-from molecules to the ecosystem"	Umea University; Swedish Research Council Vetenskapsradet(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); strong research environment, "The environment's chemistry-from molecules to the ecosystem"	This study was supported by Umea University via a Young Researcher Award to T. B., J.F., and J.K. Financial support for M.J. was provided by the Swedish Research Council Vetenskapsradet and The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. Support for this study was also provided by a small starting grant from the strong research environment, "The environment's chemistry-from molecules to the ecosystem." The data reported in this paper are archived at the research database at the Department of Ecology and Environmental Science, Umea University, and are also included in the online supplementary materials. The authors declare no competing financial interests. All procedures involving handling of fish were permitted by the Ethical Committee on Animal Experiments in Umea and comply with current Swedish law.	[Anonymous], WORLD MED SIT; Boxall ABA, 2012, ENVIRON HEALTH PERSP, V120, P1221, DOI 10.1289/ehp.1104477; Brodin T, 2004, ECOLOGY, V85, P2927, DOI 10.1890/03-3120; Calisto V, 2011, WATER RES, V45, P6097, DOI 10.1016/j.watres.2011.09.008; Calisto V, 2009, CHEMOSPHERE, V77, P1257, DOI 10.1016/j.chemosphere.2009.09.021; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; DUGATKIN LA, 1992, BEHAV ECOL, V3, P124, DOI 10.1093/beheco/3.2.124; ELLIOTT JM, 1976, J ANIM ECOL, V45, P923, DOI 10.2307/3590; Frost AJ, 2007, P ROY SOC B-BIOL SCI, V274, P333, DOI 10.1098/rspb.2006.3751; Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173; Hummel D, 2006, ENVIRON SCI TECHNOL, V40, P7321, DOI 10.1021/es061740w; Johansson F, 2003, J FRESHWATER ECOL, V18, P415, DOI 10.1080/02705060.2003.9663977; Kosjek T, 2012, WATER RES, V46, P355, DOI 10.1016/j.watres.2011.10.056; Krause J, 2002, LIVING GROUPS; PERSSON L, 1990, ECOLOGY, V71, P1699, DOI 10.2307/1937579; POST JR, 1989, CAN J FISH AQUAT SCI, V46, P1958, DOI 10.1139/f89-246; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Thomson JS, 2012, HORM BEHAV, V61, P750, DOI 10.1016/j.yhbeh.2012.03.014; Verlicchi P, 2012, SCI TOTAL ENVIRON, V429, P123, DOI 10.1016/j.scitotenv.2012.04.028; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; WERNER EE, 1988, ECOLOGY, V69, P1352, DOI 10.2307/1941633	23	526	535	16	742	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					814	815		10.1126/science.1226850	http://dx.doi.org/10.1126/science.1226850			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413353				2022-12-24	WOS:000314874400047
J	Bassik, MC; Kampmann, M; Lebbink, RJ; Wang, SY; Hein, MY; Poser, I; Weibezahn, J; Horlbeck, MA; Chen, SY; Mann, M; Hyman, AA; LeProust, EM; McManus, MT; Weissman, JS				Bassik, Michael C.; Kampmann, Martin; Lebbink, Robert Jan; Wang, Shuyi; Hein, Marco Y.; Poser, Ina; Weibezahn, Jimena; Horlbeck, Max A.; Chen, Siyuan; Mann, Matthias; Hyman, Anthony A.; LeProust, Emily M.; McManus, Michael T.; Weissman, Jonathan S.			A Systematic Mammalian Genetic Interaction Map Reveals Pathways Underlying Ricin Susceptibility	CELL			English	Article							ENDOPLASMIC-RETICULUM; TRANSLATION INITIATION; RETROGRADE TRANSPORT; SHRNA LIBRARIES; PROTEIN TOXINS; OVARIAN-CANCER; HUMAN-CELLS; E. COLI; RNAI; ORGANIZATION	Genetic interaction (GI) maps, comprising pairwise measures of how strongly the function of one gene depends on the presence of a second, have enabled the systematic exploration of gene function in microorganisms. Here, we present a two-stage strategy to construct high-density GI maps in mammalian cells. First, we use ultracomplex pooled shRNA libraries (25 shRNAs/gene) to identify high-confidence hit genes for a given phenotype and effective shRNAs. We then construct double-shRNA libraries from these to systematically measure GIs between hits. A GI map focused on ricin susceptibility broadly recapitulates known pathways and provides many unexpected insights. These include a noncanonical role for COPI, a previously uncharacterized protein complex affecting toxin clearance, a specialized role for the ribosomal protein RPS25, and functionally distinct mammalian TRAPP complexes. The ability to rapidly generate mammalian GI maps provides a potentially transformative tool for defining gene function and designing combination therapies based on synergistic pairs.	[Bassik, Michael C.; Kampmann, Martin; Wang, Shuyi; Weibezahn, Jimena; Horlbeck, Max A.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biomed Res, San Francisco, CA 94122 USA; [Bassik, Michael C.; Kampmann, Martin; Wang, Shuyi; Weibezahn, Jimena; Horlbeck, Max A.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94122 USA; [Lebbink, Robert Jan; McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94122 USA; [Lebbink, Robert Jan; McManus, Michael T.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94122 USA; [Hein, Marco Y.; Mann, Matthias] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Poser, Ina; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Chen, Siyuan; LeProust, Emily M.] Agilent Technol, Genom Solut Unit, Santa Clara, CA 95051 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Max Planck Society; Max Planck Society; Agilent Technologies	Bassik, MC (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biomed Res, San Francisco, CA 94122 USA.	bassik@cmp.ucsf.edu; martin.kampmann@ucsf.edu	mcmanus, michael/AAB-1239-2020; Hyman, Anthony A/B-3917-2017; Lebbink, Robert Jan/GNH-5209-2022; Mann, Matthias/A-3454-2013; Hein, Marco/C-2994-2014; Chen, Siyuan/C-6163-2012; Hyman, Tony/F-1923-2011	mcmanus, michael/0000-0003-3013-6569; Hyman, Anthony A/0000-0003-3664-154X; Mann, Matthias/0000-0003-1292-4799; Hein, Marco/0000-0002-9490-2261; Weissman, Jonathan/0000-0003-2445-670X; Kampmann, Martin/0000-0002-3819-7019; Lebbink, Robert Jan/0000-0002-1981-0420	Jane Coffin Childs Memorial Fund; UCSF Program for Breakthrough Biomedical Research; Leukemia and Lymphoma Society; German medical genome research grant [FKZ01GS0861]; European Community [241548]; HHMI; NIH [1U01CA168370-01, RO1 GM80783]; Howard Hughes Collaborative Initiative Award; NATIONAL CANCER INSTITUTE [U01CA168370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080783, T32GM007618] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund; UCSF Program for Breakthrough Biomedical Research; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); German medical genome research grant; European Community(European Commission); HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Collaborative Initiative Award(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Augsburg, O. Chen, C. Chu, S. Churchman, S. Collins, R. Geiger, A. Heidersbach, N. Ingolia, M. Leuscher, J. Lund, L. Mitic, W. Patena, M. Pham, D. Root, M. Schuldiner, A. Ssykor, N. Stern-Ginossar, K. Thorn, and X. Wang for technical advice and assistance and S. Collins, A. Frost, M. Jonikas, C. Jan, G. Ku, N. Shariat, P. Temkin, M. von Zastrow, D. Acosta-Alvear, and members of the McManus and Weissman labs for helpful discussions and critical reading of the manuscript. The work is supported by the Jane Coffin Childs Memorial Fund and the UCSF Program for Breakthrough Biomedical Research (M.K. and M.T.M and J.S.W.), the Leukemia and Lymphoma Society (M.C.B.), The German medical genome research grant FKZ01GS0861 (M.M. and A.A.H.), the European Community's FP7/2007-2013 under grant agreement 241548 (MitoSys Project, A.A.H.), the HHMI (J.S.W.), the NIH (1U01CA168370-01, J.S.W. and M.T.M; RO1 GM80783, M.T.M.), and a Howard Hughes Collaborative Initiative Award (J.S.W.). E.M.L. and S.C. are employees of Agilent Technologies.	Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/nmeth.1330, 10.1038/NMETH.1330]; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bonifacino JS, 2011, TRENDS CELL BIOL, V21, P159, DOI 10.1016/j.tcb.2010.11.003; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chen A, 2002, BBA-MOL CELL RES, V1589, P124, DOI 10.1016/S0167-4889(02)00163-5; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Choi C, 2011, TRAFFIC, V12, P715, DOI 10.1111/j.1600-0854.2011.01181.x; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Collins SR, 2009, NAT METHODS, V6, P721, DOI 10.1038/nmeth1009-721; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Frost A, 2012, CELL, V149, P1339, DOI 10.1016/j.cell.2012.04.028; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geiger R, 2011, NAT CELL BIOL, V13, P1305, DOI 10.1038/ncb2339; Grimmer S, 2000, MOL BIOL CELL, V11, P4205, DOI 10.1091/mbc.11.12.4205; Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Kim HG, 2010, AM J HUM GENET, V87, P465, DOI 10.1016/j.ajhg.2010.08.018; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Llorente A, 2003, J BIOL CHEM, V278, P35850, DOI 10.1074/jbc.M303425200; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Merrill MK, 2006, J VIROL, V80, P6936, DOI 10.1128/JVI.00243-06; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moreau D, 2011, DEV CELL, V21, P231, DOI 10.1016/j.devcel.2011.06.014; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Pawar V, 2011, J BIOMOL SCREEN, V16, P436, DOI 10.1177/1087057110397890; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Scrivens PJ, 2011, MOL BIOL CELL, V22, P2083, DOI 10.1091/mbc.E10-11-0873; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Yamasaki A, 2009, MOL BIOL CELL, V20, P4205, DOI 10.1091/mbc.E09-05-0387; Zong M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023350; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	52	249	255	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					909	922		10.1016/j.cell.2013.01.030	http://dx.doi.org/10.1016/j.cell.2013.01.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23394947	Green Accepted, Bronze			2022-12-24	WOS:000314945600023
J	Tropberger, P; Pott, S; Keller, C; Kamieniarz-Gdula, K; Caron, M; Richter, F; Li, GH; Mittler, G; Liu, ET; Buhler, M; Margueron, R; Schneider, R				Tropberger, Philipp; Pott, Sebastian; Keller, Claudia; Kamieniarz-Gdula, Kinga; Caron, Matthieu; Richter, Florian; Li, Guohong; Mittler, Gerhard; Liu, Edison T.; Buehler, Marc; Margueron, Raphael; Schneider, Robert			Regulation of Transcription through Acetylation of H3K122 on the Lateral Surface of the Histone Octamer	CELL			English	Article							NUCLEOSOME EVICTION; FISSION YEAST; IN-VITRO; CHROMATIN; IDENTIFICATION; DISTINCT; P300; H3; ACTIVATION; STABILITY	Histone modifications are key regulators of chromatin function. However, little is known to what extent histone modifications can directly impact on chromatin. Here, we address how a modification within the globular domain of histones regulates chromatin function. We demonstrate that H3K122ac can be sufficient to stimulate transcription and that mutation of H3K122 impairs transcriptional activation, which we attribute to a direct effect of H3K122ac on histone-DNA binding. In line with this, we find that H3K122ac defines genome-wide genetic elements and chromatin features associated with active transcription. Furthermore, H3K122ac is catalyzed by the coactivators p300/CBP and can be induced by nuclear hormone receptor signaling. Collectively, this suggests that transcriptional regulators elicit their effects not only via signaling to histone tails but also via direct structural perturbation of nucleosomes by directing acetylation to their lateral surface.	[Tropberger, Philipp; Kamieniarz-Gdula, Kinga; Richter, Florian; Mittler, Gerhard; Schneider, Robert] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Tropberger, Philipp; Schneider, Robert] Univ Strasbourg, INSERM,U964, CNRS UMR 7104, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Pott, Sebastian; Liu, Edison T.] Genome Inst Singapore, Singapore 138672, Singapore; [Keller, Claudia; Buehler, Marc] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Keller, Claudia; Buehler, Marc] Univ Basel, CH-4003 Basel, Switzerland; [Caron, Matthieu; Margueron, Raphael] Inst Curie, F-75005 Paris, France; [Caron, Matthieu; Margueron, Raphael] CNRS, UMR 3215, F-75005 Paris, France; [Caron, Matthieu; Buehler, Marc] INSERM, U934, F-75005 Paris, France; [Li, Guohong] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Friedrich Miescher Institute for Biomedical Research; University of Basel; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Chinese Academy of Sciences; Institute of Biophysics, CAS	Schneider, R (corresponding author), Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany.	schneidr@igbmc.fr	Buehler, Marc/S-5866-2019; Margueron, Raphael F/B-9996-2015	Buehler, Marc/0000-0001-6661-9795; Margueron, Raphael F/0000-0002-9093-7977; Kamieniarz-Gdula, Kinga/0000-0003-3789-5381; Caron, Matthieu/0000-0002-6905-7545; Keller Valsecchi, Claudia Isabelle/0000-0003-4135-5927	Max Planck Society; DFG [SFB 746]; Fondation pour la Recherche Medicale; ERC; Institut Nationale du Cancer; Swiss National Science Foundation; Gebert Ruf Foundation; Novartis Research Foundation; EMBO Young Investigator Programme	Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ERC(European Research Council (ERC)European Commission); Institut Nationale du Cancer; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gebert Ruf Foundation; Novartis Research Foundation; EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO))	We thank S. Daujat and all members of the Schneider and Margueron laboratories. We are grateful to H. Neumann for providing expression plasmids and advice and to G. Langst for ACF remodeling complex. We would like to thank I. del Valle for cell pellets for histone extraction. We thank H. Holz for advice and help for protein purification and M. Cohen for quantification of acetylated peptides. Work in the Schneider laboratory was supported by the Max Planck Society, the DFG (through SFB 746), the Fondation pour la Recherche Medicale, and an ERC starting grant; the R. Margueron laboratory was supported by the Institut Nationale du Cancer and Fondation pour la Recherche Medicale. Research in the laboratory of M. Buhler was supported by funds from the Swiss National Science Foundation, the ERC, the Gebert Ruf Foundation, the Novartis Research Foundation, and the EMBO Young Investigator Programme.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bintu L, 2012, CELL, V151, P738, DOI 10.1016/j.cell.2012.10.009; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Fenley AT, 2010, BIOPHYS J, V99, P1577, DOI 10.1016/j.bpj.2010.06.046; Freitas MA, 2004, J CELL BIOCHEM, V92, P691, DOI 10.1002/jcb.20106; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Garcia Benjamin A, 2009, Front Biosci (Schol Ed), V1, P142, DOI 10.2741/s14; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Hainer SJ, 2011, MOL CELL BIOL, V31, P3557, DOI 10.1128/MCB.05195-11; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Hyndman BD, 2012, BBA-GENE REGUL MECH, V1819, P446, DOI 10.1016/j.bbagrm.2012.02.009; Ito T, 2000, GENE DEV, V14, P1899; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Iwasaki W, 2011, BIOCHEMISTRY-US, V50, P7822, DOI 10.1021/bi201021h; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koopmans WJA, 2009, BIOPHYS J, V97, P195, DOI 10.1016/j.bpj.2009.04.030; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li GH, 2010, MOL CELL, V38, P41, DOI 10.1016/j.molcel.2010.01.042; Lin JJ, 2011, GENE DEV, V25, P2198, DOI 10.1101/gad.17554711; Luebben WR, 2010, P NATL ACAD SCI USA, V107, P19254, DOI 10.1073/pnas.1009650107; Luger K, 1999, METHOD ENZYMOL, V304, P3; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nightingale KP, 1998, EMBO J, V17, P2865, DOI 10.1093/emboj/17.10.2865; OwenHughes T, 1996, EMBO J, V15, P4702, DOI 10.1002/j.1460-2075.1996.tb00847.x; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Sewack GF, 1997, J BIOL CHEM, V272, P31118, DOI 10.1074/jbc.272.49.31118; Sewack GF, 2001, MOL CELL BIOL, V21, P1404, DOI 10.1128/MCB.21.4.1404-1415.2001; Sharma N, 2008, P NATL ACAD SCI USA, V105, P7959, DOI 10.1073/pnas.0800534105; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tropberger P, 2010, EPIGENETICS-US, V5, P112, DOI 10.4161/epi.5.2.11075; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Valdes-Mora F, 2012, GENOME RES, V22, P307, DOI 10.1101/gr.118919.110; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wagschal A., 2007, CSH PROTOC 2007, V2007; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	65	154	162	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					859	872		10.1016/j.cell.2013.01.032	http://dx.doi.org/10.1016/j.cell.2013.01.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415232	Bronze			2022-12-24	WOS:000314945600019
J	Krumholz, HM; Lin, ZQ; Keenan, PS; Chen, J; Ross, JS; Drye, EE; Bernheim, SM; Wang, Y; Bradley, EH; Han, LF; Normand, SLT				Krumholz, Harlan M.; Lin, Zhenqiu; Keenan, Patricia S.; Chen, Jersey; Ross, Joseph S.; Drye, Elizabeth E.; Bernheim, Susannah M.; Wang, Yun; Bradley, Elizabeth H.; Han, Lein F.; Normand, Sharon-Lise T.			Relationship Between Hospital Readmission and Mortality Rates for Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, or Pneumonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE; CARE; QUALITY; SYSTEM; URBAN	Importance The Centers for Medicare & Medicaid Services publicly reports hospital 30-day, all-cause, risk-standardized mortality rates (RSMRs) and 30-day, all-cause, risk-standardized readmission rates (RSRRs) for acute myocardial infarction, heart failure, and pneumonia. The evaluation of hospital performance as measured by RSMRs and RSRRs has not been well characterized. Objective To determine the relationship between hospital RSMRs and RSRRs overall and within subgroups defined by hospital characteristics. Design, Setting, and Participants We studied Medicare fee-for-service beneficiaries discharged with acute myocardial infarction, heart failure, or pneumonia between July 1, 2005, and June 30, 2008 (4506 hospitals for acute myocardial infarction, 4767 hospitals for heart failure, and 4811 hospitals for pneumonia). We quantified the correlation between hospital RSMRs and RSRRs using weighted linear correlation; evaluated correlations in groups defined by hospital characteristics; and determined the proportion of hospitals with better and worse performance on both measures. Main Outcome Measures Hospital 30-day RSMRs and RSRRs. Results Mean RSMRs and RSRRs, respectively, were 16.60% and 19.94% for acute myocardial infarction, 11.17% and 24.56% for heart failure, and 11.64% and 18.22% for pneumonia. The correlations between RSMRs and RSRRs were 0.03 (95% CI, -0.002 to 0.06) for acute myocardial infarction, -0.17 (95% CI, -0.20 to -0.14) for heart failure, and 0.002 (95% CI, -0.03 to 0.03) for pneumonia. The results were similar for subgroups defined by hospital characteristics. Although there was a significant negative linear relationship between RSMRs and RSRRs for heart failure, the shared variance between them was only 2.9% (r(2)=0.029), with the correlation most prominent for hospitals with RSMR <11%. Conclusion and Relevance Risk-standardized mortality rates and readmission rates were not associated for patients admitted with an acute myocardial infarction or pneumonia and were only weakly associated, within a certain range, for patients admitted with heart failure. JAMA. 2013;309(6):587-593 www.jama.com	[Krumholz, Harlan M.; Drye, Elizabeth E.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Ross, Joseph S.; Bernheim, Susannah M.] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06510 USA; [Krumholz, Harlan M.; Lin, Zhenqiu; Ross, Joseph S.; Drye, Elizabeth E.; Bernheim, Susannah M.; Wang, Yun] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Krumholz, Harlan M.; Keenan, Patricia S.; Bradley, Elizabeth H.] Yale Univ, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Wang, Yun; Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Han, Lein F.] Ctr Medicare Serv, Baltimore, MD USA; [Han, Lein F.] Ctr Medicaid Serv, Baltimore, MD USA; [Chen, Jersey] Yale Univ, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320; Normand, Sharon-Lise/0000-0001-7027-4769	National Heart, Lung, and Blood Institute [U01 HL105270-03]; Agency for Healthcare Research and Quality [K08 HS018781-03]; National Institute on Aging [K08 AG032886-05]; American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; CMS, an agency of the US Department of Health and Human Services [HHSM-500-2008-0025I/HHSM-500-T0001, 000007]; Medtronic through Yale University; CMS; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018781] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; CMS, an agency of the US Department of Health and Human Services; Medtronic through Yale University; CMS; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Krumholz and Ross report that they are recipients of a research grant from Medtronic through Yale University. Dr Krumholz chairs a cardiac scientific advisory board for United-Health. Dr Ross is a member of a scientific advisory board for FAIR Health. Dr Normand reports being a member of the Board of Directors of Frontier Science & Technology Research Foundation. Drs Drye, Krumholz, Lin, Bernheim, Wang, and Normand report that they receive contract funding from CMS to develop and maintain quality measures. No other disclosures were reported.; Dr Krumholz is supported by grant U01 HL105270-03 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. Dr Chen is supported by Career Development Award K08 HS018781-03 from the Agency for Healthcare Research and Quality. Dr Ross is supported by grant K08 AG032886-05 from the National Institute on Aging and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program. The analyses on which this publication is based were performed under contract HHSM-500-2008-0025I/HHSM-500-T0001, Modification No. 000007, entitled "Measure Instrument Development and Support," funded by CMS, an agency of the US Department of Health and Human Services.	[Anonymous], FED REG; Ash AS, STAT ISSUES ASSESSIN; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Centers for Medicare and Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P51476; Desai MM, 2009, 2009 MEASURES MAINTE; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Hadley J, 2004, HEALTH SERV RES, V39, P1527, DOI 10.1111/j.1475-6773.2004.00302.x; Hart LG, 2005, AM J PUBLIC HEALTH, V95, P1149, DOI 10.2105/AJPH.2004.042432; Heidenreich PA, 2010, J AM COLL CARDIOL, V56, P362, DOI 10.1016/j.jacc.2010.02.053; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; Krumholz HM, 2000, AM HEART J, V139, P72, DOI 10.1016/S0002-8703(00)90311-9; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Morrill R, 1999, URBAN GEOGR, V20, P727, DOI 10.2747/0272-3638.20.8.727; Normand SLT, 2002, STAT MED, V21, P331, DOI 10.1002/sim.1020; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; Ross JS, 2007, HEALTH AFFAIR, V26, P238, DOI 10.1377/hlthaff.26.1.238; Serrie J, 2012, MORE 2200 HOSP FACE	23	267	269	2	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2013	309	6					587	593		10.1001/jama.2013.333	http://dx.doi.org/10.1001/jama.2013.333			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087PH	23403683	Green Accepted			2022-12-24	WOS:000314773700031
J	Wu, C; Yosef, N; Thalhamer, T; Zhu, C; Xiao, S; Kishi, Y; Regev, A; Kuchroo, VK				Wu, Chuan; Yosef, Nir; Thalhamer, Theresa; Zhu, Chen; Xiao, Sheng; Kishi, Yasuhiro; Regev, Aviv; Kuchroo, Vijay K.			Induction of pathogenic T(H)17 cells by inducible salt-sensing kinase SGK1	NATURE			English	Article							PROTEIN-KINASE; SERUM; ACTIVATION; DIFFERENTIATION; TRANSCRIPTION; SYSTEM	T(H)17 cells (interleukin-17 (IL-17)-producing helper T cells) are highly proinflammatory cells that are critical for clearing extracellular pathogens and for inducing multiple autoimmune diseases(1). IL-23 has a critical role in stabilizing and reinforcing the T(H)17 phenotype by increasing expression of IL-23 receptor (IL-23R) and endowing T(H)17 cells with pathogenic effector functions(2,3). However, the precise molecular mechanism by which IL-23 sustains the T(H)17 response and induces pathogenic effector functions has not been elucidated. Here we used transcriptional profiling of developing T(H)17 cells to construct a model of their signalling network and nominate major nodes that regulate T(H)17 development. We identified serum glucocorticoid kinase 1 (SGK1), a serine/threonine kinase(4), as an essential node downstream of IL-23 signalling. SGK1 is critical for regulating IL-23R expression and stabilizing the T(H)17 cell phenotype by deactivation of mouse Foxo1, a direct repressor of IL-23R expression. SGK1 has been shown to govern Na+ transport and salt (NaCl) homeostasis in other cells(5-8). We show here that a modest increase in salt concentration induces SGK1 expression, promotes IL-23R expression and enhances T(H)17 cell differentiation in vitro and in vivo, accelerating the development of autoimmunity. Loss of SGK1 abrogated Na+-mediated T(H)17 differentiation in an IL-23-dependent manner. These data demonstrate that SGK1 has a critical role in the induction of pathogenic T(H)17 cells and provide a molecular insight into a mechanism by which an environmental factor such as a high salt diet triggers T(H)17 development and promotes tissue inflammation.	[Wu, Chuan; Yosef, Nir; Thalhamer, Theresa; Zhu, Chen; Xiao, Sheng; Kishi, Yasuhiro; Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Yosef, Nir; Regev, Aviv; Kuchroo, Vijay K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02140 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), Broad Inst MIT & Harvard, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	aregev@broad.mit.edu; vkuchroo@rics.bwh.harvard.edu	Wu, Chuan/H-6379-2013	Wu, Chuan/0000-0003-2288-353X	US National Institutes of Health [NS030843, NS045937, AI073748, AI045757, 1P01HG005062-01, 1P50HG006193-01, DP1-OD003958-01, K01DK090105]; National MS Society [RG2571]; Howard Hughes Medical Institute; Klarman Cell Observatory; Guthy Jackson Foundation; Austrian Science Fund (FWF) [J 3091-B12]; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG005062, P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073748, P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030843, R29NS030843, R01NS030843, R01NS045937] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National MS Society(National Multiple Sclerosis Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Klarman Cell Observatory; Guthy Jackson Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Kozoriz for cell sorting and A. Waisman for providing Il17f<SUP>Cre</SUP> mice. L. Zhou, D. Accili, J. Demoulin and K. Sato provided reagents. This work was supported by the US National Institutes of Health (NS030843, NS045937, AI073748 and AI045757 to V. K. K.; 1P01HG005062-01, 1P50HG006193-01 and DP1-OD003958-01 to A. R.; and K01DK090105 to S. X.); the National MS Society (RG2571 to V. K. K.); the Howard Hughes Medical Institute (A. R.); the Klarman Cell Observatory; Guthy Jackson Foundation; and the Austrian Science Fund (FWF, J 3091-B12 to T.T.).	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Chechik G, 2009, J COMPUT BIOL, V16, P279, DOI 10.1089/cmb.2008.13TT; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Di Pietro N, 2010, MOL ENDOCRINOL, V24, P370, DOI 10.1210/me.2009-0265; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Herrada AA, 2010, J IMMUNOL, V184, P191, DOI 10.4049/jimmunol.0802886; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Salker MS, 2011, NAT MED, V17, P1509, DOI 10.1038/nm.2498; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Shelly C, 2002, J CELL SCI, V115, P1985; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Yosef N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001935; Zhang LP, 2005, CANCER RES, V65, P457; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	23	670	692	2	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					513	517		10.1038/nature11984	http://dx.doi.org/10.1038/nature11984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23467085	Green Accepted, Green Submitted			2022-12-24	WOS:000317984400043
J	Zemach, A; Kim, MY; Hsieh, PH; Coleman-Derr, D; Eshed-Williams, L; Thao, K; Harmer, SL; Zilberman, D				Zemach, Assaf; Kim, M. Yvonne; Hsieh, Ping-Hung; Coleman-Derr, Devin; Eshed-Williams, Leor; Thao, Ka; Harmer, Stacey L.; Zilberman, Daniel			The Arabidopsis Nucleosome Remodeler DDM1 Allows DNA Methyltransferases to Access H1-Containing Heterochromatin	CELL			English	Article							HISTONE H1; TRANSPOSABLE ELEMENTS; CYTOSINE METHYLATION; GENE-EXPRESSION; RNA; MAINTENANCE; RETROTRANSPOSITION; DEMETHYLATION; DYNAMICS; PATTERNS	Nucleosome remodelers of the DDM1/Lsh family are required for DNA methylation of transposable elements, but the reason for this is unknown. How DDM1 interacts with other methylation pathways, such as small-RNA-directed DNA methylation (RdDM), which is thought to mediate plant asymmetric methylation through DRM enzymes, is also unclear. Here, we show that most asymmetric methylation is facilitated by DDM1 and mediated by the methyltransferase CMT2 separately from RdDM. We find that heterochromatic sequences preferentially require DDM1 for DNA methylation and that this preference depends on linker histone H1. RdDM is instead inhibited by heterochromatin and absolutely requires the nucleosome remodeler DRD1. Together, DDM1 and RdDM mediate nearly all transposon methylation and collaborate to repress transposition and regulate the methylation and expression of genes. Our results indicate that DDM1 provides DNA methyltransferases access to H1-containing heterochromatin to allow stable silencing of transposable elements in cooperation with the RdDM pathway.	[Zemach, Assaf; Kim, M. Yvonne; Hsieh, Ping-Hung; Coleman-Derr, Devin; Eshed-Williams, Leor; Thao, Ka; Harmer, Stacey L.; Zilberman, Daniel] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zilberman, D (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	danielz@berkeley.edu	Zhu, Anyu/J-8298-2012	Eshed Williams, Leor/0000-0002-2766-2608; Zemach, Assaf/0000-0003-3282-4445; Harmer, Stacey/0000-0001-6813-6682; Zilberman, Daniel/0000-0002-0123-8649	Jane Coffin Childs Memorial Fund for Medical Research; Taiwan Ministry of Education Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069418] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; Taiwan Ministry of Education Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Toshiro Nishimura for computational support, Minyong Chung for Illumina sequencing, and Robert Fischer for critical reading of the manuscript. A.Z. was supported by a fellowship from the Jane Coffin Childs Memorial Fund for Medical Research. P-H.H. is supported by a Taiwan Ministry of Education Scholarship. D.Z. is a Young Investigator of the Arnold and Mabel Beckman Foundation.	Ahmed I, 2011, NUCLEIC ACIDS RES, V39, P6919, DOI 10.1093/nar/gkr324; Barra JL, 2000, MOL CELL BIOL, V20, P61, DOI 10.1128/MCB.20.1.61-69.2000; Blevins T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005932; Brzeski J, 2003, J BIOL CHEM, V278, P823, DOI 10.1074/jbc.M209260200; Buisine N, 2008, GENOMICS, V91, P467, DOI 10.1016/j.ygeno.2008.01.005; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Coleman-Derr D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002988; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Ibarra CA, 2012, SCIENCE, V337, P1360, DOI 10.1126/science.1224839; Iyer VR, 2012, TRENDS CELL BIOL, V22, P250, DOI 10.1016/j.tcb.2012.02.004; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jullien PE, 2012, CURR BIOL, V22, P1825, DOI 10.1016/j.cub.2012.07.061; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee TF, 2012, EPIGENETICS-US, V7, P781, DOI 10.4161/epi.20290; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Miura A, 2009, EMBO J, V28, P1078, DOI 10.1038/emboj.2009.59; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Probst AV, 2004, PLANT CELL, V16, P1021, DOI 10.1105/tpc.018754; Qian WQ, 2012, SCIENCE, V336, P1445, DOI 10.1126/science.1219416; Raghuram N, 2009, BIOCHEM CELL BIOL, V87, P189, DOI 10.1139/O08-127; Rea M, 2012, PLANT J, V71, P776, DOI 10.1111/j.1365-313X.2012.05028.x; Rigal M, 2012, EMBO J, V31, P2981, DOI 10.1038/emboj.2012.141; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Saze H, 2011, CURR OPIN PLANT BIOL, V14, P81, DOI 10.1016/j.pbi.2010.08.017; Schoft VK, 2009, EMBO REP, V10, P1015, DOI 10.1038/embor.2009.152; Tao YG, 2011, P NATL ACAD SCI USA, V108, P5626, DOI 10.1073/pnas.1017000108; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Thomas JO, 1999, CURR OPIN CELL BIOL, V11, P312, DOI 10.1016/S0955-0674(99)80042-8; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Wierzbicki AT, 2012, GENE DEV, V26, P1825, DOI 10.1101/gad.197772.112; Wierzbicki AT, 2005, GENETICS, V169, P997, DOI 10.1534/genetics.104.031997; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; You WH, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-51; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	49	629	646	8	159	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					193	205		10.1016/j.cell.2013.02.033	http://dx.doi.org/10.1016/j.cell.2013.02.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540698	Green Accepted, Bronze			2022-12-24	WOS:000316853700016
J	Chhatriwalla, AK; Amin, AP; Kennedy, KF; House, JA; Cohen, DJ; Rao, SV; Messenger, JC; Marso, SP				Chhatriwalla, Adnan K.; Amin, Amit P.; Kennedy, Kevin F.; House, John A.; Cohen, David J.; Rao, Sunil V.; Messenger, John C.; Marso, Steven P.		Natl Cardiovasc Data Registry	Association Between Bleeding Events and In-hospital Mortality After Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITION; MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; ANTITHROMBOTIC THERAPY; ECONOMIC-EVALUATION; PROGNOSTIC IMPACT; PROPENSITY SCORE; ISCHEMIC EVENTS; RISK; BIVALIRUDIN	Importance Bleeding is the most common complication after percutaneous coronary intervention (PCI) and is associated with increased morbidity and health care costs. The incidence of bleeding-related mortality after PCI has not been described in a nationally representative population. Furthermore, the relationships among bleeding risk, bleeding site, and mortality are unclear. Objectives To describe the association between bleeding events and in-hospital mortality after PCI and to estimate the adjusted population attributable risk (estimated as the proportion of mortality risk associated with bleeding events), risk difference, and number needed to harm (NNH) for bleeding-related in-hospital mortality after PCI. Design, Setting, and Patients Data from 3 386 688 procedures in the CathPCI Registry performed in the United States between 2004 and 2011 were analyzed. The population attributable risk was calculated after adjustment for baseline demographic, clinical, and procedural variables. To calculate the NNH for bleeding-related mortality, a propensity-matched analysis was performed. Main Outcome Measures In-hospital mortality. Results There were 57 246 bleeding events (1.7%) and 22 165 in-hospital deaths (0.65%) in 3 386 688 PCI procedures. The adjusted population attributable risk for mortality related to major bleeding was 12.1% (95% CI, 11.4%-12.7%) in the entire CathPCI cohort. The propensity-matched population consisted of 56 078 procedures with a major bleeding event and 224 312 controls. In this matched cohort, major bleeding was associated with increased in-hospital mortality (5.26% vs 1.87%; risk difference, 3.39% [95% CI, 3.20%-3.59%]; NNH=29 [95% CI, 28-31]; P < .001). The association between major bleeding and in-hospital mortality was observed in all strata of preprocedural bleeding risk (low: 1.62% vs 0.17%; risk difference, 1.45% [95% CI, 1.13%-1.77%], NNH=69 [95% CI, 57-88], P < .001; intermediate: 3.27% vs 0.71%; risk difference, 2.56% [95% CI, 2.33%-2.79%], NNH=39 [95% CI, 36-43], P < .001; and high: 8.16% vs 3.45%; risk difference, 4.71% [95% CI, 4.35%-5.07%], NNH=21 [95% CI, 20-23], P < .001). Although both access-site and non-access-site bleeding were associated with increased in-hospital mortality (2.73% vs 1.87%; risk difference, 0.86% [95% CI, 0.66%-1.05%], NNH=117 [95% CI, 95-151], P < .001; and 8.25% vs 1.87%; risk difference, 6.39% [95% CI, 6.04%-6.73%], NNH=16 [95% CI, 15-17], P < .001, respectively), the NNH was lower for nonaccess bleeding. Conclusions and Relevance In a large registry of patients undergoing PCI, post-procedural bleeding events were associated with increased risk of in-hospital mortality, with an estimated 12.1% of deaths related to bleeding complications. JAMA. 2013;309(10):1022-1029 www.jama.com	[Kennedy, Kevin F.; House, John A.] St Lukes Mid Amer Heart Inst, Dept Biostat, Kansas City, MO 64111 USA; [Chhatriwalla, Adnan K.; Cohen, David J.; Marso, Steven P.] St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Chhatriwalla, Adnan K.; Cohen, David J.; Marso, Steven P.] Univ Missouri Kansas City, Sch Med, Dept Internal Med, Div Cardiol, Kansas City, MO USA; [Amin, Amit P.] Washington Univ, Sch Med, Dept Internal Med, Div Cardiol, St Louis, MO 63110 USA; [Rao, Sunil V.] Duke Clin Res Inst, Dept Internal Med, Div Cardiol, Durham, NC USA; [Messenger, John C.] Univ Colorado Denver, Dept Internal Med, Div Cardiol, Denver, CO USA; [Messenger, John C.] Denver VA Med Ctr, Denver, CO USA	Saint Luke's Mid America Heart Institute; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Washington University (WUSTL); Duke University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Chhatriwalla, AK (corresponding author), St Lukes Mid Amer Heart Inst, 4300 Wornall Rd,Ste 2000, Kansas City, MO 64111 USA.	achhatri-walla@saint-lukes.org			Medtronic; Edwards Lifesciences; Abbott Vascular; Boston Scientific; Eli Lilly; AstraZeneca; Biomet Inc; Daiichii Sankyo; Medicines Company; Novo Nordisk; Amylin Pharmaceuticals; Volcano Corporation; Terumo Medical; American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR)	Medtronic(Medtronic); Edwards Lifesciences; Abbott Vascular(Abbott Laboratories); Boston Scientific(Boston Scientific); Eli Lilly(Eli Lilly); AstraZeneca(AstraZeneca); Biomet Inc; Daiichii Sankyo; Medicines Company; Novo Nordisk(Novo Nordisk); Amylin Pharmaceuticals(Bristol-Myers Squibb); Volcano Corporation; Terumo Medical; American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR)(General Electric)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Chhatriwalla reports that he will be receiving speaking honoraria from Edwards Lifesciences to be paid directly to Saint Luke's Hospital Foundation of Kansas City. Mr House reports receiving consulting honoraria from Vita Solutions and KU Medical Center. Dr Cohen reports medical board membership for Medtronic and Abbott Vascular and reports receiving research support from Medtronic, Edwards Lifesciences, Abbott Vascular, Boston Scientific, Eli Lilly, AstraZeneca, Biomet Inc, and Daiichii Sankyo; consultant honoraria from AstraZeneca, Eli Lilly, Merck, and Janssen Pharmaceuticals; and speaking honoraria from St Jude Medical and Eli Lilly. Dr Rao reports receiving research support and consultant honoraria from The Medicines Company. Dr Marso reports that all compensation for research activities, including research grants and consulting fees from The Medicines Company, Novo Nordisk, Abbott Vascular, Amylin Pharmaceuticals, Boston Scientific, Volcano Corporation, and Terumo Medical, was paid directly to the Saint Luke's Hospital Foundation of Kansas City. No other disclosures were reported.; This research was supported by the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR).	[Anonymous], 2010, AHA HOSP STAT 2011 E; Aronow HD, 2001, AM HEART J, V142, P799, DOI 10.1067/mhj.2001.119371; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, MED DECIS MAKING, V29, P661, DOI 10.1177/0272989X09341755; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Austin PC, 2008, PHARMACOEPIDEM DR S, V17, P1202, DOI 10.1002/pds.1673; Bender R, 2007, STAT MED, V26, P5586, DOI 10.1002/sim.3061; Bender R, 2010, CONTEMP CLIN TRIALS, V31, P498, DOI 10.1016/j.cct.2010.07.005; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Brueck M, 2009, JACC-CARDIOVASC INTE, V2, P1047, DOI 10.1016/j.jcin.2009.07.016; Cohen DJ, 2004, J AM COLL CARDIOL, V44, P1792, DOI 10.1016/j.jacc.2004.05.085; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Lindsey JB, 2009, JACC-CARDIOVASC INTE, V2, P1074, DOI 10.1016/j.jcin.2009.09.002; Lopes RD, 2009, J AM COLL CARDIOL, V53, P1021, DOI 10.1016/j.jacc.2008.12.021; Manoukian SV, 2007, J AM COLL CARDIOL, V49, P1362, DOI 10.1016/j.jacc.2007.02.027; Marso SP, 2010, JAMA-J AM MED ASSOC, V303, P2156, DOI 10.1001/jama.2010.708; Mehran R, 2009, EUR HEART J SUPPL, V11, pC4, DOI 10.1093/eurheartj/sup011; Mehran R, 2009, EUR HEART J, V30, P1457, DOI 10.1093/eurheartj/ehp110; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Ndrepepa G, 2008, J AM COLL CARDIOL, V51, P690, DOI 10.1016/j.jacc.2007.10.040; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Pinto DS, 2008, J AM COLL CARDIOL, V52, P1758, DOI 10.1016/j.jacc.2008.08.021; Pocock SJ, 2010, CIRCULATION, V121, P43, DOI 10.1161/CIRCULATIONAHA.109.878017; Rao SV, 2005, AM J CARDIOL, V96, P1200, DOI 10.1016/j.amjcard.2005.06.056; Sanborn TA, 2010, CIRC-CARDIOVASC INTE, V3, P57, DOI 10.1161/CIRCINTERVENTIONS.109.896704; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Stone GW, 2007, JAMA-J AM MED ASSOC, V297, P591, DOI 10.1001/jama.297.6.591; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Suh JW, 2011, J AM COLL CARDIOL, V58, P1750, DOI 10.1016/j.jacc.2011.07.021; Verheugt FWA, 2011, JACC-CARDIOVASC INTE, V4, P191, DOI 10.1016/j.jcin.2010.10.011; Weintraub WS, 1997, J AM COLL CARDIOL, V29, P459	33	201	211	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					1022	1029		10.1001/jama.2013.1556	http://dx.doi.org/10.1001/jama.2013.1556			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23483177	Bronze			2022-12-24	WOS:000315938700031
J	Lindsey, HA; Gallie, J; Taylor, S; Kerr, B				Lindsey, Haley A.; Gallie, Jenna; Taylor, Susan; Kerr, Benjamin			Evolutionary rescue from extinction is contingent on a lower rate of environmental change	NATURE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; RIFAMPICIN-RESISTANCE; PREVENT EXTINCTION; NATURAL-SELECTION; SIGN EPISTASIS; CLIMATE-CHANGE; ADAPTATION; MUTATIONS; MODEL	The extinction rate of populations is predicted to rise under increasing rates of environmental change(1-3). If a population experiencing increasingly stressful conditions lacks appropriate phenotypic plasticity or access to more suitable habitats, then genetic change may be the only way to avoid extinction(1). Evolutionary rescue from extinction occurs when natural selection enriches a population for more stress-tolerant genetic variants(1,3). Some experimental studies have shown that lower rates of environmental change lead to more adapted populations or fewer extinctions(4-9). However, there has been little focus on the genetic changes that underlie evolutionary rescue. Here we demonstrate that some evolutionary trajectories are contingent on a lower rate of environmental change. We allowed hundreds of populations of Escherichia coli to evolve under variable rates of increase in concentration of the antibiotic rifampicin. We then genetically engineered all combinations of mutations from isolates evolved under lower rates of environmental change. By assessing fitness of these engineered strains across a range of drug concentrations, we show that certain genotypes are evolutionarily inaccessible under rapid environmental change. Rapidly deteriorating environments not only limit mutational opportunities by lowering population size, but they can also eliminate sets of mutations as evolutionary options. As anthropogenic activities are leading to environmental change at unprecedented rapidity(1), it is critical to understand how the rate of environmental change affects both demographic and genetic underpinnings of evolutionary rescue.	[Lindsey, Haley A.; Gallie, Jenna; Taylor, Susan; Kerr, Benjamin] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Lindsey, Haley A.; Gallie, Jenna; Taylor, Susan; Kerr, Benjamin] Univ Washington, BEACON Ctr Study Evolut Act, Seattle, WA 98195 USA; [Gallie, Jenna] Eawag, Dept Environm Microbiol, CH-8600 Dubendorf, Switzerland; [Gallie, Jenna] ETH, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Kerr, B (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	kerrb@uw.edu	Gallie, Jenna/ABH-7516-2020		National Science Foundation [DBI-0939454]; NSF CAREER [DEB0952825]; UW Royalty Research Fund [A74107]	National Science Foundation(National Science Foundation (NSF)); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); UW Royalty Research Fund	We thank T. Bradshaw, J. Martiny and J. Tewksbury for sharing ideas that inspired this work; the Church laboratory for supplying the pKOV vector; C. Adams, S. DeCew, K. Dickinson, S. Drescher, C. Eshelman, K. Hobbs, C. Muerdter, B. Rogers and C. Shyue for help in the laboratory; and F. Bertels, C. Eshelman, C. Glenney and S. Singhal for comments on the manuscript. This material is based in part on work supported by the National Science Foundation under Cooperative Agreement Number DBI-0939454, a NSF CAREER Award Grant (DEB0952825), and a UW Royalty Research Fund Award (A74107).	Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Bell G, 2011, SCIENCE, V332, P1327, DOI 10.1126/science.1203105; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Collins S, 2009, EVOLUTION, V63, P2952, DOI 10.1111/j.1558-5646.2009.00770.x; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Dallinger W. H., 1887, J R MICROSC SOC, V7, P185; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; GILLESPIE JH, 1983, THEOR POPUL BIOL, V23, P202, DOI 10.1016/0040-5809(83)90014-X; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Hall AR, 2011, EVOLUTION, V65, P2370, DOI 10.1111/j.1558-5646.2011.01302.x; HUEY RB, 1991, EVOLUTION, V45, P751, DOI 10.1111/j.1558-5646.1991.tb04343.x; Klironomos JN, 2005, NATURE, V433, P621, DOI 10.1038/nature03268; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lalic J, 2012, HEREDITY, V109, P71, DOI 10.1038/hdy.2012.15; Lalic J, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0396; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Martinez JL, 2009, ENVIRON POLLUT, V157, P2893, DOI 10.1016/j.envpol.2009.05.051; MacLean RC, 2010, GENETICS, V186, P1345, DOI 10.1534/genetics.110.123083; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Perron GG, 2008, J EVOLUTION BIOL, V21, P1724, DOI 10.1111/j.1420-9101.2008.01596.x; Remold SK, 2004, NAT GENET, V36, P423, DOI 10.1038/ng1324; Reynolds MG, 2000, GENETICS, V156, P1471; Roels SAB, 2011, EVOLUTION, V65, P2541, DOI 10.1111/j.1558-5646.2011.01326.x; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Skelly DK, 2007, CONSERV BIOL, V21, P1353, DOI 10.1111/j.1523-1739.2007.00764.x; Trindade S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000578; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165	30	166	167	3	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					463	467		10.1038/nature11879	http://dx.doi.org/10.1038/nature11879			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23395960				2022-12-24	WOS:000315661500035
J	Pengelly, AR; Copur, O; Jackle, H; Herzig, A; Muller, J				Pengelly, Ana Raquel; Copur, Oemer; Jaeckle, Herbert; Herzig, Alf; Mueller, Juerg			A Histone Mutant Reproduces the Phenotype Caused by Loss of Histone-Modifying Factor Polycomb	SCIENCE			English	Article							METHYLATION; MECHANISMS	Although many metazoan enzymes that add or remove specific modifications on histone proteins are essential transcriptional regulators, the functional significance of posttranslational modifications on histone proteins is not well understood. Here, we show in Drosophila that a point mutation in lysine 27 of histone H3 (H3-K27) fails to repress transcription of genes that are normally repressed by Polycomb repressive complex 2 (PRC2), the methyltransferase that modifies H3-K27. Moreover, differentiated H3-K27 mutant cells show homeotic transformations like those seen in PRC2 mutant cells. Taken together, these analyses demonstrate that H3-K27 is the crucial physiological substrate that PRC2 modifies for Polycomb repression.	[Pengelly, Ana Raquel; Copur, Oemer; Mueller, Juerg] Max Planck Inst Biochem, Chromatin & Chromosome Biol Res Grp, D-82152 Martinsried, Germany; [Jaeckle, Herbert; Herzig, Alf] Max Planck Inst Biophys Chem, Dept Mol Dev Biol, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Herzig, A (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Dev Biol, Fassberg 11, D-37077 Gottingen, Germany.	herzig@mpiib-berlin.mpg.de; muellerj@biochem.mpg.de	Müller, Jürg/ABB-3007-2020; ÇOPUR, Ömer Utku/AAG-8336-2021	Müller, Jürg/0000-0003-2391-4641; Pengelly, Ana Raquel/0000-0002-4822-4367; Herzig, Alf/0000-0003-4246-4666	Max Planck Society; Marie Curie Initial Training Network Nucleosome4D	Max Planck Society(Max Planck Society); Marie Curie Initial Training Network Nucleosome4D	The authors are supported by the Max Planck Society and a fellowship from the Marie Curie Initial Training Network Nucleosome4D (A.R.P.).	Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Gunesdogan U, 2010, EMBO REP, V11, P772, DOI 10.1038/embor.2010.124; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763	7	200	204	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					698	699		10.1126/science.1231382	http://dx.doi.org/10.1126/science.1231382			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393264				2022-12-24	WOS:000314585600043
J	Wahl, V; Ponnu, J; Schlereth, A; Arrivault, S; Langenecker, T; Franke, A; Feil, R; Lunn, JE; Stitt, M; Schmid, M				Wahl, Vanessa; Ponnu, Jathish; Schlereth, Armin; Arrivault, Stephanie; Langenecker, Tobias; Franke, Annika; Feil, Regina; Lunn, John E.; Stitt, Mark; Schmid, Markus			Regulation of Flowering by Trehalose-6-Phosphate Signaling in Arabidopsis thaliana	SCIENCE			English	Article							FLORAL INDUCTION; FT PROTEIN; TREHALOSE 6-PHOSPHATE; VEGETATIVE GROWTH; CONSTANS; PATHWAY; SYNTHASE-1; ACTIVATION; TRANSITION; GENES	The timing of the induction of flowering determines to a large extent the reproductive success of plants. Plants integrate diverse environmental and endogenous signals to ensure the timely transition from vegetative growth to flowering. Carbohydrates are thought to play a crucial role in the regulation of flowering, and trehalose-6-phosphate (T6P) has been suggested to function as a proxy for carbohydrate status in plants. The loss of TREHALOSE-6-PHOSPHATE SYNTHASE 1 (TPS1) causes Arabidopsis thaliana to flower extremely late, even under otherwise inductive environmental conditions. This suggests that TPS1 is required for the timely initiation of flowering. We show that the T6P pathway affects flowering both in the leaves and at the shoot meristem, and integrate TPS1 into the existing genetic framework of flowering-time control.	[Wahl, Vanessa; Schlereth, Armin; Arrivault, Stephanie; Franke, Annika; Feil, Regina; Lunn, John E.; Stitt, Mark] Max Planck Inst Mol Plant Physiol, Dept Metab Networks, D-14476 Potsdam, Germany; [Ponnu, Jathish; Langenecker, Tobias; Schmid, Markus] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Max Planck Society; Max Planck Society	Wahl, V (corresponding author), Max Planck Inst Mol Plant Physiol, Dept Metab Networks, Muhlenberg 1, D-14476 Potsdam, Germany.	vanessa.wahl@mpimp-golm.mpg.de; maschmid@tuebingen.mpg.de	Lunn, John Edward/AAE-9516-2019; Schmid, Markus/I-4384-2015; Stitt, Mark/GVT-1242-2022; Wahl, Vanessa/ABC-3341-2020; Ponnu, Jathish/ABC-4175-2020	Lunn, John Edward/0000-0001-8533-3004; Schmid, Markus/0000-0002-0068-2967; Ponnu, Jathish/0000-0002-3276-7068; Feil, Regina/0000-0002-9936-1337; Stitt, Mark/0000-0002-4900-1763; Wahl, Vanessa/0000-0001-7421-8801	Deutsche Forschungsgemeinschaft [SCHM-1560/6]; Priority Program 1530 (SPP1530) [SCHM-1560/8]; European Commission [245143]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Priority Program 1530 (SPP1530); European Commission(European CommissionEuropean Commission Joint Research Centre); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank C. Abel and J. Olas for help with plant work, and U. Krause for assistance with sample collection. The tps1-2 GVG:TPS1 mutant was obtained from the Smeekens laboratory, University of Utrecht, Netherlands. Microarray data reported in this study have been deposited with EBI ArrayExpress (E-MEXP-3727). Supported by Deutsche Forschungsgemeinschaft grant SCHM-1560/6 and Priority Program 1530 (SPP1530) grant SCHM-1560/8 (M.S.), European Commission FP7 collaborative project TiMet contract 245143 (M.St.), and the Max Planck Society. The authors declare no conflict of interest.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Corbesier L, 1998, PLANTA, V206, P131, DOI 10.1007/s004250050383; Corbesier L, 1996, PLANT J, V9, P947, DOI 10.1046/j.1365-313X.1996.9060947.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Eastmond PJ, 2002, PLANT J, V29, P225, DOI 10.1046/j.1365-313x.2002.01220.x; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gomez LD, 2010, PLANT J, V64, P1, DOI 10.1111/j.1365-313X.2010.04312.x; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Ponnu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00070; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; van Dijken AJH, 2004, PLANT PHYSIOL, V135, P969, DOI 10.1104/pp.104.039743; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007; Yang ZF, 2008, GENE, V407, P1, DOI 10.1016/j.gene.2007.02.034	29	414	440	18	388	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					704	707		10.1126/science.1230406	http://dx.doi.org/10.1126/science.1230406			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393265				2022-12-24	WOS:000314585600045
J	Tsai, IJ; Zarowiecki, M; Holroyd, N; Garciarrubio, A; Sanchez-Flores, A; Brooks, KL; Tracey, A; Bobes, RJ; Fragoso, G; Sciutto, E; Aslett, M; Beasley, H; Bennett, HM; Cai, JP; Camicia, F; Clark, R; Cucher, M; De Silva, N; Day, TA; Deplazes, P; Estrada, K; Fernandez, C; Holland, PWH; Hou, JL; Hu, SN; Huckvale, T; Hung, SS; Kamenetzky, L; Keane, JA; Kiss, F; Koziol, U; Lambert, O; Liu, K; Luo, XN; Luo, YF; Macchiaroli, N; Nichol, S; Paps, J; Parkinson, J; Pouchkina-Stantcheva, N; Riddiford, N; Rosenzvit, M; Salinas, G; Wasmuth, JD; Zamanian, M; Zheng, YD; Cai, XP; Soberon, X; Olson, PD; Laclette, JP; Brehm, K; Berriman, M				Tsai, Isheng J.; Zarowiecki, Magdalena; Holroyd, Nancy; Garciarrubio, Alejandro; Sanchez-Flores, Alejandro; Brooks, Karen L.; Tracey, Alan; Bobes, Raul J.; Fragoso, Gladis; Sciutto, Edda; Aslett, Martin; Beasley, Helen; Bennett, Hayley M.; Cai, Jianping; Camicia, Federico; Clark, Richard; Cucher, Marcela; De Silva, Nishadi; Day, Tim A.; Deplazes, Peter; Estrada, Karel; Fernandez, Cecilia; Holland, Peter W. H.; Hou, Junling; Hu, Songnian; Huckvale, Thomas; Hung, Stacy S.; Kamenetzky, Laura; Keane, Jacqueline A.; Kiss, Ferenc; Koziol, Uriel; Lambert, Olivia; Liu, Kan; Luo, Xuenong; Luo, Yingfeng; Macchiaroli, Natalia; Nichol, Sarah; Paps, Jordi; Parkinson, John; Pouchkina-Stantcheva, Natasha; Riddiford, Nick; Rosenzvit, Mara; Salinas, Gustavo; Wasmuth, James D.; Zamanian, Mostafa; Zheng, Yadong; Cai, Xuepeng; Soberon, Xavier; Olson, Peter D.; Laclette, Juan P.; Brehm, Klaus; Berriman, Matthew		Taenia Solium Genome Consortium	The genomes of four tapeworm species reveal adaptations to parasitism	NATURE			English	Article							ECHINOCOCCUS-MULTILOCULARIS; TAENIA-SOLIUM; GRANULOSUS; IDENTIFICATION; CULTIVATION; INFECTIONS; BIOLOGY; TARGET; HOX	Tapeworms (Cestoda) cause neglected diseases that can be fatal and are difficult to treat, owing to inefficient drugs. Here we present an analysis of tapeworm genome sequences using the human-infective species Echinococcus multilocularis, E. granulosus, Taenia solium and the laboratory model Hymenolepis microstoma as examples. The 115- to 141-megabase genomes offer insights into the evolution of parasitism. Synteny is maintained with distantly related blood flukes but we find extreme losses of genes and pathways that are ubiquitous in other animals, including 34 homeobox families and several determinants of stem cell fate. Tapeworms have specialized detoxification pathways, metabolism that is finely tuned to rely on nutrients scavenged from their hosts, and species-specific expansions of non-canonical heat shock proteins and families of known antigens. We identify new potential drug targets, including some on which existing pharmaceuticals may act. The genomes provide a rich resource to underpin the development of urgently needed treatments and control.	[Tsai, Isheng J.; Zarowiecki, Magdalena; Holroyd, Nancy; Sanchez-Flores, Alejandro; Brooks, Karen L.; Tracey, Alan; Aslett, Martin; Beasley, Helen; Bennett, Hayley M.; Clark, Richard; De Silva, Nishadi; Huckvale, Thomas; Keane, Jacqueline A.; Lambert, Olivia; Berriman, Matthew] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Tsai, Isheng J.] Miyazaki Univ, Div Parasitol, Dept Infect Dis, Fac Med, Miyazaki 8891692, Japan; [Garciarrubio, Alejandro; Sanchez-Flores, Alejandro] Univ Nacl Autonoma Mexico, Inst Biotechnol, Cuernavaca 62210, Morelos, Mexico; [Bobes, Raul J.; Fragoso, Gladis] Univ Nacl Autonoma Mexico, Inst Biomed Res, Mexico City 04510, DF, Mexico; [Cai, Jianping] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou Vet Res Inst, Lanzhou 730046, Gansu, Peoples R China; [Cucher, Marcela] Univ Buenos Aires, Inst Microbiol & Parasitol Med, Fac Med, Consejo Nacl Invest Cient Tecnol IMPAM, Buenos Aires, DF, Argentina; [Day, Tim A.] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA; [Deplazes, Peter] Univ Zurich, Inst Parasitol, Vet Fac, CH-8057 Zurich, Switzerland; [Fernandez, Cecilia] Univ Republica, Fac Quam, Montevideo 11600, Uruguay; [Holland, Peter W. H.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Hu, Songnian] Chinese Acad Sci, Beijing Inst Genom, Beijing 100029, Peoples R China; [Parkinson, John] Univ Toronto, Dept Biochem & Mol & Med Genet, Program Mol Struct & Funct, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Parkinson, John] Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany; [Riddiford, Nick] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Riddiford, Nick] Natl Univ Ireland Galway, Dept Zool, Sch Nat Sci, Galway, Ireland; [Zamanian, Mostafa] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Soberon, Xavier] Inst Nacl Medicina Genom, Mexico City 14610, DF, Mexico	Wellcome Trust Sanger Institute; University of Miyazaki; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; University of Buenos Aires; Iowa State University; University of Zurich; Universidad de la Republica, Uruguay; University of Oxford; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Wurzburg; Natural History Museum London; Ollscoil na Gaillimhe-University of Galway; McGill University; Instituto Nacional de Medicina Genomica	Berriman, M (corresponding author), Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	laclette@biomedicas.unam.mx; kbrehm@hygiene.uni-wuerzburg.de; mb4@sanger.ac.uk	Tsai, Isheng Jason/ABB-8273-2021; Zarowiecki, Magdalena/ABD-2858-2021; Ochoa-Leyva, Adrián/E-5540-2013; Tsai, Isheng J/H-6606-2014; Parkinson, John/A-4424-2008; González, Víctor/AAF-7035-2020; Olson, Peter/D-4643-2009; Zamanian, Mostafa/B-7993-2013; YD, Zh/HGA-5541-2022; Paps, Jordi/B-2098-2012; Berriman, Matthew/A-7618-2011; Zarowiecki, Magdalena/F-5037-2013; Sanchez-Flores, Alejandro/L-9454-2016; Hu, Songnian/C-6509-2013	Tsai, Isheng Jason/0000-0002-2123-5058; Ochoa-Leyva, Adrián/0000-0002-4701-2303; Parkinson, John/0000-0001-9815-1189; González, Víctor/0000-0003-4082-0022; Olson, Peter/0000-0002-4183-4533; YD, Zh/0000-0001-6795-9978; Paps, Jordi/0000-0003-2636-6636; Berriman, Matthew/0000-0002-9581-0377; Zarowiecki, Magdalena/0000-0001-6102-7731; Camicia, Federico/0000-0003-1406-0357; Sanchez-Flores, Alejandro/0000-0003-0476-3139; De Silva, Nishadi/0000-0003-4802-2375; Salinas, Gustavo/0000-0003-3350-3002; Sciutto, Edda/0000-0001-5608-5355; Keane, Jacqueline A./0000-0003-0739-6848; Riddiford, Nick/0000-0002-4739-4233; Holland, Peter/0000-0003-1533-9376; Bennett, Hayley/0000-0001-8879-2855; ying feng, luo/0000-0003-1950-9045; Hu, Songnian/0000-0003-3966-3111; Huckvale, Thomas/0000-0001-7066-2577; Day, Tim/0000-0002-9037-6540; Carrero, Julio/0000-0003-1055-5774; Koziol, Uriel/0000-0002-9699-4964; Liu, Kan/0000-0001-5625-8180; Zamanian, Mostafa/0000-0001-9233-1760; Morett, Enrique/0000-0001-5723-0032; Portillo Bobadilla, Tobias/0000-0002-3448-7959; Cucher, Marcela Alejandra/0000-0003-1357-9210; Wasmuth, James/0000-0002-9516-212X	BBSRC [BBG0038151]; SynTax joint UK Research Council; European Research Council; Canadian Institute for Health Research (CIHR MOP) [84556]; FIRCA-NIH [TW008588]; Universidad de la Republica, CSIC [CSIC 625]; Wellcome Trust through Wellcome Trust Sanger Institute [098051]; Deutsche Forschungsgemeinschaft (DFG) [BR2045/4-1]; Universidad Nacional Autonoma de Mexico; BBSRC [BB/G003815/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003815/1] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [R03TW008588] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SynTax joint UK Research Council; European Research Council(European Research Council (ERC)European Commission); Canadian Institute for Health Research (CIHR MOP)(Canadian Institutes of Health Research (CIHR)); FIRCA-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Universidad de la Republica, CSIC; Wellcome Trust through Wellcome Trust Sanger Institute; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	We thank M. Dunn and OpGen for the E. multilocularis optical map; Roche for 20kb 454 libraries; R. Rance, M. Quail, D. Willey, N. Smerdon and K. Oliver for sequencing libraries at WTSI; T. D. Otto for bioinformatics expertise; R. Davies and Q. Lin for help with data release; A. Bateman, M. Punta, P. Cogghill and J. Minstry of Pfam; N. Rowlings from MEROPS database, J. Gough at SUPERFAMILY and C. Dessimoz for OMA; C. Seed and F. Jarero for laboratory assistance; J. Overington and B. Al-Lazikani; and B. Brejova for predicting genes with ExonHunter. P.D.O. and N. P. S. were supported in part by a BBSRC grant (BBG0038151) to P.D.O. P.D.O. and Ma.Z. were supported by a SynTax joint UK Research Council grant. The European Research Council supported P.W.H.H. and J. Paps. J. Parkinson and S. S. H. were supported by an operating grant from the Canadian Institute for Health Research (CIHR MOP#84556). G. S. was supported by FIRCA-NIH (grant TW008588) and the Universidad de la Republica, CSIC (grant CSIC 625). The E. multilocularis, E. granulosus and H. microstoma genome projects were funded by the Wellcome Trust through their core support of the Wellcome Trust Sanger Institute (grant 098051). K. B. was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG; BR2045/4-1). The Taenia solium Genome Project (IMPULSA 03) was supported by the Universidad Nacional Autonoma de Mexico. The Taenia solium Genome Consortium thanks P. de la Torre, J. Yanez, P. Gaytan, S. Juarez and J. L. Fernandez for technical support; L. Herrera-Estrella and LANGEBIO, CINVESTAV-Irapuato and C. B. Shoemaker for sequencing support and other advice; and J. Watanabe (deceased), S. Sugano and Y. Suzuki for the construction and sequencing of the full-length cDNA library.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Allen MA, 2011, GENOME RES, V21, P255, DOI 10.1101/gr.113811.110; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Brehm K, 2010, PARASITOLOGY, V137, P537, DOI 10.1017/S0031182009991727; Brooke NM, 1998, NATURE, V392, P920, DOI 10.1038/31933; Brunetti E, 2012, INFECT DIS CLIN N AM, V26, P421, DOI 10.1016/j.idc.2012.02.001; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Budke CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000319; Burton JB., 2012, HUMAN PARASITOLOGY, V4; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; DeMarco R, 2010, GENOME RES, V20, P1112, DOI 10.1101/gr.100099.109; Diaz A, 2011, TRENDS PARASITOL, V27, P204, DOI 10.1016/j.pt.2010.12.012; Doudican N, 2008, MOL CANCER RES, V6, P1308, DOI 10.1158/1541-7786.MCR-07-2159; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; FRAYHA GJ, 1971, COMP BIOCHEM PHYSIOL, V39, P167, DOI 10.1016/0305-0491(71)90264-1; Garcia HH, 2007, CURR OPIN INFECT DIS, V20, P489, DOI 10.1097/QCO.0b013e3282a95e39; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Grove D.I., 1990, HIST HUMAN HELMINTHO, P848; Hancock K, 2004, MOL BIOCHEM PARASIT, V133, P115, DOI 10.1016/j.molbiopara.2003.10.001; Heath DD, 2003, ACTA TROP, V85, P133, DOI 10.1016/S0001-706X(02)00219-X; Hemphill A, 2010, PARASITOLOGY, V137, P569, DOI 10.1017/S003118200999117X; Holland PWH, 2001, J ANAT, V199, P13; Kaasch AJ, 2000, J BIOL CHEM, V275, P1112, DOI 10.1074/jbc.275.2.1112; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Marks NJ, 2010, ADV EXP MED BIOL, V692, P49; Matsumoto J, 2008, ANTIMICROB AGENTS CH, V52, P164, DOI 10.1128/AAC.00378-07; Matsumoto J, 2010, GENOME RES, V20, P636, DOI 10.1101/gr.100271.109; McVeigh P, 2012, INT J PARASITOL-DRUG, V2, P76, DOI 10.1016/j.ijpddr.2011.10.004; Obal G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001642; Pakharukova MY, 2012, MOL BIOCHEM PARASIT, V181, P190, DOI 10.1016/j.molbiopara.2011.11.005; Parkinson J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001897; Protasio AV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001455; Qian WF, 2008, GENOME RES, V18, P412, DOI 10.1101/gr.7112608; Raz E, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Repasky EA, 2011, ONCOTARGET, V2, P433; Riddiford N, 2011, DEV GENES EVOL, V221, P187, DOI 10.1007/s00427-011-0370-8; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Spakulova M, 2011, ADV PARASIT, V74, P177, DOI 10.1016/B978-0-12-385897-9.00003-3; Spiliotis M, 2010, MOL BIOCHEM PARASIT, V174, P83, DOI 10.1016/j.molbiopara.2010.07.001; Spiliotis Markus, 2009, V470, P245, DOI 10.1007/978-1-59745-204-5_17; Torgerson PR, 2011, VET PARASITOL, V182, P79, DOI 10.1016/j.vetpar.2011.07.017; Van Nassauw Luc, 2008, Travel Med Infect Dis, V6, P253, DOI 10.1016/j.tmaid.2008.06.006; Vargas-Parada L, 2001, PARASITOLOGY, V122, P583, DOI 10.1017/S0031182001007764; World Health Organization, 2012, NEGL TROP DIS; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang Y, 2011, COORDIN CHEM REV, V255, P1206, DOI 10.1016/j.ccr.2011.02.016; Zhong YF, 2011, EVOL DEV, V13, P567, DOI 10.1111/j.1525-142X.2011.00513.x	47	478	513	8	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					57	63		10.1038/nature12031	http://dx.doi.org/10.1038/nature12031			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23485966	hybrid, Green Accepted, Green Published			2022-12-24	WOS:000316993400024
J	Cabreiro, F; Au, C; Leung, KY; Vergara-Irigaray, N; Cocheme, HM; Noori, T; Weinkove, D; Schuster, E; Greene, NDE; Gems, D				Cabreiro, Filipe; Au, Catherine; Leung, Kit-Yi; Vergara-Irigaray, Nuria; Cocheme, Helena M.; Noori, Tahereh; Weinkove, David; Schuster, Eugene; Greene, Nicholas D. E.; Gems, David			Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism	CELL			English	Article							LIFE-SPAN EXTENSION; CAENORHABDITIS-ELEGANS; DIETARY RESTRICTION; GUT MICROBIOTA; DIABETES-MELLITUS; ESCHERICHIA-COLI; HOST; GENETICS; MODEL; HOMEOSTASIS	The biguanide drug metformin is widely prescribed to treat type 2 diabetes and metabolic syndrome, but its mode of action remains uncertain. Metformin also increases lifespan in Caenorhabditis elegans co-cultured with Escherichia coli. This bacterium exerts complex nutritional and pathogenic effects on its nematode predator/host that impact health and aging. We report that metformin increases lifespan by altering microbial folate and methionine metabolism. Alterations in metformin-induced longevity by mutation of worm methionine synthase (metr-1) and S-adenosylmethionine synthase (sams-1) imply metformin-induced methionine restriction in the host, consistent with action of this drug as a dietary restriction mimetic. Metformin increases or decreases worm lifespan, depending on E. coli strain metformin sensitivity and glucose concentration. In mammals, the intestinal microbiome influences host metabolism, including development of metabolic disease. Thus, metformin-induced alteration of microbial metabolism could contribute to therapeutic efficacy-and also to its side effects, which include folate deficiency and gastrointestinal upset.	[Cabreiro, Filipe; Au, Catherine; Vergara-Irigaray, Nuria; Cocheme, Helena M.; Noori, Tahereh; Schuster, Eugene; Gems, David] UCL, Inst Hlth Ageing, London WC1E 6BT, England; [Cabreiro, Filipe; Au, Catherine; Vergara-Irigaray, Nuria; Cocheme, Helena M.; Noori, Tahereh; Schuster, Eugene; Gems, David] UCL, GEE, London WC1E 6BT, England; [Leung, Kit-Yi; Greene, Nicholas D. E.] UCL, Neural Dev Unit, Inst Child Hlth, London WC1N 1EH, England; [Weinkove, David] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England	University of London; University College London; University of London; University College London; University of London; University College London; Durham University	Gems, D (corresponding author), UCL, Inst Hlth Ageing, Mortimer St, London WC1E 6BT, England.	david.gems@ucl.ac.uk		Weinkove, David/0000-0001-7399-1202; Schuster, Eugene/0000-0001-5076-2810; Au, Catherine/0000-0002-1923-9121; Cocheme, Helena/0000-0001-8637-0042; Greene, Nicholas D.E./0000-0002-4170-5248; Gems, David/0000-0002-6653-4676; Cabreiro, Filipe/0000-0002-3696-4843	Wellcome Trust (Strategic Award); European Union (LifeSpan); MRC [J003794]; Biotechnology and Biological Sciences Research Council [BB/H01974X/1] Funding Source: researchfish; Medical Research Council [MR/J003794/1, G0800339] Funding Source: researchfish; BBSRC [BB/H01974X/1] Funding Source: UKRI; MRC [G0800339, MR/J003794/1] Funding Source: UKRI	Wellcome Trust (Strategic Award)(Wellcome Trust); European Union (LifeSpan); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Dan Ackerman, Joy Alcedo, Nazif Alic, Caroline Araiz, Alex Benedetto, Steve Clarke, Goncalo Correia, Monica Driscoll, Michael Murphy, Brian Onken, Matthew Piper, Bhupinder Virk, and Matthias Ziehm for useful discussion and other help. Strains were provided by the CGC and CGSC (DBI-0742708). We acknowledge funding from the Wellcome Trust (Strategic Award), the European Union (LifeSpan) and the MRC (J003794).	Anisimov VN, 2011, AGING-US, V3, P148, DOI 10.18632/aging.100273; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bailey CJ, 2008, DIABETOLOGIA, V51, P1552, DOI 10.1007/s00125-008-1053-5; BANERJEE RV, 1990, FASEB J, V4, P1450, DOI 10.1096/fasebj.4.5.2407589; BRENNER S, 1974, GENETICS, V77, P71; Bytzer P, 2001, ALIMENT PHARM THER, V15, P137, DOI 10.1046/j.1365-2036.2001.00896.x; Cani PD, 2007, CURR OPIN CLIN NUTR, V10, P729, DOI 10.1097/MCO.0b013e3282efdebb; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Delzenne NM, 2011, CURR DIABETES REP, V11, P154, DOI 10.1007/s11892-011-0191-1; Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 2000, GENETICS, V154, P1597; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Hannich JT, 2009, DEV CELL, V16, P833, DOI 10.1016/j.devcel.2009.04.012; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Ikeda T, 2007, APPL ENVIRON MICROB, V73, P6404, DOI 10.1128/AEM.00704-07; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Kwon YK, 2008, NAT CHEM BIOL, V4, P602, DOI 10.1038/nchembio.108; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Lenaerts I, 2008, J GERONTOL A-BIOL, V63, P242, DOI 10.1093/gerona/63.3.242; Maier W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000376; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Martinez-Chantar ML, 2006, GASTROENTEROLOGY, V131, P223, DOI 10.1053/j.gastro.2006.04.019; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; McGee MD, 2011, AGING CELL, V10, P699, DOI 10.1111/j.1474-9726.2011.00713.x; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nijhout HF, 2004, J BIOL CHEM, V279, P55008, DOI 10.1074/jbc.M410818200; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; ORENTREICH N, 1993, J NUTR, V123, P269; Ottaviani E, 2011, BIOGERONTOLOGY, V12, P599, DOI 10.1007/s10522-011-9352-5; Pierotti MA, 2012, ONCOGENE; Proctor WR, 2008, DRUG METAB DISPOS, V36, P1650, DOI 10.1124/dmd.107.020180; Pyra KA, 2012, J NUTR, V142, P213, DOI 10.3945/jn.111.147132; Sahin M, 2007, J DIABETES COMPLICAT, V21, P118, DOI 10.1016/j.jdiacomp.2005.10.005; Saiki R, 2008, AGING CELL, V7, P291, DOI 10.1111/j.1474-9726.2008.00378.x; Scarpello JHB, 2008, DIABETES VASC DIS RE, V5, P157, DOI 10.3132/dvdr.2008.027; Slack C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047699; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Venn BJ, 2007, EUR J CLIN NUTR, V61, pS122, DOI 10.1038/sj.ejcn.1602942; Virk B, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-67; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Wu DQ, 2009, AGING CELL, V8, P666, DOI 10.1111/j.1474-9726.2009.00523.x; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	52	576	595	22	262	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 28	2013	153	1					228	239		10.1016/j.cell.2013.02.035	http://dx.doi.org/10.1016/j.cell.2013.02.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540700	Green Accepted, Green Published, hybrid			2022-12-24	WOS:000316853700019
J	McLauchlan, KK; Williams, JJ; Craine, JM; Jeffers, ES				McLauchlan, Kendra K.; Williams, Joseph J.; Craine, Joseph M.; Jeffers, Elizabeth S.			Changes in global nitrogen cycling during the Holocene epoch	NATURE			English	Article							RECENT ENVIRONMENTAL-CHANGES; REGIONAL PALEOLIMNOLOGICAL ASSESSMENT; SEDIMENTARY GEOCHEMICAL RECORD; LACUSTRINE ORGANIC-MATTER; MOUNTAIN NATIONAL-PARK; LAKE-SEDIMENTS; STABLE-ISOTOPES; CLIMATE-CHANGE; ALPINE LAKES; EAST-AFRICA	Human activities have doubled the pre-industrial supply of reactive nitrogen on Earth, and future rates of increase are expected to accelerate(1). Yet little is known about the capacity of the biosphere to buffer increased nitrogen influx. Past changes in global ecosystems following deglaciation at the end of the Pleistocene epoch provide an opportunity to understand better how nitrogen cycling in the terrestrial biosphere responded to changes in carbon cycling. We analysed published records of stable nitrogen isotopic values (delta N-15) in sediments from 86 lakes on six continents. Here we show that the value of sedimentary delta N-15 declined from 15,000 years before present to 7,056 +/- 597 years before present, a period of increasing atmospheric carbon dioxide concentrations and terrestrial carbon accumulation(2). Comparison of the nitrogen isotope record with concomitant carbon accumulation on land and nitrous oxide in the atmosphere suggests millennia of declining nitrogen availability in terrestrial ecosystems during the Pleistocene-Holocene transition around 11,000 years before present. In contrast, we do not observe a consistent change in global sedimentary delta N-15 values during the past 500 years, despite the potential effects of changing temperature and nitrogen influx from anthropogenic sources. We propose that the lack of a single response may indicate that modern increases in atmospheric carbon dioxide and net carbon sequestration in the biosphere have the potential to offset recent increased supplies of reactive nitrogen in some ecosystems.	[McLauchlan, Kendra K.; Williams, Joseph J.] Kansas State Univ, Dept Geog, Manhattan, KS 66506 USA; [Craine, Joseph M.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Jeffers, Elizabeth S.] Univ Oxford, Biodivers Inst, Dept Zool, Oxford OX1 3PS, England	Kansas State University; Kansas State University; University of Oxford	McLauchlan, KK (corresponding author), Kansas State Univ, Dept Geog, Manhattan, KS 66506 USA.	mclauch@ksu.edu	Craine, Joseph/D-4569-2009; Jeffers, Elizabeth S./D-4021-2013	Craine, Joseph/0000-0001-6561-3244; Jeffers, Elizabeth S./0000-0001-9679-5909; Williams, Joseph/0000-0003-4521-4902; McLauchlan, Kendra/0000-0002-6612-1097	National Science Foundation [BCS-0955225, EPS-0903806]; James Martin Fellowship at the University of Oxford	National Science Foundation(National Science Foundation (NSF)); James Martin Fellowship at the University of Oxford	This work was supported by the National Science Foundation (BCS-0955225 and EPS-0903806) and a James Martin Fellowship at the University of Oxford. We thank the many authors who contributed their data for the purpose of this analysis. We appreciate technical assistance from C. Morris, P. Long and S. McConaghy. We thank J. Marlon, S. Enders, C. Baird and S. Perakis for comments.	Abbott MB, 2000, QUATERNARY SCI REV, V19, P1801, DOI 10.1016/S0277-3791(00)00078-0; Alin SR, 2002, GEOLOGY, V30, P1143, DOI 10.1130/0091-7613(2002)030<1143:EOLUCO>2.0.CO;2; Anderson L, 2001, QUATERNARY RES, V55, P313, DOI 10.1006/qres.2001.2219; Bai E., 2009, GLOBAL BIOGEOCHEM CY, V23; Bernal S, 2012, P NATL ACAD SCI USA, V109, P3406, DOI 10.1073/pnas.1121448109; Bertrand S, 2010, PALAEOGEOGR PALAEOCL, V294, P56, DOI 10.1016/j.palaeo.2009.03.012; Blaauw M, 2010, QUAT GEOCHRONOL, V5, P512, DOI 10.1016/j.quageo.2010.01.002; Brahney J, 2008, QUATERNARY RES, V70, P213, DOI 10.1016/j.yqres.2008.05.001; Brenner M, 1999, J PALEOLIMNOL, V22, P205, DOI 10.1023/A:1008078222806; Brodie CR, 2011, QUATERNARY SCI REV, V30, P3076, DOI 10.1016/j.quascirev.2011.07.003; Bunting L, 2010, LIMNOL OCEANOGR, V55, P333, DOI 10.4319/lo.2010.55.1.0333; Canty A.J., 2002, R NEWS, V2, P2, DOI DOI 10.1159/000323281; Choudhary P, 2009, SCI TOTAL ENVIRON, V407, P2783, DOI 10.1016/j.scitotenv.2008.12.020; Choudhary P, 2009, J PALEOLIMNOL, V42, P571, DOI 10.1007/s10933-009-9306-y; Chu GQ, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012077; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Davidson E.A., 2012, EXCESS NITROGEN US E, V15; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Drew S, 2008, HYDROBIOLOGIA, V608, P35, DOI 10.1007/s10750-008-9383-3; Enders SK, 2008, LIMNOL OCEANOGR, V53, P1468, DOI 10.4319/lo.2008.53.4.1468; Engstrom DR, 2006, ECOL APPL, V16, P1194, DOI 10.1890/1051-0761(2006)016[1194:AROTCE]2.0.CO;2; Engstrom DR, 2000, NATURE, V408, P161, DOI 10.1038/35041500; Enters D, 2010, J PALEOLIMNOL, V43, P719, DOI 10.1007/s10933-009-9362-3; Fagel N, 2010, J QUATERNARY SCI, V25, P1100, DOI 10.1002/jqs.1364; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Filippi ML, 2005, QUATERNARY SCI REV, V24, P1303, DOI 10.1016/j.quascirev.2004.10.009; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Hassan KM, 1997, J PALEOLIMNOL, V18, P121, DOI 10.1023/A:1007993329040; Hastings M. G., 2005, GLOBAL BIOGEOCHEM CY, V19; Heikkila M, 2010, QUATERNARY SCI REV, V29, P2146, DOI 10.1016/j.quascirev.2010.05.010; Herczeg AL, 2001, APPL GEOCHEM, V16, P73, DOI 10.1016/S0883-2927(00)00016-0; Hietz P, 2011, SCIENCE, V334, P664, DOI 10.1126/science.1211979; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobbs WO, 2011, CAN J FISH AQUAT SCI, V68, P1480, DOI [10.1139/f2011-058, 10.1139/F2011-058]; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Holmgren SU, 2010, J PALEOLIMNOL, V43, P393, DOI 10.1007/s10933-009-9338-3; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; Houlton BZ, 2008, NATURE, V454, P327, DOI 10.1038/nature07028; Houlton BZ, 2009, P NATL ACAD SCI USA, V106, P21713, DOI 10.1073/pnas.0912111106; Hu FS, 2001, ECOSYSTEMS, V4, P358, DOI 10.1007/s10021-001-0017-0; Hyodo F, 2008, SCI TOTAL ENVIRON, V403, P139, DOI 10.1016/j.scitotenv.2008.05.010; Janbu AD, 2011, J PALEOLIMNOL, V46, P29, DOI 10.1007/s10933-011-9512-2; Jeffers ES, 2012, NEW PHYTOL, V193, P150, DOI 10.1111/j.1469-8137.2011.03907.x; Jeffers ES, 2011, J ECOL, V99, P1063, DOI 10.1111/j.1365-2745.2011.01816.x; Jeffers ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016134; Pueyo JJ, 2011, PALAEOGEOGR PALAEOCL, V307, P339, DOI 10.1016/j.palaeo.2011.05.036; Keeling CD, 2011, TELLUS B, V63, P1, DOI 10.1111/j.1600-0889.2010.00507.x; Laird K, 2001, CAN J FISH AQUAT SCI, V58, P479, DOI 10.1139/cjfas-58-3-479; Laird K, 2001, CAN J FISH AQUAT SCI, V58, P492, DOI 10.1139/cjfas-58-3-492; Lascu I, 2012, PALAEOGEOGR PALAEOCL, V337, P99, DOI 10.1016/j.palaeo.2012.04.001; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; LEAVITT PR, 1994, CAN J FISH AQUAT SCI, V51, P2411, DOI 10.1139/f94-241; Li L, 2008, GEOCHIM COSMOCHIM AC, V72, P4338, DOI 10.1016/j.gca.2008.06.026; Lobo I, 2001, J PALEOLIMNOL, V26, P119, DOI 10.1023/A:1011145227967; Lucke A, 2004, PALAEOGEOGR PALAEOCL, V211, P139, DOI 10.1016/S0031-0182(04)00259-7; Mayr C, 2009, J PALEOLIMNOL, V42, P81, DOI 10.1007/s10933-008-9249-8; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; McLauchlan KK, 2007, P NATL ACAD SCI USA, V104, P7466, DOI 10.1073/pnas.0701779104; McLauchlan KK, 2010, NEW PHYTOL, V187, P1135, DOI 10.1111/j.1469-8137.2010.03322.x; Muggeo V, 2008, R NEWS, V8, P20, DOI DOI 10.1159/000323281; Muzuka ANN, 2004, J AFR EARTH SCI, V40, P293, DOI 10.1016/j.jafrearsci.2004.12.005; Nadelhoffer KJ, 1994, STABLE ISOTOPES ECOL; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Olsen J, 2010, J PALEOLIMNOL, V43, P323, DOI 10.1007/s10933-009-9334-7; Parplies J, 2008, J PALEOLIMNOL, V40, P471, DOI 10.1007/s10933-007-9176-0; Perakis SS, 2011, OECOLOGIA, V167, P793, DOI 10.1007/s00442-011-2016-y; Perakis SS, 2011, ECOLOGY, V92, P1481, DOI 10.1890/10-1642.1; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Prentice IC, 2011, NEW PHYTOL, V189, P988, DOI 10.1111/j.1469-8137.2010.03620.x; PUEYO JJ, 2010, AN ACAD BRAS CIENC, V82, P717; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Reuss NS, 2010, ECOSYSTEMS, V13, P393, DOI 10.1007/s10021-010-9326-5; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Routh J, 2004, LIMNOL OCEANOGR, V49, P1560, DOI 10.4319/lo.2004.49.5.1560; Routh J, 2007, J PALEOLIMNOL, V37, P529, DOI 10.1007/s10933-006-9032-7; Routh J, 2009, J PALEOLIMNOL, V42, P325, DOI 10.1007/s10933-008-9279-2; Russell JM, 2009, QUATERNARY RES, V72, P315, DOI 10.1016/j.yqres.2009.06.008; Ryner M, 2007, PALAEOGEOGR PALAEOCL, V248, P440, DOI 10.1016/j.palaeo.2006.12.014; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Saros JE, 2005, CAN J FISH AQUAT SCI, V62, P1681, DOI 10.1139/F05-077; Schilt A, 2010, QUATERNARY SCI REV, V29, P182, DOI 10.1016/j.quascirev.2009.03.011; Schindler DE, 2006, CAN J FISH AQUAT SCI, V63, P1439, DOI 10.1139/F06-069; Schindler DE, 2005, ECOLOGY, V86, P3225, DOI 10.1890/04-1730; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Selbie DT, 2007, T AM FISH SOC, V136, P800, DOI 10.1577/T06-100.1; Selbie DT, 2011, CAN J FISH AQUAT SCI, V68, P675, DOI [10.1139/F11-006, 10.1139/f2011-006]; Street-Perrott FA, 2008, J QUATERNARY SCI, V23, P375, DOI 10.1002/jqs.1187; Talbot MR, 2006, J PALEOLIMNOL, V35, P467, DOI 10.1007/s10933-005-2828-z; Talbot MR, 2002, DEV PALEOENVIRON RES, V2, P401; TALBOT MR, 1992, EARTH PLANET SC LETT, V110, P23, DOI 10.1016/0012-821X(92)90036-U; Talbot MR, 2000, J PALEOLIMNOL, V23, P141, DOI 10.1023/A:1008029400463; Tareq SM, 2011, QUATERN INT, V229, P47, DOI 10.1016/j.quaint.2010.04.014; TEAM RDC, 2005, R LANGUAGE ENV STAT; Tenzer GE, 1999, ORG GEOCHEM, V30, P133, DOI 10.1016/S0146-6380(98)00209-5; Teranes JL, 2000, LIMNOL OCEANOGR, V45, P801, DOI 10.4319/lo.2000.45.4.0801; Vreca P, 2006, LIMNOL OCEANOGR, V51, P781, DOI 10.4319/lo.2006.51.1_part_2.0781; Wolfe AP, 2006, ARCT ANTARCT ALP RES, V38, P465, DOI 10.1657/1523-0430(2006)38[465:ACROAN]2.0.CO;2; Wolfe AP, 2003, GEOBIOLOGY, V1, P153, DOI 10.1046/j.1472-4669.2003.00012.x; Wolfe BB, 2003, HOLOCENE, V13, P153, DOI 10.1191/0959683603hl605ft; Wolfe BB, 1999, HOLOCENE, V9, P215, DOI 10.1191/095968399669823431; Woodward CA, 2012, J PALEOLIMNOL, V47, P167, DOI 10.1007/s10933-011-9568-z; Wooller M, 2008, J PALEOLIMNOL, V40, P63, DOI 10.1007/s10933-007-9144-8; Xu YP, 2009, APPL GEOCHEM, V24, P411, DOI 10.1016/j.apgeochem.2008.12.002; Xu-Ri, 2008, GLOBAL CHANGE BIOL, V14, P1745, DOI 10.1111/j.1365-2486.2008.01625.x	105	89	93	14	380	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					352	355		10.1038/nature11916	http://dx.doi.org/10.1038/nature11916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23518563				2022-12-24	WOS:000316650500039
J	Buczacki, SJA; Zecchini, HI; Nicholson, AM; Russell, R; Vermeulen, L; Kemp, R; Winton, DJ				Buczacki, Simon J. A.; Zecchini, Heather Ireland; Nicholson, Anna M.; Russell, Roslin; Vermeulen, Louis; Kemp, Richard; Winton, Douglas J.			Intestinal label-retaining cells are secretory precursors expressing Lgr5	NATURE			English	Article							STEM-CELLS; MARKER; SEGREGATION; HOMEOSTASIS; POLYPOSIS; QUIESCENT; RENEWAL; LRIG1; GENE; DNA	The rapid cell turnover of the intestinal epithelium is achieved from small numbers of stem cells located in the base of glandular crypts. These stem cells have been variously described as rapidly cycling or. quiescent. A functional arrangement of stem cells that reconciles both of these behaviours has so far been difficult to obtain. Alternative explanations for quiescent cells have been that they act as a parallel or reserve population that replace rapidly cycling stem cells periodically or after injury; their exact nature remains unknown. Here we show mouse intestinal quiescent cells to be precursors that are committed to mature into differentiated secretory cells of the Paneth and enteroendocrine lineage. However, crucially we find that after intestinal injury they are capable of extensive proliferation and can give rise to clones comprising the main epithelial cell types. Thus, quiescent cells can be recalled to the-stem-cell state. These findings establish quiescent cells as an effective clonogenic reserve and provide a motivation for investigating their role in pathologies such as colorectal cancers and intestinal inflammation.	[Winton, Douglas J.] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Buczacki, Simon J. A.; Zecchini, Heather Ireland; Nicholson, Anna M.; Russell, Roslin; Vermeulen, Louis; Kemp, Richard; Winton, Douglas J.] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; Cancer Research UK; CRUK Cambridge Institute	Winton, DJ (corresponding author), Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	doug.winton@cruk.cam.ac.uk	Parry, Lee/A-9623-2011; Vermeulen, Louis/B-7488-2008	Parry, Lee/0000-0002-4467-9196; Vermeulen, Louis/0000-0002-6066-789X; Buczacki, Simon/0000-0002-2975-416X; Kemp, Richard/0000-0002-0121-7709	Cancer Research UK; KWF fellowship; Cancer Research UK [22310, 17044] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); KWF fellowship; Cancer Research UK(Cancer Research UK)	This research was supported by Cancer Research UK (S.J.A.B., H.I.Z., A.M.N., R.R., R.K. and D.J.W.). L.V. was supported by a KWF fellowship. We thank D. Tan for providing the single-cell RNA amplification protocol. We also thank M. de la Roche, R. von Furstenberg and S. Henning for advice with the in vitro culture work. We acknowledge the following core facilities at CRUK/CRI: The Transgenic Laboratory, Biological Resource Unit, Flow Cytometry, Histopathology, Microscopy, Genomics and Bioinformatics and the CRUK Paterson Institute Microarray Facility. We thank R. J. Davies, A. Klein and A. Ibrahim for manuscript discussions.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Lewis A, 2010, GUT, V59, P1680, DOI 10.1136/gut.2009.193680; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038965; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464	25	525	542	5	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2013	495	7439					65	69		10.1038/nature11965	http://dx.doi.org/10.1038/nature11965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23446353				2022-12-24	WOS:000316039800040
J	Kwok, R				Kwok, Roberta			Once more, with feeling	NATURE			English	News Item							NEURAL-CONTROL; INTERFACE; AMPUTEES; ARM							Waldrop, M Mitchell/0000-0002-8063-1472				Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Dhillon GS, 2004, J HAND SURG-AM, V29A, P605, DOI 10.1016/j.jhsa.2004.02.006; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Horch K, 2011, IEEE T NEUR SYS REH, V19, P483, DOI 10.1109/TNSRE.2011.2162635; Kuiken TA, 2007, P NATL ACAD SCI USA, V104, P20061, DOI 10.1073/pnas.0706525104; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Tyler DJ, 2002, IEEE T NEUR SYS REH, V10, P294, DOI 10.1109/TNSRE.2002.806840	8	37	38	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					176	178		10.1038/497176a	http://dx.doi.org/10.1038/497176a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23393652	Bronze			2022-12-24	WOS:000318558200010
